PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Albert, R; Vereb, Z; Csomos, K; Moe, MC; Johnsen, EO; Olstad, OK; Nicolaissen, B; Rajnavolgyi, E; Fesus, L; Berta, A; Petrovski, G				Albert, Reka; Vereb, Zoltan; Csomos, Krisztian; Moe, Morten C.; Johnsen, Erik O.; Olstad, Ole Kristoffer; Nicolaissen, Bjorn; Rajnavoelgyi, Eva; Fesues, Laszlo; Berta, Andras; Petrovski, Goran			Cultivation and Characterization of Cornea Limbal Epithelial Stem Cells on Lens Capsule in Animal Material-Free Medium	PLOS ONE			English	Article							OCULAR SURFACE RECONSTRUCTION; INTACT AMNIOTIC MEMBRANE; EX-VIVO; CULTURED LIMBAL; EXPRESSION; DIFFERENTIATION; TRANSPLANTATION; DEFICIENCY; LOCATION; IDENTIFICATION	A simple, reproducible, animal-material free method for cultivating and characterizing cornea limbal epithelial stem cells (LESCs) on human lens capsule (LC) was developed for future clinical transplantation. The limbal tissue explants (26260.25 mm) were harvested from 77 cadavers and expanded ex vivo on either cell culture plates or LC in medium containing human serum as the only growth supplement. Cell outgrowth at the edge of the explants was observed within 24 hours of cultivation and achieved viable outgrowth (>97% viability as measured by MTT assay and flow cytometry) within two weeks. The outgrowing cells were examined by genome-wide microarray including markers of stemness (p63 alpha, ABCG2, CK19, Vimentin and Integrin alpha 9), proliferation (Ki-67), limbal epithelial cells (CK 8/18 and 14) and differentiated cornea epithelial cells (CK 3 and 12). Immunostaining revealed the non-hematopoietic, -endothelial and -mesenchymal stem cell phenotype of the LESCs and the localization of specific markers in situ. Cell adhesion molecules, integrins and lectin-based surface carbohydrate profiling showed a specific pattern on these cells, while colony-formation assay confirmed their clonal potency. The LESCs expressed a specific surface marker fingerprint (CD117/c-kit, CXCR4, CD144/VE-Cadherin, CD146/MCAM, CD166/ALCAM, and surface carbohydrates: WGA, ConA, RCA, PNA and AIL) which can be used for better localization of the limbal stem cell niche. In summary, we report a novel method combining the use of a medium with human serum as the only growth supplement with LC for cultivating, characterizing and expanding cornea LESCs from cadavers or alternatively from autologous donors for possible treatment of LESC deficiency.	[Albert, Reka; Berta, Andras; Petrovski, Goran] Univ Debrecen, Dept Ophthalmol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Albert, Reka; Csomos, Krisztian; Fesues, Laszlo; Petrovski, Goran] Univ Debrecen, Stem Cells & Eye Res Lab, Dept Biochem & Mol Biol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Vereb, Zoltan; Rajnavoelgyi, Eva] Univ Debrecen, Dept Immunol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Moe, Morten C.; Johnsen, Erik O.; Nicolaissen, Bjorn] Oslo Univ Hosp, Ctr Eye Res, Dept Ophthalmol, Oslo, Norway; [Moe, Morten C.; Johnsen, Erik O.; Olstad, Ole Kristoffer; Nicolaissen, Bjorn] Univ Oslo, Oslo, Norway; [Olstad, Ole Kristoffer] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway	University of Debrecen; University of Debrecen; University of Debrecen; University of Oslo; University of Oslo; University of Oslo	Petrovski, G (corresponding author), Univ Debrecen, Dept Ophthalmol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary.	gokip@med.unideb.hu	Vereb, Zoltan/I-6356-2019; Rajnavölgyi, Éva/D-4384-2013; Vereb, Zoltan/AAR-4092-2020	Vereb, Zoltan/0000-0002-9518-2155; /0000-0002-0035-1471; Petrovski, Goran/0000-0003-2905-9252	TAMOP [TAMOP-4.2.2-08/1/2008-0015]; Research Council of Norway; Blindemissionen IL; Norwegian Association of the Blind and Partially Sighted; Faculty of Medicine University of Oslo; Oslo University Hospital (Norway)	TAMOP; Research Council of Norway(Research Council of Norway); Blindemissionen IL; Norwegian Association of the Blind and Partially Sighted; Faculty of Medicine University of Oslo; Oslo University Hospital (Norway)	Partial financial support was obtained from the TAMOP-4.2.2-08/1/2008-0015 grant (Hungary), as well as the Research Council of Norway, the Blindemissionen IL, the Norwegian Association of the Blind and Partially Sighted, the Faculty of Medicine University of Oslo and Oslo University Hospital (Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpitha P, 2005, INVEST OPHTH VIS SCI, V46, P3631, DOI 10.1167/iovs.05-0343; Barnard Z, 2001, CLIN EXP OPHTHALMOL, V29, P138, DOI 10.1046/j.1442-9071.2001.00394.x; Baylis O, 2011, J CELL BIOCHEM, V112, P993, DOI 10.1002/jcb.23028; CHEN JJY, 1991, INVEST OPHTH VIS SCI, V32, P2219; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dodla MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023266; Donisi PM, 2003, CORNEA, V22, P533, DOI 10.1097/00003226-200308000-00009; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Galal A, 2007, CORNEA, V26, P473, DOI 10.1097/ICO.0b013e318033bd0f; Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a; Grueterich M, 2002, ARCH OPHTHALMOL-CHIC, V120, P783; KINOSHITA S, 1981, INVEST OPHTH VIS SCI, V21, P434; Ko JA, 2010, BIOCHEM BIOPH RES CO, V403, P305, DOI 10.1016/j.bbrc.2010.11.022; Kolli S, 2008, REGEN MED, V3, P329, DOI 10.2217/17460751.3.3.329; KRUSE FE, 1993, INVEST OPHTH VIS SCI, V34, P2976; Kulkarni BB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-526; KURPAKUS MA, 1994, CURR EYE RES, V13, P805, DOI 10.3109/02713689409025135; Lai JC, 1998, INVEST OPHTH VIS SCI, V39, P2049; LAVKER RM, 1991, INVEST OPHTH VIS SCI, V32, P1864; Lekhanont K, 2009, MOL VIS, V15, P1294; Liu XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016712; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Merjava S, 2011, INVEST OPHTH VIS SCI, V52, P787, DOI 10.1167/iovs.10-5489; Merjava S, 2009, EXP EYE RES, V89, P426, DOI 10.1016/j.exer.2009.04.009; Mort RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-4; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; NISHIDA T, 1983, J CELL BIOL, V97, P1653, DOI 10.1083/jcb.97.5.1653; Notara M, 2010, EXP EYE RES, V90, P188, DOI 10.1016/j.exer.2009.09.023; O'Sullivan F, 2007, CYTOTECHNOLOGY, V53, P101, DOI 10.1007/s10616-007-9063-6; Pajoohesh-Ganji A, 2005, BIOL CELL, V97, P265, DOI 10.1042/BC20040114; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Plummer CE, 2009, VET OPHTHALMOL, V12, P17, DOI 10.1111/j.1463-5224.2009.00741.x; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Sacchetti M, 2005, GRAEF ARCH CLIN EXP, V243, P870, DOI 10.1007/s00417-005-1159-0; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Shandadfar A, 2012, EXP EYE RES, V97, P1, DOI 10.1016/j.exer.2012.01.013; Sharma S, 2011, CORNEA, V30, P1223, DOI 10.1097/ICO.0b013e3181dc81f1; Shortt AJ, 2007, SURV OPHTHALMOL, V52, P483, DOI 10.1016/j.survophthal.2007.06.013; STEPP MA, 1993, INVEST OPHTH VIS SCI, V34, P1829; STEPP MA, 1995, J HISTOCHEM CYTOCHEM, V43, P353, DOI 10.1177/43.4.7534781; Sun TT, 2010, NATURE, V463, pE10, DOI 10.1038/nature08805; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Turner HC, 2007, INVEST OPHTH VIS SCI, V48, P2050, DOI 10.1167/iovs.06-0998; Varga N, 2011, BIOCHEM BIOPH RES CO, V414, P474, DOI 10.1016/j.bbrc.2011.09.089; Wearne KA, 2008, GLYCOCONJUGATE J, V25, P121, DOI 10.1007/s10719-007-9064-x; WOLOSIN JM, 1995, INVEST OPHTH VIS SCI, V36, P2277; Xie HT, 2012, INVEST OPHTH VIS SCI, V53, P279, DOI 10.1167/iovs.11-8441; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	54	38	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47187	10.1371/journal.pone.0047187	http://dx.doi.org/10.1371/journal.pone.0047187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056608	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400063
J	Pisarchik, AN; Pochepen, ON; Pisarchyk, LA				Pisarchik, Alexander N.; Pochepen, Olga N.; Pisarchyk, Liudmila A.			Increasing Blood Glucose Variability Is a Precursor of Sepsis and Mortality in Burned Patients	PLOS ONE			English	Article							INTENSIVE INSULIN THERAPY; SMALL-SIGNAL AMPLIFICATION; GLYCEMIC VARIABILITY; CRITICAL ILLNESS; HYPOGLYCEMIA; RISK; BIFURCATIONS; METABOLISM; NOISE; ICU	High glycemic variability, rather than a mean glucose level, is an important factor associated with sepsis and hospital mortality in critically ill patients. In this retrospective study we analyze the blood glucose data of 172 nondiabetic patients 18-60 yrs old with second and third-degree burns of total body surface area greater than 30% and 5%, respectively, admitted to ICU in 2004-2008. The analysis identified significant association of increasing daily glucose excursion (DELTA) accompanied by evident episodes of hyperglycemia (>11 mmol/l) and hypoglycemia (>2.8 mmol/l), with sepsis and forthcoming death, even when the mean daily glucose was within a range of acceptable glycemia. No association was found in sepsis complication and hospital mortality with doses of intravenous insulin and glucose infusion. A strong increase in DELTA before sepsis and death is treated as fluctuation amplification near the onset of dynamical instability.	[Pisarchik, Alexander N.] Ctr Invest Opt, Guanajuato, Mexico; [Pochepen, Olga N.] Belarus Med Acad Postgrad Educ, Minsk, BELARUS; [Pisarchyk, Liudmila A.] Univ Guanajuato, Dept Med Sci, Leon, Mexico	CIO - Centro de Investigaciones en Optica A.C.; Universidad de Guanajuato	Pisarchik, AN (corresponding author), Ctr Invest Opt, Guanajuato, Mexico.	apisarch@cio.mx	Pisarchik, Alexander N./K-9704-2019; Pisarchik, Alexander N./E-7545-2011	Pisarchik, Alexander N./0000-0003-2471-2507; Pisarchik, Alexander N./0000-0003-2471-2507	CONACYT (Mexico) [100429]	CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work is supported by CONACYT (Mexico) through project No. 100429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dorzi HM, 2010, ANAESTH INTENS CARE, V38, P695, DOI 10.1177/0310057X1003800413; Ali NA, 2008, CRIT CARE MED, V36, P2316, DOI 10.1097/CCM.0b013e3181810378; Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; Bezrukov SM, 1994, ADV CHEM SERIES, V235; Branco Ricardo G, 2005, Pediatr Crit Care Med, V6, P470, DOI 10.1097/01.PCC.0000161284.96739.3A; Branco RG, 2007, J PEDIAT-BRAZIL, V83, pS128, DOI [10.1590/S0021-75572007000700003, 10.2223/JPED.1710]; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Challet D, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/04/L04004; Chen D, 2004, NATURE, V428, P733, DOI 10.1038/nature02439; CORBALAN R, 1995, PHYS REV A, V51, P663, DOI 10.1103/PhysRevA.51.663; Cryer PE, 2006, J CLIN INVEST, V116, P1470, DOI 10.1172/JCI28735; DeFelice L. J., 1981, INTRO MEMBRANE NOISE; Dossett LA, 2008, AM SURGEON, V74, P679; Eftaxias K, 2003, NAT HAZARD EARTH SYS, V3, P217, DOI 10.5194/nhess-3-217-2003; Egi M, 2006, AM J RESP CRIT CARE, V173, P407, DOI 10.1164/rccm.200506-961OC; Egi M, 2010, ANN M AM SOC AN OCT; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Greenman JV, 2003, AM NAT, V161, P225, DOI 10.1086/345784; Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9; Horsthemke W., 1984, SPRINGER SERIES SYNE, V15; Huerta-Cuellar G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036204; Jeschke MG, 2010, ANN SURG, V252, P521, DOI 10.1097/SLA.0b013e3181f2774c; Kovatchev BP, 2006, DIABETES CARE, V29, P2433, DOI 10.2337/dc06-1085; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Ligtenberg JJM, 2006, INTENS CARE MED, V32, P435, DOI 10.1007/s00134-005-0052-y; Lind L, 1994, Clin Intensive Care, V5, P100; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; Mathijis V, 2004, CRIT CARE, V8, pR122; McCall Anthony L, 2009, J Diabetes Sci Technol, V3, P3; Mechanick JI, 2007, CURR OPIN CLIN NUTR, V10, P193, DOI 10.1097/MCO.0b013e32802b7016; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Mirani M, 2010, DIABETES TECHNOL THE, V12, P749, DOI 10.1089/dia.2010.0052; Mizock BA, 2001, BEST PRACT RES CL EN, V15, P533, DOI 10.1053/beem.2001.0168; Monnier L, 2008, DIABETES CARE, V31, pS150, DOI 10.2337/dc08-s241; Monnier Louis, 2008, J Diabetes Sci Technol, V2, P1094; Pickup JC, 2006, DIABETES-METAB RES, V22, P232, DOI 10.1002/dmrr.614; Pidcoke HF, 2009, J TRAUMA, V67, P990, DOI 10.1097/TA.0b013e3181baef4b; Pochepen O, 2010, 15 M INT SOC BURN IN, P199; Pochepen ON, 2010, J ANESTHESIOLOGY INT, V7, P17; Rake AJ, 2010, PEDIATR CRIT CARE ME, V11, P707, DOI 10.1097/PCC.0b013e3181e88b1f; Rausch JR, 2010, CURR DIABETES REP, V10, P415, DOI 10.1007/s11892-010-0152-0; Santos RL, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041104; Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021; Surovyatkina E, 2005, NONLINEAR PROC GEOPH, V12, P25, DOI 10.5194/npg-12-25-2005; Surovyatkina ED, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046125; Takao T, 2010, DIABETES RES CLIN PR, V89, P296, DOI 10.1016/j.diabres.2010.03.027; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanhorebeek I, 2007, CHEST, V132, P268, DOI 10.1378/chest.06-3121; Waeschle RM, 2008, CRIT CARE, V12, DOI 10.1186/cc7097; WIESENFELD K, 1986, PHYS REV A, V33, P629, DOI 10.1103/PhysRevA.33.629; WIESENFELD K, 1985, J STAT PHYS, V38, P1071, DOI 10.1007/BF01010430; WOLFE RR, 1979, METABOLISM, V28, P210, DOI 10.1016/0026-0495(79)90066-0; Xu K, 2008, P SOC PHOTO-OPT INS, V6826; Yamamoto N, 2010, DIABETES TECHNOL THE, V12, P775, DOI 10.1089/dia.2010.0059; Zhao XP, 2007, NONLINEAR DYNAM, V48, P381, DOI 10.1007/s11071-006-9092-2	59	27	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46582	10.1371/journal.pone.0046582	http://dx.doi.org/10.1371/journal.pone.0046582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056354	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400019
J	Aguilera, S; De la Torre-Zavala, S; Hernandez-Flores, JL; Murillo, J; Bravo, J; Alvarez-Morales, A				Aguilera, Selene; De la Torre-Zavala, Susana; Luis Hernandez-Flores, Jose; Murillo, Jesus; Bravo, Jaime; Alvarez-Morales, Ariel			Expression of the Gene for Resistance to Phaseolotoxin (argK) Depends on the Activity of Genes phtABC in Pseudomonas syringae pv. phaseolicola	PLOS ONE			English	Article							2 ORNITHINE CARBAMOYLTRANSFERASES; HALO BLIGHT; BETA-GLUCURONIDASE; TOXIN PRODUCTION; BIOSYNTHESIS; PROTEIN; CLUSTER; REGULATOR; THERMOREGULATION; TEMPERATURE	The bacterium Pseudomonas syringae pv. phaseolicola produces phaseolotoxin in a temperature dependent manner, being optimally produced between 18 degrees C and 20 degrees C, while no detectable amounts are present above 28 degrees C. Phaseolotoxin is an effective inhibitor of ornithine carbamoyltransferase (OCTase) activity from plant, mammalian and bacterial sources and causes a phenotypic requirement for arginine. To protect the cell from its own toxin, P. syringae pv. phaseolicola synthesizes a phaseolotoxin-resistant OCTase (ROCT). The ROCT is the product of the argK gene and is synthesized only under conditions leading to phaseolotoxin synthesis. The argK gene is included in a chromosomal fragment named Pht cluster, which contains genes involved in the synthesis of phaseolotoxin. The aim of the present work was to investigate the possible involvement of other genes included in the Pht cluster in the regulation of gene argK. We conducted transcriptional analyses of argK in several mutants unable to produce phaseolotoxin, transcriptional fusions and electrophoretic mobility shift assays, which allowed us to determine that genes phtABC, located within the Pht cluster, participate in the transcriptional repression of gene argK at temperatures not permissive for phaseolotoxin biosynthesis. This repression is mediated by a protein present in both toxigenic and nontoxigenic strains of P. syringae and in E. coli, and requires the coordinated participation of phtA, phtB and phtC products in order to carry out an efficient argK repression.	[Aguilera, Selene; De la Torre-Zavala, Susana; Luis Hernandez-Flores, Jose; Bravo, Jaime; Alvarez-Morales, Ariel] CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Guanajuato, Mexico; [De la Torre-Zavala, Susana] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Inst Biotecnol, Nuevo Leon, Mexico; [Murillo, Jesus] Univ Publ Navarra, Dept Agr Prod, Pamplona, Spain	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Autonoma de Nuevo Leon; Universidad Publica de Navarra	Aguilera, S (corresponding author), CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Guanajuato, Mexico.	aalvarez@ira.cinvestav.mx	Murillo, Jesus/D-2901-2009	Murillo, Jesus/0000-0001-6585-2421; Hernandez-Flores, Jose Luis/0000-0001-6331-526X; DE LA TORRE-ZAVALA, SUSANA/0000-0002-7109-0467	CONACYT (Consejo Nacional de Ciencia y Tecnologia) [SEP-2006-C01-49958/24089]; Spanish Plan Nacional I+D+I grant [AGL2008-55311-CO2-01]; FEDER	CONACYT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Spanish Plan Nacional I+D+I grant; FEDER(European Commission)	This work was funded by grants from CONACYT (Consejo Nacional de Ciencia y Tecnologia; http://www.conacyt.mx), research grant SEP-2006-C01-49958/24089 to AAM and SA (Postdoctoral scholarship), and from the Spanish Plan Nacional I+D+I grant AGL2008-55311-CO2-01 (Ministerio de Ciencia e Innovacion; http://micinn.es/), co financed by FEDER, to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera S, 2007, J BACTERIOL, V189, P2834, DOI 10.1128/JB.01845-06; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bachmann AS, 1998, PHYSIOL MOL PLANT P, V53, P287, DOI 10.1006/pmpp.1998.0183; BENDER CL, 1993, GENE, V133, P31, DOI 10.1016/0378-1119(93)90221-N; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; De la Torre-Zavala S, 2011, RES MICROBIOL, V162, P488, DOI 10.1016/j.resmic.2011.04.010; FERGUSON AR, 1980, FEMS MICROBIOL LETT, V7, P123, DOI 10.1111/j.1574-6941.1980.tb01590.x; Genka H, 2006, J MOL EVOL, V63, P401, DOI 10.1007/s00239-005-0271-4; Goss RW, 1940, PHYTOPATHOLOGY, V30, P258; Han HS, 2003, ACTA HORTIC, P403; HATZILOUKAS E, 1992, J BACTERIOL, V174, P5895, DOI 10.1128/jb.174.18.5895-5909.1992; Hernandez-Flores JL, 2004, J BACTERIOL, V186, P3653, DOI 10.1128/JB.186.11.3653-3655.2004; Hernandez-Guzman G, 2001, MOL PLANT MICROBE IN, V14, P545, DOI 10.1094/MPMI.2001.14.4.545; HRABAK EM, 1992, J BACTERIOL, V174, P3011, DOI 10.1128/JB.174.9.3011-3020.1992; JAHN O, 1987, ARCH MICROBIOL, V147, P174, DOI 10.1007/BF00415280; JAHN O, 1985, J BASIC MICROB, V25, P543, DOI 10.1002/jobm.3620250821; JEFFERSON RA, 1987, EMBO J, V6, P3901; KING EO, 1954, J LAB CLIN MED, V44, P301; Kitten T, 1998, MOL MICROBIOL, V28, P917, DOI 10.1046/j.1365-2958.1998.00842.x; Arvizu-Gomez JL, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-90; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Lopez-Lopez K, 2004, J BACTERIOL, V186, P146, DOI 10.1128/JB.186.1.146-153.2004; METCALF WW, 1993, GENE, V129, P17, DOI 10.1016/0378-1119(93)90691-U; MITCHELL RE, 1981, PHYSIOL PLANT PATHOL, V19, P227; MITCHELL RE, 1976, PHYTOCHEMISTRY, V15, P1941, DOI 10.1016/S0031-9422(00)88851-2; MITCHELL RE, 1978, PHYSIOL PLANT PATHOL, V13, P37, DOI 10.1016/0048-4059(78)90073-5; MOSQUEDA G, 1990, MOL GEN GENET, V222, P461, DOI 10.1007/BF00633857; Murillo J, 2011, RES MICROBIOL, V162, P253, DOI 10.1016/j.resmic.2010.10.011; NUSKE J, 1989, J BASIC MICROB, V29, P441, DOI 10.1002/jobm.3620290713; Park SM, 1997, J BACTERIOL, V179, P5309, DOI 10.1128/jb.179.17.5309-5317.1997; PEET RC, 1986, J BACTERIOL, V166, P1096, DOI 10.1128/jb.166.3.1096-1105.1986; PEET RC, 1987, EMBO J, V6, P3585, DOI 10.1002/j.1460-2075.1987.tb02689.x; Rico A, 2003, PHYTOPATHOLOGY, V93, P1553, DOI 10.1094/PHYTO.2003.93.12.1553; ROWLEY KB, 1993, MOL MICROBIOL, V8, P625, DOI 10.1111/j.1365-2958.1993.tb01606.x; Rowley KB, 2000, MOL PLANT MICROBE IN, V13, P1071, DOI 10.1094/MPMI.2000.13.10.1071; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sawada H, 1999, J MOL EVOL, V49, P627, DOI 10.1007/PL00006584; STASKAWICZ BJ, 1980, J BACTERIOL, V142, P474, DOI 10.1128/JB.142.2.474-479.1980; STASKAWICZ BJ, 1979, PHYTOPATHOLOGY, V69, P663, DOI 10.1094/Phyto-69-663; Tamura K, 2002, PHYSIOL MOL PLANT P, V60, P207, DOI 10.1006/pmpp.2002.0405; TOURTE C, 1995, EUR J PLANT PATHOL, V101, P483, DOI 10.1007/BF01874471; ULLRICH M, 1995, J BACTERIOL, V177, P6160, DOI 10.1128/jb.177.21.6160-6169.1995; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; ZHANG YX, 1993, J BACTERIOL, V175, P6451, DOI 10.1128/jb.175.20.6451-6458.1993	49	6	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46815	10.1371/journal.pone.0046815	http://dx.doi.org/10.1371/journal.pone.0046815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056465	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000309831500082
J	Foucher, AE; Reiser, JB; Ebel, C; Housset, D; Jault, JM				Foucher, Anne-Emmanuelle; Reiser, Jean-Baptiste; Ebel, Christine; Housset, Dominique; Jault, Jean-Michel			Potassium Acts as a GTPase-Activating Element on Each Nucleotide-Binding Domain of the Essential Bacillus subtilis EngA	PLOS ONE			English	Article							THERMAL SHIFT ASSAYS; P-LOOP GTPASES; RIBOSOMAL-SUBUNIT; ESCHERICHIA-COLI; CELLULAR FUNCTION; STRUCTURAL BASIS; ATPASE ACTIVITY; ALPHA-SUBUNIT; PROTEIN OBG; SWITCH	EngA proteins form a unique family of bacterial GTPases with two GTP-binding domains in tandem, namely GD1 and GD2, followed by a KH (K-homology) domain. They have been shown to interact with the bacterial ribosome and to be involved in its biogenesis. Most prokaryotic EngA possess a high GTPase activity in contrast to eukaryotic GTPases that act mainly as molecular switches. Here, we have purified and characterized the GTPase activity of the Bacillus subtilis EngA and two shortened EngA variants that only contain GD1 or GD2-KH. Interestingly, the GTPase activity of GD1 alone is similar to that of the whole EngA, whereas GD2-KH has a 150-fold lower GTPase activity. At physiological concentration, potassium strongly stimulates the GTPase activity of each protein construct. Interestingly, it affects neither the affinities for nucleotides nor the monomeric status of EngA or the GD1 domain. Thus, potassium likely acts as a chemical GTPase-activating element as proposed for another bacterial GTPase like MnmE. However, unlike MnmE, potassium does not promote dimerization of EngA. In addition, we solved two crystal structures of full-length EngA. One of them contained for the first time a GTP-like analogue bound to GD2 while GD1 was free. Surprisingly, its overall fold was similar to a previously solved structure with GDP bound to both sites. Our data indicate that a significant structural change must occur upon K+ binding to GD2, and a comparison with T. maritima EngA and MnmE structures allowed us to propose a model explaining the chemical basis for the different GTPase activities of GD1 and GD2.	[Foucher, Anne-Emmanuelle; Reiser, Jean-Baptiste; Ebel, Christine; Housset, Dominique; Jault, Jean-Michel] Univ Grenoble 1, Inst Biol Struct, Grenoble, France; [Foucher, Anne-Emmanuelle; Reiser, Jean-Baptiste; Ebel, Christine; Housset, Dominique; Jault, Jean-Michel] CNRS, UMR 5075, Grenoble, France; [Foucher, Anne-Emmanuelle; Reiser, Jean-Baptiste; Ebel, Christine; Housset, Dominique; Jault, Jean-Michel] CEA, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA	Foucher, AE (corresponding author), Univ Grenoble 1, Inst Biol Struct, Grenoble, France.	jean-michel.jault@ibs.fr	Reiser, Jean-Baptiste/W-7683-2019; jault, jean-michel/G-2086-2012	Reiser, Jean-Baptiste/0000-0001-6926-9137; jault, jean-michel/0000-0003-1743-2777; Ebel, Christine/0000-0002-6912-500X; HOUSSET, Dominique/0000-0003-1732-0193	Agence Nationale de la Recherche [ANR-08-Blan-0143]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the 'Agence Nationale de la Recherche', grant No: ANR-08-Blan-0143 to J.-M.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achila D, 2012, J BIOL CHEM, V287, P8417, DOI 10.1074/jbc.M111.331322; Agarwal N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034571; Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Ash MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023355; Ash MR, 2010, J BIOL CHEM, V285, P14594, DOI 10.1074/jbc.M110.111914; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bharat A, 2006, J BACTERIOL, V188, P7992, DOI 10.1128/JB.00959-06; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Brown ED, 2005, BIOCHEM CELL BIOL, V83, P738, DOI 10.1139/O05-162; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; Cooper EL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-266; Dam J, 2004, METHOD ENZYMOL, V384, P185; de Mattos MJT, 1997, J BIOTECHNOL, V59, P117; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; DIVITA G, 1993, J BIOL CHEM, V268, P13178; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galinier A, 2002, J BIOL CHEM, V277, P11362, DOI 10.1074/jbc.M109527200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Guilfoyle A, 2009, EMBO J, V28, P2677, DOI 10.1038/emboj.2009.208; Hwang J, 2001, J BIOL CHEM, V276, P31415, DOI 10.1074/jbc.M104455200; Hwang J, 2006, MOL MICROBIOL, V61, P1660, DOI 10.1111/j.1365-2958.2006.05348.x; HWANG YW, 1987, J BIOL CHEM, V262, P13081; Inoue K, 2003, MOL MICROBIOL, V48, P1005, DOI 10.1046/j.1365-2958.2003.03475.x; JAULT JM, 1991, J BIOL CHEM, V266, P8073; Jault JM, 2000, J BIOL CHEM, V275, P1773, DOI 10.1074/jbc.275.3.1773; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karbstein K, 2007, BIOPOLYMERS, V87, P1, DOI 10.1002/bip.20762; Karst JC, 2009, MICROBIOL-SGM, V155, P944, DOI 10.1099/mic.0.021543-0; Koster S, 2009, J MOL BIOL, V392, P405, DOI 10.1016/j.jmb.2009.07.020; Lamb HK, 2007, PROTEIN SCI, V16, P2391, DOI 10.1110/ps.072900907; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee R, 2011, PROTEIN EXPRES PURIF, V78, P102, DOI 10.1016/j.pep.2011.02.009; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Mehr IJ, 2000, GENETICS, V154, P523; MEURY J, 1981, EUR J BIOCHEM, V119, P165, DOI 10.1111/j.1432-1033.1981.tb05589.x; Mishra R, 2005, PROTEINS, V59, P332, DOI 10.1002/prot.20413; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Muench SP, 2006, P NATL ACAD SCI USA, V103, P12359, DOI 10.1073/pnas.0602585103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Robinson VL, 2002, STRUCTURE, V10, P1649, DOI 10.1016/S0969-2126(02)00905-X; Rodriguez-Navarro A, 2000, BBA-REV BIOMEMBRANES, V1469, P1, DOI 10.1016/S0304-4157(99)00013-1; Sato A, 2005, GENES CELLS, V10, P393, DOI 10.1111/j.1365-2443.2005.00851.x; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott JM, 2000, J BACTERIOL, V182, P2771, DOI 10.1128/JB.182.10.2771-2777.2000; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; Tomar SK, 2009, NUCLEIC ACIDS RES, V37, P2359, DOI 10.1093/nar/gkp107; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wicker-Planquart C, 2008, J BACTERIOL, V190, P681, DOI 10.1128/JB.01193-07; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Yamanaka K, 2000, J BACTERIOL, V182, P7078, DOI 10.1128/JB.182.24.7078-7082.2000; ZHONG JM, 1995, J BIOL CHEM, V270, P10002, DOI 10.1074/jbc.270.17.10002	73	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46795	10.1371/journal.pone.0046795	http://dx.doi.org/10.1371/journal.pone.0046795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056455	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500079
J	Liu, ZJ; Jin, YH; Wang, MH				Liu, Zhenjiang; Jin, Yahui; Wang, Minghua			Determination of Diniconazole in Agricultural Samples by Sol-Gel Immunoaffinity Extraction Procedure Coupled with HPLC and ELISA	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; CHROMATOGRAPHY-MASS-SPECTROMETRY; LIQUID-LIQUID MICROEXTRACTION; TRIAZOLE PESTICIDES; AQUEOUS SAMPLES; HUMAN URINE; OPTIMIZATION; PURIFICATION; METABOLITES; FUNGICIDES	Background: In the European Union (EU), the use of diniconazole-M is no longer authorized. However, residues of diniconazole-M occur in various plant commodities. Methodology/Principal Findings: A selective and simple analytical method for the trace level determination of diniconazole in soil, fruit, vegetables and water samples was developed based on immunoaffinity extraction followed by Enzyme-linked immunosorbent assay (ELISA) and the high-performance liquid chromatography (HPLC) analysis. The ELISA was based on monoclonal antibodies highly specific to diniconazole and was a fast, cost-effective, and selective screening method for the detection of diniconazole. The results of the ELISA correlated well with gas chromatography (GC) results, with the correlation coefficient of 0.9879 (n = 19). A simple gel permeation chromato- graphy clean-up method was developed to purify extracts from matrices containing high amounts of fat and natural pigments, without the need for a large dilution of the sample. The immunoaffinity column (IAC) capacity was 0.180 mg g(-1). The columns could be re-used approximately 20 times with no significant alteration in capacity. The recoveries from complex samples were in the range of 89.2% to 96.1% with a relative standard deviation (RSD) of 0.770%-6.11% by ELISA. The results were in good agreement with those obtained by HPLC method. Conclusion/Significance: The IAC extraction procedure coupled with HPLC and ELISA analysis could be also used as alternative effective analytical methods for the determination of diniconazole concentrations in complex samples.	[Liu, Zhenjiang; Jin, Yahui; Wang, Minghua] Nanjing Agr Univ, Jiangsu Key Lab Pesticide Sci, Key Lab Integrated Management Crop Dis & Pests, Dept Pesticide Sci,Coll Plant Protect,Minist Educ, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, MH (corresponding author), Nanjing Agr Univ, Jiangsu Key Lab Pesticide Sci, Key Lab Integrated Management Crop Dis & Pests, Dept Pesticide Sci,Coll Plant Protect,Minist Educ, Nanjing, Jiangsu, Peoples R China.	wangmha@njau.edu.cn			Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National "863" High-Tech Research Program of China [2011AA100806]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National "863" High-Tech Research Program of China	This work was supported by the project of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the National "863" High-Tech Research Program of China (No. 2011AA100806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordagaray A, 2011, FOOD ANAL METHOD, V4, P293, DOI 10.1007/s12161-010-9168-y; European Food Safety Authority, 2012, EFSA Journal, V10, P2590; Fang X, 2002, PESTIC, V43, P22; Farajzadeh MA, 2011, CHROMATOGRAPHIA, V73, P393, DOI 10.1007/s10337-010-1895-0; Feng XQ, 1997, PESTIC, V36, P26; Hennion MC, 1998, J CHROMATOGR A, V823, P147, DOI 10.1016/S0021-9673(98)00479-8; Huo X, 2011, CHROMATOGRAPHIA, V73, P313, DOI 10.1007/s10337-010-1875-4; Jiang XX, 2011, FOOD CHEM, V125, P1385, DOI 10.1016/j.foodchem.2010.10.010; Kaware M, 2006, J AGR FOOD CHEM, V54, P6482, DOI 10.1021/jf0607415; KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151; Montes R, 2009, J CHROMATOGR A, V1216, P5459, DOI 10.1016/j.chroma.2009.05.048; NOWINSKI RC, 1979, VIROLOGY, V93, P111, DOI 10.1016/0042-6822(79)90280-0; Nozal J, 2005, J CHROMATOGR A, V1076, P90, DOI 10.1016/j.chroma.2005.04.044; Pang GF, 2006, ANAL BIOANAL CHEM, V384, P1366, DOI 10.1007/s00216-005-0237-9; RULE GS, 1994, ANAL CHEM, V66, P230, DOI 10.1021/ac00074a009; Schedl M, 2001, ANAL CHEM, V73, P5669, DOI 10.1021/ac010868n; Shan GM, 1999, CHEM RES TOXICOL, V12, P1033, DOI 10.1021/tx990091h; Tang T, 2010, ANAL CHIM ACTA, V680, P26, DOI 10.1016/j.aca.2010.09.034; Wang Peng, 2005, Journal of Biochemical and Biophysical Methods, V62, P219, DOI 10.1016/j.jbbm.2004.11.007; Wang SL, 2007, ANAL BIOANAL CHEM, V387, P673, DOI 10.1007/s00216-006-0891-6; Wengatz I, 1998, J AGR FOOD CHEM, V46, P2211, DOI 10.1021/jf9710847; WU SG, 1993, CHEM MATER, V5, P115, DOI 10.1021/cm00025a022; Zeng DY, 2006, J AGR FOOD CHEM, V54, P8682, DOI 10.1021/jf061492n; Zhang Q, 2008, ANAL CHIM ACTA, V625, P87, DOI 10.1016/j.aca.2008.07.003	24	4	4	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46929	10.1371/journal.pone.0046929	http://dx.doi.org/10.1371/journal.pone.0046929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056532	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500112
J	Wu, J; Zhou, XL; Lu, CY; Moyer, E; Wang, H; Hong, LY; Deng, XQ				Wu Jie; Zhou Xiaolan; Lu Ciyong; Moyer, Eileen; Wang Hui; Hong Lingyao; Deng Xueqing			A Qualitative Exploration of Barriers to Condom Use among Female Sex Workers in China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; RISK BEHAVIORS; UNSAFE SEX; HIV; POPULATION; INFECTION; KNOWLEDGE; DETERMINANTS; YOUTH; AIDS	Background: Sex workers in China continue to engage in unprotected sex acts that put them at risk for contracting HIV (Human Immunodeficiency Virus) and other STIs (Sexually Transmitted Infections). The purpose of this study was to explore women's work history, the context of sex work, condom use, HIV testing services, and potential barriers to condom use in a sample of FSWs (female sex workers) in Guangzhou, China. Methodology/Principal Findings: In-depth, semi-structured, face-to-face interviews were conducted with 24 FSWs in Guangzhou, China. Informants were recruited using a purposive sampling technique. Qualitative data were coded and analyzed using NVivo 8.0. The majority of respondents were internal economic migrants who had entered the sex industry in pursuit of greater financial reward. Most women in the study were married or had steady boyfriends, and were young, with secondary education and limited knowledge about HIV and STIs. Most were not satisfied with their current living conditions and expressed a desire to leave the sex industry. Women reported that they were more likely to use condoms during sex acts with commercial partners than with non-commercial partners. The potential stigma of being seen as a sex worker prevented many from accessing HIV testing. Three key factors put these FSWs at risk for HIV and STIs: unreasonable trust toward clients, stereotypes and assumptions about customers, and financial incentives. Conclusions/Significance: These findings suggest that social and economic factors play an important role in shaping sexual decision-making among female sex workers in Guangzhou. We argue that greater insight into and attention to these factors could enhance the success of HIV prevention efforts.	[Wu Jie; Zhou Xiaolan; Lu Ciyong; Wang Hui; Hong Lingyao; Deng Xueqing] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Moyer, Eileen] Univ Amsterdam, Dept Sociol & Cultural Anthropol, Amsterdam Inst Social Sci Res, Amsterdam, Netherlands	Sun Yat Sen University; University of Amsterdam	Wu, J (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	luciyong@yahoo.cn	Moyer, Eileen/AAW-7066-2020	Moyer, Eileen/0000-0002-1233-6041	Sun Yat-sen University	Sun Yat-sen University	The authors would like to thank the Sun Yat-sen University for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Oppong A, 2007, AIDS EDUC PREV, V19, P160, DOI 10.1521/aeap.2007.19.2.160; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Anderson AF, 2003, AIDS CARE, V15, P177, DOI 10.1080/0954012031000068326; Anfara V.A., 2006, THEORETICAL FRAMEWOR, V2nd ed.; Belk RW, 1998, J PUBLIC POLICY MARK, V17, P197, DOI 10.1177/074391569801700205; China Ministry of Health, 2008, 2007 UPD HIV AIDS EP; China Ministry of Health UNAIDS and WHO, 2011, 2011 EST REP HIV AID; Ding YP, 2005, JAIDS-J ACQ IMM DEF, V38, P314; Ghimire L, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-42; Green J, 2000, INT J STD AIDS, V11, P777, DOI 10.1258/0956462001915273; Guangdong Statistic Bureau, GUANGD PROV 1 POP SA; Harrison A, 2001, REPROD HEALTH MATTER, V9, P63, DOI 10.1016/S0968-8080(01)90009-6; Huang YY, 2004, SEX TRANSM DIS, V31, P695, DOI 10.1097/01.olq.0000143107.06988.ea; Jing J, 2006, AIDS SOCIAL POLICY C, V2006, P152; Lau JTF, 2002, AIDS CARE, V14, P219, DOI 10.1080/09540120220104721; Lau JTF, 2001, AIDS CARE, V13, P221, DOI 10.1080/09540120020027396; Matteelli A, 2003, INT J STD AIDS, V14, P591, DOI 10.1258/095646203322301031; Moyer EP, 2006, EXPLORING WEALTH AFR; OConnor CC, 1996, GENITOURIN MED, V72, P47; Pan SM, 1997, CUNZAI HUANGMIU; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; QU S, 2002, AIDS BEHAV, V6, P267; Rogers SJ, 2002, AIDS EDUC PREV, V14, P217, DOI 10.1521/aeap.14.3.217.23892; Smith DJ, 2004, CULT HEALTH SEX, V6, P425, DOI 10.1080/13691050410001680528; SwartKruger J, 1997, SOC SCI MED, V45, P957, DOI 10.1016/S0277-9536(96)00417-0; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Voeten HACM, 2002, SEX TRANSM DIS, V29, P444, DOI 10.1097/00007435-200208000-00003; WALDBY C, 1993, SOC AS AIDS, P29; Wang B, 2009, SEX TRANSM DIS, V36, P134, DOI 10.1097/OLQ.0b013e318191721a; Wang Q, 2009, CHIN J AIDS STDS, V15, P398; Wong ML, 2003, SEX TRANSM INFECT, V79, P163, DOI 10.1136/sti.79.2.163; Wong WCW, 2003, AIDS PATIENT CARE ST, V17, P417, DOI 10.1089/108729103322277439; Yang Hongmei, 2005, Health Care Women Int, V26, P134, DOI 10.1080/07399330590905585; Yang XS, 2010, AIDS EDUC PREV, V22, P69, DOI 10.1521/aeap.2010.22.1.69; Zhang SX, 2000, CHIN J STDS HIV AIDS, V6, P9	35	19	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46786	10.1371/journal.pone.0046786	http://dx.doi.org/10.1371/journal.pone.0046786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056452	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500077
J	Gordts, SC; Van Craeyveld, E; Muthuramu, I; Singh, N; Jacobs, F; De Geest, B				Gordts, Stephanie C.; Van Craeyveld, Eline; Muthuramu, Ilayaraja; Singh, Neha; Jacobs, Frank; De Geest, Bart			Lipid Lowering and HDL Raising Gene Transfer Increase Endothelial Progenitor Cells, Enhance Myocardial Vascularity, and Improve Diastolic Function	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LEFT-VENTRICULAR FUNCTION; NITRIC-OXIDE SYNTHASE; APO A-I; ATHEROSCLEROTIC LESIONS; CHOLESTEROL; HYPERCHOLESTEROLEMIA; MEMBRANE; INFARCTION; EXPRESSION	Background: Hypercholesterolemia and low high density lipoprotein (HDL) cholesterol contribute to coronary heart disease but little is known about their direct effects on myocardial function. Low HDL and raised non-HDL cholesterol levels carried increased risk for heart failure development in the Framingham study, independent of any association with myocardial infarction. The objective of this study was to test the hypothesis that increased endothelial progenitor cell (EPC) number and function after lipid lowering or HDL raising gene transfer in C57BL/6 low density lipoprotein receptor deficient (LDLr-/- 2) mice may be associated with an enhanced relative vascularity in the myocardium and an improved cardiac function. Methodology/principal findings: Lipid lowering and HDL raising gene transfer were performed using the E1E3E4-deleted LDLr expressing adenoviral vector AdLDLr and the human apolipoprotein A-I expressing vector AdA-I, respectively. AdLDLr transfer in C57BL/6 LDLr-/- mice resulted in a 2.0-fold (p<0.05) increase of the circulating number of EPCs and in an improvement of EPC function as assessed by ex vivo EPC migration and EPC adhesion. Capillary density and relative vascularity in the myocardium were 28% (p<0.01) and 22% (p<0.05) higher, respectively, in AdLDLr mice compared to control mice. The peak rate of isovolumetric relaxation was increased by 12% (p<0.05) and the time constant of isovolumetric relaxation was decreased by 14% (p<0.05) after AdLDLr transfer. Similarly, HDL raising gene transfer increased EPC number and function and raised both capillary density and relative vascularity in the myocardium by 24% (p<0.05). The peak rate of isovolumetric relaxation was increased by 16% (p<0.05) in AdA-I mice compared to control mice. Conclusions/Significance: Both lipid lowering and HDL raising gene transfer have beneficial effects on EPC biology, relative myocardial vascularity, and diastolic function. These findings raise concerns over the external validity of studies evaluating myocardial biology and cardiac repair in normocholesterolemic animals.	[Gordts, Stephanie C.; Van Craeyveld, Eline; Muthuramu, Ilayaraja; Singh, Neha; Jacobs, Frank; De Geest, Bart] Catholic Univ Louvain, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium	Universite Catholique Louvain	De Geest, B (corresponding author), Catholic Univ Louvain, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium.	bart.degeest@med.kuleuven.be	Jacobs, Frank/GSD-3616-2022; Muthuramu, Ilayaraja/R-2199-2018; De Geest, Bart/AHB-0394-2022	Muthuramu, Ilayaraja/0000-0003-3550-7672; De Geest, Bart/0000-0001-5580-686X	F.W.O. project of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0599.09N]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen	F.W.O. project of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO)	This work was supported by grant F.W.O. project G.0599.09N of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. Stephanie C. Gordts is a Research Assistant of the Agentschap voor Innovatie door Wetenschap en Technologie (IWT). Eline Van Craeyveld is a Research Assistant of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. Frank Jacobs is a postdoctoral fellow of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Camici PG, 2011, J MOL CELLULAR CARDI; Den Ruijter HM, 2011, J AM COLL CARDIOL, V58, P40, DOI 10.1016/j.jacc.2010.11.072; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Feng Y, 2008, ARTERIOSCL THROM VAS, V28, P278, DOI 10.1161/ATVBAHA.107.158741; Feng YM, 2009, J MOL MED, V87, P287, DOI 10.1007/s00109-008-0427-y; Feng YM, 2009, BLOOD, V113, P755, DOI 10.1182/blood-2008-06-161794; Feron O, 1999, J CLIN INVEST, V103, P897, DOI 10.1172/JCI4829; Fransen P, 2008, PFLUG ARCH EUR J PHY, V455, P811, DOI 10.1007/s00424-007-0337-9; Gonzalez A, 2011, J AM COLL CARDIOL, V58, P1833, DOI 10.1016/j.jacc.2011.06.058; Goonasekara CL, 2010, EXPERT REV CARDIOVAS, V8, P965, DOI 10.1586/ERC.10.79; Haugaa KH, 2009, EUR HEART J, V30, P330, DOI 10.1093/eurheartj/ehn466; Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629; Huang Y, 2004, CIRCULATION, V109, P97, DOI 10.1161/01.CIR.0000109213.10461.F6; Jacobs F, 2008, GENE THER, V15, P594, DOI 10.1038/sj.gt.3303096; Jacobs F, 2011, J MOL MED, V89, P1051, DOI 10.1007/s00109-011-0778-7; Jacobs F, 2008, ATHEROSCLEROSIS, V201, P289, DOI 10.1016/j.atherosclerosis.2008.02.023; KEMPEN HJ, 1987, J LAB CLIN MED, V109, P19; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Liu YB, 2003, CIRC RES, V92, P1145, DOI 10.1161/01.RES.0000072999.51484.92; Luo TY, 2004, J BIOMED SCI, V11, P829, DOI [10.1159/000081830, 10.1007/BF02254368]; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Maltais S, 2011, EUR J CARDIO-THORAC, V39, P368, DOI 10.1016/j.ejcts.2010.04.022; Mineo C, 2006, CARDIOVASC RES, V70, P31, DOI 10.1016/j.cardiores.2006.01.025; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rubinstein J, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-56; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Sbaa E, 2006, CIRC RES, V98, P1219, DOI 10.1161/01.RES.0000220648.80170.8b; Seddon M, 2007, CARDIOVASC RES, V75, P315, DOI 10.1016/j.cardiores.2007.04.031; Shimizu I, J CLIN INVEST, V120, P1506; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Talini E, 2008, ATHEROSCLEROSIS, V197, P346, DOI 10.1016/j.atherosclerosis.2007.05.024; Templin C, 2011, INT J DEV BIOL, V55, P407, DOI 10.1387/ijdb.103219ct; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Tune JD, 2004, J APPL PHYSIOL, V97, P404, DOI 10.1152/japplphysiol.01345.2003; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Van Craeyveld E, 2012, GENE THER, V19, P860, DOI 10.1038/gt.2011.147; Van Craeyveld E, 2011, J MOL MED, V89, P555, DOI 10.1007/s00109-011-0722-x; Van Linthout S, 2002, GENE THER, V9, P1520, DOI 10.1038/sj.gt.3301824; Velagaleti RS, 2009, CIRCULATION, V120, P2345, DOI 10.1161/CIRCULATIONAHA.109.830984; Wang TD, 1998, AM J CARDIOL, V81, P531, DOI 10.1016/S0002-9149(97)00974-0; WEISS JL, 1976, J CLIN INVEST, V58, P751, DOI 10.1172/JCI108522; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5	48	24	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46849	10.1371/journal.pone.0046849	http://dx.doi.org/10.1371/journal.pone.0046849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056485	Green Submitted, gold, Green Published			2022-12-27	WOS:000309580800055
J	Pitroda, SP; Zhou, T; Sweis, RF; Filippo, M; Labay, E; Beckett, MA; Mauceri, HJ; Liang, H; Darga, TE; Perakis, S; Khan, SA; Sutton, HG; Zhang, W; Khodarev, NN; Garcia, JGN; Weichselbaum, RR				Pitroda, Sean P.; Zhou, Tong; Sweis, Randy F.; Filippo, Matthew; Labay, Edwardine; Beckett, Michael A.; Mauceri, Helena J.; Liang, Hua; Darga, Thomas E.; Perakis, Samantha; Khan, Sajid A.; Sutton, Harold G.; Zhang, Wei; Khodarev, Nikolai N.; Garcia, Joe G. N.; Weichselbaum, Ralph R.			Tumor Endothelial Inflammation Predicts Clinical Outcome in Diverse Human Cancers	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; BREAST-CANCER; SURVIVAL; LYMPHOMA; DISEASE; REPAIR; CELLS	Background: Vascular endothelial cells contribute to the pathogenesis of numerous human diseases by actively regulating the stromal inflammatory response; however, little is known regarding the role of endothelial inflammation in the growth of human tumors and its influence on the prognosis of human cancers. Methods: Using an experimental model of tumor necrosis factor-alpha (TNF-alpha)-mediated inflammation, we characterized inflammatory gene expression in immunopurified tumor-associated endothelial cells. These genes formed the basis of a multivariate molecular predictor of overall survival that was trained and validated in four types of human cancer. Results: We report that expression of experimentally derived tumor endothelial genes distinguished pathologic tissue specimens from normal controls in several human diseases associated with chronic inflammation. We trained these genes in human cancer datasets and defined a six-gene inflammatory signature that predicted significantly reduced overall survival in breast cancer, colon cancer, lung cancer, and glioma. This endothelial-derived signature predicted outcome independently of, but cooperatively with, standard clinical and pathological prognostic factors. Consistent with these findings, conditioned culture media from human endothelial cells stimulated by pro-inflammatory cytokines accelerated the growth of human colon and breast tumors in immunodeficient mice as compared with conditioned media from untreated endothelial cells. Conclusions: This study provides the first prognostic cancer gene signature derived from an experimental model of tumor-associated endothelial inflammation. These findings support the notion that activation of inflammatory pathways in nonmalignant tumor-infiltrating endothelial cells contributes to tumor growth and progression in multiple human cancers. Importantly, these results identify endothelial-derived factors that could serve as potential targets for therapy in diverse human cancers.	[Pitroda, Sean P.; Sweis, Randy F.; Filippo, Matthew; Labay, Edwardine; Beckett, Michael A.; Mauceri, Helena J.; Liang, Hua; Darga, Thomas E.; Perakis, Samantha; Sutton, Harold G.; Khodarev, Nikolai N.; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Zhou, Tong; Zhang, Wei; Garcia, Joe G. N.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Khan, Sajid A.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Weichselbaum, RR (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	rrw@radonc.uchicago.edu	khan, sajid/HGE-2406-2022	Sweis, Randy/0000-0002-0497-9637; Darga, Thomas/0000-0002-8968-6701; Hasenleithner, Samantha O./0000-0002-9401-5224	Virginia; D. K. Ludwig Fund for Cancer Research; Lung Cancer Research Foundation; Chicago Tumor Institute; Brain Tumor Program Project [PO1 CA 07193312]; United States National Institutes of Health [HL58064, HL98050, HL105371]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098050, U01HL105371, P01HL058064] Funding Source: NIH RePORTER	Virginia; D. K. Ludwig Fund for Cancer Research; Lung Cancer Research Foundation; Chicago Tumor Institute; Brain Tumor Program Project; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by funding from the Virginia and D. K. Ludwig Fund for Cancer Research (R. R. W.), Lung Cancer Research Foundation (R. R. W.), Chicago Tumor Institute (R. R. W.), and Brain Tumor Program Project (PO1 CA 07193312) (R. R. W.), in addition to, United States National Institutes of Health grants HL58064 (J.G.N.G.), HL98050 (J.G.N.G.), and HL105371 (J.G.N.G.) and a generous gift from the Foglia family (R. R. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacac M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000032; BACON PA, 1994, ANN RHEUM DIS, V53, P621, DOI 10.1136/ard.53.10.621; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Coulon S, 2011, LIVER INT, V31, P146, DOI 10.1111/j.1478-3231.2010.02369.x; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cromer WE, 2011, WORLD J GASTROENTERO, V17, P578, DOI 10.3748/wjg.v17.i5.578; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franses JW, 2011, CANCER RES, V71, P7339, DOI 10.1158/0008-5472.CAN-11-1718; Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Nutt CL, 2003, CANCER RES, V63, P1602; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Saadi A, 2010, P NATL ACAD SCI USA, V107, P2177, DOI 10.1073/pnas.0909797107; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	27	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46104	10.1371/journal.pone.0046104	http://dx.doi.org/10.1371/journal.pone.0046104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056240	gold, Green Submitted, Green Published			2022-12-27	WOS:000309580800009
J	Ahlf, S; Tziridis, K; Korn, S; Strohmeyer, I; Schulze, H				Ahlf, Soenke; Tziridis, Konstantin; Korn, Sabine; Strohmeyer, Ilona; Schulze, Holger			Predisposition for and Prevention of Subjective Tinnitus Development	PLOS ONE			English	Article							GERBIL MERIONES-UNGUICULATUS; SALICYLATE-INDUCED TINNITUS; AUDITORY-CORTEX; FUNCTIONAL-ORGANIZATION; GABAERGIC INHIBITION; INFERIOR COLLICULUS; NEURAL CHANGES; HEARING-LOSS; REORGANIZATION; PLASTICITY	Dysfunction of the inner ear as caused by presbyacusis, injuries or noise traumata may result in subjective tinnitus, but not everyone suffering from one of these diseases develops a tinnitus percept and vice versa. The reasons for these individual differences are still unclear and may explain why different treatments of the disease are beneficial for some patients but not for others. Here we for the first time compare behavioral and neurophysiological data from hearing impaired Mongolian gerbils with (T) and without (NT) a tinnitus percept that may elucidate why some specimen do develop subjective tinnitus after noise trauma while others do not. Although noise trauma induced a similar permanent hearing loss in all animals, tinnitus did develop only in about three quarters of these animals. NT animals showed higher overall cortical and auditory brainstem activity before noise trauma compared to T animals; that is, animals with low overall neuronal activity in the auditory system seem to be prone to develop tinnitus after noise trauma. Furthermore, T animals showed increased activity of cortical neurons representing the tinnitus frequencies after acoustic trauma, whereas NT animals exhibited an activity decrease at moderate sound intensities by that time. Spontaneous activity was generally increased in T but decreased in NT animals. Plastic changes of tonotopic organization were transient, only seen in T animals and vanished by the time the tinnitus percept became chronic. We propose a model for tinnitus prevention that points to a global inhibitory mechanism in auditory cortex that may prevent tinnitus genesis in animals with high overall activity in the auditory system, whereas this mechanism seems not potent enough for tinnitus prevention in animals with low overall activity.	[Ahlf, Soenke; Tziridis, Konstantin; Korn, Sabine; Strohmeyer, Ilona; Schulze, Holger] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Tziridis, K (corresponding author), Univ Erlangen Nurnberg, D-91054 Erlangen, Germany.	konstantin.tziridis@uk-erlangen.de			Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital Erlangen [E7]	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital Erlangen	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF, project E7) at the University Hospital Erlangen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apergis-Schoute AM, 2005, J NEUROSCI, V25, P5730, DOI 10.1523/JNEUROSCI.0096-05.2005; Bajo VM, 2005, J COMP NEUROL, V486, P101, DOI 10.1002/cne.20542; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Browne CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033272; Budinger E, 2000, EUR J NEUROSCI, V12, P2452, DOI 10.1046/j.1460-9568.2000.00143.x; CAMPEAU S, 1992, ANIM LEARN BEHAV, V20, P177, DOI 10.3758/BF03200415; Devarajan K, 2012, EFFECT NOISE EXPOSUR; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Eggermont JJ, 2006, ACTA OTO-LARYNGOL, V126, P9, DOI 10.1080/03655230600895259; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2003, AURIS NASUS LARYNX, V30, pS7; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Flor H, 2004, APPL PSYCHOPHYS BIOF, V29, P113, DOI 10.1023/B:APBI.0000026637.77671.f4; Foeller E, 2001, JARO, V2, P279; Gerken GM, 1996, HEARING RES, V97, P75, DOI 10.1016/0378-5955(96)00061-5; Guitton MJ, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00012; Guitton MJ, 2005, EUR J NEUROSCI, V22, P2675, DOI 10.1111/j.1460-9568.2005.04436.x; Hoffman H., 2004, TINNITUS THEORY MANA, P16; Horikawa J, 1996, J PHYSIOL-LONDON, V497, P629, DOI 10.1113/jphysiol.1996.sp021795; Kim DK, 2011, J LARYNGOL OTOL, V125, P246, DOI 10.1017/S0022215110002380; Kotak VC, 2005, J NEUROSCI, V25, P3908, DOI 10.1523/JNEUROSCI.5169-04.2005; Kurt S, 2008, BRAIN RES, V1220, P58, DOI 10.1016/j.brainres.2007.10.023; Kurt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001735; Langguth B, 2009, EXPERT OPIN EMERG DR, V14, P687, DOI 10.1517/14728210903206975; Middleton JW, 2011, P NATL ACAD SCI USA, V108, P7601, DOI 10.1073/pnas.1100223108; Moeller CK, 2010, EUR J NEUROSCI, V31, P49, DOI 10.1111/j.1460-9568.2009.07039.x; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Norena AJ, 2010, NEUROSCIENCE, V166, P1194, DOI 10.1016/j.neuroscience.2009.12.063; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Stuermer IW, 2000, HEARING RES, V146, P185, DOI 10.1016/S0378-5955(00)00113-1; THOMAS H, 1993, EUR J NEUROSCI, V5, P882, DOI 10.1111/j.1460-9568.1993.tb00940.x; Turner J, 2012, RELATIONSHIP NOISE E; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2007, PROG BRAIN RES, V166, P147, DOI 10.1016/S0079-6123(07)66013-0; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Walter M., 2012, OPEN J ACOUSTICS, V2, P34, DOI DOI 10.4236/0JA.2012.21004; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; YOUNG JS, 1983, J ACOUST SOC AM, V73, P1686, DOI 10.1121/1.389391	44	36	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e44519	10.1371/journal.pone.0044519	http://dx.doi.org/10.1371/journal.pone.0044519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056180	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600005
J	Sobenin, IA; Sazonova, MA; Ivanova, MM; Zhelankin, AV; Myasoedova, VA; Postnov, AY; Nurbaev, SD; Bobryshev, YV; Orekhov, AN				Sobenin, Igor A.; Sazonova, Margarita A.; Ivanova, Maria M.; Zhelankin, Andrey V.; Myasoedova, Veronika A.; Postnov, Anton Y.; Nurbaev, Serik D.; Bobryshev, Yuri V.; Orekhov, Alexander N.			Mutation C3256T of Mitochondrial Genome in White Blood Cells: Novel Genetic Marker of Atherosclerosis and Coronary Heart Disease	PLOS ONE			English	Article							POINT MUTATIONS; POPULATION; ARTERIES	This study was undertaken to examine the association between the level of heteroplasmy for the mutation C3256T in human white blood cells and the extent of carotid atherosclerosis, as well as the presence of coronary heart disease (CHD), the major clinical manifestation of atherosclerosis. Totally, 191 participants (84 men, 107 women) aged 65.0 years (SD 9.4) were recruited in the study; 45 (24%) of them had CHD. High-resolution B-mode ultrasonography of carotids was used to estimate the extent of carotid atherosclerosis by measuring of the carotid intima-media thickness (cIMT). DNA samples were obtained from whole venous blood, and then PCR and pyrosequencing were carried out. On the basis of pyrosequencing data, the levels of C3256T heteroplasmy in DNA samples were calculated. The presence of the mutant allele was detected in all study participants; the level of C3256T heteroplasmy in white blood cells ranged from 5% to 74%. The highly significant relationship between C3256T heteroplasmy level and predisposition to atherosclerosis was revealed. In individuals with low predisposition to atherosclerosis the mean level of C3256T heteroplasmy was 16.8%, as compared to 23.8% in moderately predisposed subjects, and further to 25.2% and 28.3% in significantly and highly predisposed subjects, respectively. The level of C3256T heteroplasmy of mitochondrial genome in human white blood cells is a biomarker of mitochondrial dysfunction and risk factor for atherosclerosis; therefore, it can be used as an informative marker of genetic susceptibility to atherosclerosis, coronary heart disease and myocardial infarction.	[Sobenin, Igor A.; Sazonova, Margarita A.; Ivanova, Maria M.; Zhelankin, Andrey V.; Myasoedova, Veronika A.; Bobryshev, Yuri V.; Orekhov, Alexander N.] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Lab Cellular Mechanisms Atherogenesis, Moscow, Russia; [Sobenin, Igor A.; Sazonova, Margarita A.; Postnov, Anton Y.] Russian Minist Hlth & Social Care, Lab Med Genet Russian Cardiol Res & Prod Complex, Moscow, Russia; [Myasoedova, Veronika A.; Nurbaev, Serik D.; Bobryshev, Yuri V.; Orekhov, Alexander N.] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Dept Clin Invest, Moscow, Russia; [Bobryshev, Yuri V.] Univ New S Wales, Fac Med, Sydney, NSW, Australia	Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Ministry of Health of the Russian Federation; University of New South Wales Sydney	Bobryshev, YV (corresponding author), Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Lab Cellular Mechanisms Atherogenesis, Moscow, Russia.	y.bobryshev@unsw.edu.au	Zhelankin, Andrey/F-8247-2014; Myasoedova, Veronika A/K-1024-2016; Orekhov, Alexander N/J-4838-2013; Bobryshev, Yuri/J-2838-2013; Sobenin, Igor A/J-4282-2013; Maria, Chicheva/I-4196-2017; Sazonova, Margarita/O-9685-2017	Zhelankin, Andrey/0000-0002-3014-2005; Myasoedova, Veronika A/0000-0001-8414-5300; Orekhov, Alexander N/0000-0002-6495-1628; Sobenin, Igor A/0000-0003-0978-6444; Maria, Chicheva/0000-0002-8014-8798; Postnov, Anton/0000-0002-2501-7269; Sazonova, Margarita/0000-0002-8610-4593	Russian Ministry of Education and Science	Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This study was supported by the Russian Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderborn A, 2000, GENOME RES, V10, P1249, DOI 10.1101/gr.10.8.1249; Baldassarre D, 2010, EUR HEART J, V31, P614, DOI 10.1093/eurheartj/ehp496; Bobryshev YV, 2011, ATHEROSCLEROSIS, V219, P171, DOI 10.1016/j.atherosclerosis.2011.07.016; Bobryshev YV, 2006, MICRON, V37, P208, DOI 10.1016/j.micron.2005.10.007; Bobryshev YV, 2005, EUR HEART J, V26, P1700, DOI 10.1093/eurheartj/ehi282; Cassandrini D, 2006, BIOCHEM BIOPH RES CO, V342, P387, DOI 10.1016/j.bbrc.2006.01.152; Chen DC, 2003, J MOL DIAGN, V5, P243, DOI 10.1016/S1525-1578(10)60481-3; Chistiakov DA, 2012, WORLD J CARDIOL, V4, P148, DOI 10.4330/wjc.v4.i5.148; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4; Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0; Lang TA, 2006, REPORT STAT MED ANNO; Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884; Lim KS, 2008, J MOL DIAGN, V10, P102, DOI 10.2353/jmoldx.2008.070081; MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913; Nishigaki Y, 2010, MITOCHONDRION, V10, P300, DOI 10.1016/j.mito.2010.01.003; Orekhov AN, 2010, ATHEROSCLEROSIS, V212, P436, DOI 10.1016/j.atherosclerosis.2010.07.009; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055; Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001; Sinclair A, 2003, ANTIMICROB AGENTS CH, V47, P3620, DOI 10.1128/AAC.47.11.3620-3622.2003; Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541	24	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46573	10.1371/journal.pone.0046573	http://dx.doi.org/10.1371/journal.pone.0046573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056349	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600043
J	Badiger, R; Mitchell, JA; Gashaw, H; Galloway-Phillipps, NA; Foser, S; Tatsch, F; Singer, T; Hansel, TT; Manigold, T				Badiger, Rekha; Mitchell, Jane A.; Gashaw, Hime; Galloway-Phillipps, Neil A.; Foser, Stefan; Tatsch, Fernando; Singer, Thomas; Hansel, Trevor T.; Manigold, Tobias			Effect of Different Interferon alpha 2 Preparations on IP10 and ET-1 Release from Human Lung Cells	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SMOOTH-MUSCLE-CELLS; BRONCHOALVEOLAR LAVAGE FLUID; NF-KAPPA-B; PULMONARY-HYPERTENSION; ENDOTHELIN-1 RELEASE; VIRUS-INFECTION; INTERSTITIAL PNEUMONITIS; PEGINTERFERON ALPHA-2B; PEGYLATED INTERFERONS	Background: Alfa-interferons (IFN alpha 2a, IFN alpha 2b, 40KDa-PEGIFN alpha 2a and 12KDa-PEGIFN alpha 2b) are effective treatments for chronic hepatitis C infection. However, their usage has been associated with a variety of adverse events, including interstitial pneumonitis and pulmonary arterial hypertension. Although rare, these adverse events can be severe and potentially life-threatening, emphasizing the need for simple biomarkers of IFN-induced lung toxicity. Methods: Human lung microvascular endothelial cells (HLMVEC), human pulmonary artery smooth muscle (HPASM) cells and A549 cells were grown under standard conditions and plated into 96- or 6-well plates. Cells were stimulated with various concentrations of different IFNs in hydrocortisone-free medium. After 24 and 48 hours, IP10 and ET-1 were measured by ELISA in conditioned medium. In a second set of experiments, cells were pre-treated with tumour necrosis factor-alpha (TNF-alpha) (10 ng/mL). Results: IFN alpha 2a, IFN alpha 2b, 40KDa-PEGIFN alpha 2a and 12KDa-PEGIFN alpha 2b, but not IFN lambda, induced IP10 (CXCL10) release and increased IP10 gene induction in HLMVEC. In addition, all four IFN alpha preparations induced IP10 release from HPASM cells and A549 cells pre-treated with TNF alpha. In each of these cell types, 40KDa-PEGIFN alpha 2a was significantly less active than the native forms of IFN alpha 2a, IFN alpha 2b or 12KDa-PEGIFN alpha 2b. Similarly, IFN alpha 2a, IFN alpha 2b and 12KDa-PEGIFN alpha 2b, but not 40KDa-PEGIFN alpha 2a, induced endothelin (ET)-1 release from HPASM cells. Conclusions: Consistent with other interstitial pulmonary diseases, both IP10 and ET1 may serve as markers to monitor IFN-induced lung toxicity in patients. In addition, both markers may also serve to help characterize the risk associated with IFN alpha preparations to induce lung toxicity.	[Badiger, Rekha; Mitchell, Jane A.; Gashaw, Hime; Galloway-Phillipps, Neil A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Foser, Stefan; Tatsch, Fernando; Singer, Thomas; Manigold, Tobias] Hoffmann La Roche AG, Basel, Switzerland; [Hansel, Trevor T.] St Marys Hosp, ICRRU, London, England; [Manigold, Tobias] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland	Imperial College London; Roche Holding; Imperial College London; University of Basel	Badiger, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	j.a.mitchell@imperial.ac.uk			Roche; Novartis; Merck; GlaxoSmithKline; Bayer-Schering; Hoffmann La Roche; GSK; Dainippon-Sumitomo	Roche(Roche Holding); Novartis(Novartis); Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Bayer-Schering(Bayer AG); Hoffmann La Roche(Hoffmann-La Roche); GSK(GlaxoSmithKline); Dainippon-Sumitomo(Dainippon Sumitomo Pharma Co., Ltd.)	SF, FT, TS and TM are employees of Roche. JAM received funding from Roche. Human IFN alpha 2a, IFN alpha 2b, 40KDa-PEGIFN alpha 2a, 12KDa-PEGIFN alpha 2b and 40KDa-PEGIFNa2a isoforms (K31, K134 and K122 [5]) were provided by Hoffmann-La Roche (Basel, Switzerland), and support for third-party writing assistance for this manuscript was provided by Hoffmann-La Roche Ltd. TH was a consultant for Roche in Non-Clinical Safety at the time of the study. TH has been Principal Investigator for respiratory clinical studies at Imperial College that have been sponsored by Novartis (2008), Merck (2009) and GlaxoSmithKline (2011); has received lecture fees from Novartis, Bayer-Schering, Merck, Hoffmann La Roche, GSK and Dainippon-Sumitomo and is involved in setting up a spin-off company with Imperial Innovations called Mucosal Diagnostics. TH has received support to attend the American Thoracic Society from Boehringer Ingelheim. All other authors have nothing to disclose. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors..	Aghemo A, 2010, NAT REV GASTRO HEPAT, V7, P485, DOI 10.1038/nrgastro.2010.101; Agostini C, 2001, AM J PATHOL, V158, P1703, DOI 10.1016/S0002-9440(10)64126-0; [Anonymous], 2001, SUMMARY PHARM TOXICO; Baron S, 1992, INTERFERON PRINCIPLE, P1; Caliceti P, 2004, DIGEST LIVER DIS, V36, pS334, DOI 10.1016/S1590-8658(04)80002-1; Chakraborty K, 2008, J INTERF CYTOK RES, V28, P487, DOI 10.1089/jir.2008.0001; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Dhillon S, 2010, DIGEST DIS SCI, V55, P1785, DOI 10.1007/s10620-010-1220-7; Donnelly RP, 2011, TRENDS IMMUNOL, V32, P443, DOI 10.1016/j.it.2011.07.002; Feld JJ, 2010, GASTROENTEROLOGY, V139, P154, DOI 10.1053/j.gastro.2010.03.037; Foser S, 2003, PHARMACOGENOMICS J, V3, P312, DOI 10.1038/sj.tpj.6500204; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Funauchi M, 2006, J RHEUMATOL, V33, P903; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; George PM, 2012, PULMONARY C IN PRESS; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Grace M, 2001, J INTERF CYTOK RES, V21, P1103, DOI 10.1089/107999001317205240; Grace MJ, 2005, J BIOL CHEM, V280, P6327, DOI 10.1074/jbc.M412134200; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Hildebrandt GC, 2004, J IMMUNOL, V173, P2050, DOI 10.4049/jimmunol.173.3.2050; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Katoh S, 2005, INT ARCH ALLERGY IMM, V137, P229, DOI 10.1159/000086335; Kelly-Scumpia KM, 2010, J EXP MED, V207, P319, DOI 10.1084/jem.20091959; Kumar KS, 2002, AM J GASTROENTEROL, V97, P2432, DOI 10.1111/j.1572-0241.2002.05999.x; Li Zhenhua, 1999, Zhonghua Jiehe He Huxi Zazhi, V22, P411; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Manicone AM, 2008, EXP LUNG RES, V34, P391, DOI 10.1080/01902140802221987; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McAllister F, 2006, J IMMUNOL, V177, P1846, DOI 10.4049/jimmunol.177.3.1846; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Nakayama S, 2005, RESP MED, V99, P1145, DOI 10.1016/j.rmed.2005.02.021; Nie L, 2008, ACTA PHARMACOL SIN, V29, P1432, DOI 10.1111/j.1745-7254.2008.00899.x; Proost P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1997; Reichenberger F, 2001, LUNG, V179, P163, DOI 10.1007/s004080000058; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Simler NR, 2004, THORAX, V59, P581, DOI 10.1136/thx.2003.009860; Slavenburg S, 2010, DIGEST DIS SCI, V55, P579, DOI 10.1007/s10620-009-0797-1; Solsky J, 2009, J HEPATOL, V50, pS238, DOI 10.1016/S0168-8278(09)60648-6; Vasakova M, 2009, SCAND J IMMUNOL, V69, P268, DOI 10.1111/j.1365-3083.2008.02222.x; Woods M, 2003, MOL PHARMACOL, V64, P923, DOI 10.1124/mol.64.4.923; Wort SJ, 2002, MOL PHARMACOL, V62, P1147, DOI 10.1124/mol.62.5.1147; Wort SJ, 2001, AM J RESP CELL MOL, V25, P104, DOI 10.1165/ajrcmb.25.1.4331; Wort SJ, 2001, AM J PHYSIOL-LUNG C, V280, pL387, DOI 10.1152/ajplung.2001.280.3.L387; Wort SJ, 2000, J CARDIOVASC PHARM, V36, pS410; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zeng XY, 2005, INFECT IMMUN, V73, P8226, DOI 10.1128/IAI.73.12.8226-8236.2005	50	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46779	10.1371/journal.pone.0046779	http://dx.doi.org/10.1371/journal.pone.0046779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056449	gold, Green Submitted, Green Published			2022-12-27	WOS:000309831500075
J	Gates, AR; Jones, DOB				Gates, Andrew R.; Jones, Daniel O. B.			Recovery of Benthic Megafauna from Anthropogenic Disturbance at a Hydrocarbon Drilling Well (380 m Depth in the Norwegian Sea)	PLOS ONE			English	Article							REMOTELY OPERATED VEHICLES; FAROE-SHETLAND CHANNEL; IN-SITU OBSERVATIONS; LONG-TERM CHANGE; OFFSHORE OIL; NORTH-SEA; PHYSICAL DISTURBANCE; WEST-COAST; DEEP; COMMUNITIES	Recovery from disturbance in deep water is poorly understood, but as anthropogenic impacts increase in deeper water it is important to quantify the process. Exploratory hydrocarbon drilling causes physical disturbance, smothering the seabed near the well. Video transects obtained by remotely operated vehicles were used to assess the change in invertebrate megafaunal density and diversity caused by drilling a well at 380 m depth in the Norwegian Sea in 2006. Transects were carried out one day before drilling commenced and 27 days, 76 days, and three years later. A background survey, further from the well, was also carried out in 2009. Porifera (45% of observations) and Cnidaria (40%) dominated the megafauna. Porifera accounted for 94% of hard-substratum organisms and cnidarians (Pennatulacea) dominated on the soft sediment (78%). Twenty seven and 76 days after drilling commenced, drill cuttings were visible, extending over 100 m from the well. In this area there were low invertebrate megafaunal densities (0.08 and 0.10 individuals m(-2)) in comparison to pre-drill conditions (0.21 individuals m(-2)). Three years later the visible extent of the cuttings had reduced, reaching 60 m from the well. Within this area the megafaunal density (0.05 individuals m(-2)) was lower than pre-drill and reference transects (0.23 individuals m(-2)). There was a significant increase in total megafaunal invertebrate densities with both distance from drilling and time since drilling although no significant interaction. Beyond the visible disturbance there were similar megafaunal densities (0.14 individuals m(-2)) to pre-drilling and background surveys. Species richness, Shannon-Weiner diversity and multivariate techniques showed similar patterns to density. At this site the effects of exploratory drilling on megafaunal invertebrate density and diversity seem confined to the extent of the visible cuttings pile. However, elevated Barium concentration and reduced sediment grain size suggest persistence of disturbance for three years, with unclear consequences for other components of the benthic fauna.	[Gates, Andrew R.; Jones, Daniel O. B.] Natl Oceanog Ctr, Ocean Biogeochem & Ecosyst Grp, Southampton, Hants, England	NERC National Oceanography Centre	Gates, AR (corresponding author), Natl Oceanog Ctr, Ocean Biogeochem & Ecosyst Grp, Southampton, Hants, England.	arg3@noc.ac.uk	Jones, Daniel/A-3412-2009; Gates, Andrew R/I-4321-2012	Jones, Daniel/0000-0001-5218-1649; Gates, Andrew R/0000-0002-2798-5044	Statoil ASA; United Kingdom Natural Environment Research Council; Natural Environment Research Council [noc010004, noc010009] Funding Source: researchfish; NERC [noc010009, noc010004] Funding Source: UKRI	Statoil ASA; United Kingdom Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Statoil ASA funded this work (www.statoil.com). The work was also funded, in part, by the United Kingdom Natural Environment Research Council as part of the Marine Environmental Mapping Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2010, R LANG ENV STAT COMP; Archambault P, 2001, MAR ECOL PROG SER, V222, P51, DOI 10.3354/meps222051; ATTRILL MJ, 1991, J MAR BIOL ASSOC UK, V71, P311, DOI 10.1017/S0025315400051626; Barlow MJ, 2001, MAR POLLUT BULL, V42, P71, DOI 10.1016/S0025-326X(00)00117-X; Beaulieu SE, 2001, MAR BIOL, V138, P803, DOI 10.1007/s002270000500; Bergmann M, 2011, DEEP-SEA RES PT I, V58, P711, DOI 10.1016/j.dsr.2011.03.007; Bergstad OA, 1999, SARSIA, V84, P67, DOI 10.1080/00364827.1999.10420452; Bett BJ, 2001, PROG OCEANOGR, V50, P349, DOI 10.1016/S0079-6611(01)00066-0; Billett DSM, 2010, DEEP-SEA RES PT II, V57, P1406, DOI 10.1016/j.dsr2.2009.02.001; BILLETT DSM, 1991, OCEANOGR MAR BIOL, V29, P259; Billett DSM, 2001, PROG OCEANOGR, V50, P325, DOI 10.1016/S0079-6611(01)00060-X; Black KS, 2002, UNDERWATER TECHNOL, V25, P51, DOI 10.3723/175605402783219208; Bluhm H, 2001, DEEP-SEA RES PT II, V48, P3841, DOI 10.1016/S0967-0645(01)00070-4; Bluhm H, 1995, MAR GEORESOUR GEOTEC, V13, P393, DOI 10.1080/10641199509388295; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Breuer E, 2004, MAR POLLUT BULL, V48, P12, DOI 10.1016/j.marpolbul.2003.08.009; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; CANTELMO FR, 1979, MAR ENVIRON RES, V2, P301, DOI 10.1016/0141-1136(79)90014-X; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Collie JS, 1997, MAR ECOL PROG SER, V155, P159, DOI 10.3354/meps155159; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Currie DR, 2005, MAR ENVIRON RES, V59, P217, DOI 10.1016/j.marenvres.2004.05.001; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; DAVIES JM, 1981, MAR POLLUT BULL, V12, P412, DOI 10.1016/0025-326X(81)90159-4; Davies JM, 1989, DRILLING WASTES; Dernie KM, 2003, J EXP MAR BIOL ECOL, V285, P415, DOI 10.1016/S0022-0981(02)00541-5; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Edwards DCB, 2008, MAR BIOL, V155, P303, DOI 10.1007/s00227-008-1028-6; Edwards DCB, 2009, ESTUAR COAST SHELF S, V82, P161, DOI 10.1016/j.ecss.2009.01.006; Engel J, 1998, CONSERV BIOL, V12, P1204, DOI 10.1046/j.1523-1739.1998.0120061204.x; Foden J, 2009, MAR ECOL PROG SER, V390, P15, DOI 10.3354/meps08169; Fox J., 2019, R COMPANION APPL REG, V.; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gage JD, 2001, CONT SHELF RES, V21, P957, DOI 10.1016/S0278-4343(00)00120-5; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; GRASSLE JF, 1975, DEEP-SEA RES, V22, P457, DOI 10.1016/0011-7471(75)90020-0; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Hannah RW, 2010, FISH B-NOAA, V108, P30; Hartley JP, 1996, MAR POLLUT BULL, V32, P727, DOI 10.1016/0025-326X(96)00033-1; Holdway DA, 2002, MAR POLLUT BULL, V44, P185, DOI 10.1016/S0025-326X(01)00197-7; Hovland M, 2010, MAR PETROL GEOL, V27, P1190, DOI 10.1016/j.marpetgeo.2010.02.005; Hovland Martin, 2008, P1; Hudson IR, 2004, J EXP MAR BIOL ECOL, V301, P75, DOI 10.1016/j.jembe.2003.09.015; Hughes SJM, 2010, J EXP MAR BIOL ECOL, V395, P37, DOI 10.1016/j.jembe.2010.08.012; Hylland K, 2008, MAR POLLUT BULL, V56, P414, DOI 10.1016/j.marpolbul.2007.11.004; Hyne NJ, 2001, NONTECHNICAL GUIDE P; Jones DOB, 2007, MAR BIOL, V151, P1731, DOI 10.1007/s00227-007-0606-3; Jones DOB, 2007, DEEP-SEA RES PT I, V54, P1111, DOI 10.1016/j.dsr.2007.04.001; Jones DOB, 2006, MAR ECOL PROG SER, V319, P43, DOI 10.3354/meps319043; Jones DOB, 2012, MAR ECOL PROG SER, V461, P71, DOI 10.3354/meps09827; Jones DOB, 2009, ZOOL SCR, V38, P41, DOI 10.1111/j.1463-6409.2007.00315.x; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Kotchen MJ, 2007, ENERG POLICY, V35, P4720, DOI 10.1016/j.enpol.2007.04.007; Kroger K, 2006, MAR ECOL PROG SER, V326, P85, DOI 10.3354/meps326085; Larsson AI, 2011, MAR POLLUT BULL, V62, P1159, DOI 10.1016/j.marpolbul.2011.03.041; Lepland A, 2008, ENVIRON GEOL, V56, P119, DOI 10.1007/s00254-007-1145-4; Magurran A.E, 2003, MEASURING BIOL DIVER; MAIR JM, 1987, MAR POLLUT BULL, V18, P628; McBride GB, 1999, AUST NZ J STAT, V41, P19, DOI 10.1111/1467-842X.00058; NEFF JM, 1989, MAR ENVIRON RES, V27, P77, DOI 10.1016/0141-1136(89)90002-0; Netto SA, 2009, DEEP-SEA RES PT II, V56, P41, DOI 10.1016/j.dsr2.2008.08.018; Nodder SD, 2003, DEEP-SEA RES PT I, V50, P959, DOI 10.1016/S0967-0637(03)00094-3; Norkko J, 2010, MAR ECOL PROG SER, V413, P253, DOI 10.3354/meps08745; O'Neill Robert V., 1999, Journal of Aquatic Ecosystem Stress and Recovery, V6, P181, DOI 10.1023/A:1009996332614; Oksanen J., 2016, R PACKAG; OLSGARD F, 1995, MAR ECOL PROG SER, V122, P277, DOI 10.3354/meps122277; Pinder D, 2001, OCEAN COAST MANAGE, V44, P579, DOI 10.1016/S0964-5691(01)00070-9; RICE AL, 1982, OCEANOL ACTA, V5, P63; RICE AL, 1992, J MAR BIOL ASSOC UK, V72, P417, DOI 10.1017/S0025315400037796; Sanchez F, 2008, J MARINE SYST, V72, P64, DOI 10.1016/j.jmarsys.2007.04.008; Sanchez F, 2009, CONT SHELF RES, V29, P1174, DOI 10.1016/j.csr.2009.01.004; Santos MFL, 2009, DEEP-SEA RES PT II, V56, P32, DOI 10.1016/j.dsr2.2008.08.017; Schaanning MT, 2008, J EXP MAR BIOL ECOL, V361, P49, DOI 10.1016/j.jembe.2008.04.014; Schratzberger M, 1999, MAR ECOL PROG SER, V181, P227, DOI 10.3354/meps181227; Schulz M, 2010, POLAR BIOL, V33, P1359, DOI 10.1007/s00300-010-0825-9; Smit MGD, 2008, ENVIRON TOXICOL CHEM, V27, P1006, DOI 10.1897/07-339.1; SMITH CR, 1983, DEEP-SEA RES, V30, P907, DOI 10.1016/0198-0149(83)90048-1; TAGATZ ME, 1978, ESTUAR COAST MAR SCI, V7, P401, DOI 10.1016/0302-3524(78)90092-0; Trannum HC, 2011, MAR ECOL PROG SER, V442, P23, DOI 10.3354/meps09340; Trannum HC, 2010, J EXP MAR BIOL ECOL, V383, P111, DOI 10.1016/j.jembe.2009.12.004; Trannum HC, 2011, MAR POLLUT BULL, V62, P2145, DOI 10.1016/j.marpolbul.2011.07.007; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; Vardaro MF, 2009, LIMNOL OCEANOGR, V54, P2081, DOI 10.4319/lo.2009.54.6.2081; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Wilson MT, 2002, HYDROBIOLOGIA, V471, P133, DOI 10.1023/A:1016509506094	86	35	35	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e44114	10.1371/journal.pone.0044114	http://dx.doi.org/10.1371/journal.pone.0044114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056177	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000309831500005
J	Liu, YQ; Cheng, X; Guo, LX; Mao, C; Chen, YJ; Liu, HX; Xiao, QC; Jiang, S; Yao, ZJ; Zhou, GB				Liu, Yong-Qiang; Cheng, Xin; Guo, Liang-Xia; Mao, Chan; Chen, Yi-Jie; Liu, Hai-Xia; Xiao, Qi-Cai; Jiang, Sheng; Yao, Zhu-Jun; Zhou, Guang-Biao			Identification of an Annonaceous Acetogenin Mimetic, AA005, as an AMPK Activator and Autophagy Inducer in Colon Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE; MAMMALIAN TARGET; RAT-LIVER; METFORMIN; ANTICANCER; INHIBITION; METABOLISM; PHOSPHORYLATION; 2-DEOXYGLUCOSE; MITOCHONDRIA	Annonaceous acetogenins, a large family of naturally occurring polyketides isolated from various species of the plant genus Annonaceae, have been found to exhibit significant cytotoxicity against a variety of cancer cells. Previous studies showed that these compounds could act on the mitochondria complex-I and block the corresponding electron transport chain and terminate ATP production. However, more details of the mechanisms of action remain ambiguous. In this study we tested the effects of a set of mimetics of annonaceous acetogenin on some cancer cell lines, and report that among them AA005 exhibits the most potent antitumor activity. AA005 depletes ATP, activates AMP-activated protein kinase (AMPK) and inhibits mTOR complex 1 (mTORC1) signal pathway, leading to growth inhibition and autophagy of colon cancer cells. AMPK inhibitors compound C and inosine repress, while AMPK activator AICAR enhances, AA005-caused proliferation suppression and subsequent autophagy of colon cancer cells. AA005 enhances the ATP depletion and AMPK activation caused by 2-deoxyglucose, an inhibitor of mitochondrial respiration and glycolysis. AA005 also inhibits chemotherapeutic agent cisplatin-triggered up-regulation of mTOR and synergizes with this drug in suppression of proliferation and induction of apoptosis of colon cancer cells. These data indicate that AA005 is a new metabolic inhibitor which exhibits therapeutic potentials in colon cancer.	[Mao, Chan; Chen, Yi-Jie; Liu, Hai-Xia; Yao, Zhu-Jun] Nanjing Univ, State Key Lab Coordinat Chem, Nanjing Natl Lab Microstruct, Sch Chem & Chem Engn, Nanjing, Jiangsu, Peoples R China; [Xiao, Qi-Cai; Jiang, Sheng] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Liu, Yong-Qiang; Cheng, Xin; Guo, Liang-Xia; Zhou, Guang-Biao] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Mol Carcinogenesis & Targeted Therapy Canc, Beijing, Peoples R China; [Liu, Yong-Qiang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Nanjing University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yao, ZJ (corresponding author), Nanjing Univ, State Key Lab Coordinat Chem, Nanjing Natl Lab Microstruct, Sch Chem & Chem Engn, Nanjing, Jiangsu, Peoples R China.	yaoz@nju.edu.cn; gbzhou@ioz.ac.cn	Zhou, Guangbiao/J-6575-2017; Zhou, Guang-Biao/ABG-5795-2021; Yao, Zhu-Jun/E-7635-2015	Zhou, Guangbiao/0000-0002-6327-2316; Xiao, Qicai/0000-0001-9383-4052; Zhou, Guang-Biao/0000-0001-6778-7133	National Key Program for Basic Research [2012CB910800, 2010CB833200, 2009CB940900]; National Natural Science Foundation [81071930, 81171925, 20972160, 21172220]; Special Foundation of President; Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX1-YW-R-26, KSCX2-YW-R-235]; National Major Scientific and Technological Program for Drug Discovery [2009ZX09103-101]	National Key Program for Basic Research(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Foundation of President; Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Major Scientific and Technological Program for Drug Discovery	This work was supported in part by the National Key Program for Basic Research (2012CB910800, 2010CB833200 and 2009CB940900), the National Natural Science Foundation (No. 81071930, 81171925, 20972160 and 21172220), the Special Foundation of President and the Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-26 and KSCX2-YW-R-235), and the National Major Scientific and Technological Program for Drug Discovery (2009ZX09103-101). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fang HT, 2012, P NATL ACAD SCI USA, V109, P2521, DOI 10.1073/pnas.1121341109; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Hu Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006257; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jiang S, 2002, J ORG CHEM, V67, P3404, DOI 10.1021/jo016396u; Jiang S, 2004, ANGEW CHEM INT EDIT, V43, P329, DOI 10.1002/anie.200352681; Kang HT, 2006, LIFE SCI, V78, P1392, DOI 10.1016/j.lfs.2005.07.001; LANDOLT JL, 1995, CHEM-BIOL INTERACT, V98, P1, DOI 10.1016/0009-2797(95)03628-Y; Liu H, 2007, INT J PRECIS ENG MAN, V8, P8; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021930; Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020159; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nakanishi S, 2011, BBA-BIOENERGETICS, V1807, P1170, DOI 10.1016/j.bbabio.2011.05.012; Neuzil J, 2007, J BIOENERG BIOMEMBR, V39, P65, DOI 10.1007/s10863-006-9060-z; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Xiao QC, 2011, BIOORG MED CHEM LETT, V21, P3613, DOI 10.1016/j.bmcl.2011.04.095; Xiao QC, 2011, J MED CHEM, V54, P525, DOI 10.1021/jm101053k; YAO ZJ, 1995, J ORG CHEM, V60, P1170, DOI 10.1021/jo00110a019; Yu XJ, 2012, CANCER LETT, V322, P185, DOI 10.1016/j.canlet.2012.03.004; Zafra-Polo MC, 1998, PHYTOCHEMISTRY, V48, P1087, DOI 10.1016/S0031-9422(97)00917-5; ZafraPolo MC, 1996, PHYTOCHEMISTRY, V42, P253, DOI 10.1016/0031-9422(95)00836-5; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhou GB, 2007, BLOOD, V109, P3441, DOI 10.1182/blood-2006-06-032250	47	30	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47049	10.1371/journal.pone.0047049	http://dx.doi.org/10.1371/journal.pone.0047049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056575	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500128
J	Martin, RM; Patel, R; Zinovik, A; Kramer, MS; Oken, E; Vilchuck, K; Bogdanovich, N; Sergeichick, N; Gunnarsson, R; Grufman, L; Foo, Y; Gusina, N				Martin, Richard M.; Patel, Rita; Zinovik, Alexander; Kramer, Michael S.; Oken, Emily; Vilchuck, Konstantin; Bogdanovich, Natalia; Sergeichick, Natalia; Gunnarsson, Robert; Grufman, Lisa; Foo, Ying; Gusina, Nina			Filter Paper Blood Spot Enzyme Linked Immunoassay for Insulin and Application in the Evaluation of Determinants of Child Insulin Resistance	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; SYNDROME-X; AUSTRALIAN CHILDREN; GLUCOSE-TOLERANCE; SYNDROME PREDICTS; YOUNG ADULTHOOD; RISK; ADOLESCENTS	Background: In large-scale epidemiology, bloodspot sampling by fingerstick onto filter paper has many advantages, including ease and low costs of collection, processing and transport. We describe the development of an enzyme-linked immunoassay (ELISA) for quantifying insulin from dried blood spots and demonstrate its application in a large trial. Methods: We adapted an existing commercial kit (Mercodia Human Insulin ELISA, 10-1113-01) to quantify insulin from two 3-mm diameter discs (approximate to 6 mu L of blood) punched from whole blood standards and from trial samples. Paediatricians collected dried blood spots in a follow-up of 13,879 fasted children aged 11.5 years (interquartile range 11.3-11.8 years) from 31 trial sites across Belarus. We quantified bloodspot insulin levels and examined their distribution by demography and anthropometry. Results: Mean intra-assay (n = 157) coefficients of variation were 15% and 6% for 'low' (6.7 mU/L) and 'high' (23.1 mU/L) values, respectively; the respective inter-assay values (n = 33) were 23% and 11%. The intraclass correlation coefficient between 50 paired whole bloodspot versus serum samples, collected simultaneously, was 0.90 (95% confidence interval 0.85 to 0.95). Bloodspot insulin was stable for at least 31 months at -80 degrees C, for one week at +30 degrees C and following four freeze-thaw cycles. Paediatricians collected a median of 8 blood spots from 13,487 (97%) children. The geometric mean insulin (log standard deviation) concentrations amongst 12,812 children were 3.0 mU/L (1.1) in boys and 4.0 mU/L (1.0) in girls and were positively associated with pubertal stage, measures of central and peripheral adiposity, height and fasting glucose. Conclusions: Our simple and convenient bloodspot assay is suitable for the measurement of insulin in very small volumes of blood collected on filter paper cards and can be applied to large-scale epidemiology studies of the early-life determinants of circulating insulin.	[Martin, Richard M.] Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Zinovik, Alexander; Vilchuck, Konstantin; Bogdanovich, Natalia; Sergeichick, Natalia; Gusina, Nina] Mother & Child Ctr, Minsk, BELARUS; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Oken, Emily] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Oken, Emily] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Gunnarsson, Robert; Grufman, Lisa] Mercodia AB, Uppsala, Sweden	University of Bristol; McGill University; McGill University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Martin, RM (corresponding author), Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	richard.martin@bristol.ac.uk		Martin, Richard/0000-0002-7992-7719	European Union [FOOD-DT-2005-007036]; Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research [MOP - 53155]; USA National Institutes of Health [050758-01A2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD069408, R01HD050758] Funding Source: NIH RePORTER	European Union(European Commission); Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the European Union, grant no. FOOD-DT-2005-007036; Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research (MOP - 53155); and the USA National Institutes of Health (reference: 050758-01A2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAO WH, 1994, ARCH INTERN MED, V154, P1842; Bao WH, 1996, CIRCULATION, V93, P54, DOI 10.1161/01.CIR.93.1.54; Barker DJP, 1998, MOTHERS BABIES HLTH; Butter NL, 2001, CLIN CHIM ACTA, V310, P141, DOI 10.1016/S0009-8981(01)00545-9; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Cruz ML, 2002, HYPERTENSION, V40, P18, DOI 10.1161/01.HYP.0000019972.37690.EF; Dwyer T, 2002, INT J OBESITY, V26, P1301, DOI 10.1038/sj.ijo.0802111; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120; International Organisation for Standardisation, 2003, 118434 ISO; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kuh D, 1997, LIFE COURSE APPROACH; Laaksonen DE, 2002, AM J EPIDEMIOL, V156, P1070, DOI 10.1093/aje/kwf145; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lawlor DA, 2002, BMJ-BRIT MED J, V325, P359, DOI 10.1136/bmj.325.7360.359; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Lynch JF, 1998, MED J AUSTRALIA, V168, P61, DOI 10.5694/j.1326-5377.1998.tb126712.x; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; McGill HC, 2002, CIRCULATION, V105, P2712, DOI 10.1161/01.CIR.0000018121.67607.CE; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Miller WG, 2009, CLIN CHEM, V55, P1011, DOI 10.1373/clinchem.2008.118380; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; National Committee for Clinical Laboratory Standards (NCCLS), 1997, A4A3 NAT COMM CLIN L; Parker SP, 1999, J CLIN PATHOL, V52, P633, DOI 10.1136/jcp.52.9.633; Pyorala M, 2000, ARTERIOSCL THROM VAS, V20, P538, DOI 10.1161/01.ATV.20.2.538; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Smith GD, 1997, LANCET, V349, P284, DOI 10.1016/S0140-6736(05)64894-5; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; WARNICK GR, 1994, ARCH PATHOL LAB MED, V118, P1110; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Williams SR, 2009, J GERONTOL B-PSYCHOL; Worthman CM, 1997, AM J PHYS ANTHROPOL, V104, P1	42	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46752	10.1371/journal.pone.0046752	http://dx.doi.org/10.1371/journal.pone.0046752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056434	Green Submitted, gold, Green Published			2022-12-27	WOS:000309831500070
J	Miyashita, H; Watanabe, T; Hayashi, H; Suzuki, Y; Nakamura, T; Ito, S; Ono, M; Hoshikawa, Y; Okada, Y; Kondo, T; Sato, Y				Miyashita, Hiroki; Watanabe, Tatsuaki; Hayashi, Hideki; Suzuki, Yasuhiro; Nakamura, Takanobu; Ito, Soichi; Ono, Manabu; Hoshikawa, Yasushi; Okada, Yoshinori; Kondo, Takashi; Sato, Yasufumi			Angiogenesis Inhibitor Vasohibin-1 Enhances Stress Resistance of Endothelial Cells via Induction of SOD2 and SIRT1	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NEGATIVE FEEDBACK REGULATOR; DNA-DAMAGE RESPONSE; SUPEROXIDE-DISMUTASE; DEACETYLASE SIRT1; OXIDATIVE STRESS; SENESCENCE; MICE; OVEREXPRESSION; PROTEIN	Vasohibin-1 (VASH1) is isolated as an endothelial cell (EC)-produced angiogenesis inhibitor. We questioned whether VASH1 plays any role besides angiogenesis inhibition, knocked-down or overexpressed VASH1 in ECs, and examined the changes of EC property. Knock-down of VASH1 induced premature senescence of ECs, and those ECs were easily killed by cellular stresses. In contrast, overexpression of VASH1 made ECs resistant to premature senescence and cell death caused by cellular stresses. The synthesis of VASH1 was regulated by HuR-mediated post-transcriptional regulation. We sought to define the underlying mechanism. VASH1 increased the expression of (superoxide dismutase 2) SOD2, an enzyme known to quench reactive oxygen species (ROS). Simultaneously, VASH1 augmented the synthesis of sirtuin 1 (SIRT1), an anti-aging protein, which improved stress tolerance. Paraquat generates ROS and causes organ damage when administered in vivo. More VASH1 (+/-) mice died due to acute lung injury caused by paraquat. Intratracheal administration of an adenovirus vector encoding human VASH1 augmented SOD2 and SIRT1 expression in the lungs and prevented acute lung injury caused by paraquat. Thus, VASH1 is a critical factor that improves the stress tolerance of ECs via the induction of SOD2 and SIRT1.	[Miyashita, Hiroki; Watanabe, Tatsuaki; Hayashi, Hideki; Suzuki, Yasuhiro; Nakamura, Takanobu; Ito, Soichi; Ono, Manabu; Sato, Yasufumi] Tohoku Univ, Dept Vasc Biol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Watanabe, Tatsuaki; Hoshikawa, Yasushi; Okada, Yoshinori; Kondo, Takashi] Tohoku Univ, Dept Thorac Surg, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Sato, Y (corresponding author), Tohoku Univ, Dept Vasc Biol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	y-sato@idac.tohoku.ac.jp	Sato, Yasufumi/AAF-3367-2019; Suzuki, Yasuhiro/GOE-4553-2022	Suzuki, Yasuhiro/0000-0001-9046-5466; Ono, Manabu/0000-0003-3831-9773	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22112006, 22590821]; Mitsubishi Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation	This work was supported by grants from the programs Grant-in-Aid for Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network" (22112006) and Grants-in-Aid for Scientific Research (C) [ 22590821] from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the 38th Research Grants in the Natural Sciences from the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018; Bertram C, 2008, BIOL CHEM, V389, P211, DOI 10.1515/BC.2008.031; Chen J, 2008, J NEPHROL, V21, P337; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Didion SP, 2005, ARTERIOSCL THROM VAS, V25, P90, DOI 10.1161/01.ATV.0000149868.74075.5d; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007; Gurevich F, 2009, AM J MED, V122, P322, DOI 10.1016/j.amjmed.2008.11.025; Han MLK, 2011, AM J RESP CRIT CARE, V183, P1311, DOI 10.1164/rccm.201102-0280UP; Heishi T, 2010, AM J PATHOL, V176, P1950, DOI 10.2353/ajpath.2010.090829; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788; Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100; Jerkic M, 2011, CARDIOVASC RES, V92, P375, DOI 10.1093/cvr/cvr232; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Minamino T, 2008, FRONT BIOSCI-LANDMRK, V13, P2971, DOI 10.2741/2902; Miyashita H, 2011, PHARMACEUTICALS, V4, P782, DOI 10.3390/ph4060782; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Namba K, 2000, ONCOGENE, V19, P106, DOI 10.1038/sj.onc.1203257; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; O'Riordan E, 2007, AM J PHYSIOL-HEART C, V292, pH285, DOI 10.1152/ajpheart.00560.2006; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Potente M, 2008, CELL CYCLE, V7, P2117, DOI 10.4161/cc.7.14.6267; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010; Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26; Shimizu K, 2005, BIOCHEM BIOPH RES CO, V327, P700, DOI 10.1016/j.bbrc.2004.12.073; Siedlinski M, 2009, EUR RESPIR J, V33, P986, DOI 10.1183/09031936.00171507; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; SUZUKI K, 1993, AM J PHYSIOL, V265, pH1173, DOI 10.1152/ajpheart.1993.265.4.H1173; Suzuki Y, 2010, J CELL SCI, V123, P3094, DOI 10.1242/jcs.067538; Takemura A, 2011, ARTERIOSCL THROM VAS, V31, P2054, DOI 10.1161/ATVBAHA.110.216739; Tomita M, 2007, TOXICOLOGY, V231, P200, DOI 10.1016/j.tox.2006.12.005; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Yamashita H, 2006, BIOCHEM BIOPH RES CO, V345, P919, DOI 10.1016/j.bbrc.2006.04.176; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224	48	52	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46459	10.1371/journal.pone.0046459	http://dx.doi.org/10.1371/journal.pone.0046459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056314	gold, Green Submitted, Green Published			2022-12-27	WOS:000309831500042
J	Oh, CJ; Kim, JY; Choi, YK; Kim, HJ; Jeong, JY; Bae, KH; Park, KG; Lee, IK				Oh, Chang Joo; Kim, Joon-Young; Choi, Young-Keun; Kim, Han-Jong; Jeong, Ji-Yun; Bae, Kwi-Hyun; Park, Keun-Gyu; Lee, In-Kyu			Dimethylfumarate Attenuates Renal Fibrosis via NF-E2-Related Factor 2-Mediated Inhibition of Transforming Growth Factor-beta/Smad Signaling	PLOS ONE			English	Article							FUMARIC-ACID ESTERS; TGF-BETA; TUBULOINTERSTITIAL FIBROSIS; ANTIOXIDANT RESPONSE; NRF2; TARGET; SUPPRESSES; DEPOSITION; INDUCTION; PSORIASIS	TGF-beta plays a key role in the development of renal fibrosis. Suppressing the TGF-beta signaling pathway is a possible therapeutic approach for preventing this disease, and reports have suggested that Nrf2 protects against renal fibrosis by inhibiting TGF-beta signaling. This study examines whether dimethylfumarate (DMF), which stimulates Nrf2, prevents renal fibrosis via the Nrf2-mediated suppression of TGF-beta signaling. Results showed that DMF increased nuclear levels of Nrf2, and both DMF and adenovirus-mediated overexpression of Nrf2 (Ad-Nrf2) decreased PAI-1, alpha-smooth muscle actin (alpha-SMA), fibronectin and type 1 collagen expression in TGF-beta-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F). Additionally, DMF and Ad-Nrf2 repressed TGF-beta-stimulated Smad3 activity by inhibiting Smad3 phosphorylation, which was restored by siRNA-mediated knockdown of Nrf2 expression. However, downregulation of the antioxidant response element (ARE)-driven Nrf2 target genes such as NQO1, HO-1 and glutathione S-transferase (GST) did not reverse the inhibitory effect of DMF on TGF-beta-induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an ARE-independent anti-fibrotic activity of DMF. Finally, DMF suppressed unilateral ureteral obstruction (UUO)-induced renal fibrosis and alpha-SMA, fibronectin and type 1 collagen expression in the obstructed kidneys from UUO mice, along with increased and decreased expression of Nrf2 and phospho-Smad3, respectively. In summary, DMF attenuated renal fibrosis via the Nrf2-mediated inhibition of TGF-beta/Smad3 signaling in an ARE-independent manner, suggesting that DMF could be used to treat renal fibrosis.	[Oh, Chang Joo; Kim, Joon-Young; Choi, Young-Keun; Kim, Han-Jong; Jeong, Ji-Yun; Bae, Kwi-Hyun; Park, Keun-Gyu; Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Res Inst Aging & Metab,WCU Program, Taegu, South Korea; [Kim, Joon-Young] Gwangju Inst Sci & Technol, GIST Coll, Kwangju, South Korea; [Kim, Han-Jong] Chonnam Natl Univ, Hwasun Hosp, Res Inst Clin Med, Hwasun, South Korea	Kyungpook National University; Gwangju Institute of Science & Technology (GIST); Chonnam National University	Lee, IK (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Res Inst Aging & Metab,WCU Program, Taegu, South Korea.	leei@knu.ac.kr	Lee, In-Kyu/AAR-6374-2021		National Research Foundation [2011-0028659, R32-10064, 2011-0019229, 2012-0006798, 2012-0001350]; Korean Ministry of Education, Science and Technology	National Research Foundation; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the National Research Foundation (2011-0028659; WCU Program, R32-10064; Future-based Technology Development Program Bio Field, 2011-0019229; and Basic Science Research Program, 2012-0006798 to J-YK and 2012-0001350 to H-JK), funded by the Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Aleksunes LM, 2010, J PHARMACOL EXP THER, V335, P2, DOI 10.1124/jpet.110.170084; BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Cross SA, 2011, J IMMUNOL, V187, P5015, DOI 10.4049/jimmunol.1101868; Ellrichmann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016172; Gagliardini E, 2006, CYTOKINE GROWTH F R, V17, P89, DOI 10.1016/j.cytogfr.2005.09.005; Gold R, 2012, CLIN IMMUNOL, V142, P44, DOI 10.1016/j.clim.2011.02.017; Gold R, 2011, CNS DRUGS, V25, P37, DOI 10.2165/11539820-000000000-00000; Ha H, 2003, J AM SOC NEPHROL, V14, pS246, DOI 10.1097/01.ASN.0000077411.98742.54; Hwang M, 2006, EXP MOL PATHOL, V81, P48, DOI 10.1016/j.yexmp.2005.11.005; Iglesias-de la Cruz MC, 2001, KIDNEY INT, V59, P87, DOI 10.1046/j.1523-1755.2001.00469.x; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jiang T, 2010, DIABETES, V59, P850, DOI 10.2337/db09-1342; Jiang Z, 2003, BIOCHEM BIOPH RES CO, V309, P961, DOI 10.1016/j.bbrc.2003.08.102; JOHNSON RJ, 1993, J AM SOC NEPHROL, V4, P119; Jung GS, 2012, J AM SOC NEPHROL, V23, P73, DOI 10.1681/ASN.2011010048; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kelly DJ, 2001, J AM SOC NEPHROL, V12, P2098, DOI 10.1681/ASN.V12102098; Kim HJ, 2010, ARTERIOSCL THROM VAS, V30, P2164, DOI 10.1161/ATVBAHA.110.212308; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Loewe R, 2006, CANCER RES, V66, P11888, DOI 10.1158/0008-5472.CAN-06-2397; Moharregh-Khiabani D, 2009, CURR NEUROPHARMACOL, V7, P60, DOI 10.2174/157015909787602788; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Ockenfels HM, 1998, BRIT J DERMATOL, V139, P390; Oh CJ, 2012, FREE RADICAL BIO MED, V52, P671, DOI 10.1016/j.freeradbiomed.2011.11.012; Papadopoulou A, 2010, EXPERT OPIN INV DRUG, V19, P1603, DOI 10.1517/13543784.2010.534778; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Sato S, 2009, BIOCHEM BIOPH RES CO, V379, P411, DOI 10.1016/j.bbrc.2008.12.088; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; Seidel P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-145; Shin DH, 2010, FREE RADICAL BIO MED, V48, P1051, DOI 10.1016/j.freeradbiomed.2010.01.021; Tsai PY, 2011, FREE RADICAL BIO MED, V50, P1503, DOI 10.1016/j.freeradbiomed.2011.02.029; Valero T, 2010, J INVEST DERMATOL, V130, P1087, DOI 10.1038/jid.2009.368; Wain EM, 2010, BRIT J DERMATOL, V162, P427, DOI 10.1111/j.1365-2133.2009.09267.x; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Yamazoe Y, 2009, CELL BIOL INT, V33, P1087, DOI 10.1016/j.cellbi.2009.06.027; Zhou AH, 2003, KIDNEY INT, V64, P92, DOI 10.1046/j.1523-1755.2003.00045.x	45	74	76	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45870	10.1371/journal.pone.0045870	http://dx.doi.org/10.1371/journal.pone.0045870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056222	Green Submitted, gold, Green Published			2022-12-27	WOS:000309831500022
J	Saias, T; Beck, F; Bodard, J; Guignard, R; du Roscoat, E				Saias, Thomas; Beck, Francois; Bodard, Julie; Guignard, Romain; du Roscoaet, Enguerrand			Social Participation, Social Environment and Death Ideations in Later Life	PLOS ONE			English	Article							OLDER-ADULTS; SUICIDE-PREVENTION; PREVALENCE; SUPPORT; IMPACT; RISK; HOME	Objective: Few studies on elders' suicide and depression have integrated social and community factors in their explicative models. Most of the studied variables used are focused on individual and based on psychopathological models. The purpose of this study is to investigate the impact of socio-environmental factors on death ideations, using data from the European SHARE cohort. Method: Social support components and death ideations have been studied, together with known individual risk factors, within a sample of 11,425 European participants in the SHARE study, aged over 64. The item evaluating death ideations was extracted from the EURO-D12 questionnaire. Results: The high prevalence of death ideations (6.9% for men and 13.0% for women) confirmed that elders' death ideations, as it is known to be linked to suicidal behaviors, is a major public health issue. Bivariate analyses revealed a strong association between community participation and death ideations. This association was no longer significant while adjusting for depressive symptomatology. The logistic model identified that factors significantly associated with death ideations, when adjusted for the other factors were: having multiple depressive symptoms (OR = 1.64 per symptom) being aged, especially over 84 (OR = 1.58), being retired for fewer than five years (OR = 1.46), being widowed (OR = 1.35) and having a long-term illness (OR = 1.28). Conclusions: Although social and community participation is associated to death ideations, this link becomes nonsignificant in a regression model taking into account other factors. It is important to notice that depressive symptoms, which are obviously closely related to death ideations, take the greatest part in the association among all associated factors. Our results suggest that, consistently with the literature, while addressing death ideation or suicide prevention, professionals have to consider first the secondary prevention of depressive symptomatology. Strategies targeting social isolation and community participation should be considered as part of primary prevention policies.	[Saias, Thomas; Beck, Francois; Bodard, Julie; Guignard, Romain; du Roscoaet, Enguerrand] Inst Natl Prevent & Educ Sante, Direct Affaires Sci, St Denis, France; [Saias, Thomas] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Beck, Francois] Univ Paris 05, EHESS, CNRS, UMR 8211,Inserm,U988,Cesames Team Cermes3, Paris, France	University of Quebec; University of Quebec Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Saias, T (corresponding author), Inst Natl Prevent & Educ Sante, Direct Affaires Sci, St Denis, France.	th.saias@gmail.com		Beck, Francois/0000-0002-4880-1638	European Commission [QLK6-CT-2001- 00360, RII-CT-2006-062193, CIT5-CT-2005-028857, CIT4-CT-2006-028812, 211909, 227822]; U.S. National Institute on Aging [U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, Y1-AG-4553-01, OGHA 04-064, IAG BSR06-11, R21 AG025169]; NATIONAL INSTITUTE ON AGING [P01AG008291, P01AG005842, P30AG012815, U01AG009740, R21AG025169] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This paper uses data from SHARE release 2.5.0. The SHARE data collection has been primarily funded by the European Commission through the 5th framework programme (project QLK6-CT-2001- 00360 in the thematic programme Quality of Life), through the 6th framework programme (projects SHARE-I3, RII-CT-2006-062193, COMPARE, CIT5-CT-2005-028857, and SHARELIFE, CIT4-CT-2006-028812) and through the 7th framework programme (SHARE-PREP, 211909 and SHARE-LEAP, 227822). Additional funding from the U.S. National Institute on Aging (U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, Y1-AG-4553-01 and OGHA 04-064, IAG BSR06-11, R21 AG025169) as well as from various national sources is gratefully acknowledged (see www.share-project.org for a full list of funding institutions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnow S, 2000, Crisis, V21, P171, DOI 10.1027//0227-5910.21.4.171; Beck F, 2011, BEH, P488; Boen H, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-27; Borsch-Supan A., 2005, SURVEY HLTH AGEING R; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX; Bruchon-Schweitzer M, 2005, PSYCHOL SANTE MODELE; Casadebaig F, 2003, REV EPIDEMIOL SANTE, V51, P55; Conwell Y, 2008, PSYCHIAT CLIN N AM, V31, P333, DOI 10.1016/j.psc.2008.01.004; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; De Leo D, 2002, BRIT J PSYCHIAT, V181, P226, DOI 10.1192/bjp.181.3.226; DELEO D, 1995, AM J PSYCHIAT, V152, P632; Dennis M, 2007, PSYCHOL MED, V37, P795, DOI 10.1017/S0033291707000013; Dube M, 2007, EUR REV APPL PSYCHOL, V57, P183, DOI 10.1016/j.erap.2005.04.004; Durkheim E., 1897, SUICIDE ETUDE SOCIOL; Erlangsen A, 2004, AGE AGEING, V33, P378, DOI 10.1093/ageing/afh128; Erlangsen A, 2011, CRISIS, V32, P106, DOI 10.1027/0227-5910/a000053; GallagherThompson D, 1997, BEHAV THER, V28, P23, DOI 10.1016/S0005-7894(97)80032-9; Heisel MJ, 2009, PROF PSYCHOL-RES PR, V40, P156, DOI 10.1037/a0014731; Keleher H, 2005, EVIDENCE BASED MENTA; Kelly BD, 2009, SOC PSYCH PSYCH EPID, V44, P971, DOI 10.1007/s00127-009-0018-4; Lapierre S, 2007, CRISIS, V28, P16, DOI 10.1027/0227-5910.28.1.16; Lapierre S, 2011, CRISIS, V32, P88, DOI 10.1027/0227-5910/a000076; Leitner M., 2008, EFFECTIVENESS INTERV; O'Connell H, 2004, BMJ-BRIT MED J, V329, P895, DOI 10.1136/bmj.329.7471.895; Organisation Mondiale de la Sante, 2002, DISTR SUIC RAT PER 1; Oyama H, 2005, PSYCHIAT CLIN NEUROS, V59, P337, DOI 10.1111/j.1440-1819.2005.01379.x; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P330, DOI 10.1192/bjp.174.4.330; Rurup ML, 2011, CRISIS, V32, P194, DOI 10.1027/0227-5910/a000079; Saias T, 2012, PRATIQUES P IN PRESS; Scocco P, 2002, INT J GERIATR PSYCH, V17, P842, DOI 10.1002/gps.691; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Turvey CL, 2002, AM J GERIAT PSYCHIAT, V10, P398; Van Orden K, 2011, CURR PSYCHIAT REP, V13, P234, DOI 10.1007/s11920-011-0193-3; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Waern M, 2003, GERONTOLOGY, V49, P328, DOI 10.1159/000071715; Wiktorsson S, 2011, J AFFECT DISORDERS, V134, P333, DOI 10.1016/j.jad.2011.06.010; World Health Organization, 2002, ACT AG POL FRAM; Yip PSF, 2003, INT J GERIATR PSYCH, V18, P1056, DOI 10.1002/gps.1014; Yur'yev A, 2010, INT PSYCHOGERIATR, V22, P1337, DOI 10.1017/S1041610210001614	39	28	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46723	10.1371/journal.pone.0046723	http://dx.doi.org/10.1371/journal.pone.0046723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056423	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500062
J	Ghorbani, M; Ardestani, MS; Gigloo, SH; Cohan, RA; Inanlou, DN; Ghorbani, P				Ghorbani, Masoud; Ardestani, Mehdi Shafiee; Gigloo, Sedigheh Hatami; Cohan, Reza Ahangari; Inanlou, Davoud Nouri; Ghorbani, Peyman			Anti Diabetic effect of CL 316,243 (A beta 3-Adrenergic Agonist) by Down Regulation of Tumour Necrosis Factor (TNF-alpha) Expression	PLOS ONE			English	Article							BROWN ADIPOCYTES; GENE-EXPRESSION; OBESITY; RECEPTORS; GLUCOSE	Objective: Obesity is a risk factor for the development of insulin resistance and is one of the most important contributors to the pathogenesis of type2 diabetes, which acts mainly through the secretion of adipokines such as TNF-alpha that may influence insulin sensitivity. TNF-alpha affects many aspects of adipocyte function, such as adipocyte development and lipid metabolism. Material and Methods: We demonstrated that there is a correlation between the expressions of TNF-a in retroperitoneal WAT and insulin-resistance in 8 genetically obese fa/fa rats. Treatment of animals with CL 316,243, alpha beta 3-adrenergic agonist, showed an improvement of insulin-resistance that was linked with the suppression of TNF-alpha mRNA expression in WAT. Results: These results confirm the association between TNF-alpha expression and the insulin-resistant condition in rats. Our finding indicates that the hyperglycaemia and hyperinsulinemia induced by insulin-resistance correlated positively with the expression of TNF-alpha mRNA in an abdominal WAT depot. Conclusion: We conclude that CL 316,243 possesses both anti-diabetic effects and anti-obesity effects in rodents.	[Ghorbani, Masoud] Pasteur Inst Iran, Dept Microbiol & Immunol, Tehran, Iran; [Ghorbani, Masoud; Gigloo, Sedigheh Hatami; Inanlou, Davoud Nouri] Pasteur Inst Iran, Karaj, Iran; [Ghorbani, Masoud] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ardestani, Mehdi Shafiee; Cohan, Reza Ahangari] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran; [Ghorbani, Peyman] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of Ottawa; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of Toronto	Ghorbani, M (corresponding author), Pasteur Inst Iran, Dept Microbiol & Immunol, Tehran, Iran.	mghorbani@irimc.org	ahangari cohan, reza/L-9626-2017; Cohan, Reza Ahangari/AAH-3594-2019; Ghorbani, Masoud/U-8549-2019; Ghorbani, Masoud/P-1544-2014	ahangari cohan, reza/0000-0002-0490-4184; Cohan, Reza Ahangari/0000-0002-0490-4184; Ghorbani, Masoud/0000-0002-2367-6690; Ghorbani, Masoud/0000-0002-4299-028X; Ghorbani, Peyman/0000-0002-7398-5141	Medical Council of Canada	Medical Council of Canada	This work was supported by grants from the Medical Council of Canada and performed in part at the University of Ottawa and completed at Pasteur Institute of Iran. No grant number was available at the time. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DALLAIRE F, 1995, BRIT J PHARMACOL, V114, P275, DOI 10.1111/j.1476-5381.1995.tb13223.x; Fu L, 2008, EUR J PHARMACOL, V584, P202, DOI 10.1016/j.ejphar.2008.01.028; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; HOFMANN C, 1994, ENDOCRINOLOGY, V134, P264, DOI 10.1210/en.134.1.264; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Howard G, 1998, ANN EPIDEMIOL, V8, P358, DOI 10.1016/S1047-2797(98)00002-7; Hyunsook K, 2006, AM J PHYSL ENDO, V290, P6; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; LARGIS EE, 1994, DRUG DEVELOP RES, V32, P69, DOI 10.1002/ddr.430320203; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; SPIEGELMAN BM, 1993, CELL, V73, P625, DOI 10.1016/0092-8674(93)90243-J; SPIEGELMAN BM, 1993, J BIOL CHEM, V268, P6823	17	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e45874	10.1371/journal.pone.0045874	http://dx.doi.org/10.1371/journal.pone.0045874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056223	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800005
J	Gonzalez-Teuber, M; Bueno, JCS; Heil, M; Boland, W				Gonzalez-Teuber, Marcia; Silva Bueno, Juan Carlos; Heil, Martin; Boland, Wilhelm			Increased Host Investment in Extrafloral Nectar (EFN) Improves the Efficiency of a Mutualistic Defensive Service	PLOS ONE			English	Article							ANT-PLANT MUTUALISM; ARABIDOPSIS-THALIANA; HERBIVORES; RESISTANCE; PROTECTION; SELECTION; TRAITS; ACACIA; PARASITE; EXPLOITATION	Extrafloral nectar (EFN) plays an important role as plant indirect defence through the attraction of defending ants. Like all rewards produced in the context of a mutualism, however, EFN is in danger of being exploited by non-ant consumers that do not defend the plant against herbivores. Here we asked whether plants, by investing more in EFN, can improve their indirect defence, or rather increase the risk of losing this investment to EFN thieves. We used the obligate plant-ant Acacia-Pseudomyrmex system and examined experimentally in the field during the dry and the rainy seasons how variations in EFN secretion are related to (i) ant activity, to (ii) the ant-mediated defence against herbivores and (iii) the exploitation of EFN by non-ant consumers. Extrafloral investment enhanced ant recruitment and was positively related to the ant mediated defence against herbivores. The ant-mediated protection from exploiters also increased in proportion to the nectar sugar concentration. Although the daily peak of EFN production coincided with the highest activity of EFN thieves, Pseudomyrmex ferrugineus ants protected this resource effectively from exploiters. Nevertheless, the defensive effects by ants differed among seasons. During the dry season, plants grew slower and secreted more EFN than in the rainy season, and thus, experienced a higher level of ant-mediated indirect defence. Our results show that an increased plant investment in an indirect defence trait can improve the resulting defensive service against both herbivores and exploiters. EFN secretion by obligate ant-plants represents a defensive trait for which the level of investment correlates positively with the beneficial effects obtained.	[Gonzalez-Teuber, Marcia; Boland, Wilhelm] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany; [Silva Bueno, Juan Carlos; Heil, Martin] CINVESTAV Irapuato, Dept Ingn Genet, Guanajuato, Mexico	Max Planck Society; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Gonzalez-Teuber, M (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Beutenberg Campus, Jena, Germany.	mgonzalez-teuber@ice.mpg.de	Heil, Martin/T-3960-2019; Heil, Martin/AAC-2730-2022; Heil, Martin/I-1797-2012; Boland, Wilhelm/K-7762-2012; González-Teuber, Marcia/ABH-2318-2021	Heil, Martin/0000-0001-8036-8697; Boland, Wilhelm/0000-0001-6784-2534; 	DFG [He 3169/4-2]; CONACyT (Consejo Nacional de Ciencia y Tecnologia); Max-Planck-Society; Alexander von Humboldt Foundation	DFG(German Research Foundation (DFG)); CONACyT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Financial support by the DFG (grant He 3169/4-2), CONACyT (Consejo Nacional de Ciencia y Tecnologia) and Max-Planck-Society is gratefully acknowledged. MGT is supported by a postdoctoral fellowship from the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, J CHEM ECOL, V25, P2285, DOI 10.1023/A:1020821823794; BAKER HG, 1978, BOT GAZ, V139, P322, DOI 10.1086/337008; BAKER HG, 1973, NATURE, V241, P543, DOI 10.1038/241543b0; Ballhorn DJ, 2007, J CHEM ECOL, V33, P2195, DOI 10.1007/s10886-007-9380-4; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; BENTLEY BL, 1977, ANNU REV ECOL SYST, V8, P407, DOI 10.1146/annurev.es.08.110177.002203; Bidart-Bouzat MG, 2008, J CHEM ECOL, V34, P1026, DOI 10.1007/s10886-008-9498-z; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Castells E, 2008, ARTHROPOD-PLANT INTE, V2, P43, DOI 10.1007/s11829-008-9032-9; Chamberlain SA, 2008, ECOLOGY, V89, P1364, DOI 10.1890/07-1139.1; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Clement LW, 2008, BEHAV ECOL SOCIOBIOL, V62, P953, DOI 10.1007/s00265-007-0520-1; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; Doebeli M, 1998, P NATL ACAD SCI USA, V95, P8676, DOI 10.1073/pnas.95.15.8676; Freitas L, 2000, FLORA, V195, P398; Gonzalez-Teuber M, 2010, PLANT PHYSIOL, V152, P1705, DOI 10.1104/pp.109.148478; Gonzalez-Teuber M, 2009, J CHEM ECOL, V35, P459, DOI 10.1007/s10886-009-9618-4; Gonzalez-Teuber M, 2009, PLANT J, V58, P464, DOI 10.1111/j.1365-313X.2009.03790.x; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Heil M, 2004, J TROP ECOL, V20, P573, DOI 10.1017/S0266467404001567; Heil M, 2004, J TROP ECOL, V20, P201, DOI 10.1017/S026646740300110X; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Heil M, 2009, P NATL ACAD SCI USA, V106, P18091, DOI 10.1073/pnas.0904304106; Irwin RE, 2010, ANNU REV ECOL EVOL S, V41, P271, DOI 10.1146/annurev.ecolsys.110308.120330; JANZEN DH, 1975, SCIENCE, V188, P936, DOI 10.1126/science.188.4191.936; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Janzen DH, 1974, SWOLLEN THORN ACACIA; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Koptur S, 1992, INSECT PLANT INTERAC, VIV, P81; Kost C, 2005, BASIC APPL ECOL, V6, P237, DOI 10.1016/j.baae.2004.11.002; Lankau RA, 2007, NEW PHYTOL, V175, P176, DOI 10.1111/j.1469-8137.2007.02090.x; LETOURNEAU DK, 1990, SCIENCE, V248, P215, DOI 10.1126/science.248.4952.215; Li Q, 2000, J CHEM ECOL, V26, P2401, DOI 10.1023/A:1005535129399; Maloof JE, 2001, AM J BOT, V88, P1960, DOI 10.2307/3558423; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Meehan CJ, 2009, CURR BIOL, V19, pR892, DOI 10.1016/j.cub.2009.08.049; Mitchell RJ, 2004, ECOLOGY, V85, P1527, DOI 10.1890/03-0388; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; ODOWD DJ, 1983, OECOLOGIA, V59, P191, DOI 10.1007/BF00378837; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; PEMBERTON RW, 1993, P ENTOMOL SOC WASH, V95, P642; PRICE PW, 1986, ECOLOGY, V67, P1593, DOI 10.2307/1939090; Raine NE, 2004, ECOL ENTOMOL, V29, P345, DOI 10.1111/j.0307-6946.2004.00608.x; RASHBROOK VK, 1992, ECOLOGY, V73, P2167, DOI 10.2307/1941464; Romero GQ, 2011, J ANIM ECOL, V80, P696, DOI 10.1111/j.1365-2656.2011.01808.x; Rose USR, 2006, FUNCT ECOL, V20, P67, DOI 10.1111/j.1365-2435.2006.01071.x; Rudgers JA, 2004, P ROY SOC B-BIOL SCI, V271, P2481, DOI 10.1098/rspb.2004.2900; Rudgers JA, 2004, ECOLOGY, V85, P192, DOI 10.1890/02-0625; SEIGLER DS, 1995, ANN MO BOT GARD, V82, P117, DOI 10.2307/2399983; Strassner M, 1999, KLIMADIAGRAMME ERD 2; TEMPEL AS, 1983, ECOLOGY, V64, P1411, DOI 10.2307/1937495; van der Meijden E, 1998, INSECT POPULATIONS IN THEORY AND IN PRACTICE, P291; van Rijn PCJ, 1999, EXP APPL ACAROL, V23, P281, DOI 10.1023/A:1006240126971; Ward Philip S., 1993, Journal of Hymenoptera Research, V2, P117; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	60	34	34	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46598	10.1371/journal.pone.0046598	http://dx.doi.org/10.1371/journal.pone.0046598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056362	Green Published, gold			2022-12-27	WOS:000309580800030
J	Li, W; Huang, XJ; Tong, HF; Wang, YX; Zhang, T; Wang, W; Dai, LL; Li, T; Lin, SZ; Wu, H				Li, Wei; Huang, Xiaojie; Tong, Hongfei; Wang, Yuxuan; Zhang, Tong; Wang, Wen; Dai, Lili; Li, Tongzeng; Lin, Shengzhang; Wu, Hao			Comparison of the Regulation of beta-Catenin Signaling by Type I, Type II and Type III Interferons in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							IFN-LAMBDA; PATHWAY; CANCER; TRANSDUCTION; REPLICATION; EXPRESSION; DEATH; FATE	Background/Objective: IFNs are a group of cytokines that possess potent antiviral and antitumor activities, while beta-catenin pathway is a proliferative pathway involved in carcinogenesis. Interaction between these two pathways has not been well elaborated in hepatocellular carcinoma (HCC). Methods: HCC cell lines, HepG2 and Huh7, were used in this study. beta-catenin protein levels and corresponding signaling activities were observed by flow cytometry and luciferase assay, respectively. Cell proliferation was quantified by counting viable cells under microscope, and apoptosis by TUNEL assay. DKK1 and GSK3 beta levels were determined by flow cytometry. Secreted DKK1 was tested by ELISA. FLUD, S3I and aDKK1 were used to inhibit STAT1, STAT3 and DKK1 activities, respectively. Results: Our findings show that all three types of IFNs, IFN alpha, IFN gamma and IFN lambda, are capable of inhibiting b-catenin signaling activity in HepG2 and Huh7 cells, where IFN gamma was the strongest (p<0.05). They expressed suppression of cellular proliferation and induced apoptosis. IFN gamma expressed greater induction ability when compared to IFN alpha and IFN lambda (p<0.05). All tested IFNs could induce DKK1 activation but not GSK3 beta in HepG2 and Huh7 cells. IFNs induced STAT1 and STAT3 activation but by using specific inhibitors, we found that only STAT3 is vital for IFN-induced DKK1 activation and apoptosis. In addition, DKK1 inhibitor blocked IFN-induced apoptosis. The pattern of STAT3 activation by different IFNs is found consistent with the levels of apoptosis with the corresponding IFNs (p<0.05). Conclusions: In hepatocellular carcinoma, all three types of IFNs are found to induce apoptosis by inhibiting beta-catenin signaling pathway via a STAT3- and DKK1-dependent pathway. This finding points to a cross-talk between different IFN types and beta-catenin signaling pathways which might be carrying a biological effect not only on HCC, but also on processes where the two pathways bridge.	[Li, Wei; Huang, Xiaojie; Zhang, Tong; Wang, Wen; Dai, Lili; Li, Tongzeng; Wu, Hao] Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Tong, Hongfei] Wenzhou Med Coll, Affiliated Hosp 2, Dept Gen Surg, Wenzhou, Zhejiang, Peoples R China; [Lin, Shengzhang] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepato Biliary Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yuxuan] SUNY Binghamton, Mat Sci & Engn Program, Binghamton, NY USA	Capital Medical University; Wenzhou Medical University; Zhejiang University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Wu, H (corresponding author), Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China.	shengzhanglin@gmail.com; wuhao90000@gmail.com	Li, Wei/I-8060-2014; Zhang, Tong/HGC-1090-2022	Li, Wei/0000-0002-9991-7892	National Natural Science Foundation of China [81161120423/H19]; Project of Beijing Municipal Science and Technology Commission [D09050703590901]; Beijing Key Laboratory [BZ0089]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [PHR201007112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Beijing Municipal Science and Technology Commission; Beijing Key Laboratory; Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality	This work is supported by National Natural Science Foundation of China (Grant # 81161120423/H19), Project of Beijing Municipal Science and Technology Commission (Grant # D09050703590901), Beijing Key Laboratory (Grant #BZ0089) and Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (Grant # PHR201007112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abushahba W, 2010, CANCER IMMUNOL IMMUN, V59, P1059, DOI 10.1007/s00262-010-0831-3; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Borden EC, 2005, J INTERF CYTOK RES, V25, P511, DOI 10.1089/jir.2005.25.511; Carruba G, 1999, ANN NY ACAD SCI, V886, P212, DOI 10.1111/j.1749-6632.1999.tb09419.x; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Dvory-Sobol H, 2006, MOL CANCER THER, V5, P2861, DOI 10.1158/1535-7163.MCT-06-0122; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kalvakolanu DV, 2004, CYTOKINE GROWTH F R, V15, P169, DOI 10.1016/j.cytogfr.2004.01.002; Kelly C, 2011, GUT, V60, P1284, DOI 10.1136/gut.2010.222976; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Lai TY, 2011, ONCOL REP, V26, P415, DOI 10.3892/or.2011.1323; Li PY, 2012, CANCER LETT, V314, P213, DOI 10.1016/j.canlet.2011.09.031; Li W, 2008, CELL PROLIFERAT, V41, P960, DOI 10.1111/j.1365-2184.2008.00558.x; Li W, 2012, ONCOLOGY LETT, V4; Li W, 2011, J IMMUNOL, V186, P6771, DOI 10.4049/jimmunol.1100099; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Merle P, 2004, GASTROENTEROLOGY, V127, P1110, DOI 10.1053/j.gastro.2004.07.009; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Parmar S, 2005, CANC TREAT, V126, P45, DOI 10.1007/0-387-24361-5_3; Parody JP, 2010, GROWTH FACTORS, V28, P166, DOI 10.3109/08977190903547863; Ceballos MP, 2011, BIOCHEM PHARMACOL, V82, P1682, DOI 10.1016/j.bcp.2011.08.001; Platanias LC, 2005, J INTERF CYTOK RES, V25, P732, DOI 10.1089/jir.2005.25.732; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Thompson MD, 2011, J HEPATOL, V54, P506, DOI 10.1016/j.jhep.2010.07.020; Zimmerer JM, 2007, CANCER IMMUNOL IMMUN, V56, P1845, DOI 10.1007/s00262-007-0329-9	32	14	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e47040	10.1371/journal.pone.0047040	http://dx.doi.org/10.1371/journal.pone.0047040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056571	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800070
J	Schils, T				Schils, Tom			Episodic Eruptions of Volcanic Ash Trigger a Reversible Cascade of Nuisance Species Outbreaks in Pristine Coral Habitats	PLOS ONE			English	Article							TROPICAL MARINE CYANOBACTERIA; TERPIOS-HOSHINOTA SUBERITIDAE; PHASE-SHIFTS; ENCRUSTING SPONGE; KILLING SPONGE; BENTHIC ALGAE; REEFS; IRON; IMPACTS; ISLANDS	Volcanically active islands abound in the tropical Pacific and harbor complex coral communities. Whereas lava streams and deep ash deposits are well-known to devastate coral communities through burial and smothering, little is known about the effect of moderate amounts of small particulate ash deposits on reef communities. Volcanic ash contains a diversity of chemical compounds that can induce nutrient enrichments triggering changes in benthic composition. Two independently collected data sets on the marine benthos of the pristine and remote reefs around Pagan Island, Northern Mariana Islands, reveal a sudden critical transition to cyanobacteria-dominated communities in 2009-2010, which coincides with a period of continuous volcanic ash eruptions. Concurrently, localized outbreaks of the coral-killing cyanobacteriosponge Terpios hoshinota displayed a remarkable symbiosis with filamentous cyanobacteria, which supported the rapid overgrowth of massive coral colonies and allowed the sponge to colonize substrate types from which it has not been documented before. The chemical composition of tephra from Pagan indicates that the outbreak of nuisance species on its reefs might represent an early succession stage of iron enrichment (a.k.a. "black reefs'') similar to that caused by anthropogenic debris like ship wrecks or natural events like particulate deposition from wildfire smoke plumes or desert dust storms. Once Pagan's volcanic activity ceased in 2011, the cyanobacterial bloom disappeared. Another group of well-known nuisance algae in the tropical Pacific, the pelagophytes, did not reach bloom densities during this period of ash eruptions but new species records for the Northern Mariana Islands were documented. These field observations indicate that the study of population dynamics of pristine coral communities can advance our understanding of the resilience of tropical reef systems to natural and anthropogenic disturbances.	Univ Guam, Marine Lab, UOG Stn, Mangilao, GU 96923 USA	University of Guam	Schils, T (corresponding author), Univ Guam, Marine Lab, UOG Stn, Mangilao, GU 96923 USA.	tom@schils.be	Schils, Tom/A-7087-2008	Schils, Tom/0000-0002-1516-9082	US Fish and Wildlife Service; University of Guam Sea Grant Program from National Sea Grant, NOAA, U.S. Department of Commerce [NA09OAR4170197]	US Fish and Wildlife Service(US Fish & Wildlife Service); University of Guam Sea Grant Program from National Sea Grant, NOAA, U.S. Department of Commerce	Funding was provided by the US Fish and Wildlife Service and the University of Guam Sea Grant Program under grant agreement #NA09OAR4170197 from National Sea Grant, NOAA, U.S. Department of Commerce. The funders had no role in data analysis, decision to publish, or preparation of the manuscript.	BANKS NG, 1984, J VOLCANOL GEOTH RES, V22, P225, DOI 10.1016/0377-0273(84)90004-0; Basso D., 2009, PERMUTATION TESTS ST, V194; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; BRYAN P G, 1973, Micronesica, V9, P237; Eldredge L.G., 1982, Information Bulletin Pacific Science Association, V34, P26; Eldredge LG, 1985, P 5 INT COR REEF C T, V4, P195; Frogner P, 2001, GEOLOGY, V29, P487, DOI 10.1130/0091-7613(2001)029<0487:FPOVAI>2.0.CO;2; Gantar M, 2011, MAR DRUGS, V9, P2089, DOI 10.3390/md9102089; Hallock P, 2005, SEDIMENT GEOL, V175, P19, DOI 10.1016/j.sedgeo.2004.12.027; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kelly LW, 2012, ISME J, V6, P638, DOI 10.1038/ismej.2011.114; Kelly Michelle, 2003, Micronesica, V35-36, P100; Kuffner IB, 2004, CORAL REEFS, V23, P455, DOI 10.1007/s00338-004-0416-8; Kuffner IB, 2001, MAR ECOL PROG SER, V222, P63, DOI 10.3354/meps222063; Larson EE, 1974, B VOLCANOL, V38, P361; Legendre P, 2011, ANOVA 1WAY R ONE WAY; Littler M.M., 1984, PROGR PHYCOLOGICAL R, V3, P323; Nagle DG, 1999, J PHYCOL, V35, P1412; Ono Shusuke, 2002, South Pacific Study, V22, P41; Pacific Islands Fisheries Science Center, 2010, PIFSC SPEC PUBL; Paczuska L, 2003, OCEANOLOGIA, V45, P679; Paul VJ, 2005, CORAL REEFS, V24, P693, DOI 10.1007/s00338-005-0061-x; PLUCERROSARIO G, 1987, CORAL REEFS, V5, P197, DOI 10.1007/BF00300963; Quigg A, 2011, P ROY SOC B-BIOL SCI, V278, P526, DOI 10.1098/rspb.2010.1356; R Development Core Team, 2012, R LANG ENV STAT COMP; Randall RH, 1985, P 5 INT COR REEF C T, V4, P261; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; Reimer JD, 2011, ZOOL STUD, V50, P394; Reimer JD, 2011, GALAXEA J CORAL REEF, V13, P35, DOI DOI 10.3755/GALAXEA.13.35; Richmond Robert H., 2008, V1, P719, DOI 10.1007/978-1-4020-6847-8_19; Sako MK, 1994, 94705 US GEOL SURV; Sangil C, 2012, MAR ENVIRON RES, V77, P120, DOI 10.1016/j.marenvres.2012.03.004; Schaffelke B, 2004, CORAL REEFS, V23, P514, DOI 10.1007/s00338-004-0439-1; SIMS JK, 1981, HAWAII MED J, V40, P243; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Smithsonian Global Volcanism Program, 2011, PAG MONTHL REP; Soong K, 2009, ZOOL STUD, V48, P596; Sorokin YI, 1998, J PLANKTON RES, V20, P1015, DOI 10.1093/plankt/20.6.1015; Sparrow L, 2007, INFLUENCE NUTR TEMPE; Stielow S, 2003, HARMFUL ALGAE, V2, P127, DOI 10.1016/S1568-9883(03)00007-6; Sukhraj NC, 2010, MARINE RESOURCE SURV; Sukhraj NC, 2010, MARINE RESOURCE SURV; Tang SL, 2011, ENVIRON MICROBIOL, V13, P1179, DOI 10.1111/j.1462-2920.2010.02418.x; Thacker RW, 2004, APPL ENVIRON MICROB, V70, P3305, DOI 10.1128/AEM.70.6.3305-3312.2004; Thacker RW, 2005, INTEGR COMP BIOL, V45, P369, DOI 10.1093/icb/45.2.369; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; TRUSDELL FA, 2006, 20061386 US GEOL SUR; US Geological Survey Volcano Hazards Program, 2011, VOLC INF PAG; Vroom PS, 2011, CORAL REEFS, V30, P1025, DOI 10.1007/s00338-011-0793-8; Vroom Peter S., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/164127; Wang JT, 2012, ZOOL STUD, V51, P314; Wang JT, 2012, ZOOL STUD, V51, P150; Work TM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002989	53	29	29	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46639	10.1371/journal.pone.0046639	http://dx.doi.org/10.1371/journal.pone.0046639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056381	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800036
J	Boyes, ME; Cluver, LD; Gardner, F				Boyes, Mark E.; Cluver, Lucie D.; Gardner, Frances			Psychometric Properties of the Child PTSD Checklist in a Community Sample of South African Children and Adolescents	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CONFIRMATORY FACTOR-ANALYSIS; PRINCIPAL-COMPONENTS-ANALYSIS; AIDS-ORPHANED CHILDREN; EVENT SCALE; SYMPTOMS; TRAUMA; IMPACT; DEPRESSION; DISASTER	Objective: The current study assessed the basic psychometric properties of the Child PTSD Checklist and examined the structure of symptoms of posttraumatic stress disorder (PTSD) in a large sample of South African youth. Methodology: The checklist was completed by 1025 (540 male; 485 female) South African youth (aged between 10 and 19 years). The factor structure of the scale was assessed with a combination of confirmatory and exploratory techniques. Internal consistencies for the full scale and all subscales were evaluated with Cronbach's alpha and McDonald's omega. Validity was assessed by comparing PTSD scores obtained by children who had and had not experienced a traumatic event, and by examining associations between total PTSD scores and known correlates of PTSD. Results: Scores on the Child PTSD Checklist clearly discriminated between youth who had experienced a traumatic event and those who had not. Internal consistencies for the full scale (and all subscales) were acceptable to good and hypothesized correlations between PTSD, depression, anxiety, somatic symptoms, and age were observed. Two of the reported fit statistics for the tripartite DSM-IV-TR model of PTSD did not meet traditional criteria and further exploratory analyses revealed a four-factor structure (broadly consistent with Simms and colleagues' Dysphoria Model of PTSD symptoms) which provided a better fit to the observed data. Conclusion: Given the continued use of the Child PTSD Checklist in South Africa, findings offer an important first step in establishing the reliability and validity of the checklist for use with South African youth. However, further evaluation of the checklist in South African samples is clearly required before conclusions regarding its use as diagnostic tool in this context can be made.	[Boyes, Mark E.; Cluver, Lucie D.; Gardner, Frances] Univ Oxford, Ctr Evidence Based Intervent, Dept Social Policy & Intervent, Oxford, England; [Cluver, Lucie D.] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa	University of Oxford; University of Cape Town	Boyes, ME (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Dept Social Policy & Intervent, Oxford, England.	mark.boyes@socres.ox.ac.uk	Boyes, Mark/G-9680-2014; Boyes, Mark/E-2084-2013	Boyes, Mark/0000-0001-5420-8606; Cluver, Lucie/0000-0002-0418-835X	Economic and Social Research Council [RES-062-23-2068]; Nuffield Foundation [OPD/35198]; ESRC [ES/H001743/1] Funding Source: UKRI; Economic and Social Research Council [ES/H001743/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Nuffield Foundation; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The writing of this study was supported by grants from the Economic and Social Research Council (grant number RES-062-23-2068, http://www.esrc.ac.uk) and the Nuffield Foundation (grant number OPD/35198, http://www.nuffieldfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya-Jackson L., 1995, CHILD PTSD CHECKLIST; AMAYAJACKSON L, 2000, ANN M AM AC CHILD AD; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson B., 2006, 030906 STAT SA; [Anonymous], 1991, MANUAL CHILD BEHAV C; Asmundson Gordon J. G., 2003, Cognitive Behaviour Therapy, V32, P26, DOI 10.1080/16506070310003648; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Blunch NJ, 2008, INTRO STRUCTURAL MOD; Boelen PA, 2008, J ANXIETY DISORD, V22, P1377, DOI 10.1016/j.janxdis.2008.01.018; Boyes ME, 2013, EUR J PSYCHOL ASSESS, V29, P113, DOI 10.1027/1015-5759/a000134; BRADY KT, 1994, AM J ADDICTION, V3, P160; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Briere J., 1996, TRAUMA SYMPTOM CHECK; Carragher N, 2010, J ANXIETY DISORD, V24, P520, DOI 10.1016/j.janxdis.2010.03.009; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Cloitre M, 2002, GENDER PTSD, P117; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Cluver L, 2009, J TRAUMA STRESS, V22, P106, DOI 10.1002/jts.20396; Cornelius JR, 2010, ADDICT BEHAV, V35, P91, DOI 10.1016/j.addbeh.2009.09.007; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DuHamel KN, 2004, PSYCHOL ASSESSMENT, V16, P255, DOI 10.1037/1040-3590.16.3.255; Dyregrov A, 1996, SCAND J PSYCHOL, V37, P339, DOI 10.1111/j.1467-9450.1996.tb00667.x; Elkit A., 2010, J ANXIETY DIORD, V24, P147, DOI [10.1016/j.janxdis.2009.10.002, DOI 10.1016/J.JANXDIS.2009.10.002]; Ensink K, 1997, S AFR MED J, V87, P1526; Field A, 2013, DISCOVERING STAT USI; Gerard A., 1999, USE PSYCHOL TESTING, P323; GIACONIA RM, 1995, J AM ACAD CHILD PSY, V34, P1369, DOI 10.1097/00004583-199510000-00023; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; GREEN BL, 1991, J AM ACAD CHILD PSY, V30, P945, DOI 10.1097/00004583-199111000-00012; GREEN BL, 1994, J AM ACAD CHILD PSY, V33, P71, DOI 10.1097/00004583-199401000-00011; Hetzel-Riggin M. D., 2009, TRAUMATOLOGY, V15, P46, DOI DOI 10.1177/1534765608331294; JOSEPH S, 1994, BEHAV RES THER, V32, P521, DOI 10.1016/0005-7967(94)90139-2; Kassam-Adams N, 2010, J AM ACAD CHILD PSY, V49, P616, DOI 10.1016/j.jaac.2010.02.011; Kendall-Tackett KA, 2000, CHILD ABUSE NEGLECT, V24, P799, DOI 10.1016/S0145-2134(00)00136-8; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; KINZIE JD, 1986, J AM ACAD CHILD PSY, V25, P370, DOI 10.1016/S0002-7138(09)60259-4; Kovacs M., 1992, CHILDRENS DEPRESSION; KUTEROVAC G, 1994, BRIT J MED PSYCHOL, V67, P363, DOI 10.1111/j.2044-8341.1994.tb01804.x; Liang HL, 2007, CHILD ABUSE NEGLECT, V31, P161, DOI 10.1016/j.chiabu.2006.08.007; Liu AZ, 2008, PSYCHIAT RES, V159, P376, DOI 10.1016/j.psychres.2007.08.015; Mansfield AJ, 2010, J TRAUMA STRESS, V23, P91, DOI 10.1002/jts.20492; Marsh HW, 2004, PSYCHOL METHODS, V9, P275, DOI 10.1037/1082-989X.9.3.275; McDonald RP, 1999, TEST THEORY UNIFIED; MCFARLANE AC, 1994, J PSYCHOSOM RES, V38, P715, DOI 10.1016/0022-3999(94)90024-8; Michael KD, 1998, J AM ACAD CHILD PSY, V37, P194, DOI 10.1097/00004583-199802000-00012; Mulis I. V. S., 2007, PIRLS 2006 IEAS PROG; NADER K, 1990, AM J PSYCHIAT, V147, P1526; Naifeh JA, 2008, J ANXIETY DISORD, V22, P1355, DOI 10.1016/j.janxdis.2008.01.016; outh African Police Services, 2009, ANN REP 2008 2009 SA; Palmieri PA, 2007, J ABNORM PSYCHOL, V116, P329, DOI 10.1037/0021-843X.116.2.329; Palmieri PA, 2007, J TRAUMA STRESS, V20, P207, DOI 10.1002/jts.20196; PYNOOS RS, 1987, ARCH GEN PSYCHIAT, V44, P1057; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; REYNOLDS CR, 1978, J ABNORM CHILD PSYCH, V6, P271, DOI 10.1007/BF00919131; RICHTERS JE, 1993, PSYCHIATRY, V56, P7; Sack WH, 1998, PERS INDIV DIFFER, V25, P57, DOI 10.1016/S0191-8869(98)00030-0; Sack WH, 1997, J AM ACAD CHILD PSY, V36, P49, DOI 10.1097/00004583-199701000-00017; SAIGH PA, 1991, BEHAV RES THER, V29, P213, DOI 10.1016/0005-7967(91)90110-O; SAYLOR CF, 1984, J CONSULT CLIN PSYCH, V52, P955, DOI 10.1037/0022-006X.52.6.955; Seedat S, 2004, BRIT J PSYCHIAT, V184, P169, DOI 10.1192/bjp.184.2.169; Seedat S, 2000, S AFR J CHILD ADOLES, V12, P38, DOI DOI 10.1080/16826108.2000.9632366; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; Snider L., 2006, PSYCHOSOCIAL VULNERA; Suliman S, 2009, COMPR PSYCHIAT, V50, P121, DOI 10.1016/j.comppsych.2008.06.006; Thabet AA, 2000, INT J SOC PSYCHIATR, V46, P266, DOI 10.1177/002076400004600404; Thabet AAM, 1999, J CHILD PSYCHOL PSYC, V40, P385, DOI 10.1111/1469-7610.00456; Ullman SE, 2008, J TRAUMA DISSOCIATIO, V9, P507, DOI 10.1080/15299730802223370; Van de Vijver F, 1996, EUR PSYCHOL, V1, P89, DOI 10.1027/1016-9040.1.2.89; WEISZ JR, 1993, CHILD DEV, V64, P98, DOI 10.1111/j.1467-8624.1993.tb02897.x; World Health Organization, 1999, WHOHSCPVI991; YULE W, 1994, PERS INDIV DIFFER, V16, P685, DOI 10.1016/0191-8869(94)90210-0	73	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46905	10.1371/journal.pone.0046905	http://dx.doi.org/10.1371/journal.pone.0046905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056523	gold, Green Published			2022-12-27	WOS:000309454000100
J	Colloca, G; Tosato, M; Vetrano, DL; Topinkova, E; Fialova, D; Gindin, J; van der Roest, HG; Landi, F; Liperoti, R; Bernabei, R; Onder, G				Colloca, Giuseppe; Tosato, Matteo; Vetrano, Davide L.; Topinkova, Eva; Fialova, Daniela; Gindin, Jacob; van der Roest, Henriette G.; Landi, Francesco; Liperoti, Rosa; Bernabei, Roberto; Onder, Graziano		SHELTER Project	Inappropriate Drugs in Elderly Patients with Severe Cognitive Impairment: Results from the Shelter Study	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; APPROPRIATE MEDICATION USE; ALZHEIMERS-DISEASE; ADVANCED DEMENTIA; OLDER; DONEPEZIL; MEMANTINE; MODERATE; CARE; EUROPE	Background: It has been estimated that Nursing Home (NH) residents with impaired cognitive status receive an average of seven to eight drugs daily. The aim of this study was to determine prevalence and factors associated with use of inappropriate drugs in elderly patients with severe cognitive impairment living in NH in Europe. Methods: Cross-sectional data from a sample of 1449 NH residents with severe cognitive impairment, participating in the Services and Health for Elderly in Long TERm care (SHELTER) study were analysed. Inappropriate drug use was defined as the use of drugs classified as rarely or never appropriate in patients with severe cognitive impairment based on the Holmes criteria published in 2008. Results: Mean age of participating residents was 84.2 +/- 8.9 years, 1087 (75.0%) were women. Inappropriate drug use was observed in 643 (44.9%) residents. Most commonly used inappropriate drugs were lipid-lowering agents (9.9%), antiplatelet agents (excluding Acetylsalicylic Acid - ASA -) (9.9%), acetylcholinesterase, inhibitors (7.2%) and antispasmodics (6.9%). Inappropriate drug use was directly associated with specific diseases including diabetes (OR 1.64; 95% CI 1.21-2.24), heart failure (OR 1.48; 95% CI 1.04-2.09), stroke (OR 1.43; 95% CI 1.06-1.93), and recent hospitalization (OR 1.69; 95% CI 1.20-2.39). An inverse relation was shown between inappropriate drug use and presence of a geriatrician in the facility (OR 0.55; 95% CI 0.39-0.77). Conclusion: Use of inappropriate drugs is common among older EU NH residents. Determinants of inappropriate drug use include comorbidities and recent hospitalization. Presence of a geriatrician in the facility staff is associated with a reduced rate of use of these medications.	[Colloca, Giuseppe; Tosato, Matteo; Vetrano, Davide L.; Landi, Francesco; Liperoti, Rosa; Bernabei, Roberto; Onder, Graziano] Univ Cattolica Sacro Cuore, Ctr Med Invecchiamento, Rome, Italy; [Topinkova, Eva; Fialova, Daniela] Charles Univ Prague, Dept Geriatr & Gerontol, Fac Med 1, Prague, Czech Republic; [Gindin, Jacob] Univ Haifa, Lab Res Geriatr & Gerontol, IL-31999 Haifa, Israel; [van der Roest, Henriette G.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Nursing Home Med, Med Ctr, Amsterdam, Netherlands	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Charles University Prague; University of Haifa; Vrije Universiteit Amsterdam	Colloca, G (corresponding author), Univ Cattolica Sacro Cuore, Ctr Med Invecchiamento, Rome, Italy.	giuseppe.colloca@rm.unicatt.it	Bernabei, Roberto/AAB-2704-2019; van der Roest, Henriëtte/AAB-3641-2019; Topinkova, Eva/A-5076-2019; Liperoti, Rosa/K-1826-2018; colloca, giuseppe/D-7387-2018; colloca, giuseppe/B-7908-2019; Tosato, Matteo/J-3863-2018; Vetrano, Davide Liborio/K-7417-2016	Bernabei, Roberto/0000-0002-9197-004X; van der Roest, Henriëtte/0000-0001-9898-923X; Topinkova, Eva/0000-0002-6786-4116; Liperoti, Rosa/0000-0003-3740-1687; colloca, giuseppe/0000-0001-6763-0793; Tosato, Matteo/0000-0001-5750-9746; Liperoti, Rosa/0000-0001-5548-3212; Vetrano, Davide Liborio/0000-0002-3099-4830	Seventh Framework Program of the European Union [IGA-MH-CR NS-10029-4]	Seventh Framework Program of the European Union(European Commission)	The SHELTER study was funded by the Seventh Framework Program of the European Union. Grant IGA-MH-CR NS-10029-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauner DJ, 2000, JAMA-J AM MED ASSOC, V283, P3230, DOI 10.1001/jama.283.24.3230; Colloca G, 2010, SURG ONCOL, V19, P124, DOI 10.1016/j.suronc.2009.11.011; Doshi JA, 2005, J AM GERIATR SOC, V53, P438, DOI 10.1111/j.1532-5415.2005.53161.x; Fried TR, 2011, ARCH INTERN MED, V171, P75, DOI 10.1001/archinternmed.2010.318; Fusco D, 2009, DRUG AGING, V26, P3, DOI 10.2165/11534620-000000000-00000; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Holmes HM, 2009, CLIN PHARMACOL THER, V85, P103, DOI 10.1038/clpt.2008.211; Holmes HM, 2008, J AM GERIATR SOC, V56, P1306, DOI 10.1111/j.1532-5415.2008.01741.x; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Huey Edward D, 2006, Alzheimers Dement, V2, P314, DOI 10.1016/j.jalz.2006.08.003; Landi F, 1999, J Nutr Health Aging, V3, P24; Lee M, 2009, J AM MED DIR ASSOC, V10, P466, DOI 10.1016/j.jamda.2009.03.014; Magaziner J, 2000, GERONTOLOGIST, V40, P663, DOI 10.1093/geront/40.6.663; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; Onder G, 2002, EUR J CLIN PHARMACOL, V58, P371, DOI 10.1007/s00228-002-0493-y; Onder G, 2012, J GERONTOL A-BIOL, V67, P698, DOI 10.1093/gerona/glr233; Onder G, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-5; Onder G, 2011, CURR DRUG METAB, V12, P647, DOI 10.2174/138920011796504563; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; Sabbagh M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-21; Schneider LS, 2012, NEW ENGL J MED, V366, P957, DOI 10.1056/NEJMe1200429; Shega Joseph W, 2003, J Palliat Med, V6, P315, DOI 10.1089/109662103764978641; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Teno JM, 2010, JAMA-J AM MED ASSOC, V303, P544, DOI 10.1001/jama.2010.79; Tjia J, 2010, J AM GERIATR SOC, V58, P880, DOI 10.1111/j.1532-5415.2010.02819.x; [No title captured]	27	36	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46669	10.1371/journal.pone.0046669	http://dx.doi.org/10.1371/journal.pone.0046669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056394	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000072
J	Dominguez-Rodrigo, M; Pickering, TR; Diez-Martin, F; Mabulla, A; Musiba, C; Trancho, G; Baquedano, E; Bunn, HT; Barboni, D; Santonja, M; Uribelarrea, D; Ashley, GM; Martinez-Avila, MD; Barba, R; Gidna, A; Yravedra, J; Arriaza, C				Dominguez-Rodrigo, Manuel; Pickering, Travis Rayne; Diez-Martin, Fernando; Mabulla, Audax; Musiba, Charles; Trancho, Gonzalo; Baquedano, Enrique; Bunn, Henry T.; Barboni, Doris; Santonja, Manuel; Uribelarrea, David; Ashley, Gail M.; del Sol Martinez-Avila, Maria; Barba, Rebeca; Gidna, Agness; Yravedra, Jose; Arriaza, Carmen			Earliest Porotic Hyperostosis on a 1.5-Million-Year-Old Hominin, Olduvai Gorge, Tanzania	PLOS ONE			English	Article							CRIBRA-ORBITALIA; INFANT-MORTALITY; CHIMPANZEES; PREDATION; PATTERNS; DISEASE; CRANIUM; ANEMIA; BOISEI; BONE	Meat-eating was an important factor affecting early hominin brain expansion, social organization and geographic movement. Stone tool butchery marks on ungulate fossils in several African archaeological assemblages demonstrate a significant level of carnivory by Pleistocene hominins, but the discovery at Olduvai Gorge of a child's pathological cranial fragments indicates that some hominins probably experienced scarcity of animal foods during various stages of their life histories. The child's parietal fragments, excavated from 1.5-million-year-old sediments, show porotic hyperostosis, a pathology associated with anemia. Nutritional deficiencies, including anemia, are most common at weaning, when children lose passive immunity received through their mothers' milk. Our results suggest, alternatively, that (1) the developmentally disruptive potential of weaning reached far beyond sedentary Holocene food-producing societies and into the early Pleistocene, or that (2) a hominin mother's meat-deficient diet negatively altered the nutritional content of her breast milk to the extent that her nursing child ultimately died from malnourishment. Either way, this discovery highlights that by at least 1.5 million years ago early human physiology was already adapted to a diet that included the regular consumption of meat.	[Dominguez-Rodrigo, Manuel; Baquedano, Enrique; Barba, Rebeca; Gidna, Agness; Arriaza, Carmen] IDEA Inst Evoluc Africa, Museo Origenes, Madrid, Spain; [Dominguez-Rodrigo, Manuel; Yravedra, Jose] Univ Complutense, Dept Prehist, E-28040 Madrid, Spain; [Pickering, Travis Rayne; Bunn, Henry T.] Univ Wisconsin Madison, Dept Anthropol, Madison, WI USA; [Pickering, Travis Rayne] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa; [Pickering, Travis Rayne] Transvaal Museum, Ditsong Natl Museum Nat Hist, Dept Vertebrates, Pliopleistocene Palaeontol Sect, Pretoria, South Africa; [Diez-Martin, Fernando] Univ Valladolid, Dept Archaeol & Prehist, Valladolid, Spain; [Mabulla, Audax] Univ Dar Es Salaam, Archaeol Unit, Dar Es Salaam, Tanzania; [Musiba, Charles] Univ Colorado Denver, Dept Anthropol, Denver, CO USA; [Trancho, Gonzalo; del Sol Martinez-Avila, Maria] Univ Complutense, Dept Anthropol, E-28040 Madrid, Spain; [Baquedano, Enrique; Arriaza, Carmen] Museo Arqueol Reg, Madrid, Spain; [Barboni, Doris] Aix Marseille Univ, CEREGE, AMU CNRS IRD Coll France, Aix En Provence, France; [Santonja, Manuel] CENIEH Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [Uribelarrea, David] Univ Complutense, Dept Geodynam, E-28040 Madrid, Spain; [Ashley, Gail M.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA	Complutense University of Madrid; University of Wisconsin System; University of Wisconsin Madison; University of Witwatersrand; Universidad de Valladolid; University of Dar es Salaam; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Complutense University of Madrid; UDICE-French Research Universities; Aix-Marseille Universite; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Complutense University of Madrid; Rutgers State University New Brunswick	Dominguez-Rodrigo, M (corresponding author), IDEA Inst Evoluc Africa, Museo Origenes, Madrid, Spain.	m.dominguez.rodrigo@gmail.com	Barboni, Doris/A-6908-2010; Manuel, Santonja/F-1698-2018; Yravedra, Jose/E-9815-2016; DEL VAL, DAVID URIBELARREA/J-4750-2017; del Carmen Arriaza Dorado, María/AAB-3468-2021; Diez-Martin, Fernando/D-6158-2016; URIBELARREA, DAVID/K-2446-2019; Yravedra, Jose/AAC-2073-2019; Baquedano, Enrique/ABE-9997-2020; Mabulla, Audax ZP/ABE-2455-2020	Barboni, Doris/0000-0001-7753-1254; DEL VAL, DAVID URIBELARREA/0000-0001-9769-3445; del Carmen Arriaza Dorado, María/0000-0003-1393-4323; Diez-Martin, Fernando/0000-0001-7284-362X; URIBELARREA, DAVID/0000-0001-9769-3445; Yravedra, Jose/0000-0002-4323-3379; Santonja, Manuel/0000-0001-5848-9011	Spanish Ministry of Science and Innovation [I+D HAR2010-18952-C02-01]; Ministry of Culture	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Culture	Funding provided by the Spanish Ministry of Science and Innovation through the project I+D HAR2010-18952-C02-01 and from the Ministry of Culture through the Archaeological Projects Abroad program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL JL, 1966, SCIENCE, V153, P760, DOI 10.1126/science.153.3737.760; Aufderheide A. C., 2011, CAMBRIDGE ENCY HUMAN, DOI DOI 10.5860/CHOICE.36-2492; Blumenschine RJ, 1986, BAR INT SERIES; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Brauer G, 2003, AM J PHYS ANTHROPOL, V120, P200, DOI 10.1002/ajpa.10144; Bunn HT, 2012, OXFORD HDB ARCHAEOLO; Campillo D, 2002, CRANEO INFANTIL ORCE; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; D'Anastasio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006439; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean M. C., 2009, 1 HUMANS ORIGIN EARL, P101; Degusta D, 2010, INT J OSTEOARCHAEOL, V20, P597, DOI 10.1002/oa.1081; Djuric M, 2008, INT J OSTEOARCHAEOL, V18, P458, DOI 10.1002/oa.955; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P77, DOI 10.1006/jhev.2000.0441; DominguezRodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Egeland CP, 2008, J HUM EVOL, V55, P1031, DOI 10.1016/j.jhevol.2008.05.021; ELNAJJAR MY, 1975, AM J ROENTGENOL, V125, P918, DOI 10.2214/ajr.125.4.918; Gentry A.W., 1978, Bulletin of the British Museum (Natural History) Geology, V29, P289; Grauer AL, 2012, BLACKW COMPANION ANT, P1; Guatelli-Steinberg D, 2003, AM J PHYS ANTHROPOL, V120, P309, DOI 10.1002/ajpa.10148; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; Hill K, 2007, J HUM EVOL, V52, P443, DOI 10.1016/j.jhevol.2006.11.003; Howell N, 2010, LIFE HIST DOBE KUNG; Huffman MA, 2009, CAM S BIO EVOL ANTHR, V57, P1; JOZSA L, 1991, Zentralblatt fuer Pathologie, V137, P41; Katzenberg MA, 1996, YEARB PHYS ANTHROPOL, V39, P177; Kennedy GE, 2005, J HUM EVOL, V48, P123, DOI 10.1016/j.jhevol.2004.09.005; LALLO JW, 1977, HUM BIOL, V49, P471; Leakey M.D., 1971, OLDUVAI GORGE; Liversidge HM, 1994, INT J OSTEOARCHAEOL, V4, P37, DOI [DOI 10.1002/0A.1390040107, DOI 10.1002/(ISSN)1099-1212]; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Ortner DJ, 1997, INT J OSTEOARCHAEOL, V7, P212, DOI 10.1002/(SICI)1099-1212(199705)7:3<212::AID-OA346>3.0.CO;2-5; PALKOVICH AM, 1987, AM J PHYS ANTHROPOL, V74, P527, DOI 10.1002/ajpa.1330740411; Pearson JA, 2010, AM J PHYS ANTHROPOL, V143, P448, DOI 10.1002/ajpa.21335; Perez PJ, 1998, ATAPUERCA EVOLUCION, P333; Pickering TR, 2012, STONE TOOLS AND FOSSIL BONES: DEBATES IN THE ARCHAEOLOGY OF HUMAN ORIGINS, P174; RAK Y, 1978, AM J PHYS ANTHROPOL, V48, P345, DOI 10.1002/ajpa.1330480311; RAK Y, 1978, AM J PHYS ANTHROPOL, V49, P71, DOI 10.1002/ajpa.1330490111; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; Ripamonti U, 1997, S AFR J SCI, V93, P177; Robinson JT, 1956, DENTITION AUSTRALOPI; ROTHSCHILD BM, 1995, NATURE, V378, P343, DOI 10.1038/378343b0; Ryan AJ, 1997, PHYSICIAN SPORTSMED, V25, P25, DOI 10.1080/00913847.1997.11439182; Schueller M, 2003, INTERNATIONAL HANDBOOK ON FINANCIAL REFORM, P73, DOI 10.1016/B978-012528628-2/50043-0; Schultz M, 2001, YEARB PHYS ANTHROPOL, V44, P106, DOI 10.1002/ajpa.10024; SMITH BH, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P143; STANFORD CB, 1994, AM J PHYS ANTHROPOL, V94, P213, DOI 10.1002/ajpa.1330940206; STUARTMACADAM P, 1992, AM J PHYS ANTHROPOL, V87, P39, DOI 10.1002/ajpa.1330870105; STUARTMACADAM P, 1987, AM J PHYS ANTHROPOL, V74, P521, DOI 10.1002/ajpa.1330740410; STUARTMACADAM P, 1989, AM J PHYS ANTHROPOL, V80, P187, DOI 10.1002/ajpa.1330800206; TAKAHATA Y, 1984, INT J PRIMATOL, V5, P213, DOI 10.1007/BF02735758; Tobias P.V., 1991, OLDUVAI GORGE, V4; Tobias PV, 1974, LEECH, V44, P119; Uehara S, 1997, PRIMATES, V38, P193, DOI 10.1007/BF02382009; Ungar P.S., 2006, EVOLUTION HUMAN DIET; Vercellotti G, 2010, INT J OSTEOARCHAEOL, V20, P358, DOI 10.1002/oa.1098; WALKER A, 1982, NATURE, V296, P248, DOI 10.1038/296248a0; Walker A., 1993, NARIOKOTOME HOMO ERE; Walker PL, 2009, AM J PHYS ANTHROPOL, V139, P109, DOI 10.1002/ajpa.21031; Wapler U, 2004, AM J PHYS ANTHROPOL, V123, P333, DOI 10.1002/ajpa.10321; WHITE TD, 1978, AM J PHYS ANTHROPOL, V49, P79, DOI 10.1002/ajpa.1330490112; Wright LE, 1998, AM ANTHROPOL, V100, P924, DOI 10.1525/aa.1998.100.4.924	64	44	45	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46414	10.1371/journal.pone.0046414	http://dx.doi.org/10.1371/journal.pone.0046414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056303	Green Published, Green Accepted, gold			2022-12-27	WOS:000309454000040
J	Franzosa, EA; Xia, Y				Franzosa, Eric A.; Xia, Yu			Independent Effects of Protein Core Size and Expression on Residue-Level Structure-Evolution Relationships	PLOS ONE			English	Article							SOLVENT ACCESSIBILITY; DETERMINANTS; SELECTION; CONTEXT; IMPACT; RATES	Recently, we demonstrated that yeast protein evolutionary rate at the level of individual amino acid residues scales linearly with degree of solvent accessibility. This residue-level structure-evolution relationship is sensitive to protein core size: surface residues from large-core proteins evolve much faster than those from small-core proteins, while buried residues are equally constrained independent of protein core size. In this work, we investigate the joint effects of protein core size and expression on the residue-level structure-evolution relationship. At the whole-protein level, protein expression is a much more dominant determinant of protein evolutionary rate than protein core size. In contrast, at the residue level, protein core size and expression both have major impacts on protein structure-evolution relationships. In addition, protein core size and expression influence residue-level structure-evolution relationships in qualitatively different ways. Protein core size preferentially affects the non-synonymous substitution rates of surface residues compared to buried residues, and has little influence on synonymous substitution rates. In comparison, protein expression uniformly affects all residues independent of degree of solvent accessibility, and affects both non-synonymous and synonymous substitution rates. Protein core size and expression exert largely independent effects on protein evolution at the residue level, and can combine to produce dramatic changes in the slope of the linear relationship between residue evolutionary rate and solvent accessibility. Our residue-level findings demonstrate that protein core size and expression are both important, yet qualitatively different, determinants of protein evolution. These results underscore the complementary nature of residue-level and whole-protein analysis of protein evolution.	[Franzosa, Eric A.; Xia, Yu] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Xia, Yu] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Xia, Yu] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Xia, Y (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	yuxia@bu.edu	Xia, Yu/W-6150-2019	Xia, Yu/0000-0002-5596-5518	National Science Foundation [CCF-1219007]; Division of Computing and Communication Foundations [1219007] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the National Science Foundation under Grant No. CCF-1219007 (to YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2003, GENETICS, V164, P1291; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Bustamante CD, 2000, MOL BIOL EVOL, V17, P301, DOI 10.1093/oxfordjournals.molbev.a026310; Choi SS, 2006, MOL BIOL EVOL, V23, P2131, DOI 10.1093/molbev/msl086; Conant GC, 2009, MOL BIOL EVOL, V26, P1155, DOI 10.1093/molbev/msp031; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Franzosa EA, 2009, MOL BIOL EVOL, V26, P2387, DOI 10.1093/molbev/msp146; Goldman N, 1998, GENETICS, V149, P445; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; OVERINGTON J, 1992, PROTEIN SCI, V1, P216; Pal C, 2001, GENETICS, V158, P927; PERUTZ MF, 1965, J MOL BIOL, V13, P669, DOI 10.1016/S0022-2836(65)80134-6; Ramsey DC, 2011, GENETICS, V188, P479, DOI 10.1534/genetics.111.128025; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Scherrer MP, BMC EVOL BIOL UNPUB; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Xia Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000413; Yang JR, 2012, P NATL ACAD SCI USA, V109, pE831, DOI 10.1073/pnas.1117408109; Yang JR, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.78; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhou T, 2008, J MOL EVOL, V66, P395, DOI 10.1007/s00239-008-9094-4	29	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46602	10.1371/journal.pone.0046602	http://dx.doi.org/10.1371/journal.pone.0046602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056364	Green Submitted, gold, Green Published			2022-12-27	WOS:000309454000060
J	Ribeiro, FJ; Castanheira-Dinis, A; Dias, JM				Ribeiro, Filomena J.; Castanheira-Dinis, Antonio; Dias, Joao M.			Personalized Pseudophakic Model for Refractive Assessment	PLOS ONE			English	Article							INTRAOCULAR-LENS POWER; IMAGE QUALITY; TOPOGRAPHY; ACCURACY; EYE; CURVATURE; CATARACT; FORMULA; SURGERY	Purpose: To test a pseudophakic eye model that allows for intraocular lens power (IOL) calculation, both in normal eyes and in extreme conditions, such as post-LASIK. Methods: Participants: The model's efficacy was tested in 54 participants (104 eyes) who underwent LASIK and were assessed before and after surgery, thus allowing to test the same method in the same eye after only changing corneal topography. Modelling: The Liou-Brennan eye model was used as a starting point, and biometric values were replaced by individual measurements. Detailed corneal surface data were obtained from topography (Orbscan (R)) and a grid of elevation values was used to define corneal surfaces in an optical ray-tracing software (Zemax (R)). To determine IOL power, optimization criteria based on values of the modulation transfer function (MTF) weighted according to contrast sensitivity function (CSF), were applied. Results: Pre-operative refractive assessment calculated by our eye model correlated very strongly with SRK/T (r = 0.959, p<0.001) with no difference of average values (16.9 +/- 2.9 vs 17.1 +/- 2.9 D, p>0.05). Comparison of post-operative refractive assessment obtained using our eye model with the average of currently used formulas showed a strong correlation (r = 0.778, p<0.001), with no difference of average values (21.5 +/- 1.7 vs 21.8 +/- 1.6 D, p>0.05). Conclusions: Results suggest that personalized pseudophakic eye models and ray-tracing allow for the use of the same methodology, regardless of previous LASIK, independent of population averages and commonly used regression correction factors, which represents a clinical advantage.	[Ribeiro, Filomena J.; Dias, Joao M.] Inst Super Tecn, GoLP Inst Plasmas & Fusao Nucl, Lab Associado, Lisbon, Portugal; [Ribeiro, Filomena J.; Castanheira-Dinis, Antonio] Univ Lisbon, Visual Sci Res Ctr, P-1699 Lisbon, Portugal; [Ribeiro, Filomena J.] Hosp da Luz, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa	Ribeiro, FJ (corresponding author), Inst Super Tecn, GoLP Inst Plasmas & Fusao Nucl, Lab Associado, Lisbon, Portugal.	filomenajribeiro@gmail.com	Dias, João M/L-6496-2013; Dias, João Mendanha/X-3491-2019	Dias, João M/0000-0003-0167-1466; Dias, João Mendanha/0000-0003-0167-1466; Ribeiro, Filomena/0000-0002-6790-443X; Castanheira Dinis, Antonio Joaquim Rodrigues/0000-0001-9781-8623				[Anonymous], ASCRS WEBS IOL POW C; Aramberri J, 2003, J CATARACT REFR SURG, V29, P2063, DOI 10.1016/S0886-3350(03)00957-X; Artal P, 2006, J VISION, V6, P1, DOI 10.1167/6.1.1; Bakaraju RC, 2008, VISION RES, V48, P1681, DOI 10.1016/j.visres.2008.04.009; Cairns G, 2005, CLIN EXP OPHTHALMOL, V33, P147, DOI 10.1111/j.1442-9071.2005.00975.x; Cairns G, 2005, J CATARACT REFR SURG, V31, P205, DOI 10.1016/j.jcrs.2004.09.047; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Cheng ACK, 2006, J CATARACT REFR SURG, V32, P1015, DOI 10.1016/j.jcrs.2006.02.033; Cheng X, 2004, J VISION, V4, P310, DOI 10.1167/4.4.7; Cruysberg LPJ, 2010, BRIT J OPHTHALMOL, V94, P106, DOI 10.1136/bjo.2009.161729; de Almeida MS, 2007, BRAZ J PHYS, V37, P378, DOI 10.1590/S0103-97332007000300008; Feiz V, 2001, CORNEA, V20, P792, DOI 10.1097/00003226-200111000-00003; Guirao A, 2003, OPTOMETRY VISION SCI, V80, P36, DOI 10.1097/00006324-200301000-00006; Hoffer KJ, 2009, J CATARACT REFR SURG, V35, P759, DOI 10.1016/j.jcrs.2009.01.005; Hoffmann PC, 1997, KLIN MONATSBL AUGENH, V211, P168, DOI 10.1055/s-2008-1035117; HOLLADAY JT, 1986, ARCH OPHTHALMOL-CHIC, V104, P539; Holladay JT, 1997, J CATARACT REFR SURG, V23, P209, DOI 10.1016/S0886-3350(97)80344-6; Jin HY, 2010, J CATARACT REFR SURG, V36, P87, DOI 10.1016/j.jcrs.2009.07.011; Jin HY, 2009, J CATARACT REFR SURG, V35, P650, DOI 10.1016/j.jcrs.2008.12.015; Kopacz Dorota, 2005, Klin Oczna, V107, P728; LEGGE GE, 1987, J OPT SOC AM A, V4, P851, DOI 10.1364/JOSAA.4.000851; Liou HL, 1997, J OPT SOC AM A, V14, P1684, DOI 10.1364/JOSAA.14.001684; Maldonado MJ, 2006, OPHTHALMOLOGY, V113, P1918, DOI 10.1016/j.ophtha.2006.05.053; Norrby S, 2008, J CATARACT REFR SURG, V34, P368, DOI 10.1016/j.jcrs.2007.10.031; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P472, DOI 10.1111/j.1600-0420.2007.00879.x; Park CY, 2012, CURR OPIN OPHTHALMOL, V23, P269, DOI 10.1097/ICU.0b013e3283543c41; Preussner PR, 2008, J CATARACT REFR SURG, V34, P802, DOI 10.1016/j.jcrs.2008.01.015; Preussner PR, 2005, J CATARACT REFR SURG, V31, P525, DOI 10.1016/j.jcrs.2004.09.016; Preussner PR, 2002, J CATARACT REFR SURG, V28, P1412, DOI 10.1016/S0886-3350(01)01346-3; Rosa N, 2002, J REFRACT SURG, V18, P720; SACHS MB, 1971, J OPT SOC AM, V61, P1176, DOI 10.1364/JOSA.61.001176; SALMON TO, 1995, OPTOMETRY VISION SCI, V72, P800, DOI 10.1097/00006324-199511000-00005; Sawides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027031; SEILER T, 1985, KLIN MONATSBL AUGENH, V187, P69, DOI 10.1055/s-2008-1050992; Thibos LN, 2002, J OPT SOC AM A, V19, P2329, DOI 10.1364/JOSAA.19.002329; VANMEETE.A, 1974, OPT ACTA, V21, P395, DOI 10.1080/713818902; Wang L, 2010, J CATARACT REFR SURG, V36, P1466, DOI 10.1016/j.jcrs.2010.03.044	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46780	10.1371/journal.pone.0046780	http://dx.doi.org/10.1371/journal.pone.0046780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056450	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000083
J	Wei, CL; Rowe, GT; Haedrich, RL; Boland, GS				Wei, Chih-Lin; Rowe, Gilbert T.; Haedrich, Richard L.; Boland, Gregory S.			Long-Term Observations of Epibenthic Fish Zonation in the Deep Northern Gulf of Mexico	PLOS ONE			English	Article							COMMUNITY STRUCTURE; STANDING STOCK; NE ATLANTIC; SEA; WATER; PACIFIC; DEPTH; CONNECTIONS; POPULATIONS; DIVERSITY	A total of 172 bottom trawl/skimmer samples (183 to 3655-m depth) from three deep-sea studies, R/V Alaminos cruises (1964-1973), Northern Gulf of Mexico Continental Slope (NGoMCS) study (1983-1985) and Deep Gulf of Mexico Benthos (DGoMB) program (2000 to 2002), were compiled to examine temporal and large-scale changes in epibenthic fish species composition. Based on percent species shared among samples, faunal groups (>= 10% species shared) consistently reoccurred over time on the shelf-break (ca. 200 m), upper-slope (ca. 300 to 500 m) and upper-to-mid slope (ca. 500 to 1500 m) depths. These similar depth groups also merged when the three studies were pooled together, suggesting that there has been no large-scale temporal change in depth zonation on the upper section of the continental margin. Permutational multivariate analysis of variance (PERMANOVA) also detected no significant species changes on the limited sites and areas that have been revisited across the studies (P>0.05). Based on the ordination of the species shared among samples, species replacement was a continuum along a depth or macrobenthos biomass gradient. Despite the well-known, close, negative relationship between water depth and macrofaunal biomass, the fish species changed more rapidly at depth shallower than 1,000 m, but the rate of change was surprisingly slow at the highest macrofaunal biomass (> 100 mg C m(-2)), suggesting that the composition of epibenthic fishes was not altered in response to the extremely high macrofaunal biomass in the upper Mississippi and De Soto Submarine Canyons. An alternative is that the pattern of fish species turnover is related to the decline in macrofaunal biomass, the presumptive prey of the fish, along the depth gradient.	[Wei, Chih-Lin] Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF, Canada; [Rowe, Gilbert T.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Haedrich, Richard L.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Boland, Gregory S.] Bur Ocean Energy Management, Branch Environm Sci, US Dept Interior, Herndon, VA USA	Memorial University Newfoundland; Texas A&M University System; Memorial University Newfoundland; United States Department of the Interior	Wei, CL (corresponding author), Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF, Canada.	cwei@mun.ca		WEI, CHIH-LIN/0000-0001-9430-0060	Bureau of Ocean Energy Management (BOEM); Oceanography Graduate Student Council at Texas AM University; Alfred P. Sloan Foundation; Canadian Healthy Oceans Network (CHONe)	Bureau of Ocean Energy Management (BOEM); Oceanography Graduate Student Council at Texas AM University; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Canadian Healthy Oceans Network (CHONe)	Minerals Management Service (MMS), now the Bureau of Ocean Energy Management (BOEM), funded the original research and provided the historical data. Additional supports were provided by Erma Lee and Luke Mooney and the Oceanography Graduate Student Council at Texas A&M University. This paper is a contribution of Continental Margin Ecosystems (COMARGE) of the Census of Marine Life (CoML), supported by the Alfred P. Sloan Foundation. Data analyses were partly supported by Canadian Healthy Oceans Network (CHONe) through a fellowship to C-L Wei.	Adler D, 2005, VIOPLOT VIOLIN PLOT; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bailey DM, 2009, P ROY SOC B-BIOL SCI, V276, P1965, DOI 10.1098/rspb.2009.0098; Bailey DM, 2006, ECOLOGY, V87, P549, DOI 10.1890/04-1832; Bett BJ, 2001, CONT SHELF RES, V21, P917, DOI 10.1016/S0278-4343(00)00119-9; Biggs DC, 2008, DEEP-SEA RES PT II, V55, P2555, DOI 10.1016/j.dsr2.2008.07.013; Billett DSM, 2010, DEEP-SEA RES PT II, V57, P1406, DOI 10.1016/j.dsr2.2009.02.001; BOLAND GS, 1991, LIMNOL OCEANOGR, V36, P1015, DOI 10.4319/lo.1991.36.5.1015; Bowman A., 2010, R PACKAGE SM NONPARA; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Carney RS, 1983, DEEP SEA BIOL, P371; Carrasson M, 2002, MAR ECOL PROG SER, V241, P41, DOI 10.3354/meps241041; Cartes JE, 2004, DEEP-SEA RES PT I, V51, P263, DOI 10.1016/j.dsr.2003.10.001; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CRABTREE RE, 1991, DEEP-SEA RES, V38, P1277, DOI 10.1016/0198-0149(91)90027-D; Drazen JC, 2001, DEEP-SEA RES PT I, V48, P909, DOI 10.1016/S0967-0637(00)00058-3; Drazen JC, 2008, LIMNOL OCEANOGR, V53, P2644, DOI 10.4319/lo.2008.53.6.2644; FROESE R, 2000, FISHBASE 2000 CONCEP; Gallaway BJ, 1987, TECHNICAL REPORT, VII; Gartner John V. Jr, 1997, P115; Gorley C.K., 2006, GETTING STARTED PRIM; HAEDRICH RL, 1975, J MAR RES, V33, P191; HECKER B, 1990, DEEP-SEA RES, V37, P37, DOI 10.1016/0198-0149(90)90028-T; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; Jochens AE, 2008, DEEP-SEA RES PT II, V55, P2541, DOI 10.1016/j.dsr2.2008.07.003; Johnson NA, 2007, DEEP-SEA RES PT I, V54, P1350, DOI 10.1016/j.dsr.2007.04.011; Kalogeropoulou V, 2010, DEEP-SEA RES PT II, V57, P1383, DOI 10.1016/j.dsr2.2009.02.002; Lampitt RS, 2010, DEEP-SEA RES PT II, V57, P1267, DOI 10.1016/j.dsr2.2010.01.003; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; Lohrenz S.E., 1999, GULF MEXICO LARGE MA, P151; MARKLE DF, 1974, MAR BIOL, V26, P225, DOI 10.1007/BF00389253; MCLELLAN HJ, 1963, J MAR RES, V21, P233; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY, P488; MULLERKARGER FE, 1991, J GEOPHYS RES-OCEANS, V96, P12645, DOI 10.1029/91JC00787; Narayanaswamy BE, 2010, MAR ECOL-EVOL PERSP, V31, P237, DOI 10.1111/j.1439-0485.2010.00360.x; Pequegnat W.E., 1983, ECOLOGICAL COMMUNITI; PEQUEGNAT WE, 1990, AM ZOOL, V30, P45; Powell Shawna M., 2003, Journal of Northwest Atlantic Fishery Science, V31, P19; R Development Core Team, 2012, R LANG ENV STAT COMP; Rex M.A., 1977, European Marine Biology Symposium, P521; Rex M.A., 2010, BIOSCIENCE; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Rowe G., 2009, NO GULF MEXICO CONTI; ROWE GT, 1969, DEEP-SEA RES, V16, P531, DOI 10.1016/0011-7471(69)90041-2; Rowe GT, 1983, SEA, P97; Ruhl HA, 2008, P NATL ACAD SCI USA, V105, P17006, DOI 10.1073/pnas.0803898105; Ruhl HA, 2008, ECOLOGY, V89, P991, DOI 10.1890/06-2025.1; Smith CR, 1997, DEEP-SEA RES PT II, V44, P2295, DOI 10.1016/S0967-0645(97)00022-2; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Smith KL, 1998, DEEP-SEA RES PT II, V45, P573, DOI 10.1016/S0967-0645(97)00094-5; SOMERO GN, 1992, EXPERIENTIA, V48, P537, DOI 10.1007/BF01920236; Sorensen T., 1948, K DANSKE VIDENSK SEL, V5, P1; Sweetman AK, 2008, MAR ECOL PROG SER, V355, P73, DOI 10.3354/meps07240; Talaue-McManus L., 2010, CARBON NUTR FLUXES C, P406; TERBORGH J, 1970, ECOLOGY, V52, P23; Wei C-L, 2010, DEEP SEA 1 IN PRESS; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Wei CL, 2009, DEEP-SEA RES PT II, V56, P1830, DOI 10.1016/j.dsr2.2009.05.006; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; [No title captured]; [No title captured]	67	8	9	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46707	10.1371/journal.pone.0046707	http://dx.doi.org/10.1371/journal.pone.0046707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056412	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000077
J	Yang, XH; Thornburg, T; Suo, ZY; Jun, SM; Robison, A; Li, JQ; Lim, T; Cao, L; Hoyt, T; Avci, R; Pascual, DW				Yang, Xinghong; Thornburg, Theresa; Suo, Zhiyong; Jun, SangMu; Robison, Amanda; Li, Jinquan; Lim, Timothy; Cao, Ling; Hoyt, Teri; Avci, Recep; Pascual, David W.			Flagella Overexpression Attenuates Salmonella Pathogenesis	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; TYPHOID-FEVER; ESCHERICHIA-COLI; IMMUNE-RESPONSES; VIRULENCE; INTERLEUKIN-1-BETA; ENTERITIDIS; EXPRESSION; CASPASE-1; SECRETION	Flagella are cell surface appendages involved in a number of bacterial behaviors, such as motility, biofilm formation, and chemotaxis. Despite these important functions, flagella can pose a liability to a bacterium when serving as potent immunogens resulting in the stimulation of the innate and adaptive immune systems. Previous work showing appendage overexpression, referred to as attenuating gene expression (AGE), was found to enfeeble wild-type Salmonella. Thus, this approach was adapted to discern whether flagella overexpression could induce similar attenuation. To test its feasibility, flagellar filament subunit FliC and flagellar regulon master regulator FlhDC were overexpressed in Salmonella enterica serovar Typhimurium wild-type strain H71. The results show that the expression of either FliC or FlhDC alone, and co-expression of the two, significantly attenuates Salmonella. The flagellated bacilli were unable to replicate within macrophages and thus were not lethal to mice. In-depth investigation suggests that flagellum-mediated AGE was due to the disruptive effects of flagella on the bacterial membrane, resulting in heightened susceptibilities to hydrogen peroxide and bile. Furthermore, flagellum-attenuated Salmonella elicited elevated immune responses to Salmonella presumably via FliC's adjuvant effect and conferred robust protection against wild-type Salmonella challenge.	[Yang, Xinghong; Thornburg, Theresa; Jun, SangMu; Robison, Amanda; Li, Jinquan; Lim, Timothy; Cao, Ling; Hoyt, Teri; Pascual, David W.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Suo, Zhiyong; Avci, Recep] Montana State Univ, Dept Phys, Imaging & Chem Anal Lab, Bozeman, MT 59717 USA; [Jun, SangMu; Pascual, David W.] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; State University System of Florida; University of Florida	Yang, XH (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	yangxh@montana.edu	Yang, Xinghong/A-5473-2012; Pascual, David/AAC-2248-2022		National Institutes of Health [R21 AI080960, R01 AI041123, P20 RR020185]; M. J. Murdock Charitable Trust; Montana State University Agricultural Experiment Station; Office of Navy Research Award [N00014-10-1-0946]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080960] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust; Montana State University Agricultural Experiment Station; Office of Navy Research Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health Grants R21 AI080960, R01 AI041123, and P20 RR020185, an equipment grant from the M. J. Murdock Charitable Trust, and the Montana State University Agricultural Experiment Station. It was also supported in part by Office of Navy Research Award N00014-10-1-0946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; BAHRANI FK, 1991, INFECT IMMUN, V59, P3574, DOI 10.1128/IAI.59.10.3574-3580.1991; Bell RL, 2011, INFECT GENET EVOL, V11, P83, DOI 10.1016/j.meegid.2010.10.005; Bergman MA, 2005, INFECT IMMUN, V73, P7226, DOI 10.1128/IAI.73.11.7226-7235.2005; Cao L, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/3/036005; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036283; Claret L, 2000, J BACTERIOL, V182, P833, DOI 10.1128/JB.182.3.833-836.2000; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Cogan TA, 2004, MICROBIOL-SGM, V150, P1063, DOI 10.1099/mic.0.26791-0; Douglass II WC, 2003, HYDROGEN PEROXIDE ME, P19; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fraser A, 2009, COCHRANE DB SYST REV, P1; Fraser A, 2007, VACCINE, V25, P7848, DOI 10.1016/j.vaccine.2007.08.027; GLICK BR, 1995, BIOTECHNOL ADV, V13, P247, DOI 10.1016/0734-9750(95)00004-A; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Heuner K, 1999, FEMS MICROBIOL LETT, V175, P69, DOI 10.1016/S0378-1097(99)00160-3; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; INOUE YH, 1989, GENE, V85, P221, DOI 10.1016/0378-1119(89)90485-X; Kawagishi I, 1996, MOL MICROBIOL, V20, P693, DOI 10.1111/j.1365-2958.1996.tb02509.x; Kennedy M, 2004, CLIN INFECT DIS, V38, pS142, DOI 10.1086/381580; Kinsella KJ, 2006, FOODBORNE PATHOG DIS, V3, P375, DOI 10.1089/fpd.2006.3.375; LEDUC M, 1980, J BACTERIOL, V142, P52, DOI 10.1128/JB.142.1.52-59.1980; Levine MM, 1999, VACCINE, V17, pS22, DOI 10.1016/S0264-410X(99)00231-5; Marcus LC, 2007, J TRAVEL MED, V14, P386, DOI 10.1111/j.1708-8305.2007.00158.x; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Namgyal P, 2011, BANGK M TYPH APR 18; Pang T, 1998, TRENDS MICROBIOL, V6, P131, DOI 10.1016/S0966-842X(98)01236-0; Robertson JMC, 2003, J MED MICROBIOL, V52, P91, DOI 10.1099/jmm.0.04901-0; Sano G, 2007, J BACTERIOL, V189, P8224, DOI 10.1128/JB.00898-07; Santos PG, 2011, LETT APPL MICROBIOL, V52, P49, DOI 10.1111/j.1472-765X.2010.02965.x; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Shimoyama T, 2009, SCIENCE, V323, P1574, DOI 10.1126/science.1170086; Sikora AE, 2007, J BACTERIOL, V189, P8484, DOI 10.1128/JB.00583-07; Smith K, 2003, POETRY REV, V93, P5; Suo ZY, 2008, LANGMUIR, V24, P4161, DOI 10.1021/la7038653; Suo ZY, 2009, ANAL CHEM, V81, P7571, DOI 10.1021/ac9014484; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; Tomoyasu T, 2003, MOL MICROBIOL, V48, P443, DOI 10.1046/j.1365-2958.2003.03437.x; van Asten FJAM, 2004, INT J MED MICROBIOL, V294, P395, DOI 10.1016/j.ijmm.2004.07.012; Varma JK, 2005, EMERG INFECT DIS, V11, P943; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Viret JF, 1999, INFECT IMMUN, V67, P3680, DOI 10.1128/IAI.67.7.3680-3685.1999; Vugia D., 2007, Morbidity and Mortality Weekly Report, V56, P336; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08; WU SG, 1995, INFECT IMMUN, V63, P4933, DOI 10.1128/IAI.63.12.4933-4938.1995; Yang XH, 2007, J IMMUNOL, V178, P1059, DOI 10.4049/jimmunol.178.2.1059; Yang XH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/632396; Yang XH, 2012, VIRULENCE, V3, P29, DOI 10.4161/viru.3.1.18447	50	36	37	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46828	10.1371/journal.pone.0046828	http://dx.doi.org/10.1371/journal.pone.0046828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056473	Green Submitted, gold, Green Published			2022-12-27	WOS:000309454000090
J	Jiang, CG; Huang, H; Liu, J; Wang, YX; Lu, ZW; Xu, ZJ				Jiang, Chunguo; Huang, Hui; Liu, Jia; Wang, Yanxun; Lu, Zhiwei; Xu, Zuojun			Adverse Events of Pirfenidone for the Treatment of Pulmonary Fibrosis: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ANTIFIBROTIC AGENT; HAMSTERS	Background: Pirfenidone (PFD) is a novel antifibrotic agent approved for patients with pulmonary fibrosis. However, there are concerns regarding toxicity of the drug. In this meta-analysis, we analyzed the adverse events (AEs) of PFD for the treatment of pulmonary fibrosis. Methods: We performed a systematic search of PubMed, Embase, ClinicalTrials.gov, and Cochrane Central Register of Controlled Trials for trials published between January 1999 and October 2011. Data extracted from literature were analyzed with Review manager 5.0.24. Results: The results of six randomized controlled trials (1073 participants) revealed that the number of individuals who discontinued PFD therapy was significantly higher than patients receiving placebo. The PFD group had a significantly higher rate of gastrointestinal (nausea, dyspepsia, diarrhea, and anorexia), neurological (dizziness and fatigue), and dermatological (photosensitivity and rash) AEs compared to the placebo group. Conclusions: PFD used for the treatment of pulmonary fibrosis is not so safe or well-tolerated. Notably, gastrointestinal, neurological and dermatological adverse effects were more common in patients receiving PFD therapy, and therefore appropriate precaution is needed.	[Jiang, Chunguo; Huang, Hui; Liu, Jia; Wang, Yanxun; Xu, Zuojun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing 100730, Peoples R China; [Jiang, Chunguo; Huang, Hui; Liu, Jia; Wang, Yanxun; Xu, Zuojun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lu, Zhiwei] Yijishan Hosp, Wannan Med Coll, Dept Resp Med, Wuhu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Wannan Medical College	Xu, ZJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing 100730, Peoples R China.	xuzj@hotmail.com			National Natural Science Foundation of China [81170055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81170055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Baba T, 2009, RESPIROLOGY S3, V14, pA156; Costabel U, 2011, P EUR RESP SOC ANN C; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Gahl WA, 2002, MOL GENET METAB, V76, P234, DOI 10.1016/S1096-7192(02)00044-6; Giri Shri N., 1999, Journal of Environmental Pathology Toxicology and Oncology, V18, P169; IYER SN, 1995, J LAB CLIN MED, V125, P779; Jadad AR, 1996, CONTROL CLIN TRIALS, V1, P1, DOI DOI 10.1016/0197-2456(95)00134-4]; King TE, 2011, AM J RESP CRIT CARE, V184, P92, DOI 10.1164/rccm.201011-1874OC; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; O'Brien K, 2011, MOL GENET METAB, V103, P128, DOI 10.1016/j.ymgme.2011.02.003; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; Raghu G, 2008, AM J RESP CRIT CARE, V178, P948, DOI 10.1164/rccm.200709-1446OC; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rubino CM, 2009, PULM PHARMACOL THER, V22, P279, DOI 10.1016/j.pupt.2009.03.003; Schelegle ES, 1997, P SOC EXP BIOL MED, V216, P392; Shi SJ, 2007, J CLIN PHARMACOL, V47, P1268, DOI 10.1177/0091270007304104; Spagnolo P, 2010, COCHRANE DB SYST REV, V9; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Zisman DA, 2010, NEW ENGL J MED, V363, P620, DOI 10.1056/NEJMoa1002110	22	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47024	10.1371/journal.pone.0047024	http://dx.doi.org/10.1371/journal.pone.0047024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056564	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400045
J	Killpack, TL; Karasov, WH				Killpack, Tess L.; Karasov, William H.			Ontogeny of Adaptive Antibody Response to a Model Antigen in Captive Altricial Zebra Finches	PLOS ONE			English	Article							KESTRELS FALCO-SPARVERIUS; WEST-NILE-VIRUS; IMMUNE-RESPONSE; HOUSE SPARROWS; TREE SWALLOWS; IMMUNOLOGICAL DEVELOPMENT; ECOLOGICAL IMMUNOLOGY; TACHYCINETA-BICOLOR; INNATE IMMUNITY; LIFE-HISTORY	Based on studies from the poultry literature, all birds are hypothesized to require at least 4 weeks to develop circulating mature B-cell lineages that express functionally different immunoglobulin specificities. However, many altricial passerines fledge at adult size less than four weeks after the start of embryonic development, and therefore may experience a period of susceptibility during the nestling and post-fledging periods. We present the first study, to our knowledge, to detail the age-related changes in adaptive antibody response in an altricial passerine. Using repeated vaccinations with non-infectious keyhole limpet hemocyanin (KLH) antigen, we studied the ontogeny of specific adaptive immune response in altricial zebra finches Taeniopygia guttata. Nestling zebra finches were first injected at 7 days (7d), 14 days (14d), or 21 days post-hatch (21d) with KLH-adjuvant emulsions, and boosted 7 days later. Adults were vaccinated in the same manner. Induced KLH-specific IgY antibodies were measured using ELISA. Comparisons within age groups revealed no significant increase in KLH-specific antibody levels between vaccination and boost in 7d birds, yet significant increases between vaccination and boost were observed in 14d, 21d, and adult groups. There was no significant difference among age groups in KLH antibody response to priming vaccination, yet KLH antibody response post-boost significantly increased with age among groups. Post-boost antibody response in all nestling age groups was significantly lower than in adults, indicating that mature adult secondary antibody response level was not achieved in zebra finches prior to fledging (21 days post-hatch in zebra finches). Findings from this study contribute fundamental knowledge to the fields of developmental immunology and ecological immunology and strengthen the utility of zebra finches as a model organism for future studies of immune ontogeny.	[Killpack, Tess L.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Karasov, William H.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Killpack, TL (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	tkillpack@wisc.edu			National Science Foundation [IOS-0615678]; USDA (Hatch); American Ornithologists' Union Student Research award, Bunde; Noland Fund awards, Graduate Women in Science Ruth Dickie Grant; National Science Foundation-Graduate Research Fellowship (NSF-GRF)	National Science Foundation(National Science Foundation (NSF)); USDA (Hatch)(United States Department of Agriculture (USDA)); American Ornithologists' Union Student Research award, Bunde; Noland Fund awards, Graduate Women in Science Ruth Dickie Grant; National Science Foundation-Graduate Research Fellowship (NSF-GRF)(National Science Foundation (NSF))	This study was supported by grants from the National Science Foundation [grant number IOS-0615678] and USDA (Hatch) to W. H. K. This study was also supported by an American Ornithologists' Union Student Research award, Bunde and Noland Fund awards, Graduate Women in Science Ruth Dickie Grant, and a National Science Foundation-Graduate Research Fellowship (NSF-GRF) to T. L. K. The Department of Forest and Wildlife Ecology, UW-Madison offset page charges for publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APANIUS V, 1998, AVIAN GROWTH DEV EVO; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Brzek P, 2007, J EXP BIOL, V210, P2361, DOI 10.1242/jeb.003517; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Davison F, 2008, AVIAN IMMUNOLOGY, P1; De Coster G, 2010, J EXP BIOL, V213, P3012, DOI 10.1242/jeb.042721; Fair JM, 1999, P ROY SOC B-BIOL SCI, V266, P1735, DOI 10.1098/rspb.1999.0840; Flies DB, 2003, J IMMUNOL METHODS, V276, P239, DOI 10.1016/S0022-1759(03)00081-4; Grindstaff JL, 2006, P ROY SOC B-BIOL SCI, V273, P2551, DOI 10.1098/rspb.2006.3608; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; Kindt T.J., 2007, KUBY IMMUNOLOGY; King MO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009639; Klasing K.C., 1999, OSTRICH, V69, P32; KOPPENHEFFER TL, 1980, AM ZOOL, V20, P864; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lozano GA, 2002, CAN J ZOOL, V80, P918, DOI 10.1139/Z02-063; Lung NP, 1996, AM J VET RES, V57, P1162; MCCORKLE FM, 1988, DEV COMP IMMUNOL, V12, P621, DOI 10.1016/0145-305X(88)90078-X; Nemeth NM, 2008, AM J TROP MED HYG, V79, P283, DOI 10.4269/ajtmh.2008.79.283; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; O'Brien VA, 2012, J WILDLIFE DIS, V48, P138, DOI 10.7589/0090-3558-48.1.138; O'Brien VA, 2010, AM J TROP MED HYG, V82, P937, DOI 10.4269/ajtmh.2010.09-0515; Palacios MG, 2009, DEV COMP IMMUNOL, V33, P456, DOI 10.1016/j.dci.2008.09.006; PELEG BA, 1985, AVIAN PATHOL, V14, P471, DOI 10.1080/03079458508436250; R Core Team, 2018, R LANG ENV STAT COMP; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Smits JEG, 2005, DEV COMP IMMUNOL, V29, P161, DOI 10.1016/j.dci.2004.06.007; Smits JEG, 2008, COMP BIOCHEM PHYS A, V151, P711, DOI 10.1016/j.cbpa.2008.08.025; Stambaugh T, 2011, WILSON J ORNITHOL, V123, P779, DOI 10.1676/10-197.1; SURESH M, 1993, DEV COMP IMMUNOL, V17, P525, DOI 10.1016/S0145-305X(05)80008-4	33	22	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47294	10.1371/journal.pone.0047294	http://dx.doi.org/10.1371/journal.pone.0047294			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056621	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400069
J	Takuno, S; Terauchi, R; Innan, H				Takuno, Shohei; Terauchi, Ryohei; Innan, Hideki			The Power of QTL Mapping with RILs	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MENDELIAN FACTORS; LINKAGE MAP; MARKERS; GENOME; POPULATIONS; INTERVAL	QTL (quantitative trait loci) mapping is commonly used to identify genetic regions responsible to important phenotype variation. A common strategy of QTL mapping is to use recombinant inbred lines (RILs), which are usually established by several generations of inbreeding of an F1 population (usually up to F6 or F7 populations). As this inbreeding process involves a large amount of labor, we are particularly interested in the effect of the number of inbreeding generations on the power of QTL mapping; a part of the labor could be saved if a smaller number of inbreeding provides sufficient power. By using simulations, we investigated the performance of QTL mapping with recombinant inbred lines (RILs). As expected, we found that the power of F4 population could be almost comparable to that of F6 and F7 populations. A potential problem in using F4 population is that a large proportion of RILs are heterozygotes. We here introduced a new method to partly relax this problem. The performance of this method was verified by simulations with a wide range of parameters including the size of the segregation population, recombination rate, genome size and the density of markers. We found our method works better than the commonly used standard method especially when there are a number of heterozygous markers. Our results imply that in most cases, QTL mapping does not necessarily require RILs at F6 or F7 generations; rather, F4 (or even F3) populations would be almost as useful as F6 or F7 populations. Because the cost to establish a number of RILs for many generations is enormous, this finding will cause a reduction in the cost of QTL mapping, thereby accelerating gene mapping in many species.	[Takuno, Shohei; Innan, Hideki] Grad Univ Adv Studies, Hayama, Kanagawa, Japan; [Terauchi, Ryohei] Iwate Biotechnol Res Ctr 22 174 4, Kitakami, Iwate, Japan	Graduate University for Advanced Studies - Japan; Iwate Biotechnology Research Center	Innan, H (corresponding author), Grad Univ Adv Studies, Hayama, Kanagawa, Japan.		Terauchi, Ryohei/Y-2992-2019	Terauchi, Ryohei/0000-0002-0095-4651; Takuno, Shohei/0000-0001-9538-7487; Innan, Hideki/0000-0001-6375-9231	Bio-oriented Technology Research Advancement Institution in Japan	Bio-oriented Technology Research Advancement Institution in Japan	This work is supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) from the Bio-oriented Technology Research Advancement Institution in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHURCHILL GA, 1994, GENETICS, V138, P963; EMERSON S., 1969, Genetic organization. A comprehensive treatise., P267; Falconer D. S., 1996, INTRO QUANTITATIVE G; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; HALDANE J. B. S., 1931, CYTOLOGIA, V3, P54; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HAYASHI T, 1994, THEOR APPL GENET, V87, P1021, DOI 10.1007/BF00225798; HENDERSON SA, 1963, HEREDITY, V18, P173, DOI 10.1038/hdy.1963.20; Hu Z, 2008, HEREDITY, V101, P48, DOI 10.1038/hdy.2008.25; Jansen RC, 2003, HDB STAT GENETICS, P589; Kao CH, 2010, GENET RES, V92, P283, DOI 10.1017/S0016672310000273; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; Li H, 2010, HEREDITY, V105, P257, DOI 10.1038/hdy.2010.56; Lynch M., 1998, GENETICS ANAL QUANTI; Mather K, 1937, CYTOLOGIA FUJII JUB, V514-526; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Meuwissen THE, 2001, GENETICS, V157, P1819; Paterson AH, 2006, NAT REV GENET, V7, P174, DOI 10.1038/nrg1806; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; SOLLER M, 1990, THEOR APPL GENET, V80, P205, DOI 10.1007/BF00224388; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Weir BS, 1987, P 2 INT C QUANT GEN; Xu SZ, 2003, GENETICS, V163, P789; Zhang LY, 2008, GENETICS, V180, P1177, DOI 10.1534/genetics.108.092122; Zhang YM, 2005, HEREDITY, V95, P96, DOI 10.1038/sj.hdy.6800702	27	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46545	10.1371/journal.pone.0046545	http://dx.doi.org/10.1371/journal.pone.0046545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056339	Green Published, gold			2022-12-27	WOS:000309889400016
J	Beitzinger, C; Stefani, C; Kronhardt, A; Rolando, M; Flatau, G; Lemichez, E; Benz, R				Beitzinger, Christoph; Stefani, Caroline; Kronhardt, Angelika; Rolando, Monica; Flatau, Gilles; Lemichez, Emmanuel; Benz, Roland			Role of N-Terminal His(6)-Tags in Binding and Efficient Translocation of Polypeptides into Cells Using Anthrax Protective Antigen (PA)	PLOS ONE			English	Article							BOTULINUM C2 TOXIN; LIPID BILAYER-MEMBRANES; CURRENT NOISE-ANALYSIS; CLOSTRIDIUM-BOTULINUM; LETHAL FACTOR; ESCHERICHIA-COLI; BACILLUS-ANTHRACIS; PORE FORMATION; BACTERIOPHAGE-LAMBDA; PHENYLALANINE CLAMP	It is of interest to define bacterial toxin biochemical properties to use them as molecular-syringe devices in order to deliver enzymatic activities into host cells. Binary toxins of the AB(7/8)-type are among the most potent and specialized bacterial protein toxins. The B subunits oligomerize to form a pore that binds with high affinity host cell receptors and the enzymatic A subunit. This allows the endocytosis of the complex and subsequent injection of the A subunit into the cytosol of the host cells. Here we report that the addition of an N-terminal His(6)-tag to different proteins increased their binding affinity to the protective antigen (PA) PA(63)-channels, irrespective if they are related (C2I) or unrelated (gpJ, EDIN) to the AB(7/8)-family of toxins. His(6)-EDIN exhibited voltage-dependent increase of the stability constant for binding by a factor of about 25 when the trans-side corresponding to the cell interior was set to -70 mV. Surprisingly, the C. botulinum toxin C2II-channel did not share this feature of PA(63). Cell-based experiments demonstrated that addition of an N-terminal His(6)-tag promoted also intoxication of endothelial cells by C2I or EDIN via PA(63). Our results revealed that addition of His(6)-tags to several factors increase their binding properties to PA(63) and enhance the property to intoxicate cells.	[Stefani, Caroline; Rolando, Monica; Flatau, Gilles; Lemichez, Emmanuel] Fac Med Nice, INSERM, U1065, C3M, F-06034 Nice, France; [Beitzinger, Christoph; Kronhardt, Angelika; Benz, Roland] Univ Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, Wurzburg, Germany; [Stefani, Caroline; Rolando, Monica; Lemichez, Emmanuel] Univ Nice Sophia Antipolis, IFR50, UFR Med, Nice, France; [Benz, Roland] Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; German Research Foundation (DFG); University of Wurzburg; UDICE-French Research Universities; Universite Cote d'Azur; University of Bremen	Lemichez, E (corresponding author), Fac Med Nice, INSERM, U1065, C3M, U210, F-06034 Nice, France.	Emmanuel.Lemichez@unice.fr; roland.benz@uni-wuerzburg.de	Lemichez, Emmanuel/G-3559-2013	Lemichez, Emmanuel/0000-0001-9080-7761; stefani, caroline/0000-0003-3420-432X; Rolando, Monica/0000-0002-3710-0115; Benz, Roland/0000-0002-9510-9265	German Research Foundation (DFG); University of Wuerzburg; Deutsche Forschungsgemeinschaft [SFB 487, GRK 1141/1]; Association pour la Recherche sur le Cancer [ARC SFI20111203659]; ANR agency [11BSV3 004 01]	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); ANR agency(French National Research Agency (ANR))	The authors like to thank R. John Collier, Harvard Medical School, Boston, USA, for critically discussing the results and Fiorella Tonello, Padua, Italy, for a batch of LF protein and the plasmid pET19PA. The authors also like to thank Alain Charbit, Necker Enfant Malades, Paris, France for the kind gift of the plasmid for MBP-gpJ production and Tobias Neumeyer for the construction of the PA mutant F427A. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. This work was supported by the Deutsche Forschungsgemeinschaft (project A5 of the SFB 487 and area 2B of GRK 1141/1), by the Association pour la Recherche sur le Cancer (Grant ARC SFI20111203659 to EL and a fellowship to CS and MR) and by the ANR agency (11BSV3 004 01) to EL.	Abrami L, J CELL BIOL, V166, P645; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, REV PHYSL BIOCH PHAR, V152, P1; Aktories K, ANAEROBE, V10, P101; Ascenzi P, 2002, FEBS LETT, V531, P384, DOI 10.1016/S0014-5793(02)03609-8; Bachmeyer C, J MOL BIOL, V333, P527; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, NAUNYN SCHMIEDEBERGS, V366, P501; Barth H, J BIOL CHEM, V277, P5074; Barth H, MICROBIOL MOL BIOL R, V68, P373; Benz R, J MEMBR BIOL, V100, P21; Benz R, J BACTERIOL, V165, P978; Benz R, BIOCH BIOPHYS ACTA, V511, P305; Berkane E, 2006, BIOCHEMISTRY-US, V45, P2708, DOI 10.1021/bi051800v; Blanke SR, P NATL ACAD SCI US, V93, P8437; Blaustein RO, P NATL ACAD SCI US, V86, P2209; Blaustein RO, J GEN PHYSL, V96, P921; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Boquet P, TRENDS CELL BIOL, V13, P238; Boyer L, 2006, J CELL BIOL, V173, P809, DOI 10.1083/jcb.200509009; Brown MJ, J BIOL CHEM, V286, P23189; Cataldi A, MOL MICROBIOL, V4, P1111; Considine RV, TOXICON, V29, P913; Doye A, METHODS ENZYMOL, V406, P447; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Finkelstein A, TOXICOLOGY, V87, P29; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Krantz BA, J MOL BIOL, V344, P739; Kronhardt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023133; Leppla SH, J APPL MICROBIOL, V87, P284; Leuber M, BIOCH BIOPHYS ACTA, V1778, P1436; Maddugoda MP, 2011, CELL HOST MICROBE, V10, P464, DOI 10.1016/j.chom.2011.09.014; Melnyk RA, P NATL ACAD SCI US, V103, P9802; Miller CJ, BIOCHEMISTRY, V38, P10432; Mock M, ANN REV MICROBIOL, V55, P647; Mogridge J, BIOCHEMISTRY, V41, P1079; Neumeyer T, 2006, BIOCHEMISTRY-US, V45, P3060, DOI 10.1021/bi0524316; Neumeyer T, J BIOL CHEM, V281, P32335; Neumeyer T, 2008, J BIOL CHEM, V283, P3904, DOI 10.1074/jbc.M709807200; Orlik F, BIOPHYS J, V88, P1715; Petosa C, NATURE, V385, P833; Rolando M, 2009, INFECT IMMUN, V77, P3596, DOI 10.1128/IAI.00186-09; Schleberger C, J MOL BIOL, V364, P705; Schmid A, J BIOL CHEM, V269, P16706; Sellman BR, J BIOL CHEM, V276, P8371; Sun J, P NATL ACAD SCI US, V105, P4346; Tonello F, BIOCH BIOPHYS RES CO, V313, P496; Turk BE, BIOCH J, V402, P405; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; Wei W, CELL, V124, P1141; Young JA, ANN REV BIOCH, V76, P243; Zhang S, BIOCHEMISTRY, V43, P6339; Zhang S, P NATL ACAD SCI US, V101, P16756	56	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46964	10.1371/journal.pone.0046964	http://dx.doi.org/10.1371/journal.pone.0046964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056543	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500115
J	Huang, W; Lin, YJ; Yi, SY; Liu, PF; Shen, J; Shao, ZZ; Liu, ZD				Huang, Wei; Lin, Yongjun; Yi, Shuyuan; Liu, Pengfu; Shen, Jie; Shao, Zongze; Liu, Ziduo			QsdH, a Novel AHL Lactonase in the RND-Type Inner Membrane of Marine Pseudoalteromonas byunsanensis Strain 1A01261	PLOS ONE			English	Article							N-ACYLHOMOSERINE LACTONASE; MULTIDRUG EFFLUX PUMP; QUORUM-SENSING SIGNAL; COLD-ADAPTED ESTERASE; PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; TI-PLASMID; ACYLASE; FAMILY; IDENTIFICATION	N-acyl-homoserine lactones (AHLs) are the main quorum-sensing (QS) signals in gram-negative bacteria. AHLs trigger the expression of genes for particular biological functions when their density reaches a threshold. In this study, we identified and cloned the qsdH gene by screening a genomic library of Pseudoalteromonas byunsanensis strain 1A01261, which has AHL-degrading activity. The qsdH gene encoded a GDSL hydrolase found to be located in the N-terminus of a multidrug efflux transporter protein of the resistance-nodulation-cell division (RND) family. We further confirmed that the GDSL hydrolase, QsdH, exhibited similar AHL-degrading activity to the full-length ORF protein. QsdH was expressed and purified to process the N-terminal signal peptide yielding a 27-kDa mature protein. QsdH was capable of inactivating AHLs with an acyl chain ranging from C-4 to C-14 with or without 3-oxo substitution. High-performance liquid chromatography (HPLC) and electrospray ionization-mass spectrometry (ESI-MS) analyses showed that QsdH functioned as an AHL lactonase to hydrolyze the ester bond of the homoserine lactone ring of AHLs. In addition, site-directed mutagenesis demonstrated that QsdH contained oxyanion holes (Ser-Gly-Asn) in conserved blocks (I, II, and III), which had important roles in its AHL-degrading activity. Furthermore, the lactonase activity of QsdH was slightly promoted by several divalent ions. Using in silico prediction, we concluded that QsdH was located at the first periplasmic loop of the multidrug efflux transporter protein, which is essential to substrate selectivity for these efflux pumps. These findings led us to assume that the QsdH lactonase and C-terminal efflux pump might be effective in quenching QS of the P. byunsanensis strain 1A01261. Moreover, it was observed that recombinant Escherichia coli producing QsdH proteins attenuated the plant pathogenicity of Erwinia carotovora, which might have potential to control of gram-negative pathogenic bacteria.	[Huang, Wei; Yi, Shuyuan; Liu, Pengfu; Shen, Jie; Liu, Ziduo] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Shao, Zongze] Third Marine Res Inst, State Ocean Adm, Xiamen, Peoples R China; [Lin, Yongjun] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University; State Oceanic Administration; Huazhong Agricultural University	Liu, ZD (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	lzd@mail.hzau.edu.cn			National Natural Sciences Foundation of China [u1170303]; Genetically Modified Organisms Breeding Major Projects of China [2011zx08001-001]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Projects of China	This work was supported by a grant from the National Natural Sciences Foundation of China (NO. u1170303) and the Genetically Modified Organisms Breeding Major Projects of China (2011zx08001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bowman JP, 2007, MAR DRUGS, V5, P220, DOI 10.3390/md20070017; Carinato ME, 1998, J BACTERIOL, V180, P3517, DOI 10.1128/JB.180.14.3517-3521.1998; Carlier A, 2003, APPL ENVIRON MICROB, V69, P4989, DOI 10.1128/AEM.69.8.4989-4993.2003; Chan YY, 2007, J BACTERIOL, V189, P4320, DOI 10.1128/JB.00003-07; Chan YY, 2005, J BACTERIOL, V187, P4707, DOI 10.1128/JB.187.14.4707-4719.2005; Cieslinski H, 2007, ARCH MICROBIOL, V188, P27, DOI 10.1007/s00203-007-0220-2; Czajkowski R, 2011, ENV MICROBIOL REP, V3, P59, DOI 10.1111/j.1758-2229.2010.00188.x; Czajkowski R, 2009, ACTA BIOCHIM POL, V56, P1; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Eda S, 2003, J BIOL CHEM, V278, P2085, DOI 10.1074/jbc.C200661200; Finch RG, 1998, J ANTIMICROB CHEMOTH, V42, P569, DOI 10.1093/jac/42.5.569; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Guan L, 1999, J BIOL CHEM, V274, P10517, DOI 10.1074/jbc.274.15.10517; Guo Xiuchun, 2008, Wei Sheng Wu Xue Bao, V48, P545; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Huang JJ, 2006, APPL ENVIRON MICROB, V72, P1190, DOI 10.1128/AEM.72.2.1190-1197.2006; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; Mei GY, 2010, APPL ENVIRON MICROB, V76, P4933, DOI 10.1128/AEM.00477-10; Middlemiss JK, 2004, J BACTERIOL, V186, P1258, DOI 10.1128/JB.186.5.1258-1269.2004; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Morohoshi T, 2008, BIOSCI BIOTECH BIOCH, V72, P1887, DOI 10.1271/bbb.80139; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Park SY, 2005, APPL ENVIRON MICROB, V71, P2632, DOI 10.1128/AEM.71.5.2632-2641.2005; Park SY, 2003, MICROBIOL-SGM, V149, P1541, DOI 10.1099/mic.0.26269-0; Park YD, 2005, INT J SYST EVOL MICR, V55, P2519, DOI 10.1099/ijs.0.63750-0; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; PIPER KR, 1993, NATURE, V362, P448, DOI 10.1038/362448a0; Poole Keith, 2001, Current Topics in Medicinal Chemistry, V1, P59, DOI 10.2174/1568026013395605; Riedel K, 2003, APPL ENVIRON MICROB, V69, P3901, DOI 10.1128/AEM.69.7.3901-3910.2003; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; Suzuki T, 2003, PROTEIN EXPRES PURIF, V30, P171, DOI 10.1016/S1046-5928(03)00128-1; Talker-Huiber D, 2003, APPL MICROBIOL BIOT, V61, P479, DOI 10.1007/s00253-003-1227-5; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; Uroz S, 2005, MICROBIOL-SGM, V151, P3313, DOI 10.1099/mic.0.27961-0; Uroz S, 2008, APPL ENVIRON MICROB, V74, P1357, DOI 10.1128/AEM.02014-07; Wang WZ, 2010, APPL ENVIRON MICROB, V76, P2524, DOI 10.1128/AEM.02738-09; Wang Y, 2008, BIOSCI BIOTECH BIOCH, V72, P1958, DOI 10.1271/bbb.80090; Wilhelm S, 1999, J BACTERIOL, V181, P6977, DOI 10.1128/JB.181.22.6977-6986.1999; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang X, 2011, APPL MICROBIOL BIOT, V90, P1963, DOI 10.1007/s00253-011-3203-9	50	7	11	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46587	10.1371/journal.pone.0046587	http://dx.doi.org/10.1371/journal.pone.0046587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056356	gold, Green Submitted, Green Published			2022-12-27	WOS:000309831500051
J	Nita, II; Hershfinkel, M; Fishman, D; Ozeri, E; Rutter, GA; Sensi, SL; Khananshvili, D; Lewis, EC; Sekler, I				Nita, Iulia I.; Hershfinkel, Michal; Fishman, Daniel; Ozeri, Eyal; Rutter, Guy A.; Sensi, Stefano L.; Khananshvili, Daniel; Lewis, Eli C.; Sekler, Israel			The Mitochondrial Na+/Ca2+ Exchanger Upregulates Glucose Dependent Ca2+ Signalling Linked to Insulin Secretion	PLOS ONE			English	Article							BETA-CELLS; ESSENTIAL COMPONENT; CALCIUM; OSCILLATIONS; METABOLISM; MEMBRANE; CHANNELS; HEART; MECHANISMS; INHIBITOR	Mitochondria mediate dual metabolic and Ca2+ shuttling activities. While the former is required for Ca2+ signalling linked to insulin secretion, the role of the latter in beta cell function has not been well understood, primarily because the molecular identity of the mitochondrial Ca2+ transporters were elusive and the selectivity of their inhibitors was questionable. This study focuses on NCLX, the recently discovered mitochondrial Na+/Ca2+ exchanger that is linked to Ca2+ signalling in MIN6 and primary beta cells. Suppression either of NCLX expression, using a siRNA construct (siNCLX) or of its activity, by a dominant negative construct (dnNCLX), enhanced mitochondrial Ca2+ influx and blocked efflux induced by glucose or by cell depolarization. In addition, NCLX regulated basal, but not glucose-dependent changes, in metabolic rate, mitochondrial membrane potential and mitochondrial resting Ca2+. Importantly, NCLX controlled the rate and amplitude of cytosolic Ca2+ changes induced by depolarization or high glucose, indicating that NCLX is a critical and rate limiting component in the cross talk between mitochondrial and plasma membrane Ca2+ signalling. Finally, knockdown of NCLX expression was followed by a delay in glucose-dependent insulin secretion. These findings suggest that the mitochondrial Na+/Ca2+ exchanger, NCLX, shapes glucose-dependent mitochondrial and cytosolic Ca2+ signals thereby regulating the temporal pattern of insulin secretion in beta cells.	[Nita, Iulia I.; Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel; [Hershfinkel, Michal; Fishman, Daniel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Morphol, Beer Sheva, Israel; [Ozeri, Eyal; Lewis, Eli C.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel; [Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Div Diabet Endocrinol & Metab,Sec Cell Biol, London, England; [Sensi, Stefano L.] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Sensi, Stefano L.] Univ G DAnnunzio, Mol Neurol Unit, Ctr Excellence Aging, Chieti, Italy; [Khananshvili, Daniel] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, Ramat Aviv, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Imperial College London; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Tel Aviv University; Sackler Faculty of Medicine	Sekler, I (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel.	sekler@bgu.ac.il	Sensi, Stefano L./J-3164-2016; Nita, Iulia/AAF-6887-2021; Sensi, Stefano L./O-1335-2019; LEWIS, ELI C/F-1552-2012	Sensi, Stefano L./0000-0002-0710-2574; Sensi, Stefano L./0000-0002-0710-2574; LEWIS, ELI C/0000-0002-4189-2207; Khananshvili, Daniel/0000-0002-4202-9966; Hershfinkel, Michal/0000-0003-1652-1989; Rutter, Guy/0000-0001-6360-0343	Israeli USA binational grant (BSF) [2009344]; Israeli Science Foundation grant (ISF) [985/05]; German Israeli Foundation (GIF); Wellcome Trust [081958/Z/07/Z]; DiabetesUK; Royal Society; Biotechnology and Biological Sciences Research Council [BB/J015873/1] Funding Source: researchfish; BBSRC [BB/J015873/1] Funding Source: UKRI	Israeli USA binational grant (BSF); Israeli Science Foundation grant (ISF); German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Wellcome Trust(Wellcome Trust); DiabetesUK(Diabetes UK); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Israeli USA binational grant (BSF) grant 2009344 to DK and IS, Israeli Science Foundation grant (ISF) 985/05 and the German Israeli Foundation (GIF) grants to IS and the Wellcome Trust (Programme Grant 081958/Z/07/Z), DiabetesUK and the Royal Society (Wolfson Research Merit Award) to GAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov D, 2010, FASEB J, V24, P4613, DOI 10.1096/fj.10-162222; ASHCROFT SJ, 1973, BIOCHEM J, V132, P223, DOI 10.1042/bj1320223; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; CARAFOLI E, 1973, EXPERIENTIA, V29, P408, DOI 10.1007/BF01926749; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Efrat S, 2004, ANN NY ACAD SCI, V1014, P88, DOI 10.1196/annals.1294.009; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Henquin JC, 2004, ANN ENDOCRINOL-PARIS, V65, P8; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Jekabsone A, 2003, J MOL CELL CARDIOL, V35, P803, DOI 10.1016/S0022-2828(03)00137-8; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Jonkers FC, 2001, DIABETES, V50, P540, DOI 10.2337/diabetes.50.3.540; Jonkers FC, 1999, J PHYSIOL-LONDON, V520, P839, DOI 10.1111/j.1469-7793.1999.00839.x; Kennedy ED, 1998, DIABETES METAB, V24, P15; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kim B, 2008, J PHYSIOL-LONDON, V586, P1683, DOI 10.1113/jphysiol.2007.148726; Lee B, 2003, DIABETES, V52, P965, DOI 10.2337/diabetes.52.4.965; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Lindskog C, 2012, J PROTEOMICS, V75, P2611, DOI 10.1016/j.jprot.2012.03.008; Luciani DS, 2007, EUR J PHARMACOL, V576, P18, DOI 10.1016/j.ejphar.2007.07.055; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; Lukyanenko V, 2009, INT J BIOCHEM CELL B, V41, P1957, DOI 10.1016/j.biocel.2009.03.011; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Neumann JT, 2011, MOL PHARMACOL, V79, P141, DOI 10.1124/mol.110.067165; Nicholls DG, 2004, J BIOENERG BIOMEMBR, V36, P277, DOI 10.1023/B:JOBB.0000041753.52832.f3; Norris SM, 2010, AM J PHYSIOL-CELL PH, V298, pC521, DOI 10.1152/ajpcell.00479.2009; Ohki EC, 2001, J NEUROSCI METH, V112, P95, DOI 10.1016/S0165-0270(01)00441-1; Palty R, 2004, J BIOL CHEM, V279, P25234, DOI 10.1074/jbc.M401229200; Palty R, 2006, BIOCHEMISTRY-US, V45, P11856, DOI 10.1021/bi060633b; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Paucek P, 2004, BBA-BIOENERGETICS, V1659, P83, DOI 10.1016/j.bbabio.2004.03.019; Pedersen MG, 2009, P NATL ACAD SCI USA, V106, P7432, DOI 10.1073/pnas.0901202106; PRENTKI M, 1983, J BIOL CHEM, V258, P7597; Quesada I, 2008, CELL CALCIUM, V43, P39, DOI 10.1016/j.ceca.2007.03.001; Robert V, 2001, EMBO J, V20, P4998, DOI 10.1093/emboj/20.17.4998; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; ROSSI CS, 1973, BIOCHEM BIOPH RES CO, V50, P846, DOI 10.1016/0006-291X(73)91322-3; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; RUTTER GA, 1990, INT J BIOCHEM, V22, P1081, DOI 10.1016/0020-711X(90)90105-C; Scanlon JM, 2000, CELL CALCIUM, V28, P317, DOI 10.1054/ceca.2000.0171; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Thu Le Thi, 2006, Eur J Pharmacol, V552, P15; White RJ, 1997, J PHYSIOL-LONDON, V498, P31, DOI 10.1113/jphysiol.1997.sp021839	51	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46649	10.1371/journal.pone.0046649	http://dx.doi.org/10.1371/journal.pone.0046649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056385	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500054
J	Adebakin, A; Bradley, J; Gumusgoz, S; Waters, EJ; Lawrence, CB				Adebakin, Adedolapo; Bradley, Jenna; Guemuesgoez, Sarah; Waters, Elizabeth J.; Lawrence, Catherine B.			Impaired Satiation and Increased Feeding Behaviour in the Triple-Transgenic Alzheimer's Disease Mouse Model	PLOS ONE			English	Article							C-FOS EXPRESSION; CENTRAL-NERVOUS-SYSTEM; OBESE ZUCKER RATS; FOOD-INTAKE; BRAIN-STEM; NUTRITIONAL-STATUS; ARCUATE NUCLEUS; DEMENTIA; CHOLECYSTOKININ; SATIETY	Alzheimer's disease (AD) is associated with non-cognitive symptoms such as changes in feeding behaviour that are often characterised by an increase in appetite. Increased food intake is observed in several mouse models of AD including the triple transgenic (3 x TgAD) mouse, but the mechanisms underlying this hyperphagia are unknown. We therefore examined feeding behaviour in 3 x TgAD mice and tested their sensitivity to exogenous and endogenous satiety factors by assessing food intake and activation of key brain regions. In the behavioural satiety sequence (BSS), 3 x TgAD mice consumed more food after a fast compared to Non-Tg controls. Feeding and drinking behaviours were increased and rest decreased in 3 x TgAD mice, but the overall sequence of behaviours in the BSS was maintained. Exogenous administration of the satiety factor cholecystokinin (CCK; 8-30 mu g/kg, i.p.) dose-dependently reduced food intake in Non-Tg controls and increased inactive behaviour, but had no effect on food intake or behaviour in 3 x TgAD mice. CCK (15 mg/kg, i.p.) increased c-Fos protein expression in the supraoptic nucleus of the hypothalamus, and the nucleus tractus solitarius (NTS) and area postrema of the brainstem to the same extent in Non-Tg and 3 x TgAD mice, but less c-Fos positive cells were detected in the paraventricular hypothalamic nucleus of CCK-treated 3 x TgAD compared to Non-Tg mice. In response to a fast or a period of re-feeding, there was no difference in the number of c-Fox positive cells detected in the arcuate nucleus of the hypothalamus, NTS and area postrema of 3 x TgAD compared to Non-Tg mice. The degree of c-Fos expression in the NTS was positively correlated to food intake in Non-Tg mice, however, this relationship was absent in 3 x TgAD mice. These data demonstrate that 3 x TgAD mice show increased feeding behaviour and insensitivity to satiation, which is possibly due to defective gut-brain signalling in response to endogenous satiety factors released by food ingestion.	[Adebakin, Adedolapo; Bradley, Jenna; Guemuesgoez, Sarah; Waters, Elizabeth J.; Lawrence, Catherine B.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Lawrence, CB (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	catherine.lawrence@manchester.ac.uk	Dapre, Elizabeth/AAD-5382-2019	Lawrence, Catherine/0000-0002-2372-2968	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Biotechnology and Biological Sciences Research Council (BBSRC) helped to fund a Masters of Research student that performed some of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTIN J, 1975, J COMP PHYSIOL PSYCH, V89, P784, DOI 10.1037/h0077040; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Becskei C, 2009, NEUROENDOCRINOLOGY, V90, P371, DOI 10.1159/000251723; Bombois S, 2010, J NUTR HEALTH AGING, V14, P212, DOI 10.1007/s12603-010-0052-7; BURNS A, 1989, PSYCHOL MED, V19, P383, DOI 10.1017/S0033291700012423; Cano V, 2003, NEUROSCI LETT, V343, P13, DOI 10.1016/S0304-3940(03)00277-5; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; CROSS AJ, 1984, J NEUROCHEM, V43, P1574, DOI 10.1111/j.1471-4159.1984.tb06081.x; Dockray GJ, 2012, CURR OPIN ENDOCRINOL, V19, P8, DOI 10.1097/MED.0b013e32834eb77d; Duca FA, 2012, BR J NUTR, P1; ERVIN GN, 1995, J PHARMACOL EXP THER, V273, P1203; Finkel SI, 2003, CLIN GERIATR MED, V19, P799, DOI 10.1016/S0749-0690(03)00046-6; GIBBS J, 1982, PEPTIDES, V3, P553, DOI 10.1016/0196-9781(82)90125-5; Gillette-Guyonnet S, 2007, J NUTR HEALTH AGING, V11, P38; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; Greenwood CE, 2005, J GERONTOL A-BIOL, V60, P499, DOI 10.1093/gerona/60.4.499; Guerin O, 2009, CLIN NUTR, V28, P141, DOI 10.1016/j.clnu.2009.01.014; Guilmeau S, 2003, DIABETES, V52, P1664, DOI 10.2337/diabetes.52.7.1664; Gustaw-Rothenberg K, 2009, INT J ENV RES PUB HE, V6, P1335, DOI 10.3390/ijerph6041335; Halford JCG, 1998, PHARMACOL BIOCHEM BE, V61, P159, DOI 10.1016/S0091-3057(98)00032-X; HAMAMURA M, 1991, J PHYSIOL-LONDON, V444, P51, DOI 10.1113/jphysiol.1991.sp018865; Hwang JP, 1997, INT J GERIATR PSYCH, V12, P902, DOI 10.1002/(SICI)1099-1166(199709)12:9<902::AID-GPS660>3.0.CO;2-Q; Keene J, 1998, INT J GERIATR PSYCH, V13, P700, DOI 10.1002/(SICI)1099-1166(1998100)13:10<700::AID-GPS855>3.0.CO;2-D; Keene JM, 1996, INT J GERIATR PSYCH, V11, P1041, DOI 10.1002/(SICI)1099-1166(199612)11:12<1041::AID-GPS541>3.0.CO;2-B; Keene JM, 1997, APPETITE, V28, P151, DOI 10.1006/appe.1996.0061; Keene JM, 1997, APPETITE, V28, P167, DOI 10.1006/appe.1996.0068; Klaffke S, 2006, ACTA NEUROL BELG, V106, P168; Knight EM, 2012, NEUROBIOL AGING, V33, P187, DOI 10.1016/j.neurobiolaging.2010.02.003; Kyle Gaye, 2011, Br J Community Nurs, V16, P6; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P360, DOI 10.1210/en.143.2.360; Lin S, 1999, BRAIN RES BULL, V49, P215, DOI 10.1016/S0361-9230(99)00049-0; LUCKMAN SM, 1992, J NEUROENDOCRINOL, V4, P149, DOI 10.1111/j.1365-2826.1992.tb00152.x; MAGGIO CA, 1988, PHYSIOL BEHAV, V43, P485, DOI 10.1016/0031-9384(88)90123-0; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; MORRIS CH, 1989, BRIT J PSYCHIAT, V154, P801, DOI 10.1192/bjp.154.6.801; Mosher JT, 1998, PEPTIDES, V19, P849, DOI 10.1016/S0196-9781(98)00025-4; Mosher JT, 1996, PEPTIDES, V17, P483, DOI 10.1016/0196-9781(96)00028-9; MUNGAS D, 1990, J AM GERIATR SOC, V38, P999, DOI 10.1111/j.1532-5415.1990.tb04423.x; Niederau C, 1997, REGUL PEPTIDES, V70, P97, DOI 10.1016/S0167-0115(97)00014-1; NISKANEN L, 1993, AGE AGEING, V22, P132, DOI 10.1093/ageing/22.2.132; OLSON BR, 1993, MOL CELL NEUROSCI, V4, P93, DOI 10.1006/mcne.1993.1011; Owyang C, 2011, J NEUROGASTROENTEROL, V17, P338, DOI 10.5056/jnm.2011.17.4.338; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Renner E, 2010, EUR J NEUROSCI, V31, P302, DOI 10.1111/j.1460-9568.2009.07053.x; Riediger T, 2004, NEUROENDOCRINOLOGY, V79, P317, DOI 10.1159/000079842; Rinaman L, 2010, BRAIN RES, V1350, P18, DOI 10.1016/j.brainres.2010.03.059; Sam AH, 2011, NEUROPHARMACOLOGY; Schwartz GJ, 2010, FORUM NUTR, V63, P141, DOI 10.1159/000264402; Singru PS, 2007, ENDOCRINOLOGY, V148, P638, DOI 10.1210/en.2006-1233; Slaughter SE, 2011, CLIN NUTR, V30, P172, DOI 10.1016/j.clnu.2010.09.001; Smith G, 1998, NEUROPSY NEUROPSY BE, V11, P97; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Smith M A, 1999, J Alzheimers Dis, V1, P203; Spindler AA, 1996, J AM DIET ASSOC, V96, P1013, DOI 10.1016/S0002-8223(96)00270-2; Stoppe G, 1999, DRUG AGING, V14, P41, DOI 10.2165/00002512-199914010-00003; Szelenyi Z, 2004, PHYSIOL BEHAV, V81, P615, DOI 10.1016/j.physbeh.2004.02.025; Timofeeva E, 2001, J COMP NEUROL, V441, P71, DOI 10.1002/cne.1398; Tsang SW, 2010, J NEUROL SCI, V288, P151, DOI 10.1016/j.jns.2009.08.066; Ueyama E, 2004, NEUROSCI LETT, V371, P40, DOI 10.1016/j.neulet.2004.08.035; Vloeberghs E, 2008, BEHAV NEUROSCI, V122, P491, DOI 10.1037/0735-7044.122.3.491; Wang L, 1998, BRAIN RES, V791, P157, DOI 10.1016/S0006-8993(98)00091-2; Wang PN, 2004, J NEUROL, V251, P314, DOI 10.1007/s00415-004-0316-4; White H, 1998, J AM GERIATR SOC, V46, P1223, DOI 10.1111/j.1532-5415.1998.tb04537.x; White Heidi K, 2004, J Am Med Dir Assoc, V5, P89, DOI 10.1097/01.JAM.0000110646.48753.EF; Zittel TT, 1999, BRAIN RES, V846, P1, DOI 10.1016/S0006-8993(99)01842-9	67	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e45179	10.1371/journal.pone.0045179	http://dx.doi.org/10.1371/journal.pone.0045179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056194	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800001
J	Hwang, W; Hackler, L; Wu, G; Ji, HK; Zack, DJ; Qian, J				Hwang, Woochang; Hackler, Laszlo, Jr.; Wu, George; Ji, Hongkai; Zack, Donald J.; Qian, Jiang			Dynamics of Regulatory Networks in the Developing Mouse Retina	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; MICRORNAS; MOTIFS; LOOP; TARGETS; IDENTIFICATION; FEEDBACK	Understanding gene regulation is crucial to dissect the molecular basis of human development and disease. Previous studies on transcription regulatory networks often focused on their static properties. Here we used retinal development as a model system to investigate the dynamics of regulatory networks that are comprised of transcription factors, microRNAs and other protein-coding genes. We found that the active sub-networks are topologically different at early and late stages of retinal development. At early stages, the active sub-networks tend to be highly connected, while at late stages, the active sub-networks are more organized in modular structures. Interestingly, network motif usage at early and late stages is also distinct. For example, network motifs containing reciprocal feedback regulatory relationships between two regulators are overrepresented in early developmental stages. Additionally, our analysis of regulatory network dynamics revealed a natural turning point at which the regulatory network undergoes drastic topological changes. Taken together, this work demonstrates that adding a dynamic dimension to network analysis can provide new insights into retinal development, and we suggest the same approach would likely be useful for the analysis of other developing tissues.	[Hwang, Woochang; Hackler, Laszlo, Jr.; Zack, Donald J.; Qian, Jiang] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet, Baltimore, MD USA; [Wu, George; Ji, Hongkai] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Qian, J (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	jiang.qian@jhmi.edu		Zack, Don/0000-0002-7966-1973	National Institute of Health [EY021897, EY001765-36]; NATIONAL EYE INSTITUTE [P30EY001765, R21EY021897] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by funding from National Institute of Health (EY021897 and EY001765-36) and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Chen L, 2011, BIOINFORMATICS, V27, P1447, DOI 10.1093/bioinformatics/btr156; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Dekel E, 2005, PHYS BIOL, V2, P81, DOI 10.1088/1478-3975/2/2/001; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Graziotto JJ, 2011, INVEST OPHTH VIS SCI, V52, P190, DOI 10.1167/iovs.10-5194; Hu JF, 2010, BIOINFORMATICS, V26, P2289, DOI 10.1093/bioinformatics/btq408; Ishihara S, 2008, J THEOR BIOL, V252, P131, DOI 10.1016/j.jtbi.2008.01.027; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Jr Hackler L, 2009, INVEST OPHTH VIS SCI, V51, P1823; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Qian J, 2005, NUCLEIC ACIDS RES, V33, P3479, DOI 10.1093/nar/gki658; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Wan J, 2011, NUCLEIC ACIDS RES, V39, P7920, DOI 10.1093/nar/gkr545; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46521	10.1371/journal.pone.0046521	http://dx.doi.org/10.1371/journal.pone.0046521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056331	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000053
J	Serra-Juhe, C; Rodriguez-Santiago, B; Cusco, I; Vendrell, T; Camats, N; Toran, N; Perez-Jurado, LA				Serra-Juhe, Clara; Rodriguez-Santiago, Benjamin; Cusco, Ivon; Vendrell, Teresa; Camats, Nuria; Toran, Nuria; Perez-Jurado, Luis A.			Contribution of Rare Copy Number Variants to Isolated Human Malformations	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL HEART-DEFECTS; ARRAY-CGH; SUBTELOMERIC REARRANGEMENTS; IMBALANCES; MUTATIONS; DELETIONS; IDENTIFICATION; MICRODELETION; ANEUPLOIDIES	Background: Congenital malformations are present in approximately 2-3% of liveborn babies and 20% of stillborn fetuses. The mechanisms underlying the majority of sporadic and isolated congenital malformations are poorly understood, although it is hypothesized that the accumulation of rare genetic, genomic and epigenetic variants converge to deregulate developmental networks. Methodology/Principal Findings: We selected samples from 95 fetuses with congenital malformations not ascribed to a specific syndrome (68 with isolated malformations, 27 with multiple malformations). Karyotyping and Multiplex Ligation-dependent Probe Amplification (MLPA) discarded recurrent genomic and cytogenetic rearrangements. DNA extracted from the affected tissue (46%) or from lung or liver (54%) was analyzed by molecular karyotyping. Validations and inheritance were obtained by MLPA. We identified 22 rare copy number variants (CNV) [>100 kb, either absent (n = 7) or very uncommon (n = 15, <1/2,000) in the control population] in 20/95 fetuses with congenital malformations (21%), including 11 deletions and 11 duplications. One of the 9 tested rearrangements was de novo while the remaining were inherited from a healthy parent. The highest frequency was observed in fetuses with heart hypoplasia (8/17, 62.5%), with two events previously related with the phenotype. Double events hitting candidate genes were detected in two samples with brain malformations. Globally, the burden of deletions was significantly higher in fetuses with malformations compared to controls. Conclusions/Significance: Our data reveal a significant contribution of rare deletion-type CNV, mostly inherited but also de novo, to human congenital malformations, especially heart hypoplasia, and reinforce the hypothesis of a multifactorial etiology in most cases.	[Serra-Juhe, Clara; Cusco, Ivon; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Unitat Genet, Barcelona, Spain; [Serra-Juhe, Clara; Cusco, Ivon; Perez-Jurado, Luis A.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Rodriguez-Santiago, Benjamin] Quantitat Genom Med Labs qGenom, Barcelona, Spain; [Vendrell, Teresa] Hosp Univ Vall dHebron, Programa Med Mol & Genet, Barcelona, Spain; [Camats, Nuria; Toran, Nuria] Hosp Univ Vall dHebron, Serv Anat Patol, Barcelona, Spain	Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Perez-Jurado, LA (corresponding author), Univ Pompeu Fabra, Unitat Genet, Barcelona, Spain.	luis.perez@upf.edu	Serra-Juhe, Clara/M-6968-2015; Cusco, I/H-2096-2014; Cusco, Ivon/AAF-4662-2021; Pérez Jurado, Luis Alberto/M-7706-2015; Camats, Nuria/K-8326-2017	Serra-Juhe, Clara/0000-0001-8471-8391; Cusco, I/0000-0003-2104-9332; Cusco, Ivon/0000-0003-2104-9332; Camats, Nuria/0000-0002-4863-8201; Rodriguez-Santiago, Benjamin/0000-0003-1167-3852	Spanish Ministry of Health [PI042063]; CIBERER (Centro de Investigacion Biomedica en Red de Enfermedades Raras) [U735-3]; European Union [LSHG-CT-2006-037627]; Fondo de Investigacion Sanitaria [FIS FI08/00365, FIS CD06/00019]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIBERER (Centro de Investigacion Biomedica en Red de Enfermedades Raras); European Union(European Commission); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by grants from the Spanish Ministry of Health (PI042063), the CIBERER (Centro de Investigacion Biomedica en Red de Enfermedades Raras)(U735-3) and the VI Framework Programme of the European Union (LSHG-CT-2006-037627). CS-J and BR-S were supported by predoctoral (FIS FI08/00365) and posdoctoral fellowships (FIS CD06/00019) of the Fondo de Investigacion Sanitaria, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengol L, 2012, HUM GENET, V131, P513, DOI 10.1007/s00439-011-1095-5; Ashleigh R, 2012, PEDIAT CARDIOL; Bendavid C, 2007, HUM MUTAT, V28, P1189, DOI 10.1002/humu.20594; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Bittel DC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-1; Botto L.D., 2003, PROG PEDIATR CARDIOL, V18, P111, DOI [10.1016/S1058-9813(03)00084-5, DOI 10.1016/S1058-9813(03)00084-5]; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Butler TL, 2010, GENET TEST MOL BIOMA, V14, P797, DOI 10.1089/gtmb.2010.0028; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cusco I, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-27; De Galan-Roosen AEM, 1998, EUR J OBSTET GYN R B, V80, P55, DOI 10.1016/S0301-2115(98)00085-2; Erdogan F, 2008, J MED GENET, V45, P704, DOI 10.1136/jmg.2008.058776; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Gonzalez JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-166; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hardin J, 2009, AM J MED GENET A, V149A, P877, DOI 10.1002/ajmg.a.32745; Hinton RB, 2007, J AM COLL CARDIOL, V50, P1590, DOI 10.1016/j.jacc.2007.07.021; Iascone M, 2011, CLIN GENET; KALTER H, 1983, NEW ENGL J MED, V308, P424, DOI 10.1056/NEJM198302243080804; KALTER H, 1983, NEW ENGL J MED, V308, P491, DOI 10.1056/NEJM198303033080904; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Koolen DA, 2004, J MED GENET, V41, P892, DOI 10.1136/jmg.2004.023671; Lavallee G, 2006, EMBO J, V25, P5201, DOI 10.1038/sj.emboj.7601379; Le Caignec C, 2005, J MED GENET, V42, P121, DOI 10.1136/jmg.2004.025478; MITCHELL SC, 1971, AM J CARDIOL, V28, P653, DOI 10.1016/0002-9149(71)90053-1; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; Nagamani SCS, 2011, EUR J HUM GENET, V19, P280, DOI 10.1038/ejhg.2010.184; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; NORA JJ, 1976, CIRCULATION, V53, P701, DOI 10.1161/01.CIR.53.4.701; Ogata Tsutomu, 2005, Pediatr Endocrinol Rev, V2, P669; Ohtoshi A, 2004, MOL CELL BIOL, V24, P7548, DOI 10.1128/MCB.24.17.7548-7558.2004; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Pietrzyk J J, 1997, Cent Eur J Public Health, V5, P86; Popp S, 2002, HUM GENET, V111, P31, DOI 10.1007/s00439-002-0739-x; Richards AA, 2008, PEDIATR RES, V64, P358, DOI 10.1203/PDR.0b013e31818095d0; Rodriguez-Santiago B, 2010, MOL PSYCHIATR, V15, P1023, DOI 10.1038/mp.2009.53; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Rooms L, 2004, HUM MUTAT, V23, P17, DOI 10.1002/humu.10300; Schaeffer AJ, 2004, AM J HUM GENET, V74, P1168, DOI 10.1086/421250; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Tyreman M, 2009, J MED GENET, V46, P531, DOI 10.1136/jmg.2008.065482; Valduga M, 2010, PRENATAL DIAG, V30, P333, DOI 10.1002/pd.2460; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Vialard F, 2009, FETAL DIAGN THER, V25, P277, DOI 10.1159/000224112; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Webber SA, 1996, J PEDIATR-US, V129, P26, DOI 10.1016/S0022-3476(96)70186-5	49	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45530	10.1371/journal.pone.0045530	http://dx.doi.org/10.1371/journal.pone.0045530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056206	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000008
J	Chen, D; Banerjee, S; Cui, QZC; Kong, DJ; Sarkar, FH; Dou, QP				Chen, Di; Banerjee, Sanjeev; Cui, Qiuzhi C.; Kong, Dejuan; Sarkar, Fazlul H.; Dou, Q. Ping			Activation of AMP-Activated Protein Kinase by 3,3 '-Diindolylmethane (DIM) Is Associated with Human Prostate Cancer Cell Death In Vitro and In Vivo	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; ANDROGEN RECEPTOR; MAMMALIAN TARGET; SKELETAL-MUSCLE; METFORMIN; APOPTOSIS; GROWTH; PHOSPHORYLATION; PROLIFERATION; INHIBITION	There is a large body of scientific evidence suggesting that 3,39-Diindolylmethane (DIM), a compound derived from the digestion of indole-3-carbinol, which is abundant in cruciferous vegetables, harbors anti-tumor activity in vitro and in vivo. Accumulating evidence suggests that AMP-activated protein kinase (AMPK) plays an essential role in cellular energy homeostasis and tumor development and that targeting AMPK may be a promising therapeutic option for cancer treatment in the clinic. We previously reported that a formulated DIM (BR-DIM; hereafter referred as B-DIM) with higher bioavailability was able to induce apoptosis and inhibit cell growth, angiogenesis, and invasion of prostate cancer cells. However, the precise molecular mechanism(s) for the anti-cancer effects of B-DIM have not been fully elucidated. In the present study, we investigated whether AMP-activated protein kinase (AMPK) is a molecular target of B-DIM in human prostate cancer cells. Our results showed, for the first time, that B-DIM could activate the AMPK signaling pathway, associated with suppression of the mammalian target of rapamycin (mTOR), down-regulation of androgen receptor (AR) expression, and induction of apoptosis in both androgen-sensitive LNCaP and androgen-insensitive C4-2B prostate cancer cells. B-DIM also activates AMPK and down-regulates AR in androgen-independent C4-2B prostate tumor xenografts in SCID mice. These results suggest that B-DIM could be used as a potential anti-cancer agent in the clinic for prevention and/or treatment of prostate cancer regardless of androgen responsiveness, although functional AR may be required.	[Chen, Di; Cui, Qiuzhi C.; Sarkar, Fazlul H.; Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Oncol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48202 USA; [Banerjee, Sanjeev; Kong, Dejuan; Sarkar, Fazlul H.; Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Sarkar, FH (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48202 USA.	fsarkar@med.wayne.edu; doup@karmanos.org		Dou, Qingping/0000-0002-6465-1473	Karmanos Cancer Institute; National Cancer Institute [1R01CA120009, 3R01CA120009-04S1, 5R01CA127258-05]; NATIONAL CANCER INSTITUTE [R01CA120009, R01CA127258] Funding Source: NIH RePORTER	Karmanos Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by grants from Karmanos Cancer Institute (to QPD) National Cancer Institute (1R01CA120009, 3R01CA120009-04S1 and 5R01CA127258-05, to QPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Anderton MJ, 2004, DRUG METAB DISPOS, V32, P632, DOI 10.1124/dmd.32.6.632; Banerjee S, 2007, CANCER RES, V67, P3818, DOI 10.1158/0008-5472.CAN-06-3879; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bhuiyan MMR, 2006, CANCER RES, V66, P10064, DOI 10.1158/0008-5472.CAN-06-2011; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Brew CT, 2006, INT J CANCER, V118, P857, DOI 10.1002/ijc.21445; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chinni SR, 2002, CLIN CANCER RES, V8, P1228; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hutber C. Adrian, 1997, American Journal of Physiology, V272, pE262; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Kong D, 2008, CANCER RES, V68, P1927, DOI 10.1158/0008-5472.CAN-07-3241; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Nemeth JA, 2002, J NATL CANCER I, V94, P17; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Pan W, 2008, ONCOL REP, V20, P1553, DOI 10.3892/or_00000179; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Truica CI, 2000, CANCER RES, V60, P4709; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	42	34	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47186	10.1371/journal.pone.0047186	http://dx.doi.org/10.1371/journal.pone.0047186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056607	gold, Green Published, Green Submitted			2022-12-27	WOS:000309889400062
J	Hilgen, G; Huebner, AK; Tanimoto, N; Sothilingam, V; Seide, C; Garrido, MG; Schmidt, KF; Seeliger, MW; Lowel, S; Weiler, R; Hubner, CA; Dedek, K				Hilgen, Gerrit; Huebner, Antje K.; Tanimoto, Naoyuki; Sothilingam, Vithiyanjali; Seide, Christina; Garrido, Marina Garcia; Schmidt, Karl-Friedrich; Seeliger, Mathias W.; Loewel, Siegrid; Weiler, Reto; Huebner, Christian A.; Dedek, Karin			Lack of the Sodium-Driven Chloride Bicarbonate Exchanger NCBE Impairs Visual Function in the Mouse Retina	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; SLC4A10 SPLICE VARIANTS; BIPOLAR CELLS; HORIZONTAL CELLS; DEVELOPMENTAL EXPRESSION; COTRANSPORTER KCC2; CL-/HCO3-EXCHANGER; INTRACELLULAR PH; GANGLION-CELLS; RESPONSES	Regulation of ion and pH homeostasis is essential for normal neuronal function. The sodium-driven chloride bicarbonate exchanger NCBE (Slc4a10), a member of the SLC4 family of bicarbonate transporters, uses the transmembrane gradient of sodium to drive cellular net uptake of bicarbonate and to extrude chloride, thereby modulating both intracellular pH (pH(i)) and chloride concentration ([Cl-](i)) in neurons. Here we show that NCBE is strongly expressed in the retina. As GABA(A) receptors conduct both chloride and bicarbonate, we hypothesized that NCBE may be relevant for GABAergic transmission in the retina. Importantly, we found a differential expression of NCBE in bipolar cells: whereas NCBE was expressed on ON and OFF bipolar cell axon terminals, it only localized to dendrites of OFF bipolar cells. On these compartments, NCBE colocalized with the main neuronal chloride extruder KCC2, which renders GABA hyperpolarizing. NCBE was also expressed in starburst amacrine cells, but was absent from neurons known to depolarize in response to GABA, like horizontal cells. Mice lacking NCBE showed decreased visual acuity and contrast sensitivity in behavioral experiments and smaller b-wave amplitudes and longer latencies in electroretinograms. Ganglion cells from NCBE-deficient mice also showed altered temporal response properties. In summary, our data suggest that NCBE may serve to maintain intracellular chloride and bicarbonate concentration in retinal neurons. Consequently, lack of NCBE in the retina may result in changes in pH(i) regulation and chloride-dependent inhibition, leading to altered signal transmission and impaired visual function.	[Huebner, Antje K.; Huebner, Christian A.] Univ Hosp Jena, Inst Human Genet, Jena, Germany; [Hilgen, Gerrit; Weiler, Reto; Dedek, Karin] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany; [Tanimoto, Naoyuki; Sothilingam, Vithiyanjali; Seide, Christina; Garrido, Marina Garcia; Seeliger, Mathias W.] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany; [Schmidt, Karl-Friedrich; Loewel, Siegrid] Univ Jena, Inst Allgemeine Zool & Tierphysiol, Jena, Germany	Friedrich Schiller University of Jena; Carl von Ossietzky Universitat Oldenburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Schiller University of Jena	Hubner, CA (corresponding author), Univ Hosp Jena, Inst Human Genet, Jena, Germany.	christian.huebner@mti.uni-jena.de; karin.dedek@uni-oldenburg.de	Hübner, Christian/A-2950-2017; Hilgen, Gerrit/AAF-5649-2021; Dedek, Karin/R-6948-2018	Hübner, Christian/0000-0002-1030-4943; Hilgen, Gerrit/0000-0001-5008-5493; Dedek, Karin/0000-0003-1490-0141	Deutsche Forschungsgemeinschaft [We849/16-1/2, Se837/5-2, 6-1/2, Hu800/4-1, 5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (www.dfg.de; We849/16-1/2 to KD and RW, Se837/5-2 and 6-1/2 to MWS, and Hu800/4-1 and 5-1 to CAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez BV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000839; Blanco R, 1996, VISION RES, V36, P3987, DOI 10.1016/S0042-6989(96)00145-9; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Carcieri SM, 2003, J NEUROPHYSIOL, V90, P1704, DOI 10.1152/jn.00127.2003; Carolina V, 2005, VISION RES, V45, P2659, DOI 10.1016/j.visres.2005.03.020; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Dedek K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001714; DEVRIES SH, 1989, J PHYSIOL-LONDON, V414, P351, DOI 10.1113/jphysiol.1989.sp017692; Dmitriev AV, 2007, VISUAL NEUROSCI, V24, P635, DOI 10.1017/S0952523807070629; Dmitriev AV, 2004, J NEUROPHYSIOL, V91, P2404, DOI 10.1152/jn.00881.2003; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Eggers ED, 2011, VISUAL NEUROSCI, V28, P95, DOI 10.1017/S0952523810000209; EXCHANGER SLCJ, 2008, J NEUROSCI, V31, P7300; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; FIVE M, JOURNAL OF BIOLOGICA, V275, P1247; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; Giffard RG, 2003, EUR J NEUROSCI, V18, P2935, DOI 10.1046/j.1460-9568.2003.03053.x; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hilgen G, 2011, J COMP NEUROL, V519, P433, DOI 10.1002/cne.22526; HU B, 2001, NEURON, V30, P515; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Hubner CA, 2004, GENE EXPR PATTERNS, V5, P219, DOI 10.1016/j.modgep.2004.08.002; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ichinose T, 2005, J PHYSIOL-LONDON, V565, P517, DOI 10.1113/jphysiol.2005.083436; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; KAILA K, 1987, NATURE, V330, P163, DOI 10.1038/330163a0; KOBAYASHI S, 1994, J NEUROSCI, V14, P6266; Lee J, 1996, BRAIN RES, V706, P210, DOI 10.1016/0006-8993(95)01214-1; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Li BQ, 2008, VISUAL NEUROSCI, V25, P109, DOI 10.1017/S0952523808080164; Liu Y, 2010, NEUROSCIENCE, V169, P951, DOI 10.1016/j.neuroscience.2010.06.005; Liu Y, 2011, BRAIN RES, V1390, P33, DOI 10.1016/j.brainres.2011.03.046; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; MCALEAR SD, 2004, ADV MOL CEL, V31, P707; MILLER RF, 1983, VISION RES, V23, P399, DOI 10.1016/0042-6989(83)90087-1; Molnar A, 2007, J NEUROPHYSIOL, V98, P3423, DOI 10.1152/jn.00838.2007; Parker MD, 2008, J BIOL CHEM, V283, P12777, DOI 10.1074/jbc.M707829200; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; Seeliger MW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1540; Sinning A, 2011, J NEUROSCI, V31, P7300, DOI 10.1523/JNEUROSCI.0269-11.2011; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; TRU M, 2008, JOURNAL OF NEUROSCIE, V28, P6818, DOI DOI 10.1167/IOVS.09-3724; Trumpler J, 2008, J NEUROSCI, V28, P6818, DOI 10.1523/JNEUROSCI.1564-08.2008; Vardi N, 2000, J NEUROSCI, V20, P7657; Vardi Noga, 2002, Keio Journal of Medicine, V51, P154; Vu TQ, 2000, J NEUROSCI, V20, P1414; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Wu S M, 1991, Neurosci Res Suppl, V15, pS117; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhang LL, 2006, J COMP NEUROL, V499, P132, DOI 10.1002/cne.21100; Zhang RW, 2010, J PHYSIOL-LONDON, V588, P2557, DOI 10.1113/jphysiol.2010.187088	60	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46155	10.1371/journal.pone.0046155	http://dx.doi.org/10.1371/journal.pone.0046155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056253	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000309889400010
J	You, YA; Huan, P; Wang, XM; Liu, BZ				You, Yanan; Huan, Pin; Wang, Xiaomei; Liu, Baozhong			The Potential Roles of a Laminin Receptor in Adhesion and Apoptosis of Cells of the Marine Bivalve Meretrix meretrix	PLOS ONE			English	Article							P53 EXPRESSION; PROTEIN; CARCINOMA; PRECURSOR; PEPTIDES; MATRIX; GROWTH; BCL-2; PCR	Background: The laminin receptors (LRs) play important roles in cell adhesion to the extracellular matrix, certain cell-cell adhesions, and the activation of many intracellular signaling pathways. Studies of LRs have primarily focused on mammals, while few studies of LRs in marine invertebrates have been reported. The functions of LRs in marine bivalve species are still unclear. Methodology/Principal Findings: In this study, we cloned and sequenced an LR gene, MmeLR, from the clam Meretrix meretrix. The MmeLR mRNA and protein detected by realtime PCR and western blots were primarily distributed in muscle tissues. Far-western analysis showed a specific interaction between recombinant MmeLR and the LR ligand laminin. The results of the binding assay suggested a role of LR in cell adhesion and apoptosis in cultured primary cells of mantle tissues from M. meretrix. The Bcl-2 mRNA expression level in primary cells cultured in matrigel (mainly laminin) coated plates was significantly higher than in cells cultured in non-coated plates at 48 h of culture, while the p53 mRNA expression pattern was inversely related to that of bcl-2, suggesting that MmeLR is involved in p53-dependent apoptosis, and the binding between MmeLR and laminin inhibits apoptosis during primary cell culture. Conclusions: Our results suggest that MmeLR may be involved in cell adhesion and apoptosis. This study may increase the understanding of the role of laminin receptor in cell adhesion and apoptosis and help to improve the culture of primary cells of marine invertebrates.	[You, Yanan; Huan, Pin; Liu, Baozhong] Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China; [You, Yanan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wang, Xiaomei] Chinese Acad Fishery Sci, Res Ctr Resources & Ecoenvironm, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Fishery Sciences	Liu, BZ (corresponding author), Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China.	bzliu@qdio.ac.cn		Huan, Pin/0000-0001-9802-9992; Liu, Baozhong/0000-0002-6090-4867	National Nature Science Foundation of China [31072249]; Chinese National High-Tech R D Program [2012AA10A410]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National High-Tech R D Program(National High Technology Research and Development Program of China)	This work was supported by the National Nature Science Foundation of China (Grant No. 31072249) and the Chinese National High-Tech R & D Program (Grant No. 2012AA10A410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; AZNAVOORIAN S, 1990, J CELL BIOL, V110, P1427, DOI 10.1083/jcb.110.4.1427; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870; BIXBY JL, 1994, J CELL BIOL, V127, P1461, DOI 10.1083/jcb.127.5.1461; Burgess JK, 2009, PULM PHARMACOL THER, V22, P379, DOI 10.1016/j.pupt.2008.12.007; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Byun EH, 2011, FEBS LETT, V585, P814, DOI 10.1016/j.febslet.2011.02.010; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Crisera CA, 2000, DIABETES, V49, P936, DOI 10.2337/diabetes.49.6.936; Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007; Easley CA, 2006, BRAIN RES, V1092, P59, DOI 10.1016/j.brainres.2006.03.099; Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5; Engbring JA, 2003, J PATHOL, V200, P465, DOI 10.1002/path.1396; Engelhardt V, 2011, J PHOTOCH PHOTOBIO B, V103, P222, DOI 10.1016/j.jphotobiol.2011.03.014; Engvall E, 1996, J CELL BIOCHEM, V61, P493; Fu YP, 2008, PROG NAT SCI, V18, P233, DOI 10.1016/j.pnsc.2007.06.009; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Givant-Horwitz V, 2005, CANCER LETT, V223, P1, DOI 10.1016/j.canlet.2004.08.030; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kargi HA, 1997, CANCER LETT, V116, P185, DOI 10.1016/S0304-3835(97)00190-0; Kim WH, 1999, ANTICANCER RES, V19, P3067; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liu BZ, 2006, AQUACULTURE, V258, P344, DOI 10.1016/j.aquaculture.2006.03.047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; Malinda KM, 1996, INT J BIOCHEM CELL B, V28, P957, DOI 10.1016/1357-2725(96)00042-8; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Montuori N, 1999, CLIN CANCER RES, V5, P1465; Omar A, 2011, EXPERT OPIN THER PAT, V21, P35, DOI 10.1517/13543776.2011.539203; Pan MH, 2007, FOOD CHEM, V102, P788, DOI 10.1016/j.foodchem.2006.06.019; Porichi O, 2009, ANTICANCER RES, V29, P3977; Rahuel C, 2008, AM J PHYSIOL-RENAL, V294, pF393, DOI 10.1152/ajprenal.00315.2007; RAO CN, 1989, BIOCHEMISTRY-US, V28, P7476, DOI 10.1021/bi00444a047; Rinkevich B, 2011, MAR BIOTECHNOL, V13, P345, DOI 10.1007/s10126-010-9354-3; ROMANOV VI, 1995, BIOCHEM BIOPH RES CO, V208, P637, DOI 10.1006/bbrc.1995.1386; Sari I, 2004, EUR J GYNAECOL ONCOL, V25, P79; Shim C, 1996, MOL REPROD DEV, V44, P44, DOI 10.1002/(SICI)1098-2795(199605)44:1&lt;44::AID-MRD5&gt;3.0.CO;2-T; Smith A. S. T, 2010, SEMIN ORTHOD, V16, P135; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; TERRANOVA VP, 1983, P NATL ACAD SCI-BIOL, V80, P444, DOI 10.1073/pnas.80.2.444; Wan Q, 2008, J VIROL, V82, P12598, DOI 10.1128/JVI.01732-08; Yue X, 2011, FISH SHELLFISH IMMUN, V30, P550, DOI 10.1016/j.fsi.2010.11.022	46	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47104	10.1371/journal.pone.0047104	http://dx.doi.org/10.1371/journal.pone.0047104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056594	Green Submitted, Green Published, gold			2022-12-27	WOS:000309889400058
J	Ghorbal, M; Scheidig-Benatar, C; Bouizem, S; Thomas, C; Paisley, G; Faltermeier, C; Liu, M; Scherf, A; Lopez-Rubio, JJ; Gopaul, DN				Ghorbal, Mehdi; Scheidig-Benatar, Christine; Bouizem, Salma; Thomas, Christophe; Paisley, Genevieve; Faltermeier, Claire; Liu, Melanie; Scherf, Artur; Lopez-Rubio, Jose-Juan; Gopaul, Deshmukh N.			Initial Characterization of the Pf-Int Recombinase from the Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; ANTIGENIC VARIATION; HOMOLOGOUS RECOMBINATION; TRYPANOSOMA-BRUCEI; STRUCTURAL BASIS; CRE RECOMBINASE; DNA-BINDING; PROTEIN; EVOLUTION; SPECIFICITY	Background: Genetic variation is an essential means of evolution and adaptation in many organisms in response to environmental change. Certain DNA alterations can be carried out by site-specific recombinases (SSRs) that fall into two families: the serine and the tyrosine recombinases. SSRs are seldom found in eukaryotes. A gene homologous to a tyrosine site-specific recombinase has been identified in the genome of Plasmodium falciparum. The sequence is highly conserved among five other members of Plasmodia. Methodology/Principal Findings: The predicted open reading frame encodes for a similar to 57 kDa protein containing a C-terminal domain including the putative tyrosine recombinase conserved active site residues R-H-R-(H/W)-Y. The N-terminus has the typical alpha-helical bundle and potentially a mixed alpha-beta domain resembling that of lambda-Int. Pf-Int mRNA is expressed differentially during the P. falciparum erythrocytic life stages, peaking in the schizont stage. Recombinant Pf-Int and affinity chromatography of DNA from genomic or synthetic origin were used to identify potential DNA targets after sequencing or micro-array hybridization. Interestingly, the sequences captured also included highly variable subtelomeric genes such as var, rif, and stevor sequences. Electrophoretic mobility shift assays with DNA were carried out to verify Pf-Int/DNA binding. Finally, Pf-Int knock-out parasites were created in order to investigate the biological role of Pf-Int. Conclusions/Significance: Our data identify for the first time a malaria parasite gene with structural and functional features of recombinases. Pf-Int may bind to and alter DNA, either in a sequence specific or in a non-specific fashion, and may contribute to programmed or random DNA rearrangements. Pf-Int is the first molecular player identified with a potential role in genome plasticity in this pathogen. Finally, Pf-Int knock-out parasite is viable showing no detectable impact on blood stage development, which is compatible with such function.	[Ghorbal, Mehdi; Bouizem, Salma; Thomas, Christophe; Paisley, Genevieve; Faltermeier, Claire; Liu, Melanie; Gopaul, Deshmukh N.] Inst Pasteur, CNRS, UMR 3525, Unite Plasticite Genome Bacterien, Paris, France; [Scheidig-Benatar, Christine; Scherf, Artur; Lopez-Rubio, Jose-Juan] Inst Pasteur, CNRS, URA 2581, Unite Biol Interact Hote Parasite, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gopaul, DN (corresponding author), Inst Pasteur, CNRS, UMR 3525, Unite Plasticite Genome Bacterien, Paris, France.	deshmukh.gopaul@pasteur.fr	Scherf, Artur/A-9674-2014; lopez-rubio, jose juan/A-4509-2014	Ghorbal, Mehdi/0000-0002-8896-2786; lopez-rubio, jose juan/0000-0002-0555-1122; Scherf, Artur/0000-0003-2411-3328; GOPAUL, Deshmukh/0000-0003-1631-3303	Institut Pasteur G5 starter Grant; CNRS URA [2185]; European Research Council Executive Agency Advance Grant [PlasmoEscape 250320]; Domaine d'Interet Majeur (DIM MalInf) - Conseil Regional Ile de France	Institut Pasteur G5 starter Grant; CNRS URA; European Research Council Executive Agency Advance Grant; Domaine d'Interet Majeur (DIM MalInf) - Conseil Regional Ile de France(Region Ile-de-France)	This research received funding from Institut Pasteur G5 starter Grant and CNRS URA 2185 to DNG and by European Research Council Executive Agency Advance Grant (PlasmoEscape 250320) to AS. MG benefits from a PhD fellowship funded by Domaine d'Interet Majeur (DIM MalInf) - Conseil Regional Ile de France and CNRS URA 2185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bhattacharyya MK, 2004, INFECT GENET EVOL, V4, P91, DOI 10.1016/j.meegid.2004.01.008; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chaconas G, 2010, ANNU REV MICROBIOL, V64, P185, DOI 10.1146/annurev.micro.112408.134037; Conway C, 2002, MOL MICROBIOL, V45, P1687, DOI 10.1046/j.1365-2958.2002.03122.x; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Esposito D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/nar/25.18.3605; FORSDYKE DR, 1995, MOL BIOL EVOL, V12, P949; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GIBBS CP, 1989, NATURE, V338, P651, DOI 10.1038/338651a0; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; McCulloch R, 1999, GENE DEV, V13, P2875, DOI 10.1101/gad.13.21.2875; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; Ram EVSR, 2008, NUCLEIC ACIDS RES, V36, P5061, DOI 10.1093/nar/gkn483; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Templeton TJ, 2009, MOL BIOCHEM PARASIT, V166, P109, DOI 10.1016/j.molbiopara.2009.04.003; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; World Health Organization, 2010, MAL FACT SHEET; Yang W, 2010, CRIT REV BIOCHEM MOL, V45, P520, DOI 10.3109/10409238.2010.513375	39	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46507	10.1371/journal.pone.0046507	http://dx.doi.org/10.1371/journal.pone.0046507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056326	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500044
J	Habig, C; Geffers, R; Distl, O				Habig, Christin; Geffers, Robert; Distl, Ottmar			Differential Gene Expression from Genome-Wide Microarray Analyses Distinguishes Lohmann Selected Leghorn and Lohmann Brown Layers	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; FEATHER PECKING BEHAVIOR; THREONINE PROTEIN-KINASE; LAYING HENS; FUNCTIONAL-ROLE; MESSENGER-RNA; STRESS; CHICKENS; DISEASE; FAMILY	The Lohmann Selected Leghorn (LSL) and Lohmann Brown (LB) layer lines have been selected for high egg production since more than 50 years and belong to the worldwide leading commercial layer lines. The objectives of the present study were to characterize the molecular processes that are different among these two layer lines using whole genome RNA expression profiles. The hens were kept in the newly developed small group housing system Eurovent German with two different group sizes. Differential expression was observed for 6,276 microarray probes (FDR adjusted P-value <0.05) among the two layer lines LSL and LB. A 2-fold or greater change in gene expression was identified on 151 probe sets. In LSL, 72 of the 151 probe sets were up-and 79 of them were down-regulated. Gene ontology (GO) enrichment analysis accounting for biological processes evinced 18 GO-terms for the 72 probe sets with higher expression in LSL, especially those taking part in immune system processes and membrane organization. A total of 32 enriched GO-terms were determined among the 79 down-regulated probe sets of LSL. Particularly, these terms included phosphorus metabolic processes and signaling pathways. In conclusion, the phenotypic differences among the two layer lines LSL and LB are clearly reflected in their gene expression profiles of the cerebrum. These novel findings provide clues for genes involved in economically important line characteristics of commercial laying hens.	[Habig, Christin; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany	University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research	Habig, C (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de			Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) via the Federal Office for Agriculture and Food (BLE) under the innovation support program [PGI-06.01-28-1-36.004-07]	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) via the Federal Office for Agriculture and Food (BLE) under the innovation support program	This project was supported by funds of the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) via the Federal Office for Agriculture and Food (BLE) under the innovation support program (PGI-06.01-28-1-36.004-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston TN, 2000, ENDOCRINOLOGY, V141, P385, DOI 10.1210/en.141.1.385; Alliston TN, 1997, MOL ENDOCRINOL, V11, P1934, DOI 10.1210/me.11.13.1934; Berczi I, 1998, ANN NY ACAD SCI, V851, P3, DOI 10.1111/j.1749-6632.1998.tb08969.x; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Brunberg E, 2011, POULTRY SCI, V90, P1145, DOI 10.3382/ps.2010-00961; Buitenhuis B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-544; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Dantzer R, 1997, ACTA PHYSIOL SCAND, V161, P43; DOHMS JE, 1991, VET IMMUNOL IMMUNOP, V30, P89, DOI 10.1016/0165-2427(91)90011-Z; Dunn IC, 2007, ANIM GENET, V38, P45, DOI 10.1111/j.1365-2052.2006.01547.x; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Eyers CE, 2005, BIOCHEM J, V389, P127, DOI 10.1042/BJ20050387; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Glaser R, 1998, ANN NY ACAD SCI, V840, P649, DOI 10.1111/j.1749-6632.1998.tb09603.x; Gross W. B., 1993, Livestock handling and transport., P21; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Kjaer JB, 1997, BRIT POULTRY SCI, V38, P333, DOI 10.1080/00071669708417999; Kjaer JB, 2000, APPL ANIM BEHAV SCI, V65, P331, DOI 10.1016/S0168-1591(99)00064-7; Lohmann, 2005, LAYER MAN GUID LOHM, P2; Magnusson U, 1998, AM J VET RES, V59, P421; Natt D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-59; Nie HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011990; PIGOT F, 1992, DIGEST DIS SCI, V37, P1396, DOI 10.1007/BF01296010; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SCANLON PD, 1979, SCIENCE, V203, P63, DOI 10.1126/science.758679; Sheridan JF, 1998, ANN NY ACAD SCI, V840, P803, DOI 10.1111/j.1749-6632.1998.tb09618.x; Stolk L, 2007, J CLIN ENDOCR METAB, V92, P3206, DOI 10.1210/jc.2006-2136; Treves S, 2004, J CELL BIOL, V166, P537, DOI 10.1083/jcb.200404079; Vits A, 2005, POULTRY SCI, V84, P1511, DOI 10.1093/ps/84.10.1511; VOGELSANG H, 1989, DIGEST DIS SCI, V34, P1094, DOI 10.1007/BF01536381; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; WEITZENBURGER D, 2006, ARCH TIERZUCHT, V46, P89; Yao JB, 2004, PHYSIOL GENOMICS, V19, P84, DOI 10.1152/physiolgenomics.00123.2004; Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	37	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46787	10.1371/journal.pone.0046787	http://dx.doi.org/10.1371/journal.pone.0046787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056453	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500078
J	Stohn, JP; Perreault, NG; Wang, QZ; Liaw, L; Lindner, V				Stohn, J. Patrizia; Perreault, Nicole G.; Wang, Qiaozeng; Liaw, Lucy; Lindner, Volkhard			Cthrc1, a Novel Circulating Hormone Regulating Metabolism	PLOS ONE			English	Article							ADIPONECTIN; TRANSPORT; FOLLICLES; MICE	Background: We discovered the gene Collagen Triple Helix Repeat Containing 1 (Cthrc1) and reported its developmental expression and induction in adventitial cells of injured arteries and dermal cells of skin wounds. The role of Cthrc1 in normal adult tissues has not yet been determined. Methodology/Principal Findings: We generated mutant mice with a novel Cthrc1 null allele by homologues recombination. Cthrc1 null mice appeared developmentally normal. On the C57BL/6J background, livers from Cthrc1 null mice accumulated vast quantities of lipid, leading to extensive macrovesicular steatosis. Glycogen levels in skeletal muscle and liver of Cthrc1 null mice on the 129S6/SvEv background were significantly increased. However, Cthrc1 expression is not detectable in these tissues in wild-type mice, suggesting that the lipid and glycogen storage phenotype may be a secondary effect due to loss of Cthrc1 production at a distant site. To investigate potential hormonal functions of Cthrc1, tissues from adult mice and pigs were examined for Cthrc1 expression by immunohistochemistry with monoclonal anti-Cthrc1 antibodies. In pigs, Cthrc1 was detected around chromophobe cells of the anterior pituitary, and storage of Cthrc1 was observed in colloid-filled follicles and the pituitary cleft. Pituitary follicles have been observed in numerous vertebrates including humans but none of the known pituitary hormones have hitherto been detected in them. In C57BL/6J mice, however, Cthrc1 was predominantly expressed in the paraventricular and supraoptic nucleus of the hypothalamus but not in the posterior pituitary. In human plasma, we detected Cthrc1 in pg/ml quantities and studies with I-125-labeled Cthrc1 revealed a half-life of 2.5 hours in circulation. The highest level of Cthrc1 binding was observed in the liver. Conclusions: Cthrc1 has characteristics of a circulating hormone generated from the anterior pituitary, hypothalamus and bone. Hormonal functions of Cthrc1 include regulation of lipid storage and cellular glycogen levels with potentially broad implications for cell metabolism and physiology.	[Stohn, J. Patrizia; Perreault, Nicole G.; Wang, Qiaozeng; Liaw, Lucy; Lindner, Volkhard] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA	Maine Medical Center	Lindner, V (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA.	lindnv@mmc.org			National Institutes of Health [HL69182]; National Center for Research Resources [P20 RR-15555];  [P20RR018789/P20GM103465];  [P30RR030927/P30GM103392]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555, P20RR018789, P30RR030927] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392, P20GM103465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grants HL69182 (V. L.) and P20 RR-15555 from the National Center for Research Resources. The Histopathology Core Facility is supported by P20RR018789/P20GM103465 (D.Wojchowski, PI) and P30RR030927/P30GM103392 (R.Friesel, PI). The Mouse Transgenic and Imaging Core is supported by P30RR030927/P30GM103392 (R.Friesel, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CIOCCA DR, 1978, TISSUE CELL, V10, P725, DOI 10.1016/0040-8166(78)90058-7; Hada Y, 2007, BIOCHEM BIOPH RES CO, V356, P487, DOI 10.1016/j.bbrc.2007.03.004; KAMEDA Y, 1991, CELL TISSUE RES, V263, P115, DOI 10.1007/BF00318406; Kimura H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003174; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; LeClair RJ, 2007, CIRC RES, V100, P826, DOI 10.1161/01.RES.0000260806.99307.72; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Ogawa S, 1996, ARCH HISTOL CYTOL, V59, P467, DOI 10.1679/aohc.59.467; Park JJ, 2008, MOL ENDOCRINOL, V22, P989, DOI 10.1210/me.2007-0473; Park J, 2009, J MOL NEUROSCI, V37, P151, DOI 10.1007/s12031-008-9098-y; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; Rosen CJ, 2004, BONE, V35, P1046, DOI 10.1016/j.bone.2004.07.008; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007	15	26	28	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47142	10.1371/journal.pone.0047142	http://dx.doi.org/10.1371/journal.pone.0047142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056600	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500140
J	Zeng, X; Xiang, JJ; Wu, MH; Xiong, W; Tang, HL; Deng, M; Li, XY; Liao, QJ; Su, B; Luo, ZH; Zhou, YH; Zhou, M; Zeng, ZY; Li, XL; Shen, SR; Shuai, CJ; Li, GY; Fang, JS; Peng, SP				Zeng, Xi; Xiang, Juanjuan; Wu, Minghua; Xiong, Wei; Tang, Hailin; Deng, Min; Li, Xiayu; Liao, Qianjin; Su, Bo; Luo, Zhaohui; Zhou, Yanhong; Zhou, Ming; Zeng, Zhaoyang; Li, Xiaoling; Shen, Shourong; Shuai, Cijun; Li, Guiyuan; Fang, Jiasheng; Peng, Shuping			Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MICRORNA EXPRESSION; CANCER-DIAGNOSIS; POTENTIAL ROLE; SERUM; PLASMA; MIRNAS; SIGNATURES; CLUSTER; ROLES	Background: MicroRNAs have been considered as a kind of potential novel biomarker for cancer detection due to their remarkable stability in the blood and the characteristics of their expression profile in many diseases. Methods: We performed microarray-based serum miRNA profiling on the serum of twenty nasopharyngeal carcinoma patients at diagnosis along with 20 non-cancerous individuals as controls. This was followed by a real-time quantitative Polymerase Chain Reaction (RT-qPCR) in a separate cohort of thirty patients with nasopharyngeal carcinoma and thirty age-matched non-cancerous volunteers. A model for diagnosis was established by a conversion of mathematical calculation formula which has been validated by analyzing 74 cases of patients with nasopharyngeal carcinoma and 57 cases of non-cancerous volunteers. Results: The profiles showed that 39 and 17 miRNAs are exclusively expressed in the serum of non-cancerous volunteers and of patients with nasopharyngeal carcinoma respectively. 4 miRNAs including miR-17, miR-20a, miR-29c, and miR-223 were found to be expressed differentially in the serum of NPC compared with that of non-cancerous control. Based on this, a diagnosis equation with Ct difference method has been established to distinguish NPC cases and non-cancerous controls and validated with high sensitivity and specificity. Conclusions: We demonstrate that the serum miRNA-based biomarker model become a novel tool for NPC detection. The circulating 4-miRNA-based method may provide a novel strategy for NPC diagnosis.	[Fang, Jiasheng] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China; [Zeng, Xi; Xiang, Juanjuan; Wu, Minghua; Xiong, Wei; Tang, Hailin; Deng, Min; Liao, Qianjin; Su, Bo; Luo, Zhaohui; Zhou, Yanhong; Zhou, Ming; Zeng, Zhaoyang; Li, Xiaoling; Li, Guiyuan; Peng, Shuping] Cent S Univ, Canc Res Inst, Changsha, Hunan, Peoples R China; [Zeng, Xi; Tang, Hailin; Deng, Min; Liao, Qianjin; Su, Bo] Univ S China, Canc Res Inst, Hengyang, Hunan, Peoples R China; [Li, Xiayu; Shen, Shourong] Cent S Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Shuai, Cijun] Cent S Univ, State Key Lab High Performance Complex Mfg, Changsha, Hunan, Peoples R China	Central South University; Central South University; University of South China; Central South University; Central South University	Fang, JS (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China.	fangjiasheng@yahoo.com.cn; shuping@csu.edu.cn	Shuai, Cijun/AAC-9740-2019; li, xia/HHZ-7468-2022	Shuai, Cijun/0000-0002-2029-5112; Zeng, Xi/0000-0001-6835-9691	program of the national natural science foundation of China [81000972, 81101643, 81171934, 81172189]; 863 national program [2012AA02A206]; program of Introducing Talents of Discipline to Universities [111-2-12]; fund of Hunan Key Laboratory of Non-resolving Inflammation and Cancer; foundation for the author of excellent doctoral dissertation of Hunan Province [741000001]; Program for Shenghua Yuying top talents of Central South University [7601110185]; Hunan Province Natural Sciences Foundation of China [10JJ7003]; Fok Ying Tong Education Foundation [121036]	program of the national natural science foundation of China(National Natural Science Foundation of China (NSFC)); 863 national program(National High Technology Research and Development Program of China); program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); fund of Hunan Key Laboratory of Non-resolving Inflammation and Cancer; foundation for the author of excellent doctoral dissertation of Hunan Province(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for Shenghua Yuying top talents of Central South University; Hunan Province Natural Sciences Foundation of China(Natural Science Foundation of Hunan Province); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by the following funds: the program of the national natural science foundation of China (81000972, 81101643, 81171934, 81172189); 863 national program (2012AA02A206); the program of Introducing Talents of Discipline to Universities (111-2-12); the fund of Hunan Key Laboratory of Non-resolving Inflammation and Cancer; the foundation for the author of excellent doctoral dissertation of Hunan Province (741000001); Program for Shenghua Yuying top talents of Central South University (7601110185), the Hunan Province Natural Sciences Foundation of China (10JJ7003), and the Fok Ying Tong Education Foundation (121036).	Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chiaretti S, 1923, HAEMATOLOGICA, V95, P1114; Eyholzer M, 2010, LEUKEMIA RES, V34, P672, DOI 10.1016/j.leukres.2009.11.019; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gourzones C, 2012, CANCER; Gourzones C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-271; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hsu CM, 2012, TUMOUR BIOL; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Ju JF, 2010, BIOANALYSIS, V2, P901, DOI [10.4155/bio.10.45, 10.4155/BIO.10.45]; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Li SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-24; Liu BS, 2012, INT J ANAL CHEM, V2012, DOI 10.1155/2012/408057; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Liu QF, 2011, INT J CANCER, V129, P2662, DOI 10.1002/ijc.25921; Liu TY, 2010, MODERN PATHOL, V23, P1507, DOI 10.1038/modpathol.2010.139; Lo AKF, 2012, J PATHOL, V227, P392, DOI 10.1002/path.4025; Luo ZH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-3; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mraz M, 2009, LEUKEMIA LYMPHOMA, V50, P506, DOI 10.1080/10428190902763517; MUIR CS, 1971, INT J CANCER, V8, P351, DOI 10.1002/ijc.2910080302; Navarro A, 2009, CANCER RES, V69, P7071, DOI 10.1158/0008-5472.CAN-09-1095; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Silva J, 2011, EUR RESPIR J, V37, P617, DOI 10.1183/09031936.00029610; Song B, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001663; Stamatopoulos B, 2009, BLOOD, V113, P5237, DOI 10.1182/blood-2008-11-189407; Takeshita Hajime, 1999, Auris Nasus Larynx, V26, P277, DOI 10.1016/S0385-8146(98)00080-7; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang G, 2010, INT UROL NEPHROL, V42, P95, DOI 10.1007/s11255-009-9584-3; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wong AMG, 2012, CANCER-AM CANCER SOC, V118, P698, DOI 10.1002/cncr.26309; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yu HB, 2012, J VIROL, V86, P3088, DOI 10.1128/JVI.05901-11; Yu SC, 2011, HISTOPATHOLOGY, V58, P896, DOI 10.1111/j.1365-2559.2011.03793.x; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang Zhen-Wu, 2009, Yichuan, V31, P1094, DOI 10.3724/SP.J.1005.2009.01094	49	117	125	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46367	10.1371/journal.pone.0046367	http://dx.doi.org/10.1371/journal.pone.0046367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056289	gold, Green Published, Green Submitted			2022-12-27	WOS:000309831500037
J	Zhu, LL; Cao, J; Sun, M; Yuen, T; Zhou, R; Li, JH; Peng, YZ; Moonga, SS; Guo, LD; Mechanick, JI; Iqbal, J; Peng, L; Blair, HC; Bian, ZA; Zaidi, M				Zhu, Ling-Ling; Cao, Jay; Sun, Merry; Yuen, Tony; Zhou, Raymond; Li, Jianhua; Peng, Yuanzhen; Moonga, Surinder S.; Guo, Lida; Mechanick, Jeffrey I.; Iqbal, Jameel; Peng, Liu; Blair, Harry C.; Bian, Zhuan; Zaidi, Mone			Vitamin C Prevents Hypogonadal Bone Loss	PLOS ONE			English	Article							ASCORBIC-ACID; MINERAL DENSITY; OSTEOBLAST; DIFFERENTIATION; ANTIOXIDANTS; HEALTH	Epidemiologic studies correlate low vitamin C intake with bone loss. The genetic deletion of enzymes involved in de novo vitamin C synthesis in mice, likewise, causes severe osteoporosis. However, very few studies have evaluated a protective role of this dietary supplement on the skeleton. Here, we show that the ingestion of vitamin C prevents the low-turnover bone loss following ovariectomy in mice. We show that this prevention in areal bone mineral density and micro-CT parameters results from the stimulation of bone formation, demonstrable in vivo by histomorphometry, bone marker measurements, and quantitative PCR. Notably, the reductions in the bone formation rate, plasma osteocalcin levels, and ex vivo osteoblast gene expression 8 weeks post-ovariectomy are all returned to levels of sham-operated controls. The study establishes vitamin C as a skeletal anabolic agent.	[Zhu, Ling-Ling; Peng, Liu; Bian, Zhuan] Wuhan Univ, Sch Stomatol, Wuhan 430072, Hubei, Peoples R China; [Zhu, Ling-Ling; Sun, Merry; Yuen, Tony; Zhou, Raymond; Li, Jianhua; Peng, Yuanzhen; Moonga, Surinder S.; Mechanick, Jeffrey I.; Iqbal, Jameel; Zaidi, Mone] Mt Sinai Sch Med, Mt Sinai Bone Program, New York, NY USA; [Cao, Jay] Agr Res Serv, Human Nutr Res Ctr, USDA, Grand Forks, ND USA; [Guo, Lida; Blair, Harry C.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Wuhan University; Icahn School of Medicine at Mount Sinai; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bian, ZA (corresponding author), Wuhan Univ, Sch Stomatol, Wuhan 430072, Hubei, Peoples R China.	kqyywjtx@hotmail.com; mone.zaidi@mssm.edu	GUO, Liang-dong/C-1407-2015		National Institute of Health [DK0804590, AG023176, AG040132]; USDA Agricultural Research Service CRIS program [5450-51000-046-00D]; NATIONAL INSTITUTE ON AGING [R01AG023176, R01AG040132] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Agricultural Research Service CRIS program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by research grants from the National Institute of Health (DK0804590, AG023176 and AG040132) and from the USDA Agricultural Research Service CRIS program 5450-51000-046-00D. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beamer WG, 2000, BONE, V27, P619, DOI 10.1016/S8756-3282(00)00369-0; DENIS I, 1994, BONE MINER, V25, P149, DOI 10.1016/S0169-6009(08)80256-5; Fain O, 2005, JOINT BONE SPINE, V72, P124, DOI 10.1016/j.jbspin.2004.01.007; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Ganta DR, 1997, ENDOCRINOLOGY, V138, P3606, DOI 10.1210/en.138.9.3606; Hie M, 2011, J NUTR BIOCHEM, V22, P164, DOI 10.1016/j.jnutbio.2010.01.002; International Osteoporosis Foundation, AS AUD EP COSTS BURD; International Schizophrenia Foundation, CHEM DOESNT WORK SO; Iqbal J, 2006, P NATL ACAD SCI USA, V103, P14925, DOI 10.1073/pnas.0606805103; Le Nihouannen D, 2010, BONE, V46, P1336, DOI 10.1016/j.bone.2009.11.021; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Morton DJ, 2001, J BONE MINER RES, V16, P135, DOI 10.1359/jbmr.2001.16.1.135; Pazianas M, 2009, REV RECENT CLIN TRIA, V4, P122, DOI 10.2174/157488709788186030; Ragab AA, 1998, J BONE MINER RES, V13, P970, DOI 10.1359/jbmr.1998.13.6.970; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Sahni S, 2009, OSTEOPOROSIS INT, V20, P1853, DOI 10.1007/s00198-009-0897-y; Sahni S, 2008, J NUTR, V138, P1931, DOI 10.1093/jn/138.10.1931; Sanbe T, 2007, J PERIODONTOL, V78, P2165, DOI 10.1902/jop.2007.070181; Simon JA, 2001, AM J EPIDEMIOL, V154, P427, DOI 10.1093/aje/154.5.427; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Sun L, 2008, P NATL ACAD SCI USA, V105, P4289, DOI 10.1073/pnas.0712395105; Takamizawa S, 2004, CELL BIOL INT, V28, P255, DOI 10.1016/j.cellbi.2004.01.010; Wolf RL, 2005, AM J CLIN NUTR, V82, P581, DOI 10.1093/ajcn/82.3.581; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	26	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47058	10.1371/journal.pone.0047058	http://dx.doi.org/10.1371/journal.pone.0047058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056580	Green Published, gold			2022-12-27	WOS:000309831500131
J	Mackintosh, JE; Murtagh, MJ; Rodgers, H; Thomson, RG; Ford, GA; White, M				Mackintosh, Joan E.; Murtagh, Madeleine J.; Rodgers, Helen; Thomson, Richard G.; Ford, Gary A.; White, Martin			Why People Do, or Do Not, Immediately Contact Emergency Medical Services following the Onset of Acute Stroke: Qualitative Interview Study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE DASH; RISK-FACTORS; SYMPTOMS; KNOWLEDGE; SEEKING; DELAY; AWARENESS; SIGNS; DETERMINANTS	Objectives: To identify the reasons why individuals contact, or delay contacting, emergency medical services in response to stroke symptoms. Design: Qualitative interview study with a purposive sample of stroke patients and witnesses, selected according to method of accessing medical care and the time taken to do so. Data were analysed using the Framework approach. Setting: Area covered by three acute stroke units in the north east of England. Participants: Nineteen stroke patients and 26 witnesses who had called for help following the onset of stroke symptoms. Results: Factors influencing who called emergency medical services and when they called included stroke severity, how people made sense of symptoms and their level of motivation to seek help. Fear of the consequences of stroke, including future dependence or disruption to family life, previous negative experience of hospitals, or involving a friend or relations in the decision to access medical services, all resulted in delayed admission. Lack of knowledge of stroke symptoms was also an important determinant. Perceptions of the remit of medical services were a major cause of delays in admission, with many people believing the most appropriate action was to telephone their GP. Variations in the response of primary care teams to acute stroke symptoms were also evident. Conclusions: The factors influencing help-seeking decisions are complex. There remains a need to improve recognition by patients, witnesses and health care staff of the need to treat stroke as a medical emergency by calling emergency medical services, as well as increasing knowledge of symptoms of stroke among patients and potential witnesses. Fear, denial and reticence to impose on others hinders the process of seeking help and will need addressing specifically with appropriate interventions. Variability in how primary care services respond to stroke needs further investigation to inform interventions to promote best practice.	[Mackintosh, Joan E.; Thomson, Richard G.; White, Martin] Newcastle Univ, Fac Med Sci, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Murtagh, Madeleine J.] Univ Leicester, Coll Med Biol Sci & Psychol, Dept Hlth Sci, Leicester, Leics, England; [Rodgers, Helen; Ford, Gary A.] Newcastle Univ, Fac Med Sci, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [White, Martin] Newcastle Univ, UKCRC Ctr Translat Res Publ Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; University of Leicester; Newcastle University - UK; Newcastle University - UK	White, M (corresponding author), Newcastle Univ, Fac Med Sci, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	martin.white@ncl.ac.uk	Ford, Gary/AAY-6405-2020; Rodgers, Helen/K-4358-2012	Ford, Gary/0000-0001-8719-4968; White, Martin/0000-0002-1861-6757	National Institute for Health Research [RP-PG-0606-1241]; National Institute for Health Research [NF-SI-0507-10249] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research commissioned by the National Institute for Health Research (www.nihr.ac.uk) under its Programme Grants for Applied Research scheme (RP-PG-0606-1241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Bray JE, 2010, INT J STROKE, V5, P440, DOI 10.1111/j.1747-4949.2010.00484.x; Brown S, 2011, STUDY PATIENTS VIEWS; Chan L, 2010, STROKE, V41, pE543, DOI 10.1161/STROKEAHA.110.586925; Chandratheva A, 2010, STROKE, V41, P1108, DOI 10.1161/STROKEAHA.109.576611; Clayman SE, 1994, SITUATED ORDER STUDI; Cowman S, 2010, BMC GERIATR, V10, DOI [10.1186/1471-2318-10-4, 10.1186/1471-2318-9-35]; Department of Health, 2009, STROK ACT FAST AW CA; Department of Health, 2007, 2007 NAT STROK STRAT; Dracup K, 1997, HEART LUNG, V26, P253, DOI 10.1016/S0147-9563(97)90082-0; DRACUP K, 1991, HEART LUNG, V20, P570; FELDMANN E, 1993, STROKE, V24, P1805, DOI 10.1161/01.STR.24.12.1805; Fussman C, 2010, STROKE, V41, P1501, DOI 10.1161/STROKEAHA.110.578195; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HARDING G, 2002, PHARM J, V269, P395; Intercollegiate Stroke Working Party, 2010, NAT SENT STROK AUD R; Jones SP, 2010, AGE AGEING, V39, P11, DOI 10.1093/ageing/afp196; Jorgensen HS, 1996, NEUROLOGY, V47, P383, DOI 10.1212/WNL.47.2.383; Kleindorfer D, 2010, AM J EMERG MED, V28, P607, DOI 10.1016/j.ajem.2009.02.016; Kleindorfer DO, 2007, STROKE, V38, P2864, DOI 10.1161/STROKEAHA.107.484329; Kothari R, 1997, STROKE, V28, P1871, DOI 10.1161/01.STR.28.10.1871; Lasserson D, 2008, BMJ, V337; Lecouturier J, 2010, BMC HLTH SERVICES RE; Leslie WS, 2000, HEART, V84, P137, DOI 10.1136/heart.84.2.137; Lin C S, 1999, Prehosp Emerg Care, V3, P194, DOI 10.1080/10903129908958936; Mandelzweig L, 2006, STROKE, V37, P1248, DOI 10.1161/01.STR.0000217200.61167.39; Moloczij N, 2008, HEALTH SOC CARE COMM, V16, P501, DOI 10.1111/j.1365-2524.2008.00771.x; Mosley I, 2007, STROKE, V38, P361, DOI 10.1161/01.STR.0000254528.17405.cc; National Institute for Health and Clinical Excellence, 2008, NICE CLIN GUID, V66, P87; Pancioli AM, 1998, JAMA-J AM MED ASSOC, V279, P1288, DOI 10.1001/jama.279.16.1288; Payne GH, 2010, J PUBLIC HEALTH MAN, V16, P345, DOI 10.1097/PHH.0b013e3181c8cb79; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rodgers H, 2010, COMPREHENSIVE STROKE; Rodgers H, 2008, BRIT MED J, V336, P337, DOI 10.1136/bmj.39456.470880.80; Rosamond WD, 1998, ACAD EMERG MED, V5, P45, DOI 10.1111/j.1553-2712.1998.tb02574.x; Ryan E, 2009, INT J STROKE, V4; SAFER MA, 1979, MED CARE, V17, P11, DOI 10.1097/00005650-197901000-00002; Schroeder EB, 2000, STROKE, V31, P2591, DOI 10.1161/01.STR.31.11.2591; Shah Muzafar, 2007, J Stroke Cerebrovasc Dis, V16, P71, DOI 10.1016/j.jstrokecerebrovasdis.2006.11.004; Silverman D., 2017, DOING QUALITATIVE RE, V5th; Teuschl Y, 2010, INT J STROKE, V5, P187, DOI 10.1111/j.1747-4949.2010.00428.x; Williams LS, 1997, STROKE, V28, P912, DOI 10.1161/01.STR.28.5.912; Yoon SS, 2002, BMJ-BRIT MED J, V324, P1065, DOI 10.1136/bmj.324.7345.1065; Zerwic J, 2007, HEART LUNG, V36, P25, DOI 10.1016/j.hrtlng.2005.12.007; Zweifler R, 1995, J STROKE CEREBROVASC, V5, P111	44	35	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46124	10.1371/journal.pone.0046124	http://dx.doi.org/10.1371/journal.pone.0046124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056247	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800011
J	Podell, BK; Ackart, DF; Kirk, NM; Eck, SP; Bell, C; Basaraba, RJ				Podell, Brendan K.; Ackart, David F.; Kirk, Natalie M.; Eck, Sarah P.; Bell, Christopher; Basaraba, Randall J.			Non-Diabetic Hyperglycemia Exacerbates Disease Severity in Mycobacterium tuberculosis Infected Guinea Pigs	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; DIABETES-MELLITUS; INSULIN-RESISTANCE; EXTRAPULMONARY TUBERCULOSIS; OXIDATIVE STRESS; IMMUNE-RESPONSE; IMPACT; RISK; METHYLGLYOXAL; INFLAMMATION	Hyperglycemia, the diagnostic feature of diabetes also occurs in non-diabetics associated with chronic inflammation and systemic insulin resistance. Since the increased risk of active TB in diabetics has been linked to the severity and duration of hyperglycemia, we investigated what effect diet-induced hyperglycemia had on the severity of Mycobacterium tuberculosis (Mtb) infection in non-diabetic guinea pigs. Post-prandial hyperglycemia was induced in guinea pigs on normal chow by feeding a 40% sucrose solution daily or water as a carrier control. Sucrose feeding was initiated on the day of aerosol exposure to the H37Rv strain of Mtb and continued for 30 or 60 days of infection. Despite more severe hyperglycemia in sucrose-fed animals on day 30, there was no significant difference in lung bacterial or lesion burden until day 60. However the higher spleen and lymph node bacterial and lesion burden at day 30 indicated earlier and more severe extrapulmonary TB in sucrose-fed animals. In both sucrose- and water-fed animals, serum free fatty acids, important mediators of insulin resistance, were increased by day 30 and remained elevated until day 60 of infection. Hyperglycemia mediated by Mtb infection resulted in accumulation of advanced glycation end products (AGEs) in lung granulomas, which was exacerbated by sucrose feeding. However, tissue and serum AGEs were elevated in both sucrose and water-fed guinea pigs by day 60. These data indicate that Mtb infection alone induces insulin resistance and chronic hyperglycemia, which is exacerbated by sucrose feeding. Moreover, Mtb infection alone resulted in the accumulation tissue and serum AGEs, which are also central to the pathogenesis of diabetes and diabetic complications. The exacerbation of insulin resistance and hyperglycemia by Mtb infection alone may explain why TB is more severe in diabetics with poorly controlled hyperglycemia compared to non-diabetics and patients with properly controlled blood glucose levels.	[Podell, Brendan K.; Ackart, David F.; Kirk, Natalie M.; Eck, Sarah P.; Basaraba, Randall J.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bell, Christopher] Colorado State Univ, Coll Appl Human Sci, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Basaraba, RJ (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	randall.basaraba@colostate.edu	Podell, Brendan/D-8396-2017	Podell, Brendan/0000-0003-2548-8826	National Institutes of Health, National Institute of Allergy and Infectious Diseases [1R21AI094123-01]; American Diabetes Association [1-11-BS-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094123] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (1R21AI094123-01; http://niaid.nih.gov) and the American Diabetes Association (1-11-BS-08; http://www.diabetes.org). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bierhaus A, 1998, CARDIOVASC RES, V37, P586, DOI 10.1016/S0008-6363(97)00233-2; Borst SE, 2004, ENDOCRINE, V23, P177, DOI 10.1385/ENDO:23:2-3:177; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Ceriello A, 1998, DIABETES CARE, V21, P1529, DOI 10.2337/diacare.21.9.1529; Cohen-Or I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017974; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Dhar A, 2011, CURR OPIN PEDIATR, V23, P269, DOI 10.1097/MOP.0b013e3283464b3e; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dooley KE, 2009, AM J TROP MED HYG, V80, P634, DOI 10.4269/ajtmh.2009.80.634; Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Harries AD, 2011, COLLABORATIVE FRAMEW; Harries AD, 2010, TROP MED INT HEALTH, V15, P659, DOI 10.1111/j.1365-3156.2010.02523.x; International Diabetes Federation, 2011, DIABETES ATLAS, V5th; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Long R, 1997, INT J TUBERC LUNG D, V1, P52; MAARTENS G, 1990, AM J MED, V89, P291, DOI 10.1016/0002-9343(90)90340-J; Mao FF, 2011, MED HYPOTHESES, V77, P66, DOI 10.1016/j.mehy.2011.03.025; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Moran A, 2007, ALCOHOL CLIN EXP RES, V31, P33, DOI 10.1111/j.1530-0277.2006.00262.x; Nemet I, 2005, CLIN BIOCHEM, V38, P379, DOI 10.1016/j.clinbiochem.2004.12.008; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Palanisamy GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026254; Peppa Melpomeni, 2005, Hormones (Athens), V4, P28; Perez-Guzman C, 2001, INT J TUBERC LUNG D, V5, P455; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; Restrepo BI, 2008, AM J TROP MED HYG, V79, P541, DOI 10.4269/ajtmh.2008.79.541; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Ribeiro R, 2005, DIABETOLOGIA, V48, P976, DOI 10.1007/s00125-005-1714-6; Root H F, 1934, Trans Am Clin Climatol Assoc, V50, P210; Sen Tiyas, 2009, J Assoc Physicians India, V57, P660; Shang S, 2012, VACCINE; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Takahashi HK, 2009, J PHARMACOL EXP THER, V330, P89, DOI 10.1124/jpet.109.150581; Torreggiani M, 2009, AM J PATHOL, V175, P1722, DOI 10.2353/ajpath.2009.090138; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; Wang CS, 2009, EPIDEMIOL INFECT, V137, P203, DOI 10.1017/S0950268808000782; Wang JY, 2005, INT J TUBERC LUNG D, V9, P777; Win MTT, 2012, EXP DIABETES RES, DOI 10.1155/2012/894605; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786	52	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46824	10.1371/journal.pone.0046824	http://dx.doi.org/10.1371/journal.pone.0046824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056469	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800052
J	Pujolar, JM; Locatello, L; Zane, L; Mazzoldi, C				Pujolar, Jose Martin; Locatello, Lisa; Zane, Lorenzo; Mazzoldi, Carlotta			Body Size Correlates with Fertilization Success but not Gonad Size in Grass Goby Territorial Males	PLOS ONE			English	Article							ZOSTERISESSOR-OPHIOCEPHALUS TELEOSTEI; SPERM COMPETITION; INVESTMENT; STRATEGIES; ALLOCATION; SNEAKING; TACTICS; FISHES	In fish species with alternative male mating tactics, sperm competition typically occurs when small males that are unsuccessful in direct contests steal fertilization opportunities from large dominant males. In the grass goby Zosterisessor ophiocephalus, large territorial males defend and court females from nest sites, while small sneaker males obtain matings by sneaking into nests. Parentage assignment of 688 eggs from 8 different nests sampled in the 2003-2004 breeding season revealed a high level of sperm competition. Fertilization success of territorial males was very high but in all nests sneakers also contributed to the progeny. In territorial males, fertilization success correlated positively with male body size. Gonadal investment was explored in a sample of 126 grass gobies collected during the period 1995-1996 in the same area (61 territorial males and 65 sneakers). Correlation between body weight and testis weight was positive and significant for sneaker males, while correlation was virtually equal to zero in territorial males. That body size in territorial males is correlated with fertilization success but not gonad size suggests that males allocate much more energy into growth and relatively little into sperm production once the needed size to become territorial is attained. The increased paternity of larger territorial males might be due to a more effective defense of the nest in comparison with smaller territorial males.	[Pujolar, Jose Martin; Locatello, Lisa; Zane, Lorenzo; Mazzoldi, Carlotta] Univ Padua, Dept Biol, Padua, Italy	University of Padua	Zane, L (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	lorenzo.zane@unipd.it	Zane, Lorenzo/G-6249-2010; LOCATELLO, LISA/AAC-5612-2020; Mazzoldi, Carlotta/AAU-8628-2020	Zane, Lorenzo/0000-0002-6963-2132; LOCATELLO, LISA/0000-0002-3530-2565; MAZZOLDI, CARLOTTA/0000-0002-2798-3030; pujolar, marti/0000-0002-5037-8840	University of Padova Young Research grant [CPDG038533]	University of Padova Young Research grant	This work was supported by a University of Padova Young Research grant (CPDG038533) to LZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2000, AM NAT, V156, P266, DOI 10.1086/303391; Bateman PW, 2001, ETHOLOGY, V107, P1087, DOI 10.1046/j.1439-0310.2001.00756.x; Birkhead TR, 1992, SPERM COMPETITION BI; Burness G, 2004, BEHAV ECOL SOCIOBIOL, V56, P65, DOI 10.1007/s00265-003-0752-7; Coleman SW, 2011, BIOL J LINN SOC, V103, P735, DOI 10.1111/j.1095-8312.2011.01673.x; Dijkstra PD, 2005, BEHAV ECOL SOCIOBIOL, V58, P136, DOI 10.1007/s00265-005-0919-5; Dodds KG, 1996, THEOR APPL GENET, V92, P966, DOI 10.1007/BF00224036; FRANCIS RC, 1983, BEHAVIOUR, V85, P292, DOI 10.1163/156853983X00273; Gallini A, 2005, MOL ECOL NOTES, V5, P24, DOI 10.1111/j.1471-8286.2004.00817.x; Gandolfi G., 1991, PESCI ACQUE INTERNE; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Jones AG, 2001, MOL ECOL NOTES, V1, P215, DOI 10.1046/j.1471-8278.2001.00062.x; Jones AG, 2001, MOL ECOL, V10, P461, DOI 10.1046/j.1365-294x.2001.01193.x; Komdeur J, 2001, P ROY SOC B-BIOL SCI, V268, P2103, DOI 10.1098/rspb.2001.1750; Kvarnemo C, 2010, J FISH BIOL, V76, P1609, DOI 10.1111/j.1095-8649.2010.02587.x; Largiader CR, 2001, HEREDITY, V86, P459, DOI 10.1046/j.1365-2540.2001.00850.x; Mackiewitz M, 2005, MAR BIOL, V148, P223; Marconato A, 1996, ENVIRON BIOL FISH, V46, P321, DOI 10.1007/BF00005009; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mazzoldi C, 2000, MAR BIOL, V137, P1041, DOI 10.1007/s002270000417; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P127, DOI 10.1098/rspb.1990.0115; Scaggiante M, 2004, HORM BEHAV, V46, P607, DOI 10.1016/j.yhbeh.2004.06.016; Scaggiante M, 1999, J EXP ZOOL, V283, P81, DOI 10.1002/(SICI)1097-010X(19990101)283:1<81::AID-JEZ9>3.0.CO;2-9; SHUSTER SM, 2003, MG BEH ECOL, pR7; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P251, DOI 10.1017/CBO9780511542602.011; Warner RR, 1997, BIOSCIENCE, V47, P561, DOI 10.2307/1313162; Watanabe M, 2008, CAN J ZOOL, V86, P1121, DOI 10.1139/Z08-093; Whiteman EA, 2004, ANIM BEHAV, V67, P239, DOI 10.1016/j.anbehav.2003.04.006; Zamudio KR, 2000, P NATL ACAD SCI USA, V97, P14427, DOI 10.1073/pnas.011544998	30	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46711	10.1371/journal.pone.0046711	http://dx.doi.org/10.1371/journal.pone.0046711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056415	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800042
J	Starr, TL; Pagant, S; Wang, CW; Schekman, R				Starr, Trevor L.; Pagant, Silvere; Wang, Chao-Wen; Schekman, Randy			Sorting Signals That Mediate Traffic of Chitin Synthase III between the TGN/Endosomes and to the Plasma Membrane in Yeast	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; ADAPTER PROTEIN COMPLEX; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; ALKALINE-PHOSPHATASE; GGA PROTEINS; EHD PROTEINS; CLATHRIN; RECOGNITION; VACUOLE	Traffic of the integral yeast membrane protein chitin synthase III (Chs3p) from the trans-Golgi network (TGN) to the cell surface and to and from the early endosomes (EE) requires active protein sorting decoded by a number of protein coats. Here we define overlapping signals on Chs3p responsible for sorting in both exocytic and intracellular pathways by the coats exomer and AP-1, respectively. Residues 19DEESLL24, near the N-terminal cytoplasmically-exposed domain, comprise both an exocytic di-acidic signal and an intracellular di-leucine signal. Additionally we show that the AP-3 complex is required for the intracellular retention of Chs3p. Finally, residues R374 and W391, comprise another signal responsible for an exomer-independent alternative pathway that conveys Chs3p to the cell surface. These results establish a role for active protein sorting at the trans-Golgi en route to the plasma membrane (PM) and suggest a possible mechanism to regulate protein trafficking.	[Starr, Trevor L.; Pagant, Silvere; Wang, Chao-Wen; Schekman, Randy] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Starr, Trevor L.] Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Schekman, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.	schekman@berkeley.edu	Starr, Trevor/AAO-3203-2020	Wang, Chao-Wen/0000-0002-4073-299X; Schekman, Randy/0000-0001-8615-6409	National Institutes of Health [GM26755]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM26755 and Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Anitei M, 2011, CURR OPIN CELL BIOL, V23, P443, DOI 10.1016/j.ceb.2011.03.013; Barfield RM, 2009, MOL BIOL CELL, V20, P4985, DOI 10.1091/mbc.E09-04-0324; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Bulik DA, 2003, EUKARYOT CELL, V2, P886, DOI 10.1128/EC.2.5.886-900.2003; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Chuang JS, 1996, J CELL BIOL, V135, P597, DOI 10.1083/jcb.135.3.597; Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Foote C, 2006, J CELL BIOL, V173, P615, DOI 10.1083/jcb.200510161; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hinners I, 2003, J CELL SCI, V116, P763, DOI 10.1242/jcs.00270; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Kato Y, 2002, NAT STRUCT BIOL, V9, P532, DOI 10.1038/nsb807; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; Owen DJ, 2004, BIOCHEM SOC T, V32, P1, DOI 10.1042/BST0320001; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; PELHAM HRB, 1995, CURR OPIN CELL BIOL, V7, P530, DOI 10.1016/0955-0674(95)80010-7; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Renard HF, 2010, TRAFFIC, V11, P931, DOI 10.1111/j.1600-0854.2010.01070.x; Sanchatjate S, 2006, MOL BIOL CELL, V17, P4157, DOI 10.1091/mbc.E06-03-0210; Santos B, 1997, MOL CELL BIOL, V17, P2485, DOI 10.1128/MCB.17.5.2485; Santos B, 2003, EUKARYOT CELL, V2, P821, DOI 10.1128/EC.2.4.821-825.2003; Santos B, 1997, J CELL BIOL, V136, P95, DOI 10.1083/jcb.136.1.95; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; SIKORSKI RS, 1989, GENETICS, V122, P19; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Trautwein M, 2006, EMBO J, V25, P943, DOI 10.1038/sj.emboj.7601007; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; Vowels JJ, 1998, EMBO J, V17, P2482, DOI 10.1093/emboj/17.9.2482; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Watson RT, 2001, AM J PHYSIOL-CELL PH, V281, pC215, DOI 10.1152/ajpcell.2001.281.1.C215; Ziman M, 1998, MOL BIOL CELL, V9, P1565, DOI 10.1091/mbc.9.6.1565; Ziman M, 1996, MOL BIOL CELL, V7, P1909, DOI 10.1091/mbc.7.12.1909	52	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46386	10.1371/journal.pone.0046386	http://dx.doi.org/10.1371/journal.pone.0046386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056294	Green Submitted, gold, Green Published			2022-12-27	WOS:000309454000036
J	Stewart, GB; Altman, DG; Askie, LM; Duley, L; Simmonds, MC; Stewart, LA				Stewart, Gavin B.; Altman, Douglas G.; Askie, Lisa M.; Duley, Lelia; Simmonds, Mark C.; Stewart, Lesley A.			Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice	PLOS ONE			English	Article							PATIENT DATA METAANALYSIS; RANDOMIZED-TRIALS; META-REGRESSION; LEVEL; MODEL; HETEROGENEITY; TIME	Background: Individual participant data (IPD) meta-analyses that obtain "raw'' data from studies rather than summary data typically adopt a "two-stage'' approach to analysis whereby IPD within trials generate summary measures, which are combined using standard meta-analytical methods. Recently, a range of "one-stage'' approaches which combine all individual participant data in a single meta-analysis have been suggested as providing a more powerful and flexible approach. However, they are more complex to implement and require statistical support. This study uses a dataset to compare "two-stage'' and "one-stage'' models of varying complexity, to ascertain whether results obtained from the approaches differ in a clinically meaningful way. Methods and Findings: We included data from 24 randomised controlled trials, evaluating antiplatelet agents, for the prevention of pre-eclampsia in pregnancy. We performed two-stage and one-stage IPD meta-analyses to estimate overall treatment effect and to explore potential treatment interactions whereby particular types of women and their babies might benefit differentially from receiving antiplatelets. Two-stage and one-stage approaches gave similar results, showing a benefit of using anti-platelets (Relative risk 0.90, 95% CI 0.84 to 0.97). Neither approach suggested that any particular type of women benefited more or less from antiplatelets. There were no material differences in results between different types of one-stage model. Conclusions: For these data, two-stage and one-stage approaches to analysis produce similar results. Although one-stage models offer a flexible environment for exploring model structure and are useful where across study patterns relating to types of participant, intervention and outcome mask similar relationships within trials, the additional insights provided by their usage may not outweigh the costs of statistical support for routine application in syntheses of randomised controlled trials. Researchers considering undertaking an IPD meta-analysis should not necessarily be deterred by a perceived need for sophisticated statistical methods when combining information from large randomised trials.	[Stewart, Gavin B.; Simmonds, Mark C.; Stewart, Lesley A.] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Askie, Lisa M.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Duley, Lelia] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham NG7 2RD, England	University of York - UK; University of Oxford; University of Sydney; University of Nottingham	Stewart, GB (corresponding author), Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.	gavin.stewart@york.ac.uk	Duley, Lelia/E-8107-2015	Duley, Lelia/0000-0001-6721-5178; Stewart, Lesley/0000-0003-0287-4724	MRC as part of the MRC-NIHR Methodology Research Programme [88053]; Medical Research Council [G0801402] Funding Source: researchfish; MRC [G0801402] Funding Source: UKRI	MRC as part of the MRC-NIHR Methodology Research Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the MRC as part of the MRC-NIHR Methodology Research Programme. Grant ID 88053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al Khalaf MM, 2011, J CLIN EPIDEMIOL, V64, P119, DOI 10.1016/j.jclinepi.2010.01.009; [Askie and The Perinatal Antiplatelet Review of International Trials (PARIS) Collaboration Steering Group PARIS Collaboration], 2005, BMC PREGNANCY CHILDB, V5, P7; [Askie and The Perinatal Antiplatelet Review of International Trials (PARIS) Collaboration Steering Group PARIS Collaboration], 2005, BMC PREGNANCY CHILDB, V1, P11; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; Bowden J, 2011, RES SYNTH METHODS, V2, P150, DOI 10.1002/jrsm.45; Clarke MJ., 2001, SYSTEMATIC REV HLTH, P109; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EYSENCK HJ, 1994, BRIT MED J, V309, P789, DOI 10.1136/bmj.309.6957.789; Fisher DJ, 2011, J CLIN EPIDEMIOL, V64, P949, DOI 10.1016/j.jclinepi.2010.11.016; Gelman A., 2007, DATA ANAL USING REGR; Greenland S, 2002, STAT MED, V21, P389, DOI 10.1002/sim.1024; Higgins JPT, 2001, STAT MED, V20, P2219, DOI 10.1002/sim.918; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Morton SC, 2004, AGENCY HEALTHCARE RE, P8; Nuesch E, 2009, INT J EPIDEMIOL, V38, P298, DOI 10.1093/ije/dyn265; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Riley RD, 2010, RES SYNTH METHODS, V1, P2, DOI 10.1002/jrsm.4; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; Simmonds MC, 2007, STAT MED, V26, P2982, DOI 10.1002/sim.2768; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; SIMMONDS MC, 2005, THESIS U CAMBRIDGE; Smith CT, 2005, STAT MED, V24, P1307, DOI 10.1002/sim.2050; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Stewart L, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P261; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; Turner RM, 2000, STAT MED, V19, P3417, DOI 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L; Vale C, 2008, J CLIN ONCOL, V26, P5802, DOI 10.1200/JCO.2008.16.4368; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03	35	136	136	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46042	10.1371/journal.pone.0046042	http://dx.doi.org/10.1371/journal.pone.0046042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056232	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000013
J	Vallabhaneni, S; Li, X; Vittinghoff, E; Donnell, D; Pilcher, CD; Buchbinder, SP				Vallabhaneni, Snigdha; Li, Xin; Vittinghoff, Eric; Donnell, Deborah; Pilcher, Christopher D.; Buchbinder, Susan P.			Seroadaptive Practices: Association with HIV Acquisition among HIV-Negative Men Who Have Sex with Men	PLOS ONE			English	Article							GAY MEN; INFECTION; BEHAVIORS; VACCINE; INCREASE; SYDNEY	Background: Although efficacy is unknown, many men who have sex with men (MSM) attempt to reduce HIV risk by adapting condom use, partner selection, or sexual position to the partner's HIV serostatus. We assessed the association of seroadaptive practices with HIV acquisition. Methodology/Principal Findings: We pooled data on North American MSM from four longitudinal HIV-prevention studies. Sexual behaviors reported during each six-month interval were assigned sequentially to one of six mutually exclusive risk categories: (1) no unprotected anal intercourse (UAI), (2) having a single negative partner, (3) being an exclusive top (only insertive anal sex), (4) serosorting (multiple partners, all HIV negative), (5) seropositioning (only insertive anal sex with potentially discordant partners), and (6) UAI with no seroadaptive practices. HIV antibody testing was conducted at the end of each interval. We used Cox models to evaluate the independent association of each category with HIV acquisition, controlling for number of partners, age, race, drug use, and intervention assignment. 12,277 participants contributed to 60,162 six-month intervals with 663 HIV seroconversions. No UAI was reported in 47.4% of intervals, UAI with some seroadaptive practices in 31.8%, and UAI with no seroadaptive practices in 20.4%. All seroadaptive practices were associated with a lower risk, compared to UAI with no seroadaptive practices. However, compared to no UAI, serosorting carried twice the risk (HR = 2.03, 95% CI: 1.51-2.73), whereas seropositioning was similar in risk (HR = 0.85, 95% CI: 0.50-1.44), and UAI with a single negative partner and as an exclusive top were both associated with a lower risk (HR = 0.56, 95% CI: 0.32-0.96 and HR = 0.55, 95% CI: 0.36-0.84, respectively). Conclusions/Significance: Seroadaptive practices appear protective when compared with UAI with no seroadaptive practices, but serosorting appears to be twice as risky as no UAI. Condom use and limiting number of partners should be advocated as first-line prevention strategies, but seroadaptive practices may be considered harm-reduction for men at greatest risk.	[Vallabhaneni, Snigdha; Vittinghoff, Eric; Pilcher, Christopher D.; Buchbinder, Susan P.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Li, Xin; Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Buchbinder, Susan P.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco; San Francisco Department of Public Health	Vallabhaneni, S (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	snigdhav@gmail.com		Donnell, Deborah/0000-0002-0587-7480	National Institutes of Health [5R01AI083060-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI083060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105, P30MH062246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by National Institutes of Health 5R01AI083060-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Morbidity and Mortality Weekly Report, V60, P689; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Butler DM, 2007, AIDS, V21, P1218, DOI 10.1097/QAD.0b013e32814db7bf; Elford J, 2007, AIDS, V21, P243, DOI 10.1097/QAD.0b013e3280118fdb; Golden M, 2011, 18 C RETR OPP INF BO; Golden M, 2012, 19 C RETR OPP INF SE; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Jin FY, 2012, SEX TRANSM DIS, V39, P191, DOI 10.1097/OLQ.0b013e3182401a2f; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Kennedy CE, 2011, 6 IAS C HIV PATH TRE; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Koblin BA, 1998, AIDS, V12, P785, DOI 10.1097/00002030-199807000-00015; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Le Talec J, 2008, 17 INT AIDS C MEX CI; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; McFarland W, 2012, AIDS BEHAV, V16, P121, DOI 10.1007/s10461-011-9936-8; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Philip SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012662; Pinkerton SD, 2008, AM J PREV MED, V35, P184, DOI 10.1016/j.amepre.2008.04.012; Snowden JM, 2009, SEX TRANSM INFECT, V85, P469, DOI 10.1136/sti.2009.036269; Thiede H, 2009, AM J PUBLIC HEALTH, V99, pS157, DOI 10.2105/AJPH.2006.098582; Van de Ven P, 2002, AIDS CARE, V14, P471, DOI 10.1080/09540120208629666; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003	25	91	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45718	10.1371/journal.pone.0045718	http://dx.doi.org/10.1371/journal.pone.0045718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056215	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000010
J	Milne, FH; Judge, DS				Milne, Fritha H.; Judge, Debra S.			A Novel Quantitative Approach to Women's Reproductive Strategies	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; FATHER ABSENCE; BIRTH INTERVALS; SEXUAL-ACTIVITY; RESPONSE RATE; K-FACTOR; RISK; POPULATION; ATTACHMENT; EVOLUTION	The patterned way in which individuals allocate finite resources to various components of reproduction (e. g. mating effort, reproductive timing and parental investment) is described as a reproductive strategy. As energy is limited, trade-offs between and within aspects of reproductive strategies are expected. The first aim of this study was to derive aspects of reproductive strategies using complete reproductive histories from 718 parous Western Australian women. Factor analysis using a subset of these participants resulted in six factors that represented 'short-term mating strategy', 'early onset of sexual activity', 'reproductive output', 'timing of childbearing', 'breastfeeding', and 'child spacing'. This factor structure was internally validated by replication using a second independent subset of the data. The second aim of this study examined trade-offs between aspects of reproductive strategies derived from aim one. Factor scores calculated for each woman were incorporated in generalised linear models and interaction terms were employed to examine the effect of mating behaviour on the relationships between reproductive timing, parental investment and overall reproductive success. Early sexual activity correlates with early reproductive onset for women displaying more long-term mating strategies. Women with more short-term mating strategies exhibit a trade-off between child quantity and child quality not observed in women with a long-term mating strategy. However, women with a short-term mating strategy who delay reproductive timing exhibit levels of parental investment (measured as breastfeeding duration per child) similar to that of women with long-term mating strategies. Reproductive delay has fitness costs (fewer births) for women displaying more short-term mating strategies. We provide empirical evidence that reproductive histories of contemporary women reflect aspects of reproductive strategies, and associations between these strategic elements, as predicted from life history theory.	[Milne, Fritha H.; Judge, Debra S.] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia	University of Western Australia	Milne, FH (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia.	fritha.milne@graduate.uwa.edu.au	judge, debra/J-5784-2012	judge, debra/0000-0003-0671-0743	School of Anatomy, Physiology Human Biology; School of Population Health at the University of Western Australia	School of Anatomy, Physiology Human Biology; School of Population Health at the University of Western Australia	The School of Anatomy, Physiology & Human Biology and the School of Population Health at the University of Western Australia provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Baschieri A, 2007, DEMOGR RES, V16, P59, DOI 10.4054/DemRes.2007.16.3; Baxter J, 2009, ACTA PAEDIATR, V98, P1274, DOI 10.1111/j.1651-2227.2009.01335.x; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Belsky J, 1997, HUM NATURE-INT BIOS, V8, P361, DOI 10.1007/BF02913039; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; BLAKE J, 1981, DEMOGRAPHY, V18, P421, DOI 10.2307/2060941; Bogaert AF, 2008, J BIOSOC SCI, V40, P623, DOI 10.1017/S0021932007002386; Bollen KA, 1989, STRUCTURAL EQUATIONS; Buss, 1994, EVOLUTION DESIRE; Castejon JL, 2010, INTELLIGENCE, V38, P481, DOI 10.1016/j.intell.2010.07.002; Chan DW, 2006, GIFTED CHILD QUART, V50, P325, DOI 10.1177/001698620605000405; CHARNOV EL, 1991, P NATL ACAD SCI USA, V88, P1134, DOI 10.1073/pnas.88.4.1134; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Child D, 2006, ESSENTIALS FACTOR AN, V3rd; Chisholm JS, 2005, HUM NATURE-INT BIOS, V16, P233, DOI 10.1007/s12110-005-1009-0; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Comrey A, 1992, 1 COURSE FACTOR ANAL, V2nd, P2; Datar A, 2010, DEMOGRAPHY, V47, P145; DiStefano C., 2009, PRACTICAL ASSESSMENT, V14, P20, DOI [DOI 10.7275/DA8T-4G52, 10.7275/da8t-4g52]; DRAPER P, 1989, ETHOL SOCIOBIOL, V10, P145, DOI 10.1016/0162-3095(89)90017-4; DRAPER P, 1982, J ANTHROPOL RES, V38, P255, DOI 10.1086/jar.38.3.3629848; Eaker S, 1998, AM J EPIDEMIOL, V147, P74; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Ellis BJ, 2007, CHILD DEV, V78, P1799, DOI 10.1111/j.1467-8624.2007.01092.x; Ellison Peter, 1999, HORMONES HLTH BEHAV, P184; Essock-Vitale SM, 1988, HUMAN REPRODUCTIVE B, P221; Etter JF, 1997, J CLIN EPIDEMIOL, V50, P1123, DOI 10.1016/S0895-4356(97)00166-2; Figueredo AJ, 2005, PERS INDIV DIFFER, V39, P1349, DOI 10.1016/j.paid.2005.06.009; Figueredo AJ, 2007, HUM NATURE-INT BIOS, V18, P47, DOI 10.1007/BF02820846; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Hayes A, 2012, FAMILIES THEN NOW 19; Hazan C., 1999, HDB ATTACHMENT THEOR, P336; Heath KM, 1998, CURR ANTHROPOL, V39, P369, DOI 10.1086/204748; Hill K, 1999, ANNU REV ANTHROPOL, V28, P397, DOI 10.1146/annurev.anthro.28.1.397; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hochberg Ze'ev, 2011, Int J Pediatr Endocrinol, V2011, P2, DOI 10.1186/1687-9856-2011-2; Holton S, 2011, J POPUL RES, V28, P353, DOI 10.1007/s12546-011-9072-3; Jones JJS, 2006, BRIT J CLIN PSYCHOL, V45, P145, DOI 10.1348/014466505X29134; JONES NB, 1986, ETHOL SOCIOBIOL, V7, P91, DOI 10.1016/0162-3095(86)90002-6; KALDENBERG DO, 1994, PUBLIC OPIN QUART, V58, P68, DOI 10.1086/269408; Kim K, 1997, EVOL HUM BEHAV, V18, P109, DOI 10.1016/S1090-5138(96)00114-6; Kline P., 2014, EASY GUIDE FACTOR AN, DOI 10.4324/9781315788135; Kohlhuber M, 2008, BRIT J NUTR, V99, P1127, DOI 10.1017/S0007114508864835; Koziel S, 2001, AM J PHYS ANTHROPOL, V115, P71, DOI 10.1002/ajpa.1058; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Lawley D.N., 1962, J R STAT SOC, V12, P209, DOI [DOI 10.2307/2986915, https://doi.org/10.2307/2986915]; Lawson DW, 2010, HUM NATURE-INT BIOS, V21, P39, DOI 10.1007/s12110-010-9080-6; Low BS, 2008, CROSS-CULT RES, V42, P201, DOI 10.1177/1069397108317669; Mace R, 1997, J BIOSOC SCI, V29, P499, DOI 10.1017/S0021932097004999; Marlowe FW, 2000, BEHAV PROCESS, V51, P45, DOI 10.1016/S0376-6357(00)00118-2; Michalski RL, 2002, PERS INDIV DIFFER, V33, P661, DOI 10.1016/S0191-8869(01)00181-7; Milne FH, 2011, MED HYPOTHESES, V77, P626, DOI 10.1016/j.mehy.2011.07.001; Milne FH, 2011, P ROY SOC B-BIOL SCI, V278, P417, DOI 10.1098/rspb.2010.1377; MULDAL AM, 1986, BEHAV ECOL SOCIOBIOL, V19, P105, DOI 10.1007/BF00299945; Mulder M. Borgerhoff, 1992, EVOL ECOL, P339, DOI DOI 10.1002/AJHB.21187; Muthen B, 2005, MPLUS DISCUSSION OBT; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Ogunlesi TA, 2010, MATERN CHILD HLTH J, V14, P459, DOI 10.1007/s10995-008-0440-3; PAGANINIHILL A, 1993, EPIDEMIOLOGY, V4, P375, DOI 10.1097/00001648-199307000-00014; Plaisant O, 2010, ANN MED-PSYCHOL, V168, P97, DOI 10.1016/j.amp.2009.09.003; PURVIS A, 1995, J ZOOL, V237, P259, DOI 10.1111/j.1469-7998.1995.tb02762.x; Rowlands IJ, 2011, GYNECOL ONCOL, V123, P537, DOI 10.1016/j.ygyno.2011.08.022; Ryan AS, 2002, PEDIATRICS, V110, P1103, DOI 10.1542/peds.110.6.1103; SANTOW G, 1991, AUST NZ J OBSTET GYN, V31, P201, DOI 10.1111/j.1479-828X.1991.tb02781.x; Schmitt DP, 2005, PERS SOC PSYCHOL B, V31, P747, DOI 10.1177/0146167204271843; SMITH DP, 1985, STUD FAMILY PLANN, V16, P154, DOI 10.2307/1967017; Smuts B., 1992, FATHER CHILD RELATIO, P1, DOI DOI 10.1002/AJHB.1310060321; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; Taveras EM, 2003, PEDIATRICS, V112, P108, DOI 10.1542/peds.112.1.108; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Weeden J, 2006, HUM NATURE-INT BIOS, V17, P377, DOI 10.1007/s12110-006-1001-3	73	1	1	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46760	10.1371/journal.pone.0046760	http://dx.doi.org/10.1371/journal.pone.0046760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NG	23056440	gold, Green Published, Green Submitted			2022-12-27	WOS:000309452600056
J	Schweizer, HP; Choi, KH				Schweizer, Herbert P.; Choi, Kyoung-Hee			Characterization of Molecular Mechanisms Controlling fabAB Transcription in Pseudomonas aeruginosa	PLOS ONE			English	Article							FATTY-ACID BIOSYNTHESIS; ESCHERICHIA-COLI; GENE-EXPRESSION; RNA; FADR; PROTEIN; CLONING; DENITRIFICATION; RECOMBINATION; CONSTRUCTION	Background: The FabAB pathway is one of the unsaturated fatty acid (UFA) synthesis pathways for Pseudomonas aeruginosa. It was previously noted that this operon was upregulated in biofilms and repressed by exogenous UFAs. Deletion of a 30 nt fabA upstream sequence, which is conserved in P. aeruginosa, P. putida, and P. syringae, led to a significant decrease in fabA transcription, suggesting positive regulation by an unknown positive regulatory mechanism. Methods/Principal Findings: Here, genetic and biochemical approaches were employed to identify a potential fabAB activator. Deletion of candidate genes such as PA1611 or PA1627 was performed to determine if any of these gene products act as a fabAB activator. However, none of these genes were involved in the regulation of fabAB transcription. Use of mariner-based random mutagenesis to screen for fabA activator(s) showed that several genes encoding unknown functions, rpoN and DesA may be involved in fabA regulation, but probably via indirect mechanisms. Biochemical attempts performed did fail to isolate an activator of fabAB operon. Conclusion/Significance: The data suggest that fabA expression might not be regulated by protein-binding, but by a distinct mechanism such as a regulatory RNA-based mechanism.	[Choi, Kyoung-Hee] Wonkwang Univ, Dept Oral Microbiol, Coll Dent, Iksan, Chonbuk, South Korea; [Schweizer, Herbert P.] Colorado State Univ, Dept Microbiol Immunol & Pathol, IDRC, Ft Collins, CO 80523 USA	Wonkwang University; Colorado State University	Choi, KH (corresponding author), Wonkwang Univ, Dept Oral Microbiol, Coll Dent, Iksan, Chonbuk, South Korea.	kheechoi@wku.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0004068]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0004068). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton HA, 1996, MOL MICROBIOL, V21, P1001, DOI 10.1046/j.1365-2958.1996.381426.x; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; CARLSON CA, 1983, APPL ENVIRON MICROB, V45, P1247, DOI 10.1128/AEM.45.4.1247-1253.1983; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; DAVIES KJP, 1989, J GEN MICROBIOL, V135, P2445; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; LARSON TJ, 1982, J BACTERIOL, V152, P1008; Lu CD, 1999, J BACTERIOL, V181, P2459, DOI 10.1128/JB.181.8.2459-2464.1999; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Repoila F, 2003, MOL MICROBIOL, V48, P855, DOI 10.1046/j.1365-2958.2003.03454.x; Sambrook J., 2001, MOL CLONING; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Subramanian C, 2010, J BACTERIOL, V192, P280, DOI 10.1128/JB.00404-09; van Aalten DMF, 2000, EMBO J, V19, P5167, DOI 10.1093/emboj/19.19.5167; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	37	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45646	10.1371/journal.pone.0045646	http://dx.doi.org/10.1371/journal.pone.0045646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056212	gold, Green Submitted, Green Published			2022-12-27	WOS:000309452600014
J	Bach, KP; Kuschel, CA; Hooper, SB; Bertram, J; McKnight, S; Peachey, SE; Zahra, VA; Flecknoe, SJ; Oliver, MH; Wallace, MJ; Bloomfield, FH				Bach, Katinka P.; Kuschel, Carl A.; Hooper, Stuart B.; Bertram, Jean; McKnight, Sue; Peachey, Shirley E.; Zahra, Valerie A.; Flecknoe, Sharon J.; Oliver, Mark H.; Wallace, Megan J.; Bloomfield, Frank H.			High Bias Gas Flows Increase Lung Injury in the Ventilated Preterm Lamb	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; ANTENATAL CORTICOSTEROIDS; MECHANICAL VENTILATION; EPITHELIAL-CELLS; UP-REGULATION; EXPRESSION; DISEASE; PRESSURE; CYR61; FIBROBLASTS	Background: Mechanical ventilation of preterm babies increases survival but can also cause ventilator-induced lung injury (VILI), leading to the development of bronchopulmonary dysplasia (BPD). It is not known whether shear stress injury from gases flowing into the preterm lung during ventilation contributes to VILI. Methods: Preterm lambs of 131 days' gestation (term = 147 d) were ventilated for 2 hours with a bias gas flow of 8 L/min (n = 13), 18 L/min (n = 12) or 28 L/min (n = 14). Physiological parameters were measured continuously and lung injury was assessed by measuring mRNA expression of early injury response genes and by histological analysis. Control lung tissue was collected from unventilated age-matched fetuses. Data were analysed by ANOVA with a Tukey post-hoc test when appropriate. Results: High bias gas flows resulted in higher ventilator pressures, shorter inflation times and decreased ventilator efficiency. The rate of rise of inspiratory gas flow was greatest, and pulmonary mRNA levels of the injury markers, EGR1 and CTGF, were highest in lambs ventilated with bias gas flows of 18 L/min. High bias gas flows resulted in increased cellular proliferation and abnormal deposition of elastin, collagen and myofibroblasts in the lung. Conclusions: High ventilator bias gas flows resulted in increased lung injury, with up-regulation of acute early response genes and increased histological lung injury. Bias gas flows may, therefore, contribute to VILI and BPD.	[Bach, Katinka P.; Oliver, Mark H.; Bloomfield, Frank H.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Kuschel, Carl A.] Royal Womens Hosp, Parkville, Vic, Australia; [Hooper, Stuart B.; Zahra, Valerie A.; Flecknoe, Sharon J.; Wallace, Megan J.] Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Bach, Katinka P.; Bertram, Jean; McKnight, Sue; Peachey, Shirley E.; Bloomfield, Frank H.] Auckland City Hosp, Newborn Serv, Auckland, New Zealand; [Oliver, Mark H.; Bloomfield, Frank H.] Natl Res Ctr Growth & Dev, Auckland, New Zealand; [Bloomfield, Frank H.] Univ Auckland, Fac Med & Hlth Sci, Dept Paediat Child & Youth Hlth, Auckland 1, New Zealand	University of Auckland; Monash University; Auckland City Hospital; University of Auckland; University of Auckland	Bach, KP (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	kittyb@adhb.govt.nz		Oliver, Mark/0000-0002-0359-2297; Wallace, Megan/0000-0001-5785-5120; Hooper, Stuart/0000-0003-1676-4825; Bloomfield, Frank/0000-0001-6424-6577	Auckland Medical Research Foundation [81502]; Health Research Council of New Zealand [06/082]; National Research Centre for Growth and Development in New Zealand [06018FB]; National Health and Medical Research Council of Australia	Auckland Medical Research Foundation; Health Research Council of New Zealand(Health Research Council of New Zealand); National Research Centre for Growth and Development in New Zealand; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank the Auckland Medical Research Foundation (grant number 81502, http://www.medicalresearch.co.nz/), the Health Research Council of New Zealand (grant number 06/082; http://www.hrc.govt.nz/), the National Research Centre for Growth and Development in New Zealand (grant number (grant number 06018FB; http://www.nrcgd.org.nz/), and the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertine KH, 1999, AM J RESP CRIT CARE, V159, P945, DOI 10.1164/ajrccm.159.3.9804027; Allison BJ, 2008, PEDIATR RES, V64, P387, DOI 10.1203/PDR.0b013e318181e05e; Bach KP, 2009, NEONATOLOGY, V96, P259, DOI 10.1159/000220765; Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6; BOROS SJ, 1984, PEDIATRICS, V74, P487; Carlton DP, 1997, J APPL PHYSIOL, V83, P1307, DOI 10.1152/jappl.1997.83.4.1307; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; COALSON JJ, 1992, AM REV RESPIR DIS, V145, P872, DOI 10.1164/ajrccm/145.4_Pt_1.872; Coalson JJ, 1999, AM J RESP CRIT CARE, V160, P1333, DOI 10.1164/ajrccm.160.4.9810071; Crowther CA, 2006, LANCET, V367, P1913, DOI 10.1016/S0140-6736(06)68846-6; DREYFUSS D, 1992, INTENS CARE MED, V18, P139, DOI 10.1007/BF01709236; Gerhardt T, 2008, NEWBORN LUNG NEONATO, P419; GREENOUGH A, 1988, EARLY HUM DEV, V17, P1, DOI 10.1016/S0378-3782(88)80051-3; HEINE UI, 1990, DEVELOPMENT, V109, P29; HERNANDEZ LA, 1989, J APPL PHYSIOL, V66, P2364, DOI 10.1152/jappl.1989.66.5.2364; Jarreau PH, 1999, J APPL PHYSIOL, V87, P36, DOI 10.1152/jappl.1999.87.1.36; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kamlin C., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004503.PUB2; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Landesberg LJ, 2001, AM J PHYSIOL-LUNG C, V281, pL1138, DOI 10.1152/ajplung.2001.281.5.L1138; LESLIE KO, 1990, DIFFERENTIATION, V44, P143, DOI 10.1111/j.1432-0436.1990.tb00547.x; LESLIE KO, 1992, CELL MOTIL CYTOSKEL, V22, P92, DOI 10.1002/cm.970220203; MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391; MCGOWAN SE, 1992, FASEB J, V6, P2895, DOI 10.1096/fasebj.6.11.1644255; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Pan LH, 2001, EUR RESPIR J, V17, P1220, DOI 10.1183/09031936.01.00074101; Perkowski S, 2003, AM J RESP CELL MOL, V28, P682, DOI 10.1165/rcmb.4692; Pierce RA, 1997, AM J PHYSIOL-LUNG C, V272, pL452, DOI 10.1152/ajplung.1997.272.3.L452; Rich PB, 2000, J TRAUMA, V49, P903, DOI 10.1097/00005373-200011000-00019; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Sakamoto S, 2004, PROSTATE, V61, P305, DOI 10.1002/pros.20098; Seeley RR, 1992, ANATOMY PHYSL, P735; SIMBRUNER G, 1981, CRIT CARE MED, V9, P509, DOI 10.1097/00003246-198107000-00002; Sinn JKH, 2002, J PAEDIATR CHILD H, V38, P597, DOI 10.1046/j.1440-1754.2002.00061.x; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Sozo F, 2006, PHYSIOL GENOMICS, V24, P105, DOI 10.1152/physiolgenomics.00148.2005; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Spitzer AR, 2003, ASSISTED VENTILATION, P149; Thibeault DW, 2003, PEDIATRICS, V111, P766, DOI 10.1542/peds.111.4.766; Thibeault DW, 2000, PEDIATRICS, V106, P1452, DOI 10.1542/peds.106.6.1452; Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Wright C, 1999, PEDIATR DEVEL PATHOL, V2, P424, DOI 10.1007/s100249900145; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; YOUNG CD, 1980, ANAT REC, V198, P245, DOI 10.1002/ar.1091980211; Zhang WS, 2000, AM J PATHOL, V157, P1311, DOI 10.1016/S0002-9440(10)64646-9; Zhou DM, 2005, J APPL PHYSIOL, V98, P2344, DOI 10.1152/japplphysiol.01093.2004	47	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47044	10.1371/journal.pone.0047044	http://dx.doi.org/10.1371/journal.pone.0047044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056572	Green Submitted, gold, Green Published			2022-12-27	WOS:000309831500126
J	Dindia, L; Murray, J; Faught, E; Davis, TL; Leonenko, Z; Vijayan, MM				Dindia, Laura; Murray, Josh; Faught, Erin; Davis, Tracy L.; Leonenko, Zoya; Vijayan, Mathilakath M.			Novel Nongenomic Signaling by Glucocorticoid May Involve Changes to Liver Membrane Order in Rainbow Trout	PLOS ONE			English	Article							STRESS-RESPONSE; PLASMA-MEMBRANES; FORCE MICROSCOPY; MESSENGER-RNA; CORTISOL; FLUIDITY; MECHANISMS; RELEASE; CELLS; HEPATOCYTES	Stress-induced glucocorticoid elevation is a highly conserved response among vertebrates. This facilitates stress adaptation and the mode of action involves activation of the intracellular glucocorticoid receptor leading to the modulation of target gene expression. However, this genomic effect is slow acting and, therefore, a role for glucocorticoid in the rapid response to stress is unclear. Here we show that stress levels of cortisol, the primary glucocorticoid in teleosts, rapidly fluidizes rainbow trout (Oncorhynchus mykiss) liver plasma membranes in vitro. This involved incorporation of the steroid into the lipid domains, as cortisol coupled to a membrane impermeable peptide moiety, did not affect membrane order. Studies confirmed that cortisol, but not sex steroids, increases liver plasma membrane fluidity. Atomic force microscopy revealed cortisol-mediated changes to membrane surface topography and viscoelasticity confirming changes to membrane order. Treating trout hepatocytes with stress levels of cortisol led to the modulation of cell signaling pathways, including the phosphorylation status of putative PKA, PKC and AKT substrate proteins within 10 minutes. The phosphorylation by protein kinases in the presence of cortisol was consistent with that seen with benzyl alcohol, a known membrane fluidizer. Our results suggest that biophysical changes to plasma membrane properties, triggered by stressor-induced glucocorticoid elevation, act as a nonspecific stress response and may rapidly modulate acute stress-signaling pathways.	[Dindia, Laura; Murray, Josh; Faught, Erin; Leonenko, Zoya; Vijayan, Mathilakath M.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Davis, Tracy L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	University of Waterloo; Idaho; University of Idaho	Vijayan, MM (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	matt.vijayan@ucalgary.ca	Vijayan, Mathilakath/AAC-2190-2020		Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC; CFI; ORF	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation); ORF	This study was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada discovery grant and Discovery Accelerator Supplement to MMV. LD was the recipient of the NSERC post-graduate scholarship. AFM infrastructure in Leonenko's lab was supported by CFI and ORF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006463; Aluru N, 2009, GEN COMP ENDOCR, V164, P142, DOI 10.1016/j.ygcen.2009.03.020; Borski RJ, 2002, STEROIDS, V67, P539, DOI 10.1016/S0039-128X(01)00197-0; Borski RJ, 2000, TRENDS ENDOCRIN MET, V11, P427, DOI 10.1016/S1043-2760(00)00325-8; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Davis TL, 2011, BIOL REPROD, V85, P770, DOI 10.1095/biolreprod.111.091926; DELICONSTANTINOS G, 1985, NEUROCHEM RES, V10, P1605, DOI 10.1007/BF00988602; ERLANGER BF, 1957, J BIOL CHEM, V228, P713; GERRITSEN ME, 1991, BIOCHIM BIOPHYS ACTA, V1065, P63, DOI 10.1016/0005-2736(91)90011-V; Gravel A, 2009, COMP BIOCHEM PHYS C, V149, P481, DOI 10.1016/j.cbpc.2008.11.002; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Hane F, 2010, NANOMED-NANOTECHNOL, V6, P808, DOI 10.1016/j.nano.2010.05.001; KAPITULNIK J, 1986, BIOCHEM J, V239, P41, DOI 10.1042/bj2390041; Katynski AL, 2004, COMP BIOCHEM PHYS C, V137, P81, DOI 10.1016/j.cca.2003.11.004; Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002; Leonenko ZV, 2004, CAN J CHEM, V82, P1128, DOI [10.1139/V04-23, 10.1139/V04-023]; Leonenko ZV, 2004, BIOPHYS J, V86, P3783, DOI 10.1529/biophysj.103.036681; LEVI M, 1995, J CLIN INVEST, V96, P207, DOI 10.1172/JCI118022; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Magonov SN, 1997, SURF SCI, V375, pL385, DOI 10.1016/S0039-6028(96)01591-9; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGuire A, 2010, GEN COMP ENDOCR, V165, P321, DOI 10.1016/j.ygcen.2009.07.016; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Moores B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025954; Nagler JJ, 2010, GEN COMP ENDOCR, V167, P326, DOI 10.1016/j.ygcen.2010.03.022; Panin LE, 2010, J PHYS CHEM B, V114, P9462, DOI 10.1021/jp911917a; REID SD, 1992, AM J PHYSIOL, V262, pR794, DOI 10.1152/ajpregu.1992.262.5.R794; Rog T, 2008, J PHYS CHEM B, V112, P1946, DOI 10.1021/jp075078h; Rose AJ, 2010, J STEROID BIOCHEM, V122, P10, DOI 10.1016/j.jsbmb.2010.02.010; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Sandhu N, 2011, AQUAT TOXICOL, V103, P92, DOI 10.1016/j.aquatox.2011.02.011; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sathiyaa R, 2001, COMP BIOCHEM PHYS B, V129, P679, DOI 10.1016/S1096-4959(01)00373-6; SOLYOM A, 1972, ENZYME, V13, P329, DOI 10.1159/000459682; SULAKHE SJ, 1987, INT J BIOCHEM, V19, P1181, DOI 10.1016/0020-711X(87)90100-5; Tasker JG, 2011, STRESS, V14, P398, DOI 10.3109/10253890.2011.586446; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Vigh L, 2007, ANN NY ACAD SCI, V1113, P40, DOI 10.1196/annals.1391.027; Zehmer JK, 2004, BBA-BIOMEMBRANES, V1664, P108, DOI 10.1016/j.bbamem.2004.04.008	41	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46859	10.1371/journal.pone.0046859	http://dx.doi.org/10.1371/journal.pone.0046859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056491	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500094
J	Funken, H; Bartels, KM; Wilhelm, S; Brocker, M; Bott, M; Bains, M; Hancock, REW; Rosenau, F; Jaeger, KE				Funken, Horst; Bartels, Kai-Malte; Wilhelm, Susanne; Brocker, Melanie; Bott, Michael; Bains, Manjeet; Hancock, Robert E. W.; Rosenau, Frank; Jaeger, Karl-Erich			Specific Association of Lectin LecB with the Surface of Pseudomonas aeruginosa: Role of Outer Membrane Protein OprF	PLOS ONE			English	Article							PA-IIL LECTIN; STRUCTURAL BASIS; GLYCOPEPTIDE DENDRIMERS; MEDIATED ADHESION; ESCHERICHIA-COLI; EPITHELIAL-CELLS; FUCOSE-BINDING; HIGH-AFFINITY; RECOGNITION; POLYACRYLAMIDE	The fucose binding lectin LecB affects biofilm formation and is involved in pathogenicity of Pseudomonas aeruginosa. LecB resides in the outer membrane and can be released specifically by treatment of an outer membrane fraction with fucose suggesting that it binds to specific ligands. Here, we report that LecB binds to the outer membrane protein OprF. In an OprF-deficient P. aeruginosa mutant, LecB is no longer detectable in the membrane but instead in the culture supernatant indicating a specific interaction between LecB and OprF.	[Funken, Horst; Bartels, Kai-Malte; Wilhelm, Susanne; Jaeger, Karl-Erich] Univ Dusseldorf, Inst Mol Enzyme Technol, Julich, Germany; [Brocker, Melanie; Bott, Michael] Forschungszentrum Julich, Inst Bio & Geosci 1, Julich, Germany; [Bains, Manjeet; Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Rosenau, Frank] Univ Ulm, Inst Pharmaceut Biotechnol, Ulm, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; University of British Columbia; Ulm University	Jaeger, KE (corresponding author), Univ Dusseldorf, Inst Mol Enzyme Technol, Julich, Germany.	karl-erich.jaeger@fz-juelich.de	jaeger, karl/ABB-1955-2020; Bott, Michael/E-8004-2011; Rosenau, Frank/AAM-8062-2020; Hancock, Robert E. W./E-1145-2013	Bott, Michael/0000-0002-4701-8254; Hancock, Robert E. W./0000-0001-5989-8503; Rosenau, Frank/0000-0002-9297-6419	German Federal Ministry of Education and Research within the project PSYSMO [0313980B]; Canadian Institutes for Health Research; Canadian Cystic Fibrosis Foundation	German Federal Ministry of Education and Research within the project PSYSMO; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation	Part of the work in the laboratory of KEJ was supported by a grant from the German Federal Ministry of Education and Research within the project PSYSMO (Nr. 0313980B). REWH was supported by a grant from the Canadian Institutes for Health Research and the Canadian Cystic Fibrosis Foundation. REWH holds a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EC, 1997, AM J RESP CRIT CARE, V155, P2102, DOI 10.1164/ajrccm.155.6.9196121; Adam EC, 1997, J LARYNGOL OTOL, V111, P760, DOI 10.1017/S0022215100138551; Arora SK, 1998, INFECT IMMUN, V66, P1000, DOI 10.1128/IAI.66.3.1000-1007.1998; AVRAMEAS S, 1969, IMMUNOCHEMISTRY, V6, P825, DOI 10.1016/0019-2791(69)90288-2; Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; Bartels KM, 2011, J BACTERIOL, V193, P1107, DOI 10.1128/JB.01507-10; Beachey EH, 1980, BACTERIAL ADHERENCE; BELLIDO F, 1992, J BACTERIOL, V174, P5196, DOI 10.1128/JB.174.16.5196-5203.1992; BEUTH J, 1987, EUR J CLIN MICROBIOL, V6, P591, DOI 10.1007/BF02014258; Brinkman FSL, 2000, J BACTERIOL, V182, P5251, DOI 10.1128/JB.182.18.5251-5255.2000; Buts L, 2003, MOL MICROBIOL, V49, P705, DOI 10.1046/j.1365-2958.2003.03600.x; Chemani C, 2009, INFECT IMMUN, V77, P2065, DOI 10.1128/IAI.01204-08; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; DOIG P, 1990, INFECT IMMUN, V58, P124, DOI 10.1128/IAI.58.1.124-130.1990; Fito-Boncompte L, 2011, INFECT IMMUN, V79, P1176, DOI 10.1128/IAI.00850-10; Gabius HJ, 2002, BBA-GEN SUBJECTS, V1572, P165, DOI 10.1016/S0304-4165(02)00306-9; Gilboa-Garber N, 2000, FEMS IMMUNOL MED MIC, V29, P53, DOI 10.1111/j.1574-695X.2000.tb01505.x; Gilboa-Garber N, 1999, FEMS IMMUNOL MED MIC, V25, P365, DOI 10.1111/j.1574-695X.1999.tb01361.x; Gilboa-Garber N, 1992, GLYCOCONJUGATES COMP; GILBOAGARBER N, 1982, METHOD ENZYMOL, V83, P378; GILBOAGARBER N, 1994, GLYCOCONJUGATE J, V11, P414, DOI 10.1007/BF00731276; Gooderham WJ, 2009, MICROBIOL-SGM, V155, P699, DOI 10.1099/mic.0.024554-0; Hancock REW, 1998, PSEUDOMONAS BIOTECHN, V10; Hauber Hans-Peter, 2008, Int J Med Sci, V5, P371; Holden PA, 1997, BIOTECHNOL BIOENG, V56, P656, DOI [10.1002/(SICI)1097-0290(19971220)56:6&lt;656::AID-BIT9&gt;3.0.CO;2-M, 10.1002/(SICI)1097-0290(19971220)56:6<656::AID-BIT9>3.0.CO;2-M]; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; HUET C, 1972, EXP CELL RES, V75, P523, DOI 10.1016/0014-4827(72)90463-6; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Johansson EMV, 2008, CHEM BIOL, V15, P1249, DOI 10.1016/j.chembiol.2008.10.009; Kolomiets E, 2009, CHEMMEDCHEM, V4, P562, DOI 10.1002/cmdc.200800380; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lerrer B, 2001, CAN J MICROBIOL, V47, P1095, DOI 10.1139/cjm-47-12-1095; Loris R, 2003, J MOL BIOL, V331, P861, DOI 10.1016/S0022-2836(03)00754-X; LUNDELL DJ, 1994, PHARMACOL THERAPEUT, V64, P1, DOI 10.1016/0163-7258(94)90031-0; Mewe M, 2005, J LARYNGOL OTOL, V119, P595, DOI 10.1258/0022215054516313; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Mitchell EP, 2005, PROTEINS, V58, P735, DOI 10.1002/prot.20330; Morimoto M, 2001, BIOMACROMOLECULES, V2, P1133, DOI 10.1021/bm010063p; NILSSON CJ, 2007, LECTINS ANAL TECHNOL; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Priester JH, 2006, APPL ENVIRON MICROB, V72, P1988, DOI 10.1128/AEM.72.3.1988-1996.2006; Rawling EG, 1998, J BACTERIOL, V180, P3556, DOI 10.1128/JB.180.14.3556-3562.1998; Scanlin TF, 2001, RESP RES, V2, P276, DOI 10.1186/rr69; Scharfman A, 2001, INFECT IMMUN, V69, P5243, DOI 10.1128/IAI.69.9.5243-5248.2001; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIMON R, 1986, METHOD ENZYMOL, V118, P640; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Sonawane A, 2006, INFECT IMMUN, V74, P7035, DOI 10.1128/IAI.00551-06; Steinberger RE, 2002, MICROBIAL ECOL, V43, P416, DOI 10.1007/s00248-001-1063-z; Steuer M.K., 1993, OTORHINOLARYNGOL NOV, V3, P19, DOI [10.1159/000312978, DOI 10.1159/000312978]; Straatsma TP, 2009, PROTEINS, V74, P475, DOI 10.1002/prot.22165; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sugawara E, 2010, MBIO, V1, DOI 10.1128/mBio.00228-10; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Tamber S, 2004, PSEUDOMONADS; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Tielker D, 2006, BIOTECHNIQUES, V41, P327, DOI 10.2144/000112236; Urban A, 2001, J BACTERIOL, V183, P587, DOI 10.1128/JB.183.2.587-596.2001; von Bismarck P, 2001, KLIN PADIATR, V213, P285, DOI 10.1055/s-2001-17220; Wilhelm S, 1999, J BACTERIOL, V181, P6977, DOI 10.1128/JB.181.22.6977-6986.1999; Winzer K, 2000, J BACTERIOL, V182, P6401, DOI 10.1128/JB.182.22.6401-6411.2000	62	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46857	10.1371/journal.pone.0046857	http://dx.doi.org/10.1371/journal.pone.0046857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056489	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500092
J	Huppert, A; Barnea, O; Katriel, G; Yaari, R; Roll, U; Stone, L				Huppert, Amit; Barnea, Oren; Katriel, Guy; Yaari, Rami; Roll, Uri; Stone, Lewi			Modeling and Statistical Analysis of the Spatio-Temporal Patterns of Seasonal Influenza in Israel	PLOS ONE			English	Article							PANDEMIC INFLUENZA; UNITED-STATES; REPRODUCTIVE NUMBER; SCHOOL CLOSURE; TRANSMISSION; DISEASE; EPIDEMICS; DYNAMICS; OUTBREAK; VACCINATION	Background: Seasonal influenza outbreaks are a serious burden for public health worldwide and cause morbidity to millions of people each year. In the temperate zone influenza is predominantly seasonal, with epidemics occurring every winter, but the severity of the outbreaks vary substantially between years. In this study we used a highly detailed database, which gave us both temporal and spatial information of influenza dynamics in Israel in the years 1998-2009. We use a discrete-time stochastic epidemic SIR model to find estimates and credible confidence intervals of key epidemiological parameters. Findings: Despite the biological complexity of the disease we found that a simple SIR-type model can be fitted successfully to the seasonal influenza data. This was true at both the national levels and at the scale of single cities. The effective reproductive number Re varies between the different years both nationally and among Israeli cities. However, we did not find differences in Re between different Israeli cities within a year. Re was positively correlated to the strength of the spatial synchronization in Israel. For those years in which the disease was more "infectious", then outbreaks in different cities tended to occur with smaller time lags. Our spatial analysis demonstrates that both the timing and the strength of the outbreak within a year are highly synchronized between the Israeli cities. We extend the spatial analysis to demonstrate the existence of high synchrony between Israeli and French influenza outbreaks. Conclusions: The data analysis combined with mathematical modeling provided a better understanding of the spatiotemporal and synchronization dynamics of influenza in Israel and between Israel and France. Altogether, we show that despite major differences in demography and weather conditions intra-annual influenza epidemics are tightly synchronized in both their timing and magnitude, while they may vary greatly between years. The predominance of a similar main strain of influenza, combined with population mixing serve to enhance local and global influenza synchronization within an influenza season.	[Barnea, Oren; Katriel, Guy; Yaari, Rami; Roll, Uri; Stone, Lewi] Tel Aviv Univ, Dept Zool, Biomath Unit, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Huppert, Amit] Chaim Sheba Med Ctr, Gertner Inst, IL-52621 Tel Hashomer, Israel; [Yaari, Rami] Tel Aviv Univ, Porter Sch Environm Studies, IL-69978 Tel Aviv, Israel; [Katriel, Guy] ORT Braude Coll, Dept Math, Karmiel, Israel	Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University	Stone, L (corresponding author), Tel Aviv Univ, Dept Zool, Biomath Unit, Fac Life Sci, IL-69978 Tel Aviv, Israel.	lewi@post.tau.ac.il	Roll, Uri/AAE-7137-2019	Roll, Uri/0000-0002-5418-1164; Stone, Lewi/0000-0002-6465-579X; Katriel, Guy/0000-0001-7411-4789	EU-FP7 Epiwork grant; Maccabi Institute for Health Services Research Grant; Israel Science Foundation; Israel Ministry of Health; Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Israel National Institute for Health Policy and Health Services Research	EU-FP7 Epiwork grant; Maccabi Institute for Health Services Research Grant; Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health; Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Israel National Institute for Health Policy and Health Services Research	This work was supported by the EU-FP7 Epiwork grant, the Maccabi Institute for Health Services Research Grant, the Israel Science Foundation and the Israel Ministry of Health. UR is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. RY is supported by the Israel National Institute for Health Policy and Health Services Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; Bailey NTJ, 1975, MATH THEORY INFECT D; Barnea O, 2011, MATH BIOSCI ENG, V8, P561, DOI 10.3934/mbe.2011.8.561; BAROYAN O V, 1971, Advances in Applied Probability, V3, P224, DOI 10.2307/1426167; Baroyan OV, 1977, MODELLING PREDICTION; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Bolker B, 2008, ECOLOGICAL MODELS DA; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; Brauer F., 2005, ELECTRON J DIFFER EQ, V2005, P29; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Chowell G, 2008, PHYS LIFE REV, V5, P50, DOI 10.1016/j.plrev.2007.12.001; Chowell G, 2010, P ROY SOC B-BIOL SCI, V277, P1857, DOI 10.1098/rspb.2009.1897; Cintron-Arias A, 2009, MATH BIOSCI ENG, V6, P261, DOI 10.3934/mbe.2009.6.261; Cliff A D, 1993, Stat Methods Med Res, V2, P43, DOI 10.1177/096228029300200104; Coelho FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019616; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Edlund S, 2011, ELECTRON J HEALTH IN, V6; Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, ECOLOGICAL IMMUNOLOG, P422, DOI [10.1038/nature01491.1., DOI 10.1038/NATURE01491.1]; Ferrari MJ, 2005, MATH BIOSCI, V198, P14, DOI 10.1016/j.mbs.2005.08.002; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Grondahl B, 1999, J CLIN MICROBIOL, V37, P1; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Heymann AD, 2009, EPIDEMIOL INFECT, V137, P1369, DOI 10.1017/S0950268809002556; Hoen AG, 2011, CAN MED ASSOC J, V183, pE1025, DOI 10.1503/cmaj.110241; Katriel G, 2011, J R SOC INTERFACE, V8, P856, DOI 10.1098/rsif.2010.0515; Katriel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009565; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lin J, 1999, MATH BIOSCI, V162, P33, DOI 10.1016/S0025-5564(99)00042-5; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Roll U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-92; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; SPICER CC, 1979, BRIT MED BULL, V35, P23, DOI 10.1093/oxfordjournals.bmb.a071536; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; STONE L, 1992, P ROY SOC B-BIOL SCI, V250, P77, DOI 10.1098/rspb.1992.0133; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Truscott J, 2012, J R SOC INTERFACE, V9, P304, DOI 10.1098/rsif.2011.0309; Truscott James, 2009, PLoS Curr, V1, pRRN1125; van Noort SP, 2012, J THEOR BIOL, V298, P131, DOI 10.1016/j.jtbi.2011.12.020; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044	58	23	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45107	10.1371/journal.pone.0045107	http://dx.doi.org/10.1371/journal.pone.0045107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056192	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500014
J	Ibanez, A; Urquina, H; Petroni, A; Baez, S; Lopez, V; do Nascimento, M; Herrera, E; Guex, R; Hurtado, E; Blenkmann, A; Beltrachini, L; Gelormini, C; Sigman, M; Lischinsky, A; Torralva, T; Torrente, F; Cetkovich, M; Manes, F				Ibanez, Agustin; Urquina, Hugo; Petroni, Agustin; Baez, Sandra; Lopez, Vladimir; do Nascimento, Micaela; Herrera, Eduar; Guex, Raphael; Hurtado, Esteban; Blenkmann, Alejandro; Beltrachini, Leandro; Gelormini, Carlos; Sigman, Mariano; Lischinsky, Alicia; Torralva, Teresa; Torrente, Fernando; Cetkovich, Marcelo; Manes, Facundo			Neural Processing of Emotional Facial and Semantic Expressions in Euthymic Bipolar Disorder (BD) and Its Association with Theory of Mind (ToM)	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SOCIAL COGNITION; HUMAN BRAIN; FACE; RECOGNITION; DEFICITS; ADOLESCENTS; PERCEPTION; DEPRESSION; RELATIVES	Background: Adults with bipolar disorder (BD) have cognitive impairments that affect face processing and social cognition. However, it remains unknown whether these deficits in euthymic BD have impaired brain markers of emotional processing. Methodology/Principal Findings: We recruited twenty six participants, 13 controls subjects with an equal number of euthymic BD participants. We used an event-related potential (ERP) assessment of a dual valence task (DVT), in which faces (angry and happy), words (pleasant and unpleasant), and face-word simultaneous combinations are presented to test the effects of the stimulus type (face vs word) and valence (positive vs. negative). All participants received clinical, neuropsychological and social cognition evaluations. ERP analysis revealed that both groups showed N170 modulation of stimulus type effects (face. word). BD patients exhibited reduced and enhanced N170 to facial and semantic valence, respectively. The neural source estimation of N170 was a posterior section of the fusiform gyrus (FG), including the face fusiform area (FFA). Neural generators of N170 for faces (FG and FFA) were reduced in BD. In these patients, N170 modulation was associated with social cognition (theory of mind). Conclusions/Significance: This is the first report of euthymic BD exhibiting abnormal N170 emotional discrimination associated with theory of mind impairments.	[Ibanez, Agustin; Urquina, Hugo; Baez, Sandra; do Nascimento, Micaela; Gelormini, Carlos; Lischinsky, Alicia; Torralva, Teresa; Torrente, Fernando; Cetkovich, Marcelo; Manes, Facundo] Favaloro Univ, Inst Cognit Neurol, Lab Expt Psychol & Neurosci, Buenos Aires, DF, Argentina; [Ibanez, Agustin; Urquina, Hugo; Baez, Sandra; do Nascimento, Micaela; Gelormini, Carlos; Lischinsky, Alicia; Torralva, Teresa; Torrente, Fernando; Cetkovich, Marcelo; Manes, Facundo] Favaloro Univ, Inst Neurosci, Buenos Aires, DF, Argentina; [Blenkmann, Alejandro] Univ Buenos Aires, Natl Sci & Tech Res Council, Epilepsy Ctr, Buenos Aires, DF, Argentina; [Ibanez, Agustin] Univ Diego Port, Santiago, Chile; [Petroni, Agustin; Sigman, Mariano] Univ Buenos Aires, Dept Phys, Integrat Neurosci Lab, Buenos Aires, DF, Argentina; [Hurtado, Esteban] Pontificia Univ Catolica Chile, Santiago, Chile; [Blenkmann, Alejandro; Beltrachini, Leandro] Natl Univ La Plata, Lab Ind Elect Control & Instrumentat, La Plata, Buenos Aires, Argentina; [Herrera, Eduar] Univ Autonoma Caribe, Barranquilla, Colombia; [Baez, Sandra] Pontificia Univ Catolica Argentina, Buenos Aires, DF, Argentina; [Urquina, Hugo] Univ Surcolombiana, Grp Invest Neurored, Neiva, Colombia; [Guex, Raphael] Univ Geneva, Lab Behav Neurol & Imaging Cognit, Geneva, Switzerland	University of Buenos Aires; University Diego Portales; University of Buenos Aires; Pontificia Universidad Catolica de Chile; National University of La Plata; Pontifical Catholic University of Argentina; University of Geneva	Ibanez, A (corresponding author), Favaloro Univ, Inst Cognit Neurol, Lab Expt Psychol & Neurosci, Buenos Aires, DF, Argentina.	aibanez@ineco.org.ar	Ibanez, Agustin/H-7976-2015; Lopez, Vladimir/N-7188-2017; Torrente, Fernando/AAD-7885-2022	Ibanez, Agustin/0000-0001-6758-5101; Torrente, Fernando/0000-0001-7470-6979; Baez, Sandra/0000-0003-0875-1709; Beltrachini, Leandro/0000-0003-4602-1416; Petroni, Agustin/0000-0001-7352-6300; Gelormini-Lezama, Carlos/0000-0002-1605-229X; Blenkmann, Alejandro Omar/0000-0002-8671-2214; Herrera, Eduar/0000-0001-9409-245X	National Scientific and Technical Research Council, Institute of Cognitive Neurology Foundation; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1090610 and 1130920]	National Scientific and Technical Research Council, Institute of Cognitive Neurology Foundation; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was partially supported by grants National Scientific and Technical Research Council, Institute of Cognitive Neurology Foundation, and Fondo Nacional de Desarrollo Cientifico y Tecnologico (1090610 and 1130920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoruso L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00124; Axelrod BN, 2000, J CLIN PSYCHOL, V56, P807, DOI 10.1002/(SICI)1097-4679(200006)56:6<807::AID-JCLP9>3.0.CO;2-N; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bermpohl F, 2009, BIPOLAR DISORD, V11, P70, DOI 10.1111/j.1399-5618.2008.00648.x; Bolbecker AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019824; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Brotman MA, 2008, AM J PSYCHIAT, V165, P385, DOI 10.1176/appi.ajp.2007.06122050; Bruhl AB, 2011, BRAIN RES, V1378, P72, DOI 10.1016/j.brainres.2010.12.084; Centorrino F, 2002, AM J PSYCHIAT, V159, P109, DOI 10.1176/appi.ajp.159.1.109; Clark L, 2005, BIOL PSYCHIAT, V57, P183, DOI 10.1016/j.biopsych.2004.11.007; Couto B, 2013, CORTEX, V49, P1420, DOI 10.1016/j.cortex.2012.08.006; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Degabriele R, J AFFECT DISORD, V133, P212; Demenescu LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015058; Dufey M, 2011, SOC NEUROSCI-UK, V6, P48, DOI 10.1080/17470911003691402; Elshahawi HH, 2011, J AFFECT DISORDERS, V130, P180, DOI 10.1016/j.jad.2010.10.027; Frazier JA, 2005, BIPOLAR DISORD, V7, P555, DOI 10.1111/j.1399-5618.2005.00258.x; Harmer CJ, 2002, BIOL PSYCHIAT, V51, P298, DOI 10.1016/S0006-3223(01)01249-5; Hassel S, 2008, BIPOLAR DISORD, V10, P916, DOI 10.1111/j.1399-5618.2008.00641.x; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Henry C, 2008, PSYCHIAT RES, V159, P1, DOI 10.1016/j.psychres.2005.11.016; Herwig U, 2010, PSYCHOL MED, V40, P789, DOI 10.1017/S0033291709991073; Herwig U, 2007, NEUROIMAGE, V34, P848, DOI 10.1016/j.neuroimage.2006.09.035; Huepe D, 2012, BEHAV NEUROL, V25, P137, DOI [10.3233/BEN-2011-0350, 10.1155/2012/194159]; Hurtado E, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-69; Ibanez A, 2012, SOC NEUROSCI-UK, V7, P632, DOI 10.1080/17470919.2012.691078; Ibanez A, 2013, CORTEX, V49, P968, DOI 10.1016/j.cortex.2012.02.014; Ibanez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037306; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ibanez A, 2012, PSYCHIAT RES, V195, P18, DOI 10.1016/j.psychres.2011.07.027; Ibanez A, 2011, SOC NEUROSCI-UK, V6, P464, DOI 10.1080/17470919.2011.620769; Ibanez A, 2011, BRAIN RES, V1398, P72, DOI 10.1016/j.brainres.2011.05.014; Ibanez A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00188; Ibanez A, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-8; Inoue Y, 2004, J AFFECT DISORDERS, V82, P403, DOI 10.1016/j.jad.2004.04.004; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Martino DJ, 2011, PSYCHIAT RES, V189, P379, DOI 10.1016/j.psychres.2011.04.033; Kalmar JH, 2009, J AM ACAD CHILD PSY, V48, P636, DOI 10.1097/CHI.0b013e31819f6fbc; Kapczinski F, 2008, NEUROSCI BIOBEHAV R, V32, P675, DOI 10.1016/j.neubiorev.2007.10.005; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; Lembke A, 2002, AM J PSYCHIAT, V159, P302, DOI 10.1176/appi.ajp.159.2.302; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; Li HJ, 2010, SCHIZOPHRENIA BULL, V36, P1029, DOI 10.1093/schbul/sbn190; Lyoo IK, 2006, CNS SPECTRUMS, V11, P269, DOI 10.1017/S1092852900020770; M'Bailara K, 2009, BIPOLAR DISORD, V11, P63, DOI 10.1111/j.1399-5618.2008.00656.x; Malhi GS, 2007, BIPOLAR DISORD, V9, P345, DOI 10.1111/j.1399-5618.2007.00485.x; Maurer U, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.018.2008; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Minassian A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024185; Murphy K, 1996, COMPR PSYCHIAT, V37, P393, DOI 10.1016/S0010-440X(96)90022-X; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pavuluri MN, 2007, BIOL PSYCHIAT, V62, P158, DOI 10.1016/j.biopsych.2006.07.011; Petroni A, 2011, NEUROSCI LETT, V505, P41, DOI 10.1016/j.neulet.2011.09.062; Phillips ML, 2003, BRIT J PSYCHIAT, V182, P190, DOI 10.1192/bjp.182.3.190; Proverbio AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011242; Reite M, 2009, BIPOLAR DISORD, V11, P371, DOI 10.1111/j.1399-5618.2009.00701.x; Rich BA, 2008, J CHILD PSYCHOL PSYC, V49, P88, DOI 10.1111/j.1469-7610.2007.01819.x; Righart R, 2008, SOC COGN AFFECT NEUR, V3, P270, DOI 10.1093/scan/nsn021; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Savitz J, 2005, BIPOLAR DISORD, V7, P216, DOI 10.1111/j.1399-5618.2005.00203.x; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Spreen O, 1981, COMPENDIUM NEUROPSYC; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Tager-Flusberg H, 2003, PHILOS T R SOC B, V358, P303, DOI 10.1098/rstb.2002.1198; Torralva T, 2011, PSYCHIAT RES, V186, P261, DOI 10.1016/j.psychres.2010.08.007; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; Vautier S, 2009, PSYCHOL ASSESSMENT, V21, P187, DOI 10.1037/a0015312; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wolf F, 2010, BIPOLAR DISORD, V12, P657, DOI 10.1111/j.1399-5618.2010.00854.x; Wong TKW, 2008, EUR J NEUROSCI, V28, P407, DOI 10.1111/j.1460-9568.2008.06328.x; Wong TKW, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-16; Yeap S, 2009, J PSYCHIATR NEUROSCI, V34, P459; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	76	28	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46877	10.1371/journal.pone.0046877	http://dx.doi.org/10.1371/journal.pone.0046877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056505	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500097
J	Ido-Kitamura, Y; Sasaki, T; Kobayashi, M; Kim, HJ; Lee, YS; Kikuchi, O; Yokota-Hashimoto, H; Iizuka, K; Accili, D; Kitamura, T				Ido-Kitamura, Yukari; Sasaki, Tsutomu; Kobayashi, Masaki; Kim, Hye-Jin; Lee, Yong-Soo; Kikuchi, Osamu; Yokota-Hashimoto, Hiromi; Iizuka, Katsumi; Accili, Domenico; Kitamura, Tadahiro			Hepatic FoxO1 Integrates Glucose Utilization and Lipid Synthesis through Regulation of Chrebp O-Glycosylation	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; ELEMENT-BINDING PROTEIN; FATTY-ACID SYNTHESIS; INSULIN SENSITIVITY; X-RECEPTOR; LIVER; GENE; LIPOGENESIS; METABOLISM; PHOSPHORYLATION	In liver, glucose utilization and lipid synthesis are inextricably intertwined. When glucose availability exceeds its utilization, lipogenesis increases, leading to increased intrahepatic lipid content and lipoprotein secretion. Although the fate of three-carbon metabolites is largely determined by flux rate through the relevant enzymes, insulin plays a permissive role in this process. But the mechanism integrating insulin receptor signaling to glucose utilization with lipogenesis is unknown. Forkhead box O1 (FoxO1), a downstream effector of insulin signaling, plays a central role in hepatic glucose metabolism through the regulation of hepatic glucose production. In this study, we investigated the mechanism by which FoxO1 integrates hepatic glucose utilization with lipid synthesis. We show that FoxO1 overexpression in hepatocytes reduces activity of carbohydrate response element binding protein (Chrebp), a key regulator of lipogenesis, by suppressing O-linked glycosylation and reducing the protein stability. FoxO1 inhibits high glucose-or O-GlcNAc transferase (OGT)-induced liver-pyruvate kinase (L-PK) promoter activity by decreasing Chrebp recruitment to the L-PK promoter. Conversely, FoxO1 ablation in liver leads to the enhanced O-glycosylation and increased protein level of Chrebp owing to decreased its ubiquitination. We propose that FoxO1 regulation of Chrebp O-glycosylation is a mechanism linking hepatic glucose utilization with lipid synthesis.	[Ido-Kitamura, Yukari; Sasaki, Tsutomu; Kobayashi, Masaki; Kim, Hye-Jin; Lee, Yong-Soo; Kikuchi, Osamu; Yokota-Hashimoto, Hiromi; Kitamura, Tadahiro] Gunma Univ, Inst Mol & Cellular Regulat, Metab Signal Res Ctr, Maebashi, Gunma, Japan; [Iizuka, Katsumi] Gifu Univ, Sch Med, Dept Endocrinol & Diabet, Div Mol & Struct, Gifu 500, Japan; [Accili, Domenico] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Ido-Kitamura, Yukari] Fujisawa Shounandai Hosp, Dept Internal Med, Fujisawa, Kanagawa, Japan	Gunma University; Gifu University; Columbia University	Kitamura, T (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Metab Signal Res Ctr, Maebashi, Gunma, Japan.	kitamura@gunma-u.ac.jp	Iizuka, Katsumi/AAB-9135-2019; Lee, Yong-Soo/AAI-7059-2020	Iizuka, Katsumi/0000-0002-9837-6238; Sasaki, Tsutomu/0000-0001-8041-1915	Takeda Science Foundation; Japan Diabetes Foundation; ONO Medical Research Foundation; Cell Science Research Foundation; Global Centers of Excellence program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539] Funding Source: NIH RePORTER	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Diabetes Foundation; ONO Medical Research Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Global Centers of Excellence program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Grants-in-Aid for Scientific Research (Y.I.-K., T.K.), Takeda Science Foundation (Y.I.-K.), Japan Diabetes Foundation (Y.I.-K.), ONO Medical Research Foundation (T.K.), The Cell Science Research Foundation (T.K.) and Global Centers of Excellence program (T.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Haeusler RA, 2008, CELL METAB, V8, P7, DOI 10.1016/j.cmet.2008.06.010; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Shin DJ, 2009, J BIOL CHEM, V284, P11110, DOI 10.1074/jbc.M808747200; Spiriti J, 2008, BIOPHYS CHEM, V134, P157, DOI 10.1016/j.bpc.2008.02.005; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298	35	53	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47231	10.1371/journal.pone.0047231	http://dx.doi.org/10.1371/journal.pone.0047231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056614	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500147
J	Soundrarajan, N; Sokalingam, S; Raghunathan, G; Budisa, N; Paik, HJ; Yoo, TH; Lee, SG				Soundrarajan, Nagasundarapandian; Sokalingam, Sriram; Raghunathan, Govindan; Budisa, Nediljko; Paik, Hyun-Jong; Yoo, Tae Hyeon; Lee, Sun-Gu			Conjugation of Proteins by Installing BIO-Orthogonally Reactive Groups at Their N-Termini	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; NONCANONICAL AMINO-ACIDS; IN-VIVO; RECOMBINANT PROTEINS; ESCHERICHIA-COLI; GENETIC-CODE; EXPRESSION; STABILITY; EVOLUTION; GFP	N-terminal site-specific modification of a protein has many advantages over methods targeting internal positions, but it is not easy to install reactive groups onto a protein in an N-terminal specific manner. We here report a strategy to incorporate amino acid analogues specifically in the N-terminus of a protein in vivo and demonstrate it by preparing green fluorescent protein (GFP) having bio-orthogonally reactive groups at its N-terminus. In the first step, GFP was engineered to be a foldable, internal methionine-free sequence via the semi-rational mutagenesis of five internal methionine residues and the introduction of mutations for GFP folding enhancement. In the second step, the N-terminus of the engineered protein was modified in vivo with bio-orthogonally functional groups by reassigning functional methionine surrogates such as L-homopropargylglycine and L-azidohomoalanine into the first methionine codon of the engineered internal methionine-free GFP. The N-terminal specific incorporation of unnatural amino acids was confirmed by ESI-MS analysis and the incorporation did not affect significantly the specific activity, refolding rate and folding robustness of the protein. The two proteins which have alkyne or azide groups at their N-termini were conjugated each other by bio-orthogonal Cu(I)-catalyzed click chemistry. The strategy used in this study is expected to facilitate bio-conjugation applications of proteins such as N-terminal specific glycosylation, labeling of fluorescent dyes, and immobilization on solid surfaces.	[Soundrarajan, Nagasundarapandian; Sokalingam, Sriram; Raghunathan, Govindan; Paik, Hyun-Jong; Lee, Sun-Gu] Pusan Natl Univ, Dept Polymer Sci & Chem Engn, Pusan, South Korea; [Budisa, Nediljko] Tech Univ Berlin, Dept Chem, Berlin, Germany; [Yoo, Tae Hyeon] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Yoo, Tae Hyeon] Ajou Univ, Dept Appl Chem & Biol Engn, Suwon 441749, South Korea	Pusan National University; Technical University of Berlin; Ajou University; Ajou University	Soundrarajan, N (corresponding author), Pusan Natl Univ, Dept Polymer Sci & Chem Engn, Pusan, South Korea.	sungulee@pusan.ac.kr	Budisa, Nediljko/T-4812-2017; Budisa, Nediljko/AAG-7291-2019; Raghunathan, Govindan/T-5299-2019; Budisa, Nediljko/AAA-4634-2022	Budisa, Nediljko/0000-0001-8437-7304; Budisa, Nediljko/0000-0001-8437-7304; Soundrarajan, Nagasundarapandian/0000-0001-5239-7992; Raghunathan, Govindan/0000-0002-1456-0768	Basic Science Program [NRF-2011-0021222]; Mid-career Research Program through the National Research Foundation of Korea [NRF-2012016803]; Ministry of Education, Science and Technology	Basic Science Program; Mid-career Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Program (NRF-2011-0021222) and Mid-career Research Program (NRF-2012016803) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyadurai N, 2009, BIOTECHNOL BIOPROC E, V14, P257, DOI [10.1007/s12257-009-0009-z, 10.1007/S12257-009-0009-Z]; Baker DP, 2006, BIOCONJUGATE CHEM, V17, P179, DOI 10.1021/bc050237q; Bessette Paul H, 2003, Methods Mol Biol, V231, P29; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; BOISSEL JP, 1988, J BIOL CHEM, V263, P8443; Budisa N, 2004, ANGEW CHEM INT EDIT, V43, P6426, DOI 10.1002/anie.200300646; Budisa N, 2004, BIOL CHEM, V385, P191, DOI 10.1515/BC.2004.038; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; HUISGEN R, 1963, ANGEW CHEM INT EDIT, V75, P604, DOI 10.1002/ange.19630751304; Ito Y, 1999, BIOCHEM BIOPH RES CO, V264, P556, DOI 10.1006/bbrc.1999.1541; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Link AJ, 2006, P NATL ACAD SCI USA, V103, P10180, DOI 10.1073/pnas.0601167103; Link AJ, 2005, METHODS, V36, P291, DOI 10.1016/j.ymeth.2005.04.005; Merkel L, 2008, CHEMBIOCHEM, V9, P1220, DOI 10.1002/cbic.200800050; Merkel L, 2007, CHEMBIOCHEM, V8, P2227, DOI 10.1002/cbic.200700540; Nagasundarapandian S, 2010, CHEMBIOCHEM, V11, P2521, DOI 10.1002/cbic.201000380; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pavoor TV, 2009, P NATL ACAD SCI USA, V106, P11895, DOI 10.1073/pnas.0902828106; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Roodveldt C, 2005, CURR OPIN STRUC BIOL, V15, P50, DOI 10.1016/j.sbi.2005.01.001; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Saerens D, 2008, SENSORS-BASEL, V8, P4669, DOI 10.3390/s8084669; Selvakumar E, 2010, CHEMBIOCHEM, V11, P498, DOI 10.1002/cbic.200900685; Soundrarajan N, 2012, AFR J BIOTECHNOL, V11, P1059; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Teerawanichpan P, 2007, BBA-GEN SUBJECTS, V1770, P1360, DOI 10.1016/j.bbagen.2007.06.005; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tomizaki KY, 2005, CHEMBIOCHEM, V6, P783, DOI 10.1002/cbic.200400232; Wang A, 2008, CHEMBIOCHEM, V9, P324, DOI 10.1002/cbic.200700379; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Yoo TH, 2007, ANGEW CHEM INT EDIT, V46, P5340, DOI 10.1002/anie.200700779; Yoo TH, 2007, P NATL ACAD SCI USA, V104, P13887, DOI 10.1073/pnas.0701904104	34	14	15	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46741	10.1371/journal.pone.0046741	http://dx.doi.org/10.1371/journal.pone.0046741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056430	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500068
J	Victor, TA; Furey, ML; Fromm, SJ; Bellgowan, PSF; Ohman, A; Drevets, WC				Victor, Teresa A.; Furey, Maura L.; Fromm, Stephen J.; Bellgowan, Patrick S. F.; Ohman, Arne; Drevets, Wayne C.			The Extended Functional Neuroanatomy of Emotional Processing Biases for Masked Faces in Major Depressive Disorder	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; FACIAL EXPRESSIONS; ANTIDEPRESSANT TREATMENT; SUSTAINED ATTENTION; AMYGDALA ACTIVATION; NEURAL RESPONSE; INFORMATION; ORGANIZATION; PROJECTIONS; NUCLEUS	Background: Major depressive disorder (MDD) is associated with a mood-congruent processing bias in the amygdala toward face stimuli portraying sad expressions that is evident even when such stimuli are presented below the level of conscious awareness. The extended functional anatomical network that maintains this response bias has not been established, however. Aims: To identify neural network differences in the hemodynamic response to implicitly presented facial expressions between depressed and healthy control participants. Method: Unmedicated-depressed participants with MDD (n = 22) and healthy controls (HC; n = 25) underwent functional MRI as they viewed face stimuli showing sad, happy or neutral face expressions, presented using a backward masking design. The blood-oxygen-level dependent (BOLD) signal was measured to identify regions where the hemodynamic response to the emotionally valenced stimuli differed between groups. Results: The MDD subjects showed greater BOLD responses than the controls to masked-sad versus masked-happy faces in the hippocampus, amygdala and anterior inferotemporal cortex. While viewing both masked-sad and masked-happy faces relative to masked-neutral faces, the depressed subjects showed greater hemodynamic responses than the controls in a network that included the medial and orbital prefrontal cortices and anterior temporal cortex. Conclusions: Depressed and healthy participants showed distinct hemodynamic responses to masked-sad and masked-happy faces in neural circuits known to support the processing of emotionally valenced stimuli and to integrate the sensory and visceromotor aspects of emotional behavior. Altered function within these networks in MDD may establish and maintain illness-associated differences in the salience of sensory/social stimuli, such that attention is biased toward negative and away from positive stimuli.	[Victor, Teresa A.; Furey, Maura L.; Fromm, Stephen J.; Drevets, Wayne C.] NIMH, NIH, Bethesda, MD 20892 USA; [Victor, Teresa A.; Bellgowan, Patrick S. F.; Drevets, Wayne C.] Laureate Inst Brain Res, Tulsa, OK USA; [Victor, Teresa A.; Ohman, Arne] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Bellgowan, Patrick S. F.] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Laureate Institute for Brain Research, Inc.; Karolinska Institutet; University of Tulsa	Victor, TA (corresponding author), NIMH, NIH, Bethesda, MD 20892 USA.	tvictor@laureateinstitute.org	Furey, Maura/H-5273-2013	Bellgowan, Patrick/0000-0002-6753-8302; Victor, Teresa/0000-0002-0112-2902	National Institute of Mental Health [Z01-MH002792]; William K. Warren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002792] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); William K. Warren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health: Grant number Z01-MH002792 "Functional Neuroimaging in Unipolar and Bipolar Depressed Patients'' (http://www.nimh.nih.gov/index.shtml) and William K. Warren Foundation (http://williamkwarrenfoundation.org/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Furey and Dr. Drevets: for relevant financial activities outside the submitted work (money paid to them and their institution): a pending patent, US Patent Application No: 2006/0270,698 entitled "Scopolamine for the Treatment of Depression and Anxiety''. NIMH is the primary patent holder. Dr. Drevets: for the work under consideration for publication: grant money to his institution (NIMH DIRP) and for relevant financial activities outside the submitted work: consultancy (money paid to him) at Myriad, Esai, Johnson & Johnson and Pfizer; grant money to his institution from the William K. Warren Foundation in support of Laureate Institute for Brain Research; payment for development of educational presentations (lecture honoraria): University of PA, Washington University, UC-Davis, CME Incorporated. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; AMARAL DG, 1992, EXP BRAIN RES, V88, P375, DOI 10.1007/BF02259113; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BORDI F, 1992, J NEUROSCI, V12, P2493; BRADLEY BP, 1995, BEHAV RES THER, V33, P755, DOI 10.1016/0005-7967(95)00029-W; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Dannlowski U, 2008, NEUROPSYCHOPHARMACOL, V33, P418, DOI 10.1038/sj.npp.1301411; Dannlowski U, 2013, HUM BRAIN MAPP, V34, P2899, DOI 10.1002/hbm.22112; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2001, SOC NEUR ABSTR, V27; Elliott R, 2000, NEUROREPORT, V11, P1739, DOI 10.1097/00001756-200006050-00028; First MB, 2002, STRUCTURED CLIN INTE; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Freese JL, 2005, J COMP NEUROL, V486, P295, DOI 10.1002/cne.20520; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harmer CJ, 2008, NEUROPHARMACOLOGY, V55, P1023, DOI 10.1016/j.neuropharm.2008.06.036; Holland PC, 2007, BEHAV NEUROSCI, V121, P80, DOI 10.1037/0735-7044.121.1.80; HOLLON SD, 1980, COGNITIVE THER RES, V4, P383, DOI 10.1007/BF01178214; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; Juruena MF, 2010, J INT NEUROPSYCH SOC, V16, P383, DOI 10.1017/S1355617709991172; Killgore WDS, 2004, NEUROIMAGE, V21, P1215, DOI 10.1016/j.neuroimage.2003.12.033; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; MAI JK, 2003, ATLAS HUMAN BRAIN; Maxwell M., 1992, MANUAL FOR THE FIGS; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; Mogg K, 2006, BEHAV RES THER, V44, P1411, DOI 10.1016/j.brat.2005.10.008; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Murray LA, 1999, MEMORY, V7, P175, DOI 10.1080/741944068; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Peper M, 2001, BIOL PSYCHOL, V58, P1, DOI 10.1016/S0301-0511(01)00098-9; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Seubert J, 2010, NEUROIMAGE, V53, P746, DOI 10.1016/j.neuroimage.2010.07.012; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Suslow T, 2010, BIOL PSYCHIAT, V67, P155, DOI 10.1016/j.biopsych.2009.07.023; Talairach J., 1988, COPLANAR STEREOTAXIC; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Wechsler D., 2011, WASI 2 WECHSLER ABBR; WELLS A, 1994, BEHAV RES THER, V32, P871, DOI 10.1016/0005-7967(94)90168-6	63	32	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46439	10.1371/journal.pone.0046439	http://dx.doi.org/10.1371/journal.pone.0046439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056309	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500040
J	Ambacher, KK; Pitzul, KB; Karajgikar, M; Hamilton, A; Ferguson, SS; Cregan, SP				Ambacher, Kristin K.; Pitzul, Kristen B.; Karajgikar, Meera; Hamilton, Alison; Ferguson, Stephen S.; Cregan, Sean P.			The JNK- and AKT/GSK3 beta- Signaling Pathways Converge to Regulate Puma Induction and Neuronal Apoptosis Induced by Trophic Factor Deprivation	PLOS ONE			English	Article							CEREBELLAR GRANULE NEURONS; PROGRAMMED CELL-DEATH; GLYCOGEN-SYNTHASE KINASE-3; ENDOPLASMIC-RETICULUM STRESS; N-TERMINAL PHOSPHORYLATION; BH3-ONLY PROTEIN PUMA; C-JUN; SYMPATHETIC NEURONS; GROWTH-FACTOR; POTASSIUM DEPRIVATION	The AKT, GSK3 and JNK family kinases have been implicated in neuronal apoptosis associated with neuronal development and several neurodegenerative conditions. However, the mechanisms by which these kinase pathways regulate apoptosis remain unclear. In this study we have investigated the role of these kinases in neuronal cell death using an established model of trophic factor deprivation induced apoptosis in cerebellar granule neurons. BCL-2 family proteins are known to be central regulators of apoptosis and we have determined that the pro-apoptotic family member Puma is transcriptionally upregulated in trophic factor deprived neurons and that Puma induction is required for apoptosis in vitro and in vivo. Importantly, we demonstrate that Puma induction is dependent on both JNK activation and AKT inactivation. AKT is known to regulate a number of downstream pathways, however we have determined that PI3K-AKT inactivation induces Puma expression through a GSK3 beta-dependent mechanism. Finally we demonstrate that the JNK and AKT/GSK3 beta pathways converge to regulate FoxO3a-mediated transcriptional activation of Puma. In summary we have identified a novel and critical link between the AKT, GSK3 beta and JNK kinases and the regulation of Puma induction and suggest that this may be pivotal to the regulation of neuronal apoptosis in neurodegenerative conditions.	[Cregan, Sean P.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Cregan, SP (corresponding author), Univ Western Ontario, Robarts Res Inst, London, ON, Canada.	scregan@robarts.ca	Cregan, Sean/M-3205-2013		Canadian Institutes of Health Research [MOP-68995]; Heart and Stroke Foundation of Ontario [NA-7380]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by grants from the Canadian Institutes of Health Research (MOP-68995) and the Heart and Stroke Foundation of Ontario (NA-7380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arboleda G, 2010, NEUROTOXICOLOGY, V31, P687, DOI 10.1016/j.neuro.2010.08.001; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bjorkblom B, 2008, J BIOL CHEM, V283, P19704, DOI 10.1074/jbc.M707744200; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Chang LK, 2002, BIOCHIMIE, V84, P223, DOI 10.1016/S0300-9084(02)01372-X; Chin PC, 2005, MOL BRAIN RES, V137, P193, DOI 10.1016/j.molbrainres.2005.03.004; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P107, DOI 10.2174/156720206776875830; Chung H, 2008, J ENDOCRINOL, V198, P511, DOI 10.1677/JOE-08-0160; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Coultas L, 2007, J CELL SCI, V120, P2044, DOI 10.1242/jcs.002063; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Cregan SP, 2000, GENE THER, V7, P1200, DOI 10.1038/sj.gt.3301208; Cregan SP, 2004, J NEUROSCI, V24, P10003, DOI 10.1523/JNEUROSCI.2114-04.2004; Cregan SP, 1999, J NEUROSCI, V19, P7860; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; DEL PL, 1997, SCIENCE, V278, P687; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eilers A, 2001, J NEUROCHEM, V76, P1439, DOI 10.1046/j.1471-4159.2001.00150.x; Eilers A, 1998, J NEUROSCI, V18, P1713; Engel T, 2010, FASEB J, V24, P853, DOI 10.1096/fj.09-145870; Enguita M, 2005, MOL PHARMACOL, V67, P1237, DOI 10.1124/mol.104.007062; Enokido Y, 1996, EUR J NEUROSCI, V8, P1812, DOI 10.1111/j.1460-9568.1996.tb01325.x; Eom TY, 2007, J BIOL CHEM, V282, P22856, DOI 10.1074/jbc.M702973200; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; Fricker M, 2010, J NEUROCHEM, V114, P772, DOI 10.1111/j.1471-4159.2010.06804.x; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Harris CA, 2001, J BIOL CHEM, V276, P37754; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hetman M, 2000, J NEUROSCI, V20, P2567; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Lee JE, 2011, TOXICOL LETT, V202, P133, DOI 10.1016/j.toxlet.2011.01.030; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Linseman DA, 2002, J NEUROSCI, V22, P9287; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Mei Y, 2008, NEUROSCIENCE, V151, P771, DOI 10.1016/j.neuroscience.2007.10.057; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Mielke K, 1999, NEUROSCIENCE, V91, P471, DOI 10.1016/S0306-4522(98)00667-8; Miller TM, 1997, J BIOL CHEM, V272, P9847; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Mochizuki H, 1996, J NEUROL SCI, V137, P120, DOI 10.1016/0022-510X(95)00336-Z; Namikawa K, 2000, J NEUROSCI, V20, P2875; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Schulz JB, 1996, J NEUROSCI, V16, P4696; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Smith MI, 2007, CELL DEATH DIFFER, V14, P1011, DOI 10.1038/sj.cdd.4402089; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; Tuffy LP, 2010, MOL CELL BIOL, V30, P5484, DOI 10.1128/MCB.00575-10; Uo T, 2007, J NEUROSCI, V27, P12198, DOI 10.1523/JNEUROSCI.3222-05.2007; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Watson A, 1998, J NEUROSCI, V18, P751; White FA, 1998, J NEUROSCI, V18, P1428; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wyttenbach A, 2006, J NEUROCHEM, V96, P1213, DOI 10.1111/j.1471-4159.2005.03676.x; Xiang H, 1998, J NEUROSCI, V18, P1363; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	90	72	74	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46885	10.1371/journal.pone.0046885	http://dx.doi.org/10.1371/journal.pone.0046885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056511	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000099
J	Kato, H; Liao, ZJ; Mitsios, JV; Wang, HY; Deryugina, EI; Varner, JA; Quigley, JP; Shattil, SJ				Kato, Hisashi; Liao, Zhongji; Mitsios, John V.; Wang, Huan-You; Deryugina, Elena I.; Varner, Judith A.; Quigley, James P.; Shattil, Sanford J.			The Primacy of beta 1 Integrin Activation in the Metastatic Cascade	PLOS ONE			English	Article							CELL LUNG-CANCER; BREAST-CARCINOMA CELLS; LYMPH-NODE METASTASIS; INTEGRIN ACTIVATION; TUMOR PROGRESSION; IN-VIVO; IMMUNOHISTOCHEMICAL EXPRESSION; ALPHA(2)BETA(1) INTEGRIN; MONOCLONAL-ANTIBODY; DECREASED SURVIVAL	After neoplastic cells leave the primary tumor and circulate, they may extravasate from the vasculature and colonize tissues to form metastases. beta 1 integrins play diverse roles in tumorigenesis and tumor progression, including extravasation. In blood cells, activation of beta 1 integrins can be regulated by "inside-out'' signals leading to extravasation from the circulation into tissues. However, a role for inside-out beta 1 activation in tumor cell metastasis is uncertain. Here we show that beta 1 integrin activation promotes tumor metastasis and that activated beta 1 integrin may serve as a biomarker of metastatic human melanoma. To determine whether beta 1 integrin activation can influence tumor cell metastasis, the beta 1 integrin subunit in melanoma and breast cancer cell lines was stably knocked down with shRNA and replaced with wild-type or constitutivelyactive beta 1. When tumor cells expressing constitutively-active beta 1 integrins were injected intravenously into chick embryos or mice, they demonstrated increased colonization of the liver when compared to cells expressing wild-type beta 1 integrins. Rescue expression with mutant beta 1 integrins revealed that tumor cell extravasation and hepatic colonization required extracellular ligand binding to beta 1 as well as beta 1 interaction with talin, an intracellular mediator of integrin activation by the Rap1 GTPase. Furthermore, shRNA-mediated knock down of talin reduced hepatic colonization by tumor cells expressing wild-type beta 1, but not constitutively-active beta 1. Overexpression in tumor cells of the tumor suppressor, Rap1GAP, inhibited Rap1 and beta 1 integrin activation as well as hepatic colonization. Using an antibody that detects activated beta 1 integrin, we found higher levels of activated beta 1 integrins in human metastatic melanomas compared to primary melanomas, suggesting that activated beta 1 integrin may serve as a biomarker of invasive tumor cells. Altogether, these studies establish that insideout activation of beta 1 integrins promotes tumor cell extravasation and colonization, suggesting diagnostic and therapeutic approaches for targeting of beta 1 integrin signaling in neoplasia.	[Kato, Hisashi; Liao, Zhongji; Mitsios, John V.; Varner, Judith A.; Shattil, Sanford J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Wang, Huan-You] Univ Calif San Diego, Dept Pathol, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Deryugina, Elena I.; Quigley, James P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Shattil, SJ (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	sshattil@ucsd.edu		Varner, Judith/0000-0002-9251-0600	 [NIH HL56595];  [NIH CA126820];  [NIH CA129484];  [NIH CA105412]; NATIONAL CANCER INSTITUTE [R01CA167426, R01CA129484, R01CA105412, R01CA126820] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by NIH HL56595, NIH CA126820, NIH CA129484, NIH CA105412. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2000, CLIN CANCER RES, V6, P96; An ZW, 2010, INT J CANCER, V127, P1999, DOI 10.1002/ijc.25223; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Barkan D, 2011, CLIN CANCER RES, V17, P7219, DOI 10.1158/1078-0432.CCR-11-0642; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bottger TC, 1999, ONCOLOGY-BASEL, V56, P308, DOI 10.1159/000011984; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; DANEN EHJ, 1994, HISTOPATHOLOGY, V24, P249, DOI 10.1111/j.1365-2559.1994.tb00517.x; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Freeman SA, 2010, CANCER RES, V70, P4590, DOI 10.1158/0008-5472.CAN-09-3414; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Han JY, 2003, LUNG CANCER-J IASLC, V41, P65, DOI 10.1016/S0169-5002(03)00146-6; Hernandez-Varas P, 2011, J BIOL CHEM, V286, P18492, DOI 10.1074/jbc.M110.189811; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jung SM, 2000, J BIOL CHEM, V275, P8016, DOI 10.1074/jbc.275.11.8016; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Lonsdorf AS, 2012, J BIOL CHEM, V287, P2168, DOI 10.1074/jbc.M111.269811; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; NATALI PG, 1993, INT J CANCER, V54, P68, DOI 10.1002/ijc.2910540112; Nevo J, 2010, ONCOGENE, V29, P6452, DOI 10.1038/onc.2010.376; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nieswandt B, 1999, CANCER RES, V59, P1295; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Nikkola J, 2004, MELANOMA RES, V14, P29, DOI 10.1097/01.cmr.0000114662.02608.a5; Oshita F, 2004, AM J CLIN ONCOL-CANC, V27, P215, DOI 10.1097/01.COC.0000054894.64867.80; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pellinen T, 2012, J CELL SCI, V125, P649, DOI 10.1242/jcs.090704; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Petrich BG, 2009, THROMB HAEMOSTASIS, V101, P1020, DOI 10.1160/TH08-08-0553; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shen ZL, 2012, AM J SURG, V203, P222, DOI 10.1016/j.amjsurg.2011.06.050; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; SIMS PJ, 1991, J BIOL CHEM, V266, P7345; Sin S, 2011, J NATL CANCER I, V103, P1323, DOI 10.1093/jnci/djr290; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAKADA Y, 1992, J CELL BIOL, V119, P913, DOI 10.1083/jcb.119.4.913; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vuoristo M, 2007, MELANOMA RES, V17, P215, DOI 10.1097/CMR.0b013e328270b935; Wang H, 2004, J CELL BIOL, V164, P935, DOI 10.1083/jcb.200309112; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wewer UM, 1997, AM J PATHOL, V151, P1191; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; ZUTTER MM, 1995, P NATL ACAD SCI USA, V92, P7411, DOI 10.1073/pnas.92.16.7411	76	48	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46576	10.1371/journal.pone.0046576	http://dx.doi.org/10.1371/journal.pone.0046576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056350	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000057
J	Song, Y; Fang, GD; Shen, HT; Li, H; Yang, WB; Pan, B; Huang, GW; Lin, GY; Ma, L; Willard, B; Gu, J; Zheng, LM; Wang, YY				Song, Yi; Fang, Guodong; Shen, Haitao; Li, Hui; Yang, Wenbing; Pan, Bing; Huang, Guowei; Lin, Guangyu; Ma, Lian; Willard, Belinda; Gu, Jiang; Zheng, Lemin; Wang, Yongyu			Human Surfactant Protein A2 Gene Mutations Impair Dimmer/Trimer Assembly Leading to Deficiency in Protein Sialylation and Secretion	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PRIMARY TRANSLATION PRODUCTS; BRONCHOALVEOLAR LAVAGE; PULMONARY-FIBROSIS; GLYCOPROTEIN-A; DEGRADATION; DOMAIN; DISEASE; LUNG; GLYCOSYLATION	Surfactant protein A2 (SP-A2) plays an essential role in surfactant metabolism and lung host defense. SP-A2 mutations in the carbohydrate recognition domain have been related to familial pulmonary fibrosis and can lead to a recombinant protein secretion deficiency in vitro. In this study, we explored the molecular mechanism of protein secretion deficiency and the subsequent biological effects in CHO-K1 cells expressing both wild-type and several different mutant forms of SP-A2. We demonstrate that the SP-A2 G231V and F198S mutants impair the formation of dimmer/trimer SP-A2 which contributes to the protein secretion defect. A deficiency in sialylation, but not N-linked glycosylation, is critical to the observed dimmer/trimer impairment-induced secretion defect. Furthermore, both mutant forms accumulate in the ER and form NP-40-insoluble aggregates. In addition, the soluble mutant SP-A2 could be partially degraded through the proteasome pathway but not the lysosome or autophagy pathway. Intriguingly, 4-phenylbutyrate acid (4-PBA), a chemical chaperone, alleviates aggregate formation and partially rescued the protein secretion of SP-A2 mutants. In conclusion, SP-A2 G231V and F198S mutants impair the dimmer/trimer assembly, which contributes to the protein sialylation and secretion deficiency. The intracellular protein mutants could be partially degraded through the proteasome pathway and also formed aggregates. The treatment of the cells with 4-PBA resulted in reduced aggregation and rescued the secretion of mutant SP-A2.	[Pan, Bing; Zheng, Lemin] Peking Univ Hlth Sci Ctr, Key Lab Mol Cardiovasc Sci, Educ Minist, Inst Cardiovasc Sci,Sch Basic Med Sci, Beijing, Peoples R China; [Pan, Bing; Zheng, Lemin] Peking Univ Hlth Sci Ctr, Key Lab Mol Cardiovasc Sci, Educ Minist, Inst Syst Biomed,Sch Basic Med Sci, Beijing, Peoples R China; [Pan, Bing; Zheng, Lemin] Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Beijing, Peoples R China; [Willard, Belinda] Cleveland Clin, Prote Lab, Cleveland, OH 44106 USA; [Song, Yi; Fang, Guodong; Shen, Haitao; Li, Hui; Yang, Wenbing; Huang, Guowei; Gu, Jiang; Wang, Yongyu] Shantou Univ Med Coll, Dept Pathol, Shantou, Guangdong, Peoples R China; [Lin, Guangyu; Ma, Lian] Shantou Univ Med Coll, Affiliated Hosp 2, Dept Pediat, Shantou, Guangdong, Peoples R China; [Lin, Guangyu; Ma, Lian] Shantou Univ Med Coll, Affiliated Hosp 2, Translat Med Ctr, Shantou, Guangdong, Peoples R China	Peking University; Peking University; Cleveland Clinic Foundation	Zheng, LM (corresponding author), Peking Univ Hlth Sci Ctr, Key Lab Mol Cardiovasc Sci, Educ Minist, Inst Cardiovasc Sci,Sch Basic Med Sci, Beijing, Peoples R China.	zhengl@bjmu.edu.cn; yywangut@gmail.com	Yang, Wenbing/AAH-5134-2021; fang, guodong/E-4809-2013; Wang, Yongyu/F-9039-2011	Wang, Yongyu/0000-0002-8804-3472; Wang, Yongyu/0000-0002-6088-8887; Gu, Jiang/0000-0002-0706-8329	Key Project of Chinese Ministry of Education [210159]; Introduction of Talents Program of Institutions of Higher Education of Guangdong Province; "973'' National ST Major Project [2010CB912504, 2011CB503900]; National Natural Science Foundation of China [30900595, 81170101]	Key Project of Chinese Ministry of Education(Ministry of Education, China); Introduction of Talents Program of Institutions of Higher Education of Guangdong Province; "973'' National ST Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Project of Chinese Ministry of Education (210159), the Introduction of Talents Program of Institutions of Higher Education of Guangdong Province (http://www.gdhed.edu.cn), "973'' National S&T Major Project (2010CB912504, 2011CB503900) and the National Natural Science Foundation of China(30900595, 81170101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2007, ANAL BIOANAL CHEM, V389, P1075, DOI 10.1007/s00216-007-1403-z; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Berg T, 2000, BBA-PROTEIN STRUCT M, V1543, P159, DOI 10.1016/S0167-4838(00)00184-9; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Floros J, 2009, CRIT REV EUKAR GENE, V19, P125, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.30; Gao EW, 1996, AM J PHYSIOL-LUNG C, V271, pL617, DOI 10.1152/ajplung.1996.271.4.L617; Garcia-Verdugo I, 2003, BIOCHEMISTRY-US, V42, P9532, DOI 10.1021/bi0347196; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Kuroki Y, 1998, BBA-MOL BASIS DIS, V1408, P334, DOI 10.1016/S0925-4439(98)00079-9; LeVine AM, 1997, J IMMUNOL, V158, P4336; Maitra M, 2010, J BIOL CHEM, V285, P22103, DOI 10.1074/jbc.M110.121467; MCCORMACK FX, 1991, AM REV RESPIR DIS, V144, P160, DOI 10.1164/ajrccm/144.1.160; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; McCormack FX, 1999, J BIOL CHEM, V274, P3173, DOI 10.1074/jbc.274.5.3173; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Mulugeta S, 2007, AM J PHYSIOL-LUNG C, V293, pL720, DOI 10.1152/ajplung.00025.2007; OREILLY MA, 1988, BIOCHIM BIOPHYS ACTA, V969, P176, DOI 10.1016/0167-4889(88)90073-0; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sorensen GL, 2007, IMMUNOBIOLOGY, V212, P381, DOI 10.1016/j.imbio.2007.01.003; SPISSINGER T, 1991, EUR J BIOCHEM, V199, P65, DOI 10.1111/j.1432-1033.1991.tb16092.x; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; WEAVER TE, 1986, BIOCHIM BIOPHYS ACTA, V869, P330, DOI 10.1016/0167-4838(86)90073-7; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0; WHITSETT JA, 1985, J BIOL CHEM, V260, P5273; WHITSETT JA, 1985, BIOCHIM BIOPHYS ACTA, V828, P162, DOI 10.1016/0167-4838(85)90053-6; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Zeitlin Pamela L., 2003, American Journal of Respiratory Cell and Molecular Biology, V29, P642, DOI 10.1165/rcmb.2002-0200WS; Zhang PN, 2001, J BIOL CHEM, V276, P19862, DOI 10.1074/jbc.M100597200	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46559	10.1371/journal.pone.0046559	http://dx.doi.org/10.1371/journal.pone.0046559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056344	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000055
J	Vannucci, FA; Foster, DN; Gebhart, CJ				Vannucci, Fabio A.; Foster, Douglas N.; Gebhart, Connie J.			Comparative Transcriptional Analysis of Homologous Pathogenic and Non-Pathogenic Lawsonia intracellularis Isolates in Infected Porcine Cells	PLOS ONE			English	Article							III SECRETION SYSTEM; ACID STRESS RESPONSES; PROLIFERATIVE ENTEROPATHY; SALMONELLA-TYPHIMURIUM; LISTERIA-MONOCYTOGENES; SYMBIONT INTRACELLULARIS; BORDETELLA-PERTUSSIS; EXPRESSION; VIRULENCE; PPGPP	Lawsonia intracellularis is the causative agent of proliferative enteropathy. This disease affects various animal species, including nonhuman primates, has been endemic in pigs, and is an emerging concern in horses. Non-pathogenic variants obtained through multiple passages in vitro do not induce disease, but bacterial isolates at low passage induce clinical and pathological changes. We hypothesize that genes differentially expressed between pathogenic (passage 10) and nonpathogenic (passage 60) L. intracellularis isolates encode potential bacterial virulence factors. The present study used high-throughput sequencing technology to characterize the transcriptional profiling of a pathogenic and a non-pathogenic homologous L. intracellularis variant during in vitro infection. A total of 401 genes were exclusively expressed by the pathogenic variant. Plasmid-encoded genes and those involved in membrane transporter (e.g. ATP-binding cassette), adaptation and stress response (e. g. transcriptional regulators) were the categories mostly responsible for this wider transcriptional landscape. The entire gene repertoire of plasmid A was repressed in the non-pathogenic variant suggesting its relevant role in the virulence phenotype of the pathogenic variant. Of the 319 genes which were commonly expressed in both pathogenic and non-pathogenic variants, no significant difference was observed by comparing their normalized transcription levels (fold change +/- 2; p<0.05). Unexpectedly, these genes demonstrated a positive correlation (r(2) = 0.81; p<0.05), indicating the involvement of gene silencing (switching off) mechanisms to attenuate virulence properties of the pathogenic variant during multiple cell passages. Following the validation of these results by reverse transcriptase-quantitative PCR using ten selected genes, the present study represents the first report characterizing the transcriptional profile of L. intracellularis. The complexity of the virulence phenotype was demonstrated by the diversity of genes exclusively expressed in the pathogenic isolate. The results support our hypothesis and provide the basis for prospective mechanistic studies regarding specific roles of target genes involved in the pathogenesis, diagnosis and control of proliferative enteropathy.	[Vannucci, Fabio A.; Gebhart, Connie J.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Foster, Douglas N.] Univ Minnesota, Dept Anim Sci, Coll Food Agr & Nat Resource Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Vannucci, FA (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	vannu008@umn.edu			Swine Disease Eradication Center of the College of Veterinary Medicine - University of Minnesota; Emerging and Zoonotic Diseases Mentored Funding Research of the College of Veterinary Medicine - University of Minnesota; Brazilian government agency "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico''	Swine Disease Eradication Center of the College of Veterinary Medicine - University of Minnesota; Emerging and Zoonotic Diseases Mentored Funding Research of the College of Veterinary Medicine - University of Minnesota; Brazilian government agency "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico''	Funding provided by Swine Disease Eradication Center of the College of Veterinary Medicine - University of Minnesota, Emerging and Zoonotic Diseases Mentored Funding Research of the College of Veterinary Medicine - University of Minnesota and Brazilian government agency "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Alarcon-Chaidez FJ, 2003, PLASMID, V49, P106, DOI 10.1016/S0147-619X(02)00155-5; Alberdi MP, 2009, VET MICROBIOL, V139, P298, DOI 10.1016/j.vetmic.2009.06.022; Beckler DC, 2004, MOL EPIDEMIOLOGIC TY, P124; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bender KS, 2007, APPL ENVIRON MICROB, V73, P5389, DOI 10.1128/AEM.00276-07; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; BERSCHNEIDER H M, 1989, Gastroenterology, V96, pA41; Biester HE, 1931, AM J PATHOL, V7, P175; Biskup UG, 2011, PLASMID, V66, P1, DOI 10.1016/j.plasmid.2011.02.006; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bobat S, 2011, EUR J IMMUNOL, V41, P1606, DOI 10.1002/eji.201041089; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Cooper DM, 1997, VET MICROBIOL, V54, P47, DOI 10.1016/S0378-1135(96)01264-3; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Evans J, 2011, PARLIAMENT AFF, V64, P1, DOI 10.1093/pa/gsq048; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fennelly NK, 2008, INFECT IMMUN, V76, P1257, DOI 10.1128/IAI.00836-07; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Fux CA, 2005, TRENDS MICROBIOL, V13, P58, DOI 10.1016/j.tim.2004.11.001; Gahan CGM, 1999, INT J FOOD MICROBIOL, V50, P93, DOI 10.1016/S0168-1605(99)00079-3; Gaillard ME, 2011, INFECT IMMUN, V79, P3677, DOI 10.1128/IAI.00136-11; Gebhart CJ, 2010, PATHOGENESIS BACTERI, P503; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Glockner G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-211; Guedes RMC, 2003, J VET DIAGN INVEST, V15, P438, DOI 10.1177/104063870301500506; Guedes RMC, 2003, VET MICROBIOL, V91, P135, DOI 10.1016/S0378-1135(02)00301-2; Guedes RMC, 2002, J VET DIAGN INVEST, V14, P528, DOI 10.1177/104063870201400618; Hartel T, 2011, INFECT IMMUN, V79, P44, DOI 10.1128/IAI.00855-10; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Heuston S, 2012, MICROBIOLOGY; Isabella VM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-51; Jacobson M, 2010, VET J, V184, P264, DOI 10.1016/j.tvjl.2009.05.010; Jain V, 2006, J MICROBIOL, V44, P1; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Kelley MF, 2010, MULTILOCUS SEQUENCIN; Klose KE, 1997, INFECT IMMUN, V65, P587, DOI 10.1128/IAI.65.2.587-596.1997; Knittel JP, 1999, US Patent, Patent No. [C12N 1/20, 120]; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; La MV, 2008, FEMS MICROBIOL REV, V32, P440, DOI 10.1111/j.1574-6976.2008.00103.x; Lafortune M, 2004, J ZOO WILDLIFE MED, V35, P549, DOI 10.1638/03-080; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAWSON GHK, 1993, J CLIN MICROBIOL, V31, P1136, DOI 10.1128/JCM.31.5.1136-1142.1993; Lawson GHK, 2000, J COMP PATHOL, V122, P77, DOI 10.1053/jcpa.1999.0347; Lumppio HL, 2001, J BACTERIOL, V183, P101, DOI 10.1128/JB.183.1.101-108.2001; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McGurrin MKJ, 2007, CAN VET J, V48, P927; McLaughlin HP, 2011, CURR OPIN BIOTECH, V22, P194, DOI 10.1016/j.copbio.2010.10.005; MCORIST S, 1995, J CLIN MICROBIOL, V33, P1314, DOI 10.1128/JCM.33.5.1314-1317.1995; McOrist S, 1996, J COMP PATHOL, V115, P35, DOI 10.1016/S0021-9975(96)80026-0; MCORIST S, 1995, INT J SYST BACTERIOL, V45, P820, DOI 10.1099/00207713-45-4-820; MCORIST S, 1995, RES VET SCI, V59, P255, DOI 10.1016/0034-5288(95)90013-6; McOrist S, 1997, VET MICROBIOL, V54, P385, DOI 10.1016/S0378-1135(96)01283-7; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Obiol-Pardo C, 2011, CURR MED CHEM, V18, P1325, DOI 10.2174/092986711795029582; Oliveira AR, 2008, DIFFERENTIATION LAWS; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Oyakhirome S, 2007, ANTIMICROB AGENTS CH, V51, P1869, DOI 10.1128/AAC.01448-06; Palyada K, 2004, J BACTERIOL, V186, P4714, DOI 10.1128/JB.186.14.4714-4729.2004; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Pusterla N, 2009, EQUINE VET EDUC, V21, P415, DOI 10.2746/095777309X453119; Pusterla N, 2009, VET MICROBIOL, V136, P173, DOI 10.1016/j.vetmic.2008.10.004; Rea RB, 2004, INFECT IMMUN, V72, P717, DOI 10.1128/IAI.72.2.717-727.2004; Ryan S, 2008, ADV APPL MICROBIOL, V65, P67, DOI 10.1016/S0065-2164(08)00603-5; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Schmitz-Esser S, 2008, J BACTERIOL, V190, P5746, DOI 10.1128/JB.00391-08; SHEPHERD N, 1980, J BACTERIOL, V143, P1332, DOI 10.1128/JB.143.3.1332-1344.1980; Stintzi A, 2005, INFECT IMMUN, V73, P1797, DOI 10.1128/IAI.73.3.1797-1810.2005; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vannucci FA, 2012, VET MICROBI IN PRESS; Vannucci FA, 2012, J CLIN MICROBIOL, V50, P1070, DOI 10.1128/JCM.05976-11; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006; Watson E, 2011, CLIN VACCINE IMMUNOL; Wattanaphansak S, 2009, VET MICROBIOL, V134, P305, DOI 10.1016/j.vetmic.2008.08.007; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zhu L, 2010, J PROTEOME RES, V9, P843, DOI 10.1021/pr9007514	90	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46708	10.1371/journal.pone.0046708	http://dx.doi.org/10.1371/journal.pone.0046708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056413	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000078
J	Wilson, MD; Saponaro, M; Leidl, MA; Svejstrup, JQ				Wilson, Marcus D.; Saponaro, Marco; Leidl, Mathias A.; Svejstrup, Jesper Q.			MultiDsk: A Ubiquitin-Specific Affinity Resin	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ARREST; POLYUBIQUITIN CHAIN; BINDING DOMAINS; DNA-DAMAGE; UBA DOMAIN; PROTEINS; REPAIR; UBIQUITYLATION; PURIFICATION	Ubiquitylation is a highly diverse and complex post-translational modification for the regulation of protein function and stability. Studies of ubiquitylation have, however, been hampered by its rapid reversal in cell extracts, for example through the action of de-ubiquitylating enzymes (DUBs). Here we describe a novel ubiquitin-binding protein reagent, MultiDsk, composed of an array of five UBA domains from the yeast ubiquitin-binding protein Dsk2, fused to GST. MultiDsk binds ubiquitylated substrates with unprecedented avidity, and can be used as both an affinity resin to study protein ubiquitylation, and to effectively protect ubiquitylated proteins from the action of DUBs and the proteasome in crude cell extracts. We use the resin to show that the Def1 protein becomes ubiquitylated in response to DNA damage, and to isolate ubiquitylated forms of RNA polymerase II.	[Wilson, Marcus D.; Saponaro, Marco; Leidl, Mathias A.; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, Potters Bar, Herts, England	Cancer Research UK	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, Potters Bar, Herts, England.	jesper.svejstrup@cancer.org.uk	Saponaro, Marco/M-1854-2015	Saponaro, Marco/0000-0002-9302-2553; Svejstrup, Jesper/0000-0003-4964-6147; Wilson, Marcus/0000-0001-9551-5514	Cancer Research UK; Association for International Cancer Research (AICR); European Research council (ERC); Cancer Research UK [11567] Funding Source: researchfish; Worldwide Cancer Research [09-0730] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Association for International Cancer Research (AICR); European Research council (ERC)(European Research Council (ERC)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	This work was supported by grants from Cancer Research UK, Association for International Cancer Research (AICR), and European Research council (ERC) (to J.Q.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; HERSHKO A, 1982, J BIOL CHEM, V257, P3964; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kang Y, 2007, J MOL BIOL, V365, P1093, DOI 10.1016/j.jmb.2006.10.056; Layfield R, 2001, PROTEOMICS, V1, P773, DOI 10.1002/1615-9861(200106)1:6<773::AID-PROT773>3.0.CO;2-0; Nagy V, 2010, BIOL CHEM, V391, P163, DOI 10.1515/bc.2010.021; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Panier S, 2012, MOL CELL; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Svejstrup JQ, 2007, TRENDS BIOCHEM SCI, V32, P165, DOI 10.1016/j.tibs.2007.02.005; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012	31	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46398	10.1371/journal.pone.0046398	http://dx.doi.org/10.1371/journal.pone.0046398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056298	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000037
J	Watsuji, TO; Nishizawa, M; Morono, Y; Hirayama, H; Kawagucci, S; Takahata, N; Sano, Y; Takai, K				Watsuji, Tomo-o; Nishizawa, Manabu; Morono, Yuki; Hirayama, Hisako; Kawagucci, Shinsuke; Takahata, Naoto; Sano, Yuji; Takai, Ken			Cell-Specific Thioautotrophic Productivity of Epsilon-Proteobacterial Epibionts Associated with Shinkaia crosnieri	PLOS ONE			English	Article							DIVERSITY; CARBON; CRAB	In this study, we report experimental evidence of the thioautotrophic activity of the epibiotic microbial community associated with the setae of Shinkaia crosnieri, a galatheid crab that is endemic to deep-sea hydrothermal systems in the Okinawa Trough in Japan. Microbial consumption of reduced sulfur compounds under in situ hydrostatic and atmospheric pressure provided evidence of sulfur-oxidizing activity by the epibiotic microbial community; the rate of sulfur oxidation was similar under in situ and decompressed conditions. Results of the microbial consumption of reduced sulfur compounds and tracer experiments using C-13-labeled bicarbonate in the presence and absence of thiosulfate (used as a thioautotrophic substrate) convincingly demonstrated that the epibiotic microbial community on S. crosnieri drove primary production via an energy metabolism that was coupled with the oxidation of reductive sulfur compounds. A combination of tracer experiments, fluorescence in situ hybridization (FISH) and nano-scale secondary ion mass spectrometry (Nano-SIMS) indicated that the filamentous cells of the genus Sulfurovum belonging to the class Epsilonproteobacteria were thioautotrophs in the epibiotic community of S. crosnieri. In conclusion, our results strongly suggest that thioautotrophic production by Sulfurovum members present as the epibiotic microbial community play a predominant role in a probable nutritional ectosymbiosis with S. crosnieri.	[Watsuji, Tomo-o; Hirayama, Hisako; Kawagucci, Shinsuke; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Subsurface Geobiol Adv Res Team SUGAR, Extremobiosphere Res Program XBR, Inst Biogeosci, Yokosuka, Kanagawa, Japan; [Nishizawa, Manabu] JAMSTEC, Precambrian Ecosyst Lab, Yokosuka, Kanagawa, Japan; [Morono, Yuki] JAMSTEC, Geomicrobiol Grp, Kochi Inst Core Sample Res, Nankoku, Kochi, Japan; [Takahata, Naoto; Sano, Yuji] Univ Tokyo, Atomosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tokyo	Watsuji, TO (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Subsurface Geobiol Adv Res Team SUGAR, Extremobiosphere Res Program XBR, Inst Biogeosci, Yokosuka, Kanagawa, Japan.	watsuji@jamstec.go.jp	Sano, Yuji/B-8971-2015; Kawagucci, Shinsuke/O-7813-2019; Takahata, Naoto/AAF-5161-2019; kawagucci, shinsuke/H-6047-2013; , 西澤学/M-9598-2016; Kawagucci, Shinsuke/H-4192-2013	Sano, Yuji/0000-0002-3305-5644; kawagucci, shinsuke/0000-0002-7807-024X; , 西澤学/0000-0002-6467-670X; Morono, Yuki/0000-0001-8928-4254	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20109005, 21244077]; Japan Agency for Marine-Earth Science and Technology (JAMSTEC)	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Marine-Earth Science and Technology (JAMSTEC)	This work was supported by a Grant-in-Aid for Science Research (Nos. 20109005 and 21244077 to K. Takai) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and by a grant from the Japan Agency for Marine-Earth Science and Technology (JAMSTEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell BJ, 2003, APPL ENVIRON MICROB, V69, P5070, DOI 10.1128/AEM.69.9.5070-5078.2003; Cary SC, 1997, APPL ENVIRON MICROB, V63, P1124, DOI 10.1128/AEM.63.3.1124-1130.1997; Dattagupta S, 2009, ISME J, V3, P935, DOI 10.1038/ismej.2009.34; Floss C, 2004, SCIENCE, V303, P1355, DOI 10.1126/science.1093283; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Goffredi SK, 2008, ENVIRON MICROBIOL, V10, P2623, DOI 10.1111/j.1462-2920.2008.01684.x; Goffredi SK, 2004, APPL ENVIRON MICROB, V70, P3082, DOI 10.1128/AEM.70.5.3082-3090.2004; Grzymski JJ, 2008, P NATL ACAD SCI USA, V105, P17516, DOI 10.1073/pnas.0802782105; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Kawagucci S, 2011, GEOCHEM J, V45, P109; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Takai K, 2009, ENVIRON MICROBIOL, V11, P1983, DOI 10.1111/j.1462-2920.2009.01921.x; Watsuji T, 2010, MICROBES ENVIRON, V25, P288, DOI 10.1264/jsme2.ME10135; WIRSEN CO, 1993, J GEOPHYS RES-SOL EA, V98, P9693, DOI 10.1029/92JB01556; Yamamoto M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00192; Yamamoto M, 2010, ENVIRON MICROBIOL, V12, P1144, DOI 10.1111/j.1462-2920.2010.02155.x; Zbinden M, 2008, J EXP MAR BIOL ECOL, V359, P131, DOI 10.1016/j.jembe.2008.03.009	20	20	20	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46282	10.1371/journal.pone.0046282	http://dx.doi.org/10.1371/journal.pone.0046282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056274	gold, Green Submitted, Green Published			2022-12-27	WOS:000309452600032
J	Macedo, GS; da Motta, LL; Giacomazzi, J; Netto, CBO; Manfredini, V; Vanzin, CS; Vargas, CR; Hainaut, P; Klamt, F; Ashton-Prolla, P				Macedo, Gabriel S.; da Motta, Leonardo Lisboa; Giacomazzi, Juliana; Netto, Cristina B. O.; Manfredini, Vanusa; Vanzin, Camila S.; Vargas, Carmen Regla; Hainaut, Pierre; Klamt, Fabio; Ashton-Prolla, Patricia			Increased Oxidative Damage in Carriers of the Germline TP53 p.R337H Mutation	PLOS ONE			English	Article							LI-FRAUMENI; BREAST-CANCER; DNA-DAMAGE; P53; PROTEIN; GENE; STRESS; R337H; ACID	Germline mutations in TP53 are the underlying defect of Li-Fraumeni Syndrome (LFS) and Li-Fraumeni-like (LFL) Syndrome, autosomal dominant disorders characterized by predisposition to multiple early onset cancers. In Brazil, a variant form of LFS/LFL is commonly detected because of the high prevalence of a founder mutation at codon 337 in TP53 (p.R337H). The p53 protein exerts multiple roles in the regulation of oxidative metabolism and cellular anti-oxidant defense systems. Herein, we analyzed the redox parameters in blood samples from p.R337H mutation carriers (C, n = 17) and non-carriers (NC, n = 17). We identified a significant increase in erythrocyte GPx activity and in plasma carbonyl content, an indicator of protein oxidative damage, in mutation carriers compared to non-carriers (P = 0.048 and P = 0.035, respectively). Mutation carriers also showed a four-fold increase in plasma malondialdehyde levels, indicating increased lipid peroxidation (NC = 40.20 +/- 0.71, C = 160.5 +/- 0.88, P<0.0001). Finally, carriers showed increased total antioxidant status but a decrease in plasma ascorbic acid content. The observed imbalance could be associated with deregulated cell bioenergetics and/or with increased inflammatory stress, two effects that may result from loss of wild-type p53 function. These findings provide the first evidence that oxidative damage occurs in carriers of a germline TP53 mutation, and these may have important implications regarding our understanding of the mechanisms responsible for germline TP53 p.R337H mutation-associated carcinogenesis.	[Macedo, Gabriel S.; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Macedo, Gabriel S.; Giacomazzi, Juliana] HCPA, Lab Med Genom, Porto Alegre, RS, Brazil; [da Motta, Leonardo Lisboa; Vanzin, Camila S.; Vargas, Carmen Regla; Klamt, Fabio] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Biol Biquim, Porto Alegre, RS, Brazil; [da Motta, Leonardo Lisboa; Klamt, Fabio] Inst Nacionais Ciencia & Tecnol Translac Med MCT, Porto Alegre, RS, Brazil; [da Motta, Leonardo Lisboa; Klamt, Fabio] Rede Gaucha Estresse Oxidat & Sinalizacao Celular, Porto Alegre, RS, Brazil; [Giacomazzi, Juliana; Klamt, Fabio; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Med Med, Porto Alegre, RS, Brazil; [Netto, Cristina B. O.; Vanzin, Camila S.; Vargas, Carmen Regla; Ashton-Prolla, Patricia] HCPA, Serv Genet Med, Porto Alegre, RS, Brazil; [Manfredini, Vanusa] Univ Fed Pampa UNIPAMPA, Campus Uruguaiana, RS, Brazil; [Hainaut, Pierre] Int Prevent Res Inst, Lyon, France	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Pampa	Ashton-Prolla, P (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.	pprolla@hcpa.ufrgs.br	Macedo, Gabriel/T-3567-2019; Motta, Leonardo L/C-1551-2015; Hainaut, Pierre/B-6018-2012; Inagemp, Inct/J-9451-2013; Ashton-Prolla, Patricia/H-2927-2012; Ashton-Prolla, Patricia/T-3515-2019; Vargas, Carmen/W-9939-2019; Giacomazzi, Juliana/F-6629-2015	Macedo, Gabriel/0000-0002-8963-9577; Motta, Leonardo L/0000-0001-6364-5007; Hainaut, Pierre/0000-0002-1303-1610; Giacomazzi, Juliana/0000-0001-5811-5140	Brazilian CNPq [133439/2010-0]; Brazilian FAPERGS-PRONEX [10/0051-9]; Brazilian FIPE/HCPA; Brazilian MCT/CNPq INCT-TM [573671/2008-7]; Brazilian FAPERGS-PRONEX; GlaxoSmithKline	Brazilian CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian FAPERGS-PRONEX; Brazilian FIPE/HCPA; Brazilian MCT/CNPq INCT-TM(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Brazilian FAPERGS-PRONEX; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by Brazilian grants from CNPq (133439/2010-0), FAPERGS-PRONEX (10/0051-9), FIPE/HCPA, MCT/CNPq INCT-TM (573671/2008-7) and FAPERGS-PRONEX (10/0027-4). Initial steps in patient recruitment were funded, in part, by a grant from GlaxoSmithKline (2009 Ethnic Research Initiative Award to PA-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Assumpcao JG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-357; Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Garritano S, 2010, HUM MUTAT, V31, P143, DOI 10.1002/humu.21151; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; Hainaut P, 2002, NAT MED, V8, P21, DOI 10.1038/nm0102-21; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147; Halliwell B., 2001, FREE RADICALS BIOL M; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Karatepe M, 2004, LC GC N AM, V22, P362; Kotsopoulos J, 2008, CLIN BREAST CANCER, V8, P506, DOI 10.3816/CBC.2008.n.061; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Latronico AC, 2001, J CLIN ENDOCR METAB, V86, P4970, DOI 10.1210/jc.86.10.4970; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LI FP, 1988, CANCER RES, V48, P5358; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Olivier M, 2003, CANCER RES, V63, P6643; Palmero EI, 2008, CANCER LETT, V261, P21, DOI 10.1016/j.canlet.2007.10.044; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Tan MJ, 1999, J BIOL CHEM, V274, P12061, DOI 10.1074/jbc.274.17.12061; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Achatz MIW, 2007, CANCER LETT, V245, P96, DOI 10.1016/j.canlet.2005.12.039; Wendel A, 1981, Methods Enzymol, V77, P325; Wong P, 2006, GASTROENTEROLOGY, V130, P73, DOI 10.1053/j.gastro.2005.10.014; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3	39	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47010	10.1371/journal.pone.0047010	http://dx.doi.org/10.1371/journal.pone.0047010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056559	Green Submitted, gold, Green Published			2022-12-27	WOS:000309889400044
J	Nsair, A; Schenke-Layland, K; Van Handel, B; Evseenko, D; Kahn, M; Zhao, P; Mendelis, J; Heydarkhan, S; Awaji, O; Vottler, M; Geist, S; Chyu, J; Gago-Lopez, N; Crooks, GM; Plath, K; Goldhaber, J; Mikkola, HKA; MacLellan, WR				Nsair, Ali; Schenke-Layland, Katja; Van Handel, Ben; Evseenko, Denis; Kahn, Michael; Zhao, Peng; Mendelis, Joseph; Heydarkhan, Sanaz; Awaji, Obina; Vottler, Miriam; Geist, Susanne; Chyu, Jennifer; Gago-Lopez, Nuria; Crooks, Gay M.; Plath, Kathrin; Goldhaber, Josh; Mikkola, Hanna K. A.; MacLellan, W. Robb			Characterization and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE; CARDIAC MYOCYTES; MAMMALIAN HEART; NEURAL CREST; FIBROBLASTS; LINEAGES; MOUSE; CARDIOMYOCYTE; DIFFERENTIATION; POPULATION	Background: Cardiovascular progenitor cells (CPCs) have been identified within the developing mouse heart and differentiating pluripotent stem cells by intracellular transcription factors Nkx2.5 and Islet 1 (Isl1). Study of endogenous and induced pluripotent stem cell (iPSC)-derived CPCs has been limited due to the lack of specific cell surface markers to isolate them and conditions for their in vitro expansion that maintain their multipotency. Methodology/Principal Findings: We sought to identify specific cell surface markers that label endogenous embryonic CPCs and validated these markers in iPSC-derived Isl1(+)/Nkx2.5(+) CPCs. We developed conditions that allow propagation and characterization of endogenous and iPSC-derived Isl1(+)/Nkx2.5(+) CPCs and protocols for their clonal expansion in vitro and transplantation in vivo. Transcriptome analysis of CPCs from differentiating mouse embryonic stem cells identified a panel of surface markers. Comparison of these markers as well as previously described surface markers revealed the combination of Flt1(+)/Flt4(+) best identified and facilitated enrichment for Isl1(+)/Nkx2.5(+) CPCs from embryonic hearts and differentiating iPSCs. Endogenous mouse and iPSC-derived Flt1(+)/Flt4(+) CPCs differentiated into all three cardiovascular lineages in vitro. Flt1(+)/Flt4(+) CPCs transplanted into left ventricles demonstrated robust engraftment and differentiation into mature cardiomyocytes (CMs). Conclusion/Significance: The cell surface marker combination of Flt1 and Flt4 specifically identify and enrich for an endogenous and iPSC-derived Isl1(+)/Nkx2.5(+) CPC with trilineage cardiovascular potential in vitro and robust ability for engraftment and differentiation into morphologically and electrophysiologically mature adult CMs in vivo post transplantation into adult hearts.	[Nsair, Ali; Schenke-Layland, Katja; Zhao, Peng; Mendelis, Joseph; Heydarkhan, Sanaz; Awaji, Obina; Chyu, Jennifer; Gago-Lopez, Nuria] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Dept Physiol & Med, Los Angeles, CA 90095 USA; [Schenke-Layland, Katja; Vottler, Miriam; Geist, Susanne] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Dept Cell & Tissue Engn, Stuttgart, Germany; [Schenke-Layland, Katja; Vottler, Miriam; Geist, Susanne] Univ Tubingen, Dept Thorac & Cardiovasc Surg, Tubingen, Germany; [Evseenko, Denis; Crooks, Gay M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Van Handel, Ben; Mikkola, Hanna K. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Van Handel, Ben; Evseenko, Denis; Crooks, Gay M.; Plath, Kathrin; Mikkola, Hanna K. A.] Univ Calif Los Angeles, David Geffen Sch Med, Edythe & Eli Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Goldhaber, Josh] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Kahn, Michael] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Kahn, Michael] Univ So Calif, Inst Stem Cell & Regenerat Med, Los Angeles, CA USA; [MacLellan, W. Robb] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Fraunhofer Gesellschaft; Eberhard Karls University of Tubingen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of Southern California; University of Southern California; University of Washington; University of Washington Seattle	Nsair, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Dept Physiol & Med, Los Angeles, CA 90095 USA.	ansair@mednet.ucla.edu	Schenke-Layland, Katja/E-5940-2013; López, Nuria Gago/M-3300-2014	Schenke-Layland, Katja/0000-0001-8066-5157; López, Nuria Gago/0000-0001-8220-7467; Plath, Kathrin/0000-0001-7796-3372; Goldhaber, Joshua/0000-0001-8413-5719	National Institutes of Health [5T32HL007895-10, P01-HL080111, R0-HL094941]; Laubisch and Cardiovascular Development Funds; Ruth Kirschstein National Research Service Award [GM007185]; Alberta Heritage Foundation for Medical Research Fellowship (AHFMR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070748, R21HL094941, R01HL070828, P01HL080111, T32HL007895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR061415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laubisch and Cardiovascular Development Funds; Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Heritage Foundation for Medical Research Fellowship (AHFMR)(Alberta Heritage Foundation for Medical Research); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (5T32HL007895-10 to KS-L; P01-HL080111 and R0-HL094941 to WRM), Laubisch and Cardiovascular Development Funds (to WRM), Ruth Kirschstein National Research Service Award (GM007185 to BVH), and the Alberta Heritage Foundation for Medical Research Fellowship (AHFMR to AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2009, NATURE, V460, P18, DOI 10.1038/460018a; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Chamuleau SAF, 2009, NETH HEART J, V17, P199, DOI 10.1007/BF03086247; Deuse T, 2011, J CELL SCI, V124, P3029, DOI 10.1242/jcs.087718; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Galli D, 2005, ARTERIOSCL THROM VAS, V25, P692, DOI 10.1161/01.ATV.0000156402.52029.ce; Hutcheson KA, 2000, CELL TRANSPLANT, V9, P359, DOI 10.1177/096368970000900307; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Khattar P, 2011, STEM CELLS DEV, V20, P1043, DOI 10.1089/scd.2010.0374; Kuraitis D, 2010, CURR OPIN CARDIOL, V25, P575, DOI 10.1097/HCO.0b013e32833f0318; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Povsic TJ, 2010, EXPERT REV CARDIOVAS, V8, P1107, DOI 10.1586/ERC.10.99; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Schenke-Layland K, 2011, BIOMATERIALS, V32, P2748, DOI 10.1016/j.biomaterials.2010.12.046; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamura Y, 2011, ARTERIOSCL THROM VAS, V31, P582, DOI 10.1161/ATVBAHA.110.214726; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Weinberger F, 2012, CIRC RES, V110, P1303, DOI 10.1161/CIRCRESAHA.111.259630; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yi BA, 2010, J CLIN INVEST, V120, P20, DOI 10.1172/JCI40820; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	40	25	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e45603	10.1371/journal.pone.0045603	http://dx.doi.org/10.1371/journal.pone.0045603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056209	Green Submitted, gold, Green Published			2022-12-27	WOS:000309889400007
J	Bustamante, N; Rico-Lastres, P; Garcia, E; Garcia, P; Menendez, M				Bustamante, Noemi; Rico-Lastres, Palma; Garcia, Ernesto; Garcia, Pedro; Menendez, Margarita			Thermal Stability of Cpl-7 Endolysin from the Streptococcus pneumoniae Bacteriophage Cp-7; Cell Wall-Targeting of Its CW_7 Motifs	PLOS ONE			English	Article							LYTIC ENZYMES; LIPOTEICHOIC ACID; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; TERMINAL DOMAIN; TEICHOIC-ACIDS; BINDING; LYSOZYME; MUREIN; RECOGNITION	Endolysins comprise a novel class of selective antibacterials refractory to develop resistances. The Cpl-7 endolysin, encoded by the Streptococcus pneumoniae bacteriophage Cp-7, consists of a catalytic module (CM) with muramidase activity and a cell wall-binding module (CWBM) made of three fully conserved CW_7 repeats essential for activity. Firstly identified in the Cpl-7 endolysin, CW_7 motifs are also present in a great variety of cell wall hydrolases encoded, among others, by human and live-stock pathogens. However, the nature of CW_7 receptors on the bacterial envelope remains unknown. In the present study, the structural stability of Cpl-7 and the target recognized by CW_7 repeats, relevant for exploitation of Cpl-7 as antimicrobial, have been analyzed, and transitions from the CM and the CWBM assigned, using circular dichroism and differential scanning calorimetry. Cpl-7 stability is maximum around 6.0-6.5, near the optimal pH for activity. Above pH 8.0 the CM becomes extremely unstable, probably due to deprotonation of the N-terminal amino-group, whereas the CWBM is rather insensitive to pH variation and its structural stabilization by GlcNAc-MurNAc-L-Ala-D-isoGln points to the cell wall muropeptide as the cell wall target recognized by the CW_7 repeats. Denaturation data also revealed that Cpl-7 is organized into two essentially independent folding units, which will facilitate the recombination of the CM and the CWBM with other catalytic domains and/or cell wall-binding motifs to yield new tailored chimeric lysins with higher bactericidal activities or new pathogen specificities.	[Bustamante, Noemi; Rico-Lastres, Palma; Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Bustamante, Noemi; Rico-Lastres, Palma; Garcia, Ernesto; Garcia, Pedro; Menendez, Margarita] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Garcia, Ernesto; Garcia, Pedro] CSIC, Ctr Invest Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Menendez, M (corresponding author), CSIC, Inst Quim Fis Rocasolano, Madrid, Spain.	mmenendez@iqfr.csic.es	Menendez, Margarita/M-1795-2014; García, Pedro/L-2808-2017	Menendez, Margarita/0000-0002-3267-4443; García, Pedro/0000-0001-6717-8717; Partearroyo Lacaba, Olvido/0000-0002-1692-4481	Ministerio de Ciencia e Innovacion (MICINN) [SAF2009-10824, BFU2009-10052]; Comunidad Autonoma de Madrid [BIPPEP2, S2010/BMD-2457]; CIBER de Enfermedades Respiratorias (CIBERES), an initiative of the ISCIII; MICINN	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); CIBER de Enfermedades Respiratorias (CIBERES), an initiative of the ISCIII; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by grants SAF2009-10824, and BFU2009-10052 from Ministerio de Ciencia e Innovacion (MICINN), and BIPPEP2 from Comunidad Autonoma de Madrid (S2010/BMD-2457). Additional funding was provided by the CIBER de Enfermedades Respiratorias (CIBERES), an initiative of the ISCIII. P. Rico-Lastres was supported by a fellowship from MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; Borysowski J, 2010, ENZYBIOTICS ANTIBIOT, P149; BRANDTS JF, 1989, BIOCHEMISTRY-US, V28, P8588, DOI 10.1021/bi00447a048; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Bustamante N, 2010, J BIOL CHEM, V285, P33184, DOI 10.1074/jbc.M110.154559; Callewaert L, 2011, CURR OPIN BIOTECH, V22, P164, DOI 10.1016/j.copbio.2010.10.012; Carreira A, 2004, J BIOL CHEM, V279, P6517, DOI 10.1074/jbc.M307662200; CROUX C, 1993, FEBS LETT, V336, P111, DOI 10.1016/0014-5793(93)81621-6; CROUX C, 1993, MOL MICROBIOL, V9, P1019, DOI 10.1111/j.1365-2958.1993.tb01231.x; Dam TK, 2008, BIOCHEMISTRY-US, V47, P8470, DOI 10.1021/bi801208b; DIAZ E, 1991, J BIOL CHEM, V266, P5464; DIAZ E, 1990, P NATL ACAD SCI USA, V87, P8125, DOI 10.1073/pnas.87.20.8125; Donovan DM, 2008, FEMS MICROBIOL LETT, V287, P22, DOI 10.1111/j.1574-6968.2008.01287.x; Draing C, 2006, J BIOL CHEM, V281, P33849, DOI 10.1074/jbc.M602676200; Farkasovska J, 2003, FOLIA MICROBIOL, V48, P737, DOI 10.1007/BF02931507; Fenton Mark, 2010, Bioeng Bugs, V1, P9, DOI 10.4161/bbug.1.1.9818; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; GARCIA E, 1988, P NATL ACAD SCI USA, V85, P914, DOI 10.1073/pnas.85.3.914; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; GARCIA P, 1990, GENE, V86, P81, DOI 10.1016/0378-1119(90)90116-9; Garcia P, 2005, PHAGES THEIR ROLE BA, P335; Hermoso JA, 2005, NAT STRUCT MOL BIOL, V12, P533, DOI 10.1038/nsmb940; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Lopez R, 2004, PNEUMOCCOCUS, P75; Low LY, 2011, J BIOL CHEM, V286, P34391, DOI 10.1074/jbc.M111.244160; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Manoharadas S, 2009, J BIOTECHNOL, V139, P118, DOI 10.1016/j.jbiotec.2008.09.003; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Monterroso B, 2008, J BIOL CHEM, V283, P28618, DOI 10.1074/jbc.M802808200; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Perl A, 2011, NAT CHEM, V3, P317, DOI 10.1038/NCHEM.1005; Porter CJ, 2007, J MOL BIOL, V366, P540, DOI 10.1016/j.jmb.2006.11.056; SANCHEZPUELLES JM, 1987, GENE, V61, P13, DOI 10.1016/0378-1119(87)90360-X; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; SANZ JM, 1993, J BIOL CHEM, V268, P6125; SANZ JM, 1992, MOL MICROBIOL, V6, P921, DOI 10.1111/j.1365-2958.1992.tb01542.x; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Seo HS, 2008, J BACTERIOL, V190, P2379, DOI 10.1128/JB.01795-07; Sheehan MM, 1997, MOL MICROBIOL, V25, P717, DOI 10.1046/j.1365-2958.1997.5101880.x; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Trifonov EN, 2009, CURR OPIN STRUC BIOL, V19, P335, DOI 10.1016/j.sbi.2009.03.007; Visweswaran G, 2012, APPL MICROBIOL BIOT, DOI [10.1007/s00253-00012-03871-00250, DOI 10.1007/S00253-00012-03871-00250]; Visweswaran GRR, 2011, APPL MICROBIOL BIOT, V92, P921, DOI 10.1007/s00253-011-3637-0; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861	59	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46654	10.1371/journal.pone.0046654	http://dx.doi.org/10.1371/journal.pone.0046654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056389	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500056
J	Jiang, LL; Teng, GMK; Chan, EYM; Au, SWN; Wise, H; Lee, SST; Cheung, WT				Jiang, Lili; Teng, Gladys M. K.; Chan, Elaine Y. M.; Au, Shannon W. N.; Wise, Helen; Lee, Susanna S. T.; Cheung, Wing-Tai			Impact of Cell Type and Epitope Tagging on Heterologous Expression of G Protein-Coupled Receptor: A Systematic Study on Angiotensin Type II Receptor	PLOS ONE			English	Article							AT(2) RECEPTOR; AT2 RECEPTOR; N-GLYCOSYLATION; LIGAND-BINDING; RAT-KIDNEY; LOCALIZATION; UBIQUITINATION; DOMAIN; AT(2)-RECEPTORS; DIFFERENTIATION	Despite heterologous expression of epitope-tagged GPCR is widely adopted for functional characterization, there is lacking of systematic analysis of the impact of expression host and epitope tag on GPCR expression. Angiotensin type II (AT2) receptor displays agonist-dependent and -independent activities, coupling to a spectrum of signaling molecules. However, consensus has not been reached on the subcellular distributions, signaling cascades and receptor-mediated actions. To examine the contributions of host cell and epitope tag on receptor expression and activity, epitope-tagged AT2 receptor variants were transiently or stably expressed in HEK293, CHO-K1 and PC12 cells. The epitope-tagged AT2 receptor variants were detected both on the cell membrane and in the perinuclear region. In transiently transfected HEK293 cells, Myc-AT2 existed predominantly as monomer. Additionally, a ladder of ubiquitinated AT2 receptor proteins was detected. By contrast, stably expressed epitope-tagged AT2 receptor variants existed as both monomer and high molecular weight complexes, and the latter was enriched in cell surface. Glycosylation promoted cell surface expression of Myc-AT2 but had no effect on AT2-GFP in HEK293 cells. In cells that stably expressed Myc-AT2, serum starvation induced apoptosis in CHO-K1 cells but not in HEK293 or PC12 cells. Instead, HEK293 and PC12 cells stably expressing Myc-AT2 exhibited partial cell cycle arrest with cells accumulating at G1 and S phases, respectively. Taken together, these results suggest that expression levels, subcellular distributions and ligand-independent constitutive activities of AT2 receptor were cell type-dependent while post-translational processing of nascent AT2 receptor protein was modulated by epitope tag and mode of expression.	[Au, Shannon W. N.; Lee, Susanna S. T.] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Jiang, Lili; Teng, Gladys M. K.; Chan, Elaine Y. M.; Wise, Helen; Cheung, Wing-Tai] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lee, SST (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	lee2022@cuhk.edu.hk; wtcheung@cuhk.edu.hk	Cheung, Wing-Tai/AAE-2658-2020; Chan, Elaine/GRR-5490-2022; Wise, Helen/J-9650-2013	Cheung, Wing-Tai/0000-0001-6358-7855; Wise, Helen/0000-0001-7027-6748	Research Committee of the Chinese University of Hong Kong [4450256]	Research Committee of the Chinese University of Hong Kong	The work was supported by a Direct Grant (4450256). The Direct Grant was issued by the Research Committee of the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Agbulut O, 2007, J BIOL CHEM, V282, P10465, DOI 10.1074/jbc.M610418200; ANAND R, 1993, BIOCHEMISTRY-US, V32, P9975, DOI 10.1021/bi00089a013; Beaudry H, 2006, ENDOCRINOLOGY, V147, P4263, DOI 10.1210/en.2006-0411; Belloni AS, 1998, ENDOCR RES, V24, P1; Bikkavilli RK, 2006, BIOCHEM PHARMACOL, V71, P319, DOI 10.1016/j.bcp.2005.10.050; BORJIGIN J, 1994, J BIOL CHEM, V269, P14715; BOULAY G, 1992, MOL PHARMACOL, V41, P809; Carey RM, 2005, CURR OPIN NEPHROL HY, V14, P67, DOI 10.1097/00041552-200501000-00011; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; de Gasparo M, 2000, PHARMACOL REV, V52, P415; de Godoy MAF, 2006, J PHARMACOL EXP THER, V319, P1088, DOI 10.1124/jpet.106.108084; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Feng YH, 2005, KIDNEY INT, V67, P1731, DOI 10.1111/j.1523-1755.2005.00270.x; Fucile S, 2002, P NATL ACAD SCI USA, V99, P3956, DOI 10.1073/pnas.052699599; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Hakam AC, 2006, AM J PHYSIOL-RENAL, V290, pF1430, DOI 10.1152/ajprenal.00218.2005; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harada K, 2010, J HISTOCHEM CYTOCHEM, V58, P585, DOI 10.1369/jhc.2010.955575; Hoffmann A, 2003, J RECEPT SIG TRANSD, V23, P111, DOI 10.1081/RRS-120018764; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Kamitani S, 2001, BBA-MOL CELL RES, V1539, P131, DOI 10.1016/S0167-4889(01)00100-8; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Lee SP, 2003, BIOCHEMISTRY-US, V42, P11023, DOI 10.1021/bi0345539; Lee YH, 2010, J CELL SCI, V123, P1634, DOI 10.1242/jcs.063545; Li JM, 2007, MOL ENDOCRINOL, V21, P499, DOI 10.1210/me.2006-0005; Liao W, 2001, BIOCHEM J, V353, P493, DOI 10.1042/0264-6021:3530493; Limon A, 2007, P NATL ACAD SCI USA, V104, P15526, DOI 10.1073/pnas.0706773104; Lin WZ, 2009, INT J CANCER, V125, P1316, DOI 10.1002/ijc.24440; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Michineau S, 2006, BIOCHEMISTRY-US, V45, P2699, DOI 10.1021/bi051674v; Milligan G, 1999, BRIT J PHARMACOL, V128, P501, DOI 10.1038/sj.bjp.0702824; Miura S, 2005, J BIOL CHEM, V280, P18237, DOI 10.1074/jbc.M500639200; Miura SI, 2000, EMBO J, V19, P4026, DOI 10.1093/emboj/19.15.4026; Mogi M, 2007, ARTERIOSCL THROM VAS, V27, P2532, DOI 10.1161/ATVBAHA.107.144154; Mogi M, 2006, HYPERTENSION, V48, P141, DOI 10.1161/01.HYP.0000229648.67883.f9; NAHMIAS C, 1995, BIOCHEM J, V306, P87, DOI 10.1042/bj3060087; Nakayama H, 2008, BIOCHEM BIOPH RES CO, V377, P550, DOI 10.1016/j.bbrc.2008.10.006; Nora EH, 1998, AM J PHYSIOL-HEART C, V275, pH1395, DOI 10.1152/ajpheart.1998.275.4.H1395; PUCELL AG, 1991, ENDOCRINOLOGY, V128, P1947, DOI 10.1210/endo-128-4-1947; Pulakat L, 2002, FEBS LETT, V524, P73, DOI 10.1016/S0014-5793(02)03005-3; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Servant G, 1996, BIOCHEM J, V313, P297, DOI 10.1042/bj3130297; SERVANT G, 1994, MOL PHARMACOL, V45, P1112; SHANMUGAM S, 1995, AM J PHYSIOL-RENAL, V268, pF922, DOI 10.1152/ajprenal.1995.268.5.F922; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Steckelings UM, 2005, PEPTIDES, V26, P1401, DOI 10.1016/j.peptides.2005.03.010; Stoll M, 2001, REGUL PEPTIDES, V99, P175, DOI 10.1016/S0167-0115(01)00246-4; Thompson MD, 2005, CRIT REV CL LAB SCI, V42, P311, DOI 10.1080/10408360591001895; Timmermans P B, 1996, Blood Press Suppl, V2, P53; Wehbi GJ, 2001, AM J PHYSIOL-RENAL, V280, pF254, DOI 10.1152/ajprenal.2001.280.2.F254; Wong PF, 2004, REGUL PEPTIDES, V117, P195, DOI 10.1016/j.regpep.2003.10.019; Wruck CJ, 2005, ARTERIOSCL THROM VAS, V25, P57, DOI 10.1161/01.ATV.0000150662.51436.14; Yamada T, 1996, P NATL ACAD SCI USA, V93, P156, DOI 10.1073/pnas.93.1.156; Yin Dezhong, 2006, J Mol Signal, V1, P2, DOI 10.1186/1750-2187-1-2; Yiu AKL, 1997, REGUL PEPTIDES, V70, P15; Zahradka P, 1998, BIOCHEM BIOPH RES CO, V252, P476, DOI 10.1006/bbrc.1998.9669; Zhang JS, 1996, J BIOL CHEM, V271, P15026, DOI 10.1074/jbc.271.25.15026; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zhao Y, 2003, J NEUROCHEM, V85, P759, DOI 10.1046/j.1471-4159.2003.01719.x; Zhu N, 1997, ANAL BIOCHEM, V246, P155, DOI 10.1006/abio.1997.2018	66	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47016	10.1371/journal.pone.0047016	http://dx.doi.org/10.1371/journal.pone.0047016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056563	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500124
J	Saxer, G; Havlak, P; Fox, SA; Quance, MA; Gupta, S; Fofanov, Y; Strassmann, JE; Queller, DC				Saxer, Gerda; Havlak, Paul; Fox, Sara A.; Quance, Michael A.; Gupta, Sharu; Fofanov, Yuriy; Strassmann, Joan E.; Queller, David C.			Whole Genome Sequencing of Mutation Accumulation Lines Reveals a Low Mutation Rate in the Social Amoeba Dictyostelium discoideum	PLOS ONE			English	Article							MODEL SYSTEM; MICROSATELLITE MUTATION; CAENORHABDITIS-ELEGANS; WIDE VIEW; EVOLUTION; SPECTRUM; RELATEDNESS; NUCLEOTIDE; ALTRUISM; REPAIR	Spontaneous mutations play a central role in evolution. Despite their importance, mutation rates are some of the most elusive parameters to measure in evolutionary biology. The combination of mutation accumulation (MA) experiments and whole-genome sequencing now makes it possible to estimate mutation rates by directly observing new mutations at the molecular level across the whole genome. We performed an MA experiment with the social amoeba Dictyostelium discoideum and sequenced the genomes of three randomly chosen lines using high-throughput sequencing to estimate the spontaneous mutation rate in this model organism. The mitochondrial mutation rate of 6.76x10(-9), with a Poisson confidence interval of 4.1x10(-9) -9.5x10(-9), per nucleotide per generation is slightly lower than estimates for other taxa. The mutation rate estimate for the nuclear DNA of 2.9x10(-11), with a Poisson confidence interval ranging from 7.4x10(-13) to 1.6x10(-10), is the lowest reported for any eukaryote. These results are consistent with low microsatellite mutation rates previously observed in D. discoideum and low levels of genetic variation observed in wild D. discoideum populations. In addition, D. discoideum has been shown to be quite resistant to DNA damage, which suggests an efficient DNA-repair mechanism that could be an adaptation to life in soil and frequent exposure to intracellular and extracellular mutagenic compounds. The social aspect of the life cycle of D. discoideum and a large portion of the genome under relaxed selection during vegetative growth could also select for a low mutation rate. This hypothesis is supported by a significantly lower mutation rate per cell division in multicellular eukaryotes compared with unicellular eukaryotes.	[Saxer, Gerda; Havlak, Paul; Fox, Sara A.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Havlak, Paul; Quance, Michael A.; Gupta, Sharu; Fofanov, Yuriy] Univ Houston, Ctr Biomed & Environm Genom, Houston, TX USA; [Strassmann, Joan E.; Queller, David C.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Rice University; University of Houston System; University of Houston; Washington University (WUSTL)	Saxer, G (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	gsaxer@rice.edu		Strassmann, Joan/0000-0003-0638-8440	National Science Foundation [DEB 0918931, DEB 1011513]; Rice University Faculty Initiative Fund [D75124 414000]; Howard Hughes pre-doctoral fellowship; National Library of Medicine Training Program in Biomedical Informatics of the Keck Center of the Gulf Coast Consortia (National Institutes of Health) [5T15LM007093-17]; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Rice University Faculty Initiative Fund; Howard Hughes pre-doctoral fellowship; National Library of Medicine Training Program in Biomedical Informatics of the Keck Center of the Gulf Coast Consortia (National Institutes of Health); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This material is based upon work supported by the National Science Foundation under grant number DEB 0918931, and DEB 1011513, as well as funding from Rice University Faculty Initiative Fund D75124 414000 to JES and DCQ, a Howard Hughes pre-doctoral fellowship to SAF and a training fellowship from the National Library of Medicine Training Program in Biomedical Informatics of the Keck Center of the Gulf Coast Consortia (National Institutes of Health Grant No. 5T15LM007093-17) to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesley SJ, 2009, MOL CELL BIOCHEM, V329, P73, DOI 10.1007/s11010-009-0111-8; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; BONNER JT, 1947, J EXP ZOOL, V106, P1, DOI 10.1002/jez.1401060102; DEERING RA, 1968, SCIENCE, V162, P1289, DOI 10.1126/science.162.3859.1289; DEERING RA, 1994, ADV SPACE RES, V14, P389, DOI 10.1016/0273-1177(94)90492-8; Deering RA, 1996, ANTIMICROB AGENTS CH, V40, P464, DOI 10.1128/AAC.40.2.464; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Drake JW, 1998, GENETICS, V148, P1667; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Escalante R, 2000, INT J DEV BIOL, V44, P819; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Fisher RA, 1930, GENETICAL THEORY NAT; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Galtier N, 2001, GENETICS, V159, P907; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Hagele S, 2000, CELL MICROBIOL, V2, P165, DOI 10.1046/j.1462-5822.2000.00044.x; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; Hasselbring BM, 2011, INFECT IMMUN, V79, P2079, DOI 10.1128/IAI.01233-10; Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115; Keightley PD, 1999, GENET RES, V74, P87, DOI 10.1017/S0016672399003894; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kondrashov FA, 2010, PHILOS T R SOC B, V365, P1169, DOI 10.1098/rstb.2009.0286; Kuzdzal-Fick JJ, 2011, SCIENCE, V334, P1548, DOI 10.1126/science.1213272; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Martinez-Alcantara A, 2009, BIOINFORMATICS, V25, P2438, DOI 10.1093/bioinformatics/btp429; McConnell R, 2007, GENETICS, V177, P1499, DOI 10.1534/genetics.107.076067; Middlemist SA, 2009, MUTATIONAL PROCESSES; Nishant KT, 2010, PLOS GENETICS, V6; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Raper K. B., 1984, DICTYOSTELIDS; Saxer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-76; Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99; Seyfert AL, 2008, GENETICS, V178, P2113, DOI 10.1534/genetics.107.081927; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Strassmann JE, 2007, NAT HIST, V116, P24; Urushihara H, 2008, DEV GROWTH DIFFER, V50, pS277, DOI 10.1111/j.1440-169X.2008.01013.x; Van Driessche N, 2002, DEVELOPMENT, V129, P1543; Wielgoss S, 2011, G3-GENES GENOM GENET, V1, P183, DOI 10.1534/g3.111.000406; Xu S, 2012, MOL BIOL EVOL, V29, P763, DOI 10.1093/molbev/msr243	50	37	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46759	10.1371/journal.pone.0046759	http://dx.doi.org/10.1371/journal.pone.0046759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056439	Green Published, gold			2022-12-27	WOS:000309831500074
J	Hur, SC; Brinckerhoff, TZ; Walthers, CM; Dunn, JCY; Di Carlo, D				Hur, Soojung Claire; Brinckerhoff, Tatiana Z.; Walthers, Christopher M.; Dunn, James C. Y.; Di Carlo, Dino			Label-Free Enrichment of Adrenal Cortical Progenitor Cells Using Inertial Microfluidics	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; MESENCHYMAL STEM-CELLS; MULTICELLULAR COMPLEXES; REGENERATIVE MEDICINE; CANCER PATIENTS; DRUG DISCOVERY; BREAST-CANCER; BLOOD; TRANSPLANTATION; DEFORMABILITY	Passive and label-free isolation of viable target cells based on intrinsic biophysical cellular properties would allow for cost savings in applications where molecular biomarkers are known as well as potentially enable the separation of cells with little-to-no known molecular biomarkers. We have demonstrated the purification of adrenal cortical progenitor cells from digestions of murine adrenal glands utilizing hydrodynamic inertial lift forces that single cells and multicellular clusters differentially experience as they flow through a microchannel. Fluorescence staining, along with gene expression measurements, confirmed that populations of cells collected in different outlets were distinct from one another. Furthermore, primary murine cells processed through the device remained highly viable and could be cultured for 10 days in vitro. The proposed target cell isolation technique can provide a practical means to collect significant quantities of viable intact cells required to translate stem cell biology to regenerative medicine in a simple label-free manner.	[Walthers, Christopher M.; Dunn, James C. Y.; Di Carlo, Dino] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90024 USA; [Hur, Soojung Claire] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02138 USA; [Brinckerhoff, Tatiana Z.; Dunn, James C. Y.] Univ Calif Los Angeles, Div Pediat Surg, Los Angeles, CA USA; [Di Carlo, Dino] Calif NanoSyst Inst, Los Angeles, CA USA; [Di Carlo, Dino] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA	University of California System; University of California Los Angeles; Harvard University; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center	Di Carlo, D (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90024 USA.	dicarlo@seas.ucla.edu	Hur, Soojung Claire C/P-6390-2014	Hur, Soojung Claire C/0000-0002-4725-5540	National Science Foundation [0930501]; National Institutes of Health [NIDDK K08DK068207]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK068207] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Science Foundation (0930501) and National Institutes of Health (NIDDK K08DK068207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, ADR GLAND PARG; Arafah BM, 2010, J CLIN ENDOCRINOLOGY, V95, P1206; Beuschlein F, 2002, ENDOCRINOLOGY, V143, P3122, DOI 10.1210/en.143.8.3122; Brandao MM, 2003, EUR J HAEMATOL, V70, P207, DOI 10.1034/j.1600-0609.2003.00027.x; BRELINSKA R, 1986, CELL TISSUE RES, V244, P673, DOI 10.1007/BF00212548; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chu YT, 2006, J PEDIATR SURG, V41, P2008, DOI 10.1016/j.jpedsurg.2006.08.027; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Darling EM, 2007, BIOPHYS J, V92, P1784, DOI 10.1529/biophysj.106.083097; Dharmasiri U, 2010, ANNU REV ANAL CHEM, V3, P409, DOI 10.1146/annurev.anchem.111808.073610; Dunn JCY, 2009, J SURG RES, V156, P317, DOI 10.1016/j.jss.2009.04.021; Dunn JCY, 2004, J PEDIATR SURG, V39, P1856, DOI 10.1016/j.jpedsurg.2004.08.006; ENNAS MG, 1989, CELL TISSUE RES, V257, P9; FORD JK, 1963, ANAT REC, V146, P125, DOI 10.1002/ar.1091460206; Gossett DR, 2010, ANAL BIOANAL CHEM, V397, P3249, DOI 10.1007/s00216-010-3721-9; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hur SC, 2011, P MICROTAS C SEATTL; Hur SC, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3608115; Hur SC, 2011, LAB CHIP, V11, P912, DOI [10.1039/c0lc00595a, 10.1039/c01c00595a]; Iannaccone P, 2002, FASEB J, V16, P41, DOI 10.1096/fj.02-0451fje; Kim AC, 2007, MOL CELL ENDOCRINOL, V265, P10, DOI 10.1016/j.mce.2006.12.028; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Mach AJ, 2010, BIOTECHNOL BIOENG, V107, P302, DOI 10.1002/bit.22833; MCCASKILL D, 1992, PLANTA, V187, P445, DOI 10.1007/BF00199962; McNeish J, 2004, NAT REV DRUG DISCOV, V3, P70, DOI 10.1038/nrd1281; Mitani F, 2003, BBA-GEN SUBJECTS, V1619, P317, DOI 10.1016/S0304-4165(02)00490-7; Mohandas N, 1978, Curr Top Hematol, V1, P71; Molnar B, 2001, CLIN CANCER RES, V7, P4080; Sakurada K, 2008, ANGEW CHEM INT EDIT, V47, P5718, DOI 10.1002/anie.200700724; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHOPPER C, 1981, J CANCER RES CLIN, V102, P159, DOI 10.1007/BF00410667; Sim TS, 2011, LAB CHIP, V11, P93, DOI [10.1039/c0lc00109k, 10.1039/c01c00109k]; Skoutelis AT, 2000, CYTOKINE, V12, P1737, DOI 10.1006/cyto.2000.0761; Stankovich BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023810; Stevens L., 1996, AVIAN BIOCH MOL BIOL; Stewart CE, 2012, J ALLERGY; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Terazono Hideyuki, 2010, Journal of Nanobiotechnology, V8, P8, DOI 10.1186/1477-3155-8-8; Torricelli F, 2001, CLIN CHEM LAB MED, V39, P494, DOI 10.1515/CCLM.2001.082; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; WEINBERG WC, 1985, SCIENCE, V227, P524, DOI 10.1126/science.3966159; Wulfing P, 2006, CLIN CANCER RES, V12, P1715, DOI 10.1158/1078-0432.CCR-05-2087; Zupekan T, 2011, J PEDIATR SURG, V46, P1208, DOI 10.1016/j.jpedsurg.2011.03.057	46	38	40	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46550	10.1371/journal.pone.0046550	http://dx.doi.org/10.1371/journal.pone.0046550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056341	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800026
J	Naudin, M; El-Hage, W; Gomes, M; Gaillard, P; Belzung, C; Atanasova, B				Naudin, Marine; El-Hage, Wissam; Gomes, Marlene; Gaillard, Philippe; Belzung, Catherine; Atanasova, Boriana			State and Trait Olfactory Markers of Major Depression	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; ODOR IDENTIFICATION; UNIPOLAR DEPRESSION; EMOTIONAL RESPONSES; FACIAL EXPRESSIONS; SCHIZOPHRENIA; RECOGNITION; VALIDATION; PERCEPTION; INTERVIEW	Nowadays, depression is a major issue in public health. Because of the partial overlap between the brain structures involved in depression, olfaction and emotion, the study of olfactory function could be a relevant way to find specific cognitive markers of depression. This study aims at determining whether the olfactory impairments are state or trait markers of major depressive episode (MDE) through the study of the olfactory parameters involving the central olfactory pathway. In a pilot study, we evaluated prospectively 18 depressed patients during acute episodes of depression and 6 weeks after antidepressant treatment (escitalopram) against 54 healthy volunteers, matched by age, gender and smoking status. We investigated the participants' abilities to identify odors (single odors and in binary mixture), to evaluate and discriminate the odors' intensity, and determine the hedonic valence of odors. The results revealed an "olfactory anhedonia" expressed by decrease of hedonic score for high emotional odorant as potential state marker of MDE. Moreover, these patients experienced an "olfactory negative alliesthesia", during the odor intensity evaluation, and failed to identify correctly two odorants with opposite valences in a binary iso-mixture, which constitute potential trait markers of the disease. This study provides preliminary evidence for olfactory impairments associated with MDE (state marker) that are persistent after the clinical improvement of depressive symptoms (trait marker). These results could be explained by the chronicity of depression and/or by the impact of therapeutic means used (antidepressant treatment). They need to be confirmed particularly the ones obtained in complex olfactory environment which corresponds a more objective daily life situation.	[Naudin, Marine; El-Hage, Wissam; Gomes, Marlene; Gaillard, Philippe; Belzung, Catherine; Atanasova, Boriana] Univ Tours, INSERM, U930, ERL 3106, Tours, France; [El-Hage, Wissam; Gaillard, Philippe] CHRU Tours, Clin Psychiat Univ, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Atanasova, B (corresponding author), Univ Tours, INSERM, U930, ERL 3106, Tours, France.	atanasova@univ-tours.fr	EL-HAGE, WISSAM/S-5014-2019; Belzung, Catherine/P-6512-2016; Gaillard, Philippe/E-7256-2019	EL-HAGE, WISSAM/0000-0003-3877-0855; Belzung, Catherine/0000-0001-6095-5974; ATANASOVA, Boriana/0000-0002-5877-4645				Abler B, 2007, J PSYCHIATR RES, V41, P511, DOI 10.1016/j.jpsychires.2006.07.020; AKIL M, 1993, CEREB CORTEX, V3, P533, DOI 10.1093/cercor/3.6.533; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENTA; Atanasova B, 2008, NEUROSCI BIOBEHAV R, V32, P1315, DOI 10.1016/j.neubiorev.2008.05.003; Atanasova B, 2010, PSYCHIAT RES, V176, P190, DOI 10.1016/j.psychres.2008.11.016; Berlin I, 1998, EUR PSYCHIAT, V13, P303, DOI 10.1016/S0924-9338(98)80048-5; Bhalla RK, 2006, AM J GERIAT PSYCHIAT, V14, P419, DOI 10.1097/01.JGP.0000203130.45421.69; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; Clepce M, 2010, NEUROSCI LETT, V471, P139, DOI 10.1016/j.neulet.2010.01.027; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Duburcq A, 1999, REV EPIDEMIOL SANTE, V47, P455; Fallon JH, 1987, CEREB CORTEX, V6, P41; Hudry J, 2002, CHEM SENSES, V27, P407, DOI 10.1093/chemse/27.5.407; KOPALA LC, 1994, SCHIZOPHR RES, V12, P205, DOI 10.1016/0920-9964(94)90030-2; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lehrner JP, 1999, NEUROSCI LETT, V272, P17, DOI 10.1016/S0304-3940(99)00566-2; LESSER IM, 1994, ARCH GEN PSYCHIAT, V51, P677; Lombion-Pouthier S, 2006, J AFFECT DISORDERS, V90, P187, DOI 10.1016/j.jad.2005.11.012; Mikhailova ES, 1996, BIOL PSYCHIAT, V40, P697, DOI 10.1016/0006-3223(96)00032-7; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; Pentzek M, 2007, AGING CLIN EXP RES, V19, P255; Pitchot W, 2008, Rev Med Liege, V63, P378; Pollatos O, 2007, J AFFECT DISORDERS, V102, P101, DOI 10.1016/j.jad.2006.12.012; Postolache TT, 1999, J AFFECT DISORDERS, V56, P27, DOI 10.1016/S0165-0327(99)00027-0; Quide Y, 2012, NEUROSCI BIOBEHAV R, V36, P626, DOI 10.1016/j.neubiorev.2011.09.004; Robin O, 1998, J DENT RES, V77, P1638, DOI 10.1177/00220345980770081201; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; SERBY M, 1990, BIOL PSYCHIAT, V28, P830, DOI 10.1016/0006-3223(90)90520-C; Serby M., 1992, SCIENCE OLFACTION, P559, DOI 10.1007/978-1-4612-2836-3_21; Settle R. G., 1991, SMELL TASTE HLTH DIS, P851; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Solomon GS, 1998, J NEUROPSYCH CLIN N, V10, P64, DOI 10.1176/jnp.10.1.64; STEINER JE, 1993, PERCEPT MOTOR SKILL, V77, P1331, DOI 10.2466/pms.1993.77.3f.1331; Surget A, 2009, NEUROPSYCHOPHARMACOL, V34, P1363, DOI 10.1038/npp.2008.76; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Suslow T, 2001, PERCEPT MOTOR SKILL, V92, P857, DOI 10.2466/PMS.92.3.857-868; Swiecicki L, 2009, PROG NEURO-PSYCHOPH, V33, P827, DOI 10.1016/j.pnpbp.2009.03.030; Tanti A, 2010, BRIT J PHARMACOL, V159, P1187, DOI 10.1111/j.1476-5381.2009.00585.x; Thomas HJ, 2002, NERVENARZT, V73, P71, DOI 10.1007/s115-002-8150-9; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5	43	59	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46938	10.1371/journal.pone.0046938	http://dx.doi.org/10.1371/journal.pone.0046938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056535	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000102
J	Li, JB; Zhang, Y; Lou, JS; Zhu, JL; He, MX; Deng, XM; Cai, ZL				Li, Jinbao; Zhang, Yan; Lou, Jingsheng; Zhu, Jiali; He, Miaoxia; Deng, Xiaoming; Cai, Zailong			Neutralisation of Peritoneal IL-17A Markedly Improves the Prognosis of Severe Septic Mice by Decreasing Neutrophil Infiltration and Proinflammatory Cytokines	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; SYNDROME SIRS; LUNG INJURY; T-CELLS; SEPSIS; INTERLEUKIN-17; MECHANISMS; MORTALITY	Purpose: The current study aimed to elucidate the role of peritoneal fluid IL-17A in septic mice, and the effects of intraperitoneal or intravenous blockade of the IL-17A pathway by anti-IL17A antibody on survival, plasma, and peritoneal cavity cytokine profile in a murine caecal ligation and puncture (CLP) sepsis model. The main source of peritoneal fluid IL-17A in septic mice was identified. Methods: Male C57BL/6 mice that underwent severe CLP or sham surgery were intraperitoneally or intravenously administered anti-IL17A antibodies or isotype antibodies. The survival rates were observed. IL-17A, TNF-alpha, and IL-6 cytokine levels were measured by ELISA. Surface and intracellular IL-17A immunofluorescence stains were detected by flow cytometry to identify the IL-17A-producing cells. Results: The IL-17A level was elevated much higher and earlier in peritoneal fluid than in the blood of the CLP mice. The intraperitoneal IL-17A blockade more significantly protects against CLP-induced mortality than intravenous blockade because of decreased TNF-alpha and IL-6 levels both in peritoneal fluid and blood, neutrophil infiltration in the peritoneal cavity, and lung injury. gamma delta T lymphocytes were identified to be the main source of IL-17A in the peritoneal fluid of septic mice. Conclusions: The earlier and higher elevated IL-17A derived from gamma delta T cells in peritoneal fluid plays a critical role during polymicrobial severe sepsis and effect of intraperitoneal IL-17A antibody administration superior to intravenous administration on survival of severe CLP-induced septic mice. The intraperitoneal blockade of IL-17A decreases proinflammatory cytokine production, neutrophil infiltration, and lung injury, thereby improving septic mice survival, which provides a new potential therapy target for sepsis.	[Li, Jinbao; Zhang, Yan; Lou, Jingsheng; Zhu, Jiali; Deng, Xiaoming; Cai, Zailong] Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol, Shanghai, Peoples R China; [Li, Jinbao; Zhang, Yan; Lou, Jingsheng; Zhu, Jiali; Deng, Xiaoming; Cai, Zailong] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China; [He, Miaoxia] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China; [Lou, Jingsheng] Gen Hosp PLA, Dept Anesthesiol, Beijing, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Chinese People's Liberation Army General Hospital	Deng, XM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol, Shanghai, Peoples R China.	deng_x@yahoo.com; czl8003@163.com	Lou, Jingsheng/ABF-7902-2021; Deng, Xiaoming/E-2876-2010	Lou, Jingsheng/0000-0002-0295-5105; 	National Natural Science Foundation of China [30971510]; 973 project [2010CB933902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China)	The present work was partially supported by a grant from the National Natural Science Foundation of China (Project No. 30971510) and 973 project (2010CB933902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Chung CS, 2006, AM J PHYSIOL-REG I, V291, pR1338, DOI 10.1152/ajpregu.00283.2006; Deans KJ, 2005, J TRAUMA, V58, P867, DOI 10.1097/01.TA.0000158244.69179.94; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Faist E, 1998, NEW HORIZ-SCI PRACT, V6, pS97; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Freitas A, 2009, J IMMUNOL, V182, P7846, DOI 10.4049/jimmunol.0803039; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kasten KR, 2010, SHOCK, V34, P327, DOI 10.1097/SHK.0b013e3181e14c2e; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Shubin NJ, 2011, CONTRIB MICROBIOL, V17, P108, DOI 10.1159/000324024; Tanino Y, 2002, AM J PHYSIOL-LUNG C, V283, pL156, DOI 10.1152/ajplung.00155.2001; Tschoep J, 2008, J LEUKOCYTE BIOL, V83, P581, DOI 10.1189/jlb.0707507; Vianna RCS, 2004, SHOCK, V21, P115, DOI 10.1097/01.shk.0000111828.07309.26; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Xu KF, 2005, P NATL ACAD SCI USA, V102, P2784, DOI 10.1073/pnas.0409871102; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354	26	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46506	10.1371/journal.pone.0046506	http://dx.doi.org/10.1371/journal.pone.0046506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056325	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600039
J	Shikatani, EA; Trifonova, A; Mandel, ER; Liu, STK; Roudier, E; Krylova, A; Szigiato, A; Beaudry, J; Riddell, MC; Haas, TL				Shikatani, Eric A.; Trifonova, Anastassia; Mandel, Erin R.; Liu, Sammy T. K.; Roudier, Emilie; Krylova, Anna; Szigiato, Andrei; Beaudry, Jacqueline; Riddell, Michael C.; Haas, Tara L.			Inhibition of Proliferation, Migration and Proteolysis Contribute to Corticosterone-Mediated Inhibition of Angiogenesis	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; ENDOTHELIAL-CELL MIGRATION; CYTOSKELETAL REARRANGEMENTS; TRANSCRIPTION FACTORS; ACTIN CYTOSKELETON; TISSUE INHIBITOR; DOWN-REGULATION; GROWTH-FACTOR; TUMOR-CELLS; IN-VITRO	The angiostatic nature of pharmacological doses of glucocorticoid steroids is well known. However, the consequences of pathophysiological elevation of endogenous glucocorticoids are not well established. In the current study, we hypothesized that the angiostatic effect of corticosterone, an endogenous glucocorticoid in rodents, occurs through multi-faceted alterations in skeletal muscle microvascular endothelial cell proliferation, migration, and proteolysis. Chronic corticosterone treatment significantly reduced the capillary to fiber ratio in the tibialis anterior muscle compared to that of placebo-treated rats. Corticosterone inhibited endothelial cell sprouting from capillary segments ex vivo. Similarly, 3-dimensional endothelial cell spheroids treated with corticosterone for 48 hours showed evidence of sprout regression and reduced sprout length. Endothelial cell proliferation was reduced in corticosterone treated cells, coinciding with elevated FoxO1 and reduced VEGF production. Corticosterone treated endothelial cells exhibited reduced migration, which correlated with a reduction in RhoA activity. Furthermore, corticosterone treated endothelial cells in both 3-dimensional and monolayer cultures had decreased MMP-2 production and activation resulting in decreased proteolysis by endothelial cells, limiting their angiogenic potential. Promoter assays revealed that corticosterone treatment transcriptionally repressed MMP-2, which may map to a predicted GRE between -1510 and -1386 bp of the MMP-2 promoter. Additionally, Sp1, a known transcriptional activator of MMP-2 was decreased following corticosterone treatment. This study provides new insights into the mechanisms by which pathophysiological levels of endogenous glucocorticoids may exert angiostatic effects.	[Shikatani, Eric A.; Mandel, Erin R.; Liu, Sammy T. K.; Roudier, Emilie; Szigiato, Andrei; Beaudry, Jacqueline; Riddell, Michael C.; Haas, Tara L.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Trifonova, Anastassia; Krylova, Anna; Haas, Tara L.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Shikatani, Eric A.; Trifonova, Anastassia; Beaudry, Jacqueline; Riddell, Michael C.; Haas, Tara L.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada; York University - Canada	Haas, TL (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	thaas@yorku.ca	Haas, Tara/F-6788-2013	Haas, Tara/0000-0001-8559-9574; Szigiato, Andrei-Alexandru/0000-0003-0862-9068	Natural Sciences and Engineering Research Council of Canada (NSERC); Heart and Stroke Foundation of Ontario; NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grants to TLH and to MCR. EAS is the recipient of a Heart and Stroke Foundation of Ontario Master's Studentship Award. AT is the recipient of a NSERC Canada Graduate Scholarships-Masters (CGSM) graduate scholarship. AK and AS are recipients of NSERC Undergraduate Student Research awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aepfelbacher M, 1997, ARTERIOSCL THROM VAS, V17, P1623, DOI 10.1161/01.ATV.17.9.1623; Aho S, 1997, EUR J BIOCHEM, V247, P503, DOI 10.1111/j.1432-1033.1997.00503.x; Aljada A, 2001, J CLIN ENDOCR METAB, V86, P5988, DOI 10.1210/jc.86.12.5988; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Blecharz KG, 2008, J CEREBR BLOOD F MET, V28, P1139, DOI 10.1038/jcbfm.2008.2; Boyd PJ, 2005, AM J PHYSIOL-CELL PH, V288, pC659, DOI 10.1152/ajpcell.00211.2004; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; CANTRILL HL, 1975, J CLIN ENDOCR METAB, V40, P1073, DOI 10.1210/jcem-40-6-1073; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Forster C, 2007, J PHYSIOL-LONDON, V580, P937, DOI 10.1113/jphysiol.2007.129007; FOLKMAN J, 1983, SCIENCE, V221, P719, DOI 10.1126/science.6192498; FOLKMAN J, 1987, ANN SURG, V206, P374, DOI 10.1097/00000658-198709000-00016; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Goldman S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-41; Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604; Haas TL, 1999, J BIOL CHEM, V274, P22679, DOI 10.1074/jbc.274.32.22679; Haas TL, 2000, AM J PHYSIOL-HEART C, V279, pH1540, DOI 10.1152/ajpheart.2000.279.4.H1540; Haller J, 2008, FRONT NEUROENDOCRIN, V29, P273, DOI 10.1016/j.yfrne.2007.10.004; Han XY, 2003, J BIOL CHEM, V278, P47785, DOI 10.1074/jbc.M309482200; HARENDZA S, 1995, J BIOL CHEM, V270, P18786, DOI 10.1074/jbc.270.32.18786; Harkness KA, 2000, BRAIN, V123, P698, DOI 10.1093/brain/123.4.698; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Ispanovic E, 2006, AM J PHYSIOL-CELL PH, V291, pC579, DOI 10.1152/ajpcell.00300.2005; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Li S, 1999, J CLIN INVEST, V103, P1141, DOI 10.1172/JCI5367; Logie JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014476; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayanagi T, 2008, J BIOL CHEM, V283, P31183, DOI 10.1074/jbc.M801606200; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oberleithner H, 2006, J CELL SCI, V119, P1926, DOI 10.1242/jcs.02886; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Park MT, 1999, MOL CELLS, V9, P476; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rubenstein NM, 2003, J BIOL CHEM, V278, P10353, DOI 10.1074/jbc.M213121200; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Song IH, 2006, MOL CELL ENDOCRINOL, V246, P142, DOI 10.1016/j.mce.2005.11.012; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Uchida C, 2008, CELL BIOL INT, V32, P769, DOI 10.1016/j.cellbi.2008.03.005; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; Yang EV, 2002, J NEUROIMMUNOL, V133, P144, DOI 10.1016/S0165-5728(02)00270-9; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	61	35	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46625	10.1371/journal.pone.0046625	http://dx.doi.org/10.1371/journal.pone.0046625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056375	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600047
J	Valente, P; Boekhout, T; Landell, MF; Crestani, J; Pagnocca, C; Sette, LD; Passarini, MRZ; Rosa, CA; Brandao, LR; Pimenta, RS; Ribeiro, JR; Garcia, KM; Lee, CF; Suh, SO; Peter, G; Dlauchy, D; Fell, JW; Scorzetti, G; Theelen, B; Vainstein, MH				Valente, Patricia; Boekhout, Teun; Landell, Melissa Fontes; Crestani, Juliana; Pagnocca, Fernando Carlos; Sette, Lara Duraes; Zambrano Passarini, Michel Rodrigo; Rosa, Carlos Augusto; Brandao, Luciana R.; Pimenta, Raphael S.; Ribeiro, Jose Roberto; Garcia, Karina Marques; Lee, Ching-Fu; Suh, Sung-Oui; Peter, Gabor; Dlauchy, Denes; Fell, Jack W.; Scorzetti, Gloria; Theelen, Bart; Vainstein, Marilene H.			Bandoniozyma gen. nov., a Genus of Fermentative and Non-Fermentative Tremellaceous Yeast Species	PLOS ONE			English	Article							CRYPTOCOCCUS-LAURENTII COMPLEX; MULTIGENE SEQUENCE-ANALYSIS; BASIDIOMYCETOUS YEAST; RIBOSOMAL-RNA; PROPOSAL; COMBINATIONS; SYSTEMATICS; PHYLOGENY; DIVERSITY; TAXA	Background: Independent surveys across the globe led to the proposal of a new basidiomycetous yeast genus within the Bulleromyces clade of the Tremellales, Bandoniozyma gen. nov., with seven new species. Methodology/Principal Findings: The species were characterized by multiple methods, including the analysis of D1/D2 and ITS nucleotide sequences, and morphological and physiological/biochemical traits. Most species can ferment glucose, which is an unusual trait among basidiomycetous yeasts. Conclusions/Significance: In this study we propose the new yeast genus Bandoniozyma, with seven species Bandoniozyma noutii sp. nov. (type species of genus; CBS 8364(T) = DBVPG 4489(T)), Bandoniozyma aquatica sp. nov. (UFMG-DH4.20(T) = CBS 12527(T) = ATCC MYA-4876(T)), Bandoniozyma complexa sp. nov. (CBS 11570(T) = ATCC MYA-4603(T) = MA28a(T)), Bandoniozyma fermentans sp. nov. (CBS 12399(T) = NU7M71(T) = BCRC 23267(T)), Bandoniozyma glucofermentans sp. nov. (CBS 10381(T) = NRRL Y-48076(T) = ATCC MYA-4760(T) = BG 02-7-15-015A-1-1(T)), Bandoniozyma tunnelae sp. nov. (CBS 8024(T) = DBVPG 7000(T)), and Bandoniozyma visegradensis sp. nov. (CBS 12505(T) = NRRL Y-48783(T) = NCAIM Y.01952(T)).	[Valente, Patricia] Univ Fed Rio Grande do Sul, Dept Microbiol Imunol & Parasitol, Porto Alegre, RS, Brazil; [Valente, Patricia; Landell, Melissa Fontes; Crestani, Juliana; Vainstein, Marilene H.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Boekhout, Teun; Theelen, Bart] Cent Bur Schimmelcultures Fungal Biodivers Ctr, Utrecht, Netherlands; [Pagnocca, Fernando Carlos; Sette, Lara Duraes] Sao Paulo State Univ, Dept Bioquim & Microbiol, Rio Claro, SP, Brazil; [Sette, Lara Duraes; Zambrano Passarini, Michel Rodrigo] Univ Estadual Campinas, Ctr Pluridisciplinar Pesquisas Quim Biol & Agr, Div Recursos Microbianos, Campinas, SP, Brazil; [Rosa, Carlos Augusto; Brandao, Luciana R.] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil; [Pimenta, Raphael S.] Univ Fed Tocantins, Lab Microbiol Ambiental & Biotecnol, Palmas, TO, Brazil; [Ribeiro, Jose Roberto; Garcia, Karina Marques] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, RJ, Brazil; [Lee, Ching-Fu] Natl Hsinchu Univ Educ, Dept Appl Sci, Hsinchu, Taiwan; [Suh, Sung-Oui] Amer Type Culture Collect, Mycol & Bot Program, Manassas, VA USA; [Peter, Gabor; Dlauchy, Denes] Corvinus Univ Budapest, Fac Food Sci, Budapest, Hungary; [Fell, Jack W.; Scorzetti, Gloria] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Key Biscayne, FL USA	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Estadual Paulista; Universidade Estadual de Campinas; Universidade Federal de Minas Gerais; Universidade Federal do Tocantins (UFT); Universidade Federal do Rio de Janeiro; National Tsing Hua University; Corvinus University Budapest	Valente, P (corresponding author), Univ Fed Rio Grande do Sul, Dept Microbiol Imunol & Parasitol, Porto Alegre, RS, Brazil.	patricia.valente@ufrgs.br	Theelen, Bart/GPP-7033-2022; Landell, Melissa F/N-9546-2013; Peter, Gabor/E-9228-2010; Boekhout, Teunis/ABF-2538-2020; Pimenta, Raphael Sanzio/ABE-4515-2021; Vainstein, Marilene H/J-5452-2014; Pimenta, Raphael Sanzio/D-9195-2013; Valente, Patricia/H-4773-2018; Passarini, Michel/H-7377-2012; Pagnocca, Fernando Carlos C/H-1688-2012	Landell, Melissa F/0000-0001-6848-0803; Boekhout, Teunis/0000-0002-0476-3609; Vainstein, Marilene H/0000-0002-3914-2300; Pimenta, Raphael Sanzio/0000-0001-7207-4437; Valente, Patricia/0000-0001-5374-0991; Pagnocca, Fernando Carlos C/0000-0002-5026-1933; Dlauchy, Denes/0000-0003-4425-6684; Sette, Lara/0000-0002-5980-3786	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conselho Nacional de Pesquisa; Brazilian Electricity Regulatory Agency; BANDEIRANTE Energy S. A.; National Science Foundation [DEB-0206521, DEB-0072741, REU, DEB-0417180, TAMOP 4.2.1/B-09/1/KMR-2010-0005]	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Pesquisa; Brazilian Electricity Regulatory Agency; BANDEIRANTE Energy S. A.; National Science Foundation(National Science Foundation (NSF))	This work was funded by Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Conselho Nacional de Pesquisa, Brazilian Electricity Regulatory Agency, BANDEIRANTE Energy S. A., National Science Foundation Grants DEB-0206521, DEB-0072741, REU, DEB-0417180 and TAMOP 4.2.1/B-09/1/KMR-2010-0005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi AO, 2005, BIOMETALS, V18, P269, DOI 10.1007/s10534-005-1539-2; Barnett JA, 2000, YEASTS CHARACTERISTI, V3; Beech IB, 1999, REV MICROBIOL, V30, P177; BOEKHOUT T, 1991, ANTON LEEUW INT J G, V59, P81, DOI 10.1007/BF00445652; Boekhout T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1339, DOI 10.1016/B978-0-444-52149-1.00100-2; Crestani J, 2009, INT J SYST EVOL MICR, V59, P631, DOI 10.1099/ijs.0.001800-0; Fell JW, 2011, ANTON LEEUW INT J G, V99, P533, DOI 10.1007/s10482-010-9521-6; Fell JW, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1595, DOI 10.1016/B978-0-444-52149-1.00134-8; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; FELL JW, 1989, TAXON, V38, P151, DOI 10.2307/1220923; Fell JW, 1987, YEASTS TAXONOMIC STU, V3, P1503; Fell JW, 2008, YEASTS TAXONOMIC STU, V3, P1847; Fonseca A, 1901, YEASTS TAXONOMIC STU, V3; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; HAGENAUER A, 1994, WERKST KORROS, V45, P355; Inacio J, 2008, FEMS YEAST RES, V8, P499, DOI 10.1111/j.1567-1364.2008.00377.x; Kirschner R, 2001, ANTON LEEUW INT J G, V80, P149, DOI 10.1023/A:1012275204498; Kurtzman CP, 2008, FEMS YEAST RES, V8, P939, DOI 10.1111/j.1567-1364.2008.00419.x; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kurtzman CP, 2010, FEMS YEAST RES, V10, P353, DOI 10.1111/j.1567-1364.2010.00625.x; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Kwon-Chung KJ, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1457, DOI 10.1016/B978-0-444-52149-1.00115-4; Margesin R, 2008, INT J SYST EVOL MICR, V58, P2977, DOI 10.1099/ijs.0.2008/000836-0; Middelhoven WJ, 2005, ANTON LEEUW INT J G, V87, P101, DOI 10.1007/s10482-004-1728-y; Millanes AM, 2011, MOL PHYLOGENET EVOL, V61, P12, DOI 10.1016/j.ympev.2011.05.014; Peter G, 2009, FEMS YEAST RES, V9, P328, DOI 10.1111/j.1567-1364.2008.00466.x; Reyes-Novelo E, 2007, REV BIOL TROP, V55, P83; Saluja P, 2007, INT J SYST EVOL MICR, V57, P414, DOI 10.1099/ijs.0.64543-0; Sampaio JP, 2004, INT J SYST EVOL MICR, V54, P987, DOI 10.1099/ijs.0.02970-0; Sampaio JP, 2002, MYCOLOGIA, V94, P873, DOI 10.2307/3761703; Sampaio JP, 2001, INT J SYST EVOL MICR, V51, P687, DOI 10.1099/00207713-51-2-687; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Sette LD, 2010, FUNGAL DIVERS, V44, P53, DOI 10.1007/s13225-010-0048-y; Shin KS, 2006, INT J SYST EVOL MICR, V56, P2241, DOI 10.1099/ijs.0.64353-0; Shockley F.W., 2009, Insecta Mundi, V0072, P1; Statzell-Tallman A, 2008, FEMS YEAST RES, V8, P103, DOI 10.1111/j.1567-1364.2007.00314.x; Sugita T, 2000, J CLIN MICROBIOL, V38, P1468, DOI 10.1128/JCM.38.4.1468-1471.2000; Takashima M, 2003, INT J SYST EVOL MICR, V53, P1187, DOI 10.1099/ijs.0.02498-0; Takashima M, 2001, J GEN APPL MICROBIOL, V47, P75, DOI 10.2323/jgam.47.75; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Bel AJE, 2008, J EXP BOT, V59, P261, DOI 10.1093/jxb/erm294; Wang QM, 2008, FEMS YEAST RES, V8, P799, DOI 10.1111/j.1567-1364.2008.00403.x; Wang QM, 2011, INT J SYST EVOL MICR, V61, P210, DOI 10.1099/ijs.0.019299-0; Zamora Fernando, 2009, P3, DOI 10.1007/978-0-387-74118-5_1; ZIMMERMANN MH, 1957, PLANT PHYSIOL, V32, P288, DOI 10.1104/pp.32.4.288	45	17	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46060	10.1371/journal.pone.0046060	http://dx.doi.org/10.1371/journal.pone.0046060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056233	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400009
J	Adur, J; Pelegati, VB; de Thomaz, AA; Baratti, MO; Almeida, DB; Andrade, LALA; Bottcher-Luiz, F; Carvalho, HF; Cesar, CL				Adur, Javier; Pelegati, Vitor B.; de Thomaz, Andre A.; Baratti, Mariana O.; Almeida, Diogo B.; Andrade, L. A. L. A.; Bottcher-Luiz, Fatima; Carvalho, Hernandes F.; Cesar, Carlos L.			Optical Biomarkers of Serous and Mucinous Human Ovarian Tumor Assessed with Nonlinear Optics Microscopies	PLOS ONE			English	Article							2ND-HARMONIC GENERATION MICROSCOPY; BASAL-CELL CARCINOMA; MULTIPHOTON MICROSCOPY; IN-VIVO; FLUORESCENCE; CANCER; COLLAGEN; BREAST; 2-PHOTON; AUTOFLUORESCENCE	Background: Nonlinear optical (NLO) microscopy techniques have potential to improve the early detection of epithelial ovarian cancer. In this study we showed that multimodal NLO microscopies, including two-photon excitation fluorescence (TPEF), second-harmonic generation (SHG), third-harmonic generation (THG) and fluorescence lifetime imaging microscopy (FLIM) can detect morphological and metabolic changes associated with ovarian cancer progression. Methodology/Principal Findings: We obtained strong TPEF + SHG + THG signals from fixed samples stained with Hematoxylin & Eosin (H&E) and robust FLIM signal from fixed unstained samples. Particularly, we imaged 34 ovarian biopsies from different patients (median age, 49 years) including 5 normal ovarian tissue, 18 serous tumors and 11 mucinous tumors with the multimodal NLO platform developed in our laboratory. We have been able to distinguish adenomas, borderline, and adenocarcinomas specimens. Using a complete set of scoring methods we found significant differences in the content, distribution and organization of collagen fibrils in the stroma as well as in the morphology and fluorescence lifetime from epithelial ovarian cells. Conclusions/Significance: NLO microscopes provide complementary information about tissue microstructure, showing distinctive patterns for serous and mucinous ovarian tumors. The results provide a basis to interpret future NLO images of ovarian tissue and lay the foundation for future in vivo optical evaluation of premature ovarian lesions.	[Adur, Javier; Pelegati, Vitor B.; de Thomaz, Andre A.; Almeida, Diogo B.; Cesar, Carlos L.] State Univ Campinas UNICAMP, Inst Phys Gleb Wataghin, Opt & Photon Res Ctr CEPOF, Biophoton Grp, Sao Paulo, Brazil; [Adur, Javier] Natl Univ Entre Rios, Sch Bioengn, Microscopy Lab Appl Mol & Cellular Studies, Oro Verde, Entre Rios, Argentina; [Andrade, L. A. L. A.] State Univ Campinas UNICAMP, Fac Med Sci, Dept Pathol Anat, Sao Paulo, Brazil; [Bottcher-Luiz, Fatima] State Univ Campinas UNICAMP, Fac Med Sci, Dept Obstet & Gynecol, Sao Paulo, Brazil; [Carvalho, Hernandes F.] State Univ Campinas UNICAMP, Dept Anat Cell Biol Physiol & Biophys, Inst Biol, Sao Paulo, Brazil; [Baratti, Mariana O.; Carvalho, Hernandes F.; Cesar, Carlos L.] INFABiC Natl Inst Sci & Technol Photon Appl Cell, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Adur, J (corresponding author), State Univ Campinas UNICAMP, Inst Phys Gleb Wataghin, Opt & Photon Res Ctr CEPOF, Biophoton Grp, Sao Paulo, Brazil.	jadur@bioingenieria.edu.ar	Adur, Javier/AAC-9601-2019; Lenz Cesar, Carlos/F-2442-2018; Cesar, Carlos/O-1470-2013; Carvalho, Hernandes/C-2046-2012; de Thomaz, Andre/G-7505-2014	Lenz Cesar, Carlos/0000-0001-5573-9636; de Thomaz, Andre/0000-0002-8318-4428	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; FAPESP-INCT-INFABIC [2008/57906-3]; FAPESP [2010/12565-4]	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP-INCT-INFABIC; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (www.fapesp.br). FAPESP Process No 2010/12565-4. FAPESP-INCT-INFABIC Process No 2008/57906-3. The funding institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adur J, 2011, P SPIE, P8086; Adur J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.081407; Adur J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3626575; Becker W., 2008, HDB BIOMEDICAL NONLI, P499; Bird DK, 2004, APPL OPTICS, V43, P5173, DOI 10.1364/AO.43.005173; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; Campagnola PJ, 2011, LASER PHOTONICS REV, V5, P13, DOI 10.1002/lpor.200910024; Chernyavskiy O, 2009, MICROSC RES TECHNIQ, V72, P411, DOI 10.1002/jemt.20687; Cicchi R, 2007, OPT EXPRESS, V15, P10135, DOI 10.1364/OE.15.010135; Cicchi R, 2007, BIOPHYS J A S, p157A; Cicchi R, 2010, J BIOPHOTONICS, V3, P34, DOI 10.1002/jbio.200910062; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Conklin MW, 2009, CELL BIOCHEM BIOPHYS, V53, P145, DOI 10.1007/s12013-009-9046-7; De Beule PAA, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2818785; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; DELCASTILLO P, 1986, HISTOCHEMISTRY, V85, P439, DOI 10.1007/BF00982676; Eliceiri KW, 2003, J BIOMED OPT, V8, P376, DOI 10.1117/1.1584053; Galletly NP, 2008, BRIT J DERMATOL, V159, P152, DOI 10.1111/j.1365-2133.2008.08577.x; Gu M., 2010, FEMTOSECOND BIOPHOTO, P9; Gubbels JAA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-8; Hall-Beyer M., 2007, GLCM TUTORIAL HOMEPA; Hart WR, 2005, INT J GYNECOL PATHOL, V24, P4, DOI 10.1097/01.pgp.0000148335.39146.a7; Hu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037962; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Jain M, 2012, ARCH PATHOL LAB MED, V136, P517, DOI 10.5858/arpa.2011-0147-OA; Kaku Tsunehisa, 2003, Medical Electron Microscopy, V36, P9, DOI 10.1007/s007950300002; Kirkpatrick ND, 2007, CANCER EPIDEM BIOMAR, V16, P2048, DOI 10.1158/1055-9965.EPI-07-0009; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; Kosaka N, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3083449; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Leppert J, 2006, NEUROSURGERY, V58, P759, DOI 10.1227/01.NEU.0000204885.45644.22; Lin SJ, 2005, OPT LETT, V30, P2275, DOI 10.1364/OL.30.002275; MAEDAYORITA K, 1984, J BIOCHEM-TOKYO, V96, P683, DOI 10.1093/oxfordjournals.jbchem.a134886; Meyer T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533268; Nadiarnykh O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-94; Nafe R, 2002, ELEC J PATHOL HISTOL, V8.3; Pawley JB, 1994, HDB BIOL CONFOCAL MI; Pelegati VB, 2012, MICROSC RES TECHNIQ, V75, P1383, DOI 10.1002/jemt.22078; Perry SW, 2012, ANN BIOMED ENG, V40, P277, DOI 10.1007/s10439-012-0512-9; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Provenzano PP, 2009, CLIN EXP METASTAS, V26, P357, DOI 10.1007/s10585-008-9204-0; Provenzano PP, 2008, MICROSC MICROANAL, V14, P532, DOI 10.1017/S1431927608080884; Rueden CT, 2009, IEEE ENG MED BIO, P4077, DOI 10.1109/IEMBS.2009.5334523; Sheth RA, 2009, GYNECOL ONCOL, V112, P616, DOI 10.1016/j.ygyno.2008.11.018; Skala MC, 2004, LASER SURG MED, V34, P25, DOI 10.1002/lsm.10239; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Skala MC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717503; Tai SP, 2006, OPT EXPRESS, V14, P6178, DOI 10.1364/OE.14.006178; Tuer A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3382908; Wang WG, 2002, CANCER RES, V62, P6278; Williams RM, 2010, TRANSL ONCOL, V3, P181, DOI 10.1593/tlo.09310; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Yan J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.026004; Zhuo SM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3441337	56	38	39	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47007	10.1371/journal.pone.0047007	http://dx.doi.org/10.1371/journal.pone.0047007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056557	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500120
J	Bai, M; Zhu, XZ; Zhang, Y; Zhang, S; Zhang, L; Xue, L; Yi, JY; Yao, SQ; Zhang, XW				Bai, Mei; Zhu, Xiongzhao; Zhang, Yi; Zhang, Sheng; Zhang, Li; Xue, Liang; Yi, Jinyao; Yao, Shuqiao; Zhang, Xiuwu			Abnormal Hippocampal BDNF and miR-16 Expression Is Associated with Depression-Like Behaviors Induced by Stress during Early Life	PLOS ONE			English	Article							CHRONIC MILD STRESS; MATERNAL SEPARATION; MESSENGER-RNA; RESPONSES; BRAIN; ANTIDEPRESSANTS; IMPAIRMENT; PLASTICITY; DISORDERS; RECEPTORS	Some environmental stressors lead to the onset of depression via inhibiting hippocampal BDNF expression, but other environmental stressors-induced depression exhibits no change in BDNF expression. The underlying mechanisms behind the divergence remain unknown. In this study, depression-like behaviors were induced in rats by maternal deprivation (MD) and chronic unpredictable stress (CUPS). Depression-like behaviors were tested by open field test, forced swimming test, and sucrose consumption test. BDNF and miR-16 expressions in the hippocampus were examined by real-time PCR. MD and CUPS rats crawled less distance, exhibited decreased vertical activity, and produced more fecal pellets than control rats in the open field test. However, MD rats crawled less distance and produced significantly less fecal pellets than CUPS rats. In the forced swimming and sucrose consumption tests, CUPS and MD rats exhibited longer floating time and consumed less sucrose than control rats, but MD rats exhibited shorter floating time and consumed less sucrose than CUPS rats. MD but not CUPS rats showed lower BDNF mRNA and higher miR-16 expression than control rats. In MD rats, BDNF mRNA expression negatively correlated with the expression of miR-16. BDNF expression positively correlated with the total distance rats crawled and vertical activity in the open field test while miR-16 expression negatively correlated the two behaviors. BDNF positively correlated with sucrose preference rate while miR-16 negatively correlated with sucrose preference rate of the sucrose consumption test. Our study suggests that MD and CUPS induced different depression-like behaviors in rats. Depression induced by MD but not CUPS was significantly associated with upregulation of miR-16 and possibly subsequent downregulation of BDNF in hippocampus.	[Bai, Mei; Zhu, Xiongzhao; Zhang, Yi; Zhang, Sheng; Zhang, Li; Xue, Liang; Yi, Jinyao; Yao, Shuqiao] Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China; [Zhang, Xiuwu] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Central South University; Duke University	Zhu, XZ (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China.	xzxzhu@yahoo.com			National Natural Science Foundation of China [81071097]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81071097). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Bian Y., 2012, BRAIN RES B; Cieslik K, 2011, PHARMACOL REP, V63, P537; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Furukawa TA, 2007, CAN J PSYCHIAT, V52, P545, DOI 10.1177/070674370705200902; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Krol J, 2011, NAT REV GENET, V11, P610; Kubera M, 2011, PROG NEURO-PSYCHOPH, V35, P744, DOI 10.1016/j.pnpbp.2010.08.026; Larsen MH, 2010, J PSYCHIATR RES, V44, P808, DOI 10.1016/j.jpsychires.2010.01.005; Launay JM, 2011, TRANSL PSYCHIAT, V2011, P1; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin YH, 2005, BEHAV BRAIN RES, V165, P63, DOI 10.1016/j.bbr.2005.06.034; Lippmann M, 2007, EUR J NEUROSCI, V25, P3091, DOI 10.1111/j.1460-9568.2007.05522.x; Longone P, 2008, NEUROCHEM INT, V52, P596, DOI 10.1016/j.neuint.2007.10.001; Masi G, 2011, CNS DRUGS, V25, P913, DOI 10.2165/11595900-000000000-00000; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Numakawa T, 2011, NEUROCHEM INT, V59, P551, DOI 10.1016/j.neuint.2011.06.009; Ottem EN, 2010, MOL CELL ENDOCRINOL, V328, P40, DOI 10.1016/j.mce.2010.07.001; Paxinos A, 2005, RAT BRAIN STEREOTACT; Ploj K, 2003, NEUROSCIENCE, V121, P787, DOI 10.1016/S0306-4522(03)00499-8; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; Razzoli M, 2009, PSYCHONEUROENDOCRINO, V34, P1405, DOI 10.1016/j.psyneuen.2009.04.018; Song L, 2006, PHARMACOL BIOCHEM BE, V83, P186, DOI 10.1016/j.pbb.2006.01.004; Storey JD, 2006, BEHAV BRAIN RES, V166, P220, DOI 10.1016/j.bbr.2005.08.002; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Yau SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024263; Zhang B, 2003, DEV BIOL, V302, P1; Zhang XW, 2007, NEUROPSYCHOPHARMACOL, V32, P377, DOI 10.1038/sj.npp.1301101; Zhao YN, 2012, BEHAV BRAIN RES, V228, P339, DOI 10.1016/j.bbr.2011.12.013; Zhu XZ, 2010, BEHAV BRAIN RES, V209, P281, DOI 10.1016/j.bbr.2010.02.005	33	137	147	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46921	10.1371/journal.pone.0046921	http://dx.doi.org/10.1371/journal.pone.0046921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056528	gold, Green Published, Green Submitted			2022-12-27	WOS:000309831500109
J	Migliolo, L; Silva, ON; Silva, PA; Costa, MP; Costa, CR; Nolasco, DO; Barbosa, JARG; Silva, MRR; Bemquerer, MP; Lima, LMP; Romanos, MTV; Freitas, SM; Magalhaes, BS; Franco, OL				Migliolo, Ludovico; Silva, Osmar N.; Silva, Paula A.; Costa, Maysa P.; Costa, Carolina R.; Nolasco, Diego O.; Barbosa, Joao A. R. G.; Silva, Maria R. R.; Bemquerer, Marcelo P.; Lima, Lidia M. P.; Romanos, Maria T. V.; Freitas, Sonia M.; Magalhaes, Beatriz S.; Franco, Octavio L.			Structural and Functional Characterization of a Multifunctional Alanine-Rich Peptide Analogue from Pleuronectes americanus	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; ANTIFREEZE PROTEINS; QUANTITATIVE-DETERMINATION; ANTIVIRAL ACTIVITY; WINTER FLOUNDER; IDENTIFICATION; MECHANISM; SEQUENCE; EXPRESSION; ALPHA	Recently, defense peptides that are able to act against several targets have been characterized. The present work focuses on structural and functional evaluation of the peptide analogue Pa-MAP, previously isolated as an antifreeze peptide from Pleuronectes americanus. Pa-MAP showed activities against different targets such as tumoral cells in culture (CACO-2, MCF-7 and HCT-116), bacteria (Escherichia coli ATCC 8739 and Staphylococcus aureus ATCC 25923), viruses (HSV-1 and HSV-2) and fungi (Candida parapsilosis ATCC 22019, Trichophyton mentagrophytes (28d&E) and T. rubrum (327)). This peptide did not show toxicity against mammalian cells such as erythrocytes, Vero and RAW 264.7 cells. Molecular mechanism of action was related to hydrophobic residues, since only the terminal amino group is charged at pH 7 as confirmed by potentiometric titration. In order to shed some light on its structure-function relations, in vitro and in silico assays were carried out using circular dichroism and molecular dynamics. Furthermore, Pa-MAP showed partial unfolding of the peptide changes in a wide pH (3 to 11) and temperature (25 to 95 degrees C) ranges, although it might not reach complete unfolding at 95 degrees C, suggesting a high conformational stability. This peptide also showed a conformational transition with a partial a-helical fold in water and a full a-helical core in SDS and TFE environments. These results were corroborated by spectral data measured at 222 nm and by 50 ns dynamic simulation. In conclusion, data reported here show that Pa-MAP is a potential candidate for drug design against pathogenic microorganisms due to its structural stability and wide activity against a range of targets.	[Migliolo, Ludovico; Silva, Osmar N.; Silva, Paula A.; Nolasco, Diego O.; Barbosa, Joao A. R. G.; Lima, Lidia M. P.; Magalhaes, Beatriz S.; Franco, Octavio L.] Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Silva, Osmar N.] Univ Fed Juiz de Fora, Programa Posgrad Genet & Biotecnol, Juiz De Fora, MG, Brazil; [Barbosa, Joao A. R. G.; Freitas, Sonia M.] Univ Brasilia, Lab Biofis, Dept Biol Celular, Brasilia, DF, Brazil; [Bemquerer, Marcelo P.] EMBRAPA Recursos Genet & Biotecnol, Lab Sintese Peptideos, Brasilia, DF, Brazil; [Costa, Maysa P.; Costa, Carolina R.; Silva, Maria R. R.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Silva, Paula A.; Romanos, Maria T. V.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Virol, Rio De Janeiro, Brazil	Universidade Catolica de Brasilia; Universidade Federal de Juiz de Fora; Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Goias; Universidade Federal do Rio de Janeiro	Franco, OL (corresponding author), Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil.	ocfranco@gmail.com	Barbosa, João/GVT-7916-2022; MIGLIOLO, LUDOVICO/AAV-6913-2021; Nolasco, Diego O/O-6743-2014; Nolasco, Diego O./D-1241-2017; Barbosa, João Alexandre/E-2261-2012; Silva, Osmar N./B-3183-2012; Silva, Osmar/M-3270-2019; Franco, Octavio L/T-3020-2017; Bemquerer, Marcelo Porto/A-9688-2013	MIGLIOLO, LUDOVICO/0000-0002-6606-2189; Nolasco, Diego O/0000-0001-7931-5475; Nolasco, Diego O./0000-0001-7931-5475; Barbosa, João Alexandre/0000-0002-0534-481X; Silva, Osmar N./0000-0003-2148-131X; Silva, Osmar/0000-0003-2148-131X; Bemquerer, Marcelo Porto/0000-0002-9740-5818; Franco, Octavio/0000-0001-9546-0525	CAPES; CNPq; FAPDF; UCB	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); UCB(UCB Pharma SA)	This work was supported by CAPES, CNPq, FAPDF and UCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, METHODS DILUTION ANT; Baek JH, 2011, PEPTIDES, V32, P568, DOI 10.1016/j.peptides.2010.12.007; Bechinger B, 2011, J PEPT SCI, V17, P306, DOI 10.1002/psc.1343; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Broekman DC, 2011, PEPTIDES, V32, P2044, DOI 10.1016/j.peptides.2011.09.012; Carrillo-Munoz A J, 2006, Rev Esp Quimioter, V19, P130; Chan WC, 2000, FMOC SOLID PHASE PEP; Chang SN, 2001, NUCLEOS NUCLEOT NUCL, V20, P1571, DOI 10.1081/NCN-100105248; Chang WT, 2011, PEPTIDES, V32, P342, DOI 10.1016/j.peptides.2010.11.003; Chernysh S, 2002, P NATL ACAD SCI USA, V99, P12628, DOI 10.1073/pnas.192301899; Crouch SR, 2004, FUNDAMENTALS ANAL CH; Cutler DM, 2007, J HEALTH ECON, V26, P1081, DOI 10.1016/j.jhealeco.2007.09.003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding T, 2010, OPT EXPRESS, V18, P27431, DOI 10.1364/OE.18.027431; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Domadia PN, 2010, J AM CHEM SOC, V132, P18417, DOI 10.1021/ja1083255; Douglas SE, 2003, DEV COMP IMMUNOL, V27, P589, DOI 10.1016/S0145-305X(03)00036-3; Fehlbaum P, 1996, P NATL ACAD SCI USA, V93, P1221, DOI 10.1073/pnas.93.3.1221; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Foubister V, 2003, DRUG DISCOV TODAY, V8, P610, DOI 10.1016/S1359-6446(03)02775-2; Franco OL, 2011, FEBS LETT, V585, P995, DOI 10.1016/j.febslet.2011.03.008; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gong ZY, 1996, J BIOL CHEM, V271, P4106, DOI 10.1074/jbc.271.8.4106; Hall T, 1999, NUCL ACIDS S SERIES, V4; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HEW CL, 1985, EUR J BIOCHEM, V151, P167, DOI 10.1111/j.1432-1033.1985.tb09081.x; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; HINCHA DK, 1993, BIOCHIM BIOPHYS ACTA, V1146, P258, DOI 10.1016/0005-2736(93)90364-6; HOLMBERG N, 1994, FEBS LETT, V349, P354, DOI 10.1016/0014-5793(94)00705-5; Huang YB, 2011, MOL CANCER THER, V10, P416, DOI 10.1158/1535-7163.MCT-10-0811; Jalili S, 2010, J COMPUT CHEM, V31, P286, DOI 10.1002/jcc.21316; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; KAMLET MJ, 1983, J ORG CHEM, V48, P2877, DOI 10.1021/jo00165a018; Khameneh ZR, 2010, EXP CLIN TRANSPLANT, V8, P146; KREIL G, 1973, EUR J BIOCHEM, V33, P558, DOI 10.1111/j.1432-1033.1973.tb02716.x; Kuiper MJ, 2002, J PEPT RES, V59, P1, DOI 10.1046/j.1397-002x.2001.00001.x; Kun H, 2008, J BIOENERG BIOMEMBR, V40, P389, DOI 10.1007/s10863-008-9164-8; Lee CC, 2011, BIOPHYS J, V100, P1688, DOI 10.1016/j.bpj.2011.02.018; Lee DG, 2004, J PEPT SCI, V10, P298, DOI 10.1002/psc.504; Lee WH, 2005, EUR J IMMUNOL, V35, P1220, DOI 10.1002/eji.200425615; Li HY, 2010, BIOCHEMISTRY-US, V49, P1259, DOI 10.1021/bi902075h; Liepinsh E, 2002, EUR J BIOCHEM, V269, P1259, DOI 10.1046/j.1432-1033.2002.02766.x; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Mandal SM, 2012, J CELL BIOCHEM, V113, P184, DOI 10.1002/jcb.23343; Mandal SM, 2011, PEPTIDES, V32, P1741, DOI 10.1016/j.peptides.2011.06.020; Mandal SM, 2009, PEPTIDES, V30, P633, DOI 10.1016/j.peptides.2008.12.001; Markoulatos P, 2001, J CLIN MICROBIOL, V39, P4426, DOI 10.1128/JCM.39.12.4426-4432.2001; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; MURPHY JB, 1960, BIOCHIM BIOPHYS ACTA, V45, P382, DOI 10.1016/0006-3002(60)91464-5; NISHIMURA T, 1977, Kitasato Archives of Experimental Medicine, V50, P39; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Oren Z, 1998, BIOPOLYMERS, V47, P451; Pan CY, 2007, DNA CELL BIOL, V26, P403, DOI 10.1089/dna.2006.0564; Park CB, 1997, FEBS LETT, V411, P173, DOI 10.1016/S0014-5793(97)00684-4; Park NG, 2011, BIOCHEMISTRY-US, V50, P3288, DOI 10.1021/bi101395j; Pelegrini PB, 2005, INT J BIOCHEM CELL B, V37, P2239, DOI 10.1016/j.biocel.2005.06.011; Pinto MFS, 2012, J BIOL CHEM, V287, P134, DOI 10.1074/jbc.M111.294009; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roccatano D, 2002, P NATL ACAD SCI USA, V99, P12179, DOI 10.1073/pnas.182199699; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rozek T, 2000, EUR J BIOCHEM, V267, P5330, DOI 10.1046/j.1432-1327.2000.01536.x; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Silva ON, 2012, BIOPOLYMERS IN PRESS; Simoes C, 2010, WORLD J MICROB BIOT, V26, P93, DOI 10.1007/s11274-009-0147-7; Soufian S., 2009, WORLD ACAD SCI ENG T, V56, P858; Subramanian S, 2009, MAR BIOTECHNOL, V11, P748, DOI 10.1007/s10126-009-9189-y; Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036; Sung WS, 2008, FEBS LETT, V582, P2463, DOI 10.1016/j.febslet.2008.06.015; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomczak MM, 2002, BIOPHYS J, V82, P874, DOI 10.1016/S0006-3495(02)75449-0; TURNER JD, 1970, ANAL BIOCHEM, V38, P423, DOI 10.1016/0003-2697(70)90467-7; Vad BS, 2010, BIOPHYS J, V98, P576, DOI 10.1016/j.bpj.2009.08.063; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WERKMEISTER JA, 1993, BIOCHIM BIOPHYS ACTA, V1157, P50, DOI 10.1016/0304-4165(93)90077-L; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilkins MR, 1999, METH MOL B, V112, P531; Yi N, 2010, PROTEIN PEPTIDE LETT, V17, P1517, DOI 10.2174/0929866511009011517; ZASLOFF M, 1988, P NATL ACAD SCI USA, V85, P910, DOI 10.1073/pnas.85.3.910; Zeng XC, 2012, PEPTIDES, V33, P44, DOI 10.1016/j.peptides.2011.11.012; Zhang L, 1998, BIOCHEM BIOPH RES CO, V247, P674, DOI 10.1006/bbrc.1998.8848	86	28	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47047	10.1371/journal.pone.0047047	http://dx.doi.org/10.1371/journal.pone.0047047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056574	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500127
J	Munkonda, MN; Lapointe, M; Miegueu, P; Roy, C; Gauvreau, D; Richard, D; Cianflone, K				Munkonda, Mercedes Nancy; Lapointe, Marc; Miegueu, Pierre; Roy, Christian; Gauvreau, Danny; Richard, Denis; Cianflone, Katherine			Recombinant Acylation Stimulating Protein Administration to C3(-/-) Mice Increases Insulin Resistance via Adipocyte Inflammatory Mechanisms	PLOS ONE			English	Article							C5A RECEPTOR C5L2; ADIPOSE-TISSUE; MACROPHAGE-INFILTRATION; ENERGY-EXPENDITURE; C3A ANAPHYLATOXIN; KNOCKOUT MICE; COMPLEMENT C3; IN-VITRO; OBESITY; DEFICIENCY	Background: Complement 3 (C3), a key component of the innate immune system, is involved in early inflammatory responses. Acylation stimulating protein (ASP; aka C3adesArg), a C3 cleavage product, is produced in adipose tissue and stimulates lipid storage. We hypothesized that, depending on the diet, chronic ASP administration in C3(-/-) mice would affect lipid metabolism and insulin sensitivity via an adaptive adipose tissue inflammatory response. Methodology/Principal Findings: C3(-/-) mice on normal low fat diet (ND) or high fat diet (HFD) were chronically administered recombinant ASP (rASP) for 25 days via an osmotic mini-pump. While there was no effect on food intake, there was a decrease in activity, with a relative increase in adipose tissue weight on ND, and a shift in adipocyte size distribution. While rASP administration to C3(-/-) mice on a ND increased insulin sensitivity, on a HFD, rASP administration had the opposite effect. Specifically, rASP administration in C3(-/-) HFD mice resulted in decreased gene expression of IRS1, GLUT4, SREBF1 and NFkB in muscle, and decreased C5L2 but increased JNK, CD36, CD11c, CCR2 and NF kappa B gene expression in adipose tissue as well as increased secretion of proinflammatory cytokines (Rantes, KC, MCP-1, IL-6 and G-CSF). In adipose tissue, although IRS1 and GLUT4 mRNA were unchanged, insulin response was reduced. Conclusion: The effects of chronic rASP administration are tissue and diet specific, rASP administration enhances the HFD induced inflammatory response leading to an insulin-resistant state. These results suggest that, in humans, the increased plasma ASP associated with obesity and cardiovascular disease could be an additional factor directly contributing to development of metabolic syndrome, insulin resistance and diabetes.	[Munkonda, Mercedes Nancy; Lapointe, Marc; Miegueu, Pierre; Roy, Christian; Gauvreau, Danny; Richard, Denis; Cianflone, Katherine] Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Laval University	Cianflone, K (corresponding author), Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	katherine.cianflone@criucpq.ulaval.ca		Lapointe, Marc/0000-0003-0461-2576	Canadian Institutes of Health Research (CIHR); CIHR doctoral fellowships	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR doctoral fellowships(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from Canadian Institutes of Health Research (CIHR) (to KC). KC holds a Canada Research Chair in Adipose Tissue. MNM and CR are supported by CIHR doctoral fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Belgardt BF, 2010, AGING-US, V2, P621, DOI 10.18632/aging.100192; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; CHARRIAUT C, 1982, P NATL ACAD SCI-BIOL, V79, P6003, DOI 10.1073/pnas.79.19.6003; Cianflone K, 2003, BBA-BIOMEMBRANES, V1609, P127, DOI 10.1016/S0005-2736(02)00686-7; COLTEN HR, 1992, ANNU REV IMMUNOL, V10, P809, DOI 10.1146/annurev.iy.10.040192.004113; Cui W, 2009, MOL IMMUNOL, V46, P3207, DOI 10.1016/j.molimm.2009.08.013; Cui W, 2009, MOL IMMUNOL, V46, P3086, DOI 10.1016/j.molimm.2009.06.007; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fischer WH, 1997, J IMMUNOL, V159, P4279; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HAEFFNERCAVAILLON N, 1987, J IMMUNOL, V139, P794; He SQ, 2009, J CLIN INVEST, V119, P2304, DOI 10.1172/JCI38289; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; HOLLERHAGE HG, 1989, ACTA NEUROPATHOL, V77, P307, DOI 10.1007/BF00687583; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huber-Lang M, 2005, J IMMUNOL, V174, P1104, DOI 10.4049/jimmunol.174.2.1104; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kalant D, 2003, J BIOL CHEM, V278, P11123, DOI 10.1074/jbc.M206169200; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Maslowska M, 2006, J LIPID RES, V47, P643, DOI 10.1194/jlr.M500500-JLR200; Maslowska M, 2005, VITAM HORM, V70, P309, DOI 10.1016/S0083-6729(05)70010-8; Murata Y, 2007, BIOCHEM BIOPH RES CO, V364, P301, DOI 10.1016/j.bbrc.2007.10.007; Murray I, 1999, BIOCHEM J, V342, P41, DOI 10.1042/0264-6021:3420041; Murray I, 1997, J LIPID RES, V38, P2492; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Onat A, 2011, CLIN CHIM ACTA, V412, P1171, DOI 10.1016/j.cca.2011.03.005; Paglialunga S, 2008, AM J PHYSIOL-ENDOC M, V294, pE521, DOI 10.1152/ajpendo.00590.2007; Paglialunga S, 2007, J ENDOCRINOL, V194, P293, DOI 10.1677/JOE-07-0205; Paglialunga Sabina, 2010, BMC Physiology, V10, P4, DOI 10.1186/1472-6793-10-4; Paglialunga S, 2009, J LIPID RES, V50, P1109, DOI 10.1194/jlr.M800430-JLR200; Roy C, 2011, AM J PHYSIOL-ENDOC M, V301, pE232, DOI 10.1152/ajpendo.00476.2010; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Takabayashi T, 1998, J INFECT DIS, V177, P1622, DOI 10.1086/515316; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Wernstedt I, 2006, ENDOCRINOLOGY, V147, P2690, DOI 10.1210/en.2005-1133; Wu Y, 2009, FERTIL STERIL, V91, P213, DOI 10.1016/j.fertnstert.2007.11.031; Xia ZN, 2004, J BIOL CHEM, V279, P4051, DOI 10.1074/jbc.M311319200; Yang Y, 2006, INT J OBESITY, V30, P439, DOI 10.1038/sj.ijo.0803173	52	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46883	10.1371/journal.pone.0046883	http://dx.doi.org/10.1371/journal.pone.0046883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056509	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500100
J	Sette, G; Salvati, V; Memeo, L; Fecchi, K; Colarossi, C; Di Matteo, P; Signore, M; Biffoni, M; D'Andrea, V; De Antoni, E; Canzonieri, V; De Maria, R; Eramo, A				Sette, Giovanni; Salvati, Valentina; Memeo, Lorenzo; Fecchi, Katia; Colarossi, Cristina; Di Matteo, Paola; Signore, Michele; Biffoni, Mauro; D'Andrea, Vito; De Antoni, Enrico; Canzonieri, Vincenzo; De Maria, Ruggero; Eramo, Adriana			EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; MESENCHYMAL STEM-CELLS; FACTOR RECEPTOR BLOCKADE; TUMOR-INITIATING CELLS; PHASE-II; DRUG-RESISTANCE; IN-VITRO; CHEMOTHERAPY; IDENTIFICATION; EXPRESSION	Background: Tumor cells with stem-like phenotype and properties, known as cancer stem cells (CSC), have been identified in most solid tumors and are presumed to be responsible for driving tumor initiation, chemoresistance, relapse, or metastasis. A subpopulation of cells with increased stem-like potential has also been identified within sarcomas. These cells are endowed with increased tumorigenic potential, chemoresistance, expression of embryonic markers, and side population(SP) phenotype. Leiomyosarcomas (LMS) are soft tissue sarcomas presumably arising from undifferentiated cells of mesenchymal origin, the Mesenchymal Stem Cells (MSC). Frequent recurrence of LMS and chemoresistance of relapsed patients may likely result from the failure to target CSC. Therefore, therapeutic cues coming from the cancer stem cell (CSC) field may drastically improve patient outcome. Methodology/Principal Findings: We expanded LMS stem-like cells from patient samples in vitro and examined the possibility to counteract LMS malignancy through a stem-like cell effective approach. LMS stem-like cells were in vitro expanded both as "tumor spheres" and as "monolayers" in Mesenchymal Stem Cell (MSC) conditions. LMS stem-like cells displayed MSC phenotype, higher SP fraction, and increased drug-extrusion, extended proliferation potential, self-renewal, and multiple differentiation ability. They were chemoresistant, highly tumorigenic, and faithfully reproduced the patient tumor in mice. Such cells displayed activation of EGFR/AKT/MAPK pathways, suggesting a possibility in overcoming their chemoresistance through EGFR blockade. IRESSA plus Vincristine treatment determined pathway inactivation, impairment of SP phenotype, high cytotoxicity in vitro and strong antitumor activity in stem-like cell-generated patient-like xenografts, targeting both stem-like and differentiated cells. Conclusions/Significance: EGFR blockade combined with vincristine determines stem-like cell effective antitumor activity in vitro and in vivo against LMS, thus providing a potential therapy for LMS patients.	[Sette, Giovanni; Salvati, Valentina; Fecchi, Katia; Di Matteo, Paola; Signore, Michele; Biffoni, Mauro; Eramo, Adriana] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Memeo, Lorenzo; Colarossi, Cristina] Mediterranean Inst Oncol, Catania, Italy; [D'Andrea, Vito; De Antoni, Enrico] Univ Roma La Sapienza, Dept Surg Sci, Rome, Italy; [Canzonieri, Vincenzo] Ist Nazl Tumori, Ctr Riferimento Oncol, Div Pathol, Aviano, Italy; [De Maria, Ruggero] Regina Elena Inst Canc Res, Rome, Italy	Istituto Superiore di Sanita (ISS); Mediterranean Institute of Oncology; Sapienza University Rome; IRCCS Aviano (CRO); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Eramo, A (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	adriana.eramo@iss.it	Biffoni, Mauro/J-8318-2016; salvati, Valentina/J-1264-2018; D'ANDREA, VITO/I-4399-2019; Eramo, Adriana/K-6694-2016; Canzonieri, Vincenzo/AAA-7951-2019; Sette, Giovanni/K-6692-2016; Canzonieri, Vincenzo/Z-5933-2019; De Maria, Ruggero/S-6385-2019; Signore, Michele/J-8563-2016; Fecchi, Katia/N-1380-2017	Biffoni, Mauro/0000-0002-1304-9060; salvati, Valentina/0000-0002-0322-3504; D'ANDREA, VITO/0000-0001-5709-2530; Eramo, Adriana/0000-0002-0814-6683; Canzonieri, Vincenzo/0000-0001-6010-0976; Sette, Giovanni/0000-0002-3378-2446; De Maria, Ruggero/0000-0003-2255-0583; Signore, Michele/0000-0002-0262-842X; Colarossi, Cristina/0000-0001-5395-8608; Fecchi, Katia/0000-0003-4397-5783; Memeo, Lorenzo/0000-0003-4251-7203	Italian Association for Cancer Research; Italian Health Ministry	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Health Ministry(Ministry of Health, Italy)	This work was supported by the Italian Association for Cancer Research and the Italian Health Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bartucci M, 2012, CELL DEATH DIFFER, V19, P768, DOI 10.1038/cdd.2011.170; Blay JY, 2003, EUR J CANCER, V39, P64, DOI 10.1016/S0959-8049(02)00480-X; Carcaboso AM, 2010, CANCER RES, V70, P4499, DOI 10.1158/0008-5472.CAN-09-4264; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Francescangeli F, 2012, STEM CELLS, V30, P1819, DOI 10.1002/stem.1163; Garcia-Carbonero R, 2004, J CLIN ONCOL, V22, P1480, DOI 10.1200/JCO.2004.02.098; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hensley ML, 2002, J CLIN ONCOL, V20, P2824, DOI 10.1200/JCO.2002.11.050; Hernando E, 2007, NAT MED, V13, P748, DOI 10.1038/nm1560; Honoki K, 2010, EXPERT REV ANTICANC, V10, P261, DOI [10.1586/era.09.184, 10.1586/ERA.09.184]; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Krikelis D, 2010, EXPERT REV ANTICANC, V10, P249, DOI 10.1586/ERA.09.176; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Mackall CL, 2002, CANCER CELL, V2, P175, DOI 10.1016/S1535-6108(02)00132-0; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; Noguchi K, 2009, CANCER SCI, V100, P1701, DOI 10.1111/j.1349-7006.2009.01213.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oda Y, 2005, INT J CANCER, V114, P854, DOI 10.1002/ijc.20589; Osuna D, 2009, REV RECENT CLIN TRIA, V4, P12, DOI 10.2174/157488709787047585; Penel N, 2010, ANN ONCOL, V21, P1361, DOI 10.1093/annonc/mdp485; Pierobon M, 2009, CLIN COLORECTAL CANC, V8, P110, DOI 10.3816/CCC.2009.n.018; Ren WH, 2008, CLIN CANCER RES, V14, P5466, DOI 10.1158/1078-0432.CCR-08-0562; Ren WH, 2008, CLIN CANCER RES, V14, P2785, DOI 10.1158/1078-0432.CCR-07-4471; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rodriguez R, 2012, CELL RES, V22, P62, DOI 10.1038/cr.2011.157; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Rubio R, 2010, CANCER RES, V70, P4185, DOI 10.1158/0008-5472.CAN-09-4640; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Talbot SM, 2003, CANCER-AM CANCER SOC, V98, P1942, DOI 10.1002/cncr.11730; Thomadaki H, 2009, ANN NY ACAD SCI, V1171, P276, DOI 10.1111/j.1749-6632.2009.04912.x; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; Van Glabbeke M, 1999, J CLIN ONCOL, V17, P150, DOI 10.1200/JCO.1999.17.1.150; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	42	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46891	10.1371/journal.pone.0046891	http://dx.doi.org/10.1371/journal.pone.0046891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056514	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500102
J	van Polanen, V; Tiest, WMB; Kappers, AML				van Polanen, Vonne; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.			Haptic Search for Hard and Soft Spheres	PLOS ONE			English	Article							VISUAL-SEARCH; SUBJECTIVE JUDGMENT; PLASTIC PROPERTIES; POP-OUT; PERCEPTION; FEATURES; BODIES	In this study the saliency of hardness and softness were investigated in an active haptic search task. Two experiments were performed to explore these properties in different contexts. In Experiment 1, blindfolded participants had to grasp a bundle of spheres and determine the presence of a hard target among soft distractors or vice versa. If the difference in compliance between target and distractors was small, reaction times increased with the number of items for both features; a serial strategy was found to be used. When the difference in compliance was large, the reaction times were independent of the number of items, indicating a parallel strategy. In Experiment 2, blindfolded participants pressed their hand on a display filled with hard and soft items. In the search for a soft target, increasing reaction times with the number of items were found, but the location of target and distractors appeared to have a large influence on the search difficulty. In the search for a hard target, reaction times did not depend on the number of items. In sum, this showed that both hardness and softness are salient features.	[van Polanen, Vonne; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands	Utrecht University	van Polanen, V (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	v.van.polanen@vu.nl	van Polanen, Vonne/AAW-3793-2020; Tiest, Wouter M Bergmann/N-8535-2013; van Polanen, Vonne/AAP-7874-2020	van Polanen, Vonne/0000-0003-3111-6199	European Commission [248587, FP7-ICT-2009-4-2-1]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission with the Collaborative Project no. 248587, "THE Hand Embodied", within the FP7-ICT-2009-4-2-1 program "Cognitive Systems and Robotics". http://www.thehandembodied.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair GWS, 1939, PROC R SOC SER B-BIO, V128, P109, DOI 10.1098/rspb.1939.0046; Coppen FMV, 1942, B J PSYCHOL-GEN SECT, V32, P231, DOI 10.1111/j.2044-8295.1942.tb01022.x; Coren S, 1992, LEFT HANDER SYNDROME; JONES LA, 1986, PSYCHOL BULL, V100, P29, DOI 10.1037/0033-2909.100.1.29; Lederman SJ, 1997, J EXP PSYCHOL HUMAN, V23, P1680, DOI 10.1037/0096-1523.23.6.1680; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LEDERMAN SJ, 1988, PERCEPT PSYCHOPHYS, V44, P222, DOI 10.3758/BF03206291; Plaisier MA, 2008, ACTA PSYCHOL, V128, P368, DOI 10.1016/j.actpsy.2008.03.011; Plaisier MA, 2010, LECT NOTES COMPUT SC, V6192, P219, DOI 10.1007/978-3-642-14075-4_31; Plaisier MA, 2009, ACTA PSYCHOL, V131, P163, DOI 10.1016/j.actpsy.2009.04.003; Plaisier MA, 2009, ATTEN PERCEPT PSYCHO, V71, P421, DOI 10.3758/APP.71.2.421; SRINIVASAN MA, 1995, J NEUROPHYSIOL, V73, P88, DOI 10.1152/jn.1995.73.1.88; Tiest WMB, 2009, IEEE T HAPTICS, V2, P189, DOI [10.1109/TOH.2009.16, 10.1109/ToH.2009.16]; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Polanen V, 2012, ATTEN PERCEPT PSYCHO, V74, P204, DOI 10.3758/s13414-011-0216-5; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Wolfe JM, 2003, PERCEPTION, V32, P645, DOI 10.1068/p3414; Wolfe JM, 1998, PSYCHOL SCI, V9, P33, DOI 10.1111/1467-9280.00006	19	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45298	10.1371/journal.pone.0045298	http://dx.doi.org/10.1371/journal.pone.0045298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056197	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500016
J	Rotherham, LS; Maserumule, C; Dheda, K; Theron, J; Khati, M				Rotherham, Lia S.; Maserumule, Charlotte; Dheda, Keertan; Theron, Jacques; Khati, Makobetsa			Selection and Application of ssDNA Aptamers to Detect Active TB from Sputum Samples	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SMEAR MICROSCOPY; IN-VITRO; DIAGNOSIS; ANTIGENS; COMPLEX; PROTEIN; ESAT-6; CFP-10	Background: Despite the enormous global burden of tuberculosis (TB), conventional approaches to diagnosis continue to rely on tests that have major drawbacks. The improvement of TB diagnostics relies, not only on good biomarkers, but also upon accurate detection methodologies. The 10-kDa culture filtrate protein (CFP-10) and the 6-kDa early secreted antigen target (ESAT-6) are potent T-cell antigens that are recognised by over 70% of TB patients. Aptamers, a novel sensitive and specific class of detection molecules, has hitherto, not been raised to these relatively TB-specific antigens. Methods: DNA aptamers that bind to the CFP-10. ESAT-6 heterodimer were isolated. To assess their affinity and specificity to the heterodimer, aptamers were screened using an enzyme-linked oligonucleotide assay (ELONA). One suitable aptamer was evaluated by ELONA using sputum samples obtained from 20 TB patients and 48 control patients (those with latent TB infection, symptomatic non TB patients, and healthy laboratory volunteers). Culture positivity for Mycobacterium tuberculosis (Mtb) served as the reference standard. Accuracy and cut-points were evaluated using ROC curve analysis. Results: Twenty-four out of the 66 aptamers that were isolated bound significantly (p, 0.05) to the CFP-10. ESAT-6 heterodimer and six were further evaluated. Their dissociation constant (K-D) values were in the nanomolar range. One aptamer, designated CSIR 2.11, was evaluated using sputum samples. CSIR 2.11 had sensitivity and specificity of 100% and 68.75% using Youden's index and 35% and 95%, respectively, using a rule-in cut-point. Conclusion: This preliminary proof-of-concept study suggests that a diagnosis of active TB using anti-CFP-10. ESAT-6 aptamers applied to human sputum samples is feasible.	[Rotherham, Lia S.; Maserumule, Charlotte; Khati, Makobetsa] CSIR, Biosci Unit, Pretoria, South Africa; [Rotherham, Lia S.; Theron, Jacques] Univ Pretoria, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa; [Maserumule, Charlotte; Dheda, Keertan; Khati, Makobetsa] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Maserumule, Charlotte; Dheda, Keertan; Khati, Makobetsa] Univ Cape Town, ZA-7925 Cape Town, South Africa	Council for Scientific & Industrial Research (CSIR) - South Africa; University of Pretoria; University of Cape Town; University of Cape Town	Khati, M (corresponding author), CSIR, Biosci Unit, Pretoria, South Africa.	Mkhati@csir.co.za	Theron, Jacques/E-4755-2010	Maserumule, Charlotte/0000-0002-0771-6031; Theron, Jacques/0000-0001-9091-3898	Department of Science Technology; Technology Innovation Agency	Department of Science Technology(Department of Science & Technology (India)); Technology Innovation Agency	This work was supported by the Department of Science & Technology (http://www.dst.gov.za/) and the Technology Innovation Agency (http://www.tia.org.za/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2011, BIOCHIMIE, V93, P1081, DOI 10.1016/j.biochi.2011.04.003; Alderson MR, 2000, J EXP MED, V191, P551, DOI 10.1084/jem.191.3.551; ANDERSEN P, 1994, IMMUNOBIOLOGY, V191, P537, DOI 10.1016/S0171-2985(11)80460-2; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; [Anonymous], WHO REP 2011 GLOB TU; Arend SM, 2000, J INFECT DIS, V181, P1850, DOI 10.1086/315448; Avci-Adali M, 2010, MOLECULES, V15, P1, DOI 10.3390/molecules15010001; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chaudhary VK, 2005, PROTEIN EXPRES PURIF, V40, P169, DOI 10.1016/j.pep.2004.10.016; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dillon DC, 2000, J CLIN MICROBIOL, V38, P3285, DOI 10.1128/JCM.38.9.3285-3290.2000; Drolet DW, 1996, NAT BIOTECHNOL, V14, P1021, DOI 10.1038/nbt0896-1021; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gey van Pittius NC, 2001, GENOME BIOL, V2; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Huang DB, 2003, P NATL ACAD SCI USA, V100, P9268, DOI 10.1073/pnas.1632011100; Jaeger J, 1998, EMBO J, V17, P4535, DOI 10.1093/emboj/17.15.4535; Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x; Jhaveri SD, 2001, CURR PROTOC NUCL ACI; Kettenberger H, 2006, NAT STRUCT MOL BIOL, V13, P44, DOI 10.1038/nsmb1032; Kulshrestha A, 2005, PROTEIN EXPRES PURIF, V44, P75, DOI 10.1016/j.pep.2005.04.014; Lange C, 2012, EUR RESPIR MONOGR, P1; Laurenson S, 2011, ANAL BIOCHEM, V410, P161, DOI 10.1016/j.ab.2010.10.038; Lee JF, 2006, CURR OPIN CHEM BIOL, V10, P282, DOI 10.1016/j.cbpa.2006.03.015; Liu J, 2006, NAT PROTOC, V1, P246, DOI 10.1038/nprot.2006.38; Liu JW, 2006, ANGEW CHEM INT EDIT, V45, P90, DOI 10.1002/anie.200502589; Low SY, 2009, BIOCHEM BIOPH RES CO, V378, P701, DOI 10.1016/j.bbrc.2008.11.087; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Maciag A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-48; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Qin LH, 2009, CLIN CHEM LAB MED, V47, P405, DOI 10.1515/CCLM.2009.097; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Shangguan D, 2007, CHEMBIOCHEM, V8, P603, DOI 10.1002/cbic.200600532; Shum KT, 2011, BIOCHEMISTRY-US, V50, P3261, DOI 10.1021/bi2001455; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang JY, 2007, EMERG INFECT DIS, V13, P553, DOI 10.3201/eid1304.051195; Wang LH, 2006, CHEM COMMUN, P3780, DOI 10.1039/b607448k; Wei H, 2007, CHEM COMMUN, P3735, DOI 10.1039/b707642h; Yang CJ, 2005, P NATL ACAD SCI USA, V102, P17278, DOI 10.1073/pnas.0508821102	54	53	59	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46862	10.1371/journal.pone.0046862	http://dx.doi.org/10.1371/journal.pone.0046862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056492	Green Published, gold			2022-12-27	WOS:000309580800056
J	Wells, R; Outhred, T; Heathers, JAJ; Quintana, DS; Kemp, AH				Wells, Ruth; Outhred, Tim; Heathers, James A. J.; Quintana, Daniel S.; Kemp, Andrew H.			Matter Over Mind: A Randomised-Controlled Trial of Single-Session Biofeedback Training on Performance Anxiety and Heart Rate Variability in Musicians	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; ARTERIAL BAROREFLEX SENSITIVITY; SOCIAL STRESS TEST; NEUROVISCERAL INTEGRATION; COGNITIVE PERFORMANCE; HRV BIOFEEDBACK; SELF-REGULATION; TRAIT ANXIETY; BETA-BLOCKADE; MODULATION	Background: Musical performance is a skilled activity performed under intense pressure, thus is often a profound source of anxiety. In other contexts, anxiety and its concomitant symptoms of sympathetic nervous system arousal have been successfully ameliorated with HRV biofeedback (HRV BF), a technique involving slow breathing which augments autonomic and emotional regulatory capacity. Objective: This randomised-controlled study explored the impact of a single 30-minute session of HRV BF on anxiety in response to a highly stressful music performance. Methods: A total of 46 trained musicians participated in this study and were randomly allocated to a slow breathing with or without biofeedback or no-treatment control group. A 3 Group x2 Time mixed experimental design was employed to compare the effect of group before and after intervention on performance anxiety (STAI-S) and frequency domain measures of HRV. Results: Slow breathing groups (n = 30) showed significantly greater improvements in high frequency (HF) and LF/HF ratio measures of HRV relative to control (n = 15) during 5 minute recordings of performance anticipation following the intervention (effect size: eta(2) = 0.122 and eta(2) = 0.116, respectively). The addition of biofeedback to a slow breathing protocol did not produce differential results. While intervention groups did not exhibit an overall reduction in self-reported anxiety, participants with high baseline anxiety who received the intervention (n = 15) displayed greater reductions in self-reported state anxiety relative to those in the control condition (n = 7) (r = 0.379). Conclusions: These findings indicate that a single session of slow breathing, regardless of biofeedback, is sufficient for controlling physiological arousal in anticipation of psychosocial stress associated with music performance and that slow breathing is particularly helpful for musicians with high levels of anxiety. Future research is needed to further examine the effects of HRV BF as a low-cost, non-pharmacological treatment for music performance anxiety.	[Wells, Ruth; Outhred, Tim; Heathers, James A. J.; Quintana, Daniel S.; Kemp, Andrew H.] Univ Sydney, Sch Psychol, SCAN Res & Teaching Unit, Sydney, NSW 2006, Australia	University of Sydney	Kemp, AH (corresponding author), Univ Sydney, Sch Psychol, SCAN Res & Teaching Unit, Sydney, NSW 2006, Australia.	andrew.kemp@sydney.edu.au	Quintana, Daniel S./H-2726-2019; Kemp, Andrew Haddon/C-7984-2012; Campailla, Jasmin/AAK-2420-2021; Wells, Ruth/H-4139-2019; Wells, Ruth E/Y-3610-2018	Quintana, Daniel S./0000-0003-2876-0004; Kemp, Andrew Haddon/0000-0003-1146-3791; Wells, Ruth E/0000-0003-2408-095X; Heathers, James/0000-0002-0936-026X; Outhred, Tim/0000-0003-2534-3635	Australian Postgraduate Award (APA); Australian Rotary Health/Hooton family scholarship; National Health and Medical Research Council (NHMRC) [571101]	Australian Postgraduate Award (APA)(Australian Government); Australian Rotary Health/Hooton family scholarship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	TO and JAH are supported by an Australian Postgraduate Award (APA), DSQ is supported by an Australian Rotary Health/Hooton family scholarship, and AHK is supported by a National Health and Medical Research Council (NHMRC) career development fellowship (571101). The funders had no role in study design, data colelction and analysis, decision to publish, or preparation of the manuscript.	Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Bernardi L, 2002, CIRCULATION, V105, P143, DOI 10.1161/hc0202.103311; Bernardi L, 2001, J HYPERTENS, V19, P947, DOI 10.1097/00004872-200105000-00016; Bernardi L, 2001, BRIT MED J, V323, P1446, DOI 10.1136/bmj.323.7327.1446; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bodner E, 2008, MED PROBL PERFORM AR, V23, P172; Boulez P, 1957, MARTEAU SANS MAITRE; Bradley RT, 2010, APPL PSYCHOPHYS BIOF, V35, P261, DOI 10.1007/s10484-010-9134-x; BRANTIGAN TA, 1978, LANCET, V2, P896; Camm AJ, 1996, EUR HEART J, V17, P354; Campbell-Sills L., 2007, HDB EMOTION REGULATI, P542; Corruble E, 2010, BEHAV MED, V36, P32, DOI 10.1080/08964280903521339; Cowan MJ, 2001, NURS RES, V50, P68, DOI 10.1097/00006199-200103000-00002; de Timary P, 2008, PSYCHONEUROENDOCRINO, V33, P1160, DOI 10.1016/j.psyneuen.2008.06.005; Del Pozo JM, 2004, AM HEART J, V147, pG1, DOI 10.1016/j.ahj.2003.08.013; Dobson MC, 2011, PSYCHOL MUSIC, V39, P240, DOI 10.1177/0305735610373562; Edwards SL, 2003, COGNITIVE THER RES, V27, P603, DOI 10.1023/A:1026395526858; Fehm L, 2006, J ANXIETY DISORD, V20, P98, DOI 10.1016/j.janxdis.2004.11.011; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Geisler FCM, 2010, PERS INDIV DIFFER, V49, P723, DOI 10.1016/j.paid.2010.06.015; Gevirtz R, 2007, PRINCIPLES PRACTICE, P209; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Gorman Jack M., 2000, American Heart Journal, V140, pS77; Gross J.J., 2014, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hassett AL, 2007, APPL PSYCHOPHYS BIOF, V32, P1, DOI 10.1007/s10484-006-9028-0; HAYES PE, 1987, J AFFECT DISORDERS, V13, P119, DOI 10.1016/0165-0327(87)90017-6; Head A, 1996, BRIT J SPORT MED, V30, P238, DOI 10.1136/bjsm.30.3.238; Healy MJR, 2000, ARCH DIS CHILD, V83, P182; Heathers JAJ, 2012, EXP PHYSIOL, V97, P556, DOI 10.1113/expphysiol.2011.063867; HEDBERG AG, 1972, PROF PSYCHOL, V3, P389, DOI 10.1037/h0020743; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Hishinuma ES, 2000, ASSESSMENT, V7, P17, DOI 10.1177/107319110000700102; Hynynen E, 2010, INT J SPORTS MED, V31, P428, DOI 10.1055/s-0030-1249625; Joseph CN, 2005, HYPERTENSION, V46, P714, DOI 10.1161/01.HYP.0000179581.68566.7d; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Karemaker JM, 2000, EUR HEART J, V21, P435, DOI 10.1053/euhj.1999.1969; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kenny DT, 2004, J ANXIETY DISORD, V18, P757, DOI 10.1016/j.janxdis.2003.09.004; Kenny DT., 2011, PSYCHOL MUSIC PERFOR; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lehrer P, 2003, APPL PSYCHOPHYS BIOF, V28, P291, DOI 10.1023/A:1027330909265; Lehrer PM, 2000, APPL PSYCHOPHYS BIOF, V25, P177, DOI 10.1023/A:1009554825745; Lopes P, 2006, PHYSL ASSESSMENT HUM; Malliani Alberto, 2005, Eur J Intern Med, V16, P12, DOI 10.1016/j.ejim.2004.06.016; Mauss IB, 2003, PSYCHOPHYSIOLOGY, V40, P648, DOI 10.1111/1469-8986.00066; Mennin DS, 2006, J CONTEMP PSYCHOTHER, V36, P95, DOI 10.1007/s10879-006-9012-2; Messiaen O, 1942, QUATUOR FIN TEMPS MU; MILLAR K, 1995, BRIT J ANAESTH, V74, P180, DOI 10.1093/bja/74.2.180; Mizuno K, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-17; Nolan RP, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2005.03.015; OSTWALD PF, 1994, WESTERN J MED, V160, P48; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Porges SW, 2003, ANN NY ACAD SCI, V1008, P31, DOI 10.1196/annals.1301.004; Porges SW, 2011, POLYVAGAL THEORY NEU; Prinsloo GE, 2011, APPL COGNITIVE PSYCH, V25, P792, DOI 10.1002/acp.1750; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Quintana DS, 2012, EUR J APPL PHYSIOL, V112, P4179, DOI 10.1007/s00421-012-2453-2; ROBSON BE, 1987, MED PROBL PERFORM AR, V2, P137; Russoniello CV, 2010, APPL PSYCHOPHYS BIOF, V35, P257, DOI 10.1007/s10484-010-9136-8; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Shirotsuki K, 2009, INT J PSYCHOPHYSIOL, V72, P198, DOI 10.1016/j.ijpsycho.2008.12.010; Siepmann M, 2008, APPL PSYCHOPHYS BIOF, V33, P195, DOI 10.1007/s10484-008-9064-z; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; STEPTOE A, 1987, BRIT J PSYCHOL, V78, P241, DOI 10.1111/j.2044-8295.1987.tb02243.x; Steptoe A., 1989, PSYCHOL MUSIC, V17, P3, DOI [10.1177/0305735689171001, DOI 10.1177/0305735689171001]; Studer R, 2011, J PSYCHOSOM RES, V70, P557, DOI 10.1016/j.jpsychores.2010.11.004; Swanson KS, 2009, APPL PSYCHOPHYS BIOF, V34, P71, DOI 10.1007/s10484-009-9077-2; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Tan G, 2011, APPL PSYCHOPHYS BIOF, V36, P27, DOI 10.1007/s10484-010-9141-y; Thayer JF, 1996, BIOL PSYCHIAT, V39, P255, DOI 10.1016/0006-3223(95)00136-0; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thompson RA, 2008, CHILD DEV PERSPECT, V2, P124, DOI 10.1111/j.1750-8606.2008.00054.x; Thurber MR, 2006, EFFECTS HEART RATE V; Tzeng YC, 2009, J APPL PHYSIOL, V107, P718, DOI 10.1152/japplphysiol.00548.2009; VANKEMENADE JFLM, 1995, PSYCHOL REP, V77, P555, DOI 10.2466/pr0.1995.77.2.555; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9; WESNER RB, 1990, J AFFECT DISORDERS, V18, P177, DOI 10.1016/0165-0327(90)90034-6; Wilhelm FH, 2001, BEHAV MODIF, V25, P513, DOI 10.1177/0145445501254003; Williams RA, 2004, NURS RES, V53, P277, DOI 10.1097/00006199-200407000-00011; Zander MF, 2010, MED PROBL PERFORM AR, V25, P54; Zucker TL, 2009, APPL PSYCHOPHYS BIOF, V34, P135, DOI 10.1007/s10484-009-9085-2; Zulfiqar U, 2010, AM J CARDIOL, V105, P1181, DOI 10.1016/j.amjcard.2009.12.022	88	92	95	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46597	10.1371/journal.pone.0046597	http://dx.doi.org/10.1371/journal.pone.0046597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	017HM	23056361	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800029
J	Cheval, L; Pierrat, F; Rajerison, R; Piquemal, D; Doucet, A				Cheval, Lydie; Pierrat, Fabien; Rajerison, Rabary; Piquemal, David; Doucet, Alain			Of Mice and Men: Divergence of Gene Expression Patterns in Kidney	PLOS ONE			English	Article							MOUSE ORTHOLOGOUS GENES; PROFILES; EVOLUTION; CELLS; TRANSCRIPTOMES; CONSERVATION; RESOURCE; LACKING; TISSUE; MODEL	Since the development of methods for homologous gene recombination, mouse models have played a central role in research in renal pathophysiology. However, many published and unpublished results show that mice with genetic changes mimicking human pathogenic mutations do not display the human phenotype. These functional differences may stem from differences in gene expression between mouse and human kidneys. However, large scale comparison of gene expression networks revealed conservation of gene expression among a large panel of human and mouse tissues including kidneys. Because renal functions result from the spatial integration of elementary processes originating in the glomerulus and the successive segments constituting the nephron, we hypothesized that differences in gene expression profiles along the human and mouse nephron might account for different behaviors. Analysis of SAGE libraries generated from the glomerulus and seven anatomically defined nephron segments from human and mouse kidneys allowed us to identify 4644 pairs of gene orthologs expressed in either one or both species. Quantitative analysis shows that many transcripts are present at different levels in the two species. It also shows poor conservation of gene expression profiles, with less than 10% of the 4644 gene orthologs displaying a higher conservation of expression profiles than the neutral expectation (p<0.05). Accordingly, hierarchical clustering reveals a higher degree of conservation of gene expression patterns between functionally unrelated kidney structures within a given species than between cognate structures from the two species. Similar findings were obtained for sub-groups of genes with either kidney-specific or housekeeping functions. Conservation of gene expression at the scale of the whole organ and divergence at the level of its constituting sub-structures likely account for the fact that although kidneys assume the same global function in the two species, many mouse "models" of human pathologies do not display the expected phenotype.	[Cheval, Lydie; Rajerison, Rabary; Doucet, Alain] Univ Paris 06, Unite Mixte Rech 872, Paris, France; [Cheval, Lydie; Rajerison, Rabary; Doucet, Alain] INSERM, Paris, France; [Cheval, Lydie; Rajerison, Rabary; Doucet, Alain] CNRS, Equipe Rech 7226, Paris, France; [Pierrat, Fabien; Piquemal, David] Skuld Tech, Montpellier, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Doucet, A (corresponding author), Univ Paris 06, Unite Mixte Rech 872, Paris, France.	alain.doucet@crc.jussieu.fr		CHEVAL, LYDIE/0000-0003-2957-6487; Piquemal, David/0000-0002-5870-4276; Pierrat, Fabien/0000-0001-7308-6827	Agence Nationale de la Recherche [ANR-06-PHYSIO-035-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	Agence Nationale de la Recherche (ANR-06-PHYSIO-035-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751; Blechschmidt S, 2008, PROG BIOPHYS MOL BIO, V98, P309, DOI 10.1016/j.pbiomolbio.2009.01.009; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; BRONSON SK, 1994, J BIOL CHEM, V269, P27155; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Cheval L, 2004, PHYSIOL GENOMICS, V19, P61, DOI 10.1152/physiolgenomics.00055.2004; Cheval L, 2011, PHYSIOL GENOMICS, V43, P161, DOI 10.1152/physiolgenomics.00093.2010; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Harries LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007855; Jordan IK, 2005, GENE, V345, P119, DOI 10.1016/j.gene.2004.11.034; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Lorenz JN, 2002, J BIOL CHEM, V277, P37871, DOI 10.1074/jbc.M205627200; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; Mattes WB, 2006, XENOBIOTICA, V36, P1081, DOI 10.1080/00498250600861793; Nomura N, 2011, AM J PHYSIOL-RENAL, V301, pF297, DOI 10.1152/ajprenal.00604.2010; Pereira V, 2009, GENETICS, V183, P1597, DOI 10.1534/genetics.109.110247; Piasecka B, 2012, BIOINFORMATICS, V28, P1865, DOI 10.1093/bioinformatics/bts266; Piquemal D, 2002, GENOMICS, V80, P361, DOI 10.1006/geno.2002.6836; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Smeets B, 2006, J PATHOL, V210, P263, DOI 10.1002/path.2051; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Virlon B, 1999, P NATL ACAD SCI USA, V96, P15286, DOI 10.1073/pnas.96.26.15286; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462	27	39	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46876	10.1371/journal.pone.0046876	http://dx.doi.org/10.1371/journal.pone.0046876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056504	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000097
J	McLaggan, D; Amezaga, MR; Petra, E; Frost, A; Duff, EI; Rhind, SM; Fowler, PA; Glover, LA; Lagido, C				McLaggan, Debbie; Amezaga, Maria R.; Petra, Eleni; Frost, Andrew; Duff, Elizabeth I.; Rhind, Stewart M.; Fowler, Paul A.; Glover, L. Anne; Lagido, Cristina			Impact of Sublethal Levels of Environmental Pollutants Found in Sewage Sludge on a Novel Caenorhabditis elegans Model Biosensor	PLOS ONE			English	Article							GENE-EXPRESSION; LIFE-SPAN; TOXICITY; EXPOSURE; GROWTH; FETAL; SHEEP; CYP35	A transgenic strain of the model nematode Caenorhabditis elegans in which bioluminescence reports on relative, whole-organism ATP levels was used to test an environmentally-relevant mixture of pollutants extracted from processed sewage sludge. Changes in bioluminescence, following exposure to sewage sludge extract, were used to assess relative ATP levels and overall metabolic health. Reproductive function and longevity were also monitored. A short (up to 8 h) sublethal exposure of L4 larval stage worms to sewage sludge extract had a concentration-dependent, detrimental effect on energy status, with bioluminescence decreasing to 50-60% of the solvent control (1% DMSO). Following longer exposure (22-24 h), the energy status of the nematodes showed recovery as assessed by bioluminescence. Continuous exposure to sewage sludge extract from the L4 stage resulted in a shorter median lifespan relative to that of solvent or medium control animals, but only in the presence of 400-600 mu M 5-fluoro-2'-deoxyuridine (FUdR), which was incorporated to inhibit reproduction. This indicated that FUdR increased lifespan, and that the effect was counteracted by SSE. Exposure to sewage sludge extract from the L1 stage led to slower growth and a delayed onset of egg laying. When L1 exposed nematodes reached the reproductive stage, no effect on egg laying rate or egg number in the uterus was observed. DMSO itself (1%) had a significant inhibitory effect on growth and development of C. elegans exposed from the L1 stage and on reproduction when exposed from the L4 stage. Results demonstrate subtle adverse effects on C. elegans of a complex mixture of environmental pollutants that are present, individually, in very low concentrations and indicate that our biosensor of energy status is a novel, sensitive, rapid, quantitative, whole-organism test system which is suitable for high throughput risk assessment of complex pollutant mixtures.	[McLaggan, Debbie; Amezaga, Maria R.; Petra, Eleni; Frost, Andrew; Fowler, Paul A.; Glover, L. Anne; Lagido, Cristina] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Rhind, Stewart M.] James Hutton Inst, Aberdeen, Scotland; [Duff, Elizabeth I.] Biomath & Stat Scotland, Aberdeen, Scotland	University of Aberdeen; James Hutton Institute; James Hutton Institute	McLaggan, D (corresponding author), Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland.	d.mclaggan@abdn.ac.uk; c.lagido@abdn.ac.uk	Fowler, Paul A/A-5644-2008	Fowler, Paul A/0000-0002-4831-9075; Lagido, Cristina/0000-0003-3947-5380; McLaggan, Debbie/0000-0003-3044-7287	Wellcome Trust [080388]; Scottish Government-Rural and Environment Science and Analytical Services Division	Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Government-Rural and Environment Science and Analytical Services Division	This work was funded by the Wellcome Trust (080388 to PAF). EID and SMR funded by Scottish Government-Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitlhadj L, 2010, MECH AGEING DEV, V131, P364, DOI 10.1016/j.mad.2010.03.002; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Baumeister R, 2006, J ENDOCRINOL, V190, P191, DOI 10.1677/joe.1.06856; Bellingham M, 2012, INT J ANDROL, V35, P317, DOI 10.1111/j.1365-2605.2011.01234.x; Bellingham M, 2010, J NEUROENDOCRINOL, V22, P527, DOI 10.1111/j.1365-2826.2010.01974.x; Bellingham M, 2009, ENVIRON HEALTH PERSP, V117, P1556, DOI 10.1289/ehp.0900699; Boerjan ML, 2002, ANIM SCI, V74, P3, DOI 10.1017/S1357729800052164; Boyd WA, 2010, TOXICOL APPL PHARM, V245, P153, DOI 10.1016/j.taap.2010.02.014; BRENNER S, 1974, GENETICS, V77, P71; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Fowler PA, 2008, MOL HUM REPROD, V14, P269, DOI 10.1093/molehr/gan020; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Girotti S, 2008, ANAL CHIM ACTA, V608, P2, DOI 10.1016/j.aca.2007.12.008; Gruber J, 2009, FEBS LETT, V583, P3377, DOI 10.1016/j.febslet.2009.09.051; Hoss S, 2007, ECOTOXICOLOGY, V16, P15, DOI 10.1007/s10646-006-0108-y; HOSONO R, 1978, EXP GERONTOL, V13, P369, DOI 10.1016/0531-5565(78)90047-5; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kortenkamp A, 2008, INT J ANDROL, V31, P233, DOI 10.1111/j.1365-2605.2007.00862.x; Lagido C, 2001, FEBS LETT, V493, P36, DOI 10.1016/S0014-5793(01)02271-2; Lagido Cristina, 2008, BMC Physiology, V8, P7, DOI 10.1186/1472-6793-8-7; Lagido C, 2009, TOXICOL SCI, V109, P88, DOI 10.1093/toxsci/kfp058; Leung MCK, 2010, TOXICOL SCI, V118, P444, DOI 10.1093/toxsci/kfq295; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lind PM, 2009, SCI TOTAL ENVIRON, V407, P2200, DOI 10.1016/j.scitotenv.2008.12.035; Lindblom TH, 2006, J EXP ZOOL PART A, V305A, P720, DOI 10.1002/jez.a.324; Mantis I, 2005, ECOTOX ENVIRON SAFE, V62, P397, DOI 10.1016/j.ecoenv.2004.12.010; Menzel R, 2005, ARCH BIOCHEM BIOPHYS, V438, P93, DOI 10.1016/j.abb.2005.03.020; Menzel R, 2001, ARCH BIOCHEM BIOPHYS, V395, P158, DOI 10.1006/abbi.2001.2568; Menzel R, 2007, J MOL BIOL, V370, P1, DOI 10.1016/j.jmb.2007.04.058; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917, DOI 10.1289/ehp.02110917; Rhind SM, 2010, J ENVIRON MONITOR, V12, P1582, DOI 10.1039/c0em00009d; Rhind SM, 2010, ANIMAL, V4, P1227, DOI 10.1017/S1751731110000595; Rhind SM, 2009, PHILOS T R SOC B, V364, P3391, DOI 10.1098/rstb.2009.0122; Rhind SM, 2005, ANIM SCI, V81, P107, DOI 10.1079/ASC42120107; Sese BT, 2009, J TOXICOL ENV HEAL A, V72, P1168, DOI 10.1080/15287390903091814; Shao CY, 2002, APPL ENVIRON MICROB, V68, P5026, DOI 10.1128/AEM.68.10.5026-5033.2002; Solis GM, 2011, MEASURING CAENORHABD, P49; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; STERRITT RM, 1980, SCI TOTAL ENVIRON, V16, P55, DOI 10.1016/0048-9697(80)90102-3; SULSTON JE, 1974, GENETICS, V77, P95; Weitz HJ, 2001, FEMS MICROBIOL LETT, V197, P159, DOI 10.1111/j.1574-6968.2001.tb10598.x	43	18	19	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46503	10.1371/journal.pone.0046503	http://dx.doi.org/10.1371/journal.pone.0046503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056324	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000051
J	Ungaro, F; De Stefano, D; Giovino, C; Masuccio, A; Miro, A; Sorrentino, R; Carnuccio, R; Quaglia, F				Ungaro, Francesca; De Stefano, Daniela; Giovino, Concetta; Masuccio, Alessia; Miro, Agnese; Sorrentino, Raffaella; Carnuccio, Rosa; Quaglia, Fabiana			PEI-Engineered Respirable Particles Delivering a Decoy Oligonucleotide to NF-kappa B: Inhibiting MUC2 Expression in LPS-Stimulated Airway Epithelial Cells	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; CONTROLLED-RELEASE; GENE-EXPRESSION; LUNG-DISEASE; DRUG-RELEASE; IN-VIVO; POLYETHYLENIMINE; MICROSPHERES; ACTIVATION	A specific and promising approach to limit inflammation and mucin iperproduction in chronic lung diseases relies on specific inhibition of nuclear Factor-kappa B (NF-kappa B) by a decoy oligonucleotide (dec-ODN). To fulfill the requirements dictated by translation of dec-ODN therapy in humans, inhalable dry powders were designed on a rational basis to provide drug protection, sustained release and to optimize pharmacological response. To this end, large porous particles (LPP) for dec-ODN delivery made of a sustained release biomaterial (poly(lactic-co-glycolic) acid, PLGA) and an "adjuvant'' hydrophilic polymer (polyethylenimine, PEI) were developed and their effects on LPS-stimulated human airway epithelial cells evaluated. The composite PLGA/PEI particles containing dec-ODN (i.e., LPPPEI) were successfully engineered for widespread deposition in the lung and prolonged release of intact dec-ODN in vitro. LPPPEI caused a prolonged inhibition of IL-8 and MUC2 expression in CF human bronchial epithelial cells and human epithelial pulmonary NCI-H292 cells, respectively, as compared to naked dec-ODN. Nonetheless, as compared to previously developed LPP, the presence of PEI was essential to construct a dec-ODN delivery system able to act in mucoepidermoid lung epithelial cells. In perspective, engineering LPP with PEI may become a key factor for tuning carrier properties, controlling lung inflammation and mucin production which, in turn, can foster in vivo translation of dec-ODN therapy.	[Ungaro, Francesca; Giovino, Concetta; Miro, Agnese; Quaglia, Fabiana] Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, Naples, Italy; [De Stefano, Daniela; Masuccio, Alessia; Sorrentino, Raffaella; Carnuccio, Rosa] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Ungaro, F (corresponding author), Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, Naples, Italy.	ungaro@unina.it	Quaglia, Fabiana/I-9415-2012	Quaglia, Fabiana/0000-0001-6223-0782; Miro, Agnese/0000-0002-2255-8094; SORRENTINO, RAFFAELLA/0000-0002-0284-5424; Ungaro, Francesca/0000-0003-0850-9533	Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus/Delegazione FFC del Lago di Garda [23/2011]	Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus/Delegazione FFC del Lago di Garda	The work has been supported by Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus/Delegazione FFC del Lago di Garda (Project FFC#23/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial support of Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus/Delegazione FFC del Lago di Garda (FFC#23/2011) is gratefully acknowledged.	[Anonymous], HDB PARTICULATE DRUG; Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117; Berger JT, 1999, AM J RESP CELL MOL, V20, P500, DOI 10.1165/ajrcmb.20.3.3383; Beyerle A, 2010, MOL PHARMACEUT, V7, P727, DOI 10.1021/mp900278x; Beyerle A, 2009, TOXICOL IN VITRO, V23, P500, DOI 10.1016/j.tiv.2009.01.001; Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107; Bragonzi A., 2002, Current Gene Therapy, V2, P295, DOI 10.2174/1566523023347832; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; De Rosa G, 2003, BIOMACROMOLECULES, V4, P529, DOI 10.1021/bm025684c; De Stefano D, 2011, J GENE MED, V13, P200, DOI 10.1002/jgm.1546; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; Edwards DA, 1998, J APPL PHYSIOL, V85, P379, DOI 10.1152/jappl.1998.85.2.379; Egashira K, 2008, J GENE MED, V10, P805, DOI 10.1002/jgm.1192; Ferrari N, 2011, FUTURE MED CHEM, V3, P1647, DOI [10.4155/fmc.11.108, 10.4155/FMC.11.108]; Gambari R, 2010, BIOCHEM PHARMACOL, V80, P1887, DOI 10.1016/j.bcp.2010.06.047; Gunther M, 2011, EUR J PHARM BIOPHARM, V77, P438, DOI 10.1016/j.ejpb.2010.11.007; Hauber Hans-Peter, 2006, Can Respir J, V13, P327; Heijerman H, 2009, J CYST FIBROS, V8, P295, DOI 10.1016/j.jcf.2009.04.005; Helander IM, 1997, MICROBIOL-UK, V143, P3193, DOI 10.1099/00221287-143-10-3193; Ibrahim BM, 2011, EXPERT OPIN DRUG DEL, V8, P451, DOI 10.1517/17425247.2011.561310; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Khalil H, 2008, ANTIMICROB AGENTS CH, V52, P1635, DOI 10.1128/AAC.01071-07; Lam JKW, 2012, ADV DRUG DELIVER REV, V64, P1, DOI 10.1016/j.addr.2011.02.006; Lemaire V, 2003, INT J PHARMACEUT, V258, P95, DOI 10.1016/S0378-5173(03)00165-0; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Patton JS, 2010, J AEROSOL MED PULM D, V23, pS71, DOI 10.1089/jamp.2010.0836; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Ungaro F, 2005, J DRUG DELIV SCI TEC, V15, P137, DOI 10.1016/S1773-2247(05)50018-2; Ungaro F, 2003, J PHARMACEUT BIOMED, V31, P143, DOI 10.1016/S0731-7085(02)00571-X; Ungaro F, 2012, J PHARM PHA IN PRESS; Ungaro F, 2010, EUR J PHARM SCI, V41, P60, DOI 10.1016/j.ejps.2010.05.011; Ungaro F, 2009, J CONTROL RELEASE, V135, P25, DOI 10.1016/j.jconrel.2008.12.011; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF	39	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46457	10.1371/journal.pone.0046457	http://dx.doi.org/10.1371/journal.pone.0046457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056313	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000046
J	Vasconcellos, AG; Morel, CM				Vasconcellos, Alexandre Guimaraes; Morel, Carlos Medicis			Enabling Policy Planning and Innovation Management through Patent Information and Co-Authorship Network Analyses: A Study of Tuberculosis in Brazil	PLOS ONE			English	Article								Introduction: New tools and approaches are necessary to facilitate public policy planning and foster the management of innovation in countries' public health systems. To this end, an understanding of the integrated way in which the various actors who produce scientific knowledge and inventions in technological areas of interest operate, where they are located and how they relate to one another is of great relevance. Tuberculosis has been chosen as a model for the present study as it is a current challenge for Brazilian research and innovation. Methodology: Publications about tuberculosis written by Brazilian authors were accessed from international databases, analyzed, processed with text searching tools and networks of coauthors were constructed and visualized. Patent applications about tuberculosis in Brazil were retrieved from the Brazilian National Institute of Industrial Property (INPI) and the European Patent Office databases, through the use of International Patent Classification and keywords and then categorized and analyzed. Results/Conclusions: Brazilian authorship of articles about tuberculosis jumped from 1% in 1995 to 5% in 2010. Article production and patent filings of national origin have been concentrated in public universities and research institutions while the participation of private industry in the filing of Brazilian patents has remained limited. The goals of national patenting efforts have still not been reached, as up to the present none of the applications filed have been granted a patent. The analysis of all this data about TB publishing and patents clearly demonstrates the importance of maintaining the continuity of Brazil's production development policies as well as government support for infrastructure projects to be employed in transforming the potential of research. This policy, which already exists for the promotion of new products and processes that, in addition to bringing diverse economic benefits to the country, will also contribute to effective dealing with public health problems affecting Brazil and the World.	[Morel, Carlos Medicis] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, Brazil; [Vasconcellos, Alexandre Guimaraes] Natl Inst Ind Property INPI, Rio De Janeiro, RJ, Brazil	Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Instituto Nacional da Propriedade Industrial (INPI)	Morel, CM (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, Brazil.	morel@cdts.fiocruz.br	Idn, Inct/J-8385-2013; Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019; Morel, Carlos/AHD-9349-2022	Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009; 	Department of Science and Technology (DECIT), Ministry of Health (FIOTEC) [439, 820]; National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology [573642/2008-7]; Ministry of Education/CAPES [573642/2008-7]; Research Foundation of the State of Rio de Janeiro (FAPERJ) [573642/2008-7]; Oswaldo Cruz Foundation (Fiocruz)	Department of Science and Technology (DECIT), Ministry of Health (FIOTEC)(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Education/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Research Foundation of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Oswaldo Cruz Foundation (Fiocruz)	Funding was provided by the Department of Science and Technology (DECIT), Ministry of Health (FIOTEC no. 439 and 820); National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (no. 573642/2008-7 and IA Productivity Fellowship to CMM); Ministry of Education/CAPES (no. 573642/2008-7); Research Foundation of the State of Rio de Janeiro (FAPERJ) (no. 573642/2008-7, post-doctoral fellowship to AGV and "Cientista do Nosso Estado" to CMM) and Oswaldo Cruz Foundation (Fiocruz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CP, 2010, HEALTH ECON, V19, P130, DOI 10.1002/hec.1454; Allarakhia M, 2012, EXPERT OPINION DRUG, P1; Analytic Technologies, 1999, UC 5 0 VERS 1 00 COM; [Anonymous], 2011, GLOB TUB CONTR 2011; Bhardwaj A, 2011, TUBERCULOSIS, V91, P479, DOI 10.1016/j.tube.2011.06.004; Bound K., 2008, BRAZIL NATURAL KNOWL; Brito RC, 2010, INT J TUBERC LUNG D, V14, P24; de Brito Bahruth E, 2004, THESIS FEDERAL U RIO; Diacon AH, 2012, LANCET; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Esteves B, 2011, NAT MED, V17, P1174, DOI 10.1038/nm1011-1174b; Frickmann Fabiana dos Santos e Souza, 2011, Journal of Technology Management & Innovation, V6, P136, DOI 10.4067/S0718-27242011000400011; Gadelha CAG, 2008, MEDICAMENTOS BRASIL; Gadelha Carlos Augusto Grabois, 2003, Ciênc. saúde coletiva, V8, P521, DOI 10.1590/S1413-81232003000200015; Gadelha CAG, 2006, REV SAUDE PUBL, V40, P11, DOI 10.1590/S0034-89102006000400003; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Light DW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4348; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Ministerio da Saude, 2011, SIT TUB BRAS; Ministerio do Desenvolvimento, TECHNICAL REPORT; Mondal R, 2007, EMERG INFECT DIS, V13, P1429, DOI 10.3201/eid1309.070443; Morel CM, 2007, NATURE, V449, P180, DOI 10.1038/449180a; Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501; Morel CM, 2003, EMBO REP, V4, pS35, DOI 10.1038/sj.embor.embor851; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; OECD, 2005, OSL MAN GUID COLL IN, V3rd; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Vasconcellos AG, 2009, 60 C NAC BOT LIVR EL, P1072; World Health Organization, 2010, TUB; World Intellectual Property Organization, FREQ ASK QUEST INT P	33	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45569	10.1371/journal.pone.0045569	http://dx.doi.org/10.1371/journal.pone.0045569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056208	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000009
J	Fricker, RA; Kuiper, JH; Gates, MA				Fricker, Rosemary A.; Kuiper, Jan Herman; Gates, Monte A.			Transplanting Intact Donor Tissue Enhances Dopamine Cell Survival and the Predictability of Motor Improvements in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							VENTRAL MESENCEPHALON; NEURAL TRANSPLANTATION; STEM-CELLS; INDUCED DYSKINESIAS; IN-VITRO; NEURONS; GRAFTS; RECOVERY; PROSPECTS; STRIATUM	Primary cell transplantation is currently the gold standard for cell replacement in Parkinson's disease. However, the number of donors needed to treat a single patient is high, and the functional outcome is sometimes variable. The present work explores the possibility of enhancing the viability and/or functionality of small amounts of ventral mesencephalic (VM) donor tissue by reducing its perturbation during preparation and implantation. Briefly, unilaterally lesioned rats received either: (1) an intact piece of half an embryonic day 13 (E13) rat VM; (2) dissociated cells from half an E13 rat VM; or (3) no transplant. D-amphetamine- induced rotations revealed that animals receiving pieces of VM tissue or dissociated cells showed significant improvement in ipsilateral rotation 4 weeks post transplantation. By 6 weeks post transplantation, animals receiving pieces of VM tissue showed a trend for further improvement, while those receiving dissociated cells remained at their 4 week scores. Postmortem cell counts showed that the number of dopaminergic neurons in dissociated cell transplants was significantly lower than that surviving in transplants of intact tissue. When assessing the correlation between the number of dopamine cells in each transplant, and the improvement in rotation bias in experimental animals, it was shown that transplants of whole pieces of VM tissue offered greater predictability of graft function based on their dopamine cell content. Such results suggest that maintaining the integrity of VM tissue during implantation improves dopamine cell content, and that the dopamine cell content of whole tissue grafts offers a more predictable outcome of graft function in an animal model of Parkinson's disease.	[Fricker, Rosemary A.; Gates, Monte A.] Keele Univ, Sch Life Sci, Inst Sci & Technol Med, Keele, Staffs, England; [Kuiper, Jan Herman] RJAH Orthopaed Hosp, Oswestry, Shrops, England	Keele University; Keele University	Gates, MA (corresponding author), Keele Univ, Sch Life Sci, Inst Sci & Technol Med, Keele, Staffs, England.	m.a.gates@keele.ac.uk	Fricker, Rosemary/ABC-3301-2021		BBSRC: Biotechnology and Biological Sciences Research Council [BB/E009433/1]; BBSRC [BB/E009433/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E009433/1] Funding Source: researchfish; Parkinson&quot;s UK [G-0911] Funding Source: researchfish	BBSRC: Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was generously funded by the BBSRC: Biotechnology and Biological Sciences Research Council (BB/E009433/1) website address: http://www.bbsrc.ac.uk/home/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; ABROUS DN, 1993, NEUROSCIENCE, V53, P187, DOI 10.1016/0306-4522(93)90297-S; Allan LE, 2010, CURR OPIN NEUROL, V23, P426, DOI 10.1097/WCO.0b013e32833b1f62; BARKER RA, 1995, CELL TRANSPLANT, V4, P173, DOI 10.1016/0963-6897(95)90032-2; Barker RA, 2010, CELL STEM CELL, V7, P148, DOI 10.1016/j.stem.2010.07.003; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Bjorklund Anders, 2005, V265, P174; Bjorklund A, 2010, PROG BRAIN RES, V184, P265, DOI 10.1016/S0079-6123(10)84014-2; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Bye CR, 2012, EXP NEUROL, V236, P58, DOI 10.1016/j.expneurol.2012.04.002; Clarkson ED, 1998, BRAIN RES, V806, P60, DOI 10.1016/S0006-8993(98)00717-3; Clarkson ED, 1999, LIFE SCI, V65, P2427, DOI 10.1016/S0024-3205(99)00254-4; Cordeiro KK, 2010, BEHAV BRAIN RES, V212, P187, DOI 10.1016/j.bbr.2010.04.012; Dowd E, 2005, BRAIN RES BULL, V68, P24, DOI 10.1016/j.brainresbull.2005.08.009; Dunnett S. B., 2010, HDB CLIN NEUROLOGY, P885; Dunnett SB, 1997, BRIT MED BULL, V53, P757; Eve DJ, 2010, MED SCI MONITOR, V16, pRA197; Freed CR, 2003, J NEUROL, V250, P44, DOI 10.1007/s00415-003-1308-5; Gates MA, 2006, EUR J NEUROSCI, V23, P1384, DOI 10.1111/j.1460-9568.2006.04637.x; Gates MA, 2004, EUR J NEUROSCI, V19, P831, DOI 10.1111/j.1460-9568.2004.03213.x; Grealish S, 2010, BRAIN, V133, P482, DOI 10.1093/brain/awp328; Karlsson J, 2005, CELL TRANSPLANT, V14, P301, DOI 10.3727/000000005783983089; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kuan WL, 2007, NEUROBIOL DIS, V25, P594, DOI 10.1016/j.nbd.2006.11.001; Lane EL, 2010, PROG BRAIN RES, V184, P295, DOI 10.1016/S0079-6123(10)84015-4; Moore AE, 2001, EXP NEUROL, V172, P363, DOI 10.1006/exnr.2001.7823; Morizane A, 2008, CELL TISSUE RES, V331, P323, DOI 10.1007/s00441-007-0541-0; NAKAO N, 1994, P NATL ACAD SCI USA, V91, P12408, DOI 10.1073/pnas.91.26.12408; Olanow CW, 2009, ANN NEUROL, V66, P591, DOI 10.1002/ana.21778; Othberg A, 1997, EXP NEUROL, V147, P498, DOI 10.1006/exnr.1997.6594; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; Torres EM, 2008, CELL TRANSPLANT, V17, P535, DOI 10.3727/096368908785096006; Torres EM, 2008, NEUROSCIENCE, V154, P631, DOI 10.1016/j.neuroscience.2008.03.048; Torres EM, 2007, NEUROSCIENCE, V146, P1606, DOI 10.1016/j.neuroscience.2007.03.037; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; Wijeyekoon R, 2009, BBA-MOL BASIS DIS, V1792, P688, DOI 10.1016/j.bbadis.2008.10.007; Wilcox R.R., 2003, APPLYING CONT STAT T, DOI [10.1016/B978-012751541-0/50029-8, DOI 10.1016/B978-012751541-0/50029-8, DOI 10.1198/TECH.2004.S233]; Zietlow R, 2008, CELL TISSUE RES, V331, P301, DOI 10.1007/s00441-007-0488-1	39	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47169	10.1371/journal.pone.0047169	http://dx.doi.org/10.1371/journal.pone.0047169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056602	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000309889400060
J	Liu, T; Zhao, YX; Tang, N; Feng, RP; Yang, XL; Lu, N; Wen, JH; Li, LS				Liu, Ting; Zhao, Yanxia; Tang, Na; Feng, Ruopeng; Yang, Xiaolong; Lu, Nicole; Wen, Jinhua; Li, Lingsong			Pax6 Directly Down-Regulates Pcsk1n Expression Thereby Regulating PC1/3 Dependent Proinsulin Processing	PLOS ONE			English	Article							CELL-DIFFERENTIATION; PRECURSOR PROSAAS; MICE; 7B2; IDENTIFICATION; SEQUENCE; GENES; CONVERTASE-1/3; TRANSCRIPTION; PURIFICATION	Background: Heterozygous paired box6 (Pax6) mutations lead to abnormal glucose metabolism in mice older than 6 months as well as in human beings. Our previous study found that Pax6 deficiency caused down-expression of prohormone convertase 1/3 (Pcsk1), resulting in defective proinsulin processing. As a protein cleaving enzyme, in addition to its expression, the activity of PC1/3 is closely related to its function. We therefore hypothesize that Pax6 mutation alters the activity of PC1/3, which affects proinsulin processing. Methodology/Principal Findings: Using quantitative RT-PCR, western blot and enzyme assay, we found that PC1/3 C-terminal cleavage and its activity were compromised in Pax6 R266Stop mutant mice, and the expression of Pcsk1n, a potent inhibitor of PC1/3, was elevated by Pax6 deficiency in the mutant mice and MIN6 cells. We confirmed the effect of proSAAS, the protein encoded by Pcsk1n, on PC1/3 C-terminal cleavage and its activity by Pcsk1n RNAi in MIN6 cells. Furthermore, by luciferase-reporter analysis, chromatin immunoprecipitation, and electrophoretic mobility shift assay, we revealed that Pax6 bound to Pcsk1n promoter and directly down-regulated its expression. Finally, by co-transfecting Pax6 siRNA with Pcsk1n siRNA, we showed that Pax6 knock-down inhibited proinsulin processing and that this effect could be rescued by proSAAS down-regulation. These findings confirm that Pax6 regulates proinsulin processing partially through proSAAS-mediated PC1/3 processing and activity. Conclusions/Significance: Collectively, the above experiments demonstrate that Pax6 can directly down-regulate Pcsk1n expression, which negatively affects PC1/3 C-terminal cleavage and activity and subsequently participates in proinsulin processing. We identified proSAAS as a novel down-regulated target of Pax6 in the regulation of glucose metabolism. This study also provides a complete molecular mechanism for the Pax6 deficiency-caused diabetes.	[Liu, Ting; Zhao, Yanxia; Tang, Na; Feng, Ruopeng; Yang, Xiaolong; Wen, Jinhua; Li, Lingsong] Peking Univ, Hlth Sci Ctr, Stem Cell Res Ctr, Beijing 100871, Peoples R China; [Liu, Ting; Zhao, Yanxia; Tang, Na; Feng, Ruopeng; Yang, Xiaolong; Wen, Jinhua; Li, Lingsong] Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Lu, Nicole; Li, Lingsong] Chinese Acad Sci, Shanghai Adv Res Inst, SARI Ctr Stem Cell & Nanomed, Shanghai, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS	Wen, JH (corresponding author), Peking Univ, Hlth Sci Ctr, Stem Cell Res Ctr, Beijing 100871, Peoples R China.	jhwen@bjmu.edu.cn	Feng, Ruopeng/A-2134-2015		973 Program from the Ministry of Science and Technology of China [2011CB966200, 2011CBA01102]; 863 Program from the Ministry of Science and Technology of China [2009DFB30300, 2011AA020106]; National Natural Science Foundation of China [31171417]; New Drug Innovation of China [2011ZX09102-010-02]	973 Program from the Ministry of Science and Technology of China(National Basic Research Program of China); 863 Program from the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Drug Innovation of China	This work was supported by Grants 973 Program (2011CB966200 and 2011CBA01102) and 863 Program (2009DFB30300 and 2011AA020106) from the Ministry of Science and Technology of China. It was also supported by National Natural Science Foundation of China (31171417) and New Drug Innovation of China (2011ZX09102-010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apletalina E, 1998, J BIOL CHEM, V273, P26589, DOI 10.1074/jbc.273.41.26589; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Boudreault A, 1998, PROTEIN EXPRES PURIF, V14, P353, DOI 10.1006/prep.1998.0964; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Cameron A, 2000, FEBS LETT, V473, P135, DOI 10.1016/S0014-5793(00)01511-8; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Clark J. Derrell, 1997, ILAR J, V38, P41; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Fortenberry Y, 2002, J BIOL CHEM, V277, P5175, DOI 10.1074/jbc.M104531200; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hori H, 2001, CELL TRANSPLANT, V10, P459; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jang ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020894; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Lamango NS, 1996, ARCH BIOCHEM BIOPHYS, V330, P238, DOI 10.1006/abbi.1996.0249; Lanoue E, 2001, ENDOCRINOLOGY, V142, P4141, DOI 10.1210/en.142.9.4141; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Mishra R, 2002, J BIOL CHEM, V277, P49488, DOI 10.1074/jbc.M206478200; Morgan DJ, 2010, J NEUROCHEM, V113, P1275, DOI 10.1111/j.1471-4159.2010.06706.x; Qian YM, 2000, J BIOL CHEM, V275, P23596, DOI 10.1074/jbc.M001583200; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Wei SW, 2004, J ENDOCRINOL, V180, P357, DOI 10.1677/joe.0.1800357; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Yasuda T, 2002, DIABETES, V51, P224, DOI 10.2337/diabetes.51.1.224; Zhou YH, 2010, J NEURO-ONCOL, V96, P191, DOI 10.1007/s11060-009-9963-8; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10299, DOI 10.1073/pnas.162352799; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	36	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46934	10.1371/journal.pone.0046934	http://dx.doi.org/10.1371/journal.pone.0046934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056534	Green Submitted, Green Published, gold			2022-12-27	WOS:000309889400038
J	Luo, J; Swaminath, G; Brown, SP; Zhang, J; Guo, Q; Chen, M; Nguyen, K; Tran, T; Miao, L; Dransfield, PJ; Vimolratana, M; Houze, JB; Wong, S; Toteva, M; Shan, B; Li, F; Zhuang, R; Lin, DCH				Luo, Jian; Swaminath, Gayathri; Brown, Sean P.; Zhang, Jane; Guo, Qi; Chen, Michael; Kathy Nguyen; Thanhvien Tran; Miao, Lynn; Dransfield, Paul J.; Vimolratana, Marc; Houze, Jonathan B.; Wong, Simon; Toteva, Maria; Shan, Bei; Li, Frank; Zhuang, Run; Lin, Daniel C. -H.			A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; STIMULATED INSULIN-SECRETION; FATTY-ACID STIMULATION; PANCREATIC BETA-CELLS; RECEPTOR GPR40; GLP-1 RECEPTOR; MOUSE MODELS; IN-VIVO; ANTAGONIST; DISCOVERY	Type 2 diabetes is characterized by impaired glucose homeostasis due to defects in insulin secretion, insulin resistance and the incretin response. GPR40 (FFAR1 or FFA1) is a G-protein-coupled receptor (GPCR), primarily expressed in insulin-producing pancreatic beta-cells and incretin-producing enteroendocrine cells of the small intestine. Several GPR40 agonists, including AMG 837 and TAK-875, have been disclosed, but no GPR40 synthetic agonists have been reported that engage both the insulinogenic and incretinogenic axes. In this report we provide a molecular explanation and describe the discovery of a unique and potent class of GPR40 full agonists that engages the enteroinsular axis to promote dramatic improvement in glucose control in rodents. GPR40 full agonists AM-1638 and AM-6226 stimulate GLP-1 and GIP secretion from intestinal enteroendocrine cells and increase GSIS from pancreatic islets, leading to enhanced glucose control in the high fat fed, streptozotocin treated and NONcNZO10/LtJ mouse models of type 2 diabetes. The improvement in hyperglycemia by AM-1638 was reduced in the presence of the GLP-1 receptor antagonist Ex(9-39)NH2.	[Luo, Jian; Swaminath, Gayathri; Zhang, Jane; Guo, Qi; Chen, Michael; Kathy Nguyen; Thanhvien Tran; Miao, Lynn; Shan, Bei; Li, Frank; Zhuang, Run; Lin, Daniel C. -H.] Amgen Inc, Dept Metab Disorders, San Francisco, CA USA; [Brown, Sean P.; Dransfield, Paul J.; Vimolratana, Marc; Houze, Jonathan B.] Amgen Inc, Dept Therapeut Discovery, San Francisco, CA USA; [Wong, Simon] Amgen Inc, Dept Pharmacokinet & Drug Metab, San Francisco, CA USA; [Toteva, Maria] Amgen Inc, Dept Pharmaceut, San Francisco, CA USA	Amgen; Amgen; Amgen; Amgen	Lin, DCH (corresponding author), Amgen Inc, Dept Metab Disorders, San Francisco, CA USA.	dclin@amgen.com			Amgen Inc.	Amgen Inc.(Amgen)	This study was supported by Amgen Inc., which played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Alquier T, 2009, DIABETES, V58, P1035, DOI 10.2337/db09-0215; Araki T, 2011, DIABETES OBES METAB; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown SP, 2012, ACS MED CHEM LETT; BRUBAKER PL, 1987, ENDOCRINOLOGY, V120, P1976, DOI 10.1210/endo-120-5-1976; Burant CF, 2012, LANCET; Cho YR, 2007, AM J PHYSIOL-ENDOC M, V293, pE327, DOI 10.1152/ajpendo.00376.2006; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Davidson Jaime A, 2010, Mayo Clin Proc, V85, pS27, DOI 10.4065/mcp.2010.0469; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; GOKE R, 1993, J BIOL CHEM, V268, P19650; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Houze JB, 2012, BIOORG MED CHEM LETT, V22, P1267, DOI 10.1016/j.bmcl.2011.10.118; Iakoubov R, 2007, ENDOCRINOLOGY, V148, P1089, DOI 10.1210/en.2006-1403; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Leiter EH, 2006, ENDOCRINOLOGY, V147, P919, DOI 10.1210/en.2005-0839; Lin D, 2012, MOL PHARM; Lin DCH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027270; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; Mundil D, 2012, DIABETES VASC DIS RE, V9, P95, DOI 10.1177/1479164112441526; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Naik H, 2012, J CLIN PHARMACOL, V52, P1007, DOI 10.1177/0091270011409230; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; Peters A, 2010, AM J MED, V123, pS28, DOI 10.1016/j.amjmed.2009.12.007; Smith NJ, 2011, MOL CELL ENDOCRINOL, V331, P241, DOI 10.1016/j.mce.2010.07.009; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Sykaras AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042373; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Telvekar VN, 2008, CURR DRUG TARGETS, V9, P899, DOI 10.2174/138945008785909301; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tomita T, 2005, BIOCHEM BIOPH RES CO, V338, P1788, DOI 10.1016/j.bbrc.2005.10.161; Tsujihata Y, 2011, J PHARM EXP THER; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680	44	101	105	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46300	10.1371/journal.pone.0046300	http://dx.doi.org/10.1371/journal.pone.0046300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056280	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400012
J	Ampuero, JS; Ocana, V; Gomez, J; Gamero, ME; Garcia, J; Halsey, ES; Laguna-Torres, VA				Ampuero, Julia S.; Ocana, Victor; Gomez, Jorge; Gamero, Maria E.; Garcia, Josefina; Halsey, Eric S.; Alberto Laguna-Torres, V.			Adenovirus Respiratory Tract Infections in Peru	PLOS ONE			English	Article							VIRUS WATCH PROGRAM; VIRAL-INFECTIONS; EPIDEMIC KERATOCONJUNCTIVITIS; MOLECULAR CHARACTERIZATION; CLINICAL CHARACTERISTICS; CONTINUING SURVEILLANCE; PEDIATRIC-PATIENTS; MILITARY RECRUITS; YORK FAMILIES; RISK-FACTORS	Background: Currently, there is a paucity of data regarding human adenovirus (HAdv) circulation in Andean regions of South America. To address this shortcoming, we report the clinical, phylogenetic, and epidemiologic characteristics of HAdv respiratory tract infection from a large sentinel surveillance study conducted among adults and children in Peru. Methods/Principal Findings: Oropharyngeal swabs were collected from participants visiting any of 38 participating health centers, and viral pathogens were identified by immunofluorescence assay in cell culture. In addition, molecular characterization was performed on 226 randomly selected HAdv samples. Between 2000 and 2010, a total of 26,375 participants with influenza-like illness (ILI) or severe acute respiratory infection (SARI) were enrolled in the study. HAdv infection was identified in 2.5% of cases and represented 6.2% of all viral pathogens. Co-infection with a heterologous virus was found in 15.5% of HAdv cases. HAdv infection was largely confined to children under the age of 15, representing 88.6% of HAdv cases identified. No clinical characteristics were found to significantly distinguish HAdv infection from other respiratory viruses. Geographically, HAdv infections were more common in sites from the arid coastal regions than in the jungle or highland regions. Co-circulation of subgroups B and C was observed each year between 2006 and 2010, but no clear seasonal patterns of transmission were detected. Conclusions/Significance: HAdv accounted for a significant fraction of those presenting with ILI and SARI in Peru and tended to affect the younger population disproportionately. Longitudinal studies will help better characterize the clinical course of patients with HAdv in Peru, as well as determine the role of co-infections in the evolution of illness.	[Ampuero, Julia S.; Gamero, Maria E.; Garcia, Josefina; Halsey, Eric S.; Alberto Laguna-Torres, V.] US Naval Med Res Unit 6, Lima, Peru; [Ocana, Victor] Ctr Salud Pachitea, Direcc Reg Salud Piura, Minist Salud, Piura, Peru; [Gomez, Jorge] Minist Salud, Direcc Gen Epidemiol, Lima, Peru	Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6)	Ampuero, JS (corresponding author), US Naval Med Res Unit 6, Lima, Peru.	sonia.ampuero@med.navy.mil	Halsey, Eric/AAC-8110-2022; Gomez, Jorge/E-5258-2012	Halsey, Eric/0000-0001-6291-8923; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301; Gomez, Jorge/0000-0003-1342-3507; Ampuero, Julia/0000-0001-5486-1656	United States Department of Defense Global Emerging Infections Systems Research Program [847705.82000.25GB.B0016]	United States Department of Defense Global Emerging Infections Systems Research Program(United States Department of Defense)	This study was funded by the United States Department of Defense Global Emerging Infections Systems Research Program, WORK UNIT NUMBER: 847705.82000.25GB.B0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; Laguna-Torres VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011719; Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; Artieda J., 2009, EURO SURVEILL, V14; AVILA M, 1990, REV INFECT DIS, V12, pS974; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; Buchen-Osmond C, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1273; Caceda ER, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001034; Cheng CC, 2008, EUR J PEDIATR, V167, P633, DOI 10.1007/s00431-007-0562-4; Choi EH, 2006, J CLIN VIROL, V35, P388, DOI 10.1016/j.jcv.2006.01.001; Cooper RJ, 2000, EPIDEMIOL INFECT, V125, P333, DOI 10.1017/S0950268899004550; Cuan Y, 2009, REV HABAN CIENC MED, V8, P0; DANGELO LJ, 1979, J INFECT DIS, V140, P42, DOI 10.1093/infdis/140.1.42; Albuquerque Maria Carolina Maciel de, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P233, DOI 10.1590/S0036-46652003000400012; Dominguez O, 2005, PEDIATR INFECT DIS J, V24, P733, DOI 10.1097/01.inf.0000172942.96436.2d; Engler HD, 1997, J CLIN MICROBIOL, V35, P2165, DOI 10.1128/JCM.35.8.2165-2167.1997; Fairchok MP, 2010, J CLIN VIROL, V49, P16, DOI 10.1016/j.jcv.2010.06.013; Feikin DR, 2012, PEDIAT INFECT DIS J; Flint S, 2009, PRINCIPLES VIROLOGY, P134; Flint S, 2009, PRINCIPLES VIROLOGY, P502; FOX JP, 1969, AM J EPIDEMIOL, V89, P25, DOI 10.1093/oxfordjournals.aje.a120913; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P327, DOI 10.1111/j.1750-2659.2009.00107.x; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Han BK, 1998, AM J ROENTGENOL, V170, P1077, DOI 10.2214/ajr.170.4.9530062; Herrera-Rodríguez Diana H., 2007, Rev. salud pública, V9, P420, DOI 10.1590/S0124-00642007000300010; JERNIGAN JA, 1993, J INFECT DIS, V167, P1307, DOI 10.1093/infdis/167.6.1307; Ji Wei, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P205; Kajon AE, 2007, J INFECT DIS, V196, P67, DOI 10.1086/518442; KELSEY DS, 1978, PEDIATRICS, V61, P291; Kolavic-Gray SA, 2002, CLIN INFECT DIS, V35, P808, DOI 10.1086/342573; Kunz Anjali N, 2010, Curr Infect Dis Rep, V12, P81, DOI 10.1007/s11908-010-0084-5; Kusznierz Gabriela F., 2007, Arch. argent. pediatr., V105, P216; Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Luiz LN, 2010, MEM I OSWALDO CRUZ, V105, P712, DOI 10.1590/S0074-02762010000500019; Mandelboim M, 2011, J CLIN MICROBIOL, V49, P597, DOI 10.1128/JCM.00979-10; Melendez CP, 2009, MOL VIS, V15, P557; Moura FEA, 2007, MEM I OSWALDO CRUZ, V102, P937, DOI 10.1590/S0074-02762007000800008; MUFSON MA, 1976, J UROLOGY, V115, P191, DOI 10.1016/S0022-5347(17)59130-2; PAHO-CDC, 2006, GEN PROT INFL SURV; Palomino MA, 2004, PEDIATR INFECT DIS J, V23, P337, DOI 10.1097/00006454-200404000-00012; PÉREZ P MARÍA JOSÉ, 2007, Rev. chil. pediatr., V78, P261; Petrie A, 2005, ASSESSING AGREEMENT, P105; Pumariega T, 2000, MEM I OSWALDO CRUZ, V95, P859, DOI 10.1590/S0074-02762000000600020; Rhee EG, 2009, PRINCIPLES PRACTICE, V143, P2027; Robinson C, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1589; Rojas LJ, 2011, EPIDEMIOL INFECT, P1; Rosete DP, 2008, MEM I OSWALDO CRUZ, V103, P195, DOI 10.1590/S0074-02762008000200012; RUUSKANEN O, 1988, ARCH DIS CHILD, V63, P1250, DOI 10.1136/adc.63.10.1250; Sendra-Gutierrez J M, 2004, Euro Surveill, V9, P27; SPIGLAND I, 1966, AM J EPIDEMIOL, V83, P413, DOI 10.1093/oxfordjournals.aje.a120595; Straliotto Selir M., 2002, Rev. Soc. Bras. Med. Trop., V35, P283, DOI 10.1590/S0037-86822002000400002; Stroparo E, 2010, REV INST MED TROP SP, V52, P317, DOI 10.1590/S0036-46652010000600006; Thavagnanam S, 2010, ACTA PAEDIATR, V99, P394, DOI 10.1111/j.1651-2227.2009.01627.x; Thomazelli LM, 2007, J PEDIAT-BRAZIL, V83, P422, DOI 10.1590/S0021-75572007000600005; Valero N, 2009, INVEST CLIN, V50, P359; VANDERVEEN J, 1962, AM J HYG, V76, P149	58	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46898	10.1371/journal.pone.0046898	http://dx.doi.org/10.1371/journal.pone.0046898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056519	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500104
J	Dolan, B; Naughton, J; Tegtmeyer, N; May, FEB; Clyne, M				Dolan, Brendan; Naughton, Julie; Tegtmeyer, Nicole; May, Felicity E. B.; Clyne, Marguerite			The Interaction of Helicobacter pylori with the Adherent Mucus Gel Layer Secreted by Polarized HT29-MTX-E12 Cells	PLOS ONE			English	Article							TREFOIL PROTEIN TFF1; MESSENGER-RNA; SURFACE MUCIN; CANCER CELLS; MUCOSA; MUC5AC; LOCALIZATION; EXPRESSION; INFECTION; GASTRITIS	Helicobacter pylori colonises the gastric mucosa of humans. The majority of organisms live in mucus. These organisms are an important reservoir for infection of the underlying epithelium. Cell culture models for H. pylori infection do not normally possess a mucus layer. The interaction of H. pylori with TFF1, a member of the trefoil factor family found in gastric mucin, is mediated by lipopolysaccharide. To test the hypothesis that the interaction of H. pylori with TFF1 promotes mucus colonization we characterised the interaction of H. pylori with a mucus secreting cell line, HT29-MTX-E12. An isogenic mutant of H. pylori with truncated core oligosaccharides was produced and binding to TFF1 and ability to colonise HT29-MTX-E12 cells determined. The adherent mucus layer of HT29-MTX-E12 cells contained the gastric mucin MUC5AC and trefoil factors, TFF1 and TFF3. H. pylori was found within the mucus layer in discrete clusters and in close association with TFF1. It also interacted with the membrane bound mucin MUC1 and replicated when co-cultured with the cells. An isogenic mutant of H. pylori with a truncated LPS core did not interact with TFF1, and colonization of HT29-MTX-E12 cells was reduced compared to the wild-type strain (p<0.05). Preincubation of cells with wild type LPS but not with truncated LPS resulted in reduced colonization by H. pylori. These results demonstrate that the interaction of TFF1 with H. pylori is important for colonization of gastric mucus and the core oligosaccharide of H. pylori LPS is critical for this interaction to occur. HT29-MTX-E12 cells are a useful system with which to study the interaction of bacteria with mucosal surfaces and the effect of such interactions on mediating colonization.	[Dolan, Brendan; Naughton, Julie; Clyne, Marguerite] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Naughton, Julie; Tegtmeyer, Nicole] Sch Biomol & Biomed Sci, Dublin, Ireland; [Dolan, Brendan; Tegtmeyer, Nicole; Clyne, Marguerite] Conway Inst Biomol & Biomed Sci, Dublin, Ireland; [Dolan, Brendan; Clyne, Marguerite] Natl Childrens Res Ctr, Dublin, Ireland; [May, Felicity E. B.] Newcastle Univ, Fac Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University College Dublin; National Children's Research Centre (NCRC); Trinity College Dublin; Newcastle University - UK	Clyne, M (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland.	marguerite.clyne@ucd.ie	Clyne, Marguerite M/H-4179-2012; Dolan, Brendan/AAE-6544-2022; Dolan, Brendan/AAK-6817-2021	Clyne, Marguerite M/0000-0003-2547-9129; Dolan, Brendan/0000-0001-9062-3882; Dolan, Brendan/0000-0001-9062-3882	Children's Medical and Research Foundation, Dublin; Science Foundation Ireland [08/SRC/B1393]	Children's Medical and Research Foundation, Dublin; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by grants from the Children's Medical and Research Foundation, Dublin (www.cmrf.org) and Science Foundation Ireland (www.sfi.ie) Grant no 08/SRC/B1393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemka A, 2010, INFECT IMMUN, V78, P2812, DOI 10.1128/IAI.01249-09; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Behrens I, 2001, PHARM RES-DORDR, V18, P1138, DOI 10.1023/A:1010974909998; Chandan V, 2007, BIOCHEM CELL BIOL, V85, P582, DOI 10.1139/O07-056; Clyne M, 2004, P NATL ACAD SCI USA, V101, P7409, DOI 10.1073/pnas.0308489101; Cottet S, 2002, J BIOL CHEM, V277, P33978, DOI 10.1074/jbc.M201726200; Guang W, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00105; Guang W, 2010, J BIOL CHEM, V285, P20547, DOI 10.1074/jbc.M110.121319; HESSEY SJ, 1990, GUT, V31, P134, DOI 10.1136/gut.31.2.134; Ishihara S, 2001, ALIMENT PHARM THERAP, V15, P1485, DOI 10.1046/j.1365-2036.2001.01067.x; Israel DA, 2006, CURR OPIN GASTROEN, V22, P3, DOI 10.1097/01.mog.0000194790.51714.f0; Keely S, 2008, PHARM RES-DORDR, V25, P1193, DOI 10.1007/s11095-007-9501-3; Lafontaine PO, 2005, INT J ONCOL, V27, P997; Lichtenberger C, 1999, J IMMUNOL METHODS, V227, P75, DOI 10.1016/S0022-1759(99)00076-9; Linden S, 2002, GASTROENTEROLOGY, V123, P1923, DOI 10.1053/gast.2002.37076; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Longman RJ, 2000, GUT, V47, P792, DOI 10.1136/gut.47.6.792; May FEB, 2004, PEPTIDES, V25, P865, DOI 10.1016/j.peptides.2003.12.024; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; Newton JL, 2000, GUT, V46, P312, DOI 10.1136/gut.46.3.312; Paulsen FP, 2003, INVEST OPHTH VIS SCI, V44, P1807, DOI 10.1167/iovs.02-0744; Prendergast MM, 2001, J CLIN MICROBIOL, V39, P1494, DOI 10.1128/JCM.39.4.1494-1500.2001; Reeves EP, 2008, GASTROENTEROLOGY, V135, P2043, DOI 10.1053/j.gastro.2008.08.049; Rowland M, 2006, GASTROENTEROLOGY, V130, P65, DOI 10.1053/j.gastro.2005.11.004; Ruchaud-Sparagano MH, 2004, CELL MOL LIFE SCI, V61, P1946, DOI 10.1007/s00018-004-4124-x; Schreiber S, 2004, P NATL ACAD SCI USA, V101, P5024, DOI 10.1073/pnas.0308386101; Skoog EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036378; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Van den Brink GR, 2000, GUT, V46, P601, DOI 10.1136/gut.46.5.601; Westley BR, 2005, BIOCHEMISTRY-US, V44, P7967, DOI 10.1021/bi047287n; Wiede A, 2001, CELL TISSUE RES, V303, P109, DOI 10.1007/s004410000297	32	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47300	10.1371/journal.pone.0047300	http://dx.doi.org/10.1371/journal.pone.0047300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056622	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500151
J	Negredo, E; Bonjoch, A; Gomez-Mateu, M; Estany, C; Puig, J; Perez-Alvarez, N; Rosales, J; di Gregorio, S; del Rio, L; Gomez, G; Clotet, B				Negredo, Eugenia; Bonjoch, Anna; Gomez-Mateu, Moises; Estany, Carla; Puig, Jordi; Perez-Alvarez, Nuria; Rosales, Joaquin; di Gregorio, Silvana; del Rio, Luis; Gomez, Guadalupe; Clotet, Bonaventura			Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; HIGH PREVALENCE; FRACTURE RISK; OSTEOPOROSIS; WOMEN; DISEASE; OSTEOCLASTOGENESIS; OSTEOBLASTS	Background: Algorithms for bone mineral density (BMD) management in HIV-infected patients are lacking. Our objective was to assess how often a dual-energy x-ray absorptiometry (DXA) scan should be performed by assessing time of progression to osteopenia/osteoporosis. Methods: All DXA scans performed between 2000 and 2009 from HIV-infected patients with at least two DXA were included. Time to an event (osteopenia and osteoporosis) was assessed using the Kaplan-Meier method. Strata (tertiles) were defined using baseline minimum T scores. Differences between strata in time to an event were compared with the log-rank test. Results: Of 391 patients (1,639 DXAs), 49.6% had osteopenia and 21.7% osteoporosis at their first DXA scan. Of the 112 (28.6%) with normal BMD, 35.7% progressed to osteopenia; median progression time was 6.7 years. These patients were stratified: "low-risk" (baseline minimum T score > -0.2 SD), "middle-risk" (between -0.2 and -0.6 SD), and "high-risk" (from -0.6 to -1 SD); median progression time to osteopenia was 8.7, >7.2, and 1.7 years, respectively (p<0.0001). Of patients with osteopenia, 23.7% progressed to osteoporosis; median progression time was >8.5 years. Progression time was >8.2 years in "low-risk" tertile (T score between -1.1 and -1.6 SD), >8.5 years in "middle-risk" (between -1.6 and -2), and 3.2 years in "high-risk" (from -2 to -2.4) (p<0.0001). Conclusions: Our results may help to define the BMD testing interval. The lowest T score tertiles would suggest recommending a subsequent DXA in 1-2 years; in the highest tertiles, >= 6 years. Early intervention in patients with bone demineralization could reduce fracture-related morbidity/mortality.	[Negredo, Eugenia; Bonjoch, Anna; Estany, Carla; Puig, Jordi; Perez-Alvarez, Nuria; Clotet, Bonaventura] Univ Autonoma Barcelona, Lluita SIDA Fdn, Hosp Univ Germans Trias & Pujol, E-08193 Barcelona, Spain; [Gomez-Mateu, Moises; Perez-Alvarez, Nuria; Gomez, Guadalupe] Univ Politecn Cataluna, Stat & Operat Res Dept, Barcelona, Spain; [Rosales, Joaquin; di Gregorio, Silvana; del Rio, Luis] CETIR Ctr Med, Barcelona, Spain; [Clotet, Bonaventura] Irsicaixa Fdn, Barcelona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Universitat Politecnica de Catalunya; Institut de Recerca de la Sida - IrsiCaixa	Negredo, E (corresponding author), Univ Autonoma Barcelona, Lluita SIDA Fdn, Hosp Univ Germans Trias & Pujol, E-08193 Barcelona, Spain.	enegredo@flsida.org	Gomez, Guadalupe/K-5352-2014; Gomez, Guadalupe/AFS-1974-2022; GÓMEZ MATEU, MOISÉS/G-3816-2011; Perez-Alvarez, Nuria/O-9244-2014; Del Rio, Luis M/H-3037-2016	Gomez, Guadalupe/0000-0003-4252-4884; Gomez, Guadalupe/0000-0003-4252-4884; GÓMEZ MATEU, MOISÉS/0000-0003-4787-6432; Perez-Alvarez, Nuria/0000-0001-6582-1553; Del Rio, Luis M/0000-0003-0720-0673; Bonjoch, Anna/0000-0002-5343-2881; Negredo, Eugenia/0000-0001-5298-1734	Spanish Ministry of Education and Science [MTM2008-06747-C02-00]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported in part by a grant from the Spanish Ministry of Education and Science [Grant number MTM2008-06747-C02-00]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Arnsten JH, 2006, CLIN INFECT DIS, V42, P1014, DOI 10.1086/501015; Bedimo R, 2011, 6 IAS C HIV PATH TRE; Bonjoch A, 2010, AIDS, V24, P2827, DOI 10.1097/QAD.0b013e328340a28d; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Bruera D, 2003, AIDS, V17, P1917, DOI 10.1097/00002030-200309050-00010; Cazanave C, 2010, CROI 2010; Cooper C., 1997, AM J MED, V103, p17S; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; Cotter EJ, 2007, AIDS RES HUM RETROV, V23, P1521, DOI 10.1089/aid.2007.0112; Dao CN, 2011, CLIN INFECT DIS, V52, P396, DOI 10.1093/cid/ciq158; Dolan SE, 2006, J CLIN ENDOCR METAB, V91, P2938, DOI 10.1210/jc.2006-0127; Fakruddin JM, 2003, J BIOL CHEM, V278, P48251, DOI 10.1074/jbc.M304676200; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gibellini D, 2008, J MED VIROL, V80, P1507, DOI 10.1002/jmv.21266; Gibellini D, 2010, BIOCHEM BIOPH RES CO, V401, P429, DOI 10.1016/j.bbrc.2010.09.071; Gibellini D, 2010, NEW MICROBIOL, V33, P109; Gomez G, 2009, STAT MODEL, V9, P259, DOI 10.1177/1471082X0900900402; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Grijsen ML, 2010, AIDS, V24, P2233, DOI 10.1097/QAD.0b013e32833c93fe; Gutierrez F, 2011, AIDS REV, V13, P109; Hoy J, 2011, CURR OPIN HIV AIDS, V6, P309, DOI 10.1097/COH.0b013e3283478741; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Knobel H, 2001, AIDS, V15, P807, DOI 10.1097/00002030-200104130-00022; Marubini E., 2004, ANAL SURVIVAL DATA C; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Ofotokun I WN, 2011, HAART INDUCED IMMUNE; Ofotokun I, 2011, DISCOV MED, V11, P385; Ofotokun I, 2010, CURR OPIN ENDOCRINOL, V17, P523, DOI 10.1097/MED.0b013e32833f48d6; Sharma, 2010, CROI 2010; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; Trombetti A, 2002, OSTEOPOROSIS INT, V13, P731, DOI 10.1007/s001980200100; Watts NB, 2008, J CLIN DENSITOM, V11, P473, DOI 10.1016/j.jocd.2008.04.003; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Yong MK, 2011, JAIDS-J ACQ IMM DEF, V57, P205, DOI 10.1097/QAI.0b013e31821ecf4c; 2001, JAMA, V285, P785	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46031	10.1371/journal.pone.0046031	http://dx.doi.org/10.1371/journal.pone.0046031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056229	Green Published, gold			2022-12-27	WOS:000309831500024
J	Olofsson, M; Eriksson, S; Jakobsson, S; Wiklund, C				Olofsson, Martin; Eriksson, Stephan; Jakobsson, Sven; Wiklund, Christer			Deimatic Display in the European Swallowtail Butterfly as a Secondary Defence against Attacks from Great Tits	PLOS ONE			English	Article							CATOCALA LEPIDOPTERA; PREY; PREDATION; INTIMIDATION; NOCTUIDAE; SURVIVAL; CRYPSIS	Background: Many animals reduce the risk of being attacked by a predator through crypsis, masquerade or, alternatively, by advertising unprofitability by means of aposematic signalling. Behavioural attributes in prey employed after discovery, however, signify the importance of also having an effective secondary defence if a predator uncovers, or is immune to, the prey's primary defence. In butterflies, as in most animals, secondary defence generally consists of escape flights. However, some butterfly species have evolved other means of secondary defence such as deimatic displays/startle displays. The European swallowtail, Papilio machaon, employs what appears to be a startle display by exposing its brightly coloured dorsal wing surface upon disturbance and, if the disturbance continues, by intermittently protracting and relaxing its wing muscles generating a jerky motion of the wings. This display appears directed towards predators but whether it is effective in intimidating predators so that they refrain from attacks has never been tested experimentally. Methodology/Principal Findings: In this study we staged encounters between a passerine predator, the great tit, Parus major, and live and dead swallowtail butterflies in a two-choice experiment. Results showed that the dead butterfly was virtually always attacked before the live butterfly, and that it took four times longer before a bird attacked the live butterfly. When the live butterfly was approached by a bird this generally elicited the butterfly's startle display, which usually caused the approaching bird to flee. We also performed a palatability test of the butterflies and results show that the great tits seemed to find them palatable. Conclusions/Significance: We conclude that the swallowtail's startle display of conspicuous coloration and jerky movements is an efficient secondary defence against small passerines. We also discuss under what conditions predator-prey systems are likely to aid the evolution of deimatic behaviours in harmless and palatable prey.	[Olofsson, Martin; Eriksson, Stephan; Jakobsson, Sven; Wiklund, Christer] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Olofsson, M (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	martin.olofsson@zoologi.su.se			Swedish Research Council [Dnr 2010-5579]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by a grant from the Swedish Research Council (http://www.vr.se) to C. Wiklund (Dnr 2010-5579). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blest A. D., 1957, Behaviour, V11, P209, DOI 10.1163/156853956X00048; Brakefield P.M., 1992, P93; Bura VL, 2011, J EXP BIOL, V214, P30, DOI 10.1242/jeb.046805; Cott H.B., 1940, ADAPTIVE COLORATION; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Edmunds M., 1974, DEFENCE ANIMALS; HASSON O, 1991, TRENDS ECOL EVOL, V6, P325, DOI 10.1016/0169-5347(91)90040-5; Janzen DH, 2010, P NATL ACAD SCI USA, V107, P11659, DOI 10.1073/pnas.0912122107; Langridge KV, 2007, CURR BIOL, V17, pR1044, DOI 10.1016/j.cub.2007.10.028; Lind J, 2005, BEHAV ECOL, V16, P945, DOI 10.1093/beheco/ari075; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; Olofsson M, 2012, BEHAV ECOL SOCIOBIOL, V66, P209, DOI 10.1007/s00265-011-1268-1; Olofsson M, 2011, ANIM BEHAV, V81, P529, DOI 10.1016/j.anbehav.2010.12.012; Pie MR, 2005, BEHAV PROCESS, V68, P47, DOI 10.1016/j.beproc.2004.11.001; Poulton E.B., 1890, COLOUR ANIMALS; R R Development Core Team, 2009, R LANG ENV STAT COMP; Ruxton G. D., 2004, AVOIDING ATTACK; Ruxton GD, 2005, TRENDS ECOL EVOL, V20, P276, DOI 10.1016/j.tree.2005.03.014; SARGENT TD, 1978, EVOLUTION, V32, P424, DOI 10.1111/j.1558-5646.1978.tb00657.x; SCHLENOFF DH, 1985, ANIM BEHAV, V33, P1057, DOI 10.1016/S0003-3472(85)80164-0; Skelhorn J, 2010, SCIENCE, V327, P51, DOI 10.1126/science.1181931; Thomas J., 2010, BUTTERFLIES BRITAIN; Vallin A, 2006, BEHAV ECOL SOCIOBIOL, V59, P455, DOI 10.1007/s00265-005-0069-9; Vallin A, 2005, P ROY SOC B-BIOL SCI, V272, P1203, DOI 10.1098/rspb.2004.3034; Wahlberg N, 2003, CLADISTICS, V19, P213, DOI [10.1016/S0748-3007(03)00027-6, 10.1111/j.1096-0031.2003.tb00364.x]; WIKLUND C, 1974, Entomologica Scandinavica, V5, P151; WIKLUND C, 1985, EVOLUTION, V39, P1155, DOI 10.1111/j.1558-5646.1985.tb00456.x	27	33	33	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47092	10.1371/journal.pone.0047092	http://dx.doi.org/10.1371/journal.pone.0047092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056590	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500136
J	Sparta, M; Alexandrova, AN				Sparta, Manuel; Alexandrova, Anastassia N.			How Metal Substitution Affects the Enzymatic Activity of Catechol-O-Methyltransferase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; TRANSITION-STATE; BETA-LACTAMASE; GROUND-STATE; FREE-ENERGY; BASIS-SETS; QM-FE; PROTEIN; APPROXIMATION; SIMULATIONS	Catechol-O-methyltransferase (COMT) degrades catecholamines, such as dopamine and epinephrine, by methylating them in the presence of a divalent metal cation (usually Mg(II)), and S-adenosyl-L-methionine. The enzymatic activity of COMT is known to be vitally dependent on the nature of the bound metal: replacement of Mg(II) with Ca(II) leads to a complete deactivation of COMT; Fe(II) is slightly less than potent Mg(II), and Fe(III) is again an inhibitor. Considering the fairly modest role that the metal plays in the catalyzed reaction, this dependence is puzzling, and to date remains an enigma. Using a quantum mechanical/molecular mechanical dynamics method for extensive sampling of protein structure, and first principle quantum mechanical calculations for the subsequent mechanistic study, we explicate the effect of metal substitution on the rate determining step in the catalytic cycle of COMT, the methyl transfer. In full accord with experimental data, Mg(II) bound to COMT is the most potent of the studied cations and it is closely followed by Fe(II), whereas Fe(III) is unable to promote catalysis. In the case of Ca(II), a repacking of the protein binding site is observed, leading to a significant increase in the activation barrier and higher energy of reaction. Importantly, the origin of the effect of metal substitution is different for different metals: for Fe(III) it is the electronic effect, whereas in the case of Ca(II) it is instead the effect of suboptimal protein structure.	[Sparta, Manuel; Alexandrova, Anastassia N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Alexandrova, AN (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	ana@chem.ucla.edu	sparta, manuel/A-5898-2009	sparta, manuel/0000-0003-4218-5229	DARPA [N66001-11-1-4138]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the DARPA Young Faculty Award N66001-11-1-4138. URL: http://www.darpa.mil/Opportunities/Universities/Young_Faculty_Award_Recipients_2011.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; AXELROD J, 1958, J BIOL CHEM, V233, P702; Bakowies D, 1996, J COMPUT CHEM, V17, P87, DOI 10.1002/(SICI)1096-987X(19960115)17:1<87::AID-JCC8>3.0.CO;2-X; Barton G. J., 1993, OC CLUSTER ANAL PROG; Barton G. J., 1993, OC CLUSTER ANAL PROG; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Ding F, 2005, J MOL BIOL, V350, P1035, DOI 10.1016/j.jmb.2005.05.017; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Dirac PAM, 1929, P R SOC LOND A-CONTA, V123, P714, DOI 10.1098/rspa.1929.0094; Dokholyan NV, 2006, CURR OPIN STRUC BIOL, V16, P79, DOI 10.1016/j.sbi.2006.01.001; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078; GULDBERG HC, 1975, PHARMACOL REV, V27, P135; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kahn K, 2000, J AM CHEM SOC, V122, P46, DOI 10.1021/ja993084o; Kuhn B, 2000, J AM CHEM SOC, V122, P2586, DOI 10.1021/ja992218v; Lau EY, 1998, J AM CHEM SOC, V120, P12387, DOI 10.1021/ja9827447; Lau EY, 2000, J AM CHEM SOC, V122, P7165, DOI 10.1021/ja000265d; Lee TS, 2000, J CHEM SOC PERK T 2, P409, DOI 10.1039/a907793f; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Ovaska M, 1998, J COMPUT AID MOL DES, V12, P301, DOI 10.1023/A:1007965026738; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Roca M, 2006, J PHYS CHEM A, V110, P503, DOI 10.1021/jp0520953; Roca M, 2005, J AM CHEM SOC, V127, P10648, DOI 10.1021/ja051503d; Roca M, 2003, J AM CHEM SOC, V125, P7726, DOI 10.1021/ja0299497; Roca M, 2006, J AM CHEM SOC, V128, P6186, DOI 10.1021/ja058826u; Rutherford K, 2008, J MOL BIOL, V380, P120, DOI 10.1016/j.jmb.2008.04.040; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Sierka M, 2003, J CHEM PHYS, V118, P9136, DOI 10.1063/1.1567253; SLATER JC, 1951, PHYS REV, V81, P385, DOI 10.1103/PhysRev.81.385; Sparta M, 2012, BIOPHYS J, V103, P767, DOI 10.1016/j.bpj.2012.06.024; Staroverov VN, 2003, J CHEM PHYS, V119, P12129, DOI 10.1063/1.1626543; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Tsao D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024287; Turbomole, 2007, TURB V6 3 2011 DEV U; Valdez CE, 2012, J PHYS CHEM B, V116, P10649, DOI 10.1021/jp302771n; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; VESER J, 1987, J BACTERIOL, V169, P3696, DOI 10.1128/jb.169.8.3696-3700.1987; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Von Arnim M, 1998, J COMPUT CHEM, V19, P1746, DOI 10.1002/(SICI)1096-987X(19981130)19:15<1746::AID-JCC7>3.0.CO;2-N; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993; Zheng YJ, 1997, J AM CHEM SOC, V119, P8137, DOI 10.1021/ja971019d	50	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47172	10.1371/journal.pone.0047172	http://dx.doi.org/10.1371/journal.pone.0047172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056605	gold, Green Published, Green Submitted			2022-12-27	WOS:000309831500142
J	Zhang, Y; Yang, ND; Zhou, F; Shen, T; Duan, T; Zhou, J; Shi, Y; Zhu, XQ; Shen, HM				Zhang, Yin; Yang, Nai-Di; Zhou, Fan; Shen, Ting; Duan, Ting; Zhou, Jing; Shi, Yin; Zhu, Xin-Qiang; Shen, Han-Ming			(-)-Epigallocatechin-3-Gallate Induces Non-Apoptotic Cell Death in Human Cancer Cells via ROS-Mediated Lysosomal Membrane Permeabilization	PLOS ONE			English	Article							EPIGALLOCATECHIN GALLATE; MOLECULAR-MECHANISMS; TEA POLYPHENOLS; CULTURE MEDIA; AUTOPHAGY; NECROSIS; ACIDIFICATION; PREVENTION; INDUCTION; DYSFUNCTION	(-)-Epigallocatechin-3-gallate (EGCG) is the most extensive studied tea polyphenol for its anti-cancer function. In this study, we report a novel mechanism of action for EGCG-mediated cell death by identifying the critical role of lysosomal membrane permeabilization (LMP). First, EGCG-induced cell death in human cancer cells (both HepG2 and HeLa) was found to be caspase-independent and accompanied by evident cytosolic vacuolization, only observable when cells were treated in serum-free medium. The cytosolic vacuolization observed in EGCG-treated cells was most probably caused by lysosomal dilation. Interestingly, EGCG was able to disrupt autophagic flux at the degradation stage by impairment of lysosomal function, and EGCG-induced cell death was independent of Atg5 or autophagy. The key finding of this study is that EGCG is able to trigger LMP, as evidenced by Lyso-Tracker Red staining, cathepsin D cytosolic translocation and cytosolic acidification. Consistently, a lysosomotropic agent, chloroquine, effectively rescues the cell death via suppressing LMP-caused cytosolic acidification. Lastly, we found that EGCG promotes production of intracellular ROS upstream of LMP and cell death, as evidenced by increased level of ROS in cells treated with EGCG and the protective effects of antioxidant N-acetylcysteine (NAC) against EGCG-mediated LMP and cell death. Taken together, data from our study reveal a novel mechanism underlying EGCG-induced cell death involving ROS and LMP. Therefore, understanding this lysosome-associated cell death pathway shed new lights on the anti-cancer effects of EGCG.	[Zhang, Yin; Zhou, Fan; Shen, Ting; Duan, Ting; Zhu, Xin-Qiang] Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Yin; Yang, Nai-Di; Zhou, Jing; Shi, Yin; Shen, Han-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Shen, Han-Ming] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Shen, Han-Ming] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore	Zhejiang University; National University of Singapore; National University of Singapore; National University of Singapore	Zhang, Y (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310003, Zhejiang, Peoples R China.	zhuxq@zju.edu.cn; han-ming_shen@nuhs.edu.sg	SHEN, Han-Ming/B-5942-2011	SHEN, Han-Ming/0000-0001-7369-5227; ZHOU, JING/0000-0002-2475-7783; Shi, Yin/0000-0003-3858-8500	China National Natural Science Foundation [81028014, 81172659]; Singapore National Medical Research Council [NMRC/1260/2010-IRG09nov070]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Singapore National Medical Research Council(National Medical Research Council, Singapore)	This study was in part supported by research grants from China National Natural Science Foundation (81028014 and 81172659 to ZXQ and SHM) and from Singapore National Medical Research Council (NMRC/1260/2010-IRG09nov070 to SHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2012, ANTIOXID REDOX SIGNA; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Chang CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028323; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Foglieni C, 2001, HISTOCHEM CELL BIOL, V115, P223; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Groth-Pedersen L, 2007, CANCER RES, V67, P2217, DOI 10.1158/0008-5472.CAN-06-3520; Hayakawa S, 2001, BIOCHEM BIOPH RES CO, V285, P1102, DOI 10.1006/bbrc.2001.5293; Henics T, 1999, BIOL CELL, V91, P485, DOI 10.1016/S0248-4900(00)88205-2; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hsuuw YD, 2007, ANN NY ACAD SCI, V1095, P428, DOI 10.1196/annals.1397.046; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; Iwasaki R, 2009, CANCER SCI, V100, P349, DOI 10.1111/j.1349-7006.2008.01046.x; Kang CH, 2008, AUTOPHAGY, V4, P82, DOI 10.4161/auto.5154; Khan N, 2008, CANCER LETT, V269, P269, DOI 10.1016/j.canlet.2008.04.014; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013; Lee JH, 2010, CANCER LETT, V290, P68, DOI 10.1016/j.canlet.2009.08.027; Lee SJ, 2009, GLIA, V57, P1351, DOI 10.1002/glia.20854; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Liu D, 2000, J BIOL CHEM, V275, P9244, DOI 10.1074/jbc.275.13.9244; Long LH, 2007, MUTAT RES-GEN TOX EN, V634, P177, DOI 10.1016/j.mrgentox.2007.07.009; Long LH, 2000, BIOCHEM BIOPH RES CO, V273, P50, DOI 10.1006/bbrc.2000.2895; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; McAfee Q, 2012, P NATL ACAD SCI USA, V109, P8253, DOI 10.1073/pnas.1118193109; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakashima S, 2003, J BIOCHEM, V134, P359, DOI 10.1093/jb/mvg153; Nilsson C, 2006, APOPTOSIS, V11, P1149, DOI 10.1007/s10495-006-7108-5; Noda C, 2007, BIOCHEM BIOPH RES CO, V362, P951, DOI 10.1016/j.bbrc.2007.08.079; Nozaki A, 2009, CHEM PHARM BULL, V57, P224, DOI 10.1248/cpb.57.224; Ostenfeld MS, 2005, CANCER RES, V65, P8975, DOI 10.1158/0008-5472.CAN-05-0269; Pryor PR, 2012, METHOD ENZYMOL, V505, P145, DOI 10.1016/B978-0-12-388448-0.00016-4; Qanungo S, 2005, CARCINOGENESIS, V26, P958, DOI 10.1093/carcin/bgi040; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Shen HM, 1996, FREE RADICAL BIO MED, V21, P139, DOI 10.1016/0891-5849(96)00019-6; Syntichaki P, 2005, CURR BIOL, V15, P1249, DOI 10.1016/j.cub.2005.05.057; Terman A, 2006, IUBMB LIFE, V58, P531, DOI 10.1080/15216540600904885; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang CS, 2000, J NUTR, V130, p472S, DOI 10.1093/jn/130.2.472S; Zhou J., 2012, AUTOPHAGY, V8	51	39	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46749	10.1371/journal.pone.0046749	http://dx.doi.org/10.1371/journal.pone.0046749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056433	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500069
J	Cabilly, Y; Barbi, M; Geva, M; Marom, L; Chetrit, D; Ehrlich, M; Elroy-Stein, O				Cabilly, Yuval; Barbi, Mali; Geva, Michal; Marom, Liraz; Chetrit, David; Ehrlich, Marcelo; Elroy-Stein, Orna			Poor Cerebral Inflammatory Response in eIF2B Knock-In Mice: Implications for the Aetiology of Vanishing White Matter Disease	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; INITIATION-FACTOR EIF2B; TRANSLATIONAL CONTROL; CHILDHOOD ATAXIA; MULTIPLE-SCLEROSIS; LEUKOENCEPHALOPATHY; ASTROCYTES; MICROGLIA; CELLS; LEUKODYSTROPHY	Background: Mutations in any of the five subunits of eukaryotic translation initiation factor 2B (eIF2B) can lead to an inherited chronic-progressive fatal brain disease of unknown aetiology termed leucoencephalopathy with vanishing white matter (VWM). VWM is one of the most prevalent childhood white matter disorders, which markedly deteriorates after inflammation or exposure to other stressors. eIF2B is a major housekeeping complex that governs the rate of global protein synthesis under normal and stress conditions. A previous study demonstrated that Eif2b5(R132H/R132H) mice suffer delayed white matter development and fail to recover from cuprizone-induced demyelination, although eIF2B enzymatic activity in the mutant brain is reduced by merely 20%. Principal Findings: Poor astrogliosis was observed in Eif2b5(R132H/R132H) mice brain in response to systemic stress induced by peripheral injections of lipopolysaccharide (LPS). Even with normal rates of protein synthesis under normal conditions, primary astrocytes and microglia isolated from mutant brains fail to adequately synthesise and secrete cytokines in response to LPS treatment despite proper induction of cytokine mRNAs. Conclusions: The mild reduction in eIF2B activity prevents the appropriate increase in translation rates upon exposure to the inflammatory stressor LPS. The data underscore the importance of fully-functional translation machinery for efficient cerebral inflammatory response upon insults. It highlights the magnitude of proficient translation rates in restoration of brain homeostasis via microglia-astrocyte crosstalk. This study is the first to suggest the involvement of microglia in the pathology of VWM disease. Importantly, it rationalises the deterioration of clinical symptoms upon exposure of VWM patients to physiological stressors and provides possible explanation for their high phenotypic variability.	[Cabilly, Yuval; Barbi, Mali; Geva, Michal; Marom, Liraz; Chetrit, David; Ehrlich, Marcelo; Elroy-Stein, Orna] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Elroy-Stein, Orna] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Elroy-Stein, O (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	ornaes@tauex.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808; Elroy-Stein, Orna/0000-0002-3716-1540	European Leukodystrophy Association (ELA) Foundation [2008-21]; Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation [1911/08]	European Leukodystrophy Association (ELA) Foundation; Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation	This study was supported by grants from the European Leukodystrophy Association (ELA) Foundation (grant no. 2008-21) and from the Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation (grant no. 1911/08) to OES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Bugiani M, 2010, J NEUROPATH EXP NEUR, V69, P987, DOI 10.1097/NEN.0b013e3181f2eafa; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Francalanci P, 2001, NEUROLOGY, V57, P265, DOI 10.1212/WNL.57.2.265; Geva M, 2010, BRAIN, V133, P2448, DOI 10.1093/brain/awq180; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Liu AR, 2011, HUM MUTAT; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Mayo L, 2007, CELL DEATH DIFFER, V14, P183, DOI 10.1038/sj.cdd.4401989; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pronk JC, 2006, MENT RETARD DEV D R, V12, P123, DOI 10.1002/mrdd.20104; Proud C G, 2001, Prog Mol Subcell Biol, V26, P95; Rodriguez D, 1999, ACTA NEUROPATHOL, V97, P469, DOI 10.1007/s004010051016; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schiffmann R, 2006, MOL GENET METAB, V88, P7, DOI 10.1016/j.ymgme.2005.10.019; Schiffmann R, 1993, CHILDHOOD ATAXIA CEN; Schonrock LM, 2000, NEUROSCI LETT, V294, P45, DOI 10.1016/S0304-3940(00)01543-3; Schwartz M, 2003, J CEREBR BLOOD F MET, V23, P385, DOI 10.1097/01.WCB.0000061881.75234.5E; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; van Neerven S, 2010, J NEUROIMMUNOL, V229, P169, DOI 10.1016/j.jneuroim.2010.08.005; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546; Wong K, 2000, ACTA NEUROPATHOL, V100, P635, DOI 10.1007/s004010000234; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	43	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46715	10.1371/journal.pone.0046715	http://dx.doi.org/10.1371/journal.pone.0046715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056417	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800043
J	Zhu, XY; Li, M; Li, XJ; Yang, ZY; Tsien, JZ				Zhu, Xiaoyuan; Li, Meng; Li, Xiaojian; Yang, Zhiyong; Tsien, Joe Z.			Robust Action Recognition Using Multi-Scale Spatial-Temporal Concatenations of Local Features as Natural Action Structures	PLOS ONE			English	Article							NEURAL MECHANISMS; CELLS; PERCEPTION; CATEGORIES; MOTION	Human and many other animals can detect, recognize, and classify natural actions in a very short time. How this is achieved by the visual system and how to make machines understand natural actions have been the focus of neurobiological studies and computational modeling in the last several decades. A key issue is what spatial-temporal features should be encoded and what the characteristics of their occurrences are in natural actions. Current global encoding schemes depend heavily on segmenting while local encoding schemes lack descriptive power. Here, we propose natural action structures, i.e., multi-size, multi-scale, spatial-temporal concatenations of local features, as the basic features for representing natural actions. In this concept, any action is a spatial-temporal concatenation of a set of natural action structures, which convey a full range of information about natural actions. We took several steps to extract these structures. First, we sampled a large number of sequences of patches at multiple spatial-temporal scales. Second, we performed independent component analysis on the patch sequences and classified the independent components into clusters. Finally, we compiled a large set of natural action structures, with each corresponding to a unique combination of the clusters at the selected spatial-temporal scales. To classify human actions, we used a set of informative natural action structures as inputs to two widely used models. We found that the natural action structures obtained here achieved a significantly better recognition performance than low-level features and that the performance was better than or comparable to the best current models. We also found that the classification performance with natural action structures as features was slightly affected by changes of scale and artificially added noise. We concluded that the natural action structures proposed here can be used as the basic encoding units of actions and may hold the key to natural action understanding.	[Zhu, Xiaoyuan; Li, Meng; Li, Xiaojian; Yang, Zhiyong; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA USA; [Zhu, Xiaoyuan; Li, Meng; Li, Xiaojian; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Yang, Zhiyong] Georgia Regents Univ, Med Coll Georgia, Dept Ophthalmol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Yang, ZY (corresponding author), Georgia Regents Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA USA.	zhyang@georgiahealth.edu; jtsien@georgiahealth.edu			National Institute of Mental Health (NIMH); National Institute of Aging (NIA); GHSU fund; Georgia Research Alliance	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); GHSU fund; Georgia Research Alliance	This research was supported by funds from National Institute of Mental Health (NIMH), National Institute of Aging (NIA), GHSU fund, and Georgia Research Alliance (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2003, J NEUROSCI, V23, P3771; Aggarwal JK, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1922649.1922653; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Blei D.M., 2006, ICML, V25-29, P113; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401, DOI [10.1145/1282280.1282340, DOI 10.1145/1282280, DOI 10.1145/1282280.1282340]; Boyd-Graber J, 2008, ADV NEURAL INFORM PR, V1, P185; Bregonzio M, 2009, PROC CVPR IEEE, P1948, DOI 10.1109/CVPRW.2009.5206779; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dollar P., 2005, Proceedings. 2nd Joint IEEE International Workshop on Visual Surveillance and Performance Evaluation of Tracking and Surveillance (VS-PETS) (IEEE Cat. No. 05EX1178), P65; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Fowlkes C, 2004, IEEE T PATTERN ANAL, V26, P214, DOI 10.1109/TPAMI.2004.1262185; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Gorelick L, 2007, IEEE T PATTERN ANAL, V29, P2247, DOI 10.1109/TPAMI.2007.70711; He XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020002; Hospedales T, 2009, IEEE I CONF COMP VIS, P1165, DOI 10.1109/ICCV.2009.5459342; Huang TK, 2006, J MACH LEARN RES, V7, P85; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Klaser A., 2008, BMVC, V275, P1; Laptev I, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P432, DOI 10.1109/iccv.2003.1238378; Laptev I, 2008, PROC CVPR IEEE, P3222, DOI 10.1109/cvpr.2008.4587756; Lazebnik S., 2006, P IEEE INT C COMP VI, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Movshon A, 1985, PATTERN RECOGN, V54, P117; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Niebles JC, 2008, INT J COMPUT VISION, V79, P299, DOI 10.1007/s11263-007-0122-4; Pinto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000579; Poppe R, 2010, IMAGE VISION COMPUT, V28, P976, DOI 10.1016/j.imavis.2009.11.014; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Schuldt C, 2004, INT C PATT RECOG, P32, DOI 10.1109/ICPR.2004.1334462; Scovanner P., 2007, P 15 ACM INT C MULT, P357, DOI DOI 10.1145/1291233.1291311; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Ullman S., 2000, HIGH LEVEL VISION OB; Wang Heng, 2009, BMVC, P1; Wang LA, 2011, INT J COMPUT VISION, V93, P162, DOI 10.1007/s11263-010-0393-z; Weinland D, 2006, COMPUT VIS IMAGE UND, V104, P249, DOI 10.1016/j.cviu.2006.07.013; Willems G, 2008, LECT NOTES COMPUT SC, V5303, P650, DOI 10.1007/978-3-540-88688-4_48; Wong S. F., 2007, IEEE C COMP VIS PATT, P1; Xu JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015796; Yao A, 2010, PROC CVPR IEEE, P2061, DOI 10.1109/CVPR.2010.5539883; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4	49	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46686	10.1371/journal.pone.0046686	http://dx.doi.org/10.1371/journal.pone.0046686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056403	Green Submitted, gold, Green Published			2022-12-27	WOS:000309580800040
J	Helmy, K; Halliday, J; Fomchenko, E; Setty, M; Pitter, K; Hafemeister, C; Holland, EC				Helmy, Karim; Halliday, John; Fomchenko, Elena; Setty, Manu; Pitter, Ken; Hafemeister, Christoph; Holland, Eric C.			Identification of Global Alteration of Translational Regulation in Glioma In Vivo	PLOS ONE			English	Article							EXISTING MESSENGER-RNAS; HIGH-GRADE GLIOMA; CNS CELL-TYPES; NEURAL PROGENITORS; PROFILING APPROACH; GENE-EXPRESSION; CANCER; GLIOBLASTOMA; GROWTH; OLIGODENDROGLIOMAS	Post-transcriptional regulation of gene expression contributes to the protein output of a cell, however, methods for measuring translational regulation in complex in vivo systems are lacking. Here, we describe a sensitive method for measuring translational regulation in defined cell populations from heterogeneous tissue in vivo. We adapted the translating ribosome affinity purification (TRAP) methodology to measure the relative occupancy of individual mRNA transcripts in translating ribosomes in the Olig2-positive tumor cell population in a genetically engineered mouse model (GEM) of glioma. Global measurement of paired ribosome-bound and total cellular mRNA populations from tumor cells in vivo identified a broad distribution of relative ribosome occupancies amongst mRNA species that was highly reproducible across biological samples. Comparison of the translation state of glioma cells to non-transformed oligodendrocyte progenitor cells in normal brain identified global alteration of translation in tumor, and specifically of genes involved in cell division and synthetic metabolism. Furthermore, investigation of alteration in steady state translational efficiencies upon loss of PTEN, one of the most frequently mutated and deleted tumor suppressors in glioma, identified differential translation of proteins involved in cellular respiration, canonically regulated by PI3K/Akt signaling, and cellular glycosylation profiles, deregulation of which is known to be associated with tumor progression. Application of the translation efficiency profiling method described here to other biological contexts and conditions would extend our knowledge of the scope and impact of this important mode of gene regulation in complex in vivo systems.	[Helmy, Karim; Halliday, John; Fomchenko, Elena; Pitter, Ken; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Helmy, Karim; Halliday, John; Fomchenko, Elena; Pitter, Ken; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Helmy, Karim] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Helmy, Karim] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Newark, NJ 07103 USA; [Halliday, John] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA; [Fomchenko, Elena; Pitter, Ken] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Setty, Manu] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Hafemeister, Christoph] NYU, Dept Biol, New York, NY 10003 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; New York University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Holland, EC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.	hollande@mskcc.org	Hafemeister, Christoph/I-8601-2019	Hafemeister, Christoph/0000-0001-6365-8254; Setty, Manu/0000-0002-0344-2627; Pitter, Kenneth/0000-0002-9450-313X	National Institutes of Health (NIH) [RO1 CA100688, U54 CA126518, U01 CA141502-01, U54 CA143798]; NATIONAL CANCER INSTITUTE [U54CA126518, U01CA105492, R01CA100688, U01CA141502, U54CA143798, U54CA163167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076028] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (NIH) grants RO1 CA100688, U54 CA126518, U01 CA141502-01, U54 CA143798. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appolloni I, 2009, INT J CANCER, V124, P2251, DOI 10.1002/ijc.24206; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Charles N, 2010, CELL CYCLE, V9, P3012, DOI 10.4161/cc.9.15.12710; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dai CK, 2005, NEOPLASIA, V7, P397, DOI 10.1593/neo.04691; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; Hakomori S, 1996, CANCER RES, V56, P5309; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Le Quesne JPC, 2010, J PATHOL, V220, P140, DOI 10.1002/path.2627; Lei L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020041; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Melamed D, 2009, METHODS, V48, P301, DOI 10.1016/j.ymeth.2009.04.020; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Rajasekhar VK, 2004, ONCOGENE, V23, P3248, DOI 10.1038/sj.onc.1207546; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weber GL, 2011, ONCOTARGET, V2, P833; Yuan K, 2008, INT J ONCOL, V32, P797	48	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46965	10.1371/journal.pone.0046965	http://dx.doi.org/10.1371/journal.pone.0046965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056544	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000105
J	Moja, L; Piatti, A; Pecoraro, V; Ricci, C; Virgili, G; Salanti, G; Germagnoli, L; Liberati, A; Banfi, G				Moja, Lorenzo; Piatti, Alessandra; Pecoraro, Valentina; Ricci, Cristian; Virgili, Gianni; Salanti, Georgia; Germagnoli, Luca; Liberati, Alessandro; Banfi, Giuseppe			Timing Matters in Hip Fracture Surgery: Patients Operated within 48 Hours Have Better Outcomes. A Meta-Analysis and Meta-Regression of over 190,000 Patients	PLOS ONE			English	Article							TIME-TO-SURGERY; ELDERLY-PATIENTS; SURGICAL FIXATION; FEMORAL FRACTURES; EARLY MORTALITY; HOSPITAL STAY; FUNNEL PLOTS; DELAY; INTERVENTION; ASSOCIATION	Background: To assess the relationship between surgical delay and mortality in elderly patients with hip fracture. Systematic review and meta-analysis of retrospective and prospective studies published from 1948 to 2011. Medline (from 1948), Embase (from 1974) and CINAHL (from 1982), and the Cochrane Library. Odds ratios (OR) and 95% confidence intervals for each study were extracted and pooled with a random effects model. Heterogeneity, publication bias, Bayesian analysis, and meta-regression analyses were done. Criteria for inclusion were retro-and prospective elderly population studies, patients with operated hip fractures, indication of timing of surgery and survival status. Methodology/Principal Findings: There were 35 independent studies, with 191,873 participants and 34,448 deaths. The majority considered a cut-off between 24 and 48 hours. Early hip surgery was associated with a lower risk of death (pooled odds ratio (OR) 0.74, 95% confidence interval (CI) 0.67 to 0.81; P<0.000) and pressure sores (0.48, 95% CI 0.38 to 0.60; P< 0.000). Meta-analysis of the adjusted prospective studies gave similar results. The Bayesian probability predicted that about 20% of future studies might find that early surgery is not beneficial for decreasing mortality. None of the confounders (e.g. age, sex, data source, baseline risk, cut-off points, study location, quality and year) explained the differences between studies. Conclusions/Significance: Surgical delay is associated with a significant increase in the risk of death and pressure sores. Conservative timing strategies should be avoided. Orthopaedic surgery services should ensure the majority of patients are operated within one or two days.	[Moja, Lorenzo] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Moja, Lorenzo; Ricci, Cristian; Germagnoli, Luca; Banfi, Giuseppe] IRCCS Galeazzi Orthoped Inst, Clin Epidemiol Unit, Milan, Italy; [Piatti, Alessandra] ASL Milano, Epidemiol Observ, Milan, Italy; [Virgili, Gianni] Univ Florence, Dept Oto Specialised Surg Sci, Florence, Italy; [Salanti, Georgia] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; [Salanti, Georgia] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece; [Liberati, Alessandro] Univ Modena & Reggio Emilia, Dept Oncol Hematol & Resp Dis, Modena, Italy	University of Milan; IRCCS Istituto Ortopedico Galeazzi; University of Florence; University of Ioannina; University of Ioannina; Universita di Modena e Reggio Emilia	Moja, L (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	moja@marionegri.it	Ricci, Cristian/AAV-3315-2021; Moja, Pasquale Lorenzo/CAH-0318-2022; Virgili, Gianni/P-6607-2014; Banfi, Giuseppe/K-6585-2015	Ricci, Cristian/0000-0003-4113-8682; Moja, Pasquale Lorenzo/0000-0001-6680-6507; Pecoraro, Valentina/0000-0002-1800-0936; Salanti, Georgia/0000-0002-3830-8508; Virgili, Gianni/0000-0002-9960-2989; Banfi, Giuseppe/0000-0001-9578-5338	Istituto di Ricovero e Cura a Carattere Scientifico Galeazzi	Istituto di Ricovero e Cura a Carattere Scientifico Galeazzi	This review was funded by the Istituto di Ricovero e Cura a Carattere Scientifico Galeazzi. Another source of institutional support was the Department of Public Health of the University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ani AN, 2008, J BONE JOINT SURG AM, V90A, P1436, DOI 10.2106/JBJS.G.00890; Bergeron E, 2006, J TRAUMA, V60, P753, DOI 10.1097/01.ta.0000214649.53190.2a; Bottle A, 2006, BMJ-BRIT MED J, V332, P947, DOI 10.1136/bmj.38790.468519.55; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; BREDAHL C, 1992, INJURY, V23, P83, DOI 10.1016/0020-1383(92)90037-S; Carretta E, 2011, INT ORTHOP, V35, P419, DOI 10.1007/s00264-010-1004-x; DAVIS TRC, 1988, INJURY, V19, P244, DOI 10.1016/0020-1383(88)90036-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dorotka R, 2003, J BONE JOINT SURG BR, V85B, P1107, DOI 10.1302/0301-620X.85B8.14282; Doruk H, 2004, ARCH GERONTOL GERIAT, V39, P179, DOI 10.1016/j.archger.2004.03.004; Elliott J, 2003, J CLIN EPIDEMIOL, V56, P788, DOI 10.1016/S0895-4356(03)00129-X; Gdalevich M, 2004, ARCH ORTHOP TRAUM SU, V124, P334, DOI 10.1007/s00402-004-0662-9; Grimes JP, 2002, AM J MED, V112, P702, DOI 10.1016/S0002-9343(02)01119-1; Handoll HHG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001704.pub3; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Holt G, 2008, J BONE JOINT SURG BR, V90B, P1357, DOI 10.1302/0301-620X.90B10.21328; Improvement IfIa, 2006, DEL QUAL VAL FOC FRA; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Khan SK, 2009, INJURY, V40, P692, DOI 10.1016/j.injury.2009.01.010; Leslie WD, 2009, JAMA-J AM MED ASSOC, V302, P883, DOI 10.1001/jama.2009.1231; Maggi S, 2010, OSTEOPOROSIS INT, V21, P223, DOI 10.1007/s00198-009-0936-8; Majumdar SR, 2006, MED CARE, V44, P552, DOI 10.1097/01.mlr.0000215812.13720.2e; Mak JCS, 2010, MED J AUSTRALIA, V192, P37, DOI 10.5694/j.1326-5377.2010.tb03400.x; McGuire KJ, 2004, CLIN ORTHOP RELAT R, P294, DOI 10.1097/01.blo.0000146743.28925.1c; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; MULLEN JO, 1992, CLIN ORTHOP RELAT R, P214; Novack V, 2007, INT J QUAL HEALTH C, V19, P170, DOI 10.1093/intqhc/mzm003; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Orosz GM, 2002, J AM GERIATR SOC, V50, P1336, DOI 10.1046/j.1532-5415.2002.50353.x; Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206; Papanikolaou PN, 2006, PLOS MED, V3, P1603, DOI 10.1371/journal.pmed.0030341; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; PARKER MJ, 1992, J BONE JOINT SURG BR, V74, P203, DOI 10.1302/0301-620X.74B2.1544952; Parker MJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000521.PUB2; Peleg K, 2011, INJURY, V42, P128, DOI 10.1016/j.injury.2009.11.016; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Radcliff TA, 2008, J BONE JOINT SURG AM, V90A, P34, DOI 10.2106/JBJS.G.00065; Rademakers LMF, 2007, EUR J TRAUMA EMERG S, V33, P238, DOI 10.1007/s00068-007-6212-8; Rae HC, 2007, ANZ J SURG, V77, P889, DOI 10.1111/j.1445-2197.2007.04267.x; Roberts SE, 2003, BRIT MED J, V327, P771, DOI 10.1136/bmj.327.7418.771; Roos LL, 1996, MED CARE, V34, P310, DOI 10.1097/00005650-199604000-00003; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P115, DOI 10.1016/j.jclinepi.2008.05.014; SCHUNEMANN HJ, 2008, COCHRANE HDB SYSTEMA, P359; Scottish Intercollegiate Guideline Network (SIGN), 2009, SIGN 111 MANAGEMENT; Seccareccia F, 2010, 1043 ISTISAN; Sexson S B, 1987, J Orthop Trauma, V1, P298, DOI 10.1097/00005131-198701040-00005; Shiga T, 2008, CAN J ANAESTH, V55, P146, DOI 10.1007/BF03016088; Siegmeth AW, 2005, J BONE JOINT SURG BR, V87B, P1123, DOI 10.1302/0301-620X.87B8; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Smektala R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-171; Spiegelhalter D. J., 2000, WINBUGS VERSION 1 3; StataCorp, 2021, STATA STAT SOFTWARE; Sterne J.A., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch10, DOI 10.1002/9780470712184.CH10]; Stoddart J, 2002, ANZ J SURG, V72, P405, DOI 10.1046/j.1445-2197.2002.02425.x; Sund R, 2005, QUAL SAF HEALTH CARE, V14, P371, DOI 10.1136/qshc.2004.012831; Swanson CE, 1998, MED J AUSTRALIA, V169, P515, DOI 10.5694/j.1326-5377.1998.tb123397.x; Verbeek DOF, 2008, INT ORTHOP, V32, P13, DOI 10.1007/s00264-006-0290-9; Weller I, 2005, J BONE JOINT SURG BR, V87B, P361, DOI 10.1302/0301-620X.87B3.15300; Wells G. A., 2007, NEWCASTLE OTTAWA SCA	63	321	346	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46175	10.1371/journal.pone.0046175	http://dx.doi.org/10.1371/journal.pone.0046175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056256	Green Published, gold			2022-12-27	WOS:000309454000023
J	Kelm-Nelson, CA; Stevenson, SA; Riters, LV				Kelm-Nelson, Cynthia A.; Stevenson, Sharon A.; Riters, Lauren V.			Context-Dependent Links between Song Production and Opioid-Mediated Analgesia in Male European Starlings (Sturnus vulgaris)	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; ENDOGENOUS OPIOIDS; PREOPTIC AREA; GONADAL-STEROIDS; SEASONAL-CHANGES; SOCIAL-BEHAVIOR; BETA-ENDORPHIN; MALE-RAT; RECEPTORS; TESTOSTERONE	Little is known about the neural mechanisms that ensure appropriate vocal behaviors within specific social contexts. Male songbirds produce spontaneous (undirected) songs as well as female-directed courtship songs. Opioid neuropeptide activity in specific brain regions is rewarding, at least in mammals, and past studies suggest that the opioid met-enkephalin in such areas is more tightly linked to undirected than female-directed song. Recent data using a song-associated place preference paradigm further suggest that production of undirected but not directed song is tightly linked to intrinsic reward. Opioids have analgesic properties. Therefore, if production of undirected song is closely linked to opioid-mediated reward, the production of undirected but not directed song should be associated with analgesia. Consistent with this prediction, in male starlings we identified a positive correlation between analgesia (decreased reactivity to a hot water bath) and undirected song (in non-breeding season condition males in affiliative flocks) but not female-directed song (in breeding season condition males presented with females). When breeding condition males were divided according to social status, a negative correlation was found in subordinate males (i.e. males that failed to acquire a nest box). These data are consistent with the hypotheses 1) that the production of undirected song is facilitated or maintained by opioids (and/or other neuromodulators that also induce analgesia) and 2) that production of female-directed song is not linked in the same way to release of the same neuromodulators. Results also demonstrate a link between analgesia and song in subordinate individuals lacking a nesting territory within the breeding season. Overall, the findings indicate that distinct neural mechanisms regulate communication in different social contexts and support the working hypothesis that undirected but not directed song is tightly linked to opioid release.	[Kelm-Nelson, Cynthia A.; Stevenson, Sharon A.; Riters, Lauren V.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kelm-Nelson, CA (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	cakelm@wisc.edu		Kelm-Nelson, Cynthia/0000-0001-6670-2177	National Institutes of Health [R01 MH 080225];  [R01 MH080225]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institutes of Health (R01 MH 080225) to LVR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The data presented in this paper are based upon work supported by grants R01 MH080225 to LVR. We acknowledge Kate Skogen and Chris Elliot for animal care taking, Griffin Gessay, Rachel McCormick and Dr. Ben Pawlisch for helping to collect pilot data.	AGMO A, 1988, PHARMACOL BIOCHEM BE, V30, P1021, DOI 10.1016/0091-3057(88)90135-9; AGMO A, 1991, BRAIN RES, V550, P343, DOI 10.1016/0006-8993(91)91339-3; AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Altier N, 1996, BRAIN RES, V718, P203, DOI 10.1016/0006-8993(96)00121-7; BOZARTH MA, 1981, LIFE SCI, V28, P551, DOI 10.1016/0024-3205(81)90148-X; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Cravatt BF, 2004, J NEUROBIOL, V61, P149, DOI 10.1002/neu.20080; Davis JF, 2010, TRENDS ENDOCRIN MET, V21, P68, DOI 10.1016/j.tem.2009.08.004; DAWSON A, 1983, GEN COMP ENDOCR, V49, P286, DOI 10.1016/0016-6480(83)90146-6; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; DEFEUDIS FV, 1982, PHARMACOL RES COMMUN, V14, P383, DOI 10.1016/S0031-6989(82)80066-0; Dunbar RIM, 2011, P R SOC B; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Evrard HC, 2004, HORM BEHAV, V45, P181, DOI 10.1016/j.yhbeh.2003.09.014; Evrard HC, 2002, J NEUROSCI METH, V116, P135, DOI 10.1016/S0165-0270(02)00034-1; FORMAN LJ, 1989, LIFE SCI, V45, P447, DOI 10.1016/0024-3205(89)90631-0; Frye CA, 2001, COGN AFFECT BEHAV NE, V1, P371, DOI 10.3758/CABN.1.4.371; Gonzalez-Flores O, 2004, HORM BEHAV, V46, P151, DOI 10.1016/j.yhbeh.2004.02.006; Hau M, 2004, HORM BEHAV, V46, P165, DOI 10.1016/j.yhbeh.2004.02.007; Heimovics SA, 2011, NEUROSCIENCE, V182, P133, DOI 10.1016/j.neuroscience.2011.03.012; Heimovics SA, 2006, HORM BEHAV, V50, P726, DOI 10.1016/j.yhbeh.2006.06.013; HOLLT V, 1985, PHILOS T ROY SOC B, V308, P299, DOI 10.1098/rstb.1985.0030; Johansson P, 1997, NEUROSCI RES, V27, P185, DOI 10.1016/S0168-0102(96)01141-8; Kavaliers M, 1998, BEHAV NEUROSCI, V112, P1001, DOI 10.1037/0735-7044.112.4.1001; Kelm CA, 2011, BEHAV BRAIN RES, V219, P15, DOI 10.1016/j.bbr.2010.12.003; Khurshid N, 2010, BEHAV BRAIN RES, V208, P359, DOI 10.1016/j.bbr.2009.12.003; Kotegawa T, 1997, J EXP ZOOL, V277, P146, DOI 10.1002/(SICI)1097-010X(19970201)277:2&lt;146::AID-JEZ6&gt;3.0.CO;2-P; MA QP, 1992, BRAIN RES BULL, V28, P931; MANSOUR A, 1987, J NEUROSCI, V7, P2445; Mattson BJ, 2001, BEHAV NEUROSCI, V115, P683, DOI 10.1037/0735-7044.115.3.683; PANKSEPP J, 1980, NEUROSCI BIOBEHAV R, V4, P473, DOI 10.1016/0149-7634(80)90036-6; Pinxten R, 2002, HORM BEHAV, V42, P307, DOI 10.1006/hbeh.2002.1824; Riters LV, 2011, NEUROSCI BIOBEHAV R, V35, P1837, DOI 10.1016/j.neubiorev.2010.12.017; Riters LV, 2010, J CHEM NEUROANAT, V39, P141, DOI 10.1016/j.jchemneu.2009.03.008; Riters LV, 2002, J COMP NEUROL, V444, P63, DOI 10.1002/cne.10131; Riters LV, 2000, HORM BEHAV, V38, P250, DOI 10.1006/hbeh.2000.1623; Riters LV, 2005, BEHAV NEUROSCI, V119, P245, DOI 10.1037/0735-7044.119.1.245; Riters LV, 2012, PHYSL BEHAV IN PRESS; Sartor JJ, 2005, BEHAV NEUROSCI, V119, P233, DOI 10.1037/0735-7044.119.1.233; Schroeder MB, 2006, PHYSIOL BEHAV, V88, P575, DOI 10.1016/j.physbeh.2006.05.011; SIMERLY RB, 1988, J COMP NEUROL, V276, P442, DOI 10.1002/cne.902760309; Stephens R, 2009, NEUROREPORT, V20, P1056, DOI 10.1097/WNR.0b013e32832e64b1; STEWART JM, 1976, NATURE, V262, P784, DOI 10.1038/262784a0; TSENG LF, 1980, J PHARMACOL EXP THER, V214, P328; Van Ree JM, 2000, EUR J PHARMACOL, V405, P89, DOI 10.1016/S0014-2999(00)00544-6; WATSON RE, 1986, BRAIN RES, V398, P157, DOI 10.1016/0006-8993(86)91261-8; Woods JK, 2010, J CHEM NEUROANAT, V40, P123, DOI 10.1016/j.jchemneu.2010.05.002; YAKSH TL, 1976, BRAIN RES, V114, P83, DOI 10.1016/0006-8993(76)91009-X	48	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46721	10.1371/journal.pone.0046721	http://dx.doi.org/10.1371/journal.pone.0046721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056422	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600055
J	Min, JY; Lee, KJ; Park, JB; Cho, SI; Park, SG; Min, K				Min, Jin-young; Lee, Kyung-jong; Park, Jae-beom; Cho, Sung-il; Park, Shin-goo; Min, Kyoungbok			Social Engagement, Health, and Changes in Occupational Status: Analysis of the Korean Longitudinal Study of Ageing (KLoSA)	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; COGNITIVE DECLINE; LIFETIME OCCUPATION; HANDGRIP STRENGTH; COMMUNITY POPULATION; OLDER WORKERS; GRIP STRENGTH; DISABILITY; RETIREMENT; MORTALITY	Background: We focused on whether changes in the occupational status of older male adults can be influenced by social engagement and health status measured at the baseline. Methods: This study used a sample of the Korean Longitudinal Study of Aging (KLoSA), and the study population was restricted to 1.531 men who were aged 55 to 80 years at the 2006 baseline survey and participated in the second survey in 2008. Social engagement and health status, measured by the number of chronic diseases, grip strength, and depressive symptoms as well as covariates (age, marital status, educational level, and household income) were based on data from the 2006 baseline survey. Occupational engagement over the first and second survey was divided into four categories: 'consistently employed' (n = 892), 'employed-unemployed' (n = 152), 'unemployed-employed' (n = 138), and 'consistently unemployed' (n = 349). Results: In the multinomial model, the 'consistently employed' and 'unemployed-employed' groups had significantly higher social engagement (1.19 and 1.32 times, respectively) than the referent. The number of chronic diseases was significantly associated with four occupational changes, and the 'unemployed-employed' had the fewest chronic conditions. Conclusion: Our finding suggests that social engagement and health status are likely to affect opportunities to continue working or to start working for older male adults.	[Lee, Kyung-jong; Park, Jae-beom; Min, Kyoungbok] Ajou Univ, Sch Med, Dept Occupat & Environm Med, Suwon 441749, South Korea; [Min, Jin-young] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Cho, Sung-il] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea; [Cho, Sung-il] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Park, Shin-goo] Inha Univ Hosp, Dept Occupat & Environm Med, Inchon, South Korea	Ajou University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inha University; Inha University Hospital	Min, K (corresponding author), Ajou Univ, Sch Med, Dept Occupat & Environm Med, Suwon 441749, South Korea.	mink1999@ajou.ac.kr						Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; Alfaro-Acha A, 2006, J GERONTOL A-BIOL, V61, P859, DOI 10.1093/gerona/61.8.859; Andel R, 2007, J AGING HEALTH, V19, P397, DOI 10.1177/0898264307300171; Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Bassuk SS, 1999, ANN INTERN MED, V131, P165, DOI 10.7326/0003-4819-131-3-199908030-00002; Bath Peter A, 2005, Eur J Ageing, V2, P24, DOI 10.1007/s10433-005-0019-4; Bennett KM, 2002, AGE AGEING, V31, P165, DOI 10.1093/ageing/31.3.165; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Black SA, 1999, ANN EPIDEMIOL, V9, P45, DOI 10.1016/S1047-2797(98)00025-8; Buchman AS, 2009, ARCH INTERN MED, V169, P1139, DOI 10.1001/archinternmed.2009.135; Buck H, 2003, AGEING WORK EUROPE S; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; DARTIGUES JF, 1992, AM J EPIDEMIOL, V135, P981, DOI 10.1093/oxfordjournals.aje.a116410; de Leon CFM, 2003, AM J EPIDEMIOL, V157, P633, DOI 10.1093/aje/kwg028; de Leon CFM, 1999, J GERONTOL B-PSYCHOL, V54, pS162, DOI 10.1093/geronb/54B.3.S162; FRESE M, 1987, SOC SCI MED, V25, P173, DOI 10.1016/0277-9536(87)90385-6; Gallo WT, 2000, J GERONTOL B-PSYCHOL, V55, pS131, DOI 10.1093/geronb/55.3.S131; Glass TA, 2006, J AGING HEALTH, V18, P604, DOI 10.1177/0898264306291017; Grundy E, 2000, AGE AGEING, V29, P149, DOI 10.1093/ageing/29.2.149; Hansson RO, 1997, J VOCAT BEHAV, V51, P202, DOI 10.1006/jvbe.1997.1605; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Isaac V, 2009, AM J GERIAT PSYCHIAT, V17, P688, DOI 10.1097/JGP.0b013e3181a88441; Jackson J, 1998, AM J OCCUP THER, V52, P326, DOI 10.5014/ajot.52.5.326; Kiosses DN, 2001, AM J GERIAT PSYCHIAT, V9, P269, DOI 10.1176/appi.ajgp.9.3.269; Krueger KR, 2009, EXP AGING RES, V35, P45, DOI 10.1080/03610730802545028; McGarry K, 2004, J HUM RESOUR, V39, P624, DOI 10.2307/3558990; Mein G, 2003, J EPIDEMIOL COMMUN H, V57, P46, DOI 10.1136/jech.57.1.46; Raji MA, 2005, J AM GERIATR SOC, V53, P1462, DOI 10.1111/j.1532-5415.2005.53457.x; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Reblin M, 2008, CURR OPIN PSYCHIATR, V21, P201, DOI 10.1097/YCO.0b013e3282f3ad89; Russo A, 2006, OCCUP ENVIRON MED, V63, P438, DOI 10.1136/oem.2005.023549; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022; Wilson RS, 2004, J NEUROL NEUROSUR PS, V75, P126	35	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46500	10.1371/journal.pone.0046500	http://dx.doi.org/10.1371/journal.pone.0046500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NG	23056323	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600038
J	Carlier, VA; VanderElst, L; Janssens, W; Jacquemin, MG; Saint-Remy, JMR				Carlier, Vincent A.; VanderElst, Luc; Janssens, Wim; Jacquemin, Marc G.; Saint-Remy, Jean-Marie R.			Increased Synapse Formation Obtained by T Cell Epitopes Containing a CxxC Motif in Flanking Residues Convert CD4+T Cells into Cytolytic Effectors	PLOS ONE			English	Article							ALTERED PEPTIDE LIGAND; SURFACE EXPRESSION; REDOX REGULATION; FAS LIGAND; ACTIVATION; IDENTIFICATION; MECHANISMS; PLASTICITY; INDUCTION; INFLUENZA	The nature of MHC class II-binding epitopes not only determines the specificity of T cell responses, but may also alter effector cell functions. Cytolytic CD4+ T cells have been observed primarily in anti-viral responses, but very little is known about the conditions under which they can be elicited. Their potential as regulators of immune responses, however, deserves investigations. We describe here that inclusion of a thiol-disulfide oxidoreductase motif within flanking residues of class II-restricted epitopes results, both in vitro and in vivo, in elicitation of antigen-specific cytolytic CD4+ T cells through increased synapse formation. We show that both naive and polarized CD4+ T cells, including Th17 cells, can be converted by cognate recognition of such modified epitopes. Cytolytic CD4+ T cells induce apoptosis on APCs by Fas-FasL interaction. These findings potentially open the way towards a novel form of antigen-specific immunosuppression.	[Carlier, Vincent A.; VanderElst, Luc; Janssens, Wim; Jacquemin, Marc G.; Saint-Remy, Jean-Marie R.] Univ Louvain, Ctr Mol & Vasc Biol, Louvain, Belgium		Saint-Remy, JMR (corresponding author), Univ Louvain, Ctr Mol & Vasc Biol, Louvain, Belgium.	jeanmarie.saint-remy@med.kuleuven.ac.be		Janssens, Wim/0000-0003-1830-2982	University of Leuven/Collen Research foundation	University of Leuven/Collen Research foundation	The work was supported by University of Leuven/Collen Research foundation funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary D, 2006, J EXP MED, V203, P995, DOI 10.1084/jem.20051287; Ahangarani RR, 2011, MOL THER, V19, P711, DOI 10.1038/mt.2010.275; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Bluestone JA, 2009, NAT REV IMMUNOL; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Brown DM, 2009, CELL IMMUNOL, V257, P69, DOI 10.1016/j.cellimm.2009.03.002; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Corse E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000481; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; GROMKOWSKI SH, 1988, EUR J IMMUNOL, V18, P1385, DOI 10.1002/eji.1830180913; Hadzic T, 2005, J IMMUNOL, V175, P7965, DOI 10.4049/jimmunol.175.12.7965; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Janssens W, 2003, J IMMUNOL, V171, P4604, DOI 10.4049/jimmunol.171.9.4604; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; KANNER SB, 1992, P NATL ACAD SCI USA, V89, P300, DOI 10.1073/pnas.89.1.300; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; Laragione T, 2003, P NATL ACAD SCI USA, V100, P14737, DOI 10.1073/pnas.2434516100; Larche M, 2005, NAT MED, V11, pS69, DOI 10.1038/nm1226; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lettau M, 2007, IMMUNOL LETT, V108, P10, DOI 10.1016/j.imlet.2006.10.001; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084/jem.20091442; Lovitch SB, 2006, J IMMUNOL, V176, P2958, DOI 10.4049/jimmunol.176.5.2958; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Mendel I, 1996, EUR J IMMUNOL, V26, P2470, DOI 10.1002/eji.1830261030; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; MURPHY DB, 1992, J IMMUNOL, V148, P3483; NAUJOKAS MF, 1995, IMMUNITY, V3, P359, DOI 10.1016/1074-7613(95)90120-5; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; Qui HZ, 2011, J IMMUNOL, V187, P3555, DOI 10.4049/jimmunol.1101244; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sant'Angelo DB, 2002, EUR J IMMUNOL, V32, P2510, DOI 10.1002/1521-4141(200209)32:9<2510::AID-IMMU2510>3.0.CO;2-Q; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Scott D, 2000, IMMUNITY, V12, P711, DOI 10.1016/S1074-7613(00)80221-6; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Tomazzolli R, 2006, ANAL BIOCHEM, V350, P105, DOI 10.1016/j.ab.2005.11.037; Varadhachary AS, 1997, P NATL ACAD SCI USA, V94, P5778, DOI 10.1073/pnas.94.11.5778; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53; Wu B, 2002, J IMMUNOL, V169, P2430, DOI 10.4049/jimmunol.169.5.2430; Wu B, 2000, EUR J IMMUNOL, V30, P291, DOI 10.1002/1521-4141(200001)30:1<291::AID-IMMU291>3.0.CO;2-T; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	55	6	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e45366	10.1371/journal.pone.0045366	http://dx.doi.org/10.1371/journal.pone.0045366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056200	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400006
J	Lin, AL; Poteet, E; Du, F; Gourav, RC; Liu, R; Wen, Y; Bresnen, A; Huang, SL; Fox, PT; Yang, SH; Duong, TQ				Lin, Ai-Ling; Poteet, Ethan; Du, Fang; Gourav, Roy C.; Liu, Ran; Wen, Yi; Bresnen, Andrew; Huang, Shiliang; Fox, Peter T.; Yang, Shao-Hua; Duong, Timothy Q.			Methylene Blue as a Cerebral Metabolic and Hemodynamic Enhancer	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; BRAIN; NEUROPROTECTION; MITOCHONDRIA; IMPAIRMENT; PERFUSION; ROTENONE; INJURY; BOLD	By restoring mitochondrial function, methylene blue (MB) is an effective neuroprotectant in many neurological disorders (e. g., Parkinson's and Alzheimer's diseases). MB has also been proposed as a brain metabolic enhancer because of its action on mitochondrial cytochrome c oxidase. We used in vitro and in vivo approaches to determine how MB affects brain metabolism and hemodynamics. For in vitro, we evaluated the effect of MB on brain mitochondrial function, oxygen consumption, and glucose uptake. For in vivo, we applied neuroimaging and intravenous measurements to determine MB's effect on glucose uptake, cerebral blood flow (CBF), and cerebral metabolic rate of oxygen (CMRO2) under normoxic and hypoxic conditions in rats. MB significantly increases mitochondrial complex I-III activity in isolated mitochondria and enhances oxygen consumption and glucose uptake in HT-22 cells. Using positron emission tomography and magnetic resonance imaging (MRI), we observed significant increases in brain glucose uptake, CBF, and CMRO2 under both normoxic and hypoxic conditions. Further, MRI revealed that MB dramatically increased CBF in the hippocampus and in the cingulate, motor, and frontoparietal cortices, areas of the brain affected by Alzheimer's and Parkinson's diseases. Our results suggest that MB can enhance brain metabolism and hemodynamics, and multimetric neuroimaging systems offer a noninvasive, nondestructive way to evaluate treatment efficacy.	[Lin, Ai-Ling; Du, Fang; Bresnen, Andrew; Huang, Shiliang; Fox, Peter T.; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Lin, Ai-Ling] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Poteet, Ethan; Gourav, Roy C.; Liu, Ran; Wen, Yi; Yang, Shao-Hua] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Inst Alzheimers Dis & Aging Res, Ft Worth, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of North Texas System; University of North Texas Health Science Center	Lin, AL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA.	lina3@uthscsa.edu; shaohua.yang@unthsc.edu; duongt@uthscsa.edu	Fox, Peter/B-4725-2010; Duong, Tim/AAL-8357-2021; Yang, Shaohua/D-1738-2013; Duong, Timothy/B-8525-2008; Huang, Shiliang/F-3143-2010; Choudhury, Gourav Roy/L-7707-2016	Fox, Peter/0000-0002-0465-2028; Duong, Tim/0000-0001-6403-2827; Choudhury, Gourav Roy/0000-0001-8664-7638; Liu, Ran/0000-0002-3882-0616	Clinical and Translational Science Award [NIH 8UL1TR000149]; Translational Technologies and Resources of UTHSCSA; National Institutes of Health (NIH) [R01NS054687, R01NS054651]; NIH/National Institutes of Neurological Disorders and Stroke [R01-NS45879]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054651, R01NS054687, R01NS045879] Funding Source: NIH RePORTER	Clinical and Translational Science Award; Translational Technologies and Resources of UTHSCSA; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Clinical and Translational Science Award (parent grant NIH 8UL1TR000149) Translational Technologies and Resources of UTHSCSA to A. L. L., National Institutes of Health (NIH) grants R01NS054687 and R01NS054651 to S.H.Y., and NIH/National Institutes of Neurological Disorders and Stroke (R01-NS45879) to T. Q. D. T. Q. D. is supported by the Stanley I. Glickman, MD, Endowed Chair in Ophthalmic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate MG, 2008, NEUROCRIT CARE, V9, P319, DOI 10.1007/s12028-008-9119-2; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Bruchey Aleksandra K, 2008, Am J Pharmacol Toxicol, V3, P72; Butterfield DA, 2006, EUR J PHARMACOL, V545, P39, DOI 10.1016/j.ejphar.2006.06.026; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; DICKINSON D B, 1970, Plant Physiology (Rockville), V46, P200, DOI 10.1104/pp.46.2.200; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Hoyer S, 1991, ANN N Y ACAD SCI, V640, P53; Ishiwata A, 2006, ACTA NEUROL SCAND, V114, P91, DOI 10.1111/j.1600-0404.2006.00661.x; Lee WC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/535902; LINDAHL PE, 1961, EXP CELL RES, V23, P228, DOI 10.1016/0014-4827(61)90033-7; Louters LL, 2006, LIFE SCI, V78, P586, DOI 10.1016/j.lfs.2005.05.082; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Nagata K, 1997, ANN NY ACAD SCI, V826, P272, DOI 10.1111/j.1749-6632.1997.tb48479.x; Natarajan A, 1999, METAB ENG, V1, P320, DOI 10.1006/mben.1999.0125; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Powers WJ, 2011, J CEREBR BLOOD F MET, V31, P1223, DOI 10.1038/jcbfm.2011.5; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Riha PD, 2011, NEUROIMAGE, V54, P2623, DOI 10.1016/j.neuroimage.2010.11.023; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Scheindlin S, 2008, MOL INTERV, V8, P268, DOI 10.1124/mi.8.6.1; SCOTT A, 1966, J BIOL CHEM, V241, P1060; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1265, DOI 10.1038/sj.jcbfm.9600132; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; TOKUMITSU Y, 1973, BIOCHIM BIOPHYS ACTA, V292, P310, DOI 10.1016/0005-2728(73)90038-8; Wainwright M, 2002, J CHEMOTHERAPY, V14, P431, DOI 10.1179/joc.2002.14.5.431; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Wrubel KM, 2007, PHARMACOL BIOCHEM BE, V86, P712, DOI 10.1016/j.pbb.2007.02.018; Zhang XA, 2006, NEUROTOX RES, V9, P47, DOI 10.1007/BF03033307; Zhu JH, 2010, J ALZHEIMERS DIS, V20, pS325, DOI 10.3233/JAD-2010-100363	36	59	61	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46585	10.1371/journal.pone.0046585	http://dx.doi.org/10.1371/journal.pone.0046585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056355	gold, Green Published, Green Submitted			2022-12-27	WOS:000309889400020
J	Maillet, A; Krainik, A; Debu, B; Tropres, I; Lagrange, C; Thobois, S; Pollak, P; Pinto, S				Maillet, Audrey; Krainik, Alexandre; Debu, Bettina; Tropres, Irene; Lagrange, Christelle; Thobois, Stephane; Pollak, Pierre; Pinto, Serge			Levodopa Effects on Hand and Speech Movements in Patients with Parkinson's Disease: A fMRI Study	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SUBTHALAMIC NUCLEUS STIMULATION; DEEP BRAIN-STIMULATION; DUAL-TASK PERFORMANCE; BASAL GANGLIA; FUNCTIONAL-ANATOMY; MOTOR CORTEX; EFFECTIVE CONNECTIVITY; BIMANUAL MOVEMENTS; NETWORK MODULATION	Levodopa (L-dopa) effects on the cardinal and axial symptoms of Parkinson's disease (PD) differ greatly, leading to therapeutic challenges for managing the disabilities in this patient's population. In this context, we studied the cerebral networks associated with the production of a unilateral hand movement, speech production, and a task combining both tasks in 12 individuals with PD, both off and on levodopa (L-dopa). Unilateral hand movements in the off medication state elicited brain activations in motor regions (primary motor cortex, supplementary motor area, premotor cortex, cerebellum), as well as additional areas (anterior cingulate, putamen, associative parietal areas); following L-dopa administration, the brain activation profile was globally reduced, highlighting activations in the parietal and posterior cingulate cortices. For the speech production task, brain activation patterns were similar with and without medication, including the orofacial primary motor cortex (M1), the primary somatosensory cortex and the cerebellar hemispheres bilaterally, as well as the left-premotor, anterior cingulate and supramarginal cortices. For the combined task off L-dopa, the cerebral activation profile was restricted to the right cerebellum (hand movement), reflecting the difficulty in performing two movements simultaneously in PD. Under L-dopa, the brain activation profile of the combined task involved a larger pattern, including additional fronto-parietal activations, without reaching the sum of the areas activated during the simple hand and speech tasks separately. Our results question both the role of the basal ganglia system in speech production and the modulation of task-dependent cerebral networks by dopaminergic treatment.	[Pinto, Serge] Aix Marseille Univ, UMR CNRS 7309, Lab Parole & Langage, Aix En Provence, France; [Maillet, Audrey; Krainik, Alexandre; Debu, Bettina; Tropres, Irene; Lagrange, Christelle] Univ Grenoble 1, Grenoble, France; [Maillet, Audrey; Krainik, Alexandre; Debu, Bettina; Tropres, Irene] INSERM UJF CEA CHU U836, Grenoble Inst Neurosci, Grenoble, France; [Krainik, Alexandre; Lagrange, Christelle; Pollak, Pierre] CHU Grenoble, F-38043 Grenoble, France; [Thobois, Stephane] Hop Neurol, Hosp Civils Lyon, Lyon, France; [Thobois, Stephane] Univ Lyon 1, UMR CNRS 5229, Ctr Neurosci Cognit, F-69365 Lyon, France; [Pollak, Pierre] Hop Cantonal Univ Geneva, Geneva, Switzerland; [Krainik, Alexandre] IRM, Grenoble, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Geneva	Pinto, S (corresponding author), Aix Marseille Univ, UMR CNRS 7309, Lab Parole & Langage, Aix En Provence, France.	serge.pinto@lpl-aix.fr	Thobois, Stephane/H-5083-2017; KRAINIK, Alexandre/L-5874-2014; Maillet, Audrey/AAQ-6027-2021; Debû, Bettina/AAB-9935-2019; krainik, alexandre/I-2431-2015	Debû, Bettina/0000-0002-2195-8846; 	French Health Ministry [PHRC 2005]	French Health Ministry	The authors wish to thank the French Health Ministry for the very helpful source of funding (PHRC 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 2008, TRENDS NEUROSCI, V31, P265, DOI 10.1016/j.tins.2008.02.011; AGID Y, 1990, ADV NEUROL, V53, P83; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Asanuma K, 2006, BRAIN, V129, P2667, DOI 10.1093/brain/awl162; Astrom M, 2010, STEREOT FUNCT NEUROS, V88, P224, DOI 10.1159/000314357; Ballanger B, 2008, J NEUROL NEUROSUR PS, V79, P1110, DOI 10.1136/jnnp.2007.141689; BENECKE R, 1986, EXP BRAIN RES, V63, P585, DOI 10.1007/BF00237481; BENECKE R, 1986, BRAIN, V109, P739, DOI 10.1093/brain/109.4.739; Berding G, 2001, MOVEMENT DISORD, V16, P1014, DOI 10.1002/mds.1212; Braak H, 1995, J NEURAL TRANSM-SUPP, P15; Brooks DJ, 2010, J NUCL MED, V51, P596, DOI 10.2967/jnumed.108.059998; Brown P, 2006, J NEURAL TRANSM-SUPP, P27, DOI 10.1007/978-3-211-45295-0_6; BROWN RG, 1993, J NEUROL NEUROSUR PS, V56, P295, DOI 10.1136/jnnp.56.3.295; Brown RG, 1998, J NEUROL NEUROSUR PS, V64, P813, DOI 10.1136/jnnp.64.6.813; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; Bunton Kate, 2008, J Med Speech Lang Pathol, V16, P141; CLARICI A, 1994, PERCEPT MOTOR SKILL, V78, P947, DOI 10.2466/pms.1994.78.3.947; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; De Letter M, 2007, CLIN LINGUIST PHONET, V21, P783, DOI 10.1080/02699200701538181; De Letter M, 2007, CLIN NEUROL NEUROSUR, V109, P495, DOI 10.1016/j.clineuro.2007.04.003; Dromey C, 2010, INT J SPEECH-LANG PA, V12, P446, DOI 10.3109/17549507.2010.485649; Fahn S., 1987, RECENT DEV PARKINSON, P153; Flasskamp A, 2012, PARKINSONISM RELAT D, V18, P343, DOI 10.1016/j.parkreldis.2011.11.021; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Halliday G, 2011, MOVEMENT DISORD, V26, P1015, DOI 10.1002/mds.23669; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Henderson JM, 2000, ANN NEUROL, V47, P345, DOI 10.1002/1531-8249(200003)47:3<345::AID-ANA10>3.3.CO;2-M; Hershey T, 2003, J NEUROL NEUROSUR PS, V74, P844, DOI 10.1136/jnnp.74.7.844; Hilker R, 2002, J NEURAL TRANSM, V109, P1257, DOI 10.1007/s00702-002-0696-5; Ho AK, 2002, J CLIN EXP NEUROPSYC, V24, P36, DOI 10.1076/jcen.24.1.36.972; HORSTINK MWIM, 1990, J NEUROL NEUROSUR PS, V53, P685, DOI 10.1136/jnnp.53.8.685; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; JENKINS IH, 1992, ANN NEUROL, V32, P749, DOI 10.1002/ana.410320608; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Klawans H L, 1986, Mov Disord, V1, P187, DOI 10.1002/mds.870010304; Kopell BH, 2006, MOVEMENT DISORD, V21, pS238, DOI 10.1002/mds.20958; KOSAKA K, 1988, CLIN NEUROPATHOL, V7, P299; Kraft E, 2009, PARKINSONISM RELAT D, V15, P558, DOI 10.1016/j.parkreldis.2009.02.005; LaPointe LL, 2010, INT J SPEECH-LANG PA, V12, P455, DOI 10.3109/17549507.2010.486446; LEENDERS KL, 1985, BRAIN, V108, P171, DOI 10.1093/brain/108.1.171; Liotti M, 2003, NEUROLOGY, V60, P432, DOI 10.1212/WNL.60.3.432; MacDonald V, 2002, MOVEMENT DISORD, V17, P1166, DOI 10.1002/mds.10258; MCFARLAND K, 1989, CORTEX, V25, P433, DOI 10.1016/S0010-9452(89)80057-7; McRitchie DA, 1997, EXP NEUROL, V144, P202, DOI 10.1006/exnr.1997.6418; MONTASTRUC JL, 1987, MOVEMENT DISORD, V2, P279, DOI 10.1002/mds.870020405; Narayana S, 2010, HUM BRAIN MAPP, V31, P222, DOI 10.1002/hbm.20859; Narayana S, 2009, AM J SPEECH-LANG PAT, V18, P146, DOI 10.1044/1058-0360(2008/08-0004); Obeso JA, 2000, TRENDS NEUROSCI, V23, pS8, DOI 10.1016/S1471-1931(00)00028-8; Palmer SJ, 2009, NEUROSCIENCE, V158, P693, DOI 10.1016/j.neuroscience.2008.06.053; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Peters S, 2003, NEUROREPORT, V14, P809, DOI 10.1097/00001756-200305060-00006; Pinto S, 2004, LANCET NEUROL, V3, P547, DOI 10.1016/S1474-4422(04)00854-3; Pinto S, 2004, BRAIN, V127, P602, DOI 10.1093/brain/awh074; Pinto S, 2011, MOVEMENT DISORD, V26, P2212, DOI 10.1002/mds.23799; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Rascol O, 1997, BRAIN, V120, P103, DOI 10.1093/brain/120.1.103; RASCOL O, 1992, ARCH NEUROL-CHICAGO, V49, P144, DOI 10.1001/archneur.1992.00530260044017; Rektorova I, 2012, J NEUROL SCI, V313, P7, DOI 10.1016/j.jns.2011.10.020; Rektorova I, 2007, MOVEMENT DISORD, V22, P2043, DOI 10.1002/mds.21548; Rochester L, 2008, MOVEMENT DISORD, V23, P2312, DOI 10.1002/mds.22219; Rowe J, 2002, BRAIN, V125, P276, DOI 10.1093/brain/awf036; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Sachin S, 2008, J NEUROL SCI, V273, P51, DOI 10.1016/j.jns.2008.06.024; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; SIMON TJ, 1987, NEUROPSYCHOLOGIA, V25, P559, DOI 10.1016/0028-3932(87)90080-7; Skodda S, 2010, J NEURAL TRANSM, V117, P197, DOI 10.1007/s00702-009-0351-5; Talairach J., 1988, COPLANAR STEREOTAXIC; Thobois S, 2002, J NEUROL, V249, P1689, DOI 10.1007/s00415-002-0906-y; Thobois S, 2000, NEUROREPORT, V11, P785, DOI 10.1097/00001756-200003200-00026; Thobois S, 2007, NEUROIMAGE, V37, P243, DOI 10.1016/j.neuroimage.2007.04.049; Tripoliti E, 2008, MOVEMENT DISORD, V23, P2377, DOI 10.1002/mds.22296; Trost M, 2006, NEUROIMAGE, V31, P301, DOI 10.1016/j.neuroimage.2005.12.024; Turner RS, 2003, NEUROIMAGE, V19, P163, DOI 10.1016/S1053-8119(03)00059-4; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2011, NEUROIMAGE, V55, P204, DOI 10.1016/j.neuroimage.2010.11.074; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	81	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46541	10.1371/journal.pone.0046541	http://dx.doi.org/10.1371/journal.pone.0046541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056337	Green Published, gold			2022-12-27	WOS:000309889400015
J	McAdams, RM; Vanderhoeven, J; Beyer, RP; Bammler, TK; Farin, FM; Liggitt, HD; Kapur, RP; Gravett, MG; Rubens, CE; Waldorf, KMA				McAdams, Ryan M.; Vanderhoeven, Jeroen; Beyer, Richard P.; Bammler, Theo K.; Farin, Federico M.; Liggitt, H. Denny; Kapur, Raj P.; Gravett, Michael G.; Rubens, Craig E.; Waldorf, Kristina M. Adams			Choriodecidual Infection Downregulates Angiogenesis and Morphogenesis Pathways in Fetal Lungs from Macaca Nemestrina	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; AMNIOTIC-FLUID; PRETERM LABOR; BRONCHOALVEOLAR LAVAGE; INFLAMMATORY RESPONSE; SIGNALING PATHWAYS; BLOOD-VESSELS; EXPRESSION; PATHOGENESIS; INTERLEUKIN-8	Background: Intrauterine exposure to amniotic fluid (AF) cytokines is thought to predispose to bronchopulmonary dysplasia (BPD). We evaluated the effects of GBS exposure on RNA expression in fetal lung tissue to determine early molecular pathways associated with fetal lung injury that may progress to BPD. Methods: Ten chronically catheterized pregnant monkeys (Macaca nemestrina) at 118-125 days gestation (term = 172 days) received choriodecidual inoculation of either: 1) Group B Streptococcus (n = 5) or 2) saline (n = 5). Cesarean section and fetal necropsy was performed in the first week after GBS or saline inoculation regardless of labor. RNA was extracted from fetal lungs and profiled by microarray. Results were analyzed using single gene, Gene Set, and Ingenuity Pathway Analysis. Validation was by RT-PCR and immunohistochemistry. Results: Despite uterine quiescence in most cases, fetal lung injury occurred in four GBS cases (intra-alveolar neutrophils, interstitial thickening) and one control (peri-mortem hemorrhage). Significant elevations of AF cytokines (TNF-alpha, IL-8, IL-1 beta, IL-6) were detected in GBS versus controls (p<0.05). Lung injury was not directly caused by GBS, because GBS was undetectable by culture and PCR in the AF and fetal lungs. A total of 335 genes were differentially expressed greater than 1.5 fold (p<0.05) with GBS exposure associated with a striking upregulation of genes in innate and adaptive immunity and downregulation of pathways for angiogenesis, morphogenesis, and cellular growth and development. Conclusions: A transient choriodecidual infection may induce fetal lung injury with profound alterations in the genetic program of the fetal lung before signs of preterm labor. Our results provide a window for the first time into early molecular pathways disrupting fetal lung angiogenesis and morphogenesis before preterm labor occurs, which may set the stage for BPD. A strategy to prevent BPD should target the fetus in utero to attenuate alterations in the fetal lung genetic program.	[McAdams, Ryan M.; Rubens, Craig E.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Vanderhoeven, Jeroen; Gravett, Michael G.; Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Beyer, Richard P.; Bammler, Theo K.; Farin, Federico M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Liggitt, H. Denny] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Kapur, Raj P.] Seattle Childrens, Dept Labs, Seattle, WA USA; [Gravett, Michael G.; Rubens, Craig E.] Global Alliance Prevent Prematur & Stillbirth, Seattle, WA USA; [Rubens, Craig E.] Seattle Childrens, Div Infect Dis, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital	McAdams, RM (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	adamsk@u.washington.edu		Vanderhoeven, Jeroen/0000-0003-1418-7630	March of Dimes [21-FY06-77, 21-FY08-562]; National Institutes of Health [AI100989, AI067910, HD-001264, HD-002274]; University of Washington Institute for Translational Health Research; Washington State Obstetrical Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001264, P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100989, K08AI067910] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Institute for Translational Health Research; Washington State Obstetrical Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful for support past and present from the March of Dimes (21-FY06-77, 21-FY08-562,) National Institutes of Health (AI100989, AI067910, HD-001264, HD-002274), University of Washington Institute for Translational Health Research, and Washington State Obstetrical Association. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfeld SK, 2012, BIRTH DEFECTS RES A, V94, P3, DOI 10.1002/bdra.22869; Albertine KH, 1999, AM J RESP CRIT CARE, V159, P945, DOI 10.1164/ajrccm.159.3.9804027; ALCORN DG, 1981, ANAT REC, V201, P655, DOI 10.1002/ar.1092010410; Bolstad B, 2005, BIOINFORMATICS COMPU; Brain JD, 1999, AM J PHYSIOL-LUNG C, V276, pL146, DOI 10.1152/ajplung.1999.276.1.L146; Bry K, 2007, AM J RESP CELL MOL, V36, P32, DOI 10.1165/rcmb.2006-0116OC; Bry K, 2006, SEMIN PERINATOL, V30, P121, DOI 10.1053/j.semperi.2006.04.009; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Chang J, 2010, PLACENTA, V31, P811, DOI 10.1016/j.placenta.2010.06.010; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chen H, 2005, AM J PHYSIOL-LUNG C, V288, pL683, DOI 10.1152/ajplung.00298.2004; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Coalson JJ, 1999, AM J RESP CRIT CARE, V160, P1333, DOI 10.1164/ajrccm.160.4.9810071; Crosas B, 2003, BIOCHEM J, V373, P973, DOI 10.1042/BJ20021818; DAMIANO VV, 1980, AM J PATHOL, V100, P349; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Paepe ME, 2010, PEDIAT DEV PATHOL; De Paepe ME, 2010, EXP LUNG RES, V36, P399, DOI 10.3109/01902141003714031; DIAMANT NE, 1985, AM REV RESPIR DIS, V131, pS29; Diaz D, 2001, TOXICOL LETT, V122, P119, DOI 10.1016/S0378-4274(01)00341-1; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; EFRON B, 2006, TESTING SIGNIFICANCE; ETTENSOHN DB, 1988, CHEST, V94, P281, DOI 10.1378/chest.94.2.281; Fok TF, 2009, SEMIN FETAL NEONAT M, V14, P49, DOI 10.1016/j.siny.2008.08.002; Galan HL, 1997, AM J OBSTET GYNECOL, V177, P42, DOI 10.1016/S0002-9378(97)70436-8; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Gao HW, 2007, EXPERT OPIN THER TAR, V11, P869, DOI 10.1517/14728222.11.7.869; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghezzi F, 1998, EUR J OBSTET GYN R B, V78, P5, DOI 10.1016/S0301-2115(97)00236-4; Gien J, 2011, CURR OPIN PEDIATR, V23, P305, DOI 10.1097/MOP.0b013e328346577f; GRAVETT MG, 1994, AM J OBSTET GYNECOL, V171, P1660, DOI 10.1016/0002-9378(94)90418-9; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Hirashima M, 2009, ANAT SCI INT, V84, P95, DOI 10.1007/s12565-009-0026-1; Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Ivanov D, 2004, CARDIOVASC RES, V64, P132, DOI 10.1016/j.cardiores.2004.06.010; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Joshi MB, 2005, FASEB J, V19, P1737, DOI 10.1096/fj.05-3834fje; Kallapur SG, 2004, AM J PHYSIOL-LUNG C, V287, pL1178, DOI 10.1152/ajplung.00049.2004; KAZMIEROWSKI JA, 1976, J IMMUNOL, V116, P615; Kevil CG, 2004, FASEB J, V18, P1321, DOI 10.1096/fj.03-1401fje; KOTECHA S, 1995, ARCH DIS CHILD-FETAL, V72, pF90, DOI 10.1136/fn.72.2.F90; Kramer BW, 2009, SEMIN FETAL NEONAT M, V14, P2, DOI 10.1016/j.siny.2008.08.011; Kramer BW, 2002, AM J PHYSIOL-LUNG C, V283, pL452, DOI 10.1152/ajplung.00407.2001; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Kunzmann S, 2011, AM J RESP CELL MOL, V45, P969, DOI 10.1165/rcmb.2010-0519OC; Larsen JW, 2008, AM J OBSTET GYNECOL, V198, P440, DOI 10.1016/j.ajog.2007.11.030; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Lee J, 2009, J MATERN-FETAL NEO M, V22, P917, DOI 10.1080/14767050902994705; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Lin YS, 2002, MOL PHARMACOL, V62, P162, DOI 10.1124/mol.62.1.162; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Melin P, 2011, CLIN MICROBIOL INFEC, V17, P1294, DOI 10.1111/j.1469-0691.2011.03576.x; MERRITT TA, 1983, J CLIN INVEST, V72, P656, DOI 10.1172/JCI111015; MIRRO R, 1990, AM J DIS CHILD, V144, P160, DOI 10.1001/archpedi.1990.02150260038022; Mohamed WAW, 2011, J TROP PEDIATRICS, V57, P385, DOI 10.1093/tropej/fmq112; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Morris AE, 2009, AM J PHYSIOL-LUNG C, V297, pL1112, DOI 10.1152/ajplung.00155.2009; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Munshi UK, 1997, PEDIATR PULM, V24, P331; OGDEN BE, 1984, AM REV RESPIR DIS, V130, P817; Paananen R, 2009, J PEDIATR-US, V154, P39, DOI 10.1016/j.jpeds.2008.07.012; Philip AGS, 2012, NEONATOLOGY, V102, P1, DOI 10.1159/000336030; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Pollack JA, 2003, AM J OBSTET GYNECOL, V189, P958, DOI 10.1067/S0002-9378(03)00719-1; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P805, DOI 10.1016/0002-9378(93)90009-8; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Smith VC, 2005, J PEDIATR-US, V146, P469, DOI 10.1016/j.jpeds.2004.12.023; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sozzani S, 2007, TRENDS IMMUNOL, V28, P385, DOI 10.1016/j.it.2007.07.006; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Speer Christian P, 2003, Semin Neonatol, V8, P29, DOI 10.1016/S1084-2756(02)00190-2; Stroustrup A, 2010, PEDIATRICS, V126, pE291, DOI 10.1542/peds.2009-3456; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas W, 2008, NEONATOLOGY, V94, P150, DOI 10.1159/000143719; Thomas WW, 2009, BOT REV, V75, P1, DOI 10.1007/s12229-009-9025-0; Thompson A, 2008, BIOMARK INSIGHTS, V3, P361; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Marter LJ, 2002, J PEDIATR-US, V140, P171, DOI 10.1067/mpd.2002.121381; Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x; Waldorf KMA, 2008, REPROD SCI, V15, P121, DOI 10.1177/1933719107310992; Waldorf KMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028972; Wang C, 2009, J BIOL CHEM, V284, P26742, DOI 10.1074/jbc.M109.022897; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X	91	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46863	10.1371/journal.pone.0046863	http://dx.doi.org/10.1371/journal.pone.0046863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056493	gold, Green Published, Green Submitted			2022-12-27	WOS:000309889400032
J	Oni, T; Gideon, HP; Bangani, N; Tsekela, R; Seldon, R; Wood, K; Wilkinson, KA; Goliath, RT; Ottenhoff, THM; Wilkinson, RJ				Oni, Tolu; Gideon, Hannah P.; Bangani, Nonzwakazi; Tsekela, Relebohile; Seldon, Ronnett; Wood, Kathryn; Wilkinson, Katalin A.; Goliath, Rene T.; Ottenhoff, Tom H. M.; Wilkinson, Robert J.			Smoking, BCG and Employment and the Risk of Tuberculosis Infection in HIV-Infected Persons in South Africa	PLOS ONE			English	Article							HEALTH-CARE WORKERS; LATENT TUBERCULOSIS; SKIN-TEST; PREVALENCE; PREDICTORS; TOBACCO	Background: The increased susceptibility to latent tuberculosis infection (LTBI) of HIV-1-infected persons represents a challenge in TB epidemic control. However few studies have evaluated LTBI predictors in a generalized HIV/TB epidemic setting. Methods: The study recruited 335 HIV-infected participants from Khayelitsha, Cape Town between February 2008 and November 2010. Tuberculin skin tests and interferon-gamma release assays were performed on all participants and active TB excluded using a symptom screen, TB microscopy and culture. Results: LTBI prevalence was 52.7% and 61.2% (TST and IGRA respectively). Being a recent TB contact (OR 2.07; 95% C.I. 1.15-3.69) was associated with TST positivity. Participants with a CD4>200 had a two-fold higher risk of IGRA positivity compared to those with CD4 counts <200 (OR 2.07; 95% C.I. 0.99-4.34). There was also a 19% increase in IGRA positivity risk for every additional year of schooling and a strong association between years of schooling and employment (p = 0.0004). A decreased risk of IGRA positivity was observed in persons with a BCG scar (OR 0.46; 95% C.I. 0.31-0.69) and in smokers (OR 0.47; 95% C.I. 0.23-0.96). Conclusion: We report the novel findings of a decreased risk of IGRA positivity in HIV-infected smokers possibly due to decreased interferon production, and in the persons with a BCG scar suggesting a protective role for BCG in this population. We also found an increased risk of TST positivity in employed persons, possibly due to ongoing transmission in public modes of transport.	[Oni, Tolu; Gideon, Hannah P.; Bangani, Nonzwakazi; Tsekela, Relebohile; Seldon, Ronnett; Wood, Kathryn; Wilkinson, Katalin A.; Goliath, Rene T.; Wilkinson, Robert J.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Wilkinson, Katalin A.; Wilkinson, Robert J.] Natl Inst Med Res, Med Res Council, London NW7 1AA, England; [Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Leiden, Netherlands	University of Cape Town; Imperial College London; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Oni, T (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa.	tolullahoni@doctors.org.uk	Wilkinson, Katalin/AAF-6805-2020; Wilkinson, Katalin/AAQ-7713-2021	Wilkinson, Katalin/0000-0002-9796-2040; Oni, Tolu/0000-0003-4499-1910; Gideon, Hannah/0000-0002-4443-2134; Wilkinson, Robert/0000-0002-2753-1800	Wellcome Trust [084323, 088316]; MRC (UK); ILULU Consortium; European Union [Sante/2006/105-061]; MRC [MC_U117588499] Funding Source: UKRI; Medical Research Council [MC_U117588499] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ILULU Consortium; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RJW is funded by the Wellcome Trust (084323, 088316) and MRC (UK). This study was supported by the ILULU Consortium, which is funded by a grant from the European Union (Sante/2006/105-061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Choi CM, 2007, RESPIROLOGY, V12, P898, DOI 10.1111/j.1440-1843.2007.01198.x; Christopher DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010408; Connell TG, 2007, CLIN VACCINE IMMUNOL, V14, P847, DOI 10.1128/CVI.00041-07; Drobniewski F, 2007, PLOS MED, V4, P273, DOI 10.1371/journal.pmed.0040055; Hiransuthikul Narin, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P804; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Lalvani A, 2010, THORAX, V65, P1036, DOI 10.1136/thx.2010.140996; Lee KJ, 2010, SCAND J INFECT DIS, V42, P672, DOI 10.3109/00365548.2010.485575; Mahomed H, 2011, INT J TUBERC LUNG D, V15, P331; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Nienhaus A, 2008, INT ARCH OCC ENV HEA, V81, P295, DOI 10.1007/s00420-007-0212-1; Oni T, 2012, CLIN VACCINE IMMUNOL; Pai M, 2007, EXPERT REV ANTI-INFE, V5, P385, DOI 10.1586/14787210.5.3.385; Pilsczek FH, 2008, REV SOC BRAS MED TRO, V41, P416, DOI 10.1590/S0037-86822008000400019; Rafiza S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-19; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Schablon A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-107; Shanaube K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018206; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; van Zyl Smit R, 2011, AM J RESP CRIT CARE, V183, pA3333; Vinton P, 2009, INFECT CONT HOSP EP, V30, P215, DOI 10.1086/595695; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	24	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47072	10.1371/journal.pone.0047072	http://dx.doi.org/10.1371/journal.pone.0047072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056584	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400053
J	Groenheit, R; Ghebremichael, S; Pennhag, A; Jonsson, J; Hoffner, S; Couvin, D; Koivula, T; Rastogi, N; Kallenius, G				Groenheit, Ramona; Ghebremichael, Solomon; Pennhag, Alexandra; Jonsson, Jerker; Hoffner, Sven; Couvin, David; Koivula, Tuija; Rastogi, Nalin; Kallenius, Gunilla			Mycobacterium tuberculosis Strains Potentially Involved TB Epidemic in Sweden a Century Ago	PLOS ONE			English	Article							GENETIC DIVERSITY; COMPLEX; DNA; SPOLIGOTYPES; TRANSMISSION; POLYMORPHISM; INFECTION; DATABASE; ANIMALS; HUMANS	A hundred years ago the prevalence of tuberculosis (TB) in Sweden was one of the highest in the world. In this study we conducted a population-based search for distinct strains of Mycobacterium tuberculosis complex isolated from patients born in Sweden before 1945. Many of these isolates represent the M. tuberculosis complex population that fueled the TB epidemic in Sweden during the first half of the 20th century. Methods: Genetic relationships between strains that caused the epidemic and present day strains were studied by spoligotyping and restriction fragment length polymorphism. Results: The majority of the isolates from the elderly population were evolutionary recent Principal Genetic Group (PGG)2/3 strains (363/409 or 88.8%), and only a low proportion were ancient PGG1 strains (24/409 or 5.9%). Twenty-two were undefined. The isolates demonstrated a population where the Euro-American superlineage dominated; in particular with Haarlem (41.1%) and T (37.7%) spoligotypes and only 21.2% belonged to other spoligotype families. Isolates from the elderly population clustered much less frequently than did isolates from a young control group population. Conclusions: A closely knit pool of PGG2/3 strains restricted to Sweden and its immediate neighbours appears to have played a role in the epidemic, while PGG1 strains are usually linked to migrants in todays Sweden. Further studies of these outbreak strains may give indications of why the epidemic waned.	[Groenheit, Ramona; Ghebremichael, Solomon; Pennhag, Alexandra; Jonsson, Jerker; Hoffner, Sven; Koivula, Tuija] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO Supranat TB Reference Lab, TB & Mycobacteria Unit, Guadeloupe, France; [Koivula, Tuija; Kallenius, Gunilla] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet	Groenheit, R (corresponding author), Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden.	ramona.groenheit@smi.se	RASTOGI, NALIN/AAP-1958-2020; Källenius, Gunilla/AGZ-3956-2022; Jonsson, Jerker/O-6675-2019	RASTOGI, NALIN/0000-0002-7199-7747; Jonsson, Jerker/0000-0003-1383-6176; Groenheit, Ramona/0000-0003-2696-437X; Kallenius, Gunilla/0000-0002-8921-0551; Couvin, David/0000-0002-7897-9023	Gunilla Kallenius from Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Swedish Heart-Lung Foundation; Swedish Vetenskapsradet	Gunilla Kallenius from Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Vetenskapsradet	This work was financed by grants to Gunilla Kallenius from Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, the Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se) and the Swedish Vetenskapsradet (http://www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; [Anonymous], 2011, STAT TUB; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; COSIVI O, 1995, REV SCI TECH OIE, V14, P733, DOI 10.20506/rst.14.3.875; Dahle UR, 2003, J CLIN MICROBIOL, V41, P2968, DOI 10.1128/JCM.41.7.2968-2973.2003; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Fletcher HA, 2003, MICROBIOL-SGM, V149, P143, DOI 10.1099/mic.0.25961-0; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Ghebremichael S, 2008, MICROBES INFECT, V10, P699, DOI 10.1016/j.micinf.2008.03.006; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P583; HERMANS PWM, 1991, INFECT IMMUN, V59, P2695, DOI 10.1128/IAI.59.8.2695-2705.1991; Johansson J., 1907, BETANKANDE FORSLAG A; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kan B, 2008, INT J TUBERC LUNG D, V12, P199; Kinander W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008373; Lillebaek T, 2004, INT J TUBERC LUNG D, V8, P1001; Lillebaek T, 2002, J INFECT DIS, V185, P401, DOI 10.1086/338342; Molina-Torres CA, 2010, J CLIN MICROBIOL, V48, P448, DOI 10.1128/JCM.01894-09; Rastogi N, 2007, MOL EVOLUTION MYCOBA; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Sandegren L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016647; Smith NH, 2011, INFECT GENET EVOL, V11, P1340, DOI 10.1016/j.meegid.2011.04.027; Soini H, 2000, J CLIN MICROBIOL, V38, P669, DOI 10.1128/JCM.38.2.669-676.2000; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Svensson E, 2011, CLIN MICROBIOL INFEC, V17, P881, DOI 10.1111/j.1469-0691.2010.03358.x; SZEWZYK R, 1995, J CLIN MICROBIOL, V33, P3183, DOI 10.1128/JCM.33.12.3183-3185.1995; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Winqvist N, 2011, INT J TUBERC LUNG D, V15, P736, DOI 10.5588/ijtld.10.0683; Winqvist N, 2011, DYNAMICS TUBERCULOSI	34	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46848	10.1371/journal.pone.0046848	http://dx.doi.org/10.1371/journal.pone.0046848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056484	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500089
J	McNeish, AJ; Jimenez-Altayo, F; Cottrell, GS; Garland, CJ				McNeish, Alister J.; Jimenez-Altayo, Francesc; Cottrell, Graeme S.; Garland, Christopher J.			Statins and Selective Inhibition of Rho Kinase Protect Small Conductance Calcium-Activated Potassium Channel Function (K(Ca)2.3) in Cerebral Arteries	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; THROMBOXANE A(2); ARACHIDONIC-ACID; RAT; SKCA; INVOLVEMENT; POTENT; K+; RECEPTORS; RESPONSES	Background: In rat middle cerebral and mesenteric arteries the K(Ca)2.3 component of endothelium-dependent hyperpolarization (EDH) is lost following stimulation of thromboxane (TP) receptors, an effect that may contribute to the endothelial dysfunction associated with cardiovascular disease. In cerebral arteries, K(Ca)2.3 loss is associated with NO synthase inhibition, but is restored if TP receptors are blocked. The Rho/Rho kinase pathway is central for TP signalling and statins indirectly inhibit this pathway. The possibility that Rho kinase inhibition and statins sustain K(Ca)2.3 hyperpolarization was investigated in rat middle cerebral arteries (MCA). Methods: MCAs were mounted in a wire myograph. The PAR2 agonist, SLIGRL was used to stimulate EDH responses, assessed by simultaneous measurement of smooth muscle membrane potential and tension. TP expression was assessed with rt-PCR and immunofluorescence. Results: Immunofluorescence detected TP in the endothelial cell layer of MCA. Vasoconstriction to the TP agonist, U46619 was reduced by Rho kinase inhibition. TP receptor stimulation lead to loss of K(Ca)2.3 mediated hyperpolarization, an effect that was reversed by Rho kinase inhibitors or simvastatin. K(Ca)2.3 activity was lost in L-NAME-treated arteries, but was restored by Rho kinase inhibition or statin treatment. The restorative effect of simvastatin was blocked after incubation with geranylgeranyl-pyrophosphate to circumvent loss of isoprenylation. Conclusions: Rho/Rho kinase signalling following TP stimulation and L-NAME regulates endothelial cell K(Ca)2.3 function. The ability of statins to prevent isoprenylation and perhaps inhibit of Rho restores/protects the input of K(Ca)2.3 to EDH in the MCA, and represents a beneficial pleiotropic effect of statin treatment.	[McNeish, Alister J.] Univ Reading, Reading Sch Pharm, Reading, Berks, England; [Jimenez-Altayo, Francesc; Garland, Christopher J.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Cottrell, Graeme S.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Reading; University of Oxford; University of Bath	McNeish, AJ (corresponding author), Univ Reading, Reading Sch Pharm, Reading, Berks, England.	a.mcneish@reading.ac.uk	McNeish, Alister/K-4521-2017; Jiménez-Altayó, Francesc/F-1245-2011; Garland, Christopher/O-1254-2015	McNeish, Alister/0000-0002-3466-8442; Jiménez-Altayó, Francesc/0000-0002-9034-2041; Cottrell, Graeme/0000-0001-9098-7627; Garland, Christopher/0000-0003-0848-6044	British Heart Foundation [FS/06/076/21988, FS/08/017/25027]; Wellcome Trust; Ministerio de Educacion y Ciencia (Espana); British Heart Foundation [PG/11/93/29143] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Ministerio de Educacion y Ciencia (Espana)(Spanish Government); British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation (http://www.bhf.org.uk) (Alister McNeish - FS/06/076/21988 and Graeme Cottrell - FS/08/017/25027) and a Wellcome Trust (www.wellcome.ac.uk) programme grant (Christopher Garland). Christopher Garland holds a Royal Society-Wolfson Research Merit Award and Francesc Jimenez-Altayo was supported by the Ministerio de Educacion y Ciencia (Espana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Ayajiki K, 2003, HYPERTENS RES, V26, P237, DOI 10.1291/hypres.26.237; BALDASSARE JJ, 1993, BIOCHEM J, V291, P235, DOI 10.1042/bj2910235; Benyo Z, 1998, J CEREBR BLOOD F MET, V18, P616, DOI 10.1097/00004647-199806000-00003; BLUM CB, 1994, AM J CARDIOL, V73, pD3, DOI 10.1016/0002-9149(94)90626-2; Cipolla MJ, 2009, STROKE, V40, P1451, DOI 10.1161/STROKEAHA.108.535435; CORSINI A, 1993, ATHEROSCLEROSIS, V101, P117, DOI 10.1016/0021-9150(93)90107-6; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Crane GJ, 2004, BRIT J PHARMACOL, V142, P43, DOI 10.1038/sj.bjp.0705756; Fang XG, 2010, J MED CHEM, V53, P5727, DOI 10.1021/jm100579r; Fu XH, 1998, FEBS LETT, V440, P183, DOI 10.1016/S0014-5793(98)01455-0; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Garland CJ, 2011, BRIT J PHARMACOL, V164, P839, DOI 10.1111/j.1476-5381.2010.01148.x; GARLAND CJ, 1992, BRIT J PHARMACOL, V105, P429, DOI 10.1111/j.1476-5381.1992.tb14270.x; Geeson J., 2002, Autonomic & Autacoid Pharmacology, V22, P297, DOI 10.1046/j.1474-8673.2002.00271.x; Hilgers RHP, 2007, AM J PHYSIOL-HEART C, V292, pH2275, DOI 10.1152/ajpheart.00949.2006; Huang JS, 2004, CELL SIGNAL, V16, P521, DOI 10.1016/j.cellsig.2003.10.008; KENT KC, 1993, CIRC RES, V72, P958, DOI 10.1161/01.RES.72.5.958; Lacza Z, 2001, STROKE, V32, P2609, DOI 10.1161/hs1101.098526; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Luykenaar KD, 2009, AM J PHYSIOL-HEART C, V296, pH917, DOI 10.1152/ajpheart.01206.2008; Marrelli SP, 2003, AM J PHYSIOL-HEART C, V285, pH1590, DOI 10.1152/ajpheart.00376.2003; MASAKI T, 1991, CIRCULATION, V84, P1457, DOI 10.1161/01.CIR.84.4.1457; McNeish AJ, 2007, BRIT J PHARMACOL, V151, P441, DOI 10.1038/sj.bjp.0707240; McNeish AJ, 2010, VASC PHARMACOL, V53, P151, DOI 10.1016/j.vph.2010.06.002; McNeish AJ, 2006, STROKE, V37, P1277, DOI 10.1161/01.STR.0000217307.71231.43; McNeish AJ, 2005, STROKE, V36, P1526, DOI 10.1161/01.STR.0000169929.66497.73; Minamiyama Y, 1997, J PHARMACOL EXP THER, V283, P1479; Plane F, 1996, BRIT J PHARMACOL, V119, P191, DOI 10.1111/j.1476-5381.1996.tb15970.x; Randriamboavonjy V, 2005, CARDIOVASC RES, V65, P487, DOI 10.1016/j.cardiores.2004.10.029; Reid HM, 2003, J BIOL CHEM, V278, P51190, DOI 10.1074/jbc.M309314200; Sakurada S, 2001, AM J PHYSIOL-CELL PH, V281, pC571, DOI 10.1152/ajpcell.2001.281.2.C571; Seto SW, 2007, BRIT J PHARMACOL, V151, P987, DOI 10.1038/sj.bjp.0707327; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; VYAS KP, 1990, DRUG METAB DISPOS, V18, P218; Wickman G, 2003, CIRC RES, V92, P809, DOI 10.1161/01.RES.0000066663.12256.B2; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Yuill KH, 2010, J VASC RES, V47, P93, DOI 10.1159/000235964	48	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46735	10.1371/journal.pone.0046735	http://dx.doi.org/10.1371/journal.pone.0046735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056429	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000309831500067
J	Zhang, J; Kasciukovic, T; White, MF				Zhang, Jing; Kasciukovic, Taciana; White, Malcolm F.			The CRISPR Associated Protein Cas4 Is a 5 ' to 3 ' DNA Exonuclease with an Iron-Sulfur Cluster	PLOS ONE			English	Article							HELICASE-NUCLEASES; ESCHERICHIA-COLI; COMPLEX; MECHANISM; REPEATS; SYSTEM; GENES; XPD; DEFENSE; FAMILY	The Cas4 protein is one of the core CRISPR-associated (Cas) proteins implicated in the prokaryotic CRISPR system for antiviral defence. Cas4 is thought to play a role in the capture of new viral DNA sequences for incorporation into the host genome. No biochemical activity has been reported for Cas4, but it is predicted to include a RecB nuclease domain. We show here that Cas4 family proteins from the archaeon Sulfolobus solfataricus utilise four conserved cysteine residues to bind an iron-sulfur cluster in an arrangement reminiscent of the AddB nuclease of Bacillus subtilis. The Cas4 family protein Sso0001 is a 5' to 3' single stranded DNA exonuclease in vitro that is stalled by extrahelical DNA adducts. A role for Cas4 in DNA duplex strand resectioning to generate recombinogenic 3' single stranded DNA overhangs is proposed. Comparison of the AddB structure with that of a related bacterial nuclease from Eubacterium rectales reveals that the iron-sulfur cluster can be replaced by a zinc ion without disrupting the protein structure, with implications for the evolution of iron-sulfur binding proteins.	[Zhang, Jing; Kasciukovic, Taciana; White, Malcolm F.] Univ St Andrews, St Andrews, Fife, Scotland	University of St Andrews	White, MF (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland.	mfw2@st-and.ac.uk	White, Malcolm F/A-6055-2010	White, Malcolm F/0000-0003-1543-9342	Biotechnology and Biological Sciences Research Council [G011400]; BBSRC [BB/G011400/1, BB/K000314/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K000314/1, BB/G011400/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (Grant number G011400). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Bernick DL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00251; Burgers PM, 2010, MOL CELL BIOL, V30, P1457, DOI 10.1128/MCB.01321-09; Gardner AF, 2011, EXTREMOPHILES, V15, P619, DOI 10.1007/s00792-011-0385-0; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kvaratskhelia M, 2000, J MOL BIOL, V295, P193, DOI 10.1006/jmbi.1999.3363; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Mui TP, 2011, J AM CHEM SOC, V133, P16378, DOI 10.1021/ja207222t; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Plagens A, 2012, J BACTERIOLOGY; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Pokharel S, 2012, NUCL ACIDS RES; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Saikrishnan K, 2012, EMBO J, V31, P1568, DOI 10.1038/emboj.2012.9; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Urzica E, 2009, BIOCHEMISTRY-US, V48, P4946, DOI 10.1021/bi900312x; Viswanathan P, 2007, J BACTERIOL, V189, P3738, DOI 10.1128/JB.00187-07; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; White MF, 2009, BIOCHEM SOC T, V37, P547, DOI 10.1042/BST0370547; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Yang W, 2011, NUCLEIC ACIDS RES, V39, P9803, DOI 10.1093/nar/gkr660; Yeeles JTP, 2007, J MOL BIOL, V371, P66, DOI 10.1016/j.jmb.2007.05.053; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013; Zhang JJ, 2011, P NATL ACAD SCI USA, V108, P11872, DOI 10.1073/pnas.1103467108; Zhang JJ, 2009, STRUCTURE, V17, P690, DOI 10.1016/j.str.2009.03.008	36	24	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47232	10.1371/journal.pone.0047232	http://dx.doi.org/10.1371/journal.pone.0047232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056615	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500148
J	Zong, XN; Li, H				Zong, Xin-Nan; Li, Hui			Secular Trends in Prevalence and Risk Factors of Obesity in Infants and Preschool Children in 9 Chinese Cities, 1986-2006	PLOS ONE			English	Article							CHILDHOOD OBESITY; NUTRITION TRANSITION; WORLDWIDE TRENDS; OVERWEIGHT; EPIDEMIC	Introduction: No prevalence/trends were reported in Chinese infants and preschool children at the national level in this historical period of 1980s-2000s. The objectives of this paper were to present the 20-year trends in prevalence and risk factors of obesity in children below 7 years. Methods: Data obtained from a series of three sequential national surveys performed using the same design in the same 9 cities in 1986, 1996 and 2006. Weight and height (length <3 years) were measured using unified procedures at each period. Obesity was defined as a weight-for-height >= 120% of median of the NCHS/WHO international reference. A population-based paired matching case-control study was employed for screening risk factors. Results: In 1986, there was no substantial obesity epidemic, but the overall obesity prevalence reached 3.4% (boys 4.1% and girls 2.7%) in 2006, rising by 2.8 times between 1986 and 2006. Reversed gender difference, relatively higher prevalence in preschool age and more rapid increase in the second 10-year were three very obvious characteristics in China, e. g. prevalence of boys 9.9% and girls 4.9% in 2006 and increasing rate of boys 0.45 percentage points per year (pp/y) and girls 0.21 pp/y at 6-7 years groups, 0.17 pp/y of the second 10-year higher 1-fold than previous. Conclusions: China has been moving into the alarming epidemic of childhood obesity. Effort should be immediately made to prevent further deterioration. High birth weight, high parental BMI and several behavioral and family-related factors were identified and had important practical value for obesity intervention.	[Zong, Xin-Nan; Li, Hui] Capital Inst Pediat, Dept Growth & Dev, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, H (corresponding author), Capital Inst Pediat, Dept Growth & Dev, Beijing, Peoples R China.	huiligrowth@163.com			Department of Maternal and Child Health Care and Community Health of the Ministry of Health of the People's Republic of China	Department of Maternal and Child Health Care and Community Health of the Ministry of Health of the People's Republic of China	This work was supported by a grant from the Department of Maternal and Child Health Care and Community Health of the Ministry of Health of the People's Republic of China (No.2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barness LA, 2007, AM J MED GENET A, V143A, P3016, DOI 10.1002/ajmg.a.32035; Baur LA, 2004, CLIN DERMATOL, V22, P338, DOI 10.1016/j.clindermatol.2004.01.005; Ben-Sefer E, 2009, INT NURS REV, V56, P166, DOI 10.1111/j.1466-7657.2008.00708.x; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2000, AM J CLIN NUTR, V72, P1032; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; DING Z, 1989, Acta Nutrimenta Sinica, V11, P266; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Falkner NH, 2001, OBES RES, V9, P32, DOI 10.1038/oby.2001.5; Fang BH, 2007, CHINESE J MATERNAL C, V18, P4; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; [华琦 HUA Qi], 2007, [中华内科杂志, Chinese Journal of Internal Medicine], V46, P923; Ji CY, 2008, INT J CARDIOL, V131, P1, DOI 10.1016/j.ijcard.2008.05.078; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Lasserre AM, 2007, SWISS MED WKLY, V137, P157; Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409; Li H, 2007, CHIN J PEDIAT, V45, P609; Li H., 2008, NATL GROWTH SURVEY C; Li H, 2002, CHIN J CHILD HLTH CA, V10, P316; Li H, 2008, CHIN J PEDIAT, V46, P174; Li Hui, 2009, Zhonghua Er Ke Za Zhi, V47, P493; Li Hui, 2009, Zhonghua Er Ke Za Zhi, V47, P487; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Matsushita Y, 2004, OBES RES, V12, P205, DOI 10.1038/oby.2004.27; Ogden CL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e1; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1136; Singh GK, 2010, ARCH PEDIAT ADOL MED, V164, P598, DOI 10.1001/archpediatrics.2010.84; Venn AJ, 2007, MED J AUSTRALIA, V186, P458, DOI 10.5694/j.1326-5377.2007.tb00997.x; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; WILLIAMS DP, 1992, AM J PUBLIC HEALTH, V82, P358, DOI 10.2105/AJPH.82.3.358; World Health Organization, 1995, PHYS STAT US INT ANT; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; You Yue, 2005, Wei Sheng Yan Jiu, V34, P620; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x; Zhang YQ., 2008, CHINESE J CHILD HLTH, V16, P397	40	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46942	10.1371/journal.pone.0046942	http://dx.doi.org/10.1371/journal.pone.0046942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056536	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500114
J	Ropcke, S; Holz, O; Lauer, G; Muller, M; Rittinghausen, S; Ernst, P; Lahu, G; Elmlinger, M; Krug, N; Hohlfeld, JM				Roepcke, Stefan; Holz, Olaf; Lauer, Gereon; Mueller, Meike; Rittinghausen, Susanne; Ernst, Peter; Lahu, Gezim; Elmlinger, Martin; Krug, Norbert; Hohlfeld, Jens M.			Repeatability of and Relationship between Potential COPD Biomarkers in Bronchoalveolar Lavage, Bronchial Biopsies, Serum, and Induced Sputum	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; VON-WILLEBRAND-FACTOR; SYSTEMIC INFLAMMATION; END-POINTS; SURROGATE; MARKERS; SMOKERS; ASTHMA; OZONE; RISK	Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory disease, primarily affecting the airways. Stable biomarkers characterizing the inflammatory phenotype of the disease, relevant for disease activity and suited to predict disease progression are needed to monitor the efficacy and safety of drug interventions. We therefore analyzed a large panel of markers in bronchoalveolar lavage, bronchial biopsies, serum and induced sputum of 23 healthy smokers and 24 smoking COPD patients (GOLD II) matched for age and gender. Sample collection was performed twice within a period of 6 weeks. Assays for over 100 different markers were validated for the respective matrices prior to analysis. In our study, we found 51 markers with a sufficient repeatability (intraclass correlation coefficient > 0.6), most of these in serum. Differences between groups were observed for markers from all compartments, which extends (von-Willebrand-factor) and confirms (e.g. C-reactive-protein, interleukin-6) previous findings. No correlations between lung and serum markers were observed, including A1AT. Airway inflammation defined by sputum neutrophils showed only a moderate repeatability. This could be improved, when a combination of neutrophils and four sputum fluid phase markers was used to define the inflammatory phenotype. In summary, our study provides comprehensive information on the repeatability and interrelationship of pulmonary and systemic COPD-related markers. These results are relevant for ongoing large clinical trials and future COPD research. While serum markers can discriminate between smokers with and without COPD, they do not seem to sufficiently reflect the disease-associated inflammatory processes within the airways.	[Holz, Olaf; Mueller, Meike; Krug, Norbert; Hohlfeld, Jens M.] Fraunhofer Inst Toxicol & Expt Med ITEM, Dept Clin Airway Res, Hannover, Germany; [Roepcke, Stefan; Lauer, Gereon; Lahu, Gezim; Elmlinger, Martin] Nycomed GmbH, Dept Biomarker Dev, Constance, Germany; [Holz, Olaf; Krug, Norbert; Hohlfeld, Jens M.] Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Rittinghausen, Susanne] Fraunhofer Inst Toxicol & Expt Med ITEM, Dept Toxicol & Environm Hyg, Hannover, Germany; [Ernst, Peter] GeneData AG, Basel, Switzerland	Fraunhofer Gesellschaft; Nycomed GmbH; Fraunhofer Gesellschaft	Holz, O (corresponding author), Fraunhofer Inst Toxicol & Expt Med ITEM, Dept Clin Airway Res, Hannover, Germany.	olaf.holz@item.fraunhofer.de		Rittinghausen, Susanne/0000-0001-6468-6994; Ernst, Peter/0000-0001-7777-1813; Hohlfeld, Jens/0000-0003-2646-6186	Nycomed GmbH	Nycomed GmbH	Fraunhofer has received a research grant for conducting the clinical study from Nycomed GmbH. The funders participated in the study design, in data analysis, pre-study assay validation and the preparation of the manuscript.	Aaron SD, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-41; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Anderson GP, 2006, EUR RESPIR J, V27, P874, DOI 10.1183/09031936.06.00029306; [Anonymous], 2010, GLOBAL STRATEGY DIAG; Barnes PJ, 2006, AM J RESP CRIT CARE, V174, P6, DOI 10.1164/rccm.200510-1659PP; Beirne P, 2009, EUR RESPIR J, V34, P1376, DOI 10.1183/09031936.00028209; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Cazzola M, 2010, PULM PHARMACOL THER, V23, P493, DOI 10.1016/j.pupt.2010.05.001; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; Crapo JD, 2010, P NATL ACAD SCI USA, V107, P8503, DOI 10.1073/pnas.1003826107; de Torres JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016021; Dickens JA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-146; Eickhoff P, 2008, AM J RESP CRIT CARE, V178, P1211, DOI 10.1164/rccm.200709-1412OC; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Grootendorst DC, 1997, CLIN EXP ALLERGY, V27, P769, DOI 10.1111/j.1365-2222.1997.tb01211.x; Hernandez ML, 2010, INHAL TOXICOL, V22, P648, DOI 10.3109/08958371003610966; Holz O, 2005, J CLIN PHARMACOL, V45, P498, DOI 10.1177/0091270004273527; Hurst JR, 2006, AM J RESP CRIT CARE, V174, P867, DOI 10.1164/rccm.200604-506OC; Jorres RA, 2010, DEUT MED WOCHENSCHR, V135, P446, DOI 10.1055/s-0030-1249185; Kolsum Umme, 2009, Int J Chron Obstruct Pulmon Dis, V4, P149; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Petty TL, 2002, CHEST, V121, p116S, DOI 10.1378/chest.121.5_suppl.116S; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Polatli M, 2008, J THROMB THROMBOLYS, V26, P97, DOI 10.1007/s11239-007-0073-1; Polosa R, 2011, INTERN EMERG MED; Sin Don D, 2009, Proc Am Thorac Soc, V6, P543, DOI 10.1513/pats.200904-019DS; Singh D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-77; Thum T, 2006, ENVIRON HEALTH PERSP, V114, P1655, DOI 10.1289/ehp.8861; Tzortzaki EG, 2007, CURR MED CHEM, V14, P1037, DOI 10.2174/092986707780362943; Ventetuolo Corey E, 2008, Proc Am Thorac Soc, V5, P617, DOI 10.1513/pats.200803-029SK; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Vestbo J, 2010, AM J RESP CRIT CARE, V182, P863, DOI 10.1164/rccm.201004-0602ED; Watz H, 2009, CHEST, V136, P1039, DOI 10.1378/chest.09-0393; Wouters Emiel F M, 2007, Proc Am Thorac Soc, V4, P626, DOI 10.1513/pats.200706-071TH	36	50	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46207	10.1371/journal.pone.0046207	http://dx.doi.org/10.1371/journal.pone.0046207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056262	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800014
J	Sozou, PD; Hartshorne, GM				Sozou, Peter D.; Hartshorne, Geraldine M.			Time to Pregnancy: A Computational Method for Using the Duration of Non-Conception for Predicting Conception	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; SUBFERTILE COUPLES; SPONTANEOUS CLEARANCE; INFERTILITY THERAPY; HUMAN-REPRODUCTION; FECUNDABILITY; AGE; MANAGEMENT; STERILITY; FECUNDITY	An important problem in reproductive medicine is deciding when people who have failed to become pregnant without medical assistance should begin investigation and treatment. This study describes a computational approach to determining what can be deduced about a couple's future chances of pregnancy from the number of menstrual cycles over which they have been trying to conceive. The starting point is that a couple's fertility is inherently uncertain. This uncertainty is modelled as a probability distribution for the chance of conceiving in each menstrual cycle. We have developed a general numerical computational method, which uses Bayes' theorem to generate a posterior distribution for a couple's chance of conceiving in each cycle, conditional on the number of previous cycles of attempted conception. When various metrics of a couple's expected chances of pregnancy were computed as a function of the number of cycles over which they had been trying to conceive, we found good fits to observed data on time to pregnancy for different populations. The commonly-used standard of 12 cycles of non-conception as an indicator of subfertility was found to be reasonably robust, though a larger or smaller number of cycles may be more appropriate depending on the population from which a couple is drawn and the precise subfertility metric which is most relevant, for example the probability of conception in the next cycle or the next 12 cycles. We have also applied our computational method to model the impact of female reproductive ageing. Results indicate that, for women over the age of 35, it may be appropriate to start investigation and treatment more quickly than for younger women. Ignoring reproductive decline during the period of attempted conception added up to two cycles to the computed number of cycles before reaching a metric of subfertility.	[Sozou, Peter D.; Hartshorne, Geraldine M.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Sozou, Peter D.] Rhein Westfal TH Aachen, Fac Business & Econ, Aachen, Germany; [Sozou, Peter D.] Univ London London Sch Econ & Polit Sci, Ctr Philosophy Nat & Social Sci, London WC2A 2AE, England; [Hartshorne, Geraldine M.] Univ Hosp Coventry & Warwickshire NHS Trust, Ctr Reprod Med, Coventry, W Midlands, England	University of Warwick; RWTH Aachen University; University of London; London School Economics & Political Science; University of Warwick	Sozou, PD (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	p.sozou@lse.ac.uk			Wellcome Trust; RWTH Aachen University; University Hospitals Coventry; Warwickshire NHS Trust	Wellcome Trust(Wellcome TrustEuropean Commission); RWTH Aachen University; University Hospitals Coventry; Warwickshire NHS Trust	PDS's salary and research expenses at the University of Warwick were covered by a Value in People Award from the Wellcome Trust ( http://www.wellcome.ac.uk/). His salary and research expenses at RWTH Aachen University are funded by RWTH Aachen University (http://www.rwth-aachen.de/go/id/bdz/). Geraldine Hartshorne's salary is provided by University Hospitals Coventry and Warwickshire NHS Trust (http://www.uhcw.nhs.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONGAARTS J, 1975, DEMOGRAPHY, V12, P645, DOI 10.2307/2060719; Bongaatrs J, 1983, FERTILITY BIOL BEHAV; Brosens I, 2004, HUM REPROD, V19, P1689, DOI 10.1093/humrep/deh314; CRAMER DW, 1979, FERTIL STERIL, V32, P80; Dunson DB, 2004, OBSTET GYNECOL, V103, P51, DOI 10.1097/01.AOG.0000100153.24061.45; Ecohard R, 2006, STAT METHODS MED RES, V15, P141; Evers JLH, 1998, HUM REPROD, V13, P1206, DOI 10.1093/humrep/13.5.1206; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; FADDY MJ, 1995, HUM REPROD, V10, P770, DOI 10.1093/oxfordjournals.humrep.a136036; Forbes C., 2011, STAT DISTRIBUTIONS; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Gnoth C, 2005, HUM REPROD, V20, P1144, DOI 10.1093/humrep/deh870; Gnoth C, 2003, HUM REPROD, V18, P1959, DOI 10.1093/humrep/deg366; Granstrom M, 1997, J CLIN MICROBIOL, V35, P468; Greenland S, 2006, INT J EPIDEMIOL, V35, P765, DOI 10.1093/ije/dyi312; HECKMAN JJ, 1990, J AM STAT ASSOC, V85, P283, DOI 10.2307/2289763; Henry, 1972, MEASUREMENT HUMAN FE; Human Fertilisation and Embryology Authority, 2010, FERT FACTS FIG 2008; Hunault CC, 2004, HUM REPROD, V19, P2019, DOI 10.1093/humrep/deh365; Juul S, 1999, HUM REPROD, V14, P1250, DOI 10.1093/humrep/14.5.1250; Lehmann M, 2004, J MED VIROL, V73, P387, DOI 10.1002/jmv.20103; Leridon H, 2008, HUM REPROD, V23, P1312, DOI 10.1093/humrep/den106; LERIDON H, 1984, FERTIL STERIL, V41, P580; Leridon H, 1973, HUMAN FERTILITY BASI; Leridon H, 2008, POP STUD-J DEMOG, V62, P15, DOI 10.1080/00324720701804207; Lindley D. V., 1965, INTRO PROBABILITY ST; Maheshwari A, 2009, REPROD BIOMED ONLINE, V18, P717, DOI 10.1016/S1472-6483(10)60019-3; MARUANI P, 1983, J THEOR BIOL, V105, P211, DOI 10.1016/S0022-5193(83)80003-4; National Institute of Clinical Excellence, 2004, FERT ASS TREATM PEOP; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; Parks KS, 1997, SEX TRANSM DIS, V24, P229, DOI 10.1097/00007435-199704000-00008; POTTER RG, 1960, MILBANK FUND Q, V38, P140, DOI 10.2307/3348778; POTTER RG, 1964, POP STUD-J DEMOG, V18, P99, DOI 10.2307/2172634; Roberts SA, 2012, HUM REPROD, V27, P436, DOI 10.1093/humrep/der420; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Sheps M. C., 1973, MATH MODELS CONCEPTI; Sozou PD, 1998, P ROY SOC B-BIOL SCI, V265, P2015, DOI 10.1098/rspb.1998.0534; SPIRA A, 1986, HUM REPROD, V1, P111, DOI 10.1093/oxfordjournals.humrep.a136353; Steures P, 2006, LANCET, V368, P216, DOI 10.1016/S0140-6736(06)69042-9; te Velde ER, 2000, LANCET, V355, P1928, DOI 10.1016/S0140-6736(00)02320-5; van der Steeg JW, 2007, HUM REPROD, V22, P536, DOI 10.1093/humrep/del378; van der Steeg JW, 2008, FERTIL STERIL, V90, P521, DOI 10.1016/j.fertnstert.2007.07.1301; Wang XB, 2003, FERTIL STERIL, V79, P577, DOI 10.1016/S0015-0282(02)04694-0; Whitworth KW, 2011, DIABETOLOGIA, V54, P516, DOI 10.1007/s00125-010-2003-6; Wood J. W., 1994, DYNAMICS HUMAN REPRO	45	29	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46544	10.1371/journal.pone.0046544	http://dx.doi.org/10.1371/journal.pone.0046544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056338	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800025
J	Chen, YC; Hung, TH; Tseng, TC; Hsieh, CC; Chen, FC; Stoffregen, TA				Chen, Yi-Chou; Hung, Ting-Hsuan; Tseng, Tzu-Chiang; Hsieh, City C.; Chen, Fu-Chen; Stoffregen, Thomas A.			Pre-Bout Standing Body Sway Differs between Adult Boxers Who Do and Do Not Report Post-Bout Motion Sickness	PLOS ONE			English	Article							CONSOLE VIDEO GAMES; STANCE WIDTH; CEREBRAL CONCUSSION; VIRTUAL-REALITY; QUIET STANCE; INSTABILITY; PERFORMANCE; STABILITY; BALANCE; SEA	Background: Motion sickness is characterized by subjective symptoms that include dizziness and nausea. Studies have shown that subjective symptoms of motion sickness are preceded by differences in standing body sway between those who experience the symptoms and those who are not. Boxers often report dizziness and nausea immediately after bouts. We predicted that pre-bout standing body sway would differ between boxers who experienced post-bout motion sickness and those who did not. Methodology/Principal Findings: We collected data on standing body sway before bouts. During measurement of body sway participants performed two visual tasks. In addition, we varied stance width (the distance between the heels). Postural testing was conducted separately before and after participants' regular warm-up routines. After bouts, we collected self-reports of motion sickness incidence and symptoms. Results revealed that standing body sway was greater after warm-up than before warm-up, and that wider stance width was associated with reduced sway. Eight of 15 amateur boxers reported motion sickness after a bout. Two statistically significant interactions revealed that standing body sway before bouts differed between participants who reported post-bout motion sickness and those who did not. Conclusions/Significance: The results suggest that susceptibility to motion sickness in boxers may be manifested in characteristic patterns of body sway. It may be possible to use pre-bout data on postural sway to predict susceptibility to post-bout motion sickness.	[Chen, Yi-Chou; Stoffregen, Thomas A.] Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA; [Hung, Ting-Hsuan] Edgewood Coll, Off Inst Res, Madison, WI USA; [Tseng, Tzu-Chiang] Chinese Cultural Univ, Grad Inst Sport Coaching Sci, Taipei, Taiwan; [Hsieh, City C.] YuanPei Univ, Coll Well Being, Hsinchu, Taiwan; [Chen, Fu-Chen] Natl Pingtung Univ Sci & Technol, Dept Recreat Sport & Hlth Promot, Pingtung, Taiwan	University of Minnesota System; University of Minnesota Twin Cities; Chinese Culture University; National Pingtung University Science & Technology	Stoffregen, TA (corresponding author), Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA.	tas@umn.edu	Stoffregen, Thomas/ABC-8710-2021					Akiduki H, 2003, NEUROSCI LETT, V340, P197, DOI 10.1016/S0304-3940(03)00098-3; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chang CH, 2012, EXP BRAIN RES, V217, P299, DOI 10.1007/s00221-011-2993-4; Chang CH, 2010, RES DEV DISABIL, V31, P1536, DOI 10.1016/j.ridd.2010.06.003; Chen FC, 2011, RES DEV DISABIL, V32, P1948, DOI 10.1016/j.ridd.2011.03.027; Chen FC, 2012, J EXP PSYCHOL-APPL, V18, P203, DOI 10.1037/a0026661; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; Dong X, 2011, J EXP PSYCHOL-APPL, V17, P128, DOI 10.1037/a0024097; Draper MH, 2001, HUM FACTORS, V43, P129, DOI 10.1518/001872001775992552; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Jang J, 2008, CLIN BIOMECH, V23, P468, DOI 10.1016/j.clinbiomech.2007.11.011; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kennedy RS, 1997, AVIAT SPACE ENVIR MD, V68, P13; KENNEDY RS, 1993, AVIAT SPACE ENVIR MD, V64, P912; Kennedy RS, 1996, INT J HUM-COMPUT INT, V8, P25, DOI 10.1080/10447319609526139; Kinsella-Shaw JM, 2006, J MOTOR BEHAV, V38, P251, DOI 10.3200/JMBR.38.4.251-264; Kondo T, 2001, APPETITE, V36, P119, DOI 10.1006/appe.2000.0391; KRAEMER WJ, 1987, INT J SPORTS MED, V8, P247, DOI 10.1055/s-2008-1025663; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Mackey DC, 2005, CLIN BIOMECH, V20, P776, DOI 10.1016/j.clinbiomech.2005.05.002; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Merhi O, 2007, HUM FACTORS, V49, P920, DOI 10.1518/001872007X230262; Moriarity JM, 2012, BRIT J SPORT MED, V46, P1011, DOI 10.1136/bjsports-2011-090893; Nachum Z, 2004, LARYNGOSCOPE, V114, P581, DOI 10.1097/00005537-200403000-00036; Ohhashi G, 2002, BRIT J SPORT MED, V36, P346, DOI 10.1136/bjsm.36.5.346; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Stoffregen TA, 2000, HUM FACTORS, V42, P458, DOI 10.1518/001872000779698097; Stoffregen TA, 1998, BRAIN RES BULL, V47, P437, DOI 10.1016/S0361-9230(98)00102-6; Stoffregen TA, 2000, HUM MOVEMENT SCI, V19, P203, DOI 10.1016/S0167-9457(00)00009-9; Stoffregen TA, 2011, SCI MOT, V74, P19, DOI DOI 10.1051/SM/2011111; Stoffregen TA, 2008, HUM FACTORS, V50, P322, DOI 10.1518/001872008X250755; Stoffregen TA, 2007, J MOTOR BEHAV, V39, P126, DOI 10.3200/JMBR.39.2.126-138; Stoffregen TA, 2011, ECOL PSYCHOL, V23, P19, DOI 10.1080/10407413.2011.539102; Stoffregen TA, 2010, ECOL PSYCHOL, V22, P169, DOI 10.1080/10407413.2010.496645; Stoffregen TA, 2009, AVIAT SPACE ENVIR MD, V80, P845, DOI 10.3357/ASEM.2572.2009; Troost B Todd, 2004, Curr Pain Headache Rep, V8, P310, DOI 10.1007/s11916-004-0014-z; Villard SJ, 2008, HUM FACTORS, V50, P332, DOI 10.1518/001872008X250728; Winer BJ, 1971, STAT PRINCIPLES EXPT; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yu Y, 2012, GAIT POSTUR IN PRESS; Yu YW, 2010, AVIAT SPACE ENVIR MD, V81, P375, DOI 10.3357/ASEM.2638.2010	52	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46136	10.1371/journal.pone.0046136	http://dx.doi.org/10.1371/journal.pone.0046136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056250	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000019
J	Dufour, CMS; Louapre, P; van Baaren, J; Martel, V				Dufour, Claire M-S; Louapre, Philippe; van Baaren, Joan; Martel, Veronique			When Parasitoid Males Make Decisions: Information Used when Foraging for Females	PLOS ONE			English	Article							PATCH-LEAVING DECISION; MALE MATE CHOICE; TIME ALLOCATION; ASOBARA-TABIDA; HOST SELECTION; RULES; STRATEGIES; EVOLUTION; BEHAVIOR; SEARCH	Optimal foraging models predict how an organism allocates its time and energy while foraging for aggregated resources. These models have been successfully applied to organisms such as predators looking for prey, female parasitoids looking for hosts, or herbivorous searching for food. In this study, information use and patch time allocation were investigated using male parasitoids looking for mates. The influence of the former presence of females in absence of mates and the occurrence of mating and other reproductive behaviours on the patch leaving tendency was investigated for the larval parasitoid Asobara tabida. Although males do not modify their patch residence time based on the number of females that visited the patch, they do show an increase in the patch residence time after mating a virgin female and performing courtship behaviour such as opening their wings. These results are in concordance with an incremental mechanism, as it has been described for females of the same species while foraging for hosts. The similarities between males and females of the same species, and the conditions under which such a patch-leaving decision rule is fitted are discussed. This is the first study describing an incremental effect of mating on patch residence time in males, thus suggesting that similar information use are probably driving different organisms foraging for resource, regardless of its nature.	[Dufour, Claire M-S; Louapre, Philippe; van Baaren, Joan; Martel, Veronique] Univ Rennes 1, UMR, CNRS, EcoBio 6553, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Dufour, CMS (corresponding author), Inst Sci Evolut Montpellier, Montpellier, France.	claire.dufour@univ-montp2.fr	Martel, Véronique/Q-5127-2019	Martel, Véronique/0000-0001-8111-5931; van baaren, joan/0000-0002-8552-9645	Agence Nationale de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR))	This research is part of the CLIMEVOL programme funded by the Agence Nationale de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Carton Y., 1986, P347; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Collett D, 1994, MODELLING SURVIVAL D; Cox DR, 1972, BIOMETRICS, V38, P67; DRIESSEN G, 1995, J ANIM ECOL, V64, P117, DOI 10.2307/5832; Driessen G, 1999, J ANIM ECOL, V68, P445, DOI 10.1046/j.1365-2656.1999.00296.x; Ellers J, 1997, J EVOLUTION BIOL, V10, P771, DOI 10.1007/s000360050053; Fauvergue X, 1998, J INSECT PHYSIOL, V44, P667, DOI 10.1016/S0022-1910(97)00172-8; GALIS F, 1981, NETH J ZOOL, V31, P596; Gibb J. A., 1962, Ibis, V104, P106, DOI 10.1111/j.1474-919X.1962.tb08633.x; HARDY ICW, 1990, BEHAVIOUR, V114, P137, DOI 10.1163/156853990X00086; HINDE RA, 1956, BRIT J PHILOS SCI, V6, P321; Hutchinson JMC, 2008, ANIM BEHAV, V75, P1331, DOI 10.1016/j.anbehav.2007.09.006; IWASA Y, 1981, AM NAT, V117, P710, DOI 10.1086/283754; Knowlton N., 1984, P61; Krebs J.R., 1973, PERSPECTIVES ETHOLOG, P73, DOI DOI 10.1007/978-1-4615-7569-6_3; KREBS JR, 1974, ANIM BEHAV, V22, P953, DOI 10.1016/0003-3472(74)90018-9; Krebs JR., 1997, BEHAV ECOLOGY EVOLUT; Laca E.A., 1996, P137; Lefebvre D, 2007, BEHAV ECOL SOCIOBIOL, V61, P1707, DOI 10.1007/s00265-007-0402-6; Lorenz K, 1970, ESSAIS COMPORTEMENT; Louapre P, 2011, BEHAV ECOL, V22, P1064, DOI 10.1093/beheco/arr090; Louapre P, 2011, PLANTE HOMME GUEPES, VI; Louapre P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014251; Maeda T, 2001, J INSECT BEHAV, V14, P829, DOI 10.1023/A:1013093518423; Martel V, 2008, J INSECT BEHAV, V21, P63, DOI 10.1007/s10905-007-9107-y; Martel V, 2008, ECOL ENTOMOL, V10, P1; Mason AC, 2001, NATURE, V410, P686, DOI 10.1038/35070564; Matthews R.W., 1975, P66; Mayland H, 2000, ENTOMOL EXP APPL, V96, P245, DOI 10.1023/A:1004047722647; MCCLELLAND DC, 1989, PSYCHOL REV, V96, P690, DOI 10.1037/0033-295X.96.4.690; MCNAMARA J, 1980, J THEOR BIOL, V85, P673, DOI 10.1016/0022-5193(80)90265-9; MCNAMARA JM, 1985, J APPL PROBAB, V22, P324, DOI 10.2307/3213776; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; Metzger M, 2010, ANIM BEHAV, V79, P1307, DOI 10.1016/j.anbehav.2010.03.003; MORRIS M, 1990, SLEEP, V13, P1; NOLDUS LPJJ, 1991, BEHAV RES METH INSTR, V23, P415, DOI 10.3758/BF03203406; Outreman Y, 2005, BEHAV ECOL SOCIOBIOL, V58, P208, DOI 10.1007/s00265-004-0895-1; PARKER GA, 1976, AM NAT, V110, P1055, DOI 10.1086/283126; Pelletier Y, 2009, J INSECT BEHAV, V22, P165, DOI 10.1007/s10905-008-9168-6; Pierre JS, 2011, OIKOS, V120, P77, DOI 10.1111/j.1600-0706.2010.18603.x; PODOLSKY RH, 1990, OECOLOGIA, V83, P83, DOI 10.1007/BF00324638; Schultheiss OC, 2008, SOC COGN AFFECT NEUR, V3, P333, DOI 10.1093/scan/nsn030; Taneyhill Dale, 2010, PSYCHE, P1, DOI [10.1155/2010/872736, DOI 10.1155/2010/872736]; Thiel A, 2006, ANIM BIOL, V56, P233, DOI 10.1163/157075606777304212; van Alpen JJM, 2003, TRENDS ECOL EVOL, V18, P81, DOI 10.1016/S0169-5347(02)00035-6; VANALPHEN JJM, 1993, NETH J ZOOL, V43, P340; VANALPHEN JJM, 1982, NETH J ZOOL, V32, P194, DOI 10.1163/002829682X00139; VANALPHEN JJM, 1983, J ANIM ECOL, V52, P937, DOI 10.2307/4465; WAAGE JK, 1979, J ANIM ECOL, V48, P353, DOI 10.2307/4166; Wajnberg E, 2003, J ANIM ECOL, V72, P618, DOI 10.1046/j.1365-2656.2003.00731.x; Wajnberg E, 1999, J ANIM ECOL, V68, P121, DOI 10.1046/j.1365-2656.1999.00270.x; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P589, DOI 10.1007/s00265-006-0198-9; WALKER WF, 1980, AM NAT, V115, P780, DOI 10.1086/283600; YDENBERG RC, 1984, BEHAVIOUR, V90, P1, DOI 10.1163/156853984X00533; [No title captured]	60	6	6	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46706	10.1371/journal.pone.0046706	http://dx.doi.org/10.1371/journal.pone.0046706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056411	Green Published, gold			2022-12-27	WOS:000309454000076
J	Fennessey, CM; Sheng, JS; Rubin, DH; McClain, MS				Fennessey, Christine M.; Sheng, Jinsong; Rubin, Donald H.; McClain, Mark S.			Oligomerization of Clostridium perfringens Epsilon Toxin Is Dependent upon Caveolins 1 and 2	PLOS ONE			English	Article							BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; HIGH-AFFINITY BINDING; PORE-FORMING TOXINS; PLASMA-MEMBRANE; ALPHA-HEMOLYSIN; MDCK CELLS; CHOLESTEROL; MICRODOMAINS; AEROLYSIN	Evidence from multiple studies suggests that Clostridium perfringens e-toxin is a pore-forming toxin, assembling into oligomeric complexes in the plasma membrane of sensitive cells. In a previous study, we used gene-trap mutagenesis to identify mammalian factors contributing to toxin activity, including caveolin-2 (CAV2). In this study, we demonstrate the importance of caveolin-2 and its interaction partner, caveolin-1 (CAV1), in e-toxin-induced cytotoxicity. Using CAV2-specific shRNA in a toxin-sensitive human kidney cell line, ACHN, we confirmed that cells deficient in CAV2 exhibit increased resistance to e-toxin. Similarly, using CAV1-specific shRNA, we demonstrate that cells deficient in CAV1 also exhibit increased resistance to the toxin. Immunoprecipitation of CAV1 and CAV2 from e-toxin-treated ACHN cells demonstrated interaction of both CAV1 and -2 with the toxin. Furthermore, blue-native PAGE indicated that the toxin and caveolins were components of a 670 kDa protein complex. Although e-toxin binding was only slightly perturbed in caveolin-deficient cells, oligomerization of the toxin was dramatically reduced in both CAV1- and CAV2-deficient cells. These results indicate that CAV1 and -2 potentiate e-toxin induced cytotoxicity by promoting toxin oligomerization - an event which is requisite for pore formation and, by extension, cell death.	[Fennessey, Christine M.; Sheng, Jinsong; Rubin, Donald H.; McClain, Mark S.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA; [Rubin, Donald H.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Rubin, Donald H.] VA Tennessee Valley Healthcare Syst, Res Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Fennessey, CM (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA.	mark.mcclain@vanderbilt.edu	McClain, Mark S/A-6942-2009	McClain, Mark S/0000-0002-9857-4883	National Institutes of Health [RO1-AI079123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by gifts from Maggie Chassman, Buisson Foundation, and the Public Health Service to DHR and National Institutes of Health grant RO1-AI079123 to MSM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Abrami L, 2000, INT J MED MICROBIOL, V290, P363; Alegre-Cebollada J, 2006, FEBS J, V273, P863, DOI 10.1111/j.1742-4658.2006.05122.x; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Bokori-Brown M, 2011, FEBS J, V278, P4589, DOI 10.1111/j.1742-4658.2011.08140.x; Borrmann E, 2001, FEMS IMMUNOL MED MIC, V31, P85, DOI 10.1111/j.1574-695X.2001.tb00503.x; BRULET P, 1976, P NATL ACAD SCI USA, V73, P2977, DOI 10.1073/pnas.73.9.2977; BUXTON D, 1976, J COMP PATHOL, V86, P67, DOI 10.1016/0021-9975(76)90029-3; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; Cai CX, 2004, BIOCHEM BIOPH RES CO, V320, P868, DOI 10.1016/j.bbrc.2004.06.030; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Dorca-Arevalo J, 2008, VET MICROBIOL, V131, P14, DOI 10.1016/j.vetmic.2008.02.015; Dorca-Arevalo J, 2012, VET MICROBIOL, V157, P179, DOI 10.1016/j.vetmic.2011.12.020; Miyakawa MEF, 2011, HUM EXP TOXICOL, V30, P275, DOI 10.1177/0960327110371700; Galdiero S, 2004, PROTEIN SCI, V13, P1503, DOI 10.1110/ps.03561104; Garcia-Saez AJ, 2011, J BIOL CHEM, V286, P37768, DOI 10.1074/jbc.M111.281592; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; GLEESONWHITE MH, 1955, LANCET, V1, P384; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hoffmann C, 2010, J CELL SCI, V123, P4280, DOI 10.1242/jcs.064006; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Ivie SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017787; KOHN J, 1955, LANCET, V1, P385; Lewis M, 2010, TOXINS, V2, P1825, DOI 10.3390/toxins2071825; Li JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002429; LINDSAY CD, 1995, TOXICOL IN VITRO, V9, P213, DOI 10.1016/0887-2333(95)00006-T; Lindsay CD, 1996, HUM EXP TOXICOL, V15, P904, DOI 10.1177/096032719601501107; Miller C, 2004, LIVER TRANSPLANT, V10, P1315, DOI 10.1002/lt.20227; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; MORINAGA G, 1965, J BACTERIOL, V90, P826, DOI 10.1128/JB.90.3.826-826.1965; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; NAGAHAMA M, 1992, INFECT IMMUN, V60, P1237, DOI 10.1128/IAI.60.3.1237-1240.1992; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Nagahama M, 1998, J NAT TOXINS, V7, P291; Nagahama M, 2003, J BIOL CHEM, V278, P36934, DOI 10.1074/jbc.M306562200; Nagahama M, 2011, FEBS J, V278, P3395, DOI 10.1111/j.1742-4658.2011.08263.x; Nelson KL, 2000, J BIOL CHEM, V275, P19839, DOI 10.1074/jbc.M002785200; Nestorovich EM, 2010, BIOPHYS J, V99, P782, DOI 10.1016/j.bpj.2010.05.014; Pany S, 2004, BIOCHEM BIOPH RES CO, V322, P29, DOI 10.1016/j.bbrc.2004.07.073; Pany S, 2007, BIOCHEM BIOPH RES CO, V363, P197, DOI 10.1016/j.bbrc.2007.08.132; Parolini I, 1999, J BIOL CHEM, V274, P25718, DOI 10.1074/jbc.274.36.25718; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelish TM, 2009, J BIOL CHEM, V284, P29446, DOI 10.1074/jbc.M109.021782; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Popoff MR, 2011, FEBS J, V278, P4602, DOI 10.1111/j.1742-4658.2011.08145.x; Robertson SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022053; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schraw W, 2002, J BIOL CHEM, V277, P34642, DOI 10.1074/jbc.M203466200; Shimada H, 2011, J BIOCHEM, V149, P103, DOI 10.1093/jb/mvq124; Shortt SJ, 2000, HUM EXP TOXICOL, V19, P108, DOI 10.1191/096032700678815710; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Soler-Jover A, 2007, TOXICON, V50, P530, DOI 10.1016/j.toxicon.2007.04.025; Soletti RC, 2010, ANTICANCER RES, V30, P1209; Srivastava SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006293; Swamy Mahima, 2006, Sci STKE, V2006, ppl4, DOI 10.1126/stke.3452006pl4; Turkcan S, 2012, BIOPHYS J, V102, P2299, DOI 10.1016/j.bpj.2012.03.072; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V324, P1130, DOI 10.1016/j.bbrc.2004.09.164; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V324, P1124, DOI 10.1016/j.bbrc.2004.09.165; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	77	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46866	10.1371/journal.pone.0046866	http://dx.doi.org/10.1371/journal.pone.0046866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056496	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600061
J	Qi, RF; Zhang, LJ; Zhong, JH; Wu, SY; Zhang, ZQ; Zhong, Y; Ni, L; Zheng, G; Jiao, Q; Wu, XJ; Fan, XX; Liu, YJ; Lu, GM				Qi, Rongfeng; Zhang, Long Jiang; Zhong, Jianhui; Wu, Shengyong; Zhang, Zhiqiang; Zhong, Yuan; Ni, Ling; Zheng, Gang; Jiao, Qing; Wu, Xingjiang; Fan, Xinxin; Liu, Yijun; Lu, Guangming			Dynamic Changes of Intrinsic Brain Activity in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt: A Resting-State fMRI Study	PLOS ONE			English	Article							HEPATIC-ENCEPHALOPATHY; DEFAULT-MODE; FUNCTIONAL CONNECTIVITY; PREVENTION; NETWORK; TIPS; ABNORMALITIES; IMPAIRMENT; ACTIVATION; AMPLITUDE	Purpose: The majority of cirrhotic patients who underwent transjugular intrahepatic portosystemic shunt (TIPS) experienced the first post-TIPS hepatic encephalopathy (HE) episode within the first three months after TIPS insertion. However, so far, little is known about the exact neuro-pathophysiological mechanism of TIPS's effects on brain function. We aimed to investigate the dynamics of brain function alteration of post-TIPS patients using resting-state functional MRI (rs-fMRI). Materials and Methods: Sixteen cirrhotic patients who were scheduled for TIPS and 16 healthy controls were included in the rs-fMRI scans. Ten patients repeated the MRI study in a median 8-day follow-up interval following TIPS and seven in a median 3-month follow-up. The amplitude of low frequency fluctuation (ALFF), an index reflecting the spontaneous brain activity, was compared between patients before TIPS and healthy controls as well as patients pre-and post-TIPS. Results: Compared with healthy controls, patients showed decreased ALFF in frontal and parietal regions and increased ALFF in insula. Patients who underwent the median 8-day follow-up fMRI examinations showed decreased ALFF in posterior cingulate cortex (PCC)/precuneus and increased ALFF in anterior cingulate cortex (ACC). Of 10 patients in this group, 9 had moderate to large increase rate of ALFF value (>20%, mean 49.19%) in ACC, while only one patient with the smallest increase rate of ALFF value (<10%) in ACC, who experienced three episodes of overt HE during the 3-month follow-up. In the median 3-month follow up observation, patients displayed persistently decreased ALFF in PCC, ACC and medial prefrontal cortex (MPFC), while no increased regional ALFF was observed. Conclusion: TIPS insertion alters cirrhotic patients' ALFF patterns in the resting state, which may imply different short-term and moderate-term effects on cirrhotic patients, i.e., both impairment and compensatory mechanism of brain functions in peri-TIPS and continuous impairment of brain function 3 months following TIPS.	[Qi, Rongfeng; Zhang, Long Jiang; Zhang, Zhiqiang; Zhong, Yuan; Ni, Ling; Zheng, Gang; Jiao, Qing; Lu, Guangming] Nanjing Univ, Coll Med, Sch Clin, Dept Med Imaging,Jinling Hosp, Nanjing, Jiangsu, Peoples R China; [Zhong, Jianhui] Zhejiang Univ, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Shengyong] Med Imaging Inst Tianjin, Tianjin, Peoples R China; [Wu, Xingjiang; Fan, Xinxin] Nanjing Univ, Coll Med, Sch Clin, Dept Gen Surg,Jinling Hosp, Nanjing, Jiangsu, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA	Nanjing University; Zhejiang University; Nanjing University; State University System of Florida; University of Florida	Qi, RF (corresponding author), Nanjing Univ, Coll Med, Sch Clin, Dept Med Imaging,Jinling Hosp, Nanjing, Jiangsu, Peoples R China.	kevinzhanglongjiang@yahoo.com.cn; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020; Wu, Shawn/J-8611-2014	Wu, Shawn/0000-0003-3432-9819	Natural Scientific Foundation of China [30700194, 81230032, 30800264, 30971019, 81101039]; Chinese Key Program [BWS11J063, 10z026]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Program	This work was supported by the grants from the Natural Scientific Foundation of China (grant no. 30700194 and no. 81230032 for Long Jiang Zhang, grant no. 30800264 for Zhiqiang Zhang, grant no. 30971019 for Qing Jiao, and grant no. 81101039 for Gang Zheng), and Chinese Key Program (grant no. BWS11J063 and no. 10z026 for Guangming Lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2012, CORTEX, V48, P604, DOI 10.1016/j.cortex.2011.02.011; Bai M, 2011, J GASTROEN HEPATOL, V26, P943, DOI 10.1111/j.1440-1746.2011.06663.x; Bajaj JS, 2008, WORLD J GASTROENTERO, V14, P3609, DOI 10.3748/wjg.14.3609; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bartels LW, 2001, J VASC INTERV RADIOL, V12, P365, DOI 10.1016/S1051-0443(07)61918-6; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chen HJ, 2011, EUR J RADIOL; Chen HJ, 2012, J NEUROL SCI, V318, P140, DOI 10.1016/j.jns.2012.02.019; Colombato L, 2007, J CLIN GASTROENTEROL, V41, pS344, DOI 10.1097/MCG.0b013e318157e500; Cordoba J, 2008, SEMIN LIVER DIS, V28, P70, DOI 10.1055/s-2008-1040322; D'Amico G, 2008, J HEPATOL, V48, P387, DOI 10.1016/j.jhep.2007.12.009; Feng YY, 2011, MAGN RESON IMAGING, V29, P958, DOI 10.1016/j.mri.2011.04.009; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Itkin M, 2009, AM J ROENTGENOL, V192, pW317, DOI 10.2214/AJR.07.2731; Iversen P, 2011, CLIN GASTROENTEROL H, V9, P1001, DOI 10.1016/j.cgh.2011.07.015; Kramer L, 2002, AM J GASTROENTEROL, V97, P162; Lo GH, 2007, ENDOSCOPY, V39, P679, DOI 10.1055/s-2007-966591; LOCKWOOD AH, 1993, HEPATOLOGY, V18, P1061; Luca A, 1999, RADIOLOGY, V212, P411, DOI 10.1148/radiology.212.2.r99au46411; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Merli M, 1998, HEPATOLOGY, V27, P48, DOI 10.1002/hep.510270109; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; Papatheodoridis GV, 1999, HEPATOLOGY, V30, P612, DOI 10.1002/hep.510300316; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Punamiya SJ, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/398291; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rossle M, 1997, LANCET, V349, P1043, DOI 10.1016/S0140-6736(96)08189-5; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Wu XJ, 2010, J HEPATO-BIL-PAN SCI, V17, P701, DOI 10.1007/s00534-010-0270-8; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang LJ, 2007, ACTA RADIOL, V48, P781, DOI 10.1080/02841850701422161; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zijlmans M, 2007, BRAIN, V130, P2343, DOI 10.1093/brain/awm141	44	10	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46681	10.1371/journal.pone.0046681	http://dx.doi.org/10.1371/journal.pone.0046681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056400	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600052
J	Sladek, M; Polidarova, L; Novakova, M; Parkanova, D; Sumova, A				Sladek, Martin; Polidarova, Lenka; Novakova, Marta; Parkanova, Daniela; Sumova, Alena			Early Chronotype and Tissue-Specific Alterations of Circadian Clock Function in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ALPHA PPAR-ALPHA; REV-ERB-ALPHA; SUPRACHIASMATIC NUCLEUS; LOCOMOTOR-ACTIVITY; METABOLIC SYNDROME; GENE-EXPRESSION; DOWN-REGULATION; BLOOD-PRESSURE; WISTAR-KYOTO; TRANSCRIPTION	Malfunction of the circadian timing system may result in cardiovascular and metabolic diseases, and conversely, these diseases can impair the circadian system. The aim of this study was to reveal whether the functional state of the circadian system of spontaneously hypertensive rats (SHR) differs from that of control Wistar rat. This study is the first to analyze the function of the circadian system of SHR in its complexity, i.e., of the central clock in the suprachiasmatic nuclei (SCN) as well as of the peripheral clocks. The functional properties of the SCN clock were estimated by behavioral output rhythm in locomotor activity and daily profiles of clock gene expression in the SCN determined by in situ hybridization. The function of the peripheral clocks was assessed by daily profiles of clock gene expression in the liver and colon by RT-PCR and in vitro using real time recording of Bmal1-dLuc reporter. The potential impact of the SHR phenotype on circadian control of the metabolic pathways was estimated by daily profiles of metabolism-relevant gene expression in the liver and colon. The results revealed that SHR exhibited an early chronotype, because the central SCN clock was phase advanced relative to light/dark cycle and the SCN driven output rhythm ran faster compared to Wistar rats. Moreover, the output rhythm was dampened. The SHR peripheral clock reacted to the dampened SCN output with tissue-specific consequences. In the colon of SHR the clock function was severely altered, whereas the differences are only marginal in the liver. These changes may likely result in a mutual desynchrony of circadian oscillators within the circadian system of SHR, thereby potentially contributing to metabolic pathology of the strain. The SHR may thus serve as a valuable model of human circadian disorders originating in poor synchrony of the circadian system with external light/dark regime.	[Sladek, Martin; Polidarova, Lenka; Novakova, Marta; Parkanova, Daniela; Sumova, Alena] Acad Sci Czech Republic, Inst Physiol, Dept Neurohumoral Regulat, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Sladek, M (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Neurohumoral Regulat, Vvi, Prague, Czech Republic.	sumova@biomed.cas.cz	Sládek, Martin/C-3383-2012; Sumova, Alena/C-3390-2012; Polidarova, Lenka/K-3550-2017	Sládek, Martin/0000-0002-9744-9386; Sumova, Alena/0000-0003-4126-5470; Polidarova, Lenka/0000-0001-9087-6388	Czech Science Foundation [P303110668, P30510P244]; Research Projects [50110509, RVO:7985823]	Czech Science Foundation(Grant Agency of the Czech Republic); Research Projects	The study was supported by the Czech Science Foundation, grants No. P303110668 and P30510P244, and by Research Projects Nos. 50110509 and RVO:7985823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; BERGER DF, 1988, J COMP PSYCHOL, V102, P279, DOI 10.1037/0735-7036.102.3.279; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carley DW, 1996, PHYSIOL BEHAV, V59, P827, DOI 10.1016/0031-9384(95)02205-8; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017339; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; He Q, 2011, AM J PHYSIOL-ENDOC M, V300, pE877, DOI 10.1152/ajpendo.00626.2010; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Kaneko K, 2009, BRAIN RES, V1263, P58, DOI 10.1016/j.brainres.2008.12.071; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LEATON RN, 1983, PHYSIOL BEHAV, V31, P103, DOI 10.1016/0031-9384(83)90103-8; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; LEMMER B, 1993, HYPERTENSION, V22, P97, DOI 10.1161/01.HYP.22.1.97; Li DM, 2011, MOL CELL ENDOCRINOL, V344, P69, DOI 10.1016/j.mce.2011.06.028; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Maywood ES, 2007, ENDOCRINOLOGY, V148, P5624, DOI 10.1210/en.2007-0660; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Naito Y, 2003, J HYPERTENS, V21, P1107, DOI 10.1097/00004872-200306000-00010; Nakahata Y, 2009, SCIENCE; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Ohno T, 2007, NUCLEIC ACIDS RES, V35, P648, DOI 10.1093/nar/gkl868; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PARE WP, 1989, PAVLOVIAN J BIOL SCI, V24, P54; PETERS RV, 1994, BRAIN RES, V639, P217, DOI 10.1016/0006-8993(94)91733-7; Polidarova L, 2011, CHRONOBIOL INT, V28, P204, DOI 10.3109/07420528.2010.548615; Polidarova L, 2009, CHRONOBIOL INT, V26, P607, DOI 10.1080/07420520902924889; Pravenec M, 2004, PHYSIOL RES, V53, pS15; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramsey KM, 2009, SCIENCE; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; ROSENWASSER AM, 1993, PHYSIOL BEHAV, V53, P23, DOI 10.1016/0031-9384(93)90006-2; Sagvolden T, 2009, NEUROPHARMACOLOGY, V57, P619, DOI 10.1016/j.neuropharm.2009.08.004; Saito H, 2008, AM J PHYSIOL-GASTR L, V295, pG395, DOI 10.1152/ajpgi.90317.2008; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schmutz I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021325; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shen GM, 2010, FEBS LETT, V584, P4366, DOI 10.1016/j.febslet.2010.09.040; Sladek M, 2007, GASTROENTEROLOGY, V133, P1240, DOI 10.1053/j.gastro.2007.05.053; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Sumova A, 2003, J BIOL RHYTHM, V18, P134, DOI 10.1177/0748730403251801; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; VANDENBUUSE M, 1994, PHYSIOL BEHAV, V55, P783, DOI 10.1016/0031-9384(94)90060-4; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001; Zhang FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016795	81	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46951	10.1371/journal.pone.0046951	http://dx.doi.org/10.1371/journal.pone.0046951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056539	gold, Green Published, Green Submitted			2022-12-27	WOS:000309452600065
J	Cook, WJ; Senkovich, O; Aleem, K; Chattopadhyay, D				Cook, William J.; Senkovich, Olga; Aleem, Khadijah; Chattopadhyay, Debasish			Crystal Structure of Cryptosporidium parvum Pyruvate Kinase	PLOS ONE			English	Article							ALLOSTERIC REGULATION; PROTEIN-STRUCTURE; MOLECULAR-BASIS; DRUG TARGETS; INHIBITORS; ISOZYME; LOCALIZES; SEQUENCE; BIOLOGY; DESIGN	Pyruvate kinase plays a critical role in cellular metabolism of glucose by serving as a major regulator of glycolysis. This tetrameric enzyme is allosterically regulated by different effector molecules, mainly phosphosugars. In response to binding of effector molecules and substrates, significant structural changes have been identified in various pyruvate kinase structures. Pyruvate kinase of Cryptosporidium parvum is exceptional among known enzymes of protozoan origin in that it exhibits no allosteric property in the presence of commonly known effector molecules. The crystal structure of pyruvate kinase from C. parvum has been solved by molecular replacement techniques and refined to 2.5 angstrom resolution. In the active site a glycerol molecule is located near the gamma-phosphate site of ATP, and the protein structure displays a partially closed active site. However, unlike other structures where the active site is closed, the alpha 6' helix in C. parvum pyruvate kinase unwinds and assumes an extended conformation. In the crystal structure a sulfate ion is found at a site that is occupied by a phosphate of the effector molecule in many pyruvate kinase structures. A new feature of the C. parvum pyruvate kinase structure is the presence of a disulfide bond cross-linking the two monomers in the asymmetric unit. The disulfide bond is formed between cysteine residue 26 in the short N-helix of one monomer with cysteine residue 312 in a long helix (residues 303-320) of the second monomer at the interface of these monomers. Both cysteine residues are unique to C. parvum, and the disulfide bond remained intact in a reduced environment. However, the significance of this bond, if any, remains unknown at this time.	[Chattopadhyay, Debasish] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [Cook, William J.; Senkovich, Olga] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Aleem, Khadijah] Univ Alabama Birmingham, Ronald E McNair Scholar Program, Birmingham, AL USA; [Chattopadhyay, Debasish] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Chattopadhyay, D (corresponding author), Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA.	debasish@uab.edu			American Foundation for AIDS Research (amFAR) [106493-25-RGGN]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	American Foundation for AIDS Research (amFAR); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was in part supported by a research grant to DC from American Foundation for AIDS Research (amFAR) no. 106493-25-RGGN. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C. parvum cDNA was obtained from the NIH AIDS Reagent Program. X-ray diffraction data were collected at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by University of Chicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Aronov AM, 1999, P NATL ACAD SCI USA, V96, P4273, DOI 10.1073/pnas.96.8.4273; Axerio-Cilies P, 2012, ACS CHEM BIOL, V7, P349, DOI 10.1021/cb2003576; Bakszt R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012736; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Barrett MP, 1999, TRENDS MICROBIOL, V7, P82, DOI 10.1016/S0966-842X(98)01433-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collinet-Adler S, 2010, EUR J CLIN MICROBIOL, V29, P927, DOI 10.1007/s10096-010-0960-9; Coombs GH, 1999, PARASITOL TODAY, V15, P333, DOI 10.1016/S0169-4758(99)01474-X; Corso PS, 2003, EMERG INFECT DIS, V9, P426, DOI 10.3201/eid0904.020417; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denton H, 1996, MOL BIOCHEM PARASIT, V76, P23, DOI 10.1016/0166-6851(95)02527-8; Dillingham RA, 2002, MICROBES INFECT, V4, P1059, DOI 10.1016/S1286-4579(02)01630-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Entrala E, 1997, FEMS MICROBIOL LETT, V151, P51, DOI 10.1111/j.1574-6968.1997.tb10393.x; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; HALL ER, 1978, INT J BIOCHEM, V9, P785, DOI 10.1016/0020-711X(78)90027-7; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Ikeda Y, 1997, J BIOL CHEM, V272, P20495, DOI 10.1074/jbc.272.33.20495; Lakhdar-Ghazal Faouzi, 2002, Current Topics in Medicinal Chemistry, V2, P439, DOI 10.2174/1568026024607472; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; Maeda T, 2009, PARASITOL INT, V58, P101, DOI 10.1016/j.parint.2008.10.005; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Morgan HP, 2011, J BIOL CHEM, V286, P31232, DOI 10.1074/jbc.M110.212613; Morgan HP, 2010, J BIOL CHEM, V285, P12892, DOI 10.1074/jbc.M109.079905; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nannini Esteban C, 2002, Curr Gastroenterol Rep, V4, P392, DOI 10.1007/s11894-002-0009-z; Nowicki MW, 2008, BIOORGAN MED CHEM, V16, P5050, DOI 10.1016/j.bmc.2008.03.045; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Saito T, 2008, J BIOL CHEM, V283, P14041, DOI 10.1074/jbc.M709015200; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Senkovich O, 2005, BBA-PROTEINS PROTEOM, V1750, P166, DOI 10.1016/j.bbapap.2005.04.009; Taber RL, 1998, BIOCHEM EDUC, V26, P73, DOI 10.1016/S0307-4412(97)00117-9; Tulloch LB, 2008, J MOL BIOL, V383, P615, DOI 10.1016/j.jmb.2008.08.037; Tzipori S, 1998, ADV PARASIT, V40, P5, DOI 10.1016/S0065-308X(08)60116-5; Tzipori S, 2002, MICROBES INFECT, V4, P1047, DOI 10.1016/S1286-4579(02)01629-5; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Zoraghi R, 2011, J BIOL CHEM, V286, P44716, DOI 10.1074/jbc.M111.289033	48	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46875	10.1371/journal.pone.0046875	http://dx.doi.org/10.1371/journal.pone.0046875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056503	gold, Green Submitted, Green Published			2022-12-27	WOS:000309889400035
J	Lee, D; Kim, KY; Noh, YH; Chai, S; Lindsey, JD; Ellisman, MH; Weinreb, RN; Ju, WK				Lee, Dongwook; Kim, Keun-Young; Noh, You Hyun; Chai, Stephen; Lindsey, James D.; Ellisman, Mark H.; Weinreb, Robert N.; Ju, Won-Kyu			Brimonidine Blocks Glutamate Excitotoxicity-Induced Oxidative Stress and Preserves Mitochondrial Transcription Factor A in Ischemic Retinal Injury	PLOS ONE			English	Article							APOPTOTIC CELL-DEATH; NMDA RECEPTOR FUNCTION; RAT RETINA; OPTIC-NERVE; SUPEROXIDE-DISMUTASE; PROAPOPTOTIC BAX; GANGLION-CELLS; DBA/2J MOUSE; DNA DAMAGE; GLAUCOMA	Glutamate excitotoxicity-induced oxidative stress have been linked to mitochondrial dysfunction in retinal ischemia and optic neuropathies including glaucoma. Brimonindine (BMD), an alpha 2-adrenergic receptor agonist, contributes to the neuroprotection of retinal ganglion cells (RGCs) against glutamate excitotoxicity or oxidative stress. However, the molecular mechanisms of BMD-associated mitochondrial preservation in RGC protection against glutamate excitotoxicity-induced oxidative stress following retinal ischemic injury remain largely unknown. Here, we tested whether activation of alpha 2 adrenergic receptor by systemic BMD treatment blocks glutamate excitotoxicity-induced oxidative stress, and preserves the expression of mitochondrial transcription factor A (Tfam) and oxidative phosphorylation (OXPHOS) complex in ischemic retina. Sprague-Dawley rats received BMD (1 mg/kg/day) or vehicle (0.9% saline) systemically and then transient ischemia was induced by acute intraocular pressure elevation. Systemic BMD treatment significantly increased RGC survival at 4 weeks after ischemia. At 24 hours, BMD significantly decreased Bax expression but increased Bcl-xL and phosphorylated Bad protein expression in ischemic retina. Importantly. BMD significantly blocked the upregulations of N-methyl-D-aspartate receptors 1 and 2A protein expression, as well as of SOD2 protein expression in ischemic retina at 24 hours. During the early neurodegeneration following ischemic injury (12-72 hours), Tfam and OXPHOS complex protein expression were significantly increased in vehicle-treated retina. At 24 hours after ischemia, Tfam immunoreactivity was increased in the outer plexiform layer, inner nuclear layer, inner plexiform layer and ganglion cell layer. Further, Tfam protein was expressed predominantly in RGCs. Finally, BMD preserved Tfam immunoreactivity in RGCs as well as Tfam/OXPHOS complex protein expression in the retinal extracts against ischemic injury. Our findings suggest that systemic BMD treatment protects RGCs by blockade of glutamate excitotoxicity-induced oxidative stress and subsequent preservation of Tfam/OXPHOS complex expression in ischemic retina.	[Lee, Dongwook; Noh, You Hyun; Chai, Stephen; Lindsey, James D.; Weinreb, Robert N.; Ju, Won-Kyu] Univ Calif San Diego, Sophie & Arthur Lab Optic Nerve Biol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Lee, Dongwook; Noh, You Hyun; Chai, Stephen; Lindsey, James D.; Weinreb, Robert N.; Ju, Won-Kyu] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Lee, Dongwook] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Biomed Res Inst, Jeonju, Jeonbuk, South Korea; [Kim, Keun-Young; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Kim, Keun-Young; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Jeonbuk National University; Jeonbuk National University Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego	Ju, WK (corresponding author), Univ Calif San Diego, Sophie & Arthur Lab Optic Nerve Biol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA.	danielju@glaucoma.ucsd.edu			National Institute of Health (NIH) [EY018658]; NCRR (National Center for Research Resources) [P41 RR004050]; Research to Prevent Blindness (New York, NY); Chonbuk National University; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018658] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR (National Center for Research Resources); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); Chonbuk National University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the National Institute of Health (NIH) grant EY018658 (WKJ), NCRR (National Center for Research Resources) P41 RR004050 (MHE), an unrestricted grant from Research to Prevent Blindness (New York, NY), and overseas research funds of Chonbuk National University in 2010 (DL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Chan ASY, 2012, INVEST OPHTH VIS SCI, V53, P704, DOI 10.1167/iovs.11-7408; Chan SW, 2011, MUTAT RES-FUND MOL M, V716, P40, DOI 10.1016/j.mrfmmm.2011.07.019; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dong CJ, 2008, INVEST OPHTH VIS SCI, V49, P4515, DOI 10.1167/iovs.08-2078; Dong CJ, 2007, INVEST OPHTH VIS SCI, V48, P1410, DOI 10.1167/iovs.06-0890; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fukui M, 2010, FREE RADICAL BIO MED, V48, P821, DOI 10.1016/j.freeradbiomed.2009.12.024; Gao H, 2002, ARCH OPHTHALMOL-CHIC, V120, P797; Goldenberg-Cohen N, 2009, CLIN EXP OPHTHALMOL, V37, P718, DOI 10.1111/j.1442-9071.2009.02108.x; Hokari M, 2010, NEUROPATHOLOGY, V30, P401, DOI 10.1111/j.1440-1789.2009.01086.x; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Ju WK, 2005, J COMP NEUROL, V488, P1, DOI 10.1002/cne.20586; Ju WK, 2008, MOL VIS, V14, P2629; Ju WK, 2009, INVEST OPHTH VIS SCI, V50, P707, DOI 10.1167/iovs.08-2499; Kong YXG, 2011, AGING CELL, V10, P572, DOI 10.1111/j.1474-9726.2011.00690.x; Lai RK, 2002, VISUAL NEUROSCI, V19, P175, DOI 10.1017/S0952523802191152; Lambert WS, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-4; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee KYC, 2010, MOL VIS, V16, P246; Lee S, 2011, EXP EYE RES, V93, P204, DOI 10.1016/j.exer.2010.07.015; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; OGIDIGBEN M, 1994, EXP EYE RES, V58, P729, DOI 10.1006/exer.1994.1070; OGUNI M, 1995, OPHTHALMIC RES, V27, P227, DOI 10.1159/000267710; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Osborne NN, 2008, PROG BRAIN RES, V173, P339, DOI 10.1016/S0079-6123(08)01124-2; Ozdemir G, 2009, J GLAUCOMA, V18, P662, DOI 10.1097/IJG.0b013e31819c46b1; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Piao Y, 2011, BIOCH BIOPHYS ACTA; Russo R, 2008, J NEUROCHEM, V107, P1347, DOI 10.1111/j.1471-4159.2008.05694.x; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Schuettauf F, 2004, ACTA NEUROPATHOL, V107, P352, DOI 10.1007/s00401-003-0816-9; Tezel G, 2003, INVEST OPHTH VIS SCI, V44, P3025, DOI 10.1167/iovs.02-1136; Toris CB, 1999, AM J OPHTHALMOL, V128, P8, DOI 10.1016/S0002-9394(99)00076-8; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Vander Heiden MG, 1999, MOL CELL, V3, P159; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wheeler LA, 2001, SURV OPHTHALMOL, V45, pS290, DOI 10.1016/S0039-6257(01)00206-5; Xu SC, 2009, FEBS J, V276, P4224, DOI 10.1111/j.1742-4658.2009.07094.x; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yin W, 2008, STROKE, V39, P3057, DOI 10.1161/STROKEAHA.108.520114; Zhi ZW, 2011, BIOMED OPT EXPRESS, V2, P579, DOI 10.1364/BOE.2.000579	51	56	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47098	10.1371/journal.pone.0047098	http://dx.doi.org/10.1371/journal.pone.0047098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056591	gold, Green Published			2022-12-27	WOS:000309889400055
J	Mariappan, N; Elks, CM; Haque, M; Francis, J				Mariappan, Nithya; Elks, Carrie M.; Haque, Masudul; Francis, Joseph			Interaction of TNF with Angiotensin II Contributes to Mitochondrial Oxidative Stress and Cardiac Damage in Rats	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE SYNTHASE; HEART-FAILURE; ATTENUATES SYMPATHOEXCITATION; PARAVENTRICULAR NUCLEUS; CARDIOVASCULAR-DISEASE; DYSFUNCTION; HYPERTENSION; INVOLVEMENT; RECEPTOR	Recent evidence suggests that tumor necrosis factor alpha (TNF) and angiotensin II (ANGII) induce oxidative stress contribute to cardiovascular disease progression. Here, we examined whether an interaction between TNF and ANGII contributes to altered cardiac mitochondrial biogenesis and ATP production to cause cardiac damage in rats. Rats received intraperitoneal injections of TNF (30 mu g/kg), TNF + losartan (LOS, 1 mg/kg), or vehicle for 5 days. Left ventricular (LV) function was measured using echocardiography. Rats were sacrificed and LV tissues removed for gene expression, electron paramagnetic resonance and mitochondrial assays. TNF administration significantly increased expression of the NADPH oxidase subunit, gp91phox, and the angiotensin type 1 receptor (AT-1R) and decreased eNOS in the LV of rats. Rats that received TNF only had increased production rates of superoxide, peroxynitrite and total reactive oxygen species (ROS) in the cytosol and increased production rates of superoxide and hydrogen peroxide in mitochondria. Decreased activities of mitochondrial complexes I, II, and III and mitochondrial genes were observed in rats given TNF. In addition, TNF administration also resulted in a decrease in fractional shortening and an increase in Tei index, suggesting diastolic dysfunction. TNF administration with concomitant LOS treatment attenuated mitochondrial damage, restored cardiac function, and decreased expression of AT1-R and NADPH oxidase subunits. Mitochondrial biogenesis and function is severely impaired by TNF as evidenced by downregulation of mitochondrial genes and increased free radical production, and may contribute to cardiac damage. These defects are independent of the downregulation of mitochondrial gene expression, suggesting novel mechanisms for mitochondrial dysfunction in rats given TNF.	[Mariappan, Nithya; Haque, Masudul; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Elks, Carrie M.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Nutr Neurosci & Aging Lab, Baton Rouge, LA USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Mariappan, N (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	nithya06@lsu.edu; jfrancis@lsu.edu	Elks, Carrie Marie/N-1961-2017		NHLBI NIH HHS [R01 HL080544] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080544] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Atlante A, 2000, J BIOL CHEM, V275, P37159, DOI 10.1074/jbc.M002361200; Csont T, 2005, J MOL CELL CARDIOL, V39, P833, DOI 10.1016/j.yjmcc.2005.07.010; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Dai DF, 2012, CARDIOVASC RES, V93, P79, DOI 10.1093/cvr/cvr274; Dikalov SI, 2002, ARCH BIOCHEM BIOPHYS, V402, P218, DOI 10.1016/S0003-9861(02)00064-4; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Ebadi M, 2003, ANTIOXID REDOX SIGN, V5, P319, DOI 10.1089/152308603322110896; Flarsheim CE, 1996, AM J PHYSIOL-HEART C, V271, pH192, DOI 10.1152/ajpheart.1996.271.1.H192; Frohlich ED, 2004, MED CLIN N AM, V88, P209, DOI 10.1016/S0025-7125(03)00117-2; Fujita T, 2007, KIDNEY INT, V72, P1543, DOI 10.1038/sj.ki.5002623; Funakoshi H, 2002, AM J PHYSIOL-HEART C, V282, pH2159, DOI 10.1152/ajpheart.00872.2001; Girouard H, 2007, ARTERIOSCL THROM VAS, V27, P303, DOI 10.1161/01.ATV.0000253885.41509.25; Granger DN, 2004, HYPERTENSION, V43, P924, DOI 10.1161/01.HYP.0000123070.31763.55; Guggilam A, 2008, EUR J HEART FAIL, V10, P625, DOI 10.1016/j.ejheart.2008.05.004; Guggilam A, 2007, AM J PHYSIOL-HEART C, V293, pH599, DOI 10.1152/ajpheart.00286.2007; Gurevitch J, 1997, J AM COLL CARDIOL, V30, P1554, DOI 10.1016/S0735-1097(97)00328-8; Higashi Yukihito, 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P133, DOI 10.2174/1568016053544363; Hitomi H, 2007, CURR OPIN CARDIOL, V22, P311, DOI 10.1097/HCO.0b013e3281532b53; Hofer T, 2009, MECH AGEING DEV, V130, P297, DOI 10.1016/j.mad.2009.01.004; Ichihara S, 2001, CIRCULATION, V104, P346, DOI 10.1161/01.CIR.104.3.346; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Jolda-Mydlowska Beata, 2003, Pol Arch Med Wewn, V109, P23; Kumarswamy R, 2009, MITOCHONDRION, V9, P1, DOI 10.1016/j.mito.2008.10.003; Lehoux S, 2006, CARDIOVASC RES, V71, P269, DOI 10.1016/j.cardiores.2006.05.008; Li JM, 2003, J AM SOC NEPHROL, V14, pS221, DOI 10.1097/01.ASN.0000077406.67663.E7; Madonna R, 2005, J BIOL CHEM, V280, P13503, DOI 10.1074/jbc.M411859200; Mariappan N, 2009, CARDIOVASC RES; Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; Millatt LJ, 1999, REGUL PEPTIDES, V81, P1, DOI 10.1016/S0167-0115(99)00027-0; Moe GW, 2004, AM J PHYSIOL-HEART C, V287, pH1813, DOI 10.1152/ajpheart.00036.2004; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; Olivares-Reyes JA, 2009, MOL CELL ENDOCRINOL, V302, P128, DOI 10.1016/j.mce.2008.12.011; Oskarsson HJ, 1997, CIRCULATION, V95, P557, DOI 10.1161/01.CIR.95.3.557; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Pohjoismaki JL, NUCL ACIDS RES; Ruiz-Ortega M, 2002, KIDNEY INT, V62, pS12, DOI 10.1046/j.1523-1755.62.s82.4.x; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Schiffrin EL, 2003, J AM COLL CARDIOL, V42, P911, DOI 10.1016/S0735-1097(03)00845-3; Sriramula S, 2008, HYPERTENSION, V51, P1345, DOI 10.1161/HYPERTENSIONAHA.107.102152; Suzuki H, 2006, ENDOCRINOLOGY, V147, P5914, DOI 10.1210/en.2006-0834; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Turner NA, 2009, AM J PHYSIOL-HEART C, V297, pH1117, DOI 10.1152/ajpheart.00372.2009; WOLF G, 1993, J AM SOC NEPHROL, V3, P1531; Woo CH, 2000, J BIOL CHEM, V275, P32357, DOI 10.1074/jbc.M005638200; Zhang GX, 2007, CARDIOVASC RES, V76, P204, DOI 10.1016/j.cardiores.2007.07.014	47	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46568	10.1371/journal.pone.0046568	http://dx.doi.org/10.1371/journal.pone.0046568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056347	Green Submitted, gold, Green Published			2022-12-27	WOS:000309889400017
J	Martins, L; Fernandez-Mallo, D; Novelle, MG; Vazquez, MJ; Tena-Sempere, M; Nogueiras, R; Lopez, M; Dieguez, C				Martins, Luis; Fernandez-Mallo, Diana; Novelle, Marta G.; Vazquez, Maria J.; Tena-Sempere, Manuel; Nogueiras, Ruben; Lopez, Miguel; Dieguez, Carlos			Hypothalamic mTOR Signaling Mediates the Orexigenic Action of Ghrelin	PLOS ONE			English	Article							AGOUTI-RELATED PEPTIDE; MAMMALIAN TARGET; NEUROPEPTIDE-Y; AMPK; INCREASES; HORMONE; GROWTH; BSX; RESISTANCE; APPETITE	Current evidence suggests that ghrelin, a stomach derived peptide, exerts its orexigenic action through specific modulation of Sirtuin1 (SIRT1)/p53 and AMP-activated protein kinase (AMPK) pathways, which ultimately increase the expression of agouti-related protein (AgRP) and neuropeptide Y (NPY) in the arcuate nucleus of the hypothalamus (ARC). However, there is a paucity of data about the possible action of ghrelin on alternative metabolic pathways at this level. Here, we demonstrate that ghrelin elicits a marked upregulation of the hypothalamic mammalian target of rapamycin (mTOR) signaling pathway. Of note, central inhibition of mTOR signaling with rapamycin decreased ghrelin's orexigenic action and normalized the mRNA expression of AgRP and NPY, as well as their key downstream transcription factors, namely cAMP response-element binding protein (pCREB) and forkhead box O1 (FoxO1, total and phosphorylated). Taken together, these data indicate that, in addition to previous reported mechanisms, ghrelin also promotes feeding through modulation of hypothalamic mTOR pathway.	[Martins, Luis; Fernandez-Mallo, Diana; Novelle, Marta G.; Vazquez, Maria J.; Nogueiras, Ruben; Lopez, Miguel; Dieguez, Carlos] Univ Santiago de Compostela, IDIS, Dept Physiol, Res Ctr Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain; [Martins, Luis; Fernandez-Mallo, Diana; Novelle, Marta G.; Vazquez, Maria J.; Tena-Sempere, Manuel; Nogueiras, Ruben; Lopez, Miguel; Dieguez, Carlos] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Santiago De Compostela, Spain; [Tena-Sempere, Manuel] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; [Tena-Sempere, Manuel] Inst Maimonides Invest Biomed IMIBIC, Cordoba, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidad de Cordoba	Lopez, M (corresponding author), Univ Santiago de Compostela, IDIS, Dept Physiol, Res Ctr Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain.	m.lopez@usc.es; carlos.dieguez@usc.es	López, Miguel/ABF-4844-2021; NOVELLE, MARTA G/AAB-9200-2019; Nogueiras, Ruben/AAS-9427-2021; Martins, Luis/AAB-5436-2020; Tena-Sempere, Manuel/AAX-3602-2021	López, Miguel/0000-0002-7823-1648; NOVELLE, MARTA G/0000-0003-0285-7182; Nogueiras, Ruben/0000-0002-9976-9930; Martins, Luis/0000-0002-2000-387X; Tena-Sempere, Manuel/0000-0002-4741-5567; dieguez, carlos/0000-0002-0919-4337	European Community [281854, 245009]; Xunta de Galicia [10PXIB208164PR, 2010/14]; Junta de Andalucia [P08-CVI-03788]; Instituto de Salud Carlos III (ISCIII) [PS09/01880]; FEDER Program of EU [BFU2011-25021, RyC-2008-02219, SAF2009-07049, RyC-2007-00211, BFU2011-29102]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BD/65379/2009]	European Community(European Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); FEDER Program of EU; Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 281854 - the ObERStress project (ML) and 245009 - the Neurofast project (RN, CD and ML), Xunta de Galicia (ML: 10PXIB208164PR; RN: 2010/14), Junta de Andalucia (MTS: P08-CVI-03788), Instituto de Salud Carlos III (ISCIII) (ML: PS09/01880), MINECO co-funded by the FEDER Program of EU (MTS: BFU2011-25021; RN: RyC-2008-02219 and SAF2009-07049; ML: RyC-2007-00211; CD: BFU2011-29102). LM is a recipient of a fellowship from Fundacao para a Ciencia e Tecnologia (FCT), Portugal (SFRH/BD/65379/2009). CIBER de Fisiopatologia de la Obesidad y Nutricion is an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Inhoff T, 2010, PEPTIDES, V31, P257, DOI 10.1016/j.peptides.2009.11.024; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; Lage R, 2006, NEUROSCI LETT, V410, P47, DOI 10.1016/j.neulet.2006.09.064; Lage R, 2010, FASEB J, V24, P2670, DOI 10.1096/fj.09-150672; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Lopez M, 2002, NEUROENDOCRINOLOGY, V75, P34, DOI 10.1159/000048219; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nogueiras R, 2008, ENDOCRINOLOGY, V149, P3009, DOI 10.1210/en.2007-1684; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Roa J, 2009, ENDOCRINOLOGY, V150, P5016, DOI 10.1210/en.2009-0096; Roa JA, 2010, TRENDS ENDOCRIN MET, V21, P519, DOI 10.1016/j.tem.2010.05.003; Ropelle ER, 2008, DIABETES, V57, P594, DOI 10.2337/db07-0573; Ropelle ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003856; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Sangiao-Alvarellos S, 2010, J NEUROENDOCRINOL, V22, P543, DOI 10.1111/j.1365-2826.2010.01994.x; Sangiao-Alvarellos S, 2009, ENDOCRINOLOGY, V150, P4562, DOI 10.1210/en.2009-0482; Seoane LM, 2004, EUR J ENDOCRINOL, V150, P731, DOI 10.1530/eje.0.1500731; Seoane LM, 2003, ENDOCRINOLOGY, V144, P544, DOI 10.1210/en.2002-220795; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Varela L, 2012, J PATHOL, V227, P209, DOI 10.1002/path.3984; Velasquez DA, 2011, DIABETES, V60, P1177, DOI 10.2337/db10-0802; Villanueva EC, 2009, ENDOCRINOLOGY, V150, P4541, DOI 10.1210/en.2009-0642; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu GY, 2009, ENDOCRINOLOGY, V150, P3637, DOI 10.1210/en.2009-0372	42	87	90	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46923	10.1371/journal.pone.0046923	http://dx.doi.org/10.1371/journal.pone.0046923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056530	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400037
J	He, X; Xing, H; Ruan, YH; Hong, KX; Cheng, CL; Hu, YY; Xin, RL; Wei, J; Feng, Y; Hsi, JH; Takebe, Y; Shao, YM				He, Xiang; Xing, Hui; Ruan, Yuhua; Hong, Kunxue; Cheng, Chunlin; Hu, Yuanyuan; Xin, Ruolei; Wei, Jing; Feng, Yi; Hsi, Jenny H.; Takebe, Yutaka; Shao, Yiming		Grp HIV Mol Epidemiologic Survey	A Comprehensive Mapping of HIV-1 Genotypes in Various Risk Groups and Regions across China Based on a Nationwide Molecular Epidemiologic Survey	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CIRCULATING RECOMBINANT; GUANGXI PROVINCE; DRUG-RESISTANCE; TYPE-1 SUBTYPES; SEX; MEN; PREVALENCE; INFECTION; DYNAMICS	Background: China is experiencing a dynamic HIV/AIDS epidemic. While serology based surveillance systems have reported the spread of HIV/AIDS, detailed tracking of its transmission in populations and regions is not possible without mapping it at the molecular level. We therefore conducted a nationwide molecular epidemiology survey across the country. Methods: HIV-1 genotypes were determined from 1,408 HIV-positive persons newly diagnosed in 2006. The prevalence of each genotype was estimated by weighting the genotype's prevalence from each province-and risk-specific subpopulation with the number of reported cases in the corresponding subgroups in that year. Results: CRF07_BC (35.5%), CRF01_AE (27.6%), CRF08_BC (20.1%), and subtype B' (9.6%) were the four main HIV-1 strains in China. CRF07_BC and CRF08_BC were the primary drivers of infection among injecting drug users in northeastern and southeastern China, respectively, and subtype B' remained dominant among former plasma donors in central China. In contrast, all four strains occurred in significant proportions among heterosexuals nationwide, pointing to an expansion of the HIV-1 epidemic from high-risk populations into the general population. CRF01_AE also replaced subtype B as the principal driver of infection among men-who-have-sex-with-men. Conclusions: Our study provides the first comprehensive baseline data on the diversity and characteristics of HIV/AIDS epidemic in China, reflecting unique region-and risk group-specific transmission dynamics. The results provide information critical for designing effective prevention measures against HIV transmission.	[He, Xiang; Xing, Hui; Ruan, Yuhua; Hong, Kunxue; Cheng, Chunlin; Hu, Yuanyuan; Xin, Ruolei; Wei, Jing; Feng, Yi; Hsi, Jenny H.; Takebe, Yutaka; Shao, Yiming] China Ctr Dis Control, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; National Institute of Infectious Diseases (NIID)	Shao, YM (corresponding author), China Ctr Dis Control, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao08@gmail.com	He, Xiang/E-7082-2013	He, Xiang/0000-0003-2428-5349	Chinese 863 Program [2006AA022418]; National Science and Technology Major Project for Infectious Diseases Control and Prevention [2008ZX10001-004, 2008ZX10001-010, 2012ZX10001-002, 2012ZX10001-008]; International Cooperative Grant [2009DFB30420]	Chinese 863 Program(National High Technology Research and Development Program of China); National Science and Technology Major Project for Infectious Diseases Control and Prevention; International Cooperative Grant	This work was supported by the Chinese 863 Program (2006AA022418), National Science and Technology Major Project for Infectious Diseases Control and Prevention (2008ZX10001-004, 010, 2012ZX10001-002, 008), and International Cooperative Grant (2009DFB30420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 1997, CHINESE J VIROL, V13, P339; Chen J, 1999, AIDS RES HUM RETROV, V15, P81, DOI 10.1089/088922299311754; Cheng Chun-Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P720; Department of Control Minister of Health China, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P7; Group for HIV Molecular Epidemiologic Survey, 2004, PROJ SUMM NAT HIV MO; Guan Y, 1997, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V11, P8; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li Y W, 1997, Zhonghua Liu Xing Bing Xue Za Zhi, V18, P217; Li Y, 2011, AIDS RES HUM RETROV, V27, P1025, DOI [10.1089/AID.2010.0344, 10.1089/aid.2010.0344]; Li Z, 2012, AIDS, V26, P877, DOI 10.1097/QAD.0b013e328351430d; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ministry of Health of China UNAIDS WHO, 2010, EST HIV AIDS CHINA 2; National Development and Reform Commission, 2006, OUTL 11 5 YEAR PLAN; National Tourism Administration of the People's Republic of China, 2007, YB CHIN TOUR STAT; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qin G, 1998, Zhonghua Liu Xing Bing Xue Za Zhi, V19, P39; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shao YM, 1994, CHINESE J VIROL, V4, P291; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Wang FX, 2007, CHINESE MED J-PEKING, V120, P2006, DOI 10.1097/00029330-200711020-00013; Wang Z, 1999, ZHONGGUO XING BING A, V5, P167; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xin RL, 2009, J GEN VIROL, V90, P1757, DOI 10.1099/vir.0.009290-0; Xing H, 2002, J CHINA AIDS STD, V2, P200; Xing Hui, 2004, Zhonghua Yufang Yixue Zazhi, V38, P300; Xu JQ, 2006, CHINESE MED J-PEKING, V119, P1941, DOI 10.1097/00029330-200612010-00002; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; Zeng Y, 1992, Arch AIDS Res, V6, P1; ZENG Y, 1986, AIDS RES, V2, pS147; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1; Zhao B, 2011, AIDS RES HUM RETROV, V27, P1047, DOI [10.1089/aid.2010.0119, 10.1089/AID.2010.0119]; Zhao F, 2009, YONSEI MED J, V50, P644, DOI 10.3349/ymj.2009.50.5.644	37	166	210	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47289	10.1371/journal.pone.0047289	http://dx.doi.org/10.1371/journal.pone.0047289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056619	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500150
J	Lubrano, C; Saponara, M; Barbaro, G; Specchia, P; Addessi, E; Costantini, D; Tenuta, M; Di Lorenzo, G; Genovesi, G; Donini, LM; Lenzi, A; Gnessi, L				Lubrano, Carla; Saponara, Maurizio; Barbaro, Giuseppe; Specchia, Palma; Addessi, Eliana; Costantini, Daniela; Tenuta, Marta; Di Lorenzo, Gabriella; Genovesi, Giuseppe; Donini, Lorenzo M.; Lenzi, Andrea; Gnessi, Lucio			Relationships between Body Fat Distribution, Epicardial Fat and Obstructive Sleep Apnea in Obese Patients with and without Metabolic Syndrome	PLOS ONE			English	Article							INSULIN-RESISTANCE; MEN; GLUCOSE; INFLAMMATION; INDIVIDUALS; ASSOCIATION; PREVALENCE; DENSITY; WEIGHT; PLASMA	Background: Obstructive sleep apnea (OSA) and metabolic syndrome, both closely related to obesity, often coexist in affected individuals; however, body mass index is not an accurate indicator of body fat and thus is not a good predictor of OSA and other comorbidities. The aim of this study was to investigate whether the occurrence of OSA could be associated with an altered body fat distribution and a more evident cardio metabolic risk independently from obesity and metabolic syndrome. Methods and Results: 171 consecutive patients (58 men and 113 women) were included in the study and underwent overnight polysomnography. Anthropometric data, blood pressure, lipid profile, glycaemic parameters were recorded. Body composition by DXA, two-dimensional echocardiography and carotid intima/media thickness measurement were performed. 67 patients (39.2%) had no OSA and 104 (60.8%) had OSA. The percentage of patients with metabolic syndrome was significantly higher among OSA patients (65.4%) that were older, heavier and showed a bigger and fatter heart compared to the control group. Upper body fat deposition index, the ratio between upper body fat (head, arms and trunk fat in kilograms) and lower body fat (legs fat in kilograms), was significantly increased in the OSA patients and significantly related to epicardial fat thickness. In patients with metabolic syndrome, multivariate regression analyses showed that upper body fat deposition index and epicardial fat showed the best association with OSA. Conclusion: The occurrence of OSA in obese people is more closely related to cardiac adiposity and to abnormal fat distribution rather than to the absolute amount of adipose tissue. In patients with metabolic syndrome the severity of OSA is associated with increase in left ventricular mass and carotid intima/media thickness.	[Lubrano, Carla; Barbaro, Giuseppe; Specchia, Palma; Addessi, Eliana; Costantini, Daniela; Tenuta, Marta; Di Lorenzo, Gabriella; Genovesi, Giuseppe; Donini, Lorenzo M.; Lenzi, Andrea; Gnessi, Lucio] Univ Roma La Sapienza, Dept Expt Med, Sect Med Physiopathol, Sect Med Physiopathol Endocrinol & Food Sci, I-00185 Rome, Italy; [Saponara, Maurizio] Univ Roma La Sapienza, Head & Neck Dept, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Lubrano, C (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Sect Med Physiopathol, Sect Med Physiopathol Endocrinol & Food Sci, I-00185 Rome, Italy.	Carla.Lubrano@uniroma1.it	Donini, Lorenzo/AAS-3873-2020; Gnessi, Lucio/K-8025-2016; Lenzi, Andrea/I-7711-2015	Donini, Lorenzo/0000-0003-4692-4754; Gnessi, Lucio/0000-0001-8217-2372; Lenzi, Andrea/0000-0002-7711-0465; Addessi, Eliana/0000-0002-0161-8844; tenuta, marta/0000-0002-7476-0737	Sapienza, University of Rome, Italy	Sapienza, University of Rome, Italy	This work was made possible by grants from Sapienza, University of Rome, Italy (www.uniroma1.it). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bitter T, 2009, EUR J HEART FAIL, V11, P602, DOI 10.1093/eurjhf/hfp057; Coughlin SR, 2004, EUR HEART J, V25, P735, DOI 10.1016/j.ehj.2004.02.021; Donini LM, 2011, DISABIL REHABIL, V33, P2509, DOI 10.3109/09638288.2011.575529; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fung JWH, 2002, CHEST, V121, P422, DOI 10.1378/chest.121.2.422; Gaborit B, 2011, INT J OBES, P1; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Genazzani AR, 2006, GYNECOL ENDOCRINOL, V22, P145, DOI 10.1080/09513590600629092; Greco EA, 2010, INT J CLIN PRACT, V64, P817, DOI 10.1111/j.1742-1241.2009.02301.x; GRUNSTEIN R, 1993, INT J OBESITY, V17, P533; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Iacobellis G, 2009, HORM METAB RES, V41, P227, DOI 10.1055/s-0028-1100412; Iacobellis G, 2008, OBESITY, V16, P887, DOI 10.1038/oby.2008.6; Iacobellis G, 2011, INT J BIOCHEM CELL B, V43, P1651, DOI 10.1016/j.biocel.2011.09.006; Iozzo P, 2011, DIABETES CARE, V34, pS371, DOI 10.2337/dc11-s250; IRIARTE MM, 1995, AM J CARDIOL, V76, pD43, DOI 10.1016/S0002-9149(99)80491-3; Isono S, 2012, RESPIROLOGY, V17, P32, DOI 10.1111/j.1440-1843.2011.02093.x; Jensen MK, 2008, CIRCULATION, V117, P3062, DOI 10.1161/CIRCULATIONAHA.107.759951; Katsuki A, 2003, DIABETES CARE, V26, P2341, DOI 10.2337/diacare.26.8.2341; Kim SK, 2010, INT J OBESITY, V34, P105, DOI 10.1038/ijo.2009.210; Lee DE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1210, DOI 10.1152/ajpendo.00015.2009; Levy P, 2008, EUR RESPIR J, V32, P1082, DOI 10.1183/09031936.00013308; Levy Patrick, 2012, Front Biosci (Elite Ed), V4, P2007; Li CY, 2010, PREV MED, V51, P18, DOI 10.1016/j.ypmed.2010.03.016; LONN L, 1994, METABOLISM, V43, P1517, DOI 10.1016/0026-0495(94)90010-8; Malavazos AE, 2010, AM J CARDIOL, V105, P1831, DOI 10.1016/j.amjcard.2010.01.368; Mammi C, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/789653; Mariani S, 2013, INT J CARDIOL, V167, P2244, DOI 10.1016/j.ijcard.2012.06.011; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Martinez-Rivera C, 2008, OBESITY, V16, P113, DOI 10.1038/oby.2007.20; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Nashi N, 2007, LARYNGOSCOPE, V117, P1467, DOI 10.1097/MLG.0b013e318068b566; Nock NL, 2009, SLEEP, V32, P615, DOI 10.1093/sleep/32.5.615; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Parish JM, 2007, J CLIN SLEEP MED, V3, P467; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Piliar G, 2008, DIABETES CARE, V31, pS303, DOI 10.2337/dc08-s272; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Saito T, 2010, ARCH ORAL BIOL, V55, P803, DOI 10.1016/j.archoralbio.2010.07.004; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Sell H, 2006, TRENDS ENDOCRIN MET, V17, P416, DOI 10.1016/j.tem.2006.10.010; Sharma SK, 2011, NEW ENGL J MED, V365, P2277, DOI 10.1056/NEJMoa1103944; Sierra-Johnson J, 2004, OBES RES, V12, P2070, DOI 10.1038/oby.2004.258; Stults-Kolehmainen MA, 2012, OBESITY, V20, P660, DOI 10.1038/oby.2011.300; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Welch KC, 2002, SLEEP, V25, P532, DOI 10.1093/sleep/25.5.530; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893	54	57	60	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47059	10.1371/journal.pone.0047059	http://dx.doi.org/10.1371/journal.pone.0047059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056581	gold, Green Published, Green Submitted			2022-12-27	WOS:000309831500132
J	Ushijima, B; Smith, A; Aeby, GS; Callahan, SM				Ushijima, Blake; Smith, Ashley; Aeby, Greta S.; Callahan, Sean M.			Vibrio owensii Induces the Tissue Loss Disease Montipora White Syndrome in the Hawaiian Reef Coral Montipora capitata	PLOS ONE			English	Article							PLAGUE-LIKE DISEASE; BAND DISEASE; CAUSATIVE AGENT; ACROPORA-PALMATA; ELKHORN CORAL; SP-NOV.; PATHOGEN; IDENTIFICATION; VIRULENCE; FLORIDA	Incidences of coral disease in the Indo-Pacific are increasing at an alarming rate. In particular, Montipora white syndrome, a tissue-loss disease found on corals throughout the Hawaiian archipelago, has the potential to degrade Hawaii's reefs. To identify the etiologic agent of Montipora white syndrome, bacteria were isolated from a diseased fragment of Montipora capitata and used in a screen for virulent strains. A single isolate, designated strain OCN002, recreated disease signs in 53% of coral fragments in laboratory infection trials when added to a final concentration of 10(7) cells/ml of seawater. In addition to displaying similar signs of disease, diseased coral fragments from the field and those from infection trials both had a dramatic increase in the abundance of associated culturable bacteria, with those of the genus Vibiro well represented. Bacteria isolated from diseased fragments used in infection trails were shown to be descendants of the original OCN002 inocula based on both the presence of a plasmid introduced to genetically tag the strain and the sequence of a region of the OCN002 genome. In contrast, OCN002 was not re-isolated from fragments that were exposed to the strain but did not develop tissue loss. Sequencing of the rrsH gene, metabolic characterization, as well as multilocus sequence analysis indicated that OCN002 is a strain of the recently described species Vibrio owensii. This investigation of Montipora white syndrome recognizes V. owensii OCN002 as the first bacterial coral pathogen identified from Hawaii's reefs and expands the range of bacteria known to cause disease in corals.	[Ushijima, Blake; Smith, Ashley; Callahan, Sean M.] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; [Ushijima, Blake; Smith, Ashley; Aeby, Greta S.] Hawaii Inst Marine Biol, Kaneohe, HI USA	University of Hawaii System	Callahan, SM (corresponding author), Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA.	scallaha@hawaii.edu		Ushijima, Blake/0000-0002-1053-5207	National Science Foundation, United States of America [OCE-0961814]; Directorate For Geosciences [0961814, 0961384] Funding Source: National Science Foundation	National Science Foundation, United States of America(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grant OCE-0961814 from the National Science Foundation, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2006, FEMS IMMUNOL MED MIC, V46, P221, DOI 10.1111/rp10.1016-j.femsim.2004.05.008; Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020370; Aeby Greta Smith, 2006, Atoll Research Bulletin, P471; Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; ANTONIUS A, 1985, PSZNI MAR ECOL, V6, P197; Antonius A., 1973, 10 M ASS ISLAND MARI, V10, P3; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Banin E, 2000, APPL ENVIRON MICROB, V66, P3031, DOI 10.1128/AEM.66.7.3031-3036.2000; Barash Y, 2005, AQUAT MICROB ECOL, V40, P183, DOI 10.3354/ame040183; Bathen KH, 1968, 14 HAW I MAR BIOL; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; BENNETT BM, 1970, BIOMETRICS, V26, P339, DOI 10.2307/2529083; Cano-Gomez A, 2010, FEMS MICROBIOL LETT, V302, P175, DOI 10.1111/j.1574-6968.2009.01850.x; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cesar Herman S. J., 2004, Pacific Science, V58, P231, DOI 10.1353/psc.2004.0014; Chimetto LA, 2011, INT J SYST EVOL MICR, V61, P362, DOI 10.1099/ijs.0.019729-0; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; DUSTAN P, 1977, ENVIRON GEOL, V2, P51, DOI 10.1007/BF02430665; EVANS AS, 1976, YALE J BIOL MED, V49, P175; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Friedlander Alan, 2008, NOAA Technical Memorandum NOS NCCOS, V73, P219; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Gomez-Leon J, 2005, APPL ENVIRON MICROB, V71, P98, DOI 10.1128/AEM.71.1.98-104.2005; GUENTZEL MN, 1975, INFECT IMMUN, V11, P890, DOI 10.1128/IAI.11.5.890-897.1975; Guvener ZT, 2003, J BACTERIOL, V185, P5431, DOI 10.1128/JB.185.18.5431-5441.2003; Haapkyla J, 2010, CORAL REEFS, V29, P1035, DOI 10.1007/s00338-010-0660-z; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; KANEKO T, 1975, APPL MICROBIOL, V29, P269, DOI 10.1128/AEM.29.2.269-274.1975; KAWAGISHI I, 1995, J BACTERIOL, V177, P5158, DOI 10.1128/jb.177.17.5158-5160.1995; Kim YR, 2005, FEMS MICROBIOL LETT, V243, P497, DOI 10.1016/j.femsle.2005.01.016; KOBAYASHI TOSHIKAZU, 1963, JAPAN JOUR BACTERIOL, V18, P387; Koch R, 1876, ATIOLOGIE MILZBRAND; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Liu PC, 1996, LETT APPL MICROBIOL, V22, P413, DOI 10.1111/j.1472-765X.1996.tb01192.x; Luna GM, 2010, ENV MICROBIOL REP, V2, P120, DOI 10.1111/j.1758-2229.2009.00114.x; Meron D, 2009, APPL ENVIRON MICROB, V75, P5704, DOI 10.1128/AEM.00198-09; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Mullen KM, 2004, CORAL HEALTH AND DISEASE, P377; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Phuoc LH, 2008, ENVIRON MICROBIOL, V10, P2718, DOI 10.1111/j.1462-2920.2008.01692.x; Pollock FJ, 2010, ENV MICROBIOL REP, V2, P172, DOI 10.1111/j.1758-2229.2009.00131.x; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Rawlings TK, 2007, APPL ENVIRON MICROB, V73, P7926, DOI 10.1128/AEM.01238-07; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Richardson LL, 1998, REV BIOL TROP, V46, P187; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Ritchie KB, 2001, HYDROBIOLOGIA, V460, P131, DOI 10.1023/A:1013181718805; Roff G, 2006, CORAL REEFS, V25, P255, DOI 10.1007/s00338-006-0099-4; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; SMITH GW, 1982, APPL ENVIRON MICROB, V43, P1244, DOI 10.1128/AEM.43.6.1244-1248.1982; Sorokin DY, 2001, APPL ENVIRON MICROB, V67, P528, DOI 10.1128/AEM.67.2.528-538.2001; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Stewart BJ, 2003, J BACTERIOL, V185, P4508, DOI 10.1128/JB.185.15.4508-4518.2003; Sussman M, 2003, ENVIRON MICROBIOL, V5, P250, DOI 10.1046/j.1462-2920.2003.00424.x; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004511; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; Sutherland KP, 2004, CORAL HEALTH AND DISEASE, P289; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thompson CC, 2008, INT J SYST EVOL MICR, V58, P617, DOI 10.1099/ijs.0.65461-0; Thompson FL, 2007, APPL ENVIRON MICROB, V73, P4279, DOI 10.1128/AEM.00020-07; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Williams GJ, 2008, CORAL REEFS, V27, P207, DOI 10.1007/s00338-007-0314-y; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wilson B, 2012, FEMS MICROBIOL ECOL, V80, P509, DOI 10.1111/j.1574-6941.2012.01319.x; Wolk CP, 2007, ARCH MICROBIOL, V188, P551, DOI 10.1007/s00203-007-0276-z; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011; ZENYOJI H, 1965, J INFECT DIS, V115, P436, DOI 10.1093/infdis/115.5.436	77	78	80	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46717	10.1371/journal.pone.0046717	http://dx.doi.org/10.1371/journal.pone.0046717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056419	Green Submitted, gold, Green Published			2022-12-27	WOS:000309831500060
J	Wei, CG; Shi, JW; Liu, B; Shi, Y; Zheng, JT; Xu, GY; Ma, JS; Wang, GQ; Li, F				Wei, Chengguo; Shi, Jingwei; Liu, Bin; Shi, Yue; Zheng, Jingtong; Xu, Guangyu; Ma, Jinshu; Wang, Guoqing; Li, Fan			Molecular Characterization of the Measles Virus Genotypes in JiLin Province, China	PLOS ONE			English	Article							POPULATION-DYNAMICS; EPIDEMIOLOGY; INFERENCE; STRAINS	Measles remains a severe global health threat, and nearly 30 million new cases are reported annually. Although many studies have analyzed measles viruses (MV) at the epidemiologic and phylogenetic levels, no study has yet to integrate these two types of data. To this end, we isolated 16 wild-type MV strains China's Jilin province. The MV genotype H1 was the most prevalent strain. After sequencing the nucleoprotein (N) genes of these strains, a maximum clade credibility tree was constructed by the Bayesian Markov Chain Monte Carlo method using 450 MV strains from GenBank with epidemiological information. The MV N gene evolution rate was 1.127E-3. Analysis of the time of the most recent common ancestor (TMRCA) for genotypes A/B/C/G/H revealed that genotypes D and B had the largest and smallest TMRCA (45.86 and 26.63, respectively). The highest level of genetic diversity for the MV N gene occurred around the year 2000. Here in this study, we uncovered the MV genotypes circulating in China's Jilin Province and estimated the epidemiologic and phylogenetic relationship for the six different genotypes of MV.	[Wei, Chengguo; Shi, Jingwei; Shi, Yue; Zheng, Jingtong; Xu, Guangyu; Ma, Jinshu; Wang, Guoqing; Li, Fan] Jilin Univ, Dept Pathogeny Biol, Norman Bethune Med Coll, Changchun 130023, Jilin, Peoples R China; [Wang, Guoqing; Li, Fan] Jilin Univ, Key Lab Zoonosis Res, Minist Educ, Changchun 130023, Jilin, Peoples R China; [Liu, Bin] Jilin Univ, Bethune Hosp 1, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, GQ (corresponding author), Jilin Univ, Dept Pathogeny Biol, Norman Bethune Med Coll, Changchun 130023, Jilin, Peoples R China.	qing8110@gmail.com; lifan@jlu.edu.cn			National Basic Research Program of China (973 program) [2011CB512003]; Graduate Innovation Fund of Jilin University [20121125]; National Natural Science Foundation of China [81071424]; Ministry of Education Major Science and Technology Innovation Program Seed Foundation [707020]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Graduate Innovation Fund of Jilin University(Jilin University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education Major Science and Technology Innovation Program Seed Foundation	This work was supported by National Basic Research Program of China (973 program, 2011CB512003) and Graduate Innovation Fund of Jilin University(Project No. 20121125). It was also supported in part by National Natural Science Foundation of China (81071424) and The Ministry of Education Major Science and Technology Innovation Program Seed Foundation (707020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P125; Blair C, 2011, J HERED, V102, P130, DOI 10.1093/jhered/esq092; Chibo D, 2002, EMERG INFECT DIS, V8, P735, DOI 10.3201/eid0807.010409; Comert Serdar, 2006, Indian Journal of Pediatrics, V73, P1119, DOI 10.1007/BF02763061; Curran J, 1999, ADV VIRUS RES, V54, P403, DOI 10.1016/S0065-3527(08)60373-5; de Swart RL, 2000, LANCET, V355, P201, DOI 10.1016/S0140-6736(99)04652-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; El Mubarak HS, 2002, J GEN VIROL, V83, P1437, DOI 10.1099/0022-1317-83-6-1437; Hilleman MR, 2001, VACCINE, V20, P651, DOI 10.1016/S0264-410X(01)00384-X; Jin L, 1998, EPIDEMIOL INFECT, V121, P691, DOI 10.1017/S0950268898001666; Jin L, 2002, J NEUROVIROL, V8, P335, DOI 10.1080/13550280290100752; Kubo H, 2003, J MED VIROL, V69, P273, DOI 10.1002/jmv.10278; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; Niedermeyer HP, 2007, ADV OTO-RHINO-LARYNG, V65, P86, DOI 10.1159/000098676; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rota PA, 2009, CURR TOP MICROBIOL, V330, P129; ROTA PA, 1994, VIROLOGY, V198, P724, DOI 10.1006/viro.1994.1086; Rota PA, 2002, EMERG INFECT DIS, V8, P902, DOI 10.3201/eid0809.020206; Schneider-Schaulies Sibylle, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004696; Tamura K, MOL BIOL EVOL; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; WHO, 2005, Wkly Epidemiol Rec, V80, P347; Xu WB, 1998, VIRUS RES, V54, P147, DOI 10.1016/S0168-1702(98)00020-3; Zhang Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-14; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	28	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46011	10.1371/journal.pone.0046011	http://dx.doi.org/10.1371/journal.pone.0046011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056226	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500023
J	Wojtalla, A; Salm, F; Christiansen, DG; Cremona, T; Cwiek, P; Shalaby, T; Gross, N; Grotzer, MA; Arcaro, A				Wojtalla, Anna; Salm, Fabiana; Christiansen, Ditte G.; Cremona, Tiziana; Cwiek, Paulina; Shalaby, Tarek; Gross, Nicole; Grotzer, Michael A.; Arcaro, Alexandre			Novel Agents Targeting the IGF-1R/PI3K Pathway Impair Cell Proliferation and Survival in Subsets of Medulloblastoma and Neuroblastoma	PLOS ONE			English	Article							FACTOR-I-RECEPTOR; GROWTH-FACTOR SYSTEM; MONOCLONAL-ANTIBODY; GENETIC ALTERATIONS; CLINICAL-RELEVANCE; ANTITUMOR-ACTIVITY; HIGH-FREQUENCY; CGH ANALYSIS; INSULIN; EXPRESSION	The receptor tyrosine kinase (RTK)/phosphoinositide 3-kinase (PI3K) pathway is fundamental for cancer cell proliferation and is known to be frequently altered and activated in neoplasia, including embryonal tumors. Based on the high frequency of alterations, targeting components of the PI3K signaling pathway is considered to be a promising therapeutic approach for cancer treatment. Here, we have investigated the potential of targeting the axis of the insulin-like growth factor-1 receptor (IGF-1R) and PI3K signaling in two common cancers of childhood: neuroblastoma, the most common extracranial tumor in children and medulloblastoma, the most frequent malignant childhood brain tumor. By treating neuroblastoma and medulloblastoma cells with R1507, a specific humanized monoclonal antibody against the IGF-1R, we could observe cell line-specific responses and in some cases a strong decrease in cell proliferation. In contrast, targeting the PI3K p110 alpha with the specific inhibitor PIK75 resulted in broad anti-proliferative effects in a panel of neuro-and medulloblastoma cell lines. Additionally, sensitization to commonly used chemotherapeutic agents occurred in neuroblastoma cells upon treatment with R1507 or PIK75. Furthermore, by studying the expression and phosphorylation state of IGF-1R/PI3K downstream signaling targets we found down-regulated signaling pathway activation. In addition, apoptosis occurred in embryonal tumor cells after treatment with PIK75 or R1507. Together, our studies demonstrate the potential of targeting the IGF-1R/PI3K signaling axis in embryonal tumors. Hopefully, this knowledge will contribute to the development of urgently required new targeted therapies for embryonal tumors.	[Wojtalla, Anna; Salm, Fabiana; Christiansen, Ditte G.; Cwiek, Paulina; Arcaro, Alexandre] Univ Bern, Dept Clin Res, Div Pediat Hematol Oncol, Bern, Switzerland; [Cremona, Tiziana; Shalaby, Tarek; Grotzer, Michael A.] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland; [Gross, Nicole] Univ Hosp CHUV, Dept Pediat, Lausanne, Switzerland	University of Bern; University Children's Hospital Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Arcaro, A (corresponding author), Univ Bern, Dept Clin Res, Div Pediat Hematol Oncol, Bern, Switzerland.	alexandre.arcaro@dkf.unibe.ch	Arcaro, Alexandre/G-1711-2010	Arcaro, Alexandre/0000-0001-9107-2947; Bronnimann, Paulina/0000-0001-7574-8214; Grotzer, Michael/0000-0002-1154-2732; Cremona, Tiziana P./0000-0003-0061-9578; Cwiek, Paulina/0000-0002-0964-6364	Gottfried und Julia Bangerter-Rhyner-Stiftung; Schuller Stiftung; Frieda Locher-Hofmann-Stiftung; Huggenberger-Bischoff Stiftung zur Krebsforschung; Jubilaumsstiftung der Schweizerischen Mobiliar Genossenschaft; Fondation FORCE; Department of Clinical Research of the University of Bern; European Union [259348]	Gottfried und Julia Bangerter-Rhyner-Stiftung; Schuller Stiftung; Frieda Locher-Hofmann-Stiftung; Huggenberger-Bischoff Stiftung zur Krebsforschung; Jubilaumsstiftung der Schweizerischen Mobiliar Genossenschaft; Fondation FORCE; Department of Clinical Research of the University of Bern; European Union(European Commission)	This work was supported by grants from the Gottfried und Julia Bangerter-Rhyner-Stiftung, Schuller Stiftung, Frieda Locher-Hofmann-Stiftung, Huggenberger-Bischoff Stiftung zur Krebsforschung, Jubilaumsstiftung der Schweizerischen Mobiliar Genossenschaft, Fondation FORCE and the Department of Clinical Research of the University of Bern. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no259348. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2002, BIOCHEM BIOPH RES CO, V296, P604, DOI 10.1016/S0006-291X(02)00917-8; Arcaro A, 2007, CURR GENOMICS, V8, P271, DOI 10.2174/138920207782446160; Arcaro A, 2007, BIOCHEM J, V406, P57, DOI 10.1042/BJ20070309; Bender A, 2011, ONCOGENE, V30, P494, DOI 10.1038/onc.2010.429; Beppu K, 2004, JNCI-J NATL CANCER I, V96, P46, DOI 10.1093/jnci/djh004; Blajecka K, 2011, CURR DRUG TARGETS, V12, P1056, DOI 10.2174/138945011795677773; Boller D, 2008, CLIN CANCER RES, V14, P1172, DOI 10.1158/1078-0432.CCR-07-0737; Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Cianfarani S, 1997, EUR J PEDIATR, V156, P256, DOI 10.1007/s004310050595; COHEN PS, 1994, BLOOD, V84, P3465; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; D'cunja J, 2007, EUR J CANCER, V43, P1581, DOI 10.1016/j.ejca.2007.03.003; Del Valle L, 2002, CLIN CANCER RES, V8, P1822; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Duplan SM, 2002, CLIN CANCER RES, V8, P246; FRIEDMAN HS, 1988, AM J PATHOL, V130, P472; FULTS D, 1992, J NEUROPATH EXP NEUR, V51, P272, DOI 10.1097/00005072-199205000-00005; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Gilbertson R, 2002, EUR J CANCER, V38, P675, DOI 10.1016/S0959-8049(01)00315-X; Gilbertson RJ, 1998, CANCER RES, V58, P3932; Gilbertson RJ, 1997, CANCER RES, V57, P3272; Grotzer MA, 2009, CURR CANCER DRUG TAR, V9, P176, DOI 10.2174/156800909787580962; Guerreiro AS, 2008, CLIN CANCER RES, V14, P6761, DOI 10.1158/1078-0432.CCR-08-0385; Guerreiro AS, 2006, INT J CANCER, V119, P2527, DOI 10.1002/ijc.22126; Hartmann W, 2006, CLIN CANCER RES, V12, P3019, DOI 10.1158/1078-0432.CCR-05-2187; HE XM, 1991, LAB INVEST, V64, P833; Hernan R, 2003, CANCER RES, V63, P140; Ho R, 2002, CANCER RES, V62, P6462; Hoebeeck J, 2009, CANCER LETT, V273, P336, DOI 10.1016/j.canlet.2008.08.019; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kim B, 2004, ONCOGENE, V23, P130, DOI 10.1038/sj.onc.1206924; Kim SY, 2009, B CANCER, V96, pE52, DOI 10.1684/bdc.2009.0915; Kim SY, 2009, ONCOLOGIST, V14, P83, DOI 10.1634/theoncologist.2008-0189; Kolb EA, 2010, PEDIATR BLOOD CANCER, V55, P67, DOI 10.1002/pbc.22479; Kovar H, 1996, CELL GROWTH DIFFER, V7, P429; Kurzrock R, 2010, CLIN CANCER RES, V16, P2458, DOI 10.1158/1078-0432.CCR-09-3220; Kuwahara Y, 2004, CLIN CANCER RES, V10, P5940, DOI 10.1158/1078-0432.CCR-04-0192; Loboda A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-26; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Manara MC, 2007, CLIN CANCER RES, V13, P1322, DOI 10.1158/1078-0432.CCR-06-1518; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Martins AS, 2006, CLIN CANCER RES, V12, P3532, DOI 10.1158/1078-0432.CCR-05-1778; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Plantaz D, 2001, INT J CANCER, V91, P680, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1114>3.0.CO;2-R; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2008, CURR OPIN PHARMACOL, V8, P384, DOI 10.1016/j.coph.2008.07.004; Rikhof B, 2009, J PATHOL, V217, P469, DOI 10.1002/path.2499; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Sartelet H, 2008, EXPERT REV ANTICANC, V8, P757, DOI 10.1586/14737140.8.5.757; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Schwab M, 1996, GENE CHROMOSOME CANC, V16, P211, DOI 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Tanno B, 2006, CLIN CANCER RES, V12, P6772, DOI 10.1158/1078-0432.CCR-06-1479; Van Roy N, 2001, GENE CHROMOSOME CANC, V32, P126, DOI 10.1002/gcc.1174; Vanhaesebroeck B, 2011, CURR TOP MICROBIOL, V347, P1, DOI 10.1007/82_2010_65; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; VanRoy N, 1997, CANCER GENET CYTOGEN, V97, P135, DOI 10.1016/S0165-4608(96)00362-7; VANROY N, 1995, EUR J CANCER, V31A, P530, DOI 10.1016/0959-8049(95)00004-3; von Bueren AO, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-19; Wang JY, 2001, ONCOGENE, V20, P3857, DOI 10.1038/sj.onc.1204532; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; WEWETZER K, 1993, J NEUROSCI RES, V36, P209, DOI 10.1002/jnr.490360211; Wojtalla A, 2011, CRIT REV ONCOL HEMAT; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; YEE D, 1990, J CLIN INVEST, V86, P1806, DOI 10.1172/JCI114910; Zoubek A, 1996, J CLIN ONCOL, V14, P1245, DOI 10.1200/JCO.1996.14.4.1245	77	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47109	10.1371/journal.pone.0047109	http://dx.doi.org/10.1371/journal.pone.0047109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056595	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000309831500137
J	Xue, QH; Zhou, Z; Lei, XB; Liu, XL; He, B; Wang, JW; Hung, T				Xue, Qinghua; Zhou, Zhuo; Lei, Xiaobo; Liu, Xinlei; He, Bin; Wang, Jianwei; Hung, Tao			TRIM38 Negatively Regulates TLR3-Mediated IFN-beta Signaling by Targeting TRIF for Degradation	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNE-RESPONSE; ADAPTER PROTEIN TRIF; UBIQUITYLATION; RESTRICTION; ACTIVATION; CLEAVAGE; TICAM-1; FAMILY	Toll-like receptors (TLRs) mediated immune response is crucial for combating pathogens and must be tightly controlled. Tripartite motif (TRIM) proteins are a family of proteins that is involved in a variety of biological and physiological processes. Some members of the TRIM family are important in the regulation of innate immunity. Although it has been shown that TRIM38 negatively regulates innate immunity, the mechanisms by which it does so have not been fully addressed. In this study, we demonstrated that TRIM38 negatively regulates Toll-like receptor 3 (TLR3)-mediated type I interferon signaling by targeting TIR domain-containing adaptor inducing IFN-beta (TRIF). We found that overexpression of TRIM38 inhibits TLR3-mediated type I interferon signaling, whereas knockdown of TRIM38 has the reverse effects. We further showed that TRIM38 targets TRIF, a critical adaptor protein downstream of TLR3. TRIF is co-immunoprecipitated with TRIM38, and domain mapping experiments show that PRYSPRY of TRIM38 interacts with the N-terminus of TRIF. Overexpression of TRIM38 decreased expression of overexpressed and endogenous TRIF. This effect could be inhibited by MG132 treatment. Furthermore, the RING/B-box domain of TRIM38 is critical for K48-linked polyubiquitination and proteasomal degradation of TRIF. Collectively, our results suggest that TRIM38 may act as a novel negative regulator for TLR3-mediated type I interferon signaling by targeting TRIF for degradation.	[Xue, Qinghua; Zhou, Zhuo; Lei, Xiaobo; Liu, Xinlei; Wang, Jianwei; Hung, Tao] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Xue, Qinghua; Zhou, Zhuo; Lei, Xiaobo; Liu, Xinlei; Wang, Jianwei; Hung, Tao] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Bin] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, JW (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	wangjw28@163.com	lei, xiaobo/GLN-4194-2022; Wang, Jianwei/AAW-9499-2020; Wang, Jianwei/W-5916-2019	Wang, Jianwei/0000-0002-1116-4559; zhou, zhuo/0000-0001-5862-9854	Chinese Ministry of Education [NCET-07-0506]; National Basic Research Program of China (973 Project) [2011CB504903]	Chinese Ministry of Education(Ministry of Education, China); National Basic Research Program of China (973 Project)(National Basic Research Program of China)	This work was supported by grants from the Chinese Ministry of Education Grant for New Century Talents (NCET-07-0506) (http://www.dost.moe.edu.cn) and the National Basic Research Program of China (973 Project, 2011CB504903) (http://www.973.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Eisenacher K, 2012, EUR J CELL BIOL, V91, P36, DOI 10.1016/j.ejcb.2011.01.011; Eldin P, 2009, J GEN VIROL, V90, P536, DOI 10.1099/vir.0.006288-0; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kalliolias GD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2881; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim J, 2011, J VIROL, V85, P8116, DOI 10.1128/JVI.00341-11; Kingeter LM, 2012, CELL MOL IMMUNOL, V9, P105, DOI 10.1038/cmi.2011.58; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Liu XL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-61; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; McCartney SA, 2009, IMMUNOL REV, V227, P87, DOI 10.1111/j.1600-065X.2008.00726.x; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Napolitano LM, 2012, IUBMB LIFE, V64, P64, DOI 10.1002/iub.580; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Seya T, 2009, IMMUNOL REV, V227, P44, DOI 10.1111/j.1600-065X.2008.00723.x; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Werts C, 2006, CELL DEATH DIFFER, V13, P798, DOI 10.1038/sj.cdd.4401890; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zhao W, 2012, J IMMUNOL, P188; Zhao W, 2012, J IMMUNOL, V188, P2567, DOI 10.4049/jimmunol.1103255; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	50	55	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46825	10.1371/journal.pone.0046825	http://dx.doi.org/10.1371/journal.pone.0046825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056470	gold, Green Submitted, Green Published			2022-12-27	WOS:000309831500086
J	Ajiro, M; Jia, R; Zhang, LF; Liu, XF; Zheng, ZM				Ajiro, Masahiko; Jia, Rong; Zhang, Lifang; Liu, Xuefeng; Zheng, Zhi-Ming			Intron Definition and a Branch Site Adenosine at nt 385 Control RNA Splicing of HPV16 E6*I and E7 Expression	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; PRE-MESSENGER-RNA; E6 ONCOPROTEIN; U2 SNRNP; POINT SEQUENCES; EXON SEQUENCES; PROTEIN; UPSTREAM; BINDING; DEGRADATION	HPV16 E6 and E7, two viral oncogenes, are expressed from a single bicistronic pre-mRNA. In this report, we provide the evidence that the bicistronic pre-mRNA intron 1 contains three 5' splice sites (5' ss) and three 3' splice sites (3' ss) normally used in HPV16(+) cervical cancer and its derived cell lines. The choice of two novel alternative 5' ss (nt 221 5' ss and nt 191 5' ss) produces two novel isoforms of E6E7 mRNAs (E6*V and E6*VI). The nt 226 59 ss and nt 409 3' ss is preferentially selected over the other splice sites crossing over the intron to excise a minimal length of the intron in RNA splicing. We identified AACAAAC as the preferred branch point sequence (BPS) and an adenosine at nt 385 ( underlined) in the BPS as a branch site to dictate the selection of the nt 409 3' ss for E6*I splicing and E7 expression. Introduction of point mutations into the mapped BPS led to reduced U2 binding to the BPS and thereby inhibition of the second step of E6E7 splicing at the nt 409 3' ss. Importantly, the E6E7 bicistronic RNA with a mutant BPS and inefficient splicing makes little or no E7 and the resulted E6 with mutations of (91)QYNK(94) to (PSFW94)-P-91 displays attenuate activity on p53 degradation. Together, our data provide structural basis of the E6E7 intron 1 for better understanding of how viral E6 and E7 expression is regulated by alternative RNA splicing. This study elucidates for the first time a mapped branch point in HPV16 genome involved in viral oncogene expression.	[Ajiro, Masahiko; Jia, Rong; Zhang, Lifang; Liu, Xuefeng; Zheng, Zhi-Ming] NCI, Tumor Virus RNA Biol Sect, HIV & AIDS Malignancy Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zheng, ZM (corresponding author), NCI, Tumor Virus RNA Biol Sect, HIV & AIDS Malignancy Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	zhengt@exchange.nih.gov	Jia, Rong/AAD-5835-2021; Zheng, Zhi-Ming/L-6383-2019	Zheng, Zhi-Ming/0000-0001-5547-7912	NCI, Center for Cancer Research, NIH; JSPS, NIH; NATIONAL CANCER INSTITUTE [ZIASC010357] Funding Source: NIH RePORTER	NCI, Center for Cancer Research, NIH; JSPS, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the Intramural Research Program of the NCI, Center for Cancer Research, NIH and JSPS Research Fellowship for Japanese biomedical and behavioral researchers at NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOVICH N, 1994, GENE DEV, V8, P843, DOI 10.1101/gad.8.7.843; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bodaghi S, 2009, VIROLOGY; BROSI R, 1993, J BIOL CHEM, V268, P17640; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen SY, 2000, P NATL ACAD SCI USA, V97, P593, DOI 10.1073/pnas.97.2.593; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; De la Rosa-Rios MA, 2006, VIRUS RES, V118, P46, DOI 10.1016/j.virusres.2005.11.010; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; FOUSER LA, 1986, CELL, V45, P81, DOI 10.1016/0092-8674(86)90540-4; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Graham SV, 2008, FRONT BIOSCI-LANDMRK, V13, P5646; Hallegger M, 2010, RNA, V16, P839, DOI 10.1261/rna.2013110; Haut DD, 1998, J VIROL, V72, P1834, DOI 10.1128/JVI.72.3.1834-1843.1998; Hicks MJ, 2010, MOL CELL BIOL, V30, P1878, DOI 10.1128/MCB.01071-09; HORNIG H, 1986, NATURE, V324, P589, DOI 10.1038/324589a0; Howley PM, 2007, FIELDS VIROLOGY, V2, P2299; Hwang DY, 1996, MOL CELL BIOL, V16, P3012; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kol G, 2005, HUM MOL GENET, V14, P1559, DOI 10.1093/hmg/ddi164; KRAMER A, 1992, MOL CELL BIOL, V12, P4545; Ladd AN, 2002, GENOME BIOL, V3; Lima WF, 1997, J BIOL CHEM, V272, P27513, DOI 10.1074/jbc.272.44.27513; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Liu ZR, 1997, RNA, V3, P1207; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; NORTON PA, 1994, NUCLEIC ACIDS RES, V22, P3854, DOI 10.1093/nar/22.19.3854; Ordonez RM, 2004, J GEN VIROL, V85, P1433, DOI 10.1099/vir.0.19317-0; Pastuszak AW, 2011, NUCLEIC ACIDS RES, V39, P2344, DOI 10.1093/nar/gkq1046; Peled-Zehavi H, 2001, MOL CELL BIOL, V21, P5232, DOI 10.1128/MCB.21.15.5232-5241.2001; Pim D, 1999, ONCOGENE, V18, P7403, DOI 10.1038/sj.onc.1203134; Pim D, 1997, ONCOGENE, V15, P257, DOI 10.1038/sj.onc.1201202; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; REED R, 1988, GENE DEV, V2, P1268, DOI 10.1101/gad.2.10.1268; REED R, 1985, CELL, V41, P95, DOI 10.1016/0092-8674(85)90064-9; Rino J, 2008, MOL CELL BIOL, V28, P3045, DOI 10.1128/MCB.02015-07; Ristriani T, 2009, ONCOGENE, V28, P762, DOI 10.1038/onc.2008.422; Roca X, 2005, RNA, V11, P683, DOI 10.1261/rna.2040605; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Rosenberger S, 2010, P NATL ACAD SCI USA, V107, P7006, DOI 10.1073/pnas.1002620107; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Rutz B, 1999, RNA, V5, P819, DOI 10.1017/S1355838299982286; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schwartz S, 2008, FRONT BIOSCI-LANDMRK, V13, P5880, DOI 10.2741/3123; Shao W, 2012, MOL CELL BIOL, V32, P470, DOI 10.1128/MCB.06234-11; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Suprynowicz FA, 2010, J VIROL, V84, P10619, DOI 10.1128/JVI.00831-10; TALERICO M, 1994, MOL CELL BIOL, V14, P3434, DOI 10.1128/MCB.14.5.3434; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; Vogel J, 1997, NUCLEIC ACIDS RES, V25, P2030, DOI 10.1093/nar/25.10.2030; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Yamamoto H, 1999, CLIN CANCER RES, V5, P1805; Yamanegi K, 2005, J VIROL, V79, P14207, DOI 10.1128/JVI.79.22.14207-14221.2005; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zhang CL, 2007, P NATL ACAD SCI USA, V104, P15028, DOI 10.1073/pnas.0703773104; Zhao XM, 2005, J VIROL, V79, P4270, DOI 10.1128/JVI.79.7.4270-4288.2005; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; Zheng ZM, 2000, J VIROL, V74, P10612, DOI 10.1128/JVI.74.22.10612-10622.2000; Zheng ZM, 2004, J MOL BIOL, V337, P1091, DOI 10.1016/j.jmb.2004.02.023; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096; Zheng ZM, 2000, J VIROL METHODS, V85, P203, DOI 10.1016/S0166-0934(99)00172-X; ZHUANG Y, 1989, Proceedings of the National Academy of Sciences of the United States of America, V86, P2752, DOI 10.1073/pnas.86.8.2752	79	38	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46412	10.1371/journal.pone.0046412	http://dx.doi.org/10.1371/journal.pone.0046412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056301	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800018
J	Lyubomir, GN; Vuorinen, A; Praxmarer, L; Chantong, B; Cereghetti, D; Winiger, R; Schuster, D; Odermatt, A				Lyubomir, G. Nashev; Vuorinen, Anna; Praxmarer, Lukas; Chantong, Boonrat; Cereghetti, Diego; Winiger, Rahel; Schuster, Daniela; Odermatt, Alex			Virtual Screening as a Strategy for the Identification of Xenobiotics Disrupting Corticosteroid Action	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; BETA-HYDROXYSTEROID DEHYDROGENASE; MINERALOCORTICOID RECEPTOR; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-3; BLOOD-PRESSURE; INHIBITORS; ACID; ALDOSTERONE; DISCOVERY; HYPERTENSION	Background: Impaired corticosteroid action caused by genetic and environmental influence, including exposure to hazardous xenobiotics, contributes to the development and progression of metabolic diseases, cardiovascular complications and immune disorders. Novel strategies are thus needed for identifying xenobiotics that interfere with corticosteroid homeostasis. 11 beta-hydroxysteroid dehydrogenase 2 (11 beta-HSD2) and mineralocorticoid receptors (MR) are major regulators of corticosteroid action. 11 beta-HSD2 converts the active glucocorticoid cortisol to the inactive cortisone and protects MR from activation by glucocorticoids. 11 beta-HSD2 has also an essential role in the placenta to protect the fetus from high maternal cortisol concentrations. Methods and Principal Findings: We employed a previously constructed 3D-structural library of chemicals with proven and suspected endocrine disrupting effects for virtual screening using a chemical feature-based 11 beta-HSD pharmacophore. We tested several in silico predicted chemicals in a 11 beta-HSD2 bioassay. The identified antibiotic lasalocid and the silanecoupling agent AB110873 were found to concentration-dependently inhibit 11 beta-HSD2. Moreover, the silane AB110873 was shown to activate MR and stimulate mitochondrial ROS generation and the production of the proinflammatory cytokine interleukin-6 (IL-6). Finally, we constructed a MR pharmacophore, which successfully identified the silane AB110873. Conclusions: Screening of virtual chemical structure libraries can facilitate the identification of xenobiotics inhibiting 11 beta-HSD2 and/or activating MR. Lasalocid and AB110873 belong to new classes of 11 beta-HSD2 inhibitors. The silane AB110873 represents to the best of our knowledge the first industrial chemical shown to activate MR. Furthermore, the MR pharmacophore can now be used for future screening purposes.	[Vuorinen, Anna; Praxmarer, Lukas; Schuster, Daniela] Univ Innsbruck, Inst Pharmacy Pharmaceut Chem, A-6020 Innsbruck, Austria; [Vuorinen, Anna; Praxmarer, Lukas; Schuster, Daniela] Univ Innsbruck, CMBI, A-6020 Innsbruck, Austria; [Lyubomir, G. Nashev; Chantong, Boonrat; Cereghetti, Diego; Winiger, Rahel; Odermatt, Alex] Univ Basel, Dept Pharmaceut Sci, Swiss Ctr Appl Human Toxicol, Basel, Switzerland; [Lyubomir, G. Nashev; Chantong, Boonrat; Cereghetti, Diego; Winiger, Rahel; Odermatt, Alex] Univ Basel, Dept Pharmaceut Sci, Div Mol & Syst Toxicol, Basel, Switzerland	University of Innsbruck; University of Innsbruck; University of Basel; University of Basel	Schuster, D (corresponding author), Univ Innsbruck, Inst Pharmacy Pharmaceut Chem, A-6020 Innsbruck, Austria.	daniela.schuster@uibk.ac.at; alex.odermatt@unibas.ch	Schuster, Daniela/C-1024-2014	Schuster, Daniela/0000-0002-9933-8938; Chantong, Boonrat/0000-0002-8638-2948; Winiger, Rahel/0000-0001-9796-5543; Odermatt, Alex/0000-0002-6820-2712	Swiss National Science Foundation [31003A-124912]; Swiss Center for Applied Human Toxicology; University of Innsbruck (Nachwuchsforderung)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Center for Applied Human Toxicology; University of Innsbruck (Nachwuchsforderung)	This work was supported by the Swiss National Science Foundation (No. 31003A-124912, http://www.snf.ch) and the Swiss Center for Applied Human Toxicology (www.scaht.org). A.O. has a Chair for Molecular and Systems Toxicology by the Novartis Research Foundation. D.S. and A.V. are grateful for their Young Talents Grants from the University of Innsbruck (Nachwuchsforderung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allera A, 2004, TOXICOLOGY, V205, P75, DOI 10.1016/j.tox.2004.06.039; Atanasov AG, 2003, BIOCHEM BIOPH RES CO, V308, P257, DOI 10.1016/S0006-291X(03)01359-7; Benediktsson R, 1997, CLIN ENDOCRINOL, V46, P161, DOI 10.1046/j.1365-2265.1997.1230939.x; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Briet M, 2010, NAT REV NEPHROL, V6, P261, DOI 10.1038/nrneph.2010.30; Classen-Houben D, 2009, J STEROID BIOCHEM, V113, P248, DOI 10.1016/j.jsbmb.2009.01.009; Deuchar GA, 2011, ENDOCRINOLOGY, V152, P236, DOI 10.1210/en.2010-0925; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Diederich S, 2000, EUR J ENDOCRINOL, V142, P200, DOI 10.1530/eje.0.1420200; Duwensee K, 2011, ATHEROSCLEROSIS, V219, P109, DOI 10.1016/j.atherosclerosis.2011.07.023; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; Ferrari P, 2010, BBA-MOL BASIS DIS, V1802, P1178, DOI 10.1016/j.bbadis.2009.10.017; Friedman A, 2009, EXPERT OPIN DRUG DEL, V6, P1113, DOI 10.1517/17425240903196743; Frieler RA, 2011, STROKE, V42, P179, DOI 10.1161/STROKEAHA.110.598441; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Gomez-Sanchez EP, 2012, MOL CELL ENDOCRINOL, V350, P289, DOI 10.1016/j.mce.2011.05.005; Groeneweg FL, 2012, MOL CELL ENDOCRINOL, V350, P299, DOI 10.1016/j.mce.2011.06.020; Hadoke PWF, 2009, BRIT J PHARMACOL, V156, P689, DOI 10.1111/j.1476-5381.2008.00047.x; Hein M., 2010, DRUG DISCOV TODAY-TE, V7, pe229, DOI [10.1016/j.ddtec.2010.12.003, DOI 10.1016/J.DDTEC.2010.12.003]; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kim CH, 2010, MOL CELL BIOCHEM, V344, P91, DOI 10.1007/s11010-010-0532-4; Kratschmar DV, 2011, J STEROID BIOCHEM, V125, P129, DOI 10.1016/j.jsbmb.2010.12.019; Lastra G, 2010, NAT REV CARDIOL, V7, P577, DOI 10.1038/nrcardio.2010.123; Lindsay RS, 1996, HYPERTENSION, V27, P1200, DOI 10.1161/01.HYP.27.6.1200; Luccio-Camelo DC, 2011, J STEROID BIOCHEM, V127, P74, DOI 10.1016/j.jsbmb.2011.04.004; Luther JM, 2006, HYPERTENSION, V48, P1050, DOI 10.1161/01.HYP.0000248135.97380.76; Ma X, 2011, TOXICOLOGY, V285, P83, DOI 10.1016/j.tox.2011.04.007; Markt P, 2009, J MED CHEM, V52, P369, DOI 10.1021/jm801044g; Matinlinna J, 2008, ACTA ODONTOL SCAND, V66, P250, DOI 10.1080/00016350802247131; McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014; Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; Nashev LG, 2010, BIOCHEM PHARMACOL, V79, P1189, DOI 10.1016/j.bcp.2009.12.005; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Odermatt A, 2008, BIOCHEM PHARMACOL, V76, P1184, DOI 10.1016/j.bcp.2008.07.019; Odermatt A, 2012, MOL CELL ENDOCRINOL, V350, P168, DOI 10.1016/j.mce.2011.07.020; Pan GR, 2006, J COLLOID INTERF SCI, V302, P287, DOI 10.1016/j.jcis.2006.06.031; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Schuster D., 2010, DRUG DISCOV TODAY, V7, P205; Schuster D, 2006, J CHEM INF MODEL, V46, P1301, DOI 10.1021/ci050237k; Schuster D, 2006, J MED CHEM, V49, P3454, DOI 10.1021/jm0600794; Schuster D, 2011, BIOORGAN MED CHEM, V19, P7168, DOI 10.1016/j.bmc.2011.09.056; Schuster D, 2011, J STEROID BIOCHEM, V125, P148, DOI 10.1016/j.jsbmb.2011.01.016; Seppa L, 2004, MED PRIN PRACT, V13, P307, DOI 10.1159/000080466; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wermuth G, 1998, PURE APPL CHEM, V70, P1129, DOI 10.1351/pac199870051129; WILSON RC, 1995, J CLIN ENDOCR METAB, V80, P3145, DOI 10.1210/jc.80.11.3145; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Young MJ, 2012, MOL CELL ENDOCRINOL, V350, P248, DOI 10.1016/j.mce.2011.09.008	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46958	10.1371/journal.pone.0046958	http://dx.doi.org/10.1371/journal.pone.0046958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056542	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800064
J	Mattos, EC; Schumacher, RI; Colli, W; Alves, MJM				Mattos, Eliciane C.; Schumacher, Robert I.; Colli, Walter; Alves, Maria Julia M.			Adhesion of Trypanosoma cruzi Trypomastigotes to Fibronectin or Laminin Modifies Tubulin and Paraflagellar Rod Protein Phosphorylation	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; SIGNALING PATHWAYS; PROTEOMIC ANALYSIS; PHOSPHATASE 2A; KINASE-C; CELLS; IDENTIFICATION; LEISHMANIA; BRUCEI; FORM	Background: The unicellular parasite Trypanosoma cruzi is the causative agent of Chagas disease in humans. Adherence of the infective stage to elements of the extracellular matrix (ECM), as laminin and fibronectin, is an essential step in host cell invasion. Although members of the gp85/TS, as Tc85, were identified as laminin and fibronectin ligands, the signaling events triggered on the parasite upon binding to these molecules are largely unexplored. Methodology/Principal Findings: Viable infective parasites were incubated with laminin, fibronectin or bovine serum albumin for different periods of time and the proteins were separated by bidimensional gels. The phosphoproteins were envisaged by specific staining and the spots showing phosphorylation levels significantly different from the control were excised and identified by MS/MS. The results of interest were confirmed by immunoblotting or immunoprecipitation and the localization of proteins in the parasite was determined by immunofluorescence. Using a host cell-free system, our data indicate that the phosphorylation contents of T. cruzi proteins encompassing different cellular functions are modified upon incubation of the parasite with fibronectin or laminin. Conclusions/Significance: Herein it is shown, for the first time, that paraflagellar rod proteins and alpha-tubulin, major structural elements of the parasite cytoskeleton, are predominantly dephosphorylated during the process, probably involving the ERK1/2 pathway. It is well established that T. cruzi binds to ECM elements during the cell infection process. The fact that laminin and fibronectin induce predominantly dephosphorylation of the main cytoskeletal proteins of the parasite suggests a possible correlation between cytoskeletal modifications and the ability of the parasite to internalize into host cells.	[Mattos, Eliciane C.; Schumacher, Robert I.; Colli, Walter; Alves, Maria Julia M.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo	Alves, MJM (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	mjmalves@iq.usp.br	Alves, Maria Julia/K-8976-2012; Colli, Walter/G-1188-2012; Colli, Walter/ABA-5440-2021; Colli, Walter/AAW-7649-2021	Alves, Maria Julia/0000-0001-7211-9631; Colli, Walter/0000-0001-7305-4673	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/52646-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);  [303539/2005-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This work was funded by research grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP # 2009/52646-6 to MJMA) and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to MJMA and WC (# 303539/2005-4). ECM is a graduate fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyweera TP, 2009, J BIOL CHEM, V284, P17648, DOI 10.1074/jbc.M902005200; ANDREWS NW, 1982, J PROTOZOOL, V29, P264, DOI 10.1111/j.1550-7408.1982.tb04024.x; Araya JE, 2008, MICROBES INFECT, V10, P892, DOI 10.1016/j.micinf.2008.05.003; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Bao Y, 2010, CELL CYCLE, V9, P2888, DOI 10.4161/cc.9.14.12372; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Casas B, 2002, EXP PARASITOL, V101, P129, DOI 10.1016/S0014-4894(02)00110-8; Caudron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013553; De Lima AR, 2006, PARASITOLOGY, V132, P511, DOI 10.1017/S0031182005009352; de Souza W, 2009, MEM I OSWALDO CRUZ, V104, P89, DOI 10.1590/S0074-02762009000900014; Detmer E, 1997, EUR J CELL BIOL, V72, P378; Drummelsmith J, 2003, MOL CELL PROTEOMICS, V2, P146, DOI 10.1074/mcp.M200085-MCP200; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Faruki S, 2000, J CELL SCI, V113, P2557; Favoreto S, 1998, EXP PARASITOL, V89, P188, DOI 10.1006/expr.1998.4285; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Fouts DL, 1998, J BIOL CHEM, V273, P21846, DOI 10.1074/jbc.273.34.21846; Freitas LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025914; Gallo G, 2011, BIOCHEM BIOPH RES CO, V408, P427, DOI 10.1016/j.bbrc.2011.04.038; Giordano R, 1999, J BIOL CHEM, V274, P3461, DOI 10.1074/jbc.274.6.3461; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; Gonzalez J, 2003, BIOCHEM J, V374, P647, DOI 10.1042/BJ20030215; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Hem S, 2010, PROTEOMICS, V10, P3868, DOI 10.1002/pmic.201000305; Henderson H, 2011, INT J ANDROL, V34, P339, DOI 10.1111/j.1365-2605.2010.01085.x; HERRERA EM, 1994, MOL BIOCHEM PARASIT, V65, P73, DOI 10.1016/0166-6851(94)90116-3; Jones A, 2006, PROTEOMICS, V6, P259, DOI 10.1002/pmic.200500119; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEY SC, 1994, EUR J IMMUNOL, V24, P99, DOI 10.1002/eji.1830240116; MacRae TH, 1997, EUR J BIOCHEM, V244, P265, DOI 10.1111/j.1432-1033.1997.00265.x; Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200; Manso Alves Maria Julia, 2010, Open Parasitology Journal, V4, P77; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Mitsopoulos C, 2003, J BIOL CHEM, V278, P18085, DOI 10.1074/jbc.M213064200; Moody TN, 2000, FEBS LETT, V470, P305, DOI 10.1016/S0014-5793(00)01347-8; Nakayasu ES, 2009, PROTEOMICS, V9, P3489, DOI 10.1002/pmic.200800874; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Oberholzer M, 2011, MOL CELL PROTEOMICS, P1; OUAISSI MA, 1984, NATURE, V308, P380, DOI 10.1038/308380a0; Paba J, 2004, J PROTEOME RES, V3, P517, DOI 10.1021/pr034075o; Parodi-Talice A, 2007, J MASS SPECTROM, V42, P1422, DOI 10.1002/jms.1267; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Rocha GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011407; Rotureau B, 2009, CELL MICROBIOL, V11, P710, DOI 10.1111/j.1462-5822.2009.01295.x; SABORIO JL, 1989, J BIOL CHEM, V264, P4071; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Szoor B, 2010, MOL BIOCHEM PARASIT, V173, P53, DOI 10.1016/j.molbiopara.2010.05.017; Tonelli RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027904; VELGE P, 1988, PARASITOLOGY, V97, P255, DOI 10.1017/S0031182000058467; WEEKS BS, 1990, J NEUROSCI RES, V27, P418, DOI 10.1002/jnr.490270321; WOLF M, 1986, J BIOL CHEM, V261, P3327; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Zhong L, 1998, FEMS MICROBIOL LETT, V161, P15, DOI 10.1111/j.1574-6968.1998.tb12923.x	59	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46767	10.1371/journal.pone.0046767	http://dx.doi.org/10.1371/journal.pone.0046767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056443	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800048
J	Chambers, JK; Uchida, K; Harada, T; Tsuboi, M; Sato, M; Kubo, M; Kawaguchi, H; Miyoshi, N; Tsujimoto, H; Nakayama, H				Chambers, James K.; Uchida, Kazuyuki; Harada, Tomoyuki; Tsuboi, Masaya; Sato, Masumi; Kubo, Masahito; Kawaguchi, Hiroaki; Miyoshi, Noriaki; Tsujimoto, Hajime; Nakayama, Hiroyuki			Neurofibrillary Tangles and the Deposition of a Beta Amyloid Peptide with a Novel N-Terminal Epitope in the Brains of Wild Tsushima Leopard Cats	PLOS ONE			English	Article							SENILE PLAQUES; ALZHEIMERS-DISEASE; TAU-PROTEIN; A-BETA; NEURODEGENERATIVE DISEASES; ANIMAL-MODELS; MOUSE MODEL; OLIGOMERS; PATHOLOGY; ACCUMULATION	Beta amyloid (A beta) deposits are seen in aged individuals in many of the mammalian species that possess the same Ab amino acid sequence as humans. Conversely, neurofibrillary tangles (NFT), the other hallmark lesion of Alzheimer's disease (AD), are extremely rare in these animals. We detected Ab deposits in the brains of Tsushima leopard cats (Prionailurus bengalensis euptilurus) that live exclusively on Tsushima Island, Japan. A beta 42 was deposited in a granular pattern in the neuropil of the pyramidal cell layer, but did not form argyrophilic senile plaques. These Ab deposits were not immunolabeled with antibodies to the N-terminal of human A beta. Sequence analysis of the amyloid precursor protein revealed an amino acid substitution at the 7th residue of the A beta peptide. In a comparison with other mammalian animals that do develop argyrophilic senile plaques, we concluded that the alternative A beta amino acid sequence displayed by leopard cats is likely to be related to its distinctive deposition pattern. Interestingly, most of the animals with these A beta deposits also developed NFTs. The distributions of hyperphosphorylated tau-positive cells and the two major isoforms of aggregated tau proteins were quite similar to those seen in Alzheimer's disease. In addition, the unphosphorylated form of GSK-3 beta colocalized with hyperphosphorylated tau within the affected neurons. In conclusion, this animal species develops AD-type NFTs without argyrophilic senile plaques.	[Chambers, James K.; Uchida, Kazuyuki; Harada, Tomoyuki; Tsuboi, Masaya; Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Tokyo, Japan; [Sato, Masumi] Natl Inst Anim Hlth, Ibaraki, Japan; [Kubo, Masahito] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pathol, Yamaguchi, Japan; [Kawaguchi, Hiroaki; Miyoshi, Noriaki] Kagoshima Univ, Lab Vet Histopathol, Joint Fac Vet Med, Kagoshima 890, Japan; [Tsujimoto, Hajime] Univ Tokyo, Dept Vet Internal Med, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Yamaguchi University; Kagoshima University; University of Tokyo	Chambers, JK (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Tokyo, Japan.	achamber@mail.ecc.u-tokyo.ac.jp		Tsujimoto, Hajime/0000-0002-3771-6235; Chambers, James/0000-0001-5273-7221	Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science [24780283]; Kyushu Regional Environment Office	Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyushu Regional Environment Office	This research was funded by Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (research project number: 24780283) [http://www.jsps.go.jp/english/e-grants/index.html]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was performed with the approval of the Japanese Ministry of the Environment and was supported by Kyushu Regional Environment Office. The authors thank Ms. Hanae Yamamoto of Tsushima Wildlife Conservation Center and Ms. Maki Okamura of Iriomote Wildlife Conservation Center for their generous cooperation.	Arima K, 2006, NEUROPATHOLOGY, V26, P475, DOI 10.1111/j.1440-1789.2006.00669.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braidy N, 2012, J NEURAL TRANSM, V119, P173, DOI 10.1007/s00702-011-0731-5; Buee L, 1999, BRAIN PATHOL, V9, P681; Capucchio MT, 2010, J COMP PATHOL, V142, P61, DOI 10.1016/j.jcpa.2009.07.007; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chambers JK, 2011, AMYLOID, V18, P63, DOI 10.3109/13506129.2011.570385; Chambers JK, 2010, AMYLOID, V17, P75, DOI 10.3109/13506129.2010.483119; COUCHIE D, 1985, FEBS LETT, V188, P331, DOI 10.1016/0014-5793(85)80397-5; de Silva R, 2003, NEUROPATH APPL NEURO, V29, P288, DOI 10.1046/j.1365-2990.2003.00463.x; Delacourte A, 1996, J NEUROPATH EXP NEUR, V55, P159, DOI 10.1097/00005072-199602000-00004; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; Ferrer I, 2012, PROG NEUROBIOL, V97, P38, DOI 10.1016/j.pneurobio.2012.03.005; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Gunn-Moore D, 2007, J SMALL ANIM PRACT, V48, P546, DOI 10.1111/j.1748-5827.2007.00386.x; Hardy J, 2006, SCIENCE, V19, P353; Hasegawa M, 2006, NEUROPATHOLOGY, V26, P484, DOI 10.1111/j.1440-1789.2006.00666.x; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Ikeda K, 1998, NEUROBIOL AGING, V19, pS85, DOI 10.1016/S0197-4580(98)00034-7; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; JOHNSTONE EM, 1991, MOL BRAIN RES, V10, P299, DOI 10.1016/0169-328X(91)90088-F; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Leroy K, 2007, NEUROPATH APPL NEURO, V33, P43, DOI 10.1111/j.1365-2990.2006.00795.x; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; MASUDA R, 1995, ZOOL SCI, V12, P655, DOI 10.2108/zsj.12.655; Miyawaki K, 2001, ACTA NEUROPATHOL, V102, P321; Mutsuga M, 2012, J VET MED SCI, V74, P51, DOI 10.1292/jvms.11-0307; NAKAMURA S, 1995, ACTA NEUROPATHOL, V90, P415, DOI 10.1007/BF00315016; Nakamura S, 1996, ACTA NEUROPATHOL, V91, P437, DOI 10.1007/s004010050448; Nakamura S, 1998, J MED PRIMATOL, V27, P244, DOI 10.1111/j.1600-0684.1998.tb00244.x; Nakayama H, 2004, MED HYPOTHESES, V63, P198, DOI 10.1016/j.mehy.2003.12.047; Nakayama H, 2001, NEUROSCI LETT, V297, P195, DOI 10.1016/S0304-3940(00)01698-0; NISHIMURA M, 1995, AM J PATHOL, V146, P1052; Nussbaum JM, 2012, NATURE IN PRESS; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Rosen RF, 2008, J COMP NEUROL, V509, P259, DOI 10.1002/cne.21744; Sarasa M, 2009, CURR ALZHEIMER RES, V6, P171, DOI 10.2174/156720509787602834; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; Serizawa S, 2012, VET PATHOL, V49, P304, DOI 10.1177/0300985811410719; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Togo T, 2002, J NEUROPATH EXP NEUR, V61, P547, DOI 10.1093/jnen/61.6.547; Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; UCHIDA K, 1992, J VET MED SCI, V54, P1023, DOI 10.1292/jvms.54.1023; UCHIDA K, 1995, VET PATHOL, V32, P412, DOI 10.1177/030098589503200410; UCHIDA K, 1990, JPN J VET SCI, V52, P605; Yamaguchi H, 1996, ACTA NEUROPATHOL, V92, P232, DOI 10.1007/s004010050513; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x	57	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46452	10.1371/journal.pone.0046452	http://dx.doi.org/10.1371/journal.pone.0046452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056312	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000045
J	Cunha, RD; Abreu, CM; Gonzalez, LMF; Nijhuis, M; de Jong, D; Aguiar, RS; Afonso, AO; Brindeiro, RM; Tanuri, A				Cunha, Rodrigo D.; Abreu, Celina M.; Gonzalez, Luis M. F.; Nijhuis, Monique; de Jong, Dorien; Aguiar, Renato S.; Afonso, Adriana O.; Brindeiro, Rodrigo M.; Tanuri, Amilcar			Differential In Vitro Kinetics of Drug Resistance Mutation Acquisition in HIV-1 RT of Subtypes B and C	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL THERAPY; VIROLOGICAL RESPONSE; REPLICATION CAPACITY; EXPERIENCED PATIENTS; NAIVE PATIENTS; NUCLEOSIDE; PROTEASE; FAILURE	Background: HIV-1 subtype B is the most prevalent in developed countries and, consequently, it has been extensively studied. On the other hand, subtype C is the most prevalent worldwide and therefore is a reasonable target for future studies. Here we evaluate the acquisition of resistance and the viability of HIV-1 subtype B and C RT clones from different isolates that were subjected to in vitro selection pressure with zidovudine (ZDV) and lamivudine (3TC). Methods/Principal Findings: MT4 cells were infected with chimeric virus pseudotyped with RT from subtype B and C clones, which were previously subjected to serial passage with increasing concentrations of ZDV and 3TC. The samples collected after each passage were analyzed for the presence of resistance mutations and VL. No differences were found between subtypes B and C in viral load and resistance mutations when these viruses were selected with 3TC. However, the route of mutations and the time to rebound of subtype B and C virus were different when subjected to ZDV treatment. In order to confirm the role of the mutations detected, other clones were generated and subjected to in vitro selection. RT subtype B virus isolates tended to acquire different ZDV resistance mutations (Q151M and D67N or T215Y, D67D/N and F214L) compared to subtype C (D67N, K70R, T215I or T215F). Conclusions/Significance: This study suggests that different subtypes have a tendency to react differently to antiretroviral drug selection in vitro. Consequently, the acquisition of resistance in patients undergoing antiretroviral therapy can be dependent on the subtypes composing the viral population.	[Cunha, Rodrigo D.; Abreu, Celina M.; Gonzalez, Luis M. F.; Aguiar, Renato S.; Afonso, Adriana O.; Brindeiro, Rodrigo M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Mol Virol Lab, Rio De Janeiro, Brazil; [Nijhuis, Monique; de Jong, Dorien] Univ Med Ctr Utrecht, Dept Virol, Utrecht, Netherlands	Universidade Federal do Rio de Janeiro; Utrecht University; Utrecht University Medical Center	Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Mol Virol Lab, Rio De Janeiro, Brazil.	atanuri@biologia.ufrj.br	Abreu, Celina Monteiro/AAT-7447-2020; Tanuri, Amilcar/AAM-8601-2021; Aguiar, Renato S/G-3542-2015	Aguiar, Renato S/0000-0001-5180-3717	Brazilian AIDS Program; CNPq	Brazilian AIDS Program; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was sponsored by Brazilian AIDS Program and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar RS, 2006, J GEN VIROL, V87, P2669, DOI 10.1099/vir.0.82046-0; Armstrong KL, 2009, J VIROL, V83, P4051, DOI 10.1128/JVI.02645-08; Boucher CAB, 1996, ANTIMICROB AGENTS CH, V40, P2404, DOI 10.1128/AAC.40.10.2404; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Puertas MC, 2009, J VIROL, V83, P7434, DOI 10.1128/JVI.00487-09; Carmona R, 2005, J CLIN VIROL, V32, P248, DOI 10.1016/j.jcv.2004.11.009; Ceccherini-Silberstein F, 2007, J INFECT DIS, V196, P1180, DOI 10.1086/521678; Cozzi-Lepri A, 2005, ANTIVIR THER, V10, P791; Dumans AT, 2004, J INFECT DIS, V189, P1232, DOI 10.1086/382483; Gonzalez LMF, 2003, ANTIMICROB AGENTS CH, V47, P2817, DOI 10.1128/AAC.47.9.2817-2822.2003; Hu ZX, 2006, J VIROL, V80, P7020, DOI 10.1128/JVI.02747-05; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Marcelin AG, 2005, ANTIMICROB AGENTS CH, V49, P1739, DOI 10.1128/AAC.49.5.1739-1744.2005; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Melikian GL, 2012, ANTIMICROB AGENTS CH, V56, P2305, DOI 10.1128/AAC.05487-11; Miller MD, 2004, J INFECT DIS, V189, P837, DOI 10.1086/381784; Munerato P, 2010, AIDS RES HUM RETROV, V26, P265, DOI 10.1089/aid.2009.0288; Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298; Ntemgwa ML, 2009, ANTIMICROB AGENTS CH, V53, P708, DOI 10.1128/AAC.01109-08; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pellegrin I, 1999, AIDS, V13, P1705, DOI 10.1097/00002030-199909100-00014; Perrin L, 1998, SCIENCE, V280, P1871, DOI 10.1126/science.280.5371.1871; Renjifo B, 2004, AIDS, V18, P1629, DOI 10.1097/01.aids.0000131392.68597.34; Rezende LF, 1998, J VIROL, V72, P2890, DOI 10.1128/JVI.72.4.2890-2895.1998; Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103; Rhee SY, 2004, ANTIMICROB AGENTS CH, V48, P3122, DOI 10.1128/AAC.48.8.3122-3126.2004; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Sturmer M, 2003, ANTIMICROB AGENTS CH, V47, P54, DOI 10.1128/AAC.47.1.54-61.2003; Svicher V, 2006, J VIROL, V80, P7186, DOI 10.1128/JVI.02084-05; van Maarseveen NM, 2006, J VIROL METHODS, V133, P185, DOI 10.1016/j.jviromet.2005.11.008; Wainberg MA, 2004, AIDS, V18, pS63, DOI 10.1097/00002030-200406003-00012; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; Wyl V Von, 2010, J INFEC DIS, V201, P000	37	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46622	10.1371/journal.pone.0046622	http://dx.doi.org/10.1371/journal.pone.0046622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056372	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000064
J	Liu, HT; Yu, SJ; Zhang, H; Xu, J				Liu, Hongtao; Yu, Shujie; Zhang, Hua; Xu, Jian			Angiogenesis Impairment in Diabetes: Role of Methylglyoxal-Induced Receptor for Advanced Glycation Endproducts, Autophagy and Vascular Endothelial Growth Factor Receptor 2	PLOS ONE			English	Article							END-PRODUCTS; GLYOXALASE-I; OXIDATIVE STRESS; VEGFR2 EXPRESSION; INSULIN-RESISTANT; TYROSINE KINASE; BECLIN 1; CELLS; MELLITUS; DISEASE	Diabetes impairs physiological angiogenesis by molecular mechanisms that are not fully understood. Methylglyoxal (MGO), a metabolite of glycolysis, is increased in patients with diabetes. This study defined the role of MGO in angiogenesis impairment and tested the mechanism in diabetic animals. Endothelial cells and mouse aortas were subjected to Western blot analysis of vascular endothelial growth factor receptor 2 (VEGFR2) protein levels and angiogenesis evaluation by endothelial cell tube formation/migration and aortic ring assays. Incubation with MGO reduced VEGFR2 protein, but not mRNA, levels in a time and dose dependent manner. Genetic knockdown of the receptor for advanced glycation endproducts (RAGE) attenuated the reduction of VEGFR2. Overexpression of Glyoxalase 1, the enzyme that detoxifies MGO, reduced the MGO-protein adducts and prevented VEGFR2 reduction. The VEGFR2 reduction was associated with impaired angiogenesis. Suppression of autophagy either by inhibitors or siRNA, but not of the proteasome and caspase, normalized both the VEGFR2 protein levels and angiogenesis. Conversely, induction of autophagy either by rapamycin or overexpression of LC3 and Beclin-1 reduced VEGFR2 and angiogenesis. MGO increased endothelial LC3B and Beclin-1, markers of autophagy, which were accompanied by an increase of both autophagic flux (LC3 punctae) and co-immunoprecipitation of VEGFR2 with LC3. Pharmacological or genetic suppression of peroxynitrite (ONOO-) generation not only blocked the autophagy but also reversed the reduction of VEGFR2 and angiogenesis. Like MGO-treated aortas from normglycemic C57BL/6J mice, aortas from diabetic db/db and Akita mice presented reductions of angiogenesis or VEGFR2. Administration of either autophagy inhibitor ex vivo or superoxide scavenger in vivo abolished the reductions. Taken together, MGO reduces endothelial angiogenesis through RAGE-mediated, ONOO(-)dependent and autophagy-induced VEGFR2 degradation, which may represent a new mechanism for diabetic angiogenesis impairment.	[Liu, Hongtao; Yu, Shujie; Zhang, Hua; Xu, Jian] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol,Harold Hamm Diabet Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Xu, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol,Harold Hamm Diabet Ctr, Oklahoma City, OK USA.	jian-xu@ouhsc.edu			NIH Grant from the COBRE Program of the National Center for Research Resources [P20 RR 024215-05]; National Scientist Development Grant from the American Heart Association [10SDG2600164]; Junior Faculty Award from the American Diabetes Association [1-12-JF-58]; Research Award from the Oklahoma Center for Advancement of Science and Technology [HR11-200]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	NIH Grant from the COBRE Program of the National Center for Research Resources; National Scientist Development Grant from the American Heart Association; Junior Faculty Award from the American Diabetes Association; Research Award from the Oklahoma Center for Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH Grant (P20 RR 024215-05) from the COBRE Program of the National Center for Research Resources, a National Scientist Development Grant (10SDG2600164) from the American Heart Association, a Junior Faculty Award (1-12-JF-58) from the American Diabetes Association, and a Research Award (HR11-200) from the Oklahoma Center for Advancement of Science and Technology (all to J.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed U, 2008, ANN NY ACAD SCI, V1126, P262, DOI 10.1196/annals.1433.035; Bansode RR, 2011, INT J BIOL SCI, V7, P629, DOI 10.7150/ijbs.7.629; Bartyik K, 2004, EUR J CANCER, V40, P2287, DOI 10.1016/j.ejca.2004.06.024; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Brouwers O, 2011, J BIOL CHEM, V286, P1374, DOI 10.1074/jbc.M110.144097; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Chou E, 2002, CIRCULATION, V105, P373, DOI 10.1161/hc0302.102143; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Devi MS, 2011, EXP BIOL MED, V236, P52, DOI 10.1258/ebm.2010.010087; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Domingues I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025668; Duh E, 1999, DIABETES, V48, P1899, DOI 10.2337/diabetes.48.10.1899; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Gabhann FM, 2008, MICROCIRCULATION, V15, P715, DOI 10.1080/10739680802095964; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Harhouri K, 2010, BLOOD, V115, P3843, DOI 10.1182/blood-2009-06-229591; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; Jesmin S, 2003, J MOL ENDOCRINOL, V31, P401, DOI 10.1677/jme.0.0310401; Jiang HM, 2004, J BIOL CHEM, V279, P55905, DOI 10.1074/jbc.M406094200; Jopling HM, 2011, BIOCHEM BIOPH RES CO, V410, P170, DOI 10.1016/j.bbrc.2011.04.093; Jopling HM, 2009, ARTERIOSCL THROM VAS, V29, P1119, DOI 10.1161/ATVBAHA.109.186239; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Karachalias N, 2003, BIOCHEM SOC T, V31, P1423; Kim W, 2005, ANN NY ACAD SCI, V1043, P553, DOI 10.1196/annals.1338.063; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KRAUS JL, 1988, RES COMMUN CHEM PATH, V59, P419; Kuczynski EA, 2011, ONCOLOGY-BASEL, V81, P126, DOI 10.1159/000332849; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Lakshmikanthan S, 2011, BLOOD, V118, P2015, DOI 10.1182/blood-2011-04-349282; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee SJ, 2011, AUTOPHAGY, V7, P829, DOI 10.4161/auto.7.8.15598; Leeper NJ, 2011, CIRCULATION, V123, P236, DOI 10.1161/CIRCULATIONAHA.110.003855; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu HT, 2009, PHARMACOL RES, V59, P167, DOI 10.1016/j.phrs.2008.12.001; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Meijer AJ, 2008, CELL METAB, V8, P275, DOI 10.1016/j.cmet.2008.09.001; Mendez JD, 2010, MOL CELL BIOCHEM, V341, P33, DOI 10.1007/s11010-010-0434-5; Miyata T, 2001, KIDNEY INT, V60, P2351, DOI 10.1046/j.1523-1755.2001.00051.x; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Nacev BA, 2011, J BIOL CHEM, V286, P44045, DOI 10.1074/jbc.M111.278754; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Naito Y, 2009, J PHYSIOL PHARMACOL, V60, P123; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Peppa M, 2003, DIABETES, V52, P2805, DOI 10.2337/diabetes.52.11.2805; Rabbani N, 2011, SEMIN CELL DEV BIOL, V22, P309, DOI 10.1016/j.semcdb.2011.02.015; Ramakrishnan S, 2007, AUTOPHAGY, V3, P512; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P608, DOI 10.1161/ATVBAHA.108.162057; Ryter Stefan W, 2010, Proc Am Thorac Soc, V7, P40, DOI 10.1513/pats.200909-100JS; Sasso FC, 2005, J AM COLL CARDIOL, V46, P827, DOI 10.1016/j.jacc.2005.06.007; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Simons M, 2005, J AM COLL CARDIOL, V46, P835, DOI 10.1016/j.jacc.2005.06.008; Smadja DM, 2007, J CELL MOL MED, V11, P1149, DOI 10.1111/j.1582-4934.2007.00090.x; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Suttisansanee U, 2011, J BIOL CHEM, V286, P38367, DOI 10.1074/jbc.M111.251603; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Tamarat R, 2003, P NATL ACAD SCI USA, V100, P8555, DOI 10.1073/pnas.1236929100; Teixeira AS, 1999, LIFE SCI, V64, P655, DOI 10.1016/S0024-3205(98)00607-9; TERMAN BI, 1991, ONCOGENE, V6, P1677; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Waltenberger J, 2009, BIOCHEM SOC T, V37, P1167, DOI 10.1042/BST0371167; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Xu J, 2006, ARTERIOSCL THROM VAS, V26, P2688, DOI 10.1161/01.ATV.0000249394.94588.82; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736; Yamagishi SI, 2008, CURR PHARM DESIGN, V14, P487, DOI 10.2174/138161208783597416; Yamagishi SI, 2011, BIOCH BIOPHYS ACTA; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168	85	73	83	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46720	10.1371/journal.pone.0046720	http://dx.doi.org/10.1371/journal.pone.0046720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056421	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000080
J	Qing, LY; Xia, Y; Zheng, YC; Zeng, XM				Qing, Liyan; Xia, Yun; Zheng, Yuchi; Zeng, Xiaomao			A De Novo Case of Floating Chromosomal Polymorphisms by Translocation in Quasipaa boulengeri (Anura, Dicroglossidae)	PLOS ONE			English	Article							RECIPROCAL TRANSLOCATION; MAXIMUM-LIKELIHOOD; INTERCHANGE; FREQUENCY; PHYLOGENETICS; HYBRIDIZATION; ORIENTATION; HYBRIDITY; SELECTION; BEHAVIOR	Very few natural polymorphisms involving interchromosomal reciprocal translocations are known in amphibians even in vertebrates. In this study, thirty three populations, including 471 individuals of the spiny frog Quasipaa boulengeri, were karyotypically examined using Giemsa stain or FISH. Five different karyomorphs were observed. The observed heteromorphism was autosomal but not sex-related, as the same heteromorphic chromosomes were found both in males and females. Our results indicated that the variant karyotypes resulted from a mutual interchange occurring between chromosomes 1 and 6. The occurrence of a nearly whole-arm translocation between chromosome no. 1 and no. 6 gave rise to a high frequency of alternate segregation and probably resulted in the maintenance of the translocation polymorphisms in a few populations. The translocation polymorphism is explained by different frequencies of segregation modes of the translocation heterozygote during meiosis. Theoretically, nine karyomorphs should be investigated, however, four expected karyotypes were not found. The absent karyomorphs may result from recessive lethal mutations, position effects, duplications and deficiencies. The phylogenetic inference proved that all populations of Q. boulengeri grouped into a monophyletic clade. The mutual translocation likely evolved just once in this species and the dispersal of the one karyomorph (type IV) can explain the chromosomal variations among populations.	[Qing, Liyan; Xia, Yun; Zheng, Yuchi; Zeng, Xiaomao] Chinese Acad Sci, Dept Herpetol, Chengdu Inst Biol, Chengdu, Peoples R China; [Qing, Liyan; Xia, Yun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zeng, XM (corresponding author), Chinese Acad Sci, Dept Herpetol, Chengdu Inst Biol, Chengdu, Peoples R China.	zengxm@cib.ac.cn	Xia, Yun/T-1095-2017	Xia, Yun/0000-0002-3039-0527; Zheng, Yuchi/0000-0002-1155-5293; Zeng, Xiaomao/0000-0002-1952-2170	National Natural Science Foundation of China (NSFC) [31272282]; Chinese Academy of Sciences (CAS) [KSCX2-EW-J-22]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	This work was partly supported by The National Natural Science Foundation of China (NSFC) 31272282 (http://www.nsfc.gov.cn/Portal0/default152.htm) and Chinese Academy of Sciences (CAS) KSCX2-EW-J-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi Ke, 2009, Current Zoology, V55, P145; Blakeslee AF, 1927, Z INDUKT ABSTAMM L S, P117; BLOOM WL, 1974, CHROMOSOMA, V49, P61; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; CARTER T. C, 1955, JOUR GENETICS, V53, P154, DOI 10.1007/BF02981519; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Che J, 2009, MOL PHYLOGENET EVOL, V50, P59, DOI 10.1016/j.ympev.2008.10.007; Chen Wenyuan, 1983, Zoological Research, V4, P83; CHIARELLI A. B., 1973, CYTOTAXONOMY VERTEBR; Cleland RE, 1926, BOT GAZ, V82, P55, DOI 10.1086/333633; DARLINGTON C. D., 1937; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fodor A., 1985, Journal of Genetics, V64, P143, DOI 10.1007/BF02931143; FUTUYMA DJ, 1997, EVOLUTIONARY BIOL; GOHIL RN, 1978, CYTOLOGIA, V43, P243, DOI 10.1508/cytologia.43.243; GOSALVEZ J, 1982, CHROMOSOMA, V86, P49, DOI 10.1007/BF00330729; Hartl DL, 1998, GENETICS PRINCIPLES; Hu JS, 2004, MOL PHYLOGENETIC STU; JAMES SH, 1970, HEREDITY, V25, P53, DOI 10.1038/hdy.1970.6; JOHN B, 1963, CHROMOSOMA, V14, P638, DOI 10.1007/BF00326516; KAUFMAN TC, 1978, GENETICS, V90, P579; KAUL D, 1981, GENETICA, V54, P241, DOI 10.1007/BF00135041; Kingston HM, 2002, ABC CLIN GENETICS; Koul A, 1966, J CYTOL GENET, V1, P87; LACHANCE LE, 1964, GENETICS, V49, P959; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; LAWRENCE CW, 1963, GENETICS, V48, P347; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; LEWIS K. R., 1957, HEREDITY, V11, P11, DOI 10.1038/hdy.1957.2; Li Shushen, 1996, Zoological Research, V17, P84; Li SS, 1999, CHINA ZOOLOGICAL SOC, P976; MCKIM KS, 1988, GENETICS, V120, P987; Muller HJ, 1930, GENETICS, V15, P283; Nai WH, 1999, HEREDITAS BEIJING, V21, P1; Pierce BA, 2002, GENETICS CONCEPTUAL; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRICE S, 1955, GENETICS, V40, P651; RICKARDS GK, 1983, ANNU REV GENET, V17, P443, DOI 10.1146/annurev.ge.17.120183.002303; Roberts PA, 1976, GENETICS BIOL DROS A, P68; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J., 2001, MOL CLONING LAB MANU; Schmid M, 2004, CYTOGENET GENOME RES, V104, P277, DOI 10.1159/000077502; Schmid M., 2010, Cytogenetic and Genome Research, V130-131, P1, DOI 10.1159/000301339; SHALEV A, 1976, CHROMOSOMA, V57, P297, DOI 10.1007/BF00295214; Siqueira S, 2004, GENET MOL BIOL, V27, P363, DOI 10.1590/S1415-47572004000300010; Smith L, 1941, J AGRIC RES, V63, P0741; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SUN S, 1967, HEREDITY, V22, P249, DOI 10.1038/hdy.1967.30; SYREN RM, 1981, CHROMOSOMA, V82, P65, DOI 10.1007/BF00285750; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang D, 2006, CHROMOSOME RES PAA B; Wang Z., 1983, Acta Herpetologica Sinica, V2, P1; WHITE M J D, 1973, P961; Yosida T. H., 1980, CYTOGENETICS BLACK R; Zhang JY, 1997, J GUIZHOU NORMAL U N, V15, P48; Zhang LL, 2007, GENETICA, V130, P193, DOI 10.1007/s10709-006-9006-8; Zhou Y, 2009, GENE, V447, P86, DOI 10.1016/j.gene.2009.07.009	61	14	18	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46163	10.1371/journal.pone.0046163	http://dx.doi.org/10.1371/journal.pone.0046163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056254	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000021
J	Saroha, A; Kumar, S; Chatterjee, BP; Das, HR				Saroha, Ashish; Kumar, Saravanan; Chatterjee, Bishnu P.; Das, Hasi R.			Jacalin Bound Plasma O-Glycoproteome and Reduced Sialylation of Alpha 2-HS Glycoprotein (A2HSG) in Rheumatoid Arthritis Patients	PLOS ONE			English	Article							ACUTE-PHASE PROTEIN; AFFINITY-CHROMATOGRAPHY; FETUIN-A; ALPHA-1-ACID GLYCOPROTEIN; GLYCOSYLATION SITES; HEAVY-CHAINS; LECTIN; SERUM; EXPRESSION; INHIBITOR	Glycosylation studies of plasma proteins can reveal information about the onset and progression of diseases, where in the glycan biosynthetic pathways are disturbed as in rheumatoid arthritis (RA). The present study was focused on analysis of O-linked glycoproteins of plasma in RA patients. Two dimensional gel electrophoresis of jacalin bound plasma of RA patients revealed a number of differentially expressed protein spots as compared to healthy controls. Eighteen protein spots were found to have statistically significant (p < 0.05) difference in their expression level from four sets of gels and were identified by MALDI-TOF MS. Most of the identified proteins were predicted to be O-glycosylated proteins by Net-O-Gly 3.1 algorithm. Among these the alpha 2HS glycoprotein (A2HSG) was found to be down regulated whereas inter alpha trypsin inhibitor H4 (ITIH4) was up regulated and this was validated by Western blotting. The glycosylation studies showed the reduced N-linked sialylation of A2HSG in RA patients. Altered glycoprotein expression and functional as well as structural studies of glycans might help in the diagnosis of RA and understanding the disease pathogenesis.	[Saroha, Ashish; Kumar, Saravanan; Das, Hasi R.] CSIR Inst Genom & Integrat Biol, Genom & Mol Med Div, Delhi, India; [Saroha, Ashish; Chatterjee, Bishnu P.] W Bengal Univ Technol, Dept Nat Sci, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Maulana Abul Kalam Azad University of Technology	Das, HR (corresponding author), CSIR Inst Genom & Integrat Biol, Genom & Mol Med Div, Delhi, India.	hdas@igib.res.in	Saroha, Ashish/A-3208-2019	Saroha, Ashish/0000-0001-6787-8633	Indian council of Medical Research (ICMR); Council of Scientific and Industrial Research (CSIR), India	Indian council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The authors wish to thank Indian council of Medical Research (ICMR) for providing the senior research fellowship to Ashish Saroha. They also gratefully acknowledge the financial support of Council of Scientific and Industrial Research (CSIR), India to carry out this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bhattacharyya S, 2008, J BONE MINER RES, V23, P1106, DOI 10.1359/JBMR.080235; Binkert C, 1999, J BIOL CHEM, V274, P28514, DOI 10.1074/jbc.274.40.28514; Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai T, 1998, BBA-GENE STRUCT EXPR, V1398, P32, DOI 10.1016/S0167-4781(98)00049-9; CARSON DA, 1987, ANNU REV IMMUNOL, V5, P109, DOI 10.1146/annurev.iy.05.040187.000545; Choi-Miura NH, 2000, INFLAMM RES, V49, P305, DOI 10.1007/PL00000211; Choi-Miura NH, 2001, BIOL PHARM BULL, V24, P214, DOI 10.1248/bpb.24.214; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Durand G, 2000, CLIN CHEM, V46, P795; Durham M, 2006, J CHROMATOGR A, V1132, P165, DOI 10.1016/j.chroma.2006.07.070; El-Shehaby AM, 2010, SCAND J CLIN LAB INV, V70, P575, DOI 10.3109/00365513.2010.528445; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gornik I, 1999, CLIN BIOCHEM, V32, P605, DOI 10.1016/S0009-9120(99)00060-0; He QY, 2003, J CELL BIOCHEM, V89, P868, DOI 10.1002/jcb.10576; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Higai K, 2005, BBA-GEN SUBJECTS, V1725, P128, DOI 10.1016/j.bbagen.2005.03.012; Jafar-Nejad H, 2010, GLYCOBIOLOGY, V20, P931, DOI 10.1093/glycob/cwq053; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kabir S, 1998, J IMMUNOL METHODS, V212, P193, DOI 10.1016/S0022-1759(98)00021-0; Kirmiz C, 2007, MOL CELL PROTEOMICS, V6, P43, DOI 10.1074/mcp.M600171-MCP200; Kundranda MN, 2004, BBA-MOL CELL RES, V1693, P111, DOI 10.1016/j.bbamcr.2004.06.005; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; MACKIEWICZ A, 1992, FOLIA HISTOCHEM CYTO, V30, P165; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Memoli B, 2007, BIOMATERIALS, V28, P4836, DOI 10.1016/j.biomaterials.2007.05.043; Mohamed E, 2008, ELECTROPHORESIS, V29, P2645, DOI 10.1002/elps.200700828; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oikawa Osamu, 2007, Clin Exp Nephrol, V11, P304, DOI 10.1007/s10157-007-0499-y; Orchard Sandra, 2007, Expert Rev Proteomics, V4, P709, DOI 10.1586/14789450.4.6.709; PARKKINEN J, 1989, CLIN CHEM, V35, P1638; Pineiro M, 2004, INFECT IMMUN, V72, P3777, DOI 10.1128/IAI.72.7.3777-3782.2004; Przybysz M, 2007, GLYCOCONJUGATE J, V24, P543, DOI 10.1007/s10719-007-9049-9; Raghav SK, 2006, GLYCOCONJUGATE J, V23, P167, DOI 10.1007/s10719-006-7922-6; Ryden I, 2002, CLIN CHIM ACTA, V317, P221, DOI 10.1016/S0009-8981(01)00803-8; Saroha A, 2011, TRENDS CARBOHYDR RES, V3, P1; Saroha A, 2011, J CHROMATOGR B, V879, P1839, DOI 10.1016/j.jchromb.2011.04.024; Sawada M, 2002, INT J CANCER, V97, P180, DOI 10.1002/ijc.1598; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schauer R., 1982, SIALIC ACIDS CHEM ME; Schwientek T, 2007, PROTEOMICS, V7, P3264, DOI 10.1002/pmic.200600793; Song J, 2006, CLIN CHEM, V52, P1045, DOI 10.1373/clinchem.2005.065722; Tachibana K, 2006, GLYCOBIOLOGY, V16, P46, DOI 10.1093/glycob/cwj038; TERCERO JC, 1988, ANAL BIOCHEM, V174, P128, DOI 10.1016/0003-2697(88)90526-X; Tilleman K, 2008, EXPERT REV PROTEOMIC, V5, P755, DOI 10.1586/14789450.5.6.755; TOLLESHAUG H, 1984, BIOCHIM BIOPHYS ACTA, V803, P182, DOI 10.1016/0167-4889(84)90008-9; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Varki A., 1999, ESSENTIALS GLYCOBIOL; Xu LX, 2005, KIDNEY INT, V68, P167, DOI 10.1111/j.1523-1755.2005.00390.x; Zhao J, 2006, J PROTEOME RES, V5, P1792, DOI 10.1021/pr060034r; Zhuo L, 2008, CONNECT TISSUE RES, V49, P311, DOI 10.1080/03008200802325458	54	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46374	10.1371/journal.pone.0046374	http://dx.doi.org/10.1371/journal.pone.0046374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056292	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000034
J	Konno, D; Iwashita, M; Satoh, Y; Momiyama, A; Abe, T; Kiyonari, H; Matsuzaki, F				Konno, Daijiro; Iwashita, Misato; Satoh, Yoshiaki; Momiyama, Asuka; Abe, Takaya; Kiyonari, Hiroshi; Matsuzaki, Fumio			The Mammalian DM Domain Transcription Factor Dmrta2 Is Required for Early Embryonic Development of the Cerebral Cortex	PLOS ONE			English	Article							NEURAL STEM-CELLS; GENE; NEUROGENESIS; EXPRESSION; NEOCORTEX; SPECIFICATION; REGULATORS; IDENTITY; FGF8; PROGENITORS	Development of the mammalian telencephalon is precisely organized by a combination of extracellular signaling events derived from signaling centers and transcription factor networks. Using gene expression profiling of the developing mouse dorsal telencephalon, we found that the DM domain transcription factor Dmrta2 (doublesex and mab-3-related transcription factor a2) is involved in the development of the dorsal telencephalon. Consistent with its medial-high/lateral-low expression pattern in the dorsal telencephalon, Dmrta2 null mutants demonstrated a dramatic reduction in medial cortical structures such as the cortical hem and the choroid plexus, and a complete loss of the hippocampus. In this mutant, the dorsal telencephalon also showed a remarkable size reduction, in addition to abnormal cell cycle kinetics and defective patterning. In contrast, a conditional Dmrta2 deletion in the telencephalon, which was accomplished after entry into the neurogenic phase, resulted in only a slight reduction in telencephalon size and normal patterning. We also found that Dmrta2 expression was decreased by a dominant-negative Tcf and was increased by a stabilized beta-catenin form. These data suggest that Dmrta2 plays pivotal roles in the early development of the telencephalon via the formation of the cortical hem, a source of Wnts, and also in the maintenance of neural progenitors as a downstream of the Wnt pathway.	[Konno, Daijiro; Iwashita, Misato; Satoh, Yoshiaki; Momiyama, Asuka; Matsuzaki, Fumio] RIKEN Ctr Dev Biol, Lab Cell Asymmetry, Kobe, Hyogo, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan	RIKEN; RIKEN	Konno, D (corresponding author), RIKEN Ctr Dev Biol, Lab Cell Asymmetry, Kobe, Hyogo, Japan.	daikon@cdb.riken.jp; fumio@cdb.riken.jp	Kiyonari, Hiroshi/N-7936-2015		RIKEN Center for Developmental Biology	RIKEN Center for Developmental Biology	Funding was provided by the RIKEN Center for Developmental Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Gennet N, 2011, P NATL ACAD SCI USA, V108, P9131, DOI 10.1073/pnas.1016679108; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hasenpusch-Theil K, 2012, CEREB CORTEX, V22, P2878, DOI 10.1093/cercor/bhr365; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Huang X, 2005, P NATL ACAD SCI USA, V102, P11349, DOI 10.1073/pnas.0505106102; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Lee SMK, 2000, DEVELOPMENT, V127, P457; Louvi A, 2007, J COMP NEUROL, V504, P550, DOI 10.1002/cne.21461; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Ohtsuka T, 2011, STEM CELLS, V29, P1817, DOI 10.1002/stem.731; Rash BG, 2006, CURR OPIN NEUROBIOL, V16, P25, DOI 10.1016/j.conb.2006.01.004; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Shan Z, 2000, CYTOGENET CELL GENET, V89, P252, DOI 10.1159/000015626; Shinozaki K, 2004, MECH DEVELOP, V121, P475, DOI 10.1016/j.mod.2004.03.013; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Subramanian L, 2009, CEREB CORTEX, V19, pI90, DOI 10.1093/cercor/bhp031; Tresser J, 2010, DEVELOPMENT, V137, P2197, DOI 10.1242/dev.045302; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Yoshizawa A, 2011, GENES CELLS, V16, P1097, DOI 10.1111/j.1365-2443.2011.01555.x	40	42	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46577	10.1371/journal.pone.0046577	http://dx.doi.org/10.1371/journal.pone.0046577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056351	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600044
J	Liovat, AS; Rey-Cuille, MA; Lecuroux, C; Jacquelin, B; Girault, I; Petitjean, G; Zitoun, Y; Venet, A; Barre-Sinoussi, F; Lebon, P; Meyer, L; Sinet, M; Muller-Trutwin, M				Liovat, Anne-Sophie; Rey-Cuille, Marie-Anne; Lecuroux, Camille; Jacquelin, Beatrice; Girault, Isabelle; Petitjean, Gael; Zitoun, Yasmine; Venet, Alain; Barre-Sinoussi, Francoise; Lebon, Pierre; Meyer, Laurence; Sinet, Martine; Mueller-Trutwin, Michaela			Acute Plasma Biomarkers of T Cell Activation Set-Point Levels and of Disease Progression in HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; AFRICAN-GREEN MONKEYS; IMMUNE ACTIVATION; LYMPH-NODES; SIV INFECTION; TYPE-1 INFECTION; DENDRITIC CELLS; I INTERFERON; VIRAL LOAD; IFN-GAMMA	T cell activation levels, viral load and CD4(+) T cell counts at early stages of HIV-1 infection are predictive of the rate of progression towards AIDS. We evaluated whether the inflammatory profile during primary HIV-1 infection is predictive of the virological and immunological set-points and of disease progression. We quantified 28 plasma proteins during acute and post-acute HIV-1 infection in individuals with known disease progression profiles. Forty-six untreated patients, enrolled during primary HIV-1 infection, were categorized into rapid progressors, progressors and slow progressors according to their spontaneous progression profile over 42 months of follow-up. Already during primary infection, rapid progressors showed a higher number of increased plasma proteins than progressors or slow progressors. The plasma levels of TGF-beta 1 and IL-18 in primary HIV-1 infection were both positively associated with T cell activation level at set-point (6 months after acute infection) and together able to predict 74% of the T cell activation variation at set-point. Plasma IP-10 was positively and negatively associated with, respectively, T cell activation and CD4(+) T cell counts at set-point and capable to predict 30% of the CD4(+) T cell count variation at set-point. Moreover, plasma IP-10 levels during primary infection were predictive of rapid progression. In primary infection, IP-10 was an even better predictor of rapid disease progression than viremia or CD4(+) T cell levels at this time point. The superior predictive capacity of IP-10 was confirmed in an independent group of 88 HIV-1 infected individuals. Altogether, this study shows that the inflammatory profile in primary HIV-1 infection is associated with T cell activation levels and CD4(+) T cell counts at set-point. Plasma IP-10 levels were of strong predictive value for rapid disease progression. The data suggest IP-10 being an earlier marker of disease progression than CD4(+) T cell counts or viremia levels.	[Liovat, Anne-Sophie; Jacquelin, Beatrice; Petitjean, Gael; Barre-Sinoussi, Francoise; Mueller-Trutwin, Michaela] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Liovat, Anne-Sophie] Univ Paris Diderot, Paris, France; [Rey-Cuille, Marie-Anne] Inst Pasteur, Unite Rech & Expertise Epidemiol Malad Emergentes, Paris, France; [Lecuroux, Camille; Girault, Isabelle; Venet, Alain; Sinet, Martine] Univ Paris Sud, INSERM, U1012 Regulat Reponse Immune Infect VIH & Autoimm, F-94275 Le Kremlin Bicetre, France; [Zitoun, Yasmine; Meyer, Laurence] Univ Paris Sud, INSERM, AP HP, Serv Epidemiol & Sante Publ,U1018, F-94275 Le Kremlin Bicetre, France; [Zitoun, Yasmine; Meyer, Laurence] CHU Necker Enfants Malades, AP HP, Virol Lab, Paris, France; [Lebon, Pierre] Univ Paris 05, Virol Lab, Paris, France; [Lebon, Pierre] Hop Cochin St Vincent de Paul, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Muller-Trutwin, M (corresponding author), Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France.	michaela.muller-trutwin@pasteur.fr	Rey-Cuille, Marie-Anne/J-7486-2012; Barre-Sinoussi, Françoise/G-8355-2011	JACQUELIN, Beatrice/0000-0002-1896-5092; Muller-Trutwin, Michaela/0000-0002-3854-2396	French National Agency for AIDS Research (ANRS); Institut Pasteur; AREVA Foundation; ANRS; Ministere de l'Enseignement Superieur et de la Recherche; Universite Paris VII-Denis Diderot; Sidaction	French National Agency for AIDS Research (ANRS)(ANRSFrench National Research Agency (ANR)); Institut Pasteur(European Commission); AREVA Foundation; ANRS(ANRSFrench National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Universite Paris VII-Denis Diderot; Sidaction	This work was supported by grants from the French National Agency for AIDS Research (ANRS), Institut Pasteur and the AREVA Foundation. G. P. and C. L. received a fellowship from ANRS. A-S. L. received fellowhips from the "Ministere de l'Enseignement Superieur et de la Recherche", "Universite Paris VII-Denis Diderot" and from Sidaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Bebell LM, 2008, J INFECT DIS, V198, P710, DOI 10.1086/590503; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Campillo-Gimenez L, 2010, J VIROL, V84, P1838, DOI 10.1128/JVI.01496-09; Cervantes-Barragan L, 2012, J IMMUNOL, V188, P3678, DOI 10.4049/jimmunol.1102422; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Diop OM, 2008, J VIROL, V82, P5145, DOI 10.1128/JVI.02433-07; Durudas A, 2009, J VIROL, V83, P12229, DOI 10.1128/JVI.01311-09; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Estes JD, 2007, J INFECT DIS, V195, P551, DOI 10.1086/510852; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Foley JF, 2005, J IMMUNOL, V174, P4892, DOI 10.4049/jimmunol.174.8.4892; Gay C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019617; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jiao YM, 2012, VIRAL IMMUNOL, V25, P333, DOI 10.1089/vim.2012.0011; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; Katsikis PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002055; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Khatissian E, 1996, RES VIROLOGY, V147, P181, DOI 10.1016/0923-2516(96)80233-0; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Kramer HB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000893; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Lecuroux C, 2009, BLOOD, V113, P3209, DOI 10.1182/blood-2008-07-167601; Lederman MM, 2008, SEMIN IMMUNOL, V20, P187, DOI 10.1016/j.smim.2008.06.001; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Meythaler M, 2009, J VIROL, V83, P572, DOI 10.1128/JVI.01715-08; Munoz A, 1997, AIDS, V11, pS69; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Piali L, 1998, EUR J IMMUNOL, V28, P961, DOI 10.1002/(SICI)1521-4141(199803)28:03<961::AID-IMMU961>3.0.CO;2-4; Ploquin MJY, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-37; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Sarkar S, 2003, J MED PRIMATOL, V32, P247, DOI 10.1034/j.1600-0684.2003.00031.x; Shi MG, 1997, J CLIN IMMUNOL, V17, P43, DOI 10.1023/A:1027336428736; Stacey AR, 2009, J VIROL, P01844; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thorburn E, 2009, APMIS, V117, P477, DOI 10.1111/j.1600-0463.2009.02446.x; Troude P, 2009, AIDS, V23, P1261, DOI 10.1097/QAD.0b013e32832b51ef; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	52	115	118	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46143	10.1371/journal.pone.0046143	http://dx.doi.org/10.1371/journal.pone.0046143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056251	Green Published, gold			2022-12-27	WOS:000309452600024
J	Bills, GF; Gonzalez-Menendez, V; Martin, J; Platas, G; Fournier, J; Persoh, D; Stadler, M				Bills, Gerald F.; Gonzalez-Menendez, Victor; Martin, Jesus; Platas, Gonzalo; Fournier, Jacques; Persoh, Derek; Stadler, Marc			Hypoxylon pulicicidum sp nov (Ascomycota, Xylariales), a Pantropical Insecticide-Producing Endophyte	PLOS ONE			English	Article							GATED CHLORIDE CHANNELS; NODULISPORIC ACID; RDNA; IDENTIFICATION; DIVERSITY; FUNGI; CHEMOTAXONOMY; DISCOVERY; AZAPHILONES; COMMUNITY	Background: Nodulisporic acids (NAs) are indole diterpene fungal metabolites exhibiting potent systemic efficacy against blood-feeding arthropods, e. g., bedbugs, fleas and ticks, via binding to arthropod specific glutamate-gated chloride channels. Intensive medicinal chemistry efforts employing a nodulisporic acid A template have led to the development of N-tert-butyl nodulisporamide as a product candidate for a once monthly treatment of fleas and ticks on companion animals. The source of the NAs is a monophyletic lineage of asexual endophytic fungal strains that is widely distributed in the tropics, tentatively identified as a Nodulisporium species and hypothesized to be the asexual state of a Hypoxylon species. Methods and Results: Inferences from GenBank sequences indicated that multiple researchers have encountered similar Nodulisporium endophytes in tropical plants and in air samples. Ascomata-derived cultures from a wood-inhabiting fungus, from Martinique and closely resembling Hypoxylon investiens, belonged to the same monophyletic clade as the NAs-producing endophytes. The hypothesis that the Martinique Hypoxylon collections were the sexual state of the NAs-producing endophytes was tested by mass spectrometric analysis of NAs, multi-gene phylogenetic analysis, and phenotypic comparisons of the conidial states. We established that the Martinique Hypoxylon strains produced an ample spectrum of NAs and were conspecific with the pantropical Nodulisporium endophytes, yet were distinct from H. investiens. A new species, H. pulicicidum, is proposed to accommodate this widespread organism. Conclusions and Significance: Knowledge of the life cycle of H. pulicicidum will facilitate an understanding of the role of insecticidal compounds produced by the fungus, the significance of its infections in living plants and how it colonizes dead wood. The case of H. pulicicidum exemplifies how life cycle studies can consolidate disparate observations of a fungal organism, whether from environmental sequences, vegetative mycelia or field specimens, resulting in holistic species concepts critical to the assessment of the dimensions of fungal diversity.	[Bills, Gerald F.; Gonzalez-Menendez, Victor; Martin, Jesus; Platas, Gonzalo] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Granada, Spain; [Fournier, Jacques] Las Muros, Rimont, Ariege, France; [Persoh, Derek; Stadler, Marc] Univ Bayreuth, Dept Mycol, Bayreuth, Germany; [Stadler, Marc] Helmholtz Ctr Infect Res GmbH, Dept Microbial Drugs, Braunschweig, Germany	University of Bayreuth; Helmholtz Association; Helmholtz-Center for Infection Research	Bills, GF (corresponding author), Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Parque Tecnol Ciencias Salud, Granada, Spain.	gerald.bills@medinaandalucia.es	Persoh, Derek/G-4527-2010; Martín-Serrano, Jesús/M-1937-2014; Stadler, Marc/AHB-7016-2022; Stadler, Marc/P-8882-2014	Persoh, Derek/0000-0001-5561-0189; Martín-Serrano, Jesús/0000-0001-7487-2790; Stadler, Marc/0000-0002-7284-8671; Stadler, Marc/0000-0002-7284-8671; Gonzalez-Menendez, Victor/0000-0001-9859-6284; Bills, Gerald/0000-0003-2352-8417	Merck Sharp & Dohme de Espana; European Cooperation in Science and Technology Actions Chemical Biology with Natural Products [CM804]; Endophytes in Agriculture and Biotechnology [FA1103]	Merck Sharp & Dohme de Espana; European Cooperation in Science and Technology Actions Chemical Biology with Natural Products; Endophytes in Agriculture and Biotechnology	Fundacion MEDINA, receives support from Merck Sharp & Dohme de Espana, a subsidary of Merck & Co., Inc. GB and MS have received indirect support from the European Cooperation in Science and Technology Actions Chemical Biology with Natural Products (CM804) and Endophytes in Agriculture and Biotechnology (FA1103) facilitating discussions and planning of the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bills G. F., 2009, SOC IND MICROBIOL NE, V59, P133; Bills G, 2009, MYCOL SER, V27, P257; Bills GF, 2012, MYCOLOGIA, V104, P962, DOI 10.3852/12-003; Bills GF, 1996, MYCOTAXON, V57, P471; Bitzer J, 2007, CHIMIA, V61, P332, DOI 10.2533/chimia.2007.332; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Blagburn BL, 2010, VET PARASITOL, V168, P312, DOI 10.1016/j.vetpar.2009.11.023; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Chen XY, 2011, WORLD J MICROB BIOT, V27, P495, DOI 10.1007/s11274-010-0480-x; Collado J, 2001, MYCOLOGIA, V93, P875, DOI 10.2307/3761753; Dombrowski AW, 1997, U.S. Patent, Patent No. [5,614,546, 5614546]; Frohlich-Nowoisky J, 2011, BIOGEOSCI DISCUSS, V8, P7071, DOI DOI 10.5194/bgd-8-7071-2011; Ganley RJ, 2004, P NATL ACAD SCI USA, V101, P10107, DOI 10.1073/pnas.0401513101; Gazis R, 2011, MOL ECOL, V20, P3001, DOI 10.1111/j.1365-294X.2011.05110.x; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Guo LD, 2000, NEW PHYTOL, V147, P617, DOI 10.1046/j.1469-8137.2000.00716.x; Hensens OD, 1999, TETRAHEDRON LETT, V40, P5455, DOI 10.1016/S0040-4039(99)01064-3; Hibbett D, 2011, NEW PHYTOL, V191, P592, DOI 10.1111/j.1469-8137.2011.03819.x; Hyde KD, 2008, FUNGAL DIVERS, V33, P163; Ju YM, 1996, MYCOL MEM, V20, P1; Kane NS, 2000, P NATL ACAD SCI USA, V97, P13949, DOI 10.1073/pnas.240464697; Kendrick B, 2011, GENERA HYPHOMYCETES; KORNERUP A., 1967, Methuen handbook of colour.; Meinke Peter T., 2002, Current Topics in Medicinal Chemistry, V2, P655, DOI 10.2174/1568026023393714; Meinke PT, 2009, J MED CHEM, V52, P3505, DOI 10.1021/jm801334v; Meinke PT, 2000, BIOORG MED CHEM LETT, V10, P2371, DOI 10.1016/S0960-894X(00)00469-8; Nagy LG, 2011, NEW PHYTOL, V191, P789, DOI 10.1111/j.1469-8137.2011.03707.x; Nylander JAA, 2004, MRMODELTEST, V2; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Ogata M, 2007, J ANTIBIOT, V60, P645, DOI 10.1038/ja.2007.83; Okane I, 2008, MYCOSCIENCE, V49, P359, DOI 10.1007/s10267-008-0440-6; Ondeyka JG, 2003, J NAT PROD, V66, P121, DOI 10.1021/np020339u; Ondeyka JG, 2002, BIOORG MED CHEM LETT, V12, P2941, DOI 10.1016/S0960-894X(02)00621-2; Ondeyka JG, 1997, J AM CHEM SOC, V119, P8809, DOI 10.1021/ja971664k; Ostlind DA, 1997, MED VET ENTOMOL, V11, P407, DOI 10.1111/j.1365-2915.1997.tb00431.x; Ostlind DA, 2001, SOUTHWEST ENTOMOL, V26, P181; Parker EJ, 2005, MYCOLOGY S, V22, P405; Persoh D, 2010, FUNGAL BIOL-UK, V114, P585, DOI 10.1016/j.funbio.2010.04.009; PETRINI L, 1985, Sydowia, V38, P216; Platas G, 2004, MYCOL RES, V108, P71, DOI 10.1017/S0953756203008815; Platas G, 2002, MYCOL RES, V106, P1293, DOI 10.1017/S0953756202006780; Platas G, 2009, MYCOTAXON, V109, P443, DOI 10.5248/109.443; Polishook JD, 2001, MYCOLOGIA, V93, P1125, DOI 10.2307/3761673; Quang DN, 2006, TETRAHEDRON, V62, P6349, DOI 10.1016/j.tet.2006.04.040; Quang DN, 2005, PHYTOCHEMISTRY, V66, P797, DOI 10.1016/j.phytochem.2005.02.006; Rayner A, 2017, NATURAL INCLUSION; Rohlfs M, 2007, BIOL LETTERS, V3, P523, DOI 10.1098/rsbl.2007.0338; Rohlfs M, 2011, FUNGAL GENET BIOL, V48, P23, DOI 10.1016/j.fgb.2010.08.008; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Saikia S, 2008, MYCOL RES, V112, P184, DOI 10.1016/j.mycres.2007.06.015; Santora KA, 2002, VET PARASITOL, V104, P257, DOI 10.1016/S0304-4017(01)00627-6; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shoop WL, 2001, J PARASITOL, V87, P1150, DOI 10.1645/0022-3395(2001)087[1150:SEONAF]2.0.CO;2; Singh SB, 2004, J NAT PROD, V67, P1496, DOI 10.1021/np0498455; Smith MM, 2000, BIOCHEMISTRY-US, V39, P5543, DOI 10.1021/bi992943i; Stadler M, 2004, MYCOTAXON, V90, P187; Stadler M, 2001, MYCOL RES, V105, P1191, DOI 10.1016/S0953-7562(08)61990-5; Stadler M., 2011, CURR RES ENV APPL MY, V1, P75, DOI [DOI 10.5943/CREAM/1/2/1, 10.5943/cream/1/2/1, DOI 10.5943/cream/1/2/1]; Stadler M, 2006, MYCOL RES, V110, P811, DOI 10.1016/j.mycres.2006.03.013; Stadler M, 2005, RRD PHYTOCHEM, V9, P41; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STROBEL G, 1993, MYCOTAXON, V47, P71; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Vicente F, 2009, MYCOL RES, V113, P754, DOI 10.1016/j.mycres.2009.02.011; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019039; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	68	75	79	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46687	10.1371/journal.pone.0046687	http://dx.doi.org/10.1371/journal.pone.0046687			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056404	gold, Green Published, Green Submitted			2022-12-27	WOS:000309889400024
J	Liu, QH; Li, ZB; Wang, H; Chen, XC; Dong, XQ; Mao, HP; Tan, JQ; Luo, N; Johnson, RJ; Chen, WQ; Yu, XQ; Chen, W				Liu, Qinghua; Li, Zhibin; Wang, Hui; Chen, Xiaochao; Dong, Xiuqing; Mao, Haiping; Tan, Jiaqing; Luo, Ning; Johnson, Richard J.; Chen, Weiqing; Yu, Xueqing; Chen, Wei			High Prevalence and Associated Risk Factors for Impaired Renal Function and Urinary Abnormalities in a Rural Adult Population from Southern China	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; REPUBLIC-OF-CHINA; BLOOD-PRESSURE; HYPERTENSION; AWARENESS; HEALTH; CKD; PREVENTION; NUTRITION	Background: The prevalence of chronic kidney disease (CKD) has increased and will continue to rise worldwide. However, data regarding the prevalence of CKD in a rural area of China are limited. We therefore investigated the prevalence and associated risk factors of impaired renal function and urinary abnormalities in an adult rural population in southern China. Methods: Between December 2006 and January 2007, residents older than 20 years from four villages in Zhuhai city were randomly selected using a stratified, multistage sampling technique. All participants were interviewed and tested for hematuria, albuminuria and estimated glomerular filtration rate (eGFR). The associations between age, gender, diabetes mellitus, hypertension, hyperuricemia, education level and indicators of renal damage were examined. Results: Overall, 1,214 subjects were enrolled in this study. After adjustment for age and gender, the prevalence of albuminuria was 7.1% (95% CI: 4.5, 8.1), reduced eGFR was 2.6% (95% CI: 1.7%, 3.3%), and hematuria was 4.6% (95% CI: 3.3%, 6.0%). Approximately 13.6% (95% CI: 12.0%, 15.1%) of the patients had at least one indicator of renal damage, but only 8.3% were previously aware. Age, diabetes, hyperlipidemia, hypertension, hyperuricemia, use of nephrotoxic medications, coronary heart disease and history of CKD were independently associated with impaired renal function and urinary abnormalities. Additionally, age, diabetes, and hypertension were independently associated with albuminuria. Age, hypertension, hyperuricemia, central obesity, and coronary heart disease were independently associated with reduced renal function. Conclusions: The high prevalence and low awareness of impaired renal function and urinary abnormalities in this population illustrates the urgent need to implement a CKD prevention program in the rural areas of southern China.	[Liu, Qinghua; Li, Zhibin; Dong, Xiuqing; Mao, Haiping; Tan, Jiaqing; Luo, Ning; Yu, Xueqing; Chen, Wei] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Key Lab Nephrol,Minist Hlth China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Zhibin] Sun Yat Sen Univ, Affiliated Hosp 1, Epidemiol Res Unit, Translat Res Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Hui] Guangzhou Med Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Chen, Xiaochao] Sun Yat Sen Univ, Dept Cardiol, Affiliated Hosp 5, Zhuhai, Peoples R China; [Johnson, Richard J.] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO USA; [Chen, Weiqing] Sun Yat Sen Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Sun Yat Sen University	Chen, W (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Key Lab Nephrol,Minist Hlth China, Guangzhou 510275, Guangdong, Peoples R China.	vvchen66@gmail.com		Mao, Haiping/0000-0002-3608-3851	National Basic Research Program of China [2011CB504000]; National Natural Science Fund for Distinguished Young Scholar [30925019]; Guangdong Province University academic and discipline development [2010-76]; Ministry of Science and Technology of China [2009DFA32820]; 5010 clinical program of Sun Yat-sen University; National Natural Science Foundation of China [30971378]; Outstanding Young Teachers Foundation of Sun Yat-sen University [09ykpy23]; Doctoral Program of Higher Education of China [20100171120067]; Natural Science Foundation of Guangdong Province [10451008901005957]; Medical Scientific Research Foundation of Guangdong Province [A2010148]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Fund for Distinguished Young Scholar; Guangdong Province University academic and discipline development; Ministry of Science and Technology of China(Ministry of Science and Technology, China); 5010 clinical program of Sun Yat-sen University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Teachers Foundation of Sun Yat-sen University; Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province	This work was supported by grants from the Project supported by the National Basic Research Program of China (No. 2011CB504000), the National Natural Science Fund for Distinguished Young Scholar (No. 30925019), Guangdong Province University academic and discipline development (No. 2010-76), International Joint Research Program of Ministry of Science and Technology of China (No. 2009DFA32820), and 5010 clinical program of Sun Yat-sen University to Dr. Xueqing Yu. Dr. Wei Chen was supported by grants from National Natural Science Foundation of China (No. 30971378), Outstanding Young Teachers Foundation of Sun Yat-sen University (09ykpy23). Dr. Qinghua Liu was supported by grants from Doctoral Program of Higher Education of China (20100171120067), Natural Science Foundation of Guangdong Province (10451008901005957), and Medical Scientific Research Foundation of Guangdong Province (A2010148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello AK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09802.x; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Chen W, 2011, NEPHROL DIAL TRANSPL, V26, P1592, DOI 10.1093/ndt/gfq608; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Guh JY, 2007, AM J KIDNEY DIS, V49, P626, DOI 10.1053/j.ajkd.2007.02.259; Hsu CC, 2006, AM J KIDNEY DIS, V48, P727, DOI 10.1053/j.ajkd.2006.07.018; HUANG ZD, 1994, J HYPERTENS, V12, P1103; Jiang LP, 2010, NEPHRON CLIN PRACT, V114, pC295, DOI 10.1159/000276582; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Lord GM, 1999, LANCET, V354, P481, DOI 10.1016/S0140-6736(99)03380-2; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Pang WY, 2010, MED PRIN PRACT, V19, P22, DOI 10.1159/000252830; STAMLER R, 1993, J HUM HYPERTENS, V7, P429; Su T, 2011, NEPHROL DIAL TRANSPL, V26, P1916, DOI 10.1093/ndt/gfq679; Sur ZQ, 2007, CLIN CARDIOL, V30, P183, DOI 10.1002/clc.20073; Wei X, 2012, NEPHROLOGY, V17, P123, DOI 10.1111/j.1440-1797.2011.01523.x; World Health Organization, 2000, AS PAC PERSP RED OB; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	26	27	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47100	10.1371/journal.pone.0047100	http://dx.doi.org/10.1371/journal.pone.0047100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056593	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400057
J	Zhang, DM; Li, Y; Cheang, WS; Lau, CW; Lin, SM; Zhang, QL; Yao, N; Wang, Y; Wu, X; Huang, Y; Ye, WC				Zhang, Dong-Mei; Li, Yong; Cheang, Wai San; Lau, Chi Wai; Lin, Shun-Ming; Zhang, Qian-Lan; Yao, Nan; Wang, Ying; Wu, Xin; Huang, Yu; Ye, Wen-Cai			Cajaninstilbene Acid Relaxes Rat Renal Arteries: Roles of Ca2+ Antagonism and Protein Kinase C-Dependent Mechanism	PLOS ONE			English	Article							CAJANUS-CAJAN L.; SMOOTH-MUSCLE; ENDOTHELIAL FUNCTION; OXIDATIVE STRESS; IN-VITRO; EXTRACTS; PHOSPHATASE; MODULATION; CELLS	Cajaninstilbene acid (CSA) is a major active component present in the leaves of Cajanus cajan (L.) Millsp. The present study explores the underlying cellular mechanisms for CSA-induced relaxation in rat renal arteries. Vascular reactivity was examined in arterial rings that were suspended in a Multi Myograph System and the expression of signaling proteins was assessed by Western blotting method. CSA (0.1-10 mu M) produced relaxations in rings pre-contracted by phenylephrine, serotonin, 9, 11-dideoxy-9 alpha, 11 alpha-epoxymethanoprostaglandin F-2 alpha (U46619), and 60 mM KCl. CSA-induced relaxations did not show difference between genders and were unaffected by endothelium denudation, nor by treatment with N-G-nitro-L-arginine methyl ester, indomethacin, ICI-182780, tetraethylammonium ion, BaCl2, glibenclamide, 4-aminopyridine or propranolol. CSA reduced contraction induced by CaCl2 (0.01-5 mM) in Ca2+-free 60 mM KCl solution and by 30 nM (-)-Bay K8644 in 15 mM KCl solution. CSA inhibited 60 mM KCl-induced Ca2+ influx in smooth muscle of renal arteries. In addition, CSA inhibited contraction evoked by phorbol 12-myristate 13-acetate (PMA, protein kinase C agonist) in Ca2+-free Krebs solution. Moreover, CSA reduced the U46619- and PMA-induced phosphorylation of myosin light chain (MLC) at Ser19 and myosin phosphatase target subunit 1 (MYPT1) at Thr853 which was associated with vasoconstriction. CSA also lowered the phosphorylation of protein kinase C (PKC delta) at Thr505. In summary, the present results suggest that CSA relaxes renal arteries in vitro via multiple cellular mechanisms involving partial inhibition of calcium entry via nifedipine-sensitive calcium channels, protein kinase C and Rho kinase.	[Cheang, Wai San; Lau, Chi Wai; Huang, Yu] Chinese Univ Hong Kong, Inst Vasc Med, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Cheang, Wai San; Lau, Chi Wai; Huang, Yu] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Dong-Mei; Li, Yong; Lin, Shun-Ming; Zhang, Qian-Lan; Yao, Nan; Wang, Ying; Wu, Xin; Ye, Wen-Cai] Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China; [Zhang, Dong-Mei; Li, Yong; Lin, Shun-Ming; Zhang, Qian-Lan; Yao, Nan; Wang, Ying; Wu, Xin; Ye, Wen-Cai] Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Jinan University; Jinan University	Huang, Y (corresponding author), Chinese Univ Hong Kong, Inst Vasc Med, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.	yu-huang@cuhk.edu.hk; chywc@yahoo.com.cn	Huang, Yu/K-2866-2017; San Cheang, Wan/W-9534-2019	Huang, Yu/0000-0002-1277-6784; Cheang, Wai San/0000-0002-1152-7997	Program for ChangJiang Scholars and Innovative Research Team in University [IRT0965]; National Science Foundation of China [30901847, 81172946]; Science and Technology Program of China [2012ZX09103101-053]; Guangzhou City [2011J2200045]	Program for ChangJiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of China; Guangzhou City	This work was supported by Program for ChangJiang Scholars and Innovative Research Team in University (IRT0965), National Science Foundation of China (No. 30901847 and 81172946), Science and Technology Program of China (2012ZX09103101-053) and Guangzhou City (2011J2200045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinloye OA, 2011, TURK J BIOCHEM, V36, P237; Anwar M.M., 2010, ADV NAT APPL SCI, V4, P311; Cheang WS, 2011, CARDIOVASC RES, V92, P267, DOI 10.1093/cvr/cvr233; COOKSEY CJ, 1982, PHYTOCHEMISTRY, V21, P2935, DOI 10.1016/0031-9422(80)85072-2; Ji XY, 2011, ACTA PHARM SIN B, V1, P93, DOI 10.1016/j.apsb.2011.06.005; Kong Y, 2010, FOOD CHEM, V121, P1150, DOI 10.1016/j.foodchem.2010.01.062; Kundu R, 2008, J ETHNOPHARMACOL, V118, P440, DOI 10.1016/j.jep.2008.05.010; Lee DL, 2004, HYPERTENSION, V44, P796, DOI 10.1161/01.HYP.0000148303.98066.ab; Leung FP, 2005, AM J PHYSIOL-RENAL, V289, pF137, DOI 10.1152/ajprenal.00353.2004; Luo QF, 2008, PHYTOMEDICINE, V15, P932, DOI 10.1016/j.phymed.2008.03.002; Luo Qing-Feng, 2008, Yaoxue Xuebao, V43, P145; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Ratz PH, 2005, AM J PHYSIOL-CELL PH, V288, pC769, DOI 10.1152/ajpcell.00529.2004; Ruan CJ, 2009, NEUROSCI LETT, V467, P159, DOI 10.1016/j.neulet.2009.10.029; Salamanca DA, 2005, BIOCHEM PHARMACOL, V70, P1537, DOI 10.1016/j.bcp.2005.07.017; Sanders KM, 2008, NEUROGASTROENT MOTIL, V20, P39, DOI 10.1111/j.1365-2982.2008.01108.x; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; SCHRAMM M, 1985, J CARDIOVASC PHARM, V7, P493, DOI 10.1097/00005344-198505000-00012; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; THOMAS G, 1985, CIRC RES, V56, P87, DOI 10.1161/01.RES.56.1.87; Tian XY, 2012, PHARMACOL RES, V65, P239, DOI 10.1016/j.phrs.2011.11.006; Watanabe Y, 2001, BLOOD, V97, P3798, DOI 10.1182/blood.V97.12.3798; Wong WT, 2010, CIRC RES, V107, P984, DOI 10.1161/CIRCRESAHA.110.222794; Wong WT, 2010, J CARDIOVASC PHARM, V55, P300, DOI 10.1097/FJC.0b013e3181d7671c; Wu N, 2010, J AGR FOOD CHEM, V58, P4737, DOI [10.1021/jf904593n, 10.1021/jf103970b]; Wu N, 2009, MOLECULES, V14, P1032, DOI 10.3390/molecules14031032; Xiao LQ, 2009, J BIOL CHEM, V284, P29365, DOI 10.1074/jbc.M109.007971; Zheng Yuan-yuan, 2007, Yaoxue Xuebao, V42, P386; Zheng Yuan-yuan, 2007, Yaoxue Xuebao, V42, P562; Zu YG, 2010, PHYTOMEDICINE, V17, P1095, DOI 10.1016/j.phymed.2010.04.005	31	8	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47030	10.1371/journal.pone.0047030	http://dx.doi.org/10.1371/journal.pone.0047030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056567	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400047
J	Honda, K; Okusaka, T; Felix, K; Nakamori, S; Sata, N; Nagai, H; Ioka, T; Tsuchida, A; Shimahara, T; Shimahara, M; Yasunami, Y; Kuwabara, H; Sakuma, T; Otsuka, Y; Ota, N; Shitashige, M; Kosuge, T; Buchler, MW; Yamada, T				Honda, Kazufumi; Okusaka, Takuji; Felix, Klaus; Nakamori, Shoji; Sata, Naohiro; Nagai, Hideo; Ioka, Tatsuya; Tsuchida, Akihiko; Shimahara, Takeshi; Shimahara, Masashi; Yasunami, Yohichi; Kuwabara, Hideya; Sakuma, Tomohiro; Otsuka, Yoshihiko; Ota, Norihito; Shitashige, Miki; Kosuge, Tomoo; Buechler, Markus W.; Yamada, Tesshi			Altered Plasma Apolipoprotein Modifications in Patients with Pancreatic Cancer: Protein Characterization and Multi-Institutional Validation	PLOS ONE			English	Article							MASS-SPECTROMETRY; DENSITY-LIPOPROTEIN; SERUM; PATTERNS; TUMOR; IDENTIFICATION; BIOMARKER; MARKERS	Background: Among the more common human malignancies, invasive ductal carcinoma of the pancreas has the worst prognosis. The poor outcome seems to be attributable to difficulty in early detection. Methods: We compared the plasma protein profiles of 112 pancreatic cancer patients with those of 103 sex- and age-matched healthy controls (Cohort 1) using a newly developed matrix-assisted laser desorption/ionization (oMALDI) QqTOF (quadrupole time-of-flight) mass spectrometry (MS) system. Results: We found that hemi-truncated apolipoprotein AII dimer (ApoAII-2; 17252 m/z), unglycosylated apolipoprotein CIII (ApoCIII-0; 8766 m/z), and their summed value were significantly decreased in the pancreatic cancer patients [P = 1.36 x 10(-21), P = 4.35 x 10(-14), and P = 1.83 x 10(-24) (Mann-Whitney U-test); area-under-curve values of 0.877, 0.798, and 0.903, respectively]. The significance was further validated in a total of 1099 plasma/serum samples, consisting of 2 retrospective cohorts [Cohort 2 (n = 103) and Cohort 3 (n = 163)] and a prospective cohort [Cohort 4 (n = 833)] collected from 8 medical institutions in Japan and Germany. Conclusions: We have constructed a robust quantitative MS profiling system and used it to validate alterations of modified apolipoproteins in multiple cohorts of patients with pancreatic cancer.	[Honda, Kazufumi; Shitashige, Miki; Yamada, Tesshi] Natl Canc Ctr, Div Chemotherapy & Clin Res, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Felix, Klaus; Buechler, Markus W.] Univ Heidelberg, Dept Surg, D-6900 Heidelberg, Germany; [Nakamori, Shoji] Natl Hosp Org, Osaka Natl Hosp, Dept Surg, Osaka, Japan; [Sata, Naohiro; Nagai, Hideo] Jichi Med Univ, Dept Surg, Shimotsuke, Japan; [Ioka, Tatsuya] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; [Tsuchida, Akihiko] Tokyo Med Univ, Dept Surg 3, Tokyo, Japan; [Shimahara, Takeshi; Shimahara, Masashi] Osaka Med Coll, Dept Oral Surg, Osaka, Japan; [Yasunami, Yohichi] Fukuoka Univ, Fac Med, Dept Regenerat Med & Transplantat, Fukuoka 81401, Japan; [Kuwabara, Hideya; Sakuma, Tomohiro] Mitsui Knowledge Ind, BioBusiness Grp, Tokyo, Japan; [Otsuka, Yoshihiko; Ota, Norihito] Molecuence Corp, Pancreat Canc Diag Project, Yokohama, Kanagawa, Japan; [Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Ruprecht Karls University Heidelberg; Osaka National Hospital; Jichi Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Medical University; Osaka Medical College; Fukuoka University; National Cancer Center - Japan	Yamada, T (corresponding author), Natl Canc Ctr, Div Chemotherapy & Clin Res, Tokyo, Japan.	tyamada@ncc.go.jp			Program for Promotion of Fundamental Studies in Health Sciences; German Research Foundation (DFG) [FE 940/2-1]	Program for Promotion of Fundamental Studies in Health Sciences; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences conducted by the National Institute of Biomedical Innovation of Japan, Health and Labour Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan, the National Cancer Center Research and Development Fund, and in part by the German Research Foundation (DFG) (FE 940/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Bondarenko PV, 1999, J LIPID RES, V40, P543; Diamandis EP, 2006, CANCER RES, V66, P5540, DOI 10.1158/0008-5472.CAN-05-4503; Duffy MJ, 2010, ANN ONCOL, V21, P441, DOI 10.1093/annonc/mdp332; Ehmann M, 2007, PANCREAS, V34, P205, DOI 10.1097/01.mpa.0000250128.57026.b2; Hartmann D, 2007, PANCREAS, V35, P334, DOI 10.1097/mpa.0b013e3180cac723; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, CANCER RES, V65, P10613, DOI 10.1158/0008-5472.CAN-05-1851; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; ITO Y, 1989, J LIPID RES, V30, P1781; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kikuchi S, 2007, CANCER SCI, V98, P822, DOI 10.1111/j.1349-7006.2007.00458.x; Lowenfels AB, 2004, JPN J CLIN ONCOL, V34, P238, DOI 10.1093/jjco/hyh045; Matsugi S, 2007, CLIN CHIM ACTA, V378, P147, DOI 10.1016/j.cca.2006.11.010; Okusaka T, 2006, J PANCREAS, V7, P332; Ono M, 2009, J BIOL CHEM, V284, P29041, DOI 10.1074/jbc.M109.041749; Pankhurst G, 2003, J LIPID RES, V44, P349, DOI 10.1194/jlr.M200256-JLR200; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Safi F, 1997, J Gastrointest Surg, V1, P106, DOI 10.1016/S1091-255X(97)80097-2; Sata N, 2009, J HEPATO-BILIARY-PAN, V16, P485, DOI 10.1007/s00534-009-0077-7; Sato S, 2005, GASTROENTEROLOGY, V129, P1225, DOI 10.1053/j.gastro.2005.07.025; Tanaka S, 2004, PANCREAS, V28, P268, DOI 10.1097/00006676-200404000-00010; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331; Yamamoto M, 1998, PANCREAS, V16, P238, DOI 10.1097/00006676-199804000-00006	26	35	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46908	10.1371/journal.pone.0046908	http://dx.doi.org/10.1371/journal.pone.0046908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056525	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500108
J	Hufford, MM; Richardson, G; Zhou, HX; Manicassamy, B; Garcia-Sastre, A; Enelow, RI; Braciale, TJ				Hufford, Matthew M.; Richardson, Graham; Zhou, Haixia; Manicassamy, Balaji; Garcia-Sastre, Adolfo; Enelow, Richard I.; Braciale, Thomas J.			Influenza-Infected Neutrophils within the Infected Lungs Act as Antigen Presenting Cells for Anti-Viral CD8(+) T Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; VIRUS INFECTION; DENDRITIC CELLS; POLYMORPHONUCLEAR LEUKOCYTES; IN-VIVO; A VIRUS; ACTIVATION; RESPONSES; MICE; IMMUNOPATHOLOGY	Influenza A virus (IAV) is a leading cause of respiratory tract disease worldwide. Anti-viral CD8(+) T lymphocytes responding to IAV infection are believed to eliminate virally infected cells by direct cytolysis but may also contribute to pulmonary inflammation and tissue damage via the release of pro-inflammatory mediators following recognition of viral antigen displaying cells. We have previously demonstrated that IAV antigen expressing inflammatory cells of hematopoietic origin within the infected lung interstitium serve as antigen presenting cells (APC) for infiltrating effector CD8(+) T lymphocytes; however, the spectrum of inflammatory cell types capable of serving as APC was not determined. Here, we demonstrate that viral antigen displaying neutrophils infiltrating the IAV infected lungs are an important cell type capable of acting as APC for effector CD8(+) T lymphocytes in the infected lungs and that neutrophils expressing viral antigen as a result of direct infection by IAV exhibit the most potent APC activity. Our findings suggest that in addition to their suggested role in induction of the innate immune responses to IAV, virus clearance, and the development of pulmonary injury, neutrophils can serve as APCs to anti-viral effector CD8(+) T cells within the infected lung interstitium.	[Hufford, Matthew M.; Zhou, Haixia; Braciale, Thomas J.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA; [Hufford, Matthew M.; Richardson, Graham; Braciale, Thomas J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Richardson, Graham] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA; [Manicassamy, Balaji; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Manicassamy, Balaji; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY USA; [Enelow, Richard I.] Dartmouth Med Sch, Dept Microbiol Immunol, Lebanon, NH USA; [Enelow, Richard I.] Dartmouth Med Sch, Dept Med, Lebanon, NH USA; [Braciale, Thomas J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Virginia; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Dartmouth College; Dartmouth College; University of Virginia	Braciale, TJ (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA.	tjb2r@virginia.edu		Manicassamy, Balaji/0000-0003-1964-0967; Garcia-Sastre, Adolfo/0000-0002-6551-1827	National Institutes of Health (NIH) [RO1 AI-15608, RO1 AI-37293, RO1 HL-33391, U-10 AI-83024, U-19 AI-83024, U19 AI-083025, U01 AI-095611, NIH K99, 1K99 AI095320-01, T32 AI007496-13]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015608, U19AI083025, K99AI095320, U19AI083024, U01AI095611, T32AI055432, T32AI007496, R01AI037293] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by grants from the National Institutes of Health (NIH) to TJB (RO1 AI-15608, RO1 AI-37293, RO1 HL-33391, and U-10 AI-83024), to RIE (U-19 AI-83024), to the Mucosal Immunity Study Team Program and AGS (U19 AI-083025 and U01 AI-095611), to BM (NIH K99 Pathway to Independence Award 1K99 AI095320-01), and to MMH (T32 AI007496-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; CASSIDY LF, 1988, J CLIN MICROBIOL, V26, P1267, DOI 10.1128/JCM.26.7.1267-1270.1988; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; FUJISAWA H, 1987, J GEN VIROL, V68, P425, DOI 10.1099/0022-1317-68-2-425; GRAHAM MB, 1993, J EXP MED, V178, P1725, DOI 10.1084/jem.178.5.1725; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; HOU S, 1995, EUR J IMMUNOL, V25, P111, DOI 10.1002/eji.1830250120; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Kobayashi SD, 2009, WIRES SYST BIOL MED, V1, P309, DOI 10.1002/wsbm.32; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Larochelle B, 1998, BLOOD, V92, P291, DOI 10.1182/blood.V92.1.291.413k34_291_299; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Mamas MA, 2008, INT J CARDIOL, V130, P304, DOI 10.1016/j.ijcard.2008.04.044; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; McGill J, 2010, J EXP MED, V207, P521, DOI 10.1084/jem.20091711; Megiovanni AM, 2006, J LEUKOCYTE BIOL, V79, P977, DOI 10.1189/jlb.0905526; Olins DE, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-39; PEPER RL, 1995, MICROB PATHOGENESIS, V19, P175, DOI 10.1006/mpat.1995.0056; Potter NS, 2001, J IMMUNOL, V167, P2538, DOI 10.4049/jimmunol.167.5.2538; Saez-Lopez C, 2005, MICROBES INFECT, V7, P1139, DOI 10.1016/j.micinf.2005.03.021; Sakai S, 2000, J VIROL, V74, P2472, DOI 10.1128/JVI.74.5.2472-2476.2000; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Sun J, 2011, NAT IMMUNOL; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Topham DJ, 1997, J IMMUNOL, V159, P5197; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860; Zhao YY, 2008, CLIN INFECT DIS, V47, P1575, DOI 10.1086/593196	39	80	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46581	10.1371/journal.pone.0046581	http://dx.doi.org/10.1371/journal.pone.0046581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056353	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500050
J	Niu, CY; Zhang, JY; Gao, F; Yang, LQ; Jia, MZ; Zhu, HN; Gong, WM				Niu, Chunyan; Zhang, Jiayu; Gao, Feng; Yang, Liuqing; Jia, Minze; Zhu, Haining; Gong, Weimin			FUS-NLS/Transportin 1 Complex Structure Provides Insights into the Nuclear Targeting Mechanism of FUS and the Implications in ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DISEASE PROGRESSION; MOTOR-NEURONS; MUTANT SOD1; MUTATIONS; PROTEIN; TLS; MODEL; ONSET; GENE	The C-terminal nuclear localization sequence of FUsed in Sarcoma (FUS-NLS) is critical for its nuclear import mediated by transportin (Trn1). Familial amyotrophic lateral sclerosis (ALS) related mutations are clustered in FUS-NLS. We report here the structural, biochemical and cell biological characterization of the FUS-NLS and its clinical implications. The crystal structure of the FUS-NLS/Trn1 complex shows extensive contacts between the two proteins and a unique alpha-helical structure in the FUS-NLS. The binding affinity between Trn1 and FUS-NLS (wide-type and 12 ALS-associated mutants) was determined. As compared to the wide-type FUS-NLS (K-D = 1.7 nM), each ALS-associated mutation caused a decreased affinity and the range of this reduction varied widely from 1.4-fold over 700-fold. The affinity of the mutants correlated with the extent of impaired nuclear localization, and more importantly, with the duration of disease progression in ALS patients. This study provides a comprehensive understanding of the nuclear targeting mechanism of FUS and illustrates the significance of FUS-NLS in ALS.	[Zhang, Jiayu; Yang, Liuqing; Zhu, Haining] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Zhang, Jiayu; Yang, Liuqing; Zhu, Haining] Univ Kentucky, Coll Med, Struct Biol Ctr, Lexington, KY USA; [Niu, Chunyan; Gao, Feng; Jia, Minze; Gong, Weimin] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100080, Peoples R China	University of Kentucky; University of Kentucky; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhu, HN (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	haining@email.uky.edu; wgong@ibp.ac.cn	Niu, Chunyan/AAM-5018-2021; Zhu, Haining/A-6076-2008; Yang, Liuqing/AAU-6593-2021	Zhu, Haining/0000-0001-5498-6694; Yang, Liuqing/0000-0003-0231-6837; Zhang, jiayu/0000-0003-0137-746X	National Institutes of Health [R01NS077284]; ALS Association [6SE340]; 973 Program of the Ministry of Science and Technology [2009CB825501, 2011CB910503]; National Natural Science Foundation of China [31021062, 31070659]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; 973 Program of the Ministry of Science and Technology(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was in part supported by the National Institutes of Health grant R01NS077284 and the ALS Association grant 6SE340 to H.Z., the 973 Program (Grant Nos. 2009CB825501 and 2011CB910503) of the Ministry of Science and Technology, and National Natural Science Foundation of China (Grant Nos. 31021062 and 31070659) to W. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baumer D, 2010, NEUROLOGY, V75, P611, DOI 10.1212/WNL.0b013e3181ed9cde; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Chio A, 2009, NEUROBIOL AGING, V30, P1272, DOI 10.1016/j.neurobiolaging.2009.05.001; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Huang EJ, 2010, BRAIN PATHOL, V20, P1069, DOI 10.1111/j.1750-3639.2010.00413.x; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lobsiger CS, 2009, P NATL ACAD SCI USA, V106, P4465, DOI 10.1073/pnas.0813339106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neumann M, 2009, ACTA NEUROPATHOL, V118, P605, DOI 10.1007/s00401-009-0581-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Suzuki N, 2010, J HUM GENET, V55, P252, DOI 10.1038/jhg.2010.16; Tan AY, 2012, P NATL ACAD SCI USA, V109, P6030, DOI 10.1073/pnas.1203028109; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xia RH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-10; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yan J, 2010, NEUROLOGY, V75, P807, DOI 10.1212/WNL.0b013e3181f07e0c; Zhang ZC, 2012, P NATL ACAD SCI; Zinszner H, 1997, ONCOGENE, V14, P451, DOI 10.1038/sj.onc.1200854; Zinszner H, 1997, J CELL SCI, V110, P1741	38	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47056	10.1371/journal.pone.0047056	http://dx.doi.org/10.1371/journal.pone.0047056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056579	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500130
J	Poudel, RC; Moller, M; Gao, LM; Ahrends, A; Baral, SR; Liu, J; Thomas, P; Li, DZ				Poudel, Ram C.; Moeller, Michael; Gao, Lian-Ming; Ahrends, Antje; Baral, Sushim R.; Liu, Jie; Thomas, Philip; Li, De-Zhu			Using Morphological, Molecular and Climatic Data to Delimitate Yews along the Hindu Kush-Himalaya and Adjacent Regions	PLOS ONE			English	Article							TAXUS-WALLICHIANA; GARHWAL HIMALAYA; TAXACEAE; PLANT; DISTRIBUTIONS; CONSERVATISM; DIVERGENCE; MEGHALAYA; BACCATA	Background: Despite the availability of several studies to clarify taxonomic problems on the highly threatened yews of the Hindu Kush-Himalaya (HKH) and adjacent regions, the total number of species and their exact distribution ranges remains controversial. We explored the use of comprehensive sets of morphological, molecular and climatic data to clarify taxonomy and distributions of yews in this region. Methodology/Principal Findings: A total of 743 samples from 46 populations of wild yew and 47 representative herbarium specimens were analyzed. Principle component analyses on 27 morphological characters and 15 bioclimatic variables plus altitude and maximum parsimony analysis on molecular ITS and trnL-F sequences indicated the existence of three distinct species occurring in different ecological (climatic) and altitudinal gradients along the HKH and adjacent regions Taxus contorta from eastern Afghanistan to the eastern end of Central Nepal, T. wallichiana from the western end of Central Nepal to Northwest China, and the first report of the South China low to mid-elevation species T. mairei in Nepal, Bhutan, Northeast India, Myanmar and South Vietnam. Conclusion/Significance: The detailed sampling and combination of different data sets allowed us to identify three clearly delineated species and their precise distribution ranges in the HKH and adjacent regions, which showed no overlap or no distinct hybrid zone. This might be due to differences in the ecological (climatic) requirements of the species. The analyses further provided the selection of diagnostic morphological characters for the identification of yews occurring in the HKH and adjacent regions. Our work demonstrates that extensive sampling combined with the analysis of diverse data sets can reliably address the taxonomy of morphologically challenging plant taxa.	[Poudel, Ram C.; Moeller, Michael; Gao, Lian-Ming; Liu, Jie; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Poudel, Ram C.; Liu, Jie; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Poudel, Ram C.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Poudel, Ram C.; Moeller, Michael; Ahrends, Antje; Thomas, Philip] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Baral, Sushim R.] Dept Plant Resources, Natl Herbarium & Plant Labs, Godawari, Lalitpur, Nepal	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Moller, M (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.	m.moeller@rbge.org.uk; gaolm@mail.kib.ac.cn; dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011; Moeller, Michael/O-9748-2015; Gao, Lian-Ming/AAU-2613-2021; Gao, Lianming/H-4527-2011	Li, De-Zhu/0000-0002-4990-724X; Moeller, Michael/0000-0002-2819-0323; Gao, Lian-Ming/0000-0001-9047-2658; Gao, Lianming/0000-0001-9047-2658; jie, liu/0000-0003-4356-1943	National Natural Science Foundation of China (NSFC) [30700042]; West Light Programme of the Chinese Academy of Sciences (CAS) [9223111W1]; Talent project of Yunnan province, China [2008YP064]; Federation of Community Forest Users in Nepal (FECOFUN); several community forest user groups	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); West Light Programme of the Chinese Academy of Sciences (CAS); Talent project of Yunnan province, China; Federation of Community Forest Users in Nepal (FECOFUN); several community forest user groups	This study was supported by the National Natural Science Foundation of China (NSFC: 30700042), the West Light Programme of the Chinese Academy of Sciences (CAS) (9223111W1) and the Talent project of Yunnan province, China (2008YP064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Department of Forests, the Department of National Parks and Wildlife Conservation, the Department of Plant Resources (Ministry of Forests & Soil Conservation) and the Department of Quarantine (Ministry of Agriculture Cooperatives) in Kathmandu, Nepal, for issuing permits (DoF066/067-827; DoA-S.S.P.C.8/4/10/175-066/67) for field collection in Nepal. We also thank the Federation of Community Forest Users in Nepal (FECOFUN), and several community forest user groups for their help and support of our study. We are thankful to the kind villagers in Xizang (Tibet) and Yunnan for helping us to find yew populations. Our special thanks to staff at the herbaria of the Royal Botanic Garden Kew (K), the Royal Botanic Garden Edinburgh (E), the Natural History Museum (BM), the National Herbarium and Plant Laboratories (KATH), the Tribhuvan University, Central Herbarium, Kathmandu (TUCH), the Institute of Botany, CAS, Beijing (PE), and the Kunming Institute of Botany, CAS, Kunming (KUN) for enabling access to study herbarium specimens. We are also grateful to Amin Shah, De-Quan Zhang, Jun-Bo Yang, Hong-Tao Li, Hai-Ying Yu, Dharma R. Dhungana, Dan Warren, Krishna K. Shrestha, Keshab R. Rajbhandari, Apsara Chapagain, Binod K. Poudel, Anuj Pokhrel, Pitambar Bhandari and Nguyen Sinh Khang for their help. Finally, we thank two anonymous reviewers for their very constructive comments. The Royal Botanic Garden Edinburgh is supported by the Rural and Environment Science and Analytical Services division (RESAS) in the Scottish Government.	Adnan S. M., 2006, Lyonia, V11, P91; [Anonymous], 2004, HOTSPOTS REVISITED E; Bahadur J, 1993, HIMALAYAS 3 POLAR RE, P181; BANERJI ML, 1963, VEGETATIO, V11, P287; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Collins D, 2003, AM J BOT, V90, P175, DOI 10.3732/ajb.90.2.175; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Debabrata Saha, 2010, Journal of Non-Timber Forest Products, V17, P387; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Exposito O, 2009, ANTI-CANCER AGENT ME, V9, P109, DOI 10.2174/187152009787047761; Farjon A, 2010, HANDBOOK OF THE WORLD'S CONIFERS, VOL 1, P1, DOI 10.1163/9789047430629; Fischer J, 2001, J BIOGEOGR, V28, P293, DOI 10.1046/j.1365-2699.2001.00554.x; Fu LK, 1999, FLORA CHINA, V4, P89; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Ghimire S.K., 2008, NONTIMBER FOREST PRO; Godsoe W, 2012, ECOGRAPHY, V35, P001; Godsoe W, 2009, NEW PHYTOL, V183, P589, DOI 10.1111/j.1469-8137.2009.02942.x; HAJRA PK, 1990, P INDIAN AS-PLANT SC, V100, P263; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hussain M., 2006, ETHNOBOTANICAL LEAFL, V10, P72; JAISWAL V, 2010, INDIAN J TRADIT KNOW, V9, P38; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kayang H, 2007, INDIAN J TRADIT KNOW, V6, P177; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Kress WJ., 2003, CHECKLIST TREES SHRU, V45; Lanker Ubeed, 2010, International Journal of Biodiversity Science Ecosystem Services & Management, V6, P20, DOI 10.1080/21513732.2010.527302; Le DK, 2003, FOREST TREE SPECIES; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; Li Jianhua, 2001, Harvard Papers in Botany, V6, P267; Liu J., 2011, THESIS CHINESE ACAD; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Manandhar NP, 2002, PLANTS PEOPLE NEPAL; Moller M, 2007, BOT J LINN SOC, V155, P307, DOI 10.1111/j.1095-8339.2007.00697.x; Mohapatra KP, 2009, NEW FOREST, V37, P109, DOI 10.1007/s11056-008-9112-9; MOLNAR P, 1986, AM SCI, V74, P144; Mulliken T, 2008, REV STATUS HARVEST T; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nasir E, 1987, FLORA PAKISTAN TAXAC, V185; Nasir E, 1987, FLORA PAKISTAN PINAC, V182; Nguyen T. B., 2007, RED DATA BOOK VIETNA, V2; Norbu PW, 1996, BASIC INFORM BHUTANS; Owen LA, 1998, GEOMORPHOLOGY, V26, P171, DOI 10.1016/S0169-555X(98)00057-9; Pearson RG, 2002, ECOL MODEL, V154, P289, DOI 10.1016/S0304-3800(02)00056-X; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips S., 2004, MAXIMUM ENTROPY APPR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phondani P. C., 2010, Ethnobotany Research and Applications, V8, P233; Poudel RC, 2012, THESIS CHINESE ACAD; Press JR., 2000, ANNOTATED CHECKLIST; Puglisi C, 2011, PHYTOTAXA, V38, P1; SCHIPPMANN U, 2001, CITES MED PLANTS SIG; Shah A, 2008, TAXON, V57, P211, DOI 10.2307/25065961; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SINGH H, 1990, ECON BOT, V44, P349, DOI 10.1007/BF03183917; Spjut Richard W., 2007, Journal of the Botanical Research Institute of Texas, V1, P203; Stearn WT, 1960, B BRIT MUS NAT HIST, V2, P61; Sundriyal M, 2004, ECON BOT, V58, P626, DOI 10.1663/0013-0001(2004)058[0626:DUOWPR]2.0.CO;2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wangchuk P., 2008, Journal of Bhutan Studies, V19, P66; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Woodward F.I., 1987, CLIMATE PLANT DISTRI	68	37	42	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46873	10.1371/journal.pone.0046873	http://dx.doi.org/10.1371/journal.pone.0046873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056501	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500096
J	Samuel, MA; Valdez, G; Tapia, JC; Lichtman, JW; Sanes, JR				Samuel, Melanie A.; Valdez, Gregorio; Tapia, Juan C.; Lichtman, Jeff W.; Sanes, Joshua R.			Agrin and Synaptic Laminin Are Required to Maintain Adult Neuromuscular Junctions	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NERVE TERMINALS; IN-VIVO; PROTEOLYTIC CLEAVAGE; INVIVO VISUALIZATION; SKELETAL-MUSCLE; TRANSGENIC MICE; DISTINCT ROLES; BASAL LAMINA; MUTANT MICE	As synapses form and mature the synaptic partners produce organizing molecules that regulate each other's differentiation and ensure precise apposition of pre- and post-synaptic specializations. At the skeletal neuromuscular junction (NMJ), these molecules include agrin, a nerve-derived organizer of postsynaptic differentiation, and synaptic laminins, muscle-derived organizers of presynaptic differentiation. Both become concentrated in the synaptic cleft as the NMJ develops and are retained in adulthood. Here, we used mutant mice to ask whether these organizers are also required for synaptic maintenance. Deletion of agrin from a subset of adult motor neurons resulted in the loss of acetylcholine receptors and other components of the postsynaptic apparatus and synaptic cleft. Nerve terminals also atrophied and eventually withdrew from muscle fibers. On the other hand, mice lacking the presynaptic organizer laminin-alpha 4 retained most of the synaptic cleft components but exhibited synaptic alterations reminiscent of those observed in aged animals. Although we detected no marked decrease in laminin or agrin levels at aged NMJs, we observed alterations in the distribution and organization of these synaptic cleft components suggesting that such changes could contribute to age-related synaptic disassembly. Together, these results demonstrate that pre- and post-synaptic organizers actively function to maintain the structure and function of adult NMJs.	[Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sanes, JR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu			NIH [R01AG32322, R01NS59853]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants R01AG32322 and R01NS59853 from the NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDONIAN MH, 1988, INT J SPORTS MED, V9, P218, DOI 10.1055/s-2007-1025009; Bair EL, 2005, NEOPLASIA, V7, P380, DOI 10.1593/neo.04619; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; Baudoin C, 2005, J INVEST DERMATOL, V125, P883, DOI 10.1111/j.0022-202X.2005.23881.x; Bezakova G, 2001, J CELL BIOL, V153, P1441, DOI 10.1083/jcb.153.7.1441; Bolliger MF, 2010, J CELL SCI, V123, P3944, DOI 10.1242/jcs.072090; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; Butikofer L, 2011, FASEB J, V25, P4378, DOI 10.1096/fj.11-191262; Burgess RW, 2002, J NEUROCHEM, V83, P271, DOI 10.1046/j.1471-4159.2002.01102.x; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Campagna JA, 1997, EUR J NEUROSCI, V9, P2269, DOI 10.1111/j.1460-9568.1997.tb01645.x; CARDASIS CA, 1987, MUSCLE NERVE, V10, P200, DOI 10.1002/mus.880100303; Cohen MW, 2000, J NEUROSCI, V20, P4912; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Deschenes MR, 2006, NEUROSCIENCE, V137, P1277, DOI 10.1016/j.neuroscience.2005.10.042; FAHIM MA, 1982, J NEUROCYTOL, V11, P641, DOI 10.1007/BF01262429; FAHIM MA, 1983, J NEUROCYTOL, V12, P13, DOI 10.1007/BF01148085; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gomez AM, 2010, AUTOIMMUNITY, V43, P353, DOI 10.3109/08916930903555943; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harvey SJ, 2007, AM J PATHOL, V171, P139, DOI 10.2353/ajpath.2007.061116; Hesser BA, 2006, MOL CELL NEUROSCI, V31, P470, DOI 10.1016/j.mcn.2005.10.020; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Marangi PA, 2001, EMBO J, V20, P7060, DOI 10.1093/emboj/20.24.7060; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Miyamaru S, 2008, LARYNGOSCOPE, V118, P1318, DOI 10.1097/MLG.0b013e31816f693f; Nishimune H, 2008, J CELL BIOL, V182, P1201, DOI 10.1083/jcb.200805095; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Ruggiu M, 2009, P NATL ACAD SCI USA, V106, P3513, DOI 10.1073/pnas.0813112106; SANES JR, 1984, J NEUROSCI, V4, P464; Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Werle MJ, 2003, J NEUROCYTOL, V32, P905, DOI 10.1023/B:NEUR.0000020631.69804.f5; WIGSTON DJ, 1990, J NEUROSCI, V10, P1753; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Yumoto N, 2012, NATURE, V489, P438, DOI 10.1038/nature11348; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	61	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46663	10.1371/journal.pone.0046663	http://dx.doi.org/10.1371/journal.pone.0046663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056392	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000071
J	Wald, NJ; Bestwick, JP; George, LM; Huttly, WJ				Wald, Nicholas J.; Bestwick, Jonathan P.; George, Lynne M.; Huttly, Wayne J.			Antenatal Screening for Down Syndrome Using Serum Placental Growth Factor with the Combined, Quadruple, Serum Integrated and Integrated Tests	PLOS ONE			English	Article							MATERNAL SERUM; NUCHAL TRANSLUCENCY; PREGNANCIES; PREECLAMPSIA; TRIMESTER; AGE; PREDICTION; TRISOMY-21; MARKERS; RISK	Objective: To estimate the value of first or second trimester placental growth factor (PlGF) as an additional antenatal screening marker for Down syndrome. Design: Nested case-control study. Setting: Antenatal screening service. Population or Sample: 532 Down syndrome pregnancies and 1,155 matched unaffected pregnancies. Methods: Stored maternal serum samples (-40 degrees C) were assayed for PlGF. Monte Carlo simulation was used to estimate the screening performance of PlGF with the Combined, Quadruple, serum Integrated and Integrated tests. Main Outcome Measures: Median PlGF levels in affected and unaffected pregnancies and screening performance (detection rates [DR] for specified false-positive rates [FPR] and vice versa). Results: First trimester median PlGF was 15%, 28% and 39% lower in Down syndrome than unaffected pregnancies at 11, 12 and 13 completed weeks' gestation respectively (all p<0.001). Second trimester median PlGF was 31% lower at 14 weeks (p<0.001), and the difference decreased (6% lower at 17 weeks). At a 90% DR with first trimester markers measured at 13 weeks, adding PlGF decreased the FPR from 11.1 to 5.1% using the Combined test, 9.3% to 4.5% using the serum Integrated test, and 3.4% to 1.5% using the Integrated test (or 1.5 to 1.4% with first trimester markers measured at 11 weeks). Adding PlGF to the Quadruple test (measured at 15 weeks) decreased the FPR from 10.0% to 9.6% at a 90% DR. Conclusions: First trimester PlGF measurements improve the performance of antenatal screening for Down syndrome using the Combined, serum Integrated and Integrated tests. Second trimester PlGF measurements are of limited value.	[Wald, Nicholas J.; Bestwick, Jonathan P.; George, Lynne M.; Huttly, Wayne J.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	Wald, NJ (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England.	n.j.wald@qmul.ac.uk	Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021					Akolekar R, 2011, PRENATAL DIAG, V31, P66, DOI 10.1002/pd.2660; Bestwick JP, 2010, J MED SCREEN, V17, P8, DOI 10.1258/jms.2010.009107; Cowans NJ, 2010, PRENATAL DIAG, V30, P449, DOI 10.1002/pd.2496; Debieve F, 2001, MOL HUM REPROD, V7, P765, DOI 10.1093/molehr/7.8.765; Koster MPH, 2011, ULTRASOUND OBST GYN, V38, P134, DOI 10.1002/uog.8881; Lambert-Messerlian GM, 2004, PRENATAL DIAG, V24, P876, DOI 10.1002/pd.998; Morris JK, 2005, J MED SCREEN, V12, P155, DOI 10.1258/0969141054855283; Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; Morris JK, 2003, PRENATAL DIAG, V23, P252, DOI 10.1002/pd.568; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Office for National Statistics, 2008, BIRTH STAT SER FM1; Office for National Statistics, 2008, BIRTH STAT SER FM1; Office for National Statistics, 2008, BIRTH STAT SER FM1; Pandya P, 2012, FETAL DIAGN THER, V31, P87, DOI 10.1159/000335684; Spencer K, 2001, PRENATAL DIAG, V21, P718, DOI 10.1002/pd.148; Su YN, 2002, PRENATAL DIAG, V22, P8, DOI 10.1002/pd.218; Wald N, 2004, PRENATAL DIAG, V24, P150, DOI 10.1002/pd.840; Wald NJ, 2012, J MED SCREEN, V19, P60, DOI 10.1258/jms.2012.011114; Wald NJ, 2006, J MED SCREEN, V13, P51, DOI 10.1258/096914106776179872; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133; Zaragoza E, 2009, ULTRASOUND OBST GYN, V33, P382, DOI 10.1002/uog.6331	21	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46955	10.1371/journal.pone.0046955	http://dx.doi.org/10.1371/journal.pone.0046955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056541	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000104
J	Lesault, PF; Theret, M; Magnan, M; Cuvellier, S; Niu, YM; Gherardi, RK; Tremblay, JP; Hittinger, L; Chazaud, B				Lesault, Pierre-Francois; Theret, Marine; Magnan, Melanie; Cuvellier, Sylvain; Niu, Yiming; Gherardi, Romain K.; Tremblay, Jacques P.; Hittinger, Luc; Chazaud, Benedicte			Macrophages Improve Survival, Proliferation and Migration of Engrafted Myogenic Precursor Cells into MDX Skeletal Muscle	PLOS ONE			English	Article							MYOBLAST TRANSFER THERAPY; HEAT-SHOCK TREATMENT; DONOR MYOBLASTS; SATELLITE CELLS; GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR; IMMUNODEFICIENT MICE; MUSCULAR-DYSTROPHY; MOUSE MUSCLES; RAPID DEATH	Transplantation of muscle precursor cells is of therapeutic interest for focal skeletal muscular diseases. However, major limitations of cell transplantation are the poor survival, expansion and migration of the injected cells. The massive and early death of transplanted myoblasts is not fully understood although several mechanisms have been suggested. Various attempts have been made to improve their survival or migration. Taking into account that muscle regeneration is associated with the presence of macrophages, which are helpful in repairing the muscle by both cleansing the debris and deliver trophic cues to myoblasts in a sequential way, we attempted in the present work to improve myoblast transplantation by coinjecting macrophages. The present data showed that in the 5 days following the transplantation, macrophages efficiently improved: i) myoblast survival by limiting their massive death, ii) myoblast expansion within the tissue and iii) myoblast migration in the dystrophic muscle. This was confirmed by in vitro analyses showing that macrophages stimulated myoblast adhesion and migration. As a result, myoblast contribution to regenerating host myofibres was increased by macrophages one month after transplantation. Altogether, these data demonstrate that macrophages are beneficial during the early steps of myoblast transplantation into skeletal muscle, showing that coinjecting these stromal cells may be used as a helper to improve the efficiency of parenchymal cell engraftment.	[Lesault, Pierre-Francois; Niu, Yiming; Gherardi, Romain K.; Hittinger, Luc] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Tremblay, Jacques P.] Univ Quebec, CRCH, Ste Foy, PQ G1V 2M3, Canada; [Lesault, Pierre-Francois; Niu, Yiming; Gherardi, Romain K.; Hittinger, Luc] Univ Paris Est Creteil, Creteil, France; [Theret, Marine; Magnan, Melanie; Cuvellier, Sylvain; Chazaud, Benedicte] INSERM, U1016, Inst Cochin, Paris, France; [Theret, Marine; Magnan, Melanie; Cuvellier, Sylvain; Chazaud, Benedicte] CNRS, UMR8104, Paris, France; [Theret, Marine; Magnan, Melanie; Cuvellier, Sylvain; Chazaud, Benedicte] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Quebec; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lesault, PF (corresponding author), Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France.	benedicte.chazaud@inserm.fr	Theret, Marine/AAT-2743-2021; Chazaud, Benedicte/N-9291-2017	Theret, Marine/0000-0002-8059-8756; Chazaud, Benedicte/0000-0002-1262-502X; Tremblay, Jacques P./0000-0001-9404-9195; Hittinger, Luc/0000-0003-1933-5815	Fondation de France; French Society of Cardiology; INSERM; Association Francaise contre les Myopathies (AFM)	Fondation de France(Fondation de France); French Society of Cardiology; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	Fondation de France, French Society of Cardiology, INSERM, Association Francaise contre les Myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Benabdallah BF, 2005, TRANSPLANTATION, V79, P1696, DOI 10.1097/01.TP.0000167379.27872.2B; Bencze M, 2012, MOL THER IN PRESS; Bouchentouf M, 2008, GENE THER, V15, P404, DOI 10.1038/sj.gt.3303059; Bouchentouf M, 2007, AM J TRANSPLANT, V7, P1491, DOI 10.1111/j.1600-6143.2007.01830.x; Bouchentouf M, 2004, TRANSPLANTATION, V77, P1349, DOI 10.1097/01.TP.0000121503.01535.F5; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; DiPasquale DM, 2007, AM J PHYSIOL-CELL PH, V293, pC1278, DOI 10.1152/ajpcell.00201.2007; El Fahime E, 2002, EXP CELL RES, V280, P169, DOI 10.1006/excr.2002.5642; Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8; Guerette B, 1997, J IMMUNOL, V159, P2522; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hodgetts SI, 2003, J CELL SCI, V116, P4131, DOI 10.1242/jcs.00721; Hodgetts SI, 2003, TRANSPLANTATION, V75, P863, DOI 10.1097/01.TP.0000053754.33317.4B; KARPATI G, 1989, AM J PATHOL, V135, P27; Kinoshita I, 1998, MUSCLE NERVE, V21, P91, DOI 10.1002/(SICI)1097-4598(199801)21:1<91::AID-MUS12>3.0.CO;2-3; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Lafreniere JF, 2006, EXP CELL RES, V312, P1127, DOI 10.1016/j.yexcr.2006.01.002; Lafreniere JF, 2004, TRANSPLANTATION, V77, P1741, DOI 10.1097/01.TP.0000131175.60047.EB; Lavasani M, 2006, HUM GENE THER, V17, P180, DOI 10.1089/hum.2006.17.180; Lescaudron L, 1999, NEUROMUSCULAR DISORD, V9, P72, DOI 10.1016/S0960-8966(98)00111-4; Malerba A, 2009, EXP CELL RES, V315, P915, DOI 10.1016/j.yexcr.2009.01.005; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Massimino ML, 1997, BIOCHEM BIOPH RES CO, V235, P754, DOI 10.1006/bbrc.1997.6823; McLennan IS, 1996, J ANAT, V188, P17; Merly F, 1998, TRANSPLANTATION, V65, P793, DOI 10.1097/00007890-199803270-00005; Mills P, 2007, EXP CELL RES, V313, P527, DOI 10.1016/j.yexcr.2006.10.032; Moens PDJ, 1996, J MUSCLE RES CELL M, V17, P37, DOI 10.1007/BF00140322; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; Motohashi N, 2008, AM J PATHOL, V173, P781, DOI 10.2353/ajpath.2008.070902; Negroni E, 2006, PATHOL BIOL, V54, P100, DOI 10.1016/j.patbio.2005.09.001; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pellegrini KL, 2011, TRANSPLANTATION, V91, P522, DOI 10.1097/TP.0b013e318208a8c0; PimoradyEsfahani A, 1997, MUSCLE NERVE, V20, P158, DOI 10.1002/(SICI)1097-4598(199702)20:2<158::AID-MUS4>3.0.CO;2-B; Riederer I, 2008, TRANSPL P, V40, P624, DOI 10.1016/j.transproceed.2008.01.026; Riederer I, 2012, MOL THER, V20, P146, DOI 10.1038/mt.2011.193; ROBERTSON TA, 1993, EXP CELL RES, V207, P321, DOI 10.1006/excr.1993.1199; Sammels LM, 2004, TRANSPLANTATION, V77, P1790, DOI 10.1097/01.tp.0000131150.76841.75; Schleicher Ulrike, 2009, V531, P203, DOI 10.1007/978-1-59745-396-7_14; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Skuk D, 2011, EXPERT OPIN BIOL TH, V11, P359, DOI 10.1517/14712598.2011.548800; Smythe GM, 2000, MUSCLE NERVE, V23, P560; Sonnet C, 2006, J CELL SCI, V119, P2497, DOI 10.1242/jcs.02988; Stanley E R, 1997, Methods Mol Biol, V75, P301; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901; Torrente Y, 2000, CELL TRANSPLANT, V9, P539, DOI 10.1177/096368970000900410; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216	53	43	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46698	10.1371/journal.pone.0046698	http://dx.doi.org/10.1371/journal.pone.0046698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056408	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600053
J	Xiong, A; Duan, LH; Chen, J; Fan, ZG; Zheng, F; Tan, Z; Gong, FL; Fang, M				Xiong, Ali; Duan, Lihua; Chen, Jie; Fan, Zhigang; Zheng, Fang; Tan, Zheng; Gong, Feili; Fang, Min			Flt3L Combined with Rapamycin Promotes Cardiac Allograft Tolerance by Inducing Regulatory Dendritic Cells and Allograft Autophagy in Mice	PLOS ONE			English	Article							KIDNEY-TRANSPLANT PATIENTS; T-CELLS; IN-VITRO; LIVER-TRANSPLANTATION; ACUTE REJECTION; CD8(+) CD28(-); GRAFT-SURVIVAL; RECIPIENTS; PROLONG; VIVO	The induction of immune tolerance is still a formidable challenge in organ transplantation. Dendritic cells (DCs) play an important role in orchestrating immune responses by either mediating protective immune responses or inducing antigen specific tolerance. Previous studies demonstrated that the fms-like tyrosine kinase 3 receptor (Flt3) and its ligand (Flt3L) play an essential role in the regulation of DC commitment and development. Here, we report a synergic effect between Flt3L and low-dose rapamycin (Rapa) in the protection of allograft rejction. It was found that Flt3L combined with Rapa significantly prolonged murine cardiac allograft survival time as compared with that of untreated recipients or recipients treated with Rapa or Flt3L alone. Mechanistic studies revealed that Flt3L combined with low-dose of Rapa induced the generation of tolerogenic DCs along with the production of CD25(+) Foxp3(+) regulatory T cells and IL-10 secretion. We also observed enhanced autophagy in the cardiac allograft, which could be another asset contributing to the enhanced allograft survival. All together, these data suggest that Flt3L combined with low-dose of Rapa could be an effective therapeutic approach to induce tolerance in clinical setting of transplantation.	[Xiong, Ali; Duan, Lihua; Chen, Jie; Fan, Zhigang; Zheng, Fang; Tan, Zheng; Gong, Feili; Fang, Min] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Hubei, Peoples R China; [Gong, Feili; Fang, Min] Minist Educ, Key Lab Organ Transplantat, Wuhan, Hubei, Peoples R China; [Gong, Feili; Fang, Min] Minist Hlth, Key Lab Organ Transplantat, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Gong, FL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Hubei, Peoples R China.	flgong@163.com; minfang89@mail.hust.edu.cn			National Natural Science Foundation of China [81072440]; NSFC-Guangdong Union Grant [U0832003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong Union Grant	This work was supported by the National Natural Science Foundation of China (Grant No. 81072440), NSFC-Guangdong Union Grant (Grant No. U0832003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, AM J TRANSPLANT, V5, P1808, DOI 10.1111/j.1600-6143.2005.00954.x; Baan CC, 2007, CLIN TRANSPLANT, V21, P63, DOI 10.1111/j.1399-0012.2006.00584.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Coates PTH, 2004, TRANSPLANTATION, V77, P1080, DOI 10.1097/01.TP.0000122183.60680.C9; CORRY RJ, 1973, TRANSPLANT P, V5, P733; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Emmanouilidis N, 2006, TRANSPLANTATION, V81, P455, DOI 10.1097/01.tp.0000195779.01491.4e; Fischer RT, 2011, TRANSPL IMMUNOL, V25, P20, DOI 10.1016/j.trim.2011.05.001; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Fu FM, 1996, TRANSPLANTATION, V62, P659, DOI 10.1097/00007890-199609150-00021; Ge W, 2009, AM J TRANSPLANT, V9, P1760, DOI 10.1111/j.1600-6143.2009.02721.x; Gotoh K, 2009, AUTOPHAGY, V5, P351, DOI 10.4161/auto.5.3.7650; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Hendrikx TK, 2009, TRANSPLANTATION, V87, P376, DOI 10.1097/TP.0b013e3181901b69; Huang Y, 2007, AM J TRANSPLANT, V7, P799, DOI 10.1111/j.1600-6143.2007.01734.x; Kahan BD, 2001, TRANSPLANTATION, V72, P1181, DOI 10.1097/00007890-200110150-00001; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lee K, 2004, J IMMUNOL, V172, P6539, DOI 10.4049/jimmunol.172.11.6539; Lin YX, 2009, HEPATOB PANCREAT DIS, V8, P241; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lunemann JD, 2009, CELL DEATH DIFFER, V16, P79, DOI 10.1038/cdd.2008.113; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; O'Connell PJ, 2002, J IMMUNOL, V168, P143, DOI 10.4049/jimmunol.168.1.143; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rastellini C, 1995, TRANSPLANTATION, V60, P1366; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; STARZL TE, 1993, HEPATOLOGY, V17, P1127; Starzl TE, 1996, IMMUNOL TODAY, V17, P577, DOI 10.1016/S0167-5699(96)10070-0; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steptoe RJ, 1997, J IMMUNOL, V159, P5483; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; Suciu-Foca N, 2005, INT IMMUNOPHARMACOL, V5, P7, DOI 10.1016/j.intimp.2004.09.003; Tantravahi J, 2007, ANNU REV MED, V58, P369, DOI 10.1146/annurev.med.58.061705.145143; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Velthuis JHL, 2007, TRANSPL IMMUNOL, V18, P159, DOI 10.1016/j.trim.2007.05.009; Velthuis JHL, 2006, AM J TRANSPLANT, V6, P2955, DOI 10.1111/j.1600-6143.2006.01566.x; Wang Z, 2009, TRANSPL P, V41, P1574, DOI 10.1016/j.transproceed.2009.01.093; Yoshizawa A, 2005, TRANSPLANT P, V37, P37, DOI 10.1016/j.transproceed.2004.12.259; Yu G, 2008, TRANSPL IMMUNOL, V18, P208, DOI 10.1016/j.trim.2007.08.006; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	53	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46230	10.1371/journal.pone.0046230	http://dx.doi.org/10.1371/journal.pone.0046230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056267	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600028
J	Zhang, HH; Zhang, XQ; Wang, WY; Xue, QS; Lu, H; Huang, JL; Gui, T; Yu, BW				Zhang, Hong-Hai; Zhang, Xiao-Qin; Wang, Wen-Yuan; Xue, Qing-Sheng; Lu, Han; Huang, Jin-Lu; Gui, Ting; Yu, Bu-Wei			Increased Synaptophysin Is Involved in Inflammation-Induced Heat Hyperalgesia Mediated by Cyclin-Dependent Kinase 5 in Rats	PLOS ONE			English	Article							SYNAPTIC-VESICLE ENDOCYTOSIS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; PROTEIN-KINASE; MEMBRANE-FUSION; TYROSINE PHOSPHORYLATION; NEUROTRANSMITTER RELEASE; CHANNEL ACTIVITY; DOWN-REGULATION; SNARE COMPLEX	Mechanisms associated with cyclin-dependent kinase 5 (Cdk5)-mediated heat hyperalgesia induced by inflammation remain undefined. This study was designed to examine whether Cdk5 mediates heat hyperalgesia resulting from peripheral injection of complete Freund's adjuvant (CFA) in the spinal dorsal horns of rats by interacting with synaptophysin, a well known membrane protein mediating the endocytosis-exocytosis cycle of synaptic vesicles as a molecular marker associated with presynaptic vesicle membranes. The role of Cdk5 in mediating synaptophysin was examined through the combined use of behavioral approaches, imaging studies, and immunoprecipitation following CFA-induced inflammatory pain. Results showed that Cdk5 colocalized with both synaptophysin and soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptors (SNAREs) consisting of VAMP-2, SNAP-25, and syntaxin 1A in spinal dorsal horn of rats. Increased synaptophysin expression of spinal cord horn neurons post intraplantar injection of CFA coincided with increased duration of heat hyperalgesia lasting from 6 h to 3 d. Intrathecal administration of roscovitine, a Cdk5 specific inhibitor, significantly depressed synaptophysin expression during peak heat hyperalgesia and heat hyperalgesia induced by peripheral injection of CFA. Data presented in this report indicated that calpain activity was transiently upregulated 6 h post CFA-treatment despite previous reports suggesting that calpain was capable of cleaving p35 into p25. Results from previous studies obtained by other laboratories demonstrated that significant changes in p35 expression levels within spinal cord horn neurons were not observed in the CFA-treated inflammatory pain model although significant upregulation of Cdk5 kinase was observed between 2 h to 7 d. Therefore, generation of p25 occurred in a calpain-independent fashion in a CFA-treated inflammatory pain model. Our results demonstrated that increased synaptophysin levels were involved in heat hyperalgesia mediated by Cdk5 in spinal cord dorsal horns of CFA-treated rats, suggesting that inhibiting abnormal activation of Cdk5-synaptophysin may present a novel target for diminishing inflammatory pain.	[Zhang, Hong-Hai; Zhang, Xiao-Qin; Wang, Wen-Yuan; Xue, Qing-Sheng; Lu, Han; Yu, Bu-Wei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Huang, Jin-Lu] Shanghai Jiao Tong Univ, Dept Pharm, Affiliated Hosp 6, Sch Med, Shanghai 200030, Peoples R China; [Gui, Ting] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Anat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, HH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Anesthesiol, Shanghai 200030, Peoples R China.	yubuwei_ruijin@163.com			National Natural Science Foundation, Beijing, P.R. China [81102513, 81072703]	National Natural Science Foundation, Beijing, P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation, Beijing, P.R. China, grant No. 81102513 to Dr. Han Lu and grant No. 81072703 to Dr. Buwei Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDER J, 1995, J NEUROSCI, V15, P511; ALDER J, 1992, SCIENCE, V257, P657, DOI 10.1126/science.1353905; Aley KO, 1999, J NEUROSCI, V19, P2181; Becher A, 1999, J NEUROSCI, V19, P1922; Bhaskar K, 2004, NEUROCHEM INT, V44, P35, DOI 10.1016/S0197-0186(03)00099-8; Camprubi-Robles M, 2009, FASEB J, V23, P3722, DOI 10.1096/fj.09-134346; Charlton E, 1995, Pain, V63, P277, DOI 10.1016/0304-3959(95)90040-3; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chou AK, 2002, NEUROSCI LETT, V333, P155, DOI 10.1016/S0304-3940(02)00575-X; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Evans GJO, 2005, BIOCHEM SOC T, V33, P1350, DOI 10.1042/BST0331350; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; Guo W, 2004, J NEUROSCI, V24, P9161, DOI 10.1523/JNEUROSCI.3422-04.2004; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; INO H, 1994, BRAIN RES, V661, P196, DOI 10.1016/0006-8993(94)91197-5; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kunz S, 2004, PAIN, V110, P409, DOI 10.1016/j.pain.2004.04.031; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Lin JY, 2011, BRAIN RES BULL, V84, P430, DOI 10.1016/j.brainresbull.2011.01.007; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; MARQUEZE-POUEY B, 1991, J NEUROSCI, V11, P3388; Matsushita M, 1996, BRAIN RES, V734, P319, DOI 10.1016/S0006-8993(96)00702-0; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Pareek TK, 2006, CELL CYCLE, V5, P585, DOI 10.4161/cc.5.6.2578; Pareek TK, 2006, P NATL ACAD SCI USA, V103, P791, DOI 10.1073/pnas.0510405103; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; POCKETT S, 1995, ANESTH ANALG, V80, P173, DOI 10.1097/00000539-199501000-00026; Pollonini G, 2008, NEUROSCIENCE, V156, P99, DOI 10.1016/j.neuroscience.2008.07.025; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; REHM H, 1986, EMBO J, V5, P535, DOI 10.1002/j.1460-2075.1986.tb04243.x; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tanaka T, 2001, J NEUROSCI, V21, P550, DOI 10.1523/JNEUROSCI.21-02-00550.2001; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; Whittaker SR, 2004, CANCER RES, V64, P262, DOI 10.1158/0008-5472.CAN-03-0110; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Xie WJ, 2010, J NEUROCHEM, V113, P1002, DOI 10.1111/j.1471-4159.2010.06664.x; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Zhang BS, 2003, PAIN, V106, P187, DOI 10.1016/j.pain.2003.08.003; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4	63	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46666	10.1371/journal.pone.0046666	http://dx.doi.org/10.1371/journal.pone.0046666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056393	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600051
J	Li, CT; Bai, YM; Tu, PC; Lee, YC; Huang, YL; Chen, TJ; Chang, WH; Su, TP				Li, Cheng-Ta; Bai, Ya-Mei; Tu, Pei-Chi; Lee, Ying-Chiao; Huang, Yu-Lin; Chen, Tzeng-Ji; Chang, Wen-Han; Su, Tung-Ping			Major Depressive Disorder and Stroke Risks: A 9-Year Follow-Up Population-Based, Matched Cohort Study	PLOS ONE			English	Article							ANTIDEPRESSANT USE; CEREBROVASCULAR EVENTS; SELECTIVE SEROTONIN; REUPTAKE INHIBITORS; BLOOD-PRESSURE; HYPERTENSION; MORTALITY; METAANALYSIS; ASSOCIATION; PREVENTION	Background and Purpose: Major depressive disorder (MDD) is characterized by recurrent depressive episodes and one of the treatment choices is antidepressants. Patients with MDD are at greater risk of developing major metabolic diseases that may in turn lead to stroke. Moreover, both depressive symptoms and taking antidepressant medications are associated with higher risk of stroke. However, whether and how clinical depression increases stroke risk remains an unanswered question. Our aim was to provide answers to this question. Methods: A matched cohort study of 5015 subjects (1003 MDD patients and 4012 control subjects) was conducted using a nationwide database. Subjects were followed to a maximum of 9 years to determine rates of newly-developed strokes, and controls and MDD groups with different levels of antidepressant refractoriness were compared to determine the temporal relation between stroke and three major metabolic comorbidities (i.e., diabetes mellitus, hypertension and hyperlipidemia). The levels of depressive symptoms and the antidepressant medications before stroke onset were investigated. Results: Patients with MDD had significantly higher rates of stroke (4.3% vs. 2.8%, p < 0.05) during the follow-up. Mediation regression analyses revealed that the occurrence of stroke in the MDD subjects was significantly mediated by the development of major metabolic diseases. Greater severity of depression, but not greater use of antidepressants, preceded the occurrence of stroke. Conclusions: A clinical diagnosis of major depression leads to stroke indirectly through more intense depressive symptoms and the development of major comorbidities.	[Li, Cheng-Ta; Bai, Ya-Mei; Tu, Pei-Chi; Lee, Ying-Chiao; Chang, Wen-Han; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Li, Cheng-Ta; Su, Tung-Ping] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Li, Cheng-Ta; Bai, Ya-Mei; Tu, Pei-Chi; Su, Tung-Ping] Natl Yang Ming Univ, Fac Med, Div Psychiat, Taipei 112, Taiwan; [Huang, Yu-Lin] Natl Yang Ming Univ, Fac Med, Dept Dermatol, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Li, CT (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	tomsu0402@gmail.com	Li, Cheng-Ta/AAI-5759-2021; Chen, TJ/AAH-8430-2021	Li, Cheng-Ta/0000-0002-0670-1153; 	Taipei Veterans General Hospital [V100D-002-1, V101D-001-1]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work is supported by grants from the Taipei Veterans General Hospital (V100D-002-1 and V101D-001-1). This study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the Bureau of National Health Insurance, Department of Health or National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RD, 1987, JAMA-J AM MED ASSOC, V257, P949, DOI 10.1001/jama.257.7.949; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beydoun MA, 2010, J AFFECT DISORDERS, V123, P52, DOI 10.1016/j.jad.2009.09.021; Burns MM, 2010, EXPERT REV NEUROTHER, V10, P1237, DOI [10.1586/ern.10.96, 10.1586/ERN.10.96]; Chen Y, 2008, ANN PHARMACOTHER, V42, P177, DOI 10.1345/aph.1K369; COLANTONIO A, 1992, AM J EPIDEMIOL, V136, P884, DOI 10.1093/aje/136.7.884; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; HASHIMOTO K, 1989, ENDOCRINOLOGY, V125, P1161, DOI 10.1210/endo-125-3-1161; Horner RD, 1998, PHARMACOTHERAPY, V18, p87S; Jonas BS, 2000, PSYCHOSOM MED, V62, P463, DOI 10.1097/00006842-200007000-00001; LARAGH J H, 1973, Transactions and Studies of the College of Physicians of Philadelphia, V41, P131; Lee HC, 2008, BIOL PSYCHIAT, V64, P912, DOI 10.1016/j.biopsych.2008.07.006; Leys D, 2002, J NEUROL, V249, P507, DOI 10.1007/s004150200057; Li CT, 2012, BRIT J PSYCHIAT, V200, P45, DOI 10.1192/bjp.bp.110.086983; Mancia G, 2004, CLIN THER, V26, P631, DOI 10.1016/S0149-2918(04)90065-3; Maurer-Spurej E, 2004, THROMB HAEMOSTASIS, V91, P119, DOI 10.1160/TH03-05-0330; Mello Andrea de Abreu Feijó de, 2003, Rev. Bras. Psiquiatr., V25, P231, DOI 10.1590/S1516-44462003000400010; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Patten SB, 2008, J POPUL THER CLIN PH, V15, pE367; Qizilbash N, 1995, LANCET, V346, P1647; Ramasubbu R, 2004, J CLIN PSYCHIAT, V65, P1642, DOI 10.4088/JCP.v65n1209; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Scalco Andréia Zavaloni, 2005, Clinics, V60, P241, DOI 10.1590/S1807-59322005000300010; Skilton MR, 2007, BIOL PSYCHIAT, V62, P1251, DOI 10.1016/j.biopsych.2007.01.012; Smoller JW, 2009, ARCH INTERN MED, V169, P2128, DOI 10.1001/archinternmed.2009.436; Suslow T, 2010, BIOL PSYCHIAT, V67, P155, DOI 10.1016/j.biopsych.2009.07.023; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064	31	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46818	10.1371/journal.pone.0046818	http://dx.doi.org/10.1371/journal.pone.0046818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056466	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500083
J	Pal, G; Vincze, C; Renner, E; Wappler, EA; Nagy, Z; Lovas, G; Dobolyi, A				Pal, Gabriella; Vincze, Csilla; Renner, Eva; Wappler, Edina A.; Nagy, Zoltan; Lovas, Gabor; Dobolyi, Arpad			Time Course, Distribution and Cell Types of Induction of Transforming Growth Factor Betas following Middle Cerebral Artery Occlusion in the Rat Brain	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; TGF-BETA; NERVOUS-SYSTEM; C-FOS; ISCHEMIC PENUMBRA; BIPHASIC EXPRESSION; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; FOCAL ISCHEMIA; MESSENGER-RNA	Transforming growth factor-beta s (TGF-beta 1-3) are cytokines that regulate the proliferation, differentiation, and survival of various cell types. The present study describes the induction of TGF-beta 1-3 in the rat after focal ischemia at 3 h, 24 h, 72 h and 1 month after transient (1 h) or permanent (24 h) middle cerebral artery occlusion (MCAO) using in situ hybridization histochemistry and quantitative analysis. Double labeling with different markers was used to identify the localization of TGF-beta mRNA relative to the penumbra and glial scar, and the types of cells expressing TGF-beta s. TGF-beta 1 expression increased 3 h after MCAO in the penumbra and was further elevated 24 h after MCAO. TGF-beta 1 was present mostly in microglial cells but also in some astrocytes. By 72 h and 1 month after the occlusion, TGF-beta 1 mRNA-expressing cells also appeared in microglia within the ischemic core and in the glial scar. In contrast, TGF-beta 2 mRNA level was increased in neurons but not in astrocytes or microglial cells in layers II, III, and V of the ipsilateral cerebral cortex 24 h after MCAO. TGF-beta 3 was not induced in cells around the penumbra. Its expression increased in only a few cells in layer II of the cerebral cortex 24 h after MCAO. The levels of TGF-beta 2 and -beta 3 decreased at subsequent time points. Permanent MCAO further elevated the levels of all 3 subtypes of TGF-bs suggesting that reperfusion is not a major factor in their induction. TGF-beta 1 did not co-localize with either Fos or ATF-3, while the co-localization of TGF-beta 2 with Fos but not with ATF-3 suggests that cortical spreading depolarization, but not damage to neural processes, might be the mechanism of induction for TGF-beta 2. The results imply that endogenous TGF-beta s are induced by different mechanisms following an ischemic attack in the brain suggesting that they are involved in distinct spatially and temporally regulated inflammatory and neuroprotective processes.	[Pal, Gabriella; Vincze, Csilla; Renner, Eva; Dobolyi, Arpad] Semmelweis Univ, Dept Anat Histol & Embryol, Neuromorphol & Neuroendocrine Res Lab, Budapest, Hungary; [Pal, Gabriella; Vincze, Csilla; Renner, Eva; Dobolyi, Arpad] Hungarian Acad Sci, Budapest, Hungary; [Vincze, Csilla; Lovas, Gabor] Semmelweis Univ, Dept Neurol, Budapest, Hungary; [Wappler, Edina A.; Nagy, Zoltan] Semmelweis Univ, Dept Sect Vasc Neurol, Ctr Cardiovasc, Budapest, Hungary; [Wappler, Edina A.] Semmelweis Univ, Dept Anesthesiol & Intens Therapy, Budapest, Hungary; [Lovas, Gabor] Jahn Ferenc Teaching Hosp, Dept Neurol, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Semmelweis University	Pal, G (corresponding author), Semmelweis Univ, Dept Anat Histol & Embryol, Neuromorphol & Neuroendocrine Res Lab, Budapest, Hungary.	dobolyi@ana.sote.hu	Dobolyi, Arpad/AAE-5913-2020	Wappler-Guzzetta, Edina/0000-0002-2195-5960; Nagy, Zoltan/0000-0001-9756-5427	Hungarian Scientific Research Fund [OTKA NNF 85612, OTKA K100319, 991]; Hungarian Academy of Sciences [22421]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	Support was provided by Hungarian Scientific Research Fund Research Grants OTKA NNF 85612 and OTKA K100319 for AD (http://www.otka.hu/?akt_menu = 991 &set_lang = 991), and a Bolyai Janos Fellowship Grant of the Hungarian Academy of Sciences (http://mta.hu/cikkek/?node_id = 22421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, BRAIN RES, V723, P206, DOI 10.1016/0006-8993(96)00253-3; Arighi CN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S5-S3; Ata AK, 1997, ACTA NEUROPATHOL, V93, P326, DOI 10.1007/s004010050623; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Barone FC, 2010, NEUROPHARMACOLOGY, V59, P650, DOI 10.1016/j.neuropharm.2010.08.016; Battaglia G, 2011, J CELL MOL MED, V15, P555, DOI 10.1111/j.1582-4934.2010.01011.x; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; Burt David W., 1994, Progress in Growth Factor Research, V5, P99; Caraci F, 2011, CNS NEUROSCI THER, V17, P237, DOI 10.1111/j.1755-5949.2009.00115.x; CHAO CC, 1995, CLIN IMMUNOL IMMUNOP, V77, P358, DOI 10.1006/clin.1995.1163; Chopp M, 1996, ACT NEUR S, V66, P21; DACUNHA A, 1993, J NEUROIMMUNOL, V42, P71, DOI 10.1016/0165-5728(93)90214-J; Dhandapani KM, 2003, CELL BIOCHEM BIOPHYS, V39, P13, DOI 10.1385/CBB:39:1:13; Dobolyi A, 2012, NEUROSCIENCE DEALING, P129, DOI [10.5772/34170, DOI 10.5772/34170]; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Fukushima T, 2007, HIPPOCAMPUS, V17, P5, DOI 10.1002/hipo.20243; Gaszner B, 2007, J COMP NEUROL, V500, P708, DOI 10.1002/cne.21177; Gault J, 2004, NEUROSURGERY, V55, P1, DOI 10.1227/01.NEU.0000126872.23715.E5; Glasper ER, 2011, J COMP NEUROL, V519, P2271, DOI 10.1002/cne.22628; Gouin A, 1996, J NEUROSCI RES, V43, P454, DOI 10.1002/(SICI)1097-4547(19960215)43:4<454::AID-JNR6>3.0.CO;2-E; GROSS CE, 1993, STROKE, V24, P558, DOI 10.1161/01.STR.24.4.558; Guegan C, 2000, BRAIN RES, V856, P93, DOI 10.1016/S0006-8993(99)02347-1; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Kawano H, 2012, CELL TISSUE RES; KIESSLING M, 1994, BRAIN PATHOL, V4, P77; KINOUCHI H, 1994, J CEREBR BLOOD F MET, V14, P808, DOI 10.1038/jcbfm.1994.101; Knuckey NW, 1996, MOL BRAIN RES, V40, P1; Konrad L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-318; Krieglstein K, 2002, J PHYSIOLOGY-PARIS, V96, P25, DOI 10.1016/S0928-4257(01)00077-8; Lagord C, 2002, MOL CELL NEUROSCI, V20, P69, DOI 10.1006/mcne.2002.1121; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Lehrmann E, 1998, GLIA, V24, P437, DOI 10.1002/(SICI)1098-1136(199812)24:4<437::AID-GLIA9>3.0.CO;2-X; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; Marin-Teva J.L., 2012, NEURON GLIA BIOL, P1; Markus A, 2007, NAT NEUROSCI, V10, P12, DOI 10.1038/nn0107-12; Martin RUS, 2009, NEUROSCIENCE, V158, P1338, DOI 10.1016/j.neuroscience.2008.11.002; Mathieu P, 2010, NEUROIMMUNOMODULAT, V17, P200, DOI 10.1159/000258723; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Namura S, 1998, J NEUROSCI, V18, P3659; Ohba N, 2003, MOL BRAIN RES, V115, P147, DOI 10.1016/S0169-328X(03)00181-5; Ohsawa K, 2000, J CELL SCI, V113, P3073; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67; PREHN JHM, 1993, J NEUROCHEM, V60, P1665, DOI 10.1111/j.1471-4159.1993.tb13389.x; Rahhal B, 2009, INT J DEV NEUROSCI, V27, P97, DOI 10.1016/j.ijdevneu.2008.08.003; Ramos-Cabrer P, 2011, STROKE, V42, pS7, DOI 10.1161/STROKEAHA.110.596684; Rau SW, 2003, J NEUROSCI, V23, P10487; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Roussa E, 2008, STEM CELLS, V26, P1683, DOI 10.1634/stemcells.2007-0805; Roussa E, 2009, ADV EXP MED BIOL, V651, P81; Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Song DY, 2011, NEUROSCI RES, V70, P428, DOI 10.1016/j.neures.2011.05.002; Sun JQ, 2010, BRAIN DEV-JPN, V32, P191, DOI 10.1016/j.braindev.2009.01.004; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; UEMURA Y, 1991, BRAIN RES, V552, P99, DOI 10.1016/0006-8993(91)90665-I; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Unsicker K, 1996, J NEUROBIOL, V29, P262, DOI 10.1002/(SICI)1097-4695(199602)29:2<262::AID-NEU10>3.0.CO;2-D; Vincze C, 2010, J COMP NEUROL, V518, P3752, DOI 10.1002/cne.22422; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; WANG XK, 1995, BRAIN RES BULL, V36, P607, DOI 10.1016/0361-9230(94)00243-T; Wappler EA, 2012, ADV TREATMENT ISCHEM, P89; Weinstein PR, 2004, STROKE, V35, P2666, DOI 10.1161/01.STR.0000144052.10644.ed; Wick W, 2006, CURR PHARM DESIGN, V12, P341, DOI 10.2174/138161206775201901; Xiao BG, 1997, NEUROSCI LETT, V226, P71, DOI 10.1016/S0304-3940(97)00234-6; Yamanaka H, 2011, J COMP NEUROL, V519, P1597, DOI 10.1002/cne.22588; Yamashita K, 1999, BRAIN RES, V836, P139, DOI 10.1016/S0006-8993(99)01626-1; Yin JR, 2009, BRAIN RES, V1263, P10, DOI 10.1016/j.brainres.2009.01.042; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	84	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46731	10.1371/journal.pone.0046731	http://dx.doi.org/10.1371/journal.pone.0046731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056426	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500064
J	Pucci, O; Qualls, C; Battisti-Charbonney, A; Balaban, DY; Fisher, JA; Duffin, J; Appenzeller, O				Pucci, Olivia; Qualls, Clifford; Battisti-Charbonney, Anne; Balaban, Dahlia Y.; Fisher, Joe A.; Duffin, Jim; Appenzeller, Otto			Human Skin Hypoxia Modulates Cerebrovascular and Autonomic Functions	PLOS ONE			English	Article							VENTILATORY RESPONSE	Because the skin is an oxygen sensor in amphibians and mice, we thought to confirm this function also in humans. The human upright posture, however, introduces additional functional demands for the maintenance of oxygen homeostasis in which cerebral blood flow and autonomic nervous system (ANS) function may also be involved. We examined nine males and three females. While subjects were breathing ambient air, at sea level, we changed gases in a plastic body-bag during two conditions of the experiment such as to induce skin hypoxia (with pure nitrogen) or skin normoxia (with air). The subjects performed a test of hypoxic ventilatory drive during each condition of the experiment. We found no differences in the hypoxic ventilatory drive tests. However, ANS function and cerebral blood flow velocities were modulated by skin hypoxia and the effect was significantly greater on the left than right middle cerebral arteries. We conclude that skin hypoxia modulates ANS function and cerebral blood flow velocities and this might impact life styles and tolerance to ambient hypoxia at altitude. Thus the skin in normal humans, in addition to its numerous other functions, is also an oxygen sensor.	[Appenzeller, Otto] New Mexico Hlth Enhancement & Marathon Clin Res F, Dept Neurol, Albuquerque, NM USA; [Pucci, Olivia; Fisher, Joe A.; Duffin, Jim] Univ Toronto, Dept Anesthesiol, Toronto, ON, Canada; [Pucci, Olivia; Fisher, Joe A.; Duffin, Jim] Univ Hlth Network, Toronto, ON, Canada; [Pucci, Olivia; Balaban, Dahlia Y.; Fisher, Joe A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Qualls, Clifford] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Battisti-Charbonney, Anne; Fisher, Joe A.; Duffin, Jim] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Health Network Toronto; University of Toronto; University of New Mexico; University of Toronto	Appenzeller, O (corresponding author), New Mexico Hlth Enhancement & Marathon Clin Res F, Dept Neurol, Albuquerque, NM USA.	OttoArun12@aol.com		Duffin, James/0000-0003-2270-7392; Balaban, Dahlia/0000-0002-8521-2402	New Mexico Health Enhancement and Marathon Clinics Research Foundation [2011-14]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER	New Mexico Health Enhancement and Marathon Clinics Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The New Mexico Health Enhancement and Marathon Clinics Research Foundation funded this study (Grant # 2011-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller O, 1997, AUTONOMIC NERVOUS SY, p[910, 621]; Appenzeller O, 2006, STROKE, V37, P1754, DOI 10.1161/01.STR.0000226973.97858.0b; Battisti-Charbonney A, 2011, RESP PHYSIOL NEUROBI, V179, P259, DOI 10.1016/j.resp.2011.09.004; Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; Drummond PD, 2006, AUTON NEUROSCI-BASIC, V128, P70, DOI 10.1016/j.autneu.2006.03.002; Duffin J, 2011, RESP PHYSIOL NEUROBI, V177, P71, DOI 10.1016/j.resp.2011.04.009; Duffin J, 2007, J PHYSIOL-LONDON, V584, P285, DOI 10.1113/jphysiol.2007.138883; Gulli G, 2007, EXP PHYSIOL, V92, P427, DOI 10.1113/expphysiol.2006.035519; Kaiser D, 2012, NATURE, V484, P164, DOI 10.1038/484164a; Minson CT, 2003, ADV EXP MED BIOL, V543, P249; MONGE MC, 1928, ANALES FACULTAD MED, V11, P76; Polak U, 2012, J VIS EXP, V60, P3416; Rahman F, 2011, CLIN AUTON RES, V21, P133, DOI 10.1007/s10286-010-0098-y; Rasmussen P, 2012, FASEB J; READ DJC, 1967, AUSTRALAS ANN MED, V16, P20; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West JB, 2002, HIGH ALT MED BIOL, V3, P401, DOI 10.1089/15270290260512882; Woos SC, 1988, ANN SPORTS MED, V4, P289; Xing GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002342	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47116	10.1371/journal.pone.0047116	http://dx.doi.org/10.1371/journal.pone.0047116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056597	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500138
J	Szabo, JK; Khwaja, N; Garnett, ST; Butchart, SHM				Szabo, Judit K.; Khwaja, Nyil; Garnett, Stephen T.; Butchart, Stuart H. M.			Global Patterns and Drivers of Avian Extinctions at the Species and Subspecies Level	PLOS ONE			English	Article							MAMMALIAN INTRODUCTIONS; PREHISTORIC EXTINCTIONS; BIRD EXTINCTIONS; HABITAT LOSS; ISLAND; RISK; CONSERVATION; BIODIVERSITY; ERADICATION; POPULATION	Birds have long fascinated scientists and travellers, so their distribution and abundance through time have been better documented than those of other organisms. Many bird species are known to have gone extinct, but information on subspecies extinctions has never been synthesised comprehensively. We reviewed the timing, spatial patterns, trends and causes of avian extinctions on a global scale, identifying 279 ultrataxa (141 monotypic species and 138 subspecies of polytypic species) that have gone extinct since 1500. Species extinctions peaked in the early 20th century, then fell until the mid 20th century, and have subsequently accelerated. However, extinctions of ultrataxa peaked in the second half of the 20th century. This trend reflects a consistent decline in the rate of extinctions on islands since the beginning of the 20th century, but an acceleration in the extinction rate on continents. Most losses (78.7% of species and 63.0% of subspecies) occurred on oceanic islands. Geographic foci of extinctions include the Hawaiian Islands (36 taxa), mainland Australia and islands (29 taxa), the Mascarene Islands (27 taxa), New Zealand (22 taxa) and French Polynesia (19 taxa). The major proximate drivers of extinction for both species and subspecies are invasive alien species (58.2% and 50.7% of species and subspecies, respectively), hunting (52.4% and 18.8%) and agriculture, including non-timber crops and livestock farming (14.9% and 31.9%). In general, the distribution and drivers of subspecific extinctions are similar to those for species extinctions. However, our finding that, when subspecies are considered, the extinction rate has accelerated in recent decades is both novel and alarming.	[Szabo, Judit K.; Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Khwaja, Nyil; Butchart, Stuart H. M.] BirdLife Int, Cambridge, England	Charles Darwin University; BirdLife International	Szabo, JK (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	judit.szabo@cdu.edu.au	Szabo, Judit K./C-1247-2012; Khwaja, Nyil/J-3160-2019; Butchart, Stuart HM/Y-2711-2018; Butchart, Stuart/AAJ-1852-2021; Garnett, Stephen/M-3877-2013	Szabo, Judit K./0000-0002-8786-1887; Khwaja, Nyil/0000-0003-1314-6984; Butchart, Stuart/0000-0002-1140-4049; Garnett, Stephen/0000-0002-0724-7060	Australian Research Council [LP0990395]	Australian Research Council(Australian Research Council)	JKS was funded under Australian Research Council Linkage 531 Grant LP0990395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson I.A.E., 1985, International Council for Bird Preservation Technical Publication, P35; Atkinson IAE, 1996, WILDLIFE BIOL, V2, P135, DOI 10.2981/wlb.1996.011; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; BirdLife International, 2012, BIRDLIFE PREV EXT PR; BirdLife International, 2011, THREATS STRESS IMP; BirdLife International, 2011, 2011 IUCN RED LIST T; BirdLife-International, 2011, BIRDLIFE CHECKL BIRD; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blackburn TM, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P85; Bonnaud E, 2007, J MAMMAL, V88, P1074, DOI 10.1644/06-MAMM-A-031R2.1; Boyer AG, 2008, DIVERS DISTRIB, V14, P509, DOI 10.1111/j.1472-4642.2007.00459.x; BRATTSTROM BH, 1990, J BIOGEOGR, V17, P177, DOI 10.2307/2845325; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2000, THREATENED BIRDS WOR, P701; Bulchart S.H.M., 2010, P13; Butchart S. H. M., 2006, Bulletin of the British Ornithologists' Club, V126, P7; Butchart SHM, 2008, BIRD CONSERV INT, V18, pS245, DOI 10.1017/S095927090800035X; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; CBD, 2011, UNEPCBDAHTEGSPIND13; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; COBLENTZ BE, 1978, BIOL CONSERV, V13, P279, DOI 10.1016/0006-3207(78)90038-1; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; COSTIN AB, 1960, J ECOL, V48, P729, DOI 10.2307/2257346; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Dickinson EC., 2003, HOWARD MOORE COMPLET; Didham RK, 2005, SCIENCE, V307, P1412, DOI 10.1126/science.1107333; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Fuller E, 2000, EXTINCT BIRDS; Fuller E., 2002, HDB BIRDS WORLD, V7, P11; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Gotelli NJ, 2013, ECOSIMR 1 00; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; IUCN, 2012, IUCN RED LIST THREAT; IUCN Standards and Petitions Subcommittee, 2011, GUID US IUCN RED LIS; JOHNSON TH, 1990, IBIS, V132, P167, DOI 10.1111/j.1474-919X.1990.tb01036.x; King W.B., 1985, International Council for Bird Preservation Technical Publication, P3; Lockwood JL, 2000, ANIM CONSERV, V3, P27, DOI 10.1111/j.1469-1795.2000.tb00084.x; Lockwood JL, 1999, CONSERV BIOL, V13, P560, DOI 10.1046/j.1523-1739.1999.98155.x; Loehle C, 2011, DIVERS DISTRIB, P1; Manne LL, 1999, NATURE, V399, P258, DOI 10.1038/20436; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; MILBERG P, 1993, ECOGRAPHY, V16, P229, DOI 10.1111/j.1600-0587.1993.tb00213.x; Mineau P, 2006, ENVIRON TOXICOL CHEM, V25, P1214, DOI 10.1897/05-035R.1; Monk K. A., 1997, ECOLOGY NUSA TENGGAR; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Phillimore Albert B., 2010, Ornithological Monographs, V67, P42; Pimm SL, 1996, BIODIVERS CONSERV, V5, P1059, DOI 10.1007/BF00052716; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PIMM SL, 1994, PHILOS T ROY SOC B, V344, P27, DOI 10.1098/rstb.1994.0047; Pimm SL, 2008, CURR BIOL, V18, pR117, DOI 10.1016/j.cub.2007.11.055; Pimm Stuart L., 1995, P75; Pratt T.K., 2009, CONSERVATION BIOL HA; Preece RC, 1998, PHILOS T ROY SOC B, V353, P347, DOI 10.1098/rstb.1998.0214; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ratcliffe N, 2009, IBIS, V151, P699, DOI 10.1111/j.1474-919X.2009.00949.x; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2006, SCIENCE, V313, P1051, DOI 10.1126/science.1131302; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Schodde R, 1999, DIRECTORY AUSTR BIRD; Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL 3; Seitre Roland, 1992, Oryx, V26, P215; SMITH FDM, 1993, TRENDS ECOL EVOL, V8, P375, DOI 10.1016/0169-5347(93)90223-C; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Steadman DW, 2002, P NATL ACAD SCI USA, V99, P3673, DOI 10.1073/pnas.072079299; Steadman DW, 1999, COLLOQ SEMI, P375; Steadman DW, 2006, EXTINCTION BIOGEOGRA; Steiner WWM, 2001, STUD AVIAN BIOL-SER, P377; STONE CP, 1987, ENVIRON CONSERV, V14, P245, DOI 10.1017/S0376892900016453; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whitten AJ, 2002, ECOLOGY SULAWESI; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	81	85	96	2	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47080	10.1371/journal.pone.0047080	http://dx.doi.org/10.1371/journal.pone.0047080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056586	gold, Green Submitted, Green Published			2022-12-27	WOS:000309831500133
J	Williams, BJ; Bhatia, S; Adams, LK; Boling, S; Carroll, JL; Li, XL; Rogers, DL; Korokhov, N; Kovesdi, I; Pereboev, AV; Curiel, DT; Mathis, JM				Williams, Briana Jill; Bhatia, Shilpa; Adams, Lisa K.; Boling, Susan; Carroll, Jennifer L.; Li, Xiao-Lin; Rogers, Donna L.; Korokhov, Nikolay; Kovesdi, Imre; Pereboev, Alexander V.; Curiel, David T.; Mathis, J. Michael			Dendritic Cell Based PSMA Immunotherapy for Prostate Cancer Using a CD40-Targeted Adenovirus Vector	PLOS ONE			English	Article							GENE-TRANSFER; IN-VIVO; VACCINE; SYSTEM; MODEL; GAMMA; MHC	Human prostate tumor vaccine and gene therapy trials using ex vivo methods to prime dendritic cells (DCs) with prostate specific membrane antigen (PSMA) have been somewhat successful, but to date the lengthy ex vivo manipulation of DCs has limited the widespread clinical utility of this approach. Our goal was to improve upon cancer vaccination with tumor antigens by delivering PSMA via a CD40-targeted adenovirus vector directly to DCs as an efficient means for activation and antigen presentation to T-cells. To test this approach, we developed a mouse model of prostate cancer by generating clonal derivatives of the mouse RM-1 prostate cancer cell line expressing human PSMA (RM-1-PSMA cells). To maximize antigen presentation in target cells, both MHC class I and TAP protein expression was induced in RM-1 cells by transduction with an Ad vector expressing interferon-gamma (Ad5-IFN gamma). Administering DCs infected ex vivo with CD40-targeted Ad5-huPSMA, as well as direct intraperitoneal injection of the vector, resulted in high levels of tumor-specific CTL responses against RM-1-PSMA cells pretreated with Ad5-IFN gamma as target cells. CD40 targeting significantly improved the therapeutic antitumor efficacy of Ad5-huPSMA encoding PSMA when combined with Ad5-IFN gamma in the RM-1-PSMA model. These results suggest that a CD-targeted adenovirus delivering PSMA may be effective clinically for prostate cancer immunotherapy.	[Korokhov, Nikolay; Kovesdi, Imre] VectorLogics Inc, Birmingham, AL USA; [Pereboev, Alexander V.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Pereboev, Alexander V.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Curiel, David T.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [Williams, Briana Jill; Bhatia, Shilpa; Adams, Lisa K.; Boling, Susan; Carroll, Jennifer L.; Li, Xiao-Lin; Rogers, Donna L.; Mathis, J. Michael] LSU Hlth Sci Ctr, Gene Therapy Program, Dept Urol, Shreveport, LA USA; [Williams, Briana Jill; Bhatia, Shilpa; Adams, Lisa K.; Boling, Susan; Carroll, Jennifer L.; Li, Xiao-Lin; Rogers, Donna L.; Mathis, J. Michael] LSU Hlth Sci Ctr, Gene Therapy Program, Dept Biochem & Mol Biol, Shreveport, LA USA; [Williams, Briana Jill; Bhatia, Shilpa; Adams, Lisa K.; Boling, Susan; Carroll, Jennifer L.; Li, Xiao-Lin; Rogers, Donna L.; Mathis, J. Michael] LSU Hlth Sci Ctr, Gene Therapy Program, Dept Cellular Biol & Anat, Shreveport, LA USA; [Williams, Briana Jill; Bhatia, Shilpa; Adams, Lisa K.; Boling, Susan; Carroll, Jennifer L.; Li, Xiao-Lin; Rogers, Donna L.; Mathis, J. Michael] LSU Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Mathis, JM (corresponding author), LSU Hlth Sci Ctr, Gene Therapy Program, Dept Urol, Shreveport, LA USA.	jmathi@lsuhsc.edu	; Mathis, J. Michael/J-1379-2018	Kovesdi, Imre/0000-0002-0322-3969; Mathis, J. Michael/0000-0001-5528-5195	Feist-Weiller Cancer Center; Louisiana Gene Therapy Research Consortium; National Institutes of Health-National Cancer Institute [2R42-CA114921]; National Institutes of Health-National Institute of Allergy and Infectious Diseases [5R33-AI076096]; NATIONAL CANCER INSTITUTE [R42CA114921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI076096] Funding Source: NIH RePORTER	Feist-Weiller Cancer Center; Louisiana Gene Therapy Research Consortium; National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by the Feist-Weiller Cancer Center, the Louisiana Gene Therapy Research Consortium, and grants from the National Institutes of Health-National Cancer Institute (2R42-CA114921) and the National Institutes of Health-National Institute of Allergy and Infectious Diseases (5R33-AI076096). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALEY PA, 1995, J STEROID BIOCHEM, V52, P403, DOI 10.1016/0960-0760(95)00001-G; Bolhassani A, MOL CANC, V10, P3; Brandao JG, 2003, VACCINE, V21, P2268, DOI 10.1016/S0264-410X(03)00050-1; Buonerba C, NAT REV CLIN ONCOL, V8, P551; Doehn C, 2008, BIODRUGS, V22, P71, DOI 10.2165/00063030-200822020-00001; Fishman M, 2009, EXPERT OPIN BIOL TH, V9, P1565, DOI 10.1517/14712590903446921; Fuessel S, 2006, PROSTATE, V66, P811, DOI 10.1002/pros.20404; Ghosh A, 2004, J CELL BIOCHEM, V91, P528, DOI 10.1002/jcb.10661; Hangalapura BN, CANC RES, V71, P5827; Hangalapura BN, J IMMUNOTHER, V33, P706; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Izumi M, 2005, J GENE MED, V7, P1517, DOI 10.1002/jgm.806; Li XL, 2009, IMMUNOLOGY, V128, P420, DOI 10.1111/j.1365-2567.2009.03127.x; Martini M, VACCINE, V28, P3548; Neeley YC, 2002, PROSTATE, V53, P183, DOI 10.1002/pros.10136; Olson WC, 2007, REV RECENT CLIN TRIA, V2, P182, DOI 10.2174/157488707781662724; Pereboev AV, 2004, MOL THER, V9, P712, DOI 10.1016/j.ymthe.2004.02.006; Procko E, 2009, CURR OPIN IMMUNOL, V21, P84, DOI 10.1016/j.coi.2009.02.003; Rein Daniel T, 2006, Future Oncol, V2, P137, DOI 10.2217/14796694.2.1.137; Selleck WA, 2003, MOL THER, V7, P185, DOI 10.1016/S1525-0016(02)00040-0; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sonpavde G, EXPERT OPIN BIOL THE, V11, P997; Stockwin LH, 2002, J IMMUNOL METHODS, V259, P205, DOI 10.1016/S0022-1759(01)00510-5; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Verdijk P, 2008, EXPERT OPIN BIOL TH, V8, P865, DOI [10.1517/14712598.8.7.865, 10.1517/14712598.8.7.865 ]; Waeckerle-Men Y, 2006, CANCER IMMUNOL IMMUN, V55, P1524, DOI 10.1007/s00262-006-0157-3	26	21	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46981	10.1371/journal.pone.0046981	http://dx.doi.org/10.1371/journal.pone.0046981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056548	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500117
J	Ye, ZH; Huang, Y; Liu, D; Chen, XY; Wang, DJ; Huang, DC; Zhao, L; Xiao, XQ				Ye, Zehui; Huang, Ying; Liu, Dan; Chen, Xiaoyi; Wang, Dongjuan; Huang, Daochao; Zhao, Li; Xiao, Xiaoqiu			Obesity Induced by Neonatal Overfeeding Worsens Airway Hyperresponsiveness and Inflammation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ALVEOLAR MACROPHAGE ACTIVATION; DIET-INDUCED OBESITY; BODY-MASS INDEX; PULMONARY RESPONSES; METABOLIC SYNDROME; IMMUNE-RESPONSE; GROWTH-FACTOR; ASTHMA; EXPRESSION	Background: Obesity is a risk factor for the development of certain respiratory diseases, and neonatal overfeeding results in an early onset of obesity in adulthood. However, the influence of neonatal overfeeding on respiratory diseases has rarely been studied. Therefore, this paper is aimed at investigating the effect of neonatal overfeeding on airway responsiveness and inflammation. Methodology/Principal Findings: The neonatal overfeeding was induced by reducing litter size to three pups per litter (small litter, SL) in contrast to the normal litter size with ten pups per litter (NL) on postnatal day 3 (P3) in male ICR mice. On P21, mice were weaned to standard chow diet. Airway responsiveness to methacholine was measured either on P21 or P150. Total and classified inflammatory cells in bronchoalveolar lavage fluid (BALF) were counted, lung inflammatory cells were evaluated through staining with hematoxylin & eosin and F4/80 immunohistochemistry; lung fibrosis was evaluated through staining with Masson and alpha-SAM immunohistochemistry. Leptin levels in serum were measured by RIA; TNF-alpha levels in serum and BALF were quantified by ELISA; mRNA levels of TNF-alpha, CTGF and TGF-beta 1 in lung tissues were measured using real-time PCR. Mice from SL exhibited accelerated body weight gain, impaired glucose tolerance and hyperleptinemia. Enhanced airway responsiveness to methacholine was observed in SL mice on P150, but not on P21. Pulmonary inflammation was evident in SL mice on P150, as reflected by inflammatory cells especially macrophages around bronchi and interstitium. BALF and serum TNF-alpha levels and lung TNF-alpha mRNA expression were significantly increased in SL mice on P150. More collagen accumulated surrounding the bronchi on P150; lung mRNA levels of TGF-beta 1 and CTGF were also increased on P150. Conclusion: In addition to inducing a variety of metabolic defects, neonatal overfeeding enhanced lung inflammation, which may lead to airway remodeling and airway hyperresponsiveness in adulthood.	[Ye, Zehui; Huang, Ying; Liu, Dan; Chen, Xiaoyi; Wang, Dongjuan; Huang, Daochao; Zhao, Li; Xiao, Xiaoqiu] Chongqing Med Univ, Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China; [Ye, Zehui; Huang, Ying; Wang, Dongjuan] Chongqing Med Univ, Dept Resp Med, Chongqing, Peoples R China; [Ye, Zehui; Liu, Dan; Chen, Xiaoyi; Wang, Dongjuan; Xiao, Xiaoqiu] Chongqing Med Univ, Chongqing Key Lab Translat Med Res Cognit Dev & L, Chongqing, Peoples R China; [Ye, Zehui; Huang, Ying; Liu, Dan; Chen, Xiaoyi; Wang, Dongjuan; Xiao, Xiaoqiu] Chongqing Med Univ, Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Ye, Zehui; Liu, Dan; Chen, Xiaoyi; Wang, Dongjuan; Xiao, Xiaoqiu] Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Huang, Y (corresponding author), Chongqing Med Univ, Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China.	huangying62@126.com; xiaoxq@cqmu.edu.cn	Xiao, Xiaoqiu/K-7672-2019	Xiao, Xiaoqiu/0000-0002-4568-8772	Natural Science Foundation Project of CQ CSTC [2009BA5087]; Chongqing Medical University	Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Chongqing Medical University	This work was supported by Natural Science Foundation Project of CQ CSTC, 2009BA5087 (to XX) (http://www.ctin.ac.cn)and intramural funding from Chongqing Medical University (to XX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, AM J RESP CELL MOL, V44, P270, DOI 10.1165/rcmb.2010-0141TR; Ask K, 2008, INT J BIOCHEM CELL B, V40, P484, DOI 10.1016/j.biocel.2007.08.016; Barranco P, 2012, NUTR HOSP, V27, P138, DOI [10.3305/nh.2012.27.1.5494, 10.1590/S0212-16112012000100016]; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Boulet LP, 2003, CURR ALLERGY ASTHM R, V3, P166, DOI 10.1007/s11882-003-0030-9; Boullu-Ciocca S, 2008, DIABETES, V57, P669, DOI 10.2337/db07-1316; Calixto MC, 2010, BRIT J PHARMACOL, V159, P617, DOI 10.1111/j.1476-5381.2009.00560.x; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Canoy D, 2004, AM J EPIDEMIOL, V159, P1140, DOI 10.1093/aje/kwh155; Davidowa H, 2007, NEUROREPORT, V18, P521, DOI 10.1097/WNR.0b013e32805dfb93; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Fresno Manuel, 2011, Archives of Physiology and Biochemistry, V117, P151, DOI 10.3109/13813455.2011.562514; Glavas MM, 2010, ENDOCRINOLOGY, V151, P1598, DOI 10.1210/en.2009-1295; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025726; Johnston RA, 2008, J APPL PHYSIOL, V104, P1727, DOI 10.1152/japplphysiol.00075.2008; Johnston RA, 2007, AM J RESP CRIT CARE, V176, P650, DOI 10.1164/rccm.200702-323OC; Johnston RA, 2010, J APPL PHYSIOL, V108, P1812, DOI 10.1152/japplphysiol.00784.2009; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Lintomen L, 2012, OBESITY, V20, P1959, DOI 10.1038/oby.2012.93; Litonjua AA, 2002, THORAX, V57, P581, DOI 10.1136/thorax.57.7.581; Lu FL, 2006, AM J PHYSIOL-LUNG C, V290, pL856, DOI 10.1152/ajplung.00386.2005; Mauad T, 2007, J ALLERGY CLIN IMMUN, V120, P997, DOI 10.1016/j.jaci.2007.06.031; McClean KM, 2008, THORAX, V63, P649, DOI 10.1136/thx.2007.086801; Mito N, 2002, METABOLISM, V51, P1241, DOI 10.1053/meta.2002.35196; O'Donnell CP, 2010, J APPL PHYSIOL, V108, P197, DOI 10.1152/japplphysiol.01208.2009; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Robinson PM, 2012, METHODS MOL BIOL, V820, P117, DOI 10.1007/978-1-61779-439-1_8; Rodrigues AL, 2007, J ENDOCRINOL, V195, P485, DOI 10.1677/JOE-07-0046; Rydell-Tormanen K, 2012, LAB INVEST, V92, P917, DOI 10.1038/labinvest.2012.57; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Santamaria F, 2011, OBESITY, V19, P1623, DOI 10.1038/oby.2011.1; Sbarbati A, 2006, PEDIATRICS, V117, P220, DOI 10.1542/peds.2004-2854; Sharma S, 2012, SURGERY, V151, P107, DOI 10.1016/j.surg.2011.06.035; Shore SA, 2007, CURR OPIN PULM MED, V13, P56, DOI 10.1097/MCP.0b013e3280110196; Shore SA, 2007, J APPL PHYSIOL, V102, P516, DOI 10.1152/japplphysiol.00847.2006; Song Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/254976; Summer R, 2008, AM J PHYSIOL-LUNG C, V294, pL1035, DOI 10.1152/ajplung.00397.2007; THOMAS PS, 1995, AM J RESP CRIT CARE, V152, P76, DOI 10.1164/ajrccm.152.1.7599866; Thomson EM, 2012, AM J PATHOL, V180, P1413, DOI 10.1016/j.ajpath.2011.12.020; Williams AS, 2012, PULM PHARMACOL THER, DOI [10.1016/j.pupt.2012.5.001, DOI 10.1016/J.PUPT.2012.5.001]; Xiao XQ, 2007, ENDOCRINOLOGY, V148, P4150, DOI 10.1210/en.2007-0373; Zammit C, 2010, INT J GEN MED, V3, P335, DOI 10.2147/IJGM.S11926; Zhu M, 2010, AM J RESP CELL MOL, V43, P487, DOI 10.1165/rcmb.2009-0086OC	47	19	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47013	10.1371/journal.pone.0047013	http://dx.doi.org/10.1371/journal.pone.0047013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056561	Green Submitted, gold, Green Published			2022-12-27	WOS:000309831500123
J	Al-Dwairi, A; Pabona, JMP; Simmen, RCM; Simmen, FA				Al-Dwairi, Ahmed; Pabona, John Mark P.; Simmen, Rosalia C. M.; Simmen, Frank A.			Cytosolic Malic Enzyme 1 (ME1) Mediates High Fat DietInduced Adiposity, Endocrine Profile, and Gastrointestinal Tract Proliferation-Associated Biomarkers in Male Mice	PLOS ONE			English	Article							COLON-CANCER CELLS; ACID SYNTHASE; COLORECTAL-CANCER; INSULIN-RESISTANCE; METABOLIC SYNDROME; EPITHELIAL-CELLS; GROWTH ARREST; SOY; ADIPONECTIN; PATHWAY	Background: Obesity and associated hormonal disturbances are risk factors for colon cancer. Cytosolic Malic Enzyme (ME1) generates NADPH used for lipogenesis in gastrointestinal (GI), liver and adipose tissues. We have reported that inclusion of soy protein isolate (SPI) in the diet lowered body fat content and colon tumor incidence of rats fed AIN-93G diet, while others have demonstrated SPI inhibition of rat hepatic ME1 expression. The present study examined the individual and combined effects of dietary SPI and absence of ME1 on: 1) serum concentrations of hormones implicated in colon cancer development, 2) expression of lipogenic and proliferation-associated genes in the mouse colon and small intestine, and 3) liver and adipose expression of lipogenic and adipocytokine genes that may contribute to colon cancer predisposition. Methods: Weanling wild type (WT) and ME1 null (MOD-1) male mice were fed high-fat (HF), iso-caloric diets containing either casein (CAS) or SPI as sole protein source for 5 wks. Somatic growth, serum hormone and glucose levels, liver and adipose tissue weights, GI tissue parameters, and gene expression were evaluated. Results: The MOD-1 genotype and SPI-HF diet resulted in decreases in: body and retroperitoneal fat weights, serum insulin, serum leptin, leptin/adiponectin ratio, adipocyte size, colon mTOR and cyclin D1 mRNA abundance, and jejunum FASN mRNA abundance, when compared to WT mice fed CAS-HF. Regardless of diet, MOD-1 mice had reductions in liver weight, liver steatosis, and colon crypt depth, and increases in adipose tissue expression of IRS1 and IRS2, compared to WT mice. SPI-HF diet reduced ME1 gene expression only in retroperitoneal fat. Conclusions: Data suggest that the pharmacological targeting of ME1 or the inclusion of soy protein in the diet may provide avenues to reduce obesity and its associated pro-tumorigenic endocrine environment and improve insulin sensitivity, potentially disrupting the obesity-colon cancer connection.	[Al-Dwairi, Ahmed; Pabona, John Mark P.; Simmen, Rosalia C. M.; Simmen, Frank A.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Simmen, Rosalia C. M.; Simmen, Frank A.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Pabona, John Mark P.; Simmen, Rosalia C. M.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Simmen, FA (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	simmenfranka@uams.edu	Simmen, Frank A/J-9464-2012	Al-Dwairi, Ahmed/0000-0002-8909-9275; Simmen, Frank/0000-0001-6842-7754	National Institutes of Health (NIH) grant [R01CA136439]; NIH NCRR [UL1RR029884]; Sturgis Foundation grant; Arkansas Biosciences Institute-Arkansas Children's Hospital Research Institute grant; UAMS Translational Research Institute; NCRR [P20-RR0202246]; NATIONAL CANCER INSTITUTE [R01CA136493] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Sturgis Foundation grant; Arkansas Biosciences Institute-Arkansas Children's Hospital Research Institute grant; UAMS Translational Research Institute; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health (NIH) grant R01CA136439 (FAS), NIH NCRR UL1RR029884 (UAMS Translational Research Institute), a Sturgis Foundation grant (FAS), and an Arkansas Biosciences Institute-Arkansas Children's Hospital Research Institute grant (RCMS). The authors utilized core facilities that were funded by the UAMS Translational Research Institute and by NCRR P20-RR0202246 (UAMS Center for Translational Neuroscience). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; Batsis JA, 2007, CLIN PHARMACOL THER, V82, P509, DOI 10.1038/sj.clpt.6100355; Beales ILP, 2007, MOL CELL ENDOCRINOL, V274, P60, DOI 10.1016/j.mce.2007.05.017; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191, DOI 10.1093/ajcn/76.6.1191; BROWN ML, 1988, J BIOL CHEM, V263, P4494; Carvalho E, 1999, FASEB J, V13, P2173, DOI 10.1096/fasebj.13.15.2173; Chuang HY, 2011, BIOMED PHARMACOTHER, V65, P286, DOI 10.1016/j.biopha.2011.02.016; Dave B, 2005, CARCINOGENESIS, V26, P1793, DOI 10.1093/carcin/bgi131; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; ez-Roux G, 2011, PLOS BIOL, V9; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Fujisawa T, 2008, GUT, V57, P1531, DOI 10.1136/gut.2008.159293; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Guri AJ, 2011, OBESITY, V19, P689, DOI 10.1038/oby.2010.230; Hakkak R, 2012, GENES NUTR, V7, P549, DOI 10.1007/s12263-012-0294-6; Heart E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1354, DOI 10.1152/ajpendo.90836.2008; Huang XF, 2009, OBES REV, V10, P610, DOI 10.1111/j.1467-789X.2009.00607.x; Huang XF, 2008, NUTR DIET, V65, pS53, DOI 10.1111/j.1747-0080.2008.00262.x; Inoue M, 2006, METABOLISM, V55, P1248, DOI 10.1016/j.metabol.2006.05.010; Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697; Johnson SM, 2010, J AM COLL SURGEONS, V210, P767, DOI 10.1016/j.jamcollsurg.2009.12.008; Kearney KE, 2009, INT J CANCER, V125, P249, DOI 10.1002/ijc.24356; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim EJ, 2005, J MED FOOD, V8, P431, DOI 10.1089/jmf.2005.8.431; Labruna G, 2011, OBESITY, V19, P1492, DOI 10.1038/oby.2010.309; LEE CY, 1980, BIOCHEMISTRY-US, V19, P5098, DOI 10.1021/bi00563a025; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; Menendez JA, 2004, ARCH IMMUNOL THER EX, V52, P414; Menendez JA, 2009, CLIN CHEM, V55, P425, DOI 10.1373/clinchem.2008.115352; Miyamoto S, 2010, CHEM-BIOL INTERACT, V183, P271, DOI 10.1016/j.cbi.2009.11.014; Mutoh M, 2011, GASTROENTEROLOGY, V140, P2000, DOI 10.1053/j.gastro.2011.02.019; Nakamura Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-100; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Otani K, 2010, CANCER LETT, V288, P177, DOI 10.1016/j.canlet.2009.06.037; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; RICHARDSON DK, 1979, HORM METAB RES, V11, P427, DOI 10.1055/s-0028-1092753; Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488; Simmen FA, 2010, J NUTR BIOCHEM, V21, P1106, DOI 10.1016/j.jnutbio.2009.09.008; Stattin P, 2004, INT J CANCER, V109, P149, DOI 10.1002/ijc.11668; Su Y, 2009, J NUTR, V139, P945, DOI 10.3945/jn.108.103820; Sugiyama M, 2009, INT J ONCOL, V34, P339, DOI 10.3892/ijo_00000156; Torre-Villalvazo I, 2008, J NUTR, V138, P462, DOI 10.1093/jn/138.3.462; Tran TT, 1996, CANCER EPIDEM BIOMAR, V5, P1013; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vinall RL, 2007, CLIN CANCER RES, V13, P6204, DOI 10.1158/1078-0432.CCR-07-0600; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Xiao R, 2008, AM J PHYSIOL-GASTR L, V294, pG868, DOI 10.1152/ajpgi.00515.2007; Xiao RJ, 2007, J ENDOCRINOL, V195, P79, DOI 10.1677/JOE-07-0256; Xiao RJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-1; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yamaji T, 2010, CANCER RES, V70, P5430, DOI 10.1158/0008-5472.CAN-10-0178; Yan L, 2010, CANCER EPIDEM BIOMAR, V19, P148, DOI 10.1158/1055-9965.EPI-09-0856; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Zhan Y, 2008, CLIN CANCER RES, V14, P5735, DOI 10.1158/1078-0432.CCR-07-5074; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhang YJ, 2009, ANN SURG ONCOL, V16, P2617, DOI 10.1245/s10434-009-0555-9; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	61	35	35	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46716	10.1371/journal.pone.0046716	http://dx.doi.org/10.1371/journal.pone.0046716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056418	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800044
J	Sun, MX; Liang, AP; Watson, GS; Watson, JA; Zheng, YM; Jiang, L				Sun, Mingxia; Liang, Aiping; Watson, Gregory S.; Watson, Jolanta A.; Zheng, Yongmei; Jiang, Lei			Compound Microstructures and Wax Layer of Beetle Elytral Surfaces and Their Influence on Wetting Properties	PLOS ONE			English	Article							WATER-REPELLENT; LEAF SURFACES; INSECT WINGS; WETTABILITY; LEGS; CONTAMINATION; MECHANISMS; COLEOPTERA; EFFICIENCY; STRENGTH	A beetles' first line of defense against environmental hazards is their mesothoracic elytra - rigid, protective forewings. In order to study the interaction of these wings with water, the surface microstructures of various beetles' elytra were observed by Environment Scanning Electron Microscopy (ESEM) and Atomic Force Microscopy (AFM). Chemistry components were ascertained using X-ray photoelectron spectroscopy (XPS). All the beetles of various habitats (including desert, plant, dung, land and water) exhibited compound microstructures on their elytra. The wetting properties of these elytra were identified using an optical contact angle meter. In general the native elytra exhibited hydrophilic or weak hydrophobic properties with contact angles (CAs) ranging from 47.5 degrees to 109.1 degrees. After treatment with chloroform, the CAs all increased on the rougher elytral surfaces. The presence of wax is not the only determinant of hydrophobic properties, but rather a combination with microscopic structures found on the surfaces. Irregularities and the presence or absence of tiny cracks, hairs (or setae), pores and protrusions are important factors which influence the wetting properties. Rougher elytral surfaces tended to present a stronger hydrophobicity. Effects on hydrophobicity, such as surface microstructures, chemistry, environment and aging (referring to the time after emergence), are also included and discussed. Our results also provide insights into the motion of water droplets when in contact with beetle elytra.	[Sun, Mingxia; Liang, Aiping] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Watson, Gregory S.; Watson, Jolanta A.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Townsville, Qld 4811, Australia; [Watson, Gregory S.; Watson, Jolanta A.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld, Australia; [Zheng, Yongmei] Beihang Univ, Sch Chem & Environm, Minist Educ, Key Lab Bioinspired Smart Interfacial Sci & Techn, Beijing, Peoples R China; [Jiang, Lei] Chinese Acad Sci, Inst Chem, Ctr Mol Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; James Cook University; James Cook University; Beihang University; Chinese Academy of Sciences; Institute of Chemistry, CAS	Liang, AP (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	liangap@ioz.ac.cn; zhengym@buaa.edu.cn	Watson, Jolanta A/A-9332-2008; Watson, Gregory S/D-2195-2009; , 许永傲/AAC-2581-2019; Sun (孙), Mingxia (明霞)/ABA-7705-2021	Watson, Jolanta A/0000-0002-5027-9025; Watson, Gregory/0000-0001-9843-9211; Sun, Mingxia/0000-0002-1184-516X	Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences [KSCX2-EW-G-4]; National Basic Research Program of China (973 Program) [2011CB302102]; National Natural Science Foundation of China [30970400, 31172128]	Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences (grant KSCX2-EW-G-4), the National Basic Research Program of China (973 Program) (grant 2011CB302102) and the National Natural Science Foundation of China (grants 30970400, 31172128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EW, 2001, ACTA MATER, V49, P2975, DOI 10.1016/S1359-6454(01)00203-8; [Anonymous], 2003, NIST XRAY PHOT SPECT; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; BARTHLOTT W, 2010, ADV MATER, V22, P2325, DOI DOI 10.1002/adma.200904411; Bhushan B, 2003, J VAC SCI TECHNOL B, V21, P2262, DOI 10.1116/1.1627336; Bhushan B, 2006, NANOTECHNOLOGY, V17, P2758, DOI 10.1088/0957-4484/17/11/008; BUCKNER JS, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P227; Byun D, 2009, J BIONIC ENG, V6, P63, DOI 10.1016/S1672-6529(08)60092-X; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Cheng Hong, 2002, Acta Entomologica Sinica, V45, P175; Dai ZD, 2010, J BIONIC ENG, V7, P6, DOI 10.1016/S1672-6529(09)60187-6; Erbil HY, 2009, LANGMUIR, V25, P14135, DOI 10.1021/la902098a; Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h; Feng L, 2011, SOFT MATTER, V7, P2977, DOI 10.1039/c0sm01032d; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Gibbs AG, 1998, AM ZOOL, V38, P471; Goodwyn PP, 2009, FUNCTIONAL SURFACES; HOLDGATE MW, 1955, J EXP BIOL, V32, P591; Hong SH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/38/385303; Hu HMS, 2011, J EXP BIOL, V214, P915, DOI 10.1242/jeb.051128; Koch K, 2008, SOFT MATTER, V4, P1943, DOI 10.1039/b804854a; Koch K, 2009, LANGMUIR, V25, P14116, DOI 10.1021/la9017322; MOUTDER JF, 1992, HDB XRAY PHOTOELECTR; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; Neinhuis C, 1998, NEW PHYTOL, V138, P91, DOI 10.1046/j.1469-8137.1998.00882.x; PAL R, 1951, B ENTOMOL RES, V51, P121; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Ren GD, 1999, DARKLING BEETLES D 3, P337; Ren LQ, 2007, J BIONIC ENG, V4, P33, DOI 10.1016/S1672-6529(07)60010-9; Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus; Shibuichi S, 1996, J PHYS CHEM-US, V100, P19512, DOI 10.1021/jp9616728; Sun Jiu-Rong, 2005, Acta Zoologica Sinica, V51, P761; Sun MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035056; Sun MX, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026003; Sun MX, 2009, J EXP BIOL, V212, P3148, DOI 10.1242/jeb.033373; Voise J, 2010, J R SOC INTERFACE, V7, P343, DOI 10.1098/rsif.2009.0210; Wagner T, 1996, ACTA ZOOL-STOCKHOLM, V77, P213, DOI 10.1111/j.1463-6395.1996.tb01265.x; Watson GS, 2008, BIOPHYS J, V94, P3352, DOI 10.1529/biophysj.107.109348; Watson GS, 2010, ACTA BIOMATER, V6, P4060, DOI 10.1016/j.actbio.2010.04.016; Watson GS, 2010, ACS NANO, V4, P129, DOI 10.1021/nn900869b; Watson GS, 2010, J STRUCT BIOL, V171, P44, DOI 10.1016/j.jsb.2010.03.008; Watson JA, 2011, BIOPHYS J, V100, P1149, DOI 10.1016/j.bpj.2010.12.3736; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Yao X, 2011, ADV MATER, V23, P719, DOI 10.1002/adma.201002689; Yao X, 2010, ADV FUNCT MATER, V20, P656, DOI 10.1002/adfm.200901775; YU PY, 1991, SYST ENTOMOL, V16, P253; Zheng YM, 2007, SOFT MATTER, V3, P178, DOI 10.1039/b612667g; 房岩, 2007, [科学通报, Chinese science bulletin], V52, P354	48	24	24	4	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46710	10.1371/journal.pone.0046710	http://dx.doi.org/10.1371/journal.pone.0046710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056414	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000309580800041
J	Xiao, Y; Li, YH; Han, J; Pan, Y; Tie, L; Li, XJ				Xiao, Yuan; Li, Yuhua; Han, Jing; Pan, Yan; Tie, Lu; Li, Xuejun			Transgelin 2 Participates in Lovastatin-Induced Anti-Angiogenic Effects in Endothelial Cells through a Phosphorylated Myosin Light Chain-Related Mechanism	PLOS ONE			English	Article							COA REDUCTASE INHIBITOR; MOLECULAR-MECHANISMS; KINASE PATHWAY; RHO-KINASE; CANCER; PROTEIN; MIGRATION; STATINS; CERIVASTATIN; INDUCTION	Background: Anti-angiogenic activity is considered to play a key role in the statin-induced anti-tumor effects. We aimed to identify new targets underlying this pleiotropic effect of lovastatin. Methodology/Principal Findings: We investigated the inhibitory effects of lovastatin on endothelial cell biology and angiogenesis in vitro. Lovastatin at high doses inhibited endothelial cell migration and tube formation. Using two-dimensional gel electrophoresis followed by mass spectrometry, we identified the up-regulation of the actin-binding protein transgelin 2 in endothelial cells following treatment with lovastatin. Changes in transgelin 2 levels were confirmed by Western blot and confocal microscopy. We further demonstrated that the Rho signaling inactivation and actin depolymerization contributed to the up-regulation of transgelin 2. The knockdown of transgelin 2 by siRNA dramatically enhanced endothelial migration and tube formation, and meanwhile attenuated the inhibitory effects of lovastatin on cell motility. Moreover, the lovastatin-induced inhibition of myosin light chain phosphorylation was also reversed by transgelin 2 knockdown. The activation of Rho GTPase in the absence of transgelin 2 may represent a mechanism underlying the regulation of phosphorylated myosin light chain by transgelin 2. Conclusions/Significance: These results strongly imply a novel role for transgelin 2 in the angiostatic activities of lovastatin.	[Xiao, Yuan; Li, Yuhua; Han, Jing; Pan, Yan; Tie, Lu; Li, Xuejun] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Xiao, Yuan; Li, Yuhua; Han, Jing; Pan, Yan; Tie, Lu; Li, Xuejun] Peking Univ, Inst Syst Biomed, Beijing 100871, Peoples R China	Peking University; Peking University	Li, XJ (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	xjli@bjmu.edu.cn	Li, yu/HHZ-5236-2022		National Natural Science Foundation of China [81020108031, 30572202, 30973558, 30772571, 30901815, 30901803]; Ministry of Science and Technology in China [2009ZX09103-144]; Ministry of Education of China (111 Projects) [B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology in China(Ministry of Science and Technology, China); Ministry of Education of China (111 Projects)(Ministry of Education, China - 111 ProjectMinistry of Education, China)	This work was supported by the National Natural Science Foundation of China (No. 81020108031, 30572202, 30973558, 30772571, 30901815, 30901803), the Major Specialized Research Fund from the Ministry of Science and Technology in China (No. 2009ZX09103-144) and Research Fund from Ministry of Education of China (111 Projects No. B07001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1990, J BIOCHEM-TOKYO, V108, P835, DOI 10.1093/oxfordjournals.jbchem.a123289; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Brandes RP, 2005, CIRC RES, V96, P927, DOI 10.1161/01.RES.0000168040.70096.2a; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Chen J, 2009, INT J MOL MED, V24, P789, DOI 10.3892/ijmm_00000293; Domhan S, 2008, MOL CANCER THER, V7, P1656, DOI 10.1158/1535-7163.MCT-08-0193; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Elsner M, 2012, J PROTEOMICS; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Grise F, 2009, BBA-REV CANCER, V1795, P137, DOI 10.1016/j.bbcan.2008.12.003; Hata Y, 2010, GRAEF ARCH CLIN EXP, V248, P667, DOI 10.1007/s00417-009-1282-4; Kaneider NC, 2001, ATHEROSCLEROSIS, V158, P23, DOI 10.1016/S0021-9150(00)00764-4; Katsumoto M, 2005, CIRC J, V69, P1547, DOI 10.1253/circj.69.1547; Kidera Yasuhiro, 2010, J Exp Clin Cancer Res, V29, P127, DOI 10.1186/1756-9966-29-127; Koch G, 1997, J PHARMACOL EXP THER, V283, P901; Laufs U, 2002, CARDIOVASC RES, V53, P911, DOI 10.1016/S0008-6363(01)00540-5; Lee EK, 2010, J PROTEOME RES, V9, P5108, DOI 10.1021/pr100378z; Leung WK, 2011, ONCOGENE; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Park HJ, 2006, STEM CELL REV, V2, P93, DOI 10.1007/s12015-006-0015-x; Ramachandran C, 2011, MOL VIS, V17, P1877; Rho JH, 2009, J PROTEOME RES, V8, P5610, DOI 10.1021/pr900705r; SHAPLAND C, 1993, J CELL BIOL, V121, P1065, DOI 10.1083/jcb.121.5.1065; Stanier P, 1998, GENOMICS, V51, P144, DOI 10.1006/geno.1998.5381; Thibault A, 1996, CLIN CANCER RES, V2, P483; van der Meel R, 2011, DRUG DISCOV TODAY, V16, P219, DOI 10.1016/j.drudis.2011.01.005; Vincent L, 2003, THROMB HAEMOSTASIS, V89, P530, DOI 10.1055/s-0037-1613384; Vincent L, 2001, FEBS LETT, V495, P159, DOI 10.1016/S0014-5793(01)02337-7; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Wu HL, 2009, CARDIOVASC RES, V81, P148, DOI 10.1093/cvr/cvn262; Xu SG, 2010, J CANCER RES CLIN, V136, P1545, DOI 10.1007/s00432-010-0812-0; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Zhang JCL, 2002, MECH DEVELOP, V115, P161, DOI 10.1016/S0925-4773(02)00088-6; Zhang YB, 2010, CANCER SCI, V101, P523, DOI 10.1111/j.1349-7006.2009.01424.x; Zhou Q, 2009, CURR PHARM DESIGN, V15, P467, DOI 10.2174/138161209787315684	35	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46510	10.1371/journal.pone.0046510	http://dx.doi.org/10.1371/journal.pone.0046510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056327	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800023
J	Alekseenko, IV; Pleshkan, VV; Kopantzev, EP; Stukacheva, EA; Chernov, IP; Vinogradova, TV; Sverdlov, ED				Alekseenko, Irina V.; Pleshkan, Victor V.; Kopantzev, Eugene P.; Stukacheva, Elena A.; Chernov, Igor P.; Vinogradova, Tatyana V.; Sverdlov, Eugene D.			Activity of the Upstream Component of Tandem TERT/Survivin Promoters Depends on Features of the Downstream Component	PLOS ONE			English	Article							CELL LUNG-CANCER; WILD-TYPE P53; GENE-EXPRESSION; SURVIVIN GENE; TRANSCRIPTIONAL INTERFERENCE; TISSUE-SPECIFICITY; CATALYTIC SUBUNIT; SP1; ACTIVATION; SYNERGISM	We spliced the promoters of the human telomerase and human survivin genes (PhTERT and PhSurv, respectively) widely used for gene therapy and known to have the broadest cancer type spectrum of activity. Two head-to-tail constructs were obtained: the PhTERT-PhSurv and PhSurv-PhTERT tandems. The splicing caused quantitative and qualitative changes in the promoter features. In both constructs, only the promoter proximal to the transcribed gene retained its ability to initiate transcription, whereas the distal promoter was silent, the phenomenon never reported before. However, the distal promoter modulated the activity of the proximal one by increasing its strength and causing an appearance of additional transcription start sites. We suggested that this suppression might be due to the presence of Sp1 transcription factor binding sites in both promoters and Sp1-bridges between these sites. Such Sp1-bridges might convert the tandem promoter linear DNA into a stem-loop structure. If localized inside the formed loop, the distal promoter could lose its ability to initiate transcription. To test this hypothesis, we constructed two modified double promoters, where the proximal PhSurv promoter was replaced either by a shortened variant of the survivin promoter (PhSurv269) or by the mouse survivin promoter. Both PhSurv substitutes were considerably shorter than PhSurv and had different numbers and/or positions of Sp1 sites. In modified tandems, transcription was initiated from both promoters. We also prepared two mutant forms of the PhSurv-PhTERT tandem with two or four Sp1 sites removed from the distal "long'' PhSurv promoter. In the first case, the distal PhSurv promoter remained silent, whereas the removal of four Sp1 binding sites restored its activity. In the majority of studied cancer cell lines the efficiency of transcription from the hTERT-(shortened hSurv269) promoter tandem was markedly higher than from each constituent promoter. In normal lung fibroblast cells, the tandem promoter activity was considerably lower.	[Alekseenko, Irina V.; Pleshkan, Victor V.; Sverdlov, Eugene D.] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Alekseenko, Irina V.; Pleshkan, Victor V.; Kopantzev, Eugene P.; Stukacheva, Elena A.; Chernov, Igor P.; Vinogradova, Tatyana V.; Sverdlov, Eugene D.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Alekseenko, IV (corresponding author), Russian Acad Sci, Inst Mol Genet, Moscow, Russia.	alekseenko.irina.v@gmail.com	Alekseenko, Irina/F-6582-2017; Pleshkan, Victor/F-9330-2017	Chernov, Igor/0000-0002-8879-1964; Pleshkan, Victor/0000-0001-5456-5582	Presidential Grant for Scientific Schools [5638.2010.4]; Basic Research Program (Physic-Chemical Biology) of the Presidium of the Russian Academy of Sciences	Presidential Grant for Scientific Schools; Basic Research Program (Physic-Chemical Biology) of the Presidium of the Russian Academy of Sciences	This work was supported by Presidential Grant for Scientific Schools (5638.2010.4) and grants from the Basic Research Program (Physic-Chemical Biology) of the Presidium of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RLP, 1980, CELL CULTURE BIOCH, P292; ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Chen JS, 2004, CANCER GENE THER, V11, P740, DOI 10.1038/sj.cgt.7700752; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; Farokhimanesh S, 2010, BIOTECHNOL PROGR, V26, P505, DOI 10.1002/btpr.353; Greger IH, 1998, NUCLEIC ACIDS RES, V26, P1294, DOI 10.1093/nar/26.5.1294; Gu R, 2003, CANCER BIOL THER, V2, pS64; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Horikawa I, 1999, CANCER RES, V59, P826; Hsu CP, 2003, EUR J SURG ONCOL, V29, P594, DOI 10.1016/S0748-7983(03)00108-2; Konopka K, 2009, CELL MOL BIOL LETT, V14, P70, DOI 10.2478/s11658-008-0034-5; Kopantzev EP, 2010, BRIT J CANCER, V102, P1533, DOI 10.1038/sj.bjc.6605652; Lee SE, 2000, ANTICANCER RES, V20, P417; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Li FZ, 1999, CANCER RES, V59, P3143; MASTRANGELO IA, 1991, P NATL ACAD SCI USA, V88, P5670, DOI 10.1073/pnas.88.13.5670; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Mirkin S. M., 2001, DNA TOPOLOGY FUNDAME; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Mityaev M, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1183, DOI 10.1134/S0006297908110035; Palmer AC, 2011, TRANSCR-AUSTIN, V2, P9, DOI 10.4161/trns.2.1.13511; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Pleshkan VV, 2008, BBA-GENE REGUL MECH, V1779, P599, DOI 10.1016/j.bbagrm.2008.06.002; Poole JC, 2001, GENE, V269, P1, DOI 10.1016/S0378-1119(01)00440-1; Poulsen TT, 2008, CANCER GENE THER, V15, P563, DOI 10.1038/cgt.2008.24; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; Sambrook J., 2001, MOL CLONING LAB MANU; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; SHEMER J, 1992, ENDOCRINOLOGY, V131, P2793, DOI 10.1210/en.131.6.2793; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Sverdlov E D, 2010, Mol Biol (Mosk), V44, P773; Sverdlov ED, 2011, CURR GENE THER, V11, P501; Takakura M, 1999, CANCER RES, V59, P551; Vaishlia N A, 2008, Mol Biol (Mosk), V42, P652; VALERIO D, 1985, EMBO J, V4, P437, DOI 10.1002/j.1460-2075.1985.tb03648.x; White NL, 1998, HUM MOL GENET, V7, P363, DOI 10.1093/hmg/7.3.363; Xu R, 2007, BIOCHEM BIOPH RES CO, V356, P286, DOI 10.1016/j.bbrc.2007.02.140; Yamamoto M, 2001, MOL THER, V3, P385, DOI 10.1006/mthe.2001.0275; Yang L, 2004, GENE THER, V11, P1215, DOI 10.1038/sj.gt.3302280; Zhu ZB, 2004, CANCER GENE THER, V11, P256, DOI 10.1038/sj.cgt.7700679	45	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46474	10.1371/journal.pone.0046474	http://dx.doi.org/10.1371/journal.pone.0046474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056318	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000049
J	Diederich, A; Schomburg, A; Colonius, H				Diederich, Adele; Schomburg, Annette; Colonius, Hans			Saccadic Reaction Times to Audiovisual Stimuli Show Effects of Oscillatory Phase Reset	PLOS ONE			English	Article							VISUAL-CORTEX; NEURONAL OSCILLATIONS; AUDITORY-CORTEX; THETA-OSCILLATIONS; PERFORMANCE; PERCEPTION; ATTENTION; SELECTION; SYNCHRONIZATION; PERIODICITY	Initiating an eye movement towards a suddenly appearing visual target is faster when an accessory auditory stimulus occurs in close spatiotemporal vicinity. Such facilitation of saccadic reaction time (SRT) is well-documented, but the exact neural mechanisms underlying the crossmodal effect remain to be elucidated. From EEG/MEG studies it has been hypothesized that coupled oscillatory activity in primary sensory cortices regulates multisensory processing. Specifically, it is assumed that the phase of an ongoing neural oscillation is shifted due to the occurrence of a sensory stimulus so that, across trials, phase values become highly consistent (phase reset). If one can identify the phase an oscillation is reset to, it is possible to predict when temporal windows of high and low excitability will occur. However, in behavioral experiments the pre-stimulus phase will be different on successive repetitions of the experimental trial, and average performance over many trials will show no signs of the modulation. Here we circumvent this problem by repeatedly presenting an auditory accessory stimulus followed by a visual target stimulus with a temporal delay varied in steps of 2 ms. Performing a discrete time series analysis on SRT as a function of the delay, we provide statistical evidence for the existence of distinct peak spectral components in the power spectrum. These frequencies, although varying across participants, fall within the beta and gamma range (20 to 40 Hz) of neural oscillatory activity observed in neurophysiological studies of multisensory integration. Some evidence for high-theta/alpha activity was found as well. Our results are consistent with the phase reset hypothesis and demonstrate that it is amenable to testing by purely psychophysical methods. Thus, any theory of multisensory processes that connects specific brain states with patterns of saccadic responses should be able to account for traces of oscillatory activity in observable behavior.	[Diederich, Adele; Schomburg, Annette] Jacobs Univ Bremen, Sch Humanities & Social Sci, Bremen, Germany; [Colonius, Hans] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany	Jacobs University; Carl von Ossietzky Universitat Oldenburg	Diederich, A (corresponding author), Jacobs Univ Bremen, Sch Humanities & Social Sci, Bremen, Germany.	a.diederich@jacobs-university.de	Colonius, Hans/D-5668-2011; Colonius, Hans/M-3350-2019	Colonius, Hans/0000-0002-9733-6939; Colonius, Hans/0000-0002-9733-6939	German Research Foundation (DFG) [DI 505/12-1, SFB/TR31]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation (DFG) grants DI 505/12-1 to AD and SFB/TR31 (Project B4) to HC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlot R, 2003, NEUROPSYCHOLOGIA, V41, P1, DOI 10.1016/S0028-3932(02)00139-2; Bauer F, 2009, P NATL ACAD SCI USA, V106, P1666, DOI 10.1073/pnas.0810496106; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Colonius H, 2011, EXP BRAIN RES, V212, P327, DOI 10.1007/s00221-011-2732-x; Colonius H, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00011; DEHAENE S, 1993, PSYCHOL SCI, V4, P264, DOI 10.1111/j.1467-9280.1993.tb00273.x; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Diederich A, 2008, BRAIN RES, V1242, P219, DOI 10.1016/j.brainres.2008.05.081; Drewes J, 2011, J NEUROSCI, V31, P4698, DOI 10.1523/JNEUROSCI.4795-10.2011; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fiebelkorn IC, 2011, J NEUROSCI, V31, P9971, DOI 10.1523/JNEUROSCI.1338-11.2011; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Fries P, 2002, J NEUROSCI, V22, P3739; GEISSLER HG, 1987, PSYCHOL RES-PSYCH FO, V49, P99, DOI 10.1007/BF00308674; Gomez-Ramirez M, 2011, J NEUROSCI, V31, P18556, DOI 10.1523/JNEUROSCI.2164-11.2011; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; LINDSLEY DB, 1952, ELECTROEN CLIN NEURO, V4, P443, DOI 10.1016/0013-4694(52)90075-8; Mathewson KE, 2010, COGNITION, V115, P186, DOI 10.1016/j.cognition.2009.11.010; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Naue N, 2011, J NEUROSCI, V31, P7729, DOI 10.1523/JNEUROSCI.1076-11.2011; Poeppel E, 1968, NATURWISSENSCHAFTEN, V55, P449; Romei V, 2012, CURR BIOL, V22, P807, DOI 10.1016/j.cub.2012.03.025; Rowland BA, 2007, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.004.2007; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Senkowski D, 2006, CEREB CORTEX, V16, P1556, DOI 10.1093/cercor/bhj091; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Thorne JD, 2011, J NEUROSCI, V31, P3853, DOI 10.1523/JNEUROSCI.6176-10.2011; Van Wanrooij MM, 2009, EXP BRAIN RES, V198, P425, DOI 10.1007/s00221-009-1815-4; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00060; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00203; VENABLES PH, 1960, BRIT J PSYCHOL, V51, P37, DOI 10.1111/j.2044-8295.1960.tb00722.x; VORBERG D, 1987, NATURWISSENSCHAFTEN, V74, P446, DOI 10.1007/BF00446104; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	44	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e44910	10.1371/journal.pone.0044910	http://dx.doi.org/10.1371/journal.pone.0044910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056186	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000005
J	Reinert, T; Borre, M; Christiansen, A; Hermann, GG; Orntoft, TF; Dyrskjot, L				Reinert, Thomas; Borre, Michael; Christiansen, Anders; Hermann, Gregers G.; Orntoft, Torben F.; Dyrskjot, Lars			Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation	PLOS ONE			English	Article							INVASIVE UROTHELIAL CARCINOMA; DNA METHYLATION; EPIGENETIC INACTIVATION; MUTATION ANALYSIS; CELL-CARCINOMA; EAU GUIDELINES; PHASE-III; MARKERS; BIOMARKERS; CYTOLOGY	Background: Non muscle invasive bladder cancer (NMIBC) has the highest recurrence rate of any malignancy and as many as 70% of patients experience relapse. Aberrant DNA methylation is present in all bladder tumors and can be detected in urine specimens. Previous studies have identified DNA methylation markers that showed significant diagnostic value. We evaluated the significance of the biomarkers for early detection of tumor recurrence in urine. Methodology/Principal Findings: The methylation levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 in urine specimens were measured by real-time PCR (MethyLight). We analyzed 390 urine sediments from 184 patients diagnosed with NMIBC. Urine from 35 age-matched control individuals was used to determine the methylation baseline levels. Recurrence was diagnosed by cystoscopy and verified by histology. Initially, we compared urine from bladder cancer patients and healthy individuals and detected significant hypermethylation of all six markers (P < 0.0001) achieving sensitivity in the range 82%-89% and specificity in the range 94%-100%. Following, we validated the urinary hypermethylation for use in recurrence surveillance and found sensitivities of 88-94% and specificities of 43-67%. EOMES, POU4F2, VIM and ZNF154 were more frequently methylated in urine from patients with higher grade tumors (P <= 0.08). Univariate Cox regression analysis showed that five markers were significantly associated with disease recurrence; HOXA9 (HR = 7.8, P = 0.006), POU4F2 (HR = 8.5, P = 0.001), TWIST1 (HR = 12.0, P = 0.015), VIM (HR = 8.0, P = 0.001), and ZNF154 (HR = 13.9, P < 0.001). Interestingly, for one group of patients (n = 15) we found that hypermethylation was consistently present in the urine samples despite the lack of tumor recurrences, indicating the presence of a field defect. Conclusion/Significance: Methylation levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 in urine specimens are promising diagnostic biomarkers for bladder cancer recurrence surveillance.	[Reinert, Thomas; Christiansen, Anders; Orntoft, Torben F.; Dyrskjot, Lars] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Borre, Michael] Aarhus Univ Hosp, Dept Urol, DK-8000 Aarhus, Denmark; [Hermann, Gregers G.] Univ Copenhagen, Frederiksberg Hosp, Dept Urol, Frederiksberg, Denmark	Aarhus University; Aarhus University; University of Copenhagen	Dyrskjot, L (corresponding author), Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark.	lars@ki.au.dk	Christiansen, Anders/I-1578-2012	Dyrskjot, Lars/0000-0001-7061-9851; Reinert, Thomas/0000-0003-4835-4804; Borre, Michael/0000-0002-1519-9185	John and Birthe Meyer Foundation; Danish Council for Independent Research; Lundbeck Foundation; NOVO Nordisk Foundation; EU grant [201663]; Danish Cancer Society; University of Aarhus; Danish Ministry of the Interior and Health	John and Birthe Meyer Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); EU grant(European Commission); Danish Cancer Society(Danish Cancer Society); University of Aarhus; Danish Ministry of the Interior and Health	This work was supported by the John and Birthe Meyer Foundation, the Danish Council for Independent Research, the Lundbeck Foundation, the NOVO Nordisk Foundation, an EU grant to UROMOL Consortium no. 201663, the Danish Cancer Society, the University of Aarhus, and the Danish Ministry of the Interior and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avritscher EBC, 2006, UROLOGY, V68, P549, DOI 10.1016/j.urology.2006.03.062; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Bergkvist A, 1965, Acta Chir Scand, V130, P371; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Brems-Eskildsen AS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-646; Campan Mihhaela, 2009, V507, P325, DOI 10.1007/978-1-59745-522-0_23; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Dalbagni G, 2001, CLIN CANCER RES, V7, P2797; Dulaimi E, 2004, CLIN CANCER RES, V10, P1887, DOI 10.1158/1078-0432.CCR-03-0127; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Gazdar AF, 2001, JNCI-J NATL CANCER I, V93, P413, DOI 10.1093/jnci/93.6.413; Grossman HB, 2007, J UROLOGY, V178, P62, DOI 10.1016/j.juro.2007.03.034; Hafner C, 2002, INT J CANCER, V101, P1, DOI 10.1002/ijc.10544; Hermann GG, 2011, BJU INT, V108, pE297, DOI 10.1111/j.1464-410X.2011.10090.x; HOLMANG S, 1995, J UROLOGY, V153, P1823, DOI 10.1016/S0022-5347(01)67321-X; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Jocham D, 2005, J UROLOGY, V174, P862, DOI 10.1097/01.ju.0000169257.19841.2a; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Lee MG, 2001, CANCER RES, V61, P6688; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lin HH, 2009, UROL ONCOL; Lotan Y, 2003, UROLOGY, V61, P109, DOI 10.1016/S0090-4295(02)02136-2; MIGEON BR, 1992, AM J MED GENET, V43, P291, DOI 10.1002/ajmg.1320430145; Millan-Rodriguez F, 2000, J UROLOGY, V164, P680, DOI 10.1016/S0022-5347(05)67280-1; Mowatt G, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14040; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Renard I, 2009, EUR UROL; Rieger-Christ KM, 2003, CANCER-AM CANCER SOC, V98, P737, DOI 10.1002/cncr.11536; Riggs A. D., 1996, EPIGENETIC MECH GENE, P29; Roupret M, 2008, BJU INT, V101, P1448, DOI 10.1111/j.1464-410X.2008.07591.x; Serizawa RR, 2010, INT J CANC; Sobin, 2009, UICC TNM CLASSIFICAT; Steineck G, 2001, CURR CLIN UROL, P1; Takahashi T, 1998, CANCER RES, V58, P5835; Urakami S, 2006, CLIN CANCER RES, V12, P383, DOI 10.1158/1078-0432.CCR-05-1344; van Rhijn BWG, 2003, CLIN CANCER RES, V9, P257; Veerla S, 2008, GENE CHROMOSOME CANC, V47, P368, DOI 10.1002/gcc.20542; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wolf H, 1986, Prog Clin Biol Res, V221, P223; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861; Zuiverloon T.C., 2011, BJU INT; Zuiverloon TCM, 2011, J UROLOGY, V186, P707, DOI 10.1016/j.juro.2011.03.141; Zuiverloon TCM, 2010, CLIN CANCER RES, V16, P3011, DOI 10.1158/1078-0432.CCR-09-3013	48	83	91	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46297	10.1371/journal.pone.0046297	http://dx.doi.org/10.1371/journal.pone.0046297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056278	gold, Green Published			2022-12-27	WOS:000309454000031
J	Park, L				Park, Leeyoung			Linkage Disequilibrium Decay and Past Population History in the Human Genome	PLOS ONE			English	Article							POSITIVE SELECTION; FINITE POPULATIONS; NATURAL-SELECTION; HAPLOTYPE MAP; SIZE; HITCHHIKING; FREQUENCIES; SNPS	The fluctuation of population size has not been well studied in the previous studies of theoretical linkage disequilibrium (LD) expectation. In this study, an improved theoretical prediction of LD decay was derived to account for the effects of changes in effective population sizes. The equation was used to estimate effective population size (N-e) assuming a constant N-e and LD at equilibrium, and these N-e estimates implied the past changes of N-e for a certain number of generations until equilibrium, which differed based on recombination rate. As the influence of recent population history on the N-e estimates is larger than old population history, recent changes in population size can be inferred more accurately than old changes. The theoretical predictions based on this improved expression showed accurate agreement with the simulated values. When applied to human genome data, the detailed recent history of human populations was obtained. The inferred past population history of each population showed good correspondence with historical studies. Specifically, four populations (three African ancestries and one Mexican ancestry) showed population growth that was significantly less than that of other populations, and two populations originated from China showed prominent exponential growth. During the examination of overall LD decay in the human genome, a selection pressure on chromosome 14, the gephyrin gene, was observed in all populations.	Yonsei Univ, Nat Sci Res Inst, Seoul 120749, South Korea	Yonsei University	Park, L (corresponding author), Yonsei Univ, Nat Sci Res Inst, Seoul 120749, South Korea.	lypark@yonsei.ac.kr			Korea Research Foundation; Korean Government (MOEHRD) [KRF-2007-532-C00017]; National Research Foundation of Korea; Korean Government [NRF-2009-353-C00061]	Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2007-532-C00017) and by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2009-353-C00061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn I, 2005, CESCHICHTE AFRIKAS; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Araki H, 2007, MOL ECOL, V16, P2261, DOI 10.1111/j.1365-294X.2007.03307.x; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Ewens W.J., 2004, MATH POPULATION GENE, DOI [DOI 10.1007/978-0-387-21822-9, 10.1007/978-0-387-21822-9]; Fay JC, 2000, GENETICS, V155, P1405; Feldman M.W., 1989, MATH EVOLUTIONARY TH; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HILL WG, 1975, THEOR POPUL BIOL, V8, P117, DOI 10.1016/0040-5809(75)90028-3; HILL WG, 1977, THEOR POPUL BIOL, V11, P239, DOI 10.1016/0040-5809(77)90026-0; Ho P-t, 1994, STUDIES POPULATION C; Iliffe J, 1996, AFRICANS HIST CONTIN; Kim Y, 2002, GENETICS, V160, P765; KIMURA M, 1973, GENETICS, V75, P199; Kimura M., 1971, THEORETICAL ASPECTS; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Manning P., 1990, SLAVERY AFRICAN LIFE; McEvedy C., 1978, ATLAS WORLD POPULATI; McEvoy BP, 2011, GENOME RES, V21, P821, DOI 10.1101/gr.119636.110; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Nomura T, 2005, GENETICS, V171, P1441, DOI 10.1534/genetics.104.029769; Park L, 2011, GENET RES, V93, P105, DOI 10.1017/S0016672310000558; Pressat R, 1970, POPULATION; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scott Susan, 2004, RETURN BLACK DEATH W; Song YS, 2007, THEOR POPUL BIOL, V71, P49, DOI 10.1016/j.tpb.2006.09.001; Spear P, 1993, INDIA MODERN HIST; SVED J A, 1971, Theoretical Population Biology, V2, P125; SVED JA, 1973, THEOR POPUL BIOL, V4, P129, DOI 10.1016/0040-5809(73)90008-7; Sved JA, 2008, AM J HUM GENET, V83, P737, DOI 10.1016/j.ajhg.2008.10.019; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Villegas DC, 1991, HIST MINIMA MEXICO; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2008, ANNU REV GENOM HUM G, V9, P129, DOI 10.1146/annurev.genom.9.081307.164347; Weir B. S., 1996, GENETIC DATA ANAL; WEIR BS, 1980, GENETICS, V95, P477; Whitney F, 2004, OUTLINE AM HIST BURE; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wright S., 1969, EVOLUTION GENETICS P; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	53	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46603	10.1371/journal.pone.0046603	http://dx.doi.org/10.1371/journal.pone.0046603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056365	Green Submitted, gold, Green Published			2022-12-27	WOS:000309452600045
J	Valque, H; Gouyer, V; Gottrand, F; Desseyn, JL				Valque, Helene; Gouyer, Valerie; Gottrand, Frederic; Desseyn, Jean-Luc			MUC5B Leads to Aggressive Behavior of Breast Cancer MCF7 Cells	PLOS ONE			English	Article							MUCIN GENE MUC5B; LARGE CENTRAL EXON; GENOMIC ORGANIZATION; ABERRANT EXPRESSION; IDENTIFICATION; CARCINOMAS; SUBTYPES; DOMAINS; TISSUES; FAMILY	The mucin MUC5B has a critical protective function in the normal lung, salivary glands, esophagus, and gallbladder, and has been reported to be aberrantly expressed in breast cancer, the second leading cause of cancer-related deaths among women worldwide. To understand better the implication of MUC5B in cancer pathogenesis, the luminal human breast cancer cell line MCF7 was transfected with a vector encoding a recombinant mini-mucin MUC5B and was then infected with a virus to deliver a short hairpin RNA to knock down the mini-mucin. The proliferative and invasive properties in Matrigel of MCF7 subclones and subpopulations were evaluated in vitro. A xenograft model was established by subcutaneous inoculation of MCF7 clones and subpopulations in SCID mice. Tumor growth was measured, and the tumors and metastases were assessed by histological and immunological analysis. The mini-mucin MUC5B promoted MCF7 cell proliferation and invasion in vitro. The xenograft experiments demonstrated that the mini-mucin promoted tumor growth and MCF7 cell dissemination. In conclusion, MUC5B expression is associated with aggressive behavior of MCF7 breast cancer cells. This study suggests that MUC5B may represent a good target for slowing tumor growth and metastasis.	[Valque, Helene; Gouyer, Valerie; Gottrand, Frederic; Desseyn, Jean-Luc] INSERM, U995, F-59045 Lille, France; [Valque, Helene; Gouyer, Valerie; Gottrand, Frederic; Desseyn, Jean-Luc] Univ Lille 2, Lille, France; [Gouyer, Valerie; Gottrand, Frederic] CHRU, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Valque, H (corresponding author), INSERM, U995, F-59045 Lille, France.	jean-luc.desseyn@inserm.fr	Desseyn, Jean-Luc/M-5070-2018; Gouyer, Valérie/R-4984-2018; gottrand, frederic F/G-7370-2015	Desseyn, Jean-Luc/0000-0001-6876-8049; Gouyer, Valérie/0000-0002-4223-7060; gottrand, frederic F/0000-0002-5290-0436				Baldus SE, 2004, CRIT REV CL LAB SCI, V41, P189, DOI 10.1080/10408360490452040; Berois N, 2003, INT J CANCER, V103, P550, DOI 10.1002/ijc.10853; Copin MC, 2001, FRONT BIOSCI, V6, pD1264, DOI 10.2741/Copin; Debailleul V, 1998, J BIOL CHEM, V273, P881, DOI 10.1074/jbc.273.2.881; Desseyn J.L., 2008, EPITHELIAL MUCINS ST, P1; Desseyn JL, 2008, GENE, V410, P215, DOI 10.1016/j.gene.2007.12.014; Desseyn JL, 2009, MOL PHYLOGENET EVOL, V52, P284, DOI 10.1016/j.ympev.2009.03.035; Desseyn JL, 1998, J BIOL CHEM, V273, P30157, DOI 10.1074/jbc.273.46.30157; Desseyn JL, 1997, J BIOL CHEM, V272, P16873, DOI 10.1074/jbc.272.27.16873; Desseyn JL, 1997, J BIOL CHEM, V272, P3168, DOI 10.1074/jbc.272.6.3168; Freire T, 2005, CANCER RES, V65, P7880, DOI 10.1158/0008-5472.CAN-04-3746; Ganapathy V, 2012, CLIN EXP METASTAS, V29, P493, DOI 10.1007/s10585-012-9466-4; Gouyer V, 2012, C MANNOSYLATIO UNPUB; Gouyer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018761; Gouyer V, 2010, HISTOCHEM CELL BIOL, V133, P517, DOI 10.1007/s00418-010-0688-8; Hamamoto A, 2005, INT J ONCOL, V26, P891; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kim Young S., 1998, Keio Journal of Medicine, V47, P10; Leir SH, 2011, EXP CELL RES, V317, P2408, DOI 10.1016/j.yexcr.2011.07.021; Liu ZD, 1997, BIOCHEM BIOPH RES CO, V231, P283, DOI 10.1006/bbrc.1997.6083; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perrais M, 2001, J BIOL CHEM, V276, P15386, DOI 10.1074/jbc.M010534200; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Rousseau K, 2003, HYBRIDOMA HYBRIDOM, V22, P293, DOI 10.1089/153685903322538818; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Sonora C, 2006, J HISTOCHEM CYTOCHEM, V54, P289, DOI 10.1369/jhc.5A6763.2005; Sternberg LR, 1999, GASTROENTEROLOGY, V116, P363, DOI 10.1016/S0016-5085(99)70133-2; Tetaert D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-39; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Valque H, 2011, HISTOCHEM CELL BIOL, V136, P699, DOI 10.1007/s00418-011-0872-5; WALSH MD, 1993, J CLIN PATHOL, V46, P922, DOI 10.1136/jcp.46.10.922; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Xui YQ, 2001, ONCOL REP, V8, P1177; Yu CJ, 1996, INT J CANCER, V69, P457, DOI 10.1002/(SICI)1097-0215(19961220)69:6<457::AID-IJC7>3.0.CO;2-3	37	31	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46699	10.1371/journal.pone.0046699	http://dx.doi.org/10.1371/journal.pone.0046699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056409	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600054
J	Burke, SJ; Goff, MR; Updegraff, BL; Lu, DH; Brown, PL; Minkin, SC; Biggerstaff, JP; Zhao, L; Karlstad, MD; Collier, JJ				Burke, Susan J.; Goff, Matthew R.; Updegraff, Barrett L.; Lu, Danhong; Brown, Patricia L.; Minkin, Steven C., Jr.; Biggerstaff, John P.; Zhao, Ling; Karlstad, Michael D.; Collier, J. Jason			Regulation of the CCL2 Gene in Pancreatic beta-Cells by IL-1 beta and Glucocorticoids: Role of MKP-1	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; DUAL-SPECIFICITY PHOSPHATASES; STIMULATED INSULIN-SECRETION; ISLET TRANSPLANTATION; DIABETES-MELLITUS; INCREASED EXPRESSION; CHEMOKINE RECEPTORS; KINASE INHIBITOR; TISSUE FACTOR	Release of pro-inflammatory cytokines from both resident and invading leukocytes within the pancreatic islets impacts the development of Type 1 diabetes mellitus. Synthesis and secretion of the chemokine CCL2 from pancreatic beta-cells in response to pro-inflammatory signaling pathways influences immune cell recruitment into the pancreatic islets. Therefore, we investigated the positive and negative regulatory components controlling expression of the CCL2 gene using isolated rat islets and INS-1-derived beta-cell lines. We discovered that activation of the CCL2 gene by IL-1 beta required the p65 subunit of NF-kappa B and was dependent on genomic response elements located in the -3.6 kb region of the proximal gene promoter. CCL2 gene transcription in response to IL-1 beta was blocked by pharmacological inhibition of the IKK beta and p38 MAPK pathways. The IL-1 beta-mediated increase in CCL2 secretion was also impaired by p38 MAPK inhibition and by glucocorticoids. Moreover, multiple synthetic glucocorticoids inhibited the IL-1 beta-stimulated induction of the CCL2 gene. Induction of the MAP Kinase Phosphatase-1 (MKP-1) gene by glucocorticoids or by adenoviral-mediated overexpression decreased p38 MAPK phosphorylation, which diminished CCL2 gene expression, promoter activity, and release of CCL2 protein. We conclude that glucocorticoid-mediated repression of IL-1 beta-induced CCL2 gene transcription and protein secretion occurs in part through the upregulation of the MKP-1 gene and subsequent deactivation of the p38 MAPK. Furthermore, the anti-inflammatory actions observed with MKP-1 overexpression were obtained without suppressing glucose-stimulated insulin secretion. Thus, MKP-1 is a possible target for anti-inflammatory therapeutic intervention with preservation of beta-cell function.	[Burke, Susan J.; Goff, Matthew R.; Updegraff, Barrett L.; Zhao, Ling; Karlstad, Michael D.; Collier, J. Jason] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [Lu, Danhong] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Brown, Patricia L.; Minkin, Steven C., Jr.; Biggerstaff, John P.] Univ Tennessee, Adv Microscopy & Imaging Ctr, Knoxville, TN USA; [Karlstad, Michael D.] Univ Tennessee, Med Ctr, Dept Surg, Grad Sch Med, Knoxville, TN 37920 USA; [Zhao, Ling; Karlstad, Michael D.; Collier, J. Jason] Univ Tennessee, Obes Res Ctr, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; Duke University; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville	Collier, JJ (corresponding author), Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA.	Jason.Collier@utk.edu	Collier, James/N-1958-2017; Collier, Susan J/N-1959-2017; Karlstad, Michael/V-3212-2019	Collier, Susan J/0000-0003-2571-4416; Karlstad, Michael/0000-0002-3190-8738	University of Tennessee, Knoxville	University of Tennessee, Knoxville	This work was supported by start-up funds provided by the University of Tennessee, Knoxville (to JJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Arumugam R, 2008, ENDOCRINOLOGY, V149, P5401, DOI 10.1210/en.2008-0051; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Beck IM, 2009, ENDOCR REV; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Bueno OF, 2001, CIRC RES, V88, P88, DOI 10.1161/01.RES.88.1.88; Burke SJ, 2011, CELL IMMUNOL, V271, P379, DOI 10.1016/j.cellimm.2011.08.004; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622; Chipitsyna G, 2007, ENDOCRINOLOGY, V148, P2198, DOI 10.1210/en.2006-1358; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Collier JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022485; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Del Guerra S, 2010, TRANSPL P, V42, P2247, DOI 10.1016/j.transproceed.2010.05.039; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461; Freudenburg W, 2010, J GEN VIROL, V91, P2278, DOI 10.1099/vir.0.022665-0; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Grewal IS, 1997, J IMMUNOL, V159, P401; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3; Jewell CM, 2012, MOL ENDOCRINOL, V26, P244, DOI 10.1210/me.2011-1116; Joanny E, 2012, BRIT J PHARMACOL, V165, P1124, DOI 10.1111/j.1476-5381.2011.01574.x; Jobin C, 1998, J IMMUNOL, V160, P410; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kato A, 2009, J IMMUNOL, V182, P7233, DOI 10.4049/jimmunol.0801375; Kim SH, 2002, J CLIN INVEST, V110, P1675, DOI 10.1172/JCI200215547; Kondo T, 2009, MOL ENDOCRINOL, V23, P1281, DOI 10.1210/me.2008-0482; Kriegel MA, 2012, P NATL ACAD SCI USA, V109, P3457, DOI 10.1073/pnas.1115308109; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kutlu B, 2003, DIABETES, V52, P348, DOI 10.2337/diabetes.52.2.348; Langer RM, 2010, TRANSPL P, V42, P1421, DOI 10.1016/j.transproceed.2010.04.021; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Lund T, 2008, TRANSPL INT, V21, P669, DOI 10.1111/j.1432-2277.2008.00664.x; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Medicherla S, 2006, J PHARMACOL EXP THER, V318, P99, DOI 10.1124/jpet.105.097857; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Omori K, 2010, PANCREAS, V39, P436, DOI 10.1097/MPA.0b013e3181c0dd8f; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Prasad RC, 2009, CANCER LETT, V275, P139, DOI 10.1016/j.canlet.2008.10.007; Rafacho A, 2010, ENDOCRINOLOGY, V151, P85, DOI 10.1210/en.2009-0704; Rotondi M, 2007, ENDOCR REV, V28, P492, DOI 10.1210/er.2006-0044; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Schroppel B, 2005, J AM SOC NEPHROL, V16, P444, DOI 10.1681/ASN.2004090743; Sekine O, 2002, J BIOL CHEM, V277, P36631, DOI 10.1074/jbc.M206266200; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Solomon M, 2010, AUTOIMMUNITY, V43, P156, DOI 10.3109/08916930903246464; Stewart DM, 2001, ENDOCRINOLOGY, V142, P98, DOI 10.1210/en.142.1.98; Storling J, 2011, ENDOCRINOLOGY, V152, P3040, DOI 10.1210/en.2010-1422; Tchen CR, 2010, J BIOL CHEM, V285, P2642, DOI 10.1074/jbc.M109.037309; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; Thompson A, 2002, METABOLISM, V51, P765, DOI 10.1053/meta.2002.32033; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Uno S, 2010, ENDOCR J, V57, P991, DOI 10.1507/endocrj.K10E-076; Westwell-Roper C, 2011, J IMMUNOL, V187, P2755, DOI 10.4049/jimmunol.1002854; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Zineh I, 2009, DIABETES CARE, V32, P465, DOI 10.2337/dc08-1849	77	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46986	10.1371/journal.pone.0046986	http://dx.doi.org/10.1371/journal.pone.0046986			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056550	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400041
J	Li, L; Chen, LL; Yang, SM; Li, TY; Li, JJ; Liu, YJ; Jia, L; Yang, BH; Bao, ZY; Li, HP; Wang, XL; Zhuang, DM; Liu, SY; Li, JY				Li, Lin; Chen, Lili; Yang, Shaomin; Li, Tianyi; Li, Jianjian; Liu, Yongjian; Jia, Lei; Yang, Bihui; Bao, Zuoyi; Li, Hanping; Wang, Xiaolin; Zhuang, Daomin; Liu, Siyang; Li, Jingyun			Recombination Form and Epidemiology of HIV-1 Unique Recombinant Strains Identified in Yunnan, China	PLOS ONE			English	Article							REVERSE TRANSCRIPTION; INTERSUBTYPE RECOMBINANTS; RETROVIRAL RECOMBINATION; TYPE-1 GENOME; DRUG-USE; INFECTION; PROVINCE	Several studies identified HIV-1 recombination in some distinct areas in Yunnan, China. However, no comprehensive studies had been fulfilled in the whole province up to now. To illustrate the epidemiology and recombination form of Unique Recombinant Forms (URFs) circulating in Yunnan, 788 HIV-1 positive individuals residing in 15 prefectures of Yunnan were randomly enrolled into the study. Full-length gag and pol genes were amplified and sequenced. Maximum likelihood tree was constructed for phylogenetic analysis. Recombinant breakpoints and genomic schematics were identified with online software jpHMM. 63 (10.2%) unique recombinant strains were identified from 617 strains with subtypes. The URFs distributed significantly differently among prefectures (Pearson chi-square test, P<0.05). IDUs contained more URFs than sexual transmitted population (Pearson chi-square test, P<0.05). Two main recombinant forms were identified by considering the presence of CRF01_AE segments in full length gag-pol genes, which were B'/C and B'/C/CRF01-AE recombinants. Three clusters were identified in the ML tree which contained more than three sequences and supported by high bootstrap values. One CRF was identified. Many of URFs contained identical breakpoints. The results will contribute to our understanding on HIV recombination and provide clues to the identification of potential CRFs in China.	[Li, Lin; Chen, Lili; Li, Tianyi; Liu, Yongjian; Jia, Lei; Bao, Zuoyi; Li, Hanping; Wang, Xiaolin; Zhuang, Daomin; Liu, Siyang; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing, Peoples R China; [Yang, Shaomin; Li, Jianjian; Yang, Bihui] Yunnan Prov Hosp Infect Dis, AIDS Care Ctr YNACC, Kunming, Yunnan, Peoples R China; [Chen, Lili] Urumqi Gen Hosp, Lanzhou Mil Area Command, Urumqi, Xinjiang, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Li, JY (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing, Peoples R China.	lijy@nic.bmi.ac.cn	Liu, Yong/GWQ-6163-2022		National Key Science and Technology Special Projects on Major Infectious Diseases [2008ZX10001-004]; National Natural Science Foundation of China [81072348]	National Key Science and Technology Special Projects on Major Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Science and Technology Special Projects on Major Infectious Diseases (Grant No. 2008ZX10001-004) and the National Natural Science Foundation of China (No. 81072348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LL, 2011, AIDS RES HUM RETROV, V27, P693, DOI [10.1089/aid.2010.0264, 10.1089/AID.2010.0264]; GOODRICH DW, 1990, P NATL ACAD SCI USA, V87, P2052, DOI 10.1073/pnas.87.6.2052; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li L, 2010, AIDS RES HUM RETROV, V26, P699, DOI 10.1089/aid.2010.0026; Liu YJ, 2011, AIDS RES HUM RETROV, V27, P445, DOI 10.1089/aid.2010.0212; LUO CC, 1995, LANCET, V345, P1051, DOI 10.1016/S0140-6736(95)90792-0; Pang W, 2012, AIDS; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; STUHLMANN H, 1992, J VIROL, V66, P2378, DOI 10.1128/JVI.66.4.2378-2388.1992; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; SUN XH, 1994, AIDS, V8, pS55; Takebe Y, 2003, AIDS, V17, P2077, DOI 10.1097/00002030-200309260-00009; Tu YQ, 2009, TRANSFUSION, V49, P1865, DOI 10.1111/j.1537-2995.2009.02219.x; Wagner R, 1996, ANTIBIOT CHEMOTHER, V48, P68; XIA MS, 1994, AIDS, V8, P1701, DOI 10.1097/00002030-199412000-00010; Yang RG, 2002, AIDS, V16, P1401, DOI 10.1097/00002030-200207050-00012; Zhang M, 2006, NUCLEIC ACIDS RES, V34, pW463, DOI 10.1093/nar/gkl255; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017; [No title captured]	26	36	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46777	10.1371/journal.pone.0046777	http://dx.doi.org/10.1371/journal.pone.0046777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056447	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400028
J	Belmont, BJ; Niles, JC				Belmont, Brian J.; Niles, Jacquin C.			Inducible Control of Subcellular RNA Localization Using a Synthetic Protein-RNA Aptamer Interaction	PLOS ONE			English	Article							ASH1 MESSENGER-RNA; TRANSLATIONAL REPRESSION; FLUORESCENT PROTEIN; BUDDING YEAST; TRANSPORT; GENOME; PHOSPHORYLATION; EXPRESSION; ELEMENTS; REVEALS	Evidence is accumulating in support of the functional importance of subcellular RNA localization in diverse biological contexts. In different cell types, distinct RNA localization patterns are frequently observed, and the available data indicate that this is achieved through a series of highly coordinated events. Classically, cis-elements within the RNA to be localized are recognized by RNA-binding proteins (RBPs), which then direct specific localization of a target RNA. Until now, the precise control of the spatiotemporal parameters inherent to regulating RNA localization has not been experimentally possible. Here, we demonstrate the development and use of a chemically-inducible RNA-protein interaction to regulate subcellular RNA localization. Our system is composed primarily of two parts: (i) the Tet Repressor protein (TetR) genetically fused to proteins natively involved in localizing endogenous transcripts; and (ii) a target transcript containing genetically encoded TetR-binding RNA aptamers. TetR-fusion protein binding to the target RNA and subsequent localization of the latter are directly regulated by doxycycline. Using this platform, we demonstrate that enhanced and controlled subcellular localization of engineered transcripts are achievable. We also analyze rules for forward engineering this RNA localization system in an effort to facilitate its straightforward application to studying RNA localization more generally.	[Belmont, Brian J.; Niles, Jacquin C.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Niles, JC (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jcniles@mit.edu		Belmont, Brian/0000-0002-8314-4565	National Institutes of Health [1DP2OD007124]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health, NIH Director's New Innovator Award Program (grant number 1DP2OD007124 to J.C.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach DL, 2001, MOL BIOL CELL, V12, P2567, DOI 10.1091/mbc.12.9.2567; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Belmont BJ, 2010, ACS CHEM BIOL, V5, P851, DOI 10.1021/cb100070j; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Bookwalter CS, 2009, MOL BIOL CELL, V20, P3414, DOI 10.1091/mbc.E08-08-0801; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chartrand P, 1999, CURR BIOL, V9, P333, DOI 10.1016/S0960-9822(99)80144-4; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Coller J, 2002, METHODS, V26, P142, DOI 10.1016/S1046-2023(02)00016-6; Fages C, 1998, J CELL SCI, V111, P3073; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Goldfless SJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks028; Gonsalvez GB, 2005, BIOL CELL, V97, P75; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; King ML, 2005, BIOL CELL, V97, P19; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lange S, 2008, TRAFFIC, V9, P1256, DOI 10.1111/j.1600-0854.2008.00763.x; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Muller M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000611; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Paquin N, 2007, MOL CELL, V26, P795, DOI 10.1016/j.molcel.2007.05.016; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Sambrook J., 2001, MOL CLONING LAB MANU; Shen Z, 2009, MOL BIOL CELL, V20, P2265, DOI 10.1091/mbc.E08-11-1151; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Vuppalanchi D, 2009, RESULTS PROBL CELL D, V48, P193, DOI 10.1007/400_2009_16; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Yang J, 2001, MOL CELL, V8, P397, DOI 10.1016/S1097-2765(01)00303-3	47	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46868	10.1371/journal.pone.0046868	http://dx.doi.org/10.1371/journal.pone.0046868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056498	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500095
J	Gadbury, GL; Allison, DB				Gadbury, Gary L.; Allison, David B.			Inappropriate Fiddling with Statistical Analyses to Obtain a Desirable P-value: Tests to Detect its Presence in Published Literature	PLOS ONE			English	Article							MIXTURE MODEL; BIAS	Much has been written regarding p-values below certain thresholds (most notably 0.05) denoting statistical significance and the tendency of such p-values to be more readily publishable in peer-reviewed journals. Intuition suggests that there may be a tendency to manipulate statistical analyses to push a "near significant p-value'' to a level that is considered significant. This article presents a method for detecting the presence of such manipulation (herein called "fiddling'') in a distribution of p-values from independent studies. Simulations are used to illustrate the properties of the method. The results suggest that the method has low type I error and that power approaches acceptable levels as the number of p-values being studied approaches 1000.	[Gadbury, Gary L.] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA; [Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	Kansas State University; University of Alabama System; University of Alabama Birmingham	Gadbury, GL (corresponding author), Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA.	gadbury@ksu.edu; Dallison@UAB.edu		Allison, David/0000-0003-3566-9399	Coca-Cola Company; United States National Institutes of Health/NIDDK [P30DK056336]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	Coca-Cola Company; United States National Institutes of Health/NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by a grant from the Coca-Cola Company and by a grant from the United States National Institutes of Health/NIDDK, P30DK056336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I have read the journal's policy and have the following conflicts. Dr. Allison has, anticipates, or has had financial interests with the Frontiers Foundation; Vivus, Inc; Kraft Foods; University of Wisconsin; University of Arizona; Paul, Weiss, Wharton & Garrison LLP; and Sage Publications. This study was funded by Coca Cola. There are no declarations of employment, consultancy, patents, products in development or marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	COWLES M, 1982, AM PSYCHOL, V37, P553, DOI 10.1037/0003-066X.37.5.553; Emerson GB, 2010, ARCH INTERN MED, V170, P1934, DOI 10.1001/archinternmed.2010.406; Hu Xiaojun, 2010, Adv Appl Stat Sci, V1, P191; Ridley J, 2007, J EVOLUTION BIOL, V20, P1082, DOI 10.1111/j.1420-9101.2006.01291.x; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Xiang QF, 2006, COMPUT STAT DATA AN, V51, P570, DOI 10.1016/j.csda.2005.11.011	8	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46363	10.1371/journal.pone.0046363	http://dx.doi.org/10.1371/journal.pone.0046363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056287	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500036
J	Lo Martire, V; Silvani, A; Bastianini, S; Berteotti, C; Zoccoli, G				Lo Martire, Viviana; Silvani, Alessandro; Bastianini, Stefano; Berteotti, Chiara; Zoccoli, Giovanna			Effects of Ambient Temperature on Sleep and Cardiovascular Regulation in Mice: The Role of Hypocretin/Orexin Neurons	PLOS ONE			English	Article							BLOOD-PRESSURE; BAROREFLEX CONTROL; ARTERIAL-PRESSURE; OREXIN NEURONS; DEFICIENT MICE; PREOPTIC AREA; HEART PERIOD; NARCOLEPSY; CATAPLEXY; CYCLE	The central neural pathways underlying the physiological coordination between thermoregulation and the controls of the wake-sleep behavior and cardiovascular function remain insufficiently understood. Growing evidence supports the involvement of hypocretin (orexin) peptides in behavioral, cardiovascular, and thermoregulatory functions. We investigated whether the effects of ambient temperature on wake-sleep behavior and cardiovascular control depend on the hypothalamic neurons that release hypocretin peptides. Orexin-ataxin3 transgenic mice with genetic ablation of hypocretin neurons (n = 11) and wild-type controls (n = 12) were instrumented with electrodes for sleep scoring and a telemetric blood pressure transducer. Simultaneous sleep and blood pressure recordings were performed on freely-behaving mice at ambient temperatures ranging between mild cold (20 degrees C) and the thermoneutral zone (30 degrees C). In both mouse groups, the time spent awake and blood pressure were higher at 20 degrees C than at 30 degrees C. The cold-related increase in blood pressure was significantly smaller in rapid-eye-movement sleep (REMS) than either in non-rapid-eye-movement sleep (NREMS) or wakefulness. Blood pressure was higher in wakefulness than either in NREMS or REMS at both ambient temperatures. This effect was significantly blunted in orexin-ataxin3 mice irrespective of ambient temperature and particularly during REMS. These data demonstrate that hypocretin neurons are not a necessary part of the central pathways that coordinate thermoregulation with wake-sleep behavior and cardiovascular control. Data also support the hypothesis that hypocretin neurons modulate changes in blood pressure between wakefulness and the sleep states. These concepts may have clinical implications in patients with narcolepsy with cataplexy, who lack hypocretin neurons.	[Lo Martire, Viviana; Silvani, Alessandro; Bastianini, Stefano; Berteotti, Chiara; Zoccoli, Giovanna] Alma Mater Studiorum Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy	University of Bologna	Zoccoli, G (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy.	giovanna.zoccoli@unibo.it	berteotti, chiara/AAK-9065-2020; Zoccoli, Giovanna/CAH-3382-2022; Bastianini, Stefano/AAO-7982-2020; Silvani, Alessandro/A-1027-2015	Bastianini, Stefano/0000-0003-2468-1704; Silvani, Alessandro/0000-0003-3992-3892; Lo Martire, Viviana/0000-0001-8696-0835; Zoccoli, Giovanna/0000-0002-9670-9959; BERTEOTTI, CHIARA/0000-0002-4143-9445	University of Bologna [RFO 10, RFO 11]; Ministry of Instruction, University and Research, Italy [prot. 2008FY7K9S]; Fondazione Cassa di Risparmio di Bologna	University of Bologna; Ministry of Instruction, University and Research, Italy; Fondazione Cassa di Risparmio di Bologna(Fondazione Carisbo)	This work was funded by the University of Bologna (RFO 10 and RFO 11; http://www.unibo.it/Portale/Ricerca/Servizi+Docenti+Ricercatori/finanziamentinaz/RFO+-+Finanziamento+alla+ricerca+di+base.htm), Ministry of Instruction, University and Research, Italy (PRIN 2008, prot. 2008FY7K9S; http://prin.miur.it/), and Fondazione Cassa di Risparmio di Bologna (http://www.fondazionecarisbo.it/fondazionecarisbo/page.do?idc=2&grp=2&ord=01&idt=3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 2009, ARCH INTERN MED, V169, P75, DOI 10.1001/archinternmed.2008.512; Bastianini S, 2011, SLEEP, V34, P213, DOI 10.1093/sleep/34.2.213; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Dauvilliers Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038977; GLOTZBACH SF, 1984, BRAIN RES, V309, P17, DOI 10.1016/0006-8993(84)91006-0; Grimaldi D, 2012, SLEEP, V35, P519, DOI 10.5665/sleep.1738; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Herrington LP, 1940, AM J PHYSIOL, V129, P0123, DOI 10.1152/ajplegacy.1940.129.1.123; Laude D, 2008, AM J PHYSIOL-REG I, V294, pR142, DOI 10.1152/ajpregu.00319.2007; Luong LNL, 2012, NEUROSCIENCE, V202, P209, DOI 10.1016/j.neuroscience.2011.11.073; Matsumoto M, 2010, J EPIDEMIOL, V20, P136, DOI 10.2188/jea.JE20090103; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Modesti PA, 2006, HYPERTENSION, V47, P155, DOI 10.1161/01.HYP.0000199192.17126.d4; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; PARMEGGIANI PIER LUIGI, 1967, BRAIN RES, V6, P789, DOI 10.1016/0006-8993(67)90139-4; PARMEGGIANI PL, 1987, SLEEP, V10, P426; PARMEGGIANI PL, 1987, BRAIN RES, V415, P79, DOI 10.1016/0006-8993(87)90270-8; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Poli F, 2009, SLEEP, V32, P1491, DOI 10.1093/sleep/32.11.1491; Richardson HL, 2008, J SLEEP RES, V17, P450, DOI [10.1111/j.1365-2869.2008.00663.x, 10.1111/j.1365-2869.2008.00667.x, 10.1111/j.1365-2869.2008.00682.x, 10.1111/j.1365-2869.2008.00672.x, 10.1111/j.1365-2869.2008.00683.x]; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; ROUSSEL B, 1984, BRAIN RES, V294, P67, DOI 10.1016/0006-8993(84)91310-6; Rusyniak DE, 2011, NEUROSCI LETT, V498, P162, DOI 10.1016/j.neulet.2011.05.006; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Satoh S, 2004, NEUROREPORT, V15, P1127, DOI 10.1097/00001756-200405190-00009; Scammell TE, 2009, SLEEP, V32, P111; Sei H, 1996, J SLEEP RES, V5, P37, DOI 10.1046/j.1365-2869.1996.00007.x; Sheth T, 1999, J AM COLL CARDIOL, V33, P1916, DOI 10.1016/S0735-1097(99)00137-0; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Silvani A, 2008, AM J PHYSIOL-REG I, V294, pR1686, DOI 10.1152/ajpregu.00756.2007; Silvani A, 2012, AM J PHYSIOL-REG I, V302, pR958, DOI 10.1152/ajpregu.00668.2011; Silvani A, 2011, AUTON NEUROSCI-BASIC, V162, P66, DOI 10.1016/j.autneu.2011.04.003; Silvani A, 2010, CLIN EXP PHARMACOL P, V37, P322, DOI 10.1111/j.1440-1681.2009.05293.x; Silvani A, 2009, HYPERTENSION, V53, P251, DOI 10.1161/HYPERTENSIONAHA.108.125542; Swoap SJ, 2008, AM J PHYSIOL-HEART C, V294, pH1581, DOI 10.1152/ajpheart.01000.2007; Swoap SJ, 2004, AM J PHYSIOL-REG I, V287, pR391, DOI 10.1152/ajpregu.00731.2003; SZYMUSIAK R, 1981, PHYSIOL BEHAV, V26, P687, DOI 10.1016/0031-9384(81)90145-1; Tupone D, 2011, J NEUROSCI, V31, P15944, DOI 10.1523/JNEUROSCI.3909-11.2011	41	41	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47032	10.1371/journal.pone.0047032	http://dx.doi.org/10.1371/journal.pone.0047032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056568	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500125
J	Oh, S; Buddenborg, S; Yoder-Himes, DR; Tiedje, JM; Konstantinidis, KT				Oh, Seungdae; Buddenborg, Sarah; Yoder-Himes, Deborah R.; Tiedje, James M.; Konstantinidis, Konstantinos T.			Genomic Diversity of Escherichia Isolates from Diverse Habitats	PLOS ONE			English	Article							COLI O157-H7; SPECIES DEFINITION; SEQUENCE; INDICATOR; WATER; GROWTH; HYBRIDIZATION; MICROARRAY; EVOLUTION; COMMENSAL	Our understanding of the Escherichia genus is heavily biased toward pathogenic or commensal isolates from human or animal hosts. Recent studies have recovered Escherichia isolates that persist, and even grow, outside these hosts. Although the environmental isolates are typically phylogenetically distinct, they are highly related to and phenotypically indistinguishable from their human counterparts, including for the coliform test. To gain insights into the genomic diversity of Escherichia isolates from diverse habitats, including freshwater, soil, animal, and human sources, we carried out comparative DNA-DNA hybridizations using a multi-genome E. coli DNA microarray. The microarray was validated based on hybridizations with selected strains whose genome sequences were available and used to assess the frequency of microarray false positive and negative signals. Our results showed that human fecal isolates share two sets of genes (n>90) that are rarely found among environmental isolates, including genes presumably important for evading host immune mechanisms (e. g., a multi-drug transporter for acids and antimicrobials) and adhering to epithelial cells (e. g., hemolysin E and fimbrial-like adhesin protein). These results imply that environmental isolates are characterized by decreased ability to colonize host cells relative to human isolates. Our study also provides gene markers that can distinguish human isolates from those of warm-blooded animal and environmental origins, and thus can be used to more reliably assess fecal contamination in natural ecosystems.	[Oh, Seungdae; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Buddenborg, Sarah; Yoder-Himes, Deborah R.; Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Konstantinidis, Konstantinos T.] Georgia Inst Technol, Ctr Bioinformat & Computat Genom, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Michigan State University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Konstantinidis, KT (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.	kostas@ce.gatech.edu	Oh, Seungdae/E-7293-2016; Konstantinidis, Kostas/ABE-7113-2020	Oh, Seungdae/0000-0002-3171-3631; Konstantinidis, Kostas/0000-0002-0954-4755; Yoder-Himes, Deborah/0000-0001-9576-3833	NSF [DEB-0516252]; U.S. Department of Energy [DE-FG02-07ER64389]	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the NSF (award DEB-0516252, http://www.nsf.gov/, to J.M.T. and K. T. K.) and the U.S. Department of Energy (award DE-FG02-07ER64389, http://energy.gov/, to J.M.T. and K. T. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-296; Alm EW, 2006, J GREAT LAKES RES, V32, P401, DOI 10.3394/0380-1330(2006)32[401:PAPGOT]2.0.CO;2; Baudisova D, 1997, WATER SCI TECHNOL, V35, P333, DOI 10.1016/S0273-1223(97)00281-3; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; del Castillo FJ, 2001, FEMS MICROBIOL LETT, V204, P281, DOI 10.1016/S0378-1097(01)00413-X; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Field KG, 2007, WATER RES, V41, P3517, DOI 10.1016/j.watres.2007.06.056; Fuentes JA, 2008, RES MICROBIOL, V159, P279, DOI 10.1016/j.resmic.2008.02.006; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hall AR, 2008, J EVOLUTION BIOL, V21, P610, DOI 10.1111/j.1420-9101.2007.01473.x; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hyma KE, 2005, J BACTERIOL, V187, P619, DOI 10.1128/JB.187.2.619-628.2005; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Ihssen J, 2007, MICROBIOL-SGM, V153, P2052, DOI 10.1099/mic.0.2006/002006-0; Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006; Ishii S, 2010, MICROBES ENVIRON, V25, P8, DOI 10.1264/jsme2.ME09172; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; Lai XH, 2000, INFECT IMMUN, V68, P4363, DOI 10.1128/IAI.68.7.4363-4367.2000; Lamark T, 1996, J BACTERIOL, V178, P1655, DOI 10.1128/jb.178.6.1655-1662.1996; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Noble RT, 2003, WATER RES, V37, P1637, DOI 10.1016/S0043-1354(02)00496-7; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Oh S, 2010, APPL ENVIRON MICROB, V76, P2980, DOI 10.1128/AEM.02826-09; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Walk ST, 2009, APPL ENVIRON MICROB, V75, P6534, DOI 10.1128/AEM.01262-09; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; Wu GH, 2008, INFECT IMMUN, V76, P845, DOI 10.1128/IAI.00956-07	44	29	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47005	10.1371/journal.pone.0047005	http://dx.doi.org/10.1371/journal.pone.0047005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056556	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500119
J	Parameswaran, S; Balasubramanian, S; Babai, N; DelDebbio, CB; Harms, DW; Gurumurthy, CB; Rao, MS; Sharp, JG; Ahmad, I				Parameswaran, Sowmya; Balasubramanian, Sudha; Babai, Norbert; DelDebbio, Carolina B.; Harms, Donald W.; Gurumurthy, Channabasavaiah B.; Rao, Mahendra S.; Sharp, John G.; Ahmad, Iqbal			Nucleic Acid and Non-Nucleic Acid-Based Reprogramming of Adult Limbal Progenitors to Pluripotency	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SOMATIC-CELLS; GENERATION; MOUSE; DIFFERENTIATION; EFFICIENT; INDUCTION; MICRORNAS; MECHANISM; THERAPY	Reprogramming somatic cells to a pluripotent state by nucleic acid based (NAB) approaches, involving the ectopic expression of transcription factors, has emerged as a standard method. We recently demonstrated that limbal progenitors that regenerate cornea are reprogrammable to pluripotency by a non-NAB approach through simple manipulation of microenvironment thus extending the possible therapeutic use of these readily accessible cells beyond the proven treatment of corneal diseases and injury. Therefore, to determine the validity and robustness of non-cell autonomous reprogramming of limbal progenitors for a wider clinical use, here, we have compared their reprogramming by non-NAB and NAB approaches. We observed that both approaches led to (1) the emergence of colonies displaying pluripotency markers, accompanied by a temporal reciprocal changes in limbal-specific and pluripotency gene expression, and (2) epigenetic alterations of Oct4 and Nanog, associated with the de-novo activation of their expression. While the efficiency of reprogramming and passaging of re-programmed cells were significantly better with the NAB approach, the non-NAB approach, in contrast, led to a regulated reprogramming of gene expression, and a significant decrease in the expression of Hormad1, a gene associated with immunogenic responses. The reprogramming efficiency by non-NAB approach was influenced by exosomes present in conditioned medium. Cells reprogrammed by both approaches were capable of differentiating along the three germ lineages and generating chimeras. The analysis suggests that both approaches are effective in reprogramming limbal progenitors but the non-NAB approach may be more suitable for potential clinical applications by averting the risk of insertional mutagenesis and immune responses associated with the NAB approach.	[Parameswaran, Sowmya; Balasubramanian, Sudha; Babai, Norbert; DelDebbio, Carolina B.; Ahmad, Iqbal] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA; [Harms, Donald W.; Gurumurthy, Channabasavaiah B.; Sharp, John G.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Rao, Mahendra S.] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; National Institutes of Health (NIH) - USA	Parameswaran, S (corresponding author), Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA.	iahmad@unmc.edu	Babai, Norbert/T-2952-2019; Gurumurthy, Channabasavaiah B/H-8268-2016; Sowmya, Parameswaran/GZK-8635-2022; Gurumurthy, Channabasavaiah B/E-7205-2011; Del Debbio, Carolina/C-4428-2012	Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; 	Lincy Foundation; Pearson Foundation; Nebraska Department of Health and Human Services; Otis Glebe Foundation	Lincy Foundation; Pearson Foundation; Nebraska Department of Health and Human Services; Otis Glebe Foundation	This work was supported by Lincy Foundation, Pearson Foundation, Nebraska Department of Health and Human Services, and Otis Glebe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Balasubramanian S, 2009, STEM CELLS, V27, P3053, DOI 10.1002/stem.242; Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Das AV, 2007, J BIOL CHEM, V282, P35187, DOI 10.1074/jbc.M706742200; Gissel Cornelia, 2006, V330, P191; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Muegge K, 2008, MOL INTERV, V8, P15, DOI 10.1124/mi.8.1.4; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Parameswaran S, 2011, STEM CELLS, V29, P1013, DOI 10.1002/stem.655; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Soto-Gutierrez A, 2007, NAT PROTOC, V2, P347, DOI 10.1038/nprot.2007.18; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhao X, 2008, STEM CELLS, V26, P939, DOI 10.1634/stemcells.2007-0727; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	40	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46734	10.1371/journal.pone.0046734	http://dx.doi.org/10.1371/journal.pone.0046734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056428	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500066
J	Wartman, LD; Welch, JS; Uy, GL; Klco, JM; Lamprecht, T; Varghese, N; Nagarajan, R; Ley, TJ				Wartman, Lukas D.; Welch, John S.; Uy, Geoffrey L.; Klco, Jeffery M.; Lamprecht, Tamara; Varghese, Nobish; Nagarajan, Rakesh; Ley, Timothy J.			Expression and Function of PML-RARA in the Hematopoietic Progenitor Cells of Ctsg-PML-RARA Mice	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PRIMARY MYELOID PROGENITORS; GENE-TRANSFER; ALPHA; MODELS; PENETRANCE; TARGET	Because PML-RARA-induced acute promyelocytic leukemia (APL) is a morphologically differentiated leukemia, many groups have speculated about whether its leukemic cell of origin is a committed myeloid precursor (e. g. a promyelocyte) versus an hematopoietic stem/progenitor cell (HSPC). We originally targeted PML-RARA expression with CTSG regulatory elements, based on the early observation that this gene was maximally expressed in cells with promyelocyte morphology. Here, we show that both Ctsg, and PML-RARA targeted to the Ctsg locus (in Ctsg-PML-RARA mice), are expressed in the purified KLS cells of these mice (KLS = Kit(+)Lin(-)Sca(+), which are highly enriched for HSPCs), and this expression results in biological effects in multi-lineage competitive repopulation assays. Further, we demonstrate the transcriptional consequences of PML-RARA expression in Ctsg-PML-RARA mice in early myeloid development in other myeloid progenitor compartments [common myeloid progenitors (CMPs) and granulocyte/monocyte progenitors (GMPs)], which have a distinct gene expression signature compared to wild-type (WT) mice. Although PML-RARA is indeed expressed at high levels in the promyelocytes of Ctsg-PML-RARA mice and alters the transcriptional signature of these cells, it does not induce their self-renewal. In sum, these results demonstrate that in the Ctsg-PML-RARA mouse model of APL, PML-RARA is expressed in and affects the function of multipotent progenitor cells. Finally, since PML/Pml is normally expressed in the HSPCs of both humans and mice, and since some human APL samples contain TCR rearrangements and express T lineage genes, we suggest that the very early hematopoietic expression of PML-RARA in this mouse model may closely mimic the physiologic expression pattern of PML-RARA in human APL patients.	[Wartman, Lukas D.; Welch, John S.; Uy, Geoffrey L.; Lamprecht, Tamara; Ley, Timothy J.] Washington Univ, Sch Med, Dept Med, Div Oncol,Sect Stem Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol,Sect Stem Cell Biol, St Louis, MO 63110 USA.	timley@wustl.edu	Uy, Geoffrey/AAD-9815-2021; Klco, Jeffery/M-9717-2018	Klco, Jeffery/0000-0003-2961-6960; Westover, Tamara/0000-0002-1000-6698; Uy, Geoffrey/0000-0002-7809-0996	Leukemia and Lymphoma Society [5340-10]; United States National Institutes of Health (NIH) [K99 HL103975]; NIH [T32 HL0078088, CA83962, CA101937]; Barnes-Jewish Hospital Foundation; National Center for Research Resources (NCRR), NIH [UL1 RR024992]; NIH Roadmap for Medical Research; NCI Cancer Center [P30 CA91842]; NATIONAL CANCER INSTITUTE [R01CA083962, P01CA101937, P30CA091842, K23CA140707] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103975, R00HL103975] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Leukemia and Lymphoma Society Fellows award 5340-10 (J.S.W.), by United States National Institutes of Health (NIH) K99 HL103975 (J.S.W), by NIH Training Grant T32 HL0078088 (L. D. W.), by NIH Grants CA83962 and CA101937 and the Barnes-Jewish Hospital Foundation (T.J.L.), and UL1 RR024992 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research. The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30 CA91842. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Bour G, 2005, P NATL ACAD SCI USA, V102, P16608, DOI 10.1073/pnas.0505556102; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Chapiro E, 2006, BLOOD, V108, P3484, DOI 10.1182/blood-2005-09-009977; Du CC, 1999, BLOOD, V94, P793, DOI 10.1182/blood.V94.2.793.414k43_793_802; Early E, 1996, P NATL ACAD SCI USA, V93, P7900, DOI 10.1073/pnas.93.15.7900; Grimwade D, 2004, LEUKEMIA, V18, P375, DOI 10.1038/sj.leu.2403234; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; Guglielmi C, 1998, BRIT J HAEMATOL, V102, P1035, DOI 10.1046/j.1365-2141.1998.00871.x; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Ilaria RL, 2004, HEMATOL ONCOL CLIN N, V18, P525, DOI 10.1016/j.hoc.2004.03.003; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kogan SC, 2007, CURR TOP MICROBIOL, V313, P3; Lane AA, 2005, MOL CELL BIOL, V25, P23, DOI 10.1128/MCB.25.1.23-33.2005; Lavau C, 2000, P NATL ACAD SCI USA, V97, P10984, DOI 10.1073/pnas.190167297; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; McCormack E, 2008, ONCOGENE, V27, P3765, DOI 10.1038/onc.2008.16; McGarry M. P., 2009, MOUSE HEMATOLOGY LAB; Minucci S, 2002, BLOOD, V100, P2989, DOI 10.1182/blood-2001-11-0089; Pandolfi PP, 1997, TRANSGENIC MODELS AC; Paredes J, 2012, BBA-REV CANCER, V1826, P297, DOI 10.1016/j.bbcan.2012.05.002; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Sternsdorf T, 2006, CANCER CELL, V9, P81, DOI 10.1016/j.ccr.2005.12.030; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; TURHAN AG, 1995, BLOOD, V85, P2154, DOI 10.1182/blood.V85.8.2154.bloodjournal8582154; Uy GL, 2010, BLOOD, V116, P3604, DOI 10.1182/blood-2008-11-189282; Walter MJ, 2005, P NATL ACAD SCI USA, V102, P12513, DOI 10.1073/pnas.0504247102; Wartman LD, 2011, J CLIN INVEST, V121, P1445, DOI 10.1172/JCI45284; Welch JS, 2011, J CLIN INVEST, V121, P1636, DOI 10.1172/JCI42953; Welch JS, 2011, BLOOD, V117, P2460, DOI 10.1182/blood-2010-08-300087; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Westervelt P, 1999, BLOOD, V93, P2143, DOI 10.1182/blood.V93.7.2143.407a32_2143_2148; Wojiski S, 2009, LEUKEMIA, V23, P1462, DOI 10.1038/leu.2009.63; Yuan W, 2007, BLOOD, V109, P961, DOI 10.1182/blood-2006-07-036640; Zhou GB, 2007, ACTA PHARMACOL SIN, V28, P1434, DOI 10.1111/j.1745-7254.2007.00684.x	40	14	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46529	10.1371/journal.pone.0046529	http://dx.doi.org/10.1371/journal.pone.0046529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056333	Green Published, gold			2022-12-27	WOS:000309831500046
J	You, WP; Zhang, QF; Verdonschot, RG				You, Wenping; Zhang, Qingfang; Verdonschot, Rinus G.			Masked Syllable Priming Effects in Word and Picture Naming in Chinese	PLOS ONE			English	Article							SPEECH PRODUCTION; LEXICAL ACCESS; LANGUAGE PRODUCTION; MANDARIN CHINESE; FUNCTIONAL UNIT; TIME COURSE; FREQUENCY; ENGLISH; SEGMENTATION; FACILITATION	Four experiments investigated the role of the syllable in Chinese spoken word production. Chen, Chen and Ferrand (2003) reported a syllable priming effect when primes and targets shared the first syllable using a masked priming paradigm in Chinese. Our Experiment 1 was a direct replication of Chen et al.'s (2003) Experiment 3 employing CV (e. g., /ba2.ying2/, strike camp) and CVG (e. g., /bai2.shou3/, white haired) syllable types. Experiment 2 tested the syllable priming effect using different syllable types: e. g., CV (/qi4.qiu2/, balloon) and CVN (/qing1.ting2/, dragonfly). Experiment 3 investigated this issue further using line drawings of common objects as targets that were preceded either by a CV (e. g., /qi3/, attempt), or a CVN (e. g., /qing2/, affection) prime. Experiment 4 further examined the priming effect by a comparison between CV or CVN priming and an unrelated priming condition using CV-NX (e. g., /mi2.ni3/, mini) and CVN-CX (e. g., /min2.ju1/, dwellings) as target words. These four experiments consistently found that CV targets were named faster when preceded by CV primes than when they were preceded by CVG, CVN or unrelated primes, whereas CVG or CVN targets showed the reverse pattern. These results indicate that the priming effect critically depends on the match between the structure of the prime and that of the first syllable of the target. The effect obtained in this study was consistent across different stimuli and different tasks (word and picture naming), and provides more conclusive and consistent data regarding the role of the syllable in Chinese speech production.	[You, Wenping; Zhang, Qingfang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Verdonschot, Rinus G.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden Univ Ctr Linguist, Leiden, Netherlands; [Verdonschot, Rinus G.] Leiden Univ, Cognit Psychol Unit, Leiden, Netherlands; [Verdonschot, Rinus G.] Nagoya Univ, Grad Sch Languages & Cultures, Nagoya, Aichi 4648601, Japan	Chinese Academy of Sciences; Institute of Psychology, CAS; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Nagoya University	Zhang, QF (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	zhangqf@psych.ac.cn			National Natural Science Foundation of China [30870761, 31170977]; Excellent Young Scientist Foundation from Institute of Psychology, Chinese Academy of Sciences [09CX232023]; Royal Netherlands Academy of Arts and Sciences [11CPD002]; Grants-in-Aid for Scientific Research [12F02315] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Young Scientist Foundation from Institute of Psychology, Chinese Academy of Sciences; Royal Netherlands Academy of Arts and Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by grants from the National Natural Science Foundation of China (30870761, 31170977) and a grant of the Excellent Young Scientist Foundation from Institute of Psychology, Chinese Academy of Sciences (09CX232023) to QZ. This research project was also supported by the Royal Netherlands Academy of Arts and Sciences through a China Exchange Program grant (11CPD002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichert I, 2004, BRAIN LANG, V88, P148, DOI 10.1016/S0093-934X(03)00296-7; *BEIJ LANG I, 1986, MOD CHIN FREQ DICT; Brand M, 2003, J MEM LANG, V48, P435, DOI 10.1016/S0749-596X(02)00522-3; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; Chen J-Y., 2003, CHINESE J PSYCHOL, V45, P107, DOI DOI 10.6129/CJP.2003.4501.07; Chen JY, 2011, COGNITION, V121, P140, DOI 10.1016/j.cognition.2011.05.009; Chen JY, 2000, PSYCHOLOGIA, V43, P15; Chen JY, 2002, J MEM LANG, V46, P751, DOI 10.1006/jmla.2001.2825; Chetail F, 2009, CAN J EXP PSYCHOL, V63, P40, DOI 10.1037/a0012944; Chinese Linguistic Data Consortium, 2003, CLDCLAC200301 TSINGH; Cholin J, 2006, COGNITION, V99, P205, DOI 10.1016/j.cognition.2005.01.009; Cholin J, 2004, J MEM LANG, V50, P47, DOI 10.1016/j.jml.2003.08.003; Cholin J, 2009, LANG COGNITIVE PROC, V24, P662, DOI 10.1080/01690960802348852; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; CUTLER A, 1986, J MEM LANG, V25, P385, DOI 10.1016/0749-596X(86)90033-1; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; DELL GS, 1988, J MEM LANG, V27, P124, DOI 10.1016/0749-596X(88)90070-8; DUPOUX E, 1993, COGNITIVE MODELS OF SPEECH PROCESSING: THE SECOND SPERLONGA MEETING, P81; Ferrand L, 1996, J MEM LANG, V35, P708, DOI 10.1006/jmla.1996.0037; Ferrand L, 1997, MEM COGNITION, V25, P458, DOI 10.3758/BF03201122; HUMPHREYS GW, 1988, COGNITIVE NEUROPSYCH, V5, P67, DOI 10.1080/02643298808252927; Kureta Y, 2006, J EXP PSYCHOL LEARN, V32, P1102, DOI 10.1037/0278-7393.32.5.1102; Laganaro M, 2006, J MEM LANG, V55, P178, DOI 10.1016/j.jml.2006.05.001; Levelt W., 1989, SPEAKING INTENTION A; Levelt W JM, 1993, TEMPORAL INFORM PROC, V682, P283; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; LEVELT WJM, 1994, COGNITION, V50, P239, DOI 10.1016/0010-0277(94)90030-2; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; MEHLER J, 1981, J VERB LEARN VERB BE, V20, P298, DOI 10.1016/S0022-5371(81)90450-3; MEYER AS, 1991, J MEM LANG, V30, P69, DOI 10.1016/0749-596X(91)90011-8; MEYER AS, 1990, J MEM LANG, V29, P524, DOI 10.1016/0749-596X(90)90050-A; O'Seaghdha PG, 2010, COGNITION, V115, P282, DOI 10.1016/j.cognition.2010.01.001; Roelofs A, 1997, LANG COGNITIVE PROC, V12, P657, DOI 10.1080/016909697386655; Roelofs A, 1997, COGNITION, V64, P249, DOI 10.1016/S0010-0277(97)00027-9; Schiller NO, 2006, MENT LEX, V1, P231, DOI 10.1075/ml.1.2.04sch; Schiller NO, 1999, BRAIN LANG, V68, P300, DOI 10.1006/brln.1999.2109; Schiller NO, 1998, J MEM LANG, V39, P484, DOI 10.1006/jmla.1998.2577; Schiller NO, 2002, PHONOL PHONET, V4-1, P35; Schiller NO, 2000, J EXP PSYCHOL LEARN, V26, P512, DOI 10.1037//0278-7393.26.2.512; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Verdonschot RG, 2011, J EXP PSYCHOL LEARN, V37, P1458, DOI 10.1037/a0024491; Wilshire CE, 2003, BRAIN LANG, V84, P424, DOI 10.1016/S0093-934X(02)00501-1; Wong AWK, 2008, J EXP PSYCHOL LEARN, V34, P1172, DOI 10.1037/a0013000; Wong AWK, 2009, PSYCHON B REV, V16, P888, DOI 10.3758/PBR.16.5.888; Yen MH, 2012, READ WRIT, V25, P1007, DOI 10.1007/s11145-011-9321-z; [张清芳 Zhang Qingfang], 2003, [心理学报, Acta Psychologica Sinica], V35, P447; Zhang QF, 2011, NEUROPSYCHOLOGIA, V49, P3813, DOI 10.1016/j.neuropsychologia.2011.09.040; Zhang QF, 2009, LANG COGNITIVE PROC, V24, P1082, DOI 10.1080/01690960802042133; Zhang QF, 2009, LANG SPEECH, V52, P113, DOI 10.1177/0023830908099885; [张清芳 ZHANG QingFang], 2008, [心理学报, Acta Psychologica Sinica], V40, P253	52	53	58	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46595	10.1371/journal.pone.0046595	http://dx.doi.org/10.1371/journal.pone.0046595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056360	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500052
J	Lei, T; Yang, JS; Zheng, L; Markowski, T; Witthuhn, BA; Ji, YD				Lei, Ting; Yang, Junshu; Zheng, Li; Markowski, Todd; Witthuhn, Bruce A.; Ji, Yinduo			The Essentiality of Staphylococcal Gcp Is Independent of Its Repression of Branched-Chain Amino Acids Biosynthesis	PLOS ONE			English	Article							ILV-LEU OPERON; REGULATED GENE-EXPRESSION; TRANSFER-RNA MODIFICATION; BACILLUS-SUBTILIS; TRANSCRIPTIONAL REGULATION; ALLELIC-REPLACEMENT; ESCHERICHIA-COLI; ANTISENSE RNA; FATTY-ACIDS; AUREUS	Our previous studies revealed that the staphylococcal protein Gcp is essential for bacterial growth; however, the essential function of Gcp remains undefined. In this study, we demonstrated that Gcp plays an important role in the modulation of the branched-chain amino acids biosynthesis pathway. Specifically, we identified that the depletion of Gcp dramatically elevated the production of key enzymes that are encoded in the ilv-leu operon and responsible for the biosynthesis of the branched-chain amino acids isoleucine, leucine, and valine (ILV) using proteomic approaches. Using qPCR and promoter-lux reporter fusions, we established that Gcp negatively modulates the transcription of the ilv-leu operon. Gel-shift assays revealed that Gcp lacks the capacity to bind the promoter region of ilv. Moreover, we found that the depletion of Gcp did not influence the transcription level of CodY, a known repressor of the ilv-leu operon, while induced the transcription of CcpA, a known positive regulator of the ilv-leu operon. In addition, the depletion of Gcp decreased the biosynthesis of N 6 threonylcarbamoyladenosine (t6A). To elucidate whether the essentiality of Gcp is attributable to its negative modulation of ILV biosynthesis, we determined the impact of the ilv-leu operon on the requirement of Gcp for growth, and revealed that the deletion of the ilv-leu operon did not affect the essentiality of Gcp. Taken together, our results indicate that the essentiality of Gcp isn't attributable to its negative regulation of ILV biosynthesis in S. aureus. These findings provide new insights into the biological function of the staphylococcal Gcp.	[Lei, Ting; Yang, Junshu; Zheng, Li; Ji, Yinduo] Univ Minnesota, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55108 USA; [Markowski, Todd; Witthuhn, Bruce A.] Univ Minnesota, Coll Biol Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ji, YD (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55108 USA.	jixxx002@umn.edu	witthuhn, bruce/GSE-3193-2022		National Institute of Allergy and Infectious Disease [AI057451]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057451] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by grant AI057451 from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Beck HC, 2004, J APPL MICROBIOL, V96, P1185, DOI 10.1111/j.1365-2672.2004.02253.x; Brinsmade SR, 2010, J BACTERIOL, V192, P6357, DOI 10.1128/JB.00937-10; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Deutsch C, 2012, J BIOL CHEM, V287, P13666, DOI 10.1074/jbc.M112.344028; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; Fan F, 2001, PLASMID, V46, P71, DOI 10.1006/plas.2001.1526; GRANDONI JA, 1992, J BACTERIOL, V174, P3212, DOI 10.1128/jb.174.10.3212-3219.1992; GRANDONI JA, 1993, J BACTERIOL, V175, P7581, DOI 10.1128/JB.175.23.7581-7593.1993; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Hashimoto C, 2011, J BACTERIOL, V193, P6075, DOI 10.1128/JB.05733-11; Hecker A, 2007, NUCLEIC ACIDS RES, V35, P6042, DOI 10.1093/nar/gkm554; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lei T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020163; LINCOLN RA, 1995, VET MICROBIOL, V45, P275, DOI 10.1016/0378-1135(95)00041-8; Loomba PS, 2010, J GLOB INFECT DIS, V2, P275, DOI 10.4103/0974-777X.68535; Ludwig H, 2002, J BACTERIOL, V184, P5174, DOI 10.1128/JB.184.18.5174-5178.2002; Luong TT, 2007, J MICROBIOL METH, V70, P186, DOI 10.1016/j.mimet.2007.04.007; MAAS WK, 1953, J BACTERIOL, V65, P388, DOI 10.1128/JB.65.4.388-393.1953; Mader U, 2004, J BACTERIOL, V186, P2240, DOI 10.1128/JB.186.8.2240-2252.2004; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Marta PT, 1996, J BACTERIOL, V178, P2150, DOI 10.1128/jb.178.7.2150-2153.1996; NUREKI O, 1994, J MOL BIOL, V236, P710, DOI 10.1006/jmbi.1994.1184; Onoue Y, 1997, INT J FOOD MICROBIOL, V36, P77, DOI 10.1016/S0168-1605(97)01250-6; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shivers RP, 2005, MOL MICROBIOL, V56, P1549, DOI 10.1111/j.1365-2958.2005.04634.x; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Tojo S, 2005, MOL MICROBIOL, V56, P1560, DOI 10.1111/j.1365-2958.2005.04635.x; Tojo S, 2004, J BACTERIOL, V186, P7971, DOI 10.1128/JB.186.23.7971-7979.2004; Wray LV, 1996, P NATL ACAD SCI USA, V93, P8841, DOI 10.1073/pnas.93.17.8841; Yan MY, 2009, PLASMID, V61, P188, DOI 10.1016/j.plasmid.2009.02.001; Yu Chuanxin, 2007, V391, P169; Yu XP, 2011, WORLD J MICROB BIOT, V27, P897, DOI 10.1007/s11274-010-0532-2; Zhang L, 2000, GENE, V255, P297, DOI 10.1016/S0378-1119(00)00325-5; Zheng L, 2005, FEMS MICROBIOL LETT, V245, P279, DOI 10.1016/j.femsle.2005.03.017; Zheng L, 2007, J BACTERIOL, V189, P2734, DOI 10.1128/JB.01806-06	45	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46836	10.1371/journal.pone.0046836	http://dx.doi.org/10.1371/journal.pone.0046836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056478	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800053
J	Fu, YC; Wang, DW; Chuang, JH				Fu, Yang-chih; Wang, Da-Wei; Chuang, Jen-Hsiang			Representative Contact Diaries for Modeling the Spread of Infectious Diseases in Taiwan	PLOS ONE			English	Article							SOCIAL MIXING PATTERNS; PANDEMIC INFLUENZA; HEALTH-CARE; PARAMETERS; NETWORKS; LESSONS; SARS	Recent studies of infectious diseases have attempted to construct more realistic parameters of interpersonal contact patterns from diary-approach surveys. To ensure that such diary-based contact patterns provide accurate baseline data for policy implementation in densely populated Taiwan, we collected contact diaries from a national sample, using 3-stage systematic probability sampling and rigorous in-person interviews. A representative sample of 1,943 contact diaries recorded a total of 24,265 wide-range, face-to-face interpersonal contacts during a 24-hour period. Nearly 70% of the contacts occurred outside of respondents' households. The most active age group was schoolchildren (ages 5-14), who averaged around 16-18 daily contacts, about 2-3 times as many as the least active age groups. We show how such parameters of contact patterns help modify a sophisticated national simulation system that has been used for years to model the spread of pandemic diseases in Taiwan. Based on such actual and representative data that enable researchers to infer findings to the whole population, our analyses aim to facilitate implementing more appropriate and effective strategies for controlling an emerging or pandemic disease infection.	[Fu, Yang-chih] Acad Sinica, Inst Sociol, Taipei 115, Taiwan; [Wang, Da-Wei] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chuang, Jen-Hsiang] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Chuang, Jen-Hsiang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chuang, Jen-Hsiang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Fu, YC (corresponding author), Acad Sinica, Inst Sociol, Taipei 115, Taiwan.	fuyc@sinica.edu.tw	Chuang, Jen-Hsiang/G-4356-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418; Fu, Yang-chih/0000-0002-2207-5623	Department of Health, Taiwan, Republic of China [DOH99-DC-1004]	Department of Health, Taiwan, Republic of China	This study was sponsored by the Department of Health, Taiwan, Republic of China (grant no. DOH99-DC-1004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Chang HJ, 2004, AM J PUBLIC HEALTH, V94, P562, DOI 10.2105/AJPH.94.4.562; Chang YH, 2004, JGSS S 2003 BIRTH JG, P149; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fu Y, 2008, SAGE HDB PUBLIC OPIN, P284, DOI [10.4135/9781848607910.n27, DOI 10.4135/9781848607910.N27]; Fu YC, 2007, FIELD METHOD, V19, P194, DOI 10.1177/1525822X06298590; Fu YC, 2005, SOC NETWORKS, V27, P169, DOI 10.1016/j.socnet.2005.01.008; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Ho TS, 2010, PEDIATR NEONATOL, V51, P83, DOI 10.1016/S1875-9572(10)60016-2; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Hsieh YH, 2004, EMERG INFECT DIS, V10, P201, DOI 10.3201/eid1002.030515; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Kanaan MN, 2005, EPIDEMIOL INFECT, V133, P1009, DOI 10.1017/S0950268805004528; Kretzschmar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005931; Larson RC, 2007, OPER RES, V55, P399, DOI 10.1287/opre.1070.0399; Lonkila M, 1999, SOCIAL NETWORKS POST; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; POOL ID, 1978, SOC NETWORKS, V1, P5, DOI 10.1016/0378-8733(78)90011-4; Smith TW, 2006, COMP SOCIOL, V5, P33, DOI 10.1163/156913306776915614; Tsai MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013292; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Watt JR, 2008, KAOHSIUNG J MED SCI, V24, P563, DOI 10.1016/S1607-551X(09)70017-8; Yang MM, 1996, GIFTS FAVORS BANQUET; Yanjie Bian, 2002, SOCIAL CONNECTIONS C; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	31	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45113	10.1371/journal.pone.0045113	http://dx.doi.org/10.1371/journal.pone.0045113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056193	Green Published, gold			2022-12-27	WOS:000309454000006
J	Ackermann, M; Koriabine, M; Hartmann-Fritsch, F; de Jong, PJ; Lewis, TD; Schetle, N; Work, TM; Dagenais, J; Balazs, GH; Leong, JAC				Ackermann, Mathias; Koriabine, Maxim; Hartmann-Fritsch, Fabienne; de Jong, Pieter J.; Lewis, Teresa D.; Schetle, Nelli; Work, Thierry M.; Dagenais, Julie; Balazs, George H.; Leong, Jo-Ann C.			The Genome of Chelonid Herpesvirus 5 Harbors Atypical Genes	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; MARINE TURTLE HERPESVIRUS; VARICELLA-ZOSTER-VIRUS; COMPLETE DNA-SEQUENCE; GREEN TURTLES; BOVINE HERPESVIRUS-1; CELL-SURFACE; IN-VITRO; FIBROPAPILLOMATOSIS; MYDAS	The Chelonid fibropapilloma-associated herpesvirus (CFPHV; ChHV5) is believed to be the causative agent of fibropapillomatosis (FP), a neoplastic disease of marine turtles. While clinical signs and pathology of FP are well known, research on ChHV5 has been impeded because no cell culture system for its propagation exists. We have cloned a BAC containing ChHV5 in pTARBAC2.1 and determined its nucleotide sequence. Accordingly, ChHV5 has a type D genome and its predominant gene order is typical for the varicellovirus genus within the alphaherpesvirinae. However, at least four genes that are atypical for an alphaherpesvirus genome were also detected, i.e. two members of the C-type lectin-like domain superfamily (F-lec1, F-lec2), an orthologue to the mouse cytomegalovirus M04 (F-M04) and a viral sialyltransferase (F-sial). Four lines of evidence suggest that these atypical genes are truly part of the ChHV5 genome: (1) the pTARBAC insertion interrupted the UL52 ORF, leaving parts of the gene to either side of the insertion and suggesting that an intact molecule had been cloned. (2) Using FP-associated UL52 (F-UL52) as an anchor and the BAC-derived sequences as a means to generate primers, overlapping PCR was performed with tumor-derived DNA as template, which confirmed the presence of the same stretch of "atypical" DNA in independent FP cases. (3) Pyrosequencing of DNA from independent tumors did not reveal previously undetected viral sequences, suggesting that no apparent loss of viral sequence had happened due to the cloning strategy. (4) The simultaneous presence of previously known ChHV5 sequences and F-sial as well as F-M04 sequences was also confirmed in geographically distinct Australian cases of FP. Finally, transcripts of F-sial and F-M04 but not transcripts of lytic viral genes were detected in tumors from Hawaiian FP-cases. Therefore, we suggest that F-sial and F-M04 may play a role in FP pathogenesis.	[Ackermann, Mathias; Hartmann-Fritsch, Fabienne; Schetle, Nelli] Univ Zurich, Inst Virol, Zurich, Switzerland; [Koriabine, Maxim; de Jong, Pieter J.] Childrens Hosp Oakland, Res Inst, BACPAC Resources Ctr, Oakland, CA 94609 USA; [Work, Thierry M.; Dagenais, Julie] US Geol Survey, Natl Wildlife Hlth Ctr Honolulu Field Stn, Honolulu, HI USA; [Balazs, George H.] Pacific Isl Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI USA; [Lewis, Teresa D.; Leong, Jo-Ann C.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA	University of Zurich; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa	Ackermann, M (corresponding author), Univ Zurich, Inst Virol, Zurich, Switzerland.	email@vetvir.uzh.ch	Leong, Jo-Ann/ABE-1443-2021; Work, Thierry M/F-1550-2015	Work, Thierry M/0000-0002-4426-9090	Hawaii Institute of Marine Biology; NSF EPSCoR; NOAA [2005-008/682]; Pfizer; UZH Stiftung fur wissenschaftliche Forschung; EPSCoR [0903833] Funding Source: National Science Foundation	Hawaii Institute of Marine Biology; NSF EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Pfizer(Pfizer); UZH Stiftung fur wissenschaftliche Forschung; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	The authors acknowledge support provided by the Hawaii Institute of Marine Biology Core Sequencing Facility, which is funded by the NSF EPSCoR program, Investing in Multidisciplinary University Activities, and the support provided by NOAA funds to the Hawaii Institute of Marine Biology-Northwestern Hawaiian Islands Coral Reef Ecosystem Reserve Partnership, MOA #2005-008/682. Financial support for MA's work was based on MA's Pfizer Award 2000, a grant to MA from the UZH Stiftung fur wissenschaftliche Forschung (http://www.researchers.uzh.ch/support/stwf.html), and a donation to MA from Martha Ackermann Kaiser. This paper is listed as HIMB contribution #1293. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Mathias, 2004, Methods Mol Biol, V256, P199; Afonso CL, 2001, J VIROL, V75, P971, DOI 10.1128/JVI.75.2.971-978.2001; Balazs GH, 1991, RES PLAN MARINE TURT; BLAHO JA, 1994, J BIOL CHEM, V269, P17401; Chen Y, 2007, J VIROL, V81, P8742, DOI 10.1128/JVI.00174-07; Coberley SS, 2002, J VIROL, V76, P10553, DOI 10.1128/JVI.76.20.10553-10558.2002; Corbett AJ, 2007, J GEN VIROL, V88, P758, DOI 10.1099/vir.0.82623-0; DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Delhon G, 2003, J VIROL, V77, P10339, DOI 10.1128/JVI.77.19.10339-10347.2003; Dewals B, 2006, J GEN VIROL, V87, P509, DOI 10.1099/vir.0.81465-0; Dewals B, 2006, J GEN VIROL, V87, P1509, DOI 10.1099/vir.0.81757-0; Ladelfa MF, 2011, VET MICROBIOL, V153, P361, DOI 10.1016/j.vetmic.2011.05.037; Foley AM, 2005, J WILDLIFE DIS, V41, P29, DOI 10.7589/0090-3558-41.1.29; FRAEFEL C, 1993, J VIROL, V67, P1328, DOI 10.1128/JVI.67.3.1328-1333.1993; Gabev Evgeni, 2009, BMC Res Notes, V2, P209, DOI 10.1186/1756-0500-2-209; Gabev E, 2010, J VIROL, V84, P5583, DOI 10.1128/JVI.00228-10; Greenblatt RJ, 2005, J VIROL, V79, P1125, DOI 10.1128/JVI.79.2.1125-1132.2005; Herbst L, 2004, CURR BIOL, V14, pR697, DOI 10.1016/j.cub.2004.08.040; Herbst Lawrence H., 1994, Annual Review of Fish Diseases, V4, P389, DOI 10.1016/0959-8030(94)90037-X; HERBST LH, 1995, DIS AQUAT ORGAN, V22, P1, DOI 10.3354/dao022001; Herbst LH, 1999, VET PATHOL, V36, P551, DOI 10.1354/vp.36-6-551; Jackson RJ, 1999, J VIROL, V73, P2376, DOI 10.1128/JVI.73.3.2376-2384.1999; JACOBSON ER, 1989, J COMP PATHOL, V101, P39, DOI 10.1016/0021-9975(89)90075-3; Kawaguchi Yasushi, 2004, Uirusu, V54, P255, DOI 10.2222/jsv.54.255; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Labiuk SL, 2009, J GEN VIROL, V90, P2829, DOI 10.1099/vir.0.013532-0; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; LEUNGTACK P, 1994, VIROLOGY, V199, P409, DOI 10.1006/viro.1994.1139; Markine-Goriaynoff N, 2004, J GEN VIROL, V85, P2741, DOI 10.1099/vir.0.80320-0; MCGEOCH DJ, 1990, J GEN VIROL, V71, P2361, DOI 10.1099/0022-1317-71-10-2361; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; McGeoch DJ, 2005, J GEN VIROL, V86, P307, DOI 10.1099/vir.0.80588-0; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Neilan JG, 1999, J GEN VIROL, V80, P2693, DOI 10.1099/0022-1317-80-10-2693; Osoegawa K, 2004, GENOME RES, V14, P780, DOI 10.1101/gr.2033904; OSOEGAWA K, 1999, CURRENT PROTOCOLS HU; Quackenbush SL, 1998, VIROLOGY, V246, P392, DOI 10.1006/viro.1998.9207; Quackenbush SL, 2001, VIROLOGY, V287, P105, DOI 10.1006/viro.2001.1023; Robinson KE, 2008, J GEN VIROL, V89, P2851, DOI 10.1099/vir.0.2008/002501-0; SMITH G. M., 1938, ZOOLOGICA [NEW YORK], V23, P93; Stacy BA, 2007, 2 HERPESVIRUSES ASS; Takashima S, 2006, J BIOCHEM, V139, P279, DOI 10.1093/jb/mvj029; Takashima S, 2000, J BIOCHEM-TOKYO, V128, P1033, DOI 10.1093/oxfordjournals.jbchem.a022831; Tillieux SL, 2008, J VIROL, V82, P11023, DOI 10.1128/JVI.00777-08; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tulman ER, 2000, J VIROL, V74, P7980, DOI 10.1128/JVI.74.17.7980-7988.2000; Vanderplasschen A, 2000, P NATL ACAD SCI USA, V97, P5756, DOI 10.1073/pnas.100058897; Voigt S, 2001, J VIROL, V75, P603, DOI 10.1128/JVI.75.2.603-611.2001; Wilcock D, 1999, J GEN VIROL, V80, P2137, DOI 10.1099/0022-1317-80-8-2137; Wisner TW, 2009, J VIROL, V83, P3115, DOI 10.1128/JVI.01462-08; Work TM, 2009, J GEN VIROL, V90, P1943, DOI 10.1099/vir.0.011650-0; Work Thierry M, 2005, Hawaii Med J, V64, P23; Work TM, 1999, J WILDLIFE DIS, V35, P804, DOI 10.7589/0090-3558-35.4.804; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Work TM, 2003, DIS AQUAT ORGAN, V53, P41, DOI 10.3354/dao053041; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002	58	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46623	10.1371/journal.pone.0046623	http://dx.doi.org/10.1371/journal.pone.0046623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056373	Green Published, gold			2022-12-27	WOS:000309452600046
J	Leroux, JS; Moore, S; Richard, L; Gauvin, L				Leroux, Janette S.; Moore, Spencer; Richard, Lucie; Gauvin, Lise			Physical Inactivity Mediates the Association between the Perceived Exercising Behavior of Social Network Members and Obesity: A Cross-Sectional Study	PLOS ONE			English	Article							ELDERLY-PEOPLE; OLDER-ADULTS; ENVIRONMENT; DECLINE; IMPACT	Objectives: Social networks influence the spread of depression, health behaviors, and obesity. The social networks of older urban-dwelling adults were examined to assess whether physical inactivity mediated the association between social networks and obesity. Methods: Data come from the Montreal Neighborhood Networks and Healthy Aging study (n = 2707). Self-reported height and weight were used to calculate body mass index (BMI) with obesity defined as a BMI >= 30. A name generator/interpreter instrument was used to elicit participants' core ties (i.e., alters), and assess whether alters exercised regularly and resided in participants' neighborhoods. The International Physical Activity Questionnaire was used to measure physical inactivity. Separate multilevel logistic regression analyses were conducted for younger (18-54 years) and older (55 years plus) age groups to examine the association between the exercising behavior of alters and obesity. Ancillary analyses examined whether the residential location of alters was associated with obesity. Mediation analyses assessed whether physical inactivity mediated the association between alter exercising behavior and obesity. Models adjusted for participant socio-demographic and -economic characteristics. Results: Among the older age stratum (55 years plus), physically inactive individuals were more likely obese (OR 2.14; 95% CIs: 1.48-3.10); participants who had more exercising alters were less likely obese (OR: 0.85; 95% CIs: 0.72-0.99). Physical inactivity mediated the association between exercising alters and obesity. Ancillary analyses showed that having exercising alters in the neighborhood compared to other locations tended to reduce the odds of obesity. Conclusion: This work demonstrates the importance of social networks among older adults in facilitating a physically active lifestyle and reducing the odds of obesity. Such findings can inform the design of public health interventions that seek to improve the environmental conditions supporting the physical activity of older adults.	[Leroux, Janette S.; Moore, Spencer] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Moore, Spencer] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Richard, Lucie; Gauvin, Lise] CHUM, Ctr Rech, Montreal, PQ, Canada; [Richard, Lucie] IRSPUM, Montreal, PQ, Canada; [Gauvin, Lise] Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada; [Richard, Lucie] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Gauvin, Lise] Univ Montreal, Fac Med, GRIS, Montreal, PQ H3C 3J7, Canada	Queens University - Canada; Queens University - Canada; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Moore, S (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	mooresp@queensu.ca	Moore, Spencer/AAJ-5022-2020	Moore, Spencer/0000-0002-1229-9578; Gauvin, Lise/0000-0002-1562-1307	Canadian Institutes of Health Research [MOP-84584]; Canadian Institutes of Health Research (CIHR) - Institute of Aging	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR) - Institute of Aging(Canadian Institutes of Health Research (CIHR))	Data collection and analysis was supported by an operating grant from the Canadian Institutes of Health Research (MOP-84584). At the time of this research, SM held a New Investigator Award from the Canadian Institutes of Health Research (CIHR) - Institute of Aging, LR was FRSQ National Scholar (#16207), and LG held a CIHR/Centre de Recherche en Prevention de l'Obesite (CRPO) Applied Public Health Chair in Neighborhoods, Lifestyle, and Healthy Body Weight. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsen MJ, 2004, J SOC PERS RELAT, V21, P249, DOI 10.1177/0265407504041386; Balfour JL, 2002, AM J EPIDEMIOL, V155, P507, DOI 10.1093/aje/155.6.507; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Bosma H, 2001, AM J EPIDEMIOL, V153, P363, DOI 10.1093/aje/153.4.363; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Clarke PJ, 2012, J EPIDEMIOL COMMUN H, V66, P730, DOI 10.1136/jech.2010.128116; Cohen L., 2005, CALIFORNIAN J HLTH P, V3, P154, DOI DOI 10.32398/CJHP.V3I3.655; Dupere S, 2007, HLTH PROMOTION CANAD; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hruschka DJ, 2011, AM J PUBLIC HEALTH, V101, pS295, DOI 10.2105/AJPH.2010.300053; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; Kegler MC, 2008, HLTH BEHAV HLTH ED T; Koehly LM, 2009, PREV CHRONIC DIS, V6; Krull JL, 1999, EVALUATION REV, V23, P418, DOI 10.1177/0193841X9902300404; Kubzansky LD, 2005, AM J EPIDEMIOL, V162, P253, DOI 10.1093/aje/kwi185; Lawton MP, 1977, HDB PSYCHOL AGING; Li FZ, 2005, J EPIDEMIOL COMMUN H, V59, P558, DOI 10.1136/jech.2004.028399; Oh JH, 2003, SOCIOL INQ, V73, P490, DOI 10.1111/1475-682X.00068; Piro FN, 2006, J EPIDEMIOL COMMUN H, V60, P626, DOI 10.1136/jech.2005.042697; Ramos M, 2003, J GERONTOL B-PSYCHOL, V58, pS253, DOI 10.1093/geronb/58.4.S253; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; SABIN EP, 1993, J APPL GERONTOL, V12, P44, DOI 10.1177/073346489301200105; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; SULS J, 1988, J APPL SOC PSYCHOL, V18, P66, DOI 10.1111/j.1559-1816.1988.tb00006.x; Thompson EE, 1998, J GERONTOL B-PSYCHOL, V53, pS354, DOI 10.1093/geronb/53B.6.S354; Umberson D, 2010, ANNU REV SOCIOL, V36, P139, DOI 10.1146/annurev-soc-070308-120011; Unger JB, 1999, J GERONTOL B-PSYCHOL, V54, pS245, DOI 10.1093/geronb/54B.5.S245; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Wight RG, 2006, AM J EPIDEMIOL, V163, P1071, DOI 10.1093/aje/kwj176; Yen I.H., 2012, J AGING RES, DOI [10.1155/2012/139523, DOI 10.1155/2012/139523]	31	22	22	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46558	10.1371/journal.pone.0046558	http://dx.doi.org/10.1371/journal.pone.0046558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NG	23056343	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600041
J	Mi, G; Di, YM; Emerson, S; Cumbie, JS; Chang, JH				Mi, Gu; Di, Yanming; Emerson, Sarah; Cumbie, Jason S.; Chang, Jeff H.			Length Bias Correction in Gene Ontology Enrichment Analysis Using Logistic Regression	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ DATA; TOOLS; GRAPH	When assessing differential gene expression from RNA sequencing data, commonly used statistical tests tend to have greater power to detect differential expression of genes encoding longer transcripts. This phenomenon, called "length bias", will influence subsequent analyses such as Gene Ontology enrichment analysis. In the presence of length bias, Gene Ontology categories that include longer genes are more likely to be identified as enriched. These categories, however, are not necessarily biologically more relevant. We show that one can effectively adjust for length bias in Gene Ontology analysis by including transcript length as a covariate in a logistic regression model. The logistic regression model makes the statistical issue underlying length bias more transparent: transcript length becomes a confounding factor when it correlates with both the Gene Ontology membership and the significance of the differential expression test. The inclusion of the transcript length as a covariate allows one to investigate the direct correlation between the Gene Ontology membership and the significance of testing differential expression, conditional on the transcript length. We present both real and simulated data examples to show that the logistic regression approach is simple, effective, and flexible.	[Mi, Gu; Di, Yanming; Emerson, Sarah] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA; [Di, Yanming; Cumbie, Jason S.; Chang, Jeff H.] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Cumbie, Jason S.; Chang, Jeff H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Chang, Jeff H.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Mi, G (corresponding author), Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA.	mig@stat.oregonstate.edu	Mi, Gu/M-6559-2015	Mi, Gu/0000-0001-8778-954X; Chang, Jeff/0000-0002-1833-0695	National Institute of General Medical Sciences of the National Institutes of Health [R01GM104977]; National Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2008-35600-04691]; Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2011-67019-30192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104977] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work of YD, SE and JHC is supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM104977. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Work in the Chang lab is also supported by the National Research Initiative Competitive Grants Program Grant no. 2008-35600-04691 and Agriculture and Food Research Initiative Competitive Grants Program Grant no. 2011-67019-30192 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A., 2009, GENE SET ENRICHMENT, V27, P1; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlson M., ORG HS EG DB GENOME; Carlson M., GO DB SET ANNOTATION; Carlson M, ORG AT TAIR DB GENOM; Cumbie JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025279; Di Y, 2011, NBPSEQ NBP NEGATIVE; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Gao LY, 2011, BIOINFORMATICS, V27, P662, DOI 10.1093/bioinformatics/btr005; Goeman J. J., 2012, GLOBALTEST R PACKAGE; Goeman JJ, 2008, BIOINFORMATICS, V24, P537, DOI 10.1093/bioinformatics/btm628; Goeman JJ, 2006, J ROY STAT SOC B, V68, P477, DOI 10.1111/j.1467-9868.2006.00551.x; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Han X, 2010, ARXIV10124397; HOLM S, 1979, SCAND J STAT, V6, P65; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Meinshausen N, 2008, BIOMETRIKA, V95, P265, DOI 10.1093/biomet/asn007; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; R Core Team, 2012, R LANG ENV STAT COMP; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290	34	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46128	10.1371/journal.pone.0046128	http://dx.doi.org/10.1371/journal.pone.0046128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056249	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600023
J	Uosaki, H; Andersen, P; Shenje, LT; Fernandez, L; Christiansen, SL; Kwon, C				Uosaki, Hideki; Andersen, Peter; Shenje, Lincoln T.; Fernandez, Laviel; Christiansen, Sofie Lindgren; Kwon, Chulan			Direct Contact with Endoderm-Like Cells Efficiently Induces Cardiac Progenitors from Mouse and Human Pluripotent Stem Cells	PLOS ONE			English	Article							DIFFERENTIATION; CARDIOMYOCYTES; POPULATION; SURVIVAL; NKX2-5; ALPHA; HEART; LINES	Rationale: Pluripotent stem cell-derived cardiac progenitor cells (CPCs) have emerged as a powerful tool to study cardiogenesis in vitro and a potential cell source for cardiac regenerative medicine. However, available methods to induce CPCs are not efficient or require high-cost cytokines with extensive optimization due to cell line variations. Objective: Based on our in-vivo observation that early endodermal cells maintain contact with nascent pre-cardiac mesoderm, we hypothesized that direct physical contact with endoderm promotes induction of CPCs from pluripotent cells. Method and Result: To test the hypothesis, we cocultured mouse embryonic stem (ES) cells with the endodermal cell line End2 by co-aggregation or End2-conditioned medium. Co-aggregation resulted in strong induction of Flk1(+) PDGFRa(+) CPCs in a dose-dependent manner, but the conditioned medium did not, indicating that direct contact is necessary for this process. To determine if direct contact with End2 cells also promotes the induction of committed cardiac progenitors, we utilized several mouse ES and induced pluripotent (iPS) cell lines expressing fluorescent proteins under regulation of the CPC lineage markers Nkx2.5 or Isl1. In agreement with earlier data, co-aggregation with End2 cells potently induces both Nkx2.5(+) and Isl1(+) CPCs, leading to a sheet of beating cardiomyocytes. Furthermore, co-aggregation with End2 cells greatly promotes the induction of KDR+ PDGFRa(+) CPCs from human ES cells. Conclusions: Our co-aggregation method provides an efficient, simple and cost-effective way to induce CPCs from mouse and human pluripotent cells.	[Uosaki, Hideki; Andersen, Peter; Shenje, Lincoln T.; Fernandez, Laviel; Kwon, Chulan] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21218 USA; [Christiansen, Sofie Lindgren] Univ Copenhagen Hosp, Reprod Biol Lab, DK-2100 Copenhagen, Denmark	Johns Hopkins University; University of Copenhagen	Kwon, C (corresponding author), Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21218 USA.	ckwon13@jhmi.edu	Uosaki, Hideki/AAQ-2619-2020	Uosaki, Hideki/0000-0002-8964-8609; Andersen, Peter/0000-0003-3971-0467; Christiansen, Sofie Lindgren/0000-0003-3810-4123	Maryland Stem Cell Research Fund; National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health [R01HL111198, R00HL092234]; Lundbeck Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111198, R00HL092234] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund; National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from Maryland Stem Cell Research Fund, the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (R01HL111198, R00HL092234) and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrell DK, 2008, STEM CELLS, V26, P387, DOI 10.1634/stemcells.2007-0599; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Fujiwara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016734; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; KEMLER R, 1981, J EMBRYOL EXP MORPH, V64, P45; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lien CL, 1999, DEVELOPMENT, V126, P75; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Saga Y, 1999, DEVELOPMENT, V126, P3437; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu XQ, 2008, DIFFERENTIATION, V76, P958, DOI 10.1111/j.1432-0436.2008.00284.x; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894	25	30	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46413	10.1371/journal.pone.0046413	http://dx.doi.org/10.1371/journal.pone.0046413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056302	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600036
J	Alshatwi, AA; Hasan, TN; Syed, NA; Shafi, G; Grace, BL				Alshatwi, Ali A.; Hasan, Tarique N.; Syed, Naveed A.; Shafi, Gowhat; Grace, B. Leena			Identification of Functional SNPs in BARD1 Gene and In Silico Analysis of Damaging SNPs: Based on Data Procured from dbSNP Database	PLOS ONE			English	Article							BREAST-CANCER RISK; CRYSTAL-STRUCTURE; PROTEIN-SEQUENCE; ANKYRIN REPEAT; BRCA1; RING; SUSCEPTIBILITY; MUTATIONS; DOMAIN; POLYMORPHISM	Background: The BARD1 gene encodes for the BRCA1-associated RING domain (BARD1) protein. Germ line and somatic mutations in BARD1 are found in sporadic breast, ovarian and uterine cancers. There is a plethora of single nucleotide polymorphisms (SNPs) which may or may not be involved in the onset of female cancers. Hence, before planning a larger population study, it is advisable to sort out the possible functional SNPs. To accomplish this goal, data available in the dbSNP database and different computer programs can be used. To the best of our knowledge, until now there has been no such study on record for the BARD1 gene. Therefore, this study was undertaken to find the functional nsSNPs in BARD1. Result: 2.85% of all SNPs in the dbSNP database were present in the coding regions. SIFT predicted 11 out of 50 nsSNPs as not tolerable and PolyPhen assessed 27 out of 50 nsSNPs as damaging. FastSNP revealed that the rs58253676 SNP in the 3' UTR may have splicing regulator and enhancer functions. In the 5' UTR, rs17489363 and rs17426219 may alter the transcriptional binding site. The intronic region SNP rs67822872 may have a medium-high risk level. The protein structures 1JM7, 3C5R and 2NTE were predicted by PDBSum and shared 100% similarity with the BARD1 amino acid sequence. Among the predicted nsSNPs, rs4986841, rs111367604, rs13389423 and rs139785364 were identified as deleterious and damaging by the SIFT and PolyPhen programs. Additionally, I-Mutant showed a decrease in stability for these nsSNPs upon mutation. Finally, the ExPASy-PROSIT program revealed that the predicted deleterious mutations are contained in the ankyrin ring and BRCT domains. Conclusion: Using the available bioinformatics tools and the data present in the dbSNP database, the four nsSNPs, rs4986841, rs111367604, rs13389423 and rs139785364, were identified as deleterious, reducing the protein stability of BARD1. Hence, these SNPs can be used for the larger population-based studies of female cancers.	[Alshatwi, Ali A.; Hasan, Tarique N.; Syed, Naveed A.; Shafi, Gowhat] King Saud Univ, Dept Food Sci & Nutr, Mol Canc Biol Res Lab, Riyadh, Saudi Arabia; [Hasan, Tarique N.] Bharathiar Univ, Ctr Res & Dev, Coimbatore, Tamil Nadu, India; [Grace, B. Leena] Vinayaka Missions Univ, Dept Biotechnol, Salem, Tami Nadu, India	King Saud University; Bharathiar University; Vinayaka Mission's Research Foundation	Alshatwi, AA (corresponding author), King Saud Univ, Dept Food Sci & Nutr, Mol Canc Biol Res Lab, Riyadh, Saudi Arabia.	alialshatwi@gmail.com	BESLIN, LEENA GRACE/J-4439-2014; Syed, Naveed/K-2318-2012; Alshatwi, Ali/E-5271-2014	BESLIN, LEENA GRACE/0000-0002-7987-0572; Alshatwi, Ali/0000-0002-2441-553X; Noorul Hasan, Tarique/0000-0002-7744-9637	Research Centre, Deanship of Research, College of Food and Agricultural Sciences, King Saud University, Riyadh, Saudi Arabia	Research Centre, Deanship of Research, College of Food and Agricultural Sciences, King Saud University, Riyadh, Saudi Arabia	This study was financially supported by the Research Centre, Deanship of Research, College of Food and Agricultural Sciences, King Saud University, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alshatwi AA, 2011, BIOINFORMATION, V7, P334; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bhagwat M., 2010, CURR PROTOC BIOINFOR, P19, DOI DOI 10.1002/0471250953.BI0119S32; Birrane G, 2007, BIOCHEMISTRY-US, V46, P7706, DOI 10.1021/bi700323t; Bosse KR, 2012, CANCER RES, V72, P2068, DOI 10.1158/0008-5472.CAN-11-3703; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Doss CGP, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-42; Dutta Shuchismita, 2007, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0109s20; Ellsworth RE, 2010, CURR GENOMICS, V11, P146, DOI 10.2174/138920210791110951; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Fox D, 2008, J BIOL CHEM, V283, P21179, DOI 10.1074/jbc.M802333200; George Priya Doss C, 2008, Genomic Med, V2, P23, DOI 10.1007/s11568-008-9019-8; Ghimenti C, 2002, GENE CHROMOSOME CANC, V33, P235, DOI 10.1002/gcc.1223; Gorringe KL, 2008, BREAST CANCER RES TR, V111, P505, DOI 10.1007/s10549-007-9799-x; Hasan Tarique N, 2011, Adv Appl Bioinform Chem, V4, P29, DOI 10.2147/AABC.S17371; Hou WK, 2007, CHINESE MED J-PEKING, V120, P1592, DOI 10.1097/00029330-200709020-00009; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Irminger-Finger I, 2002, INT J BIOCHEM CELL B, V34, P582, DOI 10.1016/S1357-2725(01)00161-3; Ishitobi M, 2003, CANCER LETT, V200, P1, DOI 10.1016/S0304-3835(03)00387-2; Johnatty SE, 2009, BREAST CANCER RES TR, V115, P145, DOI 10.1007/s10549-008-0045-y; Karppinen SM, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.020669; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Luu TD, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas018; Morris JR, 2002, J BIOL CHEM, V277, P9382, DOI 10.1074/jbc.M109249200; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Prokunina Ludmila, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007690; Rajasekaran R, 2007, GENOMICS, V90, P447, DOI 10.1016/j.ygeno.2007.07.004; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ryu GM, 2009, NUCLEIC ACIDS RES, V37, P1297, DOI 10.1093/nar/gkn1008; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sauer MK, 2005, J MED GENET, V42, P633, DOI 10.1136/jmg.2004.030049; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smith C, 2005, NATURE, V435, P991, DOI 10.1038/435991a; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Spurdle AB, 2011, CANCER EPIDEM BIOMAR, V20, P1032, DOI 10.1158/1055-9965.EPI-10-0909; Stacey SN, 2006, PLOS MED, V3, P1103, DOI 10.1371/journal.pmed.0030217; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhou XY, 2009, GYNECOL ONCOL, V114, P327, DOI 10.1016/j.ygyno.2009.05.011; Zhu Y, 2004, CANCER RES, V64, P2251, DOI 10.1158/0008-5472.CAN-03-2800	57	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e43939	10.1371/journal.pone.0043939	http://dx.doi.org/10.1371/journal.pone.0043939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056176	gold, Green Submitted, Green Published			2022-12-27	WOS:000309889400004
J	Oberhettinger, P; Schuetz, M; Leo, JC; Heinz, N; Berger, J; Autenrieth, IB; Linke, D				Oberhettinger, Philipp; Schuetz, Monika; Leo, Jack C.; Heinz, Nadja; Berger, Juergen; Autenrieth, Ingo B.; Linke, Dirk			Intimin and Invasin Export Their C-Terminus to the Bacterial Cell Surface Using an Inverse Mechanism Compared to Classical Autotransport	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; OUTER-MEMBRANE PROTEINS; GRAM-NEGATIVE BACTERIA; HIGH-LEVEL EXPRESSION; YERSINIA-ENTEROCOLITICA; 2-PARTNER SECRETION; PERIPLASMIC CHAPERONES; EPITHELIAL-CELLS; COMMON THEMES; DOMAIN	Invasin and intimin are major virulence factors of enteropathogenic Yersiniae and Escherichia coli, mediating invasion into and intimate adherence to host cells, respectively. Several studies have hinted that extracellular portion of these homologous proteins might be exported via an autotransport mechanism, but rigorous experimental proof has been lacking. Here, we present a topology model for invasin and intimin, consistent with the hypothesis that the N-terminal beta-barrel domain acts as a translocation pore to secrete the C-terminal passenger domain. We confirmed this topology model by inserting epitope tags into the loops of the beta-barrel. We further show that obstructing the pore of beta-barrel hinders the export of the passenger domain. As for classical autotransport, the biogenesis of invasin and intimin is dependent on the Bam complex and the periplasmic chaperone SurA, whereas the chaperone/protease DegP is involved in quality control. However, compared to classical autotransporters (Type Va secretion), the domain structure of intimin and invasin is inverted. We conclude that proteins of the intimin and invasin family constitute a novel group of autotransported proteins, and propose that this class of autotransporters be termed Type Ve secretion.	[Leo, Jack C.; Heinz, Nadja; Berger, Juergen; Linke, Dirk] Max Planck Inst Entwicklungsbiol, Abt 1, D-72076 Tubingen, Germany; [Oberhettinger, Philipp; Schuetz, Monika; Autenrieth, Ingo B.] Univ Tubingen, Inst Med Mikrobiol & Hyg, Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Linke, D (corresponding author), Max Planck Inst Entwicklungsbiol, Abt 1, D-72076 Tubingen, Germany.	monika.schuetz@med.uni-tuebingen.de; dirk.linke@tuebingen.mpg.de	Leo, Jack/HHS-7710-2022; Linke, Dirk/F-9147-2010; Leo, Jack C./F-2177-2011	Linke, Dirk/0000-0003-3150-6752; Leo, Jack C./0000-0002-7066-7527	German Science Foundation (DFG) [SFB766]; FEMS advanced fellowship; Max Planck Society	German Science Foundation (DFG)(German Research Foundation (DFG)); FEMS advanced fellowship; Max Planck Society(Max Planck Society)	This work was funded by the German Science Foundation (DFG, SFB766, to DL, MS, and IBA), by a FEMS advanced fellowship to JCL, and through institutional funds of the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Arnold Thomas, 2008, Curr Protoc Protein Sci, VChapter 4, DOI 10.1002/0471140864.ps0408s53; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Batchelor M, 2000, EMBO J, V19, P2452, DOI 10.1093/emboj/19.11.2452; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Grassl GA, 2003, INT J MED MICROBIOL, V293, P41, DOI 10.1078/1438-4221-00243; Grin I, 2011, ADV EXP MED BIOL, V715, P257, DOI 10.1007/978-94-007-0940-9_16; Grosskinsky U, 2007, J BACTERIOL, V189, P9011, DOI 10.1128/JB.00985-07; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Ize B, 2002, J MOL BIOL, V317, P327, DOI 10.1006/jmbi.2002.5431; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Lehr U, 2010, MOL MICROBIOL, V78, P932, DOI 10.1111/j.1365-2958.2010.07377.x; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Newman CL, 2004, CRIT REV MICROBIOL, V30, P275, DOI 10.1080/10408410490499872; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Remmert M, 2009, NUCLEIC ACIDS RES, V37, pW446, DOI 10.1093/nar/gkp325; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Schmid Y, 2004, INFECT IMMUN, V72, P6780, DOI 10.1128/IAI.72.12.6780-6789.2004; Schutz M, 2010, INFECT IMMUN, V78, P2677, DOI 10.1128/IAI.01350-09; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Thanassi DG, 2005, MOL MEMBR BIOL, V22, P63, DOI 10.1080/09687860500063290; Touze T, 2004, MOL MICROBIOL, V51, P73, DOI 10.1046/j.1365-2958.2003.03830.x; Tsai JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014403; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; Wentzel A, 2001, J BACTERIOL, V183, P7273, DOI 10.1128/JB.183.24.7273-7284.2001; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618	55	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47069	10.1371/journal.pone.0047069	http://dx.doi.org/10.1371/journal.pone.0047069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056583	gold, Green Published, Green Submitted			2022-12-27	WOS:000309889400052
J	Smelt, MJ; de Haan, BJ; Bron, PA; van Swam, I; Meijerink, M; Wells, JM; Faas, MM; de Vos, P				Smelt, Maaike J.; de Haan, Bart J.; Bron, Peter A.; van Swam, Iris; Meijerink, Marjolein; Wells, Jerry M.; Faas, Marijke M.; de Vos, Paul			L. plantarum, L. salivarius, and L. lactis Attenuate Th2 Responses and Increase Treg Frequencies in Healthy Mice in a Strain Dependent Manner	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COMPLETE GENOME SEQUENCE; INFLUENZA-VIRUS TITER; LACTOBACILLUS-PLANTARUM; DENDRITIC CELLS; DOUBLE-BLIND; IN-VITRO; CYTOKINE RESPONSE; IMMUNE-RESPONSES; ACID BACTERIA	Many studies on probiotics are aimed at restoring immune homeostasis in patients to prevent disease recurrence or reduce immune-mediated pathology. Of equal interest is the use of probiotics in sub-clinical situations, which are characterized by reduced immune function or low-grade inflammation, with an increased risk of infection or disease as a consequence. Most mechanistic studies focus on the use of probiotics in experimental disease models, which may not be informative for these sub-clinical conditions. To gain better understanding of the effects in the healthy situation, we investigated the immunomodulatory effects of two Lactobacillus probiotic strains, i.e. L. plantarum WCFS1 and L. salivarius UCC118, and a non-probiotic lactococcus strain, i.e. L. lactis MG1363, in healthy mice. We studied the effect of these bacteria on the systemic adaptive immune system after 5 days of administration. Only L. plantarum induced an increase in regulatory CD103(+) DC and regulatory T cell frequencies in the spleen. However, all three bacterial strains, including L. lactis, reduced specific splenic T helper cell cytokine responses after ex vivo restimulation. The effect on IFN-gamma, IL5, IL10, and IL17 production by CD4(+) and CD8(+) T cells was dependent on the strain administered. A shared observation was that all three bacterial strains reduced T helper 2 cell frequencies. We demonstrate that systemic immunomodulation is not only observed after treatment with probiotic organisms, but also after treatment with non-probiotic bacteria. Our data demonstrate that in healthy mice, lactobacilli can balance T cell immunity in favor of a more regulatory status, via both regulatory T cell dependent and independent mechanisms in a strain dependent manner.	[Smelt, Maaike J.; Bron, Peter A.; van Swam, Iris; Meijerink, Marjolein; Wells, Jerry M.; de Vos, Paul] Top Inst Food & Nutr, Wageningen, Netherlands; [Smelt, Maaike J.; de Haan, Bart J.; Faas, Marijke M.; de Vos, Paul] Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [Smelt, Maaike J.; de Haan, Bart J.; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Groningen, Netherlands; [Bron, Peter A.; van Swam, Iris] NIZO Food Res, Ede, Netherlands; [Meijerink, Marjolein; Wells, Jerry M.] Wageningen Univ, Dept Host Microbe Interact, Wageningen, Netherlands; [Bron, Peter A.] Kluyver Ctr Fermentat & Genom, Delft, Netherlands	Top Institute Food & Nutrition; University of Groningen; University of Groningen; NIZO Food Research; Wageningen University & Research	de Vos, P (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	p.de.vos@umcg.nl	de Vos, Paul/A-3170-2013; Meijerink, Marjolein/B-9258-2014	Meijerink, Marjolein/0000-0003-3994-9785; de vos, paul/0000-0001-9618-2408	Top Institute Food and Nutrition, Wageningen, The Netherlands	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government)	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bisgaard H, 2011, J ALLERGY CLIN IMMUN; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Boge T, 2009, VACCINE, V27, P5677, DOI 10.1016/j.vaccine.2009.06.094; Braat H, 2004, AM J CLIN NUTR, V80, P1618, DOI 10.1093/ajcn/80.6.1618; Brooks-Worrell B, 2012, TRENDS IMMUNOL; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; CHANDRA RK, 1994, NUTRITION, V10, P207; Cookson W, 2002, IMMUNOL REV, V190, P195, DOI 10.1034/j.1600-065X.2002.19015.x; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; de Vrese M, 2005, EUR J NUTR, V44, P406, DOI 10.1007/s00394-004-0541-8; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Dunne C, 1999, ANTON LEEUW INT J G, V76, P279, DOI 10.1023/A:1002065931997; Edwards CJ, 2008, J RHEUMATOL, V35, P1477; Fang F, 2008, APPL ENVIRON MICROB, V74, P3216, DOI 10.1128/AEM.02631-07; Fang H, 2000, FEMS IMMUNOL MED MIC, V29, P47, DOI 10.1111/j.1574-695X.2000.tb01504.x; Feighery LM, 2008, DIGEST DIS SCI, V53, P2495, DOI 10.1007/s10620-007-0157-y; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Foligne B, 2007, GASTROENTEROLOGY, V133, P862, DOI 10.1053/j.gastro.2007.06.018; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Guandalini S, 2010, J PEDIATR GASTR NUTR, V51, P24, DOI 10.1097/MPG.0b013e3181ca4d95; Hatakka K, 2001, BMJ-BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; Hori T, 2002, CLIN DIAGN LAB IMMUN, V9, P105, DOI 10.1128/CDLI.9.1.105-108.2002; ISOLAURI E, 1995, VACCINE, V13, P310, DOI 10.1016/0264-410X(95)93319-5; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; Ivory K, 2008, CLIN EXP ALLERGY, V38, P1282, DOI 10.1111/j.1365-2222.2008.03025.x; Jacobo P, 2011, REPRODUCTION, V141, P249, DOI 10.1530/REP-10-0362; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2003, CURR OPIN ALLERGY CL, V3, P15, DOI [10.1097/00130832-200302000-00003, 10.1097/01.all.0000053262.39029.a1]; Kalliomaki M, 2010, J NUTR, V140, p713S, DOI 10.3945/jn.109.113761; KAPLAN HB, 1991, SOC SCI MED, V33, P909, DOI 10.1016/0277-9536(91)90262-B; Kawase M, 2010, LETT APPL MICROBIOL, V51, P6, DOI 10.1111/j.1472-765X.2010.02849.x; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Matsumoto S, 2005, CLIN EXP IMMUNOL, V140, P417, DOI 10.1111/j.1365-2249.2005.02790.x; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Menard S, 2005, EXP BIOL MED, V230, P749, DOI 10.1177/153537020523001008; Miettinen M, 1998, INFECT IMMUN, V66, P6058, DOI 10.1128/IAI.66.12.6058-6062.1998; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mouni F, 2009, IMMUNOL INVEST, V38, P104, DOI 10.1080/08820130802608303; Neville BA, 2010, FUTURE MICROBIOL, V5, P759, DOI 10.2217/FMB.10.35; Niers LEM, 2005, CLIN EXP ALLERGY, V35, P1481, DOI 10.1111/j.1365-2222.2005.02375.x; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; O'Mahony L, 2006, AM J PHYSIOL-GASTR L, V290, pG839, DOI 10.1152/ajpgi.00112.2005; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Paineau D, 2008, FEMS IMMUNOL MED MIC, V53, P107, DOI 10.1111/j.1574-695X.2008.00413.x; Pathmakanthan S, 2004, J GASTROEN HEPATOL, V19, P166, DOI 10.1111/j.1440-1746.2004.03181.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Remus DM, 2011, EUR J PHARMACOL, V668, pS33, DOI 10.1016/j.ejphar.2011.07.012; Rijkers GT, 2010, J NUTR, V140, p671S, DOI 10.3945/jn.109.113779; Schultz M, 2002, INFLAMM BOWEL DIS, V8, P71, DOI 10.1097/00054725-200203000-00001; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Troost FJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-374; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Tursi A, 2004, MED SCI MONITOR, V10, pPI126; Vaarala O., 2011, CURR OPIN ENDOCRINOL; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Vaughan EE, 2002, ANTON LEEUW INT J G, V82, P341, DOI 10.1023/A:1020672724450; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Won TJ, 2011, CAN J PHYSIOL PHARM, V89, P429, DOI [10.1139/Y11-047, 10.1139/y11-047]; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xia Y, 2011, J GASTROEN HEPATOL, V26, P405, DOI 10.1111/j.1440-1746.2010.06498.x; Yang HY, 2009, NUTR RES, V29, P281, DOI 10.1016/j.nutres.2009.03.010; Yasui H, 2004, CLIN DIAGN LAB IMMUN, V11, P675, DOI 10.1128/CDLI.11.4.675-679.2004; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	77	58	65	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47244	10.1371/journal.pone.0047244	http://dx.doi.org/10.1371/journal.pone.0047244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056616	gold, Green Published			2022-12-27	WOS:000309889400066
J	Das, T; Manefield, M				Das, Theerthankar; Manefield, Mike			Pyocyanin Promotes Extracellular DNA Release in Pseudomonas aeruginosa	PLOS ONE			English	Article							BIOFILM FORMATION; CELL-DEATH; ADHESION; ROLES; GENE	Bacterial adhesion and biofilm formation are both dependent on the production of extracellular polymeric substances (EPS) mainly composed of polysaccharides, proteins, lipids, and extracellular DNA (eDNA). eDNA promotes biofilm establishment in a wide range of bacterial species. In Pseudomonas aeruginosa eDNA is major component of biofilms and is essential for biofilm formation and stability. In this study we report that production of pyocyanin in P. aeruginosa PAO1 and PA14 batch cultures is responsible for promotion of eDNA release. A phzSH mutant of P. aeruginosa PAO1 that overproduces pyocyanin displayed enhanced hydrogen peroxide (H2O2) generation, cell lysis, and eDNA release in comparison to its wildtype strain. A Delta phzA-G mutant of P. aeruginosa PA14 deficient in pyocyanin production generated negligible amounts of H2O2 and released less eDNA in comparison to its wildtype counterpart. Exogenous addition of pyocyanin or incubation with H2O2 was also shown to promote eDNA release in low pyocyanin producing (PAO1) and pyocynain deficient (PA14) strains. Based on these data and recent findings in the biofilm literature, we propose that the impact of pyocyanin on biofilm formation in P. aeruginosa occurs via eDNA release through H2O2 mediated cell lysis.	[Das, Theerthankar; Manefield, Mike] Univ New S Wales, Sch Biotechnol & Biomol Sci BABS, CMB, Sydney, NSW, Australia	University of New South Wales Sydney	Das, T (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci BABS, CMB, Sydney, NSW, Australia.	theerthankar_das11@rediffmail.com			Australian Research Council (ARC) [FT100100078]	Australian Research Council (ARC)(Australian Research Council)	This work was funded by Australian Research Council (ARC) Future Fellowship Project ID FT100100078, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Carrozzo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015638; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P1006, DOI 10.1094/MPMI.2001.14.8.1006; Das T, 2011, LANGMUIR, V27, P10113, DOI 10.1021/la202013m; Das T, 2011, SOFT MATTER, V7, P2927, DOI 10.1039/c0sm01142h; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Dhanasekaran D, 2009, INT J ENVIRON SCI TE, V6, P197; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Godeke J, 2011, APPL ENVIRON MICROB, V77, P5342, DOI 10.1128/AEM.00643-11; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; Liu HH, 2008, CURR MICROBIOL, V57, P139, DOI 10.1007/s00284-008-9166-0; Maddula VSRK, 2008, J BACTERIOL, V190, P2759, DOI 10.1128/JB.01587-07; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; Reszka KJ, 2004, FREE RADICAL BIO MED, V36, P1448, DOI 10.1016/j.freeradbiomed.2004.03.011; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Tsuneda S, 2003, FEMS MICROBIOL LETT, V223, P287, DOI 10.1016/S0378-1097(03)00399-9; Venkataraman A, 2010, ELECTROCHEM COMMUN, V12, P459, DOI 10.1016/j.elecom.2010.01.019; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08; Zheng LY, 2011, J BACTERIOL, V193, P516, DOI 10.1128/JB.01131-10	35	144	150	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46718	10.1371/journal.pone.0046718	http://dx.doi.org/10.1371/journal.pone.0046718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056420	gold, Green Published, Green Submitted			2022-12-27	WOS:000309831500061
J	Latifi, A; Luwor, RB; Bilandzic, M; Nazaretian, S; Stenvers, K; Pyman, J; Zhu, HJ; Thompson, EW; Quinn, MA; Findlay, JK; Ahmed, N				Latifi, Ardian; Luwor, Rodney B.; Bilandzic, Maree; Nazaretian, Simon; Stenvers, Kaye; Pyman, Jan; Zhu, Hongjian; Thompson, Erik W.; Quinn, Michael A.; Findlay, Jock K.; Ahmed, Nuzhat			Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; INITIATING CELLS; BREAST-CANCER; ADHESION-MOLECULE; COLORECTAL-CANCER; CARCINOMA; METASTASIS; SURVIVAL; OVEREXPRESSION	Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an attempt to identify and profile the population of ascites cells obtained from ovarian cancer patients, a novel method was developed to separate adherent (AD) and non-adherent (NAD) cells in culture. Twenty-five patients were recruited to this study; 11 chemonaive (CN) and 14 chemoresistant (CR). AD cells from both CN and CR patients exhibited mesenchymal morphology with an antigen profile of mesenchymal stem cells and fibroblasts. Conversely, NAD cells had an epithelial morphology with enhanced expression of cancer antigen 125 (CA125), epithelial cell adhesion molecule (EpCAM) and cytokeratin 7. NAD cells developed infiltrating tumors and ascites within 12-14 weeks after intraperitoneal (i.p.)injections into nude mice, whereas AD cells remained non-tumorigenic for up to 20 weeks. Subsequent comparison of selective epithelial, mesenchymal and cancer stem cell (CSC) markers between AD and NAD populations of CN and CR patients demonstrated an enhanced trend in mRNA expression of E-cadherin, EpCAM, STAT3 and Oct4 in the NAD population of CR patients. A similar trend of enhanced mRNA expression of CD44, MMP9 and Oct4 was observed in the AD population of CR patients. Hence, using a novel purification method we demonstrate for the first time a distinct separation of ascites cells into epithelial tumorigenic and mesenchymal non-tumorigenic populations. We also demonstrate that cells from the ascites of CR patients are predominantly epithelial and show a trend towards increased mRNA expression of genes associated with CSCs, compared to cells isolated from the ascites of CN patients. As the tumor cells in the ascites of ovarian cancer patients play a dominant role in disease recurrence, a thorough understanding of the biology of the ascites microenvironment from CR and CN patients is essential for effective therapeutic interventions.	[Latifi, Ardian; Quinn, Michael A.; Findlay, Jock K.; Ahmed, Nuzhat] Royal Womens Hosp, Womens Canc Res Ctr, Melbourne, Vic, Australia; [Latifi, Ardian; Thompson, Erik W.; Ahmed, Nuzhat] Univ Melbourne, St Vincent Hosp, Dept Surg, Melbourne, Vic 3010, Australia; [Luwor, Rodney B.; Zhu, Hongjian] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Melbourne, Vic 3010, Australia; [Bilandzic, Maree; Stenvers, Kaye; Findlay, Jock K.; Ahmed, Nuzhat] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Nazaretian, Simon; Pyman, Jan] Royal Womens Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; [Quinn, Michael A.; Findlay, Jock K.; Ahmed, Nuzhat] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic 3010, Australia	St Vincent's Hospital Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Prince Henry's Institute of Medical Research; University of Melbourne	Ahmed, N (corresponding author), Royal Womens Hosp, Womens Canc Res Ctr, Melbourne, Vic, Australia.	Nuzhat.Ahmed@thewomens.org.au	Thompson, Erik W/A-1425-2009; Thompson, Erik/GPK-2067-2022	Thompson, Erik W/0000-0002-9723-4924; Thompson, Erik/0000-0002-9723-4924; Zhu, Hong-Jian/0000-0002-1478-995X; Quinn, Michael/0000-0003-0694-3870; Luwor, Rodney/0000-0002-3020-4245	Women's Cancer Foundation; National Health and Medical Research Council of Australia [441101]; National Breast Cancer Foundation; Victorian Government's Operational Infrastructure Support Program (Australia)	Women's Cancer Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Victorian Government's Operational Infrastructure Support Program (Australia)	This was supported by Women's Cancer Foundation, National Health and Medical Research Council of Australia (JKF, RegKey#441101), the National Breast Cancer Foundation (EWT; EMPathy Breast Cancer Network, Australia) and the Victorian Government's Operational Infrastructure Support Program (Australia). The funders had no role in study desugn, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Antolovic D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-35; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bartkowiak K, 2012, CANCER MICROENVIRON, V5, P59, DOI 10.1007/s12307-011-0067-6; Bellone S, 2009, INT J GYNECOL CANCER, V19, P860, DOI 10.1111/IGC.0b013e3181a8331f; Bilandzic M, 2009, MOL ENDOCRINOL, V23, P539, DOI 10.1210/me.2008-0300; Bose D, 2011, BRIT J CANCER, V105, P1759, DOI 10.1038/bjc.2011.449; Brabletz T, 2012, NAT REV CANC; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Davidson B, 2001, ANAL CELL PATHOL, V23, P107, DOI 10.1155/2001/418547; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Gingis-Velitski S, 2011, CANCER RES, V71, P6986, DOI 10.1158/0008-5472.CAN-11-0629; Haviv I, 2012, CANCER MICROENVIRON, V5, P1, DOI 10.1007/s12307-012-0104-0; Ho CM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-23; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kenny HA, 2009, CANCER TREAT RES, V149, P335, DOI 10.1007/978-0-387-98094-2_16; Kleinberg L, 2008, DIAGN CYTOPATHOL, V36, P637, DOI 10.1002/dc.20879; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kuhn E, 2012, CURR OBSTET GYNECOL, V1, P1, DOI 10.1007/s13669-011-0004-1; Kunimura C, 1998, ONCOGENE, V17, P187, DOI 10.1038/sj.onc.1201916; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Liu HG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-50; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marhaba R, 2008, CURR MOL MED, V8, P784, DOI 10.2174/156652408786733667; Martin FT, 2010, BREAST CANCER RES TR, V124, P317, DOI 10.1007/s10549-010-0734-1; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Ozols RF, 2006, SEMIN ONCOL, V33, pS3, DOI 10.1053/j.seminoncol.2006.03.011; Paunescu V, 2011, J CELL MOL MED, V15, P635, DOI 10.1111/j.1582-4934.2010.01044.x; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Sarrio D, 2012, STEM CELLS, V30, P292, DOI 10.1002/stem.791; Scarberry KE, 2010, NANOMED-NANOTECHNOL, V6, P399, DOI 10.1016/j.nano.2009.11.003; Schauer IG, 2011, NEOPLASIA, V13, P393, DOI 10.1593/neo.101720; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; Vathipadiekal V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029079; Velasco-Velazquez MA, 2012, INT J BIOCHEM CELL B, V44, P573, DOI 10.1016/j.biocel.2011.12.020; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	51	143	147	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46858	10.1371/journal.pone.0046858	http://dx.doi.org/10.1371/journal.pone.0046858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056490	Green Published, gold			2022-12-27	WOS:000309831500093
J	Vadasz, I; Dada, LA; Briva, A; Helenius, IT; Sharabi, K; Welch, LC; Kelly, AM; Grzesik, BA; Budinger, GRS; Liu, J; Seeger, W; Beitel, GJ; Gruenbaum, Y; Sznajder, JI				Vadasz, Istvan; Dada, Laura A.; Briva, Arturo; Helenius, Iiro Taneli; Sharabi, Kfir; Welch, Lynn C.; Kelly, Aileen M.; Grzesik, Benno A.; Budinger, G. R. Scott; Liu, Jing; Seeger, Werner; Beitel, Greg J.; Gruenbaum, Yosef; Sznajder, Jacob I.			Evolutionary Conserved Role of c-Jun-N-Terminal Kinase in CO2-Induced Epithelial Dysfunction	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ELEVATED CO2 LEVELS; ALVEOLAR FLUID REABSORPTION; CARBON-DIOXIDE AVOIDANCE; CAENORHABDITIS-ELEGANS; KAPPA-B; INDUCED ENDOCYTOSIS; DOWN-REGULATION; JNK ACTIVATION; ALPHA-SUBUNIT	Elevated CO2 levels (hypercapnia) occur in patients with respiratory diseases and impair alveolar epithelial integrity, in part, by inhibiting Na,K-ATPase function. Here, we examined the role of c-Jun N-terminal kinase (JNK) in CO2 signaling in mammalian alveolar epithelial cells as well as in diptera, nematodes and rodent lungs. In alveolar epithelial cells, elevated CO2 levels rapidly induced activation of JNK leading to downregulation of Na, K-ATPase and alveolar epithelial dysfunction. Hypercapnia-induced activation of JNK required AMP-activated protein kinase (AMPK) and protein kinase C-zeta leading to subsequent phosphorylation of JNK at Ser-129. Importantly, elevated CO2 levels also caused a rapid and prominent activation of JNK in Drosophila S2 cells and in C. elegans. Paralleling the results with mammalian epithelial cells, RNAi against Drosophila JNK fully prevented CO2-induced downregulation of Na, K-ATPase in Drosophila S2 cells. The importance and specificity of JNK CO2 signaling was additionally demonstrated by the ability of mutations in the C. elegans JNK homologs, jnk-1 and kgb-2 to partially rescue the hypercapnia-induced fertility defects but not the pharyngeal pumping defects. Together, these data provide evidence that deleterious effects of hypercapnia are mediated by JNK which plays an evolutionary conserved, specific role in CO2 signaling in mammals, diptera and nematodes.	[Vadasz, Istvan; Dada, Laura A.; Briva, Arturo; Helenius, Iiro Taneli; Welch, Lynn C.; Kelly, Aileen M.; Budinger, G. R. Scott; Liu, Jing; Sznajder, Jacob I.] Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Vadasz, Istvan; Grzesik, Benno A.; Seeger, Werner] Univ Giessen, Dept Internal Med, Justus Liebig Univ, D-6300 Giessen, Germany; [Vadasz, Istvan; Grzesik, Benno A.; Seeger, Werner] German Ctr Lung Res, Marburg Lung Ctr, Giessen, Germany; [Briva, Arturo] Univ Republica, Fac Med, Dept Fisiopatol, Montevideo, Uruguay; [Helenius, Iiro Taneli; Beitel, Greg J.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Sharabi, Kfir; Gruenbaum, Yosef] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Northwestern University; Justus Liebig University Giessen; Universidad de la Republica, Uruguay; Northwestern University; Hebrew University of Jerusalem	Sznajder, JI (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	j-sznajder@northwestern.edu	Vadasz, Istvan/AAO-8288-2021	Seeger, Werner/0000-0003-1946-0894; Sharabi, Kfir/0000-0002-7810-6521; Vadasz, Istvan/0000-0003-1370-9783; Helenius, Iiro Taneli/0000-0002-0887-7830	University Medical Center [62589064]; Else Kroner Memorial Award; American Heart Association [AHA0715562Z];  [NIH/HL-85534];  [DFG/IRTG1062]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995] Funding Source: NIH RePORTER	University Medical Center; Else Kroner Memorial Award; American Heart Association(American Heart Association); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by NIH/HL-85534 (to LAD, YG and JIS), by DFG/IRTG1062 (to IV, WS and JIS) and by the University Medical Center Giessen and Marburg grant 62589064 (to IV). IV was supported by the Else Kroner Memorial Award. ITH was supported by a predoctoral fellowship from American Heart Association (AHA0715562Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertorello AM, 2003, MOL BIOL CELL, V14, P1149, DOI 10.1091/mbc.E02-06-0367; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen J, 2008, AM J RESP CELL MOL, V38, P32, DOI 10.1165/rcmb.2007-0121OC; Chibalin AV, 1998, J BIOL CHEM, V273, P8814, DOI 10.1074/jbc.273.15.8814; Chibalin AV, 1999, J BIOL CHEM, V274, P1920, DOI 10.1074/jbc.274.4.1920; Comellas AP, 2006, CIRC RES, V98, P1314, DOI 10.1161/01.RES.0000222418.99976.1d; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Daire V, 2009, J BIOL CHEM, V284, P31992, DOI 10.1074/jbc.M109.007906; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Donnellan F, 2010, AM J PHYSIOL-GASTR L, V298, pG37, DOI 10.1152/ajpgi.00202.2009; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Kassardjian A, 2008, J CELL PHYSIOL, V216, P615, DOI 10.1002/jcp.21436; Klein JD, 1999, AM J PHYSIOL-CELL PH, V277, pC425, DOI 10.1152/ajpcell.1999.277.3.C425; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lee VY, 2005, AM J PHYSIOL-LUNG C, V289, pL521, DOI 10.1152/ajplung.00340.2004; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Lopez-Bergami P, 2008, INT J BIOCHEM CELL B, V40, P1055, DOI 10.1016/j.biocel.2007.11.011; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Myrianthefs PM, 2005, AM J RESP CRIT CARE, V171, P1267, DOI 10.1164/rccm.200408-998OC; Putnam RW, 2010, J APPL PHYSIOL, V108, P1796, DOI 10.1152/japplphysiol.01169.2009; Ramia N, 2010, CELL BIOL INT, V34, P607, DOI 10.1042/CBI20090093; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Sharabi K, 2009, P NATL ACAD SCI USA, V106, P4024, DOI 10.1073/pnas.0900309106; Shumay E, 2007, J BIOL CHEM, V282, P21529, DOI 10.1074/jbc.M701998200; Sznajder JI, 2001, AM J RESP CRIT CARE, V163, P1293, DOI 10.1164/ajrccm.163.6.ed1801d; Vadasz I, 2005, AM J RESP CELL MOL, V33, P343, DOI 10.1165/rcmb.2004-0407OC; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vadasz I, 2007, INTENS CARE MED, V33, P1243, DOI 10.1007/s00134-007-0661-8; Vadasz I, 2012, AM J RESP CELL MOL, V46, P417, DOI 10.1165/rcmb.2011-0395PS; Vohwinkel CU, 2011, J BIOL CHEM, V286, P37067, DOI 10.1074/jbc.M111.290056; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; Welch LC, 2010, FEBS LETT, V584, P3985, DOI 10.1016/j.febslet.2010.08.002; Zhou YH, 2005, P NATL ACAD SCI USA, V102, P3875, DOI 10.1073/pnas.0500423102	40	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46696	10.1371/journal.pone.0046696	http://dx.doi.org/10.1371/journal.pone.0046696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056407	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500059
J	von Burg, S; Alvarez-Alfageme, F; Romeis, J				von Burg, Simone; Alvarez-Alfageme, Fernando; Romeis, Joerg			Indirect Effect of a Transgenic Wheat on Aphids through Enhanced Powdery Mildew Resistance	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PHLOEM SAP; RHOPALOSIPHUM-PADI; COTTON APHID; PEA APHID; INSECTS; FUNGICIDES; CULTIVARS; HOMOPTERA; COMMUNITY	In agricultural ecosystems, arthropod herbivores and fungal pathogens are likely to colonise the same plant and may therefore affect each other directly or indirectly. The fungus that causes powdery mildew (Blumeria graminis tritici) and cereal aphids are important pests of wheat but interactions between them have seldom been investigated. We studied the effects of powdery mildew of wheat on two cereal aphid species, Metopolophium dirhodum and Rhopalosiphum padi. We hypothesized that aphid number and size will be smaller on powdery mildew-infected plants than on non-infected plants. In a first experiment we used six commercially available wheat varieties whereas in the second experiment we used a genetically modified (GM) mildew-resistant wheat line and its non-transgenic sister line. Because the two lines differed only in the presence of the transgene and in powdery mildew resistance, experiment 2 avoided the confounding effect of variety. In both experiments, the number of M. dirhodum but not of R. padi was reduced by powdery mildew infection. Transgenic mildew-resistant lines therefore harboured bigger aphid populations than the non-transgenic lines. For both aphid species individual size was mostly influenced by aphid number. Our results indicate that plants that are protected from a particular pest (powdery mildew) became more favourable for another pest (aphids).	[Alvarez-Alfageme, Fernando; Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [von Burg, Simone] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; University of Zurich	Romeis, J (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	joerg.romeis@art.admin.ch	Romeis, Joerg/J-5360-2013	Romeis, Joerg/0000-0003-3652-8360; Alvarez, Fernando/0000-0001-8932-3823	Swiss National Science Foundation (SNF) [405940-115604]; Wheat consortium; National Research Programme NRP [59]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Wheat consortium; National Research Programme NRP	This project was supported by the Swiss National Science Foundation (SNF grant 405940-115604) and is part of the "Wheat consortium" (www.wheatcluster.ch), a subunit of the National Research Programme NRP 59 "Benefits and risks of the deliberate release of genetically modified plants" (www.NRP59.ch9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022690; Blackman R.L., 2000, J ECON ENTOMOL, V2; Brunner S, 2011, PLANT BIOTECHNOL J, V9, P897, DOI 10.1111/j.1467-7652.2011.00603.x; Douglas AE, 2003, ADV INSECT PHYSIOL, V31, P73, DOI 10.1016/S0065-2806(03)31002-1; GIVOVICH A, 1994, J CHEM ECOL, V20, P1923, DOI 10.1007/BF02066233; Hammerschmidt R, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P55; Hammond A.M., 1988, P381; Hatcher P. E., 2001, Biotic interactions in plant-pathogen associations, P193, DOI 10.1079/9780851995120.0193; Hatcher PE, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P133; HATCHER PE, 1995, BIOL REV, V70, P639, DOI 10.1111/j.1469-185X.1995.tb01655.x; JORGENSEN JH, 1994, CRIT REV PLANT SCI, V13, P97, DOI 10.1080/713608055; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Karley AJ, 2002, J EXP BIOL, V205, P3009; KAZEMI MH, 1992, ANN APPL BIOL, V121, P1, DOI 10.1111/j.1744-7348.1992.tb03981.x; Lagnaoui A, 1998, AM J POTATO RES, V75, P19, DOI 10.1007/BF02883513; LESZCZYNSKI B, 1995, ENTOMOL EXP APPL, V76, P157, DOI 10.1007/BF02383213; Moran PJ, 1998, OECOLOGIA, V115, P523, DOI 10.1007/s004420050550; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; NIRAZ S, 1985, INSECT SCI APPL, V6, P253, DOI 10.1017/S1742758400004513; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Oerke EC, 2004, CROP PROT, V23, P275, DOI 10.1016/j.cropro.2003.10.001; Pescod KV, 2007, PHYSIOL ENTOMOL, V32, P253, DOI 10.1111/j.1365-3032.2007.00577.x; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; RADCLIFFE EB, 1976, ENVIRON ENTOMOL, V5, P1195, DOI 10.1093/ee/5.6.1195; Roelfs A.P., 1992, RUST DIS WHEAT CONCE, P34; Rondon SI, 2004, ACTA HORTIC, P357, DOI 10.17660/ActaHortic.2004.659.47; Saikkonen K, 1999, OECOLOGIA, V121, P411, DOI 10.1007/s004420050946; SANDSTROM J, 1994, J INSECT PHYSIOL, V40, P947, DOI 10.1016/0022-1910(94)90133-3; Schulze-Lefert P, 2000, TRENDS PLANT SCI, V5, P343, DOI 10.1016/S1360-1385(00)01683-6; Smith MT, 1996, ENVIRON ENTOMOL, V25, P677, DOI 10.1093/ee/25.3.677; Srichumpa P, 2005, PLANT PHYSIOL, V139, P885, DOI 10.1104/pp.105.062406; von Burg S, 2011, BIOL LETTERS, V7, P387, DOI 10.1098/rsbl.2010.1147; von Burg S, 2010, BASIC APPL ECOL, V11, P257, DOI 10.1016/j.baae.2010.02.003; Vorburger C, 2005, EVOLUTION, V59, P1006; WALTERS DR, 1980, PHYSIOL PLANT PATHOL, V17, P369; WEIBULL J, 1987, ANN APPL BIOL, V111, P729, DOI 10.1111/j.1744-7348.1987.tb02031.x; Whitehouse MEA, 2007, AUST J AGR RES, V58, P273, DOI 10.1071/AR06100; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yardim EN, 1998, AGR ECOSYST ENVIRON, V70, P31, DOI 10.1016/S0167-8809(97)00160-6; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405	41	3	3	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46333	10.1371/journal.pone.0046333	http://dx.doi.org/10.1371/journal.pone.0046333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056284	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500035
J	Yessoufou, K; Daru, BH; Davies, TJ				Yessoufou, Kowiyou; Daru, Barnabas H.; Davies, T. Jonathan			Phylogenetic Patterns of Extinction Risk in the Eastern Arc Ecosystems, an African Biodiversity Hotspot	PLOS ONE			English	Article							CLIMATE-CHANGE; LIFE-HISTORY; TAXONOMIC SELECTIVITY; EVOLUTIONARY HISTORY; HABITAT LOSS; CONSERVATION; BIRDS; FUTURE; EARTHS; RATES	There is an urgent need to reduce drastically the rate at which biodiversity is declining worldwide. Phylogenetic methods are increasingly being recognised as providing a useful framework for predicting future losses, and guiding efforts for pre-emptive conservation actions. In this study, we used a reconstructed phylogenetic tree of angiosperm species of the Eastern Arc Mountains - an important African biodiversity hotspot - and described the distribution of extinction risk across taxonomic ranks and phylogeny. We provide evidence for both taxonomic and phylogenetic selectivity in extinction risk. However, we found that selectivity varies with IUCN extinction risk category. Vulnerable species are more closely related than expected by chance, whereas endangered and critically endangered species are not significantly clustered on the phylogeny. We suggest that the general observation for taxonomic and phylogenetic selectivity (i.e. phylogenetic signal, the tendency of closely related species to share similar traits) in extinction risks is therefore largely driven by vulnerable species, and not necessarily the most highly threatened. We also used information on altitudinal distribution and climate to generate a predictive model of at-risk species richness, and found that greater threatened species richness is found at higher altitude, allowing for more informed conservation decision making. Our results indicate that evolutionary history can help predict plant susceptibility to extinction threats in the hyper-diverse but woefully-understudied Eastern Arc Mountains, and illustrate the contribution of phylogenetic approaches in conserving African floristic biodiversity where detailed ecological and evolutionary data are often lacking.	[Yessoufou, Kowiyou; Daru, Barnabas H.] Univ Johannesburg, African Ctr DNA Barcoding, Johannesburg, Gauteng, South Africa; [Davies, T. Jonathan] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Johannesburg; McGill University	Yessoufou, K (corresponding author), Univ Johannesburg, African Ctr DNA Barcoding, Johannesburg, Gauteng, South Africa.	kyessoufou@uj.ac.za	Daru, Barnabas/B-4051-2011; Elansary, Hosam O./E-3684-2019	Daru, Barnabas/0000-0002-2115-0257; Elansary, Hosam O./0000-0002-4476-2408; Yessoufou, Prof. Kowiyou/0000-0002-4789-1723	University of Johannesburg through the African Centre for DNA Barcoding	University of Johannesburg through the African Centre for DNA Barcoding	The University of Johannesburg through the African Centre for DNA Barcoding provides financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bielby J, 2006, ANIM CONSERV, V9, P135, DOI 10.1111/j.1469-1795.2005.00013.x; Bland LM, 2012, DIVERS DISTRIB, V18, P1211, DOI 10.1111/j.1472-4642.2012.00914.x; Booth V, 2003, ENVIRON IMPACT ASSES; Bowie, 2003, THESIS U CAPE TOWN S; Bradshaw CJA, 2008, J ECOL, V96, P869, DOI 10.1111/j.1365-2745.2008.01408.x; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Burgess N., 2004, TERRESTRIAL ECOREGIO, P1; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Butchart SHM, 2010, BIOL CONSERV, V143, P239, DOI 10.1016/j.biocon.2009.10.008; Cardillo M, 2003, ANIM CONSERV, V6, P63, DOI 10.1017/S1367943003003093; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Cardillo M, 2012, TRENDS ECOL EVOL, V27, P167, DOI 10.1016/j.tree.2011.09.013; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Davenport TRB, 2006, SCIENCE, V312, P1378, DOI 10.1126/science.1125631; Davies TJ, 2012, ECOLOGY, V93, P242, DOI 10.1890/11-1360.1; Davies TJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000620; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; FJELDSA J, 1994, BIODIVERS CONSERV, V3, P207, DOI 10.1007/BF00055939; Freville H, 2007, ECOLOGY, V88, P2662, DOI 10.1890/06-1453.1; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Fuchs J, 2006, MOL PHYLOGENET EVOL, V39, P186, DOI 10.1016/j.ympev.2005.07.020; Gonzalez-Suarez M, 2012, J ANIM ECOL, V81, P1211, DOI 10.1111/j.1365-2656.2012.01999.x; Grandcolas P, 2011, CLADISTICS, V27, P181, DOI 10.1111/j.1096-0031.2010.00324.x; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huang S, 2012, BIOL LETTERS, V8, P222, DOI 10.1098/rsbl.2011.0752; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Huston MA, 2001, SCIENCE, V293, P1591, DOI 10.1126/science.293.5535.1591; *ICBP, 1992, PUTT BIOD MAP PRIOR; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; KINGDON J, 2005, BIOGEOGRAPHY ECOLOGY, P229; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Lindqvist Charlotte, 2001, Systematics and Geography of Plants, V71, P37, DOI 10.2307/3668751; Loader SP, 2004, ORG DIVERS EVOL, V4, P227, DOI 10.1016/j.ode.2004.01.005; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; LOVETT J C, 1990, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V23, P287; Lovett J. C., 1998, J E AFR NATURAL HIST, V87, P359, DOI DOI 10.2982/0012-8317(1998)87[359:ETACOE]2.0.CO;2; Lovett J.C., 1985, SWARA, V8, P8; Lovett J.C., 1988, MONOGRAPHS SYSTEMATI, V25, P591; LOVETT JC, 2004, PHYLOGENY CONSERVATI, P198; LOVETT JC, 2001, SCOPUS, V21, P1; Lovett JC, 1993, BIOGEOGRAPHY ECOLOGY, P33, DOI [10.1017/CBO9780511895692.004, 10.1017/CBO9780511895692, DOI 10.1017/CB09780511895692.004]; Lovett JC., 1998, J E AFRICAN NATURAL, V87, P59, DOI [10.2982/0012-8317(1998)87[59:ioteam]2.0.co;2, DOI 10.2982/0012-8317(1998)87[59:IOTEAM]2.0.CO;2, 10.2982/0012-8317(1998)87[59:IOTEAM]2.0.CO;2, DOI 10.2982/0012-8317(1998)87[]; Lozano FD, 2005, BIOL CONSERV, V126, P146, DOI 10.1016/j.biocon.2005.04.024; Mace G.M., 2005, ECOSYSTEMS HUMAN WEL, P77; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Masters JC, 2005, AM J PHYS ANTHROPOL, V127, P465, DOI 10.1002/ajpa.20149; Matthee CA, 2004, P ROY SOC B-BIOL SCI, V271, P1967, DOI 10.1098/rspb.2004.2806; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olwoch JM, 2007, ONDERSTEPOORT J VET, V74, P45, DOI 10.4102/ojvr.v74i1.139; Orme D, 2012, CAPER COMP ANAL PHYL; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Owens IPF, 1999, P ROY SOC B-BIOL SCI, V266, P933, DOI 10.1098/rspb.1999.0726; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PERKIN A, 2003, J E AFRICAN NATURAL, V91, P1; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Schwartz MW, 2001, ECOL LETT, V4, P464, DOI 10.1046/j.1461-0248.2001.00241.x; Sodhi NS, 2008, DIVERS DISTRIB, V14, P1, DOI 10.1111/j.1472-4642.2007.00398.x; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Thomas GH, 2008, P ROY SOC B-BIOL SCI, V275, P2077, DOI 10.1098/rspb.2008.0549; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106	88	24	24	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47082	10.1371/journal.pone.0047082	http://dx.doi.org/10.1371/journal.pone.0047082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056587	Green Published, gold			2022-12-27	WOS:000309831500134
J	Greenlee, AR; Shiao, MS; Snyder, E; Buaas, FW; Gu, TJ; Stearns, TM; Sharma, M; Murchison, EP; Puente, GC; Braun, RE				Greenlee, Anne R.; Shiao, Meng-Shin; Snyder, Elizabeth; Buaas, F. William; Gu, Tongjun; Stearns, Timothy M.; Sharma, Manju; Murchison, Elizabeth P.; Puente, Gabriella C.; Braun, Robert E.			Deregulated Sex Chromosome Gene Expression with Male Germ Cell-Specific Loss of Dicer1	PLOS ONE			English	Article							MESSENGER-RNA; MALE-INFERTILITY; MICRORNA; INACTIVATION; SPERMATOGENESIS; TRANSLATION; BIOGENESIS; REPRESSION; CHROMATIN; CLONING	MicroRNAs (miRNAs) are a class of endogenous, non-coding RNAs that mediate post-transcriptional gene silencing by inhibiting mRNA translation and promoting mRNA decay. DICER1, an RNase III endonuclease encoded by Dicer1, is required for processing short 21-22 nucleotide miRNAs from longer double-stranded RNA precursors. Here, we investigate the loss of Dicer1 in mouse postnatal male germ cells to determine how disruptions in the miRNA biogenesis pathway may contribute to infertility. Reduced levels of Dicer1 transcripts and DICER1 were confirmed in germ cell knock-out (GCKO) testes by postnatal day 18 (P18). Compared to wild-type (WT) at 8 weeks, GCKO males had no change in body weight; yet showed significant reductions in testis mass and sperm number. Histology and fertility tests confirmed spermatogenic failure in GCKO males. Array analyses at P18 showed that in comparison to WT testes, 75% of miRNA genes and 37% of protein coding genes were differentially expressed in GCKO testes. Among these, 96% of miRNA genes were significantly down-regulated, while 4% miRNA genes were overexpressed. Interestingly, we observed preferential overexpression of genes encoded on the sex chromosomes in GCKO testes, including more than 80% of previously identified targets of meiotic sex chromosome inactivation (MSCI). Compared to WT, GCKO mice showed higher percentages of germ cells at early meiotic stages (leptotene and zygotene) but lower percentages at later stages (pachytene, diplotene and metaphase I) providing evidence that deletion of Dicer1 leads to disruptions in meiotic progression. Therefore, deleting Dicer1 in early postnatal germ cells resulted in deregulation of transcripts encoded by genes on the sex chromosomes, impaired meiotic progression and led to spermatogenic failure and infertility.	[Greenlee, Anne R.; Shiao, Meng-Shin; Snyder, Elizabeth; Buaas, F. William; Gu, Tongjun; Stearns, Timothy M.; Sharma, Manju; Braun, Robert E.] Jackson Lab, Bar Harbor, ME 04609 USA; [Murchison, Elizabeth P.] Wellcome Trust Sanger Inst, Hinxton, England; [Puente, Gabriella C.] Yale Univ, New Haven, CT USA	Jackson Laboratory; Wellcome Trust Sanger Institute; Yale University	Greenlee, AR (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	anne.greenlee@jax.org	Gu, Tongjun/AAE-4801-2020	Murchison, Elizabeth Proby/0000-0001-7462-8907; Stearns, Timothy/0000-0002-5533-6076; Puente, Gabriella/0000-0001-7738-9710	National Institute of Child Health and Human Development/National Institutes of Health [HD027215-19, HD42454 (U54)]; Cancer Center [CA034196-26 (P30)]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD042454] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027215] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by The National Institute of Child Health and Human Development/National Institutes of Health Grants HD027215-19 and HD42454 (U54), entitled: Translational Control during Murine Spermatogenesis and Murine Spermatogonial Stem Cells, respectively. Both RO1s were awarded to REB. Funding for miRNA and mRNA arrays and data analysis was provided by the Cancer Center Support Grant CA034196-26 (P30). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; BRAUN RE, 1989, GENE DEV, V3, P793, DOI 10.1101/gad.3.6.793; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Cobb J, 1997, MOL REPROD DEV, V46, P489, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;489::AID-MRD7&gt;3.0.CO;2-K; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Inselman A, 2003, CYTOGENET GENOME RES, V103, P277, DOI 10.1159/000076813; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; La Salle S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095752; Liu DK, 2012, BIOCHEM BIOPH RES CO, V422, P114, DOI 10.1016/j.bbrc.2012.04.118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; MEISTRICH ML, 1978, FED PROC, V37, P2522; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nuti F, 2008, REPROD BIOMED ONLINE, V16, P504, DOI 10.1016/S1472-6483(10)60457-9; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stouffs K, 2009, HUM REPROD UPDATE, V15, P623, DOI 10.1093/humupd/dmp023; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Sun FY, 2010, DEVELOPMENT, V137, P1699, DOI 10.1242/dev.043125; Tong MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096313; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998	46	33	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46359	10.1371/journal.pone.0046359	http://dx.doi.org/10.1371/journal.pone.0046359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056286	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800016
J	Madin, JS; Hughes, TP; Connolly, SR				Madin, Joshua S.; Hughes, Terry P.; Connolly, Sean R.			Calcification, Storm Damage and Population Resilience of Tabular Corals under Climate Change	PLOS ONE			English	Article							GREAT-BARRIER-REEF; OCEAN ACIDIFICATION; CONSEQUENCES; RECRUITMENT; DIVERSITY; DYNAMICS; IMPACTS; TRENDS	Two facets of climate change-increased tropical storm intensity and ocean acidification-are expected to detrimentally affect reef-building organisms by increasing their mortality rates and decreasing their calcification rates. Our current understanding of these effects is largely based on individual organisms' short-term responses to experimental manipulations. However, predicting the ecologically-relevant effects of climate change requires understanding the longterm demographic implications of these organism-level responses. In this study, we investigate how storm intensity and calcification rate interact to affect population dynamics of the table coral Acropora hyacinthus, a dominant and geographically widespread ecosystem engineer on wave-exposed Indo-Pacific reefs. We develop a mechanistic framework based on the responses of individual-level demographic rates to changes in the physical and chemical environment, using a size-structured population model that enables us to rigorously incorporate uncertainty. We find that table coral populations are vulnerable to future collapse, placing in jeopardy many other reef organisms that are dependent upon them for shelter and food. Resistance to collapse is largely insensitive to predicted changes in storm intensity, but is highly dependent on the extent to which calcification influences both the mechanical properties of reef substrate and the colony-level trade-off between growth rate and skeletal strength. This study provides the first rigorous quantitative accounting of the demographic implications of the effects of ocean acidification and changes in storm intensity, and provides a template for further studies of climate-induced shifts in ecosystems, including coral reefs.	[Madin, Joshua S.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Hughes, Terry P.; Connolly, Sean R.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Connolly, Sean R.] James Cook Univ, Sch Marine Biol & Trop Biol, Townsville, Qld 4811, Australia	Macquarie University; James Cook University; James Cook University	Madin, JS (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	joshua.madin@mq.edu.au	Connolly, Sean R./E-7773-2011; Hughes, Terry P/L-4721-2013	Connolly, Sean R./0000-0003-1537-0859; Hughes, Terry P/0000-0002-5257-5063; Madin, Joshua/0000-0002-5005-6227	Australian Research Council [DP0987892]	Australian Research Council(Australian Research Council)	This work was funded by an Australian Research Council grant to JSM (DP0987892). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Annan JD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025259; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berumen ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P989, DOI 10.1007/s00265-007-0526-8; Cao L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035072; Caswell, 2000, MATRIX POPULATION MO; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Denny MW, 2010, ANNU REV MAR SCI, V2, P89, DOI 10.1146/annurev-marine-120308-081011; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; IPCC, 2007, CLIMATE CHANGE 2007; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C., 2002, P1091; Madin JS, 2008, BIOL LETTERS, V4, P490, DOI 10.1098/rsbl.2008.0249; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Madin JS, 2006, CORAL REEFS, V25, P635, DOI 10.1007/s00338-006-0137-2; Madin JS, 2012, J EXP BIOL, V215, P968, DOI 10.1242/jeb.061002; Madin JS, 2005, CORAL REEFS, V24, P630, DOI 10.1007/s00338-005-0042-0; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Marshall JF, 1985, P 5 INT COR REEF S, V3, P221; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; MASSEL SR, 1993, CORAL REEFS, V12, P153, DOI 10.1007/BF00334475; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pratchett MS, 2008, CORAL REEFS, V27, P541, DOI 10.1007/s00338-008-0357-8; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; STIMSON J, 1985, ECOLOGY, V66, P40, DOI 10.2307/1941305; Veron JEN, 1984, AUSTR I MARINE SCI M; Wakeford M, 2008, CORAL REEFS, V27, P1, DOI 10.1007/s00338-007-0284-0; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585	50	65	65	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46637	10.1371/journal.pone.0046637	http://dx.doi.org/10.1371/journal.pone.0046637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056379	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800034
J	Xu, WW; Mezencev, R; Kim, B; Wang, LJ; McDonald, J; Sulchek, T				Xu, Wenwei; Mezencev, Roman; Kim, Byungkyu; Wang, Lijuan; McDonald, John; Sulchek, Todd			Cell Stiffness Is a Biomarker of the Metastatic Potential of Ovarian Cancer Cells	PLOS ONE			English	Article							CYTOSKELETAL STRUCTURE; BREAST-CANCER; MECHANICS; DEFORMABILITY; BIOMECHANICS; ORGANIZATION; TWINFILIN	The metastatic potential of cells is an important parameter in the design of optimal strategies for the personalized treatment of cancer. Using atomic force microscopy (AFM), we show, consistent with previous studies conducted in other types of epithelial cancer, that ovarian cancer cells are generally softer and display lower intrinsic variability in cell stiffness than non-malignant ovarian epithelial cells. A detailed examination of highly invasive ovarian cancer cells (HEY A8) relative to their less invasive parental cells (HEY), demonstrates that deformability is also an accurate biomarker of metastatic potential. Comparative gene expression analyses indicate that the reduced stiffness of highly metastatic HEY A8 cells is associated with actin cytoskeleton remodeling and microscopic examination of actin fiber structure in these cell lines is consistent with this prediction. Our results indicate that cell stiffness may be a useful biomarker to evaluate the relative metastatic potential of ovarian and perhaps other types of cancer cells.	[Xu, Wenwei; Sulchek, Todd] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Mezencev, Roman; Wang, Lijuan; McDonald, John; Sulchek, Todd] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kim, Byungkyu; Sulchek, Todd] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Sulchek, T (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	todd.sulchek@me.gatech.edu	Xu, Wenwei/L-7693-2014; Mezencev, Roman/A-8573-2009; Xu, Wenwei/C-2490-2015; Mezencev, Roman/O-8489-2019	Mezencev, Roman/0000-0003-4361-7628; McDonald, John F/0000-0002-4263-8155	NSF [CBET-0932510]; President's Undergraduate Research Award (PURA) program; Petit Scholars Program at Georgia Tech	NSF(National Science Foundation (NSF)); President's Undergraduate Research Award (PURA) program; Petit Scholars Program at Georgia Tech	The authors thank NSF (project number CBET-0932510) for financial support of this project. The authors also thank the President's Undergraduate Research Award (PURA) program and Petit Scholars Program at Georgia Tech for providing funding to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; Bercoff J, 2003, ULTRASOUND MED BIOL, V29, P1387, DOI 10.1016/S0301-5629(03)00978-5; Bhadriraju K, 2002, EXP CELL RES, V278, P92, DOI 10.1006/excr.2002.5557; Bhoola S, 2006, OBSTET GYNECOL, V107, P1399, DOI 10.1097/01.AOG.0000220516.34053.48; BOSCH FH, 1994, EUR J HAEMATOL, V52, P35; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; ELSON EL, 1988, ANNU REV BIOPHYS BIO, V17, P397; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; FRIEDMAN E, 1984, CANCER RES, V44, P3040; Fuhrmann A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015007; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/nnano.2009.77, 10.1038/NNANO.2009.77]; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson K.L, 1985, CONTACT MECH, DOI DOI 10.1017/CBO9781139171731; KATSANTONIS J, 1994, CELL BIOCHEM FUNCT, V12, P267, DOI 10.1002/cbf.290120407; Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Lekka M, 2009, NAT NANOTECHNOL, V4, P72, DOI 10.1038/nnano.2009.004; Marquez JP, 2006, INT J SOLIDS STRUCT, V43, P6413, DOI 10.1016/j.ijsolstr.2005.11.003; McKnight AL, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781411; MILLS GB, 1990, J CLIN INVEST, V86, P851, DOI 10.1172/JCI114784; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; Mott A, 2009, J CELL PHYSIOL, V218, P315, DOI 10.1002/jcp.21606; Moustakas A, 1999, J CELL SCI, V112, P1169; Palmgren S, 2002, J CELL SCI, V115, P881; Rao JY, 2004, CURR CANCER DRUG TAR, V4, P345, DOI 10.2174/1568009043332998; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Rosenbluth MJ, 2008, LAB CHIP, V8, P1062, DOI 10.1039/b802931h; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Schafer A, 2005, ACTA BIOMATER, V1, P273, DOI 10.1016/j.actbio.2005.02.004; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Shi W, 2010, PHARMACOGENOMICS J, V10, P310, DOI 10.1038/tpj.2010.35; Sokolov I, 2007, CANCER NANOTECHNOL; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Suresh S, 2007, NAT NANOTECHNOL, V2, P748, DOI 10.1038/nnano.2007.397; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Team RDC, 2009, R LANG ENV STAT COMP; Tian Q, 2012, J INTERN MED, V271, P111, DOI 10.1111/j.1365-2796.2011.02498.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; WILLIAMSON JR, 1985, BLOOD, V65, P283; WORTHEN GS, 1989, SCIENCE, V245, P183, DOI 10.1126/science.2749255; Xu WW, 2011, LANGMUIR, V27, P8470, DOI 10.1021/la201122e; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	51	463	472	10	182	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46609	10.1371/journal.pone.0046609	http://dx.doi.org/10.1371/journal.pone.0046609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056368	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800032
J	Liu, ML; Wang, GD; Gomez-Fernandez, CR; Guo, SC				Liu, Mingli; Wang, Guangdi; Gomez-Fernandez, Carmen R.; Guo, Shanchun			RETRACTED: GREB1 Functions as a Growth Promoter and Is Modulated by IL6/STAT3 in Breast Cancer (Retracted article. See vol. 9, e102287, 2014)	PLOS ONE			English	Article; Retracted Publication							ESTROGEN-RECEPTOR-ALPHA; NF-KAPPA-B; ENDOCRINE THERAPY; TAMOXIFEN RESISTANCE; EXPRESSION SIGNATURE; RANDOMIZED-TRIAL; MICROARRAY DATA; CROSS-TALK; FOLLOW-UP; HORMONE	Background: Growth Regulation by Estrogen in Breast cancer (GREB1) was an estrogen receptor (ER) target gene, and GREB1 expression inversely correlated with HER2 status, possibly as a surrogate marker for ER status and a predictor for tamoxifen resistance in breast cancer patients. In the present study, we examine the function and regulation of GREB1 in breast cancer, with the goal to develop GREB1 as a biomarker in breast cancer with de novo and acquired tamoxifen resistance. Methods: We overexpressed GREB1 using adenovirus containing the full length GREB1 cDNA (Ad-GREB1) in breast cancer cell lines. The soft agar assay was used as a measure of anchorage independent growth. The effects of GREB1 on cell proliferation in MCF-7 cells transduced with Ad-GREB1 were also measured by the me olic activity using AlamarBlue assay. We tested whether there was interaction between STAT3 and ER, which could repress GREB1 expression by immunoprecipitation assay. The effects of IL-6/JAK/STAT3 cascade activation on estrogen-induced GREB1 promoter activity were determined by luciferase assay and those on gene expression were measured by real time reverse transcription polymerase chain reaction (qRT-PCR). Results: We found that the ability of breast cancer cells to grow in soft agar is enhanced following GREB1 transfection. In MCF-7 cells transduced with Ad-GREB1 or transfected with siRNA GREB1, the metabolic activity was increased or completely abolished, suggesting that GREB1 may function as a growth promoter in breast cancer. E2 treatment increased GREB1 promoter luciferase activity. IL-6 inhibited E2-induced GREB1 transcription activity and GREB1 mRNA expression. Constitutively expressing active STAT3 construct (STAT3-C) dramatically decreased GREB1 transcription. Conclusions: These data indicate that overexpression of GREB1 promotes cell proliferation and increases the clonogenic ability in breast cancer cells. Moreover, Il6/STAT3 modulates estrogen-induced GREB1 transcriptional activity in breast cancer cells.	[Liu, Mingli; Guo, Shanchun] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Wang, Guangdi] Xavier Univ Louisiana, Dept Chem, New Orleans, LA USA; [Liu, Mingli; Gomez-Fernandez, Carmen R.] Univ Miami Sch Med, Dept Med, Dept Pathol, Miami, FL USA	Morehouse School of Medicine; Xavier University of Louisiana; University of Miami	Liu, ML (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	mliu@msm.edu; gwang@xula.edu; sguo@msm.edu			Woman's Cancer Association of the University of Miami; RCMI grant [5G12RR026260]; Imaging Core at the University of Miami; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR026260] Funding Source: NIH RePORTER	Woman's Cancer Association of the University of Miami; RCMI grant; Imaging Core at the University of Miami; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partly supported by a grant from the Woman's Cancer Association of the University of Miami awarded to ML and RCMI grant 5G12RR026260 to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Imaging Core at the University of Miami for providing access to Zeiss LSM 510 confocal microscope and study support.	BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; CLARK GM, 1983, BREAST CANCER RES TR, V3, P157, DOI 10.1007/BF01803558; Clarke R, 2001, PHARMACOL REV, V53, P25; DANFORTH DN, 1993, CANCER RES, V53, P1538; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; Fennessy M, 2004, BRIT J SURG, V91, P699, DOI 10.1002/bjs.4603; Fernandes A, 1999, INT J CANCER, V83, P564, DOI 10.1002/(SICI)1097-0215(19991112)83:4<564::AID-IJC20>3.0.CO;2-Q; Gee JM, 2005, ENDOCR-RELAT CANCER, V12, pS99, DOI 10.1677/erc.1.01005; Ghosh MG, 2000, CANCER RES, V60, P6367; Ginestier C, 2006, CLIN CANCER RES, V12, P4533, DOI 10.1158/1078-0432.CCR-05-2339; Goetz MP, 2008, CLIN CANCER RES, V14, P5864, DOI 10.1158/1078-0432.CCR-08-0619; Goetz MP, 2006, CLIN CANCER RES, V12, P2080, DOI 10.1158/1078-0432.CCR-05-1263; Gupta N, 2012, CELL SIGNAL, V24, P151, DOI 10.1016/j.cellsig.2011.08.016; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Henriksen KL, 2008, ACTA ONCOL, V47, P795, DOI 10.1080/02841860802026993; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hnatyszyn HJ, 2010, BREAST CANCER RES TR, V122, P371, DOI 10.1007/s10549-009-0584-x; HOROBIN JM, 1991, BRIT J SURG, V78, P213, DOI 10.1002/bjs.1800780228; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Ingle JN, 2006, BREAST CANCER RES TR, V98, P217, DOI 10.1007/s10549-005-9152-1; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; JORDAN VC, 1988, CRC CR REV CL LAB SC, V26, P97, DOI 10.3109/10408368809106860; Lippman Marc E, 2008, Trans Am Clin Climatol Assoc, V119, P77; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nedergaard L, 1996, PATHOL RES PRACT, V192, P983, DOI 10.1016/S0344-0338(96)80039-2; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Osborne CK, 2005, BREAST, V14, P458, DOI 10.1016/j.breast.2005.08.024; Rae JM, 2006, PROSTATE, V66, P886, DOI 10.1002/pros.20403; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Riggins RB, 2008, CANCER RES, V68, P8908, DOI 10.1158/0008-5472.CAN-08-2669; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Singer CF, 2008, BBA-REV CANCER, V1786, P105, DOI 10.1016/j.bbcan.2008.02.003; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vendrell JA, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2158; Wang Y, 2004, FEBS LETT, V572, P238, DOI 10.1016/j.febslet.2004.06.098; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wilson BJ, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-49; Yamamoto T, 2000, FEBS LETT, V486, P143, DOI 10.1016/S0014-5793(00)02296-1; Yamashita H, 2008, INT J CLIN ONCOL, V13, P380, DOI 10.1007/s10147-008-0818-7; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59	62	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46410	10.1371/journal.pone.0046410	http://dx.doi.org/10.1371/journal.pone.0046410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056300	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000039
J	Takahashi, M; Cuatrecasas, M; Balaguer, F; Hur, K; Toiyama, Y; Castells, A; Boland, CR; Goel, A				Takahashi, Masanobu; Cuatrecasas, Miriam; Balaguer, Francesc; Hur, Keun; Toiyama, Yuji; Castells, Antoni; Boland, C. Richard; Goel, Ajay			The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer	PLOS ONE			English	Article							MICRORNA EXPRESSION; COLON-CANCER; BREAST-CANCER; MICROSATELLITE-INSTABILITY; ADJUVANT THERAPY; TUMOR-SUPPRESSOR; MISMATCH REPAIR; SOLID TUMORS; METASTASIS; SURVIVAL	Aim: Development of robust prognostic and/or predictive biomarkers in patients with colorectal cancer (CRC) is imperative for advancing treatment strategies for this disease. We aimed to determine whether expression status of certain miRNAs might have prognostic/predictive value in CRC patients treated with conventional cytotoxic chemotherapies. Methods: We studied a cohort of 273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy. In a screening set (n = 44), 13 of 21 candidate miRNAs were successfully quantified by multiplex quantitative RT-PCR. In the validation set comprising of the entire patient cohort, miR-148a expression status was assessed by quantitative RT-PCR, and its promoter methylation was quantified by bisulfite pyrosequencing. Lastly, we analyzed the associations between miR-148a expression and patient survival. Results: Among the candidate miRNAs studied, miR-148a expression was most significantly down-regulated in advanced CRC tissues. In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS), a worse therapeutic response, and poor overall survival (OS). Furthermore, miR-148a methylation status correlated inversely with its expression, and was associated with worse survival in stage IV CRC. In multivariate analysis, miR-148a expression was an independent prognostic/predictive biomarker for advanced CRC patients (DFS in stage III, low vs. high expression, HR 2.11; OS in stage IV, HR 1.93). Discussion: MiR-148a status has a prognostic/predictive value in advanced CRC patients treated with conventional chemotherapy, which has important clinical implications in improving therapeutic strategies and personalized management of this malignancy.	[Takahashi, Masanobu; Hur, Keun; Toiyama, Yuji; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Baylor Res Inst, Dallas, TX USA; [Takahashi, Masanobu; Hur, Keun; Toiyama, Yuji; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA; [Cuatrecasas, Miriam] Univ Barcelona, Dept Pathol, CDB,Biobank Hosp Clin, Tumour Bank,Hosp Clin,Inst Invest Biomed August P, Barcelona, Spain; [Balaguer, Francesc; Castells, Antoni] Univ Barcelona, Dept Gastroenterol, Hosp Clin,IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Boland, CR (corresponding author), Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Baylor Res Inst, Dallas, TX USA.	rickbo@baylorhealth.edu; ajay.goel@baylorhealth.edu	Castells, Antoni/ABC-1002-2021; Balaguer, Francesc/GPX-7801-2022; Cuatrecasas, Miriam/C-9156-2019; BALAGUER, FRANCESC/G-2389-2016	Castells, Antoni/0000-0001-8431-2033; Cuatrecasas, Miriam/0000-0003-3063-0110; Balaguer, Francesc/0000-0002-0206-0539; Goel, Ajay/0000-0003-1396-6341; Hur, Keun/0000-0002-6944-2718	National Cancer Institute, National Institutes of Health [R01 CA72851, CA129286]; Baylor Research Institute; Ministerio de Ciencia e Innovacion [SAF2010-19273]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009 SGR 849]; Fundacion Mutua Madrilena [AP7901-2010]; XBTC; BT; Biobanc; NATIONAL CANCER INSTITUTE [R01CA129286, R01CA072851] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); XBTC; BT; Biobanc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants R01 CA72851 and CA129286 from the National Cancer Institute, National Institutes of Health, by funds from the Baylor Research Institute (CRB and AG), and by grants from the Ministerio de Ciencia e Innovacion (SAF2010-19273), Agencia de Gestio d'Ajuts Universitaris i de Recerca (2009 SGR 849; AC), and Fundacion Mutua Madrilena (AP7901-2010; MC), XBTC, BT, Biobanc. MT was partially supported by a grant from the Cell Science Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bohanes P, 2011, CLIN COLORECTAL CANC, V10, P157, DOI 10.1016/j.clcc.2011.03.024; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cha ST, 2010, CANCER RES, V70, P2675, DOI 10.1158/0008-5472.CAN-09-2448; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hummel R, 2011, J GASTROINTEST SURG, V15, P429, DOI 10.1007/s11605-011-1418-9; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Jover R, 2011, GASTROENTEROLOGY, V140, P1174, DOI 10.1053/j.gastro.2010.12.035; Kalimutho M, 2011, BRIT J CANCER, V104, P1770, DOI 10.1038/bjc.2011.82; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Koopman M, 2009, EUR J CANCER, V45, P1935, DOI 10.1016/j.ejca.2009.04.023; Langer C, 2008, BLOOD, V111, P5371, DOI 10.1182/blood-2007-11-124958; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Liffers ST, 2011, LAB INVEST, V91, P1472, DOI 10.1038/labinvest.2011.99; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Michael MZ, 2003, MOL CANCER RES, V1, P882; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van Rijnsoever M, 2003, CLIN CANCER RES, V9, P2898; Van Schaeybroeck S, 2011, NAT REV CLIN ONCOL, V8, P222, DOI 10.1038/nrclinonc.2011.15; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Zhang H, 2011, CELL DEATH DIFFER	49	132	139	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46684	10.1371/journal.pone.0046684	http://dx.doi.org/10.1371/journal.pone.0046684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056401	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000074
J	Wang, F; Xing, T; Li, JH; Bai, M; Hu, RM; Zhao, ZH; Tian, SF; Zhang, ZG; Wang, NS				Wang, Feng; Xing, Tao; Li, Junhui; Bai, Mei; Hu, Ruimin; Zhao, Zhonghua; Tian, Shoufu; Zhang, Zhigang; Wang, Niansong			Renalase's Expression and Distribution in Renal Tissue and Cells	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE; TRANSPLANT RECIPIENTS; CARDIOVASCULAR FUNCTION; MONOCLONAL-ANTIBODY; DNA VACCINES; HYPERTENSION; ENZYME; DENERVATION; DOPAMINE	To study renalase's expression and distribution in renal tissues and cells, renalase coded DNA vaccine was constructed, and anti-renalase monoclonal antibodies were produced using DNA immunization and hybridoma technique, followed by further investigation with immunological testing and western blotting to detect the expression and distribution of renalase among the renal tissue and cells. Anti-renalase monoclonal antibodies were successfully prepared by using DNA immunization technique. Further studies with anti-renalase monoclonal antibody showed that renalase expressed in glomeruli, tubule, mesangial cells, podocytes, renal tubule epithelial cells and its cells supernatant. Renalase is wildly expressed in kidney, including glomeruli, tubule, mesangial cells, podocytes and tubule epithelial cells, and may be secreted by tubule epithelial cells primarily.	[Wang, Feng; Li, Junhui; Bai, Mei; Tian, Shoufu; Wang, Niansong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200030, Peoples R China; [Xing, Tao] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Hu, Ruimin; Zhao, Zhonghua; Zhang, Zhigang] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Fudan University	Wang, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200030, Peoples R China.	zyzwq1030@163.com; wangniansong2008@163.com			Project of National Nature Science Foundation of China [81100528]; Program for Excellent Young Talents of Shanghai Sixth People's Hospital [1402]; Shanghai Sixth People's Hospital Consortium Subject [1423]; Shanghai Committee of Science and Technology Research Project [114119a6100]	Project of National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Excellent Young Talents of Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital Consortium Subject; Shanghai Committee of Science and Technology Research Project	The research is supported by grant 81100528 from the Project of National Nature Science Foundation of China, Program for Excellent Young Talents of Shanghai Sixth People's Hospital (1402), Shanghai Sixth People's Hospital Consortium Subject (1423), and Shanghai Committee of Science and Technology Research Project (114119a6100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian C, 2009, VIROLOGY, V383, P39, DOI 10.1016/j.virol.2008.09.029; Bian C, 2010, ACTA BIOCH BIOPH SIN, V42, P847, DOI 10.1093/abbs/gmq099; Boomsma F, 2007, J NEURAL TRANSM, V114, P775, DOI 10.1007/s00702-007-0672-1; Buraczynska M, 2011, NEUROMOL MED, V13, P321, DOI 10.1007/s12017-011-8158-6; Chen JJ, 2005, VACCINE, V23, P4322, DOI 10.1016/j.vaccine.2005.03.035; Desir G, 2012, PEDIATR NEPHROL, V27, P719, DOI 10.1007/s00467-011-1828-7; Desir GV, 2008, CURR OPIN NEPHROL HY, V17, P181, DOI 10.1097/MNH.0b013e3282f521ba; Desir GV, 2011, CURR OPIN NEPHROL HY, V20, P31, DOI 10.1097/MNH.0b013e3283412721; Desir GV, 2007, J AM SOC HYPERTENS, V1, P99, DOI 10.1016/j.jash.2006.12.001; Desir GV, 2009, KIDNEY INT, V76, P366, DOI 10.1038/ki.2009.169; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013496; Garren H, 2009, EXPERT REV VACCINES, V8, P1195, DOI 10.1586/ERV.09.83; Ghosh SS, 2009, PEDIATR NEPHROL, V24, P367, DOI 10.1007/s00467-008-0978-8; Gu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014633; Hennebry SC, 2010, MOL PSYCHIATR, V15, P234, DOI 10.1038/mp.2009.74; Jiang WH, 2012, EXP THER MED, V4, P493, DOI 10.3892/etm.2012.616; Li G, 2008, CIRCULATION, V117, P1277, DOI 10.1161/CIRCULATIONAHA.107.732032; Malyszko J, 2011, TRANSPL P, V43, P3004, DOI 10.1016/j.transproceed.2011.08.032; Malyszko J, 2012, RENAL FAILURE, V34, P727, DOI 10.3109/0886022X.2012.681534; Medvedev AE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P951, DOI 10.1134/S0006297910080018; Milani M, 2011, J MOL BIOL, V411, P463, DOI 10.1016/j.jmb.2011.06.010; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Pandini V, 2010, PROTEIN EXPRES PURIF, V72, P244, DOI 10.1016/j.pep.2010.03.008; Paulis L, 2010, NAT REV CARDIOL, V7, P431, DOI 10.1038/nrcardio.2010.85; Przybylowski P, 2011, TRANSPL P, V43, P3888, DOI 10.1016/j.transproceed.2011.08.075; Schlaich MP, 2009, J AM SOC NEPHROL, V20, P933, DOI 10.1681/ASN.2008040402; Stec A, 2011, NEPHROL DIAL TRANSPL; Tang CK, 2009, EXPERT REV VACCINES, V8, P1161, DOI [10.1586/erv.09.79, 10.1586/ERV.09.79]; Wang F, 2011, CLIN KIDNEY J, V4, DOI 10.1093/ndtplus/sfr021; Wang Feng, 2010, Journal of Shanghai Jiaotong University (English Edition), V15, P637, DOI 10.1007/s12204-010-1061-8; Wang Feng, 2009, Journal of Shanghai Jiaotong University (English Edition), V14, P376, DOI 10.1007/s12204-009-0376-9; Wang J, 2008, MOL BIOL REP, V35, P613, DOI 10.1007/s11033-007-9131-1; Weinman EJ, 2011, AM J PHYSIOL-RENAL, V300, pF1123, DOI 10.1152/ajprenal.00744.2010; Wu YL, 2011, KIDNEY INT, V79, P853, DOI 10.1038/ki.2010.488; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Xu JC, 2007, CURR OPIN NEPHROL HY, V16, P373, DOI 10.1097/MNH.0b013e3281bd8877; Zbroch E, 2012, KIDNEY BLOOD PRESS R, V35, P395, DOI 10.1159/000338178; Zbroch E, 2012, PERITON DIALYSIS INT, V32, P348, DOI 10.3747/pdi.2011.00118; Zbroch E, 2012, POL ARCH MED WEWN, V122, P40, DOI 10.20452/pamw.1132; Zhao Q, 2007, J MOL MED, V85, P877, DOI 10.1007/s00109-006-0151-4; Zhou T, 2003, ACTA BIOCH BIOPH SIN, V35, P172	42	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46442	10.1371/journal.pone.0046442	http://dx.doi.org/10.1371/journal.pone.0046442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056310	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000044
J	Xie, H; Zhao, YG; Caramuta, S; Larsson, C; Lui, WO				Xie, Hong; Zhao, Yungang; Caramuta, Stefano; Larsson, Catharina; Lui, Weng-Onn			miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; INTEGRIN-LINKED KINASE; MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; MESENCHYMAL TRANSITION; CYR61 SUPPRESSES; FACTOR CTGF/CCN2; DOWN-REGULATION; CCN FAMILY; CARCINOMA	MicroRNAs (miRNAs) are short non-coding RNA regulators that control gene expression mainly through post-transcriptional silencing. We previously identified miR-205 in a signature for human cervical cancer using a deep sequencing approach. In this study, we confirmed that miR-205 expression was frequently higher in human cervical cancer than their matched normal tissue samples. Functionally, we demonstrate that miR-205 promotes cell proliferation and migration in human cervical cancer cells. To further understand the biological roles of miR-205, we performed in vivo crosslinking and Argonaute 2 immunoprecipitation of miRNA ribonucleoprotein complexes followed by microarray analysis (CLIP-Chip) to identify its potential mRNA targets. Applying CLIP-Chip on gain- and loss-of-function experiments, we identified a set of transcripts as potential targets of miR-205. Several targets are functionally involved in cellular proliferation and migration. Two of them, CYR61 and CTGF, were further validated by Western blot analysis and quantification of mRNA enrichment in the Ago2 immunoprecipitates using qRT-PCR. Furthermore, both CYR61 and CTGF were downregulated in cervical cancer tissues. In summary, our findings reveal novel functional roles and targets of miR-205 in human cervical cancer, which may provide new insights about its role in cervical carcinogenesis and its potential value for clinical diagnosis.	[Xie, Hong; Zhao, Yungang; Caramuta, Stefano; Larsson, Catharina; Lui, Weng-Onn] Karolinska Inst, Dept Mol Med & Surg, Canc Ctr Karolinska, Stockholm, Sweden; [Zhao, Yungang] Tianjin Sport Univ, Tianjin Key Lab Exercise Physiol & Sports Med, Tianjin, Peoples R China	Karolinska Institutet; Tianjin University of Sport	Xie, H (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Canc Ctr Karolinska, Stockholm, Sweden.	hong.xie@ki.se; weng-onn.lui@ki.se	Lui, Weng-Onn/X-5957-2019; Lui, Weng-Onn/G-6703-2013	Lui, Weng-Onn/0000-0003-4717-4473; Lui, Weng-Onn/0000-0003-4717-4473	Swedish Research Council [523-2009-3517, 521-2010-3518]; Ake Olsson's Foundation for Haematological Research; Swedish Cancer Foundation; Ake Wiberg's Foundation; King Gustaf V Jubilee Fund; Cancer Society in Stockholm; Axel and Signe Lagerman's Donation Foundation; Karolinska Institutet; Stockholm County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Olsson's Foundation for Haematological Research; Swedish Cancer Foundation; Ake Wiberg's Foundation; King Gustaf V Jubilee Fund; Cancer Society in Stockholm; Axel and Signe Lagerman's Donation Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	This work was supported by the Swedish Research Council (523-2009-3517, 521-2010-3518); the Ake Olsson's Foundation for Haematological Research; the Swedish Cancer Foundation; the Ake Wiberg's Foundation; King Gustaf V Jubilee Fund; Cancer Society in Stockholm; the Axel and Signe Lagerman's Donation Foundation; Karolinska Institutet and Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERSPERG N, 1962, J NATL CANCER I, V28, P605; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Chien W, 2006, MOL CANCER RES, V4, P591, DOI 10.1158/1541-7786.MCR-06-0029; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; Chuang JY, 2011, INT IMMUNOPHARMACOL, V11, P948, DOI 10.1016/j.intimp.2011.02.008; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Crean JK, 2006, FASEB J, V20, P1712, DOI 10.1096/fj.05-5010fje; Cui L, 2011, TUMOR BIOL, V32, P721, DOI 10.1007/s13277-011-0173-6; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Dhar A., 2010, Experimental Oncology, V32, P2; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Feng P, 2008, INT J BIOCHEM CELL B, V40, P98, DOI 10.1016/j.biocel.2007.06.020; FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543; Fromigue O, 2011, J BONE MINER RES, V26, P1533, DOI 10.1002/jbmr.343; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Goodwin CR, 2010, CANCER RES, V70, P2932, DOI 10.1158/0008-5472.CAN-09-3570; Gore-Hyer E, 2002, AM J PHYSIOL-RENAL, V283, pF707, DOI 10.1152/ajprenal.00007.2002; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hirschfeld M, 2009, CANCER RES, V69, P2082, DOI 10.1158/0008-5472.CAN-08-1997; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kikuchi R, 2007, CANCER RES, V67, P7095, DOI 10.1158/0008-5472.CAN-06-4567; Ladwa R, 2011, J CLIN PATHOL, V64, P58, DOI 10.1136/jcp.2010.082768; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Li MH, 2008, MOL CANCER RES, V6, P1649, DOI 10.1158/1541-7786.MCR-07-2048; Liu BC, 2008, AM J NEPHROL, V28, P143, DOI 10.1159/000110019; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Mao ZF, 2011, CANCER SCI, V102, P104, DOI 10.1111/j.1349-7006.2010.01746.x; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mullis TC, 2008, J CLIN PATHOL, V61, P606, DOI 10.1136/jcp.2007.052795; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Song HS, 2009, BIOCHEM BIOPH RES CO, V388, P400, DOI 10.1016/j.bbrc.2009.08.020; Song JY, 2008, INT J GYNECOL CANCER, V18, P1051, DOI 10.1111/j.1525-1438.2007.01164.x; SYKES JA, 1970, J NATL CANCER I, V45, P107; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Tong XJ, 2001, J BIOL CHEM, V276, P47709, DOI 10.1074/jbc.M107878200; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Xie D, 2001, CANCER RES, V61, P8917; Yao Q, 2009, BIOCHEM BIOPH RES CO, V388, P539, DOI 10.1016/j.bbrc.2009.08.044; Yeung CLA, 2011, ONCOGENE, V30, P2401, DOI 10.1038/onc.2010.613; Yin D, 2010, INT J CANCER, V127, P2257, DOI 10.1002/ijc.25257; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	62	83	89	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46990	10.1371/journal.pone.0046990	http://dx.doi.org/10.1371/journal.pone.0046990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056551	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000107
J	Dematheis, F; Kurtz, B; Vidal, S; Smalla, K				Dematheis, Flavia; Kurtz, Benedikt; Vidal, Stefan; Smalla, Kornelia			Microbial Communities Associated with the Larval Gut and Eggs of the Western Corn Rootworm	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; VERTICAL TRANSMISSION; PLATASPID STINKBUG; RIBOSOMAL-RNA; BACTERIA; RHIZOSPHERE; POPULATIONS; COLEOPTERA; WOLBACHIA; MAIZE	Background: The western corn rootworm (WCR) is one of the economically most important pests of maize. A better understanding of microbial communities associated with guts and eggs of the WCR is required in order to develop new pest control strategies, and to assess the potential role of the WCR in the dissemination of microorganisms, e. g., mycotoxin-producing fungi. Methodology/Principal Findings: Total community (TC) DNA was extracted from maize rhizosphere, WCR eggs, and guts of larvae feeding on maize roots grown in three different soil types. Denaturing gradient gel electrophoresis (DGGE) and sequencing of 16S rRNA gene and ITS fragments, PCR-amplified from TC DNA, were used to investigate the fungal and bacterial communities, respectively. Microorganisms in the WCR gut were not influenced by the soil type. Dominant fungal populations in the gut were affiliated to Fusarium spp., while Wolbachia was the most abundant bacterial genus. Identical ribosomal sequences from gut and egg samples confirmed a transovarial transmission of Wolbachia sp. Betaproteobacterial DGGE indicated a stable association of Herbaspirillum sp. with the WCR gut. Dominant egg-associated microorganisms were the bacterium Wolbachia sp. and the fungus Mortierella gamsii. Conclusion/Significance: The soil type-independent composition of the microbial communities in the WCR gut and the dominance of only a few microbial populations suggested either a highly selective environment in the gut lumen or a high abundance of intracellular microorganisms in the gut epithelium. The dominance of Fusarium species in the guts indicated WCR larvae as vectors of mycotoxin-producing fungi. The stable association of Herbaspirillum sp. with WCR gut systems and the absence of corresponding sequences in WCR eggs suggested that this bacterium was postnatally acquired from the environment. The present study provided new insights into the microbial communities associated with larval guts and eggs of the WCR. However, their biological role remains to be explored.	[Kurtz, Benedikt; Vidal, Stefan] Univ Gottingen, Dept Crop Sci, Gottingen, Germany; [Dematheis, Flavia; Smalla, Kornelia] Julius Kuhn Inst Fed Res Ctr Cultivated Plants JK, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany	University of Gottingen; Julius Kuhn-Institut	Vidal, S (corresponding author), Univ Gottingen, Dept Crop Sci, Gottingen, Germany.	svidal@gwdg.de	Vidal, Stefan/AAC-3130-2020; Dematheis, Flavia/GRS-2490-2022; Smalla, Kornelia/H-4002-2011	Vidal, Stefan/0000-0002-1673-4055; 	Deutsche Forschungsgemeinschaft DFG [SM59/7-1, Vi117/17-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft DFG project SM59/7-1 and Vi117/17-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2003, VET PARASITOL, V115, P125, DOI 10.1016/S0304-4017(03)00203-6; Balsanelli E, 2010, ENVIRON MICROBIOL, V12, P2233, DOI 10.1111/j.1462-2920.2010.02187.x; Barr KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011339; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Belda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021751; BRAND JM, 1975, NATURE, V254, P136, DOI 10.1038/254136a0; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Brune A., 2003, ENCY INSECTS, P1102; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL, P909; Clark TL, 2001, ANN ENTOMOL SOC AM, V94, P877, DOI 10.1603/0013-8746(2001)094[0877:OOWISD]2.0.CO;2; Costa R, 2006, ENVIRON MICROBIOL, V8, P2136, DOI 10.1111/j.1462-2920.2006.01096.x; Dasch GA, 1984, BERGEYS MANUAL SYSTE, V1, P811; Dematheis F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037288; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2007, TRENDS BIOTECHNOL, V25, P338, DOI 10.1016/j.tibtech.2007.06.003; EUTICK ML, 1978, APPL ENVIRON MICROB, V35, P823, DOI 10.1128/AEM.35.5.823-828.1978; FISCHER K, 1995, CAN J MICROBIOL, V41, P666, DOI 10.1139/m95-092; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; GILLIKIN JW, 1992, ARCH INSECT BIOCHEM, V19, P285, DOI 10.1002/arch.940190407; Giordano R, 1997, P NATL ACAD SCI USA, V94, P11439, DOI 10.1073/pnas.94.21.11439; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Hosokawa T, 2005, FEMS MICROBIOL ECOL, V54, P471, DOI 10.1016/j.femsec.2005.06.002; Kato A, 1998, J ANTIBIOT, V51, P929, DOI 10.7164/antibiotics.51.929; Kato A, 1997, J AM CHEM SOC, V119, P6680, DOI 10.1021/ja970895o; Kempson D., 1968, PEDOBIOLOGIA, V3, P1; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Kurtz B, 2010, ENVIRON ENTOMOL, V39, P1532, DOI 10.1603/EN10025; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Meyer JM, 2008, FLA ENTOMOL, V91, P294, DOI 10.1653/0015-4040(2008)91[294:MSOEIF]2.0.CO;2; Mira A, 2002, MICROBIAL ECOL, V44, P137, DOI 10.1007/s00248-002-0012-9; Molnar O, 2008, MYCOL PROG, V7, P111, DOI 10.1007/s11557-008-0558-0; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; MURDOCK LL, 1987, COMP BIOCHEM PHYS B, V87, P783, DOI 10.1016/0305-0491(87)90388-9; Oros-Sichler M, 2006, J MICROBIOL METH, V65, P63, DOI 10.1016/j.mimet.2005.06.014; PALMER LT, 1969, PHYTOPATHOLOGY, V59, P1613; PASTI MB, 1990, APPL ENVIRON MICROB, V56, P2213, DOI 10.1128/AEM.56.7.2213-2218.1990; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Rademaker JLW, 1999, MOL MICROBIAL ECOLOG; Ramirez-Puebla ST, 2010, ENVIRON ENTOMOL, V39, P1178, DOI 10.1603/EN10037; Rice M. E., 2004, Plant Health Progress, P1; Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Roehrdanz RL, 2007, ANN ENTOMOL SOC AM, V100, P522, DOI 10.1603/0013-8746(2007)100[522:WBILTM]2.0.CO;2; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; Toyota K, 2000, BIOL FERT SOILS, V31, P187, DOI 10.1007/s003740050644; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Wesseler J, 2010, J APPL ENTOMOL, V134, P385, DOI 10.1111/j.1439-0418.2010.01510.x; Wolfson J.L., 1991, P223; Yang H, 2005, ENVIRON MICROBIOL, V7, P916, DOI 10.1111/j.1462-2920.2005.00760.x; You M, 2005, APPL ENVIRON MICROB, V71, P8183, DOI 10.1128/AEM.71.12.8183-8190.2005; Yu FG, 2007, ANTIMICROB AGENTS CH, V51, P64, DOI 10.1128/AAC.00931-06; Zhang ZG, 2000, PHYTOPATHOLOGY, V90, P384, DOI 10.1094/PHYTO.2000.90.4.384; Zouache K, 2009, APPL ENVIRON MICROB, V75, P3755, DOI 10.1128/AEM.02964-08	60	22	23	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e44685	10.1371/journal.pone.0044685	http://dx.doi.org/10.1371/journal.pone.0044685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056182	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600007
J	Maughan, H; Wang, PW; Caballero, JD; Fung, P; Gong, YC; Donaldson, SL; Yuan, LJ; Keshavjee, S; Zhang, Y; Yau, YCW; Waters, VJ; Tullis, DE; Hwang, DM; Guttman, DS				Maughan, Heather; Wang, Pauline W.; Caballero, Julio Diaz; Fung, Pauline; Gong, Yunchen; Donaldson, Sylva L.; Yuan, Lijie; Keshavjee, Shaf; Zhang, Yu; Yau, Yvonne C. W.; Waters, Valerie J.; Tullis, D. Elizabeth; Hwang, David M.; Guttman, David S.			Analysis of the Cystic Fibrosis Lung Microbiota via Serial Illumina Sequencing of Bacterial 16S rRNA Hypervariable Regions	PLOS ONE			English	Article							COMMUNITIES; GENERATION; DIVERSITY; INFECTIONS	The characterization of bacterial communities using DNA sequencing has revolutionized our ability to study microbes in nature and discover the ways in which microbial communities affect ecosystem functioning and human health. Here we describe Serial Illumina Sequencing (SI-Seq): a method for deep sequencing of the bacterial 16S rRNA gene using next-generation sequencing technology. SI-Seq serially sequences portions of the V5, V6 and V7 hypervariable regions from barcoded 16S rRNA amplicons using an Illumina short-read genome analyzer. SI-Seq obtains taxonomic resolution similar to 454 pyrosequencing for a fraction of the cost, and can produce hundreds of thousands of reads per sample even with very high multiplexing. We validated SI-Seq using single species and mock community controls, and via a comparison to cystic fibrosis lung microbiota sequenced using 454 FLX Titanium. Our control runs show that SI-Seq has a dynamic range of at least five orders of magnitude, can classify >96% of sequences to the genus level, and performs just as well as 454 and paired-end Illumina methods in estimation of standard microbial ecology diversity measurements. We illustrate the utility of SI-Seq in a pilot sample of central airway secretion samples from cystic fibrosis patients.	[Maughan, Heather; Caballero, Julio Diaz; Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Wang, Pauline W.; Fung, Pauline; Gong, Yunchen; Donaldson, Sylva L.; Yuan, Lijie; Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Keshavjee, Shaf; Zhang, Yu; Hwang, David M.] Univ Toronto, Latner Thorac Surg Labs, Univ Hlth Network, Toronto, ON, Canada; [Zhang, Yu; Hwang, David M.] Univ Toronto, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada; [Yau, Yvonne C. W.; Waters, Valerie J.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Tullis, D. Elizabeth] St Michaels Hosp, Adult Cyst Fibrosis Clin, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Maughan, H (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	heather.maughan@utoronto.ca; david.guttman@utoronto.ca	Guttman, David S/A-7839-2011	Guttman, David S/0000-0001-8479-3869; Diaz Caballero, Julio/0000-0003-4664-8577; Keshavjee, Shaf/0000-0003-4547-8094	Canadian Institutes of Health Research, Human Microbiome Emerging Team Grant [CMF108027]; National Sanitarium Association; Cystic Fibrosis Canada	Canadian Institutes of Health Research, Human Microbiome Emerging Team Grant(Canadian Institutes of Health Research (CIHR)); National Sanitarium Association; Cystic Fibrosis Canada	This work was supported by: the Canadian Institutes of Health Research, Human Microbiome Emerging Team Grant (CMF108027) (http://www.cihr-irsc.gc.ca/e/193.html); the National Sanitarium Association (http://nationalsanitarium.ca/); and Cystic Fibrosis Canada (www.cysticfibrosis.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Moustafa A, 2010, JALIGNER OPEN SOURCE; Oksanen J., 2016, R PACKAG; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILSON BA, 2011, MET HUM BOD, P91; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	34	46	57	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45791	10.1371/journal.pone.0045791	http://dx.doi.org/10.1371/journal.pone.0045791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056217	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600017
J	Yu, XW; Tan, NJ; Xiao, R; Xu, Y				Yu, Xiao-Wei; Tan, Nian-Jiang; Xiao, Rong; Xu, Yan			Engineering a Disulfide Bond in the Lid Hinge Region of Rhizopus chinensis Lipase: Increased Thermostability and Altered Acyl Chain Length Specificity	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; WHOLE-CELL LIPASE; BIOCHEMICAL-CHARACTERIZATION; TRIGLYCERIDE LIPASE; MICROBIAL LIPASES; PROTEIN STABILITY; RATIONAL DESIGN; DELEMAR LIPASE; MUTAGENESIS; BRIDGE	The key to enzyme function is the maintenance of an appropriate balance between molecular stability and structural flexibility. The lid domain which is very important for "interfacial activation" is the most flexible part in the lipase structure. In this work, rational design was applied to explore the relationship between lid rigidity and lipase activity by introducing a disulfide bond in the hinge region of the lid, in the hope of improving the thermostability of R. chinensis lipase through stabilization of the lid domain without interfering with its catalytic performance. A disulfide bridge between F95C and F214C was introduced into the lipase from R. chinensis in the hinge region of the lid according to the prediction of the "Disulfide by Design" algorithm. The disulfide variant showed substantially improved thermostability with an eleven-fold increase in the t(1/2) value at 60 degrees C and a 7 degrees C increase of T-m compared with the parent enzyme, probably contributed by the stabilization of the geometric structure of the lid region. The additional disulfide bond did not interfere with the catalytic rate (k(cat)) and the catalytic efficiency towards the short-chain fatty acid substrate, however, the catalytic efficiency of the disulfide variant towards pNPP decreased by 1.5-fold probably due to the block of the hydrophobic substrate channel by the disulfide bond. Furthermore, in the synthesis of fatty acid methyl esters, the maximum conversion rate by RCLCYS reached 95% which was 9% higher than that by RCL. This is the first report on improving the thermostability of the lipase from R. chinensis by introduction of a disulfide bond in the lid hinge region without compromising the catalytic rate.	[Yu, Xiao-Wei; Xu, Yan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Yu, Xiao-Wei; Tan, Nian-Jiang; Xu, Yan] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Xiao, Rong] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08855 USA	Jiangnan University; Jiangnan University; Rutgers State University New Brunswick	Xu, Y (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	biosean@yahoo.com.cn			National High Technology Research and Development Program of China (863 Program) [2012AA022207]; National Key Basic Research and Development Program of China (973 Program) [2011CB710800]; 863 Program [2011AA02A210, 2011AA02A209]; Fundamental Research Funds for the Central Universities [JUSRP11014]; Programme of Introducing Talents of Discipline to Universities (111 Project) [111-2-06]; NSFC [20802027]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Programme of Introducing Talents of Discipline to Universities (111 Project)(Ministry of Education, China - 111 Project); NSFC(National Natural Science Foundation of China (NSFC))	Financial support from the National High Technology Research and Development Program of China (863 Program) (No. 2012AA022207), the National Key Basic Research and Development Program of China (973 Program) (No. 2011CB710800), 863 Program (No. 2011AA02A210 and 2011AA02A209), the Fundamental Research Funds for the Central Universities (JUSRP11014), the Programme of Introducing Talents of Discipline to Universities (111 Project) (111-2-06), and from NSFC (20802027) are greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg OG, 1998, BIOCHEMISTRY-US, V37, P6615, DOI 10.1021/bi972998p; Betz SF, 1996, BIOCHEMISTRY-US, V35, P7422, DOI 10.1021/bi9528558; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Cajal Y, 2000, BIOCHEMISTRY-US, V39, P413, DOI 10.1021/bi991927i; CLARKE J, 1995, J MOL BIOL, V253, P505, DOI 10.1006/jmbi.1995.0569; D'Amico S, 2002, J BIOL CHEM, V277, P46110, DOI 10.1074/jbc.M207253200; DEREWENDA U, 1992, BIOCHEMISTRY-US, V31, P1532, DOI 10.1021/bi00120a034; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Han ZL, 2009, APPL MICROBIOL BIOT, V85, P117, DOI 10.1007/s00253-009-2067-8; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; He Q, 2008, CHINESE J CATAL, V29, P41, DOI 10.1016/S1872-2067(08)60015-7; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Jeong MY, 2007, J BIOTECHNOL, V127, P300, DOI 10.1016/j.jbiotec.2006.07.005; JOERGER RD, 1994, LIPIDS, V29, P377, DOI 10.1007/BF02537305; Johnson CM, 1997, J MOL BIOL, V268, P198, DOI 10.1006/jmbi.1997.0928; KATZ BA, 1986, J BIOL CHEM, V261, P5480; Klein RR, 1997, LIPIDS, V32, P123, DOI 10.1007/s11745-997-0016-1; Kohno M, 1996, J BIOCHEM-TOKYO, V120, P505; KORDEL M, 1991, J BACTERIOL, V173, P4836, DOI 10.1128/jb.173.15.4836-4841.1991; Kourist R, 2010, EUR J LIPID SCI TECH, V112, P64, DOI 10.1002/ejlt.200900143; Li WF, 2005, BIOTECHNOL ADV, V23, P271, DOI 10.1016/j.biotechadv.2005.01.002; Mansfeld J, 1997, J BIOL CHEM, V272, P11152, DOI 10.1074/jbc.272.17.11152; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; Pandey A, 1999, BIOTECHNOL APPL BIOC, V29, P119; Quang ATL, 2012, BIOTECHNOL BIOENG, V109, P867, DOI 10.1002/bit.24371; Scheib H, 1998, PROTEIN ENG, V11, P675, DOI 10.1093/protein/11.8.675; Sun SY, 2009, BIORESOURCE TECHNOL, V100, P2607, DOI 10.1016/j.biortech.2008.11.006; Sun SY, 2009, J CHEM TECHNOL BIOT, V84, P435, DOI 10.1002/jctb.2058; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; Wu D, 2010, APPL MICROBIOL BIOT, V85, P1759, DOI 10.1007/s00253-009-2232-0; Xu Y, 2003, J AM OIL CHEM SOC, V80, P647, DOI 10.1007/s11746-003-0753-6; Xu Y, 2002, J MOL CATAL B-ENZYM, V18, P29, DOI 10.1016/S1381-1177(02)00056-5; Yu XW, 2009, J MOL CATAL B-ENZYM, V57, P304, DOI 10.1016/j.molcatb.2008.10.002	36	63	69	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46388	10.1371/journal.pone.0046388	http://dx.doi.org/10.1371/journal.pone.0046388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056295	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600035
J	Popova, EY; Xu, XM; DeWan, AT; Salzberg, AC; Berg, A; Hoh, J; Zhang, SS; Barnstable, CJ				Popova, Evgenya Y.; Xu, Xuming; DeWan, Andrew T.; Salzberg, Anna C.; Berg, Arthur; Hoh, Josephine; Zhang, Samuel S.; Barnstable, Colin J.			Stage and Gene Specific Signatures Defined by Histones H3K4me2 and H3K27me3 Accompany Mammalian Retina Maturation In Vivo	PLOS ONE			English	Article							MOUSE RETINA; GENOME-WIDE; TRANSCRIPTIONAL NETWORK; MICROARRAY ANALYSIS; FUNCTIONAL-ANALYSIS; RAT RETINA; CELL-TYPES; EXPRESSION; CHROMATIN; PIGMENTOSA	The epigenetic contribution to neurogenesis is largely unknown. There is, however, growing evidence that posttranslational modification of histones is a dynamic process that shows many correlations with gene expression. Here we have followed the genome-wide distribution of two important histone H3 modifications, H3K4me2 and H3K27me3 during late mouse retina development. The retina provides an ideal model for these studies because of its well-characterized structure and development and also the extensive studies of the retinal transcriptome and its development. We found that a group of genes expressed only in mature rod photoreceptors have a unique signature consisting of de-novo accumulation of H3K4me2, both at the transcription start site (TSS) and over the whole gene, that correlates with the increase in transcription, but no accumulation of H3K27me3 at any stage. By in silico analysis of this unique signature we have identified a larger group of genes that may be selectively expressed in mature rod photoreceptors. We also found that the distribution of H3K4me2 and H3K27me3 on the genes widely expressed is not always associated with their transcriptional levels. Different histone signatures for retinal genes with the same gene expression pattern suggest the diversities of epigenetic regulation. Genes without H3K4me2 and H3K27me3 accumulation at any stage represent a large group of transcripts never expressed in retina. The epigenetic signatures defined by H3K4me2 and H3K27me3 can distinguish cell-type specific genes from widespread transcripts and may be reflective of cell specificity during retina maturation. In addition to the developmental patterns seen in wild type retina, the dramatic changes of histone modification in the retinas of mutant animals lacking rod photoreceptors provide a tool to study the epigenetic changes in other cell types and thus describe a broad range of epigenetic events in a solid tissue in vivo.	[Popova, Evgenya Y.; Zhang, Samuel S.; Barnstable, Colin J.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA; [Popova, Evgenya Y.; Zhang, Samuel S.; Barnstable, Colin J.] Penn State Hershey Eye Ctr, Hershey, PA USA; [Xu, Xuming] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [DeWan, Andrew T.; Hoh, Josephine] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Salzberg, Anna C.] Penn State Univ, Coll Med, Bioinformat Core, Hershey, PA USA; [Berg, Arthur] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Hoh, Josephine] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Yale University	Zhang, SS (corresponding author), Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA.	ssz3@psu.edu; cbarnstable@hmc.psu.edu	Barnstable, Colin/ABB-4822-2021; Barnstable, Colin/GLU-9219-2022	Berg, Arthur/0000-0002-4097-7348; DeWan, Andrew/0000-0002-7679-8704; Barnstable, Colin/0000-0002-7011-4068	National Institutes of Health (NIH) [EY013865]; Macula Vision Research Foundation; PA Sight Conservation Eye Research; Frontiers in Eye and Vision Research Award of Penn State University; NIH, National Center for Research Resources [UL1RR033184]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013865] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; PA Sight Conservation Eye Research; Frontiers in Eye and Vision Research Award of Penn State University; NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Institutes of Health (NIH) (EY013865) and the Macula Vision Research Foundation to CJB; by PA Sight Conservation & Eye Research and the Frontiers in Eye and Vision Research Award of Penn State University to SSZ; and by NIH, National Center for Research Resources (UL1RR033184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; BARNSTABLE CJ, 1987, MOL NEUROBIOL, V1, P9, DOI 10.1007/BF02935263; BARNSTABLE CJ, 1980, NATURE, V286, P231, DOI 10.1038/286231a0; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Collin RWJ, 2010, AM J HUM GENET, V86, P783, DOI 10.1016/j.ajhg.2010.03.016; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; DEVOTO SH, 1989, J COMP NEUROL, V290, P154, DOI 10.1002/cne.902900110; Donovan SL, 2005, SEMIN CELL DEV BIOL, V16, P407, DOI 10.1016/j.semcdb.2005.02.012; Dorrell MI, 2004, INVEST OPHTH VIS SCI, V45, P1009, DOI 10.1167/iovs.03-0806; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farjo R, 2002, VISION RES, V42, P463, DOI 10.1016/S0042-6989(01)00219-X; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kizilyaprak C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011039; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morrow EM, 1998, J NEUROSCI, V18, P3738; Mu XQ, 2001, NUCLEIC ACIDS RES, V29, P4983, DOI 10.1093/nar/29.24.4983; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Nishimura DY, 2010, AM J HUM GENET, V86, P686, DOI 10.1016/j.ajhg.2010.03.005; Pekowska A, 2010, GENOME RES, V20, P1493, DOI 10.1101/gr.109389.110; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Sharon D, 2002, P NATL ACAD SCI USA, V99, P315, DOI 10.1073/pnas.012582799; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; TREISMAN JE, 1988, MOL CELL BIOL, V8, P1570, DOI 10.1128/MCB.8.4.1570; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zhang SSM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-48; Zhang SSM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-40; Zhang SSM, 2004, INVEST OPHTH VIS SCI, V45, P2407, DOI 10.1167/iovs.04-0003; Zhang SSM, 2002, MOL NEUROBIOL, V26, P137, DOI 10.1385/MN:26:2-3:137	56	43	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46867	10.1371/journal.pone.0046867	http://dx.doi.org/10.1371/journal.pone.0046867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056497	Green Submitted, gold, Green Published			2022-12-27	WOS:000309889400033
J	Sethi, G; Pathak, HB; Zhang, H; Zhou, Y; Einarson, MB; Vathipadiekal, V; Gunewardena, S; Birrer, MJ; Godwin, AK				Sethi, Geetika; Pathak, Harsh B.; Zhang, Hong; Zhou, Yan; Einarson, Margret B.; Vathipadiekal, Vinod; Gunewardena, Sumedha; Birrer, Michael J.; Godwin, Andrew K.			An RNA Interference Lethality Screen of the Human Druggable Genome to Identify Molecular Vulnerabilities in Epithelial Ovarian Cancer	PLOS ONE			English	Article							TUMOR-CELL GROWTH; RIBOSOMAL-PROTEINS; SIGNALING PATHWAY; REGULATED PROTEIN; CLINICAL-TRIALS; IN-VITRO; PLEIOTROPHIN; ANGIOGENESIS; IDENTIFICATION; ACTIVATION	Targeted therapies have been used to combat many tumor types; however, few have effectively improved the overall survival in women with epithelial ovarian cancer, begging for a better understanding of this deadly disease and identification of essential drivers of tumorigenesis that can be targeted effectively. Therefore, we used a loss-of-function screening approach to help identify molecular vulnerabilities that may represent key points of therapeutic intervention. We employed an unbiased high-throughput lethality screen using a 24,088 siRNA library targeting over 6,000 druggable genes and studied their effects on growth and/or survival of epithelial ovarian cancer (EOC) cell lines. The top 300 "hits" affecting the viability of A1847 cells were rescreened across additional EOC cell lines and non-tumorigenic, human immortalized ovarian epithelial cell lines. Fifty-three gene candidates were found to exhibit effects in all tumorigenic cell lines tested. Extensive validation of these hits refined the list to four high quality candidates (HSPA5, NDC80, NUF2, and PTN). Mechanistic studies show that silencing of three genes leads to increased apoptosis, while HSPA5 silencing appears to alter cell growth through G1 cell cycle arrest. Furthermore, two independent gene expression studies show that NDC80, NUF2 and PTN were significantly aberrantly overexpressed in serous adenocarcinomas. Overall, our functional genomics results integrated with the genomics data provide an important unbiased avenue towards the identification of prospective therapeutic targets for drug discovery, which is an urgent and unmet clinical need for ovarian cancer.	[Sethi, Geetika; Pathak, Harsh B.; Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA; [Sethi, Geetika; Pathak, Harsh B.; Godwin, Andrew K.] Univ Kansas, Med Ctr, Lab Med, Kansas City, KS 66103 USA; [Sethi, Geetika] Drexel Univ, Coll Med, Dept Biochem, Philadelphia, PA 19104 USA; [Pathak, Harsh B.; Godwin, Andrew K.] Univ Kansas, Ctr Canc, Kansas City, KS USA; [Zhou, Yan] Fox Chase Canc Ctr, Biostatist & Bioinformat Facil, Philadelphia, PA 19111 USA; [Einarson, Margret B.] Fox Chase Canc Ctr, Translat Core Facil, Philadelphia, PA 19111 USA; [Vathipadiekal, Vinod; Birrer, Michael J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Drexel University; University of Kansas; Fox Chase Cancer Center; Fox Chase Cancer Center; Harvard University; Harvard Medical School; Massachusetts General Hospital	Godwin, AK (corresponding author), Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA.	agodwin@kumc.edu		/0000-0002-8181-6890	Ovarian Cancer Research Fund; NCI [CA140323]; University of Kansas Cancer Center; Kansas Bioscience Authority Eminent Scholar Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052027] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA140323] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Kansas Cancer Center; Kansas Bioscience Authority Eminent Scholar Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported in part by a program project grant from Ovarian Cancer Research Fund (http://www.ocrf.org) and a grant from the NCI (CA140323) to AKG. The authors acknowledge support from the University of Kansas Cancer Center and the Kansas Bioscience Authority Eminent Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Broccoli Dominique, 2002, Methods Mol Med, V68, P271; Brower V, 2010, J NATL CANCER I, V102, P1459, DOI 10.1093/jnci/djq405; Charters GA, 2011, CANCER GENET-NY, V204, P477, DOI 10.1016/j.cancergen.2011.07.001; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Cohen M, 2011, CANCER LETT, V309, P104, DOI 10.1016/j.canlet.2011.05.022; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Diaz-Rodriguez E, 2010, CURR DRUG THER, V5, P29, DOI 10.2174/1574885511005010029; Eifler AC, 2011, METHODS MOL BIOL, V726, P325, DOI 10.1007/978-1-61779-052-2_21; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Gajko-Galicka A, 2002, MOL CELL BIOCHEM, V233, P159, DOI 10.1023/A:1015548131930; Gilsdorf M, 2010, NUCLEIC ACIDS RES, V38, pD448, DOI 10.1093/nar/gkp1038; Glazier A, 2011, ECONOMIST; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Grobelny JV, 2000, J CELL SCI, V113, P4577; Grzelinski M, 2009, NEOPLASIA, V11, P145, DOI 10.1593/neo.81040; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Hogg T, 2002, CURR PROTEIN PEPT SC, V3, P121, DOI 10.2174/1389203023380855; Huang S, 2009, NATURE PRECEDINGS, P713; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; Kaneko N, 2009, BIOCHEM BIOPH RES CO, V390, P1235, DOI 10.1016/j.bbrc.2009.10.127; Lai MD, 2007, CURR GENOMICS, V8, P43; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mattiuzzo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016307; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Mikelis C, 2007, RECENT PAT ANTI-CANC, V2, P175, DOI 10.2174/157489207780832405; Modugno F, 2001, ANN EPIDEMIOL, V11, P568, DOI 10.1016/S1047-2797(01)00213-7; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Morch LS, 2012, AM J EPIDEMIOL; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Nicosia SV, 2003, HEMATOL ONCOL CLIN N, V17, P927, DOI 10.1016/S0889-8588(03)00056-X; Nijhara R, ANTIPLEIOTROPHIN NEU; Nuinnum TM, 2008, GYNECOL ONCOL, V108, P34, DOI 10.1016/j.ygyno.2007.08.096; Ocak S, 2010, ONCOGENE, V29, P6331, DOI 10.1038/onc.2010.362; Papadimitriou E, 2001, BIOCHEM BIOPH RES CO, V282, P306, DOI 10.1006/bbrc.2001.4574; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Pecorari L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-58; Rink L, 2009, MOL CANCER THER, V8, P2172, DOI 10.1158/1535-7163.MCT-09-0193; Roland IH, 2003, CANCER-AM CANCER SOC, V98, P2607, DOI 10.1002/cncr.11847; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sigoillot FD, 2012, NAT METHODS; Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408; Steinmetz R, 2004, MOL ENDOCRINOL, V18, P2570, DOI 10.1210/me.2004-0082; Tarn C, 2006, CANCER RES, V66, P5477, DOI 10.1158/0008-5472.CAN-05-3906; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tiedemann RE, 2012, CANCER RES, V72, P757, DOI 10.1158/0008-5472.CAN-11-2781; Tollefsbol T, 2009, CANC EPIGENETICS; Uckun FM, 2011, BRIT J HAEMATOL, V153, P741, DOI 10.1111/j.1365-2141.2011.08671.x; Vader P, 2011, J CONTROL RELEASE; Van Goietsenoven G, 2010, FASEB J, V24, P4575, DOI 10.1096/fj.10-162263; Wang J, 2009, J CELL MOL MED, V13, P3888, DOI 10.1111/j.1582-4934.2009.00873.x; Wehling M, 2009, NAT REV DRUG DISCOV, V8, P541, DOI 10.1038/nrd2898; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Wu GK, 2008, CANCER RES, V68, P8393, DOI 10.1158/0008-5472.CAN-08-1915; Zhang JA, 2010, J IMMUNOL, V184, P7178, DOI 10.4049/jimmunol.0904169; Zhang N, 2006, BIOCHEM BIOPH RES CO, V343, P653, DOI 10.1016/j.bbrc.2006.03.006; Zhuang J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002517	68	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47086	10.1371/journal.pone.0047086	http://dx.doi.org/10.1371/journal.pone.0047086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056589	Green Submitted, Green Published, gold			2022-12-27	WOS:000309889400054
J	Guo, TM; Chen, M; Peng, DL				Guo, Taomei; Chen, Min; Peng, Danling			Emotional States Modulate the Recognition Potential during Word Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ADJECTIVES; ERP; SENTENCES; ATTENTION; COGNITION; VALENCE; AROUSAL; BIAS	This study examined emotional modulation of word processing, showing that the recognition potential (RP), an ERP index of word recognition, could be modulated by different emotional states. In the experiment, participants were instructed to compete with pseudo-competitors, and via manipulation of the outcome of this competition, they were situated in neutral, highly positive, slightly positive, highly negative or slightly negative emotional states. They were subsequently asked to judge whether the referent of a word following a series of meaningless character segmentations was an animal or not. The emotional induction task and the word recognition task were alternated. Results showed that 1) compared with the neutral emotion condition, the peak latency of the RP under different emotional states was earlier and its mean amplitude was smaller, 2) there was no significant difference between RPs elicited under positive and negative emotional states in either the mean amplitude or latency, and 3) the RP was not affected by different degrees of positive emotional states. However, compared to slightly negative emotional states, the mean amplitude of the RP was smaller and its latency was shorter in highly negative emotional states over the left hemisphere but not over the right hemisphere. The results suggest that emotional states influence word processing.	[Guo, Taomei; Chen, Min; Peng, Danling] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	Peng, DL (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	pdl3507@bnu.edu.cn			National Natural Science Foundation of China [248-202006, 31170970]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT); Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was supported by the National Natural Science Foundation of China (248-202006) and Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) to Danling Peng, and the Fundamental Research Funds for the Central Universities and the National Natural Science Foundation of China (31170970) to Taomei Guo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Bayer M, 2010, INT J PSYCHOPHYSIOL, V78, P299, DOI 10.1016/j.ijpsycho.2010.09.004; Bernat E, 2001, INT J PSYCHOPHYSIOL, V42, P11, DOI 10.1016/S0167-8760(01)00133-7; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Dillon DG, 2006, BRAIN COGNITION, V62, P43, DOI 10.1016/j.bandc.2006.03.008; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Federmeier KD, 2001, NEUROSCI LETT, V305, P149, DOI 10.1016/S0304-3940(01)01843-2; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Hinojosa JA, 2001, COGNITIVE BRAIN RES, V11, P397, DOI 10.1016/S0926-6410(01)00012-X; Ihssen N, 2007, J COGNITIVE NEUROSCI, V19, P1932, DOI 10.1162/jocn.2007.19.12.1932; Inaba M, 2005, INT J PSYCHOPHYSIOL, V57, P165, DOI 10.1016/j.ijpsycho.2005.01.002; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Lorenz AR, 2002, EMOTION, V2, P91, DOI 10.1037/1528-3542.2.2.91; Martin-Loeches M, 1999, BRAIN LANG, V70, P364, DOI 10.1006/brln.1999.2178; Martin-Loeches M, 2005, INT J PSYCHOPHYSIOL, V55, P113, DOI 10.1016/j.ijpsycho.2004.06.007; Martin-Loeches M, 2002, INT J PSYCHOPHYSIOL, V43, P155, DOI 10.1016/S0167-8760(01)00171-4; Martin-Loeches M, 2001, NEUROPSYCHOLOGIA, V39, P1086, DOI 10.1016/S0028-3932(01)00033-1; Martin-Loeches M, 2001, PSYCHOPHYSIOLOGY, V38, P114, DOI 10.1017/S004857720199105X; Martin-Loeches M, 2007, BRAIN RES REV, V53, P89, DOI 10.1016/j.brainresrev.2006.07.001; Mellers BA, 2000, PSYCHOL BULL, V126, P910, DOI 10.1037/0033-2909.126.6.910; Most SB, 2005, PSYCHON B REV, V12, P654, DOI 10.3758/BF03196754; Olafson KM, 2001, BRAIN COGNITION, V45, P15, DOI 10.1006/brcg.2000.1248; Rudell A. P., 1990, NEUR ABSTR, V16, P106; Rudell AP, 2000, BRAIN LANG, V75, P137, DOI 10.1006/brln.2000.2349; RUDELL AP, 1991, INT J NEUROSCI, V60, P85, DOI 10.3109/00207459109082040; Rudell AP, 1997, J EXP PSYCHOL HUMAN, V23, P1170; RUDELL AP, 1992, ELECTROEN CLIN NEURO, V83, P77, DOI 10.1016/0013-4694(92)90135-5; RUIZCABALLERO JA, 1994, COGNITION EMOTION, V8, P555, DOI 10.1080/02699939408408959; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Skrandies W, 2003, NEUROSCI LETT, V341, P45, DOI 10.1016/S0304-3940(03)00137-X; Skrandies W, 1998, COGNITIVE BRAIN RES, V6, P173, DOI 10.1016/S0926-6410(97)00033-5; Windmann S, 2001, J COGNITIVE NEUROSCI, V13, P577, DOI 10.1162/089892901750363172	36	13	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47083	10.1371/journal.pone.0047083	http://dx.doi.org/10.1371/journal.pone.0047083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056588	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500135
J	Qian, J; Yang, HL; Jing, JH; Zhao, H; Ni, L; Tian, DS; Wang, ZF				Qian, Jun; Yang, Huilin; Jing, Juehua; Zhao, Hong; Ni, Li; Tian, Dasheng; Wang, Zhengfei			The Early Stage Adjacent Disc Degeneration after Percutaneous Vertebroplasty and Kyphoplasty in The Treatment of Osteoporotic VCFs	PLOS ONE			English	Article							VERTEBRAL COMPRESSION FRACTURES; QUALITY-OF-LIFE; INTERVERTEBRAL DISC; BALLOON KYPHOPLASTY; CEMENT AUGMENTATION; FINITE-ELEMENT; RISK-FACTORS; MRI	Background: The purpose of this paper is to determine the early incidence of disc de-generation adjacent to the vertebral body of osteoporotic fracture treated with percutaneous vertebroplasty or balloon kyphoplasty and whether adjacent disc degeneration is accelerated by this two procedures. Methods: 182 patients with painful vertebral compression fractures were treated. A total of 97 patients were enrolled in this prospective study. 97 patients with a mean age of 65.3 years were classified into control group and surgical treatment group of non-random. 35 patients were in contol group and 62 patients who were performed percutaneous vertebroplasty or balloon kyphoplasty in treatment group. X-ray and Magnetic resonance imaging were done at the first and final visit. The grade of disc degeneration above the fractured vertebral was confirmed by evaluation of bony oedema in the fat suppressed sequences and T2-weighted image of magnetic resonance imaging. The height of degenerative disc was measured on X-ray film. Results: All patients were followed up two years after the first visit and the follow-up rate was 90.7% (88/97). The incidence of degeneration of adjacent disc above the fractured vertebral was 29.0% (9/31) in control group and 52.6% (30/57) in treatment group. It presented a statistically significant difference between two groups about the incidence of adjacent disc degeneration (P = 0.033). The percentage of adjacent disc height reduction in control group was 13.5% and 17.6% in treatment group. Statistically significant difference of VAS score and ODI was not found between the first evaluation postoperatively and the final follow-up in treatment group (P>0.05). Conclusions: Disc degeneration adjacent to the fractured vertebral is accelerated by VP and BK procedures in the early stage, but clinical outcomes has not been weakened even in the presence of accelerated disc degeneration.	[Qian, Jun; Yang, Huilin; Ni, Li; Wang, Zhengfei] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China; [Qian, Jun; Jing, Juehua; Tian, Dasheng] Anhui Med Univ, Hosp 2, Dept Orthopaed, Hefei, Anhui, Peoples R China; [Zhao, Hong] Anhui Med Univ, Hosp 2, Dept Radiol, Hefei, Anhui, Peoples R China	Soochow University - China; Anhui Medical University; Anhui Medical University	Yang, HL (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China.	huilinyangszdx@163.com						Ananthakrishnan D, 2005, CLIN BIOMECH, V20, P25, DOI 10.1016/j.clinbiomech.2004.09.004; Baroud G, 2003, EUR SPINE J, V12, P421, DOI 10.1007/s00586-002-0512-9; Benneker LM, 2005, EUR SPINE J, V14, P27, DOI 10.1007/s00586-004-0759-4; Berlemann U, 1998, Eur Spine J, V7, P212, DOI 10.1007/s005860050058; Chen BL, 2011, EUR SPINE J, V20, P1272, DOI 10.1007/s00586-011-1744-3; COOK DJ, 1993, ARTHRITIS RHEUM, V36, P750, DOI 10.1002/art.1780360603; DEXTER F, 1995, ANESTHESIOLOGY, V82, P896, DOI 10.1097/00000542-199504000-00012; Elfering A, 2002, SPINE, V27, P125, DOI 10.1097/00007632-200201150-00002; Fairbank JC, 1980, PHYSIOTHERAPY, V66, P271; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Fribourg D, 2004, SPINE, V29, P2270, DOI 10.1097/01.brs.0000142469.41565.2a; GALIBERT P, 1987, NEUROCHIRURGIE, V33, P166; Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002; Hallberg I, 2004, OSTEOPOROSIS INT, V15, P834, DOI 10.1007/s00198-004-1622-5; Hulme PA, 2006, SPINE, V31, P1983, DOI 10.1097/01.brs.0000229254.89952.6b; Hulme PA, 2009, EUR SPINE J, V18, P614, DOI 10.1007/s00586-009-0910-3; Iqbal MM, 2000, SOUTH MED J, V93, P2; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Keorochana G, 2011, SPINE, V36, P893, DOI 10.1097/BRS.0b013e3181f4d212; Kim MH, 2011, ASIAN SPINE J, V5, P180, DOI 10.4184/asj.2011.5.3.180; Lindsay R, 2005, OSTEOPOROSIS INT, V16, P78, DOI 10.1007/s00198-004-1646-x; Movrin I, 2010, ARCH ORTHOP TRAUM SU, V130, P1157, DOI 10.1007/s00402-010-1106-3; Mudano AS, 2009, OSTEOPOROSIS INT, V20, P819, DOI 10.1007/s00198-008-0745-5; Okuda S, 2004, SPINE, V29, P1535, DOI 10.1097/01.BRS.0000131417.93637.9D; Old JL, 2004, AM FAM PHYSICIAN, V69, P111; Pfirrmann CWA, 2006, J ORTHOP RES, V24, P1086, DOI 10.1002/jor.20113; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Pflugmacher R, 2006, ACTA RADIOL, V47, P830, DOI 10.1080/02841850600854928; Polikeit A, 2003, SPINE, V28, P991, DOI 10.1097/00007632-200305150-00006; Rohlmann A, 2006, EUR SPINE J, V15, P1255, DOI 10.1007/s00586-005-0018-3; Schulte TL, 2007, EUR SPINE J, V16, P2152, DOI 10.1007/s00586-007-0515-7; Silverman SL, 2002, OSTEOPOROSIS INT, V13, P858, DOI 10.1007/s001980200118; Villarraga ML, 2005, J SPINAL DISORD TECH, V18, P84, DOI 10.1097/01.bsd.0000138694.56012.ce; Voggenreiter G, 2005, SPINE, V30, P2806, DOI 10.1097/01.brs.0000190885.85675.a0; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Watts NB, 2001, OSTEOPOROSIS INT, V12, P429, DOI 10.1007/s001980170086; Weisskopf M, 2008, SPINE, V33, P178, DOI 10.1097/BRS.0b013e3181606139; Yan DL, 2011, ARCH ORTHOP TRAUM SU, V131, P645, DOI 10.1007/s00402-010-1188-y; Zhang Ji-dong, 2011, Orthop Surg, V3, P158, DOI 10.1111/j.1757-7861.2011.00141.x	39	17	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46323	10.1371/journal.pone.0046323	http://dx.doi.org/10.1371/journal.pone.0046323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056283	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500034
J	Ruiz-Grosso, P; de Mola, CL; Vega-Dienstmaier, JM; Arevalo, JM; Chavez, K; Vilela, A; Lazo, M; Huapaya, J				Ruiz-Grosso, Paulo; Loret de Mola, Christian; Vega-Dienstmaier, Johann M.; Arevalo, Jorge M.; Chavez, Kristhy; Vilela, Ana; Lazo, Maria; Huapaya, Julio			Validation of the Spanish Center for Epidemiological Studies Depression and Zung Self-Rating Depression Scales: A Comparative Validation Study	PLOS ONE			English	Article							CES-D SCALE; NEUROLOGICAL HEALTH RESEARCH; PSYCHOMETRIC PROPERTIES; PRIMARY-CARE; DETECTING DEPRESSION; UNIVERSITY-STUDENTS; ADOLESCENT STUDENTS; GENERAL-POPULATION; GREEK TRANSLATION; LATIN-AMERICA	Background: Depressive disorders are leading contributors to burden of disease in developing countries. Research aiming to improve their diagnosis and treatment is fundamental in these settings, and psychometric tools are widely used instruments to support mental health research. Our aim is to validate and compare the psychometric properties of the Spanish versions of the Center for Epidemiological Studies Depression Scale (CES-D) and the Zung Self-Rating Depression Scale (ZSDS). Methodology/Principal Findings: A Spanish version of the CES-D was revised by 5 native Spanish speaking psychiatrists using as reference the English version. A locally standardized Spanish version of the ZSDS was used. These Spanish versions were administered to 70 patients with a clinical diagnosis of DSM-IV Major Depressive Episode (MDE), 63 without major depression but with clinical diagnosis of other psychiatric disorders (OPD), and 61 with no evidence of psychiatric disorders (NEP). For both scales, Cronbach's alpha (C-alpha) and Hierarchical McDonald Omega for polychoric variables (MD-Omega) were estimated; and receiver operating characteristics (ROC) analysis performed. For the CES-D and ZSDS scales, C-alpha was 0.93 and 0.89 respectively, while MD-Omega was 0.90 and 0.75 respectively. The area under the ROC curve in MDE+OPD was 0.83 for CES-D and 0.84 for ZSDS; and in MDE+NEP was 0.98 for CES-D and 0.96 for ZSDS. Cut-off scores (co) for the highest proportions of correctly classified (cc) individuals among MDE+OPD were >= 29 for CES-D (sensitivity (ss) = 77.1/specificity (sp) = 79.4%/(cc) = 78.2%) and >= 47 for ZSDS (ss = 85.7%/sp = 71.4%/ cc = 78.9%). In the MDE+NEP, co were >= 24 for the CES-D (ss = 91.4%/sp = 96.7%/cc = 93.9%) and >= 45 for the ZSDS (ss = 91.4%/sp = 91.8%/cc = 91.6%). Conclusion: Spanish versions of the CES-D and ZSDS are valid instruments to detect depression in clinical settings and could be useful for both epidemiological research and primary clinical settings in settings similar as those of public hospitals in Lima, Peru.	[Ruiz-Grosso, Paulo; Loret de Mola, Christian; Vega-Dienstmaier, Johann M.; Arevalo, Jorge M.; Chavez, Kristhy; Vilela, Ana; Lazo, Maria; Huapaya, Julio] Univ Peruana Cayetano Heredia, Mental Hlth Working Grp, Lima, Peru; [Vega-Dienstmaier, Johann M.] Hosp Nacl Cayetano Heredia, Lima, Peru; [Ruiz-Grosso, Paulo; Loret de Mola, Christian; Chavez, Kristhy; Vilela, Ana; Lazo, Maria; Huapaya, Julio] Univ Peruana Cayetano Heredia, Alberto Hurtado Med Sch, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Ruiz-Grosso, P (corresponding author), Univ Peruana Cayetano Heredia, Mental Hlth Working Grp, Lima, Peru.	paulo.ruiz@upch.pe	Vega-Dienstmaier, Johann/Q-6709-2019; de Mola, Christian Loret/C-9534-2012; Huapaya, Julio Arturo/AAZ-9334-2021; Ruiz-Grosso, Paulo/D-1779-2018	Vega-Dienstmaier, Johann/0000-0002-5686-4014; de Mola, Christian Loret/0000-0002-5264-5914; Huapaya, Julio Arturo/0000-0001-8093-4855; Arevalo Flores, Martin/0000-0001-7849-8839; Ruiz-Grosso, Paulo/0000-0001-8003-5171				Aguilar-Navarro SG, 2007, SALUD PUBLICA MEXICO, V49, P256, DOI 10.1590/S0036-36342007000400005; Alvarado-Esquivel Cosme, 2006, Clin Pract Epidemiol Ment Health, V2, P33, DOI 10.1186/1745-0179-2-33; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Andryschenko AV, 2003, ZH NEVROPATOL PSIKH, V103, P11; Camacho PA, 2009, BIOMEDICA, V29, P260; AragonesBenaiges E, 2001, ACTAS ESP PSIQUIATRI, V29, P310; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BIGGS JT, 1978, BRIT J PSYCHIAT, V132, P381, DOI 10.1192/bjp.132.4.381; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Callahan L F, 1991, Arthritis Care Res, V4, P3, DOI 10.1002/art.1790040103; Campo Adalberto, 2006, Biomed., V26, P415; Campo-Arias A, 2006, SOC BEHAV PERSONAL, V34, P87, DOI 10.2224/sbp.2006.34.1.87; Chabrol H, 2002, ENCEPHALE, V28, P429; Cheng ST, 2005, INT J GERIATR PSYCH, V20, P465, DOI 10.1002/gps.1314; Chida F, 2004, PSYCHIAT CLIN NEUROS, V58, P420, DOI 10.1111/j.1440-1819.2004.01277.x; Cho MJ, 1998, J NERV MENT DIS, V186, P304, DOI 10.1097/00005053-199805000-00007; Cole SR, 2000, J CLIN EPIDEMIOL, V53, P285, DOI 10.1016/S0895-4356(99)00151-1; Covic T, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-41; Crockett LJ, 2005, J CONSULT CLIN PSYCH, V73, P47, DOI 10.1037/0022-006X.73.1.47; Davidson Karina W, 2008, Cleve Clin J Med, V75 Suppl 2, pS15; Dojka Ewa, 2003, Psychiatr Pol, V37, P281; Rueda-Jaimes GE, 2009, ATEN PRIM, V41, P255, DOI 10.1016/j.aprim.2008.09.005; Piera PJF, 2010, PSICOTHEMA, V22, P587; Fiestas F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-334; Fiestas F, 2008, REV BRAS PSIQUIATR, V30, P328, DOI 10.1590/S1516-44462008000400005; Fountoulakis K, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-3; Fountoulakis KN, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-6; Gonzalez-Forteza C, 2008, SALUD PUBLICA MEXICO, V50, P292, DOI 10.1590/S0036-36342008000400007; Guarneri E, 2010, EXPLORE-NY, V6, P308, DOI 10.1016/j.explore.2010.06.012; Hales DP, 2006, ETHNIC DIS, V16, P1; Miranda JJ, 2010, REV SAUDE PUBL, V44, P185, DOI 10.1590/S0034-89102010000100020; Jegede R O, 1979, Afr J Med Med Sci, V8, P133; Kitamura T, 2004, PSYCHIAT RES, V128, P281, DOI 10.1016/j.psychres.2004.06.003; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larraga L, 2006, INT J GERIATR PSYCH, V21, P1199, DOI 10.1002/gps.1642; Le HN, 2010, J IMMIGR MINOR HEALT, V12, P249, DOI 10.1007/s10903-009-9260-9; Luciano JV, 2010, QUAL LIFE RES, V19, P97, DOI 10.1007/s11136-009-9566-z; MAGRUDERHABIB K, 1990, MED CARE, V28, P239, DOI 10.1097/00005650-199003000-00004; MAHARD RE, 1988, J GERONTOL, V43, pP24, DOI 10.1093/geronj/43.1.P24; Martinez Karen G, 2003, P R Health Sci J, V22, P179; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McDonald RP, 1999, TEST THEORY UNIFIED; Mitchell AJ, 2010, AM J GERIAT PSYCHIAT, V18, P1066, DOI 10.1097/JGP.0b013e3181f60f81; MULROW CD, 1995, ANN INTERN MED, V122, P913, DOI 10.7326/0003-4819-122-12-199506150-00004; Nguyen HT, 2004, PSYCHIAT RES, V126, P177, DOI 10.1016/j.psychres.2004.02.004; Orcos RO, 2007, REV CLIN ESP, V207, P559, DOI 10.1016/S0014-2565(07)73477-X; Pandya R, 2005, PSYCHOSOMATICS, V46, P131, DOI 10.1176/appi.psy.46.2.131; Passik SD, 2000, PSYCHOSOMATICS, V41, P121, DOI 10.1176/appi.psy.41.2.121; Perel P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001696; Poulin Christiane, 2005, Chronic Dis Can, V26, P65; Powell R, 2003, MENT RETARD, V41, P88, DOI 10.1352/0047-6765(2003)041<0088:PPOTBD>2.0.CO;2; Radloff LS, 1977, APPL PSYCH MEAS, V1, P401; RANGE LM, 1990, J PERS ASSESS, V55, P804, DOI 10.1207/s15327752jpa5503&4_37; Reuland DS, 2009, ANN FAM MED, V7, P455, DOI 10.1370/afm.981; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Romera I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-4; Ros L, 2011, INT J AGING HUM DEV, V72, P83, DOI 10.2190/AG.72.2.a; Rouch-Leroyer I, 2000, AGING-CLIN EXP RES, V12, P228, DOI 10.1007/BF03339840; Ruiz-Grosso Paulo, 2011, Rev. perú. med. exp. salud publica, V28, P697, DOI 10.1590/s1726-46342011000400026; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Soler J, 1997, ACTAS LUSO-ESP NEUR, V25, P243; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steptoe A, 2009, NEUROSCI BIOBEHAV R, V33, P63, DOI 10.1016/j.neubiorev.2008.04.010; Tavares S, 2007, REV SAUDE PUBL, V41, P4; Taylor R, 2005, CLIN J PAIN, V21, P91, DOI 10.1097/00002508-200501000-00011; Trajkovic G, 2011, PSYCHIAT RES, V189, P1, DOI 10.1016/j.psychres.2010.12.007; Vazquez FL, 2007, PSYCHIAT RES, V149, P247, DOI 10.1016/j.psychres.2006.03.004; Vega-Dienstmaier JM, 2011, REV PANAM SALUD PUBL, V30, P317; Galvis FHV, 2010, REV PANAM SALUD PUBL, V27, P110, DOI 10.1590/S1020-49892010000200004; WHO (World Health Organization), 2013, SCHIST PROGR REP 200; Wilcox H, 1998, ADOLESCENCE, V33, P565; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	73	81	90	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45413	10.1371/journal.pone.0045413	http://dx.doi.org/10.1371/journal.pone.0045413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056202	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500018
J	Alen, BO; Nieto, L; Gurriaran-Rodriguez, U; Mosteiro, CS; Alvarez-Perez, JC; Otero-Alen, M; Camina, JP; Gallego, R; Garcia-Caballero, T; Martin-Pastor, M; Casanueva, FF; Jimenez-Barbero, J; Pazos, Y				Alen, Begona O.; Nieto, Lidia; Gurriaran-Rodriguez, Uxia; Mosteiro, Carlos S.; Alvarez-Perez, Juan C.; Otero-Alen, Maria; Camina, Jesus P.; Gallego, Rosalia; Garcia-Caballero, Tomas; Martin-Pastor, Manuel; Casanueva, Felipe F.; Jimenez-Barbero, Jesus; Pazos, Yolanda			The NMR Structure of Human Obestatin in Membrane-Like Environments: Insights into the Structure-Bioactivity Relationship of Obestatin	PLOS ONE			English	Article							SECONDARY STRUCTURE ANALYSES; GASTRIC-CANCER CELLS; GHRELIN-GENE; PROTEIN; PROLIFERATION; EXPRESSION; RECEPTOR; ANTIGEN; TARGET	The quest for therapeutic applications of obestatin involves, as a first step, the determination of its 3D solution structure and the relationship between this structure and the biological activity of obestatin. On this basis, we have employed a combination of circular dichroism (CD), nuclear magnetic resonance (NMR) spectroscopy, and modeling techniques to determine the solution structure of human obestatin (1). Other analogues, including human non-amidated obestatin (2) and the fragment peptides (6-23)-obestatin (3), (11-23)-obestatin (4), and (16-23)-obestatin (5) have also been scrutinized. These studies have been performed in a micellar environment to mimic the cell membrane (sodium dodecyl sulfate, SDS). Furthermore, structural-activity relationship studies have been performed by assessing the in vitro proliferative capabilities of these peptides in the human retinal pigmented epithelial cell line ARPE-19 (ERK1/2 and Akt phosphorylation, Ki67 expression, and cellular proliferation). Our findings emphasize the importance of both the primary structure (composition and size) and particular segments of the obestatin molecule that posses significant alpha-helical characteristics. Additionally, details of a species-specific role for obestatin have also been hypothesized by comparing human and mouse obestatins(1 and 6, respectively) at both the structural and bioactivity levels.	[Alen, Begona O.; Gurriaran-Rodriguez, Uxia; Mosteiro, Carlos S.; Alvarez-Perez, Juan C.; Camina, Jesus P.; Casanueva, Felipe F.; Pazos, Yolanda] Complejo Hosp Univ Santiago de Compostela CHUS, SERGAS, IDIS, Area Endocrinol Mol & Celular, Santiago De Compostela, Spain; [Alen, Begona O.; Gurriaran-Rodriguez, Uxia; Mosteiro, Carlos S.; Alvarez-Perez, Juan C.; Camina, Jesus P.; Casanueva, Felipe F.; Pazos, Yolanda] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain; [Nieto, Lidia; Jimenez-Barbero, Jesus] CIB CSIC, Ctr Invest Biol, Madrid, Spain; [Martin-Pastor, Manuel] Univ Santiago de Compostela, RIAIDT, Unidad Resonancia Magnet, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidade de Santiago de Compostela	Pazos, Y (corresponding author), Complejo Hosp Univ Santiago de Compostela CHUS, SERGAS, IDIS, Area Endocrinol Mol & Celular, Santiago De Compostela, Spain.	yolanda.pazos.randulfe@sergas.es	Perez, Juan c Alvarez/J-8294-2016; Perez, Juan Carlos Alvarez/AAE-4518-2021; Garcia-Caballero, Tomas/H-7213-2015; JIMENEZ-BARBERO, JESUS/D-4431-2014	Perez, Juan c Alvarez/0000-0001-6396-311X; Perez, Juan Carlos Alvarez/0000-0001-6396-311X; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Otero Alen, Begona/0000-0002-2876-6732; Rosalia, Gallego/0000-0002-6015-4680; Otero-Alen, Maria/0000-0002-0640-5776; Garcia-Caballero, Tomas/0000-0002-7938-1437; Gurriaran, Uxia/0000-0002-5375-0142; Martin-Pastor, Manuel/0000-0001-6024-1656	Ministerio de Economia y Competitividad [SAF2010-20451, CTQ2009-08536]; Xunta de Galicia [INCITE09PXIB 918374PR]; Instituto de Salud Carlos III (Ministerio de Economia y Competitividad, Spain) [PS09/02202, PS09/02075]; Instituto de Salud Carlos III; SERGAS; Xunta de Galicia	Ministerio de Economia y Competitividad(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Instituto de Salud Carlos III (Ministerio de Economia y Competitividad, Spain)(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); SERGAS; Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by grants from Ministerio de Economia y Competitividad (SAF2010-20451, CTQ2009-08536), Xunta de Galicia (INCITE09PXIB 918374PR) and Instituto de Salud Carlos III (Ministerio de Economia y Competitividad, Spain; PS09/02202, PS09/02075). CIBER is an initiative of Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, Spain). Instituto de Salud Carlos III and SERGAS fund the work of J.P. Camina, and Y. Pazos through a research-staff stabilization contract. Xunta de Galicia funds U. Gurriaran-Rodriguez through a research-staff contract Isabel Barreto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Camina JP, 2007, J CELL PHYSIOL, V211, P1, DOI 10.1002/jcp.20925; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gurriaran-Rodriguez U, 2011, J CELL MOL MED, V15, P1927, DOI 10.1111/j.1582-4934.2010.01192.x; Gurriaran-Rodriguez U, 2011, J ENDOCRINOL, V210, pR1, DOI 10.1530/JOE-11-0233; Keller R., 2004, COMPUTER AIDED RESON, V1; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nagaraj S, 2008, BIOCHEM BIOPH RES CO, V366, P731, DOI 10.1016/j.bbrc.2007.12.036; Pazos Y, 2007, GROWTH FACTORS, V25, P373, DOI 10.1080/08977190801889313; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Samson WK, 2007, AM J PHYSIOL-REG I, V292, pR637, DOI 10.1152/ajpregu.00395.2006; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; SCHWYZER R, 1995, J MOL RECOGNIT, V8, P3, DOI 10.1002/jmr.300080103; Scrima M, 2007, BIOCHEM BIOPH RES CO, V363, P500, DOI 10.1016/j.bbrc.2007.08.200; Seim I, 2011, MOL CELL ENDOCRINOL, V340, P111, DOI 10.1016/j.mce.2011.03.018; Subasinghage AP, 2010, PEPTIDES, V31, P1697, DOI 10.1016/j.peptides.2010.05.015; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zhang JV, 2008, MOL ENDOCRINOL, V22, P1464, DOI 10.1210/me.2007-0569; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	30	15	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e45434	10.1371/journal.pone.0045434	http://dx.doi.org/10.1371/journal.pone.0045434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056203	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800003
J	Lee, GH; Kim, SH; Homayouni, R; D'Arcangelo, G				Lee, Gum Hwa; Kim, Sun Hong; Homayouni, Ramin; D'Arcangelo, Gabriella			Dab2ip Regulates Neuronal Migration and Neurite Outgrowth in the Developing Neocortex	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; BRAIN-DEVELOPMENT; RADIAL MIGRATION; CEREBRAL-CORTEX; MOUSE-BRAIN; PHOSPHATIDYLINOSITOL 3-KINASE; DIFFERENTIAL EXPRESSION; CEREBELLAR HYPOPLASIA; CORTICAL DEVELOPMENT; TYROSINE KINASE	Dab2ip (DOC-2/DAB2 interacting protein) is a member of the Ras GTPase-activating protein (GAP) family that has been previously shown to function as a tumor suppressor in several systems. Dab2ip is also highly expressed in the brain where it interacts with Dab1, a key mediator of the Reelin pathway that controls several aspects of brain development and function. We found that Dab2ip is highly expressed in the developing cerebral cortex, but that mutations in the Reelin signaling pathway do not affect its expression. To determine whether Dab2ip plays a role in brain development, we knocked down or over expressed it in neuronal progenitor cells of the embryonic mouse neocortex using in utero electroporation. Dab2ip down-regulation severely disrupts neuronal migration, affecting preferentially late-born principal cortical neurons. Dab2ip overexpression also leads to migration defects. Structure-function experiments in vivo further show that both PH and GRD domains of Dab2ip are important for neuronal migration. A detailed analysis of transfected neurons reveals that Dab2ip down-or up-regulation disrupts the transition from a multipolar to a bipolar neuronal morphology in the intermediate zone. Knock down of Dab2ip in neurons ex-vivo indicates that this protein is necessary for proper neurite development and for the expression of several major neuronal microtubule associated proteins (MAPs), which are important for neurite growth and stabilization. Thus, our study identifies, for the first time, a critical role for Dab2ip in mammalian cortical development and begins to reveal molecular mechanisms that underlie this function.	[Lee, Gum Hwa; D'Arcangelo, Gabriella] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA; [Lee, Gum Hwa; D'Arcangelo, Gabriella] Rutgers State Univ, Grad Program Mol Biosci, Piscataway, NJ USA; [Kim, Sun Hong] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Homayouni, Ramin] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Johns Hopkins University; University of Memphis	D'Arcangelo, G (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA.	darcangelo@biology.rutgers.edu	Homayouni, Ramin/B-3547-2009; Homayouni, Ramin/U-2837-2019	Homayouni, Ramin/0000-0003-0186-5076; Homayouni, Ramin/0000-0003-0186-5076; D'Arcangelo, Gabriella/0000-0003-1575-1010	New Jersey Governor's Council for Medical Research and Treatment of Autism [10-409-SCH-E-O]; Anne B. and James B. Leathem summer research fellowships; National Institutes of Health [MH068433]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068433] Funding Source: NIH RePORTER	New Jersey Governor's Council for Medical Research and Treatment of Autism; Anne B. and James B. Leathem summer research fellowships; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded in part by Research Grant 10-409-SCH-E-O from the New Jersey Governor's Council for Medical Research and Treatment of Autism (GD), Anne B. and James B. Leathem summer research fellowships (GHL), and National Institutes of Health grant MH068433 (RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; BAAS PW, 1986, J CELL BIOL, V103, P917, DOI 10.1083/jcb.103.3.917; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Cardoso C, 2002, HUM MUTAT, V19, P4, DOI 10.1002/humu.10028; Chen H, 2006, DNA CELL BIOL, V25, P232, DOI 10.1089/dna.2006.25.232; Chen H, 2002, GENOMICS, V79, P573, DOI 10.1006/geno.2002.6739; CRANDALL JE, 1989, J NEUROCHEM, V53, P1910, DOI 10.1111/j.1471-4159.1989.tb09261.x; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gonzalez-Billault C, 2002, J NEUROSCI RES, V67, P713, DOI 10.1002/jnr.10161; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Homayouni R, 2003, MOL BRAIN RES, V115, P121, DOI 10.1016/S0169-328X(03)00176-1; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Hussman JP, 2011, MOL AUTISM, V2, DOI [10.1186/2040-2392-2-1, 10.1186/2040-2392-2-18]; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kazdoba TM, 2012, DEV NEUROSCI; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Matsumoto N, 2001, EUR J HUM GENET, V9, P5, DOI 10.1038/sj.ejhg.5200548; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Ozmen M, 2000, TURKISH J PEDIATR, V42, P210; Qiu GH, 2007, J HEPATOL, V46, P655, DOI 10.1016/j.jhep.2006.11.012; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RIEDERER B, 1985, P NATL ACAD SCI USA, V82, P6006, DOI 10.1073/pnas.82.17.6006; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sekine K, 2011, J NEUROSCI, V31, P9426, DOI 10.1523/JNEUROSCI.0650-11.2011; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Tabata H, 2003, J NEUROSCI, V23, P9996; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Takei Y, 1997, J CELL BIOL, V137, P1615, DOI 10.1083/jcb.137.7.1615; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200	55	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46592	10.1371/journal.pone.0046592	http://dx.doi.org/10.1371/journal.pone.0046592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056358	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800028
J	Wang, WQ; Wu, YR; Messing, J				Wang, Wenqin; Wu, Yongrui; Messing, Joachim			The Mitochondrial Genome of an Aquatic Plant, Spirodela polyrhiza	PLOS ONE			English	Article							GENE-TRANSFER; SEQUENCE; DNA; L.; ORGANELLAR; EVOLUTION; CONTAINS; NUCLEAR; DUCKWEEDS; PHYLOGENY	Background: Spirodela polyrhiza is a species of the order Alismatales, which represent the basal lineage of monocots with more ancestral features than the Poales. Its complete sequence of the mitochondrial (mt) genome could provide clues for the understanding of the evolution of mt genomes in plant. Methods: Spirodela polyrhiza mt genome was sequenced from total genomic DNA without physical separation of chloroplast and nuclear DNA using the SOLiD platform. Using a genome copy number sensitive assembly algorithm, the mt genome was successfully assembled. Gap closure and accuracy was determined with PCR products sequenced with the dideoxy method. Conclusions: This is the most compact monocot mitochondrial genome with 228,493 bp. A total of 57 genes encode 35 known proteins, 3 ribosomal RNAs, and 19 tRNAs that recognize 15 amino acids. There are about 600 RNA editing sites predicted and three lineage specific protein-coding-gene losses. The mitochondrial genes, pseudogenes, and other hypothetical genes (ORFs) cover 71,783 bp (31.0%) of the genome. Imported plastid DNA accounts for an additional 9,295 bp (4.1%) of the mitochondrial DNA. Absence of transposable element sequences suggests that very few nuclear sequences have migrated into Spirodela mtDNA. Phylogenetic analysis of conserved protein-coding genes suggests that Spirodela shares the common ancestor with other monocots, but there is no obvious synteny between Spirodela and rice mtDNAs. After eliminating genes, introns, ORFs, and plastid-derived DNA, nearly four-fifths of the Spirodela mitochondrial genome is of unknown origin and function. Although it contains a similar chloroplast DNA content and range of RNA editing as other monocots, it is void of nuclear insertions, active gene loss, and comprises large regions of sequences of unknown origin in non-coding regions. Moreover, the lack of synteny with known mitochondrial genomic sequences shed new light on the early evolution of monocot mitochondrial genomes.	[Wang, Wenqin; Wu, Yongrui; Messing, Joachim] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Messing, J (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08855 USA.	messing@waksman.rutgers.edu	Wang, Wenqin/AAR-2970-2021	Wang, Wenqin/0000-0001-6427-6338; Messing, Joachim/0000-0001-8260-2643				Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Adams KL, 2001, GENETICS, V158, P1289; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Bergman CM, 2007, BRIEF BIOINFORM, V8, P382, DOI 10.1093/bib/bbm048; Borsch T, 2003, J EVOLUTION BIOL, V16, P558, DOI 10.1046/j.1420-9101.2003.00577.x; Cabrera LI, 2008, AM J BOT, V95, P1153, DOI 10.3732/ajb.0800073; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Fang Y, 2012, NC0167401 NCBI GENBA; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Janssen T, 2004, BOT J LINN SOC, P4; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Knoop V, 1996, GENETICS, V142, P579; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Les DH, 2002, SYST BOT, V27, P221; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lilly JW, 2001, GENETICS, V159, P317; Ljaz S, 2010, AFRICAN J BIOTECHNOL, V9, P4; Logan DC, 2006, J EXP BOT, V57, P1225, DOI 10.1093/jxb/erj151; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lutz KA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-54; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Malek O, 1998, RNA, V4, P1599, DOI 10.1017/S1355838298981262; McDermott P, 2008, THEOR APPL GENET, V117, P459, DOI 10.1007/s00122-008-0790-7; Mower J.P., 2012, PLANT GENOME DIVERSI, P123, DOI DOI 10.1007/978-3-7091-1130-7_9; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Perrotta G, 2002, PLANT MOL BIOL, V50, P523, DOI 10.1023/A:1019878212696; Revanna KV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-316; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Satoh M, 2004, MOL GENET GENOMICS, V272, P247, DOI 10.1007/s00438-004-1058-9; Satoh M, 2006, THEOR APPL GENET, V113, P477, DOI 10.1007/s00122-006-0312-4; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; Smit A, 1996, REPEATMASKER OPEN 30; Stomp AM, 2005, BIOTECHNOL ANN REV, V11, P69, DOI 10.1016/S1387-2656(05)11002-3; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022993; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhang TW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-38	51	24	30	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46747	10.1371/journal.pone.0046747	http://dx.doi.org/10.1371/journal.pone.0046747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056432	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800047
J	Cain, AA; Kosara, R; Gibas, CJ				Cain, Aurora A.; Kosara, Robert; Gibas, Cynthia J.			GenoSets: Visual Analytic Methods for Comparative Genomics	PLOS ONE			English	Article							OUTER-MEMBRANE PROPERTIES; OMP25/OMP31 FAMILY; BRUCELLA-OVIS; GENE ONTOLOGY; VIRULENCE; IDENTIFICATION; DELETION; BROWSER; TOOL	Many important questions in biology are, fundamentally, comparative, and this extends to our analysis of a growing number of sequenced genomes. Existing genomic analysis tools are often organized around literal views of genomes as linear strings. Even when information is highly condensed, these views grow cumbersome as larger numbers of genomes are added. Data aggregation and summarization methods from the field of visual analytics can provide abstracted comparative views, suitable for sifting large multi-genome datasets to identify critical similarities and differences. We introduce a software system for visual analysis of comparative genomics data. The system automates the process of data integration, and provides the analysis platform to identify and explore features of interest within these large datasets. GenoSets borrows techniques from business intelligence and visual analytics to provide a rich interface of interactive visualizations supported by a multi-dimensional data warehouse. In GenoSets, visual analytic approaches are used to enable querying based on orthology, functional assignment, and taxonomic or user-defined groupings of genomes. GenoSets links this information together with coordinated, interactive visualizations for both detailed and high-level categorical analysis of summarized data. GenoSets has been designed to simplify the exploration of multiple genome datasets and to facilitate reasoning about genomic comparisons. Case examples are included showing the use of this system in the analysis of 12 Brucella genomes. GenoSets software and the case study dataset are freely available at http://genosets.uncc.edu. We demonstrate that the integration of genomic data using a coordinated multiple view approach can simplify the exploration of large comparative genomic data sets, and facilitate reasoning about comparisons and features of interest.	[Cain, Aurora A.; Gibas, Cynthia J.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Kosara, Robert] Univ N Carolina, Dept Comp Sci, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Gibas, CJ (corresponding author), Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.	cgibas@uncc.edu		Gibas, Cynthia/0000-0002-1288-9543	Department of Education (DOE) GAANN Graduate Fellowship program; National Science Foundation (NSF) Advance Bonnie Cone Fellowship program; NSF [1047896]	Department of Education (DOE) GAANN Graduate Fellowship program; National Science Foundation (NSF) Advance Bonnie Cone Fellowship program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by the Department of Education (DOE) GAANN Graduate Fellowship program (AC), the National Science Foundation (NSF) Advance Bonnie Cone Fellowship program (CG) and NSF 1047896 SI2-SSE: Reducing the Complexity of Comparative Genomics with Online Analytical Processing (RK and CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bellaire BH, 2003, INFECT IMMUN, V71, P1794, DOI 10.1128/IAI.71.4.1794-1803.2003; Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07; Crasta OR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002193; Gattiker A, 2009, NUCLEIC ACIDS RES, V37, pW296, DOI 10.1093/nar/gkp268; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gibas C, 2003, THIRD IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING - BIBE 2003, PROCEEDINGS, P158, DOI 10.1109/BIBE.2003.1188942; Halling SM, 2004, FRONTIER MOL CELLULA; Jacques I, 2007, VACCINE, V25, P794, DOI 10.1016/j.vaccine.2006.09.051; Jain N, 2011, FEMS MICROBIOL LETT, V316, P1, DOI 10.1111/j.1574-6968.2010.02186.x; Jenner DC, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/354649; Kimball R., 2002, DATA WAREHOUSE TOOLK; Kosara R, 2006, IEEE T VIS COMPUT GR, V12, P558, DOI 10.1109/TVCG.2006.76; Kosara R, PARALLEL SETS EAGERE; Kulikova T, 2006, NUCL ACIDS RES; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Mangan Mary E, 2009, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1909s88; Mangan ME, 2008, BIOTECHNOL ANN REV, V14, P63, DOI 10.1016/S1387-2656(08)00003-3; Martin-Martin AI, 2008, MICROBES INFECT, V10, P706, DOI 10.1016/j.micinf.2008.02.013; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Nuzzo A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-278; Nymo IH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-93; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Ratushna VG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-13; Roop RM, 2009, MED MICROBIOL IMMUNO; SHNEIDERMAN B, 1992, ACM T GRAPHIC, V11, P92, DOI 10.1145/102377.115768; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tsolis RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005519; Wang YF, 2010, FEMS MICROBIOL LETT, V303, P92, DOI 10.1111/j.1574-6968.2009.01866.x; Wattam AR, 2009, J BACTERIOL, V191, P3569, DOI 10.1128/JB.01767-08; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; Wyckoff EE, 2011, MOL MICROBIOL	37	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46401	10.1371/journal.pone.0046401	http://dx.doi.org/10.1371/journal.pone.0046401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056299	Green Published, gold			2022-12-27	WOS:000309454000038
J	De-Miguel, FF; Santamaria-Holek, I; Noguez, P; Bustos, C; Hernandez-Lemus, E; Rubi, JM				De-Miguel, Francisco F.; Santamaria-Holek, Ivan; Noguez, Paula; Bustos, Carlos; Hernandez-Lemus, Enrique; Miguel Rubi, J.			Biophysics of Active Vesicle Transport, an Intermediate Step That Couples Excitation and Exocytosis of Serotonin in the Neuronal Soma	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; CHROMAFFIN CELLS; SECRETORY GRANULES; LEECH NEURONS; RELEASE; 5-HYDROXYTRYPTAMINE; TERMINALS; CALCIUM; COMMUNICATION; TRANSMISSION	Transmitter exocytosis from the neuronal soma is evoked by brief trains of high frequency electrical activity and continues for several minutes. Here we studied how active vesicle transport towards the plasma membrane contributes to this slow phenomenon in serotonergic leech Retzius neurons, by combining electron microscopy, the kinetics of exocytosis obtained from FM1-43 dye fluorescence as vesicles fuse with the plasma membrane, and a diffusion equation incorporating the forces of local confinement and molecular motors. Electron micrographs of neurons at rest or after stimulation with 1 Hz trains showed cytoplasmic clusters of dense core vesicles at 1.5+/-0.2 and 3.7+/-0.3 mu m distances from the plasma membrane, to which they were bound through microtubule bundles. By contrast, after 20 Hz stimulation vesicle clusters were apposed to the plasma membrane, suggesting that transport was induced by electrical stimulation. Consistently, 20 Hz stimulation of cultured neurons induced spotted FM1-43 fluorescence increases with one or two slow sigmoidal kinetics, suggesting exocytosis from an equal number of vesicle clusters. These fluorescence increases were prevented by colchicine, which suggested microtubule-dependent vesicle transport. Model fitting to the fluorescence kinetics predicted that 52-951 vesicles/cluster were transported along 0.60-6.18 mu m distances at average 11-95 nms(-1) velocities. The ATP cost per vesicle fused (0.4-72.0), calculated from the ratio of the Delta G(process)/Delta G(ATP), depended on the ratio of the traveling velocity and the number of vesicles in the cluster. Interestingly, the distance-dependence of the ATP cost per vesicle was bistable, with low energy values at 1.4 and 3.3 mu m, similar to the average resting distances of the vesicle clusters, and a high energy barrier at 1.6-2.0 mu m. Our study confirms that active vesicle transport is an intermediate step for somatic serotonin exocytosis by Retzius neurons and provides a quantitative method for analyzing similar phenomena in other cell types.	[De-Miguel, Francisco F.; Noguez, Paula; Bustos, Carlos] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Santamaria-Holek, Ivan] Univ Nacl Autonoma Mexico, UMJ Fac Ciencias, Queretaro, Mexico; [Hernandez-Lemus, Enrique] Inst Nacl Med Genom, Dept Genom Computac, Mexico City, DF, Mexico; [Miguel Rubi, J.] Univ Barcelona, Fac Fis, E-08028 Barcelona, Spain	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; University of Barcelona	De-Miguel, FF (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Ciudad Univ, Mexico City 04510, DF, Mexico.	ffernand@ifc.unam.mx	Santamaria-Holek, Ivan/AAQ-9584-2021; de Miguel, Francisco Fernández/AAT-8913-2020; Bustos-Segura, Carlos/AAF-2564-2020	Bustos-Segura, Carlos/0000-0002-8624-3251; Hernandez-Lemus, Enrique/0000-0002-1872-1397; Santamaria-Holek, I./0000-0002-5306-197X	Direccion General de Apoyo del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) [IN211511, IN 102609]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico [130031]; CONACyT [193987]	Direccion General de Apoyo del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA-UNAM); Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was founded by grants IN211511 from the Direccion General de Apoyo del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) and grant 130031 from the Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico to FFM, and by DGAPA-UNAM grant IN 102609 to ISH. PN was supported by a CONACyT fellowship 193987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTY RA, 1992, BIOCHEMISTRY-US, V31, P10610, DOI 10.1021/bi00158a025; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, NEURON, V9, P805, DOI 10.1016/0896-6273(92)90235-6; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Bunin MA, 1998, J NEUROSCI, V18, P4854; CHAZAL G, 1987, J COMP NEUROL, V259, P317, DOI 10.1002/cne.902590302; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; COGGESHALL RE, 1972, ANAT RECORD, V172, P489, DOI 10.1002/ar.1091720303; Colgan LA, 2009, J NEUROSCI, V29, P15878, DOI 10.1523/JNEUROSCI.4210-09.2009; De-Miguel FF, 2005, CELL MOL NEUROBIOL, V25, P297, DOI 10.1007/s10571-005-3061-z; DIETZEL ID, 1986, J PHYSIOL-LONDON, V372, P191, DOI 10.1113/jphysiol.1986.sp016004; Fu XW, 2002, J PHYSIOL-LONDON, V539, P503, DOI 10.1113/jphysiol.2001.013071; Fuxe K, 2012, FRONT PHYSL, V3, P175; Fuxe K, 2007, BRAIN RES REV, V55, P17, DOI 10.1016/j.brainresrev.2007.02.009; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Kaushalya SK, 2008, J NEUROSCI RES, V86, P3469, DOI 10.1002/jnr.21794; Kravitz EA, 2000, J COMP PHYSIOL A, V186, P221, DOI 10.1007/s003590050423; Kuffler DP, 1987, J COMP NEUROL, V22, P516; Manneville JB, 2003, J CELL SCI, V116, P3927, DOI 10.1242/jcs.00672; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Moukhles H, 1997, NEUROSCIENCE, V76, P1159, DOI 10.1016/S0306-4522(96)00452-6; Neco P, 2003, EUR J NEUROSCI, V18, P733, DOI 10.1046/j.1460-9568.2003.02801.x; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Park JJ, 2008, MOL ENDOCRINOL, V22, P989, DOI 10.1210/me.2007-0473; Patel JC, 2009, J NEUROSCI, V29, P6568, DOI 10.1523/JNEUROSCI.0181-09.2009; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Rose SD, 2002, ANN NY ACAD SCI, V971, P222, DOI 10.1111/j.1749-6632.2002.tb04466.x; Santamaria-Holek I, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2241190; Santamaria-Holek I, 2007, J PHYS CHEM B, V111, P2293, DOI 10.1021/jp0675375; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Siddall ME, 2007, P R SOC B, V274, P1481, DOI 10.1098/rspb.2007.0248; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; Trueta C, 2003, J PHYSIOL-LONDON, V547, P405, DOI 10.1113/jphysiol.2002.030684; Trueta C, 2004, J PHYSL, V547, P309; Trueta C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00175; Velazquez-Ulloa N, 2003, J NEUROBIOL, V54, P604, DOI 10.1002/neu.10184; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Weiger WA, 1997, BIOL REV, V72, P61, DOI 10.1017/S0006323196004975; WILLARD AL, 1981, J NEUROSCI, V1, P936; Yu R, 2007, MOL MICROBIOL, V63, P454, DOI 10.1111/j.1365-2958.2006.05536.x; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104	47	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45454	10.1371/journal.pone.0045454	http://dx.doi.org/10.1371/journal.pone.0045454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056204	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000007
J	Duprez, J; Roma, LP; Close, AF; Jonas, JC				Duprez, Jessica; Roma, Leticia P.; Close, Anne-Francoise; Jonas, Jean-Christophe			Protective Antioxidant and Antiapoptotic Effects of ZnCl2 in Rat Pancreatic Islets Cultured in Low and High Glucose Concentrations	PLOS ONE			English	Article							METALLOTHIONEIN GENE-EXPRESSION; BETA-CELLS; OXIDATIVE STRESS; INSULIN-SECRETION; ZINC; APOPTOSIS; PROTEIN; ZNT8; ACTIVATION; SYSTEMS	Aim/Hypothesis: Rat pancreatic islet cell apoptosis is minimal after prolonged culture in 10 mmol/l glucose (G10), largely increased in 5 mmol/l glucose (G5) and moderately increased in 30 mmol/l glucose (G30). This glucose-dependent asymmetric V-shaped profile is preceded by parallel changes in the mRNA levels of oxidative stress-response genes like Metallothionein 1a (Mt1a). In this study, we tested the effect of ZnCl2, a potent inducer of Mt1a, on apoptosis, mitochondrial oxidative stress and alterations of glucose-induced insulin secretion (GSIS) induced by prolonged exposure to low and high vs. intermediate glucose concentrations. Methods: Male Wistar rat islets were cultured in RPMI medium. Islet gene mRNA levels were measured by RTq-PCR. Apoptosis was quantified by measuring islet cytosolic histone-associated DNA fragments and the percentage of TUNEL-positive beta-cells. Mitochondrial thiol oxidation was measured in rat islet cell clusters expressing "redox sensitive GFP'' targeted to the mitochondria (mt-roGFP1). Insulin secretion was measured by RIA. Results: As observed for Mt1a mRNA levels, beta-cell apoptosis and loss of GSIS, culture in either G5 or G30 vs. G10 significantly increased mt-roGFP1 oxidation. While TPEN decreased Mt1a/2a mRNA induction by G5, addition of 50-100 mu M ZnCl2 to the culture medium strongly increased Mt1a/2a mRNA and protein levels, reduced early mt-roGFP oxidation and significantly decreased late beta-cell apoptosis after prolonged culture in G5 or G30 vs. G10. It did not, however, prevent the loss of GSIS under these culture conditions. Conclusion: ZnCl2 reduces mitochondrial oxidative stress and improves rat beta-cell survival during culture in the presence of low and high vs. intermediate glucose concentrations without improving their acute GSIS.	[Duprez, Jessica; Roma, Leticia P.; Close, Anne-Francoise; Jonas, Jean-Christophe] Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium	Universite Catholique Louvain	Jonas, JC (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium.	jean-christophe.jonas@uclouvain.be	Close, Anne-Françoise/GWZ-2344-2022; Roma, Leticia/U-4250-2018; Jonas, Jean-Christophe/C-6766-2011	Roma, Leticia/0000-0001-9527-0529; Jonas, Jean-Christophe/0000-0001-9882-5438	Fonds de la Recherche Scientifique-FNRS (Belgium) [3.4516.09, 1.5012.11, 3.4521.12]; Societe Francophone du Diabete (France); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Belgium	Fonds de la Recherche Scientifique-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); Societe Francophone du Diabete (France); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Belgium	This work was supported by the Fonds de la Recherche Scientifique-FNRS (Belgium) (grants 3.4516.09, 1.5012.11 and 3.4521.12) and the Societe Francophone du Diabete (France). JD is recipient of a fellowship from the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Belgium. JCJ is Research Director of the Fonds de la Recherche Scientifique-FNRS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GK, 2001, BIOMETALS, V14, P223, DOI 10.1023/A:1012932712483; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Bosco Mariea D, 2010, Rev Diabet Stud, V7, P263, DOI 10.1900/RDS.2010.7.263; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cauchi S, 2010, MOL GENET METAB, V100, P77, DOI 10.1016/j.ymgme.2010.01.001; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Duprez J, 2011, BIOCHEM BIOPH RES CO, V415, P294, DOI 10.1016/j.bbrc.2011.10.048; Efanova IB, 1998, J BIOL CHEM, V273, P33501, DOI 10.1074/jbc.273.50.33501; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; FERRER R, 1984, AM J PHYSIOL, V246, pC520, DOI 10.1152/ajpcell.1984.246.5.C520; FIGLEWICZ DP, 1981, ENDOCRINOLOGY, V108, P730, DOI 10.1210/endo-108-2-730; Fischer EH, 1998, P NATL ACAD SCI USA, V95, P3333, DOI 10.1073/pnas.95.7.3333; Formigare A, 2007, COMP BIOCHEM PHYS C, V146, P443, DOI 10.1016/j.cbpc.2007.07.010; GHAFGHAZI T, 1981, DIABETES, V30, P341, DOI 10.2337/diabetes.30.4.341; Gunasekara P, 2011, DIABET METAB SYND OB, V4, P53, DOI 10.2147/DMSO.S16691; Hamatake M, 2000, J BIOCHEM-TOKYO, V128, P933, DOI 10.1093/oxfordjournals.jbchem.a022844; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hardy AB, 2011, DIABETES OBES METAB, V13, P112, DOI 10.1111/j.1463-1326.2011.01451.x; HEDING LG, 1972, DIABETOLOGIA, V8, P260, DOI 10.1007/BF01225569; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Jansen J, 2009, J NUTR BIOCHEM, V20, P399, DOI 10.1016/j.jnutbio.2009.01.009; Lefebvre B, 2012, J ENDOCRINOL, V214, P225, DOI 10.1530/JOE-12-0071; Leggate J, 2006, BIOTECHNOL LETT, V28, P1587, DOI 10.1007/s10529-006-9128-1; Maret W, 2011, J BIOL INORG CHEM, V16, P1079, DOI 10.1007/s00775-011-0800-0; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Miura T, 1997, LIFE SCI, V60, pPL301; Mocchegiani E, 2008, TRENDS MOL MED, V14, P419, DOI 10.1016/j.molmed.2008.08.002; Ohly P, 1998, TALANTA, V46, P355, DOI 10.1016/S0039-9140(97)00347-0; Ohly P, 2000, DIABETOLOGIA, V43, P1020, DOI 10.1007/s001250050009; Okamoto T, 2011, ANN TRANSPL, V16, P114; Oteiza PL, 1996, P SOC EXP BIOL MED, V213, P85, DOI 10.3181/00379727-213-44040; Parat MO, 1997, BIOL TRACE ELEM RES, V60, P187, DOI 10.1007/BF02784439; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Roma LP, 2012, DIABETOLOGIA, V55, P2226, DOI 10.1007/s00125-012-2581-6; Roma LP, 2012, BIOCHEM J, V441, P971, DOI 10.1042/BJ20111770; Samson SLA, 1998, PROG NUCLEIC ACID RE, V59, P257, DOI 10.1016/S0079-6603(08)61034-X; Sarre A, 2012, FREE RADICAL BIO MED, V52, P142, DOI 10.1016/j.freeradbiomed.2011.10.437; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Taylor CG, 2005, BIOMETALS, V18, P305, DOI 10.1007/s10534-005-3686-x; Truong-Tran AQ, 2001, BIOMETALS, V14, P315, DOI 10.1023/A:1012993017026; Untergasser G, 2000, BIOCHEM BIOPH RES CO, V279, P607, DOI 10.1006/bbrc.2000.3975; van Raalte DH, 2011, DIABETES RES CLIN PR, V93, pS37, DOI 10.1016/S0168-8227(11)70012-2	49	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46831	10.1371/journal.pone.0046831	http://dx.doi.org/10.1371/journal.pone.0046831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056475	gold, Green Submitted, Green Published			2022-12-27	WOS:000309454000092
J	Lin, CC; Yen, JC; Wu, YT; Lin, LC; Tsai, TH				Lin, Chia-Chun; Yen, Jiin-Cherng; Wu, Yu-Tse; Lin, Lie-Chwen; Tsai, Tung-Hu			Chemical Analysis and Transplacental Transfer of Oseltamivir and Oseltamivir Carboxylic Acid in Pregnant Rats	PLOS ONE			English	Article							MATERNAL TISSUE DISTRIBUTION; BLOOD-BRAIN-BARRIER; NEURAMINIDASE INHIBITORS; LIQUID-CHROMATOGRAPHY; PRODRUG OSELTAMIVIR; RO 64-0802; LC-MS/MS; INFLUENZA; PLASMA; PHOSPHATE	In view of the limited information on the pharmacokinetics of oseltamivir (OSE) during pregnancy, this study aims to evaluate the placental transportation of OSE and its active metabolite oseltamivir carboxylic acid (OCA) in rats. A validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) system coupled to an in vivo transplacental model has been developed to determine OSE and OCA in the placenta, amniotic fluids and fetus of 13-day pregnant Sprague-Dawley rats. Concentrations of OSE and OCA in plasma, amniotic fluids, placenta, and fetus were measured by the validated LC-MS/MS after OSE administration (10 mg/kg, iv). The pharmacokinetic data of both analytes were examined by non-compartmental modeling. The area under the concentration-time curve (AUC) of OCA in maternal plasma was found to be 3.6 times larger than that of OSE. The AUCs of OCA in both amniotic fluid and fetus were significantly decreased, in comparison with that in maternal plasma (reduced by 76.7 and 98.1%, respectively). We found that both OSE and OCA can penetrate the placenta, amniotic fluids and fetus in rats during pregnancy; however, the penetration of OCA was much lower than that of OSE. The mother-to-fetus transfer ratio was defined as AUC(fetus)/AUC(mother). The data demonstrated that the mother-to-fetus transfer ratio of OSE and OCA were 1.64 and 0.019, respectively, suggesting that OSE, but not OCA, penetrated through the placenta. Moreover, OCA might not be easily metabolized in the fetus due to the lack of carboxylase in the fetus.	[Wu, Yu-Tse; Lin, Lie-Chwen; Tsai, Tung-Hu] Natl Yang Ming Univ, Inst Tradit Med, Sch Med, Taipei 112, Taiwan; [Lin, Chia-Chun; Yen, Jiin-Cherng] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei 112, Taiwan; [Lin, Lie-Chwen] Natl Res Inst Chinese Med, Taipei, Taiwan; [Tsai, Tung-Hu] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan; [Wu, Yu-Tse; Tsai, Tung-Hu] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine; China Medical University Taiwan; Taipei City Hospital	Tsai, TH (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, Sch Med, Taipei 112, Taiwan.	thtsai@ym.edu.tw	Tsai, Tung-Hu/AAG-4558-2021	Tsai, Tung-Hu/0000-0002-9007-2547; Wu, Yu-Tse/0000-0002-5731-2107	National Science Council, Taiwan [NSC99-2113-M-010-001-MY3, NSC99-2628-B-010-008-MY3]; Taipei City Hospital, Taiwan [TCH 99001-62-015]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei City Hospital, Taiwan	Funding for this study was provided in part by research grants from the National Science Council (NSC99-2113-M-010-001-MY3, NSC99-2628-B-010-008-MY3) Taiwan and TCH 99001-62-015 from Taipei City Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, TAM OS PHOSPH PRESCR; Bahrami G, 2008, J CHROMATOGR B, V864, P38, DOI 10.1016/j.jchromb.2008.01.048; Berveiller P, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.023; Chang Q, 2009, BIOMED CHROMATOGR, V23, P852, DOI 10.1002/bmc.1195; Donner B, 2010, DRUG SAFETY, V33, P631, DOI 10.2165/11536370-000000000-00000; He G, 1999, CLIN PHARMACOKINET, V37, P471, DOI 10.2165/00003088-199937060-00003; He K, 2008, DRUG METAB DISPOS, V36, P2564, DOI 10.1124/dmd.108.022764; Heinig K, 2008, J CHROMATOGR B, V876, P129, DOI 10.1016/j.jchromb.2008.10.037; Hoffmann G, 2009, ANTIMICROB AGENTS CH, V53, P4753, DOI 10.1128/AAC.01541-08; Holodniy M, 2008, ANTIMICROB AGENTS CH, V52, P3013, DOI 10.1128/AAC.00047-08; Jabbaribar F, 2008, CHEM PHARM BULL, V56, P1639, DOI 10.1248/cpb.56.1639; Kanneti R, 2011, BIOMED CHROMATOGR, V25, P727, DOI 10.1002/bmc.1509; Karpf M, 2001, J ORG CHEM, V66, P2044, DOI 10.1021/jo005702l; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Lindegardh N, 2007, J CHROMATOGR B, V859, P74, DOI 10.1016/j.jchromb.2007.09.018; Lindegardh N, 2006, ANTIMICROB AGENTS CH, V50, P3197, DOI 10.1128/AAC.00500-06; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Mendel DB, 1998, ANTIMICROB AGENTS CH, V42, P640, DOI 10.1128/AAC.42.3.640; Morimoto K, 2008, DRUG METAB DISPOS, V36, P6, DOI 10.1124/dmd.107.017699; Novotna M, 2004, REPROD TOXICOL, V18, P785, DOI 10.1016/j.reprotox.2004.04.014; Ose A, 2009, DRUG METAB DISPOS, V37, P315, DOI 10.1124/dmd.108.024018; PADYKULA HA, 1958, J ANAT, V92, P118; PERROTTA CA, 1958, J ANAT, V92, P110; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Shi DS, 2006, J PHARMACOL EXP THER, V319, P1477, DOI 10.1124/jpet.106.111807; Shin HC, 2003, COMP BIOCHEM PHYS C, V136, P95, DOI 10.1016/j.cca.2003.08.004; Tanaka T, 2009, CAN MED ASSOC J, V181, P55, DOI 10.1503/cmaj.090866; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Wiltshire H, 2000, J CHROMATOGR B, V745, P373, DOI 10.1016/S0378-4347(00)00300-5; Worley KC, 2008, INFECT DIS OBSTET GY, V2008; Zollner P, 2003, LC GC EUR, V16, P163	33	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46062	10.1371/journal.pone.0046062	http://dx.doi.org/10.1371/journal.pone.0046062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056234	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000014
J	Torregroza, I; Holtzinger, A; Mendelson, K; Liu, TC; Hla, T; Evans, T				Torregroza, Ingrid; Holtzinger, Audrey; Mendelson, Karen; Liu, Ting-Chun; Hla, Timothy; Evans, Todd			Regulation of a Vascular Plexus by gata4 Is Mediated in Zebrafish through the Chemokine sdf1a	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; HEART TUBE FORMATION; TRANSCRIPTION FACTOR; LATERAL-LINE; IN-VIVO; VENTRAL MORPHOGENESIS; TRANSGENIC ZEBRAFISH; SIGNALING CONTROLS; TISSUE MIGRATION; EXPRESSION	Using the zebrafish model we describe a previously unrecognized requirement for the transcription factor gata4 controlling embryonic angiogenesis. The development of a vascular plexus in the embryonic tail, the caudal hematopoietic tissue (CHT), fails in embryos depleted of gata4. Rather than forming a normal vascular plexus, the CHT of gata4 morphants remains fused, and cells in the CHT express high levels of osteogenic markers ssp1 and runx1. Definitive progenitors emerge from the hemogenic aortic endothelium, but fail to colonize the poorly vascularized CHT. We also found abnormal patterns and levels for the chemokine sdf1a in gata4 morphants, which was found to be functionally relevant, since the embryos also show defects in development of the lateral line, a mechano-sensory organ system highly dependent on a gradient of sdf1a levels. Reduction of sdf1a levels was sufficient to rescue lateral line development, circulation, and CHT morphology. The result was surprising since neither gata4 nor sdf1a is obviously expressed in the CHT. Therefore, we generated transgenic fish that conditionally express a dominant-negative gata4 isoform, and determined that gata4 function is required during gastrulation, when it is co-expressed with sdf1a in lateral mesoderm. Our study shows that the gata4 gene regulates sdf1a levels during early embryogenesis, which impacts embryonic patterning and subsequently the development of the caudal vascular plexus.	[Torregroza, Ingrid; Holtzinger, Audrey; Mendelson, Karen; Liu, Ting-Chun; Evans, Todd] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Mendelson, Karen; Hla, Timothy] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA	Cornell University; Cornell University	Evans, T (corresponding author), Weill Cornell Med Coll, Dept Surg, New York, NY USA.	tre2003@med.cornell.edu	Hla, Timothy/G-5873-2012	Hla, Timothy/0000-0001-8355-4065	National Institutes of Health [R37HL056182]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111400, R37HL056182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported entirely by a grant from the National Institutes of Health to TE (R37HL056182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bertrand JY, 2009, CURR OPIN HEMATOL, V16, P243, DOI 10.1097/MOH.0b013e32832c05e4; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Choi J, 2011, DEVELOPMENT, V138, P1173, DOI 10.1242/dev.054049; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Glass TJ, 2011, BLOOD, V118, P766, DOI 10.1182/blood-2011-01-328476; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Harper SE, 1996, P NATL ACAD SCI USA, V93, P8536, DOI 10.1073/pnas.93.16.8536; Hattori K, 2003, LEUKEMIA LYMPHOMA, V44, P575, DOI 10.1080/1042819021000037985; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Heicklen-Klein A, 2005, SEMIN CELL DEV BIOL, V16, P95, DOI 10.1016/j.semcdb.2004.10.004; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Holtzinger A, 2007, DEV BIOL, V312, P613, DOI 10.1016/j.ydbio.2007.09.018; Holtzinger A, 2010, DEV BIOL, V337, P63, DOI 10.1016/j.ydbio.2009.10.003; Jiang YM, 1999, DEV BIOL, V216, P57, DOI 10.1006/dbio.1999.9469; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li Q, 2004, DEV BIOL, V269, P123, DOI 10.1016/j.ydbio.2004.01.020; Lian JB, 2003, J CELL PHYSIOL, V196, P301, DOI 10.1002/jcp.10316; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DD, 2011, BLOOD, V118, P289, DOI 10.1182/blood-2010-12-327403; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nair S, 2008, SCIENCE, V322, P89, DOI 10.1126/science.1160038; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; PERLIN JR, 2007, SCI STKE, pPE45, DOI DOI 10.1126/STKE.4002007PE45; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Peterkin T, 2009, DEVELOPMENT, V136, P1465, DOI 10.1242/dev.032748; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Vilz TO, 2005, EUR J NEUROSCI, V22, P1831, DOI 10.1111/j.1460-9568.2005.04378.x; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhang YY, 2011, BLOOD, V118, P4093, DOI 10.1182/blood-2011-03-342501; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	53	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46844	10.1371/journal.pone.0046844	http://dx.doi.org/10.1371/journal.pone.0046844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056483	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000094
J	Wallace, GE; Hill, CM				Wallace, Graham E.; Hill, Catherine M.			Crop Damage by Primates: Quantifying the Key Parameters of Crop-Raiding Events	PLOS ONE			English	Article							KIBALE NATIONAL-PARK; BUDONGO FOREST RESERVE; FARM-BASED MEASURES; PREDATION RISK; WILD BABOONS; CONFLICT; PATTERNS; ELEPHANTS; BEHAVIOR; PEOPLE	Human-wildlife conflict often arises from crop-raiding, and insights regarding which aspects of raiding events determine crop loss are essential when developing and evaluating deterrents. However, because accounts of crop-raiding behaviour are frequently indirect, these parameters are rarely quantified or explicitly linked to crop damage. Using systematic observations of the behaviour of non-human primates on farms in western Uganda, this research identifies number of individuals raiding and duration of raid as the primary parameters determining crop loss. Secondary factors include distance travelled onto farm, age composition of the raiding group, and whether raids are in series. Regression models accounted for greater proportions of variation in crop loss when increasingly crop and species specific. Parameter values varied across primate species, probably reflecting differences in raiding tactics or perceptions of risk, and thereby providing indices of how comfortable primates are on-farm. Median raiding-group sizes were markedly smaller than the typical sizes of social groups. The research suggests that key parameters of raiding events can be used to measure the behavioural impacts of deterrents to raiding. Furthermore, farmers will benefit most from methods that discourage raiding by multiple individuals, reduce the size of raiding groups, or decrease the amount of time primates are on-farm. This study demonstrates the importance of directly relating crop loss to the parameters of raiding events, using systematic observations of the behaviour of multiple primate species.	[Wallace, Graham E.; Hill, Catherine M.] Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev, Oxford OX3 0BP, England; [Wallace, Graham E.] Imperial Coll London, Div Ecol & Evolut, Fac Nat Sci, Ascot, Berks, England	Oxford Brookes University; Imperial College London	Wallace, GE (corresponding author), Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev, Oxford OX3 0BP, England.	gwallace3@gmail.com	Hill, Catherine M/D-3634-2009	Hill, Catherine/0000-0001-8955-6213	Leverhulme Trust; American Society of Primatologists; North of England Zoological Society; Rufford Small Grants; Parkes Foundation; Primate Society of Great Britain	Leverhulme Trust(Leverhulme Trust); American Society of Primatologists; North of England Zoological Society; Rufford Small Grants; Parkes Foundation; Primate Society of Great Britain	Funding was provided by The Leverhulme Trust, American Society of Primatologists, North of England Zoological Society, Rufford Small Grants, Parkes Foundation, and Primate Society of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; Bearder S.K., 2007, PRIMATES PERSPECTIVE, P525; BOITANI L, 1994, J MAMMAL, V75, P600, DOI 10.2307/1382507; Campbell CJ, 2007, PRIMATES PERSPECTIVE; CARE ITFC CDC WCS, 2003, RED COSTS CONS FRONT; Chiyo PI, 2005, AFR J ECOL, V43, P233, DOI 10.1111/j.1365-2028.2005.00577.x; Chiyo PI, 2005, AFR J ECOL, V43, P48, DOI 10.1111/j.1365-2028.2004.00544.x; Conover M., 2002, RESOLVING HUMAN WILD; Cowlishaw G, 1997, ANIM BEHAV, V54, P241, DOI 10.1006/anbe.1996.0466; Crockett C.M., 1980, P148; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; FAIRBANKS LA, 1993, AM J PRIMATOL, V30, P119, DOI 10.1002/ajp.1350300204; FAIRBANKS LA, 1993, BEHAVIOUR, V124, P57, DOI 10.1163/156853993X00506; Foster, 2006, UNDERSTANDING USING; Galef BG, 2004, LEARN BEHAV, V32, P53; Graham MD, 2008, ORYX, V42, P76, DOI 10.1017/S0030605308000677; Hansen LK, 2003, THESIS OXFORD BROOKE; Hill C. M., 2005, PRIMATE COMMENSALISM, P40; Hill CM, 1997, INT J PEST MANAGE, V43, P77, DOI 10.1080/096708797229022; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; Hill CM., 2002, ALBERTINE RIFT TECHN; Hill RA, 1998, J ZOOL, V245, P447, DOI 10.1111/j.1469-7998.1998.tb00119.x; Hill RA, 1999, THESIS U LIVERPOOL L; HOARE R, 1995, PACHYDERM, V19, P54; Hockings KJ, 2009, INTERACT STUD, V10, P183, DOI 10.1075/is.10.2.05hoc; HOCKINGS KJ, 2007, THESIS U STIRLING ST; Janson Charles H., 1993, P57; Lee P.C., 1986, P229; Lehner PN, 1996, HDB ETHOLOGICAL METH; MAPLES WR, 1976, AM J PHYS ANTHROPOL, V45, P309, DOI 10.1002/ajpa.1330450216; MAPLES WR, 1969, AM J PHYS ANTHROPOL, V31, P107, DOI 10.1002/ajpa.1330310116; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; Nishida T., 1987, P462; Nowak RM, 1999, WALKERS PRIMATES WOR; Osborn FV, 2003, ORYX, V37, P80, DOI 10.1017/S0030605303000152; OYARO HO, 1984, INT J PRIMATOL, V5, P371; Paterson JD, 2005, COMMENSALISM CONFLIC; Plumptre AJ, 1996, FOREST ECOL MANAG, V89, P101, DOI 10.1016/S0378-1127(96)03854-6; Priston NEC, 2012, AM J PRIMATOL, V74, P29, DOI 10.1002/ajp.21003; PRISTON NEC, 2005, THESIS U CAMBRIDGE C; QUICK DLF, 1986, PRIMATE ECOLOGY CONS, P221; Reynolds V., 2005, CHIMPANZEES BUDONGO; Rowe N, 1996, PICTORIAL GUIDE LIVI; Saj T, 1999, INT J PRIMATOL, V20, P977, DOI 10.1023/A:1020886820759; Saj TL, 2001, AFR J ECOL, V39, P195, DOI 10.1046/j.0141-6707.2000.00299.x; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Sitati NW, 2006, ORYX, V40, P279, DOI 10.1017/S0030605306000834; Smuts B. B., 1987, PRIMATE SOC; Sokal R.R., 2012, BIOMETRY; Stanford CB, 2002, INT J PRIMATOL, V23, P741, DOI 10.1023/A:1015572814388; STRUM SC, 1994, REV ECOL-TERRE VIE, V49, P295; Strum SC, 2010, INT J PRIMATOL, V31, P133, DOI 10.1007/s10764-009-9387-5; SUKUMAR R, 1988, ANIM BEHAV, V36, P1233, DOI 10.1016/S0003-3472(88)80084-8; Tweheyo M, 2005, WILDLIFE BIOL, V11, P237, DOI 10.2981/0909-6396(2005)11[237:POCRBP]2.0.CO;2; Wallace G. E., 2010, THESIS OXFORD BROOKE; Warren Y, 2003, THESIS U SURREY ROCH; Warren Y, 2007, INT J PEST MANAGE, V53, P207, DOI 10.1080/09670870701288124; Webber A.D., 2006, THESIS OXFORD BROOKE; Whiten A, 2000, COGNITIVE SCI, V24, P477; Wolfheim J, 1983, PRIMATES WORLD DISTR; Woodroffe R., 2005, CONSERV BIOL	63	38	38	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46636	10.1371/journal.pone.0046636	http://dx.doi.org/10.1371/journal.pone.0046636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056378	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000067
J	Casalino, E; Bernot, B; Bouchaud, O; Alloui, C; Choquet, C; Bouvet, E; Damond, F; Firmin, S; Delobelle, A; Nkoumazok, BE; Sahakian, GD; Viard, JP; Zbar, OZD; Aslangul, E; Krivine, A; Zundel, J; Ghosn, J; Nordmann, P; Claessens, YE; Tahi, T; Riou, B; Gautheret-Dejean, A; Katlama, C; Hausfater, P; Brun-Vezinet, F; Costagliola, D				Casalino, Enrique; Bernot, Bruno; Bouchaud, Olivier; Alloui, Chakib; Choquet, Christophe; Bouvet, Elisabeth; Damond, Florence; Firmin, Sandra; Delobelle, Aurore; Nkoumazok, Beatrice Ename; Sahakian, Guillaume Der; Viard, Jean-Paul; Zbar, Olivier Zak Dit; Aslangul, Elisabeth; Krivine, Anne; Zundel, Julie; Ghosn, Jade; Nordmann, Patrice; Claessens, Yann-Erick; Tahi, Tassadit; Riou, Bruno; Gautheret-Dejean, Agnes; Katlama, Christine; Hausfater, Pierre; Brun-Vezinet, Francoise; Costagliola, Dominique			Twelve Months of Routine HIV Screening in 6 Emergency Departments in the Paris Area: Results from the ANRS URDEP Study	PLOS ONE			English	Article							INFECTION; CARE; IMPACT; COST	Objective: In October 2009 the French National Authority for Health recommended that HIV testing be proposed at least once to all persons aged 15 to 70 years in all healthcare settings. We examined whether routine HIV screening with a rapid test in emergency departments (EDs) was feasible without dedicated staff, and whether newly diagnosed persons could be linked to care. Methods: This one-year study started in December 2009 in 6 EDs in the Paris area, using the INSTI (TM) test. Eligible individuals were persons 18 to 70 years old who did not present for a vital emergency, for blood or sexual HIV exposure, or for HIV screening. Written informed consent was required. Results: Among 183 957 eligible persons, 11 401 were offered HIV testing (6.2%), of whom 7936 accepted (69.6%) and 7215 (90.9%) were tested (overall screening rate 3.9%); 1857 non eligible persons were also tested. Fifty-five new diagnoses of HIV infection were confirmed by Western blot (0.61% (95% CI 0.46-0.79). There was one false-positive rapid test result. Among the newly diagnosed persons, 48 (87%) were linked to care, of whom 36 were not lost to follow-up at month 6 (75%); median CD4 cell count was 241/mm(3) (IQR: 52-423/mm(3)). Conclusions: Screening rates were similar to those reported in opt-in studies with no dedicated staff. The rate of new diagnoses was similar to that observed in free anonymous test centres in the Paris area, and well above the prevalence (0.1%) at which testing has been shown to be cost-effective.	[Firmin, Sandra; Delobelle, Aurore; Nkoumazok, Beatrice Ename; Katlama, Christine; Costagliola, Dominique] INSERM, U943, Paris, France; [Casalino, Enrique; Choquet, Christophe] Grp Hosp Univ Paris Nord Val de Seine, AP HP, Serv Accueil Urgences, Paris, France; [Damond, Florence; Brun-Vezinet, Francoise] Univ Paris 07, EA 4409, Paris, France; [Bernot, Bruno] CHU Avicenne, Hop Univ Paris Seine St Denis, AP HP, Serv Accueil Urgences, Bobigny, France; [Bouchaud, Olivier] CHU Avicenne, Hop Univ Paris Seine St Denis, AP HP, Serv Malad Infect & Trop, Bobigny, France; [Bouchaud, Olivier] Univ Paris 13, Bobigny, France; [Alloui, Chakib] CHU Avicenne, Hop Univ Paris Seine St Denis, AP HP, Virol Lab, Bobigny, France; [Bouvet, Elisabeth] Grp Hosp Univ Paris Nord Val de Seine, AP HP, Serv Malad Infect & Trop, Paris, France; [Damond, Florence; Brun-Vezinet, Francoise] Grp Hosp Univ Paris Nord Val de Seine, AP HP, Virol Lab, Paris, France; [Firmin, Sandra; Delobelle, Aurore; Nkoumazok, Beatrice Ename; Katlama, Christine; Costagliola, Dominique] Univ Paris 06, UMR S943, Paris, France; [Sahakian, Guillaume Der] Hop Hotel Dieu, AP HP, Serv Accueil Urgences, SMUR, F-75181 Paris, France; [Viard, Jean-Paul; Ghosn, Jade] Univ Paris 05, EA 3620, Paris, France; [Viard, Jean-Paul] Hop Hotel Dieu, AP HP, Ctr Diagnost & Therapeut, F-75181 Paris, France; [Zbar, Olivier Zak Dit] Hop Hotel Dieu, AP HP, Serv Pneumol, F-75181 Paris, France; [Aslangul, Elisabeth] Hop Hotel Dieu, AP HP, Serv Med Interne, F-75181 Paris, France; [Krivine, Anne] Hop Cochin, AP HP, Virol Lab, F-75674 Paris, France; [Zundel, Julie] Hop Bicetre, AP HP, Serv Accueil Urgences, Le Kremlin Bicetre, France; [Ghosn, Jade] Grp Hosp Bicetre, AP HP, Serv Med Interne & Malad Infect, Le Kremlin Bicetre, France; [Nordmann, Patrice] Grp Hosp Bicetre, AP HP, Lab Bacteriovirol, Le Kremlin Bicetre, France; [Nordmann, Patrice] Univ Paris 11, UMR S914, Le Kremlin Bicetre, France; [Nordmann, Patrice] INSERM, U914, F-94275 Le Kremlin Bicetre, France; [Claessens, Yann-Erick] Hop Cochin, AP HP, Serv Accueil Urgences, F-75674 Paris, France; [Tahi, Tassadit] Hop Cochin, AP HP, Serv Med Interne & Malad Infect, F-75674 Paris, France; [Riou, Bruno; Hausfater, Pierre] Grp Hosp Pitie Salpetriere, AP HP, Serv Accueil Urgences, F-75634 Paris, France; [Gautheret-Dejean, Agnes] Grp Hosp Pitie Salpetriere, APHP, Virol Lab, F-75634 Paris, France; [Katlama, Christine] Grp Hosp Pitie Salpetriere, AP HP, Serv Malad Infect, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Costagliola, D (corresponding author), INSERM, U943, Paris, France.	dominique.costagliola@upmc.fr	Costagliola, Dominique/H-5849-2011; Alloui, Chakib/U-4685-2018; Casalino, Enrique/GYU-1974-2022	Costagliola, Dominique/0000-0003-0765-0869; Casalino, Enrique/0000-0002-4352-6729	Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; Sanofi Aventis; Pfizer; Bristol-Myers-Squibb; Abbott; Boehringer-Ingelheim; Gilead Sciences; Glaxo-Smith-Kline; Janssen; Merck-Sharp Dohme-Chibret; Roche; ViiV Healthcare; ThermoFisher Scientific; BRAHMS biomarkers; BioMerieux; Radiometer; Philips; ThermoFisher Brahms; OctoPharma; LFB; Sangart; Sigma Tau; Novartis; Sanofi	Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France(ANRS); Sanofi Aventis(Sanofi-Aventis); Pfizer(Pfizer); Bristol-Myers-Squibb(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Boehringer-Ingelheim(Boehringer Ingelheim); Gilead Sciences(Gilead Sciences); Glaxo-Smith-Kline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck-Sharp Dohme-Chibret(Merck & Company); Roche(Roche Holding); ViiV Healthcare; ThermoFisher Scientific; BRAHMS biomarkers; BioMerieux; Radiometer; Philips; ThermoFisher Brahms; OctoPharma; LFB; Sangart; Sigma Tau; Novartis(Novartis); Sanofi	The URDEP Study was funded by Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France. After approving the protocol, the study sponsor had no involvement in the study design, data collection, analysis or interpretation, or the writing of the report. Dominique Costagliola had full access to all the study data. Enrique Casalino, Francoise Brun-Vezinet and Dominique Costagliola had final responsibility for the decision to submit for publication.; No authors of the ANRS URDEP study have any financial or personal relationships with people or organizations that could inappropriately influence this work, although most members of the group have, at some stage in the past, received funding from a variety of pharmaceutical companies for research, travel grants, speaking engagements or consultancy fees: Elisabeth Aslangul has received travel grants from Sanofi Aventis, Pfizer and Bristol-Myers-Squibb. Elisabeth Bouvet, Dominique Costagliola and Jean-Paul Viard have received travel grants, consultancy fees, honoraria and study grants from various pharmaceutical companies, Abbott, Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Glaxo-Smith-Kline, Janssen, Merck-Sharp & Dohme-Chibret, Roche and ViiV Healthcare. Francoise Brun-Vezinet has received travel grants, consultancy fees and study grants from Gilead Sciences, Janssen, ViiV healthcare and Merck-Sharp & Dohme-Chibret. Enrique Casalino has received travel grants from various pharmaceutical companies, Abbott, Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Glaxo-Smith-Kline, Janssen, Merck-Sharp & Dohme-Chibret, Roche and ViiV Healthcare. Florence Damond has received travel grants, and honoraria from Merck-Sharp & Dohme-Chibret. Jade Ghosn has received travel grants, honoraria and study grants from various pharmaceutical companies including Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Janssen, Merck-Sharp & Dohme-Chibret, Roche and ViiV Healthcare. Pierre Hausfater has received consultancy fees, honoraria and study grants from biodiagnostic companies, ThermoFisher Scientific, BRAHMS biomarkers, BioMerieux, Radiometer, and Philips. Christine Katlama has received travel grants, honoraria and consultantancy fees from Bristol-Myers-Squibb, Gilead Sciences, Janssen, Merck-Sharp & Dohme-Chibret, and ViiV Healthcare. Bruno Riou has received travel grants, consultancy fees, honoraria and study grants from various pharmaceutical and biomarker companies, Sanofi, Glaxo-Smith-Kline, ThermoFisher Brahms, OctoPharma, LFB, Sangart. Olivier Bouchaud has received travel grants, honoraria and study grants from various pharmaceutical companies, Abbott, Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Glaxo-Smith-Kline, Janssen, Merck-Sharp & Dohme-Chibret, Roche, ViiV Healthcare, Sigma Tau, and Novartis. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 2007, MMWR-MORBID MORTAL W, V56, P597; [Anonymous], REC SANT PUBL DEP IN; [Anonymous], 2010, PAN ET SANT, P100; [Anonymous], TIME TEST HIV EXPAND; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Cazein F., 2011, Bulletin Epidemiologique Hebdomadaire, P446; d'Almeida KW, 2012, ARCH INTERN MED, V172, P12, DOI 10.1001/archinternmed.2011.535; Haukoos JS, 2012, ARCH INTERN MED, V172, P20, DOI 10.1001/archinternmed.2011.538; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Krentz HB, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/757135; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lanoy E, 2007, ANTIVIR THER, V12, P89; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Lyss SB, 2007, JAIDS-J ACQ IMM DEF, V44, P435, DOI 10.1097/QAI.0b013e31802f83d0; Montlahuc C, 2011, 13 EUR AIDS C BELGR; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; O'Dowd A, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6063; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Sabin CA, 2010, AIDS, V24, P723, DOI 10.1097/QAD.0b013e328333fa0f; Sattin RW, 2011, ANN EMERG MED, V58, pS60, DOI 10.1016/j.annemergmed.2011.03.026; Silva A, 2007, ANN EMERG MED, V49, P564, DOI 10.1016/j.annemergmed.2006.09.028; Supervie V, 2012, HIV EUR COP 2012 C C; Torres GW, 2011, ANN EMERG MED, V58, pS104, DOI 10.1016/j.annemergmed.2011.03.034; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; White DAE, 2011, ANN EMERG MED, V58, pS89, DOI 10.1016/j.annemergmed.2011.03.032; White DAE, 2009, ANN EMERG MED, V54, P56, DOI 10.1016/j.annemergmed.2008.09.027; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132	31	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46437	10.1371/journal.pone.0046437	http://dx.doi.org/10.1371/journal.pone.0046437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056308	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600037
J	Cibois, M; Boulanger, G; Audic, Y; Paillard, L; Gautier-Courteille, C				Cibois, Marie; Boulanger, Gaella; Audic, Yann; Paillard, Luc; Gautier-Courteille, Carole			Inactivation of the Celf1 Gene that Encodes an RNA-Binding Protein Delays the First Wave of Spermatogenesis in Mice	PLOS ONE			English	Article							HORMONAL-REGULATION; MESSENGER-RNAS; EXPRESSION; GROWTH; RECEPTOR; STEROIDOGENESIS; TRANSCRIPTOME; INFERTILITY; DEFECTS; PUBERTY	Background: The first wave of spermatogenesis in mammals is characterized by a sequential and synchronous appearance of germ cells in the prepubertal testis. Post-transcriptional controls of gene expression play important roles in this process but the molecular actors that underlie them are poorly known. Methodology/principal findings: We evaluated the requirement for the RNA-binding protein CELF1 during the first wave of spermatogenesis in mice. Mice inactivated for Celf1 gene were not viable on pure genetic backgrounds. On a mixed background, we observed by histology and gene profiling by RT-qPCR that the testes of inactivated prepubertal mice were characterized by several features. (i) Spermiogenesis (differentiation of post-meiotic cells) was blocked in a subset of prepubertal inactivated mice. (ii) The appearance of the different stages of germ cell development was delayed by several days. (iii) The expression of markers of Leydig cells functions was similarly delayed. Conclusions/significance: Celf1 disruption is responsible for a blockage of spermiogenesis both in adults and in prepubertal males. Hence, the spermiogenesis defects found in Celf1-inactivated adults appear from the first wave of spermiogenesis. The disruption of Celf1 gene is also responsible for a fully penetrant delayed first wave of spermatogenesis, and a delay of steroidogenesis may be the cause for the delay of germ cells differentiation.	[Cibois, Marie; Boulanger, Gaella; Audic, Yann; Paillard, Luc; Gautier-Courteille, Carole] Univ Europeenne Bretagne, Univ Rennes 1, Rennes, France; [Cibois, Marie; Boulanger, Gaella; Audic, Yann; Paillard, Luc; Gautier-Courteille, Carole] CNRS, Inst Genet & Dev Rennes, UMR6290, Rennes, France	Universite de Bretagne Occidentale; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Gautier-Courteille, C (corresponding author), Univ Europeenne Bretagne, Univ Rennes 1, Rennes, France.	carole.gautier@univ-rennes1.fr	Paillard, Luc/AAB-2816-2022	Audic, Yann/0000-0003-2498-9792; Gautier-Courteille, Carole/0000-0002-8005-4847; Paillard, Luc/0000-0002-9290-7616	Association pour la Recherche Contre le Cancer [ARC4003]; Agence Nationale de la Recherche [ANR-07-JCJC-0097-01]	Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Association pour la Recherche Contre le Cancer [ARC4003 to LP, http://www.arc-cancer.net/] and Agence Nationale de la Recherche [ANR-07-JCJC-0097-01 to LP, http://www.agence-nationale-recherche.fr/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreau C, 2006, BIOCHIMIE, V88, P515, DOI 10.1016/j.biochi.2005.10.011; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chandrashekar V, 2004, BIOL REPROD, V71, P17, DOI 10.1095/biolreprod.103.027060; Cibois M, 2010, RNA, V16, P10, DOI 10.1261/rna.1742610; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; De Rooij DG, 2000, J ANDROL, V21, P776; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; Ezzeddine N, 2002, P NATL ACAD SCI USA, V99, P257, DOI 10.1073/pnas.012555499; Gautier-Courteille C, 2004, DEVELOPMENT, V131, P6107, DOI 10.1242/dev.01528; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Ibanez L, 2006, MOL CELL ENDOCRINOL, V254, P22, DOI 10.1016/j.mce.2006.04.010; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Kanzaki M, 1999, ENDOCRINOLOGY, V140, P1681, DOI 10.1210/en.140.4.1681; Keene DE, 2002, J ANDROL, V23, P661; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; Lalancette C, 2008, MOL GENET GENOMICS, V280, P263, DOI 10.1007/s00438-008-0361-2; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966; Paronetto MP, 2010, INT J ANDROL, V33, P2, DOI 10.1111/j.1365-2605.2009.00959.x; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Sofikitis N, 2008, J STEROID BIOCHEM, V109, P323, DOI 10.1016/j.jsbmb.2008.03.004; Sorensen K, 2010, J CLIN ENDOCR METAB, V95, P2819, DOI 10.1210/jc.2009-2484; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang GM, 2003, ENDOCRINOLOGY, V144, P5058, DOI 10.1210/en.2003-0563; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Xu QQ, 2007, ENDOCRINE, V32, P96, DOI 10.1007/s12020-007-9015-0; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang FP, 2004, ENDOCRINOLOGY, V145, P1453, DOI 10.1210/en.2003-1049; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46337	10.1371/journal.pone.0046337	http://dx.doi.org/10.1371/journal.pone.0046337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056285	Green Published, gold			2022-12-27	WOS:000309452600034
J	Beraha, E; Eggers, J; Attar, CH; Gutwinski, S; Schlagenhauf, F; Stoy, M; Sterzer, P; Kienast, T; Heinz, A; Bermpohl, F				Beraha, Esther; Eggers, Jonathan; Attar, Catherine Hindi; Gutwinski, Stefan; Schlagenhauf, Florian; Stoy, Meline; Sterzer, Philipp; Kienast, Thorsten; Heinz, Andreas; Bermpohl, Felix			Hemispheric Asymmetry for Affective Stimulus Processing in Healthy Subjects-A fMRI Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BRAIN-DAMAGED PATIENTS; AMYGDALA ACTIVATION; EMOTIONAL STIMULI; FACIAL EXPRESSIONS; PREFRONTAL CORTEX; AFFECTIVE STYLE; CEREBRAL ASYMMETRY; BLOOD-FLOW; DEPRESSION	Background: While hemispheric specialization of language processing is well established, lateralization of emotion processing is still under debate. Several conflicting hypotheses have been proposed, including right hemisphere hypothesis, valence asymmetry hypothesis and region-specific lateralization hypothesis. However, experimental evidence for these hypotheses remains inconclusive, partly because direct comparisons between hemispheres are scarce. Methods: The present fMRI study systematically investigated functional lateralization during affective stimulus processing in 36 healthy participants. We normalized our functional data on a symmetrical template to avoid confounding effects of anatomical asymmetries. Direct comparison of BOLD responses between hemispheres was accomplished taking two approaches: a hypothesis-driven region of interest analysis focusing on brain areas most frequently reported in earlier neuroimaging studies of emotion; and an exploratory whole volume analysis contrasting non-flipped with flipped functional data using paired t-test. Results: The region of interest analysis revealed lateralization towards the left in the medial prefrontal cortex (BA 10) during positive stimulus processing; while negative stimulus processing was lateralized towards the right in the dorsolateral prefrontal cortex (BA 9 & 46) and towards the left in the amygdala and uncus. The whole brain analysis yielded similar results and, in addition, revealed lateralization towards the right in the premotor cortex (BA 6) and the temporo-occipital junction (BA 19 & 37) during positive stimulus processing; while negative stimulus processing showed lateralization towards the right in the temporo-parietal junction (BA 37,39,42) and towards the left in the middle temporal gyrus (BA 21). Conclusion: Our data suggests region-specific functional lateralization of emotion processing. Findings show valence asymmetry for prefrontal cortical areas and left-lateralized negative stimulus processing in subcortical areas, in particular, amygdala and uncus.	[Beraha, Esther; Eggers, Jonathan; Attar, Catherine Hindi; Gutwinski, Stefan; Schlagenhauf, Florian; Stoy, Meline; Sterzer, Philipp; Kienast, Thorsten; Heinz, Andreas; Bermpohl, Felix] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Sterzer, Philipp; Heinz, Andreas; Bermpohl, Felix] Berlin Sch Mind & Brain, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bermpohl, F (corresponding author), Charite, Dept Psychiat & Psychotherapy, Campus Mitte, D-13353 Berlin, Germany.	felix.bermpohl@charite.de	Heinz, Andreas/ABB-7736-2020; Schlagenhauf, Florian/AFV-1764-2022	Heinz, Andreas/0000-0001-5405-9065; Schlagenhauf, Florian/0000-0001-8340-5027; Bermpohl, Felix/0000-0002-3260-6328	German Federal Ministry for Education and Research [01KR1207C]	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	The work on this study was supported by the German Federal Ministry for Education and Research (01KR1207C to FB and AH). (http://www.bmbf.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Bermpohl F, 2009, BIPOLAR DISORD, V11, P70, DOI 10.1111/j.1399-5618.2008.00648.x; CALTAGIRONE C, 1989, CORTEX, V25, P653, DOI 10.1016/S0010-9452(89)80025-5; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Caroli A, 2010, DEMENT GERIATR COGN, V29, P37, DOI 10.1159/000257761; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Davidson R.J., 1984, EMOTIONS COGNITION B, P320; Davidson Richard J., 1995, P361; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fusar-Poli P, 2009, NEUROSCI LETT, V452, P262, DOI 10.1016/j.neulet.2009.01.065; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; George MS, 1996, J NEUROPSYCH CLIN N, V8, P172; Glascher J, 2003, J NEUROSCI, V23, P10274; Gotlib IH, 1998, COGNITION EMOTION, V12, P449, DOI 10.1080/026999398379673; Gur RC, 2002, NEUROIMAGE, V16, P651, DOI 10.1006/nimg.2002.1097; GUR RC, 1994, BRAIN COGNITION, V25, P271, DOI 10.1006/brcg.1994.1036; Hagemann D, 1998, PSYCHOPHYSIOLOGY, V35, P372; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Killgore WDS, 2001, NEUROREPORT, V12, P2543, DOI 10.1097/00001756-200108080-00050; KOWNER R, 1995, NEUROPSYCHOLOGIA, V33, P539, DOI 10.1016/0028-3932(94)00137-E; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Lange K, 2003, BIOL PSYCHIAT, V53, P226, DOI 10.1016/S0006-3223(02)01455-5; Le Grand R, 2003, NAT NEUROSCI, V6, P1108, DOI 10.1038/nn1121; Lee Gregory P, 2004, Cogn Behav Neurol, V17, P9, DOI 10.1097/00146965-200403000-00002; LEVINE SC, 1986, BRAIN COGNITION, V5, P291, DOI 10.1016/0278-2626(86)90033-3; Mandal MK, 1996, INT J NEUROSCI, V84, P87, DOI 10.3109/00207459608987253; MANDAL MK, 1992, INT J NEUROSCI, V63, P187, DOI 10.3109/00207459208987194; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P399; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; PascualLeone A, 1996, NEUROLOGY, V46, P499, DOI 10.1212/WNL.46.2.499; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Reid SA, 1998, PSYCHOPHYSIOLOGY, V35, P389, DOI 10.1111/1469-8986.3540389; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; SACKEIM HA, 1978, SCIENCE, V202, P434, DOI 10.1126/science.705335; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Sander K, 2001, COGNITIVE BRAIN RES, V12, P181, DOI 10.1016/S0926-6410(01)00045-3; Schneider F, 1997, PSYCHIAT RES-NEUROIM, V76, P75, DOI 10.1016/S0925-4927(97)00063-2; Schneider F, 1995, PSYCHIAT RES-NEUROIM, V61, P265, DOI 10.1016/0925-4927(95)02678-Q; SCHWARTZ GE, 1975, SCIENCE, V190, P286, DOI 10.1126/science.1179210; STARKSTEIN SE, 1987, BRAIN, V110, P1045, DOI 10.1093/brain/110.4.1045; Tucker DM, 1995, ANN NY ACAD SCI, V769, P213, DOI 10.1111/j.1749-6632.1995.tb38141.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Watkins KE, 2001, CEREB CORTEX, V11, P868, DOI 10.1093/cercor/11.9.868; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Yang TT, 2002, NEUROREPORT, V13, P1737, DOI 10.1097/00001756-200210070-00009	60	47	48	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46931	10.1371/journal.pone.0046931	http://dx.doi.org/10.1371/journal.pone.0046931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056533	Green Published, gold			2022-12-27	WOS:000309831500113
J	Ciccarelli, A; Calza, A; Panzanelli, P; Concas, A; Giustetto, M; Sassoe-Pognetto, M				Ciccarelli, Alessandro; Calza, Arianna; Panzanelli, Patrizia; Concas, Alessandra; Giustetto, Maurizio; Sassoe-Pognetto, Marco			Organization of GABAergic Synaptic Circuits in the Rat Ventral Tegmental Area	PLOS ONE			English	Article							GABA(A) RECEPTORS; DOPAMINE NEURONS; IN-VIVO; GLUTAMATERGIC NEURONS; SUBSTANTIA-NIGRA; NUCLEUS; REWARD; BRAIN; ACTIVATION; AFFERENTS	The ventral tegmental area (VTA) is widely implicated in drug addiction and other psychiatric disorders. This brain region is densely populated by dopaminergic (DA) neurons and also contains a sparse population of gamma-aminobutyric acid (GABA)ergic cells that regulate the activity of the principal neurons. Therefore, an in-depth knowledge of the organization of VTA GABAergic circuits and of the plasticity induced by drug consumption is essential for understanding the mechanisms by which drugs induce stable changes in brain reward circuits. Using immunohistochemistry, we provide a detailed description of the localization of major GABA(A) and GABA(B) receptor subunits in the rat VTA. We show that DA and GABAergic cells express both GABA(A) and GABA(B) receptors. However VTA neurons differ considerably in the expression of GABAA receptor subunits, as the alpha 1 subunit is associated predominantly with non-DA cells, whereas the alpha 3 subunit is present at low levels in both types of VTA neurons. Using an unbiased stereological method, we then demonstrate that alpha 1-positive elements represent only a fraction of non-DA neurons and that the ratio of DA and non-DA cells is quite variable throughout the rostro-caudal extent of the VTA. Interestingly, DA and non-DA cells receive a similar density of perisomatic synapses, whereas axo-dendritic synapses are significantly more abundant in non-DA cells, indicating that local interneurons receive prominent GABAergic inhibition. These findings reveal a differential expression of GABA receptor subtypes in the two major categories of VTA neurons and provide an anatomical basis for interpreting the plasticity of inhibitory circuits induced by drug exposure.	[Ciccarelli, Alessandro; Panzanelli, Patrizia; Giustetto, Maurizio; Sassoe-Pognetto, Marco] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Ciccarelli, Alessandro; Panzanelli, Patrizia; Giustetto, Maurizio; Sassoe-Pognetto, Marco] Natl Inst Neurosci Italy, Turin, Italy; [Calza, Arianna; Concas, Alessandra] Univ Cagliari, Dept Expt Biol, Cagliari, Italy; [Calza, Arianna; Concas, Alessandra] Univ Cagliari, Ctr Excellence Neurobiol Dependence, Cagliari, Italy	University of Turin; University of Cagliari; University of Cagliari	Sassoe-Pognetto, M (corresponding author), Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy.	marco.sassoe@unito.it	Sassoe-Pognetto, Marco/AAE-3536-2022; giustetto, maurizio/D-6606-2011; Panzanelli, Patrizia/AAE-7773-2022	giustetto, maurizio/0000-0003-1323-4060; Sassoe-Pognetto, Marco/0000-0001-8906-0613; Ciccarelli, Alessandro/0000-0002-7612-8161; Panzanelli, Patrizia/0000-0002-5127-2757	Italian Telethon Foundation [GGP09196, GGP11095]; Fondazione SanPaolo [2007]; Italian MIUR [2005059123, 2008KN7J7J]; Fondazione CRT; Regione Piemonte (Ricerca Sanitaria Finalizzata) [POS FESR 07/13 BANP]	Italian Telethon Foundation(Fondazione Telethon); Fondazione SanPaolo(Compagnia di San Paolo); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione CRT(Fondazione CRT); Regione Piemonte (Ricerca Sanitaria Finalizzata)(Regione Piemonte)	This study was supported by the Italian Telethon Foundation (GGP09196 and GGP11095 to M.G.), Regione Piemonte (Ricerca Sanitaria Finalizzata 2006 to M.S-P.; POS FESR 07/13 BANP to M.G.), Fondazione SanPaolo (grant 2007 to M.S-P.) and Italian MIUR (Prin 2005059123 and Prin 2008KN7J7J to A.C. and M. S-P.). Alessandro Ciccarelli received financial support from Fondazione CRT (Progetto Lagrange 2005 and Progetto Alfieri 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes E, 2003, J PHARMACOL EXP THER, V307, P450, DOI 10.1124/jpet.103.054965; Barberis A, 2007, EUR J NEUROSCI, V25, P2726, DOI 10.1111/j.1460-9568.2007.05530.x; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bonci A, 1997, J NEUROSCI, V17, P796; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Chieng B, 2011, J PHYSIOL-LONDON, V589, P3775, DOI 10.1113/jphysiol.2011.210807; Chouinard G, 2004, J CLIN PSYCHIAT, V65, P7; CHURCHILL L, 1992, NEUROCHEM RES, V17, P101, DOI 10.1007/BF00966870; Colussi-Mas J, 2007, EUR J NEUROSCI, V26, P1011, DOI 10.1111/j.1460-9568.2007.05738.x; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Doherty M, 2007, BRAIN RES, V1150, P62, DOI 10.1016/j.brainres.2007.02.081; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Geisler S, 2008, NEUROPSYCHOPHARMACOL, V33, P2688, DOI 10.1038/sj.npp.1301650; GERMAN DC, 1993, J COMP NEUROL, V331, P297, DOI 10.1002/cne.903310302; GRACE AA, 1979, EUR J PHARMACOL, V59, P211, DOI 10.1016/0014-2999(79)90283-8; Griffiths RR, 2005, J CLIN PSYCHIAT, V66, P31; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; JOHNSON SW, 1992, J NEUROSCI, V12, P483; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1990, J PHARMACOL EXP THER, V253, P858; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Laviolette SR, 2004, EUR J NEUROSCI, V20, P2179, DOI 10.1111/j.1460-9568.2004.03665.x; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Margeta-Mitrovic M, 1999, J COMP NEUROL, V405, P299, DOI 10.1002/(SICI)1096-9861(19990315)405:3<299::AID-CNE2>3.0.CO;2-6; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Nader K, 1997, J NEUROSCI, V17, P383, DOI 10.1523/JNEUROSCI.17-01-00383.1997; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Nugent FS, 2008, J PHYSIOL-LONDON, V586, P1487, DOI 10.1113/jphysiol.2007.148098; O'Brien CP, 2005, J CLIN PSYCHIAT, V66, P28; Okada M, 2000, J NEUROSCI, V20, P2202; Olson VG, 2007, SYNAPSE, V61, P87, DOI 10.1002/syn.20345; Omelchenko N, 2009, SYNAPSE, V63, P895, DOI 10.1002/syn.20668; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Rodrigues RWP, 2004, INT J NEUROSCI, V114, P197, DOI 10.1080/00207450490249338; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Scammell TE, 2000, J NEUROSCI, V20, P8620, DOI 10.1523/JNEUROSCI.20-22-08620.2000; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Schwarzer C, 2001, J COMP NEUROL, V433, P526, DOI 10.1002/cne.1158; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Vicini S, 2001, J NEUROSCI, V21, P3009, DOI 10.1523/JNEUROSCI.21-09-03009.2001; Viltono L, 2008, J COMP NEUROL, V508, P579, DOI 10.1002/cne.21713; Wafford KA, 2005, CURR OPIN PHARMACOL, V5, P47, DOI 10.1016/j.coph.2004.08.006; Xi ZX, 1998, BRAIN RES, V798, P156, DOI 10.1016/S0006-8993(98)00406-5; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Yee BK, 2005, P NATL ACAD SCI USA, V102, P17154, DOI 10.1073/pnas.0508752102	61	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46250	10.1371/journal.pone.0046250	http://dx.doi.org/10.1371/journal.pone.0046250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056271	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500032
J	Su, G; Sung, KE; Beebe, DJ; Friedl, A				Su, Gui; Sung, Kyung E.; Beebe, David J.; Friedl, Andreas			Functional Screen of Paracrine Signals in Breast Carcinoma Fibroblasts	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; MAMMARY-TUMOR GROWTH; STROMAL FIBROBLASTS; GENE-EXPRESSION; CELL-PROLIFERATION; CANCER CELLS; PROGRESSION; HEPARANASE; RECEPTOR; MICROENVIRONMENT	Stromal fibroblasts actively participate in normal mammary gland homeostasis and in breast carcinoma growth and progression by secreting paracrine factors; however, little is known about the identity of paracrine mediators in individual patients. The purpose of this study was to characterize paracrine signaling pathways between breast carcinoma cells and breast carcinoma-associated fibroblasts (CAF) or normal mammary fibroblasts (NF), respectively. CAF and NF were isolated from breast carcinoma tissue samples and adjacent normal mammary gland tissue of 28 patients. The fibroblasts were grown in 3D collagen gel co-culture with T47D human breast carcinoma cells and T47D cell growth was measured. CAF stimulated T47D cell growth to a significantly greater degree than NF. We detected a considerable inter-individual heterogeneity of paracrine interactions but identified FGF2, HB-EGF, heparanase-1 and SDF1 as factors that were consistently responsible for the activity of carcinoma-associated fibroblasts. CAF from low-grade but not high-grade carcinomas required insulin-like growth factor 1 and transforming growth factor beta 1 to stimulate carcinoma growth. Paradoxically, blocking of membrane-type 1 matrix metalloprotease stimulated T47D cell growth in co-culture with NF. The results were largely mirrored by treating the fibroblasts with siRNA oligonucleotides prior to co-culture, implicating the fibroblasts as principal production site for the secreted mediators. In summary, we identify a paracrine signaling network with inter-individual commonalities and differences. These findings have significant implications for the design of stroma-targeted therapies.	[Su, Gui; Friedl, Andreas] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Sung, Kyung E.; Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Friedl, Andreas] William S Middleton Mem Vet Adm Med Ctr, Pathol & Lab Med Serv, Dept Vet Affairs, Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Friedl, A (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	afriedl@wisc.edu		Sung, Kyung/0000-0001-9664-6399	National Institutes of Health [RO1 CA107012]; Wisconsin Partnership program; NATIONAL CANCER INSTITUTE [R01CA107012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Partnership program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by National Institutes of Health grant RO1 CA107012 and a grant from the Wisconsin Partnership program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Baba F, 2006, BREAST CANCER RES TR, V98, P91, DOI 10.1007/s10549-005-9135-2; Bauer M, 2010, ONCOGENE, V29, P1732, DOI 10.1038/onc.2009.463; Bauer M, 2010, INTEGR BIOL-UK, V2, P371, DOI 10.1039/c0ib00001a; Belfiore A, 2008, J MAMMARY GLAND BIOL, V13, P381, DOI 10.1007/s10911-008-9099-z; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bisson C, 2003, INT J CANCER, V105, P7, DOI 10.1002/ijc.11012; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Giulianelli S, 2008, INT J CANCER, V123, P2518, DOI 10.1002/ijc.23802; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Jiang WG, 2003, CLIN CANCER RES, V9, P4274; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Littlepage LE, 2005, CANCER CELL, V7, P499, DOI 10.1016/j.ccr.2005.05.019; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Maxhimer JB, 2002, SURGERY, V132, P326, DOI 10.1067/msy.2002.125719; Meyvantsson I, 2008, LAB CHIP, V8, P717, DOI 10.1039/b715375a; Moses H, 2010, COLD SPRING HARB PER, V3; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishi E, 2004, GROWTH FACTORS, V22, P253, DOI 10.1080/08977190400008448; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Pond AC, 2010, CANCER RES, V70, P4868, DOI 10.1158/0008-5472.CAN-09-4404; Rasband W.S., 1997, IMAGE J; Ronen D, 1999, CELL GROWTH DIFFER, V10, P131; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; SINGER C, 1995, CANCER RES, V55, P2448; Singer CF, 2008, BREAST CANCER RES TR, V110, P273, DOI 10.1007/s10549-007-9725-2; Su G, 2008, CANCER RES, V68, P9558, DOI 10.1158/0008-5472.CAN-08-1645; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; Sung KE, 2009, BIOMATERIALS, V30, P4833, DOI 10.1016/j.biomaterials.2009.05.043; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	48	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46685	10.1371/journal.pone.0046685	http://dx.doi.org/10.1371/journal.pone.0046685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056402	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500057
J	Weltman, NY; Wang, DJ; Redetzke, RA; Gerdes, AM				Weltman, Nathan Y.; Wang, Dajun; Redetzke, Rebecca A.; Gerdes, A. Martin			Longstanding Hyperthyroidism Is Associated with Normal or Enhanced Intrinsic Cardiomyocyte Function despite Decline in Global Cardiac Function	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; THYROTROPIN-SUPPRESSIVE THERAPY; ISOLATED VENTRICULAR MYOCYTES; COLLAGEN GENE-EXPRESSION; THYROID-HORMONE; OXIDATIVE STRESS; RAT-HEART; CONTRACTILE FUNCTION; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION	Thyroid hormones (THs) play a pivotal role in cardiac homeostasis. TH imbalances alter cardiac performance and ultimately cause cardiac dysfunction. Although short-term hyperthyroidism typically leads to heightened left ventricular (LV) contractility and improved hemodynamic parameters, chronic hyperthyroidism is associated with deleterious cardiac consequences including increased risk of arrhythmia, impaired cardiac reserve and exercise capacity, myocardial remodeling, and occasionally heart failure. To evaluate the long-term consequences of chronic hyperthyroidism on LV remodeling and function, we examined LV isolated myocyte function, chamber function, and whole tissue remodeling in a hamster model. Three-month-old F1b hamsters were randomized to control or 10 months TH treatment (0.1% grade I desiccated TH). LV chamber remodeling and function was assessed by echocardiography at 1, 2, 4, 6, 8, and 10 months of treatment. After 10 months, terminal cardiac function was assessed by echocardiography and LV hemodynamics. Hyperthyroid hamsters exhibited significant cardiac hypertrophy and deleterious cardiac remodeling characterized by myocyte lengthening, chamber dilatation, decreased relative wall thickness, increased wall stress, and increased LV interstitial fibrotic deposition. Importantly, hyperthyroid hamsters demonstrated significant LV systolic and diastolic dysfunction. Despite the aforementioned remodeling and global cardiac decline, individual isolated cardiac myocytes from chronically hyperthyroid hamsters had enhanced function when compared with myocytes from untreated age-matched controls. Thus, it appears that long-term hyperthyroidism may impair global LV function, at least in part by increasing interstitial ventricular fibrosis, in spite of normal or enhanced intrinsic cardiomyocyte function.	[Gerdes, A. Martin] New York Inst Technol, New York Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA; [Weltman, Nathan Y.] Univ S Dakota, Sanford Sch Med, Dept Basic Biomed Sci, Sioux Falls, SD USA; [Wang, Dajun; Redetzke, Rebecca A.] Sanford Res Univ S Dakota, Cardiovasc Res Ctr, Sioux Falls, SD USA	New York Institute Technology; University of South Dakota; Sanford Health	Gerdes, AM (corresponding author), New York Inst Technol, New York Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA.	agerdes@nyit.edu	Redetzke, Rebecca/ABC-1634-2021	Redetzke, Rebecca/0000-0002-8930-6879	National Institutes of Health National Center for Research Resources Grant [2P20RR017662-06A1, R01 HL093160-01A1]; American Diabetes Association Clinical Scientist Training Award [7-10-CST-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093160] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources Grant; American Diabetes Association Clinical Scientist Training Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health National Center for Research Resources Grant 2P20RR017662-06A1, R01 HL093160-01A1 (AMG), American Diabetes Association Clinical Scientist Training Award 7-10-CST-01 (NYW & AMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand IS, 1997, CIRCULATION, V96, P3974, DOI 10.1161/01.cir.96.11.3974; Aragno M, 2008, ENDOCRINOLOGY, V149, P380, DOI 10.1210/en.2007-0877; Araujo ASR, 2011, MOL CELL ENDOCRINOL, V333, P78, DOI 10.1016/j.mce.2010.12.018; Araujo ASR, 2008, J MOL ENDOCRINOL, V41, P423, DOI 10.1677/JME-08-0024; Araujo ASR, 2006, MOL CELL ENDOCRINOL, V249, P133, DOI 10.1016/j.mce.2006.02.005; Biondi B, 1996, J CLIN ENDOCR METAB, V81, P4224, DOI 10.1210/jc.81.12.4224; BIONDI B, 1993, J CLIN ENDOCR METAB, V77, P334, DOI 10.1210/jc.77.2.334; BRADY AJ, 1991, PHYSIOL REV, V71, P413, DOI 10.1152/physrev.1991.71.2.413; Brower GL, 2006, EUR J CARDIO-THORAC, V30, P604, DOI 10.1016/j.ejcts.2006.07.006; CAMPBELL SE, 1988, J MOL CELL CARDIOL, V20, P379, DOI 10.1016/S0022-2828(88)80129-9; Chandrashekhar Y, 1999, J AM COLL CARDIOL, V34, P594, DOI 10.1016/S0735-1097(99)00222-3; Chen WJ, 2000, MOL CELL ENDOCRINOL, V162, P45, DOI 10.1016/S0303-7207(00)00203-3; Chen YF, 2008, J MOL CELL CARDIOL, V44, P180, DOI 10.1016/j.yjmcc.2007.09.009; Civelek S, 2001, J TOXICOL ENV HEAL A, V64, P499, DOI 10.1080/152873901753215957; Colligan PB, 2002, J ENDOCRINOL, V173, P257, DOI 10.1677/joe.0.1730257; Degens H, 2003, AM J PHYSIOL-HEART C, V284, pH108, DOI 10.1152/ajpheart.00282.2002; Dorr M, 2005, J CLIN ENDOCR METAB, V90, P673, DOI 10.1210/jc.2004-1554; Fatourechi V, 2000, THYROID, V10, P601, DOI 10.1089/thy.2000.10.601; Gandhi MS, 2011, HEART FAIL REV, V16, P23, DOI 10.1007/s10741-010-9169-3; GERDES A M, 1985, Canadian Journal of Cardiology, V1, P340; GERDES AM, 1992, CIRCULATION, V86, P426, DOI 10.1161/01.CIR.86.2.426; Gerdes AM, 2002, J CARD FAIL, V8, pS264, DOI 10.1054/jcaf.2002.129280; Gerdes AM, 2010, CIRCULATION, V122, P385, DOI 10.1161/CIRCULATIONAHA.109.917922; Giraud MN, 2010, INT J CARDIOL, V138, P131, DOI 10.1016/j.ijcard.2008.08.034; Gomberg-Maitland M, 1998, AM HEART J, V135, P187, DOI 10.1016/S0002-8703(98)70081-X; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Khandwala HM, 2004, SOUTH MED J, V97, P1001, DOI 10.1097/01.SMJ.0000125100.10857.54; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; KLEIN I, 1986, J CLIN INVEST, V77, P1694, DOI 10.1172/JCI112488; Kuzman JA, 2005, J APPL PHYSIOL, V99, P1428, DOI 10.1152/japplphysiol.00515.2005; Lee HW, 1998, J MOL CELL CARDIOL, V30, P2495, DOI 10.1006/jmcc.1998.0811; Lewis W, 1932, AM J PATHOL, V8, P255; LITWIN SE, 1995, CIRCULATION, V91, P2642, DOI 10.1161/01.CIR.91.10.2642; Mackiewicz U, 2012, J MOL CELL CARDIOL, V52, P978, DOI 10.1016/j.yjmcc.2012.01.008; MAGNER JA, 1988, WESTERN J MED, V149, P86; MARCUS ML, 1987, CIRCULATION, V75, P19; Maulik SK, 2012, TOXICOL MECH METHOD, V22, P359, DOI 10.3109/15376516.2012.666650; Ojamaa K, 2000, ENDOCRINOLOGY, V141, P2139, DOI 10.1210/en.141.6.2139; Park M, 2009, AM J PHYSIOL-HEART C, V297, pH785, DOI 10.1152/ajpheart.00310.2009; Petretta M, 2001, EUR J ENDOCRINOL, V145, P691, DOI 10.1530/eje.0.1450691; Ren Jun, 2001, Biological Procedures Online, V3, P43, DOI 10.1251/bpo22; Riaz Kamran, 2003, Congest Heart Fail, V9, P40, DOI 10.1111/j.1527-5299.2003.01124.x; ROBINSON TF, 1988, CIRC RES, V63, P577, DOI 10.1161/01.RES.63.3.577; RODRIGUEZ E, 1993, J MOL CELL CARDIOL, V25, P939, DOI 10.1006/jmcc.1993.1106; Roy SG, 2007, MATRIX BIOL, V26, P269, DOI 10.1016/j.matbio.2006.12.005; Savinova OV, 2011, PLOS ONE, P6; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Schlenker EH, 2000, RESP PHYSIOL, V123, P63, DOI 10.1016/S0034-5687(00)00150-X; SCHLESINGER P, 1958, AM J CARDIOL, V2, P430, DOI 10.1016/0002-9149(58)90329-1; Shenoy R, 2001, AM J PHYSIOL-HEART C, V281, pH1690, DOI 10.1152/ajpheart.2001.281.4.H1690; SHIRANI J, 1993, AM J CARDIOL, V72, P365, DOI 10.1016/0002-9149(93)90691-5; Smit JWA, 2005, J CLIN ENDOCR METAB, V90, P6041, DOI 10.1210/jc.2005-0620; Song LS, 2005, CIRC RES, V97, P457, DOI 10.1161/01.RES.0000179722.79295.d4; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tamura T, 2000, CIRCULATION, V102, P253, DOI 10.1161/01.CIR.102.2.253; Tamura T, 1998, J MOL CELL CARDIOL, V30, P2175, DOI 10.1006/jmcc.1998.0775; TOMANEK RJ, 1995, AM J PHYSIOL-HEART C, V268, pH419, DOI 10.1152/ajpheart.1995.268.1.H419; Tomanek RJ, 1998, ANAT RECORD, V251, P44; Tsutsui H, 2006, ANTIOXID REDOX SIGN, V8, P1737, DOI 10.1089/ars.2006.8.1737; Wang YY, 2010, MOL CELL ENDOCRINOL, V320, P67, DOI 10.1016/j.mce.2010.01.031; WATANABE E, 1995, INTERNAL MED, V34, P762, DOI 10.2169/internalmedicine.34.762; WHEATLEY AM, 1988, BASIC RES CARDIOL, V83, P634, DOI 10.1007/BF01906958; WOEBER KA, 1992, NEW ENGL J MED, V327, P94; Wold LE, 2001, AM J PHYSIOL-HEART C, V281, pH476, DOI 10.1152/ajpheart.2001.281.2.H476; YAO JL, 1992, CIRC RES, V71, P831, DOI 10.1161/01.RES.71.4.831; Ziegelhoffer-Mihalovicova B, 2003, MOL CELL BIOCHEM, V247, P61, DOI 10.1023/A:1024153003249; ZIERHUT W, 1989, J MOL CELL CARDIOL, V21, P617, DOI 10.1016/0022-2828(89)90827-4; ZIMMER HG, 1990, J MOL CELL CARDIOL, V22, P1231, DOI 10.1016/0022-2828(90)90060-F	71	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46655	10.1371/journal.pone.0046655	http://dx.doi.org/10.1371/journal.pone.0046655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056390	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800037
J	Ohshima, D; Inoue, J; Ichikawa, K				Ohshima, Daisuke; Inoue, Jun-ichiro; Ichikawa, Kazuhisa			Roles of Spatial Parameters on the Oscillation of Nuclear NF-kappa B: Computer Simulations of a 3D Spherical Cell	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; NEGATIVE FEEDBACK; POSTTRANSLATIONAL MODIFICATIONS; SENSITIVITY-ANALYSIS; ACTIVATION PATHWAYS; SIGNALING PATHWAY; TEMPORAL CONTROL; SYSTEMS BIOLOGY; IKK-BETA; DYNAMICS	Transcription factor NF-kappa B resides in the cytoplasm and translocates to the nucleus by application of extracellular stimuli. It is known that the nuclear NF-kappa B oscillates and different oscillation patterns lead to different gene expression. Nearly forty reports on modeling and simulation of nuclear NF-kappa B have been published to date. The computational models reported so far are temporal or two-dimensional, and the discussions on spatial parameters have not been involved or limited. Since spatial parameters in cancer cells such as nuclear to cytoplasmic volume (N/C) ratio are different from normal cells, it is important to understand the relationship between oscillation patterns and spatial parameters. Here we report simulations of a 3D computational model for the oscillation of nuclear NF-kappa B using A-Cell software. First, we found that the default biochemical kinetic constants used in the temporal model cannot replicate the experimentally observed oscillation in the 3D model. Thus, the default parameters should be changed in the 3D model. Second, spatial parameters such as N/C ratio, nuclear transport, diffusion coefficients, and the location of I kappa B synthesis were found to alter the oscillation pattern. Third, among them, larger N/C ratios resulted in persistent oscillation of nuclear NF-kappa B, and larger nuclear transport resulted in faster oscillation frequency. Our simulation results suggest that the changes in spatial parameters seen in cancer cells is one possible mechanism for alteration in the oscillation pattern of nuclear NF-kappa B and lead to the altered gene expression in these cells.	[Ohshima, Daisuke; Ichikawa, Kazuhisa] Univ Tokyo, Inst Med Sci, Div Math Oncol, Minato Ku, Tokyo, Japan; [Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Ichikawa, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Math Oncol, Minato Ku, Tokyo, Japan.	kichi@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22117002, 22117008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Biteen JS, 2010, COLD SPRING HARVOR P; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cho KH, 2003, SIMUL-T SOC MOD SIM, V79, P726, DOI 10.1177/0037549703040943; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huber MD, 2007, J CELL BIOL, V179, P583, DOI 10.1083/jcb.200710156; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Ichikawa K, 2005, NEUROINFORMATICS, V3, P49, DOI 10.1385/NI:3:1:049; Ichikawa K, 2001, BIOINFORMATICS, V17, P483, DOI 10.1093/bioinformatics/17.5.483; Ihekwaba AEC, 2005, IEE P SYST BIOL, V152, P153, DOI 10.1049/ip-syb:20050050; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Jeong E, 2011, YONSEI MED J, V52, P379, DOI [10.3349/ymj.2011.52.3.379, 10.3349/ymj.2011.52.3.429]; Joo J, 2007, ANN NY ACAD SCI, V1115, P221, DOI 10.1196/annals.1407.014; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KATSOULIS M, 1995, BRIT J CANCER, V72, P958, DOI 10.1038/bjc.1995.441; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kim D, 2009, FASEB J, V23, P2796, DOI 10.1096/fj.09-130369; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kobayashi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281pe47; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Lahav Galit, 2004, Sci STKE, V2004, ppe55, DOI 10.1126/stke.2642004pe55; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; MAHAFFY JM, 1984, J MATH BIOL, V20, P39, DOI 10.1007/BF00275860; Martinez N, 1999, CANCER RES, V59, P5408; Millot C, 2000, HISTOL HISTOPATHOL, V15, P1185, DOI 10.14670/HH-15.1185; Miyawaki A, 2011, NAT REV MOL CELL BIO, V12, P656, DOI 10.1038/nrm3199; MONTIRONI R, 1990, ANAL CELL PATHOL, V2, P277; Moss BL, 2008, J BIOL CHEM, V283, P8687, DOI 10.1074/jbc.M706831200; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; Park SG, 2006, FEBS LETT, V580, P822, DOI 10.1016/j.febslet.2006.01.004; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; PIENTA KJ, 1991, CANCER, V68, P2012, DOI 10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; SALMON I, 1992, ANAL QUANT CYTOL, V14, P47; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Terry AJ, 2011, J THEOR BIOL, V290, P7, DOI 10.1016/j.jtbi.2011.08.036; Tokuda N, 2012, BIOPHYS J, V102, P296, DOI 10.1016/j.bpj.2011.12.005; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Xu SL, 2009, SEMIN CELL DEV BIOL, V20, P620, DOI 10.1016/j.semcdb.2009.03.003; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	67	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46911	10.1371/journal.pone.0046911	http://dx.doi.org/10.1371/journal.pone.0046911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056526	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000101
J	Ostroff, RM; Mehan, MR; Stewart, A; Ayers, D; Brody, EN; Williams, SA; Levin, S; Black, B; Harbut, M; Carbone, M; Goparaju, C; Pass, HI				Ostroff, Rachel M.; Mehan, Michael R.; Stewart, Alex; Ayers, Deborah; Brody, Edward N.; Williams, Stephen A.; Levin, Stephen; Black, Brad; Harbut, Michael; Carbone, Michele; Goparaju, Chandra; Pass, Harvey I.			Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool	PLOS ONE			English	Article							SERUM; CANCER	Background: Malignant pleural mesothelioma (MM) is an aggressive, asbestos-related pulmonary cancer that is increasing in incidence. Because diagnosis is difficult and the disease is relatively rare, most patients present at a clinically advanced stage where possibility of cure is minimal. To improve surveillance and detection of MM in the high-risk population, we completed a series of clinical studies to develop a noninvasive test for early detection. Methodology/Principal Findings: We conducted multi-center case-control studies in serum from 117 MM cases and 142 asbestos-exposed control individuals. Biomarker discovery, verification, and validation were performed using SOMAmer proteomic technology, which simultaneously measures over 1000 proteins in unfractionated biologic samples. Using univariate and multivariate approaches we discovered 64 candidate protein biomarkers and derived a 13-marker random forest classifier with an AUC of 0.99+/-0.01 in training, 0.98+/-0.04 in independent blinded verification and 0.95+/-0.04 in blinded validation studies. Sensitivity and specificity at our pre-specified decision threshold were 97%/92% in training and 90%/95% in blinded verification. This classifier accuracy was maintained in a second blinded validation set with a sensitivity/specificity of 90%/89% and combined accuracy of 92%. Sensitivity correlated with pathologic stage; 77% of Stage I, 93% of Stage II, 96% of Stage III and 96% of Stage IV cases were detected. An alternative decision threshold in the validation study yielding 98% specificity would still detect 60% of MM cases. In a paired sample set the classifier AUC of 0.99 and 91%/94% sensitivity/specificity was superior to that of mesothelin with an AUC of 0.82 and 66%/88% sensitivity/specificity. The candidate biomarker panel consists of both inflammatory and proliferative proteins, processes strongly associated with asbestos-induced malignancy. Significance: The SOMAmer biomarker panel discovered and validated in these studies provides a solid foundation for surveillance and diagnosis of MM in those at highest risk for this disease.	[Ostroff, Rachel M.; Mehan, Michael R.; Stewart, Alex; Ayers, Deborah; Brody, Edward N.; Williams, Stephen A.] SomaLogic Inc, Clin Res, Boulder, CO USA; [Levin, Stephen] Mt Sinai Med Ctr, Ctr Occupat & Environm Med, New York, NY 10029 USA; [Black, Brad] Ctr Asbestos Related Dis, Libby, MT USA; [Harbut, Michael] Karmanos Canc Ctr, Environm Canc Program, Detroit, MI USA; [Carbone, Michele] Canc Res Ctr Hawaii, Dept Pathol, Honolulu, HI 96813 USA; [Goparaju, Chandra; Pass, Harvey I.] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY USA; [Goparaju, Chandra; Pass, Harvey I.] NYU, Ctr Canc, New York, NY USA	Icahn School of Medicine at Mount Sinai; Barbara Ann Karmanos Cancer Institute; Cancer Research Center of Hawaii; New York University; NYU Langone Medical Center; New York University	Ostroff, RM (corresponding author), SomaLogic Inc, Clin Res, Boulder, CO USA.	rostroff@somalogic.com		Pass, Harvey/0000-0003-3222-3471	SomaLogic; National Cancer Institute [2U01CA111295-04]; NATIONAL CANCER INSTITUTE [U01CA111295] Funding Source: NIH RePORTER	SomaLogic; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SomaLogic (http://www.somalogic.com/) funded the proteomic analyses. Funding for all other aspects of the study including cohort assembly and ELISA completion was through National Cancer Institute Early Detection Research Grant 2U01CA111295-04 (http://edrn.nci.nih.gov/) to HIP. SomaLogic had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Carbone M, 2011, P NATL ACAD SCI USA, V108, P13618, DOI 10.1073/pnas.1105887108; Chee J, 2007, BIOL CHEM, V388, P1235, DOI 10.1515/BC.2007.139; Creaney J, 2010, CANCER EPIDEM BIOMAR, V19, P2238, DOI 10.1158/1055-9965.EPI-10-0346; Creaney J, 2009, CURR OPIN PULM MED, V15, P366, DOI 10.1097/MCP.0b013e32832b98eb; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hollevoet K, 2012, J CLIN ONCOL, V30, P1541, DOI 10.1200/JCO.2011.39.6671; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kraemer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026332; Miao RQ, 2003, AM J PHYSIOL-CELL PH, V284, pC1604, DOI 10.1152/ajpcell.00524.2002; Ostroff R, 2010, J PROTEOMICS, V73, P649, DOI 10.1016/j.jprot.2009.09.004; Pass HI, 2008, ANN THORAC SURG, V85, P265, DOI 10.1016/j.athoracsur.2007.07.042; Pass HI, 2010, CANCER RES, V70, P1916, DOI 10.1158/0008-5472.CAN-09-3993; Pass HI, 2009, SEMIN THORAC CARDIOV, V21, P97, DOI 10.1053/j.semtcvs.2009.06.007; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Pinato DJ, 2012, J THORAC ONCOL, V7, P587, DOI 10.1097/JTO.0b013e31823f45c1; Roberts HC, 2009, J THORAC ONCOL, V4, P620, DOI 10.1097/JTO.0b013e31819f2e0e; Santarelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018232; SELIKOFF IJ, 1992, AM J IND MED, V22, P481, DOI 10.1002/ajim.4700220403; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; Vierikko T, 2007, EUR RESPIR J, V29, P78, DOI 10.1183/09031936.00073606	24	107	111	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46091	10.1371/journal.pone.0046091	http://dx.doi.org/10.1371/journal.pone.0046091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056237	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000016
J	Vukoti, K; Kimura, T; Macke, L; Gawrisch, K; Yeliseev, A				Vukoti, Krishna; Kimura, Tomohiro; Macke, Laura; Gawrisch, Klaus; Yeliseev, Alexei			Stabilization of Functional Recombinant Cannabinoid Receptor CB2 in Detergent Micelles and Lipid Bilayers	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; ADENOSINE A(2A) RECEPTOR; ESCHERICHIA-COLI; LIGAND STABILIZATION; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; DRUG DISCOVERY; EXPRESSION; PURIFICATION; ACTIVATION	Elucidation of the molecular mechanisms of activation of G protein-coupled receptors (GPCRs) is among the most challenging tasks for modern membrane biology. For studies by high resolution analytical methods, these integral membrane receptors have to be expressed in large quantities, solubilized from cell membranes and purified in detergent micelles, which may result in a severe destabilization and a loss of function. Here, we report insights into differential effects of detergents, lipids and cannabinoid ligands on stability of the recombinant cannabinoid receptor CB2, and provide guidelines for preparation and handling of the fully functional receptor suitable for a wide array of downstream applications. While we previously described the expression in Escherichia coli, purification and liposome-reconstitution of multi-milligram quantities of CB2, here we report an efficient stabilization of the recombinant receptor in micelles - crucial for functional and structural characterization. The effects of detergents, lipids and specific ligands on structural stability of CB2 were assessed by studying activation of G proteins by the purified receptor reconstituted into liposomes. Functional structure of the ligand binding pocket of the receptor was confirmed by binding of H-2-labeled ligand measured by solid-state NMR. We demonstrate that a concerted action of an anionic cholesterol derivative, cholesteryl hemisuccinate (CHS) and high affinity cannabinoid ligands CP-55,940 or SR-144,528 are required for efficient stabilization of the functional fold of CB2 in dodecyl maltoside (DDM)/CHAPS detergent solutions. Similar to CHS, the negatively charged phospholipids with the serine headgroup (PS) exerted significant stabilizing effects in micelles while uncharged phospholipids were not effective. The purified CB2 reconstituted into lipid bilayers retained functionality for up to several weeks enabling high resolution structural studies of this GPCR at physiologically relevant conditions.	[Vukoti, Krishna; Kimura, Tomohiro; Macke, Laura; Gawrisch, Klaus; Yeliseev, Alexei] NIAAA, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Yeliseev, A (corresponding author), NIAAA, NIH, Bethesda, MD USA.	yeliseeva@mail.nih.gov	Yeliseev, Alexei A/B-3143-2009; Kimura, Tomohiro/AEJ-1621-2022	Kimura, Tomohiro/0000-0002-4192-7852	intramural research program of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003] Funding Source: NIH RePORTER	intramural research program of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by the intramural research program of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), to KG. KG participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Attrill H, 2009, PROTEIN EXPRES PURIF, V64, P32, DOI 10.1016/j.pep.2008.10.001; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Feng W, 2002, PROTEIN EXPRES PURIF, V26, P496, DOI 10.1016/S1046-5928(02)00569-7; Filppula S, 2004, J PEPT RES, V64, P225, DOI 10.1111/j.1399-3011.2004.00188.x; Gawrisch K, 2008, CHEM PHYS LIPIDS, V153, P64, DOI 10.1016/j.chemphyslip.2008.02.016; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Grisshammer R, 1999, BIOCHEM SOC T, V27, P899, DOI 10.1042/bst0270899; Grisshammer R, 2009, METHOD ENZYMOL, V463, P631, DOI 10.1016/S0076-6879(09)63036-6; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Inagaki S, 2012, J MOL BIOL, V417, P95, DOI 10.1016/j.jmb.2012.01.023; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kimura T, 2012, J BIOL CHEM, V287, P4076, DOI 10.1074/jbc.M111.268425; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Krepkiy D, 2006, PROTEIN EXPRES PURIF, V49, P60, DOI 10.1016/j.pep.2006.03.002; Kubota M, 2009, J BIOCHEM, V146, P875, DOI 10.1093/jb/mvp132; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lin SS, 1996, BIOCHEMISTRY-US, V35, P14445, DOI 10.1021/bi961619+; LINDER ME, 1990, J BIOL CHEM, V265, P8243; Link AJ, 2008, PROTEIN SCI, V17, P1857, DOI 10.1110/ps.035980.108; Lorch M, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P361; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Magnin T, 2009, PROTEIN EXPRES PURIF, V64, P1, DOI 10.1016/j.pep.2008.09.007; Mancia F, 2007, MOL BIOSYST, V3, P723, DOI 10.1039/B713558K; McKallip RJ, 2002, BLOOD, V100, P627, DOI 10.1182/blood-2002-01-0098; Mumby SM, 1994, HETEROTRIMERIC G, V237, P254; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; O'Malley MA, 2011, BIOPHYS J, V100, pL11, DOI 10.1016/j.bpj.2010.12.3698; Ott D, 2005, PROTEIN ENG DES SEL, V18, P153, DOI 10.1093/protein/gzi012; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Pertwee RG, 2002, PHARMACOL THERAPEUT, V95, P165, DOI 10.1016/S0163-7258(02)00255-3; Ratnala VRP, 2006, BIOTECHNOL LETT, V28, P767, DOI 10.1007/s10529-006-9005-y; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Sanchez C, 2001, CANCER RES, V61, P5784; Sarramegna V, 2006, CELL MOL LIFE SCI, V63, P1149, DOI 10.1007/s00018-005-5557-6; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Serrano-Vega MJ, 2009, MOL MEMBR BIOL, V26, P385, DOI 10.3109/09687680903208239; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Sykora J, 2009, BBA-BIOMEMBRANES, V1788, P324, DOI 10.1016/j.bbamem.2008.11.008; THOMAS BF, 1990, J PHARMACOL EXP THER, V255, P624; WILDMAN DE, 1993, P NATL ACAD SCI USA, V90, P794, DOI 10.1073/pnas.90.3.794; Yao ZP, 2005, ANAL BIOCHEM, V343, P344, DOI 10.1016/j.ab.2005.05.002; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305; Yeliseev A, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P219; Yeliseev A, 2007, PROTEIN EXPRES PURIF, V53, P153, DOI 10.1016/j.pep.2006.12.003; Zhang RD, 2007, PROTEIN EXPRES PURIF, V55, P225, DOI 10.1016/j.pep.2007.03.018	48	37	37	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46290	10.1371/journal.pone.0046290	http://dx.doi.org/10.1371/journal.pone.0046290			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056277	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000030
J	Smith, ZJ; Chu, KQ; Wachsmann-Hogiu, S				Smith, Zachary J.; Chu, Kaiqin; Wachsmann-Hogiu, Sebastian			Nanometer-Scale Sizing Accuracy of Particle Suspensions on an Unmodified Cell Phone Using Elastic Light Scattering	PLOS ONE			English	Article							SIZE DISTRIBUTION; MICROSCOPY; CYTOMETRY	We report on the construction of a Fourier plane imaging system attached to a cell phone. By illuminating particle suspensions with a collimated beam from an inexpensive diode laser, angularly resolved scattering patterns are imaged by the phone's camera. Analyzing these patterns with Mie theory results in predictions of size distributions of the particles in suspension. Despite using consumer grade electronics, we extracted size distributions of sphere suspensions with better than 20 nm accuracy in determining the mean size. We also show results from milk, yeast, and blood cells. Performing these measurements on a portable device presents opportunities for field-testing of food quality, process monitoring, and medical diagnosis.	[Smith, Zachary J.; Chu, Kaiqin; Wachsmann-Hogiu, Sebastian] Univ Calif Davis, Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Wachsmann-Hogiu, Sebastian] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Smith, ZJ (corresponding author), Univ Calif Davis, Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA.	zsmith@ucdavis.edu; swachsmann@ucdavis.edu	Smith, Zachary/S-2211-2019; Smith, Zachary/K-6888-2016	Smith, Zachary/0000-0002-7946-7863; 	Center for Biophotonics Science and Technology;  [PHY0120999]	Center for Biophotonics Science and Technology; 	This work was supported by the Center for Biophotonics Science and Technology, a designated NSF Science and Technology Center managed by the University of California Davis, under Cooperative Agreement No. PHY0120999. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESSMAN JD, 1983, AM J CLIN PATHOL, V80, P322, DOI 10.1093/ajcp/80.3.322; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Damania D, 2012, CANCER RES, V72, P2720, DOI 10.1158/0008-5472.CAN-11-3807; GREEN R, 1989, BLOOD CELLS, V15, P481; Hammer M, 1998, APPL OPTICS, V37, P7410, DOI 10.1364/AO.37.007410; KIM YR, 1983, CYTOMETRY, V3, P419, DOI 10.1002/cyto.990030606; LATIMER P, 1968, J COLLOID INTERF SCI, V27, P475, DOI 10.1016/0021-9797(68)90184-7; LIN SHC, 1971, BIOCHEMISTRY-US, V10, P4788, DOI 10.1021/bi00801a029; Michalski MC, 2002, LAIT, V82, P193, DOI 10.1051/lait:2002004; Mudanyali O, 2010, LAB CHIP, V10, P2419, DOI 10.1039/c004829a; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Paquin P, 1999, INT DAIRY J, V9, P329, DOI 10.1016/S0958-6946(99)00083-7; Pasternack RM, 2011, CYTOM PART A, V79A, P137, DOI 10.1002/cyto.a.21011; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Smith ZJ, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3124797; Terry NG, 2011, GASTROENTEROLOGY, V140, P42, DOI 10.1053/j.gastro.2010.09.008; Wax A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2102767; Wilson JD, 2005, BIOPHYS J, V88, P2929, DOI 10.1529/biophysj.104.054528; Wilson JD, 2007, THESIS U ROCHESTER; Zhu HY, 2011, ANAL CHEM, V83, P6641, DOI 10.1021/ac201587a	21	15	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46030	10.1371/journal.pone.0046030	http://dx.doi.org/10.1371/journal.pone.0046030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056228	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600021
J	Dalleau, M; Ciccione, S; Mortimer, JA; Garnier, J; Benhamou, S; Bourjea, J				Dalleau, Mayeul; Ciccione, Stephane; Mortimer, Jeanne A.; Garnier, Julie; Benhamou, Simon; Bourjea, Jerome			Nesting Phenology of Marine Turtles: Insights from a Regional Comparative Analysis on Green Turtle (Chelonia mydas)	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; REPRODUCTIVE SEASONALITY; ASCENSION-ISLAND; MAYOTTE ISLAND; INDIAN-OCEAN; MIGRATION; IMPACTS; RESPONSES; PATTERNS	Changes in phenology, the timing of seasonal activities, are among the most frequently observed responses to environmental disturbances and in marine species are known to occur in response to climate changes that directly affects ocean temperature, biogeochemical composition and sea level. We examined nesting seasonality data from long-term studies at 8 green turtle (Chelonia mydas) rookeries that include 21 specific nesting sites in the South-West Indian Ocean (SWIO). We demonstrated that temperature drives patterns of nesting seasonality at the regional scale. We found a significant correlation between mean annual Sea Surface Temperature (SST) and dates of peak nesting with rookeries exposed to higher SST having a delayed nesting peak. This supports the hypothesis that temperature is the main factor determining peak nesting dates. We also demonstrated a spatial synchrony in nesting activity amongst multiple rookeries in the northern part of the SWIO (Aldabra, Glorieuses, Moheli, Mayotte) but not with the eastern and southern rookeries (Europa, Tromelin), differences which could be attributed to females with sharply different adult foraging conditions. However, we did not detect a temporal trend in the nesting peak date over the study period or an inter-annual relation between nesting peak date and SST. The findings of our study provide a better understanding of the processes that drive marine species phenology. The findings will also help to predict their ability to cope with climate change and other environmental perturbations. Despite demonstrating this spatial shift in nesting phenology, no trend in the alteration of nesting dates over more than 20 years was found.	[Dalleau, Mayeul] Univ La Reunion, UMR Espace Dev, St Denis, Reunion, France; [Dalleau, Mayeul; Ciccione, Stephane] Kelonia, Observ Tortues Marines La Reunion, St Leu, Reunion, France; [Mortimer, Jeanne A.] Seychelles Isl Fdn, Victoria, Mahe, Seychelles; [Mortimer, Jeanne A.] Univ Florida, Dept Biol, Gainesville, FL USA; [Garnier, Julie] Zool Soc London, London, England; [Dalleau, Mayeul; Benhamou, Simon] CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France; [Dalleau, Mayeul; Bourjea, Jerome] IFREMER, Delegation Locean Indien, F-97822 Le Port, Reunion, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite des Antilles; University of La Reunion; State University System of Florida; University of Florida; Zoological Society of London; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Ifremer	Dalleau, M (corresponding author), Univ La Reunion, UMR Espace Dev, St Denis, Reunion, France.	mayeuldalleau@kelonia.org		Mortimer, Jeanne A./0000-0001-6318-2890; Bourjea, Jerome/0000-0001-7149-3648	Region Reunion; Region Reunion	Region Reunion; Region Reunion	We thank all the people and organisations that made this study possible: TAAF (Terres Australes et Antarctiques Francaise), FAZSOI (Forces Armees de la Zone Sud-Ouest Ocean Indien), the Gendarmerie Nationale from La Reunion, and Meteo France Reunion for their logistic contribution on the Eparses islands, staff from ADSEINGO(Association pour le Developpement Socio-Economique du village d'Itsamia) in Moheli (Comoros), people from Oulanga Na Nyamba NGO (Mayotte), CGM of Mayotte (Conseil General de Mayotte), DAAF of Mayotte (Direction de l'Agriculture, de l'Alimentation et de la Foret), DEAL of Mayotte (Direction de l'Environnement, de l'Amenagement et du Logement) and the nature guards of OTM/SPN/DEDD of Mayotte (Observatoire des Tortues Marines/Service Patrimoine Naturel du Conseil General) with special thanks to Mireille Quillard, SIF (Seychelles Islands Foundation) and its personnel who collected data at Aldabra between 1980 and 2008, the Zoological Society of London and the Maluane conservation team (northern Mozambique) for sharing their data and the numerous volunteers involved in the beach monitoring program. We thank Pr. Georges Hughes for correcting the English writing. We thank the three anonymous reviewers for their useful comments. Mayeul Dalleau personally thanks the Region Reunion that is funding his PhD studentship. At last we wish to thanks the reviewers that contributed improving this paper.	Ackerman Ralph A., 1997, P83; [Anonymous], ORYX IN PRESS; Batschelet E, 1981, CIRCULAR STAT BIOL; Bjorndal KA, 1999, CONSERV BIOL, V13, P126, DOI 10.1046/j.1523-1739.1999.97329.x; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Bourjea J, 2007, MOL ECOL, V16, P175, DOI 10.1111/j.1365-294X.2006.03122.x; Bourjea J, INDIAN OCEA IN PRESS; Bourjea Jerome, 2007, Endangered Species Research, V3, P273, DOI 10.3354/esr00053; Bourjea Jerome, 2006, Western Indian Ocean Journal of Marine Science, V5, P209; BOWEN BW, 1992, EVOLUTION, V46, P865, DOI 10.1111/j.1558-5646.1992.tb00605.x; Broderick AC, 2001, P ROY SOC B-BIOL SCI, V268, P1481, DOI 10.1098/rspb.2001.1695; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Carr AF, 1986, SEA TURTLE SO EXCELL; Chaloupka M, 2001, BIOL CONSERV, V101, P263, DOI 10.1016/S0006-3207(00)00199-3; Chaloupka M, 2008, J EXP MAR BIOL ECOL, V356, P136, DOI 10.1016/j.jembe.2007.12.009; Chevalier J, 1999, STUDY BIMODAL NESTIN; Cliff A. D., 1981, SPATIAL PROCESSES MO; Davenport J, 1997, J THERM BIOL, V22, P479, DOI 10.1016/S0306-4565(97)00066-1; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Duhec A, 2010, CLIMATE DATA REPORT; Eckert KL, 1999, RES MANAGEMENT TECHN; Fieux M, 2001, ENCY OCEAN SCI, P728; Frazier J., 1975, Oryx, V13, P164; Frazier J, 2012, REPTILE BIODIVERSITY, P260; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Gaspar P, MARINE ECOLOGY PROGR; Glen F, 2005, MAR BIOL, V146, P1039, DOI 10.1007/s00227-004-1492-6; Godley BJ, 2002, MAR ECOL PROG SER, V226, P125, DOI 10.3354/meps226125; Godley BJ, 2001, BIOL CONSERV, V97, P151, DOI 10.1016/S0006-3207(00)00107-5; Hamann M, 2003, CRC MAR BIOL SER, P135; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes G, 1973, THESIS; Lauret-Stepler M., 2007, Endangered Species Research, V3, P217, DOI 10.3354/esr003217; Lauret-Stepler Marie, 2010, Indian Ocean Turtle Newsletter, V11, P18; le Gall J.-Y., 1987, Amphibia-Reptilia, V8, P277, DOI 10.1163/156853887X00315; le Gall J.-Y., 1987, Oceanographie Tropicale, V21, P3; Le Gall J-Y, 1988, MESOGEE, V48, P33; Lepetz V, 2009, BIODIVERS CONSERV, V18, P3185, DOI 10.1007/s10531-009-9636-0; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; Luschi P, 1998, P ROY SOC B-BIOL SCI, V265, P2279, DOI 10.1098/rspb.1998.0571; Mazaris Antonios D., 2004, Natural Resource Modeling, V17, P445; Mazaris AD, 2009, J EXP MAR BIOL ECOL, V379, P23, DOI 10.1016/j.jembe.2009.07.026; Mazaris AD, 2008, J EXP MAR BIOL ECOL, V367, P219, DOI 10.1016/j.jembe.2008.09.025; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; MILLER J.D., 2003, LOGGERHEAD SEA TURTL, P125, DOI DOI 10.1086/431100; Miller Jeffrey D., 1997, P51; MORTIMER JA, 1990, COPEIA, P802, DOI 10.2307/1446446; MORTIMER JA, 1987, COPEIA, P103, DOI 10.2307/1446043; Mortimer JA, 1984, MARINE TURTLES REPUB; Mortimer JA, 1988, GREEN TURTLE NESTING; Mortimer JA, 2011, CHELONIAN CONSERV BI, V10, P165, DOI 10.2744/CCB-0872.1; Mortimer JA, 2011, CHELONIAN CONSERV BI, V10, P26, DOI 10.2744/CCB-0830.1; MROSOVSKY N, 1991, Amphibia-Reptilia, V12, P169, DOI 10.1163/156853891X00149; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pike DA, 2009, CHELONIAN CONSERV BI, V8, P43, DOI 10.2744/CCB-0726.1; Quartly GD, 2004, DEEP-SEA RES PT II, V51, P69, DOI 10.1016/j.dsr2.2003.03.001; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Segura LN, 2010, HERPETOL CONSERV BIO, V5, P196; Sims DW, 2004, J ANIM ECOL, V73, P333, DOI 10.1111/j.0021-8790.2004.00810.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Solow AR, 2002, ECOL LETT, V5, P742, DOI 10.1046/j.1461-0248.2002.00374.x; Spotila James R., 1997, P297; Taquet C, 2006, MAR ECOL PROG SER, V306, P295, DOI 10.3354/meps306295; Team R. D. C, 2011, R LANG ENV STAT COMP; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1529-8817.2003.00817.x; Weishampel John F., 2010, Endangered Species Research, V12, P41, DOI 10.3354/esr00290; Wood DW, 2000, COPEIA, P119; Yasuda T, 2006, J ZOOL, V269, P451, DOI 10.1111/j.1469-7998.2006.00134.x; YNTEMA CL, 1980, HERPETOLOGICA, V36, P33	79	24	27	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46920	10.1371/journal.pone.0046920	http://dx.doi.org/10.1371/journal.pone.0046920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056527	Green Published, gold			2022-12-27	WOS:000309889400036
J	Kweider, N; Huppertz, B; Wruck, CJ; Beckmann, R; Rath, W; Pufe, T; Kadyrov, M				Kweider, Nisreen; Huppertz, Berthold; Wruck, Christoph Jan; Beckmann, Rainer; Rath, Werner; Pufe, Thomas; Kadyrov, Mamed			A Role for Nrf2 in Redox Signalling of the Invasive Extravillous Trophoblast in Severe Early Onset IUGR Associated with Preeclampsia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CIRCULATING ANGIOGENIC FACTORS; OXIDATIVE STRESS; HUMAN PLACENTA; GENE-EXPRESSION; MATERNAL ANEMIA; LOCALIZATION; RECEPTOR; BED; RESTRICTION	Background: Preeclampsia (PE) is characterized by increased lipid oxidation and diminished antioxidant capacity, while intrauterine growth restriction (IUGR) is characterized by impaired invasion of the extravillous trophoblast. Vascular endothelial growth factor (VEGF) has been reported to be altered in preeclampsia. A relationship between VEGF and nuclear factor erythroid 2-related factor-2 (Nrf2) has been shown in vitro, where VEGF prevents oxidative damage via activation of the Nrf2 pathway. In this study the expression of Nrf2, VEGF and 4-hydroxynonenal (4-HNE), was determined in interstitial and endovascular/intramural extravillous trophoblast (EVT) in normal pregnancies and those complicated by severe early onset IUGR associated with preeclampsia IUGR/PE. Materials and Methods: Full-thickness uterine tissues derived from caesarean hysterectomies performed in 5 healthy normotensive women delivering term infants and 6 women with severe early onset IUGR with preeclampsia (29-34 weeks gestation) were analyzed. Interstitial and endovascular extravillous trophoblast were quantified after immunohistochemical staining of paraffin sections using antibodies against Nrf2, 4-HNE, VEGF, and cytokeratin 7. Results: Uterine tissues from women suffering from severe early onset IUGR/PE were characterized by reduced invasion of extravillous trophoblast into the endometrial and myometrial segments of spiral arteries in the placental bed. Extravillous trophoblast showed an increased cytoplasmic expression of Nrf2 and 4-HNE in IUGR/PE cases. The increased expression of Nrf2 in cases of IUGR/PE was associated with decreased expression of VEGF in these cells compared to controls. Conclusion: Our data suggests that besides villous cytotrophoblast, also the extravillous trophoblast is a source of Nrf2-dependent genes. VEGF deficiency may cause higher oxidative stress in extravillous trophoblast in cases with IUGR/PE. The resulting reduced basal defence against oxidative stress and the higher vulnerability to oxidative damage may play a role in the limited trophoblast invasion into spiral arteries in cases suffering from severe early onset IUGR/PE.	[Kweider, Nisreen; Wruck, Christoph Jan; Beckmann, Rainer; Pufe, Thomas; Kadyrov, Mamed] Rhein Westfal TH Aachen, Fac Med, Dept Anat & Cell Biol, Aachen, Germany; [Huppertz, Berthold] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Rath, Werner] Rhein Westfal TH Aachen, Univ Hosp, Dept Obstet & Gynecol, D-52062 Aachen, Germany; [Kadyrov, Mamed] MEDIAN Kliniken, Baden Wurttemberg, Germany	RWTH Aachen University; Medical University of Graz; RWTH Aachen University; RWTH Aachen University Hospital	Kweider, N (corresponding author), Rhein Westfal TH Aachen, Fac Med, Dept Anat & Cell Biol, Aachen, Germany.	nkweider@ukaachen.de	Huppertz, Berthold/I-2331-2019	Huppertz, Berthold/0000-0003-4814-2158	Deutsche Forschungsgemeinschaft [Pu 214/3-2, Pu 214/4-2, Pu 214/5-2, SFB617]; START Program of the Faculty of Medicine, RWTH Aachen University; Department of Histology, Faculty of Medicine at Damascus University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); START Program of the Faculty of Medicine, RWTH Aachen University; Department of Histology, Faculty of Medicine at Damascus University	This work was supported by Deutsche Forschungsgemeinschaft Grants Pu 214/3-2, Pu 214/4-2, Pu 214/5-2, and SFB617; the START Program of the Faculty of Medicine, RWTH Aachen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Michaela Nicolau for her excellent technical assistance. We thank Wolfgang Graulich for the production of the illustration figure (1). We also gratefully thank the Department of Histology, Faculty of Medicine at Damascus University because of the scholarship of Nisreen Kweider.	AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Albaiges G, 2003, ULTRASOUND OBST GYN, V21, P170, DOI 10.1002/uog.30; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Barber A, 2001, FASEB J, V15, P1158, DOI 10.1096/fj.00-0376com; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Chigusa Y, 2012, J CLIN ENDOCRINOL ME; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Clark DE, 1996, HUM REPROD, V11, P1090; Cooper JC, 1995, J REPROD FERTIL, V105, P205; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; FRETTS RC, 1992, OBSTET GYNECOL, V79, P35; Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189; Hung TH, 2001, AM J PATHOL, V159, P1031, DOI 10.1016/S0002-9440(10)61778-6; Huppertz B, 2003, Pathologica, V95, P231; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Huppertz Berthold, 2005, Angiogenesis, V8, P157, DOI 10.1007/s10456-005-9007-8; Kadyrov M, 1998, LANCET, V352, P1747, DOI 10.1016/S0140-6736(98)02069-8; Kadyrov M, 2006, AM J OBSTET GYNECOL, V194, P557, DOI 10.1016/j.ajog.2005.07.035; Kadyrov M, 2003, PLACENTA, V24, P540, DOI 10.1053/plac.2002.0946; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kinzler WL, 2008, CURR OPIN OBSTET GYN, V20, P125, DOI 10.1097/GCO.0b013e3282f7320a; Kulkarni AV, 2010, HYPERTENS RES, V33, P561, DOI 10.1038/hr.2010.31; Kweider N, 2011, J BIOL CHEM, V286, P42863, DOI 10.1074/jbc.M111.286880; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Majima Hideyuki J, 2002, Methods Mol Biol, V196, P31; Mann Giovanni E., 2007, Shengli Xuebao, V59, P117; Martin AM, 2001, ULTRASOUND OBST GYN, V18, P583, DOI 10.1046/j.0960-7692.2001.00594.x; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MYATT L, 1992, PLACENTA, V13, P329, DOI 10.1016/0143-4004(92)90057-Z; Perkins AV, 2006, AUST NZ J OBSTET GYN, V46, P77, DOI 10.1111/j.1479-828X.2006.00532.x; Pijnenborg R, 2011, BEST PRACT RES CL OB, V25, P273, DOI 10.1016/j.bpobgyn.2010.10.009; PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Robson SC, 2002, AM J OBSTET GYNECOL, V187, P1349, DOI 10.1067/mob.2002.126866; Schiessl B, 2009, PLACENTA, V30, P79, DOI 10.1016/j.placenta.2008.10.004; Shiraishi S, 1996, PLACENTA, V17, P111, DOI 10.1016/S0143-4004(96)80004-X; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; TRUDINGER BJ, 1985, BRIT J OBSTET GYNAEC, V92, P23, DOI 10.1111/j.1471-0528.1985.tb01044.x; Vuckovic M, 1996, J ANAT, V188, P361; Wruck CJ, 2008, MOL PHARMACOL, V73, P1785, DOI 10.1124/mol.107.042499; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Wruck CJ, 2009, HISTOPATHOLOGY, V55, P102, DOI 10.1111/j.1365-2559.2009.03339.x; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	48	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47055	10.1371/journal.pone.0047055	http://dx.doi.org/10.1371/journal.pone.0047055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056578	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400050
J	Su, J; Xu, J; Li, XJ; Zhang, H; Hu, JW; Fang, RY; Chen, XM				Su, Jia; Xu, Jin; Li, Xiaojing; Zhang, Han; Hu, Juwei; Fang, Renyuan; Chen, Xiaomin			ABCB1 C3435T Polymorphism and Response to Clopidogrel Treatment in Coronary Artery Disease (CAD) Patients: A Meta-Analysis	PLOS ONE			English	Article							ACCELERATED PLATELET INHIBITION; ACUTE MYOCARDIAL-INFARCTION; ADVERSE CLINICAL EVENTS; MULTIDRUG-RESISTANCE; GENETIC POLYMORPHISMS; CARDIOVASCULAR EVENTS; ANTIPLATELET THERAPY; STENT THROMBOSIS; DRUG-RESISTANCE; REACTIVITY	Background: A number of investigators have evaluated the association between the ABCB1 polymorphism and clopidogrel responding, but the results have been inconclusive. To examine the risk of high platelet activity and poor clinical outcomes associated with the ABCB1 C3435T polymorphism in CAD patients on clopidogrel, all available studies were included in the present meta-analysis. Methods: We performed a systematic search of PubMed, Scopus and the Cochrane library database for eligible studies. Articles meeting the inclusion criteria were comprehensively reviewed, and the available data were accumulated by the meta-analysis. Results: It was demonstrated that the ABCB1 C3435T variation was associated with the risk of early major adverse cardiovascular events (MACE) (T vs. C OR, 1.34; 95% CI, 1.10 to 1.62; P = 0.003; TT vs. CC: OR, 1.77; 95% CI, 1.19 to 2.63; P = 0.005; CT + TT vs. CC: OR, 1.48; 95% CI, 1.06 to 2.06; P = 0.02) and the polymorphism was also associated with the risk of the long-term MACE in patients on clopidogrel LD 300 mg (T vs. C: OR, 1.28; 95% CI, 1.10 to 1.48; P = 0.001; TT vs. CC: OR, 1.59; 95% CI, 1.19 to 2.13; P = 0.002; CT + TT vs. CC: OR, 1.39; 95% CI, 1.08 to 1.79; P = 0.01). The comparison of TT vs. CC was associated with a reduction in the outcome of bleeding (TT vs. CC: OR, 0.51; 95% CI, 0.40 to 0.66; P<0.00001). However, the association between ABCB1 C3435T polymorphism and platelet activity and other risk of poor clinical outcomes was not significant. Conclusions: The evidence from our meta-analysis indicated that the ABCB1 C3435T polymorphism might be a risk factor for the MACE in patients on clopidogrel LD 300 mg, and that TT homozygotes decreased the outcome of bleeding compared with CC homozygotes.	[Su, Jia; Li, Xiaojing; Zhang, Han; Fang, Renyuan; Chen, Xiaomin] Ningbo Univ, Sch Med, Affiliated Ningbo Hosp 1, Dept Cardiol, Ningbo 315211, Zhejiang, Peoples R China; [Xu, Jin] Ningbo Univ, Sch Med, Inst Preventat Med, Ningbo 315211, Zhejiang, Peoples R China; [Hu, Juwei] Ningbo Univ, Sch Med, Dept Biochem & Mol Biol, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University; Ningbo University	Chen, XM (corresponding author), Ningbo Univ, Sch Med, Affiliated Ningbo Hosp 1, Dept Cardiol, Ningbo 315211, Zhejiang, Peoples R China.	chxmin@hotmail.com						Angiolillo DJ, 2005, DIABETES, V54, P2430, DOI 10.2337/diabetes.54.8.2430; Begg CB, 2002, STAT MED, V20, P641, DOI [10.1002/sim.1162, DOI 10.1002/SIM.1162]; Bonello L, 2012, THROMB RES, V130, P70, DOI 10.1016/j.thromres.2011.12.038; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047; Campo G, 2010, J THROMB THROMBOLYS, V30, P319, DOI 10.1007/s11239-010-0457-5; Cayla G, 2011, JAMA-J AM MED ASSOC, V306, P1765, DOI 10.1001/jama.2011.1529; Delaney JT, 2012, CLIN PHARMACOL THER, V91, P257, DOI 10.1038/clpt.2011.221; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FOJO A, 1986, SOMAT CELL MOLEC GEN, V12, P415, DOI 10.1007/BF01570737; Gladding P, 2008, JACC-CARDIOVASC INTE, V1, P620, DOI 10.1016/j.jcin.2008.09.008; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Jaitner J, 2012, CIRC-CARDIOVASC INTE, V5, P82, DOI 10.1161/CIRCINTERVENTIONS.111.965400; Jeong YH, 2011, CIRC-CARDIOVASC INTE, V4, P585, DOI 10.1161/CIRCINTERVENTIONS.111.962555; Jeong YH, 2010, JACC-CARDIOVASC INTE, V3, P731, DOI 10.1016/j.jcin.2010.05.007; Jung KH, 2011, CLIN PHARMACOL THER, V90, P612, DOI 10.1038/clpt.2011.163; Kim IS, 2012, BRIT J CLIN PHARMACO, V73, P629, DOI 10.1111/j.1365-2125.2011.04131.x; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Luo M, 2012, THROMB RES, V129, P754, DOI 10.1016/j.thromres.2011.12.003; Malek LA, 2008, CIRC J, V72, P1165, DOI 10.1253/circj.72.1165; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Mega JL, 2010, LANCET, V376, P1312, DOI 10.1016/S0140-6736(10)61273-1; Park Y, 2012, EUR HEART J, V33, P2151, DOI 10.1093/eurheartj/ehs083; Patti G, 2011, J AM COLL CARDIOL, V58, P1592, DOI 10.1016/j.jacc.2011.06.044; Rideg O, 2011, PHARMACOGENOMICS, V12, P1269, DOI [10.2217/PGS.11.73, 10.2217/pgs.11.73]; Sharma V, 2012, J NEUROL SCI, V315, P72, DOI 10.1016/j.jns.2011.11.027; Simon T, 2011, CLIN PHARMACOL THER, V90, P561, DOI 10.1038/clpt.2011.193; Simon T, 2011, CLIN PHARMACOL THER, V90, P287, DOI 10.1038/clpt.2011.127; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Spiewak M, 2009, KARDIOL POL, V67, P827; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Taubert D, 2006, CLIN PHARMACOL THER, V80, P486, DOI 10.1016/j.clpt.2006.07.007; Teng RL, 2012, CLIN PHARMACOKINET, V51, P305, DOI 10.2165/11630960-000000000-00000; Tiroch KA, 2010, AM HEART J, V160, P506, DOI 10.1016/j.ahj.2010.06.039; Von Beckerath N, 2007, EUR HEART J, V28, P1814, DOI 10.1093/eurheartj/ehl489; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wang XD, 2012, EUR J INTERN MED, V23, P48, DOI 10.1016/j.ejim.2011.07.016; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wright RS, 2011, J AM COLL CARDIOL, V57, P1920, DOI 10.1016/j.jacc.2011.02.009	42	56	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46366	10.1371/journal.pone.0046366	http://dx.doi.org/10.1371/journal.pone.0046366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056288	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400013
J	Tomkiewicz, C; Hans, S; Mucchielli, MH; Agier, N; Delacroix, H; Marisa, L; Brasnu, D; Aggerbeck, LP; Badoual, C; Barouki, R; Aggerbeck, M				Tomkiewicz, Celine; Hans, Stephane; Mucchielli, Marie Helene; Agier, Nicolas; Delacroix, Herve; Marisa, Laetitia; Brasnu, Daniel; Aggerbeck, Lawrence P.; Badoual, Cecile; Barouki, Robert; Aggerbeck, Martine			A Head and Neck Cancer Tumor Response-Specific Gene Signature for Cisplatin, 5-Fluorouracil Induction Chemotherapy Fails with Added Taxanes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; ORGAN PRESERVATION; PREDICTIVE FACTOR; EXPRESSION; PROTEIN; IDENTIFICATION; FLUOROURACIL; CHAPERONIN; DOCETAXEL; PATHWAYS	Background: It is a major clinical challenge to predict which patients, with advanced stage head and neck squamous cell carcinoma, will not exhibit a reduction in tumor size following induction chemotherapy in order to avoid toxic effects of ineffective chemotherapy and delays for instituting other therapeutic options. Further, it is of interest to know to what extent a gene signature, which identifies patients with tumors that will not respond to a particular induction chemotherapy, is applicable when additional chemotherapeutic agents are added to the regimen. Methodology/Principal Findings: To identify genes that predict tumor resistance to induction with cisplatin/5-fluorouracil (PF) or PF and a taxane, we analyzed patient tumor biopsies with whole genome microarrays and quantitative reverse transcriptase-PCR (TLDA) cards. A leave one out cross-validation procedure allowed evaluation of the prediction tool. A ten-gene microarray signature correctly classified 12/13 responders and 7/10 non-responders to PF (92% specificity, 82.6% accuracy). TLDA analysis (using the same classifier) of the patients correctly classified 12/12 responders and 8/10 non-responders (100% specificity, 90.9% accuracy). Further, TLDA analysis correctly predicted the response of 5 new patients and, overall, 12/12 responders and 13/15 non-responders (100% specificity, 92.6% accuracy). The protein products of the genes constituting the signature physically associate with 27 other proteins, involved in regulating gene expression, constituting an interaction network. In contrast, TLDA-based prediction (with the same gene signature) of responses to induction with PF and either of two taxanes was poor (0% specificity, 25% accuracy and 33.3% specificity, 25% accuracy). Conclusions/Significance: Successful transfer of the microarray-based gene signature to an independent, PCR-based technology suggests that TLDA-based signatures could be a useful hospital-based technology for determining therapeutic options. Although highly specific for tumor responses to PF induction, the gene signature is unsuccessful when taxanes are added. The results illustrate the subtlety in developing "personalized medicine".	[Tomkiewicz, Celine; Aggerbeck, Lawrence P.; Barouki, Robert; Aggerbeck, Martine] Ctr Univ St Peres, INSERM, UMR S747, Paris, France; [Badoual, Cecile] Univ Paris 05, INSERM, U970, PARCC Paris Cardiovasc Res Ctr, Paris, France; [Hans, Stephane; Brasnu, Daniel] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Otorhinolaryngol & Chirurg Cervicofaciale, Paris, France; [Mucchielli, Marie Helene; Agier, Nicolas; Delacroix, Herve; Marisa, Laetitia; Aggerbeck, Lawrence P.] CNRS, Ctr Genet Mol, UPR2167, Gif Sur Yvette, France; [Mucchielli, Marie Helene; Agier, Nicolas; Delacroix, Herve; Marisa, Laetitia; Aggerbeck, Lawrence P.] Gif Orsay DNA Microarray Platform, Gif Sur Yvette, France; [Mucchielli, Marie Helene] UMPC Sorbonne Univ, Univ Paris 06, Paris, France; [Delacroix, Herve] Univ Paris 11, Ctr Orsay, F-91405 Orsay, France; [Badoual, Cecile] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Anat Pathol, Paris, France; [Barouki, Robert] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Aggerbeck, M (corresponding author), Ctr Univ St Peres, INSERM, UMR S747, Paris, France.	martine.aggerbeck@parisdescartes.fr		Badoual, Cecile/0000-0002-1143-3085	CNRS (The Centre National de la Recherche Scientifique); INSERM (Institut National de la Sante et de la Recherche Medicale); Assitance Publique-Hopitaux de Paris [CRC03017]; Paris Descartes University	CNRS (The Centre National de la Recherche Scientifique); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Assitance Publique-Hopitaux de Paris; Paris Descartes University	This work was supported by the CNRS (The Centre National de la Recherche Scientifique), INSERM (Institut National de la Sante et de la Recherche Medicale), Assitance Publique-Hopitaux de Paris (CRC03017), Paris Descartes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjea A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-21; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blons H, 2004, CLIN CANCER RES, V10, P2594, DOI 10.1158/1078-0432.CCR-1116-03; Braakhuis BJM, 2005, ONCOLOGIST, V10, P493, DOI 10.1634/theoncologist.10-7-493; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chen AY, 2007, LARYNGOSCOPE, V117, P16, DOI 10.1097/01.mlg.0000240182.61922.31; Chen MZ, 2010, ANN NY ACAD SCI, V1197, P134, DOI 10.1111/j.1749-6632.2010.05197.x; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Cmelak AJ, 2007, J CLIN ONCOL, V25, P3971, DOI 10.1200/JCO.2007.10.8951; Coghlin C, 2006, J PATHOL, V210, P351, DOI 10.1002/path.2056; Colombo J, 2009, ONCOL REP, V21, P649, DOI 10.3892/or_00000268; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Deleeuw J, 1977, RECENT DEV STAT, V1; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Kruskal JB., 2006, MULTIDIMENSIONAL SCA; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Lu B, 2007, BBA-MOL CELL BIOL L, V1771, P1177, DOI 10.1016/j.bbalip.2007.05.002; Luthra R, 2006, J CLIN ONCOL, V24, P259, DOI 10.1200/JCO.2005.03.3688; Macleod K, 2005, CANCER RES, V65, P6789, DOI 10.1158/0008-5472.CAN-04-2684; Marisa L, 2007, BIOINFORMATICS, V23, P2339, DOI 10.1093/bioinformatics/btm321; MONTECLARO FS, 1993, P NATL ACAD SCI USA, V90, P6726, DOI 10.1073/pnas.90.14.6726; Motoori M, 2010, INT J ONCOL, V37, P1113, DOI 10.3892/ijo_00000763; Nemeth Z, 2005, J CRANIOFAC SURG, V16, P205; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rickman DS, 2008, ONCOGENE, V27, P6607, DOI 10.1038/onc.2008.251; Rodriguez-Pinilla M, 2004, CLIN CANCER RES, V10, P8486, DOI 10.1158/1078-0432.CCR-04-0771; Samimi G, 2005, CANCER CHEMOTH PHARM, V55, P1, DOI 10.1007/s00280-004-0819-9; Silverman RH, 2002, CANCER RES, V62, P397; Simon R, 2007, CANCER INFORM, V3, P11; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Sommer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025402; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Stirling PC, 2006, J BIOL CHEM, V281, P7012, DOI 10.1074/jbc.M513235200; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Workman P, 2012, CANCER CELL, V21, P455, DOI 10.1016/j.ccr.2012.03.030; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yokoyama A, 2004, LEUKEMIA RES, V28, P149, DOI 10.1016/S0145-2126(03)00189-9; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018135	49	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47170	10.1371/journal.pone.0047170	http://dx.doi.org/10.1371/journal.pone.0047170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056603	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400061
J	Lauritano, C; Carotenuto, Y; Miralto, A; Procaccini, G; Ianora, A				Lauritano, Chiara; Carotenuto, Ylenia; Miralto, Antonio; Procaccini, Gabriele; Ianora, Adrianna			Copepod Population-Specific Response to a Toxic Diatom Diet	PLOS ONE			English	Article							CALANUS-HELGOLANDICUS; ALPHA,BETA,GAMMA,DELTA-UNSATURATED ALDEHYDES; BIOACTIVE ALDEHYDES; HATCHING SUCCESS; STRESS-RESPONSE; MARINE DIATOMS; REPRODUCTION; ATLANTIC; SEA; QUANTIFICATION	Diatoms are key phytoplankton organisms and one of the main primary producers in aquatic ecosystems. However, many diatom species produce a series of secondary metabolites, collectively termed oxylipins, that disrupt development in the offspring of grazers, such as copepods, that feed on these unicellular algae. We hypothesized that different populations of copepods may deal differently with the same oxylipin-producing diatom diet. Here we provide comparative studies of expression level analyses of selected genes of interest for three Calanus helgolandicus populations (North Sea, Atlantic Ocean and Mediterranean Sea) exposed to the same strain of the oxylipin-producing diatom Skeletonema marinoi using as control algae the flagellate Rhodomonas baltica. Expression levels of detoxification enzymes and stress proteins (e. g. glutathione S-transferase, glutathione synthase, superoxide dismutase, catalase, aldehyde dehydrogenases and heat shock proteins) and proteins involved in apoptosis regulation and cell cycle progression were analyzed in copepods after both 24 and 48 hours of feeding on the diatom or on a control diet. Strong differences occurred among copepod populations, with the Mediterranean population of C. helgolandicus being more susceptible to the toxic diet compared to the others. This study opens new perspectives for understanding copepod population-specific responses to diatom toxins and may help in underpinning the cellular mechanisms underlying copepod toxicity during diatom blooms.	[Lauritano, Chiara; Carotenuto, Ylenia; Miralto, Antonio; Procaccini, Gabriele; Ianora, Adrianna] Stn Zool Anton Dohrn, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Lauritano, C (corresponding author), Stn Zool Anton Dohrn, Naples, Italy.	chiara.lauritano@szn.it	Procaccini, Gabriele/A-6618-2010; Carotenuto, Ylenia/ABG-4872-2021; Ianora, Adrianna/O-3408-2019; Carotenuto, Ylenia/B-5708-2013; Procaccini, Gabriele/AAA-7040-2019; Lauritano, Chiara/Q-4166-2018	Procaccini, Gabriele/0000-0002-6179-468X; Carotenuto, Ylenia/0000-0002-7188-9279; Carotenuto, Ylenia/0000-0002-7188-9279; Procaccini, Gabriele/0000-0002-6179-468X; Lauritano, Chiara/0000-0003-4580-9594	EU FP7 ASSEMBLE [227799]	EU FP7 ASSEMBLE	EU FP7 ASSEMBLE (grant agreement no. 227799) for financial support for copepod sampling in the Atlantic Ocean and North Sea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Ask J, 2006, J PLANKTON RES, V28, P683, DOI 10.1093/plankt/fbl005; Bigot A, 2010, ECOTOXICOLOGY, V19, P369, DOI 10.1007/s10646-009-0419-x; Bonnet D, 2005, PROG OCEANOGR, V65, P1, DOI 10.1016/j.pocean.2005.02.002; Bouraoui Z, 2009, ECOTOX ENVIRON SAFE, V72, P1893, DOI 10.1016/j.ecoenv.2009.05.011; Brinkmann U, 1998, AM J HUM GENET, V62, P509, DOI 10.1086/301773; Bucklin A, 1999, HYDROBIOLOGIA, V401, P239, DOI 10.1023/A:1003790411424; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Caldwell GS, 2002, AQUAT TOXICOL, V60, P123, DOI 10.1016/S0166-445X(01)00277-6; Carotenuto Y, 2005, LIMNOL OCEANOGR, V50, P449, DOI 10.4319/lo.2005.50.2.0449; Carotenuto Y, 2012, J EXP MAR BIOL ECOL, V418, P46, DOI 10.1016/j.jembe.2012.03.014; Colin SP, 2007, HARMFUL ALGAE, V6, P875, DOI 10.1016/j.hal.2007.05.003; Cutignano A, 2006, CHEMBIOCHEM, V7, P450, DOI 10.1002/cbic.200500343; d'Ippolito G, 2004, BBA-MOL CELL BIOL L, V1686, P100, DOI 10.1016/j.bbalip.2004.09.002; d'Ippolito G, 2009, NEW PHYTOL, V183, P1064, DOI 10.1111/j.1469-8137.2009.02887.x; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Fontana A, 2007, PURE APPL CHEM, V79, P481, DOI 10.1351/pac200779040481; Gerecht A, 2011, J PHYCOL, V47, P1050, DOI 10.1111/j.1529-8817.2011.01030.x; Godhe A, 2010, MOL ECOL, V19, P4478, DOI 10.1111/j.1365-294X.2010.04841.x; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Guenther J, 2009, MAR ECOL PROG SER, V385, P137, DOI 10.3354/meps08034; Halsband-Lenk C, 2005, PROG OCEANOGR, V67, P332, DOI 10.1016/j.pocean.2005.09.003; Hansen BH, 2008, AQUAT TOXICOL, V86, P157, DOI 10.1016/j.aquatox.2007.10.009; Hill RS, 2001, MAR BIOL, V139, P279; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Irigoien X, 2002, NATURE, V419, P387, DOI 10.1038/nature01055; Koski M, 2007, MAR BIOL, V151, P1785, DOI 10.1007/s00227-007-0615-2; Lauritano C, 2012, MAR ENVIRON RES, V76, P22, DOI 10.1016/j.marenvres.2011.09.015; Lauritano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026850; Lauritano C, 2011, J EXP MAR BIOL ECOL, V404, P79, DOI 10.1016/j.jembe.2011.05.009; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Martin P, 2011, DEEP-SEA RES PT I, V58, P338, DOI 10.1016/j.dsr.2011.01.006; Mary Ann lW Jordan, 2004, NATURE REV; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Olsvik PA, 2009, CHEMOSPHERE, V75, P360, DOI 10.1016/j.chemosphere.2008.12.039; Papadopoulos LN, 2005, MAR BIOL, V147, P1353, DOI 10.1007/s00227-005-0038-x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Poulet SA, 2007, J EXP MAR BIOL ECOL, V352, P187, DOI 10.1016/j.jembe.2007.07.019; Poulet SA, 2006, MAR ECOL PROG SER, V308, P129, DOI 10.3354/meps308129; Ribalet F, 2009, PROTIST, V160, P444, DOI 10.1016/j.protis.2009.01.003; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Romano G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025980; Romano G, 2010, MAR DRUGS, V8, P950, DOI 10.3390/md8040950; Salazar-Medina AJ, 2010, J BIOCHEM MOL TOXIC, V24, P218, DOI 10.1002/jbt.20326; Simon CA, 2010, AQUACULTURE, V310, P52, DOI 10.1016/j.aquaculture.2010.10.031; Snyder MJ, 2000, AQUAT TOXICOL, V48, P529, DOI 10.1016/S0166-445X(00)00085-0; Sotka E. E., 2008, P203, DOI 10.1007/978-3-540-74181-7_10; Tai CJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-110; Taylor RL, 2009, J PHYCOL, V45, P46, DOI 10.1111/j.1529-8817.2008.00625.x; Tosti E, 2003, MOL REPROD DEV, V66, P72, DOI 10.1002/mrd.10332; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Vidal DE, 2003, ARCH ENVIRON CON TOX, V45, P184, DOI 10.1007/s00244-003-0119-0; Vidoudez C, 2011, MAR DRUGS, V9, P500, DOI 10.3390/md9040500; Wichard T, 2005, J CHROMATOGR B, V814, P155, DOI 10.1016/j.jchromb.2004.10.021; Wichard T, 2008, PROG OCEANOGR, V77, P30, DOI 10.1016/j.pocean.2008.03.002	58	52	53	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47262	10.1371/journal.pone.0047262	http://dx.doi.org/10.1371/journal.pone.0047262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056617	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500149
J	Terrier, P				Terrier, Philippe			Step-to-Step Variability in Treadmill Walking: Influence of Rhythmic Auditory Cueing	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; FRACTAL DYNAMICS; LATERAL STABILIZATION; PARKINSONS-DISEASE; TIME VARIABILITY; STRIDE INTERVAL; GAIT PATTERNS; SPEED; STABILITY; WIDTH	While walking, human beings continuously adjust step length (SpL), step time (SpT), step speed (SpS = SpL/SpT) and step width (SpW) by integrating both feedforward and feedback mechanisms. These motor control processes result in correlations of gait parameters between consecutive strides (statistical persistence). Constraining gait with a speed cue (treadmill) and/or a rhythmic auditory cue (metronome), modifies the statistical persistence to anti-persistence. The objective was to analyze whether the combined effect of treadmill and rhythmic auditory cueing (RAC) modified not only statistical persistence, but also fluctuation magnitude (standard deviation, SD), and stationarity of SpL, SpT, SpS and SpW. Twenty healthy subjects performed 665 min. walking tests at various imposed speeds on a treadmill instrumented with foot-pressure sensors. Freely-chosen walking cadences were assessed during the first three trials, and then imposed accordingly in the last trials with a metronome. Fluctuation magnitude (SD) of SpT, SpL, SpS and SpW was assessed, as well as NonStationarity Index (NSI), which estimates the dispersion of local means in the times series (SD of 20 local means over 10 steps). No effect of RAC on fluctuation magnitude (SD) was observed. SpW was not modified by RAC, what is likely the evidence that lateral foot placement is separately regulated. Stationarity (NSI) was modified by RAC in the same manner as persistent pattern: Treadmill induced low NSI in the time series of SpS, and high NSI in SpT and SpL. On the contrary, SpT, SpL and SpS exhibited low NSI under RAC condition. We used relatively short sample of consecutive strides (100) as compared to the usual number of strides required to analyze fluctuation dynamics (200 to 1000 strides). Therefore, the responsiveness of stationarity measure (NSI) to cued walking opens the perspective to perform short walking tests that would be adapted to patients with a reduced gait perimeter.	[Terrier, Philippe] Inst Rech Readaptat, IRR, Sion, Switzerland; [Terrier, Philippe] Clin Romande Readaptat SuvaCare, Sion, Switzerland		Terrier, P (corresponding author), Inst Rech Readaptat, IRR, Sion, Switzerland.	philippe.terrier@crr-suva.ch	Terrier, Philippe/H-3831-2012	Terrier, Philippe/0000-0002-3693-4505	Swiss accident insurance company SUVA; State of Valais; City of Sion	Swiss accident insurance company SUVA; State of Valais; City of Sion	The study was supported by the Swiss accident insurance company SUVA, which is an independent, non-profit company under public law. The IRR (Institute for Research in Rehabilitation) is supported by the State of Valais and the City of Sion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agiovlasitis S, 2009, GAIT POSTURE, V30, P345, DOI 10.1016/j.gaitpost.2009.06.003; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Beauchet O, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-32; Bollens B, 2012, NEUROSCIENCE, V210, P234, DOI 10.1016/j.neuroscience.2012.02.039; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dean JC, 2007, IEEE T BIO-MED ENG, V54, P1919, DOI 10.1109/TBME.2007.901031; Delignieres D, 2009, J APPL PHYSIOL, V106, P1272, DOI 10.1152/japplphysiol.90757.2008; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Fairley JA, 2010, HUM MOVEMENT SCI, V29, P125, DOI 10.1016/j.humov.2009.09.002; Frenkel-Toledo S, 2005, MOVEMENT DISORD, V20, P1109, DOI 10.1002/mds.20507; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Malatesta D, 2003, J APPL PHYSIOL, V95, P2248, DOI 10.1152/japplphysiol.01106.2002; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Miyai I, 2000, ARCH PHYS MED REHAB, V81, P849, DOI 10.1053/apmr.2000.4439; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; Nordin E, 2010, GAIT POSTURE, V32, P92, DOI 10.1016/j.gaitpost.2010.03.012; O'Connor SM, 2012, GAIT POSTURE, V36, P102, DOI 10.1016/j.gaitpost.2012.01.014; Owings TM, 2004, J BIOMECH, V37, P935, DOI 10.1016/j.jbiomech.2003.11.012; Pelton TA, 2010, NEUROREHAB NEURAL RE, V24, P428, DOI 10.1177/1545968309353608; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P668, DOI 10.1177/1545968309332879; Sejdic E, 2012, HUM MOVEMENT SCI, V31, P695, DOI 10.1016/j.humov.2011.05.007; Terrier P, 2005, HUM MOVEMENT SCI, V24, P97, DOI 10.1016/j.humov.2005.03.002; Terrier P, 2003, EUR J APPL PHYSIOL, V90, P554, DOI 10.1007/s00421-003-0906-3; Terrier P, 2012, HUMAN MOVEM IN PRESS; Terrier P, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-12; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; ZARRUGH MY, 1974, EUR J APPL PHYSIOL O, V33, P293, DOI 10.1007/BF00430237; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zijlstra W, 1995, GAIT POSTURE, V3, P13, DOI [10.1016/0966-6362(95)90804-2., DOI 10.1016/0966-6362(95)90804-2]	42	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47171	10.1371/journal.pone.0047171	http://dx.doi.org/10.1371/journal.pone.0047171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056604	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500141
J	Gomes-Rezende, JA; Gomes-Alves, AG; Menino, JF; Coelho, MA; Ludovico, P; Goncalves, P; Sturme, MHJ; Rodrigues, F				Gomes-Rezende, Jessica A.; Gomes-Alves, Ana G.; Menino, Joao F.; Coelho, Marco A.; Ludovico, Paula; Goncalves, Paula; Sturme, Mark H. J.; Rodrigues, Fernando			Functionality of the Paracoccidioides Mating alpha-Pheromone-Receptor System	PLOS ONE			English	Article							PATHOGEN ASPERGILLUS-FUMIGATUS; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; YEAST PHASE; BRASILIENSIS; EXPRESSION; GENES; SEX; IDENTIFICATION; ORGANIZATION	Recent evidence suggests that Paracoccidioides species have the potential to undergo sexual reproduction, although no sexual cycle has been identified either in nature or under laboratory conditions. In the present work we detected low expression levels of the heterothallic MAT loci genes MAT1-1 and MAT1-2, the alpha-pheromone (PB alpha) gene, and the alpha- and alpha-pheromone receptor (PREB and PREA) genes in yeast and mycelia forms of several Paracoccidioides isolates. None of the genes were expressed in a mating type dependent manner. Stimulation of P. brasiliensis MAT1-2 strains with the synthetic alpha-pheromone peptide failed to elicit transcriptional activation of MAT1-2, PREB or STE12, suggesting that the strains tested are insensitive to alpha-pheromone. In order to further evaluate the biological functionality of the pair a- pheromone and its receptor, we took advantage of the heterologous expression of these Paracoccidioides genes in the corresponding S. cerevisiae null mutants. We show that S. cerevisiae strains heterologously expressing PREB respond to Pb alpha pheromone either isolated from Paracoccidioides culture supernatants or in its synthetic form, both by shmoo formation and by growth and cell cycle arrests. This allowed us to conclude that Paracoccidioides species secrete an active alpha-pheromone into the culture medium that is able to activate its cognate receptor. Moreover, expression of PREB or PB alpha in the corresponding null mutants of S. cerevisiae restored mating in these non-fertile strains. Taken together, our data demonstrate pheromone signaling activation by the Paracoccidioides alpha-pheromone through its receptor in this yeast model, which provides novel evidence for the existence of a functional mating signaling system in Paracoccidioides.	[Gomes-Rezende, Jessica A.; Gomes-Alves, Ana G.; Menino, Joao F.; Ludovico, Paula; Sturme, Mark H. J.; Rodrigues, Fernando] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Gomes-Rezende, Jessica A.; Gomes-Alves, Ana G.; Menino, Joao F.; Ludovico, Paula; Sturme, Mark H. J.; Rodrigues, Fernando] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Coelho, Marco A.; Goncalves, Paula] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, Ctr Recursos Microbiol CREM, Caparica, Portugal	Universidade do Minho; Universidade Nova de Lisboa	Rodrigues, F (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	frodrigues@ecsaude.uminho.pt	Coelho, Marco A Dias/E-7849-2011; Gonçalves, Paula/B-4016-2010; Coelho, Marco A./AAZ-4478-2021; Gonçalves, Paula/CAH-0730-2022; Sturme, Marcus H.J./A-7833-2010; Sturme, Mark/AAI-6444-2021; Gomes, Jéssica/GPF-9026-2022; Rodrigues, Fernando/T-5299-2018; Rodrigues, Fernando/A-3123-2011; Ludovico, Paula/B-4338-2011	Coelho, Marco A Dias/0000-0002-5716-0561; Gonçalves, Paula/0000-0003-2103-1060; Coelho, Marco A./0000-0002-5716-0561; Gonçalves, Paula/0000-0003-2103-1060; Sturme, Marcus H.J./0000-0001-9073-2675; Rodrigues, Fernando/0000-0001-8436-9398; Ludovico, Paula/0000-0003-4130-7167; Menino, Joao/0000-0003-3778-1747; Alves, Ana/0000-0002-3487-6321	Fundacao para a Ciencia e Tecnologia (FCT); FCT [PTDC/BIA-MIC/108309/2008]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-MIC/108309/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	MHJS and JFM were supported by Fundacao para a Ciencia e Tecnologia (FCT) grants. This work was supported by a grant from FCT (PTDC/BIA-MIC/108309/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AJ, 2007, FUNGAL GENET BIOL, V44, P1387, DOI 10.1016/j.fgb.2007.04.004; Almeida AJ, 2006, FUNGAL GENET BIOL, V43, P401, DOI 10.1016/j.fgb.2006.01.012; Almeida AJ, 2009, FUNGAL GENET BIOL, V46, P919, DOI 10.1016/j.fgb.2009.08.004; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Cherkasova V, 1999, GENETICS, V151, P989; CLARK CD, 1994, J BIOL CHEM, V269, P8831; Corte-Real, 2001, CURR PROTOC CYTOM; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Dyer PS, 2011, CURR OPIN MICROBIOL, V14, P649, DOI 10.1016/j.mib.2011.10.001; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gomez BL, 2001, INFECT IMMUN, V69, P5760, DOI 10.1128/IAI.69.9.5760-5767.2001; Goncalves-Sa J, 2010, COMMUNICATION CHOICE, P109; Goncalves-Sa J, 2011, CURR BIOL, V21, P1337, DOI 10.1016/j.cub.2011.06.054; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; GUTHRIE C, 2004, GUIDE YEAST GENETICS; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Janiak AM, 2005, FUNGAL GENET BIOL, V42, P328, DOI 10.1016/j.fgb.2005.01.006; KONOPKA JB, 1991, CELL REGUL, V2, P439, DOI 10.1091/mbc.2.6.439; KWONCHUN.KJ, 1973, MYCOLOGIA, V65, P109, DOI 10.2307/3757791; KWONCHUN.KJ, 1972, SCIENCE, V175, P326, DOI 10.1126/science.175.4019.326; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Li WJ, 2010, EUKARYOT CELL, V9, P46, DOI 10.1128/EC.00259-09; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; Marques ER, 2004, MOL GENET GENOMICS, V271, P667, DOI 10.1007/s00438-004-1016-6; Martin SH, 2011, MOL BIOL EVOL, V28, P1987, DOI 10.1093/molbev/msr022; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; Morais FV, 2000, J CLIN MICROBIOL, V38, P3960, DOI 10.1128/JCM.38.11.3960-3966.2000; Muller H, 2008, EUKARYOT CELL, V7, P848, DOI 10.1128/EC.00456-07; Nielsen K, 2007, ADV GENET, V57, P143, DOI 10.1016/S0065-2660(06)57004-X; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Poggeler S, 2001, GENE, V280, P9, DOI 10.1016/S0378-1119(01)00786-7; Porman AM, 2011, P NATL ACAD SCI USA, V108, P21158, DOI 10.1073/pnas.1112076109; Puccia R, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00257; Pyrzak W, 2008, EUKARYOT CELL, V7, P1029, DOI 10.1128/EC.00380-07; RESTREPO A, 1980, J CLIN MICROBIOL, V12, P279, DOI 10.1128/JCM.12.2.279-281.1980; Restrepo A, 2001, MED MYCOL, V39, P233, DOI 10.1080/714031028; STRAZDIS JR, 1982, J BACTERIOL, V151, P1153, DOI 10.1128/JB.151.3.1153-1161.1982; Sugui JA, 2011, MBIO, V2, DOI 10.1128/mBio.00234-11; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Torres I, 2010, FUNGAL GENET BIOL, V47, P373, DOI 10.1016/j.fgb.2009.11.005	45	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e47033	10.1371/journal.pone.0047033	http://dx.doi.org/10.1371/journal.pone.0047033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056569	Green Published, gold			2022-12-27	WOS:000309580800069
J	Hong, SL; Cossyleon, D; Hussain, WA; Walker, LJ; Barton, SJ; Rebec, GV				Hong, S. Lee; Cossyleon, Desiree; Hussain, Wajeeha A.; Walker, Lauren J.; Barton, Scott J.; Rebec, George V.			Dysfunctional Behavioral Modulation of Corticostriatal Communication in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							LOCAL-FIELD POTENTIALS; STRIATAL NEURONS; OSCILLATIONS; DYNAMICS; CORTEX; RATS	Background: In Huntington's disease (HD), motor symptoms develop prior to the widespread loss of neurons in striatum and cerebral cortex. The aim of this study was to examine dysfunctional patterns of corticostriatal communication during spontaneously occurring behaviors in a transgenic mouse model of HD. Methodology/Principal Findings: Local field potentials (LFPs) were recorded from two closely interconnected areas, motor cortex and dorsal striatum, in wild-type controls (WT, n = 14) and a widely used transgenic HD model (R6/2 mice, n = 12). All mice were between the ages of 7-9 weeks, a critical period of motor symptom development in R6/2s. Recordings were obtained while the mice were behaving freely in an open field. Specific LFP activity was extracted using timestamps for three increasingly demanding motor behaviors: 1) resting; 2) grooming; and 3) active exploration. Power spectral densities (PSD) were obtained for the cortical and striatal LFPs as well as coherence levels and relative phase across the frequency spectrum. In both brain regions, only R6/2s showed high frequency LFP oscillations during rest and grooming. As behavior increased from resting to exploring, corticostriatal synchrony at high frequencies declined in R6/2s, completely opposite to the WT pattern. R6/2s also exhibited nearly in-phase corticostriatal activity (cortex phase leads of similar to 5 degrees), while the WTs consistently showed cortical phase lags of similar to 20 degrees across all assessed behaviors, indicating a lead role for striatum. Conclusions/Significance: Our results add to growing evidence for altered communication between cortex and striatum in HD and suggest more generally that increasingly demanding motor behaviors differentially modulate corticostriatal communication. Our data also suggest conduction delays in R6/2 corticostriatal transmission, leading to compensatory speeding of LFP activity, as evidenced by the presence of high frequency LFP oscillations.	[Hong, S. Lee; Barton, Scott J.; Rebec, George V.] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; [Hong, S. Lee] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Cossyleon, Desiree; Hussain, Wajeeha A.; Walker, Lauren J.; Barton, Scott J.; Rebec, George V.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Rebec, GV (corresponding author), Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA.	rebec@indiana.edu		Hong, S. Lee/0000-0001-6044-2482	National Institute of Neurological Diseases and Stroke [R01 NS 035663]; National Institute on Aging [R21 AG 039818]; Indiana METACyt Initiative of Indiana University; Lilly Endowment; CHDI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039818, R21AG035158] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Indiana METACyt Initiative of Indiana University; Lilly Endowment; CHDI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by National Institute of Neurological Diseases and Stroke R01 NS 035663 and National Institute on Aging R21 AG 039818, by the Indiana METACyt Initiative of Indiana University (funded, in part, by a major grant from the Lilly Endowment), and by CHDI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Burns SP, 2010, J NEUROSCI, V30, P13739, DOI 10.1523/JNEUROSCI.0743-10.2010; Buzsaki G., 2006, RHYTHMS BRAIN; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Estrada-Sanchez AM, 2012, BASAL GANGLIA, V2, P57, DOI 10.1016/j.baga.2012.04.029; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Hong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030879; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Miller BR, 2008, J NEUROPHYSIOL, V100, P2205, DOI 10.1152/jn.90606.2008; Oathes DJ, 2008, BIOL PSYCHOL, V79, P165, DOI 10.1016/j.biopsycho.2008.04.005; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Orvoen S, 2012, NEUROSCI LETT, V507, P127, DOI 10.1016/j.neulet.2011.11.063; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pesaran B, 2009, NEURON, V61, P1, DOI 10.1016/j.neuron.2008.12.019; Pignatelli M, 2012, NEUROBIOL DIS, V48, P409, DOI 10.1016/j.nbd.2012.07.015; Ponzi A, 2010, J NEUROSCI, V30, P5894, DOI 10.1523/JNEUROSCI.5540-09.2010; Sharott A, 2009, J NEUROSCI, V29, P4571, DOI 10.1523/JNEUROSCI.5097-08.2009; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Unschuld PG, 2012, NEUROSCI LETT, V514, P204, DOI 10.1016/j.neulet.2012.02.095; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Walker AG, 2008, J NEUROSCI, V28, P8973, DOI 10.1523/JNEUROSCI.2804-08.2008	26	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e47026	10.1371/journal.pone.0047026	http://dx.doi.org/10.1371/journal.pone.0047026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056565	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800068
J	Ringe, R; Das, L; Choudhary, I; Sharma, D; Paranjape, R; Chauhan, VS; Bhattacharya, J				Ringe, Rajesh; Das, Lipsa; Choudhary, Ipsita; Sharma, Deepak; Paranjape, Ramesh; Chauhan, Virander Singh; Bhattacharya, Jayanta			Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; AUTOLOGOUS NEUTRALIZATION; MACROPHAGE TROPISM; HIGHLY POTENT; TYPE-1; GP120; CD4; BINDING; INDIVIDUALS; EPITOPE	Broadly neutralizing antibodies to HIV-1 usually develops in chronic infections. Here, we examined the basis of enhanced sensitivity of an env clone amplified from cross neutralizing plasma of an antiretroviral naive chronically infected Indian patient (ID50 >600-fold higher compared to other autologous env clones). The enhanced autologous neutralization of pseudotyped viruses expressing the sensitive envelope (Env) was associated with increased sensitivity to reagents and monoclonal antibodies targeting distinct sites in Env. Chimeric viruses constructed by swapping fragments of sensitive Env into resistant Env backbone revealed that the presence of unique residues within C2V3 region of gp120 governed increased neutralization. The enhanced virus neutralization was also associated with low CD4 dependence as well as increased binding of Env trimers to IgG1b12 and CD4-IgG2 and was independent of gp120 shedding. Our data highlighted vulnerabilities in the Env obtained from cross neutralizing plasma associated with the exposure of discontinuous neutralizing epitopes and enhanced autologous neutralization. Such information may aid in Env-based vaccine immunogen design.	[Ringe, Rajesh; Das, Lipsa; Choudhary, Ipsita; Sharma, Deepak; Paranjape, Ramesh; Bhattacharya, Jayanta] Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India; [Chauhan, Virander Singh] Int Ctr Genet Engn & Biotechnol, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Bhattacharya, J (corresponding author), Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India.	jbhattacharya@nariindia.org	Sharma, Deepak/GPT-1692-2022; Chauhan, Virander S./K-5276-2019	DAS, LIPSA/0000-0002-6896-4776; Sharma, Deepak/0000-0001-8436-1759; Paranjape, Ramesh/0000-0003-2948-9148	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR12853/MED/29/141/2009]; Council of Scientific and Industrial Research (CSIR); University Grants Commission (UGC), Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), Government of India(University Grants Commission, India)	This study was supported by a research grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India to JB (BT/PR12853/MED/29/141/2009). RR and DS are recipients of Senior Research Fellowships from the Council of Scientific and Industrial Research (CSIR), and the University Grants Commission (UGC), Government of India respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasa-Chapman MMI, 2005, J VIROL, V79, P2823, DOI 10.1128/JVI.79.5.2823-2830.2005; Alexandre KB, 2011, J VIROL, V85, P9039, DOI 10.1128/JVI.02675-10; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Beirnaert E, 2000, J MED VIROL, V62, P14, DOI 10.1002/1096-9071(200009)62:1&lt;14::AID-JMV3&gt;3.0.CO;2-L; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; CONLEY AJ, 1994, VACCINE, V12, P445, DOI 10.1016/0264-410X(94)90123-6; Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Duenas-Decamp MJ, 2008, J VIROL, V82, P5807, DOI 10.1128/JVI.02585-07; Duenas-Decamp MJ, 2009, J VIROL, V83, P2575, DOI 10.1128/JVI.02133-08; Dunfee RL, 2006, P NATL ACAD SCI USA, V103, P15160, DOI 10.1073/pnas.0605513103; Euler Z, 2011, J VIROL, V85, P7236, DOI 10.1128/JVI.00196-11; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Gharu L, 2009, VIRUS RES, V144, P306, DOI 10.1016/j.virusres.2009.04.020; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Hatada M, 2010, J GEN VIROL, V91, P1335, DOI 10.1099/vir.0.017426-0; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hu SL, 2007, CURR HIV RES, V5, P507, DOI 10.2174/157016207782418542; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Lynch RM, 2012, J VIROL, DOI 10.1128; Moog C, 1997, J VIROL, V71, P3734, DOI 10.1128/JVI.71.5.3734-3741.1997; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Mukhopadhyay S, 2011, AIDS RES HUM RETROVI; Mukhopadhyay S, 2012, AIDS RES HUM RETROV, V28, P739, DOI [10.1089/AID.2011.0238, 10.1089/aid.2011.0238]; Pernas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031928; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; Piantadosi A, 2007, PLOS PATHOG, V3, P1745, DOI 10.1371/journal.ppat.0030177; Piantadosi A, 2009, J VIROL, V83, P7805, DOI 10.1128/JVI.00280-09; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Ringe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037157; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; Ringe R, 2011, VIROLOGY, V418, P123, DOI 10.1016/j.virol.2011.07.015; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sanders RW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-10; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Utachee P, 2010, J VIROL, V84, P4311, DOI 10.1128/JVI.02619-09; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2003, J VIROL, V77, P6965, DOI 10.1128/JVI.77.12.6965-6978.2003	68	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46713	10.1371/journal.pone.0046713	http://dx.doi.org/10.1371/journal.pone.0046713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056416	gold, Green Submitted, Green Published			2022-12-27	WOS:000309454000079
J	van Rijsbergen, GD; Bockting, CLH; Berking, M; Koeter, MWJ; Schene, AH				van Rijsbergen, Gerard D.; Bockting, Claudi L. H.; Berking, Matthias; Koeter, Maarten W. J.; Schene, Aart H.			Can a One-Item Mood Scale Do the Trick? Predicting Relapse over 5.5-Years in Recurrent Depression	PLOS ONE			English	Article							VISUAL ANALOG SCALE; RANDOMIZED CONTROLLED-TRIAL; RATING-SCALE; RESIDUAL SYMPTOMS; COGNITIVE THERAPY; PRODROMAL SYMPTOMS; FOLLOW-UP; DISORDER; VALIDITY; RELIABILITY	Background: To examine whether a simple Visual Analogue Mood Scale (VAMS) is able to predict time to relapse over 5.5-years. Methodology/Principal Findings: 187 remitted recurrently depressed out-patients were interviewed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the 17-item Hamilton Depression rating scale (HAM-D) to verify remission status (HAM-D < 10). All patients rated their current mood with the help of a Visual Analogue Mood Scale (VAMS) at baseline and at a follow-up assessment three months later. Relapse over 5.5-years was assessed by the SCID-I. Cox regression revealed that both the VAMS at baseline and three months later significantly predicted time to relapse over 5.5-years. Baseline VAMS even predicted time to relapse when the number of previous depressive episodes and HAM-D scores were controlled for. The baseline VAMS explained 6.3% of variance in time to relapse, comparable to the HAM-D interview. Conclusions/Significance: Sad mood after remission appears to play a pivotal role in the course of depression. Since a simple VAMS predicted time to relapse, the VAMS might be an easy and time-effective way to monitor mood and risk of early relapse, and offers possibilities for daily monitoring using e-mail and SMS.	[van Rijsbergen, Gerard D.; Bockting, Claudi L. H.] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands; [Berking, Matthias] Univ Marburg, Dept Clin Psychol & Psychotherapy, Marburg, Germany; [Koeter, Maarten W. J.; Schene, Aart H.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; Philipps University Marburg; University of Amsterdam; Academic Medical Center Amsterdam	Bockting, CLH (corresponding author), Univ Groningen, Dept Clin Psychol, Groningen, Netherlands.	c.l.h.bockting@rug.nl	Schene, A.H./H-8085-2014; Bockting, Claudi L/K-3768-2019	Schene, A.H./0000-0002-1756-3235; Bockting, Claudi L/0000-0002-9220-9244	ZONMW: The Netherlands Association for Health research and Development (ZONMW)	ZONMW: The Netherlands Association for Health research and Development (ZONMW)	This research is funded by ZONMW: The Netherlands Association for Health research and Development (ZONMW, prevention: 2200.0029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn EP, 1997, J PSYCHIATR RES, V31, P569, DOI 10.1016/S0022-3956(97)00029-0; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BECH P, 1975, ACTA PSYCHIAT SCAND, V51, P161, DOI 10.1111/j.1600-0447.1975.tb00002.x; BECH P, 1981, ACTA PSYCHIAT SCAND, V63, P290, DOI 10.1111/j.1600-0447.1981.tb00676.x; BECH P, 1984, PSYCHOPHARMACOLOGY, V84, P276, DOI 10.1007/BF00427459; Bockting CL, 2011, BMC PSYCHIAT, V11, P12, DOI 10.1186/1471-244X-11-12; Bockting CLH, 2008, PSYCHOTHER PSYCHOSOM, V77, P17, DOI 10.1159/000110056; Bockting CLH, 2009, J CLIN PSYCHIAT, V70, P1621, DOI 10.4088/JCP.08m04784blu; Bockting CLH, 2006, J CLIN PSYCHIAT, V67, P747, DOI 10.4088/JCP.v67n0508; Bockting CLH, 2005, J CONSULT CLIN PSYCH, V73, P647, DOI 10.1037/0022-006X.73.4.647; CELLA DF, 1986, PSYCHOL REP, V59, P827, DOI 10.2466/pr0.1986.59.2.827; Di Benedetto M, 2005, J PSYCHOSOM RES, V59, P223, DOI 10.1016/j.jpsychores.2005.06.070; Engelhardt N, 2006, J CLIN PSYCHOPHARM, V26, P71, DOI 10.1097/01.jcp.0000194621.61868.7c; Entsuah R, 2002, J PSYCHIATR RES, V36, P437, DOI 10.1016/S0022-3956(02)00024-9; Farrer L, 2012, J MED INTERNET RES, V14, P60, DOI 10.2196/jmir.1859; FAVA GA, 1990, J AFFECT DISORDERS, V19, P149, DOI 10.1016/0165-0327(90)90020-9; FAVA GA, 1994, AM J PSYCHIAT, V151, P1295; First M.B., 1990, USERS GUIDE STRUCTUR; Hakkaart-van Roijen L, 2002, MANUAL TRIMBOS IMTA; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOOIJER C, 1991, J AFFECT DISORDERS, V22, P21, DOI 10.1016/0165-0327(91)90079-8; Iacoviello BM, 2010, J ABNORM PSYCHOL, V119, P459, DOI 10.1037/a0020114; Johansson R, 2012, PLOS ONE, V7; Johansson R, 2012, PLOS ONE, V7; Judd LL, 1998, ARCH GEN PSYCHIAT, V55, P694, DOI 10.1001/archpsyc.55.8.694; Judd LL, 1998, J AFFECT DISORDERS, V50, P97, DOI 10.1016/S0165-0327(98)00138-4; Kennedy N, 2004, J AFFECT DISORDERS, V80, P135, DOI 10.1016/S0165-0327(03)00054-5; Kertzman S, 2004, INT J GERIATR PSYCH, V19, P789, DOI 10.1002/gps.1141; Killgore WDS, 1999, PSYCHOL REP, V85, P1238, DOI 10.2466/PR0.85.7.1238-1243; Kuyken W, 2010, BEHAV RES THER, V48, P1105, DOI 10.1016/j.brat.2010.08.003; Lethbridge R, 2008, BEHAV RES THER, V46, P1142, DOI 10.1016/j.brat.2008.06.011; Lingjaerde O, 1998, PSYCHIAT RES, V81, P387, DOI 10.1016/S0165-1781(98)00119-X; LITTLE JC, 1973, BRIT J PSYCHIAT, V122, P447, DOI 10.1192/bjp.122.4.447; LURIA RE, 1975, J PSYCHIATR RES, V12, P51, DOI 10.1016/0022-3956(75)90020-5; Maas-van Schaaijk NM, 2011, ACTA PAEDIATR, V100, P708, DOI 10.1111/j.1651-2227.2011.02132.x; MAIER W, 1985, ACTA PSYCHIAT SCAND, V72, P239, DOI 10.1111/j.1600-0447.1985.tb02601.x; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Mueller TI, 1999, AM J PSYCHIAT, V156, P1000; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nyenhuis DL, 1997, CLIN NEUROPSYCHOL, V11, P407, DOI 10.1080/13854049708400470; PAYKEL ES, 1995, PSYCHOL MED, V25, P1171, DOI 10.1017/S0033291700033146; Rijsbergen GD Van, MOOD REACTI IN PRESS; Rucci P, 2011, DEPRESS ANXIETY, V28, P955, DOI 10.1002/da.20894; Ruhe HG, 2005, COMPR PSYCHIAT, V46, P417, DOI 10.1016/j.comppsych.2005.03.001; Segal ZV, 2006, ARCH GEN PSYCHIAT, V63, P749, DOI 10.1001/archpsyc.63.7.749; Segal ZV, 1999, J ABNORM PSYCHOL, V108, P3, DOI 10.1037/0021-843X.108.1.3; SIMON GE, 1993, J PSYCHIAT RES, V27, P247, DOI 10.1016/0022-3956(93)90035-Z; Taylor DJ, 2009, J AFFECTIVE DISORDER; ten Doesschate MC, 2010, J CLIN PSYCHIAT, V71, P984, DOI 10.4088/JCP.08m04858blu; ten Doesschate MC, 2009, J AFFECT DISORDERS, V115, P167, DOI 10.1016/j.jad.2008.07.011; Williams JBW, 2001, EUR ARCH PSY CLIN N, V251, P6, DOI 10.1007/BF03035120; ZEALLEY AK, 1969, P ROY SOC MED, V62, P993, DOI 10.1177/003591576906201006	52	32	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46796	10.1371/journal.pone.0046796	http://dx.doi.org/10.1371/journal.pone.0046796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056456	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000085
J	Burgos-Ramos, E; Canelles, S; Perianes-Cachero, A; Arilla-Ferreiro, E; Argente, J; Barrios, V				Burgos-Ramos, Emma; Canelles, Sandra; Perianes-Cachero, Arancha; Arilla-Ferreiro, Eduardo; Argente, Jesus; Barrios, Vicente			Adipose Tissue Promotes a Serum Cytokine Profile Related to Lower Insulin Sensitivity after Chronic Central Leptin Infusion	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FOOD RESTRICTION; GENE-EXPRESSION; OBESITY; INFLAMMATION; CELLS; ACTIVATION; ADIPOCYTES; RECEPTOR; MACROPHAGES	Obesity is an inflammatory state characterized by an augment in circulating inflammatory factors. Leptin may modulate the synthesis of these factors by white adipose tissue decreasing insulin sensitivity. We have examined the effect of chronic central administration of leptin on circulating levels of cytokines and the possible relationship with cytokine expression and protein content as well as with leptin and insulin signaling in subcutaneous and visceral adipose tissues. In addition, we analyzed the possible correlation between circulating levels of cytokines and peripheral insulin resistance. We studied 18 male Wistar rats divided into controls (C), those treated icv for 14 days with a daily dose of 12 mu g of leptin (L) and a pair-fed group (PF) that received the same food amount consumed by the leptin group. Serum leptin and insulin were measured by ELISA, mRNA levels of interferon-gamma (IFN-gamma), interleukin-2 (IL-2), IL-4, IL-6, IL-10 and tumor necrosis factor-alpha (TNF-alpha) by real time PCR and serum and adipose tissue levels of these cytokines by multiplexed bead immunoassay. Serum leptin, IL-2, IL-4, IFN-gamma and HOMA-IR were increased in L and TNF-alpha was decreased in PF and L. Serum leptin and IL-2 levels correlate positively with HOMA-IR index and negatively with serum glucose levels during an ip insulin tolerance test. In L, an increase in mRNA levels of IL-2 was found in both adipose depots and IFN-gamma only in visceral tissue. Activation of leptin signaling was increased and insulin signaling decreased in subcutaneous fat of L. In conclusion, leptin mediates the production of inflammatory cytokines by adipose tissue independent of its effects on food intake, decreasing insulin sensitivity.	[Burgos-Ramos, Emma; Canelles, Sandra; Argente, Jesus; Barrios, Vicente] Univ Autonoma Madrid, Dept Endocrinol, Hosp Infantil Univ Nino Jesus, Inst Invest La Princesa, Madrid, Spain; [Burgos-Ramos, Emma; Canelles, Sandra; Argente, Jesus; Barrios, Vicente] Univ Autonoma Madrid, Dept Pediat, Madrid, Spain; [Burgos-Ramos, Emma; Canelles, Sandra; Argente, Jesus; Barrios, Vicente] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Perianes-Cachero, Arancha; Arilla-Ferreiro, Eduardo] Univ Alcala de Henares, Dept Bioquim & Biol Mol, Fac Med, Grp Neurobioquim, E-28871 Alcala De Henares, Spain	Autonomous University of Madrid; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Alcala	Burgos-Ramos, E (corresponding author), Univ Autonoma Madrid, Dept Endocrinol, Hosp Infantil Univ Nino Jesus, Inst Invest La Princesa, Madrid, Spain.	vbarrios@telefonica.net	Arilla, Eduardo/AAB-5030-2019; Burgos Ramos, Emma/A-7070-2015; Argente, Jesús/K-1167-2014; Argente, Jesús/M-5226-2019; Sabador, Vicente Barrios/N-6982-2016; Burgos-Ramos, Emma/AAI-7833-2020	Arilla, Eduardo/0000-0001-6744-6056; Burgos Ramos, Emma/0000-0002-6942-3023; Argente, Jesús/0000-0001-5826-0276; Argente, Jesús/0000-0001-5826-0276; Sabador, Vicente Barrios/0000-0002-5507-7545; Burgos-Ramos, Emma/0000-0002-6942-3023	Fondo de Investigacion Sanitaria [PI10/0747]; Ministerio de Ciencia y Tecnologia [SAF 2010-22277]; CIBERobn [CB03/06]; Fundacion Endocrinologia y Nutricion; CIBERobn	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERobn; Fundacion Endocrinologia y Nutricion; CIBERobn	This work was supported by grants from Fondo de Investigacion Sanitaria (PI10/0747), Ministerio de Ciencia y Tecnologia (SAF 2010-22277), CIBERobn (CB03/06) and Fundacion Endocrinologia y Nutricion. S. C. is supported by CIBERobn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2005, J NUTR BIOCHEM, V16, P602, DOI 10.1016/j.jnutbio.2005.03.002; Aygun AD, 2005, MEDIAT INFLAMM, P180, DOI 10.1155/MI.2005.180; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Berdnikovs S, 2012, J IMMUNOL, V188, P874, DOI 10.4049/jimmunol.1004108; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Burgos-Ramos E, 2011, J NEUROCHEM, V117, P175, DOI 10.1111/j.1471-4159.2011.07191.x; Canavan B, 2005, J CLIN ENDOCR METAB, V90, P5779, DOI 10.1210/jc.2005-0780; Carpagnano GE, 2007, ONCOL RES, V16, P375; Cettour-Rose P, 2002, AM J PHYSIOL-ENDOC M, V283, pE980, DOI 10.1152/ajpendo.00196.2002; Cusin I, 2000, DIABETES, V49, P1101, DOI 10.2337/diabetes.49.7.1101; Pinheiro CHD, 2012, STEM CELL REV REP, V8, P363, DOI 10.1007/s12015-011-9304-0; Dalmas E, 2011, AM J CLIN NUTR, V94, P450, DOI 10.3945/ajcn.111.013771; do Nascimento CO, 2004, BIOCHEM BIOPH RES CO, V313, P702, DOI 10.1016/j.bbrc.2003.12.008; Dugdale AHA, 2010, EQUINE VET J, V42, P600, DOI 10.1111/j.2042-3306.2010.00110.x; Escriva F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Fukuda M, 2008, J NEUROSCI, V28, P13640, DOI 10.1523/JNEUROSCI.4023-08.2008; Gove ME, 2009, J LEUKOCYTE BIOL, V85, P491, DOI 10.1189/jlb.0808508; Han SN, 2011, NUTR RES, V31, P362, DOI 10.1016/j.nutres.2011.04.002; Han Y, 2010, BIOCHEM BIOPH RES CO, V394, P70, DOI 10.1016/j.bbrc.2010.02.104; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kalra SP, 2009, PEPTIDES, V30, P1957, DOI 10.1016/j.peptides.2009.07.021; Kiguchi N, 2009, BIOCHEM BIOPH RES CO, V384, P311, DOI 10.1016/j.bbrc.2009.04.121; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010; Lisi S, 2011, DIABETES, V60, P2496, DOI 10.2337/db10-1536; Lo HC, 2004, CLIN BIOCHEM, V37, P666, DOI 10.1016/j.clinbiochem.2004.02.002; Lord GM, 2002, J LEUKOCYTE BIOL, V72, P330; Malakauskas SM, 2009, MOL ENDOCRINOL, V23, P881, DOI 10.1210/me.2008-0274; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Martos-Moreno GA, 2010, CLIN CHEM LAB MED, V48, P1439, DOI 10.1515/CCLM.2010.276; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Maya-Monteiro CM, 2008, J BIOL CHEM, V283, P2203, DOI 10.1074/jbc.M706706200; Mayi TH, 2012, J BIOL CHEM, V287, P21904, DOI 10.1074/jbc.M111.315200; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Morrison CD, 2001, J ENDOCRINOL, V168, P317, DOI 10.1677/joe.0.1680317; Moschen AR, 2011, MOL MED, V17, P840, DOI 10.2119/molmed.2010.00108; Moschen AR, 2010, GUT, V59, P1259, DOI 10.1136/gut.2010.214577; Mraz M, 2011, J CLIN ENDOCR METAB, V96, pE606, DOI 10.1210/jc.2010-1858; Nakhjavani M, 2011, GYNECOL ENDOCRINOL, V27, P14, DOI 10.3109/09513590.2010.487583; Ndisang JF, 2010, ENDOCRINOLOGY, V151, P549, DOI 10.1210/en.2009-0471; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Pardo M, 2010, PEPTIDES, V31, P1912, DOI 10.1016/j.peptides.2010.06.022; Paz G, 2008, AM J PHYSIOL-ENDOC M, V295, pE1401, DOI 10.1152/ajpendo.90450.2008; Penn DM, 2006, AM J PHYSIOL-REG I, V291, pR1613, DOI 10.1152/ajpregu.00368.2006; Perez C, 2004, DIABETES, V53, P347, DOI 10.2337/diabetes.53.2.347; Prieur X, 2008, ENDOCRINOLOGY, V149, P5432, DOI 10.1210/en.2008-0498; Raicevic G, 2011, CELL IMMUNOL, V270, P207, DOI 10.1016/j.cellimm.2011.05.010; Ramsay TG, 2004, J ANIM SCI, V82, P3486; Ramsey JJ, 1998, J CLIN ENDOCR METAB, V83, P3230, DOI 10.1210/jc.83.9.3230; Reidy SP, 2000, COMP BIOCHEM PHYS A, V125, P285, DOI 10.1016/S1095-6433(00)00159-8; Rodrigues L, 2011, J PHYSIOL BIOCHEM, V67, P613, DOI 10.1007/s13105-011-0108-0; Rondinone CM, 2002, DIABETES, V51, P2405, DOI 10.2337/diabetes.51.8.2405; Roth CL, 2011, METABOLISM, V60, P445, DOI 10.1016/j.metabol.2010.03.023; Shi JG, 2012, CELL TISSUE RES, V347, P737, DOI 10.1007/s00441-011-1317-0; Siegrist-Kaiser CA, 1997, J CLIN INVEST, V100, P2858, DOI 10.1172/JCI119834; Sloan C, 2011, DIABETES, V60, P1424, DOI 10.2337/db10-1106; Stofkova A, 2009, Endocr Regul, V43, P157; Tanaka M, 2011, J NEUROSCI, V31, P8373, DOI 10.1523/JNEUROSCI.6562-10.2011; Tapia-Gonzalez S, 2011, J NEUROENDOCRINOL, V23, P365, DOI 10.1111/j.1365-2826.2011.02113.x; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wenceslau CV, 2011, TISSUE ENG PT A, V17, P2165, DOI [10.1089/ten.TEA.2010.0678, 10.1089/ten.tea.2010.0678]; Wong S, 2004, CURR DRUG TARGETS, V5, P251, DOI 10.2174/1389450043490532; Xi L, 2007, BRIT J PHARMACOL, V151, P610, DOI 10.1038/sj.bjp.0707276; Xie LL, 2010, CLIN VACCINE IMMUNOL, V17, P651, DOI 10.1128/CVI.00494-09; Yang YY, 2012, HEPATOLOGY, V55, P1540, DOI 10.1002/hep.25534; Yoshida T, 1997, BIOCHEM BIOPH RES CO, V232, P822, DOI 10.1006/bbrc.1997.6378; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zha JM, 2009, ENDOCR J, V56, P935, DOI 10.1507/endocrj.K09E-091	74	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46893	10.1371/journal.pone.0046893	http://dx.doi.org/10.1371/journal.pone.0046893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056516	gold, Green Published, Green Submitted			2022-12-27	WOS:000309452600063
J	Herrmann, F; Gross, A; Zhou, D; Kestler, HA; Kuhl, M				Herrmann, Franziska; Gross, Alexander; Zhou, Dao; Kestler, Hans A.; Kuehl, Michael			A Boolean Model of the Cardiac Gene Regulatory Network Determining First and Second Heart Field Identity	PLOS ONE			English	Article							CARDIOVASCULAR PROGENITOR CELLS; WNT/BETA-CATENIN; EXPRESSION PATTERN; SMOOTH-MUSCLE; MESP1; DIFFERENTIATION; MULTISTATIONARITY; SIMULATION; DROSOPHILA; BRACHYURY	Two types of distinct cardiac progenitor cell populations can be identified during early heart development: the first heart field (FHF) and second heart field (SHF) lineage that later form the mature heart. They can be characterized by differential expression of transcription and signaling factors. These regulatory factors influence each other forming a gene regulatory network. Here, we present a core gene regulatory network for early cardiac development based on published temporal and spatial expression data of genes and their interactions. This gene regulatory network was implemented in a Boolean computational model. Simulations reveal stable states within the network model, which correspond to the regulatory states of the FHF and the SHF lineages. Furthermore, we are able to reproduce the expected temporal expression patterns of early cardiac factors mimicking developmental progression. Additionally, simulations of knock-down experiments within our model resemble published phenotypes of mutant mice. Consequently, this gene regulatory network retraces the early steps and requirements of cardiogenic mesoderm determination in a way appropriate to enhance the understanding of heart development.	[Herrmann, Franziska; Gross, Alexander; Zhou, Dao; Kestler, Hans A.] Univ Ulm, Res Grp Bioinformat & Syst Biol, Inst Neural Informat Proc, Ulm, Germany; [Herrmann, Franziska; Kuehl, Michael] Univ Ulm, Inst Biochem & Mol Biol, Ulm, Germany; [Herrmann, Franziska; Gross, Alexander] Univ Ulm, Int Grad Sch Mol Med, Ulm, Germany	Ulm University; Ulm University; Ulm University	Herrmann, F (corresponding author), Univ Ulm, Res Grp Bioinformat & Syst Biol, Inst Neural Informat Proc, Ulm, Germany.	hans.kestler@uni-ulm.de; michael.kuehl@uni-ulm.de	Kestler, Hans A./D-5799-2012	Kestler, Hans A./0000-0002-4759-5254	German Federal Ministry of Education and Research; International Graduate School in Molecular Medicine Ulm; Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); International Graduate School in Molecular Medicine Ulm; Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	The work was supported by the German Federal Ministry of Education and Research within its joint research project SyStaR and by the International Graduate School in Molecular Medicine Ulm, funded by the Excellence Initiative of the German Federal and State Governments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Ghysen A, 2003, BIOESSAYS, V25, P802, DOI 10.1002/bies.10311; Giacomantonio CE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000936; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hopfensitz M, 2012, IEEE ACM T COMPUT BI, V9, P487, DOI 10.1109/TCBB.2011.62; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kauffman S.A., 1993, ORIGINS ORDER; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kestler HA, 2008, BIOESSAYS, V30, P1110, DOI 10.1002/bies.20834; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Kestler HA, 2011, J CELL BIOL, V193, P431, DOI 10.1083/jcb.201103167; KISPERT A, 1994, DEV BIOL, V161, P179, DOI 10.1006/dbio.1994.1019; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Li S, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040009, 10.1371/journal.pcbi.0040009.eor]; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; MacLean D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009101; Maucher M, 2011, BIOINFORMATICS, V27, P1529, DOI 10.1093/bioinformatics/btr166; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Phillips MD, 2011, INT J CARDIOL, V150, P186, DOI 10.1016/j.ijcard.2010.04.007; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Thomas R, 2001, CHAOS, V11, P180, DOI 10.1063/1.1349893; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Veliz-Cuba A, 2011, J COMPUT BIOL, V18, P783, DOI 10.1089/cmb.2011.0031; Wawra C, 2007, FEBS LETT, V581, P4043, DOI 10.1016/j.febslet.2007.07.043; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang HB, 1996, DEVELOPMENT, V122, P2977	51	50	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46798	10.1371/journal.pone.0046798	http://dx.doi.org/10.1371/journal.pone.0046798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056457	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600059
J	Meyer, HA; Endermann, T; Stephan, C; Stoedter, M; Behrends, T; Wolff, I; Jung, K; Schomburg, L				Meyer, Hellmuth A.; Endermann, Tobias; Stephan, Carsten; Stoedter, Mette; Behrends, Thomas; Wolff, Ingmar; Jung, Klaus; Schomburg, Lutz			Selenoprotein P Status Correlates to Cancer-Specific Mortality in Renal Cancer Patients	PLOS ONE			English	Article							PROSTATE-CANCER; SELENIUM STATUS; RESPONSE SYNDROME; SERUM SELENIUM; ACUTE-PHASE; VITAMIN-E; RISK; PREVENTION; SUPPLEMENTATION; METABOLISM	Selenium (Se) is an essential trace element for selenoprotein biosynthesis. Selenoproteins have been implicated in cancer risk and tumor development. Selenoprotein P (SePP) serves as the major Se transport protein in blood and as reliable biomarker of Se status in marginally supplied individuals. Among the different malignancies, renal cancer is characterized by a high mortality rate. In this study, we aimed to analyze the Se status in renal cell cancer (RCC) patients and whether it correlates to cancer-specific mortality. To this end, serum samples of RCC patients (n = 41) and controls (n = 21) were retrospectively analyzed. Serum Se and SePP concentrations were measured by X-ray fluorescence and an immunoassay, respectively. Clinical and survival data were compared to serum Se and SePP concentrations as markers of Se status by receiver operating characteristic (ROC) curve and Kaplan-Meier and Cox regression analyses. In our patients, higher tumor grade and tumor stage at diagnosis correlated to lower SePP and Se concentrations. Kaplan-Meier analyses indicated that low Se status at diagnosis (SePP<2.4 mg/l, bottom tertile of patient group) was associated with a poor 5-year survival rate of 20% only. We conclude that SePP and Se concentrations are of prognostic value in RCC and may serve as additional diagnostic biomarkers identifying a Se deficit in kidney cancer patients potentially affecting therapy regimen. As poor Se status was indicative of high mortality odds, we speculate that an adjuvant Se supplementation of Se-deficient RCC patients might be beneficial in order to stabilize their selenoprotein expression hopefully prolonging their survival. However, this assumption needs to be rigorously tested in prospective clinical trials.	[Endermann, Tobias; Stoedter, Mette; Behrends, Thomas; Schomburg, Lutz] Charite, Inst Expt Endocrinol, D-13353 Berlin, Germany; [Meyer, Hellmuth A.] Charite, Inst Physiol, D-13353 Berlin, Germany; [Meyer, Hellmuth A.; Stephan, Carsten; Wolff, Ingmar; Jung, Klaus] Charite, Dept Urol, D-13353 Berlin, Germany; [Stephan, Carsten; Jung, Klaus] Berlin Inst Urol Res, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schomburg, L (corresponding author), Charite, Inst Expt Endocrinol, D-13353 Berlin, Germany.	lutz.schomburg@charite.de	Wolff, Ingmar/ABG-7840-2021; Wolff, Ingmar/C-6059-2014; Wolff, Ingmar/Y-4974-2019; Jung, Klaus/Z-2122-2018; Schomburg, Lutz/D-8096-2013	Wolff, Ingmar/0000-0003-4197-6643; Jung, Klaus/0000-0001-9797-5362; Schomburg, Lutz/0000-0001-9445-1555; Stephan, Carsten/0000-0002-3270-258X	DFG - Deutsche Forschungsgemeinschaft [GraKo 1208]; Deutsche Krebshilfe [10-1792-SchoII]; Federal Ministry of Education and Research (BMBF, MedSys)	DFG - Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Federal Ministry of Education and Research (BMBF, MedSys)(Federal Ministry of Education & Research (BMBF))	This study was supported by DFG - Deutsche Forschungsgemeinschaft GraKo 1208, and Deutsche Krebshilfe 10-1792-SchoII (to LS), and Federal Ministry of Education and Research (BMBF, MedSys) (to HAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Bermano G, 2007, GENES NUTR, V2, P225, DOI 10.1007/s12263-007-0052-3; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Broadley MR, 2006, P NUTR SOC, V65, P169, DOI 10.1079/PNS2006490; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Chiu-Ugalde J, 2010, BIOCHEM J, V431, P103, DOI 10.1042/BJ20100779; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Combs GF, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-75; Combs GF, 2012, BR J NUTR, P1; Corpet DE, 2005, EUR J CANCER, V41, P1911, DOI 10.1016/j.ejca.2005.06.006; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; Dennert G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005195.pub2; Forceville X, 1998, CRIT CARE MED, V26, P1536, DOI 10.1097/00003246-199809000-00021; Hartikainen H, 2005, J TRACE ELEM MED BIO, V18, P309, DOI 10.1016/j.jtemb.2005.02.009; Hesketh J, 2008, ANNU REV NUTR, V28, P157, DOI 10.1146/annurev.nutr.28.061807.155446; Hoeflich J, 2010, BRIT J NUTR, V104, P1601, DOI 10.1017/S0007114510002618; Hollenbach B, 2008, J TRACE ELEM MED BIO, V22, P24, DOI 10.1016/j.jtemb.2007.11.003; Hurst R, 2010, AM J CLIN NUTR, V91, P923, DOI 10.3945/ajcn.2009.28169; Ip C, 2002, CANCER METAST REV, V21, P281, DOI 10.1023/A:1021263027659; Jacobs ET, 2004, J NATL CANCER I, V96, P1669, DOI 10.1093/jnci/djh310; Kellen E, 2006, INT J UROL, V13, P1180, DOI 10.1111/j.1442-2042.2006.01526.x; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lescure A, 2009, BBA-GEN SUBJECTS, V1790, P1569, DOI 10.1016/j.bbagen.2009.03.002; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Maehira F, 2002, CLIN CHIM ACTA, V316, P137, DOI 10.1016/S0009-8981(01)00744-6; Meyer HA, 2009, CANCER EPIDEM BIOMAR, V18, P2386, DOI 10.1158/1055-9965.EPI-09-0262; Muecke R, 2010, INTEGR CANCER THER, V9, P136, DOI 10.1177/1534735410367648; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Penney KL, 2011, CANCER PREV RES, V3, P604; Peters U, 2008, CANCER EPIDEM BIOMAR, V17, P1144, DOI 10.1158/1055-9965.EPI-07-2947; Rasmussen LB, 2009, J TRACE ELEM MED BIO, V23, P265, DOI 10.1016/j.jtemb.2009.03.009; Rayman MP, 2008, BRIT J NUTR, V100, P254, DOI 10.1017/S0007114508939830; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Renko K, 2009, FASEB J, V23, P1758, DOI 10.1096/fj.08-119370; Sanmartin C, 2008, MINI-REV MED CHEM, V8, P1020, DOI 10.2174/138955708785740625; Schomburg L, 2008, MOL NUTR FOOD RES, V52, P1235, DOI 10.1002/mnfr.200700465; Schomburg L, 2012, NAT REV ENDOCRINOL, V8, P160, DOI 10.1038/nrendo.2011.174; Schrauzer GN, 2009, CRIT REV BIOTECHNOL, V29, P81, DOI 10.1080/07388550902926725; Schweizer U, 2011, CURR OPIN PEDIATR, V23, P429, DOI 10.1097/MOP.0b013e32834877da; Steinbrecher A, 2010, CANCER EPIDEM BIOMAR, V19, P2958, DOI 10.1158/1055-9965.EPI-10-0364; Suzuki KT, 2005, TOXICOL APPL PHARM, V206, P1, DOI 10.1016/j.taap.2004.10.018; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Toulis KA, 2010, THYROID, V20, P1163, DOI 10.1089/thy.2009.0351; Townsend A, 2004, CLIN CHEM, V50, P1481, DOI 10.1373/clinchem.2004.034579; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Vogt TM, 2003, INT J CANCER, V103, P664, DOI 10.1002/ijc.10866; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642; Xia YM, 2005, AM J CLIN NUTR, V81, P829, DOI 10.1093/ajcn/81.4.829; Yu MW, 1999, AM J EPIDEMIOL, V150, P367, DOI 10.1093/oxfordjournals.aje.a010016; Zachara BA, 2006, ACTA BIOCHIM POL, V53, P663, DOI 10.18388/abp.2006_3294; Zhuo P, 2009, BBA-GEN SUBJECTS, V1790, P1546, DOI 10.1016/j.bbagen.2009.03.004	52	41	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46644	10.1371/journal.pone.0046644	http://dx.doi.org/10.1371/journal.pone.0046644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056383	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400021
J	Mofarrahi, M; Sigala, I; Guo, YT; Godin, R; Davis, EC; Petrof, B; Sandri, M; Burelle, Y; Hussain, SNA				Mofarrahi, Mahroo; Sigala, Ioanna; Guo, Yeting; Godin, Richard; Davis, Elaine C.; Petrof, Basil; Sandri, Marco; Burelle, Yan; Hussain, Sabah N. A.			Autophagy and Skeletal Muscles in Sepsis	PLOS ONE			English	Article							NF-KAPPA-B; ELECTRON-TRANSPORT CHAIN; MITOCHONDRIAL DYSFUNCTION; ACTIVATION; METABOLISM; HEART; CELL	Background: Mitochondrial injury develops in skeletal muscles during the course of severe sepsis. Autophagy is a protein and organelle recycling pathway which functions to degrade or recycle unnecessary, redundant, or inefficient cellular components. No information is available regarding the degree of sepsis-induced mitochondrial injury and autophagy in the ventilatory and locomotor muscles. This study tests the hypotheses that the locomotor muscles are more prone to sepsis-induced mitochondrial injury, depressed biogenesis and autophagy induction compared with the ventilatory muscles. Methodology/Principal Findings: Adult male C57/Bl6 mice were injected with i.p. phosphate buffered saline (PBS) or E. coli lipopolysaccharide (LPS, 20 mg/kg) and sacrificed 24 h later. The tibialis anterior (TA), soleus (SOLD) and diaphragm (DIA) muscles were quickly excised and examined for mitochondrial morphological injury, Ca++ retention capacity and biogenesis. Autophagy was detected with electron microscopy, lipidation of Lc3b proteins and by measuring gene expression of several autophagy-related genes. Electron microscopy revealed ultrastructural injuries in the mitochondria of each muscle, however, injuries were more severe in the TA and SOL muscles than they were in the DIA. Gene expressions of nuclear and mitochondrial DNA transcription factors and co-activators (indicators of biogenesis) were significantly depressed in all treated muscles, although to a greater extent in the TA and SOL muscles. Significant autophagosome formation, Lc3b protein lipidation and upregulation of autophagy-related proteins were detected to a greater extent in the TA and SOL muscles and less so in the DIA. Lipidation of Lc3b and the degree of induction of autophagy-related proteins were significantly blunted in mice expressing a muscle-specific I kappa B alpha superrepresor. Conclusion/Significance: We conclude that locomotor muscles are more prone to sepsis-induced mitochondrial injury, decreased biogenesis and increased autophagy compared with the ventilatory muscles and that autophagy in skeletal muscles during sepsis is regulated in part through the NF kappa B transcription factor.	[Mofarrahi, Mahroo; Guo, Yeting; Petrof, Basil; Hussain, Sabah N. A.] McGill Univ, Ctr Hlth, Dept Crit Care Med, Montreal, PQ, Canada; [Mofarrahi, Mahroo; Guo, Yeting; Petrof, Basil; Hussain, Sabah N. A.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Sigala, Ioanna] Univ Athens, Sch Med, Evangelismos Hosp, George P Livanos Lab,Dept Crit Care & Pulm Serv, GR-11527 Athens, Greece; [Godin, Richard; Burelle, Yan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Davis, Elaine C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy	McGill University; McGill University; Athens Medical School; Evangelismos Hospital; National & Kapodistrian University of Athens; Universite de Montreal; McGill University; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine	Hussain, SNA (corresponding author), McGill Univ, Ctr Hlth, Dept Crit Care Med, Montreal, PQ, Canada.	sabah.hussain@muhc.mcgill.ca	Burelle, Yan/AAF-8104-2021; Hussain, Sabah/ABC-5315-2021	Burelle, Yan/0000-0001-9379-146X; 	Canadian Institute of Health Research (CIHR); Natural Sciences and Engineering Council of Canada (NSERC); Fondazione Telethon Funding Source: Custom	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fondazione Telethon(Fondazione Telethon)	This work was funded by a grant from the Canadian Institute of Health Research (CIHR) awarded to Sabah N. A. Hussain and by grants from the Natural Sciences and Engineering Council of Canada (NSERC) awarded to Sabah N. A. Hussain and Yan Burelle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2004, FREE RADICAL BIO MED, V37, P1472, DOI 10.1016/j.freeradbiomed.2004.06.034; Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Boyd JH, 2006, INFECT IMMUN, V74, P6829, DOI 10.1128/IAI.00286-06; Burelle Y, 2010, J MOL CELL CARDIOL, V48, P310, DOI 10.1016/j.yjmcc.2009.09.004; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Callahan LA, 2005, AM J RESP CRIT CARE, V172, P861, DOI 10.1164/rccm.200410-1344OC; Callahan LA, 2005, J APPL PHYSIOL, V99, P1120, DOI 10.1152/japplphysiol.01157.2004; CARREIRA RS, 2010, AUTOPHAGY, V19, P6; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; DAVIS EC, 1993, LAB INVEST, V68, P89; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Fredriksson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1044, DOI 10.1152/ajpendo.00218.2006; Fredriksson K, 2007, CRIT CARE MED, V35, pS449, DOI 10.1097/01.CCM.0000278048.00896.4B; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; Gellerich FN, 2002, BIOSCIENCE REP, V22, P99, DOI 10.1023/A:1016017224003; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; HENNIG R, 1985, NATURE, V314, P164, DOI 10.1038/314164a0; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Larche J, 2006, J AM COLL CARDIOL, V48, P377, DOI 10.1016/j.jacc.2006.02.069; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marcil M, 2006, J MOL CELL CARDIOL, V41, P998, DOI 10.1016/j.yjmcc.2006.08.117; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mazure NM, 2009, AUTOPHAGY, V5, P868, DOI 10.4161/auto.9042; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nivon M, 2009, AUTOPHAGY, V5, P766, DOI 10.4161/auto.8788; Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; SCHUMER W, 1971, SURG GYNECOL OBSTETR, V133, P433; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; Trumbeckaite S, 2001, EUR J BIOCHEM, V268, P1422, DOI 10.1046/j.1432-1327.2001.02012.x; Vanasco V, 2008, FREE RADICAL RES, V42, P815, DOI 10.1080/10715760802438709; WeltyWolf KE, 1996, SHOCK, V5, P378, DOI 10.1097/00024382-199605000-00011; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	46	84	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47265	10.1371/journal.pone.0047265	http://dx.doi.org/10.1371/journal.pone.0047265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056618	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400067
J	Wahlgren, WY; Omran, H; von Stetten, D; Royant, A; van der Post, S; Katona, G				Wahlgren, Weixiao Y.; Omran, Hadil; von Stetten, David; Royant, Antoine; van der Post, Sjoerd; Katona, Gergely			Structural Characterization of Bacterioferritin from Blastochloris viridis	PLOS ONE			English	Article							IRON-CORE FORMATION; PROTEIN PORES; FERRITIN; SITE; MECHANISM; FERROXIDASE; REFINEMENT; CRYSTALS; FE	Iron storage and elimination of toxic ferrous iron are the responsibility of bacterioferritins in bacterial species. Bacterioferritins are capable of oxidizing iron using molecular oxygen and import iron ions into the large central cavity of the protein, where they are stored in a mineralized form. We isolated, crystallized bacterioferritin from the microaerophilic/anaerobic, purple non-sulfur bacterium Blastochloris viridis and determined its amino acid sequence and X-ray structure. The structure and sequence revealed similarity to other purple bacterial species with substantial differences in the pore regions. Static 3- and 4-fold pores do not allow the passage of iron ions even though structural dynamics may assist the iron gating. On the other hand the B-pore is open to water and larger ions in its native state. In order to study the mechanism of iron import, multiple soaking experiments were performed. Upon Fe(II) and urea treatment the ferroxidase site undergoes reorganization as seen in bacterioferritin from Escherichia coli and Pseudomonas aeruginosa. When soaking with Fe(II) only, a closely bound small molecular ligand is observed close to Fe-1 and the coordination of Glu94 to Fe-2 changes from bidentate to monodentate. DFT calculations indicate that the bound ligand is most likely a water or a hydroxide molecule representing a product complex. On the other hand the different soaking treatments did not modify the conformation of other pore regions.	[Wahlgren, Weixiao Y.; Omran, Hadil; Katona, Gergely] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [von Stetten, David; Royant, Antoine] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Royant, Antoine] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [van der Post, Sjoerd] Univ Gothenburg, Prote Core Facil, Gothenburg, Sweden	University of Gothenburg; European Synchrotron Radiation Facility (ESRF); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Gothenburg	Katona, G (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	gergely.katona@cmb.gu.se	Royant, Antoine/G-3684-2012; Katona, Gergely/B-3491-2008	Royant, Antoine/0000-0002-1919-8649; Katona, Gergely/0000-0002-2031-8716; van der Post, Sjoerd/0000-0002-7965-5311; von Stetten, David/0000-0001-7906-9788	Swedish Research Council; Knut and Alice Wallenberg Foundation [KAW2007.0118]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	The work was supported by the Swedish Research Council and the Knut and Alice Wallenberg Foundation (KAW2007.0118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPHICS S; Antonyuk SV, 2011, BBA-PROTEINS PROTEOM, V1814, P778, DOI 10.1016/j.bbapap.2010.12.017; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Cobessi D, 2002, ACTA CRYSTALLOGR D, V58, P29, DOI 10.1107/S0907444901017267; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Granovsky A. A., FIREFLY VERSION 7 1; Gupta V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008028; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hasan MR, 2008, J BIOL CHEM, V283, P31394, DOI 10.1074/jbc.M806025200; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Janowski R, 2008, PROTEIN SCI, V17, P1138, DOI 10.1110/ps.034819.108; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Katona G, 2007, SCIENCE, V316, P449, DOI 10.1126/science.1138885; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVI S, 1988, J BIOL CHEM, V263, P18086; LING JS, 1994, J BIOL CHEM, V269, P5595; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XS, 2007, J BIOL CHEM, V282, P31821, DOI 10.1074/jbc.C700153200; Macedo S, 2003, NAT STRUCT BIOL, V10, P285, DOI 10.1038/nsb909; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nam KH, 2010, BIOCHEM BIOPH RES CO, V391, P990, DOI 10.1016/j.bbrc.2009.12.003; Romao CV, 2000, BIOCHEMISTRY-US, V39, P6841, DOI 10.1021/bi992525d; Royant A, 2007, J APPL CRYSTALLOGR, V40, P1105, DOI 10.1107/S0021889807044196; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Singh MK, 2010, PROTEINS, V78, P1613, DOI 10.1002/prot.22691; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Swartz L, 2006, BIOCHEMISTRY-US, V45, P4421, DOI 10.1021/bi060146w; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Theil EC, 2008, INORG CHIM ACTA, V361, P868, DOI 10.1016/j.ica.2007.08.025; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; Weeratunga SK, 2010, BIOCHEMISTRY-US, V49, P1160, DOI 10.1021/bi9015204; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wong SG, 2012, BIOCHEM J, V444, P553, DOI 10.1042/BJ20112200; Yasmin S, 2011, J BIOL CHEM, V286, P3473, DOI 10.1074/jbc.M110.175034	43	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46992	10.1371/journal.pone.0046992	http://dx.doi.org/10.1371/journal.pone.0046992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056552	Green Published, gold			2022-12-27	WOS:000309889400042
J	Xu, T; Ying, J; Yao, XD; Song, YL; Ma, P; Bao, BK; Jiang, WY; Wu, XM; Tou, HF; Li, PZ; Ren, P; Fei, JX; Yang, L; Liu, Q; Xu, ZY; Zhou, TL; Ni, LY; Bao, QY				Xu, Teng; Ying, Jun; Yao, Xiaoding; Song, Yulong; Ma, Ping; Bao, Bokan; Jiang, Weiyan; Wu, Xinmei; Tou, Huifen; Li, Peizhen; Ren, Ping; Fei, Jingxian; Yang, Lei; Liu, Qi; Xu, Zuyuan; Zhou, Tieli; Ni, Liyan; Bao, Qiyu			Identification and Characterization of Two Novel bla(KLUC) Resistance Genes through Large-Scale Resistance Plasmids Sequencing	PLOS ONE			English	Article							A BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; FAMILY ENTEROBACTERIACEAE; LOOPS; INSIGHTS; PROTEIN; SPREAD; TOOL	Plasmids are important antibiotic resistance determinant carriers that can disseminate various drug resistance genes among species or genera. By using a high throughput sequencing approach, two groups of plasmids of Escherichia coli (named E1 and E2, each consisting of 160 clinical E. coli strains isolated from different periods of time) were sequenced and analyzed. A total of 20 million reads were obtained and mapped onto the known resistance gene sequences. As a result, a total of 9 classes, including 36 types of antibiotic resistant genes, were identified. Among these genes, 25 and 27 single nucleotide polymorphisms (SNPs) appeared, of which 9 and 12 SNPs are nonsynonymous substitutions in the E1 and E2 samples. It is interesting to find that a novel genotype of bla(KLUC), whose close relatives, bla(KLUC-1) and bla(KLUC-2), have been previously reported as carried on the Kluyvera cryocrescens chromosome and Enterobacter cloacae plasmid, was identified. It shares 99% and 98% amino acid identities with Kluc-1 and Kluc-2, respectively. Further PCR screening of 608 Enterobacteriaceae family isolates yielded a second variant (named bla(KLUC-4)). It was interesting to find that Kluc-3 showed resistance to several cephalosporins including cefotaxime, whereas bla(KLUC-4) did not show any resistance to the antibiotics tested. This may be due to a positively charged residue, Arg, replaced by a neutral residue, Leu, at position 167, which is located within an omega-loop. This work represents large-scale studies on resistance gene distribution, diversification and genetic variation in pooled multi-drug resistance plasmids, and provides insight into the use of high throughput sequencing technology for microbial resistance gene detection.	[Xu, Teng; Ying, Jun; Yao, Xiaoding; Song, Yulong; Ma, Ping; Jiang, Weiyan; Wu, Xinmei; Tou, Huifen; Li, Peizhen; Ren, Ping; Fei, Jingxian; Yang, Lei; Liu, Qi; Xu, Zuyuan; Zhou, Tieli; Ni, Liyan; Bao, Qiyu] Wenzhou Med Coll, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China; [Xu, Teng] Inner Mongolia Univ, Key Lab Mammalian Reprod Biol & Biotechnol, Minist Educ, Hohhot, Inner Mongolia, Peoples R China; [Bao, Bokan] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China	Wenzhou Medical University; Inner Mongolia University; China Agricultural University	Ni, LY (corresponding author), Wenzhou Med Coll, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China.	nily2001@126.com; baoqy@genomics.org.cn	Bao, Qiyu/AAH-6113-2020	Bao, Qiyu/0000-0001-6523-8763; Song, Yulong/0000-0003-4384-8311; Xu, Teng/0000-0001-6859-4202	National Natural Science Foundation of China [81171614, 31100917]; Wenzhou Science and Technology Program, China [H20100022, S20090002]; Foundation of Science and Technology Innovation Team of Zhejiang Province, China [2010R50048]; Science and Technology Foundation of Zhejiang Province, China [2008C23074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Science and Technology Program, China; Foundation of Science and Technology Innovation Team of Zhejiang Province, China; Science and Technology Foundation of Zhejiang Province, China	This work was supported by National Natural Science Foundation of China (Grant No. 81171614, 31100917, URL: http://www.nsfc.gov.cn/Portal0/default152.htm); Wenzhou Science and Technology Program, China (Grant No. H20100022, S20090002, URL: http://www.wzkj.gov.cn/); Foundation of Science and Technology Innovation Team of Zhejiang Province, China (Grant No. 2010R50048, URL: http://www.zjkjt.gov.cn/); and Science and Technology Foundation of Zhejiang Province, China (Grant No. 2008C23074, URL: http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baraniak A, 2002, ANTIMICROB AGENTS CH, V46, P151, DOI 10.1128/AAC.46.1.151-159.2002; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Cao V, 2002, ANTIMICROB AGENTS CH, V46, P1212, DOI 10.1128/AAC.46.5.1212-1217.2002; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chanawong A, 2002, ANTIMICROB AGENTS CH, V46, P630, DOI 10.1128/AAC.46.3.630-637.2002; Decousser JW, 2001, ANTIMICROB AGENTS CH, V45, P3595, DOI 10.1128/AAC.45.12.3595-3598.2001; Djamdjian L, 2011, ANTIMICROB AGENTS CH, V55, P1861, DOI 10.1128/AAC.01656-10; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; Golebiewski M, 2007, ANTIMICROB AGENTS CH, V51, P3789, DOI 10.1128/AAC.00457-07; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hansen LH, 2005, MICROB DRUG RESIST, V11, P378, DOI 10.1089/mdr.2005.11.378; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; Levy SB, 2001, CLIN INFECT DIS, V33, pS124, DOI 10.1086/321837; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Maynard C, 2003, ANTIMICROB AGENTS CH, V47, P3214, DOI 10.1128/AAC.47.10.3214-3221.2003; Palucha A, 1999, J ANTIMICROB CHEMOTH, V44, P489, DOI 10.1093/jac/44.4.489; Petrella S, 2008, ANTIMICROB AGENTS CH, V52, P3725, DOI 10.1128/AAC.00163-08; Poirel L, 2008, CLIN MICROBIOL INFEC, V14, P295, DOI 10.1111/j.1469-0691.2007.01930.x; Poirel L, 2003, ANTIMICROB AGENTS CH, V47, P2938, DOI 10.1128/AAC.47.9.2938-2945.2003; RING CS, 1992, J MOL BIOL, V224, P685, DOI 10.1016/0022-2836(92)90553-V; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Yi HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008601; Zhao FQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010141	34	7	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47197	10.1371/journal.pone.0047197	http://dx.doi.org/10.1371/journal.pone.0047197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056610	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400065
J	Chen, SH; Liu, CL; Peng, CY; Liu, HM; Hu, MY; Zhong, GH				Chen, Shaohua; Liu, Chenglan; Peng, Chuyan; Liu, Hongmei; Hu, Meiying; Zhong, Guohua			Biodegradation of Chlorpyrifos and Its Hydrolysis Product 3,5,6-Trichloro-2-Pyridinol by a New Fungal Strain Cladosporium cladosporioides Hu-01	PLOS ONE			English	Article							ORGANOPHOSPHATE PESTICIDE EXPOSURE; DEGRADING BACTERIUM; PURE CULTURES; DNA-DAMAGE; DEGRADATION; BIOREMEDIATION; DETOXIFICATION; OPTIMIZATION; INSECTICIDE; ENHANCEMENT	Intensive use of chlorpyrifos has resulted in its ubiquitous presence as a contaminant in surface streams and soils. It is thus critically essential to develop bioremediation methods to degrade and eliminate this pollutant from environments. We present here that a new fungal strain Hu-01 with high chlorpyrifos-degradation activity was isolated and identified as Cladosporium cladosporioides based on the morphology and 5.8S rDNA gene analysis. Strain Hu-01 utilized 50 mg.L-1 of chlorpyrifos as the sole carbon of source, and tolerated high concentration of chlorpyrifos up to 500 mg.L-1. The optimum degradation conditions were determined to be 26.8 degrees C and pH 6.5 based on the response surface methodology (RSM). Under these conditions, strain Hu-01 completely metabolized the supplemented chlorpyrifos (50 mg.L-1) within 5 d. During the biodegradation process, transient accumulation of 3,5,6-trichloro-2-pyridinol (TCP) was observed. However, this intermediate product did not accumulate in the medium and disappeared quickly. No persistent accumulative metabolite was detected by gas chromatopraphy-mass spectrometry (GC-MS) analysis at the end of experiment. Furthermore, degradation kinetics of chlorpyrifos and TCP followed the first-order model. Compared to the non-inoculated controls, the half-lives (t(1/2)) of chlorpyrifos and TCP significantly reduced by 688.0 and 986.9 h with the inoculum, respectively. The isolate harbors the metabolic pathway for the complete detoxification of chlorpyrifos and its hydrolysis product TCP, thus suggesting the fungus may be a promising candidate for bioremediation of chlorpyrifos-contaminated water, soil or crop.	[Chen, Shaohua; Liu, Chenglan; Peng, Chuyan; Liu, Hongmei; Hu, Meiying; Zhong, Guohua] S China Agr Univ, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zhong, GH (corresponding author), S China Agr Univ, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China.	guohuazhong@scau.edu.cn	Chen, Shaohua/AAQ-9860-2021	Chen, Shaohua/0000-0001-8306-2626	National Natural Science Foundation of China [30871660]; Guangdong Province Science and Technology Plan Project [2008B020900007]; Zhongshan City Science and Technology Plan Project [20103A181]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Plan Project; Zhongshan City Science and Technology Plan Project	This work was supported by the grant from the National Natural Science Foundation of China (No.30871660), Guangdong Province Science and Technology Plan Project (No.2008B020900007) and Zhongshan City Science and Technology Plan Project (No.20103A181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2012, CLIN TOXICOL, V50, P336; Anwar S, 2009, J HAZARD MATER, V168, P400, DOI 10.1016/j.jhazmat.2009.02.059; Bicker W, 2005, TOXICOL LETT, V159, P235, DOI 10.1016/j.toxlet.2005.05.013; Boucard TK, 2004, FEMS MICROBIOL ECOL, V47, P121, DOI 10.1016/S0168-6496(03)00253-8; Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030862; Chen SH, 2012, BIORESOURCE TECHNOL, V110, P97, DOI 10.1016/j.biortech.2012.01.106; Chen SH, 2011, BIORESOURCE TECHNOL, V102, P8110, DOI 10.1016/j.biortech.2011.06.055; Chen SH, 2011, J HAZARD MATER, V187, P433, DOI 10.1016/j.jhazmat.2011.01.049; Chen SH, 2011, APPL MICROBIOL BIOT, V90, P755, DOI 10.1007/s00253-010-3035-z; Chen XS, 2011, BIORESOURCE TECHNOL, V102, P1727, DOI 10.1016/j.biortech.2010.08.071; Cycon M, 2009, CHEMOSPHERE, V76, P494, DOI 10.1016/j.chemosphere.2009.03.023; Daam MA, 2008, ECOTOXICOLOGY, V17, P756, DOI 10.1007/s10646-008-0227-8; Ding GD, 2012, ENVIRON SCI TECHNOL, V46, P2911, DOI 10.1021/es202583d; Ding L, 2008, CURR MICROBIOL, V56, P229, DOI 10.1007/s00284-007-9063-y; Dritsa V, 2009, WATER AIR SOIL POLL, V204, P19, DOI 10.1007/s11270-009-0022-z; Dubey KK, 2012, WORLD J MICROB BIOT, V28, P1715, DOI 10.1007/s11274-011-0982-1; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Fang H, 2008, INT BIODETER BIODEGR, V61, P294, DOI 10.1016/j.ibiod.2007.10.001; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038137; Ghevariya CM, 2011, BIORESOURCE TECHNOL, V102, P9668, DOI 10.1016/j.biortech.2011.07.069; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Horne I, 2002, APPL ENVIRON MICROB, V68, P3371, DOI 10.1128/AEM.68.7.3371-3376.2002; Kulshrestha G, 2011, BIOL FERT SOILS, V47, P219, DOI 10.1007/s00374-010-0505-5; Li JQ, 2010, BIORESOURCE TECHNOL, V101, P7479, DOI 10.1016/j.biortech.2010.04.030; Li Q, 2009, TOXICOLOGY, V255, P53, DOI 10.1016/j.tox.2008.10.003; Li XH, 2008, INT BIODETER BIODEGR, V62, P331, DOI 10.1016/j.ibiod.2008.03.001; Li XH, 2007, RES MICROBIOL, V158, P143, DOI 10.1016/j.resmic.2006.11.007; Liang WQ, 2005, J AGR FOOD CHEM, V53, P7415, DOI 10.1021/jf051460k; Mallick K, 1999, B ENVIRON CONTAM TOX, V62, P48, DOI 10.1007/s001289900840; Massoud AH, 2008, J ENVIRON SCI, V20, P262, DOI 10.1016/S1001-0742(08)60041-8; Meeker JD, 2004, HUM REPROD, V19, P2573, DOI 10.1093/humrep/deh444; Mehta A, 2008, ENVIRON MOL MUTAGEN, V49, P426, DOI 10.1002/em.20397; Moon C, 2011, BIORESOURCE TECHNOL, V102, P10561, DOI 10.1016/j.biortech.2011.08.094; Oliver GR, 2000, NEUROTOXICOLOGY, V21, P203; Peng XX, 2012, J HAZARD MATER, V213, P216, DOI 10.1016/j.jhazmat.2012.01.077; RACKE KD, 1993, REV ENVIRON CONTAM T, V131, P1; RACKE KD, 1990, J AGR FOOD CHEM, V38, P1430, DOI 10.1021/jf00096a029; Rauh VA, 2012, P NATL ACAD SCI USA, V109, P7871, DOI 10.1073/pnas.1203396109; Richins RD, 1997, NAT BIOTECHNOL, V15, P984, DOI 10.1038/nbt1097-984; Riederer AM, 2010, ENVIRON SCI TECHNOL, V44, P483, DOI 10.1021/es902479h; Ruan QL, 2012, J APPL TOXICOL, V32, P527, DOI 10.1002/jat.1783; Sambrook J., 2001, MOL CLONING LAB MANU; Scheil V, 2010, ENVIRON TOXICOL, V25, P83, DOI 10.1002/tox.20477; Singh BK, 2006, FEMS MICROBIOL REV, V30, P428, DOI 10.1111/j.1574-6976.2006.00018.x; Singh BK, 2003, APPL ENVIRON MICROB, V69, P5198, DOI 10.1128/AEM.69.9.5198-5206.2003; Singh BK, 2004, APPL ENVIRON MICROB, V70, P4855, DOI 10.1128/AEM.70.8.4855-4863.2004; Singh BK, 2006, SOIL BIOL BIOCHEM, V38, P2682, DOI 10.1016/j.soilbio.2006.04.019; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Singh DP, 2011, ENVIRON SCI POLLUT R, V18, P1351, DOI 10.1007/s11356-011-0472-x; Slotkin TA, 2009, BRAIN RES, V1263, P23, DOI 10.1016/j.brainres.2009.01.049; Slotkin TA, 2008, TOXICOL APPL PHARM, V233, P211, DOI 10.1016/j.taap.2008.08.020; Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thengodkar RRM, 2010, BIODEGRADATION, V21, P637, DOI 10.1007/s10532-010-9331-6; Theriot CM, 2011, APPL MICROBIOL BIOT, V89, P35, DOI 10.1007/s00253-010-2807-9; Tse H, 2004, CHEMOSPHERE, V54, P41, DOI 10.1016/S0045-6535(03)00659-3; Tuzmen N, 2008, CELL BIOCHEM FUNCT, V26, P119, DOI 10.1002/cbf.1411; U.S. EPA, 2015, 740C15003 US EPA; Wang P, 2012, ENVIRON INT, V42, P100, DOI 10.1016/j.envint.2011.04.015; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xu F, 2012, TOXICOL MECH METHOD, V22, P309, DOI 10.3109/15376516.2012.657260; Xu GM, 2008, INT BIODETER BIODEGR, V62, P51, DOI 10.1016/j.ibiod.2007.12.001; Xu GM, 2007, BIOTECHNOL LETT, V29, P1469, DOI 10.1007/s10529-007-9444-0; Yang C, 2006, FEMS MICROBIOL LETT, V265, P118, DOI 10.1111/j.1574-6968.2006.00478.x; Yong XY, 2011, BIORESOURCE TECHNOL, V102, P7548, DOI 10.1016/j.biortech.2011.05.057; Yu YL, 2006, BIODEGRADATION, V17, P487, DOI 10.1007/s10532-005-9020-z; Zhang Q, 2012, J HAZARD MATER, V221, P178, DOI 10.1016/j.jhazmat.2012.04.024	68	45	47	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47205	10.1371/journal.pone.0047205	http://dx.doi.org/10.1371/journal.pone.0047205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056611	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500144
J	Eggers, C; Pedrosa, DJ; Kahraman, D; Maier, F; Lewis, CJ; Fink, GR; Schmidt, M; Timmermann, L				Eggers, Carsten; Pedrosa, David J.; Kahraman, Deniz; Maier, Franziska; Lewis, Catharine J.; Fink, Gereon R.; Schmidt, Matthias; Timmermann, Lars			Parkinson Subtypes Progress Differently in Clinical Course and Imaging Pattern	PLOS ONE			English	Article							DOPAMINE TRANSPORTER; DISEASE SUBTYPES; DECLINE; TREMOR; SPECT; PET; HETEROGENEITY; DEGENERATION; ASSOCIATION; DEMENTIA	Objective: To elucidate whether Parkinson's disease (PD) subtypes show a differential pattern of FP-CIT-SPECT binding during the disease course. Methods: We examined 27 patients (10 female, 17 male, mean age 61.68 +/- 11.24 years, 14 tremordominant, 13 akineticrigid) with [I-123]FP-CIT-SPECT and clinical ratings including UPDRS III after at baseline and after a mean period of 2.47 years. Patients had been classified at baseline as tremordominant or akinetic-rigid according to a "tremor score'' and "non-tremor score''. These subgroups were compared for differences in disease progression. Means of clinical ratings and the quantitative analyses of FP-CIT-SPECT for ipsi- and contralateral putamen and caudate nucleus were calculated and compared between baseline and follow-up. Results: There were no statistical differences concerning age, disease duration, L-Dopa equivalent dose, disease severity (UPDRS III) or dopaminergic uptake in FP-CIT-SPECT at baseline between both subgroups. At follow-up, akinetic-rigid patients showed a distinct and statistically significant reduction of the dopaminergic uptake associated with significant progression of the clinical symptoms (UPDRS III). In contrast, in tremor patients the aggravation of clinical symptoms and dopaminergic deficit was less pronounced without statistical significance among assessments. Conclusions: This study shows for the first time a considerable progression of clinical symptoms and in-vivo dopaminergic deficit of akinetic-rigid compared to tremordominant PD patients over time. Our data may help to improve strategic planning of further therapeutic trials and to provide a clearer prognosis for patients regarding the perspective of their disease.	[Eggers, Carsten; Pedrosa, David J.; Maier, Franziska; Lewis, Catharine J.; Fink, Gereon R.; Timmermann, Lars] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Kahraman, Deniz; Schmidt, Matthias] Univ Cologne, Dept Nucl Med, D-50931 Cologne, Germany; [Fink, Gereon R.] Forschungszentrum Julich, Cognit Neurol Sect, Inst Neurosci & Med INM 3, D-52425 Julich, Germany	University of Cologne; University of Cologne; Helmholtz Association; Research Center Julich	Eggers, C (corresponding author), Univ Cologne, Dept Neurol, D-50931 Cologne, Germany.	lars.timmermann@uk-koeln.de	Fink, Gereon R./AFW-9377-2022; Fink, Gereon R./E-1616-2012	Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Pedrosa, David/0000-0002-5403-1959; Timmermann, Lars/0000-0002-5301-3580; Maier, Franziska/0000-0002-9335-9594	University Hospital of Cologne	University Hospital of Cologne	There was no industrial funding of this study. The only financial support was given by institutional funds of the University Hospital of Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benamer HTS, 2000, MOVEMENT DISORD, V15, P503, DOI 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V; Breit S, 2006, J NEURAL TRANSM, V113, P187, DOI 10.1007/s00702-005-0311-7; BROOKS DJ, 1992, NEUROLOGY, V42, P1554, DOI 10.1212/WNL.42.8.1554; Brown RG, J NEUROL NEUROSURG P, V82, P803; Burn DJ, 2006, J NEUROL NEUROSUR PS, V77, P585, DOI 10.1136/jnnp.2005.081711; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Doder M, 2003, NEUROLOGY, V60, P601, DOI 10.1212/01.WNL.0000031424.51127.2B; Eggers C, 2011, MOVEMENT DISORD, V26, P416, DOI 10.1002/mds.23468; Fahn S, 1987, UNIFIED PARKINSONS D; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Hariz GM, 2011, ACTA NEUROL SCAND, V123, P20, DOI 10.1111/j.1600-0404.2010.01344.x; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Jellinger KA, 1999, J NEURAL TRANSM-SUPP, P1; Job DE, 2002, NEUROIMAGE, V17, P880, DOI 10.1006/nimg.2002.1180; Kalbe E, 2008, PARKINSONISM RELAT D, V14, P93, DOI 10.1016/j.parkreldis.2007.06.008; Kas A, 2007, J NUCL MED, V48, P1459, DOI 10.2967/jnumed.106.038646; KAUFMAN MJ, 1991, SYNAPSE, V9, P43, DOI 10.1002/syn.890090107; Koch W, 2005, J NUCL MED, V46, P1109; LARUELLE M, 1993, SYNAPSE, V13, P295, DOI 10.1002/syn.890130402; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Louis ED, 1999, ARCH NEUROL-CHICAGO, V56, P334, DOI 10.1001/archneur.56.3.334; Marras C, 2002, ARCH NEUROL-CHICAGO, V59, P1724, DOI 10.1001/archneur.59.11.1724; Morton RJ, 2005, NUCL MED COMMUN, V26, P1139, DOI 10.1097/00006231-200512000-00015; Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209; NIZNIK HB, 1991, J NEUROCHEM, V56, P192, DOI 10.1111/j.1471-4159.1991.tb02580.x; Nurmi E, 2001, MOVEMENT DISORD, V16, P608, DOI 10.1002/mds.1139; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; Reijnders JSAM, 2009, PARKINSONISM RELAT D, V15, P379, DOI 10.1016/j.parkreldis.2008.09.003; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Spiegel J, 2007, J NEURAL TRANSM, V114, P331, DOI 10.1007/s00702-006-0518-2; Tatsch K, 2002, EUR J NUCL MED MOL I, V29, pBP30; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; van Dyck CH, 2002, AM J GERIAT PSYCHIAT, V10, P36, DOI 10.1176/appi.ajgp.10.1.36; van Rooden SM, 2010, MOVEMENT DISORD, V25, P969, DOI 10.1002/mds.23116; Winogrodzka A, 2003, J NEUROL NEUROSUR PS, V74, P294, DOI 10.1136/jnnp.74.3.294; Winogrodzka A, 2001, J NEURAL TRANSM, V108, P1011, DOI 10.1007/s007020170019; Young AB PJ, 2002, BIOCH FUNCTIONAL ORG, P1; ZETUSKY WJ, 1985, NEUROLOGY, V35, P522, DOI 10.1212/WNL.35.4.522	40	65	68	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46813	10.1371/journal.pone.0046813	http://dx.doi.org/10.1371/journal.pone.0046813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056463	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500081
J	He, XT; Walker, TDJ; Maranga, IO; Oliver, AW; Hampson, L; Hampson, IN				He, Xiaotong; Walker, Thomas D. J.; Maranga, Innocent O.; Oliver, Anthony W.; Hampson, Lynne; Hampson, Ian N.			No Biological Evidence of XMRV Infection in Cervical Smears from HIV/HPV Positive and Negative Kenyan Women	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; GENITAL-TRACT; BLOOD-CELLS; RETROVIRUS; HOST; TRANSMISSION; EXPRESSION	Background: XMRV (xenotropic murine leukaemia virus-related virus) is a gammaretrovirus first discovered in human prostate carcinomas and later linked to chronic fatigue syndrome (CFS). Emerging conflicting data and lack of reproducibility of results within the scientific community has now led to the association of XMRV with CFS being discounted. Indeed the case for an involvement with any human disease has been questioned with the suggestion that XMRV is a laboratory generated recombinant virus. The fact that not all published positive findings can be easily explained as contamination artefacts coupled with the observation that XMRV may have a sexually transmitted mode of infectivity and can be infectious for primates, where it preferential resides in cells of the reproductive tract, prompted us to look for evidence of XMRV in the cervical cells of a cohort of Kenyan women both with and without pre-existing HIV/HPV infections. Results: Using a highly sensitive and selective triplex PCR approach we analysed DNA from the liquid based cytology (LBC) cervical smears of 224 Kenyan women. There was no evidence of XMRV expression in any of the sample population irrespective of HPV and/or HIV status. Conclusions: The data presented show no indication of XMRV infection in any of the cervical samples screened in this study. Approximately 50% of the women were HIV positive but this did not influence the findings signifying that XMRV does not act as an opportunistic infection in this cohort nor is it related to HPV status. Our results therefore support the findings that XMRV is confined to the laboratory and does not currently represent an infectious agent for humans, with a cautionary adage that such potential zoonotic viruses should be carefully monitored in the future.	[He, Xiaotong; Walker, Thomas D. J.; Oliver, Anthony W.; Hampson, Lynne; Hampson, Ian N.] Univ Manchester, St Marys Hosp, Sch Canc & Enabling Sci, Viral Oncol Labs, Manchester M13 0JH, Lancs, England; [Maranga, Innocent O.] Univ Nairobi, Dept Obstet, Nairobi, Kenya; [Maranga, Innocent O.] Univ Nairobi, Dept Gynaecol, Nairobi, Kenya	University of Manchester; University of Nairobi; University of Nairobi	Hampson, IN (corresponding author), Univ Manchester, St Marys Hosp, Sch Canc & Enabling Sci, Viral Oncol Labs, Manchester M13 0JH, Lancs, England.	ian.hampson@manchester.ac.uk		Walker, Thomas/0000-0003-4607-7321; Hampson, Lynne/0000-0002-0656-0127	Humane Research Trust; Janice Cholerton Post Graduate Support Fund; Caring Cancer Trust; Cancer Prevention Research Trust; United in Cancer UK; International Atomic Energy Agency; Wellbeing of Women; Gardiner Bequest Foundation	Humane Research Trust; Janice Cholerton Post Graduate Support Fund; Caring Cancer Trust; Cancer Prevention Research Trust; United in Cancer UK; International Atomic Energy Agency(International Atomic Energy Agency); Wellbeing of Women(Wellbeing of Women (WoW)); Gardiner Bequest Foundation	The work described was funded by charitable donations from the Humane Research Trust, The Janice Cholerton Post Graduate Support Fund, The Caring Cancer Trust, The Cancer Prevention Research Trust and United in Cancer UK. Post graduate student IOM was part funded by the International Atomic Energy Agency and Wellbeing of Women. TDJW was supported by the Gardiner Bequest Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2011, SCIENCE, V334, P1636, DOI 10.1126/science.334.6063.1636-a; Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Bourgarel M, 2010, Emerg Health Threats J, V3, pe7, DOI 10.3134/ehtj.10.163; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Craigo JK, 2006, CURR OPIN HIV AIDS, V1, P97, DOI 10.1097/01.COH.0000200507.27578.26; Das Gupta J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036072; Delviks-Frankenberry KA, 2011, ADV VIROL, V2011, DOI 10.1155/2011/797820; Galvin SR, 2006, CURR OPIN HIV AIDS, V1, P162, DOI 10.1097/01.COH.0000199799.06454.10; Gingaras C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031398; Hu LJ, 2006, AIDS RES HUM RETROV, V22, P551, DOI 10.1089/aid.2006.22.551; Jerome KR, 2011, DIAGN MICR INFEC DIS, V71, P66, DOI 10.1016/j.diagmicrobio.2011.06.003; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kearney MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030889; Kenyon JC, 2011, BR MED B; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Korn K, 2012, INFECTION, V40, P181, DOI 10.1007/s15010-012-0249-2; Le Tortorec A, 2007, GYNECOL OBSTET FERTI, V35, P1245, DOI 10.1016/j.gyobfe.2007.09.017; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Madsen BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002492; Martin J, 1999, J VIROL, V73, P2442, DOI 10.1128/JVI.73.3.2442-2449.1999; Palmarini M, 2001, J VIROL, V75, P11319, DOI 10.1128/JVI.75.23.11319-11327.2001; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; PORTIS JL, 1987, J VIROL, V61, P1037, DOI 10.1128/JVI.61.4.1037-1044.1987; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sharma P, 2011, ADV VIROL, V2011, DOI 10.1155/2011/965689; Smith-McCune KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010094; Stieler K, 2010, VIROLOGY, V399, P23, DOI 10.1016/j.virol.2009.12.028; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Switzer WM, 2011, PLOS ONE, V6, P9; Tarlinton R, 2008, CELL MOL LIFE SCI, V65, P3413, DOI 10.1007/s00018-008-8499-y; Tugizov S M, 2011, Adv Dent Res, V23, P130, DOI 10.1177/0022034511400076; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Wilson CA, 2008, CELL MOL LIFE SCI, V65, P3399, DOI 10.1007/s00018-008-8498-z	34	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47208	10.1371/journal.pone.0047208	http://dx.doi.org/10.1371/journal.pone.0047208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056612	gold, Green Published, Green Submitted			2022-12-27	WOS:000309831500145
J	Rengel, D; Arribat, S; Maury, P; Martin-Magniette, ML; Hourlier, T; Laporte, M; Vares, D; Carrere, S; Grieu, P; Balzergue, S; Gouzy, J; Vincourt, P; Langlade, NB				Rengel, David; Arribat, Sandrine; Maury, Pierre; Martin-Magniette, Marie-Laure; Hourlier, Thibaut; Laporte, Marion; Vares, Didier; Carrere, Sebastien; Grieu, Philippe; Balzergue, Sandrine; Gouzy, Jerome; Vincourt, Patrick; Langlade, Nicolas B.			A Gene-Phenotype Network Based on Genetic Variability for Drought Responses Reveals Key Physiological Processes in Controlled and Natural Environments	PLOS ONE			English	Article							OSMOTIC ADJUSTMENT; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; STRESS TOLERANCE; JASMONIC ACID; WATER-DEFICIT; ABIOTIC STRESS; DIFFERENTIAL EXPRESSION; PROLINE ACCUMULATION; ABA RESPONSES	Identifying the connections between molecular and physiological processes underlying the diversity of drought stress responses in plants is key for basic and applied science. Drought stress response involves a large number of molecular pathways and subsequent physiological processes. Therefore, it constitutes an archetypical systems biology model. We first inferred a gene-phenotype network exploiting differences in drought responses of eight sunflower (Helianthus annuus) genotypes to two drought stress scenarios. Large transcriptomic data were obtained with the sunflower Affymetrix microarray, comprising 32423 probesets, and were associated to nine morpho-physiological traits (integrated transpired water, leaf transpiration rate, osmotic potential, relative water content, leaf mass per area, carbon isotope discrimination, plant height, number of leaves and collar diameter) using sPLS regression. Overall, we could associate the expression patterns of 1263 probesets to six phenotypic traits and identify if correlations were due to treatment, genotype and/or their interaction. We also identified genes whose expression is affected at moderate and/or intense drought stress together with genes whose expression variation could explain phenotypic and drought tolerance variability among our genetic material. We then used the network model to study phenotypic changes in less tractable agronomical conditions, i.e. sunflower hybrids subjected to different watering regimes in field trials. Mapping this new dataset in the gene-phenotype network allowed us to identify genes whose expression was robustly affected by water deprivation in both controlled and field conditions. The enrichment in genes correlated to relative water content and osmotic potential provides evidence of the importance of these traits in agronomical conditions.	[Rengel, David; Hourlier, Thibaut; Vares, Didier; Carrere, Sebastien; Gouzy, Jerome; Vincourt, Patrick; Langlade, Nicolas B.] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Rengel, David; Hourlier, Thibaut; Vares, Didier; Carrere, Sebastien; Gouzy, Jerome; Vincourt, Patrick; Langlade, Nicolas B.] CNRS, LIPM, UMR2594, Castanet Tolosan, France; [Arribat, Sandrine; Martin-Magniette, Marie-Laure; Balzergue, Sandrine] Univ Evry Val dEssonne, INRA, URGV, UMR1165,ERL CNRS 8196,CP 5708, Evry, France; [Maury, Pierre; Laporte, Marion; Grieu, Philippe] Univ Toulouse, INPT ENSAT, AGIR UMR1248, Castanet Tolosan, France; [Maury, Pierre; Laporte, Marion; Grieu, Philippe] INRA, AGIR UMR1248, F-31326 Castanet Tolosan, France; [Martin-Magniette, Marie-Laure] AgroParisTech, INRA, UMR518, Paris, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Langlade, NB (corresponding author), INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France.	Nicolas.Langlade@toulouse.inra.fr	Langlade, Nicolas/C-6191-2008; Gouzy, Jerome/AAH-4977-2020; Martin-Magniette, Marie-Laure/AAP-1644-2020	Langlade, Nicolas/0000-0002-5651-1446; Gouzy, Jerome/0000-0001-5695-4557; Martin-Magniette, Marie-Laure/0000-0003-4000-9600; Maury, Pierre/0000-0002-1271-2334; Carrere, Sebastien/0000-0002-2348-0778; Hourlier, Thibaut/0000-0003-4894-7773	ANR [ANR-07-GPLA-022]; National Institute for Agronomic Research (INRA); Laboratoire d'Excellence (LABEX) entitled TULIP [ANR-10-LABX-41]	ANR(French National Research Agency (ANR)); National Institute for Agronomic Research (INRA); Laboratoire d'Excellence (LABEX) entitled TULIP	This work was supported by funds from the ANR project entitled SUNYFUEL (ANR-07-GPLA-022), from a grant from the National Institute for Agronomic Research (INRA, "package 2007") and is part of the Laboratoire d'Excellence (LABEX) entitled TULIP (ANR-10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; BOYER JS, 1968, PLANT PHYSIOL, V43, P1056, DOI 10.1104/pp.43.7.1056; Bray EA, 2002, ANN BOT-LONDON, V89, P803, DOI 10.1093/aob/mcf104; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Casadebaig P, 2008, EUR J AGRON, V28, P646, DOI 10.1016/j.eja.2008.02.001; Casadebaig P, 2011, AGR FOREST METEOROL, V151, P163, DOI 10.1016/j.agrformet.2010.09.012; Cechin I, 2006, PHOTOSYNTHETICA, V44, P143, DOI 10.1007/s11099-005-0171-2; Cherel I, 2002, PLANT CELL, V14, P1133, DOI 10.1105/tpc.000943; CHIMENTI CA, 1993, EUPHYTICA, V71, P201, DOI 10.1007/BF00040409; CHIMENTI CA, 1994, PLANT SOIL, V166, P101, DOI 10.1007/BF02185486; Conn SJ, 2011, PLANT CELL, V23, P240, DOI 10.1105/tpc.109.072769; CONROY JP, 1988, PLANT PHYSIOL, V86, P1108, DOI 10.1104/pp.86.4.1108; Coque M., 2008, P 17 INT SUNFL C COR, P725; COSGROVE DJ, 1993, PLANT PHYSIOL, V102, P1, DOI 10.1104/pp.102.1.1; Cubillos FA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-117; Cuin TA, 2007, PLANT CELL ENVIRON, V30, P875, DOI 10.1111/j.1365-3040.2007.01674.x; Cuin TA, 2008, PLANT SIGNAL BEHAV, V3, P207, DOI 10.4161/psb.3.3.4966; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Geisler M., 2009, Genes for plant abiotic stress, P55, DOI 10.1002/9780813809380.ch3; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gigon A, 2004, ANN BOT-LONDON, V94, P345, DOI 10.1093/aob/mch150; Gimeno J, 2009, PLANT MOL BIOL, V70, P403, DOI 10.1007/s11103-009-9481-2; Golldack D, 2011, PLANT CELL REP, P1; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Gouzy J, 2009, BIOINFORMATICS, V25, P670, DOI 10.1093/bioinformatics/btp024; Guan Y, 2004, PLANT PHYSIOL, V135, P1346, DOI 10.1104/pp.104.039370; Guo FO, 2003, PLANT CELL, V15, P107, DOI 10.1105/tpc.006312; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Harter AV, 2004, NATURE, V430, P201, DOI 10.1038/nature02710; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Isokpehi RD, 2011, BIOINFORMATICS BIOL, P5; JONES MM, 1980, AUST J PLANT PHYSIOL, V7, P181, DOI 10.1071/PP9800181; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Jury WA, 2005, P NATL ACAD SCI USA, V102, P15715, DOI 10.1073/pnas.0506467102; Kane NC, 2009, EVOLUTION, V63, P2061, DOI 10.1111/j.1558-5646.2009.00703.x; Kerstiens G, 1996, J EXP BOT, V47, P1813, DOI 10.1093/jxb/47.12.1813; Kiani SP, 2007, THEOR APPL GENET, V114, P193, DOI 10.1007/s00122-006-0419-7; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Liu F, 2010, CELL RES, V20, P539, DOI 10.1038/cr.2010.36; Lorenz WW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-264; Manavella PA, 2008, PLANT J, V56, P376, DOI 10.1111/j.1365-313X.2008.03604.x; Manavella PA, 2006, PLANT J, V48, P125, DOI 10.1111/j.1365-313X.2006.02865.x; Maury P, 2000, PLANT SOIL, V223, P155, DOI 10.1023/A:1004849509673; MCCREE KJ, 1984, PLANT PHYSIOL, V76, P898, DOI 10.1104/pp.76.4.898; MERRIEN A, 1981, AGRONOMIE, V1, P917, DOI 10.1051/agro:19811013; Missihoun TD, 2011, PLANTA, V233, P369, DOI 10.1007/s00425-010-1297-4; MOJAYAD F, 1994, CROP SCI, V34, P103, DOI 10.2135/cropsci1994.0011183X003400010018x; Morizet J., 1990, TOURNESOL EAU, P7; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nolot Jean-Marie, 2003, Cahiers Agricultures, V12, P387; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pose D, 2009, PLANT J, V59, P63, DOI 10.1111/j.1365-313X.2009.03849.x; Przybyla D, 2008, PLANT J, V54, P236, DOI 10.1111/j.1365-313X.2008.03409.x; Ramanjulu S, 2002, PLANT CELL ENVIRON, V25, P141, DOI 10.1046/j.0016-8025.2001.00764.x; Roche J, 2007, PLANTA, V226, P601, DOI 10.1007/s00425-007-0508-0; SADRAS VO, 1993, FIELD CROP RES, V31, P27, DOI 10.1016/0378-4290(93)90048-R; Sakamoto H, 2008, PLANT J, V56, P411, DOI 10.1111/j.1365-313X.2008.03614.x; Sanchez FJ, 1998, FIELD CROP RES, V59, P225, DOI 10.1016/S0378-4290(98)00125-7; Sasaki-Sekimoto Y, 2005, PLANT J, V44, P653, DOI 10.1111/j.1365-313X.2005.02560.x; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Schafleitner R, 2007, PLANT PHYSIOL BIOCH, V45, P673, DOI 10.1016/j.plaphy.2007.06.003; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Seiler GJ, 2004, EXPLORATION WILD HEL; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sinclair TR, 2005, AGRON J, V97, P1148, DOI 10.2134/agronj2004.0286; Sofo A, 2004, PHYSIOL PLANTARUM, V121, P58, DOI 10.1111/j.0031-9317.2004.00294.x; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Tahtiharju S, 2001, PLANT J, V26, P461, DOI 10.1046/j.1365-313X.2001.01048.x; Tardieu F, 2011, CURRENT OPINION PLAN; Tsay YF, 2011, ANNU REV PLANT BIOL, V62, P207, DOI 10.1146/annurev-arplant-042110-103837; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Vear F, 2008, EUPHYTICA, V164, P561, DOI 10.1007/s10681-008-9759-5; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Vranova E, 2000, J EXP BOT, V51, P1763, DOI 10.1093/jexbot/51.351.1763; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Wong CE, 2006, PLANT PHYSIOL, V140, P1437, DOI 10.1104/pp.105.070508; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang YY, 2007, J INTEGR PLANT BIOL, V49, P87, DOI 10.1111/j.1744-7909.2006.00417.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	107	40	42	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45249	10.1371/journal.pone.0045249	http://dx.doi.org/10.1371/journal.pone.0045249			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056196	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500015
J	Codocedo, JF; Allard, C; Godoy, JA; Varela-Nallar, L; Inestrosa, NC				Codocedo, Juan F.; Allard, Claudio; Godoy, Juan A.; Varela-Nallar, Lorena; Inestrosa, Nibaldo C.			SIRT1 Regulates Dendritic Development in Hippocampal Neurons	PLOS ONE			English	Article							MYOSIN PHOSPHATASE; POSTSYNAPTIC DENSITY; ALZHEIMERS-DISEASE; RHO; PROTECTS; PROMOTES; RESTRICTION; ACTIVATION; MECHANISM; MODELS	Dendritic arborization is required for proper neuronal connectivity. SIRT1, a NAD+ dependent histone deacetylase, has been associated to ageing and longevity, which in neurons is linked to neuronal differentiation and neuroprotection. In the present study, the role of SIRT1 in dendritic development was evaluated in cultured hippocampal neurons which were transfected at 3 days in vitro with a construct coding for SIRT1 or for the dominant negative SIRT1H363Y, which lacks the catalytic activity. Neurons overexpressing SIRT1 showed an increased dendritic arborization, while neurons overexpressing SIRT1H363Y showed a reduction in dendritic arbor complexity. The effect of SIRT1 was mimicked by treatment with resveratrol, a well known activator of SIRT1, which has no effect in neurons overexpressing SIRT1H363Y indicating that the effect of resveratrol was specifically mediated by SIRT1. Moreover, hippocampal neurons overexpressing SIRT1 were resistant to dendritic dystrophy induced by A beta aggregates, an effect that was dependent on the deacetylase activity of SIRT1. Our findings indicate that SIRT1 plays a role in the development and maintenance of dendritic branching in hippocampal neurons, and suggest that these effects are mediated by the ROCK signaling pathway.	[Codocedo, Juan F.; Allard, Claudio; Godoy, Juan A.; Varela-Nallar, Lorena; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE, Santiago, Chile	Pontificia Universidad Catolica de Chile	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE, Alameda 340, Santiago, Chile.	ninestrosa@bio.puc.cl	Godoy, Juan A/F-5398-2018; Varela-Nallar, Lorena/AAV-3304-2021	Godoy, Juan A/0000-0001-9920-6698; Varela-Nallar, Lorena/0000-0003-2588-6437; Codocedo Henriquez, Juan Francisco/0000-0002-9683-2156	Basal Center of Excellence in Aging and Regeneration [CONICYT-PFB12/2007]; CONICYT; Insertion of Postdoctoral Researchers in the Academy-CONICYT [Nu79090027]	Basal Center of Excellence in Aging and Regeneration(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Insertion of Postdoctoral Researchers in the Academy-CONICYT	This work was supported by Basal Center of Excellence in Aging and Regeneration (CONICYT-PFB12/2007) to NCI, Predoctoral fellowship from CONICYT to CA and JFC, and Insertion of Postdoctoral Researchers in the Academy-CONICYT (Nu79090027) to LVN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard CA, 2010, 2010 NEUR M PLANN SA; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Ghosh HS, 2007, BIOCHEM J, V408, P105, DOI 10.1042/BJ20070817; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kita Y, 1998, J CELL SCI, V111, P907; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pallas M, 2008, NEUROSCIENCE, V154, P1388, DOI 10.1016/j.neuroscience.2008.04.065; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Santos MJ, 2005, J BIOL CHEM, V280, P41057, DOI 10.1074/jbc.M505160200; Shen HW, 2008, BRAIN STRUCT FUNCT, V213, P149, DOI 10.1007/s00429-008-0184-2; Smith WW, 2005, J CELL BIOL, V169, P331, DOI 10.1083/jcb.200410041; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2009, GENE DEV, V23, P1849, DOI 10.1101/gad.1807009; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Yamashita K, 2007, BRAIN RES, V1154, P215, DOI 10.1016/j.brainres.2007.04.013; Yu X, 2004, NEUROPHARMACOLOGY, V47, P779, DOI 10.1016/j.neuropharm.2004.07.031; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200	53	59	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e47073	10.1371/journal.pone.0047073	http://dx.doi.org/10.1371/journal.pone.0047073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056585	Green Submitted, Green Published, gold			2022-12-27	WOS:000309580800071
J	Zhang, W; Rong, CB; Chen, C; Gao, GF				Zhang, Wen; Rong, Chengbo; Chen, Chen; Gao, George F.			Type-IVC Secretion System: A Novel Subclass of Type IV Secretion System (T4SS) Common Existing in Gram-Positive Genus Streptococcus	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; T-PILUS; SUIS 2; DIVERSITY; SEQUENCE	A growing number of pathogens are being found to possess specialized secretion systems which they use in various ways to subvert host defenses. Type IV secretion system (T4SS) is one of versatile secretion systems essential for the virulence and even survival of some bacteria species, and they enable the secretion of protein and DNA substrates across the cell envelope. T4SS was once believed to be present only in Gram-negative bacteria. In this study, we present evidence of a new subclass of T4SS, Type-IVC secretion system and indicate its common existence in the Gram-positive bacterial genus Streptococcus. We further identified that VirB1, VirB4, VirB6 and VirD4 are the minimal key components of this system. Using genome comparisons and evolutionary relationship analysis, we proposed that Type-IVC secretion system is movable via transposon factors and mediates the conjugative transfer of DNA, enhances bacterial pathogenicity, and could cause large-scale outbreaks of infections in humans.	[Zhang, Wen; Chen, Chen; Gao, George F.] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Rong, Chengbo; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences	Chen, C (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	chenchen@icdc.cn; gaof@im.ac.cn	chen, chen/AAQ-1805-2021; CHEN, CHEN/HDM-6657-2022; Gao, George Fu/ABD-5229-2021	chen, chen/0000-0003-1765-8899; 	Young Scholar Scientific Research Foundation of China CDC [2010A104]; Priority Project on Infectious Disease Control and Prevention [2008ZX10004-008]; National Natural Science Foundation of China (NSFC) [81021003]; China Postdoctoral Science Foundation [20100470590]; National Key Program of Mega Infectious Diseases [2013ZX10004-221]	Young Scholar Scientific Research Foundation of China CDC; Priority Project on Infectious Disease Control and Prevention; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key Program of Mega Infectious Diseases	Our work was supported by the Young Scholar Scientific Research Foundation of China CDC (No. 2010A104), the Priority Project on Infectious Disease Control and Prevention (No. 2008ZX10004-008), National Natural Science Foundation of China (NSFC, Grant No. 81021003), the China Postdoctoral Science Foundation (20100470590) and the National Key Program of Mega Infectious Diseases (Grant No. 2013ZX10004-221). There has been no significant financial support for this work that could have influenced its outcome.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Du PC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-135; Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Juhas M, 2007, J BACTERIOL, V189, P761, DOI 10.1128/JB.01327-06; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Magrane M, 2011, UNIPROT KNOWL HUB IN; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sexton JA, 2002, TRAFFIC, V3, P178, DOI 10.1034/j.1600-0854.2002.030303.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Waksman G, 2010, TRENDS BIOCHEM SCI, V35, P691, DOI 10.1016/j.tibs.2010.06.002; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; Wu ZW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-219; Xu LF, 2010, PROTEIN CELL, V1, P96, DOI 10.1007/s13238-010-0012-3; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Zhao Y, 2011, J INFECT DIS, V204, P274, DOI 10.1093/infdis/jir261; Zupan J, 2007, J BACTERIOL, V189, P6551, DOI 10.1128/JB.00480-07	31	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46390	10.1371/journal.pone.0046390	http://dx.doi.org/10.1371/journal.pone.0046390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056296	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800017
J	Zhou, Q; Sun, S; Tai, P; Sui, SF				Zhou, Qiang; Sun, Shan; Tai, Phang; Sui, Sen-Fang			Structural Characterization of the Complex of SecB and Metallothionein-Labeled proOmpA by Cryo-Electron Microscopy	PLOS ONE			English	Article							CHAPERONE SECB; ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; ELECTRON-MICROSCOPY; BINDING PROTEIN; PREPROTEIN TRANSLOCASE; PHYSIOLOGICAL LIGAND; MEMBRANE-VESICLES; EXPORT; VISUALIZATION	ProOmpA is a preprotein that is translocated across the plasma membrane by the general secretory pathway in Escherichia coli. The molecular chaperon SecB in Sec pathway can recognize and bind proOmpA for its translocation. However, the structure of the SecB/proOmpA complex remains unknown. Here, we constructed an uncleavable proOmpA fused with metallothionein at its C-terminus and labeled it with metals in vitro for the study of cryo-electron microscopy. Using single particle cryo-electron microscopy, we reconstructed 3D structure of the stable SecB/proOmpA complex. The structure shows that the major portion of preprotein locates on one side of SecB tetramer, resulting in an asymmetric binding pattern. This work also provides a possible approach to the structure determination of small protein complexes by cryo-electron microscopy.	[Zhou, Qiang; Sun, Shan; Sui, Sen-Fang] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Tai, Phang] Georgia State Univ, Dept Biol, Atlanta, GA USA	Tsinghua University; University System of Georgia; Georgia State University	Sui, SF (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn	Zhou, Qiang/P-8073-2015	Sui, Sen-Fang/0000-0001-5253-2592	National Basic Research program of China [2011CB910500/2010CB833706/2010CB912400]; National Natural Science Foundation of China [30830028/30970591]	National Basic Research program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research program of China (2011CB910500/2010CB833706/2010CB912400) and the National Natural Science Foundation of China (30830028/30970591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Bechtluft P, 2010, MOL BIOSYST, V6, P620, DOI 10.1039/b915435c; Bouchet-Marquis C, 2012, J STRUCT BIOL, V177, P119, DOI 10.1016/j.jsb.2011.10.007; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; Crane JM, 2006, J MOL BIOL, V363, P63, DOI 10.1016/j.jmb.2006.07.021; DECOCK H, 1992, J MOL BIOL, V224, P369, DOI 10.1016/0022-2836(92)91001-6; Diestra E, 2009, J STRUCT BIOL, V165, P157, DOI 10.1016/j.jsb.2008.11.009; Fekkes P, 1998, MOL MICROBIOL, V29, P1179, DOI 10.1046/j.1365-2958.1998.00997.x; FEKKES P, 1995, BIOCHEMISTRY-US, V34, P10078, DOI 10.1021/bi00031a032; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fukunaga Y, 2012, J ELECT MICROSC, DOI 101093/jmicro/dfs043; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; KHISTY VJ, 1995, J BIOL CHEM, V270, P25920, DOI 10.1074/jbc.270.43.25920; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Krishnan B, 2009, J MOL BIOL, V385, P1243, DOI 10.1016/j.jmb.2008.10.094; LECKER SH, 1990, EMBO J, V9, P2309, DOI 10.1002/j.1460-2075.1990.tb07402.x; Lilly AA, 2009, PROTEIN SCI, V18, P1860, DOI 10.1002/pro.197; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; Mercogliano CP, 2007, J STRUCT BIOL, V160, P70, DOI 10.1016/j.jsb.2007.06.010; Muller JP, 2000, BIOCHEM J, V348, P367, DOI 10.1042/0264-6021:3480367; Nishino Y, 2007, J ELECTRON MICROSC, V56, P93, DOI 10.1093/jmicro/dfm008; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Panse VG, 1998, BIOCHEMISTRY-US, V37, P14477, DOI 10.1021/bi980777t; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Randall LL, 1998, PROTEIN SCI, V7, P2384, DOI 10.1002/pro.5560071115; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; Randall LL, 1998, PROTEIN SCI, V7, P1195, DOI 10.1002/pro.5560070514; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; SANO T, 1992, P NATL ACAD SCI USA, V89, P1534, DOI 10.1073/pnas.89.5.1534; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Smith VF, 1997, FASEB J, V11, pA903; Tang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016498; Tang Y, 2010, SCI CHINA LIFE SCI, V53, P1049, DOI 10.1007/s11427-010-4061-x; Tang Y, 2010, BIOCHEM BIOPH RES CO, V393, P698, DOI 10.1016/j.bbrc.2010.02.062; TANI K, 1990, J BIOL CHEM, V265, P17341; Tomikiewicz D, 2008, J MOL BIOL, V377, P83, DOI 10.1016/j.jmb.2008.01.014; TOPPING TB, 1994, PROTEIN SCI, V3, P730; Topping TB, 1997, J BIOL CHEM, V272, P19314, DOI 10.1074/jbc.272.31.19314; van der Does C, 2003, METHOD ENZYMOL, V372, P86; YAMANE K, 1988, J BIOL CHEM, V263, P5368	45	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e47015	10.1371/journal.pone.0047015	http://dx.doi.org/10.1371/journal.pone.0047015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056562	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800067
J	Al-Janabi, S; MacLeod, C; Rhodes, G				Al-Janabi, Shahd; MacLeod, Colin; Rhodes, Gillian			Non-Threatening Other-Race Faces Capture Visual Attention: Evidence from a Dot-Probe Task	PLOS ONE			English	Article							EYE-GAZE; PERCEPTION; BRAIN	Visual attentional biases towards other-race faces have been attributed to the perceived threat value of such faces. It is possible, however, that they reflect the relative visual novelty of other-race faces. Here we demonstrate an attentional bias to other-race faces in the absence of perceived threat. White participants rated female East Asian faces as no more threatening than female own-race faces. Nevertheless, using a new dot-probe paradigm that can distinguish attentional capture and hold effects, we found that these other-race faces selectively captured visual attention. Importantly, this demonstration challenges previous interpretations of attentional biases to other-race faces as threat responses. Future studies will need to determine whether perceived threat increases attentional biases to other-race faces, beyond the levels seen here.	[Al-Janabi, Shahd; Rhodes, Gillian] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia; [MacLeod, Colin; Rhodes, Gillian] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia	Macquarie University; University of Western Australia	Al-Janabi, S (corresponding author), Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia.	shahd.al-janabi@mq.edu.au		MacLeod, Colin/0000-0003-2407-7339; Al-Janabi, Shahd/0000-0003-3208-9946; Rhodes, Gillian/0000-0002-3631-8518	Australian Research Council Centre of Excellence for Cognition and its Disorders [CE110001021]	Australian Research Council Centre of Excellence for Cognition and its Disorders(Australian Research Council)	This research was supported by the Australian Research Council Centre of Excellence for Cognition and its Disorders (project number CE110001021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindemann M, 2008, VIS COGN, V16, P708, DOI 10.1080/13506280701269318; Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636; Brittain PJ, 2010, SCHIZOPHR RES, V124, P134, DOI 10.1016/j.schres.2010.07.008; Cooper RM, 2006, BEHAV RES THER, V44, P1321, DOI 10.1016/j.brat.2005.10.004; Cottrell CA, 2005, J PERS SOC PSYCHOL, V88, P770, DOI 10.1037/0022-3514.88.5.770; Dickter CL, 2010, PSYCHOPHYSIOLOGY, V47, P596, DOI 10.1111/j.1469-8986.2010.00963.x; Duncan LA, 2007, EVOL HUM BEHAV, V28, P359, DOI 10.1016/j.evolhumbehav.2007.05.001; Frantz CM, 2004, PERS SOC PSYCHOL B, V30, P1611, DOI 10.1177/0146167204266650; Glauert R, 2010, INT J EAT DISORDER, V43, P42, DOI 10.1002/eat.20663; Grafton B, EUROPEAN J IN PRESS; Huber DE, 2008, J EXP PSYCHOL GEN, V137, P324, DOI 10.1037/0096-3445.137.2.324; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Ito TA, 2004, PERS SOC PSYCHOL B, V30, P1267, DOI 10.1177/0146167204264335; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Richeson JA, 2011, DOES BLACK MALE STIL; Richeson JA, 2008, GROUP PROCESS INTERG, V11, P233, DOI 10.1177/1368430207088040; Richeson JA, 2008, PSYCHOL SCI, V19, P98, DOI 10.1111/j.1467-9280.2008.02052.x; Ruz M., 2002, PSICOLOGICA, V23, P283, DOI DOI 10.1080/09084282.2010.547774; Shapiro JR, 2009, PERS SOC PSYCHOL B, V35, P1356, DOI 10.1177/0146167209339627; Trawalter S, 2008, J EXP SOC PSYCHOL, V44, P1322, DOI 10.1016/j.jesp.2008.03.006	21	14	14	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46119	10.1371/journal.pone.0046119	http://dx.doi.org/10.1371/journal.pone.0046119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056245	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000017
J	Bonifacio, M; Rigo, A; Guardalben, E; Bergamini, C; Cavalieri, E; Fato, R; Pizzolo, G; Suzuki, H; Vinante, F				Bonifacio, Massimiliano; Rigo, Antonella; Guardalben, Emanuele; Bergamini, Christian; Cavalieri, Elisabetta; Fato, Romana; Pizzolo, Giovanni; Suzuki, Hisanori; Vinante, Fabrizio			alpha-bisabolol Is an Effective Proapoptotic Agent against BCR-ABL(+) Cells in Synergism with Imatinib and Nilotinib	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; DIPHTHERIA-TOXIN; STEM-CELLS; APOPTOSIS; INHIBITOR; CANCER; COMBINATION; INVOLVEMENT; EXPRESSION	We showed that alpha-bisabolol is active against primary acute leukemia cells, including BCR-ABL(+) acute lymphoblastic leukemias (ALL). Here we studied the activity of alpha-bisabolol against BCR-ABL(+) cells using 3 cell lines (K562, LAMA-84, CML-T1) and 10 primary BCR-ABL(+) ALL samples. We found that: (a) alpha-bisabolol was effective in reducing BCR-ABL(+) cell viabilty at concentrations ranging from 53 to 73 mu M; (b) alpha-bisabolol concentrations in BCR-ABL(+) cellular compartments were 4- to 12-fold higher than in normal cells, thus indicating a preferential intake in neoplastic cells; (c) alpha-bisabolol displayed a slight to strong synergism with the Tyrosine Kinase Inhibitors (TKI) imatinib and nilotinib: the combination of alpha-bisabolol+imatinib allowed a dose reduction of each compound up to 7.2 and 9.4-fold respectively, while the combination of alpha-bisabolol+nilotinib up to 6.7 and 5-fold respectively; (d) alpha-bisabolol-induced apoptosis was associated with loss of plasma membrane integrity, irreversible opening of mitochondrial transition pore, disruption of mitochondrial potential, inhibition of oxygen consumption and increase of intracellular reactive oxygen species. These data indicate alpha-bisabolol as a candidate for treatment of BCR-ABL(+) leukemias to overcome resistance to TKI alone and to target leukemic cells through BCR-ABL-independent pathways.	[Bonifacio, Massimiliano; Rigo, Antonella; Guardalben, Emanuele; Pizzolo, Giovanni; Vinante, Fabrizio] Univ Verona, Dept Med, Sect Hematol, I-37100 Verona, Italy; [Bergamini, Christian; Fato, Romana] Univ Bologna, Dept Biochem G Moruzzi, Bologna, Italy; [Cavalieri, Elisabetta; Suzuki, Hisanori] Univ Verona, Dept Life & Reprod Sci, Biochem Sect, I-37100 Verona, Italy	University of Verona; University of Bologna; University of Verona	Vinante, F (corresponding author), Univ Verona, Dept Med, Sect Hematol, I-37100 Verona, Italy.	fabrizio.vinante@univr.it	Bonifacio, Massimiliano/AAL-4520-2020	Bonifacio, Massimiliano/0000-0003-0716-1686; Vinante, Fabrizio/0000-0002-3855-6747	Italian Association for Cancer Research (AIRC, Milan, Italy)/Cariverona Foundation (Verona, Italy); Venetian Institute of Oncology (IOV, Padua, Italy)	Italian Association for Cancer Research (AIRC, Milan, Italy)/Cariverona Foundation (Verona, Italy)(Fondazione AIRC per la ricerca sul cancro); Venetian Institute of Oncology (IOV, Padua, Italy)	This work was supported by grants from the Italian Association for Cancer Research (AIRC, Milan, Italy)/Cariverona Foundation (Verona, Italy) and from the Venetian Institute of Oncology (IOV, Padua, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Borthakur G, 2006, CANCER, V106, P346, DOI 10.1002/cncr.21590; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Cavalieri E, 2004, BIOCHEM BIOPH RES CO, V315, P589, DOI 10.1016/j.bbrc.2004.01.088; Cavalieri E, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-45; Cavalieri E, 2009, FEBS J, V276, P3990, DOI 10.1111/j.1742-4658.2009.07108.x; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; Chretien D, 2003, BIOCHEM BIOPH RES CO, V301, P222, DOI 10.1016/S0006-291X(02)03016-4; Cortes J, 2011, J CLIN ONCOL, V29, P524, DOI 10.1200/JCO.2010.31.3619; Costarelli L, 2010, ONCOL RES, V18, P409, DOI 10.3727/096504010X12671222663557; Cowan-Jacob SW, 2004, MINI-REV MED CHEM, V4, P285, DOI 10.2174/1389557043487321; Darra E, 2008, ARCH BIOCHEM BIOPHYS, V476, P113, DOI 10.1016/j.abb.2008.02.004; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Hu Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006257; Imai H, 1998, J BIOL CHEM, V273, P1990, DOI 10.1074/jbc.273.4.1990; Irvine DA, 2009, BLOOD, V114, P580, DOI 10.1182/blood.V114.22.1428.1428; JAKOVLEV V, 1979, PLANTA MED, V35, P125, DOI 10.1055/s-0028-1097194; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kano Y, 2001, BLOOD, V97, P1999, DOI 10.1182/blood.V97.7.1999; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Patra SK, 2007, ONCOL REP, V17, P1279; Pedro AS, 2009, BIOMED CHROMATOGR, V23, P966, DOI 10.1002/bmc.1208; Rigo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034432; Seki T, 2011, CANCER SCI, V102, P2199, DOI 10.1111/j.1349-7006.2011.02082.x; Vinante F, 1999, BLOOD, V93, P1715, DOI 10.1182/blood.V93.5.1715.405k26_1715_1723; Vinante F, 1999, BLOOD, V94, P3169, DOI 10.1182/blood.V94.9.3169.421k30_3169_3177; Yu CR, 2002, CLIN CANCER RES, V8, P2976; Zhang B, 2010, CANCER CELL, V17, P427, DOI 10.1016/j.ccr.2010.03.011	31	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46674	10.1371/journal.pone.0046674	http://dx.doi.org/10.1371/journal.pone.0046674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056396	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000073
J	Crease, TJ; Omilian, AR; Costanzo, KS; Taylor, DJ				Crease, Teresa J.; Omilian, Angela R.; Costanzo, Katie S.; Taylor, Derek J.			Transcontinental Phylogeography of the Daphnia pulex Species Complex	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; HOLARCTIC PHYLOGEOGRAPHY; INTEGRATED SOFTWARE; POPULATION-GROWTH; GENETIC LEGACY; NORTH; CLADOCERA; SEQUENCE; DISPERSAL; DIVERSITY	Daphnia pulex is quickly becoming an attractive model species in the field of ecological genomics due to the recent release of its complete genome sequence, a wide variety of new genomic resources, and a rich history of ecological data. Sequences of the mitochondrial NADH dehydrogenase subunit 5 and cytochrome c oxidase subunit 1 genes were used to assess the global phylogeography of this species, and to further elucidate its phylogenetic relationship to other members of the Daphnia pulex species complex. Using both newly acquired and previously published data, we analyzed 398 individuals from collections spanning five continents. Eleven strongly supported lineages were found within the D. pulex complex, and one lineage in particular, panarctic D. pulex, has very little phylogeographical structure and a near worldwide distribution. Mismatch distribution, haplotype network, and population genetic analyses are compatible with a North American origin for this lineage and subsequent spatial expansion in the Late Pleistocene. In addition, our analyses suggest that dispersal between North and South America of this and other species in the D. pulex complex has occurred multiple times, and is predominantly from north to south. Our results provide additional support for the evolutionary relationships of the eleven main mitochondrial lineages of the D. pulex complex. We found that the well-studied panarctic D. pulex is present on every continent except Australia and Antarctica. Despite being geographically very widespread, there is a lack of strong regionalism in the mitochondrial genomes of panarctic D. pulex - a pattern that differs from that of most studied cladocerans. Moreover, our analyses suggest recent expansion of the panarctic D. pulex lineage, with some continents sharing haplotypes. The hypothesis that hybrid asexuality has contributed to the recent and unusual geographic success of the panarctic D. pulex lineage warrants further study.	[Crease, Teresa J.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Omilian, Angela R.; Costanzo, Katie S.; Taylor, Derek J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Omilian, Angela R.] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Costanzo, Katie S.] Canisius Coll, Dept Biol, Buffalo, NY 14208 USA	University of Guelph; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Crease, TJ (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	tcrease@uoguelph.ca	Crease, Teresa/E-2932-2015	Crease, Teresa/0000-0001-8074-8024	Natural Sciences and Engineering Research Council of Canada; National Science Foundation, United States of America [ARC1023334, DEB0331095]; Microsoft Corporation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation, United States of America(National Science Foundation (NSF)); Microsoft Corporation(Microsoft)	TJC was funded by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (www.nserc.ca). DJT was funded by grants ARC1023334 and DEB0331095 from the National Science Foundation, United States of America (www.nsf.gov). Part of this work was carried out using the resources of the Computational Biology Service Unit from Cornell University that is partially funded by Microsoft Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Adamowicz SJ, 2002, MOL ECOL, V11, P1209, DOI 10.1046/j.1365-294X.2002.01517.x; Allen MR, 2010, MOL ECOL, V19, P3076, DOI 10.1111/j.1365-294X.2010.04728.x; [Anonymous], 2014, TRACER V1 6; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise J.C., 2000, HIST FORMATION SPECI; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BROOKS JOHN L., 1957, MEM CONNECTICUT ACAD ARTS AND SCI, V13, P1; Cerny M, 1999, LIMNOL OCEANOGR, V44, P1381, DOI 10.4319/lo.1999.44.6.1381; Colbourne JK, 1996, PHILOS T ROY SOC B, V351, P349, DOI 10.1098/rstb.1996.0028; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1006/bijl.1998.0251; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Crease TJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-212; CREASE TJ, 1990, MOL BIOL EVOL, V7, P444; Crease TJ, 1999, GENE, V233, P89, DOI 10.1016/S0378-1119(99)00151-1; Crease TJ, 1997, HEREDITY, V79, P242; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Decaestecker E, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P295, DOI 10.1007/978-90-481-2770-2_15; DEMELO R, 1994, HEREDITY, V73, P490, DOI 10.1038/hdy.1994.147; Dufresne F, 1997, P ROY SOC B-BIOL SCI, V264, P201, DOI 10.1098/rspb.1997.0028; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; Eads BD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-464; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Figuerola J, 2005, AM NAT, V165, P274, DOI 10.1086/427092; Frey D.G., 1986, Crustacean Issues, V4, P237; FREY DG, 1982, ARCH HYDROBIOL, V93, P484; Gewin V, 2005, PLOS BIOL, V3, P949, DOI 10.1371/journal.pbio.0030219; HARPENDING HC, 1994, HUM BIOL, V66, P591; Havel JE, 2000, LIMNOL OCEANOGR, V45, P1414, DOI 10.4319/lo.2000.45.6.1414; Havel JE, 2006, BIOL INVASIONS, V8, P459, DOI 10.1007/s10530-005-6410-4; Hebert PDN, 1996, CAN J ZOOL, V74, P632, DOI 10.1139/z96-073; HEBERT PDN, 1993, HEREDITY, V70, P148, DOI 10.1038/hdy.1993.24; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishida S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-52; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; KAPLAN NL, 1989, GENETICS, V123, P887; Kaufman DS, 2004, QUATERNARY SCI REV, V23, P529, DOI 10.1016/j.quascirev.2003.09.007; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Kotov AA, 2010, J PLANKTON RES, V32, P937, DOI 10.1093/plankt/fbq018; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lynch M, 2008, GENETICS, V180, P317, DOI 10.1534/genetics.107.084657; Markova S, 2007, MOL PHYLOGENET EVOL, V44, P42, DOI 10.1016/j.ympev.2006.12.025; Mergeay J, 2008, MOL ECOL, V17, P1789, DOI 10.1111/j.1365-294X.2007.03679.x; Mergeay J, 2006, P R SOC B, V273, P2839, DOI 10.1098/rspb.2006.3661; Miner BE, 2011, P ROY SOC B-BIOL SCI, V278, P1306, DOI 10.1098/rspb.2010.1663; Morgan KK, 2001, EVOLUTION, V55, P1753; Omilian AR, 2008, MOL BIOL EVOL, V25, P2129, DOI 10.1093/molbev/msn164; Paland S, 2006, SCIENCE, V311, P990, DOI 10.1126/science.1118152; Paland S, 2005, EVOLUTION, V59, P800; Paland S, 2004, THESIS INDIANA U; Papillon D, 2007, DEV GENES EVOL, V217, P315, DOI 10.1007/s00427-007-0141-8; Penton EH, 2004, MOL ECOL, V13, P97, DOI 10.1046/j.1365-294X.2003.02024.x; Peters RH, 1987, MEMORIE I ITALIANO I, V45; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schaack S, 2008, MOL ECOL, V17, P1634, DOI 10.1111/j.1365-294X.2008.03698.x; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1991, GENETICS, V129, P555; Stehli F. G, 1985, GREAT AM BIOTIC INTE; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1983, GENETICS, V105, P437; TAYLOR DJ, 1993, P ROY SOC B-BIOL SCI, V254, P163, DOI 10.1098/rspb.1993.0141; Vergilino R, 2011, MOL ECOL, V20, P1191, DOI 10.1111/j.1365-294X.2011.05004.x; Weider LJ, 1999, MOL ECOL, V8, P1, DOI 10.1046/j.1365-294X.1999.00522.x; Weider LJ, 1999, EVOLUTION, V53, P777, DOI 10.1111/j.1558-5646.1999.tb05372.x	71	84	88	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46620	10.1371/journal.pone.0046620	http://dx.doi.org/10.1371/journal.pone.0046620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056371	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000063
J	Desgardin, AD; Abramova, T; Rosanwo, TO; Kartha, S; Shim, EH; Jane, SM; Cunningham, JM				Desgardin, Aurelie D.; Abramova, Tatiana; Rosanwo, Tolulope O.; Kartha, Sreedharan; Shim, Eun-Hee; Jane, Stephen M.; Cunningham, John M.			Regulation of Delta-Aminolevulinic Acid Dehydratase by Kruppel-Like Factor 1	PLOS ONE			English	Article							BETA-GLOBIN LOCUS; TRANSCRIPTION FACTOR GATA-1; ERYTHROID 5-AMINOLEVULINATE SYNTHASE; PORPHOBILINOGEN DEAMINASE GENE; HEMOGLOBIN-STABILIZING PROTEIN; CHROMATIN REMODELING COMPLEX; EKLF-NULL MICE; CONTROL REGION; HISTONE MODIFICATION; DOWNSTREAM PROMOTER	Kruppel-like factor 1(KLF1) is a hematopoietic-specific zinc finger transcription factor essential for erythroid gene expression. In concert with the transacting factor GATA1, KLF1 modulates the coordinate expression of the genes encoding the multienzyme heme biosynthetic pathway during erythroid differentiation. To explore the mechanisms underpinning KLF1 action at the gene loci regulating the first 3 steps in this process, we have exploited the K1-ERp erythroid cell line, in which KLF1 translocates rapidly to the nucleus in response to treatment with 4-OH-Tamoxifen (4-OHT). KLF1 acts as a differentiation-independent transcriptional co-regulator of delta-aminolevulinic acid dehydratase (Alad), but not 5-aminolevulinate synthase gene (Alas2) or porphobilinogen deaminase (Pbgd). Similar to its role at the beta-globin promoter, KLF1 induces factor recruitment and chromatin changes at the Alad1b promoter in a temporally-specific manner. In contrast to these changes, we observed a distinct mechanism of histone eviction at the Alad1b promoter. Furthermore, KLF1-dependent events were not modulated by GATA1 factor promoter co-occupancy alone. These results not only enhance our understanding of erythroid-specific modulation of heme biosynthetic regulation by KLF1, but provide a model that will facilitate the elucidation of novel KLF1-dependent events at erythroid gene loci that are independent of GATA1 activity.	[Desgardin, Aurelie D.; Abramova, Tatiana; Rosanwo, Tolulope O.; Kartha, Sreedharan; Shim, Eun-Hee; Cunningham, John M.] Univ Chicago, Dept Pediat, Sect Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60637 USA; [Cunningham, John M.] Univ Chicago, Comm Dev Regenerat & Stem Cell Biol, Chicago, IL 60637 USA; [Jane, Stephen M.] Monash Univ, Alfred Hosp, Dept Clin Hematol, Australian Ctr Blood Dis, Melbourne, Vic 3181, Australia	University of Chicago; University of Chicago; Florey Institute of Neuroscience & Mental Health; Monash University	Desgardin, AD (corresponding author), Univ Chicago, Dept Pediat, Sect Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60637 USA.	adesgard@gmail.com		Jane, Stephen Marsden/0000-0002-1045-0481; Shim, Eun-Hee/0000-0002-5151-3901	Cancer Research Foundation; Satter Foundation; Hecktman fellowship	Cancer Research Foundation; Satter Foundation; Hecktman fellowship	The authors thank the Cancer Research Foundation, the Satter Foundation and the Hecktman fellowship for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Aizencang G, 2000, GENOMICS, V70, P223, DOI 10.1006/geno.2000.6373; Alhashem YN, 2011, J BIOL CHEM, V286, P24819, DOI 10.1074/jbc.M111.247536; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Arnaud L, 2010, AM J HUM GENET, V87, P721, DOI 10.1016/j.ajhg.2010.10.010; Asano H, 1998, MOL CELL BIOL, V18, P102, DOI 10.1128/MCB.18.1.102; Bardag-Gorce F, 2011, EXP MOL PATHOL, V91, P485, DOI 10.1016/j.yexmp.2011.05.003; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; BIEKER JJ, 1995, MOL CELL BIOL, V15, P852; Bishop TR, 1996, NUCLEIC ACIDS RES, V24, P2511, DOI 10.1093/nar/24.13.2511; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Borg J, 2011, HAEMATOL-HEMATOL J, V96, P635, DOI 10.3324/haematol.2011.043265; Brown RC, 2002, MOL CELL BIOL, V22, P161, DOI 10.1128/MCB.22.1.161-170.2002; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; Coghill E, 2001, BLOOD, V97, P1861, DOI 10.1182/blood.V97.6.1861; Cohen-Kaminsky S, 1998, EMBO J, V17, P5151, DOI 10.1093/emboj/17.17.5151; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Elefanty AG, 1997, BLOOD, V90, P1435, DOI 10.1182/blood.V90.4.1435.1435_1435_1447; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; GUO GG, 1994, J BIOL CHEM, V269, P12399; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; KAYA AH, 1994, GENOMICS, V19, P242, DOI 10.1006/geno.1994.1054; Keys JR, 2007, BRIT J HAEMATOL, V136, P150, DOI 10.1111/j.1365-2141.2006.06381.x; Kiekhaefer CM, 2002, P NATL ACAD SCI USA, V99, P14309, DOI 10.1073/pnas.212389499; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; Kramer MF, 2000, GENE, V247, P153, DOI 10.1016/S0378-1119(00)00103-7; Lee CH, 1999, P NATL ACAD SCI USA, V96, P12311, DOI 10.1073/pnas.96.22.12311; Li L, 2008, MOL CELL BIOCHEM, V319, P9, DOI 10.1007/s11010-008-9870-x; Lin PS, 2002, PROG NUCLEIC ACID RE, V72, P333, DOI 10.1016/S0079-6603(02)72074-6; Magness ST, 1998, BLOOD, V92, P320, DOI 10.1182/blood.V92.1.320.413k25_320_328; Matushansky I, 2000, BLOOD, V96, P2755, DOI 10.1182/blood.V96.8.2755.h8002755_2755_2764; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Perrine SP, 2009, EUR J HAEMATOL, V82, P466, DOI 10.1111/j.1600-0609.2009.01234.x; PETERS LL, 1993, NATURE, V362, P768, DOI 10.1038/362768a0; Pilon AM, 2006, MOL CELL BIOL, V26, P4368, DOI 10.1128/MCB.02216-05; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; PORCHER C, 1991, J BIOL CHEM, V266, P10562; RIFKIND RA, 1978, BLOOD CELLS, V4, P189; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Sakamoto D, 2004, MECH DEVELOP, V121, P747, DOI 10.1016/j.mod.2004.03.030; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sengupta T, 2008, MOL CELL BIOL, V28, P6160, DOI 10.1128/MCB.00919-08; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Siatecka M, 2010, P NATL ACAD SCI USA, V107, P15151, DOI 10.1073/pnas.1004996107; Singleton BK, 2008, BLOOD, V112, P2081, DOI 10.1182/blood-2008-03-145672; Singleton BK, 2011, BLOOD, V118, P3137, DOI 10.1182/blood-2011-04-349985; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Surinya KH, 1997, J BIOL CHEM, V272, P26585, DOI 10.1074/jbc.272.42.26585; Tallack MR, 2007, J MOL BIOL, V369, P313, DOI 10.1016/j.jmb.2007.02.109; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tallack MR, 2009, J BIOL CHEM, V284, P20966, DOI 10.1074/jbc.M109.006346; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; Wong EY, 2004, J BIOL CHEM, V279, P55024, DOI 10.1074/jbc.M408886200; Wontakal SN, 2012, P NATL ACAD SCI USA, V109, P3832, DOI 10.1073/pnas.1121019109; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001	81	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46482	10.1371/journal.pone.0046482	http://dx.doi.org/10.1371/journal.pone.0046482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056320	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000050
J	Erbguth, K; Prigge, M; Schneider, F; Hegemann, P; Gottschalk, A				Erbguth, Karen; Prigge, Matthias; Schneider, Franziska; Hegemann, Peter; Gottschalk, Alexander			Bimodal Activation of Different Neuron Classes with the Spectrally Red-Shifted Channelrhodopsin Chimera C1V1 in Caenorhabditis elegans	PLOS ONE			English	Article							CELLULAR CAMP; OPTOGENETIC ANALYSIS; LIGHT-ACTIVATION; OPTICAL CONTROL; MANIPULATION; TOOL	The C. elegans nervous system is particularly well suited for optogenetic analyses of circuit function: Essentially all connections have been mapped, and light can be directed at the neuron of interest in the freely moving, transparent animals, while behavior is observed. Thus, different nodes of a neuronal network can be probed for their role in controlling a particular behavior, using different optogenetic tools for photo-activation or -inhibition, which respond to different colors of light. As neurons may act in concert or in opposing ways to affect a behavior, one would further like to excite these neurons concomitantly, yet independent of each other. In addition to the blue-light activated Channelrhodopsin-2 (ChR2), spectrally red-shifted ChR variants have been explored recently. Here, we establish the green-light activated ChR chimera C1V1 (from Chlamydomonas and Volvox ChR19s) for use in C. elegans. We surveyed a number of red-shifted ChRs, and found that C1V1-ET/ET (E122T; E162T) works most reliable in C. elegans, with 540-580 nm excitation, which leaves ChR2 silent. However, as C1V1-ET/ET is very light sensitive, it still becomes activated when ChR2 is stimulated, even at 400 nm. Thus, we generated a highly efficient blue ChR2, the H134R; T159C double mutant (ChR2-HR/TC). Both proteins can be used in the same animal, in different neurons, to independently control each cell type with light, enabling a further level of complexity in circuit analyses.	[Erbguth, Karen; Gottschalk, Alexander] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Erbguth, Karen; Gottschalk, Alexander] Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany; [Prigge, Matthias; Schneider, Franziska; Hegemann, Peter] Humboldt Univ, Inst Biol Expt Biophys, D-10099 Berlin, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Humboldt University of Berlin	Gottschalk, A (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany.	a.gottschalk@em.uni-frankfurt.de	Gottschalk, Alexander/D-3155-2011	Gottschalk, Alexander/0000-0002-1197-6119	Deutsche Forschungsgemeinschaft (DFG) [HE3824/9-3, HE3824/9-4, FOR1279-P8, SFB807-P11, FOR1279-P1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) by grants HE3824/9-3, 9-4, and FOR1279-P8 to PH and SFB807-P11 and FOR1279-P1 to AG. Website of the DFG: www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bernstein JG, 2011, TRENDS COGN SCI, V15, P592, DOI 10.1016/j.tics.2011.10.003; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Husson SH, 2012, PLOS ONE IN PRESS; Husson SJ, 2012, CURR BIOL, V22, P743, DOI 10.1016/j.cub.2012.02.066; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Okazaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035370; Prigge M, 2010, CHANNELS, V4, P241, DOI 10.4161/chan.4.3.11888; Rein ML, 2012, MOL GENET GENOMICS, V287, P95, DOI 10.1007/s00438-011-0663-7; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; Schmitt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043164; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Sineshchekov OA, 2012, BIOCHEMISTRY; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Stirman JN, 2012, NAT PROTOC, V7, P207, DOI 10.1038/nprot.2011.433; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Weissenberger S, 2011, J NEUROCHEM, V116, P616, DOI 10.1111/j.1471-4159.2010.07148.x; Xu X, 2011, NAT REV GENET, V12, P793, DOI 10.1038/nrg3050; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	37	31	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46827	10.1371/journal.pone.0046827	http://dx.doi.org/10.1371/journal.pone.0046827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056472	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000089
J	Kawashima, M; Ohashi, J; Nishida, N; Tokunaga, K				Kawashima, Minae; Ohashi, Jun; Nishida, Nao; Tokunaga, Katsushi			Evolutionary Analysis of Classical HLA Class I and II Genes Suggests That Recent Positive Selection Acted on DPB1*04:01 in Japanese Population	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; LINKAGE-DISEQUILIBRIUM; HUMAN MHC; NUCLEOTIDE SUBSTITUTION; OVERDOMINANT SELECTION; HAPLOTYPE FREQUENCIES; BALANCING SELECTION; POLYMORPHISM; LOCI; RECOMBINATION	The human leukocyte antigen (HLA) genes exhibit the highest degree of polymorphism in the human genome. This high degree of variation at classical HLA class I and class II loci has been maintained by balancing selection for a long evolutionary time. However, little is known about recent positive selection acting on specific HLA alleles in a local population. To detect the signature of recent positive selection, we genotyped six HLA loci, HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, and HLADPB1 in 418 Japanese subjects, and then assessed the haplotype homozygosity (HH) of each HLA allele. There were 120 HLA alleles across the six loci. Among the 80 HLA alleles with frequencies of more than 1%, DPB1*04:01, which had a frequency of 6.1%, showed exceptionally high HH (0.53). This finding raises the possibility that recent positive selection has acted on DPB1*04:01. The DPB1*04:01 allele, which was present in the most common 6-locus HLA haplotype (4.4%), A*33:03-C*14:03-B*44:03-DRB1*13:02-DQB1*06:04-DPB1*04:01, seems to have flowed from the Korean peninsula to the Japanese archipelago in the Yayoi period. A stochastic simulation approach indicated that the strong linkage disequilibrium between DQB1*06:04 and DPB1*04:01 observed in Japanese cannot be explained without positive selection favoring DPB1*04:01. The selection coefficient of DPB1*04:01 was estimated as 0.041 (95% credible interval 0.021-0.077). Our results suggest that DPB1*04:01 has recently undergone strong positive selection in Japanese population.	[Kawashima, Minae; Nishida, Nao; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Ohashi, Jun] Univ Tsukuba, Fac Med, Ibaraki, Japan; [Nishida, Nao] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan	University of Tokyo; University of Tsukuba; National Center for Global Health & Medicine - Japan	Kawashima, M (corresponding author), Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan.	mina-e@umin.ac.jp; juno-tky@umin.ac.jp	OHASHI, JUN/G-5907-2015		National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST); KAKENHI [22133008, 23133502]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22133008, 23133502, 24790728] Funding Source: KAKEN	National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST), by KAKENHI (22133008) Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by KAKENHI (23133502) Grant-in-Aid for Scientific Research on Innovative Areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Alper CA, 2006, HUM IMMUNOL, V67, P73, DOI 10.1016/j.humimm.2005.11.006; Aly TA, 2006, DIABETES, V55, P1265, DOI 10.2337/db05-1276; AWDEH ZL, 1983, P NATL ACAD SCI-BIOL, V80, P259, DOI 10.1073/pnas.80.1.259; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; CAMPBELL RD, 1993, IMMUNOL TODAY, V14, P349, DOI 10.1016/0167-5699(93)90234-C; CULLEN M, 1995, AM J HUM GENET, V56, P1350; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DjilaliSaiah I, 1996, TISSUE ANTIGENS, V48, P87, DOI 10.1111/j.1399-0039.1996.tb02612.x; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gjesing AP, 2007, DIABETOLOGIA, V50, P563, DOI 10.1007/s00125-006-0578-8; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; HEDRICK PW, 1983, GENETICS, V104, P449; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; LEWONTIN RC, 1964, GENETICS, V49, P49; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; MITSUNAGA S, 1992, HUM IMMUNOL, V34, P203, DOI 10.1016/0198-8859(92)90113-2; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Ohashi J, 2011, MOL BIOL EVOL, V28, P849, DOI 10.1093/molbev/msq264; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Song EY, 2002, TISSUE ANTIGENS, V59, P475, DOI 10.1034/j.1399-0039.2002.590604.x; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAKAHATA N, 1990, P NATL ACAD SCI USA, V87, P2419, DOI 10.1073/pnas.87.7.2419; TAKAHATA N, 1990, GENETICS, V124, P967; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Traherne JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/journal.pgen.0020009; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WATTERSON GA, 1978, GENETICS, V88, P405; Yunis EJ, 2003, TISSUE ANTIGENS, V62, P1, DOI 10.1034/j.1399-0039.2003.00098.x	42	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46806	10.1371/journal.pone.0046806	http://dx.doi.org/10.1371/journal.pone.0046806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056460	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000087
J	Zagordi, O; Daumer, M; Beisel, C; Beerenwinkel, N				Zagordi, Osvaldo; Daeumer, Martin; Beisel, Christian; Beerenwinkel, Niko			Read length versus Depth of Coverage for Viral Quasispecies Reconstruction	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; ERROR-CORRECTION; DRUG-RESISTANCE; AMPLICONS; PLATFORMS; MUTATIONS; DIVERSITY; SPECTRA; SAMPLE	Recent advancements of sequencing technology have opened up unprecedented opportunities in many application areas. Virus samples can now be sequenced efficiently with very deep coverage to infer the genetic diversity of the underlying virus populations. Several sequencing platforms with different underlying technologies and performance characteristics are available for viral diversity studies. Here, we investigate how the differences between two common platforms provided by 454/Roche and Illumina affect viral diversity estimation and the reconstruction of viral haplotypes. Using a mixture of ten HIV clones sequenced with both platforms and additional simulation experiments, we assessed the trade-off between sequencing coverage, read length, and error rate. For fixed costs, short Illumina reads can be generated at higher coverage and allow for detecting variants at lower frequencies. They can also be sufficient to assess the diversity of the sample if sequences are dissimilar enough, but, in general, assembly of full-length haplotypes is feasible only with the longer 454/Roche reads. The quantitative comparison highlights the advantages and disadvantages of both platforms and provides guidance for the design of viral diversity studies.	[Beisel, Christian; Beerenwinkel, Niko] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Zagordi, Osvaldo] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Daeumer, Martin] Inst Immunol & Genet, Kaiserslautern, Germany; [Beerenwinkel, Niko] SIB, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Institute of Bioinformatics	Beerenwinkel, N (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	niko.beerenwinkel@bsse.ethz.ch	Zagordi, Osvaldo/H-2879-2019	Zagordi, Osvaldo/0000-0002-9082-8607; Beisel, Christian/0000-0001-5360-2193	Swiss National Science Foundation [CR32I2_127017]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Part of this work has been funded by the Swiss National Science Foundation under grant number CR32I2_127017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding has been received for this study.	Archer J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-47; Astrovskaya I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S6-S1; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bruselles A, 2009, AIDS RES HUM RETROV, V25, P937, DOI 10.1089/aid.2009.0083; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Huang A, 2011, QCOLORS ALGORITHM CO, P130; Jojic V, 2008, WORLD SCI, P114; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Poon AFY, 2011, AIDS; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Prabhakaran S, 2010, HIV HAPLOTYPE INFERE; Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627; Prosperi MCF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-5; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Skums P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S6; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Vrancken B, 2010, AIDS REV, V12, P89; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Westbrooks K, 2008, LECT N BIOINFORMAT, V4983, P159, DOI 10.1007/978-3-540-79450-9_15; Zagordi O, 2012, LECT NOTES BIOINFORM, V2012, P342; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164	34	47	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e47046	10.1371/journal.pone.0047046	http://dx.doi.org/10.1371/journal.pone.0047046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056573	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000108
J	Falciani, C; Lozzi, L; Pollini, S; Luca, V; Carnicelli, V; Brunetti, J; Lelli, B; Bindi, S; Scali, S; Di Giulio, A; Rossolini, GM; Mangoni, ML; Bracci, L; Pini, A				Falciani, Chiara; Lozzi, Luisa; Pollini, Simona; Luca, Vincenzo; Carnicelli, Veronica; Brunetti, Jlenia; Lelli, Barbara; Bindi, Stefano; Scali, Silvia; Di Giulio, Antonio; Rossolini, Gian Maria; Mangoni, Maria Luisa; Bracci, Luisa; Pini, Alessandro			Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BRANCHED NEUROTENSIN PEPTIDES; HOST-DEFENSE PEPTIDES; IN-VIVO; STRATEGIES; LIPOSOMES; LL-37; LIPOPOLYSACCHARIDE; PROTEINASES; PROTEOLYSIS	The branched M33 antimicrobial peptide was previously shown to be very active against Gram-negative bacterial pathogens, including multidrug-resistant strains. In an attempt to produce back-up molecules, we synthesized an M33 peptide isomer consisting of D-aminoacids (M33-D). This isomeric version showed 4 to 16-fold higher activity against Gram-positive pathogens, including Staphylococcus aureus and Staphylococcus epidermidis, than the original peptide, while retaining strong activity against Gram-negative bacteria. The antimicrobial activity of both peptides was influenced by their differential sensitivity to bacterial proteases. The better activity shown by M33-D against S. aureus compared to M33-L was confirmed in biofilm eradication experiments where M33-L showed 12% activity with respect to M33-D, and in vivo models where Balb-c mice infected with S. aureus showed 100% and 0% survival when treated with M33-D and M33-L, respectively. M33-D appears to be an interesting candidate for the development of novel broad-spectrum antimicrobials active against bacterial pathogens of clinical importance.	[Falciani, Chiara; Lozzi, Luisa; Pollini, Simona; Lelli, Barbara; Bindi, Stefano; Scali, Silvia; Rossolini, Gian Maria; Bracci, Luisa; Pini, Alessandro] Univ Siena, Dipartimento Biotecnol Med, I-53100 Siena, Italy; [Carnicelli, Veronica; Di Giulio, Antonio] Univ Aquila, Dipartimento Sci & Tecnol Biomed, I-67100 Laquila, Italy; [Luca, Vincenzo; Mangoni, Maria Luisa] Univ Rome, Dipartimento Sci Biochim A Fanelli, Rome, Italy; [Brunetti, Jlenia] SetLance Srl, Siena, Italy; [Bindi, Stefano; Rossolini, Gian Maria; Bracci, Luisa; Pini, Alessandro] Azienda Osped Univ Senese, Policlin Le Scotte, Siena, Italy	University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of L'Aquila; Sapienza University Rome; University of Siena; University Hospital of Siena	Pini, A (corresponding author), Univ Siena, Dipartimento Biotecnol Med, Via Laterina 8, I-53100 Siena, Italy.	alessandro.pini@unisi.it	Brunetti, Luisa/E-6464-2019; Lozzi, Luisa/Q-8542-2018; Bracci, Luisa/V-9913-2018; Pini, Alessandro/R-1359-2018; Falciani, Chiara/R-1330-2018; LUCA, Vincenzo/AAV-7385-2020; Pollini, Simona/D-1709-2017	Brunetti, Luisa/0000-0001-8144-7186; Lozzi, Luisa/0000-0002-1603-8770; Bracci, Luisa/0000-0002-0738-5746; Pini, Alessandro/0000-0002-3832-8349; Falciani, Chiara/0000-0002-1027-8482; LUCA, Vincenzo/0000-0002-7834-0334; Mangoni, Maria Luisa/0000-0002-5991-5868; ROSSOLINI, Gian Maria/0000-0002-9386-0434; CARNICELLI, Veronica/0000-0003-3375-4637; DI GIULIO, Antonio/0000-0001-8777-0160	Italian Foundation for Cystic Fibrosis [24/2011]; Tuscan Regional Administration; PROGETTO PRIN [2008KCLR7M_004]	Italian Foundation for Cystic Fibrosis(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Tuscan Regional Administration; PROGETTO PRIN(Ministry of Education, Universities and Research (MIUR))	This research was financed by the Italian Foundation for Cystic Fibrosis (project FFC#24/2011 adopted by FFC delegations from Legnago, Varese, Reggio Emilia and Assistgroup), the Tuscan Regional Administration (Project SPAC: POR CReO FESR 2007-2013) and PROGETTO PRIN (2008KCLR7M_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TM, 2007, AM J HEALTH-SYST PH, V64, P819, DOI 10.2146/ajhp060473; Bachrach G, 2008, ANTIMICROB AGENTS CH, V52, P638, DOI 10.1128/AAC.01271-07; Banbula A, 1998, STRUCTURE, V6, P1185, DOI 10.1016/S0969-2126(98)00118-X; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Ceri H, 2001, METHOD ENZYMOL, V337, P377, DOI 10.1016/S0076-6879(01)37026-X; Coccia C, 2011, EUR BIOPHYS J BIOPHY, V40, P577, DOI 10.1007/s00249-011-0681-8; de Kreij A, 2000, J BIOL CHEM, V275, P31115, DOI 10.1074/jbc.M003889200; Epand RM, 2003, METHOD ENZYMOL, V372, P124; Falciani C, 2010, CURR CANCER DRUG TAR, V10, P695, DOI 10.2174/156800910793605875; Falciani C, 2007, MOL CANCER THER, V6, P2441, DOI 10.1158/1535-7163.MCT-07-0164; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Habets MGJL, 2012, BIOL LETTERS, V8, P416, DOI 10.1098/rsbl.2011.1203; Hamamoto K, 2002, MICROBIOL IMMUNOL, V46, P741, DOI 10.1111/j.1348-0421.2002.tb02759.x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hornef Mathias W., 2005, V86, P72, DOI 10.1159/000086652; Jarvis WR, 2012, AM J INFECT CONTROL, V40, P194, DOI 10.1016/j.ajic.2012.02.001; Lai YP, 2007, MOL MICROBIOL, V63, P497, DOI 10.1111/j.1365-2958.2006.05540.x; Matsuzaki K, 1999, FEBS LETT, V449, P221, DOI 10.1016/S0014-5793(99)00443-3; Michalopoulos A, 2008, CRIT CARE CLIN, V24, P377, DOI 10.1016/j.ccc.2007.12.003; MORIHARA K, 1964, J BACTERIOL, V88, P745, DOI 10.1128/JB.88.3.745-757.1964; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Pini A, 2006, BIOCHEM J, V395, P157, DOI 10.1042/BJ20051747; Pini A, 2005, ANTIMICROB AGENTS CH, V49, P2665, DOI 10.1128/AAC.49.7.2665-2672.2005; Pini A, 2008, CURR PROTEIN PEPT SC, V9, P468, DOI 10.2174/138920308785915227; Pini A, 2007, J PEPT SCI, V13, P393, DOI 10.1002/psc.858; Pini A, 2012, AMINO ACIDS, V43, P467, DOI 10.1007/s00726-011-1103-z; Pini A, 2010, FASEB J, V24, P1015, DOI 10.1096/fj.09-145474; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Stromstedt AA, 2009, ANTIMICROB AGENTS CH, V53, P593, DOI 10.1128/AAC.00477-08; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; TEUFEL P, 1993, J BACTERIOL, V175, P4218, DOI 10.1128/JB.175.13.4218-4224.1993; Thurlow LR, 2012, FEMS IMMUNOL MED MIC, V65, P5, DOI 10.1111/j.1574-695X.2012.00937.x; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x	40	49	52	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46259	10.1371/journal.pone.0046259	http://dx.doi.org/10.1371/journal.pone.0046259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056272	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000309452600031
J	Roessner, ED; Vitacolonna, M; Hohenberger, P				Roessner, Eric Dominic; Vitacolonna, Mario; Hohenberger, Peter			Confocal Laser Scanning Microscopy Evaluation of an Acellular Dermis Tissue Transplant (Epiflex (R))	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL RECONSTRUCTION; EXTRACELLULAR-MATRIX; MECHANICAL-PROPERTIES; CLINICAL-EXPERIENCE; BASEMENT-MEMBRANE; IMMUNE-RESPONSE; ALPHA-GAL; SKIN; SCAFFOLDS	The structure of a biological scaffold is a major determinant of its biological characteristics and its interaction with cells. An acellular dermis tissue transplant must undergo a series of processing steps, to remove cells and genetic material and provide the sterility required for surgical use. During manufacturing and sterilization the structure and composition of tissue transplants may change. The composition of the human cell-free dermis transplant Epiflex (R) was investigated with specific attention paid to its structure, matrix composition, cellular content and biomechanics. We demonstrated that after processing, the structure of Epiflex remains almost unchanged with an intact collagen network and extracellular matrix (ECM) protein composition providing natural cell interactions. Although the ready to use transplant does contain some cellular and DNA debris, the processing procedure results in a total destruction of cells and active DNA which is a requirement for an immunologically inert and biologically safe substrate. Its biomechanical parameters do not change significantly during the processing.	[Roessner, Eric Dominic; Vitacolonna, Mario; Hohenberger, Peter] Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, Mannheim, Germany	Ruprecht Karls University Heidelberg	Roessner, ED (corresponding author), Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, Mannheim, Germany.	eric.roessner@googlemail.com		Smith, Mark D/0000-0003-0452-5982; Roessner, Eric Dominic/0000-0003-1173-1098				Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066; Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296; Arnold GA, 2009, VET SURG, V38, P834, DOI 10.1111/j.1532-950X.2009.00577.x; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809; Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Balbir-Gurman A, 2002, ANN RHEUM DIS, V61, P237, DOI 10.1136/ard.61.3.237; Barber FA, 2006, ARTHROSCOPY, V22, P534, DOI 10.1016/j.arthro.2005.12.021; Barber FA, 2009, ARTHROSCOPY, V25, P1233, DOI 10.1016/j.arthro.2009.05.012; Bayrak A, 2010, BIOMATERIALS, V31, P3793, DOI 10.1016/j.biomaterials.2010.01.120; Boer U, 2011, BIOMATERIALS, V32, P9730, DOI 10.1016/j.biomaterials.2011.09.015; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519; Budd J S, 1991, Eur J Vasc Surg, V5, P397, DOI 10.1016/S0950-821X(05)80171-9; Butler CE, 2004, PLAST RECONSTR SURG, V114, P464, DOI 10.1097/01.PRS.0000132670.81794.7E; Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; Dellgren G, 1999, SCAND CARDIOVASC J, V33, P259; Edelman David S, 2002, JSLS, V6, P203; Edwards C, 1995, CLIN DERMATOL, V13, P375, DOI 10.1016/0738-081X(95)00078-T; ELSNER P, 1990, BRIT J DERMATOL, V122, P607, DOI 10.1111/j.1365-2133.1990.tb07282.x; Erdag G, 2004, CELL TRANSPLANT, V13, P701, DOI 10.3727/000000004783983594; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gock H, 2004, TRANSPLANTATION, V77, P751, DOI 10.1097/01.TP.0000116420.17173.E4; Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379; Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6; Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Karpelowsky JS, 2010, PEDIATR SURG INT, V26, P315, DOI 10.1007/s00383-009-2501-0; Kim YG, 2008, PROTEOMICS, V8, P2596, DOI 10.1002/pmic.200700972; Kolker AR, 2005, ANN PLAS SURG, V55, P36, DOI 10.1097/01.sap.0000168248.83197.d4; Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619; Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167; Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Mertsching H, 2009, TRANSPLANTATION, V88, P203, DOI 10.1097/TP.0b013e3181ac15e1; Minuth WW, 2003, ZUKUNFTSTECHNOLOGIE; Miyagawa S, 2012, CURR OPIN ORGAN TRAN, V17, P174, DOI 10.1097/MOT.0b013e3283508189; Pearsall AW, 2003, ARTHROSCOPY, V19, P1091, DOI 10.1016/j.arthro.2003.10.015; PIERARD GE, 1977, ARCH DERMATOL RES, V260, P231, DOI 10.1007/BF00561418; Ponce ML, 1999, CIRC RES, V84, P688, DOI 10.1161/01.RES.84.6.688; Roessner E, 2010, CELL TISSUE IN PRESS; Roessner ED, 2009, J BIOMATER APPL; Rossner E, 2010, CELL TISSUE BANK; ROZENGURT E, 1995, CANCER SURV, V24, P81; Schwarzbauer J, 1999, CURR BIOL, V9, pR242, DOI 10.1016/S0960-9822(99)80153-5; Sheppard D, 2000, MATRIX BIOL, V19, P203, DOI 10.1016/S0945-053X(00)00065-2; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Ueno T, 2004, J GASTROINTEST SURG, V8, P109, DOI 10.1016/j.gassur.2003.09.025; Wang JH, 2000, J BIOMED MATER RES, V51, P761, DOI 10.1002/1097-4636(20000915)51:4<761::AID-JBM26>3.3.CO;2-U; Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160; Xu H, 2012, J SHOULDER ELB SURG, V21, P580, DOI 10.1016/j.jse.2011.03.014; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; Zantop T, 2006, J ORTHOP RES, V24, P1299, DOI 10.1002/jor.20071; Zervolea I, 2000, BIOCHEM BIOPH RES CO, V276, P785, DOI 10.1006/bbrc.2000.3544; Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170; Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p	63	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45991	10.1371/journal.pone.0045991	http://dx.doi.org/10.1371/journal.pone.0045991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056225	gold, Green Submitted, Green Published			2022-12-27	WOS:000309452600019
J	Uematsu, A; Matsui, M; Tanaka, C; Takahashi, T; Noguchi, K; Suzuki, M; Nishijo, H				Uematsu, Akiko; Matsui, Mie; Tanaka, Chiaki; Takahashi, Tsutomu; Noguchi, Kyo; Suzuki, Michio; Nishijo, Hisao			Developmental Trajectories of Amygdala and Hippocampus from Infancy to Early Adulthood in Healthy Individuals	PLOS ONE			English	Article							NORMAL BRAIN-DEVELOPMENT; TEMPORAL-LOBE; GRAY-MATTER; VOLUME; CHILDREN; AUTISM; MRI; ADOLESCENCE; METABOLISM; MATURATION	Knowledge of amygdalar and hippocampal development as they pertain to sex differences and laterality would help to understand not only brain development but also the relationship between brain volume and brain functions. However, few studies investigated development of these two regions, especially during infancy. The purpose of this study was to examine typical volumetric trajectories of amygdala and hippocampus from infancy to early adulthood by predicting sexual dimorphism and laterality. We performed a cross-sectional morphometric MRI study of amygdalar and hippocampal growth from 1 month to 25 years old, using 109 healthy individuals. The findings indicated significant non-linear age-related volume changes, especially during the first few years of life, in both the amygdala and hippocampus regardless of sex. The peak ages of amygdalar and hippocampal volumes came at the timing of preadolescence (9-11 years old). The female amygdala reached its peak age about one year and a half earlier than the male amygdala did. In addition, its rate of growth change decreased earlier in the females. Furthermore, both females and males displayed rightward laterality in the hippocampus, but only the males in the amygdala. The robust growth of the amygdala and hippocampus during infancy highlight the importance of this period for neural and functional development. The sex differences and laterality during development of these two regions suggest that sex-related factors such as sex hormones and functional laterality might affect brain development.	[Uematsu, Akiko; Matsui, Mie] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Psychol, Toyama 930, Japan; [Tanaka, Chiaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pediat, Toyama 930, Japan; [Takahashi, Tsutomu; Suzuki, Michio] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neuropsychiat, Toyama 930, Japan; [Noguchi, Kyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol, Toyama 930, Japan; [Nishijo, Hisao] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Syst Emot Sci, Toyama 930, Japan	University of Toyama; University of Toyama; University of Toyama; University of Toyama; University of Toyama	Matsui, M (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Psychol, Toyama 930, Japan.	mmatsui@las.u-toyama.ac.jp		Uematsu, Akiko/0000-0001-6123-4247	Japan Society for the Promotion of Science (JSPS) [20330141, 21243040]; JSPS Asian Core Program; Grants-in-Aid for Scientific Research [20330141] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (B) 20330141 and (A) 21243040 from the Japan Society for the Promotion of Science (JSPS) and JSPS Asian Core Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano F, 2012, NEUROSCIENTIST, V18, P180, DOI 10.1177/1073858410395147; Almli CR, 2007, NEUROIMAGE, V35, P308, DOI 10.1016/j.neuroimage.2006.08.058; BENES FM, 1989, SCHIZOPHRENIA BULL, V15, P585, DOI 10.1093/schbul/15.4.585; Bramen JE, 2011, CEREB CORTEX, V21, P636, DOI 10.1093/cercor/bhq137; Brenhouse HC, 2011, NEUROSCI BIOBEHAV R, V35, P1687, DOI 10.1016/j.neubiorev.2011.04.013; Buss C, 2012, P NATL ACAD SCI USA, V109, pE1312, DOI 10.1073/pnas.1201295109; CLARK AS, 1988, ENDOCRINOLOGY, V123, P932, DOI 10.1210/endo-123-2-932; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Giedd Jay N, 2008, Novartis Found Symp, V289, P101; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Gogtay N, 2006, HIPPOCAMPUS, V16, P664, DOI 10.1002/hipo.20193; GOULD E, 1990, J NEUROSCI, V10, P1286; Hardee JE, 2008, SOC COGN AFFECT NEUR, V3, P47, DOI 10.1093/scan/nsn001; Juranek J, 2006, J CHILD NEUROL, V21, P1051, DOI 10.1177/7010.2006.00237; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lombardo MV, 2012, J NEUROSCI, V32, P674, DOI 10.1523/JNEUROSCI.4389-11.2012; MARTINI L, 1991, J STEROID BIOCHEM, V39, P819, DOI 10.1016/0960-0760(91)90031-Y; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; Mosconi MW, 2009, ARCH GEN PSYCHIAT, V66, P509, DOI 10.1001/archgenpsychiatry.2009.19; Munson J, 2006, ARCH GEN PSYCHIAT, V63, P686, DOI 10.1001/archpsyc.63.6.686; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Payne C, 2010, HIPPOCAMPUS, V20, P922, DOI 10.1002/hipo.20688; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Saitoh O, 2001, BRAIN, V124, P1317, DOI 10.1093/brain/124.7.1317; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Schumann CM, 2009, BIOL PSYCHIAT, V66, P942, DOI 10.1016/j.biopsych.2009.07.007; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Suzuki M, 2005, CEREB CORTEX, V15, P187, DOI 10.1093/cercor/bhh121; Thompson DK, 2009, HIPPOCAMPUS, V19, P118, DOI 10.1002/hipo.20492; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Whitwell JL, 2001, AM J NEURORADIOL, V22, P1483	37	220	223	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46970	10.1371/journal.pone.0046970	http://dx.doi.org/10.1371/journal.pone.0046970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056545	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400040
J	Alout, H; Labbe, P; Berthomieu, A; Djogbenou, L; Leonetti, JP; Fort, P; Weill, M				Alout, Haoues; Labbe, Pierrick; Berthomieu, Arnaud; Djogbenou, Luc; Leonetti, Jean-Paul; Fort, Philippe; Weill, Mylene			Novel AChE Inhibitors for Sustainable Insecticide Resistance Management	PLOS ONE			English	Article							CULEX-PIPIENS DIPTERA; AMINO-ACID SUBSTITUTION; HIGH WOLBACHIA DENSITY; ANOPHELES-GAMBIAE; INSENSITIVE ACETYLCHOLINESTERASE; CULICIDAE; MOSQUITOS; GENES; MUTATION; COST	Resistance to insecticides has become a critical issue in pest management and it is particularly chronic in the control of human disease vectors. The gravity of this situation is being exacerbated since there has not been a new insecticide class produced for over twenty years. Reasoned strategies have been developed to limit resistance spread but have proven difficult to implement in the field. Here we propose a new conceptual strategy based on inhibitors that preferentially target mosquitoes already resistant to a currently used insecticide. Application of such inhibitors in rotation with the insecticide against which resistance has been selected initially is expected to restore vector control efficacy and reduce the odds of neo-resistance. We validated this strategy by screening for inhibitors of the G119S mutated acetylcholinesterase-1 (AChE1), which mediates insensitivity to the widely used organophosphates (OP) and carbamates (CX) insecticides. PyrimidineTrione Furan-substituted (PTF) compounds came out as best hits, acting biochemically as reversible and competitive inhibitors of mosquito AChE1 and preferentially inhibiting the mutated form, insensitive to OP and CX. PTF application in bioassays preferentially killed OP-resistant Culex pipiens and Anopheles gambiae larvae as a consequence of AChE1 inhibition. Modeling the evolution of frequencies of wild type and OP-insensitive AChE1 alleles in PTF-treated populations using the selectivity parameters estimated from bioassays predicts a rapid rise in the wild type allele frequency. This study identifies the first compound class that preferentially targets OP-resistant mosquitoes, thus restoring OP-susceptibility, which validates a new prospect of sustainable insecticide resistance management.	[Alout, Haoues; Labbe, Pierrick; Berthomieu, Arnaud; Leonetti, Jean-Paul; Fort, Philippe; Weill, Mylene] Univ Montpellier 2, Montpellier, France; [Alout, Haoues; Labbe, Pierrick; Berthomieu, Arnaud; Leonetti, Jean-Paul; Fort, Philippe; Weill, Mylene] Univ Montpellier I, Montpellier, France; [Alout, Haoues; Labbe, Pierrick; Berthomieu, Arnaud; Weill, Mylene] CNRS, Inst Sci Evolut, UMR 5554, Montpellier, France; [Djogbenou, Luc] Univ Abomey Calavi, Inst Reg Sante Publ, Cotonou, Benin; [Leonetti, Jean-Paul] CNRS, UMR 5236, Ctr Etud Agents Pathogenes & Biotechnol Sante, Montpellier, France; [Fort, Philippe] CNRS, UMR 5237, Ctr Rech Biochim Macromol, Montpellier, France	Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Abomey Calavi; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Weill, M (corresponding author), Univ Montpellier 2, Montpellier, France.	mylene.weill@univ-montp2.fr	Labbé, Pïerrick/AAL-5806-2020; Alout, Haoues/N-9556-2016; Fort, Philippe/M-9498-2015	Labbé, Pïerrick/0000-0003-0806-1919; Alout, Haoues/0000-0001-7917-2697; Fort, Philippe/0000-0001-5997-8722; Weill, Mylene/0000-0002-4043-1601; DJOGBENOU, Salako Luc/0000-0002-7381-6321	ANR (Agence Nationale pour la Recherche); Morevol Sante-Environnement (Ministere Delegue a la Recherche) of the Institut des Sciences de L'Evolution de Montpellier (UMR (Unite Mixte de Recherche) CNRS (Centre National de la Recherche Scientifique) [UM2 5554]; ANR; CNRS	ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); Morevol Sante-Environnement (Ministere Delegue a la Recherche) of the Institut des Sciences de L'Evolution de Montpellier (UMR (Unite Mixte de Recherche) CNRS (Centre National de la Recherche Scientifique); ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work received financial support by the ANR (Agence Nationale pour la Recherche), Morevol Sante-Environnement (Ministere Delegue a la Recherche) and Contribution 2012-XXX of the Institut des Sciences de L'Evolution de Montpellier (UMR (Unite Mixte de Recherche) CNRS (Centre National de la Recherche Scientifique) - UM2 5554). HA was supported by ANR (3-year grant) and CNRS (one-year SPV grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alout H, 2008, CHEM-BIOL INTERACT, V175, P138, DOI 10.1016/j.cbi.2008.03.018; Alout H, 2008, COMP BIOCHEM PHYS B, V150, P271, DOI 10.1016/j.cbpb.2008.03.008; Alout H, 2007, J MED ENTOMOL, V44, P463, DOI 10.1603/0022-2585(2007)44[463:DASCIR]2.0.CO;2; Alout H, 2007, INSECT BIOCHEM MOLEC, V37, P41, DOI 10.1016/j.ibmb.2006.10.001; Ben Cheikh R, 2009, J MED ENTOMOL, V46, P523, DOI 10.1603/033.046.0317; Berticat C, 2004, GENET RES, V83, P189, DOI 10.1017/S0016672304006792; Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Bourguet D, 1996, J ECON ENTOMOL, V89, P1060, DOI 10.1093/jee/89.5.1060; Bourguet D, 1996, PESTIC BIOCHEM PHYS, V55, P122, DOI 10.1006/pest.1996.0041; Brogdon William G, 2004, J Agromedicine, V9, P329; Casida JE, 2004, CHEM RES TOXICOL, V17, P983, DOI 10.1021/tx0499259; Cui F, 2006, J MED ENTOMOL, V43, P878, DOI 10.1603/0022-2585(2006)43[878:REOIAI]2.0.CO;2; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; Duron O, 2006, EVOLUTION, V60, P303, DOI 10.1111/j.0014-3820.2006.tb01108.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Gassmann AJ, 2009, PEST MANAG SCI, V65, P1174, DOI 10.1002/ps.1844; GEORGHIOU GP, 1966, B WORLD HEALTH ORGAN, V35, P691; Huchard E, 2006, P R SOC B, V273, P2595, DOI 10.1098/rspb.2006.3621; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Li AY, 2003, J MED ENTOMOL, V40, P942, DOI 10.1603/0022-2585-40.6.942; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Michalakis Y, 2009, NATURE, V462, P298, DOI 10.1038/462298a; Nabeshima T, 2004, BIOCHEM BIOPH RES CO, V313, P794, DOI 10.1016/j.bbrc.2003.11.141; Oakeshott JG, 2005, CHEM-BIOL INTERACT, V157, P269, DOI 10.1016/j.cbi.2005.10.041; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Raymond M, 1997, PROBIT ANAL MORTALIT; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; RIVET Y, 1994, J MED ENTOMOL, V31, P231, DOI 10.1093/jmedent/31.2.231; Rodcharoen J, 1996, J AM MOSQUITO CONTR, V12, P247; SHUTE G. T., 1956, ANN TROP MED AND PARASITOL, V50, P92; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; Yebakima A, 2004, J MED ENTOMOL, V41, P718, DOI 10.1603/0022-2585-41.4.718	44	24	25	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47125	10.1371/journal.pone.0047125	http://dx.doi.org/10.1371/journal.pone.0047125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056599	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500139
J	Felisberto-Rodrigues, C; Blangy, S; Goulet, A; Vestergaard, G; Cambillau, C; Garrett, RA; Ortiz-Lombardia, M				Felisberto-Rodrigues, Catarina; Blangy, Stephanie; Goulet, Adeline; Vestergaard, Gisle; Cambillau, Christian; Garrett, Roger A.; Ortiz-Lombardia, Miguel			Crystal Structure of ATV(ORF273), a New Fold for a Thermo- and Acido-Stable Protein from the Acidianus Two-Tailed Virus	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; SECONDARY-STRUCTURE; ARCHAEAL VIRUS; FILAMENTOUS VIRUS; FEATURES; REFINEMENT; SOFTWARE; GEOMETRY; PROGRAM; SYSTEM	Acidianus two-tailed virus (ATV) infects crenarchaea of the genus Acidianus living in terrestrial thermal springs at extremely high temperatures and low pH. ATV is a member of the Bicaudaviridae virus family and undergoes extra-cellular development of two tails, a process that is unique in the viral world. To understand this intriguing phenomenon, we have undertaken structural studies of ATV virion proteins and here we present the crystal structure of one of these proteins, ATV(ORF273). ATV(ORF273) forms tetramers in solution and a molecular envelope is provided for the tetramer, computed from small-angle X-ray scattering (SAXS) data. The crystal structure has properties typical of hyperthermostable proteins, including a relatively high number of salt bridges. However, the protein also exhibits flexible loops and surface pockets. Remarkably, ATV(ORF273) displays a new alpha+beta protein fold, consistent with the absence of homologues of this protein in public sequence databases.	[Felisberto-Rodrigues, Catarina; Blangy, Stephanie; Goulet, Adeline; Cambillau, Christian; Ortiz-Lombardia, Miguel] Aix Marseille Univ, CNRS, AFMB, UMR 7257, Marseille, France; [Vestergaard, Gisle; Garrett, Roger A.] Univ Copenhagen, Archaea Ctr, Dept Biol, Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Copenhagen	Ortiz-Lombardia, M (corresponding author), Aix Marseille Univ, CNRS, AFMB, UMR 7257, Campus Luminy, Marseille, France.	miguel.ortiz-lombardia@afmb.univ-mrs.fr	Garrett, Roger A/M-2450-2014	Garrett, Roger A/0000-0001-8452-9099; Vestergaard, Gisle/0000-0003-2541-4974; Goulet, Adeline/0000-0002-5971-9488	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/44380/2008]; Ville de Marseille; Danish Natural Science Research Council	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Ville de Marseille(Region Provence-Alpes-Cote d'Azur); Danish Natural Science Research Council(Danish Natural Science Research Council)	C.F.-R. was funded by a doctoral fellowship from the Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/), Portugal (SFRH/BD/44380/2008). The Ville de Marseille (http://www.marseille.fr) provided a financial installation aid to M.O.-L. The Archaea Centre, Copenhagen was supported by a grant from the Danish Natural Science Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Blanc E., 2011, BUSTER VERSION 2 11; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Goulet A, 2010, J VIROL, V84, P5025, DOI 10.1128/JVI.01664-09; Goulet A, 2010, ACTA CRYSTALLOGR D, V66, P304, DOI 10.1107/S0907444909051798; Goulet A, 2009, P NATL ACAD SCI USA, V106, P21155, DOI 10.1073/pnas.0909893106; Goulet A, 2009, PROTEINS, V76, P1020, DOI 10.1002/prot.22448; Goulet A, 2009, PROTEIN SCI, V18, P1316, DOI 10.1002/pro.122; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Haring M, 2005, NATURE, V436, P1101, DOI 10.1038/4361101a; Hendlich M, 2003, J MOL BIOL, V326, P607, DOI 10.1016/S0022-2836(02)01408-0; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jambon M, 2003, PROTEINS, V52, P137, DOI 10.1002/prot.10339; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Mochizuki T, 2012, P NATL ACAD SCI USA, V109, P13386, DOI 10.1073/pnas.1203668109; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prangishvili D, 2006, J MOL BIOL, V359, P1203, DOI 10.1016/j.jmb.2006.04.027; Prangishvili D, 2012, ARCH VIROL, V157, P791, DOI 10.1007/s00705-012-1229-7; Prangishvill D, 2006, VIRUS RES, V117, P52, DOI 10.1016/j.virusres.2006.01.007; Scheele U, 2011, J VIROL, V85, P4812, DOI 10.1128/JVI.00072-11; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TORSVIK T, 1974, NATURE, V248, P680, DOI 10.1038/248680a0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xiang XY, 2005, J VIROL, V79, P8677, DOI 10.1128/JVI.79.14.8677-8686.2005; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609	57	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45847	10.1371/journal.pone.0045847	http://dx.doi.org/10.1371/journal.pone.0045847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056221	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500021
J	Gonzalez, IT; Barrientos, G; Freitag, N; Otto, T; Thijssen, VLJL; Moschansky, P; von Kwiatkowski, P; Klapp, BF; Winterhager, E; Bauersachs, S; Blois, SM				Gonzalez, Irene Tirado; Barrientos, Gabriela; Freitag, Nancy; Otto, Teresa; Thijssen, Victor L. J. L.; Moschansky, Petra; von Kwiatkowski, Petra; Klapp, Burghard F.; Winterhager, Elke; Bauersachs, Stefan; Blois, Sandra M.			Uterine NK Cells Are Critical in Shaping DC Immunogenic Functions Compatible with Pregnancy Progression	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; IN-VIVO; OLIGONUCLEOTIDE MICROARRAYS; EXPRESSION PROFILES; INTERFERON-GAMMA; GENE-EXPRESSION; T-CELLS; MICE; GROWTH	Dendritic cell (DC) and natural killer (NK) cell interactions are important for the regulation of innate and adaptive immunity, but their relevance during early pregnancy remains elusive. Using two different strategies to manipulate the frequency of NK cells and DC during gestation, we investigated their relative impact on the decidualization process and on angiogenic responses that characterize murine implantation. Manipulation of the frequency of NK cells, DC or both lead to a defective decidual response characterized by decreased proliferation and differentiation of stromal cells. Whereas no detrimental effects were evident upon expansion of DC, NK cell ablation in such expanded DC mice severely compromised decidual development and led to early pregnancy loss. Pregnancy failure in these mice was associated with an unbalanced production of anti-angiogenic signals and most notably, with increased expression of genes related to inflammation and immunogenic activation of DC. Thus, NK cells appear to play an important role counteracting potential anomalies raised by DC expansion and overactivity in the decidua, becoming critical for normal pregnancy progression.	[Gonzalez, Irene Tirado; Barrientos, Gabriela; Freitag, Nancy; Moschansky, Petra; von Kwiatkowski, Petra; Klapp, Burghard F.; Blois, Sandra M.] Med Univ Berlin, Charite Ctr Internal Med & Dermatol 12, Lab Reprod Med, Berlin, Germany; [Barrientos, Gabriela] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Fisiol Mol Placentaria, Buenos Aires, DF, Argentina; [Otto, Teresa; Winterhager, Elke] Univ Duisburg Essen, Univ Hosp, Inst Mol Biol, Essen, Germany; [Thijssen, Victor L. J. L.] Vrije Univ Amsterdam Med Ctr, Angiogenesis Lab, Dept Radiotherapy, Amsterdam, Netherlands; [Bauersachs, Stefan] Ludwig Maximilians Univ Munchen, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Buenos Aires; University of Duisburg Essen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Munich	Gonzalez, IT (corresponding author), Med Univ Berlin, Charite Ctr Internal Med & Dermatol 12, Lab Reprod Med, Berlin, Germany.	sandra.blois@charite.de	Thijssen, Victor LJL/B-2792-2009; Freitag, Nancy/AAQ-2290-2020; Barrientos, Gabriela/ABC-8266-2020	Thijssen, Victor LJL/0000-0002-6146-1842; Freitag, Nancy/0000-0001-5972-1863; Barrientos, Gabriela/0000-0002-5613-023X; Bauersachs, Stefan/0000-0003-2450-1216; Blois, Sandra M/0000-0002-0434-2660	Deutsche Forschungsgemeinschaft (DFG) [BL1115/1-1]; Habilitation Program of the Charite; DAAD (German Academic Exchange Service)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Habilitation Program of the Charite; DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grant BL1115/1-1 to S. M. B. I. T. G. received a fellowship from the Habilitation Program of the Charite and G. B. a Ph.D. fellowship from DAAD (German Academic Exchange Service). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Bany BM, 2011, REPRODUCTION; Bany BM, 2006, DEV BIOL, V294, P445, DOI 10.1016/j.ydbio.2006.03.006; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; BEBAWY ST, 1986, J LEUKOCYTE BIOL, V39, P423, DOI 10.1002/jlb.39.4.423; Bilinski P, 1998, GENE DEV, V12, P2234, DOI 10.1101/gad.12.14.2234; Blois SM, 2008, J MOL MED, V86, P837, DOI 10.1007/s00109-008-0342-2; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Blois SM, 2004, BIOL REPROD, V70, P1018, DOI 10.1095/biolreprod.103.022640; Chakraborty D, 2011, P NATL ACAD SCI USA, V108, P16295, DOI 10.1073/pnas.1109478108; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Croy BA, 2003, REPRODUCTION, V126, P149, DOI 10.1530/rep.0.1260149; Davis S, 1999, CURR TOP MICROBIOL, V237, P173; Dietl J, 2006, PLACENTA, V27, P341, DOI 10.1016/j.placenta.2005.05.001; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gotsch F, 2007, J MATERN-FETAL NEO M, V20, P777, DOI 10.1080/14767050701483298; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Huang SJ, 2008, J PATHOL, V214, P328, DOI 10.1002/path.2257; Ichiba T, 2003, BLOOD, V102, P763, DOI 10.1182/blood-2002-09-2748; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kammerer U, 2003, AM J PATHOL, V162, P887, DOI 10.1016/S0002-9440(10)63884-9; Karsten CM, 2009, EUR J IMMUNOL, V39, P2203, DOI 10.1002/eji.200838844; Klauber N, 1997, NAT MED, V3, P443, DOI 10.1038/nm0497-443; Krey G, 2008, J MOL MED, V86, P999, DOI 10.1007/s00109-008-0379-2; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Laskarin G, 2008, AM J REPROD IMMUNOL, V59, P433, DOI 10.1111/j.1600-0897.2008.00599.x; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Lima PDA, 2012, J LEUKOCYTE BIOL, V92, P195, DOI 10.1189/jlb.0312136; Lin Y, 2008, CLIN IMMUNOL, V126, P104, DOI 10.1016/j.clim.2007.09.006; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Norwitz Errol R, 2007, Reprod Biomed Online, V14 Spec No 1, P101, DOI 10.1016/S1472-6483(10)61464-2; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; SALEH AA, 1992, ARCH GYNECOL OBSTET, V251, P105, DOI 10.1007/BF02718370; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vacca P, 2010, P NATL ACAD SCI USA, V107, P11918, DOI 10.1073/pnas.1001749107; Vigano P, 2001, MOL HUM REPROD, V7, P971, DOI 10.1093/molehr/7.10.971; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Zhang JH, 2011, CELL MOL IMMUNOL, V8, P1, DOI 10.1038/cmi.2010.38	49	41	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46755	10.1371/journal.pone.0046755	http://dx.doi.org/10.1371/journal.pone.0046755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056436	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500071
J	Levine, H; Balicer, RD; Zarka, S; Sela, T; Rozhavski, V; Cohen, D; Kayouf, R; Ambar, R; Porat, N; Dagan, R				Levine, Hagai; Balicer, Ran D.; Zarka, Salman; Sela, Tamar; Rozhavski, Vladislav; Cohen, Daniel; Kayouf, Raid; Ambar, Ruhama; Porat, Nurith; Dagan, Ron			Dynamics of Pneumococcal Acquisition and Carriage in Young Adults during Training in Confined Settings in Israel	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE CARRIAGE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; CHILDREN; TRANSMISSION; OUTBREAK; SEROTYPE; HEALTHY; COLONIZATION; COMMUNITY	Background: Outbreaks and sporadic cases of pneumococcal illness occur among young adults in confined settings. Our aim was to characterize pneumococcal acquisition and carriage among healthy young adults in Israel during military training in confined settings. Methods: During the years 2007-2008, an observational longitudinal study was conducted in three cohorts of healthy soldiers, during a 7-month basic training period. Epidemiological data, oropharyngeal and nasopharyngeal cultures were sampled on 5 occasions: before and 3, 6, 12 and 24 weeks after start of training. Samples were processed within 2-18 hours. Relatedness of isolates was investigated by capsular typing of all isolates and pulsed-field gel electrophoresis to determine acquisition and transmission. Carriage and acquisition patterns were analyzed and multivariable logistic regression analysis was performed to assess the impact of time on acquisition after mixing, controlling for other covariates. Results: Pneumococci were recovered on 202 of 1872 visits among 742 individuals, including 40 different serotypes. Mean carriage prevalence increased in all visits following training initiation. Acquisition during training was high, as 36.9% of individuals acquired pneumococci at least once during training, and for almost one fourth of the whole population this occurred during the first 6 weeks. Significant clustering was noted. Sharing drinking glass/bottle was found to be a significant and common risk factor for pneumococcal acquisition. Conclusions: Pneumococcal acquisition is highly frequent when young adults live in close contact in confined settings, especially early after mixing.	[Levine, Hagai; Balicer, Ran D.; Zarka, Salman; Sela, Tamar; Rozhavski, Vladislav; Kayouf, Raid; Ambar, Ruhama] Israel Def Forces, Med Corps, Tel Hashomer, Israel; [Levine, Hagai] Braun Hebrew Univ, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Balicer, Ran D.; Porat, Nurith; Dagan, Ron] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Zarka, Salman] Univ Haifa, Sch Publ Hlth, IL-31999 Haifa, Israel; [Cohen, Daniel] Tel Aviv Univ, Sch Publ Hlth, IL-69978 Tel Aviv, Israel; [Dagan, Ron] Soroka Univ, Med Ctr, Pediat Infect Dis Unit, Beer Sheva, Israel	Ben Gurion University; University of Haifa; Tel Aviv University; Ben Gurion University; Soroka Medical Center	Levine, H (corresponding author), Israel Def Forces, Med Corps, Tel Hashomer, Israel.	hlevine@hadassah.org.il	; Levine, Hagai/B-4329-2012	Cohen, Daniel/0000-0003-2664-2303; Levine, Hagai/0000-0002-5597-4916	Israel Defence Force; Israeli Ministry of Defence	Israel Defence Force; Israeli Ministry of Defence	This study was supported by a research grant of the Israel Defence Force and the Israeli Ministry of Defence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Balicer RD, 2010, VACCINE, V28, P5591, DOI 10.1016/j.vaccine.2010.06.031; Block C, 1999, EPIDEMIOL INFECT, V122, P51, DOI 10.1017/S0950268898001769; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Crum NF, 2003, AM J PREV MED, V25, P107, DOI 10.1016/S0749-3797(03)00114-4; Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679; Dagan R, 2000, CLIN INFECT DIS, V30, P319, DOI 10.1086/313645; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; Dawood FS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-157; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Givon-Lavi N, 1999, CLIN INFECT DIS, V29, P1274, DOI 10.1086/313465; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935; Greenberg D, 2004, J CLIN MICROBIOL, V42, P4604, DOI 10.1128/JCM.42.10.4604-4609.2004; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; JOUSIMIESSOMER HR, 1989, J CLIN MICROBIOL, V27, P2736, DOI 10.1128/JCM.27.12.2736-2743.1989; Kellner JD, 1998, PEDIATR INFECT DIS J, V17, P279, DOI 10.1097/00006454-199804000-00004; Leino T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-173; Levine H, 2012, EPIDEMIOL INFECT, V140, P561, DOI 10.1017/S0950268811000884; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980; Moore M, 2008, CONTROL COMMUNICABLE, P471; Musher DM, 1997, CLIN INFECT DIS, V24, P441, DOI 10.1093/clinids/24.3.441; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Porat N, 2004, J INFECT DIS, V189, P385, DOI 10.1086/381183; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Yagupsky P, 1998, J INFECT DIS, V177, P1003, DOI 10.1086/515239	29	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46491	10.1371/journal.pone.0046491	http://dx.doi.org/10.1371/journal.pone.0046491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056322	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500043
J	Li, BC; Yang, GY; Wu, L; Feng, Y				Li, Binchun; Yang, Guangyu; Wu, Lie; Feng, Yan			Role of the NC-Loop in Catalytic Activity and Stability in Lipase from Fervidobacterium changbaicum	PLOS ONE			English	Article							ALPHA/BETA-HYDROLASE FOLD; AMINO-ACID AMINOTRANSFERASE; PROTEIN SECONDARY STRUCTURE; CLEAVAGE PRODUCT HYDROLASE; PSEUDOMONAS-FLUORESCENS; HALOALKANE DEHALOGENASES; SUBSTRATE-SPECIFICITY; STRUCTURE PREDICTION; EPOXIDE HYDROLASES; CRYSTAL-STRUCTURES	Flexible NC-loops between the catalytic domain and the cap domain of the alpha/beta hydrolase fold enzymes show remarkable diversity in length, sequence, and configuration. Recent investigations have suggested that the NC-loop might be involved in catalysis and substrate recognition in many enzymes from the alpha/beta hydrolase fold superfamily. To foster a deep understanding of its role in catalysis, stability, and divergent evolution, we here systemically investigated the function of the NC-loop (residues 131-151) in a lipase (FClip1) from thermophilic bacterium Fervidobacterium changbaicum by loop deletion, alanine-scanning mutagenesis and site-directed mutagenesis. We found that the upper part of the NC-loop (residues 131-138) was of great importance to enzyme catalysis. Single substitutions in this region could fine-tune the activity of FClip1 as much as 41-fold, and any deletions from this region rendered the enzyme completely inactive. The lower part of the NC-loop (residues 139-151) was capable of enduring extensive deletions without loss of activity. The shortened mutants in this region were found to show both improved activity and increased stability simultaneously. We therefore speculated that the NC-loop, especially the lower part, would be a perfect target for enzyme engineering to optimize the enzymatic properties, and might present a hot zone for the divergent evolution of alpha/beta hydrolases. Our findings may provide an opportunity for better understanding of the mechanism of divergent evolution in the alpha/beta hydrolase fold superfamily, and may also guide the design of novel biocatalysts for industrial applications.	[Li, Binchun; Yang, Guangyu; Wu, Lie; Feng, Yan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Li, Binchun; Wu, Lie; Feng, Yan] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China	Shanghai Jiao Tong University; Jilin University	Feng, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	yfeng2009@sjtu.edu.cn	Wu, Lie/E-1952-2017	Wu, Lie/0000-0002-5577-4084	National Basic Research Program of China (973 program) [2012CB721000, 2011CBA00800]; Natural Science Foundation of China [30970632]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program of China (973 program, 2012CB721000 and 2011CBA00800), and the Natural Science Foundation of China (30970632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, ENZYMES LIPID MODIFI; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; Bains J, 2011, J MOL BIOL, V406, P649, DOI 10.1016/j.jmb.2011.01.007; Barth S, 2004, BIOINFORMATICS, V20, P2845, DOI 10.1093/bioinformatics/bth284; Barth S, 2004, PROTEINS, V55, P846, DOI 10.1002/prot.20013; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai JG, 2011, APPL MICROBIOL BIOT, V89, P1463, DOI 10.1007/s00253-010-2971-y; Calvo E, 2006, J EXP BIOL, V209, P2651, DOI 10.1242/jeb.02267; Cheeseman JD, 2004, ACTA CRYSTALLOGR D, V60, P1237, DOI 10.1107/S0907444904010522; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chovancova E, 2007, PROTEINS, V67, P305, DOI 10.1002/prot.21313; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Dignam JD, 2001, J BIOL CHEM, V276, P4028, DOI 10.1074/jbc.M006840200; DUGI KA, 1992, J BIOL CHEM, V267, P25086; Elfstrom LT, 2006, BIOCHEMISTRY-US, V45, P205, DOI 10.1021/bi051893g; Fushinobu S, 2005, BIOSCI BIOTECH BIOCH, V69, P491, DOI 10.1271/bbb.69.491; Fushinobu S, 2002, PROTEIN SCI, V11, P2184, DOI 10.1110/ps.0209602; Gutierrez A, 1998, PROTEIN ENG, V11, P53, DOI 10.1093/protein/11.1.53; Gutierrez A, 2000, EUR J BIOCHEM, V267, P7218, DOI 10.1046/j.1432-1327.2000.01833.x; Herdendorf TJ, 2006, BIOCHEMISTRY-US, V45, P3235, DOI 10.1021/bi052231u; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jochens H, 2009, ANGEW CHEM INT EDIT, V48, P3532, DOI 10.1002/anie.200806276; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Knofel T, 2001, J MOL BIOL, V309, P255, DOI 10.1006/jmbi.2001.4657; Levisson M, 2007, FEBS J, V274, P2832, DOI 10.1111/j.1742-4658.2007.05817.x; Lu Y, 1997, CURR OPIN STRUC BIOL, V7, P495, DOI 10.1016/S0959-440X(97)80112-1; Maes EM, 2004, BIOCHEMISTRY-US, V43, P6679, DOI 10.1021/bi049748a; MCPHALEN CA, 1985, P NATL ACAD SCI USA, V82, P7242, DOI 10.1073/pnas.82.21.7242; Miled N, 2003, COMP BIOCHEM PHYS B, V136, P131, DOI 10.1016/S1096-4959(03)00183-0; Nagi AD, 1997, FOLD DES, V2, P67, DOI 10.1016/S1359-0278(97)00007-2; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nardini M, 1999, J BIOL CHEM, V274, P14579, DOI 10.1074/jbc.274.21.14579; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Park SY, 2008, J MOL BIOL, V376, P1426, DOI 10.1016/j.jmb.2007.12.062; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Scalley-Kim M, 2003, PROTEIN SCI, V12, P197, DOI 10.1110/ps.0232003; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tawfik DS, 2006, SCIENCE, V311, P475, DOI 10.1126/science.1123883; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03	48	14	15	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46881	10.1371/journal.pone.0046881	http://dx.doi.org/10.1371/journal.pone.0046881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056508	Green Submitted, gold, Green Published			2022-12-27	WOS:000309831500099
J	Martens, U; Wahl, P; Hassler, U; Friese, U; Gruber, T				Martens, Ulla; Wahl, Patricia; Hassler, Uwe; Friese, Uwe; Gruber, Thomas			Implicit and Explicit Contributions to Object Recognition: Evidence from Rapid Perceptual Learning	PLOS ONE			English	Article							GAMMA-BAND RESPONSES; TOP-DOWN FACILITATION; INFORMATION-FLOW; HUMAN EEG; MEMORY; BRAIN; MECHANISMS; REPETITION; RETRIEVAL; TASK	The present study investigated implicit and explicit recognition processes of rapidly perceptually learned objects by means of steady-state visual evoked potentials (SSVEP). Participants were initially exposed to object pictures within an incidental learning task (living/non-living categorization). Subsequently, degraded versions of some of these learned pictures were presented together with degraded versions of unlearned pictures and participants had to judge, whether they recognized an object or not. During this test phase, stimuli were presented at 15 Hz eliciting an SSVEP at the same frequency. Source localizations of SSVEP effects revealed for implicit and explicit processes overlapping activations in orbito-frontal and temporal regions. Correlates of explicit object recognition were additionally found in the superior parietal lobe. These findings are discussed to reflect facilitation of object-specific processing areas within the temporal lobe by an orbito-frontal top-down signal as proposed by bi-directional accounts of object recognition.	[Martens, Ulla; Wahl, Patricia; Hassler, Uwe; Gruber, Thomas] Univ Osnabruck, Inst Expt Psychol 1, Osnabruck, Germany; [Friese, Uwe] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University Osnabruck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Martens, U (corresponding author), Univ Osnabruck, Inst Expt Psychol 1, Osnabruck, Germany.	umartens@uni-osnabrueck.de	Martens, Ulla/B-7990-2010; Haßler, Uwe/ABD-3215-2021					Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; DALLENBACH KM, 1951, AM J PSYCHOL, V64, P431; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Friese U, 2012, NEUROIMAGE, V59, P861, DOI 10.1016/j.neuroimage.2011.07.073; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Gruber T, 2006, NEUROIMAGE, V29, P888, DOI 10.1016/j.neuroimage.2005.09.004; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gruber T, 2002, J COGNITIVE NEUROSCI, V14, P732, DOI 10.1162/08989290260138636; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kaspar K, 2010, BRAIN RES, V1343, P112, DOI 10.1016/j.brainres.2010.04.072; Keil A, 2003, COGN AFFECT BEHAV NE, V3, P195, DOI 10.3758/CABN.3.3.195; Martens U, 2012, EUR J NEUROSCI, V36, P2989, DOI 10.1111/j.1460-9568.2012.08222.x; Martens U, 2012, NEUROREPORT, V23, P337, DOI 10.1097/WNR.0b013e3283516542; Martens U, 2011, J NEUROSCI, V31, P17713, DOI 10.1523/JNEUROSCI.4743-11.2011; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Regan D., 1989, HUMAN BRAIN ELECTROP; Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Schott BH, 2005, P NATL ACAD SCI USA, V102, P1257, DOI 10.1073/pnas.0409070102; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wimber M, 2012, CURR BIOL, V22, P1482, DOI 10.1016/j.cub.2012.05.054	36	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47009	10.1371/journal.pone.0047009	http://dx.doi.org/10.1371/journal.pone.0047009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056558	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500121
J	Sandberg, MEC; Hall, P; Hartman, M; Johansson, ALV; Eloranta, S; Ploner, A; Czene, K				Sandberg, Maria E. C.; Hall, Per; Hartman, Mikael; Johansson, Anna L. V.; Eloranta, Sandra; Ploner, Alexander; Czene, Kamila			Estrogen Receptor Status in Relation to Risk of Contralateral Breast Cancer-A Population-Based Cohort Study	PLOS ONE			English	Article							EPIDEMIOLOGY; RADIATION; AGE; ASSOCIATIONS; IMMUNOASSAY; PROGNOSIS; CARCINOMA; SUBTYPES; THERAPY; WOMEN	Background: It is unclear whether estrogen receptor (ER)-status of first primary breast cancer is associated with risk of metachronous (non-simultaneous) contralateral breast cancer (CBC), and to what extent endocrine therapy affects this association. Methods: We studied the effect of ER-status of the first cancer on the risk of CBC overall, and for different ER-subtypes of CBC, using a large, population-based cohort. The cohort consisted of all women diagnosed with breast cancer in the Stockholm region 1976-2005; 25715 patients, of whom 940 suffered CBC. The relative risk was analyzed mainly using standardized incidence ratios (SIR). Results: Women with breast cancer had a doubled risk of CBC compared to the risk of breast cancer in the general female population (SIR: 2.22 [2.08-2.36]), for women with a previous ER-positive cancer: SIR = 2.30 (95% CI: 2.11-2.50) and for women with a previous ER-negative cancer: SIR = 2.17 (95% CI: 1.82-2.55). The relative risk of ER-positive and ER-negative CBC was very similar for women with ER-positive first cancer (SIR = 2.02 [95% CI: 1.80-2.27] and SIR = 1.89 [95% CI: 1.46-2.41] respectively) while for patients with ER-negative first cancer the relative risk was significantly different (SIR = 1.27 [95% CI: 0.94-1.68] for ER-positive CBC and SIR = 4.96 [95% CI: 3.67-6.56] for ER-negative CBC). Patients with ER-positive first cancer who received hormone therapy still had a significantly higher risk of CBC than the risk of breast cancer for the general female population (SIR = 1.74 [95% CI: 1.47-2.03]). Conclusion: The risk of CBC for a breast cancer patient is increased to about two-fold, compared to the risk of breast cancer in the general female population. This excess risk decreases, but does not disappear, with adjuvant endocrine therapy. Patients with ER-positive first cancers have an increased risk for CBC of both ER subtypes, while patients with ER-negative first cancer have a specifically increased risk of ER-negative CBC.	[Sandberg, Maria E. C.; Hall, Per; Hartman, Mikael; Johansson, Anna L. V.; Eloranta, Sandra; Ploner, Alexander; Czene, Kamila] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hartman, Mikael] Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Hartman, Mikael] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore	Karolinska Institutet; National University of Singapore	Sandberg, MEC (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Maria.Sandberg@ki.se	Eloranta, Sandra/X-6661-2018; Hartman, Mikael/B-4324-2011	Hartman, Mikael/0000-0001-5726-9965; Johansson, Anna/0000-0002-1191-7231; Czene, Kamila/0000-0002-3233-5695; Schelin, Maria EC./0000-0001-5486-7556; Ploner, Alexander/0000-0002-5042-8326	Swedish Research Council [521-2008-2728]; Swedish Cancer Society [5128-B07-01PAF]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This study was financed by the Swedish Research Council grant no: 521-2008-2728. Kamila Czene was financed by the Swedish Cancer Society grant no: 5128-B07-01PAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; ABE O, 1995, NEW ENGL J MED, V333, P1444; ADAMI HO, 1985, CANCER, V55, P643, DOI 10.1002/1097-0142(19850201)55:3<643::AID-CNCR2820550328>3.0.CO;2-L; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Anderson WF, 2001, J CLIN ONCOL, V19, P18, DOI 10.1200/JCO.2001.19.1.18; Bertelsen L, 2009, EPIDEMIOLOGY, V20, P175, DOI 10.1097/EDE.0b013e318190eee6; Bouchardy C, 2010, BREAST CANC RES TREA; Chen Y, 1999, CANCER EPIDEM BIOMAR, V8, P855; Chen Y, 2001, BREAST CANCER RES TR, V67, P35, DOI 10.1023/A:1010665603732; Coradini D, 1998, EUR J CANCER, V34, P825, DOI 10.1016/S0959-8049(97)10121-6; Delage V, 1997, BRIT J CANCER, V76, P519, DOI 10.1038/bjc.1997.418; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Fisher B, 2004, LANCET, V364, P858, DOI 10.1016/S0140-6736(04)16981-X; Fowble B, 2001, INT J RADIAT ONCOL, V51, P679, DOI 10.1016/S0360-3016(01)01665-0; GREENE GL, 1980, P NATL ACAD SCI-BIOL, V77, P5115, DOI 10.1073/pnas.77.9.5115; HANKEY BF, 1983, J NATL CANCER I, V70, P797; Hartman M, 2005, LANCET ONCOL, V6, P377, DOI 10.1016/S1470-2045(05)70174-1; Hartman M, 2007, J CLIN ONCOL, V25, P4210, DOI 10.1200/JCO.2006.10.5056; HEALEY EA, 1993, J CLIN ONCOL, V11, P1545, DOI 10.1200/JCO.1993.11.8.1545; Hill-Kayser CE, 2006, INT J RADIAT ONCOL, V66, P1313, DOI 10.1016/j.ijrobp.2006.07.009; HORN PL, 1988, CANCER-AM CANCER SOC, V62, P412, DOI 10.1002/1097-0142(19880715)62:2<412::AID-CNCR2820620228>3.0.CO;2-3; Hungness ES, 2000, SURGERY, V128, P702, DOI 10.1067/msy.2000.108780; Jobsen JJ, 2003, BREAST, V12, P83, DOI 10.1016/S0960-9776(02)00278-3; Khoshnoud MR, 2011, BREAST CANCER RES TR, V126, P421, DOI 10.1007/s10549-010-1202-7; Klien John P, 1997, SURVIVAL ANAL TECHNI; Kollias J, 1999, EUR J SURG ONCOL, V25, P584, DOI 10.1053/ejso.1999.0711; Kurian AW, 2009, JNCI-J NATL CANCER I, V101, P1058, DOI 10.1093/jnci/djp181; Li C, 2003, BRIT J CANCER, V89, P513, DOI 10.1038/sj.bjc.6601042; Li CI, 2009, CANCER RES, V69, P6865, DOI 10.1158/0008-5472.CAN-09-1355; Li CI, 2001, J NATL CANCER I, V93, P1008, DOI 10.1093/jnci/93.13.1008; Ma HY, 2006, BREAST CANCER RES, V8, DOI [10.1186/bcr1525, 10.1186/bcr1512]; Mariani L, 1997, BREAST CANCER RES TR, V44, P167, DOI 10.1023/A:1005765403093; Newman LA, 2001, CANCER-AM CANCER SOC, V91, P1845, DOI 10.1002/1097-0142(20010515)91:10<1845::AID-CNCR1205>3.0.CO;2-Z; Nichols HB, 2011, J CLIN ONCOL, V29, P1564, DOI 10.1200/JCO.2010.32.7395; Palacios J, 2008, PATHOBIOLOGY, V75, P85, DOI 10.1159/000123846; POUSETTE A, 1986, CANCER RES, V46, P4308; ROBBINS GF, 1964, CANCER-AM CANCER SOC, V17, P1501, DOI 10.1002/1097-0142(196412)17:12<1501::AID-CNCR2820171202>3.0.CO;2-P; Sandberg MEC, 2012, BREAST CANCER RES TR, V134, P793, DOI 10.1007/s10549-012-2096-3; Sandberg MEC, 2010, BREAST CANCER RES TR, V122, P889, DOI 10.1007/s10549-010-0748-8; SCHOTTEN.D, 1971, J NATL CANCER I, V46, P161; Swain SM, 2004, J NATL CANCER I, V96, P516, DOI 10.1093/jnci/djh097; Teraoka SN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3057; Vaittinen P, 2000, INT J CANCER, V88, P998, DOI 10.1002/1097-0215(20001215)88:6<998::AID-IJC25>3.0.CO;2-0; Vichapat V, 2011, EUR J CANCER, V47, P1919, DOI 10.1016/j.ejca.2011.05.004; WRANGE O, 1978, ANAL BIOCHEM, V85, P461, DOI 10.1016/0003-2697(78)90243-9; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526	46	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46535	10.1371/journal.pone.0046535	http://dx.doi.org/10.1371/journal.pone.0046535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056335	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500047
J	Ellis, RD; Wu, YM; Martin, LB; Shaffer, D; Miura, K; Aebig, J; Orcutt, A; Rausch, K; Zhu, DM; Mogensen, A; Fay, MP; Narum, DL; Long, C; Miller, L; Durbin, AP				Ellis, Ruth D.; Wu, Yimin; Martin, Laura B.; Shaffer, Donna; Miura, Kazutoyo; Aebig, Joan; Orcutt, Andrew; Rausch, Kelly; Zhu, Daming; Mogensen, Anders; Fay, Michael P.; Narum, David L.; Long, Carole; Miller, Louis; Durbin, Anna P.			Phase 1 Study in Malaria Naive Adults of BSAM2/Alhydrogel (R)+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; PLASMODIUM-FALCIPARUM; ANTIBODY TITER; TRIAL; PROTECTION; CHILDREN; IMMUNITY; IMMUNOGENICITY; RESPONSES; ADJUVANT	A Phase 1 dose escalating study was conducted in malaria naive adults to assess the safety, reactogenicity, and immunogenicity of the blood stage malaria vaccine BSAM2/Alhydrogel (R)+ CPG 7909. BSAM2 is a combination of the FVO and 3D7 alleles of recombinant AMA1 and MSP1(42), with equal amounts by weight of each of the four proteins mixed, bound to Alhydrogel (R), and administered with the adjuvant CPG 7909. Thirty ( 30) volunteers were enrolled in two dose groups, with 15 volunteers receiving up to three doses of 40 mu g total protein at Days 0, 56, and 180, and 15 volunteers receiving up to three doses of 160 mu g protein on the same schedule. Most related adverse events were mild or moderate, but 4 volunteers experienced severe systemic reactions and two were withdrawn from vaccinations due to adverse events. Geometric mean antibody levels after two vaccinations with the high dose formulation were 136 mu g/ml for AMA1 and 78 mu g/ml for MSP1(42). Antibody responses were not significantly different in the high dose versus low dose groups and did not further increase after third vaccination. In vitro growth inhibition was demonstrated and was closely correlated with anti-AMA1 antibody responses. A Phase 1b trial in malaria-exposed adults is being conducted.	[Ellis, Ruth D.; Wu, Yimin; Martin, Laura B.; Aebig, Joan; Orcutt, Andrew; Rausch, Kelly; Zhu, Daming; Mogensen, Anders; Narum, David L.; Miller, Louis] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Shaffer, Donna; Durbin, Anna P.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Baltimore, MD USA; [Miura, Kazutoyo; Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Rockville, MD USA; [Long, Carole] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wu, YM (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA.	yiwu@niaid.nih.gov	Martin, Laura/N-1789-2013; Miura, Kazutoyo/AAY-9751-2020; Fay, Michael P/A-2974-2008	Martin, Laura/0000-0002-4431-4381; Miura, Kazutoyo/0000-0003-4455-2432; Fay, Michael P/0000-0002-8643-9625; Narum, David/0000-0003-3041-5402	National Institutes of Health, National Institute of Allergy and Infectious Disease; PATH Malaria Vaccine Initiative (MVI); United States Agency for International Development (USAID) Malaria Vaccine Development Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, ZIAAI001020] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PATH Malaria Vaccine Initiative (MVI); United States Agency for International Development (USAID) Malaria Vaccine Development Program(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural program of the National Institutes of Health, National Institute of Allergy and Infectious Disease. Support for the Growth Inhibition Assay (GIA) Reference Center was provided in part by the PATH Malaria Vaccine Initiative (MVI) and by the United States Agency for International Development (USAID) Malaria Vaccine Development Program through a 361 cooperative agreement between USAID and MVI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Duncan CJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022271; Duncan CJA, 2012, HUMAN VACCINES IMMUN, V8; Dutta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008138; Ellis RW, 2009, HUM VACCINES, V5, P1; Ellis RD, 2010, HUM VACCINES, V6, P627, DOI 10.4161/hv.6.8.11446; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Fay MP, 2005, BIOSTATISTICS, V6, P171, DOI 10.1093/biostatistics/kxh027; Genton B, 2000, VACCINE, V18, P2504, DOI 10.1016/S0264-410X(00)00036-0; Genton B, 2003, VACCINE, V22, P30, DOI 10.1016/S0264-410X(03)00536-X; Giersing B, 2005, INFECT IMMUN, V73, P3963, DOI 10.1128/IAI.73.7.3963-3970.2005; Goodman AL, 2010, ANN TROP MED PARASIT, V104, P189, DOI 10.1179/136485910X12647085215534; Krieg AM, 2004, J IMMUNOTHER, V27, P460, DOI 10.1097/00002371-200411000-00006; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Narum DL, 2006, INFECT IMMUN, V74, P5529, DOI 10.1128/IAI.00573-06; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Ouattara A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-175; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Sagara I, 2009, VACCINE, V27, P7292, DOI 10.1016/j.vaccine.2009.10.087; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; WHO, 2011, WORLD MALARIA REPORT 2011, P1	34	39	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46094	10.1371/journal.pone.0046094	http://dx.doi.org/10.1371/journal.pone.0046094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056238	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800008
J	Nagaraja, T; Chen, L; Balasubramanian, A; Groopman, JE; Ghoshal, K; Jacob, ST; Leask, A; Brigstock, DR; Anand, AR; Ganju, RK				Nagaraja, Tirumuru; Chen, Li; Balasubramanian, Anuradha; Groopman, Jerome E.; Ghoshal, Kalpana; Jacob, Samson T.; Leask, Andrew; Brigstock, David R.; Anand, Appakkudal R.; Ganju, Ramesh K.			Activation of the Connective Tissue Growth Factor (CTGF)-Transforming Growth Factor beta 1 (TGF-beta 1) Axis in Hepatitis C Virus-Expressing Hepatocytes	PLOS ONE			English	Article							PANCREATIC STELLATE CELLS; LIVER FIBROSIS; TGF-BETA; FACTOR CTGF/CCN2; MESENCHYMAL TRANSITION; CTGF EXPRESSION; GENE; FIBROGENESIS; FIBROBLASTS; RAT	Background: The pro-fibrogenic cytokine connective tissue growth factor (CTGF) plays an important role in the development and progression of fibrosis in many organ systems, including liver. However, its role in the pathogenesis of hepatitis C virus (HCV)-induced liver fibrosis remains unclear. Methods: In the present study, we assessed CTGF expression in HCV-infected hepatocytes using replicon cells containing full-length HCV genotype 1 and the infectious HCV clone JFH1 (HCV genotype 2) by real-time PCR, Western blot analysis and confocal microscopy. We evaluated transforming growth factor beta 1 (TGF-beta 1) as a key upstream mediator of CTGF production using neutralizing antibodies and shRNAs. We also determined the signaling molecules involved in CTGF production using various immunological techniques. Results: We demonstrated an enhanced expression of CTGF in two independent models of HCV infection. We also demonstrated that HCV induced CTGF expression in a TGF-beta 1-dependent manner. Further dissection of the molecular mechanisms revealed that CTGF production was mediated through sequential activation of MAPkinase and Smad-dependent pathways. Finally, to determine whether CTGF regulates fibrosis, we showed that shRNA-mediated knock-down of CTGF resulted in reduced expression of fibrotic markers in HCV replicon cells. Conclusion: Our studies demonstrate a central role for CTGF expression in HCV-induced liver fibrosis and highlight the potential value of developing CTGF-based anti-fibrotic therapies to counter HCV-induced liver damage.	[Chen, Li; Brigstock, David R.] Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA; [Nagaraja, Tirumuru; Anand, Appakkudal R.; Ganju, Ramesh K.] Ohio State Univ, Dept Pathol, Wexner Med Ctr, Columbus, OH 43210 USA; [Balasubramanian, Anuradha; Groopman, Jerome E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA; [Ghoshal, Kalpana; Jacob, Samson T.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Leask, Andrew] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Ohio; Ohio State University; Western University (University of Western Ontario)	Brigstock, DR (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA.	David.Brigstock@nationwidechildrens.org; Appakkudal.Anand@osumc.edu; Ramesh.Ganju@osumc.edu	Leask, Andrew/G-5217-2015; Leask, Andy/ABH-9433-2020		National Institutes of Health [RO1 HL087576, R01AA016003]; Ohio State University; Nationwide Children's Hospital, Columbus, OH; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University(Ohio State University); Nationwide Children's Hospital, Columbus, OH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants National Institutes of Health RO1 HL087576 to RKG, R01AA016003 to DRB and a collaborative seed grant from The Ohio State University' and Nationwide Children's Hospital, Columbus, OH to RKG and DRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2006, HCV REPLICON SYSTEMS; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Charrier AL, 2010, LAB INVEST, V90, P1179, DOI 10.1038/labinvest.2010.82; Chen L, 2010, J HEPATOL; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Dong ZZ, 2008, HEPATOB PANCREAT DIS, V7, P288; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Gao R, 2006, GUT, V55, P856, DOI 10.1136/gut.2005.079178; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gore-Hyer E, 2002, AM J PHYSIOL-RENAL, V283, pF707, DOI 10.1152/ajprenal.00007.2002; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gressner OA, 2007, J HEPATOL, V47, P699, DOI 10.1016/j.jhep.2007.05.015; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hall CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012154; Hora C, 2008, LIVER INT, V28, P370, DOI 10.1111/j.1478-3231.2007.01608.x; Kovalenko E, 2009, J VIRAL HEPATITIS, V16, P612, DOI 10.1111/j.1365-2893.2009.01110.x; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Lin WY, 2011, J BIOL CHEM, V286, P2665, DOI 10.1074/jbc.M110.168286; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Nelson DR, 1997, J VIRAL HEPATITIS, V4, P29, DOI 10.1046/j.1365-2893.1997.00124.x; Nitta T, 2008, HEPATOLOGY, V48, P909, DOI 10.1002/hep.22397; Paradis V, 1999, HEPATOLOGY, V30, P968, DOI 10.1002/hep.510300425; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Presser LD, 2011, VIROLOGY, V412, P284, DOI 10.1016/j.virol.2010.12.051; Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3; Shin JY, 2005, EXP MOL MED, V37, P138, DOI 10.1038/emm.2005.19; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Xu SW, 2007, ARTHRITIS RHEUM-US, V56, P4189, DOI 10.1002/art.23134; Yokoi H, 2004, J AM SOC NEPHROL, V15, P1430, DOI 10.1097/01.ASN.0000130565.69170.85; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhao Z, 2005, FASEB J, V19, P2081, DOI 10.1096/fj.05-4359fje; Zoulim F, 2003, REV MED VIROL, V13, P57, DOI 10.1002/rmv.371	36	32	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46526	10.1371/journal.pone.0046526	http://dx.doi.org/10.1371/journal.pone.0046526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056332	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800024
J	Stotz, SC; Clapham, DE				Stotz, Stephanie C.; Clapham, David E.			Anion-Sensitive Fluorophore Identifies the Drosophila Swell-Activated Chloride Channel in a Genome-Wide RNA Interference Screen	PLOS ONE			English	Article							BESTROPHIN FAMILY; CL-CHANNEL; PROTEIN; CALCIUM; BINDING; CONDUCTANCE; PHYSIOLOGY; INDICATOR; TRANSPORT; DISEASE	When cells swell in hypo-osmotic solutions, chloride-selective ion channels (Cl-swell) activate to reduce intracellular osmolality and prevent catastrophic cell rupture. Despite intensive efforts to assign a molecular identity to the mammalian Clswell channel, it remains unknown. In an unbiased genome-wide RNA interference (RNAi) screen of Drosophila cells stably expressing an anion-sensitive fluorescent indicator, we identify Bestrophin 1 (dBest1) as the Drosophila C-lswell channel. Of the 23 screen hits with mammalian homologs and predicted transmembrane domains, only RNAi specifically targeting dBest1 eliminated the Cl-swell current (I-Clswell). We further demonstrate the essential contribution of dBest1 to Drosophila I-Clswell with the introduction of a human Bestrophin disease-associated mutation (W94C). Overexpression of the W94C construct in Drosophila cells significantly reduced the endogenous I-Clswell. We confirm that exogenous expression of dBest1 alone in human embryonic kidney (HEK293) cells creates a clearly identifiable Drosophila-like I-Clswell. In contrast, activation of mouse Bestrophin 2 (mBest2), the closest mammalian ortholog of dBest1, is swell-insensitive. The first 64 residues of dBest1 conferred swell activation to mBest2. The chimera, however, maintains mBest2-like pore properties, strongly indicating that the Bestrophin protein forms the Cl-swell channel itself rather than functioning as an essential auxiliary subunit. dBest1 is an anion channel clearly responsive to swell; this activation depends upon its N-terminus.	[Stotz, Stephanie C.; Clapham, David E.] Boston Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Boston, MA USA; [Clapham, David E.] Boston Childrens Hosp, Manton Ctr Orphan Dis, Boston, MA USA; [Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Boston Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Boston, MA USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428	Tommy Kaplan Fellowship, Boston Children's Hospital, Boston; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067761] Funding Source: NIH RePORTER	Tommy Kaplan Fellowship, Boston Children's Hospital, Boston; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SCS is supported by the Tommy Kaplan Fellowship, Boston Children's Hospital, Boston. Howard Hughes Medical Institute provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Baumgarten CM, 2003, PROG BIOPHYS MOL BIO, V82, P25, DOI 10.1016/S0079-6107(03)00003-8; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Chien LT, 2008, J GEN PHYSIOL, V132, P537, DOI 10.1085/jgp.200810065; de Tassigny AD, 2003, FUND CLIN PHARMACOL, V17, P539, DOI 10.1046/j.1472-8206.2003.00197.x; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Fischmeister R, 2005, J PHYSIOL-LONDON, V562, P477, DOI 10.1113/jphysiol.2004.075622; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; GILL DR, 1992, CELL, V71, P23, DOI 10.1016/0092-8674(92)90263-C; GOSLING M, 1995, J PHYSIOL-LONDON, V485, P671, DOI 10.1113/jphysiol.1995.sp020761; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; LANDRY D, 1993, J BIOL CHEM, V268, P14948; Markova O, 2008, J NEUROSCI METH, V170, P67, DOI 10.1016/j.jneumeth.2007.12.016; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Milenkovic VM, 2011, J CELL SCI, V124, P2988, DOI 10.1242/jcs.085878; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; MOORMAN JR, 1992, J BIOL CHEM, V267, P14551; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; PAULMICHL M, 1992, NATURE, V356, P238, DOI 10.1038/356238a0; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Qu ZQ, 2003, J BIOL CHEM, V278, P49563, DOI 10.1074/jbc.M308414200; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Szucs G, 1996, PFLUG ARCH EUR J PHY, V431, P467, DOI 10.1007/s004240050023; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wachter RM, 2000, J MOL BIOL, V301, P157, DOI 10.1006/jmbi.2000.3905; Worby C.A., 2004, CURR PROTOC MOL BIOL; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008	47	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46865	10.1371/journal.pone.0046865	http://dx.doi.org/10.1371/journal.pone.0046865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056495	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800058
J	Takarada, T; Nakamichi, N; Kitajima, S; Fukumori, R; Nakazato, R; Le, NQ; Kim, YH; Fujikawa, K; Kou, M; Yoneda, Y				Takarada, Takeshi; Nakamichi, Noritaka; Kitajima, Seiya; Fukumori, Ryo; Nakazato, Ryota; Nguyen Quynh Le; Kim, Yeong-Hun; Fujikawa, Koichi; Kou, Miki; Yoneda, Yukio			Promoted Neuronal Differentiation after Activation of Alpha4/Beta2 Nicotinic Acetylcholine Receptors in Undifferentiated Neural Progenitors	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; INTRACELLULAR CALCIUM LEVELS; FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; SUBVENTRICULAR ZONE; PARKINSONS-DISEASE; CEREBRAL-CORTEX; DENTATE GYRUS; ADULT	Background: Neural progenitor is a generic term used for undifferentiated cell populations of neural stem, neuronal progenitor and glial progenitor cells with abilities for proliferation and differentiation. We have shown functional expression of ionotropic N-methyl-D-aspartate (NMDA) and gamma-aminobutyrate type-A receptors endowed to positively and negatively regulate subsequent neuronal differentiation in undifferentiated neural progenitors, respectively. In this study, we attempted to evaluate the possible functional expression of nicotinic acetylcholine receptor (nAChR) by undifferentiated neural progenitors prepared from neocortex of embryonic rodent brains. Methodology/Principal Findings: Reverse transcription polymerase chain reaction analysis revealed mRNA expression of particular nAChR subunits in undifferentiated rat and mouse progenitors prepared before and after the culture with epidermal growth factor under floating conditions. Sustained exposure to nicotine significantly inhibited the formation of neurospheres composed of clustered proliferating cells and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide reduction activity at a concentration range of 1 mu M to 1 mM without affecting cell survival. In these rodent progenitors previously exposed to nicotine, marked promotion was invariably seen for subsequent differentiation into cells immunoreactive for a neuronal marker protein following the culture of dispersed cells under adherent conditions. Both effects of nicotine were significantly prevented by the heteromeric alpha 4 beta 2 nAChR subtype antagonists dihydro-beta-erythroidine and 4-(5-ethoxy-3-pyridinyl)-N-methyl-(3E)-3-buten-1-amine, but not by the homomeric alpha 7 nAChR subtype antagonist methyllycaconitine, in murine progenitors. Sustained exposure to nicotine preferentially increased the expression of Math1 among different basic helix-loop-helix proneural genes examined. In undifferentiated progenitors from embryonic mice defective of NMDA receptor subunit-1, nicotine was still effective in significantly inhibiting the proliferation. Conclusions/Significance: Functional alpha 4 beta 2 nAChR subtype would be constitutively expressed to play a role in the mechanism underlying the determination of proliferation and subsequent differentiation fate into a neuronal lineage in association with preferential promotion of Math1 expression in undifferentiated neural progenitors of developing rodent neocortex independently of NMDA receptor activation.	[Takarada, Takeshi; Nakamichi, Noritaka; Kitajima, Seiya; Fukumori, Ryo; Nakazato, Ryota; Nguyen Quynh Le; Kim, Yeong-Hun; Fujikawa, Koichi; Kou, Miki; Yoneda, Yukio] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yoneda, Y (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Yoneda, Yukio/ABI-1864-2020; Nakamichi, Noritaka/D-8403-2015; Nakamichi, Noritaka/AAB-7388-2020	Yoneda, Yukio/0000-0002-4624-177X; Nakamichi, Noritaka/0000-0002-0283-3546; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22500330, 21659018]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research to T. T. (No. 22500330) and Y.Y. (No. 21659018) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam MF, 2004, MOVEMENT DISORD, V19, P614, DOI 10.1002/mds.20029; ALTMAN J, 1967, NATURE, V214, P1098, DOI 10.1038/2141098a0; Atluri P, 2001, DEV BIOL, V240, P143, DOI 10.1006/dbio.2001.0453; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Cavanagh JFR, 1997, CEREB CORTEX, V7, P293, DOI 10.1093/cercor/7.4.293; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dickinson JA, 2007, J NEUROCHEM, V100, P1089, DOI 10.1111/j.1471-4159.2006.04273.x; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fukumori R, 2010, J PHARMACOL SCI, V112, P273, DOI 10.1254/jphs.09294FP; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Joo JY, 2007, J CELL SCI, V120, P1358, DOI 10.1242/jcs.002154; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kitayama T, 2004, J NEUROSCI RES, V76, P599, DOI 10.1002/jnr.20095; Kitayama T, 2003, J NEUROCHEM, V84, P767, DOI 10.1046/j.1471-4159.2003.01567.x; Lacomme M, 2012, MOL CELL BIOL, V32, P2596, DOI 10.1128/MCB.06745-11; Lindstrom J, 1996, PROG BRAIN RES, V109, P125; Liu L, 1998, BRAIN RES, V809, P238, DOI 10.1016/S0006-8993(98)00862-2; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; MORENS DM, 1995, NEUROLOGY, V45, P1041, DOI 10.1212/WNL.45.6.1041; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamichi N, 2009, J PHARMACOL SCI, V110, P133, DOI 10.1254/jphs.08R03CR; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Rathouz MM, 1996, MOL NEUROBIOL, V12, P117, DOI 10.1007/BF02740649; RATHOUZ MM, 1994, J NEUROSCI, V14, P6935; Resende RR, 2008, EXP CELL RES, V314, P1429, DOI 10.1016/j.yexcr.2008.01.003; SEGUELA P, 1993, J NEUROSCI, V13, P596; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; VANDUIJN CM, 1991, BRIT MED J, V302, P1491, DOI 10.1136/bmj.302.6791.1491; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; Weiland S, 2000, BEHAV BRAIN RES, V113, P43, DOI 10.1016/S0166-4328(00)00199-6; Yoneyama M, 2008, J NEUROSCI RES, V86, P2392, DOI 10.1002/jnr.21696; Yoneyama M, 2007, J NEUROCHEM, V100, P1667, DOI 10.1111/j.1471-4159.2006.04322.x; Young A, 2011, NEUROSCIENCE, V192, P793, DOI 10.1016/j.neuroscience.2011.04.039	43	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46177	10.1371/journal.pone.0046177	http://dx.doi.org/10.1371/journal.pone.0046177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056257	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800013
J	Jaine, FRA; Couturier, LIE; Weeks, SJ; Townsend, KA; Bennett, MB; Fiora, K; Richardson, AJ				Jaine, Fabrice R. A.; Couturier, Lydie I. E.; Weeks, Scarla J.; Townsend, Kathy A.; Bennett, Michael B.; Fiora, Kym; Richardson, Anthony J.			When Giants Turn Up: Sighting Trends, Environmental Influences and Habitat Use of the Manta Ray Manta alfredi at a Coral Reef	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; SPATIAL DYNAMICS; NINGALOO REEF; WHALE SHARKS; CATCH RATES; ZOOPLANKTON; CIRCULATION; CURRENTS; SEA	Manta rays Manta alfredi are present all year round at Lady Elliot Island (LEI) in the southern Great Barrier Reef, Australia, with peaks in abundance during autumn and winter. Drivers influencing these fluctuations in abundance of M. alfredi at the site remain uncertain. Based on daily count, behavioural, weather and oceanographic data collected over a three-year period, this study examined the link between the relative number of sightings of manta rays at LEI, the biophysical environment, and the habitat use of individuals around the LEI reef using generalised additive models. The response variable in each of the three generalised additive models was number of sightings (per trip at sea) of cruising, cleaning or foraging M. alfredi. We used a set of eleven temporal, meteorological, biological, oceanographic and lunar predictor variables. Results for cruising, cleaning and foraging M. alfredi explained 27.5%, 32.8% and 36.3% of the deviance observed in the respective models and highlighted five predictors (year, day of year, wind speed, chlorophyll-a concentration and fraction of moon illuminated) as common influences to the three models. There were more manta rays at LEI in autumn and winter, slower wind speeds, higher productivity, and around the new and full moon. The winter peak in sightings of foraging M. alfredi was found to precede peaks in cleaning and cruising activity around the LEI reef, which suggests that enhanced food availability may be a principal driver for this seasonal aggregation. A spatial analysis of behavioural observations highlighted several sites around the LEI reef as 'multi-purpose' areas where cleaning and foraging activities commonly occur, while the southern end of the reef is primarily a foraging area. The use of extensive citizen science datasets, such as those collected by dive operators in this study, is encouraged as they can provide valuable insights into a species' ecology.	[Jaine, Fabrice R. A.; Weeks, Scarla J.] Univ Queensland, Sch Geog Planning & Environm Management, Biophys Oceanog Grp, St Lucia, Qld, Australia; [Jaine, Fabrice R. A.; Couturier, Lydie I. E.; Richardson, Anthony J.] CSIRO Marine & Atmospher Res, Ecosci Precinct, Climate Adaptat Flagship, Dutton Pk, Australia; [Couturier, Lydie I. E.; Bennett, Michael B.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Townsend, Kathy A.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Townsend, Kathy A.] Univ Queensland, Moreton Bay Res Stn, Dunwich, Australia; [Fiora, Kym] Lady Elliot Isl Eco Resort, Watersports, Torquay, Australia; [Richardson, Anthony J.] Univ Queensland, Sch Math & Phys, Ctr Applicat Nat Resource Math, St Lucia, Qld, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of Queensland; University of Queensland; University of Queensland	Jaine, FRA (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Biophys Oceanog Grp, St Lucia, Qld, Australia.	f.jaine@uq.edu.au	Richardson, Anthony J/B-3649-2010; Bennett, Michael/A-7218-2012; Couturier, Lydie I. E./J-9695-2014; Bennett, Michael/L-4483-2019; Jaine, Fabrice/D-1622-2016; Townsend, Kathy Ann/K-9486-2016; Weeks, Scarla J/E-8632-2013; Couturier, Lydie/I-9793-2019	Richardson, Anthony J/0000-0002-9289-7366; Couturier, Lydie I. E./0000-0002-3885-3397; Bennett, Michael/0000-0001-8051-0040; Jaine, Fabrice/0000-0002-9304-5034; Townsend, Kathy Ann/0000-0002-2581-2158; Weeks, Scarla J/0000-0002-0579-7069; Couturier, Lydie/0000-0002-3885-3397	Australian Research Council [LP110100712]; University of Queensland; Earthwatch Institute Australia; Brother Pty Ltd; Lady Elliot Island Eco Resort	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland); Earthwatch Institute Australia; Brother Pty Ltd; Lady Elliot Island Eco Resort	This work was funded by the Australian Research Council (Linkage Grant LP110100712) and supported by the University of Queensland, Earthwatch Institute Australia, Brother Pty Ltd and Lady Elliot Island Eco Resort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2000, ENVIRON BIOL FISH, V58, P33, DOI 10.1023/A:1007657019696; AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Agenbag JJ, 2003, PROG OCEANOGR, V59, P275, DOI 10.1016/j.pocean.2003.07.004; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; ANDREWS JC, 1989, DEEP-SEA RES, V36, P957, DOI 10.1016/0198-0149(89)90037-X; ANDREWS JC, 1982, MAR ECOL PROG SER, V8, P257, DOI 10.3354/meps008257; [Anonymous], 1967, TREATISE LIMNOL; ATKINSON LP, 1978, B MAR SCI, V28, P667; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Bhattacharjee Y, 2005, SCIENCE, V308, P1402, DOI 10.1126/science.308.5727.1402; Bigelow KA, 1999, FISH OCEANOGR, V8, P178, DOI 10.1046/j.1365-2419.1999.00105.x; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Burrage DM, 1996, REMOTE SENS ENVIRON, V56, P21, DOI 10.1016/0034-4257(95)00226-X; Carleton JH, 2001, MAR BIOL, V139, P705; Choukroun S, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005761; Clark T.B., 2010, THESIS U HAWAII MANO; Cotton PA, 2005, FISH OCEANOGR, V14, P151, DOI 10.1111/j.1365-2419.2005.00331.x; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Delaney DG, 2008, BIOL INVASIONS, V10, P117, DOI 10.1007/s10530-007-9114-0; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; FLAGG CN, 1994, DEEP-SEA RES PT II, V41, P411, DOI 10.1016/0967-0645(94)90030-2; Friedlaender AS, 2006, MAR ECOL PROG SER, V317, P297, DOI 10.3354/meps317297; Goffredo S, 2010, ECOL APPL, V20, P2170, DOI 10.1890/09-1546.1; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; GRIFFIN DA, 1987, AUST J MAR FRESH RES, V38, P461; Guisan A, 2006, J APPL ECOL, V43, P386, DOI 10.1111/j.1365-2664.2006.01164.x; GYURIS E, 1994, CORAL REEFS, V13, P137, DOI 10.1007/BF00301189; HAMNER WM, 1981, LIMNOL OCEANOGR, V26, P1084, DOI 10.4319/lo.1981.26.6.1084; HAMNER WM, 1977, AUST J MAR FRESH RES, V28, P333; Hastie GD, 2005, ICES J MAR SCI, V62, P760, DOI 10.1016/j.icesjms.2005.02.004; HASTIE T, 1987, J AM STAT ASSOC, V82, P371, DOI 10.2307/2289439; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Homma K, 1999, PROCEEDINGS OF THE 5TH INDO-PACIFIC FISH CONFERENCE, P209; Hooker SK, 1999, P ROY SOC B-BIOL SCI, V266, P671, DOI 10.1098/rspb.1999.0688; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jaine FRA, J FISH BIOL IN PRESS; KLEYPAS JA, 1994, INT J REMOTE SENS, V15, P2051, DOI 10.1080/01431169408954227; Klimley AP, 2001, MAR BIOL, V138, P1; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Luiz OJ, 2009, ICHTHYOL RES, V56, P96, DOI 10.1007/s10228-008-0060-3; Marshall A, 2011, IUCN 2011 IUCN RED L; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall AD, 2010, AFR J MAR SCI, V32, P573, DOI 10.2989/1814232X.2010.538152; Marshall A.D., 2009, THESIS U QUEENSLAND; Marshall AD, 2009, ZOOTAXA, P1; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; O'Donoghue SH, 2010, AFR J MAR SCI, V32, P361, DOI 10.2989/1814232X.2010.502640; O'Dor RK, 2002, B MAR SCI, V71, P601; O'Shea OR, 2010, MAR FRESHWATER RES, V61, P65, DOI 10.1071/MF08301; OREILLY JE, 2000, 2000206892 NASA GO 3, V11; Panigada S, 2008, REMOTE SENS ENVIRON, V112, P3400, DOI 10.1016/j.rse.2007.11.017; Papastamatiou YP, 2012, MAR ECOL PROG SER, V456, P233, DOI 10.3354/meps09721; Pillans RD, 2006, THESIS U QUEENSLAND; PLOURDE S, 1993, MAR ECOL PROG SER, V102, P217, DOI 10.3354/meps102217; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; PRESSLEY PH, 1980, ENVIRON BIOL FISH, V5, P153; RECHER H F, 1972, Emu, V72, P85; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Samoilys MA, 1997, MAR ECOL PROG SER, V160, P149, DOI 10.3354/meps160149; Schofield G, 2009, J ANIM ECOL, V78, P14, DOI 10.1111/j.1365-2656.2008.01454.x; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V382, P77, DOI 10.1016/j.jembe.2009.10.015; Sleeman JC, 2007, MAR FRESHWATER RES, V58, P608, DOI 10.1071/MF06213; Taylor J. G., 1999, Journal of the Royal Society of Western Australia, V82, P57; Walsh WA, 2001, FISH RES, V53, P115, DOI 10.1016/S0165-7836(00)00306-4; Weeks SJ, 2010, CORAL REEFS, P1; White WT, 2006, FISH RES, V82, P65, DOI 10.1016/j.fishres.2006.08.008; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753; WOLANSKI E, 1994, MARINE SCI SERIES; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295	87	73	76	2	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46170	10.1371/journal.pone.0046170	http://dx.doi.org/10.1371/journal.pone.0046170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056255	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000022
J	Liu, MY; Qiao, GR; Jiang, J; Yang, HQ; Xie, LH; Xie, JZ; Zhuo, RY				Liu, Mingying; Qiao, Guirong; Jiang, Jing; Yang, Huiqin; Xie, Lihua; Xie, Jinzhong; Zhuo, Renying			Transcriptome Sequencing and De Novo Analysis for Ma Bamboo (Dendrocalamus latiflorus Munro) Using the Illumina Platform	PLOS ONE			English	Article							SSR-MARKERS; GENE DISCOVERY; RNA-SEQ; EXPRESSION; ARABIDOPSIS; MICROSATELLITES; ANNOTATION; RICE; TOOL; CONSERVATION	Background: Bamboo occupies an important phylogenetic node in the grass family with remarkable sizes, woodiness and a striking life history. However, limited genetic research has focused on bamboo partially because of the lack of genomic resources. The advent of high-throughput sequencing technologies enables generation of genomic resources in a short time and at a minimal cost, and therefore provides a turning point for bamboo research. In the present study, we performed de novo transcriptome sequencing for the first time to produce a comprehensive dataset for the Ma bamboo (Dendrocalamus latiflorus Munro). Results: The Ma bamboo transcriptome was sequenced using the Illumina paired-end sequencing technology. We produced 15,138,726 reads and assembled them into 103,354 scaffolds. A total of 68,229 unigenes were identified, among which 46,087 were annotated in the NCBI non-redundant protein database and 28,165 were annotated in the Swiss-Prot database. Of these annotated unigenes, 11,921 and 10,147 unigenes were assigned to gene ontology categories and clusters of orthologous groups, respectively. We could map 45,649 unigenes onto 292 pathways using the Kyoto Encyclopedia of Genes and Genomes Pathway database. The annotated unigenes were compared against Moso bamboo, rice and millet. Unigenes that did not match any of those three sequence datasets are considered to be Ma bamboo unique. We predicted 105 unigenes encoding eight key enzymes involved in lignin biosynthesis. In addition, 621 simple sequence repeats (SSRs) were detected. Conclusion: Our data provide the most comprehensive transcriptomic resource currently available for D. latiflorus Munro. Candidate genes potentially involved in growth and development were identified, and those predicted to be unique to Ma bamboo are expected to give a better insight on Ma bamboo gene diversity. Numerous SSRs characterized contributed to marker development. These data constitute a new valuable resource for genomic studies on D. latiflorus Munro and, more generally, bamboo.	[Liu, Mingying; Qiao, Guirong; Jiang, Jing; Xie, Lihua; Zhuo, Renying] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Liu, Mingying; Qiao, Guirong; Jiang, Jing; Yang, Huiqin; Xie, Lihua; Xie, Jinzhong; Zhuo, Renying] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Peoples R China; [Yang, Huiqin] Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Peoples R China	Chinese Academy of Forestry; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF; Xinjiang University	Zhuo, RY (corresponding author), Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	zhuory@gmail.com	Liu, Mingying/ABE-3277-2020; Xie, Lihua/D-2236-2009; Xie, li/HGE-6052-2022; Liu, Mingying/U-7104-2018	Xie, Lihua/0000-0002-7137-4136; Liu, Mingying/0000-0001-6261-8832; zhuo, renying/0000-0002-7063-3714	Zhejiang Public technology research [2012C22099]; National Non-profit Research Institute of CAF [CAFYBB2011001]; Zhejiang province major project [2010C12010]	Zhejiang Public technology research; National Non-profit Research Institute of CAF; Zhejiang province major project	This work was supported by agricultural projects of Zhejiang Public technology research (No. 2012C22099), a Grant for National Non-profit Research Institute of CAF (No. CAFYBB2011001) and a Zhejiang province major project ( No. 2010C12010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ArguelloAstorga GR, 1996, PLANT PHYSIOL, V112, P1151, DOI 10.1104/pp.112.3.1151; Ariizumi T, 2011, PLANT PHYSIOL, V155, P765, DOI 10.1104/pp.110.166272; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Buell CR, 2009, PLANT PHYSIOL, V149, P111, DOI 10.1104/pp.108.128926; Chang ST, 2000, J WOOD SCI, V46, P40, DOI 10.1007/BF00779551; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Cui K, 2012, J PROTEOME RES, V11, P2492, DOI 10.1021/pr2011878; Das M, 2008, ADV BOT RES, V47, P225, DOI 10.1016/S0065-2296(08)00005-0; Eckert KA, 2002, BIOCHEMISTRY-US, V41, P10490, DOI 10.1021/bi025918c; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Gao ZM, 2011, PLANT CELL REP, V30, P2045, DOI 10.1007/s00299-011-1112-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gui YJ, 2010, J INTEGR PLANT BIOL, V52, P1008, DOI 10.1111/j.1744-7909.2010.00965.x; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hsu YH, 2000, PLANT PATHOL, V49, P101, DOI 10.1046/j.1365-3059.2000.00433.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lin CS, 2007, NEW FOREST, V34, P177, DOI 10.1007/s11056-007-9045-8; Lin XC, 2010, GENET MOL RES, V9, P1085, DOI 10.4238/vol9-2gmr804; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Luo HM, 2010, PHYSIOL PLANTARUM, V139, P1, DOI 10.1111/j.1399-3054.2009.01339.x; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Pauli S, 2004, J VIROL, V78, P12120, DOI 10.1128/JVI.78.22.12120-12128.2004; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Rai V, 2011, GENE, V478, P19, DOI 10.1016/j.gene.2011.01.004; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sato Y, 2001, J PLANT RES, V114, P147, DOI 10.1007/PL00013978; Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6; Severing EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030524; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Yu CW, 2011, PLANT PHYSIOL, V156, P173, DOI 10.1104/pp.111.174417; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875	59	100	114	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46766	10.1371/journal.pone.0046766	http://dx.doi.org/10.1371/journal.pone.0046766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056442	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000082
J	Wang, JH; Chen, XT; Wen, ZS; Zheng, M; Deng, JM; Wang, MZ; Lin, HX; Chen, K; Li, J; Yun, JP; Luo, RZ; Song, LB				Wang, Jian-Hua; Chen, Xiu-Ting; Wen, Zhe-Sheng; Zheng, Min; Deng, Jian-Ming; Wang, Ming-Zhi; Lin, Huan-Xin; Chen, Kun; Li, Jun; Yun, Jing-Ping; Luo, Rong-Zhen; Song, Li-Bing			High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis	PLOS ONE			English	Article							CANCER; GOLGI; MTOR	Background: Whether the expression of Golgi phosphoprotein 3 (GOLPH3) correlates with esophageal cancer tumorigenesis is currently unclear. The aim of this study was to examine GOLPH3 expression in patients with esophageal squamous cell cancer (ESCC) and explore its clinical significance. Methods: Differences in the expression of GOLPH3 at the mRNA and protein level were examined via quantitative reverse transcriptase PCR and western blotting, respectively. GOLPH3 expression levels in ESCC tissue were determined through immunohistochemistry, and were compared in accordance with specific clinicopathological features of the patients and tissue specimens. Factors associated with patient survival were also analyzed. Results: A notably higher level of GOLPH3 expression was found in ESCC cell lines and tissues at both mRNA and protein levels. High expression of GOLPH3 in ESCC patients was positively associated with clinical stage, TNM classification, histological differentiation and vital status (all P < 0.0001). Expression of GOLPH3 was found to be an independent prognostic factor in ESCC patients. ESCC patients expressing high levels of GOLPH3 exhibited a substantially lower 5-year overall survival than GOLPH3-negative patients. Furthermore, a significant correlation between high GOLPH3 expression and shorter overall survival time was found in different subgroups of ESCC patients stratified by the clinical stage, T classification, and lymph node metastasis. Conclusions: Experiments demonstrated potential involvement of GOLPH3 in the development, differentiation, and tumorigenesis of ESCC, and concludes the possibility of its use as a diagnostic and prognostic marker in patients with ESCC.	[Wang, Jian-Hua; Deng, Jian-Ming; Wang, Ming-Zhi] Second Peoples Hosp Guangdong Prov, Dept Chest, Guangzhou, Guangdong, Peoples R China; [Chen, Xiu-Ting; Wen, Zhe-Sheng; Zheng, Min; Song, Li-Bing] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Zhe-Sheng] Sun Yat Sen Univ, Ctr Canc, Dept Chest, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Min] Sun Yat Sen Univ, Ctr Canc, Dept Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Huan-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Radiotherapy, Guangzhou 510275, Guangdong, Peoples R China; [Yun, Jing-Ping; Luo, Rong-Zhen] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Kun] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jun] Sun Yat Sen Univ, Inst Biochem, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wang, JH (corresponding author), Second Peoples Hosp Guangdong Prov, Dept Chest, Guangzhou, Guangdong, Peoples R China.	wangjh296@163.com	Song, LB/AAL-1968-2020		Guangdong Provincial Medical Research Foundation [A2009143]; National Natural Science Foundation of China [81171948]; Natural Science Foundation of China [30900569]	Guangdong Provincial Medical Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Guangdong Provincial Medical Research Foundation (No. A2009143), supported in part by the National Natural Science Foundation of China (grant 81171948) to Min Zheng, and supported in part by the Natural Science Foundation of China (No. 30900569) to Li-Bing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Ganesh B, 2009, CANCER EPIDEMIOL, V33, P431, DOI 10.1016/j.canep.2009.09.002; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Kim SH, 2006, CANCER RES, V66, P10415, DOI 10.1158/0008-5472.CAN-06-2104; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; Mandard AM, 2000, MUTAT RES-REV MUTAT, V462, P335, DOI 10.1016/S1383-5742(00)00019-3; Planchamp C, 2007, MOL PHARMACOL, V71, P1089, DOI 10.1124/mol.106.030759; Polednak AP, 2003, INT J CANCER, V105, P98, DOI 10.1002/ijc.11029; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Tong L, 2012, DIS ESOPHAGUS, V25, P72, DOI 10.1111/j.1442-2050.2011.01211.x; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zheng M, 2010, OBSTET GYNECOL, V116, P884, DOI 10.1097/AOG.0b013e3181f104ce	17	53	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45622	10.1371/journal.pone.0045622	http://dx.doi.org/10.1371/journal.pone.0045622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056210	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600011
J	Hao, YQ; Zhao, XF; She, DY; Xu, B; Zhang, DY; Liao, WJ				Hao, Yi-Qi; Zhao, Xin-Feng; She, Deng-Ying; Xu, Bing; Zhang, Da-Yong; Liao, Wan-Jin			The Role of Late-Acting Self-Incompatibility and Early-Acting Inbreeding Depression in Governing Female Fertility in Monkshood, Aconitum kusnezoffii	PLOS ONE			English	Article							EMBRYO-LETHAL MUTANTS; REPRODUCTIVE SUCCESS; ARABIDOPSIS-THALIANA; HIGHBUSH BLUEBERRY; FLOWERING PLANTS; GENETIC LOAD; EVOLUTION; STERILITY; FERTILIZATION; CONSEQUENCES	Reduced seed yields following self-pollination have repeatedly been observed, but the underlying mechanisms remain elusive when self-pollen tubes can readily grow into ovaries, because pre-, post-zygotic late-acting self-incompatibility (LSI), or early-acting inbreeding depression (ID) can induce self-sterility. The main objective of this study was to differentiate these processes in Aconitum kusnezoffii, a plant lacking stigmatic or stylar inhibition of self-pollination. We performed a hand-pollination experiment in a natural population of A. kusnezoffii, compared seed set among five pollination treatments, and evaluated the distribution of seed size and seed set. Embryonic development suggested fertilization following self-pollination. A partial pre-zygotic LSI was suggested to account for the reduced seed set by two lines of evidence. The seed set of chase-pollination treatment significantly exceeded that of self-pollination treatment, and the proportion of unfertilized ovules was the highest following self-pollination. Meanwhile, early-acting ID, rather than post-zygotic LSI, was suggested by the findings that the size of aborted selfed seeds varied continuously and widely; and the selfed seed set both exhibited a continuous distribution and positively correlated with the crossed seed set. These results indicated that the embryos were aborted at different stages due to the expression of many deleterious alleles throughout the genome during seed maturation. No signature of post-zygotic LSI was found. Both partial pre-zygotic LSI and early-acting ID contribute to the reduction in selfed seed set in A. kusnezoffii, with pre-zygotic LSI rejecting part of the self-pollen and early-acting ID aborting part of the self-fertilized seeds.	[Liao, Wan-Jin] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; Beijing Normal Univ, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Liao, WJ (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	liaowj@bnu.edu.cn	Zhang, Da-Yong/B-3078-2011	Zhang, Da-Yong/0000-0003-1056-8735; Zhao, Xin-Feng/0000-0002-8110-0008	National Natural Science Foundation of China [31121003, 30430160]; Fundamental Research Funds for the Central Universities; National University Student Innovation Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National University Student Innovation Program	This study was supported by the National Natural Science Foundation of China (31121003; 30430160), the Fundamental Research Funds for the Central Universities, and the National University Student Innovation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A. M., 2008, P73, DOI 10.1007/978-3-540-68486-2_4; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Darwin CR, 1876, EFFECTS CROSS SELF F; deNettancourt D, 1997, SEX PLANT REPROD, V10, P185, DOI 10.1007/s004970050087; Franklin F. C. H., 1995, V158, P1; Gibbs PE, 1999, INT J PLANT SCI, V160, P72, DOI 10.1086/314108; Gibbs PE, 1999, ANN BOT-LONDON, V84, P449, DOI 10.1006/anbo.1999.0933; Glover B.J., 2007, UNDERSTANDING FLOWER; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Hokanson K, 2000, SEX PLANT REPROD, V13, P145, DOI 10.1007/s004970000046; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; KENRICK J, 1986, PLANTA, V169, P245, DOI 10.1007/BF00392321; KREBS SL, 1991, AM J BOT, V78, P1427, DOI 10.2307/2445281; KREBS SL, 1990, THEOR APPL GENET, V79, P825, DOI 10.1007/BF00224252; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Liao WJ, 2009, ANN BOT-LONDON, V104, P1405, DOI 10.1093/aob/mcp237; Lipow SR, 1999, AM J BOT, V86, P1114, DOI 10.2307/2656974; Lipow SR, 2000, GENETICS, V154, P893; LLOYD DG, 1979, AM NAT, V113, P67, DOI 10.1086/283365; Mahy G, 1999, ANN BOT-LONDON, V83, P697, DOI 10.1006/anbo.1999.0874; MATTON DP, 1994, P NATL ACAD SCI USA, V91, P1992, DOI 10.1073/pnas.91.6.1992; MEINKE DW, 1979, DEV BIOL, V72, P50, DOI 10.1016/0012-1606(79)90097-6; MEINKE DW, 1982, THEOR APPL GENET, V63, P381, DOI 10.1007/BF00303912; Nuortila C, 2006, ANN BOT FENN, V43, P36; Porcher E, 2009, J EVOLUTION BIOL, V22, P708, DOI 10.1111/j.1420-9101.2009.01705.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sage T. L., 1994, Genetic control of self-incompatibility and reproductive development in flowering plants., P116; Sage TL, 1999, AM J BOT, V86, P855, DOI 10.2307/2656706; Sage TL, 2003, ANN BOT-LONDON, V91, P807, DOI 10.1093/aob/mcg085; Sears ER, 1937, GENETICS, V22, P130; SEAVEY SR, 1986, BOT REV, V52, P195, DOI 10.1007/BF02861001; Valtuena FJ, 2010, AM J BOT, V97, P123, DOI 10.3732/ajb.0800332; WIENS D, 1987, OECOLOGIA, V71, P501, DOI 10.1007/BF00379288; WILLIAMS EG, 1986, AUST J BOT, V34, P413, DOI 10.1071/BT9860413	35	24	26	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47034	10.1371/journal.pone.0047034	http://dx.doi.org/10.1371/journal.pone.0047034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056570	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400048
J	Krissi, H; Eitan, R; Ram, E; Peled, Y				Krissi, Haim; Eitan, Ram; Ram, Edward; Peled, Yoav			How Accurate Is Preoperative Evaluation of Pelvic Organ Prolapse in Women Undergoing Vaginal Reconstruction Surgery?	PLOS ONE			English	Article								Objective: To evaluate the differences between the in-office and intraoperative techniques used to evaluate pelvic organ prolapse. Materials and Methods: A prospective study included 25 women undergoing vaginal reconstruction surgery including vaginal hysterectomy for pelvic organ prolapse. The outpatient pelvic and site-specific vaginal examination was performed in the lithotomy position with the Valsalva maneuver. Repeated intraoperative examination was performed under general anesthesia with standard mild cervical traction. The Pelvic Organ Prolapse Quantification system (POPQ) was used for both measurements and staging. The values found under the two conditions were compared. Results: The intraoperative POPQ-measurements values were significantly higher than the outpatient values for apical wall prolapse in 17/25 (68%) women and for anterior wall prolapse in 8/25 (32%) women. There was not a significant difference in the posterior wall where increase in staging was shown in 3/25 (12%) patients. Conclusions: Clinicians and patients should be alert to the possibility that pelvic organ measurements performed under general anesthesia with mild traction may be different from preoperative evaluation.	[Krissi, Haim; Eitan, Ram; Peled, Yoav] Helen Schneider Hosp Women, Rabin Med Ctr, Dept Obstet & Gynecol, Urogynecol Unit, Petah Tiqwa, Israel; [Krissi, Haim; Eitan, Ram; Ram, Edward; Peled, Yoav] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ram, Edward] Hasharon Hosp, Rabin Med Ctr, Div Surg, Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center	Krissi, H (corresponding author), Helen Schneider Hosp Women, Rabin Med Ctr, Dept Obstet & Gynecol, Urogynecol Unit, Petah Tiqwa, Israel.	haimkr@clalit.org.il	Ram, Edward/C-7881-2019; Ram, Edward/L-5148-2017	Ram, Edward/0000-0002-1855-2415				Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Cohen SJ, 1972, ABDOMINAL VAGINAL HY; Darjent D, 2004, VAGINAL LAPAROSCOPIC, P47; Mol BW, 2009, COCHRANE DATABASE SY, V8; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Su H, 2012, TAIWAN J OBSTET GYNE, V51, P217, DOI 10.1016/j.tjog.2012.04.009; Vierhout ME, 2006, INT UROGYNECOL J, V17, P46, DOI 10.1007/s00192-005-1347-9; Vineyard DD, 2002, AM J OBSTET GYNECOL, V186, P1155, DOI 10.1067/mob.2002.122985	8	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47027	10.1371/journal.pone.0047027	http://dx.doi.org/10.1371/journal.pone.0047027			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056566	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400046
J	Bourget, G				Bourget, Gulhan			Handling Missing Data in Transmission Disequilibrium Test in Nuclear Families with One Affected Offspring	PLOS ONE			English	Article							ASSOCIATION; LINKAGE	The Transmission Disequilibrium Test (TDT) compares frequencies of transmission of two alleles from heterozygote parents to an affected offspring. This test requires all genotypes to be known from all members of the nuclear families. However, obtaining all genotypes in a study might not be possible for some families, in which case, a data set results in missing genotypes. There are many techniques of handling missing genotypes in parents but only a few in offspring. The robust TDT (rTDT) is one of the methods that handles missing genotypes for all members of nuclear families [with one affected offspring]. Even though all family members can be imputed, the rTDT is a conservative test with low power. We propose a new method, Mendelian Inheritance TDT (MITDT-ONE), that controls type I error and has high power. The MITDT-ONE uses Mendelian Inheritance properties, and takes population frequencies of the disease allele and marker allele into account in the rTDT method. One of the advantages of using the MITDT-ONE is that the MITDT-ONE can identify additional significant genes that are not found by the rTDT. We demonstrate the performances of both tests along with Sib-TDT (S-TDT) in Monte Carlo simulation studies. Moreover, we apply our method to the type 1 diabetes data from the Warren families in the United Kingdom to identify significant genes that are related to type 1 diabetes.	Calif State Univ Fullerton, Dept Math, Fullerton, CA 92634 USA	California State University System; California State University Fullerton	Bourget, G (corresponding author), Calif State Univ Fullerton, Dept Math, Fullerton, CA 92634 USA.	galpargu@fullerton.edu			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Allen AS, 2003, AM J HUM GENET, V72, P671, DOI 10.1086/368276; Alpargu G, 2011, COMPUT STAT DATA AN, V55, P1236, DOI 10.1016/j.csda.2010.09.004; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Cervino ACL, 2000, AM J HUM GENET, V67, P120, DOI 10.1086/302992; Chen YH, 2004, GENET EPIDEMIOL, V27, P131, DOI 10.1002/gepi.20004; Clayton D, 1999, AM J HUM GENET, V65; Ewens WJ, 1997, CURRENT PROTOCOL S15; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Knapp M, 1999, AM J HUM GENET, V64; Knapp M, 1999, AM J HUM GENET, V64; Little R.J.A., 2002, STAT ANAL MISSING DA; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McGinnis RE, 1998, ANN HUM GENET, V62, P159, DOI 10.1046/j.1469-1809.1998.6220159.x; Monks SA, 1998, AM J HUM GENET, V63, P1507, DOI 10.1086/302104; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Sebastiani P, 2004, GENETICS, V168, P2329, DOI 10.1534/genetics.103.025841; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337	23	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46100	10.1371/journal.pone.0046100	http://dx.doi.org/10.1371/journal.pone.0046100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056239	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500026
J	Kulangara, C; Luedin, S; Dietz, O; Rusch, S; Frank, G; Mueller, D; Moser, M; Kajava, AV; Corradin, G; Beck, HP; Felger, I				Kulangara, Caroline; Luedin, Samuel; Dietz, Olivier; Rusch, Sebastian; Frank, Geraldine; Mueller, Dania; Moser, Mirjam; Kajava, Andrey V.; Corradin, Giampietro; Beck, Hans-Peter; Felger, Ingrid			Cell Biological Characterization of the Malaria Vaccine Candidate Trophozoite Exported Protein 1	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; MAURERS CLEFTS; HOST-CELL; MEMBRANE; CYTOADHERENCE; SEQUENCE; ANTIGEN; IDENTIFICATION	In a genome-wide screen for alpha-helical coiled coil motifs aiming at structurally defined vaccine candidates we identified PFF0165c. This protein is exported in the trophozoite stage and was named accordingly Trophozoite exported protein 1 (Tex1). In an extensive preclinical evaluation of its coiled coil peptides Tex1 was identified as promising novel malaria vaccine candidate providing the rational for a comprehensive cell biological characterization of Tex1. Antibodies generated against an intrinsically unstructured N-terminal region of Tex1 and against a coiled coil domain were used to investigate cytological localization, solubility and expression profile. Co-localization experiments revealed that Tex1 is exported across the parasitophorous vacuole membrane and located to Maurer's clefts. Change in location is accompanied by a change in solubility: from a soluble state within the parasite to a membrane-associated state after export to Maurer's clefts. No classical export motifs such as PEXEL, signal sequence/anchor or transmembrane domain was identified for Tex1.	[Kulangara, Caroline; Luedin, Samuel; Dietz, Olivier; Rusch, Sebastian; Mueller, Dania; Moser, Mirjam; Beck, Hans-Peter; Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Frank, Geraldine; Corradin, Giampietro] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Kulangara, Caroline; Luedin, Samuel; Dietz, Olivier; Rusch, Sebastian; Mueller, Dania; Moser, Mirjam; Beck, Hans-Peter; Felger, Ingrid] Univ Basel, Basel, Switzerland; [Kajava, Andrey V.] Univ Montpellier 1 & 2, Ctr Natl Rech Sci, Ctr Rech Biochim Macromol, Montpellier, France	University of Basel; Swiss Tropical & Public Health Institute; University of Lausanne; University of Basel; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Felger, I (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	ingrid.felger@unibas.ch	Kajava, Andrey V/E-1107-2014	Kajava, Andrey V/0000-0002-2342-6886; Felger, Ingrid/0000-0003-1255-2606; Beck, Hans-Peter/0000-0001-8326-4834; Ludin, Samuel/0000-0002-2803-2536	Swiss National Science Foundation [310030-112244]; Novartis Stiftung fur Medizinisch-Biologische Forschung; EMVI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Stiftung fur Medizinisch-Biologische Forschung; EMVI	The project was supported by the Swiss National Science Foundation (http://www.snf.ch/) grant number 310030-112244, by the Novartis Stiftung fur Medizinisch-Biologische Forschung (http://www.stiftungmedbiol.novartis.com/) and EMVI (http://www.emvi.org). This study was funded by the Novartis Stiftung fur Medizinisch-Biologische Forschung (http://www.stiftungmedbiol.novartis.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agak GW, 2008, VACCINE, V26, P1963, DOI 10.1016/j.vaccine.2008.02.020; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; BARNES DA, 1994, MOL BIOCHEM PARASIT, V66, P21, DOI 10.1016/0166-6851(94)90032-9; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Bourke PF, 1996, MOL BIOCHEM PARASIT, V82, P25, DOI 10.1016/0166-6851(96)02715-6; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Caly DL, 2010, J MOL BIOL, V403, P405, DOI 10.1016/j.jmb.2010.08.051; Child MA, 2010, MOL MICROBIOL, V78, P187, DOI 10.1111/j.1365-2958.2010.07324.x; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Corradin Giarnpietro, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P259, DOI 10.2174/187153007782794371; CULVENOR JG, 1987, EXP PARASITOL, V63, P58, DOI 10.1016/0014-4894(87)90078-6; DAY KP, 1993, P NATL ACAD SCI USA, V90, P8292, DOI 10.1073/pnas.90.17.8292; Dixon MWA, 2008, TRAFFIC, V9, P1316, DOI 10.1111/j.1600-0854.2008.00768.x; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Hanssen E, 2008, MOL MICROBIOL, V69, P938, DOI 10.1111/j.1365-2958.2008.06329.x; Helg A, 2003, J IMMUNOL METHODS, V276, P19, DOI 10.1016/S0022-1759(03)00075-9; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; JENSEN JB, 1978, AM J TROP MED HYG, V27, P743, DOI 10.4269/ajtmh.1978.27.743; KNAPP B, 1989, MOL BIOCHEM PARASIT, V37, P47, DOI 10.1016/0166-6851(89)90101-1; Kulangara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005419; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Okitsu SL, 2007, PEPTIDES, V28, P2051, DOI 10.1016/j.peptides.2007.08.007; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Pachlatko E, 2010, MOL MICROBIOL, V77, P1136, DOI 10.1111/j.1365-2958.2010.07278.x; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Saridaki T, 2009, TRAFFIC, V10, P137, DOI 10.1111/j.1600-0854.2008.00860.x; Spielmann T, 2006, MOL BIOL CELL, V17, P3613, DOI 10.1091/mbc.E06-04-0291; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Spycher C, 2003, J BIOL CHEM, V278, P35373, DOI 10.1074/jbc.M305851200; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; Spycher C, 2006, MOL CELL BIOL, V26, P4074, DOI 10.1128/MCB.00095-06; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; Walshaw J, 2001, PROTEIN SCI, V10, P668, DOI 10.1110/ps.36901; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	42	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46112	10.1371/journal.pone.0046112	http://dx.doi.org/10.1371/journal.pone.0046112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056243	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000309831500027
J	Villumsen, KR; Dalsgaard, I; Holten-Andersen, L; Raida, MK				Villumsen, Kasper Romer; Dalsgaard, Inger; Holten-Andersen, Lars; Raida, Martin Kristian			Potential Role of Specific Antibodies as Important Vaccine Induced Protective Mechanism against Aeromonas salmonicida in Rainbow Trout	PLOS ONE			English	Article							SALMO-SALAR L; ONCORHYNCHUS-MYKISS WALBAUM; HUMORAL IMMUNE-RESPONSE; INTRAPERITONEAL VACCINATION; IMMERSION VACCINATION; SYSTEMIC AUTOIMMUNITY; GAIRDNERI RICHARDSON; FISH; L.	Furunculosis caused by infection with Aeromonas salmonicida subsp. salmonicida has been a known threat to aquaculture for more than a century. Efficient prophylactic approaches against this disease are essential for continued growth of salmonid aquaculture. Since the introduction of successful oil-adjuvanted vaccines in the early 1990's, a number of studies have been published on the protective as well as adverse effects of these vaccines. Most studies focus on vaccination of salmon (Salmo salar). However, rainbow trout (Oncorhynchus mykiss) are also very susceptible to infection and are vaccinated accordingly. In this study we have examined the protection against infection with a Danish strain of A. salmonicida in both vaccinated and non-vaccinated rainbow trout. A commercial and an experimental auto-vaccine were tested. The protective effects of the vaccines were evaluated through an A. salmonicida challenge 18 weeks post vaccination. Both vaccines resulted in a significantly increased survival in the vaccinated fish during a 28 day challenge period relative to non-vaccinated fish (P = 0.01 and P = 0.001 for the commercial and experimental vaccine, respectively). Throughout the entire experiment, the presence of specific antibodies in plasma was monitored using ELISA. A significant increase in specific antibody levels was seen in fish vaccinated with both vaccines during the 18 weeks between vaccination and challenge. Within 3 days post challenge, a significant decrease in specific antibodies occurred in vaccinated fish. A positive correlation was found between mean levels of specific antibodies pre challenge and overall survival. This correlation, along with the observed depletion of antibodies during the initial phase of infection, suggests that specific antibodies play an essential role in vaccine mediated protection against A. salmonicida in rainbow trout.	[Villumsen, Kasper Romer; Holten-Andersen, Lars; Raida, Martin Kristian] Univ Copenhagen, Fac Hlth & Med Sci, Lab Aquat Pathobiol, DK-1168 Copenhagen, Denmark; [Dalsgaard, Inger] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark	University of Copenhagen; Technical University of Denmark	Villumsen, KR (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Lab Aquat Pathobiol, DK-1168 Copenhagen, Denmark.	krv@life.ku.dk	Villumsen, Kasper Rømer/L-2471-2019	Villumsen, Kasper Rømer/0000-0002-0616-4095; Dalsgaard, Inger/0000-0003-2066-1060	Danish Agency for Science Technology and Innovation [274-07-0354, 11-105095]; University of Copenhagen	Danish Agency for Science Technology and Innovation; University of Copenhagen	This study was partially funded by the Danish Agency for Science Technology and Innovation (www.en.fi.dk), grant numbers 274-07-0354 & 11-105095, as well as by a PhD-stipend from the University of Copenhagen (www.ku.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS A, 1988, AQUACULTURE, V69, P15, DOI 10.1016/0044-8486(88)90182-2; Bernoth EM, 1997, FURUNCULOSIS HIST DI; Bricknell IR, 1999, FISH SHELLFISH IMMUN, V9, P139, DOI 10.1006/fsim.1998.0183; Dalsgaard I, 2000, J FISH DIS, V23, P199, DOI 10.1046/j.1365-2761.2000.00242.x; Duff DCB, 1942, J IMMUNOL, V44, P87; ELLIS AE, 1988, VET IMMUNOL IMMUNOP, V19, P153, DOI 10.1016/0165-2427(88)90006-2; Emmerich R., 1894, ARCH HYG BAKTERIOL, V21, P1; Erdal J. I., 1992, Fish & Shellfish Immunology, V2, P99, DOI 10.1016/S1050-4648(05)80039-7; Hastein T, 2005, DEV BIOLOGICALS, V121, P55; HASTINGS TS, 1988, J FISH DIS, V11, P147, DOI 10.1111/j.1365-2761.1988.tb00534.x; Haugarvoll E, 2010, VACCINE, V28, P4961, DOI 10.1016/j.vaccine.2010.05.032; Holten-Andersen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029571; JOHNSON KA, 1984, J FISH DIS, V7, P101, DOI 10.1111/j.1365-2761.1984.tb00912.x; Koppang EO, 2008, J IMMUNOL, V181, P4807, DOI 10.4049/jimmunol.181.7.4807; KRANTZ GE, 1963, J IMMUNOL, V91, P757; Midtlying PJ, 1996, FISH SHELLFISH IMMUN, V6, P335, DOI 10.1006/fsim.1996.0034; Midtlyng PJ, 1996, FISH SHELLFISH IMMUN, V6, P553, DOI 10.1006/fsim.1996.0052; Midtlyng PJ, 1996, FISH SHELLFISH IMMUN, V6, P599, DOI 10.1006/fsim.1996.0055; Mutoloki S, 2004, FISH SHELLFISH IMMUN, V16, P633, DOI 10.1016/j.fsi.2003.10.002; O'Dowd AM, 1999, FISH SHELLFISH IMMUN, V9, P125, DOI 10.1006/fsim.1998.0182; Pedersen K, 2008, J FISH DIS, V31, P659, DOI 10.1111/j.1365-2761.2008.00941.x; Plant KP, 2011, DEV COMP IMMUNOL, V35, P1256, DOI 10.1016/j.dci.2011.03.007; Raida MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018832; RODGERS CJ, 1990, DIS AQUAT ORGAN, V8, P69, DOI 10.3354/dao008069; Romstad AB, 2011, BIOLOGICALS; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89	26	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46733	10.1371/journal.pone.0046733	http://dx.doi.org/10.1371/journal.pone.0046733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056427	Green Published, gold			2022-12-27	WOS:000309831500065
J	Zimmermann, K; Leidl, C; Kaschka, M; Carr, RW; Terekhin, P; Handwerker, HO; Forster, C				Zimmermann, Katharina; Leidl, Caroline; Kaschka, Miriam; Carr, Richard W.; Terekhin, Pavel; Handwerker, Hermann O.; Forster, Clemens			Central Projection of Pain Arising from Delayed Onset Muscle Soreness (DOMS) in Human Subjects	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ANTERIOR CINGULATE CORTEX; FUNCTIONAL MRI; CENTRAL REPRESENTATION; SOMATOTOPIC ORGANIZATION; MECHANICAL HYPERESTHESIA; CORTICAL REORGANIZATION; HYPERTONIC SALINE; CUTANEOUS HEAT; STIMULATION	Delayed onset muscle soreness (DOMS) is a subacute pain state arising 24-48 hours after a bout of unaccustomed eccentric muscle contractions. Functional magnetic resonance imaging (fMRI) was used to examine the patterns of cortical activation arising during DOMS-related pain in the quadriceps muscle of healthy volunteers evoked by either voluntary contraction or physical stimulation. The painful movement or physical stimulation of the DOMS-affected thigh disclosed widespread activation in the primary somatosensory and motor (S1, M1) cortices, stretching far beyond the corresponding areas somatotopically related to contraction or physical stimulation of the thigh; activation also included a large area within the cingulate cortex encompassing posteroanterior regions and the cingulate motor area. Pain-related activations were also found in premotor (M2) areas, bilateral in the insular cortex and the thalamic nuclei. In contrast, movement of a DOMS-affected limb led also to activation in the ipsilateral anterior cerebellum, while DOMS-related pain evoked by physical stimulation devoid of limb movement did not.	[Zimmermann, Katharina; Leidl, Caroline; Kaschka, Miriam; Carr, Richard W.; Terekhin, Pavel; Handwerker, Hermann O.; Forster, Clemens] Univ Erlangen Nurnberg, Dept Physiol & Pathophysiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Zimmermann, K (corresponding author), Univ Erlangen Nurnberg, Dept Physiol & Pathophysiol, D-91054 Erlangen, Germany.	zimmermann@physiologie1.uni-erlangen.de	Carr, Richard/AAE-9188-2020; Carr, Richard/GSD-4859-2022	Carr, Richard/0000-0001-8617-9133; Zimmermann, Katharina/0000-0003-2529-0692	Deutsche Forschungsgemeinschaft DFG [SFB 353]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft DFG SFB 353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Arendt-Nielsen L, 2001, CLIN J PAIN, V17, P11, DOI 10.1097/00002508-200103000-00003; Babenko V, 1999, EUR J PAIN-LONDON, V3, P93, DOI 10.1053/eujp.1998.0103; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; DAMASIO H, 1995, HUMAN BRAIN ANATOMY; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; Dimitrova A, 2003, J NEUROPHYSIOL, V90, P1877, DOI 10.1152/jn.00053.2003; Graven-Nielsen T, 2001, CLIN J PAIN, V17, P2, DOI 10.1097/00002508-200103000-00002; GravenNielsen T, 1997, PAIN, V69, P137, DOI 10.1016/S0304-3959(96)03270-8; HANDWERKER HO, 1987, EXP BRAIN RES, V65, P493; Henderson LA, 2007, PAIN, V128, P20, DOI 10.1016/j.pain.2006.08.013; Henderson LA, 2006, PAIN, V120, P286, DOI 10.1016/j.pain.2005.11.003; Jantsch HHF, 2005, PAIN, V118, P390, DOI 10.1016/j.pain.2005.09.017; Korotkov A, 2002, NEUROSCI LETT, V335, P119, DOI 10.1016/S0304-3940(02)01181-3; Kupers RC, 2004, PAIN, V108, P284, DOI 10.1016/j.pain.2003.12.029; Kwan CL, 2000, PAIN, V85, P359, DOI 10.1016/S0304-3959(99)00287-0; Liu HL, 2000, MAGN RESON IMAGING, V18, P931, DOI 10.1016/S0730-725X(00)00214-9; Liu HL, 2000, MAGNET RESON MED, V43, P768, DOI 10.1002/(SICI)1522-2594(200005)43:5<768::AID-MRM22>3.0.CO;2-8; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; MENSE S, 1993, PAIN, V54, P241, DOI 10.1016/0304-3959(93)90027-M; Montes C, 2005, PAIN, V113, P223, DOI 10.1016/j.pain.2004.09.044; MORGAN DL, 1990, BIOPHYS J, V57, P209, DOI 10.1016/S0006-3495(90)82524-8; Niddam DM, 2008, NEUROIMAGE, V39, P1299, DOI 10.1016/j.neuroimage.2007.09.051; Niddam DM, 2009, J CHIN MED ASSOC, V72, P285, DOI 10.1016/S1726-4901(09)70374-0; Niddam DM, 2002, NEUROIMAGE, V17, P1437, DOI 10.1006/nimg.2002.1270; Pandya DN, 1996, PHILOS T ROY SOC B, V351, P1423, DOI 10.1098/rstb.1996.0127; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploner M, 1999, PAIN, V81, P211, DOI 10.1016/S0304-3959(99)00012-3; POCKETT S, 1995, ANESTH ANALG, V80, P173, DOI 10.1097/00000539-199501000-00026; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Ruehle BS, 2006, J NEUROSCI, V26, P5492, DOI 10.1523/JNEUROSCI.2059-05.2006; Schoedel ALA, 2008, PAIN, V135, P131, DOI 10.1016/j.pain.2007.05.014; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Stippich C, 2007, NEUROIMAGE, V34, P1227, DOI 10.1016/j.neuroimage.2006.08.046; Strigo IA, 2003, J NEUROPHYSIOL, V89, P3294, DOI 10.1152/jn.01048.2002; Svensson P, 1998, PAIN, V74, P93, DOI 10.1016/S0304-3959(97)00156-5; Svensson P, 2003, PAIN, V101, P221, DOI 10.1016/S0304-3959(02)00079-9; Svensson P, 1997, J NEUROPHYSIOL, V78, P450, DOI 10.1152/jn.1997.78.1.450; Svensson P, 2001, J OROFAC PAIN, V15, P117; Svensson P, 1997, EVOKED POTENTIAL, V104, P343, DOI 10.1016/S0168-5597(97)00026-9; Taguchi T, 2005, J NEUROPHYSIOL, V94, P2822, DOI 10.1152/jn.00470.2005; Takahashi K, 2011, NEUROSCI RES, V70, P285, DOI 10.1016/j.neures.2011.04.001; Talairach J., 1988, COPLANAR STEREOTAXIC; Thunberg J, 2005, EUR J PAIN, V9, P185, DOI 10.1016/j.ejpain.2004.05.003; TOREBJORK HE, 1984, PAIN, V18, P145, DOI 10.1016/0304-3959(84)90882-0; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wiech K, 2000, SCAND J RHEUMATOL, V29, P13, DOI 10.1080/030097400446571	52	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47230	10.1371/journal.pone.0047230	http://dx.doi.org/10.1371/journal.pone.0047230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056613	Green Submitted, gold, Green Published			2022-12-27	WOS:000309831500146
J	Craig, DPA; Grice, JW; Varnon, CA; Gibson, B; Sokolowski, MBC; Abramson, CI				Craig, David Philip Arthur; Grice, James W.; Varnon, Chris A.; Gibson, B.; Sokolowski, Michel B. C.; Abramson, Charles I.			Social Reinforcement Delays in Free-Flying Honey Bees (Apis mellifera L.)	PLOS ONE			English	Article							INSECT SOCIETIES; BETTA-SPLENDENS; NECTAR; RECEIVERS; FORAGERS; BEHAVIOR; INFORMATION; MOTIVATION; COLONIES; INTERVAL	Free-flying honey bees (Apis mellifera L.) reactions were observed when presented with varying schedules of postreinforcement delays of 0 s, 300 s, or 600 s. We measured inter-visit-interval, response length, inter-response-time, and response rate. Honey bees exposed to these post-reinforcement delay intervals exhibit one of several patterns compared to groups not encountering delays, and had longer inter-visit-intervals. We observed no group differences in inter-response time. Honey bees with higher response rates tended to not finish the experiment. The removal of the delay intervals increased response rates for those subjects that completed the trials.	[Craig, David Philip Arthur; Grice, James W.; Varnon, Chris A.; Gibson, B.; Abramson, Charles I.] Oklahoma State Univ, Dept Psychol, Stillwater, OK 74078 USA; [Sokolowski, Michel B. C.] Univ Picardie Jules Verne, Dept Psychol, Amiens, Picardy, France	Oklahoma State University System; Oklahoma State University - Stillwater; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Abramson, CI (corresponding author), Oklahoma State Univ, Dept Psychol, Stillwater, OK 74078 USA.	charles.abramson@okstate.edu		, Charles/0000-0001-8961-3089; Grice, James/0000-0001-7500-8427; Sokolowski, Michel/0000-0003-0357-1629	National Science Foundation [OISE-1043057]	National Science Foundation(National Science Foundation (NSF))	Parts of this work and its publication have been supported by a grant from the National Science Foundation (OISE-1043057). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2009, ANIM BEHAV, V78, P633, DOI 10.1016/j.anbehav.2009.05.029; Abramson C. I., 1990, INVERTEBRATE LEARNIN; Abramson CI, 2007, TRENDS ALCOHOL ABUSE, P197; Anderson C, 1999, BEHAV ECOL SOCIOBIOL, V46, P73, DOI 10.1007/s002650050595; BENTLEY B, 1983, BIOL NECTARIES; Bowen J, 1966, PSYCHON SCI, V6, P131; BRONSTEIN PM, 1981, J COMP PHYSIOL PSYCH, V95, P943, DOI 10.1037/h0077841; BRONSTEIN PM, 1983, AM J PSYCHOL, V96, P163, DOI 10.2307/1422809; Bronstein PM, 2006, ANN NY ACAD SCI, V443, P158; Cakmak I, 2010, J INSECT BEHAV, V23, P100, DOI 10.1007/s10905-009-9199-7; CAPALDI EJ, 1968, PSYCHON SCI, V13, P279, DOI 10.3758/BF03342523; Chen YL, 2008, ARCH INSECT BIOCHEM, V68, P241, DOI 10.1002/arch.20259; CHUNG SH, 1965, J EXP ANAL BEHAV, V8, P439, DOI 10.1901/jeab.1965.8-439; Chung SH, 1967, J APPL BEHAV ANAL, V8, P67; Cogan DC, 1966, PSYCHON SCI, V6, P343; DAVIS AD, 1954, J EXP PSYCHOL, V48, P275, DOI 10.1037/h0060738; De Marco RJ, 2006, J EXP BIOL, V209, P421, DOI 10.1242/jeb.02025; DOOLITTLE GM, 1907, AM BEE J, V42, P653; Dyer FC, 2002, NATURWISSENSCHAFTEN, V89, P262, DOI 10.1007/s00114-002-0311-5; Farina WM, 1996, BEHAV ECOL SOCIOBIOL, V38, P59, DOI 10.1007/s002650050217; FEHRER E, 1956, J EXP PSYCHOL, V52, P167, DOI 10.1037/h0045052; Galizia C., 2011, HONEYBEE NEUROBIOLOG; Giray T, 1996, P NATL ACAD SCI USA, V93, P11718, DOI 10.1073/pnas.93.21.11718; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Graham J.M., 1999, HIVE HONEY BEE; Grice JW, 2011, OBSERVATION ORIENTED MODELING: ANALYSIS OF CAUSE IN THE BEHAVIORAL SCIENCES, P1; Grice JW, 2012, BEHAV SCI-BASEL, V2, P1, DOI 10.3390/bs2010001; Hart AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P244, DOI 10.1007/s002650000306; HEINRICH B, 1979, SCIENCE, V205, P1269, DOI 10.1126/science.205.4412.1269; McCain G, 1967, PSYCHON SCI, V7, P121; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Mikulka PJ, 1967, PSYCHON SCI, V9, P381; Moffatt L, 2000, J COMP PHYSIOL A, V186, P299, DOI 10.1007/s003590050430; Nunez JA, 1996, BEE WORLD, V77, P182, DOI 10.1080/0005772X.1996.11099313; POSEY TB, 1970, PSYCHON SCI, V21, P45, DOI 10.3758/BF03332427; RABINOWI.FM, 1969, J EXP PSYCHOL, V81, P177, DOI 10.1037/h0027471; Ratnieks FLW, 1999, AM NAT, V154, P536, DOI 10.1086/303256; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; ROSEN AJ, 1968, PSYCHOL REP, V23, P107, DOI 10.2466/pr0.1968.23.1.107; Sanderson CE, 2006, ETHOLOGY, V112, P937, DOI 10.1111/j.1439-0310.2006.01245.x; SIZEMORE OJ, 1978, J EXP ANAL BEHAV, V30, P169, DOI 10.1901/jeab.1978.30-169; Sokolowski MB, 2012, ALCOHOL CLI IN PRESS; Sokolowski MBC, 2010, J NEUROSCI METH, V188, P235, DOI 10.1016/j.jneumeth.2010.02.013; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; Wainselboim AJ, 2003, J COMP PHYSIOL A, V189, P39, DOI 10.1007/s00359-002-0373-z; WELLS H, 1992, ECOL ENTOMOL, V17, P280, DOI 10.1111/j.1365-2311.1992.tb01059.x; WELLS H, 1981, J APICULT RES, V20, P172, DOI 10.1080/00218839.1981.11100493; WELLS H, 1986, J ANIM ECOL, V55, P881, DOI 10.2307/4422; WILLIAMS RL, 1967, J EXP PSYCHOL, V74, P420, DOI 10.1037/h0024727	52	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46729	10.1371/journal.pone.0046729	http://dx.doi.org/10.1371/journal.pone.0046729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056425	Green Published, gold			2022-12-27	WOS:000309580800045
J	Fragoso, MA; Patel, AK; Nakamura, REI; Yi, H; Surapaneni, K; Hackam, AS				Fragoso, Miryam A.; Patel, Amit K.; Nakamura, Rei E. I.; Yi, Hyun; Surapaneni, Krishna; Hackam, Abigail S.			The Wnt/beta-Catenin Pathway Cross-Talks with STAT3 Signaling to Regulate Survival of Retinal Pigment Epithelium Cells	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; CANONICAL WNT PATHWAY; BETA-CATENIN; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; GROWTH-FACTORS; ACTIVATION; EXPRESSION; RPE; TRANSCRIPTION-3	Wnt/beta-catenin signaling is an essential pathway that regulates numerous cellular processes, including cell survival. The molecular mechanisms contributing to pro-survival Wnt signaling are mostly unknown. Signal transducer and activator of transcription proteins (STATs) are a well-described family of transcription factors. STAT3 induces expression of antiapoptotic genes in many tissues and is a downstream mediator of protective growth factors and cytokines. In this study, we investigated whether pro-survival Wnt signaling is mediated by STAT3. The Wnt3a ligand activated Wnt signaling in the retinal pigment epithelium ARPE-19 cell line and significantly increased the viability of cells exposed to oxidative stress. Furthermore, Wnt3a increased STAT3 activation and nuclear translocation, as measured by an antibody against phosphorylated STAT3. Reducing STAT3 levels with siRNA eliminated Wnt3a-dependent protection from oxidative stress. Together, these data demonstrate a previously unknown link between Wnt3a-mediated activation of STAT3 and cell survival, and indicate cross-talk between two important pro-survival signaling pathways.	[Fragoso, Miryam A.; Patel, Amit K.; Nakamura, Rei E. I.; Yi, Hyun; Surapaneni, Krishna; Hackam, Abigail S.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami	Hackam, AS (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	ahackam@med.miami.edu			NEI RO1 ARRA [EY017837-03S1]; Karl Kirchgessner Foundation; Research to Prevent Blindness Unrestricted Grant; NEI Center Core Grant [P30EY014801]; NATIONAL EYE INSTITUTE [R01EY017837, P30EY014801] Funding Source: NIH RePORTER	NEI RO1 ARRA; Karl Kirchgessner Foundation; Research to Prevent Blindness Unrestricted Grant(Research to Prevent Blindness (RPB)); NEI Center Core Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NEI RO1 ARRA supplement EY017837-03S1 and the Karl Kirchgessner Foundation. Institutional support to BPEI was from the Research to Prevent Blindness Unrestricted Grant and an NEI Center Core Grant P30EY014801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Anand M, 2011, HAEMATOL-HEMATOL J, V96, P253, DOI 10.3324/haematol.2010.027086; Armanious H, 2010, INT J CLIN EXP PATHO, V3, P654; Bazan NG, 2006, ADV EXP MED BIOL, V572, P531; Benchabane H, 2009, ADV EXP MED BIOL, V656, P75, DOI 10.1007/978-1-4419-1145-2_7; Burgi S, 2009, MOL VIS, V15, P1631; Burke JM, 2011, MOL VIS, V17, P2864; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chowers I, 2004, INVEST OPHTH VIS SCI, V45, P2098, DOI 10.1167/iovs.03-0863; Das AV, 2008, DEV NEUROSCI-BASEL, V30, P389, DOI 10.1159/000178017; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Do Rhee K, 2007, INVEST OPHTH VIS SCI, V48, P1389, DOI 10.1167/iovs.06-0677; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; El Nakamura R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-52; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fasler-Kan E, 2005, OPHTHALMOLOGICA, V219, P214, DOI 10.1159/000085730; Fragoso MA, 2011, CELL MOL NEUROBIOL, V31, P163, DOI 10.1007/s10571-010-9603-z; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Fukuoka Y, 2001, CURR EYE RES, V23, P320, DOI 10.1076/ceyr.23.5.320.5437; Hackam AS, 2004, MOL VIS, V10, P637; Haider KH, 2010, CARDIOVASC RES, V88, P168, DOI 10.1093/cvr/cvq151; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hunter DD, 2004, MOL CELL NEUROSCI, V27, P477, DOI 10.1016/j.mcn.2004.08.003; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Kassen SC, 2009, EXP EYE RES, V88, P1051, DOI 10.1016/j.exer.2009.01.007; Kawada M, 2006, CANCER RES, V66, P2913, DOI 10.1158/0008-5472.CAN-05-3460; Lee HS, 2010, J CELL SCI, V123, P1959, DOI 10.1242/jcs.063784; Liang CM, 2010, MOL VIS, V16, P2559; Limoli CL, 2004, P NATL ACAD SCI USA, V101, P16052, DOI 10.1073/pnas.0407065101; Lin S, 2009, MOL VIS, V15, P26; Liou G, 2002, MOL VIS, V8, P483; Luo Y, 2006, INVEST OPHTH VIS SCI, V47, P3644, DOI 10.1167/iovs.06-0166; Ma H, 2012, J MOL CELL CARDIOL, V52, P1282, DOI 10.1016/j.yjmcc.2012.02.011; Mizukami M, 2009, EXP EYE RES, V89, P462, DOI 10.1016/j.exer.2009.04.011; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Seitz R, 2010, J NEUROSCI, V30, P5998, DOI 10.1523/JNEUROSCI.0730-10.2010; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Sun XG, 2010, FEBS J, V277, P4789, DOI 10.1111/j.1742-4658.2010.07884.x; Tell S, 2006, BIOCHEM BIOPH RES CO, V349, P261, DOI 10.1016/j.bbrc.2006.08.044; Tezel G, 1999, CURR EYE RES, V19, P377, DOI 10.1076/ceyr.19.5.377.5293; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031; Wada M, 2001, CURR EYE RES, V23, P226, DOI 10.1076/ceyr.23.3.226.5467; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P474, DOI 10.1562/2005-10-21-RA-725; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Yamashina K, 2006, J BIOCHEM, V139, P305, DOI 10.1093/jb/mvj033; Yan S, 2008, CANCER LETT, V271, P85, DOI 10.1016/j.canlet.2008.05.035; Yi H, 2007, INVEST OPHTH VIS SCI, V48, P5733, DOI 10.1167/iovs.07-0097; Yi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036560; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Zhang SSM, 2005, EXP EYE RES, V81, P103, DOI 10.1016/j.exer.2005.01.016; Zhang SSM, 2003, EXP EYE RES, V76, P421, DOI 10.1016/S0014-4835(03)00002-2; Zhou T, 2010, INVEST OPHTH VIS SCI, V51, P4371, DOI 10.1167/iovs.09-4278	61	47	49	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46892	10.1371/journal.pone.0046892	http://dx.doi.org/10.1371/journal.pone.0046892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056515	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800061
J	Peng, R; Fu, Q; Hong, HZ; Schwaegler, T; Lan, Q				Peng, Rong; Fu, Qiang; Hong, Huazhu; Schwaegler, Tyler; Lan, Que			THAP and ATF-2 Regulated Sterol Carrier Protein-2 Promoter Activities in the Larval Midgut of the Yellow Fever Mosquito, Aedes aegypti	PLOS ONE			English	Article							SYNTHETIC MULTIVULVA GENES; RNA RECOGNITION MOTIFS; TRANSCRIPTION FACTOR; PUPAL COMMITMENT; FAT-BODY; CLASS-B; DNA; CHOLESTEROL; EXPRESSION; GROWTH	Expression of sterol carrier protein-2 (SCP-2) in Aedes aegypti shows a distinct temporal/spatial pattern throughout the life cycle. In order to identify the transcription factors responsible for the larval temporal/spatial regulation of AeSCP-2 transcription, AeSCP-2 promoter activities were studied in vivo via transient transfection of promoter/reporter gene assays. Regulatory sequences upstream -1.3 kb of the transcription start site of AeSCP-2 were found to be critical for the in vivo temporal/spatial promoter activity. Interestingly, the -1.6 kb promoter sequence efficiently drove the larval midgut-specific siRNA expression, indicating that the -1.6 kb upstream sequence is sufficient for temporal/spatial AeSCP-2 transcriptional activity. Four transcription factors were identified in the midgut nuclear extract from feeding larvae via labeled -1.6/-1.3 kb DNA probe pull-down and proteomic analysis. Co-transfection of the promoter/reporter gene with inducible siRNA expression of each transcription factor was performed to confirm the regulatory function of individual transcription factor on AeSCP-2 transcriptional activities in the larval midgut. The results indicate that two of the identified transcription factors, Thanatos-associated protein (THAP) and activating transcription factor-2 (ATF-2), antagonistically control AeSCP-2 transcriptional activity in the midgut of feeding larvae via the regulatory sequences between -1.6 to -1.3 kb 5' upstream of the transcription start site. In vivo expression knockdown of THAP and ATF-2 resulted in significant changes in developmental progression, which may be partially due to their effects on AeSCP-2 expression.	[Peng, Rong; Hong, Huazhu] Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Fu, Qiang; Schwaegler, Tyler; Lan, Que] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	Central China Normal University; University of Wisconsin System; University of Wisconsin Madison	Peng, R (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China.	prhh@sina.com; qlan@wisc.edu			United States National Institutes of Health Research [5R01AI067422]; University of Wisconsin-Madison Graduate School [MSN123516]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067422] Funding Source: NIH RePORTER	United States National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison Graduate School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the United States National Institutes of Health Research Grant #5R01AI067422 and University of Wisconsin-Madison Graduate School award #MSN123516 to Q. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019090; Balakrishnan MP, 2009, AM J PHYSIOL-HEART C, V297, pH643, DOI 10.1152/ajpheart.00234.2009; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Bhoumik A, 2007, PIGM CELL RES, V20, P498, DOI 10.1111/j.1600-0749.2007.00414.x; Blitzer EJ, 2005, INSECT MOL BIOL, V14, P301, DOI 10.1111/j.1365-2583.2005.00560.x; Boxem M, 2002, CURR BIOL, V12, P906, DOI 10.1016/S0960-9822(02)00844-8; Campagne S, 2010, NUCLEIC ACIDS RES, V38, P3466, DOI 10.1093/nar/gkq053; Cassola A, 2010, RNA BIOL, V7, P339, DOI 10.4161/rna.7.3.12087; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Chesney MA, 2006, GENETICS, V172, P915, DOI 10.1534/genetics.105.048751; CLAYTON RB, 1964, J LIPID RES, V5, P3; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; DWIVEDI AK, 1982, ENTOMON, V7, P411; Dyer DH, 2008, J LIPID RES, V49, P644, DOI 10.1194/jlr.M700460-JLR200; Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Isoe J, 2007, INSECT MOL BIOL, V16, P83, DOI 10.1111/j.1365-2583.2006.00704.x; Jouni ZE, 2002, ARCH INSECT BIOCHEM, V49, P167, DOI 10.1002/arch.10017; KOMNICK H, 1994, COMP BIOCHEM PHYS A, V107, P553, DOI 10.1016/0300-9629(94)90039-6; Krebs KC, 2003, INSECT MOL BIOL, V12, P51, DOI 10.1046/j.1365-2583.2003.00386.x; KUTHIALA A, 1988, ARCH INSECT BIOCHEM, V7, P225, DOI 10.1002/arch.940070402; Lan Q, 2004, INSECT MOL BIOL, V13, P519, DOI 10.1111/j.0962-1075.2004.00510.x; Lan Q, 2004, J INSECT PHYSIOL, V50, P667, DOI 10.1016/j.jinsphys.2004.04.012; LANGLEY PA, 1987, J INSECT PHYSIOL, V33, P981, DOI 10.1016/0022-1910(87)90011-4; Lopez D, 2007, BIOCHEM BIOPH RES CO, V357, P549, DOI 10.1016/j.bbrc.2007.03.194; Macfarlan T, 2006, MOL ENDOCRINOL, V20, P335, DOI 10.1210/me.2005-0248; Margam VM, 2006, J INSECT PHYSIOL, V52, P558, DOI 10.1016/j.jinsphys.2006.02.003; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; Nes WD, 1997, LIPIDS, V32, P1317, DOI 10.1007/s11745-006-0170-5; Nicholas HR, 2008, J MOL BIOL, V375, P1, DOI 10.1016/j.jmb.2007.10.041; NODA H, 1979, J INSECT PHYSIOL, V25, P443, DOI 10.1016/0022-1910(79)90012-X; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; Peng R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018030; Radek JT, 2010, BIOCHEMISTRY-US, V49, P7532, DOI 10.1021/bi902026v; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; RITTER KS, 1981, J INSECT PHYSIOL, V27, P175, DOI 10.1016/0022-1910(81)90125-6; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Sabogal A, 2010, NAT STRUCT MOL BIOL, V17, P117, DOI 10.1038/nsmb.1742; Sano Y, 2005, MOL BIOL CELL, V16, P2934, DOI 10.1091/mbc.E04-11-1008; SAS Institute, 1999, US GUID VERS 8; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Telang A, 2007, J EXP BIOL, V210, P854, DOI 10.1242/jeb.02715; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Vyazunova I, 2010, INSECT MOL BIOL, V19, P205, DOI 10.1111/j.1365-2583.2009.00959.x; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhu CY, 2009, CELL DEATH DIFFER, V16, P395, DOI 10.1038/cdd.2008.160	50	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46948	10.1371/journal.pone.0046948	http://dx.doi.org/10.1371/journal.pone.0046948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056538	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800063
J	Bittner, KC; Andrasfalvy, BK; Magee, JC				Bittner, Katie C.; Andrasfalvy, Bertalan K.; Magee, Jeffrey C.			Ion Channel Gradients in the Apical Tuft Region of CA1 Pyramidal Neurons	PLOS ONE			English	Article							EXCITATORY SYNAPSES; HCN1 CHANNELS; DENDRITES; AMPA; EXPRESSION; SPIKES; NUMBER; CELLS; LOCALIZATION; PROPAGATION	Dendritic ion channels play a critical role in shaping synaptic input and are fundamentally important for synaptic integration and plasticity. In the hippocampal region CA1, somato-dendritic gradients of AMPA receptors and the hyperpolarization-activated cation conductance (I-h) counteract the effects of dendritic filtering on the amplitude, time-course, and temporal integration of distal Schaffer collateral (SC) synaptic inputs within stratum radiatum (SR). While ion channel gradients in CA1 distal apical trunk dendrites within SR have been well characterized, little is known about the patterns of ion channel expression in the distal apical tuft dendrites within stratum lacunosum moleculare (SLM) that receive distinct input from the entorhinal cortex via perforant path (PP) axons. Here, we measured local ion channels densities within these distal apical tuft dendrites to determine if the somato-dendritic gradients of I-h and AMPA receptors extend into distal tuft dendrites. We also determined the densities of voltage-gated sodium channels and NMDA receptors. We found that the densities of AMPA receptors, I-h,I- and voltage-gated sodium channels are similar in tuft dendrites in SLM when compared with distal apical dendrites in SR, while the ratio of NMDA receptors to AMPA receptors increases in tuft dendrites relative to distal apical dendrites within SR. These data indicate that the somato-dendritic gradients of I-h and AMPA receptors in apical dendrites do not extend into the distal tuft, and the relative densities of voltage-gated sodium channels and NMDA receptors are poised to support nonlinear integration of correlated SC and PP input.	[Bittner, Katie C.; Andrasfalvy, Bertalan K.; Magee, Jeffrey C.] HHMI Janelia Farm Res Campus, Ashburn, VA USA	Howard Hughes Medical Institute	Bittner, KC (corresponding author), HHMI Janelia Farm Res Campus, Ashburn, VA USA.	bittnerk@janelia.hhmi.org		Bittner, Katie/0000-0002-2554-2637	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by Howard Hughes Medical Institute (hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151, DOI 10.1523/JNEUROSCI.21-23-09151.2001; Andreasen M, 1998, J PHYSIOL-LONDON, V507, P441, DOI 10.1111/j.1469-7793.1998.441bt.x; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Lewis AS, 2011, J NEUROSCI, V31, P7424, DOI 10.1523/JNEUROSCI.0936-11.2011; Lidierth M, 2009, J NEUROSCI METH, V178, P188, DOI 10.1016/j.jneumeth.2008.11.004; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Stricker C, 1996, J PHYSIOL-LONDON, V490, P419, DOI 10.1113/jphysiol.1996.sp021155; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015	26	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46652	10.1371/journal.pone.0046652	http://dx.doi.org/10.1371/journal.pone.0046652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056387	Green Submitted, gold, Green Published			2022-12-27	WOS:000309454000069
J	Chen, SH; Li, YN; Stojanovic, A; Zhang, J; Wang, YB; Wang, QM; Seiler, T				Chen, Shihao; Li, Yini; Stojanovic, Aleksander; Zhang, Jia; Wang, Yibo; Wang, Qinmei; Seiler, Theo			Evaluation of the Efficacy of Excimer Laser Ablation of Cross-Linked Porcine Cornea	PLOS ONE			English	Article							PELLUCID MARGINAL DEGENERATION; TOPOGRAPHY-GUIDED PRK; ULTRAVIOLET-A LIGHT; PHOTOREFRACTIVE KERATECTOMY; BULLOUS KERATOPATHY; IN-VIVO; LINKING; COLLAGEN; RIBOFLAVIN; KERATOCONUS	Background: Combination of riboflavin/UVA cross-linking (CXL) and excimer laser ablation is a promising therapy for treating corneal ectasia. The cornea is strengthened by cross-linking, while the irregular astigmatism is reduced by laser ablation. This study aims to compare the efficacy of excimer laser ablation on porcine corneas with and without cross-linking. Methods and Findings: The porcine cornea was de-epithelialized and treated with 0.1% riboflavin solution for 30 minutes. A half of the cornea was exposed to UVA-radiation for another 30 minutes while the controlled half of the cornea was protected from the UVA using a metal shield. Photo therapeutic keratectomy (PTK) was then performed on the central cornea. Corneal thickness of 5 paired locations on the horizontal line, +/- 0.5, +/- 1.0, +/- 1.5, +/- 2.0, and +/- 2.5 mm from the central spot, were measured using optical coherence tomography prior to and after PTK. The ablation depth was then determined by the corneal thickness. There was a 9% difference (P<0.001) in the overall ablation depth between the CXL-half corneas (15 +/- 22 mu m) and the control-half corneas (174 +/- 26 mu m). The ablation depths of all 5 correspondent locations on the CXL-half were significantly smaller (P<0.001). Conclusion: The efficacy of the laser ablation seems to be lower in cross-linked cornea. Current ablation algorithms may need to be modified for cross-linked corneas.	[Chen, Shihao; Li, Yini; Zhang, Jia; Wang, Yibo; Wang, Qinmei] Wenzhou Med Coll, Affiliated Eye Hosp, Wenzhou, Zhejiang, Peoples R China; [Stojanovic, Aleksander] Univ Hosp N Norway, Eye Dept, Tromso, Norway; [Seiler, Theo] Inst Refract & Ophthalm Surg, Zurich, Switzerland; [Stojanovic, Aleksander] Synslaser Kirurgi AS, Tromso, Norway	Wenzhou Medical University; UiT The Arctic University of Tromso; University Hospital of North Norway	Wang, QM (corresponding author), Wenzhou Med Coll, Affiliated Eye Hosp, Wenzhou, Zhejiang, Peoples R China.	wqm2@mail.eye.ac.cn						Bohnke M, 1998, J REFRACT SURG, V14, P140; Ehlers N, 2009, J REFRACT SURG, V25, pS803, DOI 10.3928/1081597X-20090813-08; Faber C, 2008, SCAND J LAB ANIM SCI, V35, P39; Fagerholm P, 2003, ACTA OPHTHALMOL SCAN, V81, P19, DOI 10.1034/j.1600-0420.2003.00015.x; Ferrari TM, 2009, EUR J OPHTHALMOL, V19, P295, DOI 10.1177/112067210901900221; Gartry D S, 1991, Refract Corneal Surg, V7, P420; Hafezi F, 2007, J CATARACT REFR SURG, V33, P2035, DOI 10.1016/j.jcrs.2007.07.028; Huebscher HJ, 1996, INVEST OPHTH VIS SCI, V37, P42; Kampik D, 2010, INVEST OPHTH VIS SCI, V51, P3929, DOI 10.1167/iovs.09-4524; Kanellopoulos AJ, 2007, CORNEA, V26, P891, DOI 10.1097/ICO.0b013e318074e424; Kanellopoulos AJ, 2009, J REFRACT SURG, V25, pS812, DOI 10.3928/1081597X-20090813-10; Kohlhaas M, 2006, J CATARACT REFR SURG, V32, P279, DOI 10.1016/j.jcrs.2005.12.092; Krueger RR, 2008, J REFRACT SURG, V24, pS730, DOI 10.3928/1081597X-20080901-17; Krueger RR, 2010, J REFRACT SURG, V26, pS827, DOI 10.3928/1081597X-20100921-11; KRUEGER RR, 1985, ARCH OPHTHALMOL-CHIC, V103, P1741; Kymionis GD, 2009, OPHTHALMOLOGY, V116, P2336, DOI 10.1016/j.ophtha.2009.09.018; Mazzotta C, 2011, CORNEA, V30, P225, DOI 10.1097/ICO.0b013e3181e16de5; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; Sanchez I, 2011, GRAEF ARCH CLIN EXP, V249, P475, DOI 10.1007/s00417-011-1617-9; Sauer A, 2010, INVEST OPHTH VIS SCI, V51, P3950, DOI 10.1167/iovs.09-4013; Schnitzler E, 2000, KLIN MONATSBL AUGENH, V217, P190, DOI 10.1055/s-2000-10344; Seiler T., 1996, Investigative Ophthalmology and Visual Science, V37, pS1017; SEILER T, 1991, OPHTHALMOLOGY, V98, P1156; Seiler T, 2006, CORNEA, V25, P1057, DOI 10.1097/01.ico.0000225720.38748.58; Sondergaard AP, 2010, CURR EYE RES, V35, P116, DOI 10.3109/02713680903431847; Spadea L, 2010, J REFRACT SURG, V26, P375, DOI 10.3928/1081597X-20100114-03; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Stojanovic A, 2010, J REFRACT SURG, V26, P145, DOI 10.3928/1081597X-20100121-10; Vinciguerra P, 2009, OPHTHALMOLOGY, V116, P369, DOI 10.1016/j.ophtha.2008.09.048; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2010, J CATARACT REFR SURG, V36, P114, DOI 10.1016/j.jcrs.2009.07.044; Wollensak G, 2009, OPHTHALMIC RES, V41, P114, DOI 10.1159/000187630	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46232	10.1371/journal.pone.0046232	http://dx.doi.org/10.1371/journal.pone.0046232			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056269	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000026
J	Hindrikson, M; Mannil, P; Ozolins, J; Krzywinski, A; Saarma, U				Hindrikson, Maris; Maennil, Peep; Ozolins, Janis; Krzywinski, Andrzej; Saarma, Urmas			Bucking the Trend in Wolf-Dog Hybridization: First Evidence from Europe of Hybridization between Female Dogs and Male Wolves	PLOS ONE			English	Article							CANIS-LUPUS; GENETIC DIVERSITY; DOMESTIC DOGS; DNA ANALYSIS; MITOCHONDRIAL; POPULATION; SEQUENCE; PROGRAM; IDENTIFICATION; INFERENCE	Studies on hybridization have proved critical for understanding key evolutionary processes such as speciation and adaptation. However, from the perspective of conservation, hybridization poses a concern, as it can threaten the integrity and fitness of many wild species, including canids. As a result of habitat fragmentation and extensive hunting pressure, gray wolf (Canis lupus) populations have declined dramatically in Europe and elsewhere during recent centuries. Small and fragmented populations have persisted, but often only in the presence of large numbers of dogs, which increase the potential for hybridization and introgression to deleteriously affect wolf populations. Here, we demonstrate hybridization between wolf and dog populations in Estonia and Latvia, and the role of both genders in the hybridization process, using combined analysis of maternal, paternal and biparental genetic markers. Eight animals exhibiting unusual external characteristics for wolves - six from Estonia and two from Latvia - proved to be wolf-dog hybrids. However, one of the hybridization events was extraordinary. Previous field observations and genetic studies have indicated that mating between wolves and dogs is sexually asymmetrical, occurring predominantly between female wolves and male dogs. While this was also the case among the Estonian hybrids, our data revealed the existence of dog mitochondrial genomes in the Latvian hybrids and, together with Y chromosome and autosomal microsatellite data, thus provided the first evidence from Europe of mating between male wolves and female dogs. We discuss patterns of sexual asymmetry in wolf-dog hybridization.	[Hindrikson, Maris; Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-50090 Tartu, Estonia; [Maennil, Peep] Estonian Environm Informat Ctr, Tartu, Estonia; [Ozolins, Janis] State Forest Res Inst Silava, Salaspils, Latvia; [Krzywinski, Andrzej] Wildlife Pk Kadzidlowo, Ruciane Nida, Poland	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Latvian State Forest Research Institute "Silava"	Saarma, U (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	Urmas.Saarma@ut.ee	Saarma, Urmas/AAC-9813-2019; Saarma, Urmas/J-6448-2015; Hindrikson, Maris/G-4573-2017	Saarma, Urmas/0000-0002-3222-571X; Saarma, Urmas/0000-0002-3222-571X; Hindrikson, Maris/0000-0001-8094-1860	Environmental Investment Centre; Estonian Ministry of Education and Sciences [SF0180122s08]; Estonian Science Foundation [7040]; European Union through the European Regional Development Fund (Centre of Excellence FIBIR); Estonian Doctoral School of Ecology and Environmental Sciences	Environmental Investment Centre; Estonian Ministry of Education and Sciences(Ministry of Education and Research, Estonia); Estonian Science Foundation; European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); Estonian Doctoral School of Ecology and Environmental Sciences	This work was supported by grants from the Environmental Investment Centre, the Estonian Ministry of Education and Sciences (target financing project SF0180122s08), the Estonian Science Foundation (grant 7040) and from the European Union through the European Regional Development Fund (Centre of Excellence FIBIR), and from the Estonian Doctoral School of Ecology and Environmental Sciences. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AK is employed by Wildlife Park Kadzidlowo and, therefore, Wildlife Park Kadzidlowo played a role in the data collection and analysis of the manuscript.	Adams JR, 2003, MOL ECOL, V12, P2175, DOI 10.1046/j.1365-294X.2003.01895.x; Allee W.C, 1931, ANIMAL AGGREGATION S; Anderson EC, 2002, GENETICS, V160, P1217; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Andersone Z, 2002, MAMM BIOL, V67, P79, DOI 10.1078/1616-5047-00012; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bannasch DL, 2005, MAMM GENOME, V16, P273, DOI 10.1007/s00335-004-2435-8; Belkhir K, 2004, GENETIX 4 05 2 SOFTW; BENECKE N, 1987, J ARCHAEOL SCI, V14, P31, DOI 10.1016/S0305-4403(87)80004-3; BIBIKOV DI, 1985, WOLF HIST SYSTEMATIC; Bjornerfeldt S, 2006, GENOME RES, V16, P990, DOI 10.1101/gr.5117706; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Boitani I, 1992, WOLVES EUROPE; Boitani L., 1982, P158; Boitani Luigi, 2003, P317; Bondarev AJ, 2002, WOLF W SIBERIA ALTAY; Elledge AE, 2008, WILDLIFE RES, V35, P812, DOI 10.1071/WR07056; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; FREDHOLM M, 1995, MAMM GENOME, V6, P11, DOI 10.1007/BF00350887; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GOTTELLI D, 1994, MOL ECOL, V3, P301, DOI 10.1111/j.1365-294X.1994.tb00070.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gray AP, 1954, MAMMALIAN HYBRIDS CH; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hedrick P., 1983, GENETICS POPULATIONS; Heg D., 2008, P 6 AS PAC BIOINF C, P321; HOLMES NG, 1995, ANIM GENET, V26, P132, DOI 10.1111/j.1365-2052.1995.tb02659.x; Iacolina L, 2010, MAMM BIOL, V75, P341, DOI 10.1016/j.mambio.2010.02.004; Ishadov NI, 1977, NUMBER BEHAV WOLVES, P213; Jedrzejewski W, 2005, ACTA THERIOL, V50, P3, DOI 10.1007/BF03192614; Kim KS, 1998, MOL PHYLOGENET EVOL, V10, P210, DOI 10.1006/mpev.1998.0513; Kojola I, 2002, WILDLIFE SOC B, V30, P498; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Laikre L, 2010, CONSERV BIOL, V24, P86, DOI 10.1111/j.1523-1739.2009.01425.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Munoz-Fuentes V, 2010, CONSERV GENET, V11, P547, DOI 10.1007/s10592-009-9974-1; NEI M, 1978, GENETICS, V89, P583; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Olsen S.J., 1985, ORIGINS DOMESTIC DOG; OSTRANDER EA, 1993, GENOMICS, V16, P207, DOI 10.1006/geno.1993.1160; Pavlov MP, 1990, WOLF, P5; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; Randi E, 2002, CONSERV GENET, V3, P31; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROUSSET F, 1995, GENETICS, V140, P1413; Rutledge LY, 2010, HEREDITY, V105, P520, DOI 10.1038/hdy.2010.6; Ryadov L.S., 1978, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V83, P39; Sabanejev LP, 1988, GAME ANIMALS; SHIBUYA H, 1994, ANIM GENET, V25, P122, DOI 10.1111/j.1365-2052.1994.tb00094.x; Sundqvist AK, 2001, MOL ECOL, V10, P1959, DOI 10.1046/j.1365-294X.2001.01326.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdmann Harri, 2004, Baltic Forestry, V10, P83; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verardi A, 2006, MOL ECOL, V15, P2845, DOI 10.1111/j.1365-294X.2006.02995.x; Vila C, 2003, HEREDITY, V90, P17, DOI 10.1038/sj.hdy.6800175; Vila C, 1999, CONSERV BIOL, V13, P195, DOI 10.1046/j.1523-1739.1999.97425.x; WAYNE RK, 1989, J HERED, V80, P447, DOI 10.1093/oxfordjournals.jhered.a110896; WAYNE RK, 1991, NATURE, V351, P565, DOI 10.1038/351565a0; Webb KM, 2009, J FORENSIC SCI, V54, P275, DOI 10.1111/j.1556-4029.2008.00952.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	72	74	76	2	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46465	10.1371/journal.pone.0046465	http://dx.doi.org/10.1371/journal.pone.0046465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056315	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000047
J	Kietrys, DM; Barr-Gillespie, AE; Amin, M; Wade, CK; Popoff, SN; Barbe, MF				Kietrys, David M.; Barr-Gillespie, Ann E.; Amin, Mamta; Wade, Christine K.; Popoff, Steve N.; Barbe, Mary F.			Aging Contributes to Inflammation in Upper Extremity Tendons and Declines in Forelimb Agility in a Rat Model of Upper Extremity Overuse	PLOS ONE			English	Article							CARPAL-TUNNEL-SYNDROME; TUMOR-NECROSIS-FACTOR; ANIMAL-MODEL; MUSCULOSKELETAL DISORDERS; SUPRASPINATUS TENDON; FLEXOR TENOSYNOVIUM; MOTOR-PERFORMANCE; WORK; AGE; INTERLEUKIN-6	We sought to determine if tendon inflammatory and histopathological responses increase in aged rats compared to young rats performing a voluntary upper extremity repetitive task, and if these changes are associated with motor declines. Ninety-six female Sprague-Dawley rats were used in the rat model of upper extremity overuse: 67 aged and 29 young adult rats. After a training period of 4 weeks, task rats performed a voluntary high repetition low force (HRLF) handle-pulling task for 2 hrs/day, 3 days/wk for up to 12 weeks. Upper extremity motor function was assessed, as were inflammatory and histomorphological changes in flexor digitorum and supraspinatus tendons. The percentage of successful reaches improved in young adult HRLF rats, but not in aged HRLF rats. Forelimb agility decreased transiently in young adult HRLF rats, but persistently in aged HRLF rats. HRLF task performance for 12 weeks lead to increased IL-1beta and IL-6 in flexor digitorum tendons of aged HRLF rats, compared to aged normal control (NC) as well as young adult HRLF rats. In contrast, TNF-alpha increased more in flexor digitorum tendons of young adult 12-week HRLF rats than in aged HRLF rats. Vascularity and collagen fibril organization were not affected by task performance in flexor digitorum tendons of either age group, although cellularity increased in both. By week 12 of HRLF task performance, vascularity and cellularity increased in the supraspinatus tendons of only aged rats. The increased cellularity was due to increased macrophages and connective tissue growth factor (CTGF)-immunoreactive fibroblasts in the peritendon. In conclusion, aged rat tendons were overall more affected by the HRLF task than young adult tendons, particularly supraspinatus tendons. Greater inflammatory changes in aged HRLF rat tendons were observed, increases associated temporally with decreased forelimb agility and lack of improvement in task success.	[Amin, Mamta; Popoff, Steve N.; Barbe, Mary F.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA; [Kietrys, David M.] Univ Med & Dent New Jersey, Dept Rehabil & Movement Sci, Sch Hlth Related Profess, Stratford, NJ USA; [Barr-Gillespie, Ann E.] Univ Pacific, Coll Hlth Profess, Hillsboro, OR USA; [Wade, Christine K.] Thomas Jefferson Univ, Dept Phys Therapy, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of the Pacific; Jefferson University	Barbe, MF (corresponding author), Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA.	mary.barbe@temple.edu		Barbe, Mary/0000-0002-5235-9803	National Institute for Occupational Safety and Health [OH03970, UO103970]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH003970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056019] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described here was supported by Grant Number OH03970 and Grant Number UO103970 from the National Institute for Occupational Safety and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SA, 2011, J CELL BIOCHEM, V112, P1084, DOI 10.1002/jcb.23022; Akrouf Q. A. S., 2010, Eastern Mediterranean Health Journal, V16, P94; Archambault JM, 2007, J ORTHOP RES, V25, P617, DOI 10.1002/jor.20347; Asundi KR, 2008, ANN BIOMED ENG, V36, P237, DOI 10.1007/s10439-007-9427-2; Barbe MF, 2003, J ORTHOPAED RES, V21, P167, DOI 10.1016/S0736-0266(02)00086-4; Barbe MF, 2008, J ORTHOPAED RES, V26, P1; Barr AE, 2003, J BONE MINER RES, V18, P2023, DOI 10.1359/jbmr.2003.18.11.2023; BELMIN J, 1995, AM J PHYSIOL-HEART C, V268, pH2288, DOI 10.1152/ajpheart.1995.268.6.H2288; Berglund M, 2007, J HAND SURG-EUR VOL, V32E, P581, DOI 10.1016/j.jhse.2007.05.017; Bernard B., 1997, MUSCULOSKELETAL DISO; Brewer JB, 1979, AM J SPORTS MED, V7, P102; Bystrom S, 1995, J HAND SURG-BRIT EUR, V20B, P782, DOI 10.1016/S0266-7681(95)80047-6; Carp SJ, 2007, CLIN SCI, V112, P305, DOI 10.1042/CS20060050; Carpenter JE, 1998, AM J SPORT MED, V26, P801, DOI 10.1177/03635465980260061101; Clark BD, 2004, J ORTHOP SPORT PHYS, V34, P244, DOI 10.2519/jospt.2004.34.5.244; Clark BD, 2003, J NEUROTRAUM, V20, P681, DOI 10.1089/089771503322144590; Cook JL, 2004, J ORTHOP RES, V22, P334, DOI 10.1016/j.orthres.2003.08.005; Coq JO, 2009, EXPT NEUROL IN PRESS; DAYNES RA, 1993, J IMMUNOL, V150, P5219; Driban JB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/691412; Elliott MB, 2010, NEUROSCIENCE, V170, P929, DOI 10.1016/j.neuroscience.2010.07.041; Elliott MB, 2009, NEUROSCIENCE, V158, P922, DOI 10.1016/j.neuroscience.2008.10.050; ERSHLER WB, 1993, LYMPHOKINE CYTOK RES, V12, P225; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Fedorczyk JM, 2010, J ORTHOPAEDIC RES; Freeland AE, 2002, MICROSURG, V22, P378, DOI 10.1002/micr.10065; Freeland AE, 2002, ORTHOPEDICS, V25, P753; Gerr F, 2002, AM J IND MED, V41, P221, DOI 10.1002/ajim.10066; Health and Safety Executive Laboratory web site, RR799 HLTH SAF EX LA; Hsu JC, 2003, ACTA ORTHOPAEDICA SC, V74, P89; Kietrys DM, 2011, J MOTOR BEHAV, V43, P465, DOI 10.1080/00222895.2011.627897; Kilbom, 1996, Int J Occup Environ Health, V2, P239; Langberg H, 2002, J PHYSIOL-LONDON, V542, P985, DOI 10.1113/jphysiol.2002.019141; Lee MW, 2002, CANCER LETT, V182, P75; McDermott HJ, 2010, OCCUP MED-OXFORD, V60, P193, DOI 10.1093/occmed/kqq026; Millar NL, 2009, J BONE JOINT SURG BR, V91B, P417, DOI 10.1302/0301-620X.91B3.21652; Millar NL, 2008, CLIN ORTHOP RELAT R, V466, P1569, DOI 10.1007/s11999-008-0265-9; Miranda H, 2008, ANN RHEUM DIS, V67, P218, DOI 10.1136/ard.2007.069419; Nakamichi K, 1998, J HAND SURG-AM, V23A, P1015, DOI 10.1016/S0363-5023(98)80009-9; Nunes IL, 2009, WORK, V34, P133, DOI 10.3233/WOR-2009-0912; Panni AS, 1996, ARTHROSCOPY, V12, P531, DOI 10.1016/S0749-8063(96)90190-5; Perry SM, 2005, J SHOULDER ELB SURG, V14, p79S, DOI 10.1016/j.jse.2004.09.020; Rani S, 2009, J HISTOCHEMISTRY CYT; Rani S, 2010, J CELL PHYSIOL, V225, P152, DOI 10.1002/jcp.22208; Rani S, 2009, BONE, V44, P502, DOI 10.1016/j.bone.2008.11.012; RANNEY D, 1995, ERGONOMICS, V38, P1408, DOI 10.1080/00140139508925198; Rechardt M, 2011, CYTOKINE, V54, P149, DOI 10.1016/j.cyto.2011.02.003; Roubenoff R, 2003, AM J MED, V115, P429, DOI 10.1016/j.amjmed.2003.05.001; SCHRIMSHER GW, 1992, EXP NEUROL, V117, P287, DOI 10.1016/0014-4886(92)90138-G; SCHUIND F, 1990, J HAND SURG-AM, V15A, P497, DOI 10.1016/0363-5023(90)90070-8; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; Soslowsky LJ, 2002, ANN BIOMED ENG, V30, P1057, DOI 10.1114/1.1509765; Soslowsky LJ, 2000, J SHOULDER ELB SURG, V9, P79, DOI 10.1067/mse.2000.101962; Statistics BoL, 2011, NONF OCC INJ ILLN RE; Sun HB, 2008, CLIN ORTHOP RELAT R, V466, P1555, DOI 10.1007/s11999-008-0278-4; Szomor ZL, 2006, J ORTHOP RES, V24, P80, DOI 10.1002/jor.20009; Tucci M A, 1997, Biomed Sci Instrum, V33, P246; van Rijn RM, 2010, SCAND J WORK ENV HEA, V36, P189, DOI 10.5271/sjweh.2895; Voloshin I, 2005, ARTHROSCOPY, V21, P1076, DOI 10.1016/j.arthro.2005.05.017; Xin DL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-63	61	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46954	10.1371/journal.pone.0046954	http://dx.doi.org/10.1371/journal.pone.0046954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056540	Green Published, gold			2022-12-27	WOS:000309454000103
J	Minde, DP; Maurice, MM; Rudiger, SGD				Minde, David P.; Maurice, Madelon M.; Rudiger, Stefan G. D.			Determining Biophysical Protein Stability in Lysates by a Fast Proteolysis Assay, FASTpp	PLOS ONE			English	Article							P53 CORE DOMAIN; GREEN FLUORESCENT PROTEIN; ALPHA-SYNUCLEIN; NMR-SPECTROSCOPY; SCANNING CALORIMETRY; ESCHERICHIA-COLI; PYRUVATE-KINASE; BINDING PROTEIN; IN-VITRO; THERMOLYSIN	The biophysical stability is an important parameter for protein activity both in vivo and in vitro. Here we propose a method to analyse thermal melting of protein domains in lysates: Fast parallel proteolysis (FASTpp). Combining unfolding by a temperature gradient in a thermal cycler with simultaneous proteolytic cleavage of the unfolded state, we probed stability of single domains in lysates. We validated FASTpp on proteins from 10 kDa to 240 kDa and monitored stabilisation and coupled folding and binding upon interaction with small-molecule ligands. Within a total reaction time of approximately 1 min, we probed subtle stability differences of point mutations with high sensitivity and in agreement with data obtained by intrinsic protein fluorescence. We anticipate a wide range of applications of FASTpp in biomedicine and protein engineering as it requires only standard laboratory equipment.	[Maurice, Madelon M.] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Minde, David P.; Rudiger, Stefan G. D.] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Maurice, MM (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	M.M.Maurice@umcutrecht.nl; s.g.d.rudiger@uu.nl	Minde, David Paul/D-3847-2012; Rüdiger, Stefan GD/G-4906-2012	Minde, David Paul/0000-0002-2985-622X; Rüdiger, Stefan GD/0000-0002-1807-2972; minde, david/0000-0003-2471-0421; Maurice, Madelon/0000-0001-6885-5361	European Union [MEXT-CT-2005-025651]; VIDI by the Netherlands Organization for Scientific Research (NWO) [700.55.421]; Utrecht University; European Research Council (ERC-StG) [242958]	European Union(European Commission); VIDI by the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Utrecht University; European Research Council (ERC-StG)(European Research Council (ERC))	SGDR was supported by a Marie-Curie Excellence Grant of the European Union (MEXT-CT-2005-025651), a VIDI career development grant (700.55.421) by the Netherlands Organization for Scientific Research (NWO) and a High Potential Grant of Utrecht University. MMM was supported by the European Research Council (ERC-StG no. 242958) and a High Potential Grant of Utrecht University. URLs of funders: NWO: http://www.nwo.nl/; EU: http://europa.eu/index_en.htm; Utrecht University: http://www.uu.nl/; ERC: http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Banci L, 1997, BIOCHEMISTRY-US, V36, P9867, DOI 10.1021/bi970724w; Bark SJ, 2001, J AM CHEM SOC, V123, P1774, DOI 10.1021/ja002909n; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Cabantous Stephanie, 2005, Journal of Structural and Functional Genomics, V6, P113, DOI 10.1007/s10969-005-5247-5; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; DEMEL RA, 1989, J BIOL CHEM, V264, P3988; DESMAZEA.MJ, 1971, EUR J BIOCHEM, V19, P51, DOI 10.1111/j.1432-1033.1971.tb01286.x; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Ignatova Zoya, 2009, V490, P165, DOI 10.1007/978-1-59745-367-7_7; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Kudryashova EV, 1998, BBA-PROTEIN STRUCT M, V1386, P199, DOI 10.1016/S0167-4838(98)00055-7; KUNUGI S, 1982, EUR J BIOCHEM, V124, P157, DOI 10.1111/j.1432-1033.1982.tb05919.x; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; Mansfeld J, 1997, J BIOL CHEM, V272, P11152, DOI 10.1074/jbc.272.17.11152; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Miklos AC, 2010, BIOCHEMISTRY-US, V49, P6984, DOI 10.1021/bi100727y; Minde DP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-101; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Noutsou M, 2011, J MOL BIOL, V405, P773, DOI 10.1016/j.jmb.2010.11.013; Novokhatny V, 1997, PROTEIN SCI, V6, P141; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Reckel S, 2012, CHEMBIOCHEM, V13, P534, DOI 10.1002/cbic.201100721; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Schreiber SL, 2010, NAT BIOTECHNOL, V28, P904, DOI 10.1038/nbt0910-904; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsvetkov P, 2012, MOL BIOSYST, V8, P368, DOI 10.1039/c1mb05283g; Tur-Arlandis G, 2010, BIOPHYS J, V98, pL12, DOI 10.1016/j.bpj.2009.11.028; Veltman OR, 1998, BIOCHEMISTRY-US, V37, P5312, DOI 10.1021/bi9725879; Wang QH, 2011, BIOCHEMISTRY-US, V50, P9225, DOI 10.1021/bi201287e; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Williams R, 2006, BIOCHEMISTRY-US, V45, P5421, DOI 10.1021/bi0524262; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011	46	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46147	10.1371/journal.pone.0046147	http://dx.doi.org/10.1371/journal.pone.0046147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056252	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000020
J	Narendran, R; Frankle, WG; Mason, NS; Muldoon, MF; Moghaddam, B				Narendran, Rajesh; Frankle, William G.; Mason, Neale S.; Muldoon, Matthew F.; Moghaddam, Bita			Improved Working Memory but No Effect on Striatal Vesicular Monoamine Transporter Type 2 after Omega-3 Polyunsaturated Fatty Acid Supplementation	PLOS ONE			English	Article							INDUCED DOPAMINE RELEASE; POSITRON-EMISSION-TOMOGRAPHY; SEROTONINERGIC NEUROTRANSMISSION; COGNITIVE PERFORMANCE; ALZHEIMERS-DISEASE; DEFICIENCY; OMEGA-3-FATTY-ACIDS; COCAINE; TRANSMISSION; BINDING	Studies in rodents indicate that diets deficient in omega-3 polyunsaturated fatty acids (n-3 PUFA) lower dopamine neurotransmission as measured by striatal vesicular monoamine transporter type 2 (VMAT2) density and amphetamine-induced dopamine release. This suggests that dietary supplementation with fish oil might increase VMAT2 availability, enhance dopamine storage and release, and improve dopamine-dependent cognitive functions such as working memory. To investigate this mechanism in humans, positron emission tomography (PET) was used to measure VMAT2 availability pre- and post-supplementation of n-3 PUFA in healthy individuals. Healthy young adult subjects were scanned with PET using [C-11]-(+)-alpha-dihydrotetrabenzine (DTBZ) before and after six months of n-3 PUFA supplementation (Lovaza, 2 g/day containing docosahexaenonic acid, DHA 750 mg/d and eicosapentaenoic acid, EPA 930 mg/d). In addition, subjects underwent a working memory task (n-back) and red blood cell membrane (RBC) fatty acid composition analysis pre- and post-supplementation. RBC analysis showed a significant increase in both DHA and EPA post-supplementation. In contrast, no significant change in [C-11] DTBZ binding potential (BPND) in striatum and its subdivisions were observed after supplementation with n-3 PUFA. No correlation was evident between n-3 PUFA induced change in RBC DHA or EPA levels and change in [C-11] DTBZ BPND in striatal subdivisions. However, pre- supplementation RBC DHA levels was predictive of baseline performance (i.e., adjusted hit rate, AHR on 3-back) on the n-back task (y = 0.19+0.07, r(2) = 0.55, p = 0.009). In addition, subjects AHR performance improved on 3-back post-supplementation (pre 0.65 +/- 0.27, post 0.80 +/- 0.15, p = 0.04). The correlation between n-back performance, and DHA levels are consistent with reports in which higher DHA levels is related to improved cognitive performance. However, the lack of change in [C-11] DBTZ BPND indicates that striatal VMAT2 regulation is not the mechanism of action by which n-3 PUFA improves cognitive performance.	[Narendran, Rajesh; Frankle, William G.; Mason, Neale S.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Narendran, Rajesh; Frankle, William G.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Muldoon, Matthew F.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Moghaddam, Bita] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Narendran, R (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	narendranr@upmc.edu		Frankle, William/0000-0003-0356-4197	National Institute On Drug Abuse (NIDA) [R21DA023450, R03DA024704]; American Reinvestment and Recovery Act of (ARRA); NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023450, R03DA024704] Funding Source: NIH RePORTER	National Institute On Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); American Reinvestment and Recovery Act of (ARRA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project described was supported by award numbers R21DA023450 and R03DA024704 from the National Institute On Drug Abuse (NIDA) and American Reinvestment and Recovery Act of 2009 (ARRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; ARNSTEN AFT, 1994, PSYCHOPHARMACOLOGY, V116, P143, DOI 10.1007/BF02245056; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Chan GLY, 1999, J NUCL MED, V40, P283; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; Delion S, 1996, J NEUROCHEM, V66, P1582; DELION S, 1994, J NUTR, V124, P2466, DOI 10.1093/jn/124.12.2466; Freund-Levi Y, 2008, INT J GERIATR PSYCH, V23, P161, DOI 10.1002/gps.1857; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Fusar-Poli P, 2012, J CLIN PSYCHOPHARM, V32, P179, DOI 10.1097/JCP.0b013e318248b7bb; GANDELMAN MS, 1994, J PHARM SCI, V83, P1014, DOI 10.1002/jps.2600830718; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; KILBOURN M, 1995, EUR J PHARMACOL, V278, P249, DOI 10.1016/0014-2999(95)00162-E; Kodas E, 2002, J LIPID RES, V43, P1209, DOI 10.1194/jlr.M200132-JLR200; Koeppe RA, 1997, J CEREBR BLOOD F MET, V17, P919, DOI 10.1097/00004647-199709000-00001; Laruelle M, 1997, SYNAPSE, V25, P1, DOI 10.1002/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Martinez D, 2007, AM J PSYCHIAT, V164, P622, DOI 10.1176/appi.ajp.164.4.622; Martinez D, 2011, AM J PSYCHIAT, V168, P634, DOI 10.1176/appi.ajp.2010.10050748; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; MOGHADDAM B, 1993, SYNAPSE, V13, P215, DOI 10.1002/syn.890130304; Muldoon MF, 2010, J NUTR, V140, P848, DOI 10.3945/jn.109.119578; NARENDRAN R, 2010, J PHARMACOL EXP THER, V63, P574; Narendran R, 2012, AM J PSYCHIAT, V169, P55, DOI 10.1176/appi.ajp.2011.11010126; Ortega R M, 2012, Br J Nutr, V107 Suppl 2, pS261, DOI 10.1017/S000711451200164X; Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969; Reddy RD, 2004, SCHIZOPHRENIA BULL, V30, P901, DOI 10.1093/oxfordjournals.schbul.a007140; Richardson AJ, 2006, INT REV PSYCHIATR, V18, P155, DOI 10.1080/09540260600583031; Sarris J, 2012, J CLIN PSYCHIAT, V73, P81, DOI 10.4088/JCP.10r06710; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Stough C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.019; Sublette ME, 2011, J CLIN PSYCHIAT, V72, P1577, DOI 10.4088/JCP.10m06634; Turnbull T, 2008, ARCH PSYCHIAT NURS, V22, P305, DOI 10.1016/j.apnu.2008.02.011; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Zimmer L, 1999, LIPIDS, V34, pS251, DOI 10.1007/BF02562309; Zimmer L, 2000, J LIPID RES, V41, P32; Zimmer L, 2000, NEUROSCI LETT, V284, P25, DOI 10.1016/S0304-3940(00)00950-2; Zimmer L, 2002, AM J CLIN NUTR, V75, P662, DOI 10.1093/ajcn/75.4.662	44	24	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46832	10.1371/journal.pone.0046832	http://dx.doi.org/10.1371/journal.pone.0046832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056476	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000093
J	Roszczenko, P; Radomska, KA; Wywial, E; Collet, JF; Jagusztyn-Krynicka, EK				Roszczenko, Paula; Radomska, Katarzyna A.; Wywial, Ewa; Collet, Jean-Francois; Jagusztyn-Krynicka, Elzbieta K.			A Novel Insight into the Oxidoreductase Activity of Helicobacter pylori HP0231 Protein	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; CAMPYLOBACTER-JEJUNI; OXIDATIVE STRESS; IN-VIVO; ISOMERASE; DSBA; IDENTIFICATION; CONSTRUCTION; MUTANTS; SYSTEM	Background: The formation of a disulfide bond between two cysteine residues stabilizes protein structure. Although we now have a good understanding of the Escherichia coli disulfide formation system, the machineries at work in other bacteria, including pathogens, are poorly characterized. Thus, the objective of this work was to improve our understanding of the disulfide formation machinery of Helicobacter pylori, a leading cause of ulcers and a risk factor for stomach cancer worldwide. Methods and Results: The protein HP0231 from H. pylori, a structural counterpart of E. coli DsbG, is the focus of this research. Its function was clarified by using a combination of biochemical, microbiological and genetic approaches. In particular, we determined the biochemical properties of HP0231 as well as its redox state in H. pylori cells. Conclusion: Altogether our results show that HP0231 is an oxidoreductase that catalyzes disulfide bond formation in the periplasm. We propose to call it HpDsbA.	[Roszczenko, Paula; Radomska, Katarzyna A.; Jagusztyn-Krynicka, Elzbieta K.] Univ Warsaw, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland; [Roszczenko, Paula] Univ Warsaw, Coll Interfac Individual Studies Math & Nat Sci, Warsaw, Poland; [Wywial, Ewa] Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, Warsaw, Poland; [Collet, Jean-Francois] Catholic Univ Louvain, WELBIO Walloon Excellence Life Sci & Biotechnol, B-1200 Brussels, Belgium; [Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Collet, Jean-Francois] Brussels Ctr Redox Biol, Brussels, Belgium	University of Warsaw; University of Warsaw; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Universite Catholique Louvain; WELBIO; Universite Catholique Louvain	Jagusztyn-Krynicka, EK (corresponding author), Univ Warsaw, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland.	kjkryn@biol.uw.edu.pl		Collet, Jean-Francois/0000-0001-8069-7036; Jagusztyn-Krynicka, Elzbieta/0000-0003-0484-9290; Roszczenko-Jasinska, Paula/0000-0002-5887-9308	European Union Structural Funds: Centre of Advanced Technology BIM - Equipment purchase for the Laboratory of Biological and Medical Imaging	European Union Structural Funds: Centre of Advanced Technology BIM - Equipment purchase for the Laboratory of Biological and Medical Imaging	The electron microscopy studies were performed in the Laboratory of Electron Microscopy, Nencki Institute of Experimental Biology, Warsaw, Poland by using electron microscope JEM1400 (JEOL Co., Japan, 2008) equipped with an energy-dispersive full range X-ray microanalysis system (EDS INCA Energy TEM, Oxford Instruments, Great Britain), a tomographic holder equipment and a high resolution digital camera (CCD MORADA, SiSOlympus, Germany). The above mentioned equipment was installed within the project sponsored by the European Union Structural Funds: Centre of Advanced Technology BIM - Equipment purchase for the Laboratory of Biological and Medical Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2008, GUT, V57, P1065, DOI 10.1136/gut.2007.145839; Asakura H, 2010, MOL MICROBIOL, V78, P1130, DOI 10.1111/j.1365-2958.2010.07393.x; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Bleumink-Pluym NMC, 1999, MICROBIOL-UK, V145, P2145, DOI 10.1099/13500872-145-8-2145; Bumann D, 2004, PROTEOMICS, V4, P2843, DOI 10.1002/pmic.200400909; Bumann D, 2002, INFECT IMMUN, V70, P3396, DOI 10.1128/IAI.70.7.3396-3403.2002; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Collet JF, 2003, J BIOL CHEM, V278, P45325, DOI 10.1074/jbc.M307818200; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Godlewska R, 2006, INT J MED MICROBIOL, V296, P321, DOI 10.1016/j.ijmm.2005.11.010; Grabowska AD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-166; Handa O, 2011, REDOX REP, V16, P1, DOI 10.1179/174329211X12968219310756; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Heuermann D, 1998, MOL GEN GENET, V257, P519, DOI 10.1007/s004380050677; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Kaakoush NO, 2007, FEMS IMMUNOL MED MIC, V50, P177, DOI 10.1111/j.1574-695X.2007.00259.x; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; Magnus M, 2012, BIOCH BIOPHYS ACTA; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Raczko AM, 2005, MICROBIOL-SGM, V151, P219, DOI 10.1099/mic.0.27483-0; Sabarth N, 2002, J BIOL CHEM, V277, P27896, DOI 10.1074/jbc.M204473200; Sabarth N, 2002, INFECT IMMUN, V70, P6499, DOI 10.1128/IAI.70.11.6499-6503.2002; Sambrook J., 2001, MOL CLONING LAB MANU; Sardesai AA, 2003, EMBO J, V22, P1461, DOI 10.1093/emboj/cdg152; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki H, 2012, J CLIN BIOCHEM NUTR, V50, P35, DOI [10.3164/jcbn.11-11SSR, 10.3164/jcbn.11-115SR]; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Waidner B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000669; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x; Yoon JY, 2011, FEBS LETT, V585, P3862, DOI 10.1016/j.febslet.2011.10.042; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016; Zeng X, 2005, WORLD J GASTROENTERO, V11, P3255, DOI 10.3748/wjg.v11.i21.3255	45	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46563	10.1371/journal.pone.0046563	http://dx.doi.org/10.1371/journal.pone.0046563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056345	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000056
J	Morris, LX; Spradling, AC				Morris, Lucy X.; Spradling, Allan C.			Steroid Signaling within Drosophila Ovarian Epithelial Cells Sex-Specifically Modulates Early Germ Cell Development and Meiotic Entry	PLOS ONE			English	Article							STEM-CELLS; NICHE FORMATION; OOGENESIS; ECDYSONE; MECHANISMS; PROTEIN; GROWTH; GENE; DIFFERENTIATION; REQUIREMENTS	Drosophila adult females but not males contain high levels of the steroid hormone ecdysone, however, the roles played by steroid signaling during Drosophila gametogenesis remain poorly understood. Drosophila germ cells in both sexes initially follow a similar pathway. After germline stem cells are established, their daughters form interconnected cysts surrounded by somatic escort (female) or cyst (male) cells and enter meiosis. Subsequently, female cysts acquire a new covering of somatic cells to form follicles. Knocking down expression of the heterodimeric ecdysteroid receptor (EcR/Usp) or the E75 early response gene in escort cells disrupts 16-cell cyst production, meiotic entry and follicle formation. Escort cells lose their squamous morphology and unsheath germ cells. By contrast, disrupting ecdysone signaling in males does not perturb cyst development or ensheathment. Thus, sex-specific steroid signaling is essential for female germ cell development at the time male and female pathways diverge. Our results suggest that steroid signaling plays an important sex-specific role in early germ cell development in Drosophila, a strategy that may be conserved in mammals.	[Morris, Lucy X.; Spradling, Allan C.] Carnegie Inst, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Spradling, AC (corresponding author), Carnegie Inst, Dept Embryol, Howard Hughes Med Inst, 115 W Univ Pkwy, Baltimore, MD USA.	spradling@ciwemb.edu			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study was funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables ET, 2010, CELL STEM CELL, V7, P581, DOI 10.1016/j.stem.2010.10.001; Arnold AP, 2012, TRENDS GENET, V28, P55, DOI 10.1016/j.tig.2011.10.004; BOWNES M, 1983, J EMBRYOL EXP MORPH, V78, P249; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Buszczak M, 2006, GENE DEV, V20, P977, DOI 10.1101/gad.1396306; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; DING D, 1993, P NATL ACAD SCI USA, V90, P2512, DOI 10.1073/pnas.90.6.2512; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; FULLER MT, 1993, DEV DROSOPHILA MELAN, V1, P71; GAREN A, 1977, P NATL ACAD SCI USA, V74, P5099, DOI 10.1073/pnas.74.11.5099; Gaziova I, 2004, DEVELOPMENT, V131, P2715, DOI 10.1242/dev.01143; Hackney JF, 2007, DEV DYNAM, V236, P1213, DOI 10.1002/dvdy.21140; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kirilly D, 2011, DEVELOPMENT, V138, P5087, DOI 10.1242/dev.067850; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; LIN HF, 1994, DEVELOPMENT, V120, P947; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Morris LX, 2011, DEVELOPMENT, V138, P2207, DOI 10.1242/dev.065508; Nystul T, 2010, GENETICS, V184, P503, DOI 10.1534/genetics.109.109538; ORO AE, 1992, DEVELOPMENT, V115, P449; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Salz HK, 2011, CURR OPIN GENET DEV, V21, P395, DOI 10.1016/j.gde.2011.03.001; SHEA MJ, 1990, GENE DEV, V4, P1128, DOI 10.1101/gad.4.7.1128; Sim H, 2008, TRENDS ENDOCRIN MET, V19, P213, DOI 10.1016/j.tem.2008.04.002; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Tennessen JM, 2011, CURR BIOL, V21, pR750, DOI 10.1016/j.cub.2011.06.033; Terashima J, 2005, J ENDOCRINOL, V187, P69, DOI 10.1677/joe.1.06220; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; van Werven FJ, 2011, PHILOS T R SOC B, V366, P3521, DOI 10.1098/rstb.2011.0081; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; White-Cooper H, 2010, REPRODUCTION, V139, P11, DOI 10.1530/REP-09-0083	40	62	64	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46109	10.1371/journal.pone.0046109	http://dx.doi.org/10.1371/journal.pone.0046109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056242	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600022
J	Rosa, IC; Pereira, JL; Costa, R; Goncalves, F; Prezant, R				Rosa, Ines Correia; Pereira, Joana Luisa; Costa, Raquel; Goncalves, Fernando; Prezant, Robert			Effects of Upper-Limit Water Temperatures on the Dispersal of the Asian Clam Corbicula fluminea	PLOS ONE			English	Article							DREISSENA-POLYMORPHA; RIVER; MULLER; MUSSEL; BIVALVIA; GROWTH; POPULATION; REPRODUCTION; SURVIVAL; MOLLUSKS	Temperature is a determinant environmental variable in metabolic rates of organisms ultimately influencing important physiological and behavioural features. Stressful conditions such as increasing temperature, particularly within high ranges occurring in the summer, have been suggested to induce flotation behaviour in Corbicula fluminea which may be important in dispersal of this invasive species. However, there has been no experimental evidence supporting this hypothesis. It was already proven that C. fluminea drift is supported by a mucilaginous drogue line produced by mucocytes present in the ctenidia. Detailed microscopic examination of changes in these cells and quantification of clam flotation following one, two and three weeks of exposure to 22, 25 and 30 degrees C was carried out so that the effects of increasing water temperatures in dispersal patterns could be discussed. Results show that changes in temperature triggered an acceleration of the mucocytes production and stimulated flotation behaviour, especially following one week of exposure. Dilution of these effects occurred following longer exposure periods. It is possible that these bivalves perceive changing temperature as a stress and respond accordingly in the short-term, and then acclimate to the new environmental conditions. The response patterns suggest that increasing water temperatures could stimulate C. fluminea population expansion.	[Rosa, Ines Correia; Pereira, Joana Luisa; Goncalves, Fernando] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Rosa, Ines Correia; Pereira, Joana Luisa; Goncalves, Fernando] CESAM Ctr Environm & Marine Studies, Aveiro, Portugal; [Costa, Raquel] Univ Coimbra, Dept Chem Engn, CIEPQPF, Coimbra, Portugal; [Prezant, Robert] Montclair State Univ, Coll Sci & Math, Montclair, NJ USA	Universidade de Aveiro; Universidade de Aveiro; Universidade de Coimbra; Montclair State University	Pereira, JL (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	jpereira@ua.pt	Pereira, Joana Luísa/A-5003-2009; Prezant, R. S./AAA-5428-2019; Gonçalves, Fernando J. M./B-8000-2008; Rosa, Ines/I-5925-2014	Pereira, Joana Luísa/0000-0001-7573-6184; Gonçalves, Fernando J. M./0000-0002-9326-187X; Rosa, Ines/0000-0001-9530-1057; Costa, Raquel/0000-0003-4077-103X	Portuguese Foundation for Science and Technology - FCT [SFRH/BD/33395/2008, SFRH/BPD/44733/2008]; European Regional Development Fund - EDRF, through the Operational Competitiveness Programme - COMPETE; FCT [PTDC/AAC-AMB/113515/2009]; Fundação para a Ciência e a Tecnologia [PTDC/AAC-AMB/113515/2009] Funding Source: FCT	Portuguese Foundation for Science and Technology - FCT(Portuguese Foundation for Science and Technology); European Regional Development Fund - EDRF, through the Operational Competitiveness Programme - COMPETE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	Ines C Rosa and Joana L Pereira are recipients of individual scholarships by the Portuguese Foundation for Science and Technology - FCT (SFRH/BD/33395/2008 and SFRH/BPD/44733/2008, respectively). This study was supported by the European Regional Development Fund - EDRF, through the Operational Competitiveness Programme - COMPETE, and by national funds through FCT under the scope of the project PTDC/AAC-AMB/113515/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE DW, 1978, J MOLLUS STUD, V44, P49; ALLAN J. D., 2008, STREAM ECOLOGY STRUC; ARAUJO R, 1993, AM MALACOL BULL, V10, P39; Bodis E, 2012, BIOLOGIA, V67, P739, DOI 10.2478/s11756-012-0062-5; Boltovskoy D, 1997, ARCH HYDROBIOL, V138, P483; Brancotte V, 2002, B FR PECHE PISCIC, P325, DOI 10.1051/kmae:2002038; Britton J. C., 1982, MALACOL REV S, P1; BRITTON JC, 1982, P S REC BENTH INV TE, P21; Byrne M, 2000, HYDROBIOLOGIA, V418, P185, DOI 10.1023/A:1003986512832; Cairns J., 1980, DYNAMICS CONTROL ASI; CAMPBELL N, 1996, BIOLOGY; Cantanhede G, 2008, ECOL FRESHW FISH, V17, P47, DOI 10.1111/j.1600-0633.2007.00258.x; Clarke M, 1996, AM MALACOL BULL, V13, P105; Elliott P, 2005, WATER ENVIRON J, V19, P367, DOI 10.1111/j.1747-6593.2005.tb00575.x; Flynn AM, 2010, J EXP MAR BIOL ECOL, V383, P32, DOI 10.1016/j.jembe.2009.10.017; French JRP, 1996, J FRESHWATER ECOL, V11, P183, DOI 10.1080/02705060.1996.9663477; Galbraith HS, 2009, HYDROBIOLOGIA, V636, P35, DOI 10.1007/s10750-009-9933-3; GAMMERT C, 1988, Rhinology (Utrecht), V26, P41; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Jenner HA, 1998, HYDROECOLOGIE APPL, V10, P1; JOY JE, 1985, NAUTILUS, V99, P110; Karatayev AY, 2005, NATO SCI S SS IV EAR, V47, P239; KRAEMER LR, 1986, AM MALACOL BULL, V4, P61; KRATZ WA, 1955, AM J BOT, V42, P282, DOI 10.2307/2438564; Lancaster J, 1996, CAN J FISH AQUAT SCI, V53, P572, DOI 10.1139/cjfas-53-3-572; Larsen PS, 2009, J EXP MAR BIOL ECOL, V381, P67, DOI 10.1016/j.jembe.2009.09.021; Larsen PS, 2008, AQUAT BIOL, V4, P47, DOI 10.3354/ab00093; Lui KKY, 2004, J SHELLFISH RES, V23, P421; Mackie GL, 2010, MONITORING AND CONTROL OF MACROFOULING MOLLUSKS IN FRESH WATER SYSTEMS, 2ND EDITION, P1; McMahon R.F., 1983, P505; Morgan DE, 2003, J SHELLFISH RES, V22, P193; Morton B, 1977, FRESHWATER FOULING B, P1; Moyo NAG, 2011, PHYS CHEM EARTH, V36, P876, DOI 10.1016/j.pce.2011.07.056; Muller O, 2011, MALACOLOGIA, V53, P367, DOI 10.4002/040.053.0207; Peyer SM, 2010, J EXP BIOL, V213, P2602, DOI 10.1242/jeb.042549; PREZANT RS, 1984, SCIENCE, V225, P1491, DOI 10.1126/science.225.4669.1491; PREZANT RS, 1986, T AM MICROSC SOC, V105, P338, DOI 10.2307/3226519; Prezant RS, 1990, FORM FUNCTION PHYLOG, P83; Purves W. K., 2001, LIFE SCI BIOL; Quiniou SMA, 1998, FISH SHELLFISH IMMUN, V8, P1, DOI 10.1006/fsim.1997.0115; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Rajagopal S, 1999, MAR FRESHW BEHAV PHY, V32, P239, DOI 10.1080/10236249909379052; Rajagopal S., 1996, Netherlands Journal of Aquatic Ecology, V30, P187, DOI 10.1007/BF02272238; Renard E, 2000, MOL ECOL, V9, P2009, DOI 10.1046/j.1365-294X.2000.01104.x; Robinson AT, 2001, N AM J FISH MANAGE, V21, P809, DOI 10.1577/1548-8675(2001)021<0809:JGONFI>2.0.CO;2; Rosa IC, 2011, ECOL ECON, V70, P1805, DOI 10.1016/j.ecolecon.2011.05.006; Sousa R, 2007, ESTUAR COAST SHELF S, V74, P166, DOI 10.1016/j.ecss.2007.04.011; TOWNSEND CR, 1976, J ANIM ECOL, V45, P759, DOI 10.2307/3579; Tran D, 2011, CHRONOBIOL INT, V28, P307, DOI 10.3109/07420528.2011.565897; Trichkova TA, 2008, J NAT HIST, V42, P619, DOI 10.1080/00222930701835589; Vazquez KE, 2010, RANGE EXTENSION PARA; Viergutz C, 2007, OECOLOGIA, V151, P115, DOI 10.1007/s00442-006-0544-7; Voelz NJ, 1998, J FRESHWATER ECOL, V13, P39, DOI 10.1080/02705060.1998.9663589; Vohmann A, 2010, BIOL INVASIONS, V12, P53, DOI 10.1007/s10530-009-9429-0; Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3; Wang WX, 1997, MAR ECOL PROG SER, V148, P71, DOI 10.3354/meps148071; Weitere M, 2009, GLOBAL CHANGE BIOL, V15, P2838, DOI 10.1111/j.1365-2486.2009.01925.x; WELCH K J, 1984, Freshwater Invertebrate Biology, V3, P139, DOI 10.2307/1467187; WILLIAMS DD, 1990, ARCH HYDROBIOL, V119, P167; YOUNG GA, 1985, MAR ECOL PROG SER, V24, P261, DOI 10.3354/meps024261; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	62	22	23	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46635	10.1371/journal.pone.0046635	http://dx.doi.org/10.1371/journal.pone.0046635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056377	gold, Green Published			2022-12-27	WOS:000309452600048
J	Placone, J; Hristova, K				Placone, Jesse; Hristova, Kalina			Direct Assessment of the Effect of the Gly380Arg Achondroplasia Mutation on FGFR3 Dimerization Using Quantitative Imaging FRET	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; TRANSMEMBRANE DOMAIN; ENERGY-TRANSFER; PHYSICAL BASIS; ACTIVATION; COMPLEX; PRINCIPLES; ENERGETICS; DISORDERS; DWARFISM	The Gly380Arg mutation in FGFR3 is the genetic cause for achondroplasia (ACH), the most common form of human dwarfism. The mutation has been proposed to increase FGFR3 dimerization, but the dimerization propensities of wild-type and mutant FGFR3 have not been compared. Here we use quantitative imaging FRET to characterize the dimerization of wild-type FGFR3 and the ACH mutant in plasma membrane-derived vesicles from HEK293T cells. We demonstrate a small, but statistically significant increase in FGFR3 dimerization due to the ACH mutation. The data are consistent with the idea that the ACH mutation causes a structural change which affects both the stability and the activity of FGFR3 dimers in the absence of ligand.	[Placone, Jesse; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	kh@jhu.edu	Placone, Jesse K/M-6388-2015; Hristova, Kalina/A-3326-2010	Placone, Jesse K/0000-0002-3464-8177; 	National Institutes of Health [GM095930]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [GM095930]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevington PR, 1969, DATA REDUCTION ERROR; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Chen FH, 2011, BIOCHEMISTRY-US, V50, P8576, DOI 10.1021/bi200986f; Chen FH, 2011, BBA-BIOMEMBRANES, V1808, P2045, DOI 10.1016/j.bbamem.2011.04.007; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; DECROUYCHANEL A, 1995, J BIOL CHEM, V270, P10571, DOI 10.1074/jbc.270.18.10571; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044; He LJ, 2011, J BIOL CHEM, V286, P13272, DOI 10.1074/jbc.M110.205583; He LJ, 2010, J BIOL CHEM, V285, P30103, DOI 10.1074/jbc.M109.094086; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3475, DOI 10.1021/bi00283a026; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3466, DOI 10.1021/bi00283a025; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; L'Horte CGM, 2005, EXP CELL RES, V304, P417; Li E, 2008, ANAL CHEM, V80, P5976, DOI 10.1021/ac800616u; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; MAYNARD JA, 1981, J BONE JOINT SURG AM, V63, P969, DOI 10.2106/00004623-198163060-00015; Merzlyakov M, 2007, J MEMBRANE BIOL, V215, P93, DOI 10.1007/s00232-007-9009-0; Merzlyakov M, 2008, METHOD ENZYMOL, V450, P107, DOI 10.1016/S0076-6879(08)03406-X; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; WILKIE AOM, 1995, CURR BIOL, V5, P500; WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1; You M, 2006, BIOCHEMISTRY-US, V45, P5551, DOI 10.1021/bi060113g	42	44	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46678	10.1371/journal.pone.0046678	http://dx.doi.org/10.1371/journal.pone.0046678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056398	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400023
J	Shen, LR; Liu, DD; Li, ML; Jin, F; Din, MH; Parnell, LD; Lai, CQ				Shen, Lirong; Liu, Dandan; Li, Meilu; Jin, Feng; Din, Meihui; Parnell, Laurence D.; Lai, Chao-Qiang			Mechanism of Action of Recombinant Acc-Royalisin from Royal Jelly of Asian Honeybee against Gram-Positive Bacteria	PLOS ONE			English	Article							ANTIBACTERIAL PEPTIDE; ESCHERICHIA-COLI; ANTIMICROBIAL PEPTIDES; EXPRESSION SYSTEMS; DEFENSIN; GENE; PROTEIN	The antibacterial activity of royalisin, an antimicrobial peptide from the royal jelly produced by honeybees, has been addressed extensively. However, its mechanism of action remains unclear. In this study, a recombinant royalisin, RAcc-royalisin from the royal jelly of Asian honeybee Apis cerana cerana, was expressed by fusing with glutathione S-transferase (GST) in Escherichia coli BL21, isolated and purified. The agar dilution assays with inhibition zone showed that RAcc-royalisin, similar to nisin, inhibits the growth of Gram-positive bacteria. The antibacterial activity of RAcc-royalisin was associated with its concentration, and was weakened by heat treatment ranging from 55 degrees C to 85 degrees C for 15 min. Both RAcc-royalisin and nisin exhibited the minimum inhibitory concentrations (MIC) of 62.5 mu g/ml, 125 mu g/ml, and 250 mu g/ml against Gram-positive bacterial strains, Bacillus subtilis and Micrococcus flavus and Staphyloccocus aureus in the microplate assay, respectively. However, RAcc-royalisin did not show antimicrobial activity against tested Gram-negative bacterial and fungal strains. The antibacterial activity of RAcc-royalisin agrees well with the decrease in bacterial cell hydrophobicity, the leakage of 260-nm absorbing materials, and the observation by transmission electron microscopy, all indicating that RAcc-royalisin induced the disruption and dysfunction of cell walls and membranes. This is the first report detailing the antibacterial mechanism of royalisin against Gram-positive bacteria, and provides insight into the application of recombinant royalisin in food and pharmaceutical industries as an antimicrobial agent.	[Shen, Lirong; Liu, Dandan; Li, Meilu; Jin, Feng; Din, Meihui] Zhejiang Univ, Dept Food Sci & Nutr, Sch Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Parnell, Laurence D.; Lai, Chao-Qiang] Tufts Univ, Nutr & Genom Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Zhejiang University; Tufts University; United States Department of Agriculture (USDA)	Shen, LR (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Sch Biosyst Engn & Food Sci, Zijinggang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	shenlirong@zju.edu.cn		Lai, Chao-Qiang/0000-0003-1107-8375	Scientific and Technical Programs of Zhejiang [2011C22029]; Scientific and Technical Programs of Hangzhou [20110232B52]; National program (863) of High-Technology Research and Development from The Ministry of Science and Technology of China [2007AA10Z324]	Scientific and Technical Programs of Zhejiang; Scientific and Technical Programs of Hangzhou; National program (863) of High-Technology Research and Development from The Ministry of Science and Technology of China(National High Technology Research and Development Program of China)	This work was supported by Scientific and Technical Programs of Zhejiang (No. 2011C22029) (http://www.zjkjt.gov.cn/); Scientific and Technical Programs of Hangzhou (No. 20110232B52) (http://www.hznet.com.cn/); and National program (863) of High-Technology Research and Development from The Ministry of Science and Technology of China (No. 2007AA10Z324) (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bachanova K, 2002, APIDOLOGIE, V33, P259, DOI 10.1051/apido:2002015; BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6; Bilikova K, 2001, APIDOLOGIE, V32, P275, DOI 10.1051/apido:2001129; Carson CF, 2002, ANTIMICROB AGENTS CH, V46, P1914, DOI 10.1128/AAC.46.6.1914-1920.2002; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; Cho WL, 1996, INSECT BIOCHEM MOLEC, V26, P395, DOI 10.1016/0965-1748(95)00108-5; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; COCIANCICH S, 1993, J BIOL CHEM, V268, P19239; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; GAO FH, 1991, APPL ENVIRON MICROB, V57, P2164, DOI 10.1128/AEM.57.8.2164-2170.1991; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; LAVALLIE ER, 1995, CURR OPIN BIOTECH, V6, P501, DOI 10.1016/0958-1669(95)80083-2; Li YF, 2011, PROTEIN EXPRES PURIF, V80, P260, DOI 10.1016/j.pep.2011.08.001; Nakajima Y, 2003, BBA-GEN SUBJECTS, V1624, P125, DOI 10.1016/j.bbagen.2003.10.004; Pazgier M, 2007, CURR PHARM DESIGN, V13, P3096, DOI 10.2174/138161207782110381; Shen LR, 2010, J AGR FOOD CHEM, V58, P2266, DOI 10.1021/jf902574t; Skosyrev VS, 2003, PROTEIN EXPRES PURIF, V28, P350, DOI 10.1016/S1046-5928(02)00697-6; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Tseng JM, 2011, BIOTECHNOL PROGR, V27, P153, DOI 10.1002/btpr.528; Xu P, 2009, PLOS ONE, V4, P1; Zhang H, 2009, J FOOD SCI, V74, pM418, DOI 10.1111/j.1750-3841.2009.01300.x; Zhang J, 2011, PROTEIN EXPRES PURIF, V78, P189, DOI 10.1016/j.pep.2011.04.014	24	33	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47194	10.1371/journal.pone.0047194	http://dx.doi.org/10.1371/journal.pone.0047194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056609	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400064
J	Al Kaabi, A; Traupe, T; Stutz, M; Buchs, N; Heller, M				Al Kaabi, Ali; Traupe, Tobias; Stutz, Monika; Buchs, Natasha; Heller, Manfred			Cause or Effect of Arteriogenesis: Compositional Alterations of Microparticles from CAD Patients Undergoing External Counterpulsation Therapy	PLOS ONE			English	Article							CELL-DERIVED MICROPARTICLES; INDUCE ANGIOGENESIS; COLLATERAL FLOW; NITRIC-OXIDE; ANGINA; LIPOPROTEINS; MODULATION; RECEPTOR; ENHANCE; RESERVE	Recently, a clinical study on patients with stable coronary artery disease (CAD) showed that external counterpulsation therapy (ECP) at high (300 mmHg) but not at low inflation pressure (80 mmHg) promoted coronary collateral growth, most likely due to shear stress-induced arteriogenesis. The exact molecular mechanisms behind shear stress-induced arteriogenesis are still obscure. We therefore characterized plasma levels of circulating microparticles (MPs) from these CAD patients because of their ambivalent nature as a known cardiovascular risk factor and as a promoter of neovascularization in the case of platelet-derived MPs. MPs positive for Annexin V and CD31CD41 were increased, albeit statistically significant (P < 0.05, vs. baseline) only in patients receiving high inflation pressure ECP as determined by flow cytometry. MPs positive for CD62E, CD146, and CD14 were unaffected. In high, but not in low, inflation pressure treatment, change of CD31CD41 was inversely correlated to the change in collateral flow index (CFI), a measure for collateral growth. MPs from the high inflation pressure group had a more sustained pro-angiogenic effect than the ones from the low inflation pressure group, with the exception of one patient showing also an increased CFI after treatment. A total of 1005 proteins were identified by a label-free proteomics approach from MPs of three patients of each group applying stringent acceptance criteria. Based on semi-quantitative protein abundance measurements, MPs after ECP therapy contained more cellular proteins and increased CD31, corroborating the increase in MPs. Furthermore, we show that MP-associated factors of the innate immune system were decreased, many membrane-associated signaling proteins, and the known arteriogenesis stimulating protein transforming growth factor beta-1 were increased after ECP therapy. In conclusion, our data show that ECP therapy increases platelet-derived MPs in patients with CAD and that the change in protein cargo of MPs is likely in favor of a pro angiogenic/arteriogenic property.	[Al Kaabi, Ali; Stutz, Monika; Buchs, Natasha; Heller, Manfred] Univ Bern, Dept Clin Res, Bern, Switzerland; [Traupe, Tobias] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Al Kaabi, A (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	manfred.heller@dkf.unibe.ch		Traupe, Tobias/0000-0002-7051-4096; Heller, Manfred/0000-0002-6364-7325	Swiss National Science Foundation [3200BO-113888]; Swiss Heart Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation	Supported by the Swiss National Science Foundation grant 3200BO-113888 (www.snf.ch) to MH and the Swiss Heart Foundation (www.swissheart.ch) to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, FASEB J, V21, P2735, DOI 10.1096/fj.07-8079com; Akhtar M, 2006, AM J CARDIOL, V98, P28, DOI 10.1016/j.amjcard.2006.01.053; Arora RR, 1999, J AM COLL CARDIOL, V33, P1833, DOI 10.1016/S0735-1097(99)00140-0; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1918, DOI 10.1016/S0735-1097(03)00428-5; Braith RW, 2010, CIRCULATION, V122, P1612, DOI 10.1161/CIRCULATIONAHA.109.923482; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Burnier L, 2009, THROMB HAEMOSTASIS, V101, P439, DOI 10.1160/TH08-08-0521; Buschmann EE, 2009, EUR J CLIN INVEST, V39, P866, DOI 10.1111/j.1365-2362.2009.02192.x; Calvo D, 1998, J LIPID RES, V39, P777; Chen YW, 2010, THROMB HAEMOSTASIS, V104, P293, DOI 10.1160/TH09-09-0633; Deindl E, 2005, CELL BIOCHEM BIOPHYS, V43, P1, DOI 10.1385/CBB:43:1:001; Garcia BA, 2005, J PROTEOME RES, V4, P1516, DOI 10.1021/pr0500760; Gloekler S, 2010, HEART, V96, P202, DOI 10.1136/hrt.2009.184507; Heller M, 2007, MOL CELL PROTEOMICS, V6, P1059, DOI 10.1074/mcp.M600326-MCP200; Hoopmann MR, 2007, ANAL CHEM, V79, P5620, DOI 10.1021/ac0700833; Iruela-Arispe ML, 2004, INT J BIOCHEM CELL B, V36, P1070, DOI 10.1016/j.biocel.2004.01.025; Janowska-Wieczorek A, 2001, BLOOD, V98, P3143, DOI 10.1182/blood.V98.10.3143; Kim HK, 2004, BRIT J HAEMATOL, V124, P376, DOI 10.1046/j.1365-2141.2003.04773.x; Leroyer AS, 2008, J INTERN MED, V263, P528, DOI 10.1111/j.1365-2796.2008.01957.x; Little KM, 2010, SEMIN THROMB HEMOST, V36, P845, DOI 10.1055/s-0030-1267038; Manchanda A, 2007, J AM COLL CARDIOL, V50, P1523, DOI 10.1016/j.jacc.2007.07.024; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Masuda D, 2001, EUR HEART J, V22, P1451, DOI 10.1053/euhj.2000.2545; Mause SF, 2010, CIRCULATION, V122, P495, DOI 10.1161/CIRCULATIONAHA.109.909473; Meier P, 2009, CIRCULATION, V120, P1355, DOI 10.1161/CIRCULATIONAHA.109.866269; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Mostefai HA, 2008, J IMMUNOL, V180, P5028, DOI 10.4049/jimmunol.180.7.5028; Nielsen CT, 2012, ARTHRITIS RHEUM-US, V64, P1227, DOI 10.1002/art.34381; Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6; Ostergaard O, 2012, J PROTEOME RES, V11, P2154, DOI 10.1021/pr200901p; Peterson DB, 2008, PROTEOMICS, V8, P2430, DOI 10.1002/pmic.200701029; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/00002030-200301030-00006; Schirmer SH, 2009, HEART, V95, P191, DOI 10.1136/hrt.2007.136119; Seiler C, 1998, J AM COLL CARDIOL, V32, P1272, DOI 10.1016/S0735-1097(98)00384-2; Shechter M, 2003, J AM COLL CARDIOL, V42, P2090, DOI 10.1016/j.jacc.2003.05.013; Stalder D, 2008, J PROTEOM BIOINFORM, V1, P389; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Traupe T, 2010, CIRCULATION, V122, P1210, DOI 10.1161/CIRCULATIONAHA.109.930651; van der Zee PM, 2010, CLIN IMMUNOL, V135, P490, DOI 10.1016/j.clim.2010.01.002; van Royen N, 2002, FASEB J, V16, P432, DOI 10.1096/fj.01-0563fje; VanWijk MJ, 2002, AM J OBSTET GYNECOL, V187, P450, DOI 10.1067/mob.2002.124279; Zbinden R, 2007, EUR J CARDIOV PREV R, V14, P250, DOI 10.1097/HJR.0b013e3280565dee; Zhang Y, 2010, ARTERIOSCL THROM VAS, V30, P773, DOI 10.1161/ATVBAHA.109.197806	49	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46822	10.1371/journal.pone.0046822	http://dx.doi.org/10.1371/journal.pone.0046822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056467	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500085
J	Kondratov, AG; Kvasha, SM; Stoliar, LA; Romanenko, AM; Zgonnyk, YM; Gordiyuk, VV; Kashuba, EV; Rynditch, AV; Zabarovsky, ER; Kashuba, VI				Kondratov, Aleksandr G.; Kvasha, Sergiy M.; Stoliar, Liubov A.; Romanenko, Alina M.; Zgonnyk, Yury M.; Gordiyuk, Vasily V.; Kashuba, Elena V.; Rynditch, Alla V.; Zabarovsky, Eugene R.; Kashuba, Vladimir I.			Alterations of the WNT7A Gene in Clear Cell Renal Cell Carcinomas	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; LUNG-CANCER; MICROSATELLITE ANALYSIS; EPIGENETIC ANALYSIS; SIGNALING PATHWAY; METHYLATION; TRANSFORMATION; EXPRESSION; RASSF1A; CATENIN	WNT7A (wingless-type MMTV integration site family, member 7A) is a known tumor suppressor gene of non-small cell lung carcinomas (NSCLC) and is frequently inactivated due to CpG-island hypermethylation in human cancers. The members of WNT family are involved in cell signaling and play crucial roles in cancer development. In the present work hypermethylation of the WNT7A gene was detected in 66% (29/44) of analyzed clear cell renal cell carcinomas (RCCs) using methyl-specific PCR (MSP). Moreover, bisulfite sequencing confirmed intensive hypermethylation of the 5'-CpG island of the WNT7A gene. Methylation analysis revealed positive correlations between tumor stage, Fuhrman nuclear grade and WNT7A hypermethylation. Additionally, restoration of WNT7A gene expression in the A498 cell line by 5-aza-2'-deoxycytidine treatment confirmed a direct contribution of hypermethylation in silencing of the WNT7A gene. High frequency of loss of heterozygosity (LOH) was demonstrated on chromosome 3p25 in regions surrounding the WNT7A gene. The frequent down-regulation of WNT7A gene expression was detected in 88% (15/17) of clear cell RCCs. We have also shown that the WNT7A gene possesses tumor suppression function by colony-formation and cell proliferation assays in RCC cell lines. In summary, the WNT7A gene is inactivated by genetic/epigenetic alterations in clear cell RCC and demonstrates tumor suppressor properties.	[Kondratov, Aleksandr G.; Kvasha, Sergiy M.; Stoliar, Liubov A.; Gordiyuk, Vasily V.; Kashuba, Vladimir I.] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Dept Mol Oncogenet, Kiev, Ukraine; [Romanenko, Alina M.; Zgonnyk, Yury M.] Ukraine Acad Med Sci, Inst Urol, Kiev, Ukraine; [Rynditch, Alla V.] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Dept Funct Genom, Kiev, Ukraine; [Kashuba, Elena V.; Zabarovsky, Eugene R.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Kashuba, Elena V.] Natl Acad Sci Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Kiev, Ukraine; [Zabarovsky, Eugene R.] RAN, VA Engelhardt Mol Biol Inst, Lab Struct & Funct Genom, Moscow, Russia; [Zabarovsky, Eugene R.] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; National Academy of Medical Sciences of Ukraine; O. F. Vozianov Institute of Urology of the National Academy of Medical Sciences of Ukraine; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Karolinska Institutet; National Academy of Sciences Ukraine; Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology of NASU; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Linkoping University	Kondratov, AG (corresponding author), Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Dept Mol Oncogenet, Kiev, Ukraine.	o.g.kondratov@imbg.org.ua	Kashuba, Elena/O-5389-2015; Kashuba, Elena/Q-4739-2019; Kashuba, Vladimir I/N-3732-2017; Kashuba, Vladimir/AAO-7742-2020	Kashuba, Elena/0000-0001-7001-4035; Kashuba, Elena/0000-0001-7001-4035; Kashuba, Vladimir I/0000-0001-9416-8282; Kondratov, Oleksandr/0000-0001-8305-2989; Rynditch, Alla/0000-0003-1590-7839	State Fond of Fundamental Research [F46/457-2011]; Swedish Cancer Society; Swedish Institute; Swedish Research Council; EACR	State Fond of Fundamental Research; Swedish Cancer Society(Swedish Cancer Society); Swedish Institute; Swedish Research Council(Swedish Research CouncilEuropean Commission); EACR	This work was supported by the State Fond of Fundamental Research (grant No F46/457-2011). E. R. Zabarovsky was supported by research grants from the Swedish Cancer Society, the Swedish Institute and the Swedish Research Council. A. Kondratov was partially supported by a travel fellowship from EACR for research in the MTC department of Karolinska Institute (Sweden, Stockholm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimov A, 2000, ONCOGENE, V19, P1392, DOI 10.1038/sj.onc.1203449; Arai E, 2008, CLIN CANCER RES, V14, P5531, DOI 10.1158/1078-0432.CCR-08-0443; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Arai E, 2011, INT J CLIN EXP PATHO, V4, P58; Buechling T, 2011, CURR TOP DEV BIOL, V97, P21, DOI 10.1016/B978-0-12-385975-4.00008-5; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chen XQ, 1999, CLIN CANCER RES, V5, P2297; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; Corcoran MM, 1998, BLOOD, V91, P1382, DOI 10.1182/blood.V91.4.1382; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dmitriev AA, 2012, EPIGENETICS-US, V7, P502, DOI 10.4161/epi.19801; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Elo JP, 1997, CANCER RES, V57, P3356; Glavac D, 1996, PFLUGERS ARCH, V431, P193; Goessl C, 1998, CANCER RES, V58, P4728; Haraldson K, 2012, BIOCHIMIE, V94, P1151, DOI 10.1016/j.biochi.2012.01.019; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Katoh M, 2003, INT J MOL MED, V12, P811; Katoh M, 2005, ONCOL REP, V14, P1583; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kondratov AG, 2012, MOL MED REP, V5, P509, DOI 10.3892/mmr.2011.681; Kurasawa Y, 2012, ONCOGENE, V31, P1963, DOI 10.1038/onc.2011.373; Kvasha S, 2008, CANCER LETT, V265, P250, DOI 10.1016/j.canlet.2008.02.036; Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272; Li JF, 2002, P NATL ACAD SCI USA, V99, P10724, DOI 10.1073/pnas.132271699; Liang H, 2003, CELL, P349; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Merritt MA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-378; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Morrissey C, 2001, CANCER RES, V61, P7277; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ochoa-Hernandez AB, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-60; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Onay H, 2009, UROL INT, V83, P107, DOI 10.1159/000224878; Psutka SP, 2011, INTERVENTIONAL ONCOL; Ramburan A, 2004, MODERN PATHOL, V17, P89, DOI 10.1038/modpathol.3800022; Rowley H, 1996, ARCH OTOLARYNGOL, V122, P497; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sanz-Casla MT, 2003, UROL RES, V31, P159, DOI 10.1007/s00240-003-0308-3; Sato N, 2003, CANCER RES, V63, P3735; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Sebova K, 2011, CANCER BIOMARK, V10, P13, DOI 10.3233/CBM-2012-0230; Senchenko VN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-75; Skrypkina IYa, 2006, REPORTS NATL ACAD SC, P188; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; Tennis MA, 2012, P AM THORAC SOC, V9, P83; Tennis MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032921; Tsutomu N, 2007, BIOMATERIALS, P844; Wang FL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003031; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Yoshioka S, 2012, MOL CANCER RES, V10, P469, DOI 10.1158/1541-7786.MCR-11-0177; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835	55	25	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47012	10.1371/journal.pone.0047012	http://dx.doi.org/10.1371/journal.pone.0047012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056560	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500122
J	Lindhoud, S; Westphal, AH; Visser, AJWG; Borst, JW; van Mierlo, CPM				Lindhoud, Simon; Westphal, Adrie H.; Visser, Antonie J. W. G.; Borst, Jan Willem; van Mierlo, Carlo P. M.			Fluorescence of Alexa Fluor Dye Tracks Protein Folding	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; BETA PARALLEL PROTEIN; MOLTEN-GLOBULE STATE; AZOTOBACTER-VINELANDII; FLAVODOXIN-II; APOFLAVODOXIN; MOLECULE; PATHWAY; INHIBITOR; LANDSCAPE	Fluorescence spectroscopy is an important tool for the characterization of protein folding. Often, a protein is labeled with appropriate fluorescent donor and acceptor probes and folding-induced changes in Forster Resonance Energy Transfer (FRET) are monitored. However, conformational changes of the protein potentially affect fluorescence properties of both probes, thereby profoundly complicating interpretation of FRET data. In this study, we assess the effects protein folding has on fluorescence properties of Alexa Fluor 488 (A488), which is commonly used as FRET donor. Here, A488 is covalently attached to Cys69 of apoflavodoxin from Azotobacter vinelandii. Although coupling of A488 slightly destabilizes apoflavodoxin, the three-state folding of this protein, which involves a molten globule intermediate, is unaffected. Upon folding of apoflavodoxin, fluorescence emission intensity of A488 changes significantly. To illuminate the molecular sources of this alteration, we applied steady state and time-resolved fluorescence techniques. The results obtained show that tryptophans cause folding-induced changes in quenching of Alexa dye. Compared to unfolded protein, static quenching of A488 is increased in the molten globule. Upon populating the native state both static and dynamic quenching of A488 decrease considerably. We show that fluorescence quenching of Alexa Fluor dyes is a sensitive reporter of conformational changes during protein folding.	[Lindhoud, Simon; Westphal, Adrie H.; Visser, Antonie J. W. G.; Borst, Jan Willem; van Mierlo, Carlo P. M.] Wageningen Univ, Biochem Lab, Wageningen, Netherlands; [Visser, Antonie J. W. G.; Borst, Jan Willem] Wageningen Univ, Microspectroscopy Ctr, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van Mierlo, CPM (corresponding author), Wageningen Univ, Biochem Lab, Wageningen, Netherlands.	carlo.vanmierlo@wur.nl	Westphal, Adrie Herman/L-3517-2019; Borst, Jan Willem/B-1259-2011; vanMierlo, Carlo p/B-4491-2016	Westphal, Adrie Herman/0000-0003-4264-6267; vanMierlo, Carlo p/0000-0002-5358-8392	Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organization for Scientific Research (NWO) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; AMIR D, 1987, BIOCHEMISTRY-US, V26, P2162, DOI 10.1021/bi00382a015; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Choi J, 2011, PHYS CHEM CHEM PHYS, V13, P5651, DOI 10.1039/c0cp02689a; Deniz AA, 2000, P NATL ACAD SCI USA, V97, P5179, DOI 10.1073/pnas.090104997; Deniz AA, 1999, P NATL ACAD SCI USA, V96, P3670, DOI 10.1073/pnas.96.7.3670; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; HAAS E, 1978, BIOPOLYMERS, V17, P11, DOI 10.1002/bip.1978.360170103; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Laptenok SP, 2011, BIOCHEMISTRY-US, V50, P3441, DOI 10.1021/bi101965d; Nabuurs SM, 2010, EUR BIOPHYS J BIOPHY, V39, P689, DOI 10.1007/s00249-009-0556-4; Nabuurs SM, 2009, J AM CHEM SOC, V131, P8290, DOI 10.1021/ja9014309; Nabuurs SM, 2008, J AM CHEM SOC, V130, P16914, DOI 10.1021/ja803841n; Nozaki Y, 1972, METHODS ENZYMOL, P26; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rhoades E, 2004, J AM CHEM SOC, V126, P14686, DOI 10.1021/ja046209k; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Sillen A, 1998, PHOTOCHEM PHOTOBIOL, V67, P475, DOI 10.1562/0031-8655(1998)067<0475:TCUOFP>2.3.CO;2; Steensma E, 1996, EUR J BIOCHEM, V235, P167, DOI 10.1111/j.1432-1033.1996.00167.x; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Visser NV, 2008, BIOPHYS J, V95, P2462, DOI 10.1529/biophysj.108.132001; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398	41	18	21	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46838	10.1371/journal.pone.0046838	http://dx.doi.org/10.1371/journal.pone.0046838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056480	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500088
J	Ogura, T				Ogura, Toshihiko			High-Contrast Observation of Unstained Proteins and Viruses by Scanning Electron Microscopy	PLOS ONE			English	Article							26S PROTEASOME; PARTICLE; RESOLUTION; CELLS; SEM	Scanning electron microscopy (SEM) is an important tool for the nanometre-scale analysis of the various samples. Imaging of biological specimens can be difficult for two reasons: (1) Samples must often be left unstained to observe detail of the biological structures; however, lack of staining significantly decreases image contrast. (2) Samples are prone to serious radiation damage from electron beam. Herein we report a novel method for sample preparation involving placement on a new metal-coated insulator film. This method enables obtaining high-contrast images from unstained proteins and viruses by scanning electron microscopy with minimal electron radiation damage. These images are similar to those obtained by transmission electron microscopy. In addition, the method can be easily used to observe specimens of proteins, viruses and other organic samples by using SEM.	Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Ogura, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Cent 2, Tsukuba, Ibaraki, Japan.	t-ogura@aist.go.jp	Ogura, Toshihiko/M-4089-2018		Canon foundation; KAKENHI of the Japan Society for the Promotion of Science	Canon foundation(Canon Foundation); KAKENHI of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Canon foundation, and KAKENHI Grant-in-Aid for Scientific Research (B) of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister W, 2000, TRENDS BIOCHEM SCI, V25, P624, DOI 10.1016/S0968-0004(00)01720-5; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Czajkowsky DM, 2009, P NATL ACAD SCI USA, V106, P14960, DOI 10.1073/pnas.0903805106; Drouin D, 2007, SCANNING, V29, P92, DOI 10.1002/sca.20000; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929; FEINSTEIN A, 1969, NATURE, V224, P1307, DOI 10.1038/2241307a0; Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202; FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; Fursey GN, 2003, APPL SURF SCI, V215, P113, DOI 10.1016/S0169-4332(03)00315-5; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HENDERSON R, 1985, ULTRAMICROSCOPY, V16, P139, DOI 10.1016/0304-3991(85)90069-5; IKAI A, 1991, FEBS LETT, V292, P21, DOI 10.1016/0014-5793(91)80824-M; KISELEV NA, 1990, ELECTRON MICROSC REV, V3, P43, DOI 10.1016/0892-0354(90)90013-I; LAMED R, 1987, J MICROBIOL METH, V7, P233, DOI 10.1016/0167-7012(87)90045-5; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lapeyrade M, 1999, J VAC SCI TECHNOL A, V17, P433, DOI 10.1116/1.582106; Leis A, 2009, TRENDS BIOCHEM SCI, V34, P60, DOI 10.1016/j.tibs.2008.10.011; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; Ogura T, 2008, BIOCHEM BIOPH RES CO, V377, P79, DOI 10.1016/j.bbrc.2008.09.097; Ogura T, 2009, BIOCHEM BIOPH RES CO, V380, P254, DOI 10.1016/j.bbrc.2009.01.046; RICHARDS SR, 1984, WATER RES, V18, P767, DOI 10.1016/0043-1354(84)90173-8; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; ROHRMANN GF, 1992, J GEN VIROL, V73, P749, DOI 10.1099/0022-1317-73-4-749; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Tanaka K, 1997, MOL BIOL REP, V24, P3, DOI 10.1023/A:1006876904158; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; van Loo ND, 2001, J VIROL, V75, P961, DOI 10.1128/JVI.75.2.961-970.2001; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958	30	4	5	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46904	10.1371/journal.pone.0046904	http://dx.doi.org/10.1371/journal.pone.0046904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056522	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500106
J	Parris, BA; Bate, S; Brown, SD; Hodgson, TL				Parris, Benjamin A.; Bate, Sarah; Brown, Scott D.; Hodgson, Timothy L.			Facilitating Goal-Oriented Behaviour in the Stroop Task: When Executive Control Is Influenced by Automatic Processing	PLOS ONE			English	Article							COGNITIVE CONTROL; INTERFERENCE; ACTIVATION; NEGLECT; ATTENTION; MEMORY	A portion of Stroop interference is thought to arise from a failure to maintain goal-oriented behaviour (or goal neglect). The aim of the present study was to investigate whether goal-relevant primes could enhance goal maintenance and reduce the Stroop interference effect. Here it is shown that primes related to the goal of responding quickly in the Stroop task (e. g. fast, quick, hurry) substantially reduced Stroop interference by reducing reaction times to incongruent trials but increasing reaction times to congruent and neutral trials. No effects of the primes were observed on errors. The effects on incongruent, congruent and neutral trials are explained in terms of the influence of the primes on goal maintenance. The results show that goal priming can facilitate goal-oriented behaviour and indicate that automatic processing can modulate executive control.	[Parris, Benjamin A.; Bate, Sarah] Bournemouth Univ, Psychol Res Ctr, Poole BH12 5BB, Dorset, England; [Brown, Scott D.] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia; [Hodgson, Timothy L.] Lincoln Univ, Sch Psychol, Brayford Pool, Lincoln, England	Bournemouth University; University of Newcastle; University of Lincoln	Parris, BA (corresponding author), Bournemouth Univ, Psychol Res Ctr, Poole BH12 5BB, Dorset, England.	bparris@bournemouth.ac.uk	Parris, B. A./G-6385-2013; Brown, Scott/C-1861-2008	Parris, B. A./0000-0003-2402-2100; Brown, Scott/0000-0002-9060-6756; Hodgson, Timothy/0000-0002-0860-8892				Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Burt JS, 2002, J EXP PSYCHOL HUMAN, V28, P1019, DOI 10.1037//0096-1523.28.5.1019; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Cohen Jeffrey A., 1994, ATTENTION PERFORM, p[1, 68]; De Jong R, 1999, ACTA PSYCHOL, V101, P379, DOI 10.1016/S0001-6918(99)00012-8; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Duncan J, 2008, J EXP PSYCHOL GEN, V137, P131, DOI 10.1037/0096-3445.137.1.131; Ferguson M, 2007, HDB MOTIVATION SCI; Hassin Ran R., 2005, NEW UNCONSCIOUS; Hinton Jr WM, 1976, DISS ABSTR INT, V37; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kuhl J, 1999, J EXP PSYCHOL GEN, V128, P382, DOI 10.1037/0096-3445.128.3.382; LOGAN GD, 1982, J EXP PSYCHOL HUMAN, V8, P502, DOI 10.1037/0096-1523.8.4.502; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; NEILL WT, 1978, PERCEPT PSYCHOPHYS, V23, P80, DOI 10.3758/BF03214299; OREGAN JK, 1992, J EXP PSYCHOL HUMAN, V18, P185, DOI 10.1037/0096-1523.18.1.185; Parris BA, 2007, EXP PSYCHOL, V54, P273, DOI 10.1027/1618-3169.54.4.273; Roelofs A, 2003, PSYCHOL REV, V110, P88, DOI 10.1037/0033-295X.110.1.88; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; Verbruggen F, 2009, J EXP PSYCHOL LEARN, V35, P1381, DOI 10.1037/a0016645	24	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46994	10.1371/journal.pone.0046994	http://dx.doi.org/10.1371/journal.pone.0046994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056553	Green Published, Green Accepted, gold			2022-12-27	WOS:000309831500118
J	Braun, SD; Ziegler, A; Methner, U; Slickers, P; Keiling, S; Monecke, S; Ehricht, R				Braun, Sascha D.; Ziegler, Albrecht; Methner, Ulrich; Slickers, Peter; Keiling, Silke; Monecke, Stefan; Ehricht, Ralf			Fast DNA Serotyping and Antimicrobial Resistance Gene Determination of Salmonella enterica with an Oligonucleotide Microarray-Based Assay	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ESCHERICHIA-COLI; FOOD ANIMALS; MULTIPLEX; IDENTIFICATION; SEQUENCE; PCR; TYPHIMURIUM; SEROVARS; STRAINS	Salmonellosis caused by Salmonella (S.) belongs to the most prevalent food-borne zoonotic diseases throughout the world. Therefore, serotype identification for all culture-confirmed cases of Salmonella infection is important for epidemiological purposes. As a standard, the traditional culture method (ISO 6579: 2002) is used to identify Salmonella. Classical serotyping takes 4-5 days to be completed, it is labor-intensive, expensive and more than 250 non-standardized sera are necessary to characterize more than 2,500 Salmonella serovars currently known. These technical difficulties could be overcome with modern molecular methods. We developed a microarray based serogenotyping assay for the most prevalent Salmonella serovars in Europe and North America. The current assay version could theoretically discriminate 28 O-antigens and 86 H-antigens. Additionally, we included 77 targets analyzing antimicrobial resistance genes. The Salmonella assay was evaluated with a set of 168 reference strains representing 132 serovars previously serotyped by conventional agglutination through various reference centers. 117 of 132 (81%) tested serovars showed an unique microarray pattern. 15 of 132 serovars generated a pattern which was shared by multiple serovars (e.g., S. ser. Enteritidis and S. ser. Nitra). These shared patterns mainly resulted from the high similarity of the genotypes of serogroup A and D1. Using patterns of the known reference strains, a database was build which represents the basis of a new PatternMatch software that can serotype unknown Salmonella isolates automatically. After assay verification, the Salmonella serogenotyping assay was used to identify a field panel of 105 Salmonella isolates. All were identified as Salmonella and 93 of 105 isolates (88.6%) were typed in full concordance with conventional serotyping. This microarray based assay is a powerful tool for serogenotyping.	[Braun, Sascha D.; Ziegler, Albrecht; Slickers, Peter; Monecke, Stefan; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Methner, Ulrich; Keiling, Silke] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany	Alere; Friedrich Loeffler Institute; Technische Universitat Dresden	Braun, SD (corresponding author), Alere Technol GmbH, Jena, Germany.	sascha.braun@clondiag.com			Alere Technologies GmbH	Alere Technologies GmbH	Funding was provided by Alere Technologies GmbH (http://alere-technologies.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum MF, 2011, J ANTIMICROB CHEMOTH, V66, P550, DOI 10.1093/jac/dkq498; [Anonymous], 1934, J HYG-CAMBRIDGE, V34, P333; [Anonymous], 2007, 65792002 EN ISO; Aslani MM, 2009, IRAN J PUBLIC HEALTH, V38, P70; Aslani MM, 2009, JPN J INFECT DIS, V62, P16; Ballmer K, 2007, J CLIN MICROBIOL, V45, P370, DOI 10.1128/JCM.01361-06; Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Ben-Darif E, 2010, J CLIN MICROBIOL, V48, P1055, DOI 10.1128/JCM.01566-09; Burnens AP, 1996, J CLIN MICROBIOL, V34, P1641, DOI 10.1128/JCM.34.7.1641-1645.1996; Chan YY, 2004, ANTIMICROB AGENTS CH, V48, P1128, DOI 10.1128/AAC.48.4.1128-1135.2004; CLOUTHIER SC, 1993, J BACTERIOL, V175, P2523, DOI 10.1128/JB.175.9.2523-2533.1993; Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07; Franklin K, 2011, J CLIN MICROBIOL, V49, P2954, DOI 10.1128/JCM.02347-10; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Geue L, 2010, APPL ENVIRON MICROB, V76, P5510, DOI 10.1128/AEM.00743-10; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; Jarvinen AK, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-161; Kim S, 2006, J CLIN MICROBIOL, V44, P3608, DOI 10.1128/JCM.00701-06; Kostic T, 2007, ANAL BIOCHEM, V360, P244, DOI 10.1016/j.ab.2006.09.026; LINDBERG AA, 1980, J GEN MICROBIOL, V116, P25; LIU D, 1991, J BACTERIOL, V173, P4814, DOI 10.1128/jb.173.15.4814-4819.1991; Malorny B, 2007, MOL CELL PROBE, V21, P56, DOI 10.1016/j.mcp.2006.08.005; Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058; MASTEN BJ, 1993, J BACTERIOL, V175, P5359, DOI 10.1128/JB.175.17.5359-5365.1993; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McQuiston JR, 2011, J CLIN MICROBIOL, V49, P565, DOI 10.1128/JCM.01323-10; McQuiston JR, 2004, J CLIN MICROBIOL, V42, P1923, DOI 10.1128/JCM.42.5.1923-1932.2004; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Munoz N, 2010, J MOL DIAGN, V12, P220, DOI 10.2353/jmoldx.2010.090036; Ogunniyi AD, 1997, INFECT IMMUN, V65, P708, DOI 10.1128/IAI.65.2.708-717.1997; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Reeves PP, 2002, CURR TOP MICROBIOL, V264, P109; Ruettger A, 2011, MOL CELL PROBE, V25, P19, DOI 10.1016/j.mcp.2010.09.004; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; SILVERMAN M, 1979, P NATL ACAD SCI USA, V76, P391, DOI 10.1073/pnas.76.1.391; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; Szmolka A, 2012, VET MICROBIOL, V156, P110, DOI 10.1016/j.vetmic.2011.09.030; Tosini F, 1998, ANTIMICROB AGENTS CH, V42, P3053, DOI 10.1128/AAC.42.12.3053; Uma B, 2010, INDIAN J GASTROENTER, V29, P201, DOI 10.1007/s12664-010-0044-x; Wattiau P, 2008, INT J FOOD MICROBIOL, V123, P293, DOI 10.1016/j.ijfoodmicro.2008.01.006; ZIEG J, 1980, P NATL ACAD SCI-BIOL, V77, P4196, DOI 10.1073/pnas.77.7.4196; 2010, EFSA J, V8	45	32	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46489	10.1371/journal.pone.0046489	http://dx.doi.org/10.1371/journal.pone.0046489			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056321	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800022
J	Heys, JJ; Rajaraman, PK; Gedeon, T; Miller, JP				Heys, Jeffrey J.; Rajaraman, Prathish K.; Gedeon, Tomas; Miller, John P.			A Model of Filiform Hair Distribution on the Cricket Cercus	PLOS ONE			English	Article							GIANT INTERNEURON SYSTEM; ACHETA-DOMESTICUS; SOMATOTOPIC MAP; SENSORY SYSTEM; SENSING HAIRS; INFORMATION; PHYSIOLOGY; INSIGHTS; POSITION	Crickets and other orthopteran insects sense air currents with a pair of abdominal appendages resembling antennae, called cerci. Each cercus in the common house cricket Acheta domesticus is covered with between 500 to 750 filiform mechanosensory hairs. The distribution of the hairs on the cerci, as well as the global patterns of their movement axes, are very stereotypical across different animals in this species, and the development of this system has been studied extensively. Although hypotheses regarding the mechanisms underlying pattern development of the hair array have been proposed in previous studies, no quantitative modeling studies have been published that test these hypotheses. We demonstrate that several aspects of the global pattern of mechanosensory hairs can be predicted with considerable accuracy using a simple model based on two independent morphogen systems. One system constrains inter-hair spacing, and the second system determines the directional movement axes of the hairs.	[Heys, Jeffrey J.; Gedeon, Tomas; Miller, John P.] Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA; [Gedeon, Tomas] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Heys, JJ (corresponding author), Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA.	jeffrey.heys@coe.montana.edu; jpm@cns.montana.edu	Miller, John J/GZG-5663-2022	Rajaraman, Prathish Kumar/0000-0002-9796-8653	National Science Foundation (NSF) [CMMI-0849433, DMS-0818785]; National Institutes of Health (NIH) [R01 MH-064416]; Flight Attendants Medical Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064416] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was financially supported by National Science Foundation (NSF) grant CMMI-0849433, NSF grant DMS-0818785, National Institutes of Health (NIH) grant R01 MH-064416, and the Flight Attendants Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 2007, INTRO SYSTEMS BIOL D; BACON JP, 1984, J PHYSIOL-LONDON, V352, P601, DOI 10.1113/jphysiol.1984.sp015312; Bathellier B, 2012, J R SOC INTERFACE, V9, P1131, DOI 10.1098/rsif.2011.0690; Casas J, 2010, J R SOC INTERFACE, V7, P1487, DOI 10.1098/rsif.2010.0093; Cressie N, 1991, STAT SPATIAL DATA; Cummins B, 2007, J THEOR BIOL, V247, P266, DOI 10.1016/j.jtbi.2007.02.003; Cummins B, 2012, FRONTIERS IN SENSING: FROM BIOLOGY TO ENGINEERING, P239; Dangles O, 2008, J COMP PHYSIOL A, V194, P653, DOI 10.1007/s00359-008-0339-x; DUMPERT K, 1977, J COMP PHYSIOL, V122, P9, DOI 10.1007/BF00611245; EDWARDS JS, 1974, PROC R SOC SER B-BIO, V185, P83, DOI 10.1098/rspb.1974.0007; Fortin M.-J., 2002, ENCY ENV, V4, P2051, DOI [10.1002/9780470057339.vas039, DOI 10.1002/9780470057339]; GNATZY W, 1980, CELL TISSUE RES, V213, P441; JACOBS GA, 1987, J COMP NEUROL, V265, P145, DOI 10.1002/cne.902650110; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; LANDOLFA MA, 1995, J COMP PHYSIOL A, V177, P759; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; LEE KJ, 1994, NATURE, V369, P215, DOI 10.1038/369215a0; Matei D, 2012, SCIENCE, V335, P76, DOI 10.1126/science.1210299; Miller JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027873; Morelli LG, 2012, SCIENCE, V336, P187, DOI 10.1126/science.1215478; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; MURPHEY RK, 1980, J COMP NEUROL, V191, P53, DOI 10.1002/cne.901910103; MURPHEY RK, 1981, DEV BIOL, V88, P236, DOI 10.1016/0012-1606(81)90167-6; MURPHEY RK, 1990, J NEUROBIOL, V21, P120, DOI 10.1002/neu.480210109; MURPHEY RK, 1981, DEV BIOL, V88, P247, DOI 10.1016/0012-1606(81)90168-8; Neagu A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178104; PALKA J, 1977, J COMP PHYSIOL, V119, P267, DOI 10.1007/BF00656638; PALKA J, 1977, J COMP PHYSIOL, V119, P301, DOI 10.1007/BF00656640; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; SAKAGUCHI DS, 1983, J COMP PHYSIOL, V150, P141, DOI 10.1007/BF00606364; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; STERN C, 1954, AM SCI, V42, P212; TOBIAS M, 1979, J COMP PHYSIOL, V129, P51, DOI 10.1007/BF00679911; Tostevin F, 2007, PLOS COMPUT BIOL, V3, P763, DOI 10.1371/journal.pcbi.0030078; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; Upton GJG, 1985, SPATIAL DATA ANAL EX; WALTHALL WW, 1986, DEV BIOL, V113, P182, DOI 10.1016/0012-1606(86)90121-1	38	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46588	10.1371/journal.pone.0046588	http://dx.doi.org/10.1371/journal.pone.0046588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056357	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800027
J	Thompson, ED; Mayer, GD; Glover, CN; Capo, T; Walsh, PJ; Hogstrand, C				Thompson, E. David; Mayer, Gregory D.; Glover, Chris N.; Capo, Tom; Walsh, Patrick J.; Hogstrand, Christer			Zinc Hyperaccumulation in Squirrelfish (Holocentrus adscenscionis) and Its Role in Embryo Viability	PLOS ONE			English	Article							WATER RAINBOW-TROUT; FEMALE SQUIRRELFISH; GENE-EXPRESSION; VITELLOGENIN; BINDING; PHYSIOLOGY; PROTEIN; METALLOTHIONEIN; ZEBRAFISH; OOCYTES	Female squirrelfish (Fam. Holocentridae) can accumulate and temporarily sequester copious amounts of zinc (Zn) in their livers. There, it is initially compartmentalized before a subsequent, estrogen-triggered redistribution to the ovaries. Here we show that cellular uptake of Zn is also influenced by estrogen signaling, and that estrogen increases concentrations of the plasma Zn-binding protein vitellogenin (VTG). However, estrogen-mediated increases in VTG are not sufficient to accommodate the magnitude of hepato-ovarian Zn transfer in female squirrelfish (Holocentrus adscensionis). These findings suggest that holocentrids have acquired the ability to use hormonal cues to drive hepatic uptake and storage of Zn, signal for its physiological redistribution, and influence the capacity for systemic transport of Zn beyond the mediation of increased plasma VTG concentrations. Such specific adaptations suggest an advantage for the oocyte, which is corroborated in further studies where we determined that oocyte Zn concentrations are positively correlated with egg viability in captivespawned squirrelfish. The novel nature of these findings underlies the importance of Zn in squirrelfish reproductive biology.	[Thompson, E. David] No Kentucky Univ, Dept Biol Sci, Highland Hts, KY 41076 USA; [Mayer, Gregory D.] Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth, Lubbock, TX 79409 USA; [Glover, Chris N.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Capo, Tom; Walsh, Patrick J.; Hogstrand, Christer] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA; [Walsh, Patrick J.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Hogstrand, Christer] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England	Northern Kentucky University; Texas Tech University System; Texas Tech University; University of Canterbury; University of Miami; University of Ottawa; University of London; King's College London	Thompson, ED (corresponding author), No Kentucky Univ, Dept Biol Sci, Highland Hts, KY 41076 USA.	thompsone1@nku.edu	Mayer, Gregory D/A-8459-2017; Mayer, Gregory D/K-4496-2012; Mayer, Gregory/N-1401-2019; Hogstrand, Christer/C-9041-2013	Mayer, Gregory D/0000-0002-2652-9856; Mayer, Gregory D/0000-0002-2652-9856; Mayer, Gregory/0000-0002-2652-9856; Glover, Chris/0000-0001-9170-5759; Hogstrand, Christer/0000-0001-7545-6975	National Science Foundation (NSF) [IBN-9631441]; University of London; Natural Sciences and Engineering Council of Canada; Canada Research Chairs Program	National Science Foundation (NSF)(National Science Foundation (NSF)); University of London; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	This study was in part funded by National Science Foundation (NSF) grant IBN-9631441 to CH and travel grants from the University of London Central Research Fund to CH and CNG. PJW is supported by a Discovery Grant from the Natural Sciences and Engineering Council of Canada and the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATCHISON GJ, 1987, ENVIRON BIOL FISH, V18, P11, DOI 10.1007/BF00002324; BENTLEY PJ, 1991, COMP BIOCHEM PHYS C, V100, P491, DOI 10.1016/0742-8413(91)90028-R; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSSELBERG D, 1994, J NEUROPHYSIOL, V71, P1491, DOI 10.1152/jn.1994.71.4.1491; Carrillo M., 2000, Cahiers Options Mediterraneennes, V47, P61; CRAIK JCA, 1988, AQUACULTURE, V73, P309, DOI 10.1016/0044-8486(88)90064-6; Davies SJ, 2010, ESSENTIAL REV EXPT B; DYKE B, 1987, BIOCHEMISTRY-US, V26, P3228, DOI 10.1021/bi00385a044; EID AE, 1994, AQUACULTURE, V119, P259, DOI 10.1016/0044-8486(94)90180-5; ElTanani MKK, 1997, J STEROID BIOCHEM, V60, P269, DOI 10.1016/S0960-0760(96)00226-9; Falchuk KH, 2001, BIOMETALS, V14, P385, DOI 10.1023/A:1012994427351; Feeney GP, 2005, BBA-GENE STRUCT EXPR, V1732, P88, DOI 10.1016/j.bbaexp.2005.12.002; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; GHOSH P, 1995, MAR ENVIRON RES, V39, P165, DOI 10.1016/0141-1136(94)00035-N; Glover CN, 2003, PHYSIOL BIOCHEM ZOOL, V76, P321, DOI 10.1086/375428; Glover CN, 2002, J EXP BIOL, V205, P151; HOGSTRAND C, 1990, TOXICOL APPL PHARM, V103, P56, DOI 10.1016/0041-008X(90)90262-S; Hogstrand C, 1996, MAR BIOL, V125, P23, DOI 10.1007/BF00350757; Hogstrand C, 1996, J EXP BIOL, V199, P2543; Hogstrand C, 1996, AM J PHYSIOL-REG I, V270, pR1141; Hogstrand C, 2008, BIOCHEM SOC T, V36, P1252, DOI 10.1042/BST0361252; Huddleston JR, 2006, APPL ENVIRON MICROB, V72, P7036, DOI 10.1128/AEM.00774-06; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; MONTORZI M, 1994, BIOCHEM BIOPH RES CO, V200, P1407, DOI 10.1006/bbrc.1994.1607; MUNKITTRICK KR, 1989, ECOTOX ENVIRON SAFE, V18, P15, DOI 10.1016/0147-6513(89)90088-2; NAGLER JJ, 1990, BIOCHEM CELL BIOL, V68, P330, DOI 10.1139/o90-045; Nordberg M, 1998, TALANTA, V46, P243, DOI 10.1016/S0039-9140(97)00345-7; PATERSON PG, 1991, J NUTR, V121, P338, DOI 10.1093/jn/121.3.338; Qiu A, 2007, AQUAT TOXICOL, V84, P142, DOI 10.1016/j.aquatox.2007.02.020; Riggio M, 2003, COMP BIOCHEM PHYS C, V135, P191, DOI 10.1016/S1532-0456(03)00107-8; Shinozaki-Mendes RA, 2007, SCI MAR, V71, P715, DOI 10.3989/scimar.2007.71n4715; SILVERSAND C, 1989, J CHROMATOGR, V478, P387, DOI 10.1016/S0021-9673(01)84408-3; SILVERSAND C, 1993, J EXP ZOOL, V267, P587, DOI 10.1002/jez.1402670606; Thompson ED, 2003, COMP BIOCHEM PHYS A, V134, P819, DOI 10.1016/S1095-6433(03)00015-1; Thompson ED, 2002, J EXP BIOL, V205, P3367; Thompson ED, 2001, AM J PHYSIOL-REG I, V280, pR527, DOI 10.1152/ajpregu.2001.280.2.R527; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wallace R A, 1985, Dev Biol (N Y 1985), V1, P127; WEITZEL G, 1954, H-S Z PHYSIOL CHEM, V296, P19, DOI 10.1515/bchm2.1954.296.1.19; WOLFFE AP, 1985, EUR J BIOCHEM, V146, P489, DOI 10.1111/j.1432-1033.1985.tb08678.x; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545	43	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46127	10.1371/journal.pone.0046127	http://dx.doi.org/10.1371/journal.pone.0046127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056248	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800012
J	Ash, A; Scholz, T; de Chambrier, A; Brabec, J; Oros, M; Kar, PK; Chavan, SP; Mariaux, J				Ash, Anirban; Scholz, Tomas; de Chambrier, Alain; Brabec, Jan; Oros, Mikulas; Kar, Pradip Kumar; Chavan, Shivaji Prabhakar; Mariaux, Jean			Revision of Gangesia (Cestoda: Proteocephalidea) in the Indomalayan Region: Morphology, Molecules and Surface Ultrastructure	PLOS ONE			English	Article							TAPEWORMS PLATYHELMINTHES; SCOLEX MORPHOLOGY; CLARIAS-BATRACHUS; CARYOPHYLLIDEA; EUCESTODA; SILURIFORMES; EVOLUTION	Tapeworms of Gangesia Woodland, 1924 (Cestoda: Proteocephalidea) parasitic in freshwater fishes in the Indomalayan Region were critically reviewed. Evaluation of type specimens and newly collected materials from Bangladesh, Cambodia and India, as well as critical examination of extensive literature have shown that only the following four species, instead of 48 nominal species of Gangesia and Silurotaenia Nybelin, 1942 reported from this region (36 new synonymies proposed), are valid: Gangesia bengalensis (Southwell, 1913), type-species of the genus and most common parasite of Wallago attu (Siluridae), G. macrones Woodland, 1924 typical of Sperata seenghala (Bagridae), both species characterized by the possession of two circles of hooks on the rostellum-like organ and several rows of hooklets on the anterior margins of suckers; G. agraensis Verma, 1928 from W. attu (typical host), which has the scolex with only one circle of hooks and 1-3 incomplete rows of tiny hooklets on the suckers; and G. vachai (Gupta and Parmar, 1988) n. comb. from several catfishes, which possesses 4-6 circles of hooks and 5-11 rows of hooklets on the anterior half of suckers. Scolex morphology, including surface ultrastructure (microtriches), of all but one species (G. vachai) is described for the first time using scanning electron microscopy. A phylogenetic analysis based on the partial sequences encoding the large nuclear ribosomal subunit RNA gene has shown that three Indomalayan species, namely G. bengalensis, G. macrones and G. vachai, form a monophyletic group within Gangesia, whereas G. agraensis tends to form a clade with the Palaearctic species of the genus. A table with differential characters of all species from the Indomalayan Region is also provided together with a key to identification of genera of the subfamily Gangesiinae. The present study demonstrates that species of Silurotaenia do not occur in the Indomalayan region.	[Ash, Anirban; Scholz, Tomas; Brabec, Jan] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Ash, Anirban; Scholz, Tomas; Brabec, Jan] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [de Chambrier, Alain; Mariaux, Jean] Nat Hist Museum, Dept Invertebrates, Geneva, Switzerland; [Kar, Pradip Kumar] Jhargram Raj Coll, Medinipur, W Bengal, India; [Oros, Mikulas] Slovak Acad Sci, Inst Parasitol, Kosice, Slovakia; [Chavan, Shivaji Prabhakar] Swami Ramanand Teerth Marathwada Univ, Sch Life Sci, Nanded, Maharashtra, India	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Slovak Academy of Sciences; Swami Ramanand Teerth Marathwada University	Scholz, T (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	tscholz@paru.cas.cz	Ash, Anirban/ABC-8513-2021; Scholz, Tomas/G-8360-2014; Brabec, Jan/G-8419-2014; Ash, Anirban/ABC-4280-2021; Oros, Mikuláš/AAP-8046-2020; Mariaux, Jean/A-1142-2010	Scholz, Tomas/0000-0002-6340-3750; Brabec, Jan/0000-0002-2636-414X; Ash, Anirban/0000-0002-2983-9657; Oros, Mikuláš/0000-0002-0518-5708; Mariaux, Jean/0000-0002-9601-855X	Institute of Parasitology, Ceske Budejovice [RVO: 60077344]; Czech Science Foundation [524/08/0885, P505/12/G112, 206/09/H026]; Slovak Research and Development Agency [LPP-0171-09, APVV 0653-11]; Grant Agency VEGA [2/0129/12]; National Science Foundation, United States of America (PBI award) [0818696, 0818823]	Institute of Parasitology, Ceske Budejovice; Czech Science Foundation(Grant Agency of the Czech Republic); Slovak Research and Development Agency(Slovak Research and Development Agency); Grant Agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); National Science Foundation, United States of America (PBI award)	This study was financially supported by the Institute of Parasitology, Ceske Budejovice (institutional support RVO: 60077344), Czech Science Foundation (Projects Nos. 524/08/0885, P505/12/G112 and 206/09/H026), Slovak Research and Development Agency (No. LPP-0171-09 and APVV 0653-11), Grant Agency VEGA (No. 2/0129/12) and National Science Foundation, United States of America (PBI award Nos. 0818696 and 0818823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, CRC HDB TAPEWORM IDE; Arandas Rego A., 1984, Acta Amazonica, V14, P86; Ash A, 2011, J PARASITOL, V97, P899, DOI 10.1645/GE-2661.1; Ash A, 2011, J PARASITOL, V97, P435, DOI 10.1645/GE-2625.1; Ash A, 2010, REV SUISSE ZOOL, V117, P665; Begum IJ, 2007, NATL J LIFE SCI, V4, P38; Bhavare V.V., 2012, DAV International Journal of Science, V1, P112; Bhure D. B., 2011, Flora and Fauna (Jhansi), V17, P83; Bhure D. B., 2010, Asian Journal of Animal Science, V5, P205; Brabec J, 2012, INT J PARASITOL, V42, P259, DOI 10.1016/j.ijpara.2012.01.005; Chavan SP, 1997, THESIS B AMBEDKAR MA; Chervy L, 2009, FOLIA PARASIT, V56, P199, DOI 10.14411/fp.2009.025; de Chambrier A, 2004, SYST PARASITOL, V57, P159, DOI 10.1023/B:SYPA.0000019083.26876.34; de Chambrier A, 2001, REV SUISSE ZOOL, V108, P303, DOI 10.5962/bhl.part.79632; de Chambrier A, 2008, J PARASITOL, V94, P202, DOI 10.1645/GE-1275.1; Deshmukh S.V., 1989, Indian Journal of Helminthology, V41, P75; Deshmukh S.V., 1989, Indian Journal of Parasitology, V13, P63; Dhar R.L., 1984, Indian Journal of Helminthology, V35, P73; Dhar R.L., 1980, Indian Journal of Helminthology, V31, P111; Drummond AJ, 2010, GENEIOUS V5 3; Dubinina M.N., 1971, Parazitologicheskii Sb zool Inst Akad Nauk SSSR, V25, P77; Dubinina MN., 1987, KEY PARASITES FRESHW, V3, P5; FERNANDO C. H., 1963, Z PARASITENK, V23, P141; Fotedar DN, 1974, P 11 IND SCI C SEC L; Freze, 1965, ESSENTIALS CESTODOLO, V5; FROESE R., 2012, FISHBASE; Gavhane A.B., 1991, Rivista di Parassitologia, V8, P23; GUPTA N K, 1979, Research Bulletin of the Panjab University Science, V30, P27; Gupta V., 1988, Indian Journal of Helminthology, V40, P27; Gupta V., 1984, Indian Journal of Helminthology, V34, P44; Hiware C.J., 1999, Rivista di Parassitologia, V16, P111; Hiware C.J., 1995, Rivista di Parassitologia, V12, P171; Hiware CJ, 2004, RIV PARASSITOL, V12, P171; ICZN, 1999, INT COD ZOOL NOM; Jadhav B.V., 1997, Rivista di Parassitologia, V14, P289; JADHAV B V, 1983, Rivista di Parassitologia, V44, P171; Jadhav BV, 2001, P V N CAPOOR COMM, P60; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kuchta R, 2010, FOLIA PARASIT, V57, P185, DOI 10.14411/fp.2010.025; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Malhotra SK, 1981, MARATHWADA U J SCI, V19, P41; Malhotra SK, 1980, SCI ENV, V3, P9; Nybelin O., 1942, GOTEBORGS KUNGL VE B, V14, P1; Olson PD, 2001, MOL PHYLOGENET EVOL, V19, P443, DOI 10.1006/mpev.2001.0930; Oros M, 2010, FOLIA PARASIT, V57, P37, DOI 10.14411/fp.2010.006; Patel N. G., 1999, Uttar Pradesh Journal of Zoology, V19, P75; Pawar R.T., 2008, Flora and Fauna - Jhansi, V14, P85; Pawar S. B., 2004, Uttar Pradesh Journal of Zoology, V24, P201; Reddy Y., 2011, INT MULTIDISCIPLINAR, V1, P31; Rego A.A., 1994, P257; Rehana R, 1971, Pakistan Journal of Zoology, V3, P217; Rehana R, 1973, SIND J SCI, V2, P195; Rehana R, 1979, THESIS U KARACHI KAR; Sahoo S. K., 2006, Indian Journal of Fisheries, V53, P327; Sambrook J., 2001, MOL CLONING LAB MANU; Scholz T, 1999, PARASITOL RES, V85, P1, DOI 10.1007/s004360050498; Scholz T., 1998, STUDIE AV CR; Shimazu T, 1997, FOLIA PARASIT, V46, P37; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shinde G. B., 1984, Rivista di Parassitologia, V1(45), P83; SHINDE G B, 1983, Rivista di Parassitologia, V44, P309; Shinde G.B., 1999, Rivista di Parassitologia, V16, P17; Shinde G.B., 1990, Indian Journal of Parasitology, V14, P141; SHINDE G B, 1975, Marathwada University Journal of Sciences, V14, P355; Singh K. S., 1948, Indian Journal of Helminthology, V1, P41; Southwell T., 1913, Records of the Indian Museum, V9; Southwell T., 1913, Records of the Indian Museum, V9; SOUTHWELL T, 1930, FAUNA BRIT INDIA INC, V1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; VERMA S. C., 1928, ALLAHABAD UNIV STUDIES, V4, P119; Waeschenbach A, 2007, MOL PHYLOGENET EVOL, V45, P311, DOI 10.1016/j.ympev.2007.03.019; Wankhede Hemlata, 2005, P103; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Woodland W. N., 1924, Parasitology Cambridge, V16, P441; Yamaguti S., 1934, Japanese Journal of Zoology, V6, P1; Yamaguti S., 1959, SYSTEMA HELMINTHUM, VII, P1; Zehnder MP, 1999, INT J PARASITOL, V29, P1841, DOI 10.1016/S0020-7519(99)00122-8	79	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46421	10.1371/journal.pone.0046421	http://dx.doi.org/10.1371/journal.pone.0046421			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056306	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000043
J	Le, LP; Dias-Santagata, D; Pawlak, AC; Cosper, AK; Nguyen, AT; Selim, MA; Deng, A; Horick, NK; Iafrate, AJ; Mihm, MC; Hoang, MP				Le, Long P.; Dias-Santagata, Dora; Pawlak, Amanda C.; Cosper, Arjola K.; Anh Thu Nguyen; Selim, M. Angelica; Deng, April; Horick, Nora K.; Iafrate, A. John; Mihm, Martin C., Jr.; Hoang, Mai P.			Apocrine-Eccrine Carcinomas: Molecular and Immunohistochemical Analyses	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE INHIBITORS; IN-SITU HYBRIDIZATION; FACTOR RECEPTOR GENE; MUTATIONAL-ANALYSIS; HIGH-FREQUENCY; BREAST-CANCER; ANTITUMOR-ACTIVITY; P53 MUTATIONS; COPY NUMBER	Apocrine-eccrine carcinomas are rare and associated with poor prognosis. Currently there is no uniform treatment guideline. Chemotherapeutic drugs that selectively target cancer-promoting pathways may complement conventional therapeutic approaches. However, studies on genetic alterations and EGFR and Her2 status of apocrine-eccrine carcinomas are few in number. In addition, hormonal studies have not been comprehensive and performed only on certain subsets of apocrine-eccrine carcinomas. To investigate whether apocrine-eccrine carcinomas express hormonal receptors or possess activation of oncogenic pathways that can be targeted by available chemotherapeutic agent we performed immunohistochemistry for AR, PR, ER, EGFR, and HER2 expression; fluorescence in situ hybridization (FISH) for EGFR and ERBB2 gene amplification; and molecular analyses for recurrent mutations in 15 cancer genes including AKT-1, EGFR, PIK3CA, and TP53 on 54 cases of apocrine-eccrine carcinomas. They include 10 apocrine carcinomas, 7 eccrine carcinomas, 9 aggressive digital papillary adenocarcinomas, 10 hidradenocarcinomas, 11 porocarcinomas, 1 adenoid cystic carcinoma, 4 malignant chondroid syringomas, 1 malignant spiradenoma, and 1 malignant cylindroma. AR, ER, PR, EGFR and HER2 expression was seen in 36% (19/53), 27% (14/51), 16% (8/51), 85% (44/52) and 12% (6/52), respectively. Polysomy or trisomy of EGFR was detected by FISH in 30% (14/46). Mutations of AKT-1, PIK3CA, and TP53 were detected in 1, 3, and 7 cases, respectively (11/47, 23%). Additional investigation regarding the potential treatment of rare cases of apocrine-eccrine carcinomas with PI3K/Akt/mTOR pathway inhibitors, currently in clinical testing, may be of clinical interest.	[Le, Long P.; Dias-Santagata, Dora; Pawlak, Amanda C.; Cosper, Arjola K.; Anh Thu Nguyen; Iafrate, A. John; Hoang, Mai P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Le, Long P.; Dias-Santagata, Dora; Pawlak, Amanda C.; Cosper, Arjola K.; Anh Thu Nguyen; Iafrate, A. John; Hoang, Mai P.] Harvard Univ, Sch Med, Boston, MA USA; [Selim, M. Angelica] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Deng, April] Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA USA; [Horick, Nora K.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA; [Mihm, Martin C., Jr.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Duke University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Hoang, MP (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	mhoang@partners.org						Adelson K, 2011, ENDOCRIN METAB CLIN, V40, P519, DOI 10.1016/j.ecl.2011.05.011; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Battistella M, 2010, J EUR ACAD DERMATOL, V24, P199, DOI 10.1111/j.1468-3083.2009.03301.x; Berns EMJJ, 1996, GENE CHROMOSOME CANC, V16, P170, DOI 10.1002/(SICI)1098-2264(199607)16:3<170::AID-GCC3>3.0.CO;2-W; Biernat W, 1998, INT J CANCER, V76, P317, DOI 10.1002/(SICI)1097-0215(19980504)76:3<317::AID-IJC5>3.0.CO;2-Y; Blake PW, 2010, ARCH DERMATOL, V146, P625, DOI 10.1001/archdermatol.2010.105; Busam KJ, 1999, MODERN PATHOL, V12, P786; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; CHOUDHRY R, 1992, J ENDOCRINOL, V133, P467, DOI 10.1677/joe.0.1330467; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; de Giorgi V, 2007, DERMATOL SURG, V33, P374, DOI 10.1111/j.1524-4725.2007.33077.x; Dias-Santagata D, 2011, MODERN PATHOL, V24, P974, DOI 10.1038/modpathol.2011.48; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Duke WH, 2000, AM J SURG PATHOL, V24, P775, DOI 10.1097/00000478-200006000-00002; ELLEDGE RM, 1994, BREAST CANCER RES TR, V32, P39, DOI 10.1007/BF00666204; Ettl T, 2011, HUM PATHOL IN PRESS; Gatalica Z, 1997, PATHOL RES PRACT, V193, P753, DOI 10.1016/S0344-0338(97)80053-2; Growdon WB, 2008, GYNECOL ONCOL, V111, P289, DOI 10.1016/j.ygyno.2008.07.038; Gutermuth J, 2004, J EUR ACAD DERMATOL, V18, P477, DOI 10.1111/j.1468-3083.2004.00949.x; Hidaka T, 2012, ACTA DERM V IN PRESS; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Janisson-Dargaud D, 2008, J CUTAN PATHOL, V35, P916, DOI 10.1111/j.1600-0560.2007.00935.x; Jaspers HCJ, 2011, J CLIN ONCOL, V29, pE473, DOI 10.1200/JCO.2010.32.8351; Kazakov DV, 2009, AM J DERMATOPATH, V31, P236, DOI 10.1097/DAD.0b013e3181984f10; LeBoit PE, 2006, WORLD HLTH ORG CLASS; Lee Y, 2012, CLIN CANCER RES, V18, P1760, DOI 10.1158/1078-0432.CCR-11-2582; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li AR, 2008, J MOL DIAGN, V10, P242, DOI 10.2353/jmoldx.2008.070178; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Lo Nigro C, 2012, BRIT J CANCER, V106, P397, DOI 10.1038/bjc.2011.464; Michelucci A, 2009, DIAGN MOL PATHOL, V18, P200, DOI 10.1097/PDM.0b013e31818e5fa4; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Nash JW, 2007, J CUTAN PATHOL, V34, P49, DOI 10.1111/j.1600-0560.2006.00570.x; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Piris A, 2010, AM J DERMATOPATH, V32, P586, DOI 10.1097/DAD.0b013e3181cd64f2; Rapakko K, 2001, BRIT J CANCER, V84, P116, DOI 10.1054/bjoc.2000.1530; Riely GJ, 2008, J THORAC ONCOL, V3, pS146, DOI 10.1097/JTO.0b013e318174e96e; Robson A, 2001, AM J SURG PATHOL, V25, P710, DOI 10.1097/00000478-200106000-00002; Robson A, 2008, AM J SURG PATHOL, V32, P682, DOI 10.1097/PAS.0b013e3181590ba4; Ruijs MWG, 2010, J MED GENET, V47, P421, DOI 10.1136/jmg.2009.073429; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Schroder U, 2004, ANN OTO RHINOL LARYN, V113, P242, DOI 10.1177/000348940411300314; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Soung YH, 2006, ONCOLOGY-BASEL, V70, P285, DOI 10.1159/000096289; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; SWANSON PE, 1991, AM J SURG PATHOL, V15, P835, DOI 10.1097/00000478-199109000-00003; Takata M, 1998, HUM PATHOL, V29, P193, DOI 10.1016/S0046-8177(98)90234-9; Takata M, 2000, J CUTAN PATHOL, V27, P30, DOI 10.1034/j.1600-0560.2000.027001030.x; Tavassoli FA., 1996, BREAST J, V2, P261, DOI [10.1111/j.1524-4741.1996.tb00107.x, DOI 10.1111/J.1524-4741.1996.TB00107.X]; Tlemcani K, 2010, J CLIN ONCOL, V28, pE412, DOI 10.1200/JCO.2009.26.1891; Turke AB, 2010, CLIN CANCER RES, V16, P3523, DOI 10.1158/1078-0432.CCR-10-1201; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wang Y, 2005, HUMAN MUTATION, P787; WONG TY, 1994, CANCER, V73, P1631, DOI 10.1002/1097-0142(19940315)73:6<1631::AID-CNCR2820730615>3.0.CO;2-7; Zeidan Youssef H, 2010, J Med Case Rep, V4, P147, DOI 10.1186/1752-1947-4-147	60	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47290	10.1371/journal.pone.0047290	http://dx.doi.org/10.1371/journal.pone.0047290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056620	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400068
J	Ajakaiye, MA; Jacob, A; Wu, RQ; Yang, WL; Nicastro, J; Coppa, GF; Wang, P				Ajakaiye, Michael A.; Jacob, Asha; Wu, Rongqian; Yang, Weng Lang; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping			Recombinant Human MFG-E8 Attenuates Intestinal Injury and Mortality in Severe Whole Body Irradiation in Rats	PLOS ONE			English	Article							EGF FACTOR-VIII; GASTROINTESTINAL-SYNDROME; IN-VIVO; P53; APOPTOSIS; PROTEIN; ANTIGEN; CELLS; MICE; REPERFUSION	The gastrointestinal (GI) syndrome component of acute radiation syndrome (ARS) results from depletion of immature parenchymal stem cells after high dose irradiation and contributes significantly to early mortality. It is associated with severe, irreparable damage in the GI tract and extremely low survival. There is a need for the development of viable mitigators of whole body irradiation (WBI) due to the possibility of unexpected high level radiation exposure from nuclear accidents or attacks. We therefore examined the effect of recombinant human milk fat globule-EGF factor 8 (rhMFG-E8) in mitigating damage after WBI. Male Sprague-Dawley rats were exposed to 10 Gy WBI using Cesium-137 as the radiation source. The animals in the treatment group received rhMFG-E8 (166 mu g/kg BW) subcutaneously once a day with the first dose given 6 h after WBI. Blood and tissue samples from the ileum were collected after 3 days of treatment. A separate cohort of animals was treated for 7 days and the 21 day mortality rate was determined. Treatment with rhMFG-E8 significantly improved the survival from 31% to 75% over 21 days. Furthermore, rhMFG-E8 treatment resulted in a 36% reduction in the radiation injury intestinal mucosal damage score, corresponding to visible histological changes. MFG-E8 gene expression was significantly decreased in WBI-induced animals as compared to sham controls. Treatment with rhMFG-E8 increased p53 and p21 expression by 207% and 84% compared to untreated controls. This was accompanied by an 80% increase in the expression of anti-apoptotic cell regulator Bcl-2. p53 and p21 levels correlate with improved survival after radiation injury. These cell regulators arrest the cell after DNA damage and enable DNA repair as well as optimize cell survival. Taken together, these results indicate that rhMFG-E8 ameliorates the GI syndrome and improves survival after WBI by minimizing intestinal cell damage and optimizing recovery.	[Wang, Ping] Hofstra N Shore LIJ Sch Med, Ctr Immunol & Inflammat, Feinstein Inst Med Res, Manhasset, NY USA; Hofstra N Shore LIJ Sch Med, Dept Surg, Manhasset, NY USA	Hofstra University; Northwell Health; Hofstra University; Northwell Health	Wang, P (corresponding author), Hofstra N Shore LIJ Sch Med, Ctr Immunol & Inflammat, Feinstein Inst Med Res, Manhasset, NY USA.	pwang@nshs.edu	Varghese, Asha/AAK-4922-2021; Wu, Rongqian/I-3614-2012	Wu, Rongqian/0000-0003-0993-4531; Wang, Ping/0000-0002-1557-0394	National Institutes of Health (NIH) [R33 A1080536, R01 GM057468]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057468] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants (R33 A1080536 and R01 GM057468 to P. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Bu HF, 2007, J CLIN INVEST, V117, P3673, DOI 10.1172/JCI31841; Chogle A, 2011, MOL MED, V17, P502, DOI 10.2119/molmed.2010.00074; Chumakov PM, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1399, DOI 10.1134/S0006297907130019; Citrin D, 2010, ONCOLOGIST, V15, P360, DOI 10.1634/theoncologist.2009-S104; Couto JR, 1996, DNA CELL BIOL, V15, P281, DOI 10.1089/dna.1996.15.281; Cui TP, 2010, AM J RESP CRIT CARE, V181, P238, DOI 10.1164/rccm.200804-625OC; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Hvarregaard J, 1996, EUR J BIOCHEM, V240, P628, DOI 10.1111/j.1432-1033.1996.0628h.x; Hwang JM, 2003, J SURG RES, V109, P149, DOI 10.1016/S0022-4804(02)00096-3; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Kouvaris JR, 2007, ONCOLOGIST, V12, P738, DOI 10.1634/theoncologist.12-6-738; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Li Q, 2011, RADIAT RES, V176, P17, DOI 10.1667/RR2393.1; Matsuda A, 2011, MOL MED, V17, P126, DOI 10.2119/molmed.2010.00135; Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa; Miksa M, 2006, SHOCK, V25, P586, DOI 10.1097/01.shk.0000209533.22941.d0; Miksa M, 2009, J IMMUNOL, V183, P5983, DOI 10.4049/jimmunol.0802994; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Qiang XL, 2011, INT J MOL MED, V28, P1071, DOI 10.3892/ijmm.2011.782; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Shi J, 2008, J THROMB HAEMOST, V6, P1167, DOI 10.1111/j.1538-7836.2008.03010.x; Singh VK, 2005, EXP MOL PATHOL, V78, P156, DOI 10.1016/j.yexmp.2004.10.003; Sitko JC, 2008, CELL SIGNAL, V20, P2221, DOI 10.1016/j.cellsig.2008.08.011; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Wang B, 2010, CELL CYCLE, V9, P870, DOI 10.4161/cc.9.5.10825; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Wolbarst AB, 2010, RADIOLOGY, V254, P660, DOI 10.1148/radiol.09090330	41	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46540	10.1371/journal.pone.0046540	http://dx.doi.org/10.1371/journal.pone.0046540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056336	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500048
J	Wu, KC; McDonald, PR; Liu, JJ; Chaguturu, R; Klaassen, CD				Wu, Kai Connie; McDonald, Peter R.; Liu, Jie Jerry; Chaguturu, Rathnam; Klaassen, Curtis D.			Implementation of a High-Throughput Screen for Identifying Small Molecules to Activate the Keap1-Nrf2-ARE Pathway	PLOS ONE			English	Article							CYTOPROTECTIVE ENZYMES; NRF2; MICE; KEAP1; CANCER; GENE; CARCINOGENS; MECHANISMS; GENERATION; INDUCTION	Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that induces a battery of cytoprotective genes involved in antioxidant defense through binding to Antioxidant Response Elements (ARE) located in the promoter regions of these genes. To identify Nrf2 activators for the treatment of oxidative/electrophilic stress-induced diseases, the present study developed a high-throughput assay to evaluate Nrf2 activation using AREc32 cells that contain a luciferase gene under the control of ARE promoters. Of the 47,000 compounds screened, 238 (top 0.5% hits) of the chemicals increased the luminescent signal more than 14.4-fold and were re-tested at eleven concentrations in a range of 0.01-30 mu M. Of these 238 compounds, 231 (96%) increased the luminescence signal in a concentration-dependent manner. Chemical structure relationship analysis of these 231 compounds indicated enrichment of four chemical scaffolds (diaryl amides and diaryl ureas, oxazoles and thiazoles, pyranones and thiapyranones, and pyridinones and pyridazinones). In addition, 30 of these 231 compounds were highly effective and/or potent in activating Nrf2, with a greater than 80-fold increase in luminescence, or an EC50 lower than 1.6 mu M. These top 30 compounds were also screened in Hepa1c1c7 cells for an increase in Nqo1 mRNA, the prototypical Nrf2-target gene. Of these 30 compounds, 17 increased Nqo1 mRNA in a concentration-dependent manner. In conclusion, the present study documents the development, implementation, and validation of a high-throughput screen to identify activators of the Keap1-Nrf2-ARE pathway. Results from this screening identified Nrf2 activators, and provide novel insights into chemical scaffolds that might prevent oxidative/electrophilic stress-induced toxicity and carcinogenesis.	[Liu, Jie Jerry; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA; [Wu, Kai Connie] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [McDonald, Peter R.] Univ Kansas, High Throughput Screening Lab, Lawrence, KS 66045 USA; [Chaguturu, Rathnam] SRI Int, Ctr Adv Drug Res, Harrisonburg, VA USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; SRI International	Klaassen, CD (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA.	cklaasse@kumc.edu	Wu, Kai/I-2202-2013		United States National Institutes of Health [DK081461]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081461] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present study was funded by United States National Institutes of Health grant DK081461. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell PJ, 2005, MOL CELL ENDOCRINOL, V243, P27, DOI 10.1016/j.mce.2005.08.002; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Copple Ian M, 2010, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-642-00663-0_9; Dinkova-Kostova AT, 2010, J BIOL CHEM, V285, P33747, DOI 10.1074/jbc.M110.163485; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Eggler AL, 2008, MOL NUTR FOOD RES, V52, pS84, DOI 10.1002/mnfr.200700249; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Gebel S, 2010, TOXICOL SCI, V115, P238, DOI 10.1093/toxsci/kfq039; Giudice A, 2010, METHODS MOL BIOL, V647, P37, DOI 10.1007/978-1-60761-738-9_3; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610; JEFFREY AM, 1985, PHARMACOL THERAPEUT, V28, P237, DOI 10.1016/0163-7258(85)90013-0; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kumar V, 2011, J MED CHEM, V54, P4147, DOI 10.1021/jm2002348; Lee CY, 2010, EUR J MED CHEM, V45, P2957, DOI 10.1016/j.ejmech.2010.03.023; Li WG, 2006, J BIOL CHEM, V281, P27251, DOI 10.1074/jbc.M602746200; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Ramos-Gomez M, 2003, CARCINOGENESIS, V24, P461, DOI 10.1093/carcin/24.3.461; Reisman SA, 2009, TOXICOL SCI, V109, P31, DOI 10.1093/toxsci/kfp047; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Tanaka A, 2010, BIOORGAN MED CHEM, V18, P3133, DOI 10.1016/j.bmc.2010.03.034; Tanaka Y, 2009, TOXICOL SCI, V108, P247, DOI 10.1093/toxsci/kfp020; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Wu KC, 2011, TOXICOL SCI, V123, P590, DOI 10.1093/toxsci/kfr183; Wu KC, 2012, TOXICOL APPL PHARM; Wu KC, 2012, FREE RADIC RES; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	28	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e44686	10.1371/journal.pone.0044686	http://dx.doi.org/10.1371/journal.pone.0044686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056183	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500006
J	Zhu, SJ; Wildonger, J; Barshow, S; Younger, S; Huang, YL; Lee, T				Zhu, Sijun; Wildonger, Jill; Barshow, Suzanne; Younger, Susan; Huang, Yaling; Lee, Tzumin			The bHLH Repressor Deadpan Regulates the Self-renewal and Specification of Drosophila Larval Neural Stem Cells Independently of Notch	PLOS ONE			English	Article							NERVOUS-SYSTEM; HES GENES; POSTEMBRYONIC NEUROBLASTS; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTORS; SPINDLE ORIENTATION; TUMOR SUPPRESSORS; PROGENITOR CELLS; MAMMALIAN HAIRY; PROLIFERATION	Neural stem cells (NSCs) are able to self-renew while giving rise to neurons and glia that comprise a functional nervous system. However, how NSC self-renewal is maintained is not well understood. Using the Drosophila larval NSCs called neuroblasts (NBs) as a model, we demonstrate that the Hairy and Enhancer-of-Split (Hes) family protein Deadpan (Dpn) plays important roles in NB self-renewal and specification. The loss of Dpn leads to the premature loss of NBs and truncated NB lineages, a process likely mediated by the homeobox protein Prospero (Pros). Conversely, ectopic/over-expression of Dpn promotes ectopic self-renewing divisions and maintains NB self-renewal into adulthood. In type II NBs, which generate transit amplifying intermediate neural progenitors (INPs) like mammalian NSCs, the loss of Dpn results in ectopic expression of type I NB markers Asense (Ase) and Pros before these type II NBs are lost at early larval stages. Our results also show that knockdown of Notch leads to ectopic Ase expression in type II NBs and the premature loss of type II NBs. Significantly, dpn expression is unchanged in these transformed NBs. Furthermore, the loss of Dpn does not inhibit the over-proliferation of type II NBs and immature INPs caused by over-expression of activated Notch. Our data suggest that Dpn plays important roles in maintaining NB self-renewal and specification of type II NBs in larval brains and that Dpn and Notch function independently in regulating type II NB proliferation and specification.	[Zhu, Sijun; Wildonger, Jill; Barshow, Suzanne; Younger, Susan] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Younger, Susan] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Huang, Yaling; Lee, Tzumin] Howard Hughes Med Inst, Ashburn, VA USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Zhu, SJ (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA.	sijun.zhu@ucsf.edu	Barshow, Suzanne/GVS-8898-2022	Barshow, Suzanne/0000-0002-6744-1834	United States National Institutes of Health (NIH) [2R37NS040929]; Howard Hughes Medical Institute; California Institute of Regenerative Medicine; NIH [F32HD053199]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD053199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the United States National Institutes of Health (NIH) grant 2R37NS040929 (Yuh Nung Jan), Howard Hughes Medical Institute, the California Institute of Regenerative Medicine Training Grant II (S.Z.) and the NIH grant F32HD053199 (J.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009; Cau E, 2000, DEVELOPMENT, V127, P2323; Chang KC, 2012, BIOESSAYS, V34, P301, DOI 10.1002/bies.201100090; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; JARMAN AP, 1993, DEVELOPMENT, V119, P19; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li L, 2000, GENE DEV, V14, P147; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; San-Juan BP, 2011, DEV BIOL, V352, P70, DOI 10.1016/j.ydbio.2011.01.019; Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060; Song Y, 2011, GENE DEV, V25, P2644, DOI 10.1101/gad.171959.111; Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Torii MA, 1999, DEVELOPMENT, V126, P443; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007; Xiao Q, 2012, DEVELOPMENT, V139, P2670, DOI 10.1242/dev.081687; YOUNGERSHEPHERD S, 1992, CELL, V70, P911, DOI 10.1016/0092-8674(92)90242-5; Zacharioudaki E, 2012, DEVELOPMENT, V139, P1258, DOI 10.1242/dev.071779; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zhu SJ, 2011, P NATL ACAD SCI USA, V108, P20615, DOI 10.1073/pnas.1118595109	48	32	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46724	10.1371/journal.pone.0046724	http://dx.doi.org/10.1371/journal.pone.0046724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056424	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500063
J	Baker, ME; Chandsawangbhuwana, C				Baker, Michael E.; Chandsawangbhuwana, Charlie			3D Models of MBP, a Biologically Active Metabolite of Bisphenol A, in Human Estrogen Receptor alpha and Estrogen Receptor beta	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; LIGAND-BINDING DOMAIN; NUCLEAR RECEPTOR; SCORING FUNCTION; AFFINITY PREDICTION; CRYSTAL-STRUCTURE; GENE-EXPRESSION; HUMAN EXPOSURE; ESTRADIOL; SPECIFICITY	Bisphenol A [BPA] is a widely dispersed environmental chemical that is of much concern because the BPA monomer is a weak transcriptional activator of human estrogen receptor alpha [ER alpha] and ER beta in cell culture. A BPA metabolite, 4-methyl-2,4-bis(4-hydroxyphenyl) pent-1-ene [MBP], has transcriptional activity at nM concentrations, which is 1000-fold lower than the concentration for estrogenic activity of BPA, suggesting that MBP may be an environmental estrogen. To investigate the structural basis for the activity of MBP at nM concentrations and the lower activity of BPA for human ER alpha and ER beta, we constructed 3D models of human ER alpha and ER beta with MBP and BPA for comparison with estradiol in these ERs. These 3D models suggest that MBP, but not BPA, has key contacts with amino acids in human ERa and ERb that are important in binding of estradiol by these receptors. Metabolism of BPA to MBP increases the spacing between two phenolic rings, resulting in contacts between MBP and ER alpha and ER beta that mimic those of estradiol with these ERs. Mutagenesis of residues on these ERs that contact the phenolic hydroxyls will provide a test for our 3D models. Other environmental chemicals containing two appropriately spaced phenolic rings and an aliphatic spacer instead of an estrogenic B and C ring also may bind to ERa or ERb and interfere with normal estrogen physiology. This analysis also may be useful in designing novel chemicals for regulating the actions of human ER alpha and ER beta.	[Baker, Michael E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chandsawangbhuwana, Charlie] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Baker, ME (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mbaker@ucsd.edu	Baker, Michael/ABB-8508-2020	Baker, Michael/0000-0003-4387-3269				Baker ME, 2005, INTEGR COMP BIOL, V45, P172, DOI 10.1093/icb/45.1.172; Baker ME, 2011, BIOCHEM PHARMACOL, V82, P1, DOI 10.1016/j.bcp.2011.03.008; Baker ME, 2009, BIOCHEM BIOPH RES CO, V386, P516, DOI 10.1016/j.bbrc.2009.06.079; Baker ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006038; Billon-Gales A, 2011, P NATL ACAD SCI USA, V108, P13311, DOI 10.1073/pnas.1105632108; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Celik L, 2007, BIOCHEMISTRY-US, V46, P1743, DOI 10.1021/bi061656t; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; Eiler S, 2001, PROTEIN EXPRES PURIF, V22, P165, DOI 10.1006/prep.2001.1409; Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007; Gould JC, 1998, MOL CELL ENDOCRINOL, V142, P203, DOI 10.1016/S0303-7207(98)00084-7; Hall JM, 2002, J BIOL CHEM, V277, P44455, DOI 10.1074/jbc.M200849200; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jeyakunnar M, 2011, J BIOL CHEM, V286, P12971, DOI 10.1074/jbc.M110.205112; Katzenellenbogen JA, 2011, J MED CHEM, V54, P5271, DOI 10.1021/jm200801h; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lappano R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016631; le Maire A, 2010, CELL MOL LIFE SCI, V67, P1219, DOI 10.1007/s00018-009-0249-2; Manas ES, 2004, J AM CHEM SOC, V126, P15106, DOI 10.1021/ja047633o; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Minutolo F, 2011, MED RES REV, V31, P364, DOI 10.1002/med.20186; Mocklinghoff S, 2010, CHEMBIOCHEM, V11, P2251, DOI 10.1002/cbic.201000532; MORRIS GM, 2009, J COMPUT CHEM; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242; Okuda K, 2010, TOXICOL LETT, V197, P7, DOI 10.1016/j.toxlet.2010.04.017; Richter CA, 2007, ENVIRON HEALTH PERSP, V115, P902, DOI 10.1289/ehp.9804; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Seo JW, 2006, J MED CHEM, V49, P2496, DOI 10.1021/jm0512037; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sladek FM, 2011, MOL CELL ENDOCRINOL, V334, P3, DOI 10.1016/j.mce.2010.06.018; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Velec HFG, 2005, J MED CHEM, V48, P6296, DOI 10.1021/jm050436v; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Yoshihara S, 2004, TOXICOL SCI, V78, P50, DOI 10.1093/toxsci/kfh047	55	39	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46078	10.1371/journal.pone.0046078	http://dx.doi.org/10.1371/journal.pone.0046078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056236	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800007
J	Craig, RB; Summa, CM; Corti, M; Pincus, SH				Craig, Ryan B.; Summa, Christopher M.; Corti, Miriam; Pincus, Seth H.			Anti-HIV Double Variable Domain Immunoglobulins Binding Both gp41 and gp120 for Targeted Delivery of Immunoconjugates	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FUSION INHIBITOR T-20; CD4-PSEUDOMONAS EXOTOXIN; MOLECULAR CHARACTERIZATION; ANTIRETROVIRAL THERAPY; MONOCLONAL-ANTIBODIES; INFECTED-CELLS; SOLUBLE CD4; HTLV-III; NEUTRALIZATION	Background: Anti-HIV immunoconjugates targeted to the HIV envelope protein may be used to eradicate the latent reservoir of HIV infection using activate-and-purge protocols. Previous studies have identified the two target epitopes most effective for the delivery of cytotoxic immunoconjugates the CD4-binding site of gp120, and the hairpin loop of gp41. Here we construct and test tetravalent double variable domain immunoglobulin molecules (DVD-Igs) that bind to both epitopes. Methods: Synthetic genes that encode DVD-Igs utilizing V-domains derived from human anti-gp120 and anti-gp41 Abs were designed and expressed in 293F cells. A series of constructs tested different inter-V-linker domains and orientations of the two V domains. Antibodies were tested for binding to recombinant Ag and native Env expressed on infected cells, for neutralization of infectious HIV, and for their ability to deliver cytotoxic immunoconjugates to infected cells. Findings: The outer V-domain was the major determinant of binding and functional activity of the DVD-Ig. Function of the inner V-domain and bifunctional binding required at least 15 AA in the inter-V-domain linker. A molecular model showing the spatial orientation of the two epitopes is consistent with this observation. Linkers that incorporated helical domains (A[EAAAK](n)A) resulted in more effective DVD-Igs than those based solely on flexible domains ([GGGGS](n)). In general, the DVD-Igs outperformed the less effective parental antibody and equaled the activity of the more effective. The ability of the DVD-Igs to deliver cytotoxic immunoconjugates in the absence of soluble CD4 was improved over that of either parent. Conclusions: DVD-Igs can be designed that bind to both gp120 and gp41 on the HIV envelope. DVD-Igs are effective in delivering cytotoxic immunoconjugates. The optimal design of these DVD-Igs, in which both domains are fully functional, has not yet been achieved.	[Craig, Ryan B.; Pincus, Seth H.] LSU Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Craig, Ryan B.; Summa, Christopher M.; Corti, Miriam; Pincus, Seth H.] Childrens Hosp, Res Inst Children, New Orleans, LA USA; [Summa, Christopher M.] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA; [Pincus, Seth H.] LSU Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; University of Louisiana System; University of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Pincus, SH (corresponding author), LSU Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA.	spincus@chnola-research.org			Research Institute for Children, Children's Hospital New Orleans; Louisiana Vaccine Center; Bill and Melinda Gates Foundation [OPP1045974]	Research Institute for Children, Children's Hospital New Orleans; Louisiana Vaccine Center; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Research Institute for Children, Children's Hospital New Orleans, the Louisiana Vaccine Center, and the Bill and Melinda Gates Foundation, Grant OPP1045974. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; ASHORN P, 1990, P NATL ACAD SCI USA, V87, P8889, DOI 10.1073/pnas.87.22.8889; ASHORN P, 1991, J INFECT DIS, V163, P703, DOI 10.1093/infdis/163.4.703; ASHORN P, 1992, J ACQ IMMUN DEF SYND, V5, P70; Baden LR, 2012, NEW ENGL J MED, V366, P1343, DOI 10.1056/NEJMe1202492; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; BARBAS CF, 1994, P NATL ACAD SCI USA, V91, P3809, DOI 10.1073/pnas.91.9.3809; Berger EA, 2011, CURR OPIN HIV AIDS, V6, P80, DOI 10.1097/COH.0b013e3283412515; Berger EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000803; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CHAUDHARY VK, 1988, NATURE, V335, P369, DOI 10.1038/335369a0; Chen WZ, 2010, ANTIVIR RES, V88, P107, DOI 10.1016/j.antiviral.2010.08.004; Chen XY, 2010, BIOTECHNIQUES, V49, P513, DOI 10.2144/000113450; Dadachova E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031866; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dey B, 2003, J VIROL, V77, P2859, DOI 10.1128/JVI.77.5.2859-2865.2003; DiGiammarino EL, 2011, MABS-AUSTIN, V3, P487, DOI 10.4161/mabs.3.5.16326; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GARLICK RL, 1990, AIDS RES HUM RETROV, V6, P465, DOI 10.1089/aid.1990.6.465; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; Goldstein H, 2000, J INFECT DIS, V181, P921, DOI 10.1086/315351; Gu JJ, 2012, METHOD ENZYMOL, V502, P25, DOI 10.1016/B978-0-12-416039-2.00002-1; Hamer DH, 2004, CURR HIV RES, V2, P99, DOI 10.2174/1570162043484915; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; JACOBSON JM, 1993, J INFECT DIS, V168, P298, DOI 10.1093/infdis/168.2.298; Kennedy PE, 2006, J LEUKOCYTE BIOL, V80, P1175, DOI 10.1189/jlb.0306139; Korber B, 2011, SCIENCE, V333, P1589, DOI 10.1126/science.1211919; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Lagenaur LA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-11; LETVIN NL, 1986, J CLIN INVEST, V78, P666, DOI 10.1172/JCI112625; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lueders KK, 2004, AIDS RES HUM RETROV, V20, P145, DOI 10.1089/088922204773004851; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; Marsden MD, 2008, AIDS RES HUM RETROV, V24, P1399, DOI 10.1089/aid.2008.0082; McHugh L, 2002, J BIOL CHEM, V277, P34383, DOI 10.1074/jbc.M205456200; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mouquet H, 2012, P NATL ACAD SCI USA, V109, P875, DOI 10.1073/pnas.1120059109; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Pincus SH, 1996, AIDS RES HUM RETROV, V12, P1041, DOI 10.1089/aid.1996.12.1041; PINCUS SH, 1990, J EXP MED, V172, P745, DOI 10.1084/jem.172.3.745; PINCUS SH, 1991, J IMMUNOL, V146, P4315; PINCUS SH, 1990, J INFECT DIS, V162, P1233, DOI 10.1093/infdis/162.6.1233; Pincus SH, 2003, J IMMUNOL, V170, P2236, DOI 10.4049/jimmunol.170.4.2236; PINCUS SH, 1993, P NATL ACAD SCI USA, V90, P332, DOI 10.1073/pnas.90.1.332; PINCUS SH, 1989, J IMMUNOL, V142, P3070; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shan DM, 1999, J IMMUNOL, V162, P6589; SHAW GM, 1984, SCIENCE, V226, P1165, DOI 10.1126/science.6095449; TILL M, 1988, CANCER RES, V48, P1119; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WELTMAN JK, 1986, BIOTECHNIQUES, V4, P224; West AP, 2010, J VIROL, V84, P261, DOI 10.1128/JVI.01528-09; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Wu CB, 2009, MABS, V1, P339, DOI 10.4161/mabs.1.4.8755; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	71	20	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46778	10.1371/journal.pone.0046778	http://dx.doi.org/10.1371/journal.pone.0046778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056448	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800049
J	Gould, DW; Lukic, S; Chen, KC				Gould, David W.; Lukic, Sergio; Chen, Kevin C.			Selective Constraint on Copy Number Variation in Human Piwi-Interacting RNA Loci	PLOS ONE			English	Article							PIRNA CLUSTERS; HUMAN GENOME; DROSOPHILA; ALIGNMENT; EVOLUTION; MICRORNAS	Piwi-interacting RNAs (piRNAs) are a recently discovered class of small non-coding RNA found in animals. PiRNAs are primarily expressed in the germline where their best understood function is to repress transposable elements. Unlike previous studies that investigated the evolution of piRNA-generating loci at the level of nucleotide substitutions, here we studied the evolution of piRNA-generating loci at the level of copy number variation (i.e. duplications and deletions) using genome-wide copy number variation data from three human populations. Our analysis shows that at the level of copy number variation there is strong selective constraint and a very high mutation rate in human piRNA-generating loci. Our results differ from a model of positive selection on copy number variation in piRNA-generating loci previously proposed in rodents. We discuss possible reasons for this difference based on the transposable element insertion histories in the rodent and primate lineages.	[Chen, Kevin C.] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08855 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Chen, KC (corresponding author), Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08855 USA.	kcchen@biology.rutgers.edu	Chen, Kevin/GYU-8963-2022		National Institutes of Health [R00HG004515]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG004515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the National Institutes of Health (R00HG004515 to KC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Assis R, 2009, P NATL ACAD SCI USA, V106, P7079, DOI 10.1073/pnas.0900523106; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Castillo DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-258; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kolaczkowski B, 2011, MOL BIOL EVOL, V28, P1033, DOI 10.1093/molbev/msq284; Kumar M, 2012, BRIEF FUNCT GENOMICS; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu J, 2010, GENOME RES, V20, P212, DOI 10.1101/gr.095406.109; Lukic S, 2011, MOL BIOL EVOL, V28, P3061, DOI 10.1093/molbev/msr141; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smit AFA, 2010, REPEATMASKER OPEN 3; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	21	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46611	10.1371/journal.pone.0046611	http://dx.doi.org/10.1371/journal.pone.0046611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056369	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800033
J	Legind, CN; Rein, A; Serre, J; Brochier, V; Haudin, CS; Cambier, P; Houot, S; Trapp, S				Legind, Charlotte N.; Rein, Arno; Serre, Jeanne; Brochier, Violaine; Haudin, Claire-Sophie; Cambier, Philippe; Houot, Sabine; Trapp, Stefan			Simultaneous Simulations of Uptake in Plants and Leaching to Groundwater of Cadmium and Lead for Arable Land Amended with Compost or Farmyard Manure	PLOS ONE			English	Article							HEAVY-METALS; SOIL; EXPOSURE; WHEAT; BIOAVAILABILITY; ELEMENTS; MAIZE	The water budget of soil, the uptake in plants and the leaching to groundwater of cadmium (Cd) and lead (Pb) were simulated simultaneously using a physiological plant uptake model and a tipping buckets water and solute transport model for soil. Simulations were compared to results from a ten-year experimental field study, where four organic amendments were applied every second year. Predicted concentrations slightly decreased (Cd) or stagnated (Pb) in control soils, but increased in amended soils by about 10% (Cd) and 6% to 18% (Pb). Estimated plant uptake was lower in amended plots, due to an increase of Kd (dry soil to water partition coefficient). Predicted concentrations in plants were close to measured levels in plant residues (straw), but higher than measured concentrations in grains. Initially, Pb was mainly predicted to deposit from air into plants (82% in 1998); the next years, uptake from soil became dominating (30% from air in 2006), because of decreasing levels in air. For Cd, predicted uptake from air into plants was negligible (1-5%).	[Legind, Charlotte N.; Rein, Arno; Trapp, Stefan] Tech Univ Denmark, Dept Environm Engn, DK-2800 Lyngby, Denmark; [Serre, Jeanne; Brochier, Violaine] Veolia Environm Res & Innovat, Rueil Malmaison, France; [Haudin, Claire-Sophie; Cambier, Philippe; Houot, Sabine] INRA, UMR 1091, Environm & Arable Crop Res Unit, F-78850 Thiverval Grignon, France	Technical University of Denmark; Veolia; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Legind, CN (corresponding author), Tech Univ Denmark, Dept Environm Engn, DK-2800 Lyngby, Denmark.	chanl@env.dtu.dk	Rein, Arno/I-1556-2015; Trapp, Stefan A J/G-7159-2011	Rein, Arno/0000-0002-1136-3558; Trapp, Stefan A J/0000-0001-8968-6296	Veolia Environnement RI; INRA (French National Institute for Agricultural Research) de Grignon	Veolia Environnement RI; INRA (French National Institute for Agricultural Research) de Grignon	The work received funding from Veolia Environnement R&I and INRA (French National Institute for Agricultural Research) de Grignon. The funders had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	AIRPARIF, 2008, RAPP ACT 2008; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Azimi S, 2004, WATER AIR SOIL POLL, V157, P295, DOI 10.1023/B:WATE.0000038903.25700.5a; Barber S., 1981, MODELING WASTEWATER; Barber S.A., 1995, SOIL NUTR BIOAVAILAB; Bauer-Gottwein P, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006067; Cambier P, 2007, JOURN TECHN RET SOL, P108; Chaney R. L., 2010, Trace elements in soils, P409; DASILVA CC, 1986, AGR FOREST METEOROL, V36, P249; De Temmerman L, 2004, J ATMOS CHEM, V49, P121, DOI 10.1007/s10874-004-1219-6; Diacono M, 2010, AGRON SUSTAIN DEV, V30, P401, DOI 10.1051/agro/2009040; Gondek K, 2010, INT AGROPHYS, V24, P35; Herren T, 1997, ANN BOT-LONDON, V80, P623, DOI 10.1006/anbo.1997.0492; Hough RL, 2004, ENVIRON HEALTH PERSP, V112, P215, DOI 10.1289/ehp.5589; HOUOT S, 2005, FUTURE RESIDUAL WAST; Ingwersen J, 2005, J ENVIRON QUAL, V34, P1026, DOI 10.2134/jeq2003.0238; Kay AL, 2008, J HYDROL, V358, P221, DOI 10.1016/j.jhydrol.2008.06.005; Larcher W., 1995, PHYSL PLANT ECOLOGY; Lavado RS, 2007, AGR ECOSYST ENVIRON, V118, P312, DOI 10.1016/j.agee.2006.06.001; Legind CN, 2010, SAR QSAR ENVIRON RES, V21, P513, DOI 10.1080/1062936X.2010.502296; Legind CN, 2011, PEST MANAG SCI, V67, P521, DOI 10.1002/ps.2087; Legind CN, 2009, ENVIRON POLLUT, V157, P778, DOI 10.1016/j.envpol.2008.11.021; Masson P, 1999, ANALUSIS, V27, P813, DOI 10.1051/analusis:1999148; Masson P, 2000, J ANAL ATOM SPECTROM, V15, P543, DOI 10.1039/a909651e; McLaughlin MJ, 2011, DEALING WITH CONTAMINATED SITES: FROM THEORY TOWARDS PRACTICAL APPLICATION, P325, DOI 10.1007/978-90-481-9757-6_8; Mench M, 1997, ENVIRON POLLUT, V95, P93, DOI 10.1016/S0269-7491(96)00078-4; Montemurro F, 2010, COMPOST SCI UTIL, V18, P47; Peijnenburg W, 2000, ARCH ENVIRON CON TOX, V39, P420, DOI 10.1007/s002440010123; Penn State University Laboratory (PSU), BARB CUSHM MOD; Peralta-Videa JR, 2009, INT J BIOCHEM CELL B, V41, P1665, DOI 10.1016/j.biocel.2009.03.005; Prohl G, 2009, J ENVIRON RADIOACTIV, V100, P675, DOI 10.1016/j.jenvrad.2008.10.006; Rein A, 2011, SAR QSAR ENVIRON RES, V22, P191, DOI 10.1080/1062936X.2010.548829; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Sauve S, 2000, ENVIRON SCI TECHNOL, V34, P1125, DOI 10.1021/es9907764; SITTE P, 1991, LEHRBUCH BOT HOCHSCH; Smith SR, 2009, ENVIRON INT, V35, P142, DOI 10.1016/j.envint.2008.06.009; Sterckeman T, 2011, ENVIRON EXP BOT, V74, P131, DOI 10.1016/j.envexpbot.2011.05.010; Trapp S, 1998, CHEMODYNAMICS ENV MO; Walter H, 1986, ALLGEMEINE GEOBOTANI	39	27	27	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e47002	10.1371/journal.pone.0047002	http://dx.doi.org/10.1371/journal.pone.0047002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056555	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800066
J	Liu, MX; Qi, L; Zeng, Y; Yang, Y; Bi, Y; Shi, XD; Zhu, H; Zhou, ZM; Sha, JH				Liu, Mingxi; Qi, Lin; Zeng, Yan; Yang, Yang; Bi, Ye; Shi, Xiaodan; Zhu, Hui; Zhou, Zuomin; Sha, Jiahao			Transient Scrotal Hyperthermia Induces Lipid Droplet Accumulation and Reveals a Different ADFP Expression Pattern between the Testes and Liver in Mice	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; ADULT MALE-MICE; PROTEOMIC ANALYSIS; SERTOLI-CELLS; LONG-CHAIN; RAT TESTES; SPERMATOGENESIS; PROTEIN; MEN; TESTOSTERONE	Background: In most mammals, the testes provide a stable environment for spermatogenesis, which depends on a lower temperature than the core body temperature. It has been reported that mild testicular heating safely and reversibly suppresses spermatogenesis, and is under consideration for its potential application as a male contraceptive. Previously, we focused on the molecular mechanism of germ cell apoptosis and anti-apoptotic factors induced by heat treatment in humans and mice. However, the recovery process remains under investigation. Results: In this study, we found that lipid droplets in mouse testes are dramatically increased after a brief period of scrotal hyperthermia, and gradually dissipate following temperature normalization. Analysis of the human testis proteome revealed nine proteins associated with lipid droplets. Two of them, ADFP (also known as ADRP and PLIN2) and TIP47 (also known as PLIN3) may participate in acute lipid droplet formation in mammalian testes. We show that Adfp expression is upregulated after scrotal heat treatment in mice. Surprisingly, we find Adfp lacking its 5'-UTR is observed in Adfp(Delta 1/Delta 1) mouse testes, but is not detectable in liver. Conclusions: These results reveal testis Adfp transcriptional regulation is tissue-specific, and is associated with lipid droplet accumulation induced by heat. The results also indicate that the testes could retain functional proteins through testes-specific transcriptional regulation.	[Liu, Mingxi; Qi, Lin; Zeng, Yan; Yang, Yang; Bi, Ye; Shi, Xiaodan; Zhu, Hui; Zhou, Zuomin; Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, ZM (corresponding author), Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	zhouzm@njmu.edu.cn	Bi, Ye/A-6272-2017	Liu, Mingxi/0000-0001-6499-7899	China National 973 Program Project [2011CB944304]	China National 973 Program Project(National Basic Research Program of China)	This work was supported by China National 973 Program Project (2011CB944304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREU I, 1982, CELL TISSUE RES, V222, P143; Aktas C, 2009, J MOL HISTOL, V40, P31, DOI 10.1007/s10735-009-9210-9; BARTH AD, 1994, CAN VET J, V35, P93; Bensoussan K, 1998, J ANDROL, V19, P266; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bonde JP, 2010, ASIAN J ANDROL, V12, P152, DOI 10.1038/aja.2009.83; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; CHOWDHURY AK, 1964, AM J ANAT, V115, P509, DOI 10.1002/aja.1001150307; Cui YG, 2008, J PROTEOME RES, V7, P3984, DOI 10.1021/pr800259t; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Furland NE, 2007, BIOL REPROD, V77, P181, DOI 10.1095/biolreprod.106.056556; Furland NE, 2011, LIPIDS, V46, P443, DOI 10.1007/s11745-011-3527-3; Furland NE, 2003, LIPIDS, V38, P73, DOI 10.1007/s11745-003-1033-9; Grinspon RP, 2010, HORM RES PAEDIAT, V73, P81, DOI 10.1159/000277140; HAND JW, 1979, INT J RADIAT BIOL, V35, P521, DOI 10.1080/09553007914550631; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Ivell R, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-15; KANDEEL FR, 1988, FERTIL STERIL, V49, P1; KERR JB, 1975, J REPROD FERTIL, V43, P1; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Kyronlahti A, 2011, MOL CELL ENDOCRINOL, V333, P85, DOI 10.1016/j.mce.2010.12.019; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Lue YH, 2006, J CLIN ENDOCR METAB, V91, P539, DOI 10.1210/jc.2005-1808; LYNCH R, 1986, FERTIL STERIL, V46, P476; Mark M, 2004, P NATL ACAD SCI USA, V101, P4453, DOI 10.1073/pnas.0400234101; MIEUSSET R, 1995, INT J ANDROL, V18, P169, DOI 10.1111/j.1365-2605.1995.tb00408.x; MIEUSSET R, 1994, INT J ANDROL, V17, P186, DOI 10.1111/j.1365-2605.1994.tb01241.x; MIEUSSET R, 1992, J REPROD FERTIL, V94, P337, DOI 10.1530/jrf.0.0940337; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Nistal M, 2005, FERTIL STERIL, V83, P1489, DOI 10.1016/j.fertnstert.2004.12.032; PANIAGUA R, 1987, J REPROD FERTIL, V80, P335; Paul C, 2009, BIOL REPROD, V80, P913, DOI 10.1095/biolreprod.108.071779; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Wang C, 2007, J CLIN ENDOCR METAB, V92, P3292, DOI 10.1210/jc.2007-0367; Xiong WP, 2009, REPRODUCTION, V137, P469, DOI 10.1530/REP-08-0343; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zhu H, 2010, PROTEOMICS, V10, P3480, DOI 10.1002/pmic.201000281; Zhu YF, 2006, J PROTEOME RES, V5, P2217, DOI 10.1021/pr0600733	42	17	17	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e45694	10.1371/journal.pone.0045694	http://dx.doi.org/10.1371/journal.pone.0045694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056214	Green Submitted, Green Published, gold			2022-12-27	WOS:000309580800004
J	Rundqvist, L; Tengel, T; Zdunek, J; Bjorn, E; Schleucher, J; Alcocer, MJC; Larsson, G				Rundqvist, Louise; Tengel, Tobias; Zdunek, Janusz; Bjorn, Erik; Schleucher, Jurgen; Alcocer, Marcos J. C.; Larsson, Goran			Solution Structure, Copper Binding and Backbone Dynamics of Recombinant Ber e 1-The Major Allergen from Brazil Nut	PLOS ONE			English	Article							NMR RELAXATION DATA; LIPID TRANSFER PROTEIN; 2S ALBUMIN; PEANUT ALLERGENS; MOLECULAR-DYNAMICS; IMMUNE-RESPONSES; CHEMICAL-SHIFTS; DISPERSION NMR; FOOD ALLERGY; IN-VITRO	Background: The 2S albumin Ber e 1 is the major allergen in Brazil nuts. Previous findings indicated that the protein alone does not cause an allergenic response in mice, but the addition of components from a Brazil nut lipid fraction were required. Structural details of Ber e 1 may contribute to the understanding of the allergenic properties of the protein and its potential interaction partners. Methodology/Principal Findings: The solution structure of recombinant Ber e 1 was solved using NMR spectroscopy and measurements of the protein back bone dynamics at a residue-specific level were extracted using 15 N-spin relaxation. A hydrophobic cavity was identified in the structure of Ber e 1. Using the paramagnetic relaxation enhancement property of Cu2+ in conjunction with NMR, it was shown that Ber e 1 is able to specifically interact with the divalent copper ion and the binding site was modeled into the structure. The IgE binding region as well as the copper binding site show increased dynamics on both fast ps-ns timescale as well as slower ms-ms timescale. Conclusions/Significance: The overall fold of Ber e 1 is similar to other 2S albumins, but the hydrophobic cavity resembles that of a homologous non-specific lipid transfer protein. Ber e 1 is the first 2S albumin shown to interact with Cu2+ ions. This Cu2+ binding has minimal effect on the electrostatic potential on the surface of the protein, but the charge distribution within the hydrophobic cavity is significantly altered. As the hydrophobic cavity is likely to be involved in a putative lipid interaction the Cu2+ can in turn affect the interaction that is essential to provoke an allergenic response.	[Rundqvist, Louise; Tengel, Tobias; Schleucher, Jurgen; Larsson, Goran] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Zdunek, Janusz] Prot Constructor Developers Co, Umea, Sweden; [Bjorn, Erik] Umea Univ, Dept Chem, Umea, Sweden; [Alcocer, Marcos J. C.] Univ Nottingham, Dept Nutr Sci, Loughborough, Leics, England	Umea University; Umea University; University of Nottingham	Larsson, G (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	Goran.Larsson@medchem.umu.se	Magaña, Felipe/B-6966-2013	Alcocer, Marcos/0000-0002-6828-2855	Wenner-Gren foundations; Cancer och Allergifonden; Astma och Allergiforbundet; Magn. Bervalls stiftelse; Konsul Th C Berghs stiftelse; Lars Hiertasmine; Medical faculty at Umea University; Kempe foundations	Wenner-Gren foundations; Cancer och Allergifonden; Astma och Allergiforbundet; Magn. Bervalls stiftelse; Konsul Th C Berghs stiftelse; Lars Hiertasmine; Medical faculty at Umea University; Kempe foundations	This work was supported by grants from the Wenner-Gren foundations (GL), Cancer och Allergifonden (GL), Astma och Allergiforbundet (GL), Magn. Bervalls stiftelse (GL), Konsul Th C Berghs stiftelse (GL) Lars Hiertasmine (GL), the Medical faculty at Umea University (GL), and the Kempe foundations (LR, TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Akke M, 1998, NAT STRUCT BIOL, V5, P55, DOI 10.1038/nsb0198-55; Alcocer M, 2012, BIOTECHNOL LETT, V34, P597, DOI 10.1007/s10529-011-0831-1; Alcocer MJC, 2004, J MOL BIOL, V343, P759, DOI 10.1016/j.jmb.2004.08.065; Alcocer MJC, 2002, J MOL BIOL, V324, P165, DOI 10.1016/S0022-2836(02)01061-6; ALTENBACH SB, 1987, PLANT MOL BIOL, V8, P239, DOI 10.1007/BF00015032; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bansal AS, 2007, J INVEST ALLERG CLIN, V17, P189; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Brix S, 2004, INT ARCH ALLERGY IMM, V135, P216, DOI 10.1159/000081306; Brunger AT, 1992, X PLOR VERSION 3 0 S; Christodoulou J, 2004, P NATL ACAD SCI USA, V101, P10949, DOI 10.1073/pnas.0400928101; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; de Lamotte F, 2001, CR ACAD SCI II C, V4, P839, DOI 10.1016/S1387-1609(01)01298-1; Dearman RJ, 2007, CLIN EXP ALLERGY, V37, P582, DOI 10.1111/j.1365-2222.2007.02689.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; Gangabadage CS, 2008, J BIOL CHEM, V283, P17416, DOI 10.1074/jbc.M800756200; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koppelman SJ, 2010, MOL NUTR FOOD RES, V54, P1711, DOI 10.1002/mnfr.201000011; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; KREBBERS E, 1988, PLANT PHYSIOL, V87, P859, DOI 10.1104/pp.87.4.859; KREIS M, 1985, J MOL BIOL, V183, P499, DOI 10.1016/0022-2836(85)90017-8; Larsson G, 2005, BIOPHYS J, V89, P1214, DOI 10.1529/biophysj.104.055780; Larsson G, 2003, J BIOMOL NMR, V27, P291, DOI 10.1023/A:1025836018993; Lehmann K, 2006, BIOCHEM J, V395, P463, DOI 10.1042/BJ20051728; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MONSALVE RI, 1991, FEBS LETT, V295, P207, DOI 10.1016/0014-5793(91)81419-9; Moreno F Javier, 2008, Open Biochem J, V2, P16, DOI 10.2174/1874091X00802010016; Moreno FJ, 2004, BBA-PROTEINS PROTEOM, V1698, P175, DOI 10.1016/j.bbapap.2003.11.007; Murtagh GJ, 2003, CLIN EXP ALLERGY, V33, P1147, DOI 10.1046/j.1365-2222.2003.01736.x; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Naozuka J, 2007, J BRAZIL CHEM SOC, V18, P1547, DOI 10.1590/S0103-50532007000800015; Nordlee JA, 1996, NEW ENGL J MED, V334, P688, DOI 10.1056/NEJM199603143341103; ONADERRA M, 1994, EUR J BIOCHEM, V225, P609, DOI 10.1111/j.1432-1033.1994.00609.x; Orekhov VY, 1995, APPL MAGN RESON, V9, P581, DOI 10.1007/BF03162365; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Pantoja-Uceda D, 2004, BIOCHEMISTRY-US, V43, P16036, DOI 10.1021/bi048069x; Pantoja-Uceda D, 2004, BIOCHEMISTRY-US, V43, P6976, DOI 10.1021/bi0496900; Pantoja-Uceda D, 2003, BIOCHEMISTRY-US, V42, P13839, DOI 10.1021/bi0352217; Pastorello EA, 1998, J ALLERGY CLIN IMMUN, V102, P1021, DOI 10.1016/S0091-6749(98)70341-0; Pickford Andrew R, 2004, Methods Mol Biol, V278, P17; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pons JL, 2003, J BIOL CHEM, V278, P14249, DOI 10.1074/jbc.M211683200; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Radauer C, 2007, J ALLERGY CLIN IMMUN, V120, P518, DOI 10.1016/j.jaci.2007.07.024; Rico M, 1996, BIOCHEMISTRY-US, V35, P15672, DOI 10.1021/bi961748q; Ruiter B, 2012, J ALLERGY CLIN IMMUN, V129, P921, DOI 10.1016/j.jaci.2012.01.080; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SZYPERSKI T, 1993, J BIOMOL NMR, V3, P151; Tengel T, 2005, J BIOMOL NMR, V32, P336, DOI 10.1007/s10858-005-8875-y; Ubbink M, 1996, EUR J BIOCHEM, V242, P132, DOI 10.1111/j.1432-1033.1996.0132r.x; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; van Wijk F, 2005, TOXICOL SCI, V86, P333, DOI 10.1093/toxsci/kfi187; Viles JH, 2001, J BIOMOL NMR, V21, P1, DOI 10.1023/A:1011966718826; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zdunek J, 2003, BIOCHEMISTRY-US, V42, P1872, DOI 10.1021/bi0267184	69	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46435	10.1371/journal.pone.0046435	http://dx.doi.org/10.1371/journal.pone.0046435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056307	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800019
J	Ben-Tov, M; Levy-Tzedek, S; Karniel, A				Ben-Tov, Mor; Levy-Tzedek, Shelly; Karniel, Amir			The Effects of Rhythmicity and Amplitude on Transfer of Motor Learning	PLOS ONE			English	Article							DISCRETE MOVEMENTS; VISUAL FEEDBACK; TARGET WIDTH; AIMING TASK; DYNAMICS; ADAPTATION; FREQUENCY; FASTER; UNITS	We perform rhythmic and discrete arm movements on a daily basis, yet the motor control literature is not conclusive regarding the mechanisms controlling these movements; does a single mechanism generate both movement types, or are they controlled by separate mechanisms? A recent study reported partial asymmetric transfer of learning from discrete movements to rhythmic movements. Other studies have shown transfer of learning between large-amplitude to small-amplitude movements. The goal of this study is to explore which aspect is important for learning to be transferred from one type of movement to another: rhythmicity, amplitude or both. We propose two hypotheses: (1) Rhythmic and discrete movements are generated by different mechanisms; therefore we expect to see a partial or no transfer of learning between the two types of movements; (2) Within each movement type (rhythmic/discrete), there will be asymmetric transition of learning from larger movements to smaller ones. We used a learning-transfer paradigm, in which 70 participants performed flexion/extension movements with their forearm, and switched between types of movement, which differed in amplitude and/or rhythmicity. We found partial transfer of learning between discrete and rhythmic movements, and an asymmetric transfer of learning from larger movements to smaller movements (within the same type of movement). Our findings suggest that there are two different mechanisms underlying the generation of rhythmic and discrete arm movements, and that practicing on larger movements helps perform smaller movements; the latter finding might have implications for rehabilitation.	[Ben-Tov, Mor; Karniel, Amir] Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel; [Levy-Tzedek, Shelly] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci ELSC, Jerusalem, Israel	Ben Gurion University; Hebrew University of Jerusalem	Karniel, A (corresponding author), Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.	shelly@huji.ac.il	Levy-Tzedek, Shelly/E-8612-2017	Ben-Tov, Mor/0000-0003-0283-1724	Israel Science Foundation [1018/08]; Edmond and Lily Safra Center for Brain Sciences (ELSC) fellowship	Israel Science Foundation(Israel Science Foundation); Edmond and Lily Safra Center for Brain Sciences (ELSC) fellowship	This research was supported by the Israel Science Foundation (grant No. 1018/08). SL is supported by an Edmond and Lily Safra Center for Brain Sciences (ELSC) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeele S, 2003, EXP BRAIN RES, V148, P128, DOI 10.1007/s00221-002-1317-0; Braden HW, 2008, Q J EXP PSYCHOL, V61, P1321, DOI 10.1080/17470210701557639; BROWN SH, 1984, EXP BRAIN RES, V55, P523; Buchanan JJ, 2004, NEUROSCI LETT, V367, P317, DOI 10.1016/j.neulet.2004.06.028; Buchanan JJ, 2003, EXP BRAIN RES, V150, P473, DOI 10.1007/s00221-003-1471-z; Buchanan JJ, 2006, EXP BRAIN RES, V175, P710, DOI 10.1007/s00221-006-0589-1; Dean NJ, 2008, ACTA PSYCHOL, V127, P355, DOI 10.1016/j.actpsy.2007.07.004; Degallier S, 2010, BIOL CYBERN, P1; Doeringer JA, 1998, J NEUROPHYSIOL, V80, P1787, DOI 10.1152/jn.1998.80.4.1787; Farley BG, 2005, EXP BRAIN RES, V167, P462, DOI 10.1007/s00221-005-0179-7; GUIARD Y, 1993, ACTA PSYCHOL, V82, P139, DOI 10.1016/0001-6918(93)90009-G; Hogan N, 2007, EXP BRAIN RES, V181, P13, DOI 10.1007/s00221-007-0899-y; Howard IS, 2011, J NEUROPHYSIOL, V105, P1722, DOI 10.1152/jn.00780.2010; Ikegami T, 2010, J NEUROSCI, V30, P4515, DOI 10.1523/JNEUROSCI.3066-09.2010; Kitazawa S, 1997, J NEUROSCI, V17, P1481; Levy-Tzedek S, 2011, J NEUROPHYSIOL, V106, P2120, DOI 10.1152/jn.00266.2011; Levy-Tzedek S, 2011, BRAIN RES BULL, V85, P283, DOI 10.1016/j.brainresbull.2010.11.010; Levy-Tzedek S, 2011, EXP BRAIN RES, V211, P277, DOI 10.1007/s00221-011-2685-0; Levy-Tzedek S, 2010, EXP BRAIN RES, V202, P733, DOI 10.1007/s00221-010-2176-8; MATSUOKA K, 1987, BIOL CYBERN, V56, P345, DOI 10.1007/BF00319514; Mottet D, 1999, BIOL CYBERN, V80, P235, DOI 10.1007/s004220050521; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Schaal S, 2001, NONLINEAR DYNAMICAL, P117; SCHONER G, 1990, BIOL CYBERN, V63, P257, DOI 10.1007/BF00203449; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Torre K, 2009, EXP BRAIN RES, V199, P157, DOI 10.1007/s00221-009-1991-2	27	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46983	10.1371/journal.pone.0046983	http://dx.doi.org/10.1371/journal.pone.0046983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056549	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000106
J	DeLorenzo, S; Brauer, SL; Edgmont, CA; Herfort, L; Tebo, BM; Zuber, P				DeLorenzo, Suzanne; Braeuer, Suzanna L.; Edgmont, Chelsea A.; Herfort, Lydie; Tebo, Bradley M.; Zuber, Peter			Ubiquitous Dissolved Inorganic Carbon Assimilation by Marine Bacteria in the Pacific Northwest Coastal Ocean as Determined by Stable Isotope Probing	PLOS ONE			English	Article							SP NOV.; DIVERSITY; SEQUENCE; FIXATION; GROWTH; GENES; PROTEOBACTERIA; ECOPHYSIOLOGY; THIOBACILLI; METABOLISM	In order to identify bacteria that assimilate dissolved inorganic carbon (DIC) in the northeast Pacific Ocean, stable isotope probing (SIP) experiments were conducted on water collected from 3 different sites off the Oregon and Washington coasts in May 2010, and one site off the Oregon Coast in September 2008 and March 2009. Samples were incubated in the dark with 2 mM C-13-NaHCO3, doubling the average concentration of DIC typically found in the ocean. Our results revealed a surprising diversity of marine bacteria actively assimilating DIC in the dark within the Pacific Northwest coastal waters, indicating that DIC fixation is relevant for the metabolism of different marine bacterial lineages, including putatively heterotrophic taxa. Furthermore, dark DIC-assimilating assemblages were widespread among diverse bacterial classes. Alphaproteobacteria, Gammaproteobacteria, and Bacteroidetes dominated the active DIC-assimilating communities across the samples. Actinobacteria, Betaproteobacteria, Deltaproteobacteria, Planctomycetes, and Verrucomicrobia were also implicated in DIC assimilation. Alteromonadales and Oceanospirillales contributed significantly to the DIC-assimilating Gammaproteobacteria within May 2010 clone libraries. 16S rRNA gene sequences related to the sulfur-oxidizing symbionts Arctic96BD-19 were observed in all active DIC assimilating clone libraries. Among the Alphaproteobacteria, clones related to the ubiquitous SAR11 clade were found actively assimilating DIC in all samples. Although not a dominant contributor to our active clone libraries, Betaproteobacteria, when identified, were predominantly comprised of Burkholderia. DIC-assimilating bacteria among Deltaproteobacteria included members of the SAR324 cluster. Our research suggests that DIC assimilation is ubiquitous among many bacterial groups in the coastal waters of the Pacific Northwest marine environment and may represent a significant metabolic process.	[DeLorenzo, Suzanne; Braeuer, Suzanna L.; Edgmont, Chelsea A.; Herfort, Lydie; Tebo, Bradley M.; Zuber, Peter] Oregon Hlth & Sci Univ, Ctr Coastal Margin Observat & Predict, Beaverton, OR USA; [DeLorenzo, Suzanne; Braeuer, Suzanna L.; Edgmont, Chelsea A.; Herfort, Lydie; Tebo, Bradley M.; Zuber, Peter] Oregon Hlth & Sci Univ, Div Environm & Biomol Syst, Beaverton, OR USA; [Braeuer, Suzanna L.] Appalachian State Univ, Boone, NC 28608 USA	Oregon Health & Science University; Oregon Health & Science University; University of North Carolina; Appalachian State University	DeLorenzo, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Coastal Margin Observat & Predict, Beaverton, OR USA.	delorenz@ebs.ogi.edu	Tebo, Bradley M/A-8432-2017	Tebo, Bradley M/0000-0002-6301-4325; Zuber, Peter/0000-0003-1757-7837	National Science Foundation grant [OCE/0424602]	National Science Foundation grant(National Science Foundation (NSF))	This work was carried out within the context of the Science and Technology Center for Coastal Margin Observation and Prediction (CMOP), supported by National Science Foundation grant number OCE/0424602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2010, ISME J, V4, P1581, DOI 10.1038/ismej.2010.69; Anderson CR, 2009, GEOMICROBIOL J, V26, P189, DOI 10.1080/01490450902724840; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Bassham SH, 1957, PATH CARBON PHOTOSHY, P104; BASTIDE A, 1989, J GEN MICROBIOL, V135, P2869; Blum JS, 2009, APPL ENVIRON MICROB, V75, P1950, DOI 10.1128/AEM.02614-08; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Buckley DH, 2007, APPL ENVIRON MICROB, V73, P3189, DOI 10.1128/AEM.02609-06; Caspi R, 1996, MICROBIOL-UK, V142, P2549, DOI 10.1099/00221287-142-9-2549; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dick GJ, 2008, APPL ENVIRON MICROB, V74, P2646, DOI 10.1128/AEM.01656-07; Doronia NV, 1985, MIKROBIOLOGIYA, V52, P885; Drummond AJ, 2010, GENEIOUS V5 3; Eiler A, 2006, APPL ENVIRON MICROB, V72, P7431, DOI 10.1128/AEM.01559-06; Feisthauer S, 2008, ENVIRON MICROBIOL, V10, P1641, DOI 10.1111/j.1462-2920.2008.01573.x; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Frias-Lopez J, 2009, ENVIRON MICROBIOL, V11, P512, DOI 10.1111/j.1462-2920.2008.01793.x; Gallagher E, 2005, APPL ENVIRON MICROB, V71, P5192, DOI 10.1128/AEM.71.9.5192-5196.2005; Glaubitz S, 2010, FEMS MICROBIOL ECOL, V74, P32, DOI 10.1111/j.1574-6941.2010.00944.x; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Pereira PR, 2010, ISME J, V4, P472, DOI 10.1038/ismej.2009.142; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Herfort L, 2011, AQUAT MICROB ECOL, V62, P85, DOI 10.3354/ame01460; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Khadem AF, 2011, J BACTERIOL, V193, P4438, DOI 10.1128/JB.00407-11; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Kuenen JG, 2008, NAT REV MICROBIOL, V6, P320, DOI 10.1038/nrmicro1857; KUENEN JG, 1982, PHILOS T R SOC B, V298, P473, DOI 10.1098/rstb.1982.0093; LAGET M, 1987, FOLIA MICROBIOL, V32, P116, DOI 10.1007/BF02883238; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Madhaiyan M, 2010, INT J SYST EVOL MICR, V60, P2187, DOI 10.1099/ijs.0.014019-0; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Moreira D, 1997, INT J SYST BACTERIOL, V47, P522, DOI 10.1099/00207713-47-2-522; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Park SW, 2003, J BACTERIOL, V185, P142, DOI 10.1128/JB.185.1.142-147.2003; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Radajewski S, 2003, CURR OPIN BIOTECH, V14, P296, DOI 10.1016/S0958-1669(03)00064-8; Ro YT, 1997, J BACTERIOL, V179, P6041, DOI 10.1128/jb.179.19.6041-6047.1997; Romanenko V. I., 1964, MIKROBIOLOGIYA, V33, P610; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; SCHAFERJOHANN J, 1993, J BACTERIOL, V175, P7329; SCHINK B, 1987, ARCH MICROBIOL, V147, P321, DOI 10.1007/BF00406127; Selesi D, 2005, APPL ENVIRON MICROB, V71, P175, DOI 10.1128/AEM.71.1.175-184.2005; Selesi D, 2007, J MICROBIOL METH, V69, P497, DOI 10.1016/j.mimet.2007.03.002; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; SOROKIN JI, 1966, Z ALLG MIKROBIOL, V6, P69, DOI 10.1002/jobm.3630060107; STANGE L, 1960, BIOCHIM BIOPHYS ACTA, V37, P92, DOI 10.1016/0006-3002(60)90082-2; Steindler L, 2012, PLOS ONE, V6; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Thrash JC, 2010, J BACTERIOL, V192, P3842, DOI 10.1128/JB.00511-10; Tolli J, 2005, APPL ENVIRON MICROB, V71, P8411, DOI 10.1128/AEM.71.12.8411-8418.2005; Videmsek U, 2009, MICROB ECOL, V58, P1, DOI 10.1007/s00248-008-9442-3; WANG X, 1993, J BACTERIOL, V175, P7109, DOI 10.1128/jb.175.21.7109-7114.1993; Yuan HZ, 2012, APPL ENVIRON MICROB, V78, P2328, DOI 10.1128/AEM.06881-11	59	34	36	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46695	10.1371/journal.pone.0046695	http://dx.doi.org/10.1371/journal.pone.0046695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056406	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000075
J	Fenimore, PW; Muhammad, MA; Fischer, WM; Foley, BT; Bakken, RR; Thurmond, JR; Yusim, K; Yoon, H; Parker, M; Hart, MK; Dye, JM; Korber, B; Kuiken, C				Fenimore, Paul W.; Muhammad, Majidat A.; Fischer, William M.; Foley, Brian T.; Bakken, Russell R.; Thurmond, James R.; Yusim, Karina; Yoon, Hyejin; Parker, Michael; Hart, Mary Kate; Dye, John M.; Korber, Bette; Kuiken, Carla			Designing and Testing Broadly-Protective Filoviral Vaccines Optimized for Cytotoxic T-Lymphocyte Epitope Coverage	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEMORRHAGIC-FEVER; EBOLA; RESPONSES; INFECTION; IMMUNITY; BREADTH	We report the rational design and in vivo testing of mosaic proteins for a polyvalent pan-filoviral vaccine using a computational strategy designed for the Human Immunodeficiency Virus type 1 (HIV-1) but also appropriate for Hepatitis C virus (HCV) and potentially other diverse viruses. Mosaics are sets of artificial recombinant proteins that are based on natural proteins. The recombinants are computationally selected using a genetic algorithm to optimize the coverage of potential cytotoxic T lymphocyte (CTL) epitopes. Because evolutionary history differs markedly between HIV-1 and filoviruses, we devised an adapted computational technique that is effective for sparsely sampled taxa; our first significant result is that the mosaic technique is effective in creating high-quality mosaic filovirus proteins. The resulting coverage of potential epitopes across filovirus species is superior to coverage by any natural variants, including current vaccine strains with demonstrated cross-reactivity. The mosaic cocktails are also robust: mosaics substantially outperformed natural strains when computationally tested against poorly sampled species and more variable genes. Furthermore, in a computational comparison of cross-reactive potential a design constructed prior to the Bundibugyo outbreak performed nearly as well against all species as an updated design that included Bundibugyo. These points suggest that the mosaic designs would be more resilient than natural-variant vaccines against future Ebola outbreaks dominated by novel viral variants. We demonstrate in vivo immunogenicity and protection against a heterologous challenge in a mouse model. This design work delineates the likely requirements and limitations on broadly-protective filoviral CTL vaccines.	[Fenimore, Paul W.; Fischer, William M.; Foley, Brian T.; Yusim, Karina; Yoon, Hyejin; Korber, Bette; Kuiken, Carla] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM USA; [Muhammad, Majidat A.; Bakken, Russell R.; Parker, Michael; Dye, John M.] USA, Med Res Inst Infect Dis, Div Virol, Frederick, MD USA; [Thurmond, James R.] Indiana Univ, Bloomington, IN USA; [Hart, Mary Kate] DynPort Vaccine Co, Frederick, MD USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Indiana University System; Indiana University Bloomington	Fenimore, PW (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM USA.	paulf@lanl.gov	Foley, Brian T/N-4527-2018; Fischer, Will/AAD-2807-2019	Foley, Brian T/0000-0002-1086-0296; Fischer, Will/0000-0003-4579-4062; Korber, Bette/0000-0002-2026-5757; Thurmond, Jim/0000-0002-5142-2583; Dye, John/0000-0002-0883-5016	Defense Threat Reduction Agency [CBM.VAXPLAT.05.10.RD.005]; USAMRIID [TA2F06062]; Los Alamos National Laboratory [20050155DR]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); USAMRIID; Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	Funding was provided by the Defense Threat Reduction Agency, project #CBM.VAXPLAT.05.10.RD.005 and by USAMRIID subcontract TA2F06062 and Los Alamos National Laboratory Directed Research funds 20050155DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Bruno WJ, 1996, MOL BIOL EVOL, V13, P1368, DOI 10.1093/oxfordjournals.molbev.a025583; Cohen J, 2004, INFECT DIS, V2004, P2106; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hart MK, 2005, United State Patent Application, Patent No. 20100034843; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Kuhn JH, 2008, FILOVIRUSES COMPENDI; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; MIRANDA MEG, 1991, LANCET, V337, P425, DOI 10.1016/0140-6736(91)91199-5; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Ndhlovu ZM, 2011, J IMMUNOL, V186, P6914, DOI 10.4049/jimmunol.1004231; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pushko P, 2000, VACCINE, V19, P142, DOI 10.1016/S0264-410X(00)00113-4; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Santra S, 2012, VIROLOGY, V428, P121, DOI 10.1016/j.virol.2012.03.012; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Siegert R, 1987, DEUT MED WOCHENSCHR, V103, P1176; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037; Yusim K, 2010, J GEN VIROL, V91, P1194, DOI 10.1099/vir.0.017491-0	34	20	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e44769	10.1371/journal.pone.0044769	http://dx.doi.org/10.1371/journal.pone.0044769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056184	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000004
J	Hove-Jensen, B; McSorley, FR; Zechel, DL				Hove-Jensen, Bjarne; McSorley, Fern R.; Zechel, David L.			Catabolism and Detoxification of 1-Aminoalkylphosphonic Acids: N-Acetylation by the phnO Gene Product	PLOS ONE			English	Article							CARBON-PHOSPHORUS LYASE; BOND-CLEAVAGE; DEGRADATION; GLYPHOSATE; IDENTIFICATION; PHOSPHATE; PHOSPHONATES; METABOLISM; OPERONS; CLONING	In Escherichia coli uptake and catabolism of organophosphonates are governed by the phnCDEFGHIJKLMNOP operon. The phnO cistron is shown to encode aminoalkylphosphonate N-acetyltransferase, which utilizes acetylcoenzyme A as acetyl donor and aminomethylphosphonate, (S)- and (R)-1-aminoethylphosphonate, 2-aminoethyl- and 3-aminopropylphosphonate as acetyl acceptors. Aminomethylphosphonate, (S)-1-aminoethylphosphonate, 2-aminoethyl- and 3-aminopropylphosphonate are used as phosphate source by E. coli phn(+) strains. 2-Aminoethyl- or 3-aminopropylphosphonate but not aminomethylphosphonate or (S)-1-aminoethylphosphonate is used as phosphate source by phnO strains. Neither phn+ nor phnO strains can use (R)-1-aminoethylphosphonate as phosphate source. Utilization of aminomethylphosphonate or (S)-1-aminoethylphosphonate requires the expression of phnO. In the absence of phnO-expression (S)-1-aminoethylphosphonate is bacteriocidal and rescue of phnO strains requires the simultaneous addition of D-alanine and phosphate. An intermediate of the carbon-phosphorus lyase pathway, 5'-phospho-alpha-D-ribosyl 1'-(2-N-acetamidoethylphosphonate), a substrate for carbon-phosphorus lyase, was found to accumulate in cultures of a phnP mutant strain. The data show that the physiological role of N-acetylation by phnO-specified aminoalkylphosphonate N-acetyltransferase is to detoxify (S)-1-aminoethylphosphonate, an analog of D-alanine, and to prepare (S)-1-aminoethylphosphonate and aminomethylphosphonate for utilization of the phosphorus-containing moiety.	[Hove-Jensen, Bjarne; McSorley, Fern R.; Zechel, David L.] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Hove-Jensen, B (corresponding author), Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada.	bjarne.hovejensen@chem.queensu.ca; dlzechel@chem.queensu.ca		Zechel, David/0000-0002-1570-599X	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation; Ontario Early Researcher Award	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	Funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canadian Foundation for Innovation, and by an Ontario Early Researcher Award (to DLZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2008, J BACTERIOL, V190, P1072, DOI 10.1128/JB.01274-07; ATHERTON FR, 1979, ANTIMICROB AGENTS CH, V15, P696, DOI 10.1128/AAC.15.5.696; AVILA LZ, 1991, BIOORG MED CHEM LETT, V1, P51, DOI 10.1016/S0960-894X(01)81089-1; AVILA LZ, 1987, J AM CHEM SOC, V109, P6758, DOI 10.1021/ja00256a033; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BORDWELL FG, 1992, J AM CHEM SOC, V114, P7623, DOI 10.1021/ja00046a003; BORDWELL FG, 1990, J ORG CHEM, V55, P6078, DOI 10.1021/jo00312a008; Borggaard OK, 2008, PEST MANAG SCI, V64, P441, DOI 10.1002/ps.1512; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; CHEN CM, 1990, J BIOL CHEM, V265, P4461; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Errey JC, 2006, BIOCHEMISTRY-US, V45, P3033, DOI 10.1021/bi052297p; Gebhard S, 2008, J BACTERIOL, V190, P1335, DOI 10.1128/JB.01764-07; Hawkins CL, 2001, BBA-BIOENERGETICS, V1504, P196, DOI 10.1016/S0005-2728(00)00252-8; HOULBERG U, 1983, J BACTERIOL, V154, P1485, DOI 10.1128/JB.154.3.1485-1488.1983; Hove-Jensen B, 2003, J BACTERIOL, V185, P2793, DOI 10.1128/JB.185.9.2793-2801.2003; Hove-Jensen B, 2011, J AM CHEM SOC, V133, P3617, DOI 10.1021/ja1102713; Hove-Jensen B, 2010, J BACTERIOL, V192, P370, DOI 10.1128/JB.01131-09; Iqbal S, 2004, J BACTERIOL, V186, P6118, DOI 10.1128/jb.186.18.6118-6123.2004; Jensen K. F., 2008, ECOSAL ESCHERICHIA C; JIANG WH, 1995, J BACTERIOL, V177, P6411, DOI 10.1128/jb.177.22.6411-6421.1995; Jochimsen B, 2011, P NATL ACAD SCI USA, V108, P11393, DOI 10.1073/pnas.1104922108; Kamat SS, 2011, NATURE, V480, P570, DOI 10.1038/nature10622; Krath BN, 1999, PLANT PHYSIOL, V119, P497, DOI 10.1104/pp.119.2.497; MAKINO K, 1991, J BACTERIOL, V173, P2665, DOI 10.1128/jb.173.8.2665-2672.1991; METCALF WW, 1993, J BACTERIOL, V175, P3430, DOI 10.1128/jb.175.11.3430-3442.1993; Miller JH, 1982, SHORT COURSE BACTERI; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; PIPKE R, 1988, APPL ENVIRON MICROB, V54, P1293, DOI 10.1128/AEM.54.5.1293-1296.1988; Rizk SS, 2006, PROTEIN SCI, V15, P1745, DOI 10.1110/ps.062135206; RUEPPEL ML, 1977, J AGR FOOD CHEM, V25, P517, DOI 10.1021/jf60211a018; White AK, 2004, J BACTERIOL, V186, P4730, DOI 10.1128/JB.186.14.4730-4739.2004; Yakovleva GM, 1998, APPL MICROBIOL BIOT, V49, P573, DOI 10.1007/s002530051215	33	25	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46416	10.1371/journal.pone.0046416	http://dx.doi.org/10.1371/journal.pone.0046416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056305	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000042
J	Kralik, JD; Xu, ER; Knight, EJ; Khan, SA; Levine, WJ				Kralik, Jerald D.; Xu, Eric R.; Knight, Emily J.; Khan, Sara A.; Levine, William J.			When Less Is More: Evolutionary Origins of the Affect Heuristic	PLOS ONE			English	Article							SOMATIC MARKER HYPOTHESIS; PREFERENCE REVERSALS; RETROSPECTIVE EVALUATIONS; SEPARATE EVALUATIONS; PREFRONTAL CORTEX; QUANTITY; PERFORMANCE; INTEGRATION; RESPONSES; JOINT	The human mind is built for approximations. When considering the value of a large aggregate of different items, for example, we typically do not summate the many individual values. Instead, we appear to form an immediate impression of the likeability of the option based on the average quality of the full collection, which is easier to evaluate and remember. While useful in many situations, this affect heuristic can lead to apparently irrational decision-making. For example, studies have shown that people are willing to pay more for a small set of high-quality goods than for the same set of high-quality goods with lower-quality items added [e.g. 1]. We explored whether this kind of choice behavior could be seen in other primates. In two experiments, one in the laboratory and one in the field, using two different sets of food items, we found that rhesus monkeys preferred a highly-valued food item alone to the identical item paired with a food of positive but lower value. This finding provides experimental evidence that, under certain conditions, macaque monkeys follow an affect heuristic that can cause them to prefer less food. Conservation of this affect heuristic could account for similar 'irrational' biases in humans, and may reflect a more general complexity reduction strategy in which averages, prototypes, or stereotypes represent a set or group.	[Kralik, Jerald D.; Xu, Eric R.; Knight, Emily J.; Khan, Sara A.; Levine, William J.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Kralik, JD (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	Jerald.D.Kralik@Dartmouth.edu		Knight, Emily/0000-0002-6971-1148	National Institute of Mental Health (NIMH) [NIMH 1 K22 MH071756-01]; National Center for Research Resources (NCRR) [CM-5 P40 RR003640-20]; NATIONAL INSTITUTE OF MENTAL HEALTH [K22MH071756] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Grant NIMH 1 K22 MH071756-01 from the National Institute of Mental Health (NIMH), a component of the National Institutes of Health (NIH): http://www.nimh.nih.gov/index.shtml. Grant CM-5 P40 RR003640-20 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH): http://www.ncats.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addessi E, 2011, P ROY SOC B-BIOL SCI, V278, P849, DOI 10.1098/rspb.2010.1602; Anderson JR, 2000, J EXP PSYCHOL ANIM B, V26, P87, DOI 10.1037/0097-7403.26.1.87; Baumgartner H, 1997, J MARKETING RES, V34, P219, DOI 10.2307/3151860; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Beran MJ, 2009, LEARN MOTIV, V40, P186, DOI 10.1016/j.lmot.2008.11.002; Boysen ST, 1996, J EXP PSYCHOL-ANIM B, V22, P76, DOI 10.1037/0097-7403.22.1.76; BOYSEN ST, 1995, J EXP PSYCHOL ANIM B, V21, P82, DOI 10.1037/0097-7403.21.1.82; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; De Neys W, 2011, CONT TOP COGN NEUROS, P125; Do AM, 2008, PSYCHON B REV, V15, P96, DOI 10.3758/PBR.15.1.96; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Fooden J, 2000, FIELDIANA ZOOL, V96, P1, DOI DOI 10.5962/BHL.TITLE.7192; FREDRICKSON BL, 1993, J PERS SOC PSYCHOL, V65, P45, DOI 10.1037/0022-3514.65.1.45; Genty E, 2011, BEHAV PROCESS, V86, P133, DOI 10.1016/j.beproc.2010.10.006; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Goel V, 2003, NEUROIMAGE, V20, P2314, DOI 10.1016/j.neuroimage.2003.07.027; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Hassin R. R., 2010, SELF CONTROL SOC MIN; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Hsee CK, 2010, PERSPECT PSYCHOL SCI, V5, P343, DOI 10.1177/1745691610374586; Hsee CK, 1998, J BEHAV DECIS MAKING, V11, P107, DOI 10.1002/(SICI)1099-0771(199806)11:2<107::AID-BDM292>3.3.CO;2-P; Hsee CK, 1999, PSYCHOL BULL, V125, P576, DOI 10.1037/0033-2909.125.5.576; Hsee CK, 2004, J PERS SOC PSYCHOL, V86, P680, DOI 10.1037/0022-3514.86.5.680; Hsee CK, 1996, ORGAN BEHAV HUM DEC, V67, P247, DOI 10.1006/obhd.1996.0077; Janson CH, 1986, FRUGIVORES SEED DISP; Janson CH, 2007, ANIM COGN, V10, P357, DOI 10.1007/s10071-007-0080-9; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KAHNEMAN D, 1993, PSYCHOL SCI, V4, P401, DOI 10.1111/j.1467-9280.1993.tb00589.x; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 1982, JUDGEMENT UNCERTAINT; Kahneman D., 2005, CAMBRIDGE HDB THINKI, P267, DOI DOI 10.1111/COGS.12119; Khan SA, 2011, PSYCHOL SCI, V22, P1001, DOI 10.1177/0956797611415543; Kralik JD, 2002, J COMP PSYCHOL, V116, P39, DOI 10.1037//0735-7036.116.1.39; Kralik JD, 2011, J COMP PSYCHOL; Kralik JD, 2011, BEHAV PROCESSES; Kurtz JL, 2007, J EXP SOC PSYCHOL, V43, P979, DOI 10.1016/j.jesp.2006.10.020; Lakshminarayanan VR, 2011, J EXP SOC PSYCHOL, V47, P689, DOI 10.1016/j.jesp.2010.12.011; Lakshminaryanan V, 2008, PHILOS T R SOC B, V363, P3837, DOI 10.1098/rstb.2008.0149; LEIGHTON M, 1993, INT J PRIMATOL, V14, P257, DOI 10.1007/BF02192635; List JA, 2002, AM ECON REV, V92, P1636, DOI 10.1257/000282802762024692; Mazur JE, 2005, LEARNING BEHAV; MELLERS BA, 1992, ORGAN BEHAV HUM DEC, V51, P313, DOI 10.1016/0749-5978(92)90016-Z; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murray EA, 2005, ANIM BEHAV, V69, P991, DOI 10.1016/j.anbehav.2004.06.034; Normand E, 2009, ANIM COGN, V12, P797, DOI 10.1007/s10071-009-0239-7; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Redelmeier DA, 1996, PAIN, V66, P3, DOI 10.1016/0304-3959(96)02994-6; Redelmeier DA, 2003, PAIN, V104, P187, DOI 10.1016/S0304-3959(03)00003-4; Reisberg D, 2010, COGNITION EXPLORING; REYNOLDS GS, 1961, J EXP ANAL BEHAV, V4, P57, DOI 10.1901/jeab.1961.4-57; Russell SP, 2010, ARTIFICIAL INTELLIGE; Schreiber CA, 2000, J EXP PSYCHOL GEN, V129, P27, DOI 10.1037//0096-3445.129.1.27; Shifferman EM, 2009, ANIM COGN, V12, P547, DOI 10.1007/s10071-009-0215-2; Silberberg A, 1998, J EXP PSYCHOL ANIM B, V24, P215, DOI 10.1037/0097-7403.24.2.215; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Stanovich K.E., 2012, OXFORD HDB THINKING; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Vlamings PHJM, 2006, J EXP PSYCHOL-ANIM B, V32, P60, DOI 10.1037/0097-7403.32.1.60; Vogel ER, 2007, ANIM BEHAV, V74, P71, DOI 10.1016/j.anbehav.2007.02.003; Williams BA, 2002, ANIM LEARN BEHAV, V30, P1, DOI 10.3758/BF03192905; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Xu ER, 2011, Q J EXP PSYCHOL, V64, P2301, DOI 10.1080/17470218.2011.591936; Xueqing Sun, 2011, Journal of Control Theory and Applications, V9, P440, DOI 10.1007/s11768-011-1047-6; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zentall TR, 2007, J EXP ANAL BEHAV, V88, P131, DOI 10.1901/jeab.2007.27-06	75	40	41	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46240	10.1371/journal.pone.0046240	http://dx.doi.org/10.1371/journal.pone.0046240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056270	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000027
J	Couto, JP; Almeida, A; Daly, L; Sobrinho-Simoes, M; Bromberg, JF; Soares, P				Couto, Joana P.; Almeida, Ana; Daly, Laura; Sobrinho-Simoes, Manuel; Bromberg, Jacqueline F.; Soares, Paula			AZD1480 Blocks Growth and Tumorigenesis of RET- Activated Thyroid Cancer Cell Lines	PLOS ONE			English	Article							TYROSINE KINASE; AZD6244 ARRY-142886; INHIBITOR AZD6244; SIGNAL TRANSDUCER; EPITHELIAL-CELLS; BREAST-CANCER; STAT3; CARCINOMA; PROTOONCOGENE; ONCOGENE	Persistent RET activation is a frequent event in papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC). In these cancers, RET activates the ERK/MAPK, the PI3K/AKT/mTOR and the JAK/STAT3 pathways. Here, we tested the efficacy of a JAK1/2-inhibitor, AZD1480, in the in vitro and in vivo growth of thyroid cancer cell lines expressing oncogenic RET. Thyroid cancer cell lines harboring RET/PTC1 (TPC-1), RET M918T (MZ-CRC1) and RET C634W (TT) alterations, as well as TPC-1 xenografts, were treated with JAK inhibitor, AZD1480. This inhibitor led to growth inhibition and/or apoptosis of the thyroid cancer cell lines in vitro, as well as to tumor regression of TPC-1 xenografts, where it efficiently blocked STAT3 activation in tumor and stromal cells. This inhibition was associated with decreased proliferation, decreased blood vessel density, coupled with increased necrosis. However, AZD1480 repressed the growth of STAT3-deficient TPC-1 cells in vitro and in vivo, demonstrating that its effects in this cell line were independent of STAT3 in the tumor cells. In all cell lines, the JAK inhibitor reduced phospho-Y1062 RET levels, and mTOR effector phospho-S6, while JAK1/2 downregulation by siRNA did not affect cell growth nor RET and S6 activation. In conclusion, AZD1480 effectively blocks proliferation and tumor growth of activated RET-thyroid cancer cell lines, likely through direct RET inhibition in cancer cells as well as by modulation of the microenvironment (e. g. via JAK/phospho-STAT3 inhibition in endothelial cells). Thus, AZD1480 should be considered as a therapeutic agent for the treatment of RET-activated thyroid cancers.	[Couto, Joana P.; Almeida, Ana; Sobrinho-Simoes, Manuel; Soares, Paula] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Couto, Joana P.; Almeida, Ana; Sobrinho-Simoes, Manuel; Soares, Paula] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Almeida, Ana] Univ Porto, Inst Biomed Sci Abel Salazar, P-4100 Oporto, Portugal; [Daly, Laura; Bromberg, Jacqueline F.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Sobrinho-Simoes, Manuel] Hosp Sao Joao, Dept Pathol, Oporto, Portugal; [Bromberg, Jacqueline F.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Universidade do Porto; Universidade do Porto; Universidade do Porto; Memorial Sloan Kettering Cancer Center; Sao Joao Hospital; Cornell University	Couto, JP (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	bromberj@mskcc.org; psoares@ipatimup.pt	Soares, Paula/B-6054-2008; Sobrinho-Simões, Manuel/J-8290-2013	Soares, Paula/0000-0001-9607-6998; Sobrinho-Simoes, Manuel/0000-0003-1613-1235	Portuguese Foundation for Science and Technology (FCT); FCT [SFRH/BD/40260/2007, SFRH/BD/79135/2011]; Marjorie and Charles Holloway Foundation; Lerner Foundation; Sussman Family Fund; Astra Zeneca;  [R01-CA87637-06];  [U54:CA148967]; NATIONAL CANCER INSTITUTE [R01CA087637, U54CA148967] Funding Source: NIH RePORTER	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Marjorie and Charles Holloway Foundation; Lerner Foundation; Sussman Family Fund; Astra Zeneca(AstraZeneca); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Portuguese Foundation for Science and Technology (FCT). Joana P. Couto is supported by an FCT grant SFRH/BD/40260/2007. Ana Almeida is supported by an FCT grant SFRH/BD/79135/2011. J. Bromberg is supported by R01-CA87637-06, U54:CA148967, Marjorie and Charles Holloway Foundation, Lerner Foundation, Sussman Family Fund and Astra Zeneca. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education that is partially supported by the FCT. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Ball DW, 2007, J CLIN ENDOCR METAB, V92, P4712, DOI 10.1210/jc.2007-1184; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; Dvorakova S, 2008, MOL CELL ENDOCRINOL, V284, P21, DOI 10.1016/j.mce.2007.12.016; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Hwang JH, 2003, MOL ENDOCRINOL, V17, P1155, DOI 10.1210/me.2002-0401; Iwahashi N, 2002, BIOCHEM BIOPH RES CO, V294, P642, DOI 10.1016/S0006-291X(02)00528-4; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Leboeuf R, 2008, J CLIN ENDOCR METAB, V93, P2194, DOI 10.1210/jc.2007-2825; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; McFarland BC, 2011, MOL CANCER THER, V10, P2384, DOI 10.1158/1535-7163.MCT-11-0480; Meireles AM, 2007, THYROID, V17, P707, DOI 10.1089/thy.2007.0097; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Menacho IP, 2005, CANCER RES, V65, P1729, DOI 10.1158/0008-5472.CAN-04-2363; Meng JR, 2009, CANCER BIOL THER, V8, P2073, DOI 10.4161/cbt.8.21.9844; Mora LB, 2002, CANCER RES, V62, P6659; Murakami H, 1999, BIOCHEM BIOPH RES CO, V262, P68, DOI 10.1006/bbrc.1999.1186; Muzza M, 2009, CLIN ENDOCRINOL OXF; Phay JE, 2010, CLIN CANCER RES, V16, P5936, DOI 10.1158/1078-0432.CCR-09-0786; Prazeres H, 2011, J THROID RES, V2011, DOI 10.4061/2011/678357; Puxeddu E, 2005, ENDOCR-RELAT CANCER, V12, P319, DOI 10.1677/erc.1.00947; Quintas-Cardama A, 2011, NAT REV DRUG DISCOV, V10, P127, DOI 10.1038/nrd3264; Russell JP, 2004, J IMMUNOL, V172, P4059, DOI 10.4049/jimmunol.172.7.4059; Russell JP, 2003, ONCOGENE, V22, P4569, DOI 10.1038/sj.onc.1206759; Sandberg EM, 2004, CELL BIOCHEM BIOPHYS, V41, P207, DOI 10.1385/CBB:41:2:207; Schuringa JJ, 2001, ONCOGENE, V20, P5350, DOI 10.1038/sj.onc.1204715; Scuto A, 2011, LEUKEMIA, V25, P538, DOI 10.1038/leu.2010.289; Segouffin-Cariou C, 2000, J BIOL CHEM, V275, P3568, DOI 10.1074/jbc.275.5.3568; Shinohara S, 2004, ONCOGENE, V23, P7571, DOI 10.1038/sj.onc.1207964; Soares P, 1998, J PATHOL, V185, P71; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Xin H, 2011, CANCER RES, V71, P6601, DOI 10.1158/0008-5472.CAN-11-1217	44	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46869	10.1371/journal.pone.0046869	http://dx.doi.org/10.1371/journal.pone.0046869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056499	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600062
J	Covell, DG				Covell, David G.			Integrating Constitutive Gene Expression and Chemoactivity: Mining the NCI60 Anticancer Screen	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; CANCER-CELL LINES; OXIDATIVE STRESS; CONNECTIVITY MAP; DRUG DEVELOPMENT; SMALL MOLECULES; NORMAL-TISSUES; TUMOR; CAMPTOTHECIN; MECHANISM	Studies into the genetic origins of tumor cell chemoactivity pose significant challenges to bioinformatic mining efforts. Connections between measures of gene expression and chemoactivity have the potential to identify clinical biomarkers of compound response, cellular pathways important to efficacy and potential toxicities; all vital to anticancer drug development. An investigation has been conducted that jointly explores tumor-cell constitutive NCI60 gene expression profiles and small-molecule NCI60 growth inhibition chemoactivity profiles, viewed from novel applications of self-organizing maps (SOMs) and pathway-centric analyses of gene expressions, to identify subsets of over- and under-expressed pathway genes that discriminate chemo-sensitive and chemo-insensitive tumor cell types. Linear Discriminant Analysis (LDA) is used to quantify the accuracy of discriminating genes to predict tumor cell chemoactivity. LDA results find 15% higher prediction accuracies, using similar to 30% fewer genes, for pathway-derived discriminating genes when compared to genes derived using conventional gene expression-chemoactivity correlations. The proposed pathway-centric data mining procedure was used to derive discriminating genes for ten well-known compounds. Discriminating genes were further evaluated using gene set enrichment analysis (GSEA) to reveal a cellular genetic landscape, comprised of small numbers of key over and under expressed on- and off-target pathway genes, as important for a compound's tumor cell chemoactivity. Literature-based validations are provided as support for chemo-important pathways derived from this procedure. Qualitatively similar results are found when using gene expression measurements derived from different microarray platforms. The data used in this analysis is available at http://pubchem.ncbi.nlm.nih.gov/ and http://www.ncbi.nlm.nih.gov/projects/geo (GPL96, GSE32474).	NIH, Dev Therapeut Program, Frederick Natl Lab, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Covell, DG (corresponding author), NIH, Dev Therapeut Program, Frederick Natl Lab, Frederick, MD USA.	covelld@mail.nih.gov						Araujo J, 2010, CANCER TREAT REV, V36, P492, DOI 10.1016/j.ctrv.2010.02.015; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen B, 2010, J MOL GRAPH MODEL, V28, P420, DOI 10.1016/j.jmgm.2009.10.001; Cheng TJ, 2011, J CHEM INF MODEL, V51, P2440, DOI 10.1021/ci200192v; Cheng TJ, 2010, BIOINFORMATICS, V26, P2881, DOI 10.1093/bioinformatics/btq550; Covell DG, 2005, PROTEINS, V59, P403, DOI 10.1002/prot.20392; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Deng N, 2012, GUT; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Francia G, 2010, NAT BIOTECHNOL, V28, P561, DOI 10.1038/nbt0610-561; Glover CJ, 2007, BIOCHEM PHARMACOL, V73, P331, DOI 10.1016/j.bcp.2006.10.005; Gopal YNV, 2009, MOL CANCER THER, V8, P552, DOI 10.1158/1535-7163.MCT-08-0661; Gupta M, 1997, CLIN CANCER RES, V3, P1653; Haarer BK, 2004, MOL BIOL CELL, V15, P4522, DOI 10.1091/mbc.E04-06-0445; Holmes E, 2000, CHEM RES TOXICOL, V13, P471, DOI 10.1021/tx990210t; HOWELL BW, 1994, MOL CELL BIOL, V14, P5402, DOI 10.1128/MCB.14.8.5402; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang R, 2006, GENOMICS, V87, P315, DOI 10.1016/j.ygeno.2005.11.011; Huang R, 2005, PHARMACOGENOMICS J, V5, P381, DOI 10.1038/sj.tpj.6500331; Huang RL, 2006, MOL CANCER THER, V5, P2417, DOI 10.1158/1535-7163.MCT-06-0239; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Iyer S, 1998, CANCER RES, V58, P4510; JAKOBSSON B, 1989, ANTICANCER RES, V9, P285; Jettte L, 2008, ANTICANCER RES, V28, P2175; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Knockaert M, 2002, ONCOGENE, V21, P6413, DOI 10.1038/sj.onc.1205908; Kohonen T., 1997, SPRINGER SERIES INFO; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Le Tourneau C, 2010, J CLIN ONCOL, V28, P1401, DOI 10.1200/JCO.2009.25.9606; Lee AC, 2008, J CHEM INF MODEL, V48, P1379, DOI 10.1021/ci800097k; Lee S, 2002, MOL CELLS, V14, P348; Li QL, 2010, DRUG DISCOV TODAY, V15, P1052, DOI 10.1016/j.drudis.2010.10.003; Lin HL, 2003, BRIT J CANCER, V88, P973, DOI 10.1038/sj.bjc.6600788; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Maeshima K, 2010, NAT STRUCT MOL BIOL, V17, P1065, DOI 10.1038/nsmb.1878; Malumbres M, 2000, BIOL CHEM, V381, P827, DOI 10.1515/BC.2000.105; Marinari B, 2008, P NATL ACAD SCI USA, V105, P17091, DOI 10.1073/pnas.0809288105; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g; Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morandi E, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-66; Nakatsu N, 2005, MOL CANCER THER, V4, P399; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Newell DR, 2005, EUR J CANCER, V41, P676, DOI 10.1016/j.ejca.2004.12.024; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Petrangolini G, 2006, J PHARMACOL EXP THER, V318, P939, DOI 10.1124/jpet.106.103481; Rabow AA, 2002, J MED CHEM, V45, P818, DOI 10.1021/jm010385b; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rossi F, 2010, MOL CANCER RES, V8, P1271, DOI 10.1158/1541-7786.MCR-10-0065; Saito A, 2004, STROKE, V35, P1443, DOI 10.1161/01.STR.0000128416.28778.7a; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; SENDEROFF RI, 1990, INVEST OPHTH VIS SCI, V31, P2572; Sharma V, 2004, CHEM BIOL, V11, P1689, DOI 10.1016/j.chembiol.2004.10.006; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Sleno L, 2008, CURR OPIN CHEM BIOL, V12, P46, DOI 10.1016/j.cbpa.2008.01.022; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Strobl JS, 1998, BREAST CANCER RES TR, V51, P83, DOI 10.1023/A:1006046604062; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teicher BA, 2010, ANTICANCER DRUG DEV; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WARNER E, 1995, INT J GYNECOL CANCER, V5, P161, DOI 10.1046/j.1525-1438.1995.05030161.x; WEINSTEIN JN, 1992, SCIENCE, V258, P447, DOI 10.1126/science.1411538; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562; Wilson TR, 2009, CURR CANCER DRUG TAR, V9, P307, DOI 10.2174/156800909788166547; Won HJ, 2010, ANTI-CANCER DRUG, V21, P270, DOI 10.1097/CAD.0b013e328334562c; Wu YY, 2007, APOPTOSIS, V12, P593, DOI 10.1007/s10495-006-0007-y; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Zhang W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002429; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	78	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e44631	10.1371/journal.pone.0044631	http://dx.doi.org/10.1371/journal.pone.0044631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056181	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600006
J	Maymo, JL; Perez-Perez, A; Maskin, B; Duenas, JL; Calvo, JC; Margalet, VS; Varone, CL				Lorena Maymo, Julieta; Perez-Perez, Antonio; Maskin, Bernardo; Luis Duenas, Jose; Carlos Calvo, Juan; Sanchez Margalet, Victor; Laura Varone, Cecilia			The Alternative Epac/cAMP Pathway and the MAPK Pathway Mediate hCG Induction of Leptin in Placental Cells	PLOS ONE			English	Article							PROTEIN-KINASE-A; HUMAN CHORIONIC-GONADOTROPIN; CYCLIC-AMP; B-RAF; HUMAN TROPHOBLAST; SIGNALING PATHWAYS; CROSS-TALK; GENE-EXPRESSION; CAMP; ACTIVATION	Pleiotropic effects of leptin have been identified in reproduction and pregnancy, particularly in the placenta, where it works as an autocrine hormone. In this work, we demonstrated that human chorionic gonadotropin (hCG) added to JEG-3 cell line or to placental explants induces endogenous leptin expression. We also found that hCG increased cAMP intracellular levels in BeWo cells in a dose-dependent manner, stimulated cAMP response element (CRE) activity and the cotransfection with an expression plasmid of a dominant negative mutant of CREB caused a significant inhibition of hCG stimulation of leptin promoter activity. These results demonstrate that hCG indeed activates cAMP/PKA pathway, and that this pathway is involved in leptin expression. Nevertheless, we found leptin induction by hCG is dependent on cAMP levels. Treatment with (Bu)(2)cAMP in combination with low and non stimulatory hCG concentrations led to an increase in leptin expression, whereas stimulatory concentrations showed the opposite effect. We found that specific PKA inhibition by H89 caused a significant increase of hCG leptin induction, suggesting that probably high cAMP levels might inhibit hCG effect. It was found that hCG enhancement of leptin mRNA expression involved the MAPK pathway. In this work, we demonstrated that hCG leptin induction through the MAPK signaling pathway is inhibited by PKA. We observed that ERK1/2 phosphorylation increased when hCG treatment was combined with H89. In view of these results, the involvement of the alternative cAMP/Epac signaling pathway was studied. We observed that a cAMP analogue that specifically activates Epac (CPT-OMe) stimulated leptin expression by hCG. In addition, the overexpression of Epac and Rap1 proteins increased leptin promoter activity and enhanced hCG. In conclusion, we provide evidence suggesting that hCG induction of leptin gene expression in placenta is mediated not only by activation of the MAPK signaling pathway but also by the alternative cAMP/Epac signaling pathway.	[Lorena Maymo, Julieta; Carlos Calvo, Juan; Laura Varone, Cecilia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Perez-Perez, Antonio; Sanchez Margalet, Victor] Univ Seville, Fac Med, Hosp Univ Virgen Macarena, Dept Bioquim Med & Biol Mol, Seville, Spain; [Maskin, Bernardo] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Luis Duenas, Jose] Hosp Univ Virgen Macarena, Serv Ginecol & Obstet, Seville, Spain; [Carlos Calvo, Juan] IBYME, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital Universitario Virgen Macarena; University of Sevilla; Hospital Universitario Virgen Macarena; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Varone, CL (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina.	cvarone@qb.fcen.uba.ar	Maymo, Julieta/AAU-3777-2020; Dueñas-Díez, José-Luis/E-6320-2010; Sánchez-Margalet, Victor/AAB-9986-2021; Pérez -Perez, Antonio/GRF-5099-2022	Maymo, Julieta/0000-0003-1308-9887; Dueñas-Díez, José-Luis/0000-0001-7596-6289; Sánchez-Margalet, Victor/0000-0001-8638-8680; Pérez -Perez, Antonio/0000-0002-5660-735X; Varone, Cecilia/0000-0001-5930-4082	Consejo Nacional de Investigaciones Cientificas Y Tecnicas (CONICET) [PIP 2010-247]; Instituto de Salud Carlos III [CM07/00025]; Universidad de Buenos Aires (UBACYT); ANPCyT [PICT 2008-0425]; Fundacion Florencio Fiorini, Buenos Aires, Argentina; Instituto de Salud Carlos III, Spain [PS09/00119]	Consejo Nacional de Investigaciones Cientificas Y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Universidad de Buenos Aires (UBACYT)(University of Buenos Aires); ANPCyT(ANPCyT); Fundacion Florencio Fiorini, Buenos Aires, Argentina; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	JLM is supported by a Consejo Nacional de Investigaciones Cientificas Y Tecnicas (CONICET) fellowship. APP is a research fellow supported by the Instituto de Salud Carlos III (CM07/00025). This project was supported by the Universidad de Buenos Aires (UBACYT), the ANPCyT (PICT 2008-0425), the CONICET (PIP 2010-247), the Fundacion Florencio Fiorini, Buenos Aires, Argentina and the Instituto de Salud Carlos III (PS09/00119), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini G, 2002, J BIOL CHEM, V277, P34601, DOI 10.1074/jbc.M205172200; Amsterdam A, 2002, MOL CELL ENDOCRINOL, V187, P69, DOI 10.1016/S0303-7207(01)00701-8; Bajoria R, 2002, PLACENTA, V23, P103, DOI 10.1053/plac.2001.0769; Bi S, 1997, J BIOL CHEM, V272, P30583, DOI 10.1074/jbc.272.48.30583; Bornfeldt KE, 1999, CELL SIGNAL, V11, P465, DOI 10.1016/S0898-6568(99)00020-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; Cameo Paula, 2004, Reprod Biol Endocrinol, V2, P50, DOI 10.1186/1477-7827-2-50; Cameron MR, 1996, BIOL REPROD, V55, P111, DOI 10.1095/biolreprod55.1.111; Cass LA, 1999, MOL CELL BIOL, V19, P5882; Cauzac M, 2003, PLACENTA, V24, P378, DOI 10.1053/plac.2002.0915; Cervero A, 2005, REPROD BIOMED ONLINE, V10, P217, DOI 10.1016/S1472-6483(10)60943-1; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; CLEGG CH, 1992, BIOCHEMISTRY-US, V31, P3720, DOI 10.1021/bi00129a023; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Coya R, 2001, BIOL REPROD, V65, P814, DOI 10.1095/biolreprod65.3.814; Coya R, 2006, GYNECOL ENDOCRINOL, V22, P620, DOI 10.1080/09513590601012587; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DEMERS LM, 1973, BIOCHIM BIOPHYS ACTA, V313, P202; Domali E, 2002, J Matern Fetal Neonatal Med, V12, P222, DOI 10.1080/713605673; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FAURE M, 1994, J BIOL CHEM, V269, P7851; Fitzgerald JS, 2005, CHEM IMMUNOL ALLERGY, V88, P181, DOI 10.1159/000087834; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Gambino YP, 2012, PLACENTA, V33, pS63, DOI 10.1016/j.placenta.2011.12.001; Gambino YP, 2010, BIOL REPROD, V83, P42, DOI 10.1095/biolreprod.110.083535; Ge YC, 2011, REPRODUCTION, V142, P369, DOI 10.1530/REP-11-0053; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; Hardie L, 1997, CLIN ENDOCRINOL, V47, P101, DOI 10.1046/j.1365-2265.1997.2441017.x; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Henson MC, 2000, BIOL REPROD, V63, P1219, DOI 10.1095/biolreprod63.5.1219; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Henson MC, 2002, SEMIN REPROD MED, V20, P113, DOI 10.1055/s-2002-32502; Henson MC, 2005, BIOL REPROD; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Houseknecht KL, 1998, DOMEST ANIM ENDOCRIN, V15, P457, DOI 10.1016/S0739-7240(98)00035-6; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacNicol MC, 1999, J BIOL CHEM, V274, P13193, DOI 10.1074/jbc.274.19.13193; Magarinos MP, 2007, BIOL REPROD, V76, P203, DOI 10.1095/biolreprod.106.051391; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Maymo JL, 2011, PLACENTA, V32, pS146, DOI 10.1016/j.placenta.2011.01.004; Maymo JL, 2010, ENDOCRINOLOGY, V151, P3738, DOI 10.1210/en.2010-0064; Maymo JL, 2009, ENDOCRINOLOGY, V150, P304, DOI 10.1210/en.2008-0522; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; Menon KMJ, 2004, BIOL REPROD, V70, P861, DOI 10.1095/biolreprod.103.024471; MENON KMJ, 1973, J CLIN ENDOCR METAB, V36, P1104, DOI 10.1210/jcem-36-6-1104; Monjo M, 2005, AM J PHYSIOL-ENDOC M, V289, pE145, DOI 10.1152/ajpendo.00563.2004; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Perez-Perez A, 2008, ARCH BIOCHEM BIOPHYS, V477, P390, DOI 10.1016/j.abb.2008.06.015; Perez-Perez A, 2010, BIOCHEM BIOPH RES CO, V396, P956, DOI 10.1016/j.bbrc.2010.05.031; Perez-Perez A, 2009, BIOL REPROD, V81, P826, DOI 10.1095/biolreprod.109.076513; Pidoux G, 2007, J CELL PHYSIOL, V212, P26, DOI 10.1002/jcp.20995; Popovic Vera, 2002, Hormones (Athens), V1, P204; Randeva HS JA, 2001, FETAL MATERN MED REV, V12, P198; Rao CV, 2001, SEMIN REPROD MED, V19, P7, DOI 10.1055/s-2001-13906; REBUTBONNETON C, 1992, MOL CELL ENDOCRINOL, V85, P65, DOI 10.1016/0303-7207(92)90125-P; Reitman ML, 2001, BIOCHEM SOC T, V29, P68, DOI 10.1042/BST0290068; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Sagawa N, 2002, PLACENTA, V23, pS80, DOI 10.1053/plac.2002.0814; Salvador LM, 2002, ENDOCRINOLOGY, V143, P2986, DOI 10.1210/en.143.8.2986; Schubring C, 1998, HORM RES, V50, P276, DOI 10.1159/000023290; SEGALOFF DL, 1993, ENDOCR REV, V14, P324, DOI 10.1210/er.14.3.324; Seminara SB, 2006, ENDOCRINOLOGY, V147, P2122, DOI 10.1210/en.2005-1550; Senaris R, 1997, ENDOCRINOLOGY, V138, P4501, DOI 10.1210/en.138.10.4501; Serrano MA, 2007, PLACENTA, V28, P107, DOI 10.1016/j.placenta.2006.03.009; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHI QJ, 1993, ENDOCRINOLOGY, V132, P1387, DOI 10.1210/en.132.3.1387; Srisuparp S, 2003, BIOL REPROD, V68, P457, DOI 10.1095/biolreprod.102.007625; Standley PR, 2002, AM J HYPERTENS, V15, P565, DOI 10.1016/S0895-7061(02)02272-0; Staples KJ, 2001, J IMMUNOL, V167, P2074, DOI 10.4049/jimmunol.167.4.2074; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; STRAUSS JF, 1992, PLACENTA, V13, P389, DOI 10.1016/0143-4004(92)90047-W; Syme MR, 2004, CLIN PHARMACOKINET, V43, P487, DOI 10.2165/00003088-200443080-00001; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Terasaki T, 2001, BIOL PHARM BULL, V24, P111, DOI 10.1248/bpb.24.111; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WANG H, 1991, J BIOL CHEM, V266, P780; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yoshie M, 2010, HUM REPROD, V25, P2229, DOI 10.1093/humrep/deq190; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905; Zygmunt M, 1998, PLACENTA, V19, P587, DOI 10.1016/S0143-4004(98)90019-4	94	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46216	10.1371/journal.pone.0046216	http://dx.doi.org/10.1371/journal.pone.0046216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056265	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600026
J	Zhou, Y; Wang, Z; Qin, LD; Wan, JQ; Sun, YW; Su, SS; Ding, WN; Xu, JR				Zhou, Yan; Wang, Zhen; Qin, Ling-di; Wan, Jie-qing; Sun, Ya-wen; Su, Shan-shan; Ding, Wei-na; Xu, Jian-rong			Early Altered Resting-State Functional Connectivity Predicts the Severity of Post-Traumatic Stress Disorder Symptoms in Acutely Traumatized Subjects	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; HUMAN BRAIN; NETWORK CONNECTIVITY; AMYGDALA; HIPPOCAMPAL; EXTINCTION; RESPONSES; ANXIETY; GYRUS; PTSD	The goal of this study was to investigate the relationship between resting-state functional connectivity and the severity of post-traumatic stress disorder (PTSD) symptoms in 15 people who developed PTSD following recent trauma. Fifteen participants who experienced acute traumatic events underwent a 7.3-min resting functional magnetic resonance imaging scan within 2 days post-event. All the patients were diagnosed with PTSD within 1 to 6 months after trauma. Brain areas in which activity was correlated with that of the posterior cingulate cortex (PCC) were assessed. To assess the relationship between the severity of PTSD symptoms and PCC connectivity, contrast images representing areas positively correlated with the PCC were correlated with the subject's Clinician-Administered PTSD Scale scores (CAPS) when they were diagnosed. Furthermore, the PCC, medial prefrontal cortex and bilateral amygdala were selected to assess the correlation of the strength of functional connectivity with the CAPS. Resting state connectivity with the PCC was negatively correlated with CAPS scores in the left superior temporal gyrus and right hippocampus/amygdala. Furthermore, the strength of connectivity between the PCC and bilateral amygdala, and even between the bilateral amygdala could predict the severity of PTSD symptoms later. These results suggest that early altered resting-state functional connectivity of the PCC with the left superior temporal gyrus, right hippocampus and amygdala could predict the severity of the disease and may be a major risk factor that predisposes patients to develop PTSD.	[Zhou, Yan; Qin, Ling-di; Sun, Ya-wen; Ding, Wei-na; Xu, Jian-rong] Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Wang, Zhen; Su, Shan-shan] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Wan, Jie-qing] Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, Y (corresponding author), Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	clare1475@hotmail.com; wangzhen@smhc.org.cn	Wang, Zhen/A-2389-2011; Lang, Steven/AAE-8102-2021	Wang, Zhen/0000-0003-4319-5314; Lang, Steven/0000-0003-1669-9146	National Natural Science Foundation of China [30800370, 81171325]; Pu Jiang Talent Project [09PJ408900]; Shanghai Science and Technology Committee Medical guide project [114119a0900]; Shanghai Leading Academic Discipline Project [S30203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pu Jiang Talent Project; Shanghai Science and Technology Committee Medical guide project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This research was supported by the National Natural Science Foundation of China (No. 30800370), National Natural Science Foundation of China (No. 81171325), Pu Jiang Talent Project (No. 09PJ408900), Shanghai Science and Technology Committee Medical guide project (No. 114119a0900), and Shanghai Leading Academic Discipline Project (Project No. S30203). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2010, PREVENTION GUIDE POS; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P544, DOI 10.1016/S0006-3223(01)01374-9; Dickie EW, 2011, NEUROPSYCHOLOGIA, V49, P1771, DOI 10.1016/j.neuropsychologia.2011.02.055; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guo M, 2012, ASIAN PAC J TROP MED, V5, P162, DOI 10.1016/S1995-7645(12)60017-0; Hayes JP, 2011, J PSYCHIATR RES, V45, P660, DOI 10.1016/j.jpsychires.2010.10.007; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; PANDYA DN, 1995, REV NEUROL, V151, P486; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 1997, ANN NY ACAD SCI, V821, P83, DOI 10.1111/j.1749-6632.1997.tb48271.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Yin Y, 2011, NEUROSCI LETT, V498, P185, DOI 10.1016/j.neulet.2011.02.069	34	68	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46833	10.1371/journal.pone.0046833	http://dx.doi.org/10.1371/journal.pone.0046833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056477	Green Submitted, gold, Green Published			2022-12-27	WOS:000309452600060
J	Huang, CC; Yan, SH; Chen, D; Chen, BC; Zhao, NW				Huang, Cheng-cai; Yan, Shi-hai; Chen, Dan; Chen, Bi-cheng; Zhao, Ning-wei			Application of On-Line nanoLC-IT-TOF in the Identification of Serum beta-Catenin Complex in Mice Scald Model	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CANCER; PROLIFERATION; ACTIVATION; PATHWAY; GROWTH; PHOSPHORYLATION; STABILIZATION; INHIBITION; CARCINOMA	Severe burn shock remains an unresolved clinical problem with an urgent need to explore novel therapeutic treatments. Intracellular beta-catenin, through interaction with other proteins, has been reported to be able to regulate the size of cutaneous wounds. Higher expression of beta-catenin is associated with larger sized wounds. However, the identification of serum beta-catenin complex is difficult and has been rarely reported. The exploitation of more binding partners can contribute to uncovering the exact mechanisms behind serum beta-catenin mediated biological effects. Here, we describe a method that consists of immunoprecipitation, SDS-PAGE, in-gel digestion, and nanoLC coupled to LCMS-IT-TOF for the investigation of serum beta-catenin complex in mice scald model. Among selected gel bands obtained from the protein gels, a total of 31 peptides were identified and sequenced with high statistical significance (p<0.01). Three proteins (alpha-2-marcoglobulin, serine protease inhibitor A3K, and serine protease inhibitor A1A) were identified and validated with high reliability and high reproducibility. It was inferred that these proteins might interact with serum beta-catenin, which could affect the wound healing resulting from burn shock. Our study demonstrated that the on-line coupling of nano-LC with a LCMS-IT-TOF mass spectrometer was capable of sensitive and automated characterization of the serum beta-catenin complex in mice scald model.	[Huang, Cheng-cai; Zhao, Ning-wei] Shimadzu China Co Ltd, Life Sci & Clin Med Dept, Shanghai, Peoples R China; [Yan, Shi-hai] Jiangsu Prov Hosp Tradit Chinese Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Chen, Dan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Chen, Bi-cheng] Wenzhou Med Coll, Affiliated Hosp 1, Dept Surg, Wenzhou, Peoples R China; [Zhao, Ning-wei] Royal Inst Technol KTH, Sch Biotechnol, Stockholm, Sweden	Nanjing University of Chinese Medicine; Nanjing University; Wenzhou Medical University; Royal Institute of Technology	Zhao, NW (corresponding author), Shimadzu China Co Ltd, Life Sci & Clin Med Dept, Shanghai, Peoples R China.	sshznw@shimadzu.com.cn						Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; DeMeo DL, 2004, THORAX, V59, P259, DOI 10.1136/thx.2003.006502; Eugene K, 2006, TRENDS MICROBIOL, V14, P229; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hofmann S, 2005, MOL CELL PROTEOMICS, V4, P1888, DOI 10.1074/mcp.M500076-MCP200; Holland J, 1997, J BIOL CHEM, V272, P9108; Kneidinger N, 2011, AM J RESP CRIT CARE, V183, P723, DOI 10.1164/rccm.200910-1560OC; KRAUS C, 1994, GENOMICS, V23, P272, DOI 10.1006/geno.1994.1493; Leng JP, 2011, J AM SOC MASS SPECTR, V22, P1204, DOI 10.1007/s13361-011-0129-5; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Lu Q, 2009, PROSTATE, V69, P411, DOI 10.1002/pros.20902; Ma K, 2009, ANAL CHIM ACTA, V650, P227, DOI 10.1016/j.aca.2009.07.046; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Omori E, 2011, ONCOGENE, V30, P3336, DOI 10.1038/onc.2011.49; Posthaus H, 2002, J CELL SCI, V115, P4587, DOI 10.1242/jcs.00141; Prevotat L, 2006, GASTROENTEROLOGY, V131, P1142, DOI 10.1053/j.gastro.2006.07.017; Saldanha G, 2004, BRIT J DERMATOL, V151, P157, DOI 10.1111/j.1365-2133.2004.06048.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Wang XS, 2008, CANCER EPIDEM BIOMAR, V17, P2101, DOI 10.1158/1055-9965.EPI-08-0134; Webb DJ, 1996, J BIOL CHEM, V271, P24982, DOI 10.1074/jbc.271.40.24982; Zekri ARN, 2011, ONCOL REP, V26, P825, DOI 10.3892/or.2011.1355; Zhang B, 2009, INVEST OPHTH VIS SCI, V50, P3943, DOI 10.1167/iovs.08-2954; Zhao ZH, 2009, GLYCOCONJUGATE J, V26, P173, DOI 10.1007/s10719-008-9174-0	33	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46530	10.1371/journal.pone.0046530	http://dx.doi.org/10.1371/journal.pone.0046530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056334	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400014
J	Athearn, K; Sample, CJ; Barefoot, BE; Williams, KL; Ramsburg, EA				Athearn, Kathleen; Sample, Christopher J.; Barefoot, Brice E.; Williams, Kristi L.; Ramsburg, Elizabeth A.			Acute Reactogenicity after Intramuscular Immunization with Recombinant Vesicular Stomatitis Virus Is Linked to Production of IL-1 beta	PLOS ONE			English	Article							T-CELL RESPONSES; INFLUENZA-VIRUS; INFLAMMATORY RESPONSE; RECEPTOR ANTAGONIST; PHOSPHOLIPASE A(2); LETHAL CHALLENGE; INTERLEUKIN-1-BETA; PROTECTION; INDUCTION; INFECTION	Vaccines based on live viruses are attractive because they are immunogenic, cost-effective, and can be delivered by multiple routes. However, live virus vaccines also cause reactogenic side effects such as fever, myalgia, and injection site pain that have reduced their acceptance in the clinic. Several recent studies have linked vaccine-induced reactogenic side effects to production of the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) in humans. Our objective was therefore to determine whether IL-1 beta contributed to pathology after immunization with recombinant vesicular stomatitis virus (rVSV) vaccine vectors, and if so, to identify strategies by which IL-1 beta mediated pathology might be reduced without compromising immunogenicity. We found that an rVSV vaccine induced local and systemic production of IL-1 beta in vivo, and that accumulation of IL-1 beta correlated with acute pathology after rVSV immunization. rVSV-induced pathology was reduced in mice deficient in the IL-1 receptor Type I, but the IL-1R-/- mice were fully protected from lethal rechallenge with a high dose of VSV. This result demonstrated that IL-1 contributed to reactogenicity of the rVSV, but was dispensable for induction of protective immunity. The amount of IL-1 beta detected in mice deficient in either caspase-1 or the inflammasome adaptor molecule ASC after rVSV immunization was not significantly different than that produced by wild type animals, and caspase-1-/- and ASC-/- mice were only partially protected from rVSV-induced pathology. Those data support the idea that some of the IL-1 beta expressed in vivo in response to VSV may be activated by a caspase-1 and ASC-independent mechanism. Together these results suggest that rVSV vectors engineered to suppress the induction of IL-1 beta, or signaling through the IL-1R would be less reactogenic in vivo, but would retain their immunogenicity and protective capacity. Such rVSV would be highly desirable as either vaccine vectors or oncolytic therapies, and would likely be better tolerated in human vaccinees.	[Athearn, Kathleen; Sample, Christopher J.; Barefoot, Brice E.; Ramsburg, Elizabeth A.] Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27706 USA; [Athearn, Kathleen; Sample, Christopher J.; Barefoot, Brice E.; Williams, Kristi L.; Ramsburg, Elizabeth A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Athearn, Kathleen; Ramsburg, Elizabeth A.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Williams, Kristi L.] Duke Univ, Sch Med, Sch Nursing, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Ramsburg, EA (corresponding author), Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27706 USA.	elizabeth.ramsburg@dm.duke.edu			United States National Institutes of Health [AI089756, AI51445];  [UC6 AI058607]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089756, UC6AI058607, P30AI051445] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by United States National Institutes of Health grants AI089756 (to KLW), and AI51445 (to EAR). A portion of the work was conducted in the Global Health Research Building at Duke University, which receives support from grant number UC6 AI058607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; ANGEL J, 1994, EUR J BIOCHEM, V226, P125, DOI 10.1111/j.1432-1033.1994.tb20033.x; Barefoot BE, 2009, CLIN VACCINE IMMUNOL, V16, P488, DOI 10.1128/CVI.00451-08; Brydon L, 2009, BRAIN BEHAV IMMUN, V23, P217, DOI 10.1016/j.bbi.2008.09.007; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Clarke DK, 2007, J VIROL, V81, P2056, DOI 10.1128/JVI.01911-06; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Fantuzzi G, 1996, J LEUKOCYTE BIOL, V59, P489, DOI 10.1002/jlb.59.4.489; Farez MF, 2011, ARCH NEUROL; FIELDS BN, 1967, NEW ENGL J MED, V277, P889, DOI 10.1056/NEJM196711092771901; Finck BN, 1997, BRAIN RES, V761, P333, DOI 10.1016/S0006-8993(97)00451-4; Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534; Furst DE, 2004, CLIN THER, V26, P1960, DOI 10.1016/j.clinthera.2004.12.019; Hadaschik BA, 2008, CANCER RES, V68, P4506, DOI 10.1158/0008-5472.CAN-08-0238; Higashi S, 2000, INFLAMM RES, V49, P102, DOI 10.1007/s000110050566; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Iyer AV, 2009, VACCINE, V27, P893, DOI 10.1016/j.vaccine.2008.11.087; Izurieta HS, 2005, JAMA-J AM MED ASSOC, V294, P2720, DOI 10.1001/jama.294.21.2720; JOHNSON KM, 1966, AM J TROP MED HYG, V15, P244, DOI 10.4269/ajtmh.1966.15.244; Kahn JS, 2001, J VIROL, V75, P11079, DOI 10.1128/JVI.75.22.11079-11087.2001; Kapadia SU, 2005, VIROLOGY, V340, P174, DOI 10.1016/j.virol.2005.06.016; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; Lachmann HJ, 2011, ARTHRITIS RHEUM-US, V63, P314, DOI 10.1002/art.30105; LESNIKOV VA, 1991, CYTOKINE, V3, P195, DOI 10.1016/1043-4666(91)90016-7; MacKenzie D, 2009, NEW SCI, V4; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nigrovic PA, 2011, ARTHRITIS RHEUM-US, V63, P545, DOI 10.1002/art.30128; Opstelten W, 2001, AM J MED, V111, P474, DOI 10.1016/S0002-9343(01)00880-4; Ozduman K, 2008, J NEUROSCI, V28, P1882, DOI 10.1523/JNEUROSCI.4905-07.2008; PLAKHOV IV, 1995, VIROLOGY, V209, P257, DOI 10.1006/viro.1995.1252; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Publicover J, 2006, J VIROL, V80, P7028, DOI 10.1128/JVI.00478-06; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Ramsburg EA, 2007, J IMMUNOL, V178, P6350, DOI 10.4049/jimmunol.178.10.6350; Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Stanley SL, 2007, J INFECT DIS, V196, P212, DOI 10.1086/518794; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; TESH RB, 1969, AM J EPIDEMIOL, V90, P255, DOI 10.1093/oxfordjournals.aje.a121068; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Usonis V, 1999, PEDIATR INFECT DIS J, V18, P42, DOI 10.1097/00006454-199901000-00011; VANBLEEK GM, 1990, NATURE, V348, P213; Velan B, 2011, VACCINE, V29, P1173, DOI 10.1016/j.vaccine.2010.12.006; Vestergaard M, 2004, JAMA-J AM MED ASSOC, V292, P351, DOI 10.1001/jama.292.3.351; Wicker S, 2009, INFECTION, V37, P197, DOI 10.1007/s15010-008-8200-2; Wollmann G, 2005, J VIROL, V79, P6005, DOI 10.1128/JVI.79.10.6005-6022.2005; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	58	5	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46516	10.1371/journal.pone.0046516	http://dx.doi.org/10.1371/journal.pone.0046516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056330	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500045
J	de la Fuente, L; Rosales-Statkus, ME; Hoyos, J; Pulido, J; Santos, S; Bravo, MJ; Barrio, G; Fernandez-Balbuena, S; Belza, MJ				de la Fuente, Luis; Elena Rosales-Statkus, Maria; Hoyos, Juan; Pulido, Jose; Santos, Sara; Jose Bravo, Maria; Barrio, Gregorio; Fernandez-Balbuena, Sonia; Jose Belza, Maria		Madrid Rapid HIV Testing Grp	Are Participants in a Street-Based HIV Testing Program Able to Perform Their Own Rapid Test and Interpret the Results?	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; RECOMMENDATIONS; COLLECTION; INFECTION; HOME; USA	Objective: Availability of over-the-counter rapid HIV tests could improve access to testing those reluctant or unable to use current services. We aimed to evaluate the feasibility of HIV self-testing using a finger-stick whole-blood rapid test (Determine (TM) HIV Combo) to detect both antigen and antibody. Methods: Before being tested, 313 participants in a street-based testing program were given adapted instructions and a test kit, and performed the self-test without supervision. These participants, together with another 207 who performed supervised self-testing, received additional instructions on how to interpret the test results shown in six colour photos and filled out a questionnaire. Logistic regression and generalized estimating equations (GEE) were used in the statistical analysis. Results: About 8.0% (95%CI:4.8%-11.2%) obtained an invalid self-test. An invalid result was inversely associated with male participants who had sex with men (OR = 0.3;95%CI:0.1-1.0). Of the 3111 photos interpreted, 4.9% (95%CI:4.1-5.7) were incorrect. Only 1.1% (95%CI:0.3-1.8) of the positive results were interpreted as negative. Age 30 or older (OR = 2.1; 95%CI:1.2-3.7), having been born in Latin America (OR = 1.6; 95%CI:1.1-2.2), and not having university education (OR = 2.1; 95% CI: 1.2-3.7) were associated with misinterpreting test results in the GEE. Participant's perceptions of both their proficiency when conducting the test and interpretation were related with actual outcomes. Most participants (83.9%) were more motivated than before to use the self-test in the future, and 51.7% would pay >10 Euros for the test if it was sold in pharmacies. Conclusions: This is the first study showing that blood-based self-testing with current technology is feasible in HIV-negative participants demanding the test and without prior training or supervision. Bearing in mind that it was conducted under difficult weather conditions and using a complex kit, over-the-counter tests could be a feasible option to complement current diagnostic strategies. More studies are needed to accommodate technology, minimise interpretation mistakes and provide on-line support.	[de la Fuente, Luis; Hoyos, Juan; Pulido, Jose; Jose Bravo, Maria; Barrio, Gregorio; Jose Belza, Maria] CIBER Epidemiol & Salud Publ, Madrid, Spain; [de la Fuente, Luis; Pulido, Jose; Santos, Sara; Jose Bravo, Maria; Fernandez-Balbuena, Sonia] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain; [Elena Rosales-Statkus, Maria] Hosp Cent Cruz Roja San Jose & Santa Adela, Serv Med Prevent, Madrid, Spain; [Hoyos, Juan; Barrio, Gregorio; Jose Belza, Maria] Inst Salud Carlos III, Escuela Nacl Sanidad, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); Instituto de Salud Carlos III; Escuela Nacional de Sanidad (ENS)	Hoyos, J (corresponding author), CIBER Epidemiol & Salud Publ, Madrid, Spain.	jhoyos@isciii.es	J, Pulido/E-6945-2011; Molist, Gemma/S-4934-2016	J, Pulido/0000-0001-8487-7384; Molist, Gemma/0000-0002-0927-1945; BARRIO, GREGORIO/0000-0002-6257-3213; Hoyos, Juan/0000-0003-3772-2771; De la Fuente, Luis/0000-0003-4527-1608; Ruiz, Monica/0000-0002-4670-9037; VALLEJO, FERNANDO/0000-0002-5753-5482; Belza Egozcue, Maria Jose/0000-0003-4816-7750; Fernandez-Balbuena, Sonia/0000-0002-2447-2956; Bravo, Maria Jose/0000-0001-5901-3517	Fundacion para la Investigacion y Prevencion del Sida en Espana [FIPSE: 36634/07]; Fondo de Investigacion Sanitaria [FIS:PI09/9074]	Fundacion para la Investigacion y Prevencion del Sida en Espana; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This study was funded by Fundacion para la Investigacion y Prevencion del Sida en Espana (FIPSE: 36634/07) and by the Fondo de Investigacion Sanitaria (FIS:PI09/9074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, CAN MED ASSOC J, V162, P1545; [Anonymous], HIV TEST INCR UPT EF; [Anonymous], 2000, CMAJ, V162, P1547; Belza MJ, 2012, SEX TRANSM INFECT, V88, P218, DOI 10.1136/sextrans-2011-050131; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; British HIV Association British Association of Sexual Health and HIV British Infection Society, UK NAT GUID HIV TEST; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Colfax GN, 2002, AIDS CARE, V14, P675, DOI 10.1080/0954012021000005533a; Cummiskey J., 2008, Morbidity and Mortality Weekly Report, V57, P660; Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1; Fox J, 2011, SEX TRANSM INFECT, V87, P178, DOI 10.1136/sti.2010.042564; Frith L, 2007, LANCET, V369, P243, DOI 10.1016/S0140-6736(07)60113-5; Gaydos CA, 2011, ANN EMERG MED, V58, pS74, DOI 10.1016/j.annemergmed.2011.03.029; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; Lee VJ, 2007, JAIDS-J ACQ IMM DEF, V45, P449, DOI 10.1097/QAI.0b013e318095a3f3; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Moreno S, 2010, ANTIVIR THER, V15, P9, DOI 10.3851/IMP1523; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Rosenberg NE, 2011, J INFECT DIS; Service Evaluation Economique et Sante Publique, DEP INF VIH FRANC ST; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; Spielberg F, 2003, NAT HIV PREV C ATL 2; Stata Corp LP, 2010, STAT IC VERS 11 1 CO; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; US Food & Drug Administration, VACC BLOOD BIOL; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; Walensky RP, 2006, ANN INTERN MED, V145, P459, DOI 10.7326/0003-4819-145-6-200609190-00010; WHO Regional Office for Europe, SCAL HIV TEST COUNS	31	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46555	10.1371/journal.pone.0046555	http://dx.doi.org/10.1371/journal.pone.0046555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056342	Green Published, gold			2022-12-27	WOS:000309831500049
J	Kayali, S; Giraud, G; Morle, F; Guyot, B				Kayali, Samer; Giraud, Guillaume; Morle, Francois; Guyot, Boris			Spi-1, Fli-1 and Fli-3 (miR-17-92) Oncogenes Contribute to a Single Oncogenic Network Controlling Cell Proliferation in Friend Erythroleukemia	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ERYTHROID-DIFFERENTIATION; GENE-EXPRESSION; ETS FAMILY; CLUSTER; MURINE; ACTIVATION; GROWTH; ROLES; LEUKEMIA	Clonal erythroleukemia developing in susceptible mice infected by Friend virus complex are associated with highly recurrent proviral insertions at one of three loci called Spi-1, Fli-1 or Fli-3, leading to deregulated expression of oncogenic Spi-1 or Fli-1 transcription factors or miR-17-92 miRNA cluster, respectively. Deregulated expression of each of these three oncogenes has been independently shown to contribute to cell proliferation of erythroleukemic clones. Previous studies showed a close relationship between Spi-1 and Fli-1, which belong to the same ETS family, Spi-1 activating fli-1 gene, and both Spi-1 and Fli-1 activating multiple common target genes involved in ribosome biogenesis. In this study, we demonstrated that Spi-1 and Fli-1 are also involved in direct miR-17-92 transcriptional activation through their binding to a conserved ETS binding site in its promoter. Moreover, we demonstrated that physiological re-expression of exogenous miR-17 and miR-20a are able to partially rescue the proliferation loss induced by Fli-1 knock-down and identified HBP1 as a target of these miRNA in erythroleukemic cells. These results establish that three of the most recurrently activated oncogenes in Friend erythroleukemia are actually involved in a same oncogenic network controlling cell proliferation. The putative contribution of a similar ETS-miR-17-92 network module in other normal or pathological proliferative contexts is discussed.	[Kayali, Samer; Giraud, Guillaume; Morle, Francois; Guyot, Boris] Univ Lyon 1, CNRS, UMR5534, CGPhiMC, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kayali, S (corresponding author), Univ Lyon 1, CNRS, UMR5534, CGPhiMC, F-69365 Lyon, France.	Francois.morle@univ-lyon1.fr	GIRAUD, Guillaume/AAS-4693-2021	Giraud, Guillaume/0000-0003-0700-8403; Guyot, Boris/0000-0002-4512-7123	Centre national de la recherche scientifique (CNRS); Universite Lyon; Ligue Nationale contre le Cancer; Syrian University of Alep; Societe Francaise d'Hematologie	Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Lyon; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Syrian University of Alep; Societe Francaise d'Hematologie	This work was supported by grants from the Centre national de la recherche scientifique (CNRS) and Universite Lyon, and by specific grants from the Ligue Nationale contre le Cancer (Equipe labellisee 2009-2012 and Comites du Rhone, de la Drome et du Cantal). BG and FM are permanent employees of CNRS and Institut National de la Sante et de la Recherche Medicale (INSERM) respectively. SK was supported by a three-year Ph.D. scholarship from the Syrian University of Alep (2008-2011) and by 6 months' salary from the Societe Francaise d'Hematologie (2012). GG was supported by four-year Ph.D. salary from the Ligue Nationale contre le Cancer (2007-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ano S, 2004, J BIOL CHEM, V279, P2993, DOI 10.1074/jbc.M303816200; Barnache S, 1998, ONCOGENE, V16, P2989, DOI 10.1038/sj.onc.1202095; Blair DG, 2000, ONCOGENE, V19, P6472, DOI 10.1038/sj.onc.1204046; Bradshaw S, 2008, CLIN IMMUNOL, V129, P19, DOI 10.1016/j.clim.2008.05.010; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Campaner S, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-6; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Chen YC, 2010, ONCOGENE, V29, P3067, DOI 10.1038/onc.2010.97; Choe KS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077727; CHOPPIN J, 1985, EXP HEMATOL, V13, P610; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cui JW, 2009, LEUKEMIA, V23, P1311, DOI 10.1038/leu.2009.20; Cui JW, 2007, BLOOD, V110, P2631, DOI 10.1182/blood-2006-10-053850; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Escamilla-Powers JR, 2010, J BIOL CHEM, V285, P4847, DOI 10.1074/jbc.M109.074856; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Ji M, 2011, AM J PATHOL, V179, P1645, DOI 10.1016/j.ajpath.2011.06.008; Juban G, 2009, MOL CELL BIOL, V29, P2852, DOI 10.1128/MCB.01435-08; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Lakhanpal GK, 2010, BLOOD, V116, P428, DOI 10.1182/blood-2009-10-250217; Lee CR, 2003, ANTICANCER RES, V23, P2159; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li YM, 2012, BLOOD, V119, P4486, DOI 10.1182/blood-2011-09-378687; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Moreau-Gachelin F, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-99; Morris EE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3189; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Papetti M, 2007, MOL CANCER RES, V5, P1053, DOI 10.1158/1541-7786.MCR-07-0145; Pereira R, 1999, ONCOGENE, V18, P1597, DOI 10.1038/sj.onc.1202534; Pospisil V, 2011, EMBO J, V30, P4450, DOI 10.1038/emboj.2011.317; Rimmele P, 2007, BLOOD, V109, P3007, DOI 10.1182/blood-2006-03-006718; Rostad K, 2007, INT J ONCOL, V30, P19; Sakurai T, 2007, CANCER SCI, V98, P1775, DOI 10.1111/j.1349-7006.2007.00598.x; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; SINGER D, 1974, P NATL ACAD SCI USA, V71, P2668, DOI 10.1073/pnas.71.7.2668; Starck J, 1999, MOL CELL BIOL, V19, P121; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Truong AHL, 2005, ONCOGENE, V24, P962, DOI 10.1038/sj.onc.1208323; van Haaften G, 2010, GENE DEV, V24, P1, DOI 10.1101/gad.1887110; Xiang J, 2010, CURR GENOMICS, V11, P129, DOI 10.2174/138920210790886853; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014; Zhang XK, 2004, J IMMUNOL, V173, P6481, DOI 10.4049/jimmunol.173.10.6481; Zhuo DX, 2010, J BIOL CHEM, V285, P31491, DOI 10.1074/jbc.M109.068387	56	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46799	10.1371/journal.pone.0046799	http://dx.doi.org/10.1371/journal.pone.0046799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056458	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500080
J	Wong, A; Shafiee, MJ; Azimifar, Z				Wong, Alexander; Shafiee, Mohammad Javad; Azimifar, Zohreh			Statistical Conditional Sampling for Variable-Resolution Video Compression	PLOS ONE			English	Article								In this study, we investigate a variable-resolution approach to video compression based on Conditional Random Field and statistical conditional sampling in order to further improve compression rate while maintaining high-quality video. In the proposed approach, representative key-frames within a video shot are identified and stored at full resolution. The remaining frames within the video shot are stored and compressed at a reduced resolution. At the decompression stage, a region-based dictionary is constructed from the key-frames and used to restore the reduced resolution frames to the original resolution via statistical conditional sampling. The sampling approach is based on the conditional probability of the CRF modeling by use of the constructed dictionary. Experimental results show that the proposed variable-resolution approach via statistical conditional sampling has potential for improving compression rates when compared to compressing the video at full resolution, while achieving higher video quality when compared to compressing the video at reduced resolution.	[Wong, Alexander] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada; [Shafiee, Mohammad Javad; Azimifar, Zohreh] Shiraz Univ, Sch Elect & Comp Engn, Shiraz, Iran	University of Waterloo; Shiraz University	Wong, A (corresponding author), Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada.	a28wong@uwaterloo.ca	MohammadShafiee, MohammadReza/J-2988-2013; Wong, Alexander/GZM-2929-2022	Wong, Alexander/0000-0002-5295-2797	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors would like to thank the Natural Sciences and Engineering Research Council of Canada for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezdek J, 1984, COMPUTERS GEOSCIENCE; Bjontegaard G, 2000, H 26L TEST MODEL LON; Chou LC, 2007, 14TH INTERNATIONAL CONFERENCE ON IMAGE ANALYSIS AND PROCESSING, PROCEEDINGS, P399, DOI 10.1109/ICIAP.2007.4362811; Cook GW, 2006, IEEE T IMAGE PROCESS, V15, P2170, DOI 10.1109/TIP.2006.875185; Deforges Olivier, 2008, Proceedings 3rd International Design and Test Workshop (IDT 2008), P187, DOI 10.1109/IDT.2008.4802494; Deforges O, 2000, 2000 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, PROCEEDINGS VOLS I-III, P107, DOI 10.1109/ICME.2000.869556; Deforges O, 2007, IEEE T CIRC SYST VID, V17, P974, DOI 10.1109/TCSVT.2007.897112; Int Telecommun Union-Telecommun, 1999, NARR BAND VIS TEL SY; Int Telecommun Union-Telecommun, 1994, GEN COD MOV PICT ASS; Kong D, 2006, INT C PATT RECOG, P619; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Li J., 2009, 2009 IEEE 36th International Conference on Plasma Science (ICOPS), DOI 10.1109/PLASMA.2009.5227467; Sahabi H., 1995, Proceedings of the 8th International Conference on VLSI Design (Cat. No.95TH802), P214, DOI 10.1109/ICVD.1995.512111; Sullivan GJ, 1998, IEEE SIGNAL PROC MAG, V15, P74, DOI 10.1109/79.733497; Video Trace Library, 2012, TRAC YUV VID SEQ; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wei L, 2009, P SOC PHOTO-OPT INS, V7495; Wiegand T, 1999, IEEE T CIRC SYST VID, V9, P70, DOI 10.1109/76.744276; Wiegand T, 2003, IEEE T CIRC SYST VID, V13, P560, DOI 10.1109/TCSVT.2003.815165; Wiegand T, 1996, IEEE T CIRC SYST VID, V6, P182, DOI 10.1109/76.488825; Wiegand T., 2001, MULTIFRAME MOTION CO; Xiong RQ, 2008, IEEE T CIRC SYST VID, V18, P145, DOI 10.1109/TCSVT.2007.913765	22	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45002	10.1371/journal.pone.0045002	http://dx.doi.org/10.1371/journal.pone.0045002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056188	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500009
J	Espirito-Santo, MM; Neves, FS; Fernandes, GW; Silva, JO				Espirito-Santo, Mario M.; Neves, Frederico S.; Wilson Fernandes, G.; Silva, Jhonathan O.			Plant Phenology and Absence of Sex-Biased Gall Attack on Three Species of Baccharis	PLOS ONE			English	Article							REPRODUCTIVE PHENOLOGY; NUTRIENT ALLOCATION; HERBIVORY; SYNCHRONIZATION; CECIDOMYIIDAE; PATTERNS; DEFENSE; DIPTERA; GROWTH; VIGOR	Background: Dioecy represents a source of variation in plant quality to herbivores due to sexual differences in intensity and timing of resource allocation to growth, defense and reproduction. Male plants have higher growth rates and should be more susceptible to herbivores than females, due to a lower investment in defense and reproduction. Methodology/Principal Findings: We compared resource investment to growth and reproduction and its consequences to herbivore attack on three Baccharis species along one year (B. dracunculifolia, B. ramosissima, and B. concinna). Phenological patterns presented by the three species of Baccharis were quite different over time, but the number of fourth-level shoots and plant growth rate did not differ between sexes in any studied species. Intersexual difference in reproductive investment was only observed for B. concinna, with female individuals supporting higher inflorescence density than male individuals throughout the year. Gall abundance on the three Baccharis species was not influenced by plant sex. However, all plant traits evaluated here positively influenced the gall abundance on B. concinna, whereas only the number of fourth-level shoots positively influenced gall abundance on B. ramosissima and B. dracunculifolia. Conclusions/Significance: The absence of differential reproductive allocation may have contributed to similar growth and shoot production between the sexes, with bottom-up effects resulting in gender similarities in gall abundance patterns. The number of fourth-level shoots, an indicator of meristem availability to herbivores, was the most important driver of the abundance of the galling insects regardless of host plant gender or species. Albeit the absence of intersexual variation in insect gall abundance is uncommon in the literature, the detailed study of the exceptions may bring more light to understand the mechanisms and processes behind such trend.	[Silva, Jhonathan O.] Univ Brasilia, Inst Ciencias Biol, Dept Ecol, Brasilia, DF, Brazil; [Espirito-Santo, Mario M.; Neves, Frederico S.] Univ Estadual Montes Claros, Ctr Ciencias Biol & Saude, Dept Biol Geral, Montes Claros, MG, Brazil; [Neves, Frederico S.; Wilson Fernandes, G.] ICB Univ Fed Minas Gerais, Ecol Evolut & Biodiversidade DBG, Belo Horizonte, MG, Brazil	Universidade de Brasilia; Universidade Estadual de Montes Claros; Universidade Federal de Minas Gerais	Silva, JO (corresponding author), Univ Brasilia, Inst Ciencias Biol, Dept Ecol, Brasilia, DF, Brazil.	jhonathanos@gmail.com	Espirito-Santo, Mario/O-4813-2014; Neves, Frederico/E-5777-2013; Silva, Jhonathan/I-5475-2018; Fernandes, Geraldo/AAN-5602-2021	Espirito-Santo, Mario/0000-0001-8274-3075; Neves, Frederico/0000-0002-2691-3743; Silva, Jhonathan/0000-0001-9893-7501; Fernandes, Geraldo/0000-0003-1559-6049	Fundacao de Amparo a Pesquisa de Minas Gerais (Fapemig); Postgraduate Program in Ecologia, Conservacao e Manejo da Vida Silvestre of the Universidade Federal de Minas Gerais (UFMG)	Fundacao de Amparo a Pesquisa de Minas Gerais (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Postgraduate Program in Ecologia, Conservacao e Manejo da Vida Silvestre of the Universidade Federal de Minas Gerais (UFMG)	This study was supported by Fundacao de Amparo a Pesquisa de Minas Gerais (Fapemig) and the Postgraduate Program in Ecologia, Conservacao e Manejo da Vida Silvestre of the Universidade Federal de Minas Gerais (UFMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN J, 1987, OECOLOGIA, V72, P161, DOI 10.1007/BF00379262; AGREN J, 1988, ECOLOGY, V69, P962, DOI 10.2307/1941251; Antos JA, 1999, J ECOL, V87, P77, DOI 10.1046/j.1365-2745.1999.00331.x; Araújo Ana Paula A., 2003, Rev. Bras. entomol., V47, P483, DOI 10.1590/S0085-56262003000400001; Barroso G.M., 1976, RODRIGUESIA, V40, P3; BOECKLEN WJ, 1990, ECOLOGY, V71, P581, DOI 10.2307/1940311; Borchert R, 2002, BIOTROPICA, V34, P27, DOI 10.1111/j.1744-7429.2002.tb00239.x; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; BULLOCK SH, 1981, ECOLOGY, V62, P1494, DOI 10.2307/1941506; Burckhardt D, 2004, J NAT HIST, V38, P2051, DOI 10.1080/0022293032000140903; Carneiro MAA, 2006, REV BRAS ENTOMOL, V50, P394, DOI 10.1590/S0085-56262006000300009; Carneiro MAA, 2009, REV BRAS ENTOMOL, V53, P365, DOI 10.1590/S0085-56262009000300010; Cepeda-Cornejo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009824; Cornelissen T, 2005, OIKOS, V111, P488, DOI 10.1111/j.1600-0706.2005.14075.x; Cornelissen T, 2008, OIKOS, V117, P1121, DOI 10.1111/j.0030-1299.2008.16588.x; Cornelissen TG, 2001, AUSTRAL ECOL, V26, P246, DOI 10.1046/j.1442-9993.2001.01109.x; Crawley M. J, 2002, STAT COMPUTING INTRO; de Araujo Ana Maria, 1995, Revista Brasileira de Entomologia, V39, P347; DELPH LF, 1993, AM J BOT, V80, P607, DOI 10.2307/2445429; Detoni MD, 2011, AUST J BOT, V59, P509, DOI 10.1071/BT11104; Espirito-Santo M.M., 1999, ACTA BOT BRAS, V13, P167, DOI [DOI 10.1590/S0102-33061999000200006, 10.1590/S0102-33061999000200006]; Espirito-Santo MM, 2007, OECOLOGIA, V153, P353, DOI 10.1007/s00442-007-0737-8; Espirito-Santo MM, 2003, ANN BOT-LONDON, V91, P13, DOI 10.1093/aob/mcg001; Espirito-Santo MM, 2002, AUSTRAL ECOL, V27, P249, DOI 10.1046/j.1442-9993.2002.01185.x; Espirito-Santo MM, 1998, ENVIRON ENTOMOL, V27, P870, DOI 10.1093/ee/27.4.870; Faria ML, 2001, ECOL ENTOMOL, V26, P37, DOI 10.1046/j.1365-2311.2001.00291.x; Fernandes GW, 1996, TROP ZOOL, V9, P315, DOI 10.1080/03946975.1996.10539315; Ferrari JM, 1977, OREADES, V6, P3; Gomes Vania, 2002, Acta Bot. Bras., V16, P421, DOI 10.1590/S0102-33062002000400005; Hartley SE, 1998, OECOLOGIA, V113, P492, DOI 10.1007/s004420050401; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hesse E, 2011, ANN BOT-LONDON, V107, P1039, DOI 10.1093/aob/mcr046; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; Inbar M, 2010, ARTHROPOD-PLANT INTE, V4, P1, DOI 10.1007/s11829-009-9082-7; JANZEN DH, 1967, EVOLUTION, V21, P620, DOI 10.1111/j.1558-5646.1967.tb03416.x; KRISCHIK VA, 1990, OECOLOGIA, V83, P182, DOI 10.1007/BF00317750; Lara DP, 2008, REV BRAS ENTOMOL, V52, P78, DOI 10.1590/S0085-56262008000100014; Madeira Bruno G., 1997, P135; Madeira JA, 1999, J TROP ECOL, V15, P463, DOI 10.1017/S0266467499000954; Mani M.S., 1964, ECOLOGY PLANT GALLS, DOI 10.1007/978-94-017-6230-4; Mani M.S., 1992, BIOL INSECT INDUCED, P3; Marques AR, 2002, PLANT BIOLOGY, V4, P94, DOI 10.1055/s-2002-20441; Matsushita M, 2011, J ECOL, V99, P1520, DOI 10.1111/j.1365-2745.2011.01866.x; Munguia-Rosas MA, 2011, PLANT SPEC BIOL, V26, P205, DOI 10.1111/j.1442-1984.2011.00320.x; NESOM G L, 1988, Phytologia, V65, P160; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Rocheleau AF, 2001, AM J BOT, V88, P659, DOI 10.2307/2657066; Santos JC, 2008, EVOL ECOL, V22, P123, DOI 10.1007/s10682-007-9162-z; Santos JC, 2010, ACTA OECOL, V36, P617, DOI 10.1016/j.actao.2010.09.007; Sloan SA, 2007, BIOTROPICA, V39, P195, DOI 10.1111/j.1744-7429.2006.00249.x; WATSON MA, 1995, TRENDS ECOL EVOL, V10, P180, DOI 10.1016/S0169-5347(00)89046-1; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Yukawa J, 2006, POPUL ECOL, V48, P13, DOI 10.1007/s10144-005-0233-0; Yukawa J, 2000, POPUL ECOL, V42, P105, DOI 10.1007/PL00011989; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zhang X., 2012, PHENOLOGY CLIMATE CH, P125	56	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46896	10.1371/journal.pone.0046896	http://dx.doi.org/10.1371/journal.pone.0046896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056517	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800062
J	Wei, P; Tang, HW; Li, DH				Wei, Peng; Tang, Hongwei; Li, Donghui			Insights into Pancreatic Cancer Etiology from Pathway Analysis of Genome-Wide Association Study Data	PLOS ONE			English	Article							OLFACTORY RECEPTOR GENES; SUSCEPTIBILITY LOCI; DUCTAL ADENOCARCINOMA; MOLECULAR NETWORKS; CELLS; DISEASES; VARIANTS; REGION; PROLIFERATION; METAANALYSIS	Background: Pancreatic cancer is the fourth leading cause of cancer death in the U. S. and the etiology of this highly lethal disease has not been well defined. To identify genetic susceptibility factors for pancreatic cancer, we conducted pathway analysis of genome-wide association study (GWAS) data in 3,141 pancreatic cancer patients and 3,367 controls with European ancestry. Methods: Using the gene set ridge regression in association studies (GRASS) method, we analyzed 197 pathways identified from the Kyoto Encyclopedia of Genes and Genomes database. We used the logistic kernel machine (LKM) test to identify major contributing genes to each pathway. We conducted functional enrichment analysis of the most significant genes (P<0.01) using the Database for Annotation, Visualization, and Integrated Discovery (DAVID). Results: Two pathways were significantly associated with risk of pancreatic cancer after adjusting for multiple comparisons (P<0.00025) and in replication testing: neuroactive ligand-receptor interaction, (Ps<0.00002), and the olfactory transduction pathway (P = 0.0001). LKM test identified four genes that were significantly associated with risk of pancreatic cancer after Bonferroni correction (P<1 x 10(-5)): ABO, HNF1A, OR13C4, and SHH. Functional enrichment analysis using DAVID consistently found the G protein-coupled receptor signaling pathway (including both neuroactive ligand-receptor interaction and olfactory transduction pathways) to be the most significant pathway for pancreatic cancer risk in this study population. Conclusion: These novel findings provide new perspectives on genetic susceptibility to and molecular mechanisms of pancreatic cancer.	[Tang, Hongwei; Li, Donghui] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Wei, Peng] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, Houston, TX USA; [Wei, Peng] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Li, DH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA.	dli@mdanderson.org	Wei, Peng/X-2306-2019	Wei, Peng/0000-0001-7758-6116	National Institutes of Health [RO1 CA98380-05]; National Institutes of Health through MD Anderson's Cancer Center Support Grant [CA016672]; NIH [R01HL106034-01]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA098380] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through MD Anderson's Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health through a supplemental grant to RO1 CA98380-05 (to D.L.) and through MD Anderson's Cancer Center Support Grant (CA016672). P.W. was partially supported by NIH R01HL106034-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Anney RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-46; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen LS, 2010, AM J HUM GENET; Darrah R, 2010, PHYSIOL GENOMICS, V41, P71, DOI 10.1152/physiolgenomics.00185.2009; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Fehringer G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031816; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Hayes GM, 2007, GASTROENTEROLOGY, V133, P853, DOI 10.1053/j.gastro.2007.06.013; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jia PL, 2012, J MED GENET, V49, P96, DOI 10.1136/jmedgenet-2011-100397; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lauc G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001256; Li DH, 2012, CARCINOGENESIS, V33, P1384, DOI 10.1093/carcin/bgs151; Luo L, 2010, EUR J HUM GENET, V18, P1045, DOI 10.1038/ejhg.2010.62; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pierce BL, 2011, CANCER RES, V71, P4352, DOI 10.1158/0008-5472.CAN-11-0124; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rehfeld JF, 2004, BEST PRACT RES CL EN, V18, P569, DOI 10.1016/j.beem.2004.07.002; Rukstalis JM, 2009, ISLETS, V1, P177, DOI 10.4161/isl.1.3.9877; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schoof N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029451; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; Turetsky BI, 2009, SCHIZOPHRENIA BULL, V35, P1117, DOI 10.1093/schbul/sbp111; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57	51	59	59	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46887	10.1371/journal.pone.0046887	http://dx.doi.org/10.1371/journal.pone.0046887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056513	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800060
J	Diamanti, J; Capocasa, F; Balducci, F; Battino, M; Hancock, J; Mezzetti, B				Diamanti, Jacopo; Capocasa, Franco; Balducci, Francesca; Battino, Maurizio; Hancock, Jim; Mezzetti, Bruno			Increasing Strawberry Fruit Sensorial and Nutritional Quality Using Wild and Cultivated Germplasm	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; FRAGARIA-X-ANANASSA; ANTHOCYANIN CONTENT; RESISTANCE; BENZOTHIADIAZOLE; PHENOLICS	Background: Increasing antioxidant levels in fruit through breeding is an important option to support higher antioxidant intake particularly when fruit consumption is low. Indeed, if nutritional components are also combined with a high standard of sensorial fruit quality, the perspective for consumer health can be further improved by encouraging more fruit consumption. Wild species are valued by strawberry breeders as sources of novel traits, especially for pest resistance and abiotic stress tolerance. Furthermore, previous investigations have shown improvements in fruit nutritional quality in breeding material that originated from Fragaria virginiana ssp. glauca (FVG) inter-species crosses. Recently, commercial varieties of strawberries have also shown interesting variability in fruit nutritional quality. Results: Strawberry fruit sensorial and nutritional qualities generated by Fragaria inter-species and intra-species crosses were evaluated on 78 offspring derived from 8 families: two that originated from F. x ananassa intra-species crossing; three from back-crossing of F1- FVG x F. x ananassa; and three from back-crossing of BC1- FVG x F. x ananassa. The genetic variability from the three types of cross combinations was analyzed by calculation of the correlations among the fruit sensorial and nutritional parameters. The results obtained show that two subsequent back-crossing generations from an inter-species crossing combination with F. virginiana ssp. glauca provides useful improvement of the fruit nutritional and sensorial qualities that is combined with agronomic standards that are close to those requested at the commercial level. Improvements of these traits can also be achieved by programming F. x ananassa intra-species crosses and producing progeny with productivity traits more similar to those of the commercial cultivars. Conclusions: The two types of combination programs (inter-species back-crosses, and intra-species crosses) can be used to improve strawberry nutritional quality.	[Diamanti, Jacopo; Capocasa, Franco; Balducci, Francesca; Mezzetti, Bruno] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy; [Battino, Maurizio] Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy; [Hancock, Jim] Michigan State Univ, Dept Med, E Lansing, MI 48824 USA	Marche Polytechnic University; Marche Polytechnic University; Michigan State University	Mezzetti, B (corresponding author), Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy.	b.mezzetti@univpm.it	Mezzetti, Bruno/AAB-8500-2019; Mezzetti, Bruno/AAE-7696-2019; Capocasa, Franco/ABA-7508-2020; Battino, Maurizio/E-6103-2012	Battino, Maurizio/0000-0002-7250-1782; Mezzetti, Bruno/0000-0001-9307-812X; CAPOCASA, Franco/0000-0002-2593-8535	Italian Ministry of Environment; EU FP7 EUBerry project [265942]	Italian Ministry of Environment; EU FP7 EUBerry project	The research work was carried out thanks to the project on 'Valorization of Red Fruit Genetic Resources' supported by the Italian Ministry of Environment and for the last analyses to the EU FP7 EUBerry project No. 265942. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P3110, DOI 10.1105/tpc.104.023895; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; Azodanlou R, 2003, J AGR FOOD CHEM, V51, P715, DOI 10.1021/jf0200467; Battino M, 2009, NUTR REV, V67, pS145, DOI 10.1111/j.1753-4887.2009.00178.x; Bringhurst RS, 1978, FRAGARIA GENETICS, V90, P510; Capocasa F, 2008, BIOFACTORS, V34, P67, DOI 10.1002/biof.5520340107; Capocasa F, 2009, ACTA HORTIC, V842, P129, DOI 10.17660/ActaHortic.2009.842.12; Carbone F, 2009, PLANT CELL ENVIRON, V32, P1117, DOI 10.1111/j.1365-3040.2009.01994.x; Coelho CM, 2007, THEOR APPL GENET, V115, P1147, DOI 10.1007/s00122-007-0640-z; Connor AM, 2002, J AM SOC HORTIC SCI, V127, P82, DOI 10.21273/JASHS.127.1.82; Connor AM, 2005, J AM SOC HORTIC SCI, V3, P130; Darrow GM, 1966, STRAWBERRY HIST BREE; Deighton N, 2000, J SCI FOOD AGR, V80, P1307, DOI 10.1002/1097-0010(200007)80:9&lt;1307::AID-JSFA638&gt;3.0.CO;2-P; DellaPenna D, 2001, PLANT PHYSIOL, V125, P160, DOI 10.1104/pp.125.1.160; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Giusti M. M., 2001, CURR PROTOC FOOD ANA, V00, DOI DOI 10.1002/0471142913.FAF0102S00; GOODING HJ, 1981, J HORTIC SCI, V56, P239, DOI 10.1080/00221589.1981.11514995; HAIR FH, 1998, MULTIVARIATE DATA AN; HANCOCK J, 1995, FRUIT VARIETIES J, V49, P85; Hancock JF, 2002, EUPHYTICA, V126, P177, DOI 10.1023/A:1016309724998; Harland S.C., 1957, HEREDITY, V11, P257; Hebert C, 2002, ACTA HORTIC, P659, DOI 10.17660/ActaHortic.2002.567.143; Hukkanen AT, 2007, J AGR FOOD CHEM, V55, P1862, DOI 10.1021/jf063452p; KADER AA, 1991, STRAWBERRY INTO THE 21ST CENTURY, P145; Karjalainen R, 2002, ACTA HORTIC, P353, DOI 10.17660/ActaHortic.2002.567.76; Lerceteau-Kohler E, 2012, THEOR APPL GENET, V124, P1059, DOI 10.1007/s00122-011-1769-3; Maas J.L., 1998, COMPENDIUM STRAWBERR; Meyers KJ, 2003, J AGR FOOD CHEM, V51, P6887, DOI 10.1021/jf034506n; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Olsson ME, 2004, J AGR FOOD CHEM, V52, P2490, DOI 10.1021/jf030461e; Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d; Proteggente AR, 2002, FREE RADICAL RES, V36, P217, DOI 10.1080/10715760290006484; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Scalzo J, 2005, NUTRITION, V21, P207, DOI 10.1016/j.nut.2004.03.025; SJULIN TM, 1987, J AM SOC HORTIC SCI, V112, P375; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Tulipani S, 2008, J AGR FOOD CHEM, V56, P696, DOI 10.1021/jf0719959; Tulipani S, 2011, FOOD CHEM, V124, P906, DOI 10.1016/j.foodchem.2010.07.018; Tulipani S, 2009, FOOD CHEM, V117, P181, DOI 10.1016/j.foodchem.2009.03.096; Wang SY, 2007, J AM SOC HORTIC SCI, V132, P629, DOI 10.21273/JASHS.132.5.629; Wang SY, 2000, J AGR FOOD CHEM, V48, P140, DOI 10.1021/jf9908345; Wang SY, 2002, J AGR FOOD CHEM, V50, P6534, DOI 10.1021/jf020614i; Zheng W, 2003, J AGR FOOD CHEM, V51, P502, DOI 10.1021/jf020728u; Zorrilla-Fontanesi Y, 2011, THEOR APPL GENET, V123, P755, DOI 10.1007/s00122-011-1624-6	45	69	70	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46470	10.1371/journal.pone.0046470	http://dx.doi.org/10.1371/journal.pone.0046470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056317	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000048
J	Palmieri, N; Nolte, V; Suvorov, A; Kosiol, C; Schlotterer, C				Palmieri, Nicola; Nolte, Viola; Suvorov, Anton; Kosiol, Carolin; Schloetterer, Christian			Evaluation of Different Reference Based Annotation Strategies Using RNA-Seq - A Case Study in Drososphila pseudoobscura	PLOS ONE			English	Article							DROSOPHILA-PSEUDOOBSCURA; GENE-EXPRESSION; TRANSCRIPTOME; QUANTIFICATION; MELANOGASTER; GENERATION; REVEALS; TOPHAT	RNA-Seq is a powerful tool for the annotation of genomes, in particular for the identification of isoforms and UTRs. Nevertheless, several software tools exist and no standard strategy to obtain a reliable annotation is yet established. We tested different combinations of the most commonly used reference-based alignment tools (TopHat, GSNAP) in combination with two frequently used reference-based assemblers (Cufflinks, Scripture) and evaluated the potential of RNA-Seq to improve the annotation of Drosophila pseudoobscura. While GSNAP maps a higher proportion of reads, TopHat resulted in a more accurate annotation when used in combination with Cufflinks. Scripture had the lowest sensitivity. Interestingly, after subsampling to the same coverage for GSNAP and TopHat, we find that both mappers have similar performance, implying that the advantage of TopHat is mainly an artifact of the lower coverage. Overall, we observed a low concordance among the different approaches tested both at junction and isoform levels. Using data from both sexes of two adult strains of D. pseudoobscura we detected alternative splicing for about 30% of the FlyBase multiple-exon genes. Moreover, we extended the boundaries for 6523 genes (about 40%). We annotated 669 new genes, 45% of them with splicing evidence. Most of the new genes are located on unassembled contigs, reflecting their incomplete annotation. Finally, we identified 99 additional new genes that are not represented in the current genome contigs of D. pseudoobscura, probably due to location in genomic regions that are difficult to assemble (e.g. heterochromatic regions).	[Palmieri, Nicola; Nolte, Viola; Suvorov, Anton; Kosiol, Carolin; Schloetterer, Christian] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria	University of Veterinary Medicine Vienna	Palmieri, N (corresponding author), Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria.	nicola.palmieri@vetmeduni.ac.at	Schlötterer, Christian/G-6326-2010; Schlötterer, Christian/Q-5264-2019; Suvorov, Anton/AAB-1774-2019	Schlötterer, Christian/0000-0003-4710-6526; Schlötterer, Christian/0000-0003-4710-6526; Suvorov, Anton/0000-0003-3898-9195	Austrian Science Funds (FWF) [P22834]; Austrian Science Fund (FWF) [P 22834] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work has been funded by the Austrian Science Funds (FWF, P22834). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Birse CE, 1997, EMBO J, V16, P3633, DOI 10.1093/emboj/16.12.3633; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Daines B, 2011, GENOME RES, V21, P315, DOI 10.1101/gr.107854.110; Eck S, 2008, GENE, V424, P102, DOI 10.1016/j.gene.2008.07.033; Farlow A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000819; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hong X, 2006, MOL BIOL EVOL, V23, P2392, DOI 10.1093/molbev/msl111; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Jiang ZF, 2009, GENETICS, V183, P1175, DOI 10.1534/genetics.109.105775; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Li W, 2011, J COMPUT BIOL, V18, P1693, DOI 10.1089/cmb.2011.0171; Meisel RP, 2010, MOL BIOL EVOL, V27, P1963, DOI 10.1093/molbev/msq085; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parsch J, 2010, MOL BIOL EVOL, V27, P1226, DOI 10.1093/molbev/msq046; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rogers MF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r4; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stevison LS, 2011, GENOME BIOL EVOL, V3, P830, DOI 10.1093/gbe/evr081; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	43	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46415	10.1371/journal.pone.0046415	http://dx.doi.org/10.1371/journal.pone.0046415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056304	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000041
J	Sandberg, M; Lundberg, P				Sandberg, Mikael; Lundberg, Per			Political Institutions and Their Historical Dynamics	PLOS ONE			English	Article							DEMOCRACY; DIFFUSION	Traditionally, political scientists define political institutions deductively. This approach may prevent from discovery of existing institutions beyond the definitions. Here, a principal component analysis was used for an inductive extraction of dimensions in Polity IV data on the political institutions of all nations in the world the last two centuries. Three dimensions of institutions were revealed: core institutions of democracy, oligarchy, and despotism. We show that, historically and on a world scale, the dominance of the core institutions of despotism has first been replaced by a dominance of the core institutions of oligarchy, which in turn is now being followed by an increasing dominance by the core institutions of democracy. Nations do not take steps from despotic, to oligarchic and then to democratic institutions, however. Rather, nations hosting the core democracy institutions have succeeded in historically avoiding both the core institutions of despotism and those of oligarchy. On the other hand, some nations have not been influenced by any of these dimensions, while new institutional combinations are increasingly influencing others. We show that the extracted institutional dimensions do not correspond to the Polity scores for autocracy, "anocracy'' and democracy, suggesting that changes in regime types occur at one level, while institutional dynamics work on another. Political regime types in that sense seem "canalized'', i.e., underlying institutional architectures can and do vary, but to a considerable extent independently of regime types and their transitions. The inductive approach adds to the deductive regime type studies in that it produces results in line with modern studies of cultural evolution and memetic institutionalism in which institutions are the units of observation, not the nations that acts as host for them.	[Sandberg, Mikael; Lundberg, Per] Lund Univ, Theoret Populat Ecol & Evolut Grp, Dept Biol, Lund, Sweden; [Sandberg, Mikael] Halmstad Univ, Sch Social & Hlth Sci, Halmstad, Sweden	Lund University; Halmstad University	Sandberg, M (corresponding author), Lund Univ, Theoret Populat Ecol & Evolut Grp, Dept Biol, Lund, Sweden.	mikael.sandberg@hh.se	Sandberg, Mikael/I-2821-2014	Sandberg, Mikael/0000-0001-9495-3571; Lundberg, Per/0000-0002-9609-726X	Swedish Research Council [2010-5444]; Kimmo Eriksson's Swedish Research Council [2009-2390]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Kimmo Eriksson's Swedish Research Council	This study was supported by the Swedish Research Council project 2010-5444 (to PL) and Kimmo Eriksson's Swedish Research Council project 2009-2390 (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg M, 2002, SOCIAL CAPITAL DEMOC; Almond Gabriel A., 1963, CIVIC CULTURE POLITI; Aristotle, 1998, ARISTOTLE POLITICS; Barro RJ, 1999, J POLIT ECON, V107, pS158, DOI 10.1086/250107; Bowles S, 2004, ROUNDTABLE SER BEHAV, P1; Brinks D, 2001, ANN M AM POL SCI ASS; Collier D, 1997, WORLD POLIT, V49, P430, DOI 10.1353/wp.1997.0009; Coppedge M, 2008, J POLIT, V70, P632, DOI 10.1017/S0022381608080663; Coppedge M, 2011, PERSPECT POLIT, V9, P247, DOI 10.1017/S1537592711000880; Dahl, 1989, DEMOCRACY ITS CRITIC; Dahl Robert, 1971, POLYARCHY PARTICIPAT; Dawkins R., 1982, pi; Dawkins R, 1986, BLIND WATCHMAKER, P9; Dawkins Richard, 1976, SELFISH GENE; DIAMOND L, 1992, AM BEHAV SCI, V35, P450, DOI 10.1177/0002764292035004007; Diamond LJ, 1993, GLOBAL RESURGENCE DE; Eckstein Harry, 1975, PATTERNS AUTHORITY S; Epstein DL, 2006, AM J POLIT SCI, V50, P551, DOI 10.1111/j.1540-5907.2006.00201.x; Gates S, 2006, AM J POLIT SCI, V50, P893, DOI 10.1111/j.1540-5907.2006.00222.x; Gleditsch KS, 2006, INT ORGAN, V60, P911, DOI 10.1017/S0020818306060309; GURR TR, 1974, AM POLIT SCI REV, V68, P1482, DOI 10.2307/1959937; Hadenius, 1992, DEMOCRACY DEV; Hodgson G.M., 1988, EC I MANIFESTO MODER; Huntington Samuel P., 1991, 3 WAVE DEMOCRATIZATI; Inglehart R., 2005, MODERNIZATION CULTUR; Institute S, 2008, SAS STAT 9 2 US GUID; JAGGERS K, 1995, J PEACE RES, V32, P469, DOI 10.1177/0022343395032004007; Lijphart A., 2012, PATTERNS DEMOCRACY G; Lindenfors P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028270; Linz JJ., 1996, PROBLEMS DEMOCRATIC; Lipset S.M., 1960, POLITICAL MAN SOCIAL; Marshall M., 2010, POLITY 4 PROJECT POL; Marshall MG, 2002, POLITICAL REGIME CHA; Moore Barrington, 1993, SOCIAL ORIGINS DICTA; Morris DW, 2011, PILLARS OF EVOLUTION: FUNDAMENTAL PRINCIPLES OF THE ECO-EVOLUTIONARY PROCESS; North D. C., 1990, I I CHANGE EC PERFOR; O'Donnell Guillermo, 1986, TRANSITIONS AUTHORIT; O'Loughlin J, 1998, ANN ASSOC AM GEOGR, V88, P545, DOI 10.1111/0004-5608.00112; Olsen, 1989, REDISCOVERING I; Olsen JP, 1983, ORG DEMOCRACY POLITI; Ostrom, 2015, GOVERNING COMMONS EV, DOI DOI 10.1017/CBO9780511807763; Peters B.Guy., 2019, I THEORY POLITICAL S; Pierson P, 2004, POLITICS IN TIME: HISTORY, INSTITUTIONS, AND SOCIAL ANALYSIS, P1; Przeworski Adam, 1991, DEMOCRACY MARKET POL; Putnam R.D., 1992, MAKING DEMOCRACY WOR; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ringen S, 2011, SOCIETY, V48, P12, DOI 10.1007/s12115-010-9382-7; Schumpeter J. A., 1942, CAPITALISM SOCIALISM; STARR H, 1991, J CONFLICT RESOLUT, V35, P356, DOI 10.1177/0022002791035002010; Vanhanen T., 2003, DEMOCRATIZATION COMP; Vanhanen T., 1997, PROSPECTS DEMOCRACY; Veblen Thorstein, 1899, THEORY LEISURE CLASS; Waddington C. H., 1957, STRATEGY GENES, P11; Wejnert B, 2005, AM SOCIOL REV, V70, P53, DOI 10.1177/000312240507000104; Young H. P., 1998, INDIVIDUAL STRATEGY	55	1	1	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45838	10.1371/journal.pone.0045838	http://dx.doi.org/10.1371/journal.pone.0045838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056219	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000011
J	Khemlani, SS; Lotstein, M; Johnson-Laird, P				Khemlani, Sangeet S.; Lotstein, Max; Johnson-Laird, Phil			The Probabilities of Unique Events	PLOS ONE			English	Article							JUDGMENT; MODEL	Many theorists argue that the probabilities of unique events, even real possibilities such as President Obama's re-election, are meaningless. As a consequence, psychologists have seldom investigated them. We propose a new theory (implemented in a computer program) in which such estimates depend on an intuitive non-numerical system capable only of simple procedures, and a deliberative system that maps intuitions into numbers. The theory predicts that estimates of the probabilities of conjunctions should often tend to split the difference between the probabilities of the two conjuncts. We report two experiments showing that individuals commit such violations of the probability calculus, and corroborating other predictions of the theory, e. g., individuals err in the same way even when they make non-numerical verbal estimates, such as that an event is highly improbable.	[Khemlani, Sangeet S.] USN, Res Lab, Navy Ctr Appl Res Artificial Intelligence, Washington, DC 20375 USA; [Lotstein, Max; Johnson-Laird, Phil] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Princeton University	Khemlani, SS (corresponding author), USN, Res Lab, Navy Ctr Appl Res Artificial Intelligence, Washington, DC 20375 USA.	skhemlani@gmail.com			National Science Foundation Graduate Research Fellowship; National Science Foundation [SES 0844851]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	This research was supported by a National Science Foundation Graduate Research Fellowship, as well as National Science Foundation Grant No. SES 0844851 to study deductive and probabilistic reasoning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, SUBJECTIVE PROBABILI; [Anonymous], 1993, THEORY PROBABILITY C; Barth H, 2006, COGNITION, V98, P199, DOI 10.1016/j.cognition.2004.09.011; Carey S., 2009, ORIGIN CONCEPTS; Cosmides L, 1996, COGNITION, V58, P1, DOI 10.1016/0010-0277(95)00664-8; De Finetti B., 1970, ACTA PSYCHOL, V34, P129, DOI 10.1016/0001-6918(70)90012-0; Dehaene S., 1997, NUMBER SENSE; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Fantino E, 1997, PSYCHON B REV, V4, P96, DOI 10.3758/BF03210779; Gigerenzer G, 2005, RISK ANAL, V25, P623, DOI 10.1111/j.1539-6924.2005.00608.x; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Girotto V, 2004, PSYCHOLOGIA, V47, P207, DOI 10.2117/psysoc.2004.207; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; Hopcroft J. E., 1979, FORMAL LANGUAGES THE; Johnson-Laird, 1983, MENTAL MODELS; Johnson-Laird Philip Nicholas, 2006, WE REASON; Johnson-Laird PN, 1999, PSYCHOL REV, V106, P62, DOI 10.1037/0033-295X.106.1.62; Kahneman D., 2011, THINKING FAST SLOW; Khemlani S, 2012, IMMEDIATE INFE UNPUB; Khemlani S, 2013, ARGUM COMPUT, V4, P4, DOI 10.1080/19462166.2012.674060; Khemlani S, 2009, MEM COGNITION, V37, P615, DOI 10.3758/MC.37.5.615; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pascal B., 1966, PENSEES; Pothos EM, 2012, BEHAV BRAIN IN PRESS; Ramsey F. P., 1990, FP RAMSEY PHILOS PAP; Savage L. J., 1972, FDN STAT; Stanovich K. E., 1999, WHO IS RATIONAL STUD; Turing AM, 1939, P LOND MATH SOC, V45, P161; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; Verschueren N, 2005, THINK REASONING, V11, P239, DOI 10.1080/13546780442000178; von Mises Richard, 1961, PROBABILITY STAT TRU, VSecond; Wolfe CR, 2010, J BEHAV DECIS MAKING, V23, P203, DOI 10.1002/bdm.650; WYER RS, 1976, ORGAN BEHAV HUM PERF, V15, P1, DOI 10.1016/0030-5073(76)90026-X; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45975	10.1371/journal.pone.0045975	http://dx.doi.org/10.1371/journal.pone.0045975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NG	23056224	gold, Green Submitted, Green Published			2022-12-27	WOS:000309452600018
J	Spaak, E; Zeitler, M; Gielen, S				Spaak, Eelke; Zeitler, Magteld; Gielen, Stan			Hippocampal Theta Modulation of Neocortical Spike Times and Gamma Rhythm: A Biophysical Model Study	PLOS ONE			English	Article							PREFRONTAL CORTEX; NEURONAL OSCILLATIONS; SYNAPTIC INHIBITION; PHASE PRECESSION; GAP-JUNCTIONS; CELLS; NETWORK; SYNCHRONIZATION; ACTIVATION; SYNAPSES	The hippocampal theta and neocortical gamma rhythms are two prominent examples of oscillatory neuronal activity. The hippocampus has often been hypothesized to influence neocortical networks by its theta rhythm, and, recently, evidence for such a direct influence has been found. We examined a possible mechanism for this influence by means of a biophysical model study using conductance-based model neurons. We found, in agreement with previous studies, that networks of fast-spiking GABA -ergic interneurons, coupled with shunting inhibition, synchronize their spike activity at a gamma frequency and are able to impose this rhythm on a network of pyramidal cells to which they are coupled. When our model was supplied with hippocampal theta-modulated input fibres, the theta rhythm biased the spike timings of both the fast-spiking and pyramidal cells. Furthermore, both the amplitude and frequency of local field potential gamma oscillations were influenced by the phase of the theta rhythm. We show that the fast-spiking cells, not pyramidal cells, are essential for this latter phenomenon, thus highlighting their crucial role in the interplay between hippocampus and neocortex.	[Spaak, Eelke] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Zeitler, Magteld; Gielen, Stan] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Spaak, E (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands.	eelke.spaak@donders.ru.nl	Spaak, Eelke/Y-3826-2019; Zeitler, Magteld/K-2039-2016; Spaak, Eelke/W-9804-2018; Gielen, Stan CAM/D-3380-2009	Spaak, Eelke/0000-0002-2018-3364; Zeitler, Magteld/0000-0001-6241-9921; Spaak, Eelke/0000-0002-2018-3364; 	Netherlands Organization for Scientific Research [635.100.019]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO Grant No. 635.100.019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Baranauskas G, 2012, J NEUROPHYSIOL, V107, P984, DOI 10.1152/jn.00470.2011; Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; BUHL EH, 1995, EUR J NEUROSCI, V7, P1989, DOI 10.1111/j.1460-9568.1995.tb00721.x; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Cunningham MO, 2003, J NEUROSCI, V23, P9761; Degenetais E, 2003, CEREB CORTEX, V13, P782, DOI 10.1093/cercor/13.7.782; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; GABBIANI F, 1994, J NEUROPHYSIOL, V72, P999, DOI 10.1152/jn.1994.72.2.999; Gabbott P, 2002, BRAIN RES, V946, P314, DOI 10.1016/S0006-8993(02)02487-3; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Jensen O, 2012, TRENDS COGNITIVE SCI; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kleppe IC, 1999, BIOPHYS J, V77, P1418, DOI 10.1016/S0006-3495(99)76990-0; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; LILEY DTJ, 1994, NETWORK-COMP NEURAL, V5, P175, DOI 10.1088/0954-898X/5/2/004; Lin SC, 2006, J NEUROPHYSIOL, V96, P3209, DOI 10.1152/jn.00524.2006; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Mazzoni A, 2010, NEUROIMAGE, V52, P956, DOI 10.1016/j.neuroimage.2009.12.040; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Reilly RC, 2002, TRENDS COGN SCI, V6, P505, DOI 10.1016/S1364-6613(02)02005-3; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Pettersen KH, 2012, HANDBOOK OF NEURAL ACTIVITY MEASUREMENT, P92; ROSENE DL, 1977, SCIENCE, V198, P315, DOI 10.1126/science.410102; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sohal VS, 2005, P NATL ACAD SCI USA, V102, P18638, DOI 10.1073/pnas.0509291102; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Wang XJ, 1996, J NEUROSCI, V16, P6402	65	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45688	10.1371/journal.pone.0045688	http://dx.doi.org/10.1371/journal.pone.0045688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056213	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600015
J	Fak, F; Backhed, F				Fak, Frida; Backhed, Fredrik			Lactobacillus reuteri Prevents Diet-Induced Obesity, but not Atherosclerosis, in a Strain Dependent Fashion in Apoe-/- Mice	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; GUT MICROBIOTA; ENDOTOXEMIA; CHOLESTEROL; METABOLISM; INTESTINE	Objective: To investigate whether the specific strains of Lactobacillus reuteri modulates the metabolic syndrome in Apoe-/- mice. Methods: 8 week-old Apoe-/- mice were subdivided into four groups who received either L. reuteri ATCC PTA 4659 (ATCC), DSM 17938 (DSM), L6798, or no bacterial supplement in the drinking water for 12 weeks. The mice were fed a high-fat Western diet with 0.2% cholesterol and body weights were monitored weekly. At the end of the study, oral glucose and insulin tolerance tests were conducted. In addition, adipose and liver weights were recorded along with analyses of mRNA expression of ileal Angiopoietin-like protein 4 (Angptl4), the macrophage marker F4/80 encoded by the gene Emr1 and liver Acetyl-CoA carboxylase 1 (Acc1), Fatty acid synthase (Fas) and Carnitine palmitoyltransferase 1a (Cpt1a). Atherosclerosis was assessed in the aortic root region of the heart. Results and Conclusions: Mice receiving L. reuteri ATCC gained significantly less body weight than the control mice, whereas the L6798 mice gained significantly more. Adipose and liver weights were also reduced in the ATCC group. Serum insulin levels were lower in the ATCC group, but no significant effects were observed in the glucose or insulin tolerance tests. Lipogenic genes in the liver were not altered by any of the bacterial treatments, however, increased expression of Cpt1a was found in the ATCC group, indicating increased beta-oxidation. Correspondingly, the liver trended towards having lower fat content. There were no effects on inflammatory markers, blood cholesterol or atherosclerosis. In conclusion, the probiotic L. reuteri strain ATCC PTA 4659 partly prevented diet-induced obesity, possibly via a previously unknown mechanism of inducing liver expression of Cpt1a.	[Fak, Frida; Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Fak, Frida; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Backhed, F (corresponding author), Univ Gothenburg, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden.	fredrik.backhed@wlab.gu.se	Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818	Biogaia AB	Biogaia AB	This work was supported by Biogaia AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The final version of the manuscript was approved by Biogaia AB.; The authors declare that they received funding from a commercial source (Biogaia AB). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. FB is a scientific founder of MetaboGen and owns equity in the company. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andrade S, 2009, J DAIRY RES, V76, P469, DOI 10.1017/S0022029909990173; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Cakir T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100085; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cavallini D, 2009, LIPIDS HLTH DIS, V8, P1188; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Luoto R, 2010, INT J OBESITY, V34, P1531, DOI 10.1038/ijo.2010.50; Naruszewicz M, 2002, AM J CLIN NUTR, V76, P1249, DOI 10.1093/ajcn/76.6.1249; Portugal LR, 2006, BRAZ J MED BIOL RES, V39, P629, DOI 10.1590/S0100-879X2006000500010; Rault-Nania MH, 2006, BRIT J NUTR, V96, P840, DOI 10.1017/BJN20061913; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Schreurs M, 2010, OBES REV, V11, P380, DOI 10.1111/j.1467-789X.2009.00642.x; Taranto MP, 2000, J DAIRY SCI, V83, P401, DOI 10.3168/jds.S0022-0302(00)74895-8; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100	21	106	112	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46837	10.1371/journal.pone.0046837	http://dx.doi.org/10.1371/journal.pone.0046837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056479	gold, Green Published, Green Submitted			2022-12-27	WOS:000309889400030
J	Hendricks, WD; Byrum, CA; Meyer-Bernstein, EL				Hendricks, William D.; Byrum, Christine A.; Meyer-Bernstein, Elizabeth L.			Characterization of Circadian Behavior in the Starlet Sea Anemone, Nematostella vectensis	PLOS ONE			English	Article							CORAL ACROPORA-MILLEPORA; DIEL VERTICAL MIGRATION; RETINAL GANGLION-CELLS; ADRIATIC SEA; RHYTHMS; LIGHT; JELLYFISH; EXPANSION; RESPONSES; CYCLES	Background: Although much is known about how circadian systems control daily cycles in the physiology and behavior of Drosophila and several vertebrate models, marine invertebrates have often been overlooked in circadian rhythms research. This study focuses on the starlet sea anemone, Nematostella vectensis, a species that has received increasing attention within the scientific community for its potential as a model research organism. The recently sequenced genome of N. vectensis makes it an especially attractive model for exploring the molecular evolution of circadian behavior. Critical behavioral data needed to correlate gene expression patterns to specific behaviors are currently lacking in N. vectensis. Methodology/Principal Findings: To detect the presence of behavioral oscillations in N. vectensis, locomotor activity was evaluated using an automated system in an environmentally controlled chamber. Animals exposed to a 24 hr photoperiod (12 hr light: 12 hr dark) exhibited locomotor behavior that was both rhythmic and predominantly nocturnal. The activity peak occurred in the early half of the night with a 2-fold increase in locomotion. Upon transfer to constant lighting conditions (constant light or constant dark), an approximately 24 hr rhythm persisted in most animals, suggesting that the rhythm is controlled by an endogenous circadian mechanism. Fourier analysis revealed the presence of multiple peaks in some animals suggesting additional rhythmic components could be present. In particular, an approximately 12 hr oscillation was often observed. The nocturnal increase in generalized locomotion corresponded to a 24 hr oscillation in animal elongation. Conclusions/Significance: These data confirm the presence of a light-entrainable circadian clock in Nematostella vectensis. Additional components observed in some individuals indicate that an endogenous clock of approximately 12 hr frequency may also be present. By describing rhythmic locomotor behavior in N. vectensis, we have made important progress in developing the sea anemone as a model organism for circadian rhythm research.	[Meyer-Bernstein, Elizabeth L.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; Coll Charleston, Program Neurosci, Charleston, SC 29424 USA	College of Charleston; College of Charleston	Meyer-Bernstein, EL (corresponding author), Coll Charleston, Dept Biol, Charleston, SC 29424 USA.	meyerbernsteine@cofc.edu		Hendricks, William/0000-0003-2841-577X; Byrum, Christine/0000-0002-6653-7922	National Institutes of Health (NIH) from the National Center for Research Resource; College of Charleston; Howard Hughes Medical Institute (HHMI); NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Center for Research Resource; College of Charleston; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by National Institutes of Health (NIH) Grant P20 RR-016461 from the National Center for Research Resource, The College of Charleston, and a Howard Hughes Medical Institute (HHMI) Undergraduate Education Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2004, ZOOL SCI, V21, P29, DOI 10.2108/zsj.21.29; Akiyama T, 1997, ZOOL SCI, V14, P901, DOI 10.2108/zsj.14.901; ANDERSON DM, 1987, NATURE, V325, P616, DOI 10.1038/325616a0; BATHAM EJ, 1950, J EXP BIOL, V27, P377; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Chabot CC, 2008, BIOL BULL-US, V215, P34, DOI 10.2307/25470681; Churcher AM, 2011, GENOME BIOL EVOL, V3, P36, DOI 10.1093/gbe/evq079; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; DOWSE HB, 1990, PROG CLIN BIOL RES, V341, P691; ELLIOTT J, 1989, BIOL BULL-US, V176, P218, DOI 10.2307/1541980; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Gray DR, 1999, ANIM BEHAV, V57, P387, DOI 10.1006/anbe.1998.0975; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Hoadley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019755; Honda N, 2009, FISHERIES SCI, V75, P947, DOI 10.1007/s12562-009-0114-0; Imafuku M, 1980, PUBLICATIONS SETO MA, V25; Kaartvedt S, 2007, LIMNOL OCEANOGR, V52, P975, DOI 10.4319/lo.2007.52.3.0975; Last KS, 2009, CHRONOBIOL INT, V26, P167, DOI 10.1080/07420520902774524; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Levy O, 2006, J EXP BIOL, V209, P273, DOI 10.1242/jeb.01983; Levy O, 2003, J EXP BIOL, V206, P4041, DOI 10.1242/jeb.00622; Levy O, 2001, BIOL BULL, V200, P118, DOI 10.2307/1543305; Lucic D, 2009, MAR ECOL-EVOL PERSP, V30, P16, DOI 10.1111/j.1439-0485.2008.00264.x; Malej A, 2007, MAR BIOL, V151, P827, DOI 10.1007/s00227-006-0503-1; Meyer-Bernstein EL, 2001, NEUROSCIENTIST, V7, P496, DOI 10.1177/107385840100700606; MILLS CE, 1983, J PLANKTON RES, V5, P619, DOI 10.1093/plankt/5.5.619; MORI S, 1960, COLD SPRING HARB SYM, V25, P333, DOI 10.1101/SQB.1960.025.01.034; Naylor E., 1985, Symposia of the Society for Experimental Biology, P63; Palmer JD, 2000, BIOESSAYS, V22, P32, DOI 10.1002/(SICI)1521-1878(200001)22:1<32::AID-BIES7>3.3.CO;2-L; Parker GH, 1919, ELEMENTARY NERVOUS S, P150; PEARSE VB, 1974, BIOL BULL, V147, P641, DOI 10.2307/1540747; Pepiroon S, 1983, MAR BEHAV PHYSL, V9, P171; Plachetzki DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001054; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012805; Reitzel AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-230; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Schuyler Q, 1997, J PLANKTON RES, V19, P1417, DOI 10.1093/plankt/19.10.1417; SEBENS KP, 1977, MAR BIOL, V43, P247, DOI 10.1007/BF00402317; Shalapyonok A, 1998, APPL ENVIRON MICROB, V64, P1066; Spadinger R, 1999, FRESHWATER BIOL, V41, P567, DOI 10.1046/j.1365-2427.1999.00408.x; Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059; SWEENEY BM, 1976, BIOL BULL, V151, P236, DOI 10.2307/1540717; Vize PD, 2009, BIOL BULL-US, V216, P131; WARMAN CG, 1995, J EXP MAR BIOL ECOL, V189, P93, DOI 10.1016/0022-0981(95)00014-I; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729	48	19	19	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46843	10.1371/journal.pone.0046843	http://dx.doi.org/10.1371/journal.pone.0046843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056482	gold, Green Submitted, Green Published			2022-12-27	WOS:000309889400031
J	Krausz, C; Giachini, C; Lo Giacco, D; Daguin, F; Chianese, C; Ars, E; Ruiz-Castane, E; Forti, G; Rossi, E				Krausz, Csilla; Giachini, Claudia; Lo Giacco, Deborah; Daguin, Fabrice; Chianese, Chiara; Ars, Elisabet; Ruiz-Castane, Eduard; Forti, Gianni; Rossi, Elena			High Resolution X Chromosome-Specific Array-CGH Detects New CNVs in Infertile Males	PLOS ONE			English	Article							COPY NUMBER; Y-CHROMOSOME; POLYMORPHISMS; AZOOSPERMIA; GENES; MEN; OLIGOZOOSPERMIA; COHORT; GENOME	Context: The role of CNVs in male infertility is poorly defined, and only those linked to the Y chromosome have been the object of extensive research. Although it has been predicted that the X chromosome is also enriched in spermatogenesis genes, no clinically relevant gene mutations have been identified so far. Objectives: In order to advance our understanding of the role of X-linked genetic factors in male infertility, we applied high resolution X chromosome specific array-CGH in 199 men with different sperm count followed by the analysis of selected, patient-specific deletions in large groups of cases and normozoospermic controls. Results: We identified 73 CNVs, among which 55 are novel, providing the largest collection of X-linked CNVs in relation to spermatogenesis. We found 12 patient-specific deletions with potential clinical implication. Cancer Testis Antigen gene family members were the most frequently affected genes, and represent new genetic targets in relationship with altered spermatogenesis. One of the most relevant findings of our study is the significantly higher global burden of deletions in patients compared to controls due to an excessive rate of deletions/person (0.57 versus 0.21, respectively; p = 8.785x10(-6)) and to a higher mean sequence loss/person (11.79 Kb and 8.13 Kb, respectively; p = 3.435x10(-4)). Conclusions: By the analysis of the X chromosome at the highest resolution available to date, in a large group of subjects with known sperm count we observed a deletion burden in relation to spermatogenic impairment and the lack of highly recurrent deletions on the X chromosome. We identified a number of potentially important patient-specific CNVs and candidate spermatogenesis genes, which represent novel targets for future investigations.	[Krausz, Csilla; Giachini, Claudia; Daguin, Fabrice; Chianese, Chiara] Univ Florence, Dept Clin Physiopathol, Mol Genet Lab, Unit Sexual Med & Androl, Florence, Italy; [Krausz, Csilla; Lo Giacco, Deborah; Ruiz-Castane, Eduard] Fundacio Puigvert, Androl Serv, Barcelona, Spain; [Lo Giacco, Deborah; Ars, Elisabet] Univ Autonoma Barcelona, Fundacio Puigvert, Mol Biol Lab, E-08193 Barcelona, Spain; [Forti, Gianni] Univ Florence, Dept Clin Physiopathol, Endocrinol Unit, Florence, Italy; [Rossi, Elena] Univ Pavia, I-27100 Pavia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Florence; Fundacio Puigvert; Autonomous University of Barcelona; Fundacio Puigvert; University of Florence; University of Pavia	Krausz, C (corresponding author), Univ Florence, Dept Clin Physiopathol, Mol Genet Lab, Unit Sexual Med & Androl, Florence, Italy.	c.krausz@dfc.unifi.it	Ars, Elisabet/AAM-8454-2021; Rossi, Elena/O-1664-2016	Ars, Elisabet/0000-0002-4118-4358; Rossi, Elena/0000-0001-9152-435X; Krausz, Csilla Gabriella/0000-0001-6748-8918	Tuscan Regional Health Research Program; Italian Ministry of University; Italian Telethon [GGP08204]; Spanish Ministry of Health [FIS-08/1138, FIS-11/02254]	Tuscan Regional Health Research Program; Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Italian Telethon(Fondazione Telethon); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported by the Tuscan Regional Health Research Program ("Progetto Salute 2009") to GF, the Italian Ministry of University (grant PRIN 2010-2012 to CK), the Italian Telethon (Grant GGP08204 to CK) and the Spanish Ministry of Health (grant FIS-08/1138, grant FIS-11/02254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Aston KI, 2009, J ANDROL, V30, P711, DOI 10.2164/jandrol.109.007971; DELCASTILLO EB, 1947, J CLIN ENDOCRINOL, V7, P493; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Jensen TK, 2009, AM J EPIDEMIOL, V170, P559, DOI 10.1093/aje/kwp168; Jorgez CJ, 2011, J CLIN ENDOCR METAB, V96, pE674, DOI 10.1210/jc.2010-2018; Krausz C, 2011, J ENDOCRINOL INVEST, V34, P376, DOI [10.1007/BF03347463, 10.3275/7612]; Krausz C, 2009, J MED GENET, V46, P21, DOI 10.1136/jmg.2008.059915; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; Maduro MR, 2003, MOL HUM REPROD, V9, P61, DOI 10.1093/molehr/gag013; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Nuti F, 2008, REPROD BIOMED ONLINE, V16, P504, DOI 10.1016/S1472-6483(10)60457-9; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Salonia A, 2009, EUR UROL, V56, P1025, DOI 10.1016/j.eururo.2009.03.001; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stevenson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-129; Stouffs K, HUM REPROD, V27, P921; Stouffs K, 2009, HUM REPROD UPDATE, V15, P623, DOI 10.1093/humupd/dmp023; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; Tuttelmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019426; Tyler-Smith C, 2009, NEW ENGL J MED, V360, P925, DOI 10.1056/NEJMe0900301; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927	26	52	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e44887	10.1371/journal.pone.0044887	http://dx.doi.org/10.1371/journal.pone.0044887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056185	gold, Green Published, Green Submitted			2022-12-27	WOS:000309889400005
J	Field, D; Begley, M; O'Connor, PM; Daly, KM; Hugenholtz, F; Cotter, PD; Hill, C; Ross, RP				Field, Des; Begley, Maire; O'Connor, Paula M.; Daly, Karen M.; Hugenholtz, Floor; Cotter, Paul D.; Hill, Colin; Ross, R. Paul			Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; C-TERMINAL PART; ANTIMICROBIAL ACTIVITY; LANTIBIOTIC NISIN; PEPTIDE; BIOSYNTHESIS; ENTEROCOCCI; EXPRESSION; IMMUNITY; MODE	Nisin is a bacteriocin widely utilized in more than 50 countries as a safe and natural antibacterial food preservative. It is the most extensively studied bacteriocin, having undergone decades of bioengineering with a view to improving function and physicochemical properties. The discovery of novel nisin variants with enhanced activity against clinical and foodborne pathogens has recently been described. We screened a randomized bank of nisin A producers and identified a variant with a serine to glycine change at position 29 (S29G), with enhanced efficacy against S. aureus SA113. Using a site-saturation mutagenesis approach we generated three more derivatives (S29A, S29D and S29E) with enhanced activity against a range of Gram positive drug resistant clinical, veterinary and food pathogens. In addition, a number of the nisin S29 derivatives displayed superior antimicrobial activity to nisin A when assessed against a range of Gram negative food-associated pathogens, including E. coli, Salmonella enterica serovar Typhimurium and Cronobacter sakazakii. This is the first report of derivatives of nisin, or indeed any lantibiotic, with enhanced antimicrobial activity against both Gram positive and Gram negative bacteria.	[O'Connor, Paula M.; Cotter, Paul D.; Ross, R. Paul] Moorepark Food Res Ctr, TEAGASC, Fermoy, Cork, Ireland; [Field, Des; Begley, Maire; Daly, Karen M.; Hugenholtz, Floor; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Cotter, Paul D.; Hill, Colin; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	Teagasc; University College Cork; University College Cork	Cotter, PD (corresponding author), Moorepark Food Res Ctr, TEAGASC, Fermoy, Cork, Ireland.	paul.cotter@teagasc.ie; c.hill@ucc.ie	Ross, Paul/A-7584-2015; Field, Des/AAU-6785-2021; Cotter, Paul/AAX-5449-2021; Hill, Colin/A-5611-2012; Cotter, Paul/B-7781-2008; STANTON, CATHERINE/A-9549-2015	Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; Hill, Colin/0000-0002-8527-1445; Cotter, Paul/0000-0002-5465-9068; Field, Des/0000-0003-4425-5817; O'Connor, Paula M./0000-0001-6462-2077; Hugenholtz, Floor/0000-0001-8173-197X; STANTON, CATHERINE/0000-0002-6724-7011	Irish Government under the National Development Plan, through Science Foundation Ireland Investigator awards [10/IN.1/B3027, 06/IN.1/B98]	Irish Government under the National Development Plan, through Science Foundation Ireland Investigator awards(Science Foundation Ireland)	This work was supported by the Irish Government under the National Development Plan, through Science Foundation Ireland Investigator awards (10/IN.1/B3027) and (06/IN.1/B98) (http://www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard AN, 2009, CHEM BIOL, V16, P490, DOI 10.1016/j.chembiol.2009.03.011; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Bonev B, 2008, J ANTIMICROB CHEMOTH, V61, P1295, DOI 10.1093/jac/dkn090; Breukink E, 1998, BIOCHEMISTRY-US, V37, P8153, DOI 10.1021/bi972797l; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brumfitt W, 2002, J ANTIMICROB CHEMOTH, V50, P731, DOI 10.1093/jac/dkf190; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Carroll James, 2010, Bioeng Bugs, V1, P408, DOI 10.4161/bbug.1.6.13642; Chan WC, 1996, FEBS LETT, V390, P129, DOI 10.1016/0014-5793(96)00638-2; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Delves-Broughton J, 2005, FOOD AUST, V57, P525; Demel RA, 1996, EUR J BIOCHEM, V235, P267, DOI 10.1111/j.1432-1033.1996.00267.x; DODD HM, 1992, APPL ENVIRON MICROB, V58, P3683, DOI 10.1128/AEM.58.11.3683-3693.1992; DODD HM, 1995, GENE, V162, P163, DOI 10.1016/0378-1119(95)00342-4; Dodd HM, 1996, MICROBIOL-SGM, V142, P47, DOI 10.1099/13500872-142-1-47; Field D, 2008, MOL MICROBIOL, V69, P218, DOI 10.1111/j.1365-2958.2008.06279.x; Field D, 2010, MOL MICROBIOL, V78, P1077, DOI 10.1111/j.1365-2958.2010.07406.x; Field D, 2010, MICROB BIOTECHNOL, V3, P473, DOI 10.1111/j.1751-7915.2010.00184.x; Galvez A, 2010, CURR OPIN BIOTECH, V21, P142, DOI 10.1016/j.copbio.2010.01.005; Hoffmann A, 2004, APPL ENVIRON MICROB, V70, P3263, DOI 10.1128/AEM.70.6.3263-3271.2004; Islam MR, 2009, MOL MICROBIOL, V72, P1438, DOI 10.1111/j.1365-2958.2009.06733.x; KALCHAYANAND N, 1992, LETT APPL MICROBIOL, V15, P239, DOI 10.1111/j.1472-765X.1992.tb00773.x; Klein G, 2003, INT J FOOD MICROBIOL, V88, P123, DOI 10.1016/S0168-1605(03)00175-2; KUIPERS OP, 1992, J BIOL CHEM, V267, P24340; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kuipers OP, 1996, ANTON LEEUW INT J G, V69, P161, DOI 10.1007/BF00399421; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Martin I, 1996, EUR J BIOCHEM, V239, P156, DOI 10.1111/j.1432-1033.1996.0156u.x; McGowan LL, 2006, J FOOD PROTECT, V69, P2976, DOI 10.4315/0362-028X-69.12.2976; Mondino SSB, 2003, MICROB DRUG RESIST, V9, P167, DOI 10.1089/107662903765826769; Naghmouchi K, 2010, PROBIOTICS ANTIMICRO, V2, P98, DOI 10.1007/s12602-009-9033-8; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; O'Driscoll J, 2004, APPL ENVIRON MICROB, V70, P5546, DOI 10.1128/AEM.70.9.5546-5556.2004; Piper Clare, 2009, Curr Drug Discov Technol, V6, P1; Piper C, 2009, J ANTIMICROB CHEMOTH, V64, P546, DOI 10.1093/jac/dkp221; Rink R, 2007, APPL ENVIRON MICROB, V73, P5809, DOI 10.1128/AEM.01104-07; ROLLEMA HS, 1995, APPL ENVIRON MICROB, V61, P2873, DOI 10.1128/AEM.61.8.2873-2878.1995; Rouse S, 2012, MICROB BIOTECHNOL, V5, P501, DOI 10.1111/j.1751-7915.2011.00324.x; SAHL H, 2008, MICROBE, V3, P467; Sen AK, 1999, EUR J BIOCHEM, V261, P524, DOI 10.1046/j.1432-1327.1999.00303.x; Severina E, 1998, J ANTIMICROB CHEMOTH, V41, P341, DOI 10.1093/jac/41.3.341; STEVENS KA, 1991, APPL ENVIRON MICROB, V57, P3613, DOI 10.1128/AEM.57.12.3613-3615.1991; Sun ZZ, 2009, ANTIMICROB AGENTS CH, V53, P1964, DOI 10.1128/AAC.01382-08; Vaara M, 2010, CURR OPIN MICROBIOL, V13, P574, DOI 10.1016/j.mib.2010.09.002; van Kraaij C, 1999, NAT PROD REP, V16, P575, DOI 10.1039/a804531c; van Kraaij C, 1998, BIOCHEMISTRY-US, V37, P16033, DOI 10.1021/bi980931b; van Kraaij C, 2000, EUR J BIOCHEM, V267, P901, DOI 10.1046/j.1432-1327.2000.01075.x; VanKraaij C, 1997, EUR J BIOCHEM, V247, P114; Viguier C, 2009, TRENDS BIOTECHNOL, V27, P486, DOI 10.1016/j.tibtech.2009.05.004; VILJANEN P, 1984, ANTIMICROB AGENTS CH, V25, P701, DOI 10.1128/AAC.25.6.701; Yuan J, 2004, APPL MICROBIOL BIOT, V64, P806, DOI 10.1007/s00253-004-1599-1	55	144	151	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46884	10.1371/journal.pone.0046884	http://dx.doi.org/10.1371/journal.pone.0046884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056510	gold, Green Published			2022-12-27	WOS:000309831500101
J	Lam, S; Chen, KC; Ng, MML; Chu, JJH				Lam, Shirley; Chen, Karen Caiyun; Ng, Mary Mah-Lee; Chu, Justin Jang Hann			Expression of Plasmid-Based shRNA against the E1 and nsP1 Genes Effectively Silenced Chikungunya Virus Replication	PLOS ONE			English	Article							INTERFERENCE-MEDIATED INHIBITION; RNA INTERFERENCE; MAMMALIAN-CELLS; SIRNA; INDUCTION; VACCINE; ACTIVATION; INFECTION	Background: Chikungunya virus (CHIKV) is a re-emerging alphavirus that causes chikungunya fever and persistent arthralgia in humans. Currently, there is no effective vaccine or antiviral against CHIKV infection. Therefore, this study evaluates whether RNA interference which targets at viral genomic level may be a novel antiviral strategy to inhibit the medically important CHIKV infection. Methods: Plasmid-based small hairpin RNA (shRNA) was investigated for its efficacy in inhibiting CHIKV replication. Three shRNAs designed against CHIKV Capsid, E1 and nsP1 genes were transfected to establish stable shRNA-expressing cell clones. Following infection of stable shRNA cells clones with CHIKV at M.O.I. 1, viral plaque assay, Western blotting and transmission electron microscopy were performed. The in vivo efficacy of shRNA against CHIKV replication was also evaluated in a suckling murine model of CHIKV infection. Results: Cell clones expressing shRNAs against CHIKV E1 and nsP1 genes displayed significant inhibition of infectious CHIKV production, while shRNA Capsid demonstrated a modest inhibitory effect as compared to scrambled shRNA cell clones and non-transfected cell controls. Western blot analysis of CHIKV E2 protein expression and transmission electron microscopy of shRNA E1 and nsP1 cell clones collectively demonstrated similar inhibitory trends against CHIKV replication. shRNA E1 showed non cell-type specific anti-CHIKV effects and broad-spectrum silencing against different geographical strains of CHIKV. Furthermore, shRNA E1 clones did not exert any inhibition against Dengue virus and Sindbis virus replication, thus indicating the high specificity of shRNA against CHIKV replication. Moreover, no shRNA-resistant CHIKV mutant was generated after 50 passages of CHIKV in the stable cell clones. More importantly, strong and sustained anti-CHIKV protection was conferred in suckling mice pre-treated with shRNA E1. Conclusion: Taken together, these data suggest the promising efficacy of anti-CHIKV shRNAs, in particular, plasmid-shRNA E1, as a novel antiviral strategy against CHIKV infection.	[Lam, Shirley; Chen, Karen Caiyun; Chu, Justin Jang Hann] Natl Univ Singapore, Yong Loo Lin Sch Med, Lab Mol RNA Virol & Antiviral Strategies, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Ng, Mary Mah-Lee] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Flavivirol Lab,Dept Microbiol, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Chu, JJH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Lab Mol RNA Virol & Antiviral Strategies, Natl Univ Hlth Syst, Singapore 117595, Singapore.	miccjh@nus.edu.sg	Chu, Justin Jang Hann/ABA-8297-2021; Ng, Mei Li/Q-3704-2016	Ng, Mei Li/0000-0001-9917-4534; Chu, Justin Jang Hann/0000-0002-1673-6819	Singapore Biomedical Research Council; Agency of Science & Technology Research grant [R182-000-158-305]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency of Science & Technology Research grant	This study is supported by the Singapore Biomedical Research Council, Agency of Science & Technology Research grant (R182-000-158-305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; BRIGHTON SW, 1984, S AFR MED J, V66, P217; Chen Y, 2003, BIOCHEM BIOPH RES CO, V311, P398, DOI 10.1016/j.bbrc.2003.10.009; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dahlgren C, 2006, BIOCHEM BIOPH RES CO, V341, P1211, DOI 10.1016/j.bbrc.2006.01.085; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Dash PK, 2008, BIOCHEM BIOPH RES CO, V376, P718, DOI 10.1016/j.bbrc.2008.09.040; de Lamballerie Xavier, 2009, Infectious Disorders - Drug Targets, V9, P101; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; HARRISON VR, 1971, J IMMUNOL, V107, P643; HENLE W, 1959, J EXP MED, V110, P525, DOI 10.1084/jem.110.4.525; Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004; Konishi M, 2006, J VIRAL HEPATITIS, V13, P756, DOI 10.1111/j.1365-2893.2006.00752.x; Leroy E, 2008, J VIROL, V5, P114; LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4; Matsumiya T, 2007, J IMMUNOL, V179, P4542, DOI 10.4049/jimmunol.179.7.4542; McClain DJ, 1998, J INFECT DIS, V177, P634, DOI 10.1086/514240; Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486; Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0; Noridah O, 2007, Med J Malaysia, V62, P323; O'Brien L, 2007, ANTIVIR RES, V75, P20, DOI 10.1016/j.antiviral.2006.11.007; Ong SP, 2008, VIRUS RES, V135, P292, DOI 10.1016/j.virusres.2008.04.014; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Raemdonck K, 2006, BIOCHEMISTRY-US, V45, P10614, DOI 10.1021/bi060351b; ROBINSON M. C., 1955, TANGANYIKA TERRITORY IN 1952 53 I TRANS ROY SOC TROP MED AND HYG, V49, P28, DOI 10.1016/0035-9203(55)90080-8; Saraswathy TS, 2010, ANN MICROSCOPY, V10, P36; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Seyhan AA, 2007, OLIGONUCLEOTIDES, V17, P473, DOI 10.1089/oli.2007.0079; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sui HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005671; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10; Yang J, 2009, BBA-GENE REGUL MECH, V1789, P642, DOI 10.1016/j.bbagrm.2009.05.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	30	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46396	10.1371/journal.pone.0046396	http://dx.doi.org/10.1371/journal.pone.0046396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056297	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500039
J	Little, R; Slavny, P; Dixon, R				Little, Richard; Slavny, Peter; Dixon, Ray			Influence of PAS Domain Flanking Regions on Oligomerisation and Redox Signalling By NifL	PLOS ONE			English	Article							AZOTOBACTER-VINELANDII NIFL; REGULATORY PROTEIN; NITROGEN-FIXATION; TRANSDUCTION; LIGHT; DIMERIZATION; MECHANISM; SYSTEM; SWITCH; 2-OXOGLUTARATE	Per-ARNT-Sim (PAS) domains constitute a typically dimeric, conserved alpha/beta tertiary fold of approximately 110 amino acids that perform signalling roles in diverse proteins from all kingdoms of life. The amino terminal PAS1 domain of NifL from Azotobacter vinelandii accommodates a redox-active FAD group; elevation of cytosolic oxygen concentrations result in FAD oxidation and a concomitant conformational re-arrangement that is relayed via a short downstream linker to a second PAS domain, PAS2. At PAS2, the signal is amplified and passed on to effector domains generating the 'on' (inhibitory) state of the protein. Although the crystal structure of oxidised PAS1 reveals regions that contribute to the dimerisation interface, 21 amino acids at the extreme N-terminus of NifL, are unresolved. Furthermore, the structure and function of the linker between the two PAS domains has not been determined. In this study we have investigated the importance to signalling of residues extending beyond the core PAS fold. Our results implicate the N-terminus of PAS1 and the helical linker connecting the two PAS domains in redox signal transduction and demonstrate a role for these flanking regions in controlling the oligomerisation state of PAS1 in solution.	[Little, Richard; Slavny, Peter; Dixon, Ray] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dixon, R (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich Res Pk, Norwich, Norfolk, England.	ray.dixon@jic.ac.uk		Slavny, Peter/0000-0003-0757-8326; Dixon, Ray/0000-0002-6348-639X	Biotechnology and Biological Sciences Research Council [BB/J004561/1]; John Innes Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000016] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grant BB/J004561/1 from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) and the John Innes Foundation (www.jic.ac.uk).	Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Etzkorn M, 2008, NAT STRUCT MOL BIOL, V15, P1031, DOI 10.1038/nsmb.1493; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Hefti MH, 2001, ANAL BIOCHEM, V295, P180, DOI 10.1006/abio.2001.5214; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Hill S, 1996, P NATL ACAD SCI USA, V93, P2143, DOI 10.1073/pnas.93.5.2143; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; Little R, 2000, EMBO J, V19, P6041, DOI 10.1093/emboj/19.22.6041; Little R, 2003, J BIOL CHEM, V278, P28711, DOI 10.1074/jbc.M301992200; Little R, 2002, J BIOL CHEM, V277, P15472, DOI 10.1074/jbc.M112262200; Little R, 2007, J BIOL CHEM, V282, P13429, DOI 10.1074/jbc.M610827200; Little R, 2011, MOL MICROBIOL, V82, P222, DOI 10.1111/j.1365-2958.2011.07812.x; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Martinez-Argudo I, 2004, P NATL ACAD SCI USA, V101, P16316, DOI 10.1073/pnas.0405312101; Martinez-Argudo I, 2004, J BACTERIOL, V186, P601, DOI 10.1128/JB.186.3.601-610.2004; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2010, J MOL BIOL, V400, P477, DOI 10.1016/j.jmb.2010.05.019; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Nan BY, 2010, MOL MICROBIOL, V75, P1484, DOI 10.1111/j.1365-2958.2010.07069.x; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Perry S, 2005, J MOL BIOL, V346, P935, DOI 10.1016/j.jmb.2004.12.033; Reyes-Ramirez F, 2001, J BACTERIOL, V183, P3076, DOI 10.1128/JB.183.10.3076-3082.2001; Slavny P, 2010, MOL MICROBIOL, V75, P61, DOI 10.1111/j.1365-2958.2009.06956.x; Soderback E, 1998, MOL MICROBIOL, V28, P179, DOI 10.1046/j.1365-2958.1998.00788.x; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Zoltowski BD, 2008, BIOCHEMISTRY-US, V47, P7012, DOI 10.1021/bi8007017	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46651	10.1371/journal.pone.0046651	http://dx.doi.org/10.1371/journal.pone.0046651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056386	gold, Green Submitted, Green Published			2022-12-27	WOS:000309831500055
J	Nye, JVC; Androuschak, G; Desierto, D; Jones, G; Yudkevich, M				Nye, John V. C.; Androuschak, Gregory; Desierto, Desiree; Jones, Garett; Yudkevich, Maria			2D:4D Asymmetry and Gender Differences in Academic Performance	PLOS ONE			English	Article							DIGIT RATIO 2D/4D; TESTOSTERONE	Exposure to prenatal androgens affects both future behavior and life choices. However, there is still relatively limited evidence on its effects on academic performance. Moreover, the predicted effect of exposure to prenatal testosterone (T)-which is inversely correlated with the relative length of the second to fourth finger lengths (2D:4D)-would seem to have ambiguous effects on academic achievement since traits like aggressiveness or risk-taking are not uniformly positive for success in school. We provide the first evidence of a non-linear, quadratic, relationship between 2D:4D and academic achievement using samples from Moscow and Manila. We also find that there is a gender differentiated link between various measures of academic achievement and measured digit ratios. These effects are different depending on the field of study, choice of achievement measure, and use of the right hand or left digit ratios. The results seem to be asymmetric between Moscow and Manila where the right (left) hand generates inverted-U (U-shaped) curves in Moscow while the pattern for hands reverses in Manila. Drawing from unusually large and detailed samples of university students in two countries not studied in the digit literature, our work is the first to have a large cross country comparison that includes two groups with very different ethnic compositions.	[Nye, John V. C.; Jones, Garett] George Mason Univ, Dept Econ, Fairfax, VA 22030 USA; [Androuschak, Gregory; Yudkevich, Maria] Natl Res Univ, Higher Sch Econ, Lab Inst Anal Econ Reforms, Moscow, Russia; [Desierto, Desiree] Univ Philippines, Sch Econ, Quezon City 1101, Philippines	George Mason University; HSE University (National Research University Higher School of Economics); University of the Philippines System; University of the Philippines Diliman	Nye, JVC (corresponding author), George Mason Univ, Dept Econ, Fairfax, VA 22030 USA.	jnye@gmu.edu	Yudkevich, Maria/G-9608-2015; Nye, John/D-9246-2016	Yudkevich, Maria/0000-0001-9753-0902; Nye, John/0000-0001-9316-9929				Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Branas-Garza P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029842; Brosnan M, 2011, PERS INDIV DIFFER, V51, P371, DOI 10.1016/j.paid.2010.07.009; Brosnan MJ, 2008, BRIT J PSYCHOL, V99, P75, DOI 10.1348/000712607X197406; Bull R, 2010, LEARN INDIVID DIFFER, V20, P246, DOI 10.1016/j.lindif.2009.12.002; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; DeRaad B, 1996, EUR J PERSONALITY, V10, P303, DOI 10.1002/(SICI)1099-0984(199612)10:5<303::AID-PER262>3.0.CO;2-2; Heckman JJ, 2006, J LABOR ECON, V24, P411, DOI 10.1086/504455; Honekopp J, 2011, PERS INDIV DIFFER, V51, P381, DOI 10.1016/j.paid.2010.05.003; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019332; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT., 2002, DIGIT RATIO; Plomin R, 1997, INTELLIGENCE, V24, P53, DOI 10.1016/S0160-2896(97)90013-1; Romano M, 2006, BIOL PSYCHOL, V71, P175, DOI 10.1016/j.biopsycho.2005.03.006; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Stenstrom E, 2011, PERS INDIV DIFFER, V51, P412, DOI 10.1016/j.paid.2010.07.003; Voracek M, 2011, PERS INDIV DIFFER, V51, P417, DOI 10.1016/j.paid.2010.06.009	18	15	16	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46319	10.1371/journal.pone.0046319	http://dx.doi.org/10.1371/journal.pone.0046319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056282	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500033
J	Tan, YY; Kodzius, R; Tay, BH; Tay, A; Brenner, S; Venkatesh, B				Tan, Yue Ying; Kodzius, Rimantas; Tay, Boon-Hui; Tay, Alice; Brenner, Sydney; Venkatesh, Byrappa			Sequencing and Analysis of Full-Length cDNAs, 5 '-ESTs and 3 '-ESTs from a Cartilaginous Fish, the Elephant Shark (Callorhinchus milii)	PLOS ONE			English	Article							NONCODING RNAS; SALMO-SALAR; TRANSCRIPTOME; DATABASE; GENOME; ANNOTATION; GNATHOSTOMES; CONSTRUCTION; ELASMOBRANCH; VERTEBRATE	Cartilaginous fishes are the most ancient group of living jawed vertebrates (gnathostomes) and are, therefore, an important reference group for understanding the evolution of vertebrates. The elephant shark (Callorhinchus milii), a holocephalan cartilaginous fish, has been identified as a model cartilaginous fish genome because of its compact genome (similar to 910 Mb) and a genome project has been initiated to obtain its whole genome sequence. In this study, we have generated and sequenced full-length enriched cDNA libraries of the elephant shark using the 'oligo-capping' method and Sanger sequencing. A total of 6,778 full-length protein-coding cDNA and 10,701 full-length noncoding cDNA were sequenced from six tissues (gills, intestine, kidney, liver, spleen, and testis) of the elephant shark. Analysis of their polyadenylation signals showed that polyadenylation usage in elephant shark is similar to that in mammals. Furthermore, both coding and noncoding transcripts of the elephant shark use the same proportion of canonical polyadenylation sites. Besides BLASTX searches, protein-coding transcripts were annotated by Gene Ontology, InterPro domain, and KEGG pathway analyses. By comparing elephant shark genes to bony vertebrate genes, we identified several ancient genes present in elephant shark but differentially lost in tetrapods or teleosts. Only similar to 6% of elephant shark noncoding cDNA showed similarity to known noncoding RNAs (ncRNAs). The rest are either highly divergent ncRNAs or novel ncRNAs. In addition to full-length transcripts, 30,375 5'-ESTs and 41,317 3'-ESTs were sequenced and annotated. The clones and transcripts generated in this study are valuable resources for annotating transcription start sites, exon-intron boundaries, and UTRs of genes in the elephant shark genome, and for the functional characterization of protein sequences. These resources will also be useful for annotating genes in other cartilaginous fishes whose genomes have been targeted for whole genome sequencing.	[Tan, Yue Ying; Kodzius, Rimantas; Tay, Boon-Hui; Tay, Alice; Brenner, Sydney; Venkatesh, Byrappa] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore, Singapore; [Venkatesh, Byrappa] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Venkatesh, B (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore, Singapore.	mcbbv@imcb.a-star.edu.sg	K, Rimantas/H-4512-2019	K, Rimantas/0000-0001-9417-8894; Venkatesh, Byrappa/0000-0003-3620-0277	Biomedical Research Council of A*STAR, Singapore	Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	This project was funded by the Biomedical Research Council of A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-502; Andrew W, 1974, CIRCULATORY SYSTEMS, P133; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bernardi G, 2012, MAR GENOM, V7, P3, DOI 10.1016/j.margen.2012.02.002; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Bussotti G, 2011, NUCLEIC ACIDS RES, V39, P6886, DOI 10.1093/nar/gkr335; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Chen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011546; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; HART S, 1988, DEV COMP IMMUNOL, V12, P453, DOI 10.1016/0145-305X(88)90065-1; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Hubbard SJ, 2005, GENOME RES, V15, P174, DOI 10.1101/gr.3011405; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Inoue J, 2010, SYST BIOL, V59, P74, DOI 10.1093/sysbio/syp078; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; King BL, 2011, SCIENCE, V334, P1517, DOI 10.1126/science.1210912; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Morin RD, 2006, GENOME RES, V16, P796, DOI 10.1101/gr.4871006; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nazarian J, 2011, MAR GENOM, V4, P33, DOI 10.1016/j.margen.2010.12.004; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Ohta Y, 2004, J IMMUNOL, V173, P4553, DOI 10.4049/jimmunol.173.7.4553; Oulion S, 2010, MOL BIOL EVOL, V27, P2829, DOI 10.1093/molbev/msq172; Parton A, 2010, COMP BIOCHEM PHYS D, V5, P199, DOI 10.1016/j.cbd.2010.04.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Sansom IJ, 1996, NATURE, V379, P628, DOI 10.1038/379628a0; Scheetz TE, 2004, GENOME RES, V14, P733, DOI 10.1101/gr.1414204; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Suzuki Yutaka, 2003, Methods Mol Biol, V221, P73; Takechi M, 2011, J EXP ZOOL PART B, V316B, P526, DOI 10.1002/jez.b.21427; Venkatesh B, 2005, CURR BIOL, V15, pR82, DOI 10.1016/j.cub.2005.01.021; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901	47	12	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47174	10.1371/journal.pone.0047174	http://dx.doi.org/10.1371/journal.pone.0047174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056606	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500143
J	Wimmerova, M; Kozmon, S; Necasova, I; Mishra, SK; Komarek, J; Koca, J				Wimmerova, Michaela; Kozmon, Stanislav; Necasova, Ivona; Mishra, Sushil Kumar; Komarek, Jan; Koca, Jaroslav			Stacking Interactions between Carbohydrate and Protein Quantified by Combination of Theoretical and Experimental Methods	PLOS ONE			English	Article							SMALL MOLECULAR-INTERACTIONS; DENSITY-FUNCTIONAL THEORY; SEPARATE TOTAL ENERGIES; INTERACTIONS AB-INITIO; DOT-PI-INTERACTIONS; O HYDROGEN-BONDS; AROMATIC INTERACTIONS; RALSTONIA-SOLANACEARUM; STRUCTURAL BASIS; EXCHANGE-ENERGY	Carbohydrate - receptor interactions are an integral part of biological events. They play an important role in many cellular processes, such as cell-cell adhesion, cell differentiation and in-cell signaling. Carbohydrates can interact with a receptor by using several types of intermolecular interactions. One of the most important is the interaction of a carbohydrate's apolar part with aromatic amino acid residues, known as dispersion interaction or CH/pi interaction. In the study presented here, we attempted for the first time to quantify how the CH/pi interaction contributes to a more general carbohydrate - protein interaction. We used a combined experimental approach, creating single and double point mutants with high level computational methods, and applied both to Ralstonia solanacearum (RSL) lectin complexes with alpha-L-Me-fucoside. Experimentally measured binding affinities were compared with computed carbohydrate-aromatic amino acid residue interaction energies. Experimental binding affinities for the RSL wild type, phenylalanine and alanine mutants were -8.5, -7.1 and -4.1 kcal.mol(-1), respectively. These affinities agree with the computed dispersion interaction energy between carbohydrate and aromatic amino acid residues for RSL wild type and phenylalanine, with values -8.8, -7.9 kcal.mol(-1), excluding the alanine mutant where the interaction energy was -0.9 kcal.mol(-1). Molecular dynamics simulations show that discrepancy can be caused by creation of a new hydrogen bond between the alpha-L-Me-fucoside and RSL. Observed results suggest that in this and similar cases the carbohydrate-receptor interaction can be driven mainly by a dispersion interaction.	[Wimmerova, Michaela; Kozmon, Stanislav; Koca, Jaroslav] Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Wimmerova, Michaela; Kozmon, Stanislav; Necasova, Ivona; Mishra, Sushil Kumar; Komarek, Jan; Koca, Jaroslav] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CS-61137 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Wimmerova, M (corresponding author), Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic.	michaw@chemi.muni.cz; jkoca@chemi.muni.cz	Mishra, Sushil K./AAV-9553-2021; Kozmon, Stanislav/D-8525-2012; Koca, Jaroslav/E-4460-2012; Komarek, Jan/N-5564-2019; Wimmerova, Michaela/A-4114-2010; Kozmon, Stanislav/AAQ-6945-2020; Nečasová, Ivona/ABB-7674-2020; Mishra, Sushil K./O-4779-2014	Mishra, Sushil K./0000-0002-3080-9754; Kozmon, Stanislav/0000-0002-0946-3453; Koca, Jaroslav/0000-0002-2780-4901; Komarek, Jan/0000-0003-4496-1658; Wimmerova, Michaela/0000-0002-7108-4198; Kozmon, Stanislav/0000-0002-0946-3453; Mishra, Sushil K./0000-0002-3080-9754	European Union under the Seventh Framework Programme by CEITEC from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; SYLICA [286154]; SoMoPro [2SGA2747, 229603]; Czech Science Foundation [GD301/09/H004,303/09/1168]; South Moravian region	European Union under the Seventh Framework Programme by CEITEC from European Regional Development Fund; SYLICA; SoMoPro; Czech Science Foundation(Grant Agency of the Czech Republic); South Moravian region	The research leading to these results obtained financial contribution from the European Union under the Seventh Framework Programme by CEITEC (CZ.1.05/1.1.00/02.0068) project from European Regional Development Fund, SYLICA (Contract No. 286154 under "Capacities" specific programme) and SoMoPro (No. 2SGA2747, under the FP/2007-2013 grant agreement No. 229603) programme, and the Czech Science Foundation (GD301/09/H004,303/09/1168). The research is also co-funded by the South Moravian region. The authors would like to thank the Czech National Supercomputing Centre, METACENTRUM, for providing computational resources. Access to the MetaCentrum computing facilities is provided under the research intent MSM6383917201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Ahlrichs R, 2009, TURBOMOLE V6 0; Arda A, 2011, CHEM-EUR J, V17, P4821, DOI 10.1002/chem.201002872; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bernardi A, 2004, CHEM-EUR J, V10, P4395, DOI 10.1002/chem.200400084; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Boys SF, 2002, MOL PHYS, V100, P65, DOI 10.1080/00268970110088901; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Campbell B, 2001, SMITHSONIAN, V32, P18; Case D.A., 2022, AMBER 2020; Cerny J, 2007, PHYS CHEM CHEM PHYS, V9, P5291, DOI 10.1039/b704781a; Cobb BA, 2005, EUR J IMMUNOL, V35, P352, DOI 10.1002/eji.200425889; DeMarco ML, 2008, GLYCOBIOLOGY, V18, P426, DOI 10.1093/glycob/cwn026; Dreitlein WB, 2001, CLIN THER, V23, P327, DOI 10.1016/S0149-2918(01)80042-4; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Fernandez MD, 2005, J AM CHEM SOC, V127, P7379, DOI 10.1021/ja051020+; Grabowski SJ, 2011, J PHYS CHEM A, V115, P4765, DOI 10.1021/jp2005327; Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hattig C, 2000, J CHEM PHYS, V113, P5154, DOI 10.1063/1.1290013; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Hosono M, 2005, BBA-GEN SUBJECTS, V1725, P160, DOI 10.1016/j.bbagen.2005.07.009; Jimenez-Barbero J, 2006, ACS SYM SER, V930, P60; Jimenez-Barbero J, 2006, ADV CARBOHYD CHEM BI, V60, P303, DOI 10.1016/S0065-2318(06)60007-3; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; Klaholz BP, 2002, STRUCTURE, V10, P1197, DOI 10.1016/S0969-2126(02)00828-6; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; Kozmon S, 2011, CHEM-EUR J, V17, P5680, DOI 10.1002/chem.201002876; Kumar RM, 2010, J PHYS CHEM A, V114, P4313, DOI 10.1021/jp907547f; Kumari M, 2011, PHYS CHEM CHEM PHYS, V13, P6517, DOI 10.1039/c0cp02559c; Lucas R, 2011, J AM CHEM SOC, V133, P1909, DOI 10.1021/ja108962j; Manikandan K, 2004, PROTEINS, V56, P768, DOI 10.1002/prot.20152; Maresca M, 2008, PHYS CHEM CHEM PHYS, V10, P2792, DOI 10.1039/b802594k; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Patrick WM, 2010, FEBS J, V277, P4549, DOI 10.1111/j.1742-4658.2010.07869.x; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; PERDEW JP, 1986, PHYS REV B, V33, P8800, DOI 10.1103/PhysRevB.33.8800; Pitonak M, 2008, CHEMPHYSCHEM, V9, P1636, DOI 10.1002/cphc.200800286; Raju RK, 2008, PHYS CHEM CHEM PHYS, V10, P6500, DOI 10.1039/b809164a; Ramirez-Gualito K., 2010, J NAT PRODUCTS, V73, P1623; Ramirez-Gualito K, 2009, J AM CHEM SOC, V131, P18129, DOI 10.1021/ja903950t; Riley KE, 2007, J PHYS CHEM A, V111, P8257, DOI 10.1021/jp073358r; Scheiner S, 2001, J BIOL CHEM, V276, P9832, DOI 10.1074/jbc.M010770200; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharma R, 2008, PHYS CHEM CHEM PHYS, V10, P2767, DOI 10.1039/b719764k; Spiwok V, 2004, CARBOHYD RES, V339, P2275, DOI 10.1016/j.carres.2004.06.016; Su Z, 2009, CHEM PHYS LETT, V471, P17, DOI 10.1016/j.cplett.2009.02.043; Sujatha MS, 2007, J MOL STRUC-THEOCHEM, V814, P11, DOI 10.1016/j.theochem.2007.02.032; Takahashi O, 2010, CHEM REV, V110, P6049, DOI 10.1021/cr100072x; Terraneo G, 2007, J AM CHEM SOC, V129, P2890, DOI 10.1021/ja066633g; Tsuzuki S, 2009, J PHYS CHEM B, V113, P5617, DOI 10.1021/jp8093726; Vacas T, 2010, J AM CHEM SOC, V132, P12074, DOI 10.1021/ja1046439; Watanabe Y, 2009, J CHROMATOGR A, V1216, P8563, DOI 10.1016/j.chroma.2009.10.046; Weigend F, 1998, CHEM PHYS LETT, V294, P143, DOI 10.1016/S0009-2614(98)00862-8; Weigend F, 1997, THEOR CHEM ACC, V97, P331, DOI 10.1007/s002140050269; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weiss MS, 2001, TRENDS BIOCHEM SCI, V26, P521, DOI 10.1016/S0968-0004(01)01935-1; Woods RJ, 2008, J COMPUT CHEM, V29, P622	62	48	48	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46032	10.1371/journal.pone.0046032	http://dx.doi.org/10.1371/journal.pone.0046032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056230	gold, Green Submitted, Green Published			2022-12-27	WOS:000309831500025
J	Zhao, J; Li, QL; Bi, HY				Zhao, Jing; Li, Qing-Lin; Bi, Hong-Yan			The Characteristics of Chinese Orthographic Neighborhood Size Effect for Developing Readers	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; LEXICAL ACCESS; FREQUENCY; CHILDREN; ACQUISITION; ACTIVATION; SKILLS; AGE	Orthographic neighborhood size (N size) effect in Chinese character naming has been studied in adults. In the present study, we aimed to explore the developmental characteristics of Chinese N size effect. One hundred and seventeen students (40 from the 3rd grade with mean age of 9 years; 40 from the 5th grade with mean age of 11 years; 37 from the 7th grade with mean age of 13 years) were recruited in the study. A naming task of Chinese characters was adopted to elucidate N-size- effect development. Reaction times and error rates were recorded. Results showed that children in the 3rd grade named characters from large neighborhoods faster than named those from small neighborhoods, revealing a facilitatory N size effect; the 5th graders showed null N size effect; while the 7th graders showed an inhibitory N size effect, with longer reaction times for the characters from large neighborhoods than for those from small neighborhoods. The change from facilitation to inhibition of neighborhood size effect across grades suggested the transition from broadly tuned to finely tuned lexical representation in reading development, and the possible inhibition from higher frequency neighbors for higher graders.	[Zhao, Jing; Li, Qing-Lin; Bi, Hong-Yan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Zhao, Jing; Li, Qing-Lin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bi, HY (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	bihy@psych.ac.cn	zhao, jing/B-3868-2019		National Natural Science Foundation of China [30970910, 30770726]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Natural Science Foundation of China (30970910, 30770726). The website for the foundation is http://www.nsfc.gov.cn/Portal0/default166.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JD, 2008, J FLUENCY DISORD, V33, P135, DOI 10.1016/j.jfludis.2008.04.001; Dunabeitia JA, 2008, SPAN J PSYCHOL, V11, P26, DOI 10.1017/S113874160000408X; ANDREWS S, 1989, J EXP PSYCHOL LEARN, V15, P802, DOI 10.1037/0278-7393.15.5.802; ANDREWS S, 1992, J EXP PSYCHOL LEARN, V18, P234, DOI 10.1037/0278-7393.18.2.234; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; Bi H-Y., 2006, ACTA PSYCHOL SINICA, V38, P7; Cao F, 2011, NEUROIMAGE, V57, P750, DOI 10.1016/j.neuroimage.2010.09.047; Cao F, 2009, HUM BRAIN MAPP, V30, P797, DOI 10.1002/hbm.20546; Carreiras M, 1997, J EXP PSYCHOL LEARN, V23, P857, DOI 10.1037/0278-7393.23.4.857; Castles A, 1999, LANG COGNITIVE PROC, V14, P201, DOI 10.1080/016909699386347; Castles A, 2007, J EXP CHILD PSYCHOL, V97, P165, DOI 10.1016/j.jecp.2007.01.006; Chen BG, 2009, ACTA PSYCHOL, V130, P196, DOI 10.1016/j.actpsy.2008.12.004; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Coltheart M., 1977, ATTENTION PERFORM, P535, DOI DOI 10.1006/BRLN.2001.2475; Fang S.-P., 1986, LINGUISTICS PSYCHOL, P11; Forster KI, 1996, J EXP PSYCHOL LEARN, V22, P696, DOI 10.1037/0278-7393.22.3.696; Frith U., 1985, SURFACE DYSLEXIA NEU, P301, DOI DOI 10.4324/9781315108346-18; Garlock VM, 2001, J MEM LANG, V45, P468, DOI 10.1006/jmla.2000.2784; Grainger J, 1996, PSYCHOL REV, V103, P518, DOI 10.1037/0033-295X.103.3.518; Grainger J, 2012, COGNITION, V123, P280, DOI 10.1016/j.cognition.2012.01.003; Hue C-W., 1992, ADV PSYCHOL, V90, P93, DOI [DOI 10.1016/S0166-4115(08)61888-9, 10.1016/S0166-4115(08)61888-9]; LAXON VJ, 1988, BRIT J EDUC PSYCHOL, V58, P103, DOI 10.1111/j.2044-8279.1988.tb00882.x; Lee CY, 2004, NEUROIMAGE, V23, P1235, DOI 10.1016/j.neuroimage.2004.07.064; Li QL, 2011, ACTA PSYCHOL, V136, P35, DOI 10.1016/j.actpsy.2010.09.012; Li Y, 1993, INFORM ANAL USAGE CH, P5; Marinus E, 2010, J EXP CHILD PSYCHOL, V106, P129, DOI 10.1016/j.jecp.2010.01.004; PEEREMAN R, 1995, J EXP PSYCHOL LEARN, V21, P409, DOI 10.1037/0278-7393.21.2.409; Perfetti CA, 1998, J EXP PSYCHOL LEARN, V24, P101, DOI 10.1037/0278-7393.24.1.101; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; SEARS CR, 1995, J EXP PSYCHOL HUMAN, V21, P876, DOI 10.1037/0096-1523.21.4.876; Snowling M, 1997, TRENDS COGN SCI, V1, P88, DOI 10.1016/S1364-6613(97)89053-5; Tan LH, 1998, READ WRIT, V10, P165, DOI 10.1023/A:1008086231343; van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584; Zhao J, 2011, CHINESE J ERGON, V17, P1; Zhu X, 1988, P S CHIN LANG CHAR, P85	35	3	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46922	10.1371/journal.pone.0046922	http://dx.doi.org/10.1371/journal.pone.0046922			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	23056529	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500110
J	Davenport, LC; Bazan, IN; Erazo, NC				Davenport, Lisa C.; Nole Bazan, Ines; Carlos Erazo, Nancy			East with the Night: Longitudinal Migration of the Orinoco Goose (Neochen jubata) between Manu National Park, Peru and the Llanos de Moxos, Bolivia	PLOS ONE			English	Article							GRAZING LAWNS; DYNAMICS; ANIMALS; AMAZON	We report on the intra-Amazonian migration of a pair of Orinoco Geese (Neochen jubata) from Manu National Park, Peru. The species is Critically Endangered in Peru, so a major aim of the study was to aid conservation planning by learning the wet season location of the country's last known breeding population. We captured a breeding pair on October 27, 2010, and fitted the birds with Microwave Telemetry, Inc. GPS/Argos satellite PTT's. The pair migrated similar to 655 km from Manu National Park to the Llanos de Moxos, Bolivia (Dept. of Beni) in a predominantly longitudinal migration, reaching their final destination on December 23, 2010. Major movements (>5 km per time period) were almost exclusively at night and were undertaken with and without moonlight. Foraging areas used at stopovers in the Llanos de Moxos were remarkably limited, suggesting the importance of grazing lawns maintained by the geese and other herbivores, possibly including cattle. Orinoco Geese are resident in the Llanos de Moxos year-round, so the Manu geese represent a partial migration from the Beni region. We hypothesize that cavity nest limitation explains the partial migration of Orinoco Geese from the Llanos de Moxos.	[Davenport, Lisa C.] Duke Univ, Ctr Trop Conservat, Durham, NC 27706 USA; [Nole Bazan, Ines] Univ Nacl Mayor San Marcos, Lima 14, Peru; [Carlos Erazo, Nancy] Univ Peruana Cayetano Heredia, Lima, Peru	Duke University; Universidad Nacional Mayor de San Marcos; Universidad Peruana Cayetano Heredia	Davenport, LC (corresponding author), Duke Univ, Ctr Trop Conservat, Durham, NC 27706 USA.	lisa.davenport@duke.edu	Carlos, Nancy/B-2473-2016	Carlos, Nancy/0000-0002-9108-2069; Davenport, Lisa/0000-0002-2573-1622	Disney Worldwide Conservation Fund; The Conservation Food and Health Foundation; Max Planck Institute for Ornithology, Konstanz, Germany	Disney Worldwide Conservation Fund; The Conservation Food and Health Foundation; Max Planck Institute for Ornithology, Konstanz, Germany	This work was supported by the Disney Worldwide Conservation Fund (http://thewaltdisneycompany.com/citizenship/disney-worldwide-conservation-fund), The Conservation Food and Health Foundation (http://cfhfoundation.grantsmanagement08.com/), and the Max Planck Institute for Ornithology, Konstanz, Germany (http://www.orn.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by the Disney Worldwide Conservation Fund, a commercial entity. This relationship does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; Davenport LC, 2012, DATA E NIGHT LONGITU, DOI [10.5441/001/1.ct8sk835, DOI 10.5441/001/1.CT8SK835]; EMLEN ST, 1967, AUK, V84, P309, DOI 10.2307/4083084; GENTRY AH, 1990, 4 NEOTROPICAL RAINFO, P542; Jahn Alex E., 2006, Hornero, V21, P99; Jahn AE, 2010, J ANIM ECOL, V79, P983, DOI 10.1111/j.1365-2656.2010.01713.x; KRIESE K.D., 2004, THESIS U CALIFORNIA; Malecki R.A., 2011, GOOSE B, V12, P19; Mayle FE, 2007, PHILOS T R SOC B, V362, P291, DOI 10.1098/rstb.2006.1987; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; Miller MR, 2005, CAN J ZOOL, V83, P1314, DOI 10.1139/Z05-125; Person BT, 2003, OECOLOGIA, V135, P583, DOI 10.1007/s00442-003-1197-4; Petrie SA, 2003, CAN J ZOOL, V81, P861, DOI 10.1139/Z03-063; Sekercioglu CH, 2010, J ANIM ECOL, V79, P933, DOI 10.1111/j.1365-2656.2010.01739.x; Veigl FX, 2006, MONUMENTA AMAZONIC B, V11, P203; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wilcove DS, 2007, WAY HOME DECLINE WOR; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Wu L, 2012, NEURAL CORRELATES MA, DOI [10.1126/science.1216567, DOI 10.1126/SCIENCE.1216567]	19	15	16	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46886	10.1371/journal.pone.0046886	http://dx.doi.org/10.1371/journal.pone.0046886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056512	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800059
J	Majid, S; Dar, AA; Saini, S; Shahryari, V; Arora, S; Zaman, MS; Chang, I; Yamamura, S; Chiyomaru, T; Fukuhara, S; Tanaka, Y; Deng, GR; Tabatabai, ZL; Dahiya, R				Majid, Shahana; Dar, Altaf A.; Saini, Sharanjot; Shahryari, Varahram; Arora, Sumit; Zaman, Mohd Saif; Chang, Inik; Yamamura, Soichiro; Chiyomaru, Takeshi; Fukuhara, Shinichiro; Tanaka, Yuichiro; Deng, Guoren; Tabatabai, Z. Laura; Dahiya, Rajvir			MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer	PLOS ONE			English	Article							PROTEIN-KINASE; RHO-GTPASES; SIGNATURE	MicroRNAs (miRNAs) are non-protein-coding sequences that can function as oncogenes or tumor suppressor genes. This study documents the tumor suppressor role of miR-1280 in bladder cancer. Quantitative real-time PCR and in situ hybridization analyses showed that miR-1280 is significantly down-regulated in bladder cancer cell lines and tumors compared to a non-malignant cell line or normal tissue samples. To decipher the functional significance of miR-1280 in bladder cancer, we ectopically over-expressed miR-1280 in bladder cancer cell lines. Over-expression of miR-1280 had antiproliferative effects and impaired colony formation of bladder cancer cell lines. FACS (fluorescence activated cell sorting) analysis revealed that re-expression of miR-1280 in bladder cancer cells induced G2-M cell cycle arrest and apoptosis. Our results demonstrate that miR-1280 inhibited migration and invasion of bladder cancer cell lines. miR-1280 also attenuated ROCK1 and RhoC protein expression. Luciferase reporter assays demonstrated that oncogene ROCK1 is a direct target of miR-1280 in bladder cancer. This study also indicates that miR-1280 may be of diagnostic and prognostic importance in bladder cancer. For instance, ROC analysis showed that miR-1280 expression can distinguish between malignant and normal bladder cancer cases and Kaplan-Meier analysis revealed that patients with miR-1280 high expression had higher overall survival compared to those with low miR-1280 expression. In conclusion, this is the first study to document that miR-1280 functions as a tumor suppressor by targeting oncogene ROCK1 to invasion/migration and metastasis. Various compounds are currently being used as ROCK1 inhibitors; therefore restoration of tumor suppressor miR-1280 might be therapeutically useful either alone or in combination with these compounds in the treatment of bladder cancer.	[Majid, Shahana; Saini, Sharanjot; Shahryari, Varahram; Arora, Sumit; Zaman, Mohd Saif; Chang, Inik; Yamamura, Soichiro; Chiyomaru, Takeshi; Fukuhara, Shinichiro; Tanaka, Yuichiro; Deng, Guoren; Tabatabai, Z. Laura; Dahiya, Rajvir] VA Med Ctr, Dept Urol, San Francisco, CA USA; [Majid, Shahana; Saini, Sharanjot; Shahryari, Varahram; Arora, Sumit; Zaman, Mohd Saif; Chang, Inik; Yamamura, Soichiro; Chiyomaru, Takeshi; Fukuhara, Shinichiro; Tanaka, Yuichiro; Deng, Guoren; Tabatabai, Z. Laura; Dahiya, Rajvir] UCSF, San Francisco, CA USA; [Dar, Altaf A.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA	University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute	Dahiya, R (corresponding author), VA Med Ctr, Dept Urol, San Francisco, CA USA.	rdahiya@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health [RO1CA138642, RO1CA130860, RO1CA160079]; VA Merit Review; VA Program Project; NATIONAL CANCER INSTITUTE [R01CA160079, R01CA130860, R01CA138642] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review(US Department of Veterans Affairs); VA Program Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Center for Research Resources of the National Institutes of Health through Grant Number RO1CA138642, RO1CA130860, RO1CA160079 and VA Merit Review and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; del Peso L, 1997, ONCOGENE, V15, P3047; Imamura F, 2000, JPN J CANCER RES, V91, P811, DOI 10.1111/j.1349-7006.2000.tb01018.x; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Piepoli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033663; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Sequeira L, 2008, CLIN EXP METASTAS, V25, P569, DOI 10.1007/s10585-008-9173-3; Tang AT, 2012, CELL SIGNAL, V24, P1375, DOI 10.1016/j.cellsig.2012.03.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103	23	49	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46743	10.1371/journal.pone.0046743	http://dx.doi.org/10.1371/journal.pone.0046743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056431	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800046
J	Perets, R; Kaplan, T; Stein, I; Hidas, G; Tayeb, S; Avraham, E; Ben-Neriah, Y; Simon, I; Pikarsky, E				Perets, Ruth; Kaplan, Tommy; Stein, Ilan; Hidas, Guy; Tayeb, Shay; Avraham, Eti; Ben-Neriah, Yinon; Simon, Itamar; Pikarsky, Eli			Genome-Wide Analysis of Androgen Receptor Targets Reveals COUP-TF1 as a Novel Player in Human Prostate Cancer	PLOS ONE			English	Article							LEYDIG-CELL DEVELOPMENT; TRANSCRIPTION FACTOR-I; DNA-BINDING; GLUCOCORTICOID-RECEPTORS; GENE-EXPRESSION; CHROMATIN IMMUNOPRECIPITATION; FUNCTIONAL-CHARACTERIZATION; RESPONSE ELEMENT; CONTROLLED-TRIAL; LNCAP CELLS	Androgen activity plays a key role in prostate cancer progression. Androgen receptor (AR) is the main mediator of androgen activity in the prostate, through its ability to act as a transcription mediator. Here we performed a genome-wide analysis of human AR binding to promoters in the presence of an agonist or antagonist in an androgen dependent prostate cancer cell line. Many of the AR bound promoters are bound in all examined conditions while others are bound only in the presence of an agonist or antagonist. Several motifs are enriched in AR bound promoters, including the AR Response Element (ARE) half-site and recognition elements for the transcription factors OCT1 and SOX9. This suggests that these 3 factors could define a module of co-operating transcription factors in the prostate. Interestingly, AR bound promoters are preferentially located in AT rich genomic regions. Analysis of mRNA expression identified chicken ovalbumin upstream promoter-transcription factor 1 (COUP-TF1) as a direct AR target gene that is downregulated upon binding by the agonist liganded AR. COUP-TF1 immunostaining revealed nucleolar localization of COUP-TF1 in epithelium of human androgen dependent prostate cancer, but not in adjacent benign prostate epithelium. Stromal cells both in human and mouse prostate show nuclear COUP-TF1 staining. We further show that there is an inverse correlation between COUP-TF1 expression in prostate stromal cells and the rising levels of androgen with advancing puberty. This study extends the pool of recognized putative AR targets and identifies a negatively regulated target of AR - COUP-TF1 - which could possibly play a role in human prostate cancer.	[Perets, Ruth; Stein, Ilan; Hidas, Guy; Tayeb, Shay; Avraham, Eti; Ben-Neriah, Yinon; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Pathol, IL-91010 Jerusalem, Israel; [Perets, Ruth; Stein, Ilan; Hidas, Guy; Tayeb, Shay; Avraham, Eti; Ben-Neriah, Yinon; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Immunol, IL-91010 Jerusalem, Israel; [Hidas, Guy] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Urol, IL-91010 Jerusalem, Israel; [Simon, Itamar] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Kaplan, Tommy] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Kaplan, Tommy] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Jerusalem, Israel; [Perets, Ruth] Rambam Hlth Care Campus, Div Oncol, Haifa, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of California System; University of California Berkeley; Hebrew University of Jerusalem; Rambam Health Care Campus	Pikarsky, E (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Pathol, IL-91010 Jerusalem, Israel.	Peli@hadassah.org.il	pikarsky, eli/GXV-7099-2022; Ben-Neriah, Yinon/L-6285-2019; Kaplan, Tommy/T-2528-2017	Kaplan, Tommy/0000-0002-1892-5461; pikarsky, eli/0000-0003-4186-7105	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation; Prostate Cancer Foundation; European Molecular Biology Organization (EMBO)	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation(Israel Science Foundation); Prostate Cancer Foundation; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This research was funded by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF), Israel Science Foundation and the Prostate Cancer Foundation (EP). TK was supported by a European Molecular Biology Organization (EMBO) long-term post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Baker PJ, 2003, ENDOCRINOLOGY, V144, P138, DOI 10.1210/en.2002-220637; Barash Y, 2005, BIOINFORMATICS, V21, P596, DOI 10.1093/bioinformatics/bti041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; CHANG SM, 1989, ENDOCRINOLOGY, V125, P2719, DOI 10.1210/endo-125-5-2719; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; CLAESSENS F, 1993, ANN NY ACAD SCI, V684, P199, DOI 10.1111/j.1749-6632.1993.tb32283.x; CLAESSENS F, 1989, BIOCHEM BIOPH RES CO, V164, P833, DOI 10.1016/0006-291X(89)91534-9; Claessens F, 1996, J BIOL CHEM, V271, P19013, DOI 10.1074/jbc.271.32.19013; CLAESSENS F, 1990, MOL CELL ENDOCRINOL, V74, P203, DOI 10.1016/0303-7207(90)90225-W; CONNOR H, 1995, J BIOL CHEM, V270, P15066, DOI 10.1074/jbc.270.25.15066; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Denis LJ, 1998, EUR UROL, V33, P144, DOI 10.1159/000019546; Fenton MA, 1997, CLIN CANCER RES, V3, P1383; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Georget V, 2002, BIOCHEMISTRY-US, V41, P11824, DOI 10.1021/bi0259150; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Guo L, 2001, J BIOL CHEM, V276, P2797, DOI 10.1074/jbc.C000822200; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Huang LW, 2007, ENDOCRINOLOGY, V148, P1235, DOI 10.1210/en.2006-1250; Ishioka J, 2009, INT J UROL, V16, P516, DOI 10.1111/j.1442-2042.2009.02284.x; Jariwala U, 2009, PROSTATE, V69, P392, DOI 10.1002/pros.20893; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeyaraj DA, 2005, STEROIDS, V70, P704, DOI 10.1016/j.steroids.2005.03.015; Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645; KELLY WK, 1993, J UROLOGY, V149, P607; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Le Dily F, 2008, BREAST CANCER RES TR, V110, P69, DOI 10.1007/s10549-007-9693-6; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Ng CKL, 2012, NUCLEIC ACIDS RES, V40, P4933, DOI 10.1093/nar/gks153; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Odom Duncan T, 2006, Mol Syst Biol, V2; Palena C, 2007, CLIN CANCER RES, V13, P2471, DOI 10.1158/1078-0432.CCR-06-2353; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Pu YB, 2007, ENDOCRINOLOGY, V148, P1697, DOI 10.1210/en.2006-1113; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; RENOIR JM, 1990, J BIOL CHEM, V265, P10740; Ricke WA, 2006, INT J CANCER, V118, P2123, DOI 10.1002/ijc.21614; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Scheideler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-340; SCHELLHAMMER P, 1995, UROLOGY, V45, P745, DOI 10.1016/S0090-4295(99)80077-6; Schoenmakers E, 1999, BIOCHEM J, V341, P515, DOI 10.1042/0264-6021:3410515; Schoenmakers E, 2000, J BIOL CHEM, V275, P12290, DOI 10.1074/jbc.275.16.12290; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Shaked H, 2008, CANCER RES, V68, P9671, DOI 10.1158/0008-5472.CAN-08-0865; Stark LA, 2005, MOL CELL BIOL, V25, P5985, DOI 10.1128/MCB.25.14.5985-6004.2005; Thomsen MK, 2008, DIFFERENTIATION, V76, P728, DOI 10.1111/j.1432-0436.2008.00293.x; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; WILDING G, 1989, PROSTATE, V14, P103, DOI 10.1002/pros.2990140204; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Wu XF, 2010, REPRODUCTION, V140, P113, DOI 10.1530/REP-09-0349; Yamaguchi H, 2004, DEV BIOL, V266, P238, DOI 10.1016/j.ydbio.2003.10.038; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang C, 2002, ONCOGENE, V21, P2854, DOI 10.1038/sj.onc.1205386; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang LJ, 2009, J BIOL CHEM, V284, P6156, DOI 10.1074/jbc.M807713200; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200	73	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46467	10.1371/journal.pone.0046467	http://dx.doi.org/10.1371/journal.pone.0046467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056316	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800020
J	Naurin, S; Hasselquist, D; Bensch, S; Hansson, B				Naurin, Sara; Hasselquist, Dennis; Bensch, Staffan; Hansson, Bengt			Sex-Biased Gene Expression on the Avian Z Chromosome: Highly Expressed Genes Show Higher Male-Biased Expression	PLOS ONE			English	Article							MALE-DRIVEN EVOLUTION; X-LINKED GENES; DOSAGE COMPENSATION; RAPID EVOLUTION; SUBSTITUTION RATES; DNA-SEQUENCES; UP-REGULATION; ZEBRA FINCH; DROSOPHILA; PATTERNS	Dosage compensation, the process whereby expression of sex-linked genes remains similar between sexes (despite heterogamety) and balanced with autosomal expression, was long believed to be essential. However, recent research has shown that several lineages, including birds, butterflies, monotremes and sticklebacks, lack chromosome-wide dosage compensation mechanisms and do not completely balance the expression of sex-linked and autosomal genes. To obtain further understanding of avian sex-biased gene expression, we studied Z-linked gene expression in the brain of two songbirds of different genera (zebra finch, Taeniopygia guttata, and common whitethroat, Sylvia communis) using microarray technology. In both species, the male-bias in gene expression was significantly higher for Z than for autosomes, although the ratio of Z-linked to autosomal expression (Z:A) was relatively close to one in both sexes (range: 0.89-1.01). Interestingly, the Z-linked male-bias in gene expression increased with expression level, and genes with low expression showed the lowest degree of sex-bias. These results support the view that the heterogametic females have up-regulated their single Z-linked homologues to a high extent when the W-chromosome degraded and thereby managed to largely balance their Z:A expression with the exception of highly expressed genes. The male-bias in highly expressed genes points towards male-driven selection on Z-linked loci, and this and other possible hypotheses are discussed.	[Naurin, Sara; Hasselquist, Dennis; Bensch, Staffan; Hansson, Bengt] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Hansson, B (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	bengt.hansson@biol.lu.se	Hasselquist, Dennis/M-5223-2014; Hansson, Bengt/L-8874-2013	Hasselquist, Dennis/0000-0002-0056-6616; Hansson, Bengt/0000-0001-6694-8169	Helge Axon Johnsons Stiftelse; Crafoord Foundation; Swedish Research Council [621-2007-5385, 621-2010-5399, 621-2010-5277, 621-2007-5381, 621-2009-4945]	Helge Axon Johnsons Stiftelse; Crafoord Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work has been supported financially by Helge Axon Johnsons Stiftelse (to SN), The Crafoord Foundation (to BH), the Swedish Research Council (to DH, 621-2007-5385 and 621-2010-5399; SB, 621-2010-5277; BH, 621-2007-5381, 621-2009-4945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunkumar KP, 2009, GENETICS, V182, P493, DOI 10.1534/genetics.108.099994; Axelsson E, 2004, MOL BIOL EVOL, V21, P1538, DOI 10.1093/molbev/msh157; Bailey RI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017358; BAKER BS, 1994, ANNU REV GENET, V28, P491, DOI 10.1146/annurev.ge.28.120194.002423; Baker DA, 2011, GENETICS, V189, P1117, DOI 10.1534/genetics.111.133157; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Bergero R, 2009, TRENDS ECOL EVOL, V24, P94, DOI 10.1016/j.tree.2008.09.010; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Connallon T, 2005, TRENDS GENET, V21, P495, DOI 10.1016/j.tig.2005.07.006; Connallon T, 2011, GENOME BIOL EVOL, V3, P151, DOI 10.1093/gbe/evr004; Connallon T, 2011, GENETICS, V187, P919, DOI 10.1534/genetics.110.123729; Connallon T, 2010, EVOLUTION, V64, P3417, DOI 10.1111/j.1558-5646.2010.01136.x; Connallon T, 2010, EVOLUTION, V64, P1671, DOI 10.1111/j.1558-5646.2009.00934.x; Deakin JE, 2009, CHROMOSOME RES, V17, P671, DOI 10.1007/s10577-009-9058-6; Deakin JE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000140; Deng XX, 2011, NAT GENET, V43, P1179, DOI 10.1038/ng.948; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; ELLEGREN H, 2008, P ROYAL SOC B, V276, P361; Ellegren H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-40; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Good JM, 2005, MOL BIOL EVOL, V22, P1044, DOI 10.1093/molbev/msi087; Hahn MW, 2005, CURR BIOL, V15, pR192, DOI 10.1016/j.cub.2005.03.005; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Itoh Y, 2010, GENOME RES, V20, P512, DOI 10.1101/gr.102343.109; Jagadeeshan S, 2005, MOL BIOL EVOL, V22, P1793, DOI 10.1093/molbev/msi175; Jonsson KA, 2006, J BIOGEOGR, V33, P1155, DOI 10.1111/j.1365-2699.2006.01507.x; Julien P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001328; Kaiser VB, 2006, EVOLUTION, V60, P1945, DOI 10.1111/j.0014-3820.2006.tb00537.x; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kharchenko PV, 2011, NAT GENET, V43, P1167, DOI 10.1038/ng.991; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Leder EH, 2010, MOL BIOL EVOL, V27, P1495, DOI 10.1093/molbev/msq031; Liao BY, 2006, MOL BIOL EVOL, V23, P1119, DOI 10.1093/molbev/msj119; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Lin H, 2011, NAT GENET, V43, P1169, DOI 10.1038/ng.992; LINDSLEY DL, 1972, GENETICS, V71, P157; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Mank JE, 2009, HEREDITY, V102, P312, DOI 10.1038/hdy.2008.116; Mank JE, 2007, MOL BIOL EVOL, V24, P2698, DOI 10.1093/molbev/msm208; Mank JE, 2007, TRENDS ECOL EVOL, V22, P389, DOI 10.1016/j.tree.2007.05.003; Mank JE, 2007, GENOME RES, V17, P618, DOI 10.1101/gr.6031907; Mank JE, 2011, EVOLUTION, V65, P2133, DOI 10.1111/j.1558-5646.2011.01316.x; Mank JE, 2010, MOL BIOL EVOL, V27, P661, DOI 10.1093/molbev/msp282; Mank JE, 2009, BIOL LETTERS, V5, P409, DOI 10.1098/rsbl.2008.0732; Mank JE, 2009, TRENDS GENET, V25, P226, DOI 10.1016/j.tig.2009.03.005; Mank JE, 2009, EVOLUTION, V63, P1464, DOI 10.1111/j.1558-5646.2009.00618.x; Mank JE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-148; Meiklejohn CD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001126; Meisel RP, 2011, MOL BIOL EVOL, V28, P1893, DOI 10.1093/molbev/msr010; Melamed E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r202; Naurin S, 2008, MOL ECOL RESOUR, V8, P275, DOI 10.1111/j.1471-8286.2007.01979.x; Naurin S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-37; Naurin S, 2010, TRENDS GENET, V26, P15, DOI 10.1016/j.tig.2009.11.006; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Ohno S., 1967, SEX CHROMOSOMES SEX; Pal C, 2001, GENETICS, V158, P927; Patten MM, 2009, EVOLUTION, V63, P2888, DOI 10.1111/j.1558-5646.2009.00764.x; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Prince EG, 2010, GENOME BIOL EVOL, V2, P336, DOI 10.1093/gbe/evq024; Proschel M, 2006, GENETICS, V174, P893, DOI 10.1534/genetics.106.058008; Qvarnstrom A, 2009, HEREDITY, V102, P4, DOI 10.1038/hdy.2008.93; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Reinius B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-614; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Rosenbusch B, 2004, HEREDITAS, V141, P97, DOI 10.1111/j.1601-5223.2004.01803.x; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; Schoenmakers S, 2010, CHROMOSOMA, V119, P311, DOI 10.1007/s00412-010-0258-9; Schoenmakers S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000466; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Vicoso B, 2009, J MOL EVOL, V68, P576, DOI 10.1007/s00239-009-9235-4; Walters JR, 2011, GENOME BIOL EVOL, V3, P491, DOI 10.1093/gbe/evr036; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wolf JBW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-91; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Zha XF, 2009, INSECT BIOCHEM MOLEC, V39, P315, DOI 10.1016/j.ibmb.2008.12.003; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323	95	23	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46854	10.1371/journal.pone.0046854	http://dx.doi.org/10.1371/journal.pone.0046854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056488	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000095
J	van Heerwaarden, J; Del Vecchyo, DO; Alvarez-Buylla, ER; Bellon, MR				van Heerwaarden, Joost; Ortega Del Vecchyo, Diego; Alvarez-Buylla, Elena R.; Bellon, Mauricio R.			New Genes in Traditional Seed Systems: Diffusion, Detectability and Persistence of Transgenes in a Maize Metapopulation	PLOS ONE			English	Article							POPULATION-GENETICS; MEXICO; LANDRACES; OAXACA; FLOW; DOMESTICATION; INTROGRESSION; CONSERVATION; MANAGEMENT; DIVERSITY	Gene flow of transgenes into non-target populations is an important biosafety concern. The case of genetically modified GM) maize in Mexico has been of particular interest because of the country's status as center of origin and landrace diversity. In contrast to maize in the U. S. and Europe, Mexican landraces form part of an evolving metapopulation in which new genes are subject to evolutionary processes of drift, gene flow and selection. Although these processes are affected by seed management and particularly seed flow, there has been little study into the population genetics of transgenes under traditional seed management. Here, we combine recently compiled data on seed management practices with a spatially explicit population genetic model to evaluate the importance of seed flow as a determinant of the long-term fate of transgenes in traditional seed systems. Seed flow between farmers leads to a much wider diffusion of transgenes than expected by pollen movement alone, but a predominance of seed replacement over seed mixing lowers the probability of detection due to a relative lack of homogenization in spatial frequencies. We find that in spite of the spatial complexities of the modeled system, persistence probabilities under positive selection are estimated quite well by existing theory. Our results have important implications concerning the feasibility of long term transgene monitoring and control in traditional seed systems.	[van Heerwaarden, Joost] Univ Wageningen & Res Ctr, Plant Sci Grp, Wageningen, Netherlands; [van Heerwaarden, Joost; Ortega Del Vecchyo, Diego; Alvarez-Buylla, Elena R.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Alvarez-Buylla, Elena R.] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [Ortega Del Vecchyo, Diego] Univ Calif Los Angeles, Interdept PhD Program Bioinformat, Los Angeles, CA USA; [Bellon, Mauricio R.] Biovers Int, Rome, Italy	Wageningen University & Research; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of California System; University of California Los Angeles; Alliance; Bioversity International	van Heerwaarden, J (corresponding author), Univ Wageningen & Res Ctr, Plant Sci Grp, Wageningen, Netherlands.	joost.vanheerwaarden@wur.nl	Vecchyo, Diego Ortega-Del/AAB-8246-2019; van Heerwaarden, Joost/A-1424-2014; Bellon, Mauricio/L-9546-2019	Vecchyo, Diego Ortega-Del/0000-0003-4054-3766; van Heerwaarden, Joost/0000-0002-4959-3914; Bellon, Mauricio/0000-0003-0642-3402; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473	Rockefeller Foundation [FS013, FS185]; UC MEXUS-CONACYT [CN08-187]; CONACYT [124909];  [SEMARNAT-CONACYT0538/A-1]	Rockefeller Foundation; UC MEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	Funding was provided by the Rockefeller Foundation (grants FS013 & FS185), UC MEXUS-CONACYT CN08-187, SEMARNAT-CONACYT0538/A-1 (ucmexus.ucr.edu), CONACYT 124909 "Red Complejidad, Ciencia y Sociedad,'' and a UC MEXUS-CONACYT doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badstue LB, 2007, WORLD DEV, V35, P1579, DOI 10.1016/j.worlddev.2006.05.023; Bellon MR, 2011, P NATL ACAD SCI USA, V108, P13432, DOI 10.1073/pnas.1103373108; BELLON MR, 1991, HUM ECOL, V19, P389, DOI 10.1007/BF00888984; Bellon MR, 2004, PLANT PHYSIOL, V134, P883, DOI 10.1104/pp.103.038331; BELLON MR, 1994, ECON BOT, V48, P196, DOI 10.1007/BF02908218; Brush SB, 2007, AGR ECOSYST ENVIRON, V121, P211, DOI 10.1016/j.agee.2006.12.018; Bucchini L, 2002, ENVIRON HEALTH PERSP, V110, P5, DOI 10.1289/ehp.021105; Chambers KJ, 2010, PROF GEOGR, V62, P305, DOI 10.1080/00330124.2010.483624; Chapman MA, 2006, NEW PHYTOL, V170, P429, DOI 10.1111/j.1469-8137.2006.01710.x; Dyer GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029067; Dyer GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005734; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; ELLSTRAND NC, 1990, BIOSCIENCE, V40, P438, DOI 10.2307/1311390; FAO, 2004, STAT AGR COMM MARK; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; KIMURA M, 1962, GENETICS, V47, P713; Louette D, 1997, ECON BOT, V51, P20, DOI 10.1007/BF02910401; Ma BL, 2004, CROP SCI, V44, P1273, DOI 10.2135/cropsci2004.1273; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; MELLON M, 2004, GONE SEED TRANSGENIC; Mercer KL, 2008, AGR ECOSYST ENVIRON, V123, P109, DOI 10.1016/j.agee.2007.05.007; Messeguer J, 2006, PLANT BIOTECHNOL J, V4, P633, DOI 10.1111/j.1467-7652.2006.00207.x; Ortiz-Garcia S, 2005, P NATL ACAD SCI USA, V102, P12338, DOI 10.1073/pnas.0503356102; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; R Development Core Team, 2009, R LANG ENV STAT COMP; Schoen DJ, 2008, BIOSCIENCE, V58, P71, DOI 10.1641/B580112; Serratos-Hernandez Jose-Antonio, 2004, Environmental Biosafety Research, V3, P149, DOI 10.1051/ebr:2004013; Serratos-Hernandez JA, 2007, FRONT ECOL ENVIRON, V5, P247, DOI 10.1890/1540-9295(2007)5[247:TPIMIT]2.0.CO;2; Smale M, 1999, EC WORKING PAPERS; Snow AA, 1999, MOL ECOL, V8, P605, DOI 10.1046/j.1365-294x.1999.00596.x; Stewart CN, 2008, NAT BIOTECHNOL, V26, P1222, DOI 10.1038/nbt1108-1222; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; van Heerwaarden J, 2009, THEOR APPL GENET, V119, P875, DOI 10.1007/s00122-009-1096-0; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; [No title captured]	37	16	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46123	10.1371/journal.pone.0046123	http://dx.doi.org/10.1371/journal.pone.0046123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056246	gold, Green Published			2022-12-27	WOS:000309454000018
J	Liu, HT; Wang, WJ; Song, G; Qu, YH; Li, SH; Fjeldsa, J; Lei, FM				Liu, Huatao; Wang, Wenjuan; Song, Gang; Qu, Yanhua; Li, Shou-Hsien; Fjeldsa, Jon; Lei, Fumin			Interpreting the Process behind Endemism in China by Integrating the Phylogeography and Ecological Niche Models of the Stachyridopsis ruficeps	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENE FLOW; TEMPERATE PLANTS; CLIMATE-CHANGE; MOLECULAR PHYLOGEOGRAPHY; SPECIES DELIMITATION; ALCIPPE-MORRISONIA; QUATERNARY CLIMATE; PARSIMONY ANALYSIS; CANORUM-CANORUM	An area of endemism (AOE) is a complex expression of the ecological and evolutionary history of a species. Here we aim to address the principal drivers of avian diversification in shaping patterns of endemism in China by integrating genetic, ecological, and distributional data on the Red-headed Tree Babbler (Stachyridopsis ruficeps), which is distributed across the eastern Himalayas and south China. We sequenced two mtDNA markers from 182 individuals representing all three of the primary AOEs in China. Phylogenetic inferences were used to reconstruct intraspecific phylogenetic relationships. Divergence time and population demography were estimated to gain insight into the evolutionary history of the species. We used Ecological niche modeling to predict species' distributions during the Last Glacial Maximum (LGM) and in the present. Finally, we also used two quantitative tests, an identity test and background test to assess the similarity of ecological niche preferences between adjacent lineages. We found five primary reciprocally monophyletic clades, typically separated approximately 0.2-2.27 MYA, of which three were deeply isolated endemic lineages located in the three AOEs. All phylogroups were detected to have undergone population expansion during the past 0.3 MY. Niche models showed discontinuous habitats, and there were three barriers of less suitable habitat during the LGM and in modern times. Ecoclimatic niches may diverge significantly even over recent timescales, as each phylogroup had a unique distribution, and unique niche characteristics. Vicariant events associated with geographical and ecological barriers, glacial refuges and ecological differentiation may be the main drivers forming the pattern of endemism in China.	[Liu, Huatao; Wang, Wenjuan; Song, Gang; Qu, Yanhua; Lei, Fumin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Wang, Wenjuan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Li, Shou-Hsien] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Fjeldsa, Jon] Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Taiwan Normal University	Liu, HT (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	leifm@ioz.ac.cn	Fjeldså, Jon/A-9699-2013	Fjeldså, Jon/0000-0003-0790-3600	National Science Fund for Distinguished Young Scientists [30925008]; NSFC [30970345]; CAS [KSCX2-YW-Z-012]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]	National Science Fund for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NSFC(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences	This research was supported by grants from the National Science Fund for Distinguished Young Scientists (No. 30925008) to FL, NSFC (30970345), the CAS Innovation Program (KSCX2-YW-Z-012) to YQ, and also grant No. O529YX5105 from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke M, 2009, P ROY SOC B-BIOL SCI, V276, P2359, DOI 10.1098/rspb.2009.0015; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; BARTON NH, 1979, HEREDITY, V43, P333, DOI 10.1038/hdy.1979.86; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bowie RC, 2004, MOL PHYLOGENET EVOL, V33, P56, DOI 10.1016/j.ympev.2004.04.013; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Chen YH, 2007, CURR SCI INDIA, V92, P480; CHENG J, 2001, GEOSCIENCE, V15, P290; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Crother BI, 2011, J BIOGEOGR, V38, P1009, DOI 10.1111/j.1365-2699.2011.02483.x; Dai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029329; Del Hoyo J., 2007, HDB BIRDS WORLD, V12; Dickinson EC., 2003, HOWARD MOORE COMPLET; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; GIBBARD PL, 2007, GLOBAL CHRONOSTRATIG; Gomez A, 2000, P ROY SOC B-BIOL SCI, V267, P2189, DOI 10.1098/rspb.2000.1268; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hasumi H., 2004, K 1 COUPLED GCM MIRO; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Huang XL, 2010, INT J MOL SCI, V11, P2097, DOI 10.3390/ijms11052097; Huang ZH, 2010, MOL PHYLOGENET EVOL, V56, P273, DOI 10.1016/j.ympev.2010.01.028; Jakob SS, 2007, MOL ECOL, V16, P1713, DOI 10.1111/j.1365-294X.2007.03228.x; Johnson NK, 2004, EVOLUTION, V58, P1122; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Lei FM, 2003, BIODIVERS CONSERV, V12, P239, DOI 10.1023/A:1021928801558; Lei FM, 2007, BIODIVERS CONSERV, V16, P1119, DOI 10.1007/s10531-006-9080-3; Lei FM, 2012, SCIENCE, V335, P284, DOI 10.1126/science.335.6066.284-b; Li JW, 2010, MOL ECOL, V19, P494, DOI 10.1111/j.1365-294X.2009.04494.x; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Li SH, 2006, IBIS, V148, P698, DOI 10.1111/j.1474-919X.2006.00571.x; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu HY, 2003, FLORA, V198, P249, DOI 10.1078/0367-2530-00098; Lohman DJ, 2010, BIOL CONSERV, V143, P1885, DOI 10.1016/j.biocon.2010.04.042; Lovette IJ, 2005, TRENDS ECOL EVOL, V20, P57, DOI 10.1016/j.tree.2004.11.011; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Lozier JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005901; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Meng K, 2008, J BIOGEOGR, V35, P1241, DOI 10.1111/j.1365-2699.2007.01843.x; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qian H, 2001, NATURE, V413, P130, DOI 10.1038/35093169; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; QUADE J, 1989, NATURE, V342, P163, DOI 10.1038/342163a0; Rambaut A, 2005, TRACER V1 3; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sandel B, 2012, SCIENCE, V335, P285, DOI 10.1126/science.335.6066.285-a; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TAJIMA F, 1983, GENETICS, V105, P437; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wan SM, 2006, PALAEOGEOGR PALAEOCL, V241, P139, DOI 10.1016/j.palaeo.2006.06.013; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Xie Y, 2004, BIODIVERS CONSERV, V13, P1391, DOI 10.1023/B:BIOC.0000019396.31168.ba; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x; Zhang RZ, 1999, ZOOGEOGRAPHIC REGION; Zheng ZX, 1959, DELIMITATION ZOOGEOG; Zou FH, 2007, MOL PHYLOGENET EVOL, V44, P165, DOI 10.1016/j.ympev.2006.12.004	109	27	31	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46761	10.1371/journal.pone.0046761	http://dx.doi.org/10.1371/journal.pone.0046761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056441	gold, Green Submitted, Green Published			2022-12-27	WOS:000309452600057
J	Will, T; Steckbauer, K; Hardt, M; van Bel, AJE				Will, Torsten; Steckbauer, Kathrin; Hardt, Martin; van Bel, Aart J. E.			Aphid Gel Saliva: Sheath Structure, Protein Composition and Secretory Dependence on Stylet-Tip Milieu	PLOS ONE			English	Article							SIEVE-TUBE OCCLUSION; ACYRTHOSIPHON-PISUM; PEA APHID; HEMIPTERA; IDENTIFICATION; INOCULATION; PENETRATION; DELPHACIDAE	In order to separate and analyze saliva types secreted during stylet propagation and feeding, aphids were fed on artificial diets. Gel saliva was deposited as chains of droplets onto Parafilm membranes covering the diets into which watery saliva was secreted. Saliva compounds collected from the diet fluid were separated by SDS-PAGE, while non-soluble gel saliva deposits were processed in a novel manner prior to protein separation by SDS-PAGE. Soluble (watery saliva) and non-soluble (gel saliva) protein fractions were significantly different. To test the effect of the stylet milieu on saliva secretion, aphids were fed on various diets. Hardening of gel saliva is strongly oxygen-dependent, probably owing to formation of sulfide bridges by oxidation of sulphydryl groups. Surface texture of gel saliva deposits is less pronounced under low-oxygen conditions and disappears in dithiothreitol containing diet. Using diets mimicking sieve-element sap and cell-wall fluid respectively showed that the soluble protein fraction was almost exclusively secreted in sieve elements while non-soluble fraction was preferentially secreted at cell wall conditions. This indicates that aphids are able to adapt salivary secretion in dependence of the stylet milieu.	[Will, Torsten; Steckbauer, Kathrin; van Bel, Aart J. E.] Univ Giessen, Dept Gen Bot, Plant Cell Biol Res Grp, Giessen, Germany; [Hardt, Martin] Univ Giessen, Cent Biotech Facil, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Will, T (corresponding author), Univ Giessen, Res Grp Appl Entomol, Dept Phytopathol & Appl Zool, Giessen, Germany.	Torsten.Will@agrar.uni-giessen.de	Will, Torsten/I-3178-2012					Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Brentassi ME, 2007, ANN SOC ENTOMOL FR, V43, P205, DOI 10.1080/00379271.2007.10697512; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Cooper WR, 2011, ENVIRON ENTOMOL, V40, P151, DOI 10.1603/EN10153; COSGROVE DJ, 1983, PLANT PHYSIOL, V72, P326, DOI 10.1104/pp.72.2.326; Freeman TP, 2001, ANN ENTOMOL SOC AM, V94, P761, DOI 10.1603/0013-8746(2001)094[0761:SPBBAH]2.0.CO;2; Furch ACU, 2007, J EXP BOT, V58, P2827, DOI 10.1093/jxb/erm143; Furch ACU, 2010, J EXP BOT, V61, P3697, DOI 10.1093/jxb/erq181; Furch ACU, 2009, PLANT CELL, V21, P2118, DOI 10.1105/tpc.108.063107; Hewer A, 2011, J EXP BIOL, V214, P3868, DOI 10.1242/jeb.060913; Hewer A, 2010, J EXP BIOL, V213, P4030, DOI 10.1242/jeb.046326; KIMMINS FM, 1986, ENTOMOL EXP APPL, V41, P283, DOI 10.1007/BF00221258; Knoblauch M, 1998, PLANT CELL, V10, P35, DOI 10.1105/tpc.10.1.35; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martin B, 1997, J GEN VIROL, V78, P2701, DOI 10.1099/0022-1317-78-10-2701; McLean D.L., 1984, Bulletin of the Entomological Society of America, V30, P26; MCLEAN DL, 1965, NATURE, V205, P1130, DOI 10.1038/2051130a0; MILES P. W., 1965, J INSECT PHYSIOL, V11, P1261, DOI 10.1016/0022-1910(65)90119-8; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MILES PW, 1987, EXPERIENTIA, V43, P937, DOI 10.1007/BF01951678; MILES PW, 1964, EXPERIENTIA, V20, P582, DOI 10.1007/BF02150309; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; POLLARD DG, 1973, B ENTOMOL RES, V62, P631, DOI 10.1017/S0007485300005526; Ponsen MB, 1972, MEDEDELINGEN LANDBOU, V16, P1; Powell G, 2005, J GEN VIROL, V86, P469, DOI 10.1099/vir.0.80632-0; SCHOENLE EJ, 1984, J BIOL CHEM, V259, P2112; Song N, 2009, ZOOL SCI, V26, P851, DOI 10.2108/zsj.26.851; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; van der Westhuizen AJ, 1998, PLANT CELL REP, V18, P132, DOI 10.1007/s002990050545; WENSLER RJ, 1969, J MORPHOL, V129, P473, DOI 10.1002/jmor.1051290406; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Will T, 2009, J EXP BIOL, V212, P3305, DOI 10.1242/jeb.028514	37	48	53	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46903	10.1371/journal.pone.0046903	http://dx.doi.org/10.1371/journal.pone.0046903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056521	gold, Green Submitted, Green Published			2022-12-27	WOS:000309452600064
J	Hitzler, M; Majdic, O; Heine, G; Worm, M; Ebert, G; Luch, A; Peiser, M				Hitzler, Manuel; Majdic, Otto; Heine, Guido; Worm, Margitta; Ebert, Grit; Luch, Andreas; Peiser, Matthias			Human Langerhans Cells Control Th Cells via Programmed Death-Ligand 1 in Response to Bacterial Stimuli and Nickel-Induced Contact Allergy	PLOS ONE			English	Article							DENDRITIC CELLS; INTERLEUKIN 22; HOST-DEFENSE; PD-1; TOLERANCE; EXPRESSION; BLOCKADE; IMMATURE; DISTINCT; B7-H1	Langerhans cells (LCs) are suspected to initiate inflammatory immune responses to contact allergens and pathogenic bacteria. In chronic infectious diseases, programmed death ligand (PD-L) 1 exhibits both inhibitory and costimulatory functions on T cell-mediated activation and tolerance. Here, we investigated the effects of contact allergens and bacterial stimuli on PD-L1 expression in LCs and the effects of altered PD-L1 expression on cytokine release of subsequently cocultured T cells. Monocyte-derived LCs (MoLCs), LCs, and skin sections of patients suffering from allergic contact dermatitis were challenged with nickel and then analyzed for PD-L1 expression by confocal laser scanning microscopy and flow cytometry. In blocking experiments, we found that the release of Th cell specific cytokines was dependent on both stimulation of LCs and inhibition of PD-L1-PD-1 interactions. Stimulation with peptidoglycan (PGN) or lipopolysaccharide (LPS) and blockage of PD-L1 with a specific antibody triggered the release of high levels of IL-17, IL-22, TNF-alpha, and IFN-gamma in CD4(+) T cells. If nickel was used as a stimulus, blockage of PD-L1 led to high amounts of TNF-alpha and IL-22. A closer look revealed PD-L1-dependent upregulation of IL-17 secretion in FACS-sorted CCR6(+)/CCR4(+) T memory cells. In the presence of anti-PD-L1, PGN induced secretion of IFN-gamma and IL-17 in total CCR6(+) cells, while nickel triggered secretion of IFN-gamma and IL-17 exclusively in CCR6(+)/CCR4(+) cells. Our findings suggest that PD-L1 on LCs plays a crucial role in type IV allergic reactions and in response to bacterial stimuli by controlling the nature of inflammatory Th cell responses.	[Hitzler, Manuel; Luch, Andreas; Peiser, Matthias] German Fed Inst Risk Assessment BfR, Dept Prod Safety, Berlin, Germany; [Majdic, Otto] Med Univ, Inst Immunol, Vienna, Austria; [Heine, Guido; Worm, Margitta] Charite, CCM, Allergy Ctr Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Ebert, Grit] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany	Federal Institute for Risk Assessment; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Peiser, M (corresponding author), German Fed Inst Risk Assessment BfR, Dept Prod Safety, Berlin, Germany.	matthias.peiser@bfr.bund.de	Heine, Guido/G-1656-2018	Heine, Guido/0000-0003-1467-9862; Worm, Margitta/0000-0002-3449-1245	German Federal Institute for Risk Assessment [SFP1322-345]; Federal Ministry of Education and Research (BMBF) [0315724]	German Federal Institute for Risk Assessment; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by an intramural grant at the German Federal Institute for Risk Assessment (SFP1322-345) and by the Federal Ministry of Education and Research (BMBF) project 0315724. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA S, 1990, J IMMUNOL, V145, P2791; Aiba S, 1997, EUR J IMMUNOL, V27, P3031, DOI 10.1002/eji.1830271141; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Geissmann F, 2002, J EXP MED, V196, P417, DOI 10.1084/jem.20020018; GRABBE S, 1995, J IMMUNOL, V155, P4207; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Kaplan DH, 2008, EUR J IMMUNOL, V38, P2369, DOI 10.1002/eji.200838397; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Katayama I, 1997, BRIT J DERMATOL, V136, P846, DOI 10.1046/j.1365-2133.1997.01842.x; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim HK, 2006, J LEUKOCYTE BIOL, V79, P686, DOI 10.1189/jlb.0805436; Kim YS, 2010, J IMMUNOL, V185, P5648, DOI 10.4049/jimmunol.1001713; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Larsen JM, 2009, J ALLERGY CLIN IMMUN, V123, P486, DOI 10.1016/j.jaci.2008.09.036; McAleer JP, 2010, TRENDS IMMUNOL, V31, P429, DOI 10.1016/j.it.2010.08.005; Milovanovic M, 2010, J INVEST DERMATOL, V130, P2621, DOI 10.1038/jid.2010.175; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Peiser M, 2003, J IMMUNOL METHODS, V279, P41, DOI 10.1016/S0022-1759(03)00257-6; Pena-Cruz V, 2010, J INVEST DERMATOL, V130, P2222, DOI 10.1038/jid.2010.127; Reiser H, 1996, EUR J IMMUNOL, V26, P880, DOI 10.1002/eji.1830260424; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; Tang AM, 1997, EUR J IMMUNOL, V27, P3143, DOI 10.1002/eji.1830271210; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tsushima F, 2003, EUR J IMMUNOL, V33, P2773, DOI 10.1002/eji.200324084; Wang SD, 2000, BLOOD, V96, P2808; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	40	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46776	10.1371/journal.pone.0046776	http://dx.doi.org/10.1371/journal.pone.0046776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056446	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400027
J	Chieh, JJ; Huang, KW; Lee, YD; Horng, HE; Yang, HC; Hong, CY				Chieh, Jen-Jie; Huang, Kai-Wen; Lee, Yang-De; Horng, Herng-Er; Yang, Hong-Chang; Hong, Chin-Yih			In Vivo Screening of Hepatocellular Carcinoma Using AC Susceptibility of Anti-Alpha Fetoprotein-Activated Magnetic Nanoparticles	PLOS ONE			English	Article								With antibody-mediated magnetic nanoparticles (MNPs) applied in cancer examinations, patients must pay at least twice for MNP reagents in immunomagnetic reduction (IMR) of in vitro screening and magnetic resonance imaging (MRI) of in vivo tests. This is because the high maintenance costs and complex analysis of MRI have limited the possibility of in vivo screening. Therefore, this study proposes novel methods for in vivo screening of tumors by examining the AC susceptibility of bound MNPs using scanning superconducting-quantum-interference-device (SQUID) biosusceptometry (SSB), thereby demonstrating high portability and improved economy. The favorable agreement between in vivo tests using SSB and MRI demonstrated the feasibility of in vivo screening using SSB for hepatocellular carcinoma (HCC) targeted by anti-alpha fetoprotein (AFP)-mediated MNPs. The magnetic labeling was also proved by in vitro tests using SSB and biopsy assays. Therefore, patients receiving bioprobe-mediated MNPs only once can undergo in vivo screening using SSB in the future.	[Chieh, Jen-Jie; Lee, Yang-De; Horng, Herng-Er] Natl Taiwan Normal Univ, Inst Electroopt Sci & Technol, Taipei, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ Hosp, Angiogenesis Ctr, Taipei, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yang, Hong-Chang] Kun Shan Univ, Dept Electroopt Engn, Tainan, Taiwan; [Hong, Chin-Yih] Natl Chung Hsing Univ, Grad Inst Biomed Engn, Taichung 40227, Taiwan	National Taiwan Normal University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Kun Shan University; National Chung Hsing University	Chieh, JJ (corresponding author), Natl Taiwan Normal Univ, Inst Electroopt Sci & Technol, Taipei, Taiwan.	phyfv001@ntnu.edu.tw; hcyang@phys.ntu.edu.tw		Chieh, Jen-Jie/0000-0002-7144-2637; HUANG, KAI-WEN/0000-0001-6375-8714	National Science Council of Taiwan [NSC100-2221-E003-013, NSC100-2112-M003-010, NSC 100-2120-M-002-015, NSC101-2120-M168-001, NSC 101-2221-E003-005]; Department of Health [DOH99-TD-N-111-008, DOH100-TD-N-111-008, DOH101-TD-N-111-004]; National Taiwan Normal University	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health; National Taiwan Normal University	This work was supported by the National Science Council of Taiwan under grant number NSC100-2221-E003-013, NSC100-2112-M003-010, NSC 100-2120-M-002-015, NSC101-2120-M168-001, NSC 101-2221-E003-005, the Department of Health under grant number DOH99-TD-N-111-008, DOH100-TD-N-111-008, DOH101-TD-N-111-004, and National Taiwan Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chieh JJ, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3623795; Chieh JJ, 2011, IEEE T BIO-MED ENG, V58, P2719, DOI 10.1109/TBME.2010.2090042; Duguet E, 2006, NANOMEDICINE-UK, V1, P157, DOI 10.2217/17435889.1.2.157; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; HILL DA, 1985, BIOELECTROMAGNETICS, V6, P33, DOI 10.1002/bem.2250060104; Hong C. Y., 2006, APPL PHYS LETT, V88; Horng HE, 2005, IEEE T APPL SUPERCON, V15, P668, DOI 10.1109/TASC.2005.849995; Huang KW, 2012, INT J NANOMED, V7, DOI 10.2147/IJN.S28245; Kircher MF, 2003, CANCER RES, V63, P8122; Liao SH, 2009, SUPERCOND SCI TECH, V22; Lin SB, 2000, J HEPATOL, V33, P601, DOI 10.1034/j.1600-0641.2000.033004601.x; Nair BG, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/45/455102; Prijic S, 2011, RADIOL ONCOL, V45, P1, DOI 10.2478/v10019-011-0001-z; Qiao JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018103; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Tseng HY, 2009, IET NANOBIOTECHNOL, V3, P46, DOI 10.1049/iet-nbt.2008.0013; Tsuchiya K, 2011, INT J NANOMED, V6, P1, DOI 10.2147/IJN.S22189; Wang J, 2010, INT J NANOMED, V5, P861, DOI 10.2147/IJN.S13662; Watkin KL, 2002, ACAD RADIOL, V9, pS285, DOI 10.1016/S1076-6332(03)80205-2; Yang SY, 2008, J MAGN MAGN MATER, V320, P2688, DOI 10.1016/j.jmmm.2008.05.048	20	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46756	10.1371/journal.pone.0046756	http://dx.doi.org/10.1371/journal.pone.0046756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056437	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500072
J	Coffey, K; Blackburn, TJ; Cook, S; Golding, BT; Griffin, RJ; Hardcastle, IR; Hewitt, L; Huberman, K; McNeill, HV; Newell, DR; Roche, C; Ryan-Munden, CA; Watson, A; Robson, CN				Coffey, Kelly; Blackburn, Timothy J.; Cook, Susan; Golding, Bernard T.; Griffin, Roger J.; Hardcastle, Ian R.; Hewitt, Lorraine; Huberman, Kety; McNeill, Hesta V.; Newell, David R.; Roche, Celine; Ryan-Munden, Claudia A.; Watson, Anna; Robson, Craig N.			Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; DNA-DAMAGE RESPONSE; ANDROGEN RECEPTOR; IN-VITRO; ACETYLATION; COACTIVATOR; PROTEIN; APOPTOSIS; ACTIVATION; EXPRESSION	Tip60 (KAT5) is a histone acetyltransferase (HAT enzyme) involved in multiple cellular processes including transcriptional regulation, DNA damage repair and cell signalling. In prostate cancer, aggressive cases over-express Tip60 which functions as an androgen receptor co-activator via direct acetylation of lysine residues within the KLKK motif of the receptor hinge region. The purpose of this study was to identify and characterise a Tip60 acetylase inhibitor. High-throughput screening revealed an isothiazole that inhibited both Tip60 and p300 HAT activity. This substance (initially identified as 4-methyl-5-bromoisothiazole) and other isothiazoles were synthesised and assayed against Tip60. Although an authentic sample of 4-methyl-5-bromoisothiazole was inactive against Tip60, in an in vitro HAT assay, 1,2-bis(isothiazol-5-yl)disulfane (NU9056) was identified as a relatively potent inhibitor (IC50 2 mu M). Cellular activity was confirmed by analysis of acetylation of histone and non-histone proteins in a prostate cancer cell line model. NU9056 treatment inhibited cellular proliferation in a panel of prostate cancer cell lines (50% growth inhibition, 8-27 mu M) and induced apoptosis via activation of caspase 3 and caspase 9 in a concentration-and time-dependent manner. Also, decreased androgen receptor, prostate specific antigen, p53 and p21 protein levels were demonstrated in response to treatment with NU9056. Furthermore, pre-treatment with NU9056 inhibited both ATM phosphorylation and Tip60 stabilization in response to ionising radiation. Based on the activity of NU9056 and the specificity of the compound towards Tip60 relative to other HAT enzymes, these chemical biology studies have identified Tip60 as a potential therapeutic target for the treatment of prostate cancer.	[Coffey, Kelly; Cook, Susan; Hewitt, Lorraine; McNeill, Hesta V.; Ryan-Munden, Claudia A.; Robson, Craig N.] Newcastle Univ, Solid Tumour Target Discovery Lab, Newcastle Canc Ctr, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Blackburn, Timothy J.; Golding, Bernard T.; Griffin, Roger J.; Hardcastle, Ian R.; Newell, David R.; Roche, Celine; Watson, Anna] Newcastle Univ, Drug Discovery & Imaging Grp, Newcastle Canc Ctr, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Huberman, Kety] OSI Pharmaceut Inc, Farmingdale, NY USA; [Blackburn, Timothy J.; Golding, Bernard T.; Griffin, Roger J.; Hardcastle, Ian R.; Roche, Celine; Watson, Anna] Newcastle Univ, Res & Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Astellas Pharmaceuticals; OSI Pharmaceuticals; Newcastle University - UK	Robson, CN (corresponding author), Newcastle Univ, Solid Tumour Target Discovery Lab, Newcastle Canc Ctr, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	c.n.robson@ncl.ac.uk	Hardcastle, Ian/AAY-3748-2020; Coffey, Kelly/AAZ-4433-2020	Hardcastle, Ian/0000-0001-7495-3769; Coffey, Kelly/0000-0003-0502-2914; Pendlebury, Anna/0000-0002-4033-8458	Cancer Research UK (CRUK) [C240/A7409, C29821/A10348]; Medical Research Council (MRC) PROMPT [G0100100/64424]; OSI Pharmaceuticals; MRC [G0900871] Funding Source: UKRI; Cancer Research UK [15751] Funding Source: researchfish; Medical Research Council [G0900871] Funding Source: researchfish	Cancer Research UK (CRUK)(Cancer Research UK); Medical Research Council (MRC) PROMPT; OSI Pharmaceuticals(Astellas Pharmaceuticals); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by Cancer Research UK (CRUK) (C240/A7409; C29821/A10348) (www.cancerresearchuk.org) and Medical Research Council (MRC) PROMPT (G0100100/64424) (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge OSI Pharmaceuticals for sponsorship of this research collaboration, Dr Jacqueline Stockley and Dr Stuart Williamson for providing expertise in flow cytometry; Miss Lynsey Rogerson, Miss Grace Tan, Mr Christopher J. Keilty and Dr Fadhel Shaheen for technical assistance. The use of the EPSRC mass spectrometry service at the University of Wales (Swansea) is gratefully acknowledged.	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Biel M, 2004, ANGEW CHEM INT EDIT, V43, P3974, DOI 10.1002/anie.200453879; Blum KA, 2009, BRIT J HAEMATOL, V147, P507, DOI 10.1111/j.1365-2141.2009.07881.x; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Culig Z, 2006, J CELL BIOCHEM, V99, P373, DOI 10.1002/jcb.20898; Dekker FJ, 2009, BIOORGAN MED CHEM, V17, P460, DOI 10.1016/j.bmc.2008.12.008; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gavaravarapu S, 2000, BIOCHEM BIOPH RES CO, V269, P758, DOI 10.1006/bbrc.2000.2358; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gorsuch S, 2009, BIOORGAN MED CHEM, V17, P467, DOI 10.1016/j.bmc.2008.11.079; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lin XH, 2001, CANCER RES, V61, P8611; Mai A, 2008, J MED CHEM, V51, P2279, DOI 10.1021/jm701595q; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Park KC, 2005, BIOCHEM BIOPH RES CO, V331, P1469, DOI 10.1016/j.bbrc.2005.04.030; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Rigas AC, 2007, ONCOGENE, V26, P7611, DOI 10.1038/sj.onc.1210586; Sbardella G, 2008, BIOORG MED CHEM LETT, V18, P2788, DOI 10.1016/j.bmcl.2008.04.017; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Shiota M, PROSTATE, V70, P540; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Stimson L, 2005, MOL CANCER THER, V4, P1521, DOI 10.1158/1535-7163.MCT-05-0135; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595	39	87	93	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45539	10.1371/journal.pone.0045539	http://dx.doi.org/10.1371/journal.pone.0045539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056207	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500020
J	Keller, MJ; Carpenter, CA; Lo, YT; Einstein, MH; Liu, CZ; Fredricks, DN; Herold, BC				Keller, Marla J.; Carpenter, Colleen A.; Lo, Yungtai; Einstein, Mark H.; Liu, Congzhou; Fredricks, David N.; Herold, Betsy C.			Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel: Candidate Antimicrobial Contraceptive	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HERPES-SIMPLEX-VIRUS; CONTROLLED-TRIAL; BACTERIAL VAGINOSIS; GENITAL-TRACT; HORMONAL CONTRACEPTION; HIV-1 TRANSMISSION; QUANTITATIVE PCR; CLINICAL-TRIALS; MOUSE MODEL	Background: Acidform gel, an acid-buffering product that inactivates spermatozoa, may be an effective topical non-hormonal contraceptive. This study was designed to evaluate the safety of vaginal dosing and effects of Acidform on mucosal immune mediators, antimicrobial properties of genital secretions, and vaginal microbiota. Methods: Thirty-six sexually abstinent U.S. women were randomized to apply Acidform or hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days. Safety was assessed by symptoms and pelvic examination. The impact of gel on mucosal immunity was assessed by quantifying cytokines, chemokines, antimicrobial proteins and antimicrobial activity of genital secretions collected by cervicovaginal lavage (CVL) at screening, 2 hours after gel application, and on days 7, 14 and 21. Vaginal microbiota was characterized at enrollment and day 14 using species-specific quantitative PCR assays. Results: The median vaginal and cervical pH was significantly lower 2 hours after application of Acidform and was associated with an increase in the bactericidal activity of CVL against E. coli. However, 65% of women who received Acidform had at least one local adverse event compared with 11% who received placebo (p = 0.002). While there was no increase in inflammatory cytokines or chemokines, CVL concentrations of lactoferrin and interleukin-1 receptor antagonist (IL-1ra), an anti-inflammatory protein, were significantly lower following Acidform compared to HEC placebo gel application. There were no significant changes in Lactobacillus crispatus or Lactobacillus jensenii in either group but there was a decrease in Gardnerella vaginalis in the Acidform group (p = 0.08). Conclusions: Acidform gel may augment mucosal defense as evidenced by an increase in bactericidal activity of genital secretions against E. coli and a decrease in Gardnerella vaginalis colonization. However, Acidform was associated with more irritation than placebo and lower levels of antimicrobial (lactoferrin) and anti-inflammatory (IL-1ra) proteins. These findings indicate the need for additional safety studies of this candidate non-hormonal contraceptive.	[Keller, Marla J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Keller, Marla J.; Carpenter, Colleen A.; Lo, Yungtai; Einstein, Mark H.; Herold, Betsy C.] Montefiore Med Ctr, Bronx, NY 10467 USA; [Keller, Marla J.; Einstein, Mark H.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY 10467 USA; [Carpenter, Colleen A.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Keller, Marla J.; Einstein, Mark H.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Womens Hlth, Bronx, NY 10467 USA; [Lo, Yungtai; Einstein, Mark H.] Albert Einstein Coll Med, Dept Epidemiol, Bronx, NY 10467 USA; [Lo, Yungtai; Einstein, Mark H.] Albert Einstein Coll Med, Dept Populat Hlth, Bronx, NY 10467 USA; [Herold, Betsy C.] Albert Einstein Coll Med, Dept Microbiol, Bronx, NY 10467 USA; [Herold, Betsy C.] Albert Einstein Coll Med, Dept Immunol, Bronx, NY 10467 USA; [Liu, Congzhou; Fredricks, David N.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Fred Hutchinson Cancer Center	Keller, MJ (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	marla.keller@einstein.yu.edu		Herold, Betsy/0000-0001-9974-0786	National Institutes of Health [U01 AI069551, UL1 RR025750, P30 AI51519, U19 AI076980]; NATIONAL CANCER INSTITUTE [R01CA148966, P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519, U01AI069551, U19AI076980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (U01 AI069551, UL1 RR025750, P30 AI51519, U19 AI076980). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral E, 2004, CONTRACEPTION, V70, P492, DOI 10.1016/j.contraception.2004.06.007; Amaral E, 1999, CONTRACEPTION, V60, P361, DOI 10.1016/S0010-7824(99)00102-X; [Anonymous], 2004, DIVISION AIDS TABLE; Austin MN, 2009, SEX TRANSM DIS, V36, P368, DOI 10.1097/OLQ.0b013e3181972397; Barnhart KT, 2007, OBSTET GYNECOL, V110, P577, DOI 10.1097/01.AOG.0000278078.45640.13; Eschenbach DA, 2001, J INFECT DIS, V183, P913, DOI 10.1086/319251; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Garg S, 2001, CONTRACEPTION, V64, P67, DOI 10.1016/S0010-7824(01)00217-7; Ghartey JP, 2012, AM J OBSTET IN PRESS; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hogarty K, 2007, SEX TRANSM DIS, V34, P1000, DOI 10.1097/OLQ.0b013e3180f62f81; Kalyoussef S, 2012, J INFECT DIS UNPUB; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Katzen LL, 2011, SEX TRANSM DIS, V38, P1050, DOI 10.1097/OLQ.0b013e31822e6160; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Keller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016475; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Lavreys L, 2004, AIDS, V18, P695, DOI 10.1097/00002030-200403050-00017; Madan RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040415; Marchetti M, 2004, VIROLOGY, V318, P405, DOI 10.1016/j.virol.2003.09.029; Martin HL, 1998, J INFECT DIS, V178, P1053, DOI 10.1086/515654; Mayer KH, 2001, CLIN INFECT DIS, V32, P476, DOI 10.1086/318496; Moench TR, 2012, SEX TRANSM DIS, V39, P335, DOI 10.1097/OLQ.0b013e31824790bb; Pilipenko V, 1999, C INT SOC SEX TRANSM; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roddy RE, 2002, JAMA-J AM MED ASSOC, V287, P1117, DOI 10.1001/jama.287.9.1117; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Rosner B., 1999, FUNDAMENTALS BIOSTAT; SCHWARTZ J, 2006, 14 DAY SAFETY ACCEPT; Shrier LA, 2003, J ADOLESCENT HEALTH, V32, P183, DOI 10.1016/S1054-139X(02)00536-0; Spencer SE, 2004, J INFECT DIS, V189, P410, DOI 10.1086/381125; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Tuyama ACG, 2006, J INFECT DIS, V194, P795, DOI 10.1086/506948; USALA SJ, 1989, J REPROD MED, V34, P292; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; van de Wijgert J, 2001, J ACQ IMMUN DEF SYND, V26, P21, DOI 10.1097/00126334-200101010-00003; von Mollendorf CE, 2010, CONTRACEPTION, V81, P232, DOI 10.1016/j.contraception.2009.10.011; Wallace AR, 2007, CONTRACEPTION, V76, P53, DOI 10.1016/j.contraception.2006.10.012	40	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46901	10.1371/journal.pone.0046901	http://dx.doi.org/10.1371/journal.pone.0046901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056520	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500105
J	Santos, CL; Correia-Neves, M; Moradas-Ferreira, P; Mendes, MV				Santos, Catarina Lopes; Correia-Neves, Margarida; Moradas-Ferreira, Pedro; Mendes, Marta Vaz			A Walk into the LuxR Regulators of Actinobacteria: Phylogenomic Distribution and Functional Diversity	PLOS ONE			English	Article							TO-CELL COMMUNICATION; MYCOBACTERIUM-TUBERCULOSIS; GENE-EXPRESSION; STRESS-RESPONSE; QUORUM; TRANSCRIPTION; BIOSYNTHESIS; EVOLUTION; NETWORK; FAMILY	LuxR regulators are a widely studied group of bacterial helix-turn-helix (HTH) transcription factors involved in the regulation of many genes coding for important traits at an ecological and medical level. This regulatory family is particularly known by their involvement in quorum-sensing (QS) mechanisms, i.e., in the bacterial ability to communicate through the synthesis and binding of molecular signals. However, these studies have been mainly focused on Gram-negative organisms, and the presence of LuxR regulators in the Gram-positive Actinobacteria phylum is still poorly explored. In this manuscript, the presence of LuxR regulators among Actinobacteria was assayed using a domain-based strategy. A total of 991 proteins having one LuxR domain were identified in 53 genome-sequenced actinobacterial species, of which 59% had an additional domain. In most cases (53%) this domain was REC (receiver domain), suggesting that LuxR regulators in Actinobacteria may either function as single transcription factors or as part of two-component systems. The frequency, distribution and evolutionary stability of each of these sub-families of regulators was analyzed and contextualized regarding the ecological niche occupied by each organism. The results show that the presence of extra-domains in the LuxR-regulators was likely driven by a general need to physically uncouple the signal sensing from the signal transduction. Moreover, the total frequency of LuxR regulators was shown to be dependent on genetic, metabolic and ecological variables. Finally, the functional annotation of the LuxR regulators revealed that the bacterial ecological niche has biased the specialization of these proteins. In the case of pathogens, our results suggest that LuxR regulators can be involved in virulence and are therefore promising targets for future studies in the health-related biotechnology field.	[Santos, Catarina Lopes; Moradas-Ferreira, Pedro; Mendes, Marta Vaz] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Correia-Neves, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Correia-Neves, Margarida] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Moradas-Ferreira, Pedro] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Minho; Universidade do Porto	Santos, CL (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	cls@ibmc.up.pt	Correia-Neves, Margarida/C-9122-2009; Mendes, Marta Vaz/A-8541-2008; MORADAS-FERREIRA, PEDRO/E-6357-2012; Correia-Neves, Margarida/AAH-4636-2020	Correia-Neves, Margarida/0000-0002-2202-5431; Mendes, Marta Vaz/0000-0002-6105-522X; MORADAS-FERREIRA, PEDRO/0000-0003-2994-0314; Correia-Neves, Margarida/0000-0002-2202-5431; Lopes dos Santos, Catarina/0000-0002-4273-1077	European Regional Development Fund through COMPETE program; FCT - Fundacao para a Ciencia e Tecnologia [FCOMP-01-0124-FEDER-022718, FCT Pest-C/SAU/LA0002/2011]; POPH QREN Tipologia 4.2 Promocao do Emprego Cientifico program; European Social Fund; Portuguese national funds from the MCTES; FCT [SFRH/BPD/62978/2009]	European Regional Development Fund through COMPETE program; FCT - Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); POPH QREN Tipologia 4.2 Promocao do Emprego Cientifico program; European Social Fund(European Social Fund (ESF)); Portuguese national funds from the MCTES; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by the European Regional Development Fund through COMPETE program and FCT - Fundacao para a Ciencia e Tecnologia, with the project FCOMP-01-0124-FEDER-022718 (ref FCT Pest-C/SAU/LA0002/2011). MVM was supported by "Programa Ciencia 2007'' sponsored by POPH QREN Tipologia 4.2 Promocao do Emprego Cientifico program and co-financed by the European Social Fund and Portuguese national funds from the MCTES. CLS was supported by the FCT fellowship SFRH/BPD/62978/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014792; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Alonso-Hearn M, 2010, INNATE IMMUN-LONDON, V16, P235, DOI 10.1177/1753425909339811; Anton N, 2007, MICROBIOL-SGM, V153, P3174, DOI 10.1099/mic.0.2007/009126-0; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Banaiee N, 2006, INFECT IMMUN, V74, P6449, DOI 10.1128/IAI.00190-06; Castro LI, 2005, FEBS J, V272, P3085, DOI 10.1111/j.1742-4658.2005.04722.x; Coenye T, 2005, FEMS MICROBIOL REV, V29, P147, DOI 10.1016/j.femsre.2004.11.004; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Drummond A., 2011, GENEIOUS V5 5; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; Eberl L, 1996, MOL MICROBIOL, V20, P127, DOI 10.1111/j.1365-2958.1996.tb02495.x; Ferluga S, 2007, MOL PLANT PATHOL, V8, P529, DOI [10.1111/j.1364-3703.2007.00415.x, 10.1111/J.1364-3703.2007.00415.X]; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Fuqua C, 1998, CURR OPIN MICROBIOL, V1, P183, DOI 10.1016/S1369-5274(98)80009-X; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Gao BL, 2012, MICROBIOL MOL BIOL R, V76, P66, DOI 10.1128/MMBR.05011-11; Geier H, 2008, APPL ENVIRON MICROB, V74, P1798, DOI 10.1128/AEM.02066-07; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gray KM, 2001, MICROBIOL-SGM, V147, P2379, DOI 10.1099/00221287-147-8-2379; Guerra SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031475; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo J, 2010, MOL GENET GENOMICS, V283, P123, DOI 10.1007/s00438-009-0502-2; Hartkoorn RC, 2012, J BACTERIOL, V194, P2001, DOI 10.1128/JB.06692-11; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Jukes TH, 1969, EVOLUTION PROTEIN MO; Kato JY, 2007, P NATL ACAD SCI USA, V104, P2378, DOI 10.1073/pnas.0607472104; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Lechner A, 2011, CHEM BIOL, V18, P1527, DOI 10.1016/j.chembiol.2011.10.014; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Marchler-Bauer A., NUCL ACIDS RES, V39, pD225; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; Muttucumaru DGN, 2011, TUBERCULOSIS, V91, P111, DOI 10.1016/j.tube.2010.11.010; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Ohsawa T, 2006, J BIOCHEM, V139, P203, DOI 10.1093/jb/mvj023; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Santos CL, 2009, FEMS MICROBIOL REV, V33, P411, DOI 10.1111/j.1574-6976.2008.00154.x; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Sturme MHJ, 2007, MICROBIOL-SGM, V153, P3939, DOI 10.1099/mic.0.2007/012831-0; Sturme MHJ, 2002, ANTON LEEUW INT J G, V81, P233, DOI 10.1023/A:1020522919555; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Yanai I, 2002, GENOME BIOL, V3; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	54	41	43	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46758	10.1371/journal.pone.0046758	http://dx.doi.org/10.1371/journal.pone.0046758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056438	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500073
J	Au, KF; Underwood, JG; Lee, L; Wong, WH				Au, Kin Fai; Underwood, Jason G.; Lee, Lawrence; Wong, Wing Hung			Improving PacBio Long Read Accuracy by Short Read Alignment	PLOS ONE			English	Article								The recent development of third generation sequencing (TGS) generates much longer reads than second generation sequencing (SGS) and thus provides a chance to solve problems that are difficult to study through SGS alone. However, higher raw read error rates are an intrinsic drawback in most TGS technologies. Here we present a computational method, LSC, to perform error correction of TGS long reads (LR) by SGS short reads (SR). Aiming to reduce the error rate in homopolymer runs in the main TGS platform, the PacBio (R) RS, LSC applies a homopolymer compression (HC) transformation strategy to increase the sensitivity of SR-LR alignment without scarifying alignment accuracy. We applied LSC to 100,000 PacBio long reads from human brain cerebellum RNA-seq data and 64 million single-end 75 bp reads from human brain RNA-seq data. The results show LSC can correct PacBio long reads to reduce the error rate by more than 3 folds. The improved accuracy greatly benefits many downstream analyses, such as directional gene isoform detection in RNA-seq study. Compared with another hybrid correction tool, LSC can achieve over double the sensitivity and similar specificity.	[Au, Kin Fai; Wong, Wing Hung] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Underwood, Jason G.; Lee, Lawrence] Pacific Biosci Calif, Menlo Pk, CA USA	Stanford University	Wong, WH (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.	whwong@stanford.edu			National Institutes of Health [R01HG005717, R01HD057970]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057970] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health [R01HG005717 to K.F.A. and R01HD057970 to W.H.W.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JJ, 2011, P NATL ACAD SCI USA, V108, P19867, DOI 10.1073/pnas.1113972108; Mason Christopher E, 2012, Genome Biol, V13, P314, DOI 10.1186/gb-2012-13-3-314; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mu JC, 2012, BIOINFORMATICS; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621	8	219	230	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46679	10.1371/journal.pone.0046679	http://dx.doi.org/10.1371/journal.pone.0046679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056399	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800039
J	Li, KR; Zhang, JQ; Li, JYH				Li, Kairong; Zhang, Jiaqing; Li, James Y. H.			Gbx2 Plays an Essential but Transient Role in the Formation of Thalamic Nuclei	PLOS ONE			English	Article							REGULATORY GENES; SONIC HEDGEHOG; EXPRESSION; MOUSE; IDENTITY; DIFFERENTIATION; SPECIFICATION; PROJECTIONS; BOUNDARIES; ABSENCE	Unlike the laminar arrangement of neurons in the neocortex, thalamic neurons aggregate to form about dozens of nuclei, many of which make topographic connections with specific areas in the neocortex. The molecular mechanisms underlying the formation of thalamic nuclei remain largely unknown. Homeodomain transcription factor Gbx2 is specifically expressed in the developing thalamus. Deleting Gbx2 leads to severe disruption of the histogenesis of the thalamus in mice, demonstrating an essential role of Gbx2 in this brain structure. Using inducible genetic fate mapping, we have previously shown that the neuronal precursors for different sets of thalamic nuclei have distinctive onset and duration of Gbx2 expression, suggesting that the dynamic expression of Gbx2 plays an important role in the specification and differentiation of thalamic nuclei. Here, we showed that the Gbx2 lineage exclusively gives rise to neurons but not glia in the thalamus. We performed conditional deletion to examine the temporal requirements of Gbx2 in the developing thalamus in mice. Corresponding to the dynamic and differential expression of Gbx2 in various thalamic nucleus groups, deleting Gbx2 at different embryonic stages disrupts formation of distinct sets of thalamic nuclei. Interestingly, different thalamic nuclei have remarkably different requirements of Gbx2 for the survival of thalamic neurons. Furthermore, although Gbx2 expression persists in many thalamic nuclei until adulthood, only the initial expression of Gbx2 following neurogenesis is crucial for the differentiation of thalamic nuclei. Our results indicate that the dynamic expression of Gbx2 may act as an important determinant in coupling with other developmental programs to generate distinct thalamic nuclei.	[Zhang, Jiaqing] Jinan Univ, Biochem Dept Med Sch, Guangzhou, Guangdong, Peoples R China; [Li, Kairong; Li, James Y. H.] Univ Connecticut Hlth Ctr, Dept Genet & Dev Biol, Farmington, CT USA	Jinan University; University of Connecticut	Li, JYH (corresponding author), Univ Connecticut Hlth Ctr, Dept Genet & Dev Biol, Farmington, CT USA.	jali@uchc.edu			National Institute of Health [R01 MH094914]; NICHD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094914] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Health R01 MH094914 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Li Chen for initiating the project, Ms. Qiuxia Guo for excellent technical assistance, Dr. Shen-Ju Chou for providing advice on the examination of cortical sensory map. We thank Drs. Rashmi Bensal, Xue-Jun Li, Richard Mains, for providing the antibodies against CC1, Sox2, and NPY. The Nkx2.2 monoclonal antibody developed by T. Jessell was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	ANGEVINE JB, 1970, J COMP NEUROL, V139, P129, DOI 10.1002/cne.901390202; BULFONE A, 1993, J NEUROSCI, V13, P3155; CAVINESS VS, 1980, J COMP NEUROL, V194, P335, DOI 10.1002/cne.901940205; Chen L, 2010, J NEUROSCI; Chen L, 2009, DEVELOPMENT, V136, P1317, DOI 10.1242/dev.030510; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; HOHLABRAHAO JC, 1991, EXP BRAIN RES, V87, P283; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Jones EG, 2004, J COMP NEUROL, V477, P55, DOI 10.1002/cne.20234; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Kataoka A, 2008, DEVELOPMENT, V135, P2873, DOI 10.1242/dev.021618; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Lotto RB, 2001, J NEUROSCI, V21, P3904, DOI 10.1523/JNEUROSCI.21-11-03904.2001; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Nakagawa Y, 2001, J NEUROSCI, V21, P2711, DOI 10.1523/JNEUROSCI.21-08-02711.2001; Persico AM, 2001, J NEUROSCI, V21, P6862, DOI 10.1523/JNEUROSCI.21-17-06862.2001; Petrovic M, 2008, NATURE, V456, P800, DOI 10.1038/nature07407; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STEINDLER DA, 1993, ANNU REV NEUROSCI, V16, P445, DOI 10.1146/annurev.ne.16.030193.002305; Szabo NE, 2009, J NEUROSCI, V29, P2453, DOI 10.1523/JNEUROSCI.4524-08.2009; Vue TY, 2007, J COMP NEUROL, V505, P73, DOI 10.1002/cne.21467; Vue TY, 2009, J NEUROSCI, V29, P4484, DOI 10.1523/JNEUROSCI.0656-09.2009; Wassarman KM, 1997, DEVELOPMENT, V124, P2923	28	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e47111	10.1371/journal.pone.0047111	http://dx.doi.org/10.1371/journal.pone.0047111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056596	Green Submitted, Green Published, gold			2022-12-27	WOS:000309580800072
J	Orenstein, LAV; Orenstein, EW; Teguete, I; Kodio, M; Tapia, M; Sow, SO; Levine, MM				Orenstein, Lauren A. V.; Orenstein, Evan W.; Teguete, Ibrahima; Kodio, Mamoudou; Tapia, Milagritos; Sow, Samba O.; Levine, Myron M.			Background Rates of Adverse Pregnancy Outcomes for Assessing the Safety of Maternal Vaccine Trials in Sub-Saharan Africa	PLOS ONE			English	Article							CONGENITAL-ANOMALIES; CHANGING PATTERNS; NEONATAL TETANUS; GESTATIONAL-AGE; VIRUS-INFECTION; WEST-AFRICA; MORTALITY; MORBIDITY; INFLUENZA; COUNTRIES	Background: Maternal immunization has gained traction as a strategy to diminish maternal and young infant mortality attributable to infectious diseases. Background rates of adverse pregnancy outcomes are crucial to interpret results of clinical trials in Sub-Saharan Africa. Methods: We developed a mathematical model that calculates a clinical trial's expected number of neonatal and maternal deaths at an interim safety assessment based on the person-time observed during different risk windows. This model was compared to crude multiplication of the maternal mortality ratio and neonatal mortality rate by the number of live births. Systematic reviews of severe acute maternal morbidity (SAMM), low birth weight (LBW), prematurity, and major congenital malformations (MCM) in Sub-Saharan African countries were also performed. Findings: Accounting for the person-time observed during different risk periods yields lower, more conservative estimates of expected maternal and neonatal deaths, particularly at an interim safety evaluation soon after a large number of deliveries. Median incidence of SAMM in 16 reports was 40.7 (IQR: 10.6-73.3) per 1,000 total births, and the most common causes were hemorrhage (34%), dystocia (22%), and severe hypertensive disorders of pregnancy (22%). Proportions of liveborn infants who were LBW (median 13.3%, IQR: 9.9-16.4) or premature (median 15.4%, IQR: 10.6-19.1) were similar across geographic region, study design, and institutional setting. The median incidence of MCM per 1,000 live births was 14.4 (IQR: 5.5-17.6), with the musculoskeletal system comprising 30%. Interpretation: Some clinical trials assessing whether maternal immunization can improve pregnancy and young infant outcomes in the developing world have made ethics- based decisions not to use a pure placebo control. Consequently, reliable background rates of adverse pregnancy outcomes are necessary to distinguish between vaccine benefits and safety concerns. Local studies that quantify population-based background rates of adverse pregnancy outcomes will improve safety assessment of interventions during pregnancy.	[Tapia, Milagritos; Sow, Samba O.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Orenstein, Lauren A. V.; Orenstein, Evan W.] Emory Univ, Sch Med, Atlanta, GA USA; [Orenstein, Lauren A. V.; Orenstein, Evan W.; Kodio, Mamoudou; Tapia, Milagritos; Sow, Samba O.] Ctr Dev Vaccins Mali, Bamako, Mali; [Teguete, Ibrahima] Gabriel Toure Teaching Hosp, Dept Obstet & Gynecol, Bamako, Mali	University System of Maryland; University of Maryland Baltimore; Emory University	Levine, MM (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	MLevine@medicine.umaryland.edu	Orenstein, Evan/F-1954-2013; Orenstein, Evan/CAH-5618-2022; Orenstein, Evan/ABG-3276-2021	Orenstein, Evan/0000-0003-3756-8575; Orenstein, Evan/0000-0003-3756-8575	Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; Infectious Disease Society of America Medical Scholarship; Emory University School of Medicine; Benjamin H. Kean Traveling Fellowship in Tropical Medicine; Bill & Melinda Gates Foundation [OPP1002744]	Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; Infectious Disease Society of America Medical Scholarship; Emory University School of Medicine; Benjamin H. Kean Traveling Fellowship in Tropical Medicine; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Lauren Orenstein's participation was supported by the Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship, the Infectious Disease Society of America Medical Scholarship, and Emory University School of Medicine. Evan Orenstein's participation was supported by the Benjamin H. Kean Traveling Fellowship in Tropical Medicine, the Infectious Disease Society of America Medical Scholarship, and Emory University School of Medicine. Additional support was provided by grant OPP1002744 from the Bill & Melinda Gates Foundation (M. M. Levine, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUDU OO, 1988, INT J GYNECOL OBSTET, V27, P63, DOI 10.1016/0020-7292(88)90089-6; Ahman E, 2007, NEONATAL PERINATAL M; Ahuka O L, 2006, East Afr Med J, V83, P95; Ali AA, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-48; Bakare T I B, 2009, Afr J Paediatr Surg, V6, P28, DOI 10.4103/0189-6725.48572; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Bouvier-Colle MH, 2001, ACTA OBSTET GYN SCAN, V80, P113; Cham M, 2007, Glob Public Health, V2, P359, DOI 10.1080/17441690600918188; Cham M, 2009, ACTA OBSTET GYN SCAN, V88, P343, DOI 10.1080/00016340902730318; Chou D, 2010, TRENDS MATERNAL MORT; Cochet L, 2003, SAMJ S AFR MED J, V93, P700; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; DELPORT SD, 1995, S AFR MED J, V85, P11; Demographic and Health Surveys, 2012, DEMOGRAPHIC HLTH SUR; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; EMBREE JE, 1989, PEDIATR INFECT DIS J, V8, P700, DOI 10.1097/00006454-198910000-00008; Eregie CO, 2000, J TROP PEDIATRICS, V46, P140, DOI 10.1093/tropej/46.3.140; FARR V, 1969, AM J OBSTET GYNECOL, V103, P380, DOI 10.1016/0002-9378(69)90497-9; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Gandhi MN, 2004, INT J GYNECOL OBSTET, V87, P180, DOI 10.1016/j.ijgo.2004.07.012; GARTY BZ, 1994, CLIN DIAGN LAB IMMUN, V1, P667, DOI 10.1128/CDLI.1.6.667-669.1994; Gessessew Amanuel, 2007, Ethiop Med J, V45, P47; GREENWOOD AM, 1987, B WORLD HEALTH ORGAN, V65, P635; GUPTA B, 1969, West African Medical Journal and Nigerian Practitioner, V18, P22; Healy CM, 2006, CURR OPIN INFECT DIS, V19, P271, DOI 10.1097/01.qco.0000224822.65599.5b; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hoj L, 1999, INT J EPIDEMIOL, V28, P70, DOI 10.1093/ije/28.1.70; Kaye DK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-65; KHAN AA, 1977, E AFR MED J, V54, P631; LEVINE MM, 1974, LANCET, V2, P34; Lori JR, 2012, MIDWIFERY, V28, P67, DOI 10.1016/j.midw.2010.12.001; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x; MARTEY JO, 1994, E AFR MED J, V71, P656; Mayi-Tsonga Sosthene, 2007, Sante, V17, P111; McDermott JM, 1996, AM J TROP MED HYG, V55, P66, DOI 10.4269/ajtmh.1996.55.66; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moretti ME, 2005, EPIDEMIOLOGY, V16, P216, DOI 10.1097/01.ede.0000152903.55579.15; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-94; Okong P, 2006, ACTA OBSTET GYN SCAN, V85, P797, DOI 10.1080/00016340600593331; Oladapo OT, 2007, INT J GYNECOL OBSTET, V98, P278, DOI 10.1016/j.ijgo.2007.05.018; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Prual A, 1998, Afr J Reprod Health, V2, P10; Prual A, 2000, B WORLD HEALTH ORGAN, V78, P593; Queisser-Luft A., 2002, Archives of Gynecology and Obstetrics, V266, P163, DOI 10.1007/s00404-001-0265-4; RAHMAN M, 1982, B WORLD HEALTH ORGAN, V60, P261; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Ronsmans C, 2004, NUMBERS REV MATERNAL; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; SHIJA JK, 1985, CENT AFR J MED, V31, P145; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; STEVENSO.AC, 1966, B WORLD HEALTH ORGAN, VS 34, P9; SUKHANI S, 1977, MED J ZAMBIA, V11, P127; United Nations Children's Fund, 2011, STAT WORLDS CHILDR 2; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; van den Berg JP, 2010, PEDIATR INFECT DIS J, V29, P801, DOI 10.1097/INF.0b013e3181dc4f77; Vandecruys HIB, 2002, EUR J OBSTET GYN R B, V102, P6, DOI 10.1016/S0301-2115(01)00558-9; Vandelaer J, 2003, VACCINE, V21, P3442, DOI 10.1016/S0264-410X(03)00347-5; VENTER PA, 1995, S AFR MED J, V85, P15; Walraven G, 2000, B WORLD HEALTH ORGAN, V78, P603; World Health Organization, 2004, INT STAT CLASS DIS H; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	68	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46638	10.1371/journal.pone.0046638	http://dx.doi.org/10.1371/journal.pone.0046638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056380	Green Submitted, Green Published, gold			2022-12-27	WOS:000309580800035
J	Zou, YZ; Weis, WI; Kobilka, BK				Zou, Yaozhong; Weis, William I.; Kobilka, Brian K.			N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; ANTAGONIST; COMPLEX; GPCR	A highly crystallizable T4 lysozyme (T4L) was fused to the N-terminus of the beta(2) adrenergic receptor (beta(2)AR), a G-protein coupled receptor (GPCR) for catecholamines. We demonstrate that the N-terminal fused T4L is sufficiently rigid relative to the receptor to facilitate crystallogenesis without thermostabilizing mutations or the use of a stabilizing antibody, G protein, or protein fused to the 3rd intracellular loop. This approach adds to the protein engineering strategies that enable crystallographic studies of GPCRs alone or in complex with a signaling partner.	[Zou, Yaozhong; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kobilka@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Kobilka, Brian/0000-0001-5958-3990	National Institutes of Health [NS028471, GM083118, GM56169]; Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118, R01GM056169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge support from National Institutes of Health Grants NS028471 and GM083118 ( B. K. K.), GM56169 ( W. I. W.), and the Mathers Foundation ( B. K. K. and W. I. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Swaminath G, 2002, MOL PHARMACOL, V61, P65, DOI 10.1124/mol.61.1.65; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	18	66	68	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46039	10.1371/journal.pone.0046039	http://dx.doi.org/10.1371/journal.pone.0046039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056231	Green Submitted, gold, Green Published			2022-12-27	WOS:000309580800006
J	Boone, DR; Sell, SL; Micci, MA; Crookshanks, JM; Parsley, M; Uchida, T; Prough, DS; DeWitt, DS; Hellmich, HL				Boone, Deborah R.; Sell, Stacy L.; Micci, Maria-Adelaide; Crookshanks, Jeanna M.; Parsley, Margaret; Uchida, Tatsuo; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.			Traumatic Brain Injury-Induced Dysregulation of the Circadian Clock	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SUPRACHIASMATIC NUCLEUS; ALZHEIMERS-DISEASE; RAT HIPPOCAMPUS; GENE-EXPRESSION; HEAD TRAUMA; RHYTHMS; MEMORY; NEURONS; OSCILLATION	Circadian rhythm disturbances are frequently reported in patients recovering from traumatic brain injury (TBI). Since circadian clock output is mediated by some of the same molecular signaling cascades that regulate memory formation (cAMP/MAPK/CREB), cognitive problems reported by TBI survivors may be related to injury-induced dysregulation of the circadian clock. In laboratory animals, aberrant circadian rhythms in the hippocampus have been linked to cognitive and memory dysfunction. Here, we addressed the hypothesis that circadian rhythm disruption after TBI is mediated by changes in expression of clock genes in the suprachiasmatic nuclei (SCN) and hippocampus. After fluid-percussion TBI or sham surgery, male Sprague-Dawley rats were euthanized at 4 h intervals, over a 48 h period for tissue collection. Expression of circadian clock genes was measured using quantitative real-time PCR in the SCN and hippocampus obtained by laser capture and manual microdissection respectively. Immunofluorescence and Western blot analysis were used to correlate TBI-induced changes in circadian gene expression with changes in protein expression. In separate groups of rats, locomotor activity was monitored for 48 h. TBI altered circadian gene expression patterns in both the SCN and the hippocampus. Dysregulated expression of key circadian clock genes, such as Bmal1 and Cry1, was detected, suggesting perturbation of transcriptional-translational feedback loops that are central to circadian timing. In fact, disruption of circadian locomotor activity rhythms in injured animals occurred concurrently. These results provide an explanation for how TBI causes disruption of circadian rhythms as well as a rationale for the consideration of drugs with chronobiotic properties as part of a treatment strategy for TBI.	[Boone, Deborah R.; Sell, Stacy L.; Micci, Maria-Adelaide; Crookshanks, Jeanna M.; Parsley, Margaret; Uchida, Tatsuo; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	Moody Foundation/Mission Connect; Department of Anesthesiology	Moody Foundation/Mission Connect; Department of Anesthesiology	This study was supported in part by the Moody Foundation/Mission Connect and in part by the Department of Anesthesiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2000, NEUROREPORT, V11, P3261, DOI 10.1097/00001756-200009280-00042; Akashi M, 2008, J NEUROSCI, V28, P4619, DOI 10.1523/JNEUROSCI.3410-07.2008; Alamili M, 2010, DAN MED BULL, V57; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; BARNES CA, 1977, SCIENCE, V197, P91, DOI 10.1126/science.194313; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Benca R, 2009, BRAIN RES REV, V62, P57, DOI 10.1016/j.brainresrev.2009.09.005; Boyce P, 2010, AUST FAM PHYSICIAN, V39, P307; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Cheeseman JF, 2012, P NATL ACAD SCI USA, V109, P7061, DOI 10.1073/pnas.1201734109; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Chen Z, 2007, CELL CYCLE, V6, P2906, DOI 10.4161/cc.6.23.5041; Craig LA, 2008, BRAIN RES BULL, V76, P141, DOI 10.1016/j.brainresbull.2008.02.013; Dawson D, 1996, PHARMACOL THERAPEUT, V69, P15, DOI 10.1016/0163-7258(95)02020-9; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Eckel-Mahan KL, 2009, EMBO REP, V10, P584, DOI 10.1038/embor.2009.123; Gamsby JJ, 2009, J BIOL RHYTHM, V24, P193, DOI 10.1177/0748730409334748; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Gerstner JR, 2012, FRONTIERS MOL NEUROS, V5, P1; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gouin JP, 2010, J AFFECT DISORDERS, V126, P161, DOI 10.1016/j.jad.2010.04.002; Halberg Franz, 2003, J Circadian Rhythms, V1, P2, DOI 10.1186/1740-3391-1-2; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; LeSauter J, 1999, J NEUROSCI, V19, P5574; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Mendlewicz J, 2009, CNS DRUGS, V23, P15, DOI 10.2165/11318630-000000000-00000; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Rawashdeh O, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00027; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; SAS Institute Inc, 2004, SAS STAT US GUID VER; Sassone-Corsi P, 2010, MOL ENDOCRINOL, V24, P2081, DOI 10.1210/me.2010-0359; Schaaf MJM, 2000, MOL BRAIN RES, V75, P342, DOI 10.1016/S0169-328X(99)00314-9; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Sprouse J, 2006, BIOL PSYCHIAT, V60, P896, DOI 10.1016/j.biopsych.2006.03.003; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Uz T, 2005, NEUROSCIENCE, V134, P1309, DOI 10.1016/j.neuroscience.2005.05.003; Volicer L, 2001, AM J PSYCHIAT, V158, P704, DOI 10.1176/appi.ajp.158.5.704; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	68	56	59	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46204	10.1371/journal.pone.0046204	http://dx.doi.org/10.1371/journal.pone.0046204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056261	Green Published, gold			2022-12-27	WOS:000309454000025
J	Han, XM; Zhang, J; Guo, L; Cao, RH; Li, YZ; Li, N; Ma, Q; Wu, JL; Wang, YC; Si, SY				Han, Xiaomin; Zhang, Jing; Guo, Liang; Cao, Rihui; Li, Yongzhen; Li, Ni; Ma, Qin; Wu, Jialin; Wang, Yanchang; Si, Shuyi			A Series of Beta-Carboline Derivatives Inhibit the Kinase Activity of PLKs	PLOS ONE			English	Article							POLO-LIKE-KINASE; PROGNOSTIC-SIGNIFICANCE; PHASE-I; SPINDLE FORMATION; TUMOR-GROWTH; CANCER; EXPRESSION; POLO-LIKE-KINASE-1; APOPTOSIS; DEPLETION	Polo-like kinases play an essential role in the ordered execution of mitotic events and 4 mammalian PLK family members have been identified. Accumulating evidence indicates that PLK1 is an attractive target for anticancer drugs. In this paper, a series of beta-carboline derivatives were synthesized and three compounds, DH281, DH285 and DH287, were identified as potent new PLK inhibitors. We employed various biochemical and cellular approaches to determine the effects of these compounds on the activity of PLK1 and other mitotic kinases and on cell cycle progression. We found that these three compounds could selectively inhibit the kinase activity of purified PLK1, PLK2 and PLK3 in vitro. They show strong antitumor activity against a number of cancer cell lines with relatively low micromolar IC(50)s, but are relatively less toxic to non-cancer cells (MRC5). Moreover, these compounds could induce obvious accumulation of HeLa cells in G(2)/M and S phases and trigger apoptosis. Although MRC5 cells show clear S-phase arrest after treatment with these compounds, the G2/M arrest and apoptosis are less insignificant, indicating the distinct sensitivity between normal and cancer cells. We also found that HeLa cells treated with these drugs exhibit monopolar spindles and increased Wee1 protein levels, the characteristics of cells treated with PLK1 inhibitors. Together, these results demonstrate that DH281, DH285 and DH287 beta-carboline compounds are new PLK inhibitors with potential for cancer treatment.	[Guo, Liang; Cao, Rihui; Ma, Qin; Wu, Jialin] Xinjiang Huashidan Pharmaceut Co, Urumqi, Peoples R China; [Han, Xiaomin; Zhang, Jing; Li, Yongzhen; Li, Ni; Si, Shuyi] Peking Union Med Coll, Inst Med Biotechnol, Beijing 100021, Peoples R China; [Han, Xiaomin; Zhang, Jing; Li, Yongzhen; Li, Ni; Si, Shuyi] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wang, Yanchang] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; State University System of Florida; Florida State University	Wu, JL (corresponding author), Xinjiang Huashidan Pharmaceut Co, Urumqi, Peoples R China.	hsd_100@163.com; yanchang.wang@med.fsu.edu; sisyimb@hotmail.com		Wang, Yanchang/0000-0001-6782-0570	Major-Project from Ministry of Sciences and Technology, People's Republic of China [2012ZX09301002-001/003, 2010ZX9401-403]; Youth Science Funds from National Science Foundation of China, People's Republic of China [81128014]; Overseas, Hong Kong & Macao Scholars Collaborated Researching Fund from National Science Foundation of China, People's Republic of China [81128014]; Research Scholar Grant from the American Cancer Society [RSG-08-104-010CCG]; National Institutes of Health [R15GM097326-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM097326] Funding Source: NIH RePORTER	Major-Project from Ministry of Sciences and Technology, People's Republic of China; Youth Science Funds from National Science Foundation of China, People's Republic of China; Overseas, Hong Kong & Macao Scholars Collaborated Researching Fund from National Science Foundation of China, People's Republic of China; Research Scholar Grant from the American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Major-Project (2012ZX09301002-001/003 and 2010ZX9401-403) from Ministry of Sciences and Technology, People's Republic of China; Youth Science Funds (81001387) and Overseas, Hong Kong & Macao Scholars Collaborated Researching Fund (81128014) from National Science Foundation of China, People's Republic of China. Y.W. was supported by the Research Scholar Grant (RSG-08-104-010CCG) from the American Cancer Society and the R15GM097326-01 from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Chen XH, 2006, WORLD J GASTROENTERO, V12, P29, DOI 10.3748/wjg.v12.i1.29; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; Deveau AM, 2001, BIOORG MED CHEM LETT, V11, P1251, DOI 10.1016/S0960-894X(01)00136-6; Garland LL, 2006, CLIN CANCER RES, V12, P5182, DOI 10.1158/1078-0432.CCR-06-0214; Gray PJ, 2004, MOL CANCER THER, V3, P641; Guan R, 2005, CANCER RES, V65, P2698, DOI 10.1158/0008-5472.CAN-04-2131; Ishida J, 1999, BIOORG MED CHEM LETT, V9, P3319, DOI 10.1016/S0960-894X(99)00598-3; Jimeno A, 2008, J CLIN ONCOL, V26, P5504, DOI 10.1200/JCO.2008.17.9788; Knecht R, 1999, CANCER RES, V59, P2794; Kneisel L, 2002, J CUTAN PATHOL, V29, P354, DOI 10.1034/j.1600-0560.2002.290605.x; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li Y, 2007, CANCER BIOL THER, V6, P1193; Liu H, 2006, MOL BIOL CELL, pE5; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; McInnes C, 2005, CURR TOP MED CHEM, V5, P181, DOI 10.2174/1568026053507660; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Nogawa M, 2005, J CLIN INVEST, V115, P978, DOI 10.1172/JCI200523043; Olmos D, 2009, J CLIN ONCOL, V27; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Sobhani AM, 2002, J PHARM PHARM SCI, V5, P19; Song B, 2011, MOL CELL BIOL, V31, P4844, DOI 10.1128/MCB.06110-11; Song YC, 2004, BIOCHEM BIOPH RES CO, V317, P128, DOI 10.1016/j.bbrc.2004.03.019; Spankuch B, 2004, JNCI-J NATL CANCER I, V96, P862, DOI 10.1093/jnci/djh146; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Takahashi T, 2003, CANCER SCI, V94, P148, DOI 10.1111/j.1349-7006.2003.tb01411.x; Takai N, 2001, CANCER LETT, V169, P41, DOI 10.1016/S0304-3835(01)00522-5; Takai N, 2001, CANCER LETT, V164, P41, DOI 10.1016/S0304-3835(00)00703-5; Tokumitsu Y, 1999, INT J ONCOL, V15, P687; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Weichert W, 2005, VIRCHOWS ARCH, V446, P442, DOI 10.1007/s00428-005-1212-8; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Wolf G, 1997, ONCOGENE, V14, P543, DOI 10.1038/sj.onc.1200862; Zhang J, 2009, CANCER BIOL THER, V8, P2374, DOI 10.4161/cbt.8.24.10182	43	32	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46546	10.1371/journal.pone.0046546	http://dx.doi.org/10.1371/journal.pone.0046546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056340	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000054
J	Hayes, CD; Dey, D; Palavicini, JP; Wang, HJ; Araki, W; Lakshmana, MK				Hayes, Crystal D.; Dey, Debleena; Palavicini, Juan Pablo; Wang, Hongjie; Araki, Wataru; Lakshmana, Madepalli K.			Chronic Cladribine Administration Increases Amyloid Beta Peptide Generation and Plaque Burden in Mice	PLOS ONE			English	Article							PRECURSOR PROTEIN; 2-CHLORODEOXYADENOSINE; TOXICITY; DISEASE; PIN1; PHARMACOKINETICS; MULTICENTER; LYMPHOMAS; LEUKEMIA; THERAPY	Background: The clinical uses of 2-chloro-2'-deoxyadenosine (2-CDA) or cladribine which was initially prescribed to patients with hematological and lymphoid cancers is now extended to treat patients with multiple sclerosis (MS). Previous data has shown that 2-CDA has high affinity to the brain and readily passes through the blood brain barrier reaching CSF concentrations 25% of that found in plasma. However, whether long-term administration of 2-CDA can lead to any adverse effects in patients or animal models is not yet clearly known. Methodology: Here we show that exposure of 2-CDA to CHO cells stably expressing wild-type APP751 increased generation and secretion of amyloid beta peptide (A beta) in to the conditioned medium. Interestingly, increased A beta levels were noticed even at non-toxic concentrations of 2-CDA. Remarkably, chronic treatment of APdE9 mice, a model of Alzheimer's disease with 2-CDA for 60 days increased amyloid plaque burden by more than 1-fold. Increased A beta generation appears to result from increased turnover of APP as revealed by cycloheximide-chase experiments. Additionally, surface labeling of APP with biotin and immunoprecipitation of surface labeled proteins with anti-biotin antibody also indicated increased APP at the cell surface in 2-CDA treated cells compared to controls. Increased turnover of APP by 2-CDA in turn might be a consequence of decreased protein levels of PIN 1, which is known to regulate cis-trans isomerization and phosphorylation of APP. Most importantly, like many other oncology drugs, 2-CDA administration led to significant delay in acquiring a reward-based learning task in a T maze paradigm. Conclusions: Taken together, these data provide compelling evidence for the first time that chronic 2-CDA administration can increase amyloidogenic processing of APP leading to robustly increased plaque burden which may be responsible for the observed deficits in learning skills. Thus chronic treatment of mice with 2-CDA can have deleterious effects in vivo.	[Hayes, Crystal D.; Dey, Debleena; Palavicini, Juan Pablo; Wang, Hongjie; Lakshmana, Madepalli K.] Torrey Pines Inst Mol Studies, Neurobiol Sect, Port St Lucie, FL USA; [Araki, Wataru] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Demyelinating Dis & Aging, Kodaira, Tokyo 1870031, Japan	Torrey Pines Institute for Molecular Studies, Florida; National Center for Neurology & Psychiatry - Japan	Lakshmana, MK (corresponding author), Torrey Pines Inst Mol Studies, Neurobiol Sect, Port St Lucie, FL USA.	mlakshmana@tpims.org	Araki, Wataru/G-7913-2014	Araki, Wataru/0000-0001-8467-6937	Alzheimer's and Aging Institute; TPIMS, Florida	Alzheimer's and Aging Institute; TPIMS, Florida	The authors are grateful to the seed money obtained in the form of a small institutional grant from Alzheimer's and Aging Institute, TPIMS, Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyriou AA, 2011, J PAIN SYMPTOM MANAG, V41, P126, DOI 10.1016/j.jpainsymman.2010.04.021; Asher Arash, 2011, Am J Phys Med Rehabil, V90, pS16, DOI 10.1097/PHM.0b013e31820be463; BEUTLER E, 1992, LANCET, V340, P952, DOI 10.1016/0140-6736(92)92826-2; Blum KA, 2006, CANCER, V107, P2817, DOI 10.1002/cncr.22344; CARSON DA, 1983, BLOOD, V62, P737; CARSON DA, 1977, P NATL ACAD SCI USA, V74, P5677, DOI 10.1073/pnas.74.12.5677; CHESON BD, 1994, J CLIN ONCOL, V12, P2216, DOI 10.1200/JCO.1994.12.10.2216; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Davis Jr JC, 1988, ARTHRITIS RHEUM, V41, P335; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Developmental Therapeutics Program NCI/NIH, DEV THER PROGR; Djaldetti R, 1996, J SUBMICR CYTOL PATH, V28, P319; Duddy M, 2011, J NEUROL, V258, P728, DOI 10.1007/s00415-011-6009-x; Gasperini C, 2011, EXPERT OPIN EMERG DR, V16, P697, DOI 10.1517/14728214.2011.642861; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Gold R, 2011, CNS DRUGS, V25, P37, DOI 10.2165/11539820-000000000-00000; Hartman WR, 2004, MOL PHARMACOL, V65, P227, DOI 10.1124/mol.65.1.227; Hartung HP, 2010, J NEUROL, V257, P163, DOI 10.1007/s00415-009-5359-0; Hentosh P, 2010, EXPERT OPIN DRUG MET, V6, P75, DOI 10.1517/17425250903393745; KAWASAKI H, 1993, BLOOD, V81, P597; Khachanova N V, 2011, Zh Nevrol Psikhiatr Im S S Korsakova, V111, P99; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Liliemark J, 1997, CLIN PHARMACOKINET, V32, P120, DOI 10.2165/00003088-199732020-00003; Lindemalm S, 2004, CANCER LETT, V210, P171, DOI 10.1016/j.canlet.2004.03.007; Lotfi K, 2003, LEUKEMIA LYMPHOMA, V44, P1705, DOI 10.1080/1042819031000099698; Lu PJ, 1999, NATURE, V399, P784; Myers Jamie S, 2012, Oncol Nurs Forum, V39, pE31, DOI 10.1188/12.ONF.E31-E40; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Ogura M, 2004, INT J HEMATOL, V80, P267, DOI 10.1532/IJH97.04077; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Rice GPA, 2000, NEUROLOGY, V54, P1145, DOI 10.1212/WNL.54.5.1145; Robak T, 2000, BRIT J HAEMATOL, V108, P357; Roe CM, 2005, NEUROLOGY, V64, P895, DOI 10.1212/01.WNL.0000152889.94785.51; Romine JS, 1999, P ASSOC AM PHYSICIAN, V111, P35, DOI 10.1046/j.1525-1381.1999.09115.x; Rummel MJ, 1999, ANN ONCOL, V10, P115, DOI 10.1023/A:1008325212484; Salvat C, 2009, ANN C EUR COMM TREAT; SAVEN A, 1994, ANN INTERN MED, V120, P784, DOI 10.7326/0003-4819-120-9-199405010-00010; SAVEN A, 1993, J CLIN ONCOL, V11, P671, DOI 10.1200/JCO.1993.11.4.671; Schirmer M, 1997, SCAND J RHEUMATOL, V26, P376, DOI 10.3109/03009749709065702; SETO S, 1985, J CLIN INVEST, V75, P377, DOI 10.1172/JCI111710; Sipe Jack C, 2005, Expert Rev Neurother, V5, P721, DOI 10.1586/14737175.5.6.721; SIPE JC, 1994, LANCET, V344, P9, DOI 10.1016/S0140-6736(94)91046-4; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Tack GJ, 2011, WORLD J GASTROENTERO, V17, P506, DOI 10.3748/wjg.v17.i4.506; VAHDAT L, 1994, BLOOD, V84, P3429; Zachariae R, 2011, NAT REV UROL, V8, P182, DOI 10.1038/nrurol.2011.29	49	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45841	10.1371/journal.pone.0045841	http://dx.doi.org/10.1371/journal.pone.0045841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056220	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000012
J	Liu, AG; Liu, Y; Jin, ZG; Hu, Q; Lin, L; Jou, D; Yang, J; Xu, ZH; Wang, H; Li, CL; Lin, JY				Liu, Aiguo; Liu, Yan; Jin, Zhigang; Hu, Qun; Lin, Li; Jou, David; Yang, Jing; Xu, Zhenghu; Wang, Hong; Li, Chenglong; Lin, Jiayuh			XZH-5 Inhibits STAT3 Phosphorylation and Enhances the Cytotoxicity of Chemotherapeutic Drugs in Human Breast and Pancreatic Cancer Cells	PLOS ONE			English	Article							MOLECULAR TARGETS; LIVER-CANCER; IL-6; GROWTH; ACTIVATION; TRANSFORMATION; APOPTOSIS; TUMORS	Constitutive activation of Signal Transducers and Activators of Transcription 3 (STAT3) signaling is frequently detected in breast and pancreatic cancer. Inhibiting constitutive STAT3 signaling represents a promising molecular target for therapeutic approach. Using structure-based design, we developed a non-peptide cell-permeable, small molecule, termed as XZH-5, which targeted STAT3 phosphorylation. XZH-5 was found to inhibit STAT3 phosphorylation (Tyr705) and induce apoptosis in human breast and pancreatic cancer cell lines expressing elevated levels of phosphorylated STAT3. XZH-5 could also inhibit interleukin-6-induced STAT3 phosphorylation in cancer cell lines expressing low phosphorylated STAT3. Inhibition of STAT3 signaling by XZH-5 was confirmed by the down-regulation of downstream targets of STAT3, such as Cyclin D1, Bcl-2, and Survivin at mRNA level. In addition, XZH-5 inhibited colony formation, cell migration, and enhanced the cytotoxicity of chemotherapeutic drugs when combined with Doxorubicin or Gemcitabine. Our results indicate that XZH-5 may be a potential therapeutic agent for breast and pancreatic cancers with constitutive STAT3 signaling.	[Liu, Aiguo; Hu, Qun] Huazhong Univ Sci & Technol, Dept Pediat, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China; [Liu, Aiguo; Liu, Yan; Lin, Li; Jou, David; Lin, Jiayuh] Nationwide Childrens Hosp, Ctr Childhood Canc, Res Inst, Columbus, OH USA; [Lin, Jiayuh] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Jin, Zhigang; Yang, Jing] Univ Illinois, Dept Comparat Biosci, Coll Vet Med, Urbana, IL USA; [Lin, Li] Huazhong Univ Sci & Technol, Div Cardiol, Dept Internal Med, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China; [Xu, Zhenghu; Wang, Hong] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; [Li, Chenglong] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA	Huazhong University of Science & Technology; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Urbana-Champaign; Huazhong University of Science & Technology; University System of Ohio; Miami University; University System of Ohio; Ohio State University	Liu, AG (corresponding author), Huazhong Univ Sci & Technol, Dept Pediat, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China.	aiguoliu20@yahoo.com.cn; lin.674@osu.edu	Jin, Zhigang/T-7125-2019; Xu, Zhenghu/M-4226-2014; Lin, Jiayuh/E-3515-2011; Li, Chenglong/E-7182-2010	Jin, Zhigang/0000-0001-7557-2968; Li, Chenglong/0000-0003-3174-8719	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093217] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Buettner R, 2002, CLIN CANCER RES, V8, P945; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Greten FR, 2002, GASTROENTEROLOGY, V123, P2052, DOI 10.1053/gast.2002.37075; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hutzen B, 2009, INT J ONCOL, V35, P867, DOI 10.3892/ijo_00000401; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu AG, 2011, CANCER SCI, V102, P1381, DOI 10.1111/j.1349-7006.2011.01932.x; Liu Y, 2011, CANC PREV RES PHILA; Liu Y, 2011, APOPTOSIS, V16, P502, DOI 10.1007/s10495-011-0578-0; Liu Y, 2010, J BIOL CHEM, V285, P27429, DOI 10.1074/jbc.M110.142752; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	28	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46624	10.1371/journal.pone.0046624	http://dx.doi.org/10.1371/journal.pone.0046624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056374	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000065
J	Yadama, GN; Peipert, J; Sahu, M; Biswas, P; Dyda, V				Yadama, Gautam N.; Peipert, John; Sahu, Manoranjan; Biswas, Pratim; Dyda, Venkat			Social, Economic, and Resource Predictors of Variability in Household Air Pollution from Cookstove Emissions	PLOS ONE			English	Article							SOLID-FUEL; INDOOR; METAANALYSIS; COMBUSTION; CHILDREN; INDIA; RISK; RECOMMENDATIONS; COUNTRIES; EXPOSURE	We examine if social and economic factors, fuelwood availability, market and media access are associated with owning a modified stove and variation in household emissions from biomass combustion, a significant environmental and health concern in rural India. We analyze cross-sectional household socio-economic data, and PM2.5 and particulate surface area concentration in household emissions from cookstoves (n = 100). This data set combines household social and economic variables with particle emissions indexes associated with the household stove. The data are from the Foundation for Ecological Society, India, from a field study of household emissions. In our analysis, we find that less access to ready and free fuelwood and higher wealth are associated with owning a replacement/modified stove. We also find that additional kitchen ventilation is associated with a 12% reduction in particulate emissions concentration (p < 0.05), after we account for the type of stove used. We did not find a significant association between replacement/modified stove on household emissions when controlling for additional ventilation. Higher wealth and education are associated with having additional ventilation. Social caste, market and media access did not have any effect on the presence of replacement or modified stoves or additional ventilation. While the data available to us does not allow an examination of direct health outcomes from emissions variations, adverse environmental and health impacts of toxic household emissions are well established elsewhere in the literature. The value of this study is in its further examination of the role of social and economic factors and available fuelwood from commons in type of stove use, and additional ventilation, and their effect on household emissions. These associations are important since the two direct routes to improving household air quality among the poor are stove type and better ventilation.	[Yadama, Gautam N.] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA; [Peipert, John] Washington Univ, Sch Med, Div Gen Med Sci, St Louis, MO USA; [Sahu, Manoranjan] Univ Illinois, Adv Energy Technol Initiat, Urbana, IL USA; [Sahu, Manoranjan; Biswas, Pratim] Washington Univ, Dept Energy Environm & Chem Engn, Aerosol & Air Qual Res Lab, St Louis, MO USA; [Dyda, Venkat] Fdn Ecol Secur, Papagni Regional Cell, Madanapalle, India	Washington University (WUSTL); Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL)	Yadama, GN (corresponding author), Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA.	yadama@wustl.edu	Biswas, P/F-6696-2019	Peipert, John/0000-0001-5762-7881	McDonnell Academy Global Energy and Environment Partnership, Washington University in St. Louis	McDonnell Academy Global Energy and Environment Partnership, Washington University in St. Louis	Seed funding for data analysis is provided by a grant from the McDonnell Academy Global Energy and Environment Partnership, Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 1997, DEV CHANGE, V28, P435, DOI 10.1111/1467-7660.00050; [Anonymous], 2009, ENERGY ACCESS SITUAT; Balakrishnan K, 2002, ENVIRON HEALTH PERSP, V110, P1069, DOI 10.1289/ehp.021101069; Barnes DF, 1994, ENERGY POLICY, P242; Bruce N, 2004, J EXPO ANAL ENV EPID, V14, pS26, DOI 10.1038/sj.jea.7500355; Chareunsy AK, 2012, J CONTEMP ASIA, V42, P276, DOI 10.1080/00472336.2012.668352; Cooke P, 2008, ENVIRON DEV ECON, V13, P103, DOI 10.1017/S1355770X0700397X; Dankwa-Mullan I, 2010, AM J PUBLIC HEALTH, V100, pS12, DOI 10.2105/AJPH.2010.191619; Dasgupta S, 2006, INDOOR AIR, V16, P426, DOI 10.1111/j.1600-0668.2006.00436.x; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Friel S, 2008, LANCET, V372, P1677, DOI 10.1016/S0140-6736(08)61692-X; *GOV IND, 2009, NEW IN IMPR BIOM COO, DOI DOI 10.1111/J.1600-0668.2006.00436.X; Hu GP, 2010, CHEST, V138, P20, DOI 10.1378/chest.08-2114; Hu GP, 2009, CURR OPIN PULM MED, V15, P158, DOI 10.1097/MCP.0b013e3283218304; International Energy Agency, 2010, EN POV MAK MOD EN AC; JODHA NS, 1986, ECON POLIT WEEKLY, V21, P1169; KRIEGER N, 2010, J EPIDEMIOLOGY COMMN, P1, DOI DOI 10.1017/S1355770X0700397X; Krieger N, 2010, ANN REV PUBLIC HLTH, P1; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Lewis JJ, 2012, ENV HLTH PERSPECT; Link CF, 2012, SOC SCI RES, V41, P598, DOI 10.1016/j.ssresearch.2011.12.007; Long J.Scott., 2005, REGRESSION MODELS CA; Long JS, 2005, WHAT MAKES PEOPLE CO; Martin WJ, 2011, SCIENCE, V334, P180, DOI 10.1126/science.1213088; MASERA OR, 2000, LINEAR FUEL SWITCHIN, P12; Mishra V, 2003, INT J EPIDEMIOL, V32, P847, DOI 10.1093/ije/dyg240; Mishra V K, 1999, Int J Infect Dis, V3, P119, DOI 10.1016/S1201-9712(99)90032-2; Olsson J, 2009, J TRANSP GEOGR, V17, P476, DOI 10.1016/j.jtrangeo.2008.09.001; PANDEY S, 1992, SOC SERV REV, V66, P582, DOI 10.1086/603949; Po JYT, 2011, THORAX, V66, P232, DOI 10.1136/thx.2010.147884; Romieu I, 2009, AM J RESP CRIT CARE, V180, P649, DOI 10.1164/rccm.200810-1556OC; Sahu M, 2011, ENVIRON SCI TECHNOL, V45, P2428, DOI 10.1021/es1029415; Smith KR, 2002, INDOOR AIR, V12, P198, DOI 10.1034/j.1600-0668.2002.01137.x; Venkataraman C, 2010, ENERGY SUSTAIN DEV, V14, P63, DOI 10.1016/j.esd.2010.04.005; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X	35	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46381	10.1371/journal.pone.0046381	http://dx.doi.org/10.1371/journal.pone.0046381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056293	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000035
J	Gillet, E; Meys, JFA; Verstraelen, H; Verhelst, R; De Sutter, P; Temmerman, M; Vanden Broeck, D				Gillet, Evy; Meys, Joris F. A.; Verstraelen, Hans; Verhelst, Rita; De Sutter, Philippe; Temmerman, Marleen; Vanden Broeck, Davy			Association between Bacterial Vaginosis and Cervical Intraepithelial Neoplasia: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HUMAN-PAPILLOMAVIRUS INFECTION; RISK-FACTORS; WOMEN; DIAGNOSIS; CANCER; DYSBACTERIOSIS; NITROSAMINES; EPIDEMIOLOGY; PATHOGENESIS; INFLAMMATION	Objective: Bacterial vaginosis (BV), the most common vaginal disorder among women of reproductive age, has been suggested as co-factor in the development of cervical cancer. Previous studies examining the relationship between BV and cervical intra-epithelial neoplasia (CIN) provided inconsistent and conflicting results. The aim of this study is to clarify the association between these two conditions. Methods: A systematic review and meta-analysis were conducted to summarize published literature on the association between BV and cervical pre-cancerous lesions. An extensive search of electronic databases Medline (Pubmed) and Web of Science was performed. The key words 'bacterial vaginosis' and 'bacterial infections and vaginitis' were used in combination with 'cervical intraepithelial neoplasia', 'squamous intraepithelial lesions', 'cervical lesions', 'cervical dysplasia', and 'cervical screening'. Eligible studies required a clear description of diagnostic methods used for detecting both BV and cervical precancerous lesions. Publications were included if they either reported odds ratios (OR) and corresponding 95% confidence intervals (CI) representing the magnitude of association between these two conditions, or presented data that allowed calculation of the OR. Results: Out of 329 articles, 17 cross-sectional and 2 incidence studies were selected. In addition, two studies conducted in The Netherlands, using the national KOPAC system, were retained. After testing for heterogeneity and publication bias, meta-analysis and meta-regression were performed, using a random effects model. Although heterogeneity among studies was high (chi(2) = 164.7, p < 0.01, I-2 = 88.5), a positive association between BV and cervical pre-cancerous lesions was found, with an overall estimated odds ratio of 1.51 (95% CI, 1.24-1.83). Meta-regression analysis could not detect a significant difference between studies based on BV diagnosis, CIN diagnosis or study population. Conclusions: Although most studies were cross-sectional and heterogeneity was high, this meta-analysis confirms a connection between BV and CIN.	[Gillet, Evy; Verhelst, Rita; Temmerman, Marleen; Vanden Broeck, Davy] Univ Ghent, Int Ctr Reprod Hlth ICRH, B-9000 Ghent, Belgium; [Gillet, Evy; De Sutter, Philippe] Vrije Univ Brussel, Dept Gynaecol, Brussels, Belgium; [Meys, Joris F. A.] Univ Ghent, Dept Appl Math Biometr & Proc Control, Fac Biosci Engn, B-9000 Ghent, Belgium; [Verstraelen, Hans] Ghent Univ Hosp, Dept Obstet & Gynaecol, Ghent, Belgium	Ghent University; Vrije Universiteit Brussel; Ghent University; Ghent University; Ghent University Hospital	Vanden Broeck, D (corresponding author), Univ Ghent, Int Ctr Reprod Hlth ICRH, B-9000 Ghent, Belgium.	davy.vandenbroeck@ugent.be	Verstraelen, Hans/A-5602-2008; Verstraelen, Hans/AAA-8694-2019	Verstraelen, Hans/0000-0002-4070-1587; De Sutter, Philippe/0000-0002-3064-3344	Research Foundation - Flanders (FWO); FWO	Research Foundation - Flanders (FWO)(FWO); FWO(FWO)	DVB has a post-doctoral fellowship of the Research Foundation - Flanders (FWO). Part of this work was supported by the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrington J. W., 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P383; Bauer G, 2001, MED HYPOTHESES, V57, P252, DOI 10.1054/mehy.2000.1285; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behbakht Kian, 2002, Infect Dis Obstet Gynecol, V10, P181, DOI 10.1155/S1064744902000200; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Bosch FX, 2007, DIS MARKERS, V23, P213, DOI 10.1155/2007/914823; Boyle DCM, 2003, INT J GYNECOL CANCER, V13, P159, DOI 10.1046/j.1525-1438.2003.13007.x; Boyle DCM, 1999, INT J GYNECOL CANCER, V9, P177; Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Cauci Sabina, 2004, Curr Infect Dis Rep, V6, P450, DOI 10.1007/s11908-004-0064-8; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; da Silva CS, 2004, GYNECOL OBSTET INVES, V58, P189, DOI 10.1159/000079822; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Discacciati MG, 2006, DIAGN CYTOPATHOL, V34, P323, DOI 10.1002/dc.20431; Discacciati MG, 2006, DIAGN CYTOPATHOL, V34, P272, DOI 10.1002/dc.20418; Eichholzer M, 1998, NUTR REV, V56, P95; ELTABBAKH GH, 1995, OBSTET GYNECOL, V85, P499, DOI 10.1016/0029-7844(94)00450-R; Engberts MK, 2007, CANCER CYTOPATHOL, V111, P269, DOI 10.1002/cncr.22947; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; FIGO IFoGaO, 2009, GLOB GUID CERV CANC; Frega A, 1997, EUR J GYNAECOL ONCOL, V18, P76; GUIJON F, 1992, INT J GYNECOL OBSTET, V37, P185, DOI 10.1016/0020-7292(92)90379-W; GUIJON FB, 1985, AM J OBSTET GYNECOL, V151, P185, DOI 10.1016/0002-9378(85)90009-2; Gutman RE, 2005, OBSTET GYNECOL, V105, P551, DOI 10.1097/01.AOG.0000145752.97999.67; HARINGTON JS, 1975, S AFR MED J, V49, P443; Hawes SE, 2002, J NATL CANCER I, V94, P1592; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hudson MMT, 1997, GENITOURIN MED, V73, P306; Huh WK, 2009, OBSTET GYNECOL, V114, P139, DOI 10.1097/AOG.0b013e3181ab6878; Juneja A, 2003, Indian J Cancer, V40, P15; KHARSANY ABM, 1993, GENITOURIN MED, V69, P357; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036; Lehtovirta P, 2008, INT J STD AIDS, V19, P37, DOI 10.1258/ijsa.2007.005672; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Nam KH, 2009, J GYNECOL ONCOL, V20, P39, DOI 10.3802/jgo.2009.20.1.39; PAVIC N, 1984, MED HYPOTHESES, V15, P433, DOI 10.1016/0306-9877(84)90159-2; PETERS N, 1995, SEX TRANSM DIS, V22, P296, DOI 10.1097/00007435-199509000-00005; PLATZCHRISTENSEN JJ, 1994, ACTA OBSTET GYN SCAN, V73, P586, DOI 10.3109/00016349409006278; Roeters AME, 2010, DIAGN CYTOPATHOL, V38, P85, DOI 10.1002/dc.21169; Schiff M, 2000, AM J EPIDEMIOL, V152, P716, DOI 10.1093/aje/152.8.716; Simoes JA, 2006, INT J GYNECOL OBSTET, V94, P28, DOI 10.1016/j.ijgo.2006.04.013; Spinillo A, 2006, OBSTET GYNECOL, V107, P314, DOI 10.1097/01.AOG.0000196723.76228.ea; Stanley MA, 2009, INDIAN J MED RES, V130, P266; Sterne J. A. C., 2009, METAANALYSIS STATA U; Sweet R L, 2000, Infect Dis Obstet Gynecol, V8, P184, DOI 10.1155/S1064744900000260; Tavares-Murta BM, 2008, EUR J OBSTET GYN R B, V138, P93, DOI 10.1016/j.ejogrb.2007.06.015; Team RDC, 2009, R LANG ENV STAT COMP; Uthayakumar S., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P572; Verbrucigen BSM, 2006, DIAGN CYTOPATHOL, V34, P377, DOI 10.1002/dc.20374; Verstraelen H, 2008, INT J STD AIDS, V19, P575, DOI 10.1258/ijsa.2008.008189; Verstraelen H, 2009, EXPERT REV ANTI-INFE, V7, P1109, DOI [10.1586/eri.09.87, 10.1586/ERI.09.87]; Vetrano G, 2007, EUR J GYNAECOL ONCOL, V28, P310; Viechtbauer W, J STAT SOFT IN PRESS; Wolrath H, 2001, J CLIN MICROBIOL, V39, P4026, DOI 10.1128/JCM.39.11.4026-4031.2001	56	84	112	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45201	10.1371/journal.pone.0045201	http://dx.doi.org/10.1371/journal.pone.0045201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056195	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600008
J	Joshi, AD; Loilome, W; Siu, IM; Tyler, B; Gallia, GL; Riggins, GJ				Joshi, Avadhut D.; Loilome, Watcharin; Siu, I-Mei; Tyler, Betty; Gallia, Gary L.; Riggins, Gregory J.			Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy	PLOS ONE			English	Article							PHASE-II TRIAL; EGFR; GROWTH; GEFITINIB; ERLOTINIB; CELLS; SENSITIVITY; PROTEIN; GLIOMAS	Glioblastoma multiforme (GBM) is the most common intracranial cancer but despite recent advances in therapy the overall survival remains about 20 months. Whole genome exon sequencing studies implicate mutations in the receptor tyrosine kinase pathways (RTK) for driving tumor growth in over 80% of GBMs. In spite of various RTKs being mutated or altered in the majority of GBMs, clinical studies have not been able to demonstrate efficacy of molecular targeted therapies using tyrosine kinase inhibitors in GBMs. Activation of multiple downstream signaling pathways has been implicated as a possible means by which inhibition of a single RTK has been ineffective in GBM. In this study, we sought a combination of approved drugs that would inhibit in vitro and in vivo growth of GBM oncospheres. A combination consisting of gefitinib and sunitinib acted synergistically in inhibiting growth of GBM oncospheres in vitro. Sunitinib was the only RTK inhibitor that could induce apoptosis in GBM cells. However, the in vivo efficacy testing of the gefitinib and sunitinib combination in an EGFR amplified/PTEN wild type GBM xenograft model revealed that gefitinib alone could significantly improve survival in animals whereas sunitinib did not show any survival benefit. Subsequent testing of the same drug combination in a different syngeneic glioma model that lacked EGFR amplification but was more susceptible to sunitinib in vitro demonstrated no survival benefit when treated with gefitinib or sunitinib or the gefitinib and sunitinib combination. Although a modest survival benefit was obtained in one of two animal models with EGFR amplification due to gefitinib alone, the addition of sunitinib, to test our best in vitro combination therapy, did not translate to any additional in vivo benefit. Improved targeted therapies, with drug properties favorable to intracranial tumors, are likely required to form effective drug combinations for GBM.	[Joshi, Avadhut D.; Loilome, Watcharin; Siu, I-Mei; Tyler, Betty; Gallia, Gary L.; Riggins, Gregory J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA	Johns Hopkins University	Riggins, GJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	griggin1@jhmi.edu	Loilome, Watcharin/AAW-6203-2021		National Institutes of Health (NIH) [R01 NS052507]; Virginia; D.K. Ludwig Fund for Cancer Research; Children's Cancer Foundation; Irving J. Sherman M. D. Neurosurgery Research Professorship; Matt Trainham ABTA; Faculty of Medicine at Khon Kaen University, Thailand; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052507] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia; D.K. Ludwig Fund for Cancer Research; Children's Cancer Foundation; Irving J. Sherman M. D. Neurosurgery Research Professorship; Matt Trainham ABTA; Faculty of Medicine at Khon Kaen University, Thailand; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by National Institutes of Health (NIH) Grant R01 NS052507, the Virginia and D.K. Ludwig Fund for Cancer Research, and the Children's Cancer Foundation. GJR is supported by the Irving J. Sherman M. D. Neurosurgery Research Professorship. AJ was supported by Matt Trainham ABTA basic research fellowship (http://www.abta.org/). WL was supported by the Faculty of Medicine at Khon Kaen University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielen A, 2011, MOL CANCER THER, V10, P1407, DOI 10.1158/1535-7163.MCT-11-0205; Cappuzzo F, 2005, J NATL CANCER I, V97, P868, DOI 10.1093/jnci/dji169; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; de Vries NA, 2012, INVEST NEW DRUG, V30, P443, DOI 10.1007/s10637-010-9569-1; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Edwards LA, 2006, MOL CANCER THER, V5, P645, DOI 10.1158/1535-7163.MCT-05-0099; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Guillamo JS, 2009, CLIN CANCER RES, V15, P3697, DOI 10.1158/1078-0432.CCR-08-2042; Hegi ME, 2011, MOL CANCER THER, V10, P1102, DOI 10.1158/1535-7163.MCT-11-0048; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Neyns B, 2011, J NEURO-ONCOL, V103, P491, DOI 10.1007/s11060-010-0402-7; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sathornsumetee S, 2009, EXPERT OPIN INV DRUG, V18, P277, DOI [10.1517/13543780802692603, 10.1517/13543780802692603 ]; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Trembath DG, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-30; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773	25	36	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e44372	10.1371/journal.pone.0044372	http://dx.doi.org/10.1371/journal.pone.0044372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056179	Green Submitted, gold, Green Published			2022-12-27	WOS:000309452600003
J	Lee, U; Lee, H; Muller, M; Noh, GJ; Mashour, GA				Lee, UnCheol; Lee, HeonSoo; Mueller, Markus; Noh, Gyu-Jeong; Mashour, George A.			Genuine and Spurious Phase Synchronization Strengths during Consciousness and General Anesthesia	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; VOLUME-CONDUCTION; EEG; COHERENCE; BINDING; HUMANS; MODELS; INDEX; NOISE; MEG	Spectral content in a physiological dataset of finite size has the potential to produce spurious measures of coherence. This is especially true for electroencephalography (EEG) during general anesthesia because of the significant alteration of the power spectrum. In this study we quantitatively evaluated the genuine and spurious phase synchronization strength (PSS) of EEG during consciousness, general anesthesia, and recovery. A computational approach based on the randomized data method was used for evaluating genuine and spurious PSS. The validity of the method was tested with a simulated dataset. We applied this method to the EEG of normal subjects undergoing general anesthesia and investigated the finite size effects of EEG references, data length and spectral content on phase synchronization. The most influential factor for genuine PSS was the type of EEG reference; the most influential factor for spurious PSS was the spectral content. Genuine and spurious PSS showed characteristic temporal patterns for each frequency band across consciousness and anesthesia. Simultaneous measurement of both genuine and spurious PSS during general anesthesia is necessary in order to avoid incorrect interpretations regarding states of consciousness.	[Lee, UnCheol; Lee, HeonSoo; Mashour, George A.] Univ Michigan, Dept Anesthesiol, Sch Med, Div Neuroanesthesiol, Ann Arbor, MI 48109 USA; [Lee, HeonSoo] POSTECH, Dept Phys, Pohang, South Korea; [Mueller, Markus] Univ Nacl Autonoma Mexico, Fac Ciencias, Univ Autonoma Estado Morelos, Centro Int Ciencias, Cuernavaca 62191, Morelos, Mexico; [Noh, Gyu-Jeong] Univ Ulsan, Coll Med, Dept Clin Pharmacol & Therapeut, Dept Anesthesiol & Pain Med,Asan Med Ctr, Seoul, South Korea; [Mashour, George A.] Univ Michigan, Grad Program Neurosci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Pohang University of Science & Technology (POSTECH); Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; University of Ulsan; University of Michigan System; University of Michigan	Lee, U (corresponding author), Univ Michigan, Dept Anesthesiol, Sch Med, Div Neuroanesthesiol, Ann Arbor, MI 48109 USA.	uclee@med.umich.edu		Muller, Markus Franziskus/0000-0002-2653-6204	Department of Anesthesiology, University of Michigan, Ann Arbor; National Institutes of Health [RR024987-01]; Consejo Nacional de Ciencia y Tecnologia, Mexico; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024987] Funding Source: NIH RePORTER	Department of Anesthesiology, University of Michigan, Ann Arbor(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the Department of Anesthesiology, University of Michigan, Ann Arbor; National Institutes of Health KL2 grant (RR024987-01) (GAM, UL); Consejo Nacional de Ciencia y Tecnologia, Mexico (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allefeld C, 2007, INT J BIFURCAT CHAOS, V17, P3493, DOI 10.1142/S0218127407019251; American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P111; Aviyente S, 2011, HUM BRAIN MAPP, V32, P80, DOI 10.1002/hbm.21000; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Cui D, 2010, NEURAL NETWORKS, V23, P698, DOI 10.1016/j.neunet.2010.04.003; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Foster BL, 2008, COGN NEURODYNAMICS, V2, P283, DOI 10.1007/s11571-008-9063-z; Galka A, 2003, INT J BIFURCAT CHAOS, V13, P723, DOI 10.1142/S0218127403006881; Gencer NG, 2004, PHYS MED BIOL, V49, P701, DOI 10.1088/0031-9155/49/5/004; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Kugiumtzis D, 2000, PHYS REV E, V62, pR25, DOI 10.1103/PhysRevE.62.R25; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; Lee U, 2011, ANESTHESIOLOGY, V114, P872, DOI 10.1097/ALN.0b013e31821102c9; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Lee U, 2009, CONSCIOUS COGN, V18, P56, DOI 10.1016/j.concog.2008.10.005; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Mhuircheartaigh RN, 2010, J NEUROSCI, V30, P9095, DOI 10.1523/JNEUROSCI.5516-09.2010; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Muller M, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/10009; Muller MF, 2011, J CLIN NEUROPHYSIOL, V28, P450, DOI 10.1097/WNP.0b013e318231c894; Muller M, 2005, PHYS REV E, V71, P1; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Peltier SJ, 2005, NEUROREPORT, V16, P285, DOI 10.1097/00001756-200502280-00017; Plerou V, 1999, PHYS REV LETT, V83, P1471, DOI 10.1103/PhysRevLett.83.1471; Rummel C, 2007, J NEUROSCI METH, V166, P138, DOI 10.1016/j.jneumeth.2007.06.023; Rummel C, 2010, J NEUROSCI METH, V191, P94, DOI 10.1016/j.jneumeth.2010.05.022; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schiff SJ, 2005, NEUROINFORMATICS, V3, P315, DOI 10.1385/NI:3:4:315; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Seba P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198104; Sheeba JH, 2008, BIOPHYS J, V95, P2722, DOI 10.1529/biophysj.108.134635; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; VONDERMALSBURG C, 1995, CURR OPIN NEUROBIOL, V5, P520, DOI 10.1016/0959-4388(95)80014-X; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Zaveri HP, 2000, CLIN NEUROPHYSIOL, V111, P1293, DOI 10.1016/S1388-2457(00)00321-7	37	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46313	10.1371/journal.pone.0046313	http://dx.doi.org/10.1371/journal.pone.0046313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056281	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600033
J	O'Dell, WB; Baker, DC; McLain, SE				O'Dell, William B.; Baker, David C.; McLain, Sylvia E.			Structural Evidence for Inter-Residue Hydrogen Bonding Observed for Cellobiose in Aqueous Solution	PLOS ONE			English	Article							SYNCHROTRON X-RAY; CONFORMATIONAL-ANALYSIS; GLYCOSIDIC LINKAGES; CRYSTAL-STRUCTURE; D-GLUCOSE; CELLULOSE; HYDRATION; WATER; NMR; H-1-NMR	The structure of the disaccharide cellulose subunit cellobiose (4-O-beta-D-glucopyranosyl-D-glucose) in solution has been determined via neutron diffraction with isotopic substitution (NDIS), computer modeling and nuclear magnetic resonance (NMR) spectroscopic studies. This study shows direct evidence for an intramolecular hydrogen bond between the reducing ring HO3 hydroxyl group and the non-reducing ring oxygen (O5') that has been previously predicted by computation and NMR analysis. Moreover, this work shows that hydrogen bonding to the non-reducing ring O5' oxygen is shared between water and the HO3 hydroxyl group with an average of 50% occupancy by each hydrogen-bond donor. The glycosidic torsion angles phi(H) and psi(H) from the neutron diffraction-based model show a fairly tight distribution of angles around approximately 22 degrees and -40 degrees, respectively, in solution, consistent with the NMR measurements. Similarly, the hydroxymethyl torsional angles for both reducing and non-reducing rings are broadly consistent with the NMR measurements in this study, as well as with those from previous measurements for cellobiose in solution.	[O'Dell, William B.; Baker, David C.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA; [McLain, Sylvia E.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Tennessee System; University of Tennessee Knoxville; University of Oxford	Baker, DC (corresponding author), Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA.	dcbaker@utk.edu; sylvia.mclain@bioch.ox.ac.uk	O'Dell, William B/R-2753-2017	O'Dell, William B/0000-0002-8063-5190; McLain, Sylvia/0000-0002-3347-7759	LDRD (Laboratory Directed Research and Development) - SEED from Oak Ridge National Laboratory; University of Tennessee; Engineering and Physical Sciences Research Council [EP/J002615/1] Funding Source: researchfish; EPSRC [EP/J002615/1] Funding Source: UKRI	LDRD (Laboratory Directed Research and Development) - SEED from Oak Ridge National Laboratory; University of Tennessee; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an LDRD (Laboratory Directed Research and Development) - SEED money grant from Oak Ridge National Laboratory, operated by UT-Batelle for the United States Department of Energy. SEM received additional support from the Engineering and Physical Sciences Research Council, United Kingdom. WBO recieved a travel grant from the Chancellor's Honors Program, University of Tennessee, in support of this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283; Barnett CB, 2008, J PHYS CHEM B, V112, P15450, DOI 10.1021/jp8067409; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bernet B, 2000, HELV CHIM ACTA, V83, P2055, DOI 10.1002/1522-2675(20000906)83:9&lt;2055::AID-HLCA2055&gt;3.0.CO;2-C; Bowron DT, 2006, J AM CHEM SOC, V128, P5119, DOI 10.1021/ja0583057; Cheetham NWH, 2003, CARBOHYD RES, V338, P955, DOI 10.1016/S0008-6215(03)00069-7; Christensen NJ, 2010, CARBOHYD RES, V345, P474, DOI 10.1016/j.carres.2009.12.009; CHU SSC, 1968, ACTA CRYSTALL B-STRU, VB 24, P830, DOI 10.1107/S0567740868003250; Cloran F, 1999, J AM CHEM SOC, V121, P9843, DOI 10.1021/ja984384t; De Spirito M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041801; Deetlefs M, 2005, J PHYS CHEM B, V109, P1593, DOI 10.1021/jp047742p; Dixit S, 2002, NATURE, V416, P829, DOI 10.1038/416829a; Flugge LA, 1999, J AM CHEM SOC, V121, P7228, DOI 10.1021/ja990561u; Foglia F, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3488998; French AD, 2006, CAN J CHEM, V84, P603, DOI 10.1139/V06-050; French AD, 2012, CARBOHYD RES, V350, P68, DOI 10.1016/j.carres.2011.12.023; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Hargreaves R, 2011, J AM CHEM SOC, V133, P16524, DOI 10.1021/ja205804k; HARVEY JM, 1978, J SOLUTION CHEM, V7, P571, DOI 10.1007/BF00646035; Headen TF, 2010, J AM CHEM SOC, V132, P5735, DOI 10.1021/ja909084e; Hulme EC, 2006, BIOPHYS J, V91, P2371, DOI 10.1529/biophysj.106.089185; Imberti S, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/40/404212; *IUPAC IUB JOINT C, 1983, PURE APPL CHEM, V55, P1269; Kamm B, 2006, BIOREFINERIES - INDUSTRIAL PROCESSES AND PRODUCTS: STATUS QUO AND FUTURE DIRECTIONS, VOL 1, P3; KROON J, 1994, J MOL STRUCT, V322, P27, DOI 10.1016/0022-2860(94)87018-7; LEEFLANG BR, 1992, CARBOHYD RES, V230, P41, DOI 10.1016/S0008-6215(00)90512-3; Malardier-Jugroot C, 2010, PHYS CHEM CHEM PHYS, V12, P382, DOI 10.1039/b915346b; Mancinelli R, 2007, J PHYS CHEM B, V111, P13570, DOI 10.1021/jp075913v; Mancinelli R, 2007, PHYS CHEM CHEM PHYS, V9, P2959, DOI 10.1039/b701855j; Mason PE, 2005, J PHYS CHEM B, V109, P13104, DOI 10.1021/jp040622x; Mason PE, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2393237; McLain SE, 2004, ANGEW CHEM INT EDIT, V43, P1952, DOI 10.1002/anie.200353289; McLain SE, 2008, ANGEW CHEM INT EDIT, V47, P9059, DOI 10.1002/anie.200802679; McLain SE, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2784555; Meyer KH, 1928, BER DTSCH CHEM GES, V61, P593, DOI 10.1002/cber.19280610402; Meyer KH, 1936, HELV CHIM ACTA, V20, P232; Missori M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238001; NISHIDA Y, 1984, TETRAHEDRON LETT, V25, P1575, DOI 10.1016/S0040-4039(01)90014-0; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Olsson U, 2008, J PHYS CHEM B, V112, P4447, DOI 10.1021/jp710977k; OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579; Pagnotta SE, 2010, J PHYS CHEM B, V114, P4904, DOI 10.1021/jp911940h; PARFONDRY A, 1977, CARBOHYD RES, V59, P299, DOI 10.1016/S0008-6215(00)83172-9; Pereira CS, 2006, BIOPHYS J, V90, P4337, DOI 10.1529/biophysj.106.081539; Pincu M, 2011, J PHYS CHEM A, V115, P9498, DOI 10.1021/jp112109p; POPPE L, 1994, NAT STRUCT BIOL, V1, P215, DOI 10.1038/nsb0494-215; REES DA, 1968, CARBOHYD RES, V7, P334, DOI 10.1016/S0008-6215(00)81206-9; Rockwell GD, 1998, J AM CHEM SOC, V120, P10953, DOI 10.1021/ja981958l; Roslund MU, 2008, CARBOHYD RES, V343, P101, DOI 10.1016/j.carres.2007.10.008; Sears V.F., 1992, NEUTRON NEWS, V3, P26, DOI [10.1080/10448639208218770, DOI 10.1080/10448639208218770]; SHALLENBERGER RS, 1982, ADV SUGAR CHEM PRINC; Shen TY, 2009, J AM CHEM SOC, V131, P14786, DOI 10.1021/ja9034158; Soper A.K., 1989, ATLAS ANAL TIME OF F; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; Soper AK, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.104204; Sponsler O. L., 1926, COLLOID S MONOGRAPH, V4, P174; Stenutz R, 2002, J ORG CHEM, V67, P949, DOI 10.1021/jo010985i; Sugiyama H, 2000, J MOL STRUCT, V556, P173, DOI 10.1016/S0022-2860(00)00630-X; Sugiyama M, 2000, TMRSJ, V25, P743; Towey JJ, 2011, J PHYS CHEM B, V115, P7799, DOI 10.1021/jp203140b; Umemura M, 2005, J MOL STRUC-THEOCHEM, V730, P1, DOI 10.1016/j.theochem.2005.05.034; Venturi G, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3176413; WILLKER W, 1995, MAGN RESON CHEM, V33, P632, DOI 10.1002/mrc.1260330804; Zhang WH, 2009, CARBOHYD RES, V344, P1582, DOI 10.1016/j.carres.2009.06.007; Zhou H, 2007, J ORG CHEM, V72, P7071; Zugenmaier P., 2008, CRYSTALLINE CELLULOS, DOI 10.1007/978-3-540-73934-0	67	32	32	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45311	10.1371/journal.pone.0045311	http://dx.doi.org/10.1371/journal.pone.0045311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056199	gold, Green Submitted, Green Published			2022-12-27	WOS:000309452600010
J	Yan, XC; Chen, ZF; Sun, J; Matsumura, K; Wu, RSS; Qian, PY				Yan, Xing-Cheng; Chen, Zhang-Fan; Sun, Jin; Matsumura, Kiyotaka; Wu, Rudolf S. S.; Qian, Pei-Yuan			Transcriptomic Analysis of Neuropeptides and Peptide Hormones in the Barnacle Balanus amphitrite: Evidence of Roles in Larval Settlement	PLOS ONE			English	Article							STOMATOGASTRIC NERVOUS-SYSTEM; TACHYKININ-RELATED PEPTIDES; PIGMENT-DISPERSING HORMONE; PROTEIN COMPLEX SIPC; METHYL FARNESOATE; DIURETIC HORMONE; CYPRIS LARVA; IDENTIFICATION; COCKROACH; METAMORPHOSIS	The barnacle Balanus amphitrite is a globally distributed marine crustacean and has been used as a model species for intertidal ecology and biofouling studies. Its life cycle consists of seven planktonic larval stages followed by a sessile juvenile/adult stage. The transitional processes between larval stages and juveniles are crucial for barnacle development and recruitment. Although some studies have been conducted on the neuroanatomy and neuroactive substances of the barnacle, a comprehensive understanding of neuropeptides and peptide hormones remains lacking. To better characterize barnacle neuropeptidome and its potential roles in larval settlement, an in silico identification of putative transcripts encoding neuropeptides/peptide hormones was performed, based on transcriptome of the barnacle B. amphitrite that has been recently sequenced. Potential cleavage sites andstructure of mature peptides were predicted through homology search of known arthropod peptides. In total, 16 neuropeptide families/subfamilies were predicted from the barnacle transcriptome, and 14 of them were confirmed as genuine neuropeptides by Rapid Amplification of cDNA Ends. Analysis of peptide precursor structures and mature sequences showed that some neuropeptides of B. amphitrite are novel isoforms and shared similar characteristics with their homologs from insects. The expression profiling of predicted neuropeptide genes revealed that pigment dispersing hormone, SIFamide, calcitonin, and B-type allatostatin had the highest expression level in cypris stage, while tachykinin-related peptide was down regulated in both cyprids and juveniles. Furthermore, an inhibitor of proprotein convertase related to peptide maturation effectively delayed larval metamorphosis. Combination of real-time PCR results and bioassay indicated that certain neuropeptides may play an important role in cypris settlement. Overall, new insight into neuropeptides/peptide hormones characterized in this study shall provide a platform for unraveling peptidergic control of barnacle larval behavior and settlement process.	[Yan, Xing-Cheng; Chen, Zhang-Fan; Matsumura, Kiyotaka; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Sun, Jin] Hong Kong Baptist Univ, Dept Biol, Kowloon Tong, Hong Kong, Peoples R China; [Wu, Rudolf S. S.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong Baptist University; University of Hong Kong	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	boqianpy@ust.hk	Sun, Jin/C-1458-2010	Sun, Jin/0000-0001-8002-6881; Qian, Pei-Yuan/0000-0003-4074-9078	China Ocean Mineral Resources Research and Development Association [DY125-15-T-02]; King Abdullah University of Science and Technology (KAUST) [SA-C0040/UK-C001]	China Ocean Mineral Resources Research and Development Association; King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This work was supported by a research grant (DY125-15-T-02) from China Ocean Mineral Resources Research and Development Association and an Award (SA-C0040/UK-C001) from King Abdullah University of Science and Technology (KAUST) to PY Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak A, 2005, J MOL MED, V83, P844, DOI 10.1007/s00109-005-0710-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boonen K, 2008, J SEP SCI, V31, P427, DOI 10.1002/jssc.200700450; Brugge VAT, 2008, J EXP BIOL, V211, P382, DOI 10.1242/jeb.013771; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Christie AE, 2010, J EXP BIOL, V213, P118, DOI 10.1242/jeb.037077; Christie AE, 1997, J EXP BIOL, V200, P2279; Christie AE, 2008, GEN COMP ENDOCR, V157, P174, DOI 10.1016/j.ygcen.2008.03.027; Christie AE, 2010, GEN COMP ENDOCR, V167, P164, DOI 10.1016/j.ygcen.2010.01.005; Clare AS, 2000, BIOFOULING, V15, P57, DOI 10.1080/08927010009386298; Clark AC, 2004, J NEUROSCI, V24, P4283, DOI 10.1523/JNEUROSCI.4938-03.2004; Coast GM, 2005, J EXP BIOL, V208, P3281, DOI 10.1242/jeb.01760; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; De Gregoris TB, 2011, BIOFOULING, V27, P367, DOI 10.1080/08927014.2011.577211; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; Dircksen H, 2000, J EXP BIOL, V203, P2807; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; FREEMAN JA, 1983, J CRUSTACEAN BIOL, V3, P173, DOI 10.2307/1548253; Furuya K, 2000, P NATL ACAD SCI USA, V97, P6469, DOI 10.1073/pnas.97.12.6469; Fusetani N, 2004, NAT PROD REP, V21, P94, DOI 10.1039/b302231p; Gallus L, 2009, MICROSC RES TECHNIQ, V72, P101, DOI 10.1002/jemt.20649; Grimmelikhuijzen CJP, 2002, CAN J ZOOL, V80, P1690, DOI 10.1139/Z02-137; GWILLIAM GF, 1979, J MORPHOL, V159, P297, DOI 10.1002/jmor.1051590302; Harrison PJH, 1999, BIOL BULL, V197, P144, DOI 10.2307/1542611; Holmgren S, 2001, BRAIN RES BULL, V55, P723, DOI 10.1016/S0361-9230(01)00556-1; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Jorge-Rivera JC, 1997, J EXP BIOL, V200, P2937; Lange AB, 2001, PEPTIDES, V22, P229, DOI 10.1016/S0196-9781(00)00386-7; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Liu F, 2006, MOL CELL PROTEOMICS, V5, P510, DOI 10.1074/mcp.M400114-MCP200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZ MW, 1995, REGUL PEPTIDES, V57, P227, DOI 10.1016/0167-0115(95)00036-B; LUCAS MI, 1979, MAR BIOL, V55, P221, DOI 10.1007/BF00396822; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; Ma MM, 2009, GEN COMP ENDOCR, V161, P320, DOI 10.1016/j.ygcen.2009.01.015; Matsumura K, 1998, P ROY SOC B-BIOL SCI, V265, P1825, DOI 10.1098/rspb.1998.0508; Matsumura K, 1998, J EXP ZOOL, V281, P12, DOI 10.1002/(SICI)1097-010X(19980501)281:1<12::AID-JEZ3>3.3.CO;2-L; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Meinertzhagen IA, 1996, TRENDS NEUROSCI, V19, P285, DOI 10.1016/S0166-2236(96)10033-3; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Montagne N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-62; Nagaraju GPC, 2007, AQUACULTURE, V272, P39, DOI 10.1016/j.aquaculture.2007.05.014; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Petri B, 1997, J NEUROSCI, V17, P4087; Polanska MA, 2007, CELL TISSUE RES, V330, P331, DOI 10.1007/s00441-007-0473-8; RAINBOW PS, 1977, MAR BIOL, V42, P337, DOI 10.1007/BF00402196; RAO KR, 1985, P NATL ACAD SCI USA, V82, P5319, DOI 10.1073/pnas.82.16.5319; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; Semmler H, 2008, ARTHROPOD STRUCT DEV, V37, P383, DOI 10.1016/j.asd.2008.01.007; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Shimizu K, 1996, J EXP ZOOL, V276, P87, DOI 10.1002/(SICI)1097-010X(19961001)276:2<87::AID-JEZ1>3.0.CO;2-9; SKIEBE P, 1994, J EXP BIOL, V194, P195; Smith PA, 2000, INSECT BIOCHEM MOLEC, V30, P885, DOI 10.1016/S0965-1748(00)00062-X; Stemmler EA, 2007, PEPTIDES, V28, P2104, DOI 10.1016/j.peptides.2007.08.019; Stemmler EA, 2007, J NEUROCHEM, V101, P1351, DOI 10.1111/j.1471-4159.2007.04520.x; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Thiyagarajan V, 2008, PROTEOMICS, V8, P3164, DOI 10.1002/pmic.200700904; Tobe SS, 2000, J INSECT PHYSIOL, V46, P231, DOI 10.1016/S0022-1910(99)00175-4; Vanden Broeck J, 1999, ANN NY ACAD SCI, V897, P374, DOI 10.1111/j.1749-6632.1999.tb07907.x; Vazquez-Acevedo N, 2009, BIOL BULL-US, V217, P313, DOI 10.1086/BBLv217n3p313; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Verleyen P, 2009, GEN COMP ENDOCR, V162, P27, DOI 10.1016/j.ygcen.2008.10.020; Weaver R. J., 1998, Recent advances in arthropod endocrinology., P3; Weaver RJ, 2009, ANN NY ACAD SCI, V1163, P316, DOI 10.1111/j.1749-6632.2009.04459.x; Webster SG, 1998, BIOL BULL-US, V195, P282, DOI 10.2307/1543140; Winther AME, 2001, J EXP BIOL, V204, P1269; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Yamamoto H, 1999, J EXP ZOOL, V284, P746, DOI 10.1002/(SICI)1097-010X(19991201)284:7<746::AID-JEZ4>3.0.CO;2-J; Yamamoto H, 1997, J EXP ZOOL, V278, P349, DOI 10.1002/(SICI)1097-010X(19970815)278:6<349::AID-JEZ2>3.0.CO;2-O; Yamamoto H, 1996, J EXP ZOOL, V275, P339, DOI 10.1002/(SICI)1097-010X(19960801)275:5<339::AID-JEZ2>3.0.CO;2-Q; Yamamoto H, 1997, ZOOL SCI, V14, P887, DOI 10.2108/zsj.14.887; Yasuda-Kamatani Y, 2000, GEN COMP ENDOCR, V118, P161, DOI 10.1006/gcen.1999.7453	75	41	41	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46513	10.1371/journal.pone.0046513	http://dx.doi.org/10.1371/journal.pone.0046513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056329	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600040
J	Low, VF; Fiorini, Z; Fisher, L; Jasoni, CL				Low, Victoria F.; Fiorini, Zeno; Fisher, Lorryn; Jasoni, Christine L.			Netrin-1 Stimulates Developing GnRH Neurons to Extend Neurites to the Median Eminence in a Calcium-Dependent Manner	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; AXON GUIDANCE; NERVE GROWTH; FGF RECEPTOR; MIGRATION; DCC; EXPRESSION; OUTGROWTH; MOUSE; ORIGIN	Hypothalamic gonadotropin-releasing hormone (GnRH) neurons are required for fertility in all mammalian species studied to date. In rodents, GnRH neuron cell bodies reside in the rostral hypothalamus, and most extend a single long neuronal process in the caudal direction to terminate at the median eminence (ME), the site of hormone secretion. The molecular cues that GnRH neurites use to grow and navigate to the ME during development, however, remain poorly described. Reverse transcription-PCR (RT-PCR) identified mRNAs encoding Netrin-1, and its receptor, DCC, in the fetal preoptic area (POA) and mediobasal hypothalamus (MBH), respectively, from gestational day 12.5 (GD12.5), a time when the first GnRH neurites extend toward the MBH. Moreover, a subpopulation of GnRH neurons from GD14.5 through GD18.5 express the Netrin-1 receptor, DCC, suggesting a role for Netrin-1/DCC signaling in GnRH neurite growth and/or guidance. In support of this notion, when GD15.5 POA explants, containing GnRH neurons actively extending neurites, were grown in three-dimensional collagen gels and challenged with exogenous Netrin-1 (100 ng/ml or 400 ng/ml) GnRH neurite growth was stimulated. In addition, Netrin-1 provided from a fixed source was able to stimulate outgrowth, although it did not appear to chemoattract GnRH neurites. Finally, the effects of Netrin-1 on the outgrowth of GnRH neurites could be inhibited by blocking either L-type voltage-gated calcium channels (VGCCs) with nifedipine (10 mu M), or ryanodine receptors with ryanodine (10 mu M). This is consistent with the role of Ca2+ from extra-and intracellular sources in Netrin-1/DCC-dependent growth cone motility in other neurons. These results indicate that Netrin-1 directly stimulates the growth of a subpopulation of GnRH neurites that express DCC, provide further understanding of the mechanisms by which GnRH nerve terminals arrive at their site of hormone secretion, and identify an additional neuronal population whose neurites utilize Netrin-1/DCC signaling for their development.	[Low, Victoria F.; Fiorini, Zeno; Fisher, Lorryn; Jasoni, Christine L.] Univ Otago, Dept Anat, Ctr Neuroendocrinol, Sch Med Sci, Dunedin, New Zealand	University of Otago	Jasoni, CL (corresponding author), Univ Otago, Dept Anat, Ctr Neuroendocrinol, Sch Med Sci, Dunedin, New Zealand.	christine.jasoni@anatomy.otago.ac.nz		Fiorini, Zeno/0000-0001-5218-2502	New Zealand Lottery Health Grant	New Zealand Lottery Health Grant	This work was supported by a New Zealand Lottery Health Grant to Christine Jasoni. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlvarezBolado G, 1997, CELL TISSUE RES, V290, P197, DOI 10.1007/s004410050923; Belisle JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035911; Bless E, 2006, EUR J NEUROSCI, V24, P654, DOI 10.1111/j.1460-9568.2006.04955.x; Bless EP, 2005, ENDOCRINOLOGY, V146, P463, DOI 10.1210/en.2004-0838; Cariboni A, 2005, DEVELOPMENT, V132, P4709, DOI 10.1242/dev.02033; Cariboni A, 2007, TRENDS NEUROSCI, V30, P638, DOI 10.1016/j.tins.2007.09.002; Constantin S, 2009, ENDOCRINOLOGY, V150, P1400, DOI 10.1210/en.2008-0979; Cronin AS, 2004, EUR J NEUROSCI, V20, P338, DOI 10.1111/j.1460-9568.2004.03490.x; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1999, J NEUROSCI, V19, P9900; Fiorini Z, 2010, J NEUROENDO IN PRESS; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Gibson MJ, 2000, ENDOCRINOLOGY, V141, P3065, DOI 10.1210/en.141.9.3065; Gill JC, 2006, BIOL REPROD, V74, P463, DOI 10.1095/biolreprod.105.046904; Herbison AE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1415; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Izzi L, 2011, CLIN GENET, V80, P226, DOI 10.1111/j.1399-0004.2011.01735.x; Jacobowitz D.M, 1998, CHEMOARCHITECTONIC A; Jasoni CL, 2009, DEV DYNAM, V238, P524, DOI 10.1002/dvdy.21869; Jovanovic JN, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00014; Kastenhuber E, 2009, J NEUROSCI, V29, P8914, DOI 10.1523/JNEUROSCI.0568-09.2009; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Lee KH, 2008, ARCH OTOLARYNGOL, V134, P146, DOI 10.1001/archoto.2007.6; LEVINE JE, 2003, ENCY HORMONES, P157; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; MERCHENTHALER I, 1989, ENDOCRINOLOGY, V125, P2812, DOI 10.1210/endo-125-6-2812; Miller NLG, 2009, HUM MOL GENET, V18, P248, DOI 10.1093/hmg/ddn344; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Nicol X, 2011, P NATL ACAD SCI USA, V108, P13776, DOI 10.1073/pnas.1100247108; Pierce A, 2008, MOL ENDOCRINOL, V22, P2481, DOI 10.1210/me.2008-0169; Piper M, 2009, CEREB CORTEX, V19, pI11, DOI 10.1093/cercor/bhp027; Pujic Z, 2008, J NEUROSCI METH, V170, P220, DOI 10.1016/j.jneumeth.2008.01.014; Ratcliffe EM, 2008, DEV NEUROBIOL, V68, P960, DOI 10.1002/dneu.20634; Ricano-Cornejo I, 2011, J NEUROSCI RES, V89, P1531, DOI 10.1002/jnr.22684; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Schwarting GA, 2004, EUR J NEUROSCI, V19, P11, DOI 10.1111/j.1460-9568.2004.03094.x; Schwarting GA, 2001, J NEUROSCI, V21, P911, DOI 10.1523/JNEUROSCI.21-03-00911.2001; Schwarting GA, 2006, J NEUROSCI, V26, P6834, DOI 10.1523/JNEUROSCI.1728-06.2006; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Spergel DJ, 1999, J NEUROSCI, V19, P2037; Tobet SA, 2006, ENDOCRINOLOGY, V147, P1159, DOI 10.1210/en.2005-1275; Tsai PS, 2005, MOL ENDOCRINOL, V19, P225, DOI 10.1210/me.2004-0330; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Wierman ME, 2011, FRONT NEUROENDOCRIN, V32, P43, DOI 10.1016/j.yfrne.2010.07.005; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Wray S, 2002, FRONT NEUROENDOCRIN, V23, P292, DOI 10.1016/S0091-3022(02)00001-8; WRAY S, 1989, DEV BRAIN RES, V46, P309, DOI 10.1016/0165-3806(89)90295-2; Wu TJ, 1997, J NEUROBIOL, V33, P983, DOI 10.1002/(SICI)1097-4695(199712)33:7<983::AID-NEU9>3.0.CO;2-4; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	52	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46999	10.1371/journal.pone.0046999	http://dx.doi.org/10.1371/journal.pone.0046999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056554	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400043
J	Wang, XC; Shi, ZH; Xue, JH; Zhang, L; Feng, LN; Zhang, ZM				Wang Xiaocheng; Shi Zhaohui; Xue Junhui; Zhang Lei; Feng Lining; Zhang Zuoming			Expression of Calcitonin Gene-Related Peptide in Efferent Vestibular System and Vestibular Nucleus in Rats with Motion Sickness	PLOS ONE			English	Article							HUMAN COCHLEA; BRAIN-STEM; INNER-EAR; NEUROTRANSMITTERS; IMMUNOREACTIVITY; ACETYLCHOLINE; LOCALIZATION; NEURONS	Motion sickness presents a challenge due to its high incidence and unknown pathogenesis although it is a known fact that a functioning vestibular system is essential for the perception of motion sickness. Recent studies show that the efferent vestibular neurons contain calcitonin gene-related peptide (CGRP). It is a possibility that the CGRP immunoreactivity (CGRPi) fibers of the efferent vestibular system modulate primary afferent input into the central nervous system; thus, making it likely that CGRP plays a key role in motion sickness. To elucidate the relationship between motion sickness and CGRP, the effects of CGRP on the vestibular efferent nucleus and the vestibular nucleus were investigated in rats with motion sickness. Methods: An animal model of motion sickness was created by subjecting rats to rotary stimulation for 30 minutes via a trapezoidal stimulation pattern. The number of CGRPi neurons in the vestibular efferent nucleus at the level of the facial nerve genu and the expression level of CGRPi in the vestibular nucleus of rats were measured. Using the ABC method of immunohistochemistry technique, measurements were taken before and after rotary stimulation. The effects of anisodamine on the expression of CGRP in the vestibular efferent nucleus and the vestibular nucleus of rats with motion sickness were also investigated. Results and Discussion: Both the number of CGRPi neurons in the vestibular efferent nucleus and expression level in the vestibular nucleus increased significantly in rats with motion sickness compared to that of controls. The increase of CGRP expression in rats subjected to rotary stimulation 3 times was greater than those having only one-time stimulation. Administration of anisodamine decreased the expression of CGRP within the vestibular efferent nucleus and the vestibular nucleus in rats subjected to rotary stimulation. In conclusion, CGRP possibly plays a role in motion sickness and its mechanism merits further investigation.	[Wang Xiaocheng; Xue Junhui; Zhang Lei; Feng Lining; Zhang Zuoming] Fourth Mil Med Univ, Dept Clin Aerosp Med, Key Lab Aerosp Med, Minist Educ, Xian 710032, Peoples R China; [Shi Zhaohui] Fourth Mil Med Univ, Dept Otolaryngol Head & Neck Surg, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Feng, LN (corresponding author), Fourth Mil Med Univ, Dept Clin Aerosp Med, Key Lab Aerosp Med, Minist Educ, Xian 710032, Peoples R China.	liningfeng@hotmail.com; xiao-chengwang@hotmail.com		Wang, Xiaocheng/0000-0002-2220-6398	Shaanxi Natural Science Fund, China [2009K17-02(46)]	Shaanxi Natural Science Fund, China	This work was supported by grants from the Shaanxi Natural Science Fund 2009K17-02(46), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buyuklu F, 2009, EUR ARCH OTO-RHINO-L, V266, P1365, DOI 10.1007/s00405-009-0927-6; Chi FL, 2007, NEUROENDOCRINOLOGY, V85, P131, DOI 10.1159/000101959; Chi FL, 1999, CHINESE J OTORHINOLA, V34, P11; [付静宜 Fu Jingyi], 2003, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V29, P35; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Hu SQ, 1996, PERCEPT MOTOR SKILL, V82, P859, DOI 10.2466/pms.1996.82.3.859; Huang J, 2011, BRAIN BEHAV IMMUN, V25, P787, DOI 10.1016/j.bbi.2011.02.007; Jiang Z, 2000, CHIN J NAUT MED, V7, P97; Kennedy RS, 2010, APPL ERGON, V41, P494, DOI 10.1016/j.apergo.2009.11.006; Kong WJ, 2002, EUR J NEUROSCI, V15, P487, DOI 10.1046/j.0953-816x.2001.01880.x; Kong WJ, 2002, HEARING RES, V167, P136, DOI 10.1016/S0378-5955(02)00382-9; Mapp PI, 2012, BRIT J PHARMACOL, V10, P1476; OHNO K, 1991, BRAIN RES, V566, P103, DOI 10.1016/0006-8993(91)91686-U; OHNO K, 1993, ACTA OTO-LARYNGOL, P16; Perachio AA, 1989, NEUR ABSTR, V15, P518; Schrott-Fischer A, 2007, ACTA OTO-LARYNGOL, V127, P13, DOI 10.1080/00016480600652123; Shupak A, 2006, AVIAT SPACE ENVIR MD, V77, P1213; Spinks AB, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002851.pub3; TANAKA M, 1989, BRAIN RES, V504, P31, DOI 10.1016/0006-8993(89)91593-X; THOMPSON GC, 1995, BRAIN RES, V683, P140, DOI 10.1016/0006-8993(95)00364-V; Vause CV, 2010, NEUROSCI LETT, V473, P163, DOI 10.1016/j.neulet.2010.01.074; WACKYM PA, 1991, OTOLARYNG HEAD NECK, V105, P493, DOI 10.1177/019459989110500401; WACKYM PA, 1993, ACTA OTO-LARYNGOL, V113, P601, DOI 10.3109/00016489309135871; Yu XH, 2007, PHYSIOL BEHAV, V92, P702, DOI 10.1016/j.physbeh.2007.05.067; Zajonc Timothy P, 2006, Ear Nose Throat J, V85, P25; 姜正林, 1999, [中华航海医学杂志, Chinese Journal of Nautical Medicine], V6, P20	26	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47308	10.1371/journal.pone.0047308	http://dx.doi.org/10.1371/journal.pone.0047308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056625	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400072
J	Xiao, T; Xiao, Z; Ke, XY; Hong, SS; Yang, HY; Su, YL; Chu, KK; Xiao, X; Shen, JY; Liu, YJ				Xiao, Ting; Xiao, Zhou; Ke, Xiaoyan; Hong, Shanshan; Yang, Hongyu; Su, Yanli; Chu, Kangkang; Xiao, Xiang; Shen, Jiying; Liu, Yijun			Response Inhibition Impairment in High Functioning Autism and Attention Deficit Hyperactivity Disorder: Evidence from Near-Infrared Spectroscopy Data	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; SPECTRUM DISORDER; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; MOTOR INHIBITION; STROOP TASK; CHILDREN; ACTIVATION; ADHD; COMMON	Background: Response inhibition, an important domain of executive function (EF), involves the ability to suppress irrelevant or interfering information and impulses. Previous studies have shown impairment of response inhibition in high functioning autism (HFA) and attention deficit hyperactivity disorder (ADHD), but more recent findings have been inconsistent. To date, almost no studies have been conducted using functional imaging techniques to directly compare inhibitory control between children with HFA and those with ADHD. Method: Nineteen children with HFA, 16 age-and intelligence quotient (IQ)-matched children with ADHD, and 16 typically developing (TD) children were imaged using functional near-infrared spectroscopy (NIRS) while performing Go/No-go and Stroop tasks. Results: Compared with the TD group, children in both the HFA and ADHD groups took more time to respond during the No-go blocks, with reaction time longest for HFA and shortest for TD. Children in the HFA and ADHD groups also made a greater number of reaction errors in the No-go blocks than those in the TD group. During the Stroop task, there were no significant differences between these three groups in reaction time and omission errors. Both the HFA and ADHD groups showed a higher level of inactivation in the right prefrontal cortex (PFC) during the No-go blocks, relative to the TD group. However, no significant differences were found between groups in the levels of oxyhemoglobin concentration in the PFC during the Stroop task. Conclusion: Functional brain imaging using NIRS showed reduced activation in the right PFC in children with HFA or ADHD during an inhibition task, indicating that inhibitory dysfunction is a shared feature of both HFA and ADHD.	[Xiao, Ting; Xiao, Zhou; Ke, Xiaoyan; Su, Yanli; Chu, Kangkang; Xiao, Xiang; Shen, Jiying] Nanjing Med Univ, Nanjing Brain Hosp, Child Mental Hlth Res Ctr, Nanjing, Jiangsu, Peoples R China; [Hong, Shanshan; Yang, Hongyu] Southeast Univ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, McKnight Brain Inst, Gainesville, FL USA	Nanjing Medical University; Southeast University - China; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ke, XY (corresponding author), Nanjing Med Univ, Nanjing Brain Hosp, Child Mental Hlth Res Ctr, Nanjing, Jiangsu, Peoples R China.	kexynj@hotmail.com			Health Research Projects of JiangSu [H200948]; National Natural Science Foundation of China [81071111]; Key Program of Medical Development of Nanjing [ZKX10023]	Health Research Projects of JiangSu; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Medical Development of Nanjing	The work was supported by the Health Research Projects of JiangSu (No. H200948), the National Natural Science Foundation of China (No. 81071111) and the Key Program of Medical Development of Nanjing (No. ZKX10023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NC, 2009, J AUTISM DEV DISORD, V39, P1112, DOI 10.1007/s10803-009-0721-8; Ames CS, 2007, J AUTISM DEV DISORD, V37, P1761, DOI 10.1007/s10803-006-0309-5; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Biro S, 2001, DEV PSYCHOPATHOL, V13, P97, DOI 10.1017/S0954579401001079; Bishop DVM, 2005, AUTISM, V9, P29, DOI 10.1177/1362361305049028; Bledsoe JC, 2010, ARCH CLIN NEUROPSYCH, V6, P1; Boecker M, 2007, BEHAV BRAIN RES, V176, P259, DOI 10.1016/j.bbr.2006.10.009; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; Casey BJ, 2001, CLIN NEUROSCI RES, V1, P267, DOI 10.1016/S1566-2772(01)00013-5; Christ SE, 2007, J AUTISM DEV DISORD, V37, P1155, DOI 10.1007/s10803-006-0259-y; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; Geurts HM, 2004, J CHILD PSYCHOL PSYC, V45, P836, DOI 10.1111/j.1469-7610.2004.00276.x; Goldberg MC, 2005, J AUTISM DEV DISORD, V35, P279, DOI 10.1007/s10803-005-3291-4; Herrmann MJ, 2005, BEHAV BRAIN RES, V160, P135, DOI 10.1016/j.bbr.2004.11.032; Iarocci G, 2004, J AUTISM DEV DISORD, V34, P257, DOI 10.1023/B:JADD.0000029548.84041.69; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Lopez BR, 2005, J AUTISM DEV DISORD, V35, P445, DOI 10.1007/s10803-005-5035-x; Mosconi MW, 2009, PSYCHOL MED, V39, P1559, DOI 10.1017/S0033291708004984; Ozonoff S, 1999, J AUTISM DEV DISORD, V29, P171, DOI 10.1023/A:1023052913110; Ozonoff S, 1997, J AUTISM DEV DISORD, V27, P59, DOI 10.1023/A:1025821222046; Plaisted K, 2003, PHILOS T ROY SOC B, V358, P375, DOI 10.1098/rstb.2002.1211; Raymaekers R, 2007, J CLIN EXP NEUROPSYC, V29, P418, DOI 10.1080/13803390600737990; Robinson S, 2009, BRAIN COGNITION, V71, P362, DOI 10.1016/j.bandc.2009.06.007; Rommelse NNJ, 2010, EUR CHILD ADOLES PSY, V19, P281, DOI 10.1007/s00787-010-0092-x; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rubia K, 2008, AM J PSYCHIAT, V165, P889, DOI 10.1176/appi.ajp.2008.07071084; Rubia K, 2010, HUM BRAIN MAPP, V31, P287, DOI 10.1002/hbm.20864; Schmitz N, 2006, BIOL PSYCHIAT, V59, P7, DOI 10.1016/j.biopsych.2005.06.007; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Smith AB, 2006, AM J PSYCHIAT, V163, P1044, DOI 10.1176/appi.ajp.163.6.1044; Verte S, 2006, J NEUROSCI METH, V151, P5, DOI 10.1016/j.jneumeth.2005.08.023; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Yang HY, 2007, BEHAV BRAIN RES, V178, P172, DOI 10.1016/j.bbr.2006.11.039; [杨娟 YANG Juan], 2008, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V16, P225; Zang YF, 2005, BRAIN DEV-JPN, V27, P544, DOI 10.1016/j.braindev.2004.11.009	36	65	69	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46569	10.1371/journal.pone.0046569	http://dx.doi.org/10.1371/journal.pone.0046569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	021MR	23056348	gold, Green Submitted, Green Published			2022-12-27	WOS:000309889400018
J	Zeng, M; Yan, HB; Chen, Y; Zhao, HJ; Lv, Y; Liu, C; Zhou, P; Zhao, B				Zeng, Min; Yan, Hongbing; Chen, Yi; Zhao, Han-jun; Lv, Yuan; Liu, Cheng; Zhou, Peng; Zhao, Bo			Suppression of NF-kappa B Reduces Myocardial No-Reflow	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; C-REACTIVE PROTEIN; INFARCT SIZE; TNF-ALPHA; DYSFUNCTION; EXPRESSION; ADMISSION; ADHESION; MODEL; DOG	No-reflow phenomenon is a risk factor which severely compromises the benefits of coronary revascularization in patients with acute myocardial infarction. Inflammatory response, as an essential component of cardiac ischemia/reperfusion (I/R) injury, has been suggested to contribute to the myocardial no-reflow. Since nuclear factor kappa B (NF-kappa B) is a key mediator of inflammation, we reasoned that inhibition of NF-kappa B might reduce the extent of no-reflow. To test this hypothesis, the left circumflex coronary arteries of New Zealand white male rabbits were ligated for 1.5 h, followed by reperfusion for 1 h to induce I/R injury. Pretreatment of the rabbits with a specific NF-kappa B inhibitor, pyrrolidine dithiocarbamate (PDTC), significantly attenuated neutrophil infiltration in the no-reflow area as well as the expansion of no-reflow. These beneficial effects were associated with a marked reduction in the serum levels of myocardial induced I/R tumor necrosis factor-alpha (TNF-alpha), intercellular adhesion molecule-1 (ICAM-1), and CXCL16. Consistently, simulative I/R culture of human umbilical vein endothelial cells (HUVECs) resulted in an increase of TNF-alpha, ICAM-1 and CXCL16, and all of these changes were significantly suppressed by pretreatment of the cells with PDTC or with siRNA-mediated p65 knockdown. Our data thus suggest that inhibition of NF-kappa B may reduce I/R-associated myocardial no-reflow through reduction of myocardial inflammation.	[Yan, Hongbing; Zhao, Han-jun; Liu, Cheng] Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Cardiovasc Inst, Beijing 100021, Peoples R China; [Yan, Hongbing; Zhao, Han-jun; Liu, Cheng] Peking Union Med Coll, Fuwai Hosp, Beijing 100021, Peoples R China; [Yan, Hongbing; Zhao, Han-jun; Liu, Cheng] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zeng, Min; Chen, Yi; Lv, Yuan; Zhou, Peng; Zhao, Bo] Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing, Peoples R China; [Zeng, Min] Peoples Hosp Hainan Prov, Haikou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University	Yan, HB (corresponding author), Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Cardiovasc Inst, Beijing 100021, Peoples R China.	yan591204@yahoo.com.cn			Natural Science Foundation of China [81070167]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China 81070167 to H.Y.(http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Briaud SA, 2001, AM J PHYSIOL-HEART C, V280, pH60, DOI 10.1152/ajpheart.2001.280.1.H60; Celik T, 2009, INT J CARDIOL, V136, P86, DOI 10.1016/j.ijcard.2008.03.058; Chan W, 2011, AM J CARDIOL; ENGLER RL, 1983, AM J PATHOL, V111, P98; Fischer Uwe M, 2006, Interact Cardiovasc Thorac Surg, V5, P531, DOI 10.1510/icvts.2006.130765; Frantz S, 2007, AM J PATHOL, V171, P507, DOI 10.2353/ajpath.2007.061042; Fukushima S, 2006, CIRCULATION, V114, pI251, DOI 10.1161/CIRCULATIONAHA.105.000794; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH2242, DOI 10.1152/ajpheart.00587.2008; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Jaffe R, 2008, CIRCULATION, V117, P3152, DOI 10.1161/CIRCULATIONAHA.107.742312; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; LITT MR, 1989, CIRCULATION, V80, P1816, DOI 10.1161/01.CIR.80.6.1816; Mitsuoka H, 2009, J ATHEROSCLER THROMB, V16, P586, DOI 10.5551/jat.1081; Moss NC, 2007, AM J PHYSIOL-HEART C, V293, pH2248, DOI 10.1152/ajpheart.00776.2007; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; Reffelmann T, 2002, AM J PHYSIOL-HEART C, V283, pH1099, DOI 10.1152/ajpheart.00270.2002; Rezkalla SH, 2008, CATHETER CARDIO INTE, V72, P950, DOI 10.1002/ccd.21715; Ruth JH, 2010, ARTHRITIS RHEUM-US, V62, P2536, DOI 10.1002/art.27518; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Stansfield WE, 2007, ANN THORAC SURG, V84, P120, DOI 10.1016/j.athoracsur.2007.02.049; Takahashi T, 2007, AM J CARDIOL, V100, P35, DOI 10.1016/j.amjcard.2007.02.049; Venkatachalam K, 2009, J BIOL CHEM, V284, P7853, DOI 10.1074/jbc.M808824200; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zeng M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010966	27	24	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47306	10.1371/journal.pone.0047306	http://dx.doi.org/10.1371/journal.pone.0047306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056624	gold, Green Published, Green Submitted			2022-12-27	WOS:000309889400071
J	Hediger, MR; Jensen, JH; De Vico, L				Hediger, Martin R.; Jensen, Jan H.; De Vico, Luca			BioFET-SIM Web Interface: Implementation and Two Applications	PLOS ONE			English	Article							LABEL-FREE; CHARGE-DISTRIBUTION; SILICON NANOWIRES; PDB2PQR; LENGTH	We present a web interface which allows us to conveniently set up calculations based on the BioFET-SIM model. With the interface, the signal of a BioFET sensor can be calculated depending on its parameters, as well as the signal dependence on pH. As an illustration, two case studies are presented. In the first case, a generic peptide with opposite charges on both ends is inverted in orientation on a semiconducting nanowire surface leading to a corresponding change in sign of the computed sensitivity of the device. In the second case, the binding of an antibody/antigen complex on the nanowire surface is studied in terms of orientation and analyte/nanowire surface distance. We demonstrate how the BioFET-SIM web interface can aid in the understanding of experimental data and postulate alternative ways of antibody/antigen orientation on the nanowire surface.	[Hediger, Martin R.; Jensen, Jan H.; De Vico, Luca] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark	University of Copenhagen	Hediger, MR (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	martin@chem.ku.dk	De Vico, Luca/D-2267-2009; Jensen, Jan Halborg/G-4338-2010; De Vico, Luca/HFZ-7775-2022	De Vico, Luca/0000-0002-2821-5711; Jensen, Jan Halborg/0000-0002-1465-1010; De Vico, Luca/0000-0002-2821-5711	Universitetsforskningens Investeringskapital Synthetic Biology program	Universitetsforskningens Investeringskapital Synthetic Biology program	MRH acknowledges financial support from the Universitetsforskningens Investeringskapital Synthetic Biology program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berthing T., 2009, J NANONEUROSCI, V1, P3, DOI DOI 10.1166/JNS.2009.001; Bjork MT, 2009, NAT NANOTECHNOL, V4, P103, DOI [10.1038/nnano.2008.400, 10.1038/NNANO.2008.400]; Chang HK, 2011, ACS NANO, V5, P9883, DOI 10.1021/nn2035796; Chen H, 2008, COMPUT METHOD APPL M, V197, P3366, DOI 10.1016/j.cma.2008.02.007; Chen Y, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2392828; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Curreli M, 2008, IEEE T NANOTECHNOL, V7, P651, DOI 10.1109/TNANO.2008.2006165; De Vico L, 2011, NANOSCALE, V3, P3635, DOI 10.1039/c1nr10316d; De Vico L, 2011, NANOSCALE, V3, P706, DOI 10.1039/c0nr00442a; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dorvel B, 2012, ACS NANO; Dorvel BR, 2012, ACS NANO, V6, P6150, DOI 10.1021/nn301495k; Duan XX, 2012, NAT NANOTECHNOL, V7, P401, DOI [10.1038/nnano.2012.82, 10.1038/NNANO.2012.82]; Gao XPA, 2010, NANO LETT, V10, P547, DOI 10.1021/nl9034219; Garnett EC, 2009, NAT NANOTECHNOL, V4, P311, DOI [10.1038/nnano.2009.43, 10.1038/NNANO.2009.43]; Hakim MMA, 2012, NANO LETT, V12, P1868, DOI 10.1021/nl2042276; Hanson RM, 2010, J APPL CRYSTALLOGR, V43, P1250, DOI 10.1107/S0021889810030256; Heitzinger C, 2009, SIM SEM PROC DEV SIS, P1; Heitzinger C, 2007, J COMPUT ELECTRON, V6, P387, DOI 10.1007/s10825-006-0139-x; Heitzinger C, 2008, J PHYS CONF SER, V107, DOI 10.1088/1742-6596/107/1/012004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Liang GC, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115302; Liu YCC, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/24/245105; LLC Schrodinger, 2010, PYMOL MOL GRAPHICS S; Medici, 2003, MED 2 DIM DEV SIM PR; Nair PR, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2211310; Nair P. R., 2008, BIOSENSORLAB, DOI 10254/nanohub-r2929.5; Nair PR, 2008, NANO LETT, V8, P1281, DOI 10.1021/nl072593i; Nair PR, 2007, IEEE T ELECTRON DEV, V54, P3400, DOI 10.1109/TED.2007.909059; Nair PR, 2010, J APPL PHYS, V107, DOI 10.1063/1.3310531; Neizvestny IG, 2009, RUSS MICROELECTRON+, V38, P223, DOI 10.1134/S1063739709040015; Nitzan A, 2002, J CHEM PHYS, V117, P10837, DOI 10.1063/1.1522406; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Park HH, 2006, NANOWIRE, DOI 10254/nanohub-r1307.8; Patolsky F, 2006, ANAL CHEM, V78, P4260, DOI 10.1021/ac069419j; Punzet M, 2012, NANOSCALE, V4, P2431, DOI 10.1039/c2nr12038k; Roy S, 2009, NANO TODAY, V4, P318, DOI 10.1016/j.nantod.2009.06.003; Shinwari MW, 2007, MICROELECTRON RELIAB, V47, P2025, DOI 10.1016/j.microrel.2006.10.003; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Sorensen MH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2779930; Stern E, 2007, NANO LETT, V7, P3405, DOI 10.1021/nl071792z; Stern E, 2007, NATURE, V445, P519, DOI 10.1038/nature05498; Tian RH, 2011, LAB CHIP, V11, P1952, DOI 10.1039/c0lc00605j; Ullmann GM, 1999, EUR BIOPHYS J BIOPHY, V28, P533, DOI 10.1007/s002490050236; Vacic A, 2011, J AM CHEM SOC, V133, P13886, DOI 10.1021/ja205684a; Windbacher T, 2010, COMM COM INF SC, V52, P85; Wong IY, 2009, NANO LETT, V9, P3521, DOI 10.1021/nl901710n; YATES DE, 1974, J CHEM SOC FARAD T 1, V70, P1807, DOI 10.1039/f19747001807; Zhang XG, 2009, NANO LETT, V9, P4306, DOI 10.1021/nl902533n	52	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45379	10.1371/journal.pone.0045379	http://dx.doi.org/10.1371/journal.pone.0045379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056201	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500017
J	Kim, SH; Min, KS; Kim, NH; Yoon, JT				Kim, Sang Hwan; Min, Kwan Sik; Kim, Nam Hyung; Yoon, Jong Taek			Differential Expression of Programmed Cell Death on the Follicular Development in Normal and Miniature Pig Ovary	PLOS ONE			English	Article							APOPTOSIS; PROTEIN; FRAGMENTATION; AUTOPHAGY; OOCYTE	Follicles are important in oocyte maturation. Successful estrous cycle requires remodeling of follicular cells, and proper execution of programmed cell death is crucial for normal follicular development. The objectives of the present study were to understand programmed cell death during follicle development, to analyze the differential follicle development patterns, and to assess the patterns of apoptosis and autophagy expression during follicle development in normal and miniature pigs. Through the analysis of differential patterns of programmed cell death during follicular development in porcine, MAP1LC3A, B and other autophagy-associated genes (ATG5, mTOR, Beclin-1) were found to increase in normal pigs, while it decreased in miniature pigs. However, for the apoptosis-associated genes, progression of genes during follicular development increased in miniature pigs, while it decreased in normal pigs. Thus, results show that normal and miniature pigs showed distinct patterns of follicular remodeling manifesting that programmed cell death largely depends on the types of pathway during follicular development (Type II or autophagy for normal pigs and Type I or apoptosis for miniature pigs).	[Yoon, Jong Taek] Hankyong Natl Univ, Dept Anim Life Sci, Ansung, Gyeonggi Do, South Korea; [Kim, Sang Hwan] Hankyong Natl Univ, Inst Genet Engn, Ansung, Gyeonggi Do, South Korea; [Min, Kwan Sik] Hankyong Natl Univ, Grad Sch Bio & Informat Technol, Ansung, Gyeonggi Do, South Korea; [Kim, Nam Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungbuk, South Korea	Hankyong National University; Hankyong National University; Hankyong National University; Chungbuk National University	Yoon, JT (corresponding author), Hankyong Natl Univ, Dept Anim Life Sci, Ansung, Gyeonggi Do, South Korea.	jtyoon@hknu.ac.kr		Kim, SangHwan/0000-0003-0996-6912	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008029]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008029), Rural Development Administration, Republic of Korea (http://atis.rda.go.kr). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILLIG H, 1993, ENDOCRINOLOGY, V133, P2204, DOI 10.1210/en.133.5.2204; BILLIG H, 1994, ENDOCRINOLOGY, V134, P245, DOI 10.1210/en.134.1.245; Billig H, 1996, HUM REPROD UPDATE, V2, P103, DOI 10.1093/humupd/2.2.103; Byskov AG., 1979, OVARIAN FOLLICULAR D, P41; Choi JY, 2010, FERTIL STERIL, V93, P2532, DOI 10.1016/j.fertnstert.2009.11.021; CLARK JR, 1982, THERIOGENOLOGY, V18, P697, DOI 10.1016/0093-691X(82)90035-8; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; DAILEY RA, 1976, J ANIM SCI, V43, P175, DOI 10.2527/jas1976.431175x; Day BN, 1968, REPRODUCTION FARM AN, P279; Dor FJMF, 2004, TRANSPLANTATION, V78, P15, DOI 10.1097/01.TP.0000130487.68051.EB; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Focchi G R, 1996, Sao Paulo Med J, V114, P1173; Gilbert SF, 2000, DEV BIOL, P212; GUTHRIE HD, 1995, J ANIM SCI, V73, P2834; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOWARD PK, 1982, ANAT REC, V203, P55, DOI 10.1002/ar.1092030106; Hsu SY, 2000, PHYSIOL REV, V80, P593, DOI 10.1152/physrev.2000.80.2.593; HUGHES FM, 1991, ENDOCRINOLOGY, V129, P2415, DOI 10.1210/endo-129-5-2415; Hwang SO, 2008, AUTOPHAGY, V4, P70, DOI 10.4161/auto.5065; Hwang SO, 2008, BIOTECHNOL BIOENG, V99, P678, DOI 10.1002/bit.21589; Kim SH, 2009, REPROD DEV BIOL, V33, P156; KING BF, 1993, J ANIM SCI, V71, P975, DOI 10.2527/1993.714975x; Manabe N, 1998, APOPTOSIS ITS ROLES, P97; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; MCCONKEY DJ, 1989, J BIOL CHEM, V264, P13399; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Othman EQG, 2009, J CLIN LAB ANAL, V23, P249, DOI 10.1002/jcla.20309; SAWYER HR, 1995, J REPROD FERTIL, P97; SHAW HJ, 1985, J REPROD FERTIL, V75, P17, DOI 10.1530/jrf.0.0750017; Smitz JEJ, 2002, REPRODUCTION, V123, P185, DOI 10.1530/rep.0.1230185; Thomas FH, 2003, HUM REPROD UPDATE, V9, P541, DOI 10.1093/humupd/dmg042; TILLY JL, 1992, SERONO SYM, V94, P157; Wartenberg H, 2001, ANAT EMBRYOL, V204, P421, DOI 10.1007/s00429-001-0216-7	36	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46194	10.1371/journal.pone.0046194	http://dx.doi.org/10.1371/journal.pone.0046194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056260	gold, Green Submitted, Green Published			2022-12-27	WOS:000309831500030
J	Plourde, JR; Pyles, JA; Layton, RC; Vaughan, SE; Tipper, JL; Harrod, KS				Plourde, Jennifer R.; Pyles, John A.; Layton, R. Colby; Vaughan, Sarah E.; Tipper, Jennifer L.; Harrod, Kevin S.			Neurovirulence of H5N1 Infection in Ferrets Is Mediated by Multifocal Replication in Distinct Permissive Neuronal Cell Regions	PLOS ONE			English	Article							INFLUENZA-A H5N1; BRONCHIAL EPITHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; VIRUS-INFECTION; HUMAN AIRWAY; RECEPTOR SPECIFICITY; RESPIRATORY-TRACT; MICE; HUMANS; DIFFERENTIATION	Highly pathogenic avian influenza A (HPAI), subtype H5N1, remains an emergent threat to the human population. While respiratory disease is a hallmark of influenza infection, H5N1 has a high incidence of neurological sequelae in many animal species and sporadically in humans. We elucidate the temporal/spatial infection of H5N1 in the brain of ferrets following a low dose, intranasal infection of two HPAI strains of varying neurovirulence and lethality. A/Vietnam/1203/2004 (VN1203) induced mortality in 100% of infected ferrets while A/Hong Kong/483/1997 (HK483) induced lethality in only 20% of ferrets, with death occurring significantly later following infection. Neurological signs were prominent in VN1203 infection, but not HK483, with seizures observed three days post challenge and torticollis or paresis at later time points. VN1203 and HK483 replication kinetics were similar in primary differentiated ferret nasal turbinate cells, and similar viral titers were measured in the nasal turbinates of infected ferrets. Pulmonary viral titers were not different between strains and pathological findings in the lungs were similar in severity. VN1203 replicated to high titers in the olfactory bulb, cerebral cortex, and brain stem; whereas HK483 was not recovered in these tissues. VN1203 was identified adjacent to and within the olfactory nerve tract, and multifocal infection was observed throughout the frontal cortex and cerebrum. VN1203 was also detected throughout the cerebellum, specifically in Purkinje cells and regions that coordinate voluntary movements. These findings suggest the increased lethality of VN1203 in ferrets is due to increased replication in brain regions important in higher order function and explains the neurological signs observed during H5N1 neurovirulence.	[Plourde, Jennifer R.; Pyles, John A.; Layton, R. Colby; Vaughan, Sarah E.; Tipper, Jennifer L.; Harrod, Kevin S.] Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA; [Plourde, Jennifer R.; Vaughan, Sarah E.; Harrod, Kevin S.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico	Harrod, KS (corresponding author), Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA.	kharrod@lrri.org		Harrod, Kevin/0000-0003-0780-9470; Vaughan, Sarah/0000-0001-7962-4526				Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chan RWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008713; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Layton RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020641; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971; Mitchell H, 2011, J VIROL, V85, P1125, DOI 10.1128/JVI.01722-10; Mori I, 2005, J NEUROVIROL, V11, P129, DOI 10.1080/13550280590922793; Mori I, 2002, J GEN VIROL, V83, P2109, DOI 10.1099/0022-1317-83-9-2109; Ng WF, 2007, LANCET, V370, P1106, DOI 10.1016/S0140-6736(07)61490-1; Nishimura H, 2000, J GEN VIROL, V81, P2503, DOI 10.1099/0022-1317-81-10-2503; Park CH, 2002, ARCH VIROL, V147, P1425, DOI 10.1007/s00705-001-0750-x; REINACHER M, 1983, LAB INVEST, V49, P686; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shinya K, 2011, J VIROL, V85, P5202, DOI 10.1128/JVI.00239-11; Tanaka H, 2003, VET MICROBIOL, V95, P1, DOI 10.1016/S0378-1135(03)00132-9; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	29	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46605	10.1371/journal.pone.0046605	http://dx.doi.org/10.1371/journal.pone.0046605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056366	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500053
J	Yamanaka, K; Dorjsuren, D; Eoff, RL; Egli, M; Maloney, DJ; Jadhav, A; Simeonov, A; Lloyd, RS				Yamanaka, Kinrin; Dorjsuren, Dorjbal; Eoff, Robert L.; Egli, Martin; Maloney, David J.; Jadhav, Ajit; Simeonov, Anton; Lloyd, R. Stephen			A Comprehensive Strategy to Discover Inhibitors of the Translesion Synthesis DNA Polymerase kappa	PLOS ONE			English	Article							CROSS-LINKS; ERROR-FREE; REPLICATION; BYPASS; ADDUCTS; REPAIR; IOTA; MECHANISM; ACROLEIN	Human DNA polymerase kappa (pol kappa) is a translesion synthesis (TLS) polymerase that catalyzes TLS past various minor groove lesions including N-2-dG linked acrolein-and polycyclic aromatic hydrocarbon-derived adducts, as well as N-2-dG DNA-DNA interstrand cross-links introduced by the chemotherapeutic agent mitomycin C. It also processes ultraviolet light-induced DNA lesions. Since pol kappa TLS activity can reduce the cellular toxicity of chemotherapeutic agents and since gliomas overexpress pol kappa, small molecule library screens targeting pol kappa were conducted to initiate the first step in the development of new adjunct cancer therapeutics. A high-throughput, fluorescence-based DNA strand displacement assay was utilized to screen similar to 16,000 bioactive compounds, and the 60 top hits were validated by primer extension assays using non-damaged DNAs. Candesartan cilexetil, manoalide, and MK-886 were selected as proof-of-principle compounds and further characterized for their specificity toward pol kappa by primer extension assays using DNAs containing a site-specific acrolein-derived, ring-opened reduced form of gamma-HOPdG. Furthermore, candesartan cilexetil could enhance ultraviolet light-induced cytotoxicity in xeroderma pigmentosum variant cells, suggesting its inhibitory effect against intracellular pol kappa. In summary, this investigation represents the first high-throughput screening designed to identify inhibitors of pol kappa, with the characterization of biochemical and biologically relevant endpoints as a consequence of pol kappa inhibition. These approaches lay the foundation for the future discovery of compounds that can be applied to combination chemotherapy.	[Yamanaka, Kinrin; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA; [Yamanaka, Kinrin] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Dorjsuren, Dorjbal; Maloney, David J.; Jadhav, Ajit; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Eoff, Robert L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Ctr Mol Toxicol, Nashville, TN 37212 USA; [Egli, Martin] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Arkansas System; University of Arkansas Medical Sciences; Vanderbilt University; Vanderbilt University	Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA.	lloydst@ohsu.edu		Lloyd, R. Stephen/0000-0001-7273-372X; Jadhav, Ajit/0000-0001-7955-1451	National Institute of Environmental Health Sciences [ES05355]; National Cancer Institute [CA106858]; National Institute of Mental Health [R03 MH 094179]; National Institute of General Medical Sciences [R00 GM 084460]; NATIONAL CANCER INSTITUTE [P01CA160032, R01CA106858] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338, R00GM084460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH094179] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Environmental Health Sciences [ES05355 to R. S. L.], National Cancer Institute [CA106858 to R. S. L.], National Institute of Mental Health [R03 MH 094179 to R. S. L.], and National Institute of General Medical Sciences [R00 GM 084460 to R. L. E.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Cleaver JE, 1999, CANCER RES, V59, P1102; Dorjsuren D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp641; Ebada SS, 2010, MAR DRUGS, V8, P313, DOI 10.3390/md8020313; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Folmer F, 2010, BIOCHEM PHARMACOL, V80, P1793, DOI 10.1016/j.bcp.2010.08.024; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Ishida T, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/650514; Kimura T, 2009, BIOORGAN MED CHEM, V17, P1811, DOI 10.1016/j.bmc.2009.01.064; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lehoczky P, 2007, FEMS MICROBIOL REV, V31, P109, DOI 10.1111/j.1574-6976.2006.00046.x; Mamelak AN, 2005, ONCOLOGY-NY, V19, P1803; Maruo S, 2011, BIOORGAN MED CHEM, V19, P5803, DOI 10.1016/j.bmc.2011.08.023; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Minko IG, 2009, CHEM RES TOXICOL, V22, P759, DOI 10.1021/tx9000489; Mizushina Y, 2011, INT J MOL SCI, V12, P1115, DOI 10.3390/ijms12021115; Mizushina Y, 2010, BIOCHEM PHARMACOL, V80, P1125, DOI 10.1016/j.bcp.2010.06.031; Mizushina Y, 2009, MAR DRUGS, V7, P624, DOI 10.3390/md7040624; Mizushina Y, 2009, MOLECULES, V14, P102, DOI 10.3390/molecules14010102; Nakao Y, 2007, J NAT PROD, V70, P689, DOI 10.1021/np060600x; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rechkoblit O, 2002, J BIOL CHEM, V277, P30488, DOI 10.1074/jbc.M201167200; Sassa A, 2011, MUTAT RES-GEN TOX EN, V718, P10, DOI 10.1016/j.mrgentox.2010.11.002; Smirnov SV, 1998, BRIT J PHARMACOL, V124, P572, DOI 10.1038/sj.bjp.0701855; Wang HB, 2010, NEURO-ONCOLOGY, V12, P679, DOI 10.1093/neuonc/nop074; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wolfle WT, 2005, MOL CELL BIOL, V25, P8748, DOI 10.1128/MCB.25.19.8748-8754.2005; Yamanaka K, 2012, DNA REPAIR CANC BENC; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2002, MUTAT RES-FUND MOL M, V510, P23, DOI 10.1016/S0027-5107(02)00249-X; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	40	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45032	10.1371/journal.pone.0045032	http://dx.doi.org/10.1371/journal.pone.0045032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056190	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500011
J	Leung, L; Radulovich, N; Zhu, CQ; Organ, S; Bandarchi, B; Pintilie, M; To, C; Panchal, D; Tsao, MS				Leung, Lisa; Radulovich, Nikolina; Zhu, Chang-Qi; Organ, Shawna; Bandarchi, Bizhan; Pintilie, Melania; To, Christine; Panchal, Devang; Tsao, Ming Sound			Lipocalin2 Promotes Invasion, Tumorigenicity and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; GENE-EXPRESSION; CANCER; CARCINOMA; METASTASIS; GROWTH; NGAL; SUPPRESSES; ACTIVATION; COMPLEX	Lipocalin 2 (LCN2) is a small secreted protein and its elevated expression has been observed in pancreatic as well as other cancer types. LCN2 has been reported to promote resistance to drug-induced apoptosis, enhance invasion through its physical association with matrix metalloproteinase-9, and promote in vivo tumor growth. LCN2 was found to be commonly expressed in patient PDAC samples and its pattern of immunohistochemical staining intensified with increasing severity in high-grade precursor lesions. Downregulation of LCN2 in two pancreatic ductal adenocarcinoma cell lines (BxPC3 and HPAF-II) with high LCN2 expression significantly reduced attachment, invasion, and tumour growth in vivo, but not proliferation or motility. Downregulation of LCN2 in two pancreatic ductal adenocarcinoma cell lines (BxPC3 and HPAF-II) with high expression significantly reduced attachment, invasion, and tumour growth in vivo. In contrast, LCN2 overexpression in PANC1, with low endogenous expression, significantly increased invasion, attachment, and enhanced tumor growth. Suppression of LCN2 in BxPC3 and HPAF-II cells increased their sensitivity to gemcitabine in vitro, and in vivo when BxPC3 was tested. Furthermore, LCN2 promotes expression of VEGF and HIF1A which contribute to enhanced vascularity. These overall results demonstrate that LCN2 plays an important role in the malignant progression of pancreatic ductal carcinoma and is a potential therapeutic target for this disease.	[Leung, Lisa; Radulovich, Nikolina; Zhu, Chang-Qi; Organ, Shawna; Bandarchi, Bizhan; Pintilie, Melania; To, Christine; Panchal, Devang; Tsao, Ming Sound] Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON, Canada; [Leung, Lisa; Tsao, Ming Sound] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Radulovich, Nikolina; Organ, Shawna; Tsao, Ming Sound] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto	Tsao, MS (corresponding author), Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON, Canada.	Ming.Tsao@uhn.on.ca	Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022	Tsao, Ming Sound/0000-0002-9160-5405; Zhu, ChangQi/0000-0002-9992-0258	Canadian Cancer Society Research Institute grant [700809]; Canadian Institutes of Health Research grant [MOP-49585]; Ontario Ministry of Health and Long Term Care; Canadian Institutes of Health Research	Canadian Cancer Society Research Institute grant; Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Cancer Society Research Institute grant #700809, Canadian Institutes of Health Research grant MOP-49585, and partly by the Ontario Ministry of Health and Long Term Care. Nikolina Radulovich is the Vanier Scholar of Canada (funded by Canadian Institutes of Health Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, CANCER RES, V61, P4320; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Chakraborty S, 2010, AM J GASTROENTEROL, V105, P2050, DOI 10.1038/ajg.2010.23; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v; Hu LM, 2009, LAB INVEST, V89, P531, DOI 10.1038/labinvest.2009.17; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kubben FJGM, 2007, EUR J CANCER, V43, P1869, DOI 10.1016/j.ejca.2007.05.013; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Laurell H, 2006, WORLD J GASTROENTERO, V12, P3344, DOI 10.3748/wjg.v12.i21.3344; Lee HJ, 2006, INT J CANCER, V118, P2490, DOI 10.1002/ijc.21657; Leng XH, 2011, J CELL PHYSIOL, V226, P309, DOI 10.1002/jcp.22403; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Mannelqvist M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-169; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Navab R, 2009, NEOPLASIA, V11, P1292, DOI 10.1593/neo.09622; Pham NA, 2007, PANCREAS, V35, pE16, DOI 10.1097/mpa.0b013e318095a747; Playford RJ, 2006, GASTROENTEROLOGY, V131, P809, DOI 10.1053/j.gastro.2006.05.051; Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208; Radulovich N, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-24; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Tschesche H, 2001, EUR J BIOCHEM, V268, P1918, DOI 10.1046/j.1432-1327.2001.02066.x; Venkatesha S, 2006, MOL CANCER RES, V4, P821, DOI 10.1158/1541-7786.MCR-06-0110; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhang HH, 2007, J CLIN PATHOL, V60, P555, DOI 10.1136/jcp.2006.039297	32	52	55	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46677	10.1371/journal.pone.0046677	http://dx.doi.org/10.1371/journal.pone.0046677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056397	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800038
J	Raineri, M; Gonzalez, B; Goitia, B; Garcia-Rill, E; Krasnova, IN; Cadet, JL; Urbano, FJ; Bisagno, V				Raineri, Mariana; Gonzalez, Betina; Goitia, Belen; Garcia-Rill, Edgar; Krasnova, Irina N.; Cadet, Jean Lud; Urbano, Francisco J.; Bisagno, Veronica			Modafinil Abrogates Methamphetamine-Induced Neuroinflammation and Apoptotic Effects in the Mouse Striatum	PLOS ONE			English	Article							NIGROSTRIATAL DOPAMINE NEURONS; PROMOTING DRUG MODAFINIL; INDUCED NEUROTOXICITY; MICROGLIAL ACTIVATION; SUBSTITUTED AMPHETAMINES; TYROSINE-HYDROXYLASE; C57BL/6J MOUSE; BRAIN; DEATH; TRANSPORTERS	Methamphetamine is a drug of abuse that can cause neurotoxic damage in humans and animals. Modafinil, a wakepromoting compound approved for the treatment of sleeping disorders, is being prescribed off label for the treatment of methamphetamine dependence. The aim of the present study was to investigate if modafinil could counteract methamphetamine-induced neuroinflammatory processes, which occur in conjunction with degeneration of dopaminergic terminals in the mouse striatum. We evaluated the effect of a toxic methamphetamine binge in female C57BL/6 mice (4 x 5 mg/kg, i.p., 2 h apart) and modafinil co-administration (2 x 90 mg/kg, i.p., 1 h before the first and fourth methamphetamine injections) on glial cells (microglia and astroglia). We also evaluated the striatal expression of the pro-apoptotic BAX and anti-apoptotic Bcl-2 proteins, which are known to mediate methamphetamine-induced apoptotic effects. Modafinil by itself did not cause reactive gliosis and counteracted methamphetamine-induced microglial and astroglial activation. Modafinil also counteracted the decrease in tyrosine hydroxylase and dopamine transporter levels and prevented methamphetamine-induced increases in the pro-apoptotic BAX and decreases in the anti-apoptotic Bcl-2 protein expression. Our results indicate that modafinil can interfere with methamphetamine actions and provide protection against dopamine toxicity, cell death, and neuroinflammation in the mouse striatum.	[Raineri, Mariana; Gonzalez, Betina; Bisagno, Veronica] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Invest Farmacol, Buenos Aires, DF, Argentina; [Goitia, Belen; Urbano, Francisco J.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Fisiol Biol Mol & Neurociencias, Lab Fisiol & Biol Mol, Buenos Aires, DF, Argentina; [Krasnova, Irina N.; Cadet, Jean Lud] NIH NIDA Intramural Res Program, Mol Neuropsychiat Res Branch, Baltimore, MD USA; [Garcia-Rill, Edgar] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Ctr Translat Neurosci, Little Rock, AR 72205 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Arkansas System; University of Arkansas Medical Sciences	Bisagno, V (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Invest Farmacol, Buenos Aires, DF, Argentina.	vbisagno@ffyb.uba.ar	Raineri, Mariana/P-9660-2018; Raineri, Mariana/P-5911-2019	Raineri, Mariana/0000-0002-1989-5137; Raineri, Mariana/0000-0002-1989-5137; Garcia-Rill, Edgar/0000-0003-1367-3071	FONCYT-Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [BID 1728 OC.AR]; PICT; PIDRI-PRH; CONICET-PIP [2011-2013-11420100100072]; NIH [P20 GM103425-09]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000551, ZIADA000552] Funding Source: NIH RePORTER	FONCYT-Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyTFONCyT); PICT(ANPCyT); PIDRI-PRH; CONICET-PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by: FONCYT-Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina), BID 1728 OC.AR. PICT 2007-1009, PICT 2008-2019 and PIDRI-PRH 2007, CONICET-PIP 2011-2013-11420100100072, and by NIH P20 GM103425-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballon JS, 2006, J CLIN PSYCHIAT, V67, P554, DOI 10.4088/JCP.v67n0406; Beauvais G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028946; BOWYER JF, 1994, J PHARMACOL EXP THER, V268, P1571; Bowyer JF, 2008, SYNAPSE, V62, P193, DOI 10.1002/syn.20478; BROWN SJ, 1982, BRAIN RES, V234, P275, DOI 10.1016/0006-8993(82)90868-X; Callahan BT, 2001, J NEUROCHEM, V77, P1348, DOI 10.1046/j.1471-4159.2001.00341.x; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; COX B, 1977, BRIT J PHARMACOL, V61, P83, DOI 10.1111/j.1476-5381.1977.tb09742.x; Davidson C, 2001, BRAIN RES REV, V36, P1, DOI 10.1016/S0165-0173(01)00054-6; De la Garza R, 2010, DRUG ALCOHOL DEPEN, V106, P173, DOI 10.1016/j.drugalcdep.2009.08.013; Deng XL, 2007, BIOL PSYCHIAT, V61, P1235, DOI 10.1016/j.biopsych.2006.09.010; Deng XL, 1999, J NEUROSCI, V19, P10107; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; Fumagalli F, 1998, J NEUROSCI, V18, P4861; FUXE K, 1992, EXP BRAIN RES, V88, P117, DOI 10.1007/BF02259133; Garcia-Rill E, 2007, SLEEP, V30, P1405, DOI 10.1093/sleep/30.11.1405; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Gruner JA, 2009, SLEEP, V32, P1425, DOI 10.1093/sleep/32.11.1425; Holtz NA, 2012, DRUG ALCOHOL DEPEN, V120, P233, DOI 10.1016/j.drugalcdep.2011.07.010; Jayanthi S, 2001, FASEB J, V15, P1745, DOI 10.1096/fj.01-0025com; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Jenner P, 2000, EXP BRAIN RES, V133, P178, DOI 10.1007/s002210000370; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; LaVoie MJ, 2004, EXP NEUROL, V187, P47, DOI 10.1016/j.expneurol.2004.01.010; Loland CJ, 2012, BIOL PSYCHI IN PRESS; McGaugh J, 2009, J CLIN PSYCHOPHARM, V29, P488, DOI 10.1097/JCP.0b013e3181b591e0; MILLER DB, 1994, J PHARMACOL EXP THER, V270, P752; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; OCALLAGHAN JP, 1994, J PHARMACOL EXP THER, V270, P741; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pu Cunfeng, 1993, Developmental Brain Research, V72, P325, DOI 10.1016/0165-3806(93)90201-K; Raineri M, 2011, SYNAPSE, V65, P1087, DOI 10.1002/syn.20943; Reichel CM, 2012, INT J NEUROPSYCHOPH, V15, P919, DOI 10.1017/S1461145711000988; RICAURTE GA, 1982, BRAIN RES, V235, P93, DOI 10.1016/0006-8993(82)90198-6; Sandoval V, 2003, J PHARMACOL EXP THER, V304, P1181, DOI 10.1124/jpet.102.045005; Schmitt KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025790; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; STREIT WJ, 1990, J HISTOCHEM CYTOCHEM, V38, P1683, DOI 10.1177/38.11.2212623; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Thomas DM, 2005, J PHARMACOL EXP THER, V313, P870, DOI 10.1124/jpet.104.080242; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; UEKI A, 1993, EXP BRAIN RES, V93, P259; Urbano FJ, 2007, P NATL ACAD SCI USA, V104, P12554, DOI 10.1073/pnas.0705087104; van Vlieta SAM, 2008, BRAIN RES, V1189, P219, DOI 10.1016/j.brainres.2007.10.059; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Volz TJ, 2007, J NEUROCHEM, V101, P883, DOI 10.1111/j.1471-4159.2006.04419.x; Xie T, 2000, J NEUROSCI, V20, P7838; Zhu JPQ, 2006, NEUROSCIENCE, V140, P607, DOI 10.1016/j.neuroscience.2006.02.055; Zolkowska D, 2009, J PHARMACOL EXP THER, V329, P738, DOI 10.1124/jpet.108.146142	50	63	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46599	10.1371/journal.pone.0046599	http://dx.doi.org/10.1371/journal.pone.0046599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056363	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800031
J	Voeghtly, LM; Mamula, K; Campbell, JL; Shriver, CD; Ellsworth, RE				Voeghtly, Laura M.; Mamula, Kim; Campbell, J. Leigh; Shriver, Craig D.; Ellsworth, Rachel E.			Molecular Alterations Associated with Breast Cancer Mortality	PLOS ONE			English	Article							EXPRESSION; HETEROZYGOSITY; PROGNOSIS; PATTERNS; REGIONS; RECURRENCE; LOSSES; ASSAY; 8P22	Background: Breast cancer is a heterogeneous disease and patients with similar pathologies and treatments may have different clinical outcomes. Identification of molecular alterations associated with disease outcome may improve risk assessment and treatments for aggressive breast cancer. Methods: Allelic imbalance (AI) data was generated for 122 invasive breast tumors with known clinical outcome. Levels and patterns of AI were compared between patients who died of disease (DOD) and those with >= 5 years disease-free survival (DFS) using Student t-test and chi-square analysis with a significance value of P<0.05. Results: Levels of AI were significantly higher in tumors from the 31 DOD patients (28.6%) compared to the 91 DFS patients (20.1%). AI at chromosomes 7q31, 8p22, 13q14, 17p13.3, 17p13.1 and 22q12.3 was associated with DOD while AI at 16q22-q24 was associated with DFS. After multivariate analysis, AI at chromosome 8p22 remained an independent predictor of breast cancer mortality. The frequency of AI at chromosome 13q14 was significantly higher in patients who died >= 5 years compared to those who died <5 years from diagnosis. Conclusion: Tumors from DOD compared to DFS patients are marked by increased genomic instability and AI at chromosome 8p22 is significantly associated with breast cancer morality, independent of other clinicopathological factors. AI at chromosome 13q14 was associated with late (>5-years post-diagnosis) mortality but not with death from disease within five years, suggesting that patients with short- and long-term mortality may have distinct genetic diseases.	[Campbell, J. Leigh; Ellsworth, Rachel E.] Henry M Jackson Fdn Advancement Mil Med, Clin Breast Care Project, Windber, PA USA; [Voeghtly, Laura M.; Mamula, Kim] Windber Res Inst, Clin Breast Care Project, Windber, PA USA; [Shriver, Craig D.] Walter Reed Natl Mil Med Ctr, Clin Breast Care Project, Washington, DC USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Windber Research Institute; Walter Reed National Military Medical Center	Ellsworth, RE (corresponding author), Henry M Jackson Fdn Advancement Mil Med, Clin Breast Care Project, Windber, PA USA.	r.ellsworth@wriwindber.org			United States Department of Defense (Military Molecular Medicine Initiative) [MDA W81XWH-05-2-0075]	United States Department of Defense (Military Molecular Medicine Initiative)(United States Department of Defense)	This research was supported by a grant from the United States Department of Defense (Military Molecular Medicine Initiative MDA W81XWH-05-2-0075, Protocol 01-20006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Joint Committee on Cancer, 2010, AJCC CANC STAGING MA; [Anonymous], 2011, BREAST CANC FACTS FI; BIECHE I, 1992, LANCET, V339, P139, DOI 10.1016/0140-6736(92)90208-K; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015737; Dellas A, 2002, CLIN CANCER RES, V8, P1210; Dexter TJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-127; Downing TE, 2010, CANCER GENET CYTOGEN, V198, P52, DOI 10.1016/j.cancergencyto.2009.12.007; Eden P, 2004, EUR J CANCER, V40, P1837, DOI 10.1016/j.ejca.2004.02.025; Ellsworth DL, 2003, BIOTECHNIQUES, V34, P42, DOI 10.2144/03341bm05; Ellsworth RE, 2008, BREAST CANCER RES TR, V107, P259, DOI 10.1007/s10549-007-9547-2; Ellsworth RE, 2009, PATHOL ONCOL RES, V15, P541, DOI 10.1007/s12253-009-9151-3; Ellsworth RE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-297; Ellsworth RE, 2003, CANCER EPIDEM BIOMAR, V12, P915; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Emi, 1999, Breast Cancer, V6, P351, DOI 10.1007/BF02966452; Goodison S, 2012, CANCER RES, V65, P6042; Gort M, 2007, BREAST CANCER RES TR, V102, P219, DOI 10.1007/s10549-006-9327-4; Hirano A, 2001, CLIN CANCER RES, V7, P876; Medintz IL, 2000, GENOME RES, V10, P1211, DOI 10.1101/gr.10.8.1211; Natrajan R, 2009, GENE CHROMOSOME CANC, V48, P351, DOI 10.1002/gcc.20646; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3276; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rennstam K, 2003, CANCER RES, V63, P8861; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Thompson PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023543; Utada Y, 2000, CANCER, V88, P1410, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1410::AID-CNCR19>3.3.CO;2-O; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weber-Mangal S, 2003, INT J CANCER, V107, P583, DOI 10.1002/ijc.11460; Yokota T, 1999, LOCALIZATION TUMOR S, V85, P452; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zhou X, 2008, INT J ONCOL, V32, P1285	36	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46814	10.1371/journal.pone.0046814	http://dx.doi.org/10.1371/journal.pone.0046814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056464	Green Submitted, gold, Green Published			2022-12-27	WOS:000309580800050
J	Ardanov, P; Sessitsch, A; Haggman, H; Kozyrovska, N; Pirttila, AM				Ardanov, Pavlo; Sessitsch, Angela; Haggman, Hely; Kozyrovska, Natalia; Pirttila, Anna Maria			Methylobacterium-Induced Endophyte Community Changes Correspond with Protection of Plants against Pathogen Attack	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; QUORUM-SENSING SIGNALS; PINUS-SYLVESTRIS L.; BACTERIAL COMMUNITIES; MICROBIAL COMMUNITIES; POTATO PLANTS; IN-VITRO; GROWTH; DEFENSE; INOCULATION	Plant inoculation with endophytic bacteria that normally live inside the plant without harming the host is a highly promising approach for biological disease control. The mechanism of resistance induction by beneficial bacteria is poorly understood, because pathways are only partly known and systemic responses are typically not seen. The innate endophytic community structures change in response to external factors such as inoculation, and bacterial endophytes can exhibit direct or indirect antagonism towards pathogens. Earlier we showed that resistance induction by an endophytic Methylobacterium sp. in potato towards Pectobacterium atrosepticum was dependent on the density of the inoculum, whereas the bacterium itself had no antagonistic activity. To elucidate the role of innate endophyte communities in plant responses, we studied community changes in both in vitro and greenhouse experiments using various combinations of plants, endophyte inoculants, and pathogens. Induction of resistance was studied in several potato (Solanum tuberosum L.) cultivars by Methylobacterium sp. IMBG290 against the pathogens P. atrosepticum, Phytophthora infestans and Pseudomonas syringae pv. tomato DC3000, and in pine (Pinus sylvestris L.) by M. extorquens DSM13060 against Gremmeniella abietina. The capacities of the inoculated endophytic Methylobacterium spp. strains to induce resistance were dependent on the plant cultivar, pathogen, and on the density of Methylobacterium spp. inoculum. Composition of the endophyte community changed in response to inoculation in shoot tissues and correlated with resistance or susceptibility to the disease. Our results demonstrate that endophytic Methylobacterium spp. strains have varying effects on plant disease resistance, which can be modulated through the endophyte community of the host.	[Ardanov, Pavlo; Haggman, Hely; Pirttila, Anna Maria] Univ Oulu, Dept Biol, Oulu, Finland; [Sessitsch, Angela] AIT Austrian Inst Technol GmbH, Bioresources Unit, Tulln, Austria; [Kozyrovska, Natalia] NASU, Inst Mol Biol & Genet, Kiev, Ukraine	University of Oulu; Austrian Institute of Technology (AIT); National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Pirttila, AM (corresponding author), Univ Oulu, Dept Biol, Oulu, Finland.	am.pirttila@oulu.fi	Kozyrovska, Natalia O./P-1635-2017; Sessitsch, Angela/AAW-3191-2020	Sessitsch, Angela/0000-0003-0137-930X; Ardanov, Pavlo/0000-0003-0229-915X; Kozyrovska, Natalia/0000-0002-2849-3471; Pirttila, Anna Maria/0000-0002-2455-6375	Academy of Finland [134487, 129852, 113607]; University of Oulu; Finnish Graduate School in Plant Biology	Academy of Finland(Academy of Finland); University of Oulu; Finnish Graduate School in Plant Biology	This work was supported by the Academy of Finland (134487 to Pavlo Ardanov, 129852, 113607 to Anna Maria Pirttila), the University of Oulu (stipend to Pavlo Ardanov) and the Finnish Graduate School in Plant Biology (salary and travel grants to Pavlo Ardanov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Andreote FD, 2006, CAN J MICROBIOL, V52, P419, DOI 10.1139/W05-142; Andreote FD, 2010, ANTON LEEUW INT J G, V97, P389, DOI 10.1007/s10482-010-9421-9; Andreote FD, 2009, APPL ENVIRON MICROB, V75, P3396, DOI 10.1128/AEM.00491-09; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; Berg G, 2005, FEMS MICROBIOL ECOL, V51, P215, DOI 10.1016/j.femsec.2004.08.006; Castro-Sowinski S, 2007, FEMS MICROBIOL LETT, V276, P1, DOI 10.1111/j.1574-6968.2007.00878.x; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Conn VM, 2004, APPL ENVIRON MICROB, V70, P6407, DOI 10.1128/AEM.70.11.6407-6413.2004; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; De Gara L, 2003, PLANT PHYSIOL BIOCH, V41, P863, DOI 10.1016/S0981-9428(03)00135-9; Ding S, 2011, PHYSIOL PLANTARUM, V141, P141, DOI 10.1111/j.1399-3054.2010.01428.x; Doornbos R. F., 2009, IOBC/WPRS Bulletin, V43, P307; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hartmann M, 2008, FEMS MICROBIOL ECOL, V63, P249, DOI 10.1111/j.1574-6941.2007.00427.x; HIMEJIMA M, 1992, J CHEM ECOL, V18, P1809, DOI 10.1007/BF02751105; Hosni T, 2011, ISME J, V5, P1857, DOI 10.1038/ismej.2011.65; Ivarez-Loayza P, 2011, PLOS ONE, V6; Kariola T, 2003, MOL PLANT MICROBE IN, V16, P179, DOI 10.1094/MPMI.2003.16.3.179; Koskimaki JJ, 2008, PHYSIOL PLANTARUM, V133, P49; Lian J, 2008, J GEN APPL MICROBIOL, V54, P83, DOI 10.2323/jgam.54.83; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Navarre DA, 2007, CROP PROTECTION PROD, P186; Pavlo A, 2011, BIOL CONTROL, V56, P43, DOI 10.1016/j.biocontrol.2010.09.014; PETAISTO RL, 1993, EUR J FOREST PATHOL, V23, P385; Pirttila AM, 2000, APPL ENVIRON MICROB, V66, P3073, DOI 10.1128/AEM.66.7.3073-3077.2000; Pirttila AM, 2005, TREE PHYSIOL, V25, P289, DOI 10.1093/treephys/25.3.289; Pirttila AM, 2002, PLANTA, V214, P848, DOI 10.1007/s00425-001-0709-x; Pirttila AM, 2009, MYCOL SER, V27, P235; Podolich O, 2009, J APPL MICROBIOL, V106, P728, DOI 10.1111/j.1365-2672.2008.03951.x; Podolich O. V., 2007, Biopolimery i Kletka, V23, P21; Podolich OV, 2006, PROCEED UZHGOROD U, V18, P165; Poonguzhali S, 2007, J MICROBIOL BIOTECHN, V17, P226; Rasche F, 2006, J APPL ECOL, V43, P555, DOI 10.1111/j.1365-2664.2006.01169.x; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Reiter B, 2002, APPL ENVIRON MICROB, V68, P2261, DOI 10.1128/AEM.68.5.2261-2268.2002; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Scott B, 2007, PLANT SIGNAL BEHAV, V2, P171, DOI 10.4161/psb.2.3.3725; Sessitsch A, 2004, CAN J MICROBIOL, V50, P239, DOI [10.1139/w03-118, 10.1139/W03-118]; Sessitsch A, 2002, FEMS MICROBIOL ECOL, V39, P23, DOI 10.1111/j.1574-6941.2002.tb00903.x; Sessitsch A, 2008, PROSPECTS APPL PLANT, P23; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Somma M, 2004, ANAL FOOD SAMPLES PR, P14; SOUTHERN EM, 1979, ANAL BIOCHEM, V100, P319, DOI 10.1016/0003-2697(79)90235-5; Thomas P, 2008, PLANT CELL TISS ORG, V93, P39, DOI 10.1007/s11240-008-9340-x; Trotsenko YA, 2001, MICROBIOLOGY+, V70, P623, DOI 10.1023/A:1013167612105; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Yu Z, 2000, J CHEM ECOL, V26, P2119, DOI 10.1023/A:1005568416040; Zaets I., 2012, TOXICITY HEAVY METAL, P203, DOI DOI 10.1007/978-3-7091-0730-0_12	56	64	70	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46802	10.1371/journal.pone.0046802	http://dx.doi.org/10.1371/journal.pone.0046802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056459	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000086
J	Chen, R; Jiang, LY; Qiao, GX				Chen, Rui; Jiang, Li-Yun; Qiao, Ge-Xia			The Effectiveness of Three Regions in Mitochondrial Genome for Aphid DNA Barcoding: A Case in Lachininae	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; EVOLUTION; HEMIPTERA; SEQUENCES; INSECTA; NUMBER	Background: The mitochondrial gene COI has been widely used by taxonomists as a standard DNA barcode sequence for the identification of many animal species. However, the COI region is of limited use for identifying certain species and is not efficiently amplified by PCR in all animal taxa. To evaluate the utility of COI as a DNA barcode and to identify other barcode genes, we chose the aphid subfamily Lachninae (Hemiptera: Aphididae) as the focus of our study. We compared the results obtained using COI with two other mitochondrial genes, COII and Cytb. In addition, we propose a new method to improve the efficiency of species identification using DNA barcoding. Methodology/Principal Findings: Three mitochondrial genes (COI, COII and Cytb) were sequenced and were used in the identification of over 80 species of Lachninae. The COI and COII genes demonstrated a greater PCR amplification efficiency than Cytb. Species identification using COII sequences had a higher frequency of success (96.9% in "best match'' and 90.8% in "best close match'') and yielded lower intra-and higher interspecific genetic divergence values than the other two markers. The use of "tag barcodes'' is a new approach that involves attaching a species-specific tag to the standard DNA barcode. With this method, the "barcoding overlap'' can be nearly eliminated. As a result, we were able to increase the identification success rate from 83.9% to 95.2% by using COI and the "best close match'' technique. Conclusions/Significance: A COII-based identification system should be more effective in identifying lachnine species than COI or Cytb. However, the Cytb gene is an effective marker for the study of aphid population genetics due to its high sequence diversity. Furthermore, the use of "tag barcodes'' can improve the accuracy of DNA barcoding identification by reducing or removing the overlap between intra-and inter-specific genetic divergence values.	[Chen, Rui; Jiang, Li-Yun; Qiao, Ge-Xia] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Chen, Rui] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, LY (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	jiangliyun@gmail.com; qiaogx@ioz.ac.cn			National Natural Sciences Foundation of China [30830017]; National Science Funds for Distinguished Young Scientists [31025024]; National Science Fund for Fostering Talents in Basic Research [J0930004]; Ministry of Science and Technology of the People's Republic of China (MOST) [2011FY120200]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Funds for Distinguished Young Scientists; National Science Fund for Fostering Talents in Basic Research; Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China)	This work was funded by the National Natural Sciences Foundation of China (No. 30830017), National Science Funds for Distinguished Young Scientists (No. 31025024), National Science Fund for Fostering Talents in Basic Research (No. J0930004), and the Ministry of Science and Technology of the People's Republic of China (MOST Grant No. 2011FY120200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Harry M, 1998, MOL PHYLOGENET EVOL, V9, P542, DOI 10.1006/mpev.1998.0508; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heie O.E., 1987, World Crop Pests, V2A, P367; Heie O.E., 1980, Fauna Entomologica Scandinavica, V9, P1; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Lopez P, 2002, MOL BIOL EVOL, V19, P1; McKenzie M, 2003, MOL BIOL EVOL, V20, P1117, DOI 10.1093/molbev/msg132; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nei M, 2000, MOL EVOLUTION PHYLOG; Philippe H, 2001, TRENDS BIOCHEM SCI, V26, P414, DOI 10.1016/S0968-0004(01)01877-1; Remaudiere G., 1997, Catalogue des Aphididae du monde: Homoptera Aphidoidea.; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; STERN DL, 1994, P ROY SOC B-BIOL SCI, V256, P203, DOI 10.1098/rspb.1994.0071; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zhang DX, 1997, INSECT MOL BIOL, V6, P143, DOI 10.1111/j.1365-2583.1997.tb00082.x; Zhang GX, 1983, EC INSECT FAUNA CH 1, V25, P1; Zhang He-Cai, 2006, Acta Entomologica Sinica, V49, P521	36	40	45	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46190	10.1371/journal.pone.0046190	http://dx.doi.org/10.1371/journal.pone.0046190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056258	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000024
J	Eaton, JM; Dess, NK; Chapman, CD				Eaton, John M.; Dess, Nancy K.; Chapman, Clinton D.			Sweet Success, Bitter Defeat: A Taste Phenotype Predicts Social Status in Selectively Bred Rats	PLOS ONE			English	Article							SUBMISSIVE BEHAVIOR; FOOD-DEPRIVATION; ACOUSTIC STARTLE; SACCHARIN INTAKE; GENE-EXPRESSION; ANIMAL-MODEL; BAD TASTE; STRESS; PERSONALITY; DOMINANCE	For social omnivores such as rats and humans, taste is far more than a chemical sense activated by food. By virtue of evolutionary and epigenetic elaboration, taste is associated with negative affect, stress vulnerability, responses to psychoactive substances, pain, and social judgment. A crucial gap in this literature, which spans behavior genetics, affective and social neuroscience, and embodied cognition, concerns links between taste and social behavior in rats. Here we show that rats selectively bred for low saccharin intake are subordinate to high-saccharin-consuming rats when they compete in weight-matched dyads for food, a task used to model depression. Statistical and experimental controls suggest that differential resource utilization within dyads is not an artifact of individual-level processes such as apparatus habituation or ingestive motivation. Tail skin temperature measurements showed that LoS rats display larger hyperthermic responses to social interaction after status is established, evidence linking taste, social stress, autonomic reactivity, and depression-like symptoms. Based on regression using early- and late-competition predictors to predict dyadic disparity in final competition scores, we tentatively suggest that HiS rats emerge as dominant both because of an "early surge" on their part and because LoS acquiesce later. These findings should invigorate the comparative study of individual differences in social status and its relationship to mental and physical health.	[Eaton, John M.; Dess, Nancy K.; Chapman, Clinton D.] Occidental Coll, Dept Psychol, Los Angeles, CA 90041 USA	Occidental College	Dess, NK (corresponding author), Occidental Coll, Dept Psychol, Los Angeles, CA 90041 USA.	dessnk@oxy.edu			Fletcher-Jones Foundation	Fletcher-Jones Foundation	All funding was intramural. It included a fellowship for the first author made possible due to a grant to Occidental College from the Fletcher-Jones Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren G, 2009, PHYSIOL BEHAV, V96, P374, DOI 10.1016/j.physbeh.2008.11.003; BAENNING.LP, 1970, J COMP PHYSIOL PSYCH, V71, P202, DOI 10.1037/h0029162; Barnum CJ, 2008, BRAIN BEHAV IMMUN, V22, P517, DOI 10.1016/j.bbi.2007.10.004; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Carroll ME, 2008, BEHAV PHARMACOL, V19, P435, DOI 10.1097/FBP.0b013e32830c3632; Carroll ME, 2007, PSYCHOPHARMACOLOGY, V190, P331, DOI 10.1007/s00213-006-0600-3; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Coleman SL, 2005, COGN AFFECT BEHAV NE, V5, P434, DOI 10.3758/CABN.5.4.434; Cubitt KF, 2008, PHYSIOL BEHAV, V94, P529, DOI 10.1016/j.physbeh.2008.03.009; Dess NK, 2000, PHYSIOL BEHAV, V69, P247, DOI 10.1016/S0031-9384(99)00246-2; Dess NK, 1996, ANIM LEARN BEHAV, V24, P105, DOI 10.3758/BF03198958; Dess NK, 2007, INT J COMP PSYCHOL, V20, P317; Eskine KJ, 2011, PSYCHOL SCI, V22, P295, DOI 10.1177/0956797611398497; Froese T, 2012, PHENOMENOL COGN SCI, V11, P205, DOI 10.1007/s11097-012-9254-2; Fuchs E, 2005, CNS SPECTRUMS, V10, P182, DOI 10.1017/S1092852900010038; Gonzales M, 2008, BIOL PSYCHOL, V79, P193, DOI 10.1016/j.biopsycho.2008.04.011; Gosnell BA, 2010, PHYSIOL BEHAV, V99, P529, DOI 10.1016/j.physbeh.2010.01.010; Gresack J, 2010, NEUROPEPTIDES, V44, P349, DOI 10.1016/j.npep.2010.04.005; Griffin D, 2003, PHILOS T R SOC B, V358, P573, DOI 10.1098/rstb.2002.1263; Hirschberger G, 2005, BASIC APPL SOC PSYCH, V27, P179, DOI 10.1207/s15324834basp2702_9; HOWELLS GN, 1974, PSYCHOL REC, V24, P101, DOI 10.1007/BF03394221; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; JOLY D, 1991, BEHAV PHARMACOL, V2, P205; Kenny D, 2006, DYADIC DATA ANAL, P46; KENNY DA, 1995, PERS RELATIONSHIP, V2, P67, DOI 10.1111/j.1475-6811.1995.tb00078.x; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Lewkowski MD, 2008, PAIN, V135, P75, DOI 10.1016/j.pain.2007.05.003; Macht M, 2007, PHYSIOL BEHAV, V90, P466, DOI 10.1016/j.physbeh.2006.10.011; Malatynska E, 2005, NEUROSCI BIOBEHAV R, V29, P715, DOI 10.1016/j.neubiorev.2005.03.014; Malatynska E, 2007, J NEUROSCI METH, V165, P175, DOI 10.1016/j.jneumeth.2007.05.035; Mathew SJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2080, DOI 10.1038/sj.npp.1301652; McClintock MK, 2005, J GERONTOL B-PSYCHOL, V60, P32, DOI 10.1093/geronb/60.Special_Issue_1.32; McEwan K, 2012, BRIT J CLIN PSYCHOL, V51, P19, DOI 10.1111/j.2044-8260.2011.02010.x; McLaughlin IB, 2011, PHARMACOL BIOCHEM BE, V97, P500, DOI 10.1016/j.pbb.2010.10.009; Meier BP, 2012, J PERS SOC PSYCHOL, V102, P163, DOI 10.1037/a0025253; Mennella JA, 2010, ADDICTION, V105, P666, DOI 10.1111/j.1360-0443.2009.02865.x; Miczek KA, 2011, BEHAV GENET, V41, P787, DOI 10.1007/s10519-011-9462-5; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Pinhasov A, 2005, BEHAV PHARMACOL, V16, P657, DOI 10.1097/00008877-200512000-00009; Price TF, 2012, MOTIV EMOTION, V36, P27, DOI 10.1007/s11031-011-9258-1; Regier PS, 2012, BEHAV BRAIN RES, V233, P271, DOI 10.1016/j.bbr.2012.05.021; Rivers JJ, 2010, DOMINANCE HLTH ROLE, P87; Rozin P, 1996, CURR DIR PSYCHOL SCI, V5, P18, DOI 10.1111/1467-8721.ep10772690; Scott TR, 2010, CHEMOSENS PERCEPT, V3, P3, DOI 10.1007/s12078-009-9055-3; Smith KB, 2011, POLIT PSYCHOL, V32, P369, DOI 10.1111/j.1467-9221.2010.00821.x; SYME GJ, 1972, PSYCHON SCI, V29, P297; Thiele TE, 1997, PHYSIOL BEHAV, V61, P149, DOI 10.1016/S0031-9384(96)00355-1; Trillmich F, 2011, DEV PSYCHOBIOL, V53, P505, DOI 10.1002/dev.20573; Ulrich-Lai YM, 2010, P NATL ACAD SCI USA, V107, P20529, DOI 10.1073/pnas.1007740107; VanderWeele DA, 2002, PHYSIOL BEHAV, V75, P97, DOI 10.1016/S0031-9384(01)00641-2; von Collani G, 2009, J INDIVID DIFFER, V30, P107, DOI 10.1027/1614-0001.30.2.107; Wang XT, 2010, PSYCHOL SCI, V21, P183, DOI 10.1177/0956797609358096	53	13	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46606	10.1371/journal.pone.0046606	http://dx.doi.org/10.1371/journal.pone.0046606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056367	Green Published, gold			2022-12-27	WOS:000309454000061
J	Lin, YF; Wilson, JH				Lin, Yunfu; Wilson, John H.			Nucleotide Excision Repair, Mismatch Repair, and RLoops Modulate Convergent Transcription-Induced Cell Death and Repeat Instability	PLOS ONE			English	Article							RNA-POLYMERASE-II; FRAGILE-X LOCI; CAG REPEAT; NEURODEGENERATIVE DISEASES; ANTISENSE TRANSCRIPTION; TRINUCLEOTIDE REPEATS; GENETIC INSTABILITY; MYOTONIC-DYSTROPHY; FORMING SEQUENCE; TRANSGENIC MICE	Expansion of CAG-CTG tracts located in specific genes is responsible for 13 human neurodegenerative disorders, the pathogenic mechanisms of which are not yet well defined. These disease genes are ubiquitously expressed in human tissues, and transcription has been identified as one of the major pathways destabilizing the repeats. Transcription-induced repeat instability depends on transcription-coupled nucleotide excision repair (TC-NER), the mismatch repair (MMR) recognition component MSH2/MSH3, and RNA/DNA hybrids (R-loops). Recently, we reported that simultaneous sense and antisense transcription-convergent transcription-through a CAG repeat not only promotes repeat instability, but also induces a cell stress response, which arrests the cell cycle and eventually leads to massive cell death via apoptosis. Here, we use siRNA knockdowns to investigate whether NER, MMR, and R-loops also modulate convergent-transcription-induced cell death and repeat instability. We find that siRNA-mediated depletion of TC-NER components increases convergent transcription-induced cell death, as does the simultaneous depletion of RNase H1 and RNase H2A. In contrast, depletion of MSH2 decreases cell death. These results identify TC-NER, MMR recognition, and R-loops as modulators of convergent transcription-induced cell death and shed light on the molecular mechanism involved. We also find that the TC-NER pathway, MSH2, and R-loops modulate convergent transcription-induced repeat instability. These observations link the mechanisms of convergent transcription-induced repeat instability and convergent transcription-induced cell death, suggesting that a common structure may trigger both outcomes.	[Lin, Yunfu; Wilson, John H.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine	Wilson, JH (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	jwilson@bcm.edu	lin, yunfu/C-4813-2011		NIH [GM38219]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the NIH (GM38219) to J.H.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Camenisch U, 2006, NAT STRUCT MOL BIOL, V13, P278, DOI 10.1038/nsmb1061; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Chung DW, 2011, HUM MOL GENET, V20, P3467, DOI 10.1093/hmg/ddr263; Cleary JD, 2003, CYTOGENET GENOME RES, V100, P25, DOI 10.1159/000072837; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; Dion V, 2008, HUM MOL GENET, V17, P1306, DOI 10.1093/hmg/ddn019; Ditlevson JV, 2008, NUCLEIC ACIDS RES, V36, P3163, DOI 10.1093/nar/gkn136; GACY AM, 1995, CELL, V81, P533; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hubert L, 2011, HUM MOL GENET, V20, P4822, DOI 10.1093/hmg/ddr421; Hubert L, 2011, MOL CELL BIOL, V31, P3105, DOI 10.1128/MCB.05158-11; Jung J, 2007, SCIENCE, V315, P1857, DOI 10.1126/science.1139517; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kovtun IV, 2011, AGING-US, V3, P509, DOI 10.18632/aging.100324; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Lawlor KT, 2011, HUM MOL GENET, V20, P3757, DOI 10.1093/hmg/ddr292; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lin YF, 2007, MOL CELL BIOL, V27, P6209, DOI 10.1128/MCB.00739-07; Lin YF, 2011, CELL CYCLE, V10, P611, DOI 10.4161/cc.10.4.14729; Lin YF, 2010, MOL CELL BIOL, V30, P4435, DOI 10.1128/MCB.00332-10; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Lin YF, 2009, DNA REPAIR, V8, P878, DOI 10.1016/j.dnarep.2009.04.024; Lin YF, 2009, MOL CARCINOGEN, V48, P350, DOI 10.1002/mc.20488; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Ljungman M, 2007, CELL CYCLE, V6, P2252, DOI 10.4161/cc.6.18.4751; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Oussatcheva EA, 2001, J BIOL CHEM, V276, P30878, DOI 10.1074/jbc.M104697200; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Parsons MA, 1998, J BIOL CHEM, V273, P26998, DOI 10.1074/jbc.273.41.26998; Pearson CE, 1997, HUM MOL GENET, V6, P1117, DOI 10.1093/hmg/6.7.1117; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pelletier R, 2005, NUCLEIC ACIDS RES, V33, P5667, DOI 10.1093/nar/gki880; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Salinas-Rios V, 2011, NUCLEIC ACIDS RES, V39, P7444, DOI 10.1093/nar/gkr429; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Savouret C, 2004, MOL CELL BIOL, V24, P629, DOI 10.1128/MCB.24.2.629-637.2004; Sopher BL, 2011, NEURON, V70, P1071, DOI 10.1016/j.neuron.2011.05.027; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; Tornaletti S, 2008, J BIOL CHEM, V283, P12756, DOI 10.1074/jbc.M705003200; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021	59	31	34	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46807	10.1371/journal.pone.0046807	http://dx.doi.org/10.1371/journal.pone.0046807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056461	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000088
J	Marley, A; von Zastrow, M				Marley, Aaron; von Zastrow, Mark			A Simple Cell-Based Assay Reveals That Diverse Neuropsychiatric Risk Genes Converge on Primary Cilia	PLOS ONE			English	Article							CANDIDATE GENE; SCHIZOPHRENIA; PROTEIN; CILIOGENESIS; MUTATIONS; INTERACTS; DISEASE; DISRUPTED-IN-SCHIZOPHRENIA-1; TRANSLOCATION; CILIOPATHY	Human genetic studies are beginning to identify a large number of genes linked to neuropsychiatric disorders. It is increasingly evident that different genes contribute to risk for similar syndromes and, conversely, the same genes or even the same alleles cross over traditional diagnostic categories. A current challenge is to understand the cellular biology of identified risk genes. However, most genes associated with complex neuropsychiatric phenotypes are not related through a known biochemical pathway, and many have an entirely unknown cellular function. One possibility is that diverse disease-linked genes converge at a higher-level cellular structure. The synapse is already known to be one such convergence, and emerging evidence suggests the primary cilium as another. Because many genes associated with neuropsychiatric illness are expressed also outside the nervous system, as are cilia, we tested the hypothesis that such genes affect conserved features of the primary cilium. Using RNA interference to test 41 broadly expressed candidate genes associated with schizophrenia, bipolar affective disorder, autism spectrum disorder and intellectual disability, we found 20 candidates that reduce ciliation in NIH3T3 cells when knocked down, and three whose manipulation increases cilia length. Three of the candidate genes were previously implicated in cilia formation and, altogether, approximately half of the candidates tested produced a ciliary phenotype. Our results support the hypothesis that primary cilia indeed represent a conserved cellular structure at which the effects of diverse neuropsychiatric risk genes converge. More broadly, they suggest a relatively simple cell-based approach that may be useful for exploring the complex biological underpinnings of neuropsychiatric disease.	[von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	mark.vonzastrow@ucsf.edu			National Institutes of Health (NIH) [DA010154]; Friends of Langley Porter Endowed Chair for Research in Schizophrenia and Depression; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R37DA010711] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends of Langley Porter Endowed Chair for Research in Schizophrenia and Depression; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were supported by the National Institutes of Health (NIH) (DA010154) and the Friends of Langley Porter Endowed Chair for Research in Schizophrenia and Depression. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avasthi P, 2012, ACS CHEM BIOL, V7, P911, DOI 10.1021/cb200349v; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Coene KLM, 2011, HUM MOL GENET, V20, P3592, DOI 10.1093/hmg/ddr280; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Grant SG, 2012, CURR OPIN NEUROBIOL; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Knight HM, 2009, AM J HUM GENET, V85, P833, DOI 10.1016/j.ajhg.2009.11.003; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028	34	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46647	10.1371/journal.pone.0046647	http://dx.doi.org/10.1371/journal.pone.0046647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056384	Green Submitted, gold, Green Published			2022-12-27	WOS:000309454000068
J	Bendtsen, KMB; Krych, L; Sorensen, DB; Pang, WY; Nielsen, DS; Josefsen, K; Hansen, LH; Sorensen, SJ; Hansen, AK				Bendtsen, Katja Maria Bangsgaard; Krych, Lukasz; Sorensen, Dorte Bratbo; Pang, Wanyong; Nielsen, Dennis Sandris; Josefsen, Knud; Hansen, Lars H.; Sorensen, Soren J.; Hansen, Axel Kornerup			Gut Microbiota Composition Is Correlated to Grid Floor Induced Stress and Behavior in the BALB/c Mouse	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; INTESTINAL MICROBIOTA; GASTROINTESTINAL-TRACT; LIGHT/DARK BOX; OPEN-FIELD; ANXIETY; MICE; GENISTEIN; BACTERIUM; CYTOKINES	Stress has profound influence on the gastro-intestinal tract, the immune system and the behavior of the animal. In this study, the correlation between gut microbiota composition determined by Denaturing Grade Gel Electrophoresis (DGGE) and tag-encoded 16S rRNA gene amplicon pyrosequencing (454/FLX) and behavior in the Tripletest (Elevated Plus Maze, Light/Dark Box, and Open Field combined), the Tail Suspension Test, and Burrowing in 28 female BALB/c mice exposed to two weeks of grid floor induced stress was investigated. Cytokine and glucose levels were measured at baseline, during and after exposure to grid floor. Stressing the mice clearly changed the cecal microbiota as determined by both DGGE and pyrosequencing. Odoribacter, Alistipes and an unclassified genus from the Coriobacteriaceae family increased significantly in the grid floor housed mice. Compared to baseline, the mice exposed to grid floor housing changed the amount of time spent in the Elevated Plus Maze, in the Light/Dark Box, and burrowing behavior. The grid floor housed mice had significantly longer immobility duration in the Tail Suspension Test and increased their number of immobility episodes from baseline. Significant correlations were found between GM composition and IL-1 alpha, IFN-gamma, closed arm entries of Elevated Plus Maze, total time in Elevated Plus Maze, time spent in Light/Dark Box, and time spent in the inner zone of the Open Field as well as total time in the Open Field. Significant correlations were found to the levels of Firmicutes, e. g. various species of Ruminococccaceae and Lachnospiraceae. No significant difference was found for the evaluated cytokines, except an overall decrease in levels from baseline to end. A significant lower level of blood glucose was found in the grid floor housed mice, whereas the HbA1c level was significantly higher. It is concluded that grid floor housing changes the GM composition, which seems to influence certain anxiety-related parameters.	[Bendtsen, Katja Maria Bangsgaard; Sorensen, Dorte Bratbo; Pang, Wanyong; Hansen, Axel Kornerup] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Krych, Lukasz; Nielsen, Dennis Sandris] Univ Copenhagen, Dept Food Sci, Fac Hlth & Med Sci, Copenhagen, Denmark; [Josefsen, Knud] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Hansen, Lars H.; Sorensen, Soren J.] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Bendtsen, KMB (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark.	kab@life.ku.dk	Nielsen, Dennis/A-9769-2015; Sørensen, Søren Johannes/N-2120-2019; Krych, Luaksz/F-4446-2015; Sørensen, Søren J/J-5015-2014	Nielsen, Dennis/0000-0001-8121-1114; Sørensen, Søren Johannes/0000-0001-6227-9906; Krych, Luaksz/0000-0003-3224-1346; Sørensen, Søren J/0000-0001-6227-9906; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Sorensen, Dorte Bratbo/0000-0002-6144-1710	Villum Foundation; Center for Applied Laboratory Animal Research	Villum Foundation(Villum Fonden); Center for Applied Laboratory Animal Research	Wanyong Pang was financed by a grant from the Villum Foundation. This research was supported by the Center for Applied Laboratory Animal Research (www.calar.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; Bleich A, 2012, COMP IMMUNOL MICROB, V35, P81, DOI 10.1016/j.cimid.2011.12.006; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Caporaso JG, 2009, PYNAST FLEXIBLE TOOL; Caso JR, 2008, CURR MOL MED, V8, P299, DOI 10.2174/156652408784533751; Chang L, 2011, GASTROENTEROLOGY, V140, P761, DOI 10.1053/j.gastro.2011.01.032; Chang YC, 1995, J NAT PROD, V58, P1901, DOI 10.1021/np50126a016; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Deacon RMJ, 2009, BEHAV BRAIN RES, V200, P128, DOI 10.1016/j.bbr.2009.01.007; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Desbonnet L, 2008, J PSYCHIATR RES, V43, P164, DOI 10.1016/j.jpsychires.2008.03.009; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Fraser LM, 2010, PSYCHOPHARMACOLOGY, V211, P99, DOI 10.1007/s00213-010-1873-0; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Haas BJ, 2011, CHIMERIC 16S RRNA SE; Hansen AK, 2002, COUNC EUR CONV ETS A; Hansen CHF, 2012, PLOS ONE IN PRESS; Hansen CHF, 2012, DIABETOLOGI IN PRESS; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Hufeldt MR, 2010, LAB ANIM-UK, V44, P283, DOI 10.1258/la.2010.010058; Husum H, 2002, NEUROPHARMACOLOGY, V42, P798, DOI 10.1016/S0028-3908(02)00038-2; Jayagopal V, 2002, DIABETES CARE, V25, P1709, DOI 10.2337/diacare.25.10.1709; Krohn TC, 2003, ANIM WELFARE, V12, P53; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; MARTI O, 1994, PHYSIOL BEHAV, V55, P747, DOI 10.1016/0031-9384(94)90055-8; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Matthies A, 2008, APPL ENVIRON MICROB, V74, P4847, DOI 10.1128/AEM.00555-08; Monteleone I, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/297645; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nagai F, 2010, INT J SYST EVOL MICR, V60, P1296, DOI 10.1099/ijs.0.014571-0; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Neufeld KA, 2009, J PSYCHIATR NEUROSCI, V34, P230; Neufeld Karen-Anne M, 2011, Commun Integr Biol, V4, P492, DOI 10.4161/cib.4.4.15702; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Pang W, 2011, LAB ANIM IN PRESS; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Pruett SB, 2001, INT IMMUNOPHARMACOL, V1, P507, DOI 10.1016/S1567-5769(00)00030-8; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ramos A, 2008, BEHAV BRAIN RES, V193, P277, DOI 10.1016/j.bbr.2008.06.007; Ripoll N, 2003, BEHAV BRAIN RES, V143, P193, DOI 10.1016/S0166-4328(03)00034-2; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Salonen A, 2010, MICROBIOL-SGM, V156, P3205, DOI 10.1099/mic.0.043257-0; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Sim YB, 2010, ARCH PHARM RES, V33, P1679, DOI 10.1007/s12272-010-1018-3; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Sorensen DB, 2005, SCAND J LAB ANIM SCI, V32, P117; Stub C, 2002, SCAND J LAB ANIM SCI, V29, P149; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Weiss IC, 1999, BEHAV PHARMACOL, V10, P139, DOI 10.1097/00008877-199903000-00003; Wilson KH, 2006, ANAEROBE, V12, P249, DOI 10.1016/j.anaerobe.2006.09.002; Wolin MJ, 2008, INT J SYST EVOL MICR, V58, P742, DOI 10.1099/ijs.0.65850-0; Wolin MJ, 2003, APPL ENVIRON MICROB, V69, P6321, DOI 10.1128/AEM.69.10.6321-6326.2003; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	67	169	174	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46231	10.1371/journal.pone.0046231	http://dx.doi.org/10.1371/journal.pone.0046231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056268	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600029
J	Bloom, CI; Graham, CM; Berry, MPR; Wilkinson, KA; Oni, T; Rozakeas, F; Xu, ZH; Rossello-Urgell, J; Chaussabel, D; Banchereau, J; Pascual, V; Lipman, M; Wilkinson, RJ; O'Garra, A				Bloom, Chloe I.; Graham, Christine M.; Berry, Matthew P. R.; Wilkinson, Katalin A.; Oni, Tolu; Rozakeas, Fotini; Xu, Zhaohui; Rossello-Urgell, Jose; Chaussabel, Damien; Banchereau, Jacques; Pascual, Virginia; Lipman, Marc; Wilkinson, Robert J.; O'Garra, Anne			Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; TREATMENT RESPONSE; TUBERCULOSIS; BIOMARKERS; RESISTANCE; DRUGS; EMERGENCE; SIGNATURE; CULTURE	Rationale: Globally there are approximately 9 million new active tuberculosis cases and 1.4 million deaths annually. Effective antituberculosis treatment monitoring is difficult as there are no existing biomarkers of poor adherence or inadequate treatment earlier than 2 months after treatment initiation. Inadequate treatment leads to worsening disease, disease transmission and drug resistance. Objectives: To determine if blood transcriptional signatures change in response to antituberculosis treatment and could act as early biomarkers of a successful response. Methods: Blood transcriptional profiles of untreated active tuberculosis patients in South Africa were analysed before, during (2 weeks and 2 months), at the end of (6 months) and after (12 months) antituberculosis treatment, and compared to individuals with latent tuberculosis. An active-tuberculosis transcriptional signature and a specific treatment-response transcriptional signature were derived. The specific treatment response transcriptional signature was tested in two independent cohorts. Two quantitative scoring algorithms were applied to measure the changes in the transcriptional response. The most significantly represented pathways were determined using Ingenuity Pathway Analysis. Results: An active tuberculosis 664-transcript signature and a treatment specific 320-transcript signature significantly diminished after 2 weeks of treatment in all cohorts, and continued to diminish until 6 months. The transcriptional response to treatment could be individually measured in each patient. Conclusions: Significant changes in the transcriptional signatures measured by blood tests were readily detectable just 2 weeks after treatment initiation. These findings suggest that blood transcriptional signatures could be used as early surrogate biomarkers of successful treatment response.	[Bloom, Chloe I.; Graham, Christine M.; Berry, Matthew P. R.; Rozakeas, Fotini; O'Garra, Anne] MRC Natl Inst Med Res, Div Immunoregulat, London, England; [Wilkinson, Katalin A.; Wilkinson, Robert J.] MRC Natl Inst Med Res, Div Mycobacterial Res, London, England; [Berry, Matthew P. R.] Imperial Coll Healthcare NHS Trust, Dept Resp Med, London, England; [Wilkinson, Katalin A.; Oni, Tolu; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Oni, Tolu; Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Wright Fleming Inst, London, England; [Xu, Zhaohui; Rossello-Urgell, Jose; Chaussabel, Damien; Banchereau, Jacques; Pascual, Virginia] INSERM, Baylor Inst Immunol Research ANRS Ctr Human Vacci, Dallas, TX USA; [Chaussabel, Damien] Benaroya Res Inst, Seattle, WA USA; [Lipman, Marc] Royal Free Hosp NHS Trust, Dept Thorac Med, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; Imperial College London; University of Cape Town; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Benaroya Research Institute; University of London; University College London	Bloom, CI (corresponding author), MRC Natl Inst Med Res, Div Immunoregulat, London, England.	cbloom@nimr.mrc.ac.uk	Pascual, Virginia/ABD-3099-2020; Bloom, Chloe/ABC-1693-2020; Wilkinson, Katalin/AAF-6805-2020; Chaussabel, Damien/AAX-1909-2020; Wilkinson, Katalin/AAQ-7713-2021	Bloom, Chloe/0000-0003-1285-7602; Wilkinson, Katalin/0000-0002-9796-2040; Oni, Tolu/0000-0003-4499-1910; Chaussabel, Damien/0000-0002-6131-7242; Lipman, Marc/0000-0001-7501-4448; O'Garra, Anne/0000-0001-9845-6134; Wilkinson, Robert/0000-0002-2753-1800; Xu, Zhaohui/0000-0003-0645-1737; Graham, Christine/0000-0001-9329-6231	Medical Research Council [U117565642]; Institute Merieux; European Union; Wellcome Trust [088316, 084323]; MRC [MC_EX_G0802346, MC_U117565642, MC_U117588499] Funding Source: UKRI; Medical Research Council [MC_U117565642, MC_EX_G0802346, MC_U117588499] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute Merieux; European Union(European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Sources of funding were the Medical Research Council (U117565642), Institute Merieux, European Union and Wellcome Trust (088316 and 084323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A U. S. patent has been assigned for the findings in this manuscript. Title: Early Detection of Tuberculosis Treatment Response. Serial No.: 61/610,121. Filing Date: March 13, 2012.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; [Center for Communicable Disease Control and Prevention CCDC], 2007, REP TUB US 2007 C; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P2329, DOI 10.1128/AAC.00185-07; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; JINDANI A, 1980, AM REV RESPIR DIS, V121, P939; Joosten SA, 2012, GENES IMMUN, V13, P71, DOI 10.1038/gene.2011.64; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Nahid P, 2011, AM J RESP CRIT CARE, V184, P972, DOI 10.1164/rccm.201105-0827WS; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; Pfyffer GE, 1997, J CLIN MICROBIOL, V35, P2229, DOI 10.1128/JCM.35.9.2229-2234.1997; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; World Health Organization, 2010, GLOB TUB CONTR; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	27	143	149	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46191	10.1371/journal.pone.0046191	http://dx.doi.org/10.1371/journal.pone.0046191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056259	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600025
J	Marchese, S; Silva, E				Marchese, Stephanie; Silva, Elisabete			Disruption of 3D MCF-12A Breast Cell Cultures by Estrogens - An In Vitro Model for ER-Mediated Changes Indicative of Hormonal Carcinogenesis	PLOS ONE			English	Article							MAMMARY EPITHELIAL ACINI; GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; LUMEN FORMATION; CANCER CELLS; BISPHENOL-A; PROLIFERATION; ACTIVATION; APOPTOSIS; MORPHOGENESIS	Introduction: Estrogens regulate the proliferation of normal and neoplastic breast epithelium. Although the intracellular mechanisms of estrogens in the breast are largely understood, little is known about how they induce changes in the structure of the mammary epithelium, which are characteristic of breast cancer. In vitro three dimensional (3D) cultures of immortalised breast epithelial cells recapitulate features of the breast epithelium in vivo, including formation of growth arrested acini with hollow lumen and basement membrane. This model can also reproduce features of malignant transformation and breast cancer, such as increased cellular proliferation and filling of the lumen. However, a system where a connection between estrogen receptor (ER) activation and disruption of acini formation can be studied to elucidate the role of estrogens is still missing. Methods/Principal Findings: We describe an in vitro 3D model for breast glandular structure development, using breast epithelial MCF-12A cells cultured in a reconstituted basement membrane matrix. These cells are estrogen receptor (ER) a, ERb and G-protein coupled estrogen receptor 1 (GPER) competent, allowing the investigation of the effects of estrogens on mammary gland formation and disruption. Under normal conditions, MCF-12A cells formed organised acini, with deposition of basement membrane and hollow lumen. However, treatment with 17 beta-estradiol, and the exogenous estrogens bisphenol A and propylparaben resulted in deformed acini and filling of the acinar lumen. When these chemicals were combined with ER and GPER inhibitors (ICI 182,780 and G-15, respectively), the deformed acini recovered normal features, such as a spheroid shape, proliferative arrest and luminal clearing, suggesting a role for the ER and GPER in the estrogenic disruption of acinar formation. Conclusion: This new model offers the opportunity to better understand the role of the ER and GPER in the morphogenesis of breast glandular structure as well as the events implicated in breast cancer initiation and progression.	[Marchese, Stephanie; Silva, Elisabete] UCL Sch Pharm, London, England; [Silva, Elisabete] Brunel Univ, Inst Environm, Uxbridge UB8 3PH, Middx, England	University of London; University College London; Brunel University	Silva, E (corresponding author), UCL Sch Pharm, London, England.	elisabete.silva@brunel.ac.uk			School of Pharmacy Studentship	School of Pharmacy Studentship	Stephanie Marchese was funded by a School of Pharmacy Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Altucci L, 1996, ONCOGENE, V12, P2315; Bedard PL, 2008, BREAST CANCER RES TR, V108, P307, DOI 10.1007/s10549-007-9606-8; Bratton MR, 2010, INT J ONCOL, V37, P541, DOI 10.3892/ijo_00000703; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Cheskis BJ, 2004, J CELL BIOCHEM, V93, P20, DOI 10.1002/jcb.20180; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Fernandez SV, 2010, TOXICOL PATHOL, V38, P110, DOI 10.1177/0192623309354108; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Gompel A, 2004, MATURITAS, V49, P16, DOI 10.1016/j.maturitas.2004.06.009; Gompel A, 2000, STEROIDS, V65, P593, DOI 10.1016/S0039-128X(00)00172-0; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Harris J, 1999, DIS BREAST; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Ignatov T, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.034; Kabil A, 2008, CARCINOGENESIS, V29, P1862, DOI 10.1093/carcin/bgn138; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; LaPensee EW, 2010, CANCER LETT, V290, P167, DOI 10.1016/j.canlet.2009.09.005; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu YE, 2007, ONCOGENE, V26, P2115, DOI 10.1038/sj.onc.1210000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; PAINE TM, 1992, INT J CANCER, V50, P463, DOI 10.1002/ijc.2910500323; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Robbins AS, 2007, J CLIN ONCOL, V25, P3437, DOI 10.1200/JCO.2007.11.4132; Russo J, 2002, ENVIRON MOL MUTAGEN, V39, P254, DOI 10.1002/em.10052; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Russo J, 2006, FASEB J, V20, P1622, DOI 10.1096/fj.05-5399com; Silva E, 2007, ENVIRON HEALTH PERSP, V115, P91, DOI 10.1289/ehp.9363; Silva E, 2010, TOXICOL APPL PHARM, V245, P159, DOI 10.1016/j.taap.2010.02.015; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; SOULE HD, 1990, CANCER RES, V50, P6075; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Thompson A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1983; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Yanochko GM, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1392	47	42	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45767	10.1371/journal.pone.0045767	http://dx.doi.org/10.1371/journal.pone.0045767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056216	Green Published, Green Submitted, gold			2022-12-27	WOS:000309452600016
J	Paschou, M; Doxakis, E				Paschou, Maria; Doxakis, Epaminondas			Neurofibromin 1 Is a miRNA Target in Neurons	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; CANALIZATION; GTPASE; DOMAIN; BDNF; GAP; PCR	Mutations of the neurofibromin 1 gene cause neurofibromatosis type 1, a disease in which learning and behavioral abnormalities are common. The disease is completely penetrant but shows variable phenotypic expression in patients. The repertoire of regulatory interactions utilized by neurons to control neurofibromin 1 expression is poorly understood. Here, we examined the contribution of microRNAs into this regulatory network. Using reporter assays, we provided evidence that miR-128 and to a lesser extent miR-137 and miR-103 reduced neurofibromin 1 reporter levels through specific binding to Nf1 3'-UTR. Mutations in all three predicted binding sites eliminated the reporter response. MiR-128 and miR-137, unlike miR-103 that showed a more ubiquitous expression, were predominantly expressed in brain with a distribution that resembled neurofibromin 1 expression in different tissues as well as during the course of neuronal development. In the nervous system, all three microRNAs showed highest expression in neurons and least in Schwann cells and astrocytes. Overexpression of miR-128 alone or with miR-103 and miR-137 significantly reduced endogenous neurofibromin 1 protein levels, while antisense inhibition of these microRNAs enhanced translation of endogenous neurofibromin 1 and reporter in primary cultures of hippocampal neurons. These findings revealed a significant additional mechanism by which neurofibromin 1 is regulated in neurons and implicated new candidates for the treatment of multifarious neurofibromatosis type 1 cognitive symptoms.	[Paschou, Maria; Doxakis, Epaminondas] Acad Athens, Mol & Cellular Neurobiol Lab, Biomed Res Fdn, Ctr Neurosci & Social Psychiat, Athens, Greece	Academy of Athens	Paschou, M (corresponding author), Acad Athens, Mol & Cellular Neurobiol Lab, Biomed Res Fdn, Ctr Neurosci & Social Psychiat, Athens, Greece.	edoxakis@bioacademy.gr		Doxakis, Epaminondas/0000-0003-1305-0739; Paschou, Maria/0000-0002-6167-352X	General Secretariat for Research and Technology; Greek General Secretariat for Research and Technology [13894]; Academy of Athens	General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Greek General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Academy of Athens	This work was funded by grants from General Secretariat for Research and Technology to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Paulos Alexakos for excellent veterinary assistance. ED has received funding from the Greek General Secretariat for Research and Technology (Grant ID 13894) and the Academy of Athens.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ANDERSEN LB, 1993, MOL CELL BIOL, V13, P487, DOI 10.1128/MCB.13.1.487; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; BAIZER L, 1993, J NEUROCHEM, V61, P2054, DOI 10.1111/j.1471-4159.1993.tb07442.x; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Barron VA, 2010, NUCLEIC ACIDS RES, V38, P253, DOI 10.1093/nar/gkp766; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chai GL, 2010, CANCER SCI, V101, P1997, DOI 10.1111/j.1349-7006.2010.01616.x; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Doxakis E, 2004, CURR BIOL, V14, P1761, DOI 10.1016/j.cub.2004.09.050; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Friedman JM, 1999, AM J MED GENET, V89, P1; Ge LM, 1997, BIOTECHNIQUES, V22, P28, DOI 10.2144/97221bm03; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huson SHR, 1994, NEUROFIBROMATOSES PA; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Lin Q, 2011, NAT NEUROSCI, V14, P1115, DOI 10.1038/nn.2891; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Pichardo-Casas I, 2012, BRAIN RES, V1436, P20, DOI 10.1016/j.brainres.2011.12.001; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07	36	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46773	10.1371/journal.pone.0046773	http://dx.doi.org/10.1371/journal.pone.0046773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056445	gold, Green Published, Green Submitted			2022-12-27	WOS:000309452600058
J	Pitpitan, EV; Kalichman, SC; Cain, D; Eaton, LA; Carey, KB; Carey, MP; Harel, O; Simbayi, LC; Mehlomakhulu, V; Mwaba, K				Pitpitan, Eileen V.; Kalichman, Seth C.; Cain, Demetria; Eaton, Lisa A.; Carey, Kate B.; Carey, Michael P.; Harel, Ofer; Simbayi, Leickness C.; Mehlomakhulu, Vuyelwa; Mwaba, Kelvin			Condom Negotiation, HIV Testing, and HIV Risks among Women from Alcohol Serving Venues in Cape Town, South Africa	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; SEXUAL-BEHAVIOR; AIDS-PREVENTION; AMERICAN WOMEN; KNOWLEDGE; PLACES; INFECTION; ATTITUDES; PATRONS	Background: Women in South Africa are at particularly high-risk for HIV infection and are dependent on their male partners' use of condoms for sexual risk reduction. However, many women are afraid to discuss condoms with male partners, placing them at higher risk of HIV infection. Purpose: To examine the association between fear of condom negotiation with HIV testing and transmission risk behaviors, including alcohol use and sexual risks among South African women. Method: Women (N = 1333) residing in a primarily Xhosa-speaking African township in Cape Town and attending informal alcohol-serving venues (shebeens) completed anonymous surveys. Logistic regression was used to test the hypothesis that fear of condom negotiation would be associated with increased risk for HIV. Results: Compared to women who did not fear condom negotiation, those who did were significantly less likely to have been tested for HIV, were more likely to have experienced relationship abuse, and to report more alcohol use and more unprotected sex. Conclusions: For women in South Africa, fear of condom negotiation is related to higher risk of HIV. HIV prevention efforts, including targeted HIV counseling and testing, must directly address gender issues.	[Pitpitan, Eileen V.; Kalichman, Seth C.; Cain, Demetria; Eaton, Lisa A.; Harel, Ofer] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA; [Carey, Kate B.; Carey, Michael P.] Brown Univ, Dept Behav & Social Sci, Providence, RI 02912 USA; [Carey, Michael P.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Carey, Michael P.] Miriam Hosp, Ctr Behav Med, Providence, RI 02906 USA; [Simbayi, Leickness C.; Mehlomakhulu, Vuyelwa] Human Sci Res Council, Cape Town, South Africa; [Mwaba, Kelvin] Univ Western Cape, Cape Town, South Africa; [Carey, Michael P.] Miriam Hosp, Ctr Prevent Med, Providence, RI USA	University of Connecticut; Brown University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Human Sciences Research Council-South Africa; University of the Western Cape; Lifespan Health Rhode Island; Miriam Hospital	Pitpitan, EV (corresponding author), Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA.	epitpitan@ucsd.edu	Carey, Kate/GLU-7707-2022; Harel, Ofer/L-8906-2019	Harel, Ofer/0000-0002-1054-3055	National Institute on Alcohol Abuse and Alcoholism [R01-AA017399]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017399] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This project was supported by National Institute on Alcohol Abuse and Alcoholism Grants R01-AA017399 (http://www.niaaa.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cline RJ Welch, 1992, HEALTH COMMUN, V4, P39, DOI DOI 10.1207/S15327027HC0401_4; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Jurgensen M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-2; Kalichman SC, 1998, J WOMENS HEALTH, V7, P371, DOI 10.1089/jwh.1998.7.371; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; KONDELULE JK, 1989, AIDS, V3, P513, DOI 10.1097/00002030-198908000-00005; LINDAN C, 1991, AIDS, V5, P993, DOI 10.1097/00002030-199108000-00011; Michael-Johnson P, 1989, AIDS COMMUNICATION M; Mittal M, FEAR VIOLEN IN PRESS; Morojele NK, 2006, SOC SCI MED, V62, P217, DOI 10.1016/j.socscimed.2005.05.031; Napper LE, 2010, AIDS BEHAV, V14, P152, DOI 10.1007/s10461-009-9575-5; Pitpitan EV, 2012, SOC SCI MED, V75, P1417, DOI 10.1016/j.socscimed.2012.06.020; Pitpitan EV, 2012, ANN BEHAV MED, V43, P362, DOI 10.1007/s12160-012-9346-9; Raiford JL, 2009, AM J PUBLIC HEALTH, V99, P1067, DOI 10.2105/AJPH.2007.131482; Shisana O, 2009, S AFRICAN NATL HIV P; UNAIDS, GLOB REP UNAIDS REP; Weir SS, 2003, AIDS, V17, P895, DOI 10.1097/00002030-200304110-00015; Weir SS, 2002, SEX TRANSM INFECT, V78, pI106, DOI 10.1136/sti.78.suppl_1.i106; WILSON D, 1988, CENT AFR J MED, V34, P95	21	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45631	10.1371/journal.pone.0045631	http://dx.doi.org/10.1371/journal.pone.0045631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NG	23056211	gold, Green Published			2022-12-27	WOS:000309452600012
J	Hui, W; Chen, C; Hsieh, FS				Hui Wang; Chen Chen; Hsieh Fushing			Extracting Multiscale Pattern Information of fMRI Based Functional Brain Connectivity with Application on Classification of Autism Spectrum Disorders	PLOS ONE			English	Article							COGNITIVE CONTROL; CHILDREN; SCHIZOPHRENIA; DIAGNOSIS; NETWORKS; STATE; TASK; MRI	We employed a multi-scale clustering methodology known as "data cloud geometry" to extract functional connectivity patterns derived from functional magnetic resonance imaging (fMRI) protocol. The method was applied to correlation matrices of 106 regions of interest (ROIs) in 29 individuals with autism spectrum disorders (ASD), and 29 individuals with typical development (TD) while they completed a cognitive control task. Connectivity clustering geometry was examined at both "fine" and "coarse" scales. At the coarse scale, the connectivity clustering geometry produced 10 valid clusters with a coherent relationship to neural anatomy. A supervised learning algorithm employed fine scale information about clustering motif configurations and prevalence, and coarse scale information about intra-and inter-regional connectivity; the algorithm correctly classified ASD and TD participants with sensitivity of 82.8% and specificity of 82.8%. Most of the predictive power of the logistic regression model resided at the level of the fine-scale clustering geometry, suggesting that cellular versus systems level disturbances are more prominent in individuals with ASD. This article provides validation for this multi-scale geometric approach to extracting brain functional connectivity pattern information and for its use in classification of ASD.	[Hui Wang; Chen Chen; Hsieh Fushing] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA	University of California System; University of California Davis	Hsieh, FS (corresponding author), Univ Calif Davis, Dept Stat, Davis, CA 95616 USA.	fushing@wald.ucdavis.edu			National Science Foundation (NSF) [DMS-1007219]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research was partly supported by National Science Foundation (NSF) grant: DMS-1007219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; Blatt M, 1997, NEURAL COMPUT, V9, P1805, DOI 10.1162/neco.1997.9.8.1805; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Fushing H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061110; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Lee PS, 2007, NEUROIMAGE, V38, P184, DOI 10.1016/j.neuroimage.2007.07.013; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rosano C, 2005, NEUROIMAGE, V28, P881, DOI 10.1016/j.neuroimage.2005.05.059; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Snitz BE, 2005, AM J PSYCHIAT, V162, P2322, DOI 10.1176/appi.ajp.162.12.2322; Solomon M, 2008, INT J DEV NEUROSCI, V26, P239, DOI 10.1016/j.ijdevneu.2007.11.001; Solomon M, 2009, NEUROPSYCHOLOGIA, V47, P2515, DOI 10.1016/j.neuropsychologia.2009.04.019; Stevenson JL, 2010, J NEUROSCI, V30, P16763, DOI 10.1523/JNEUROSCI.4946-10.2010; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2011, BIOL PSYCHIAT, V70, P833, DOI 10.1016/j.biopsych.2011.07.014; Williams DL, 2006, CHILD NEUROPSYCHOL, V12, P279, DOI 10.1080/09297040600681190; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	34	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45502	10.1371/journal.pone.0045502	http://dx.doi.org/10.1371/journal.pone.0045502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056205	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500019
J	Kadiallah, A; Franklin, DW; Burdet, E				Kadiallah, Abdelhamid; Franklin, David W.; Burdet, Etienne			Generalization in Adaptation to Stable and Unstable Dynamics	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; SIGNAL-DEPENDENT NOISE; IMPEDANCE CONTROL; MOTOR ADAPTATION; ADAPTIVE-CONTROL; INTERNAL-MODELS; ARM MOVEMENTS; SHORT-TERM; MUSCLE; STABILITY	Humans skillfully manipulate objects and tools despite the inherent instability. In order to succeed at these tasks, the sensorimotor control system must build an internal representation of both the force and mechanical impedance. As it is not practical to either learn or store motor commands for every possible future action, the sensorimotor control system generalizes a control strategy for a range of movements based on learning performed over a set of movements. Here, we introduce a computational model for this learning and generalization, which specifies how to learn feedforward muscle activity in a function of the state space. Specifically, by incorporating co-activation as a function of error into the feedback command, we are able to derive an algorithm from a gradient descent minimization of motion error and effort, subject to maintaining a stability margin. This algorithm can be used to learn to coordinate any of a variety of motor primitives such as force fields, muscle synergies, physical models or artificial neural networks. This model for human learning and generalization is able to adapt to both stable and unstable dynamics, and provides a controller for generating efficient adaptive motor behavior in robots. Simulation results exhibit predictions consistent with all experiments on learning of novel dynamics requiring adaptation of force and impedance, and enable us to re-examine some of the previous interpretations of experiments on generalization.	[Kadiallah, Abdelhamid; Burdet, Etienne] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Franklin, David W.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England	Imperial College London; University of Cambridge	Burdet, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	eburdet@imperial.ac.uk	Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Burdet, Etienne/0000-0002-2123-0185	EU-FP7 VIACTORS grant; Wellcome Trust; Algerian government	EU-FP7 VIACTORS grant; Wellcome Trust(Wellcome TrustEuropean Commission); Algerian government	There are no current external funding sources for this study. However, EB was supported in part by the EU-FP7 VIACTORS grant, DWF by the Wellcome Trust and HK by a scholarship from the Algerian government. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bien Z., 1998, ITERATIVE LEARNING C; Burdet E, 2006, BIOL CYBERN, V94, P20, DOI 10.1007/s00422-005-0025-9; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Burdet E, 1998, IEEE CONTR SYST MAG, V18, P39, DOI 10.1109/37.664654; Burdet E, 1998, BIOL CYBERN, V78, P307, DOI 10.1007/s004220050435; Burdet E, 1996, THESIS ETH ZURICH SW; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; CRAGO PE, 1976, J NEUROPHYSIOL, V39, P925, DOI 10.1152/jn.1976.39.5.925; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Diedrichsen J, 2007, CURR BIOL, V17, P1675, DOI 10.1016/j.cub.2007.08.051; Dimitriou M, 2012, J NEUROPHYSIOL, V107, P890, DOI 10.1152/jn.00787.2011; Dimitriou M, 2010, CURR BIOL, V20, P1763, DOI 10.1016/j.cub.2010.08.049; Dimitriou M, 2008, J NEUROSCI, V28, P12632, DOI 10.1523/JNEUROSCI.3357-08.2008; Donchin O, 2003, J NEUROSCI, V23, P9032; Duda R.O., 2006, PATTERN CLASSIFICATI; Emken JL, 2007, J NEUROPHYSIOL, V97, P3997, DOI 10.1152/jn.01095.2006; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Franklin DW, 2008, J NEUROSCI, V28, P14165, DOI 10.1523/JNEUROSCI.4406-08.2008; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Gowrishankar G, 2010, P INT C ROB AUT ICRA; Gribble PL, 2000, EXP BRAIN RES, V135, P474, DOI 10.1007/s002210000547; Guigon E, 2007, J NEUROPHYSIOL, V97, P331, DOI 10.1152/jn.00290.2006; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kadiallah A, 2011, J NEUROPHYSIOL, V106, P2737, DOI 10.1152/jn.00079.2011; Kamper DG, 2000, MUSCLE NERVE, V23, P954, DOI 10.1002/(SICI)1097-4598(200006)23:6<954::AID-MUS17>3.0.CO;2-0; Kargo WJ, 2008, J NEUROSCI, V28, P2409, DOI 10.1523/JNEUROSCI.3229-07.2008; KATAYAMA M, 1993, BIOL CYBERN, V69, P353, DOI 10.1007/BF01185407; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KIRSCH RF, 1994, IEEE T BIO-MED ENG, V41, P758, DOI 10.1109/10.310091; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; LACQUANITI F, 1987, BRAIN RES, V406, P373, DOI 10.1016/0006-8993(87)90810-9; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; Loeb GE, 1999, EXP BRAIN RES, V126, P1, DOI 10.1007/s002210050712; LOEB GE, 1990, COLD SH Q B, V55, P791; Mcqueen J., 1967, P 5 BERK S MATH STAT, V1, P281; Milner TE, 2005, J PHYSIOL-LONDON, V567, P651, DOI 10.1113/jphysiol.2005.090449; MUSSAIVALDI FA, 1992, BIOL CYBERN, V67, P491, DOI 10.1007/BF00198756; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Pruszynski JA, 2012, EXP BRAIN RES, V218, P341, DOI 10.1007/s00221-012-3041-8; Rancourt D, 2001, J MOTOR BEHAV, V33, P193, DOI 10.1080/00222890109603150; Sanner RM, 1999, BIOL CYBERN, V80, P369, DOI 10.1007/s004220050532; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shemmell J, 2009, J NEUROSCI, V29, P13255, DOI 10.1523/JNEUROSCI.0892-09.2009; Slotine J.J.E., 1991, APPL NONLINEAR CONTR; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Stroeve S, 1999, BIOL CYBERN, V81, P495, DOI 10.1007/s004220050578; Tee KP, 2010, BIOL CYBERN, V102, P31, DOI 10.1007/s00422-009-0348-z; Thoroughman KA, 2005, J NEUROSCI, V25, P8948, DOI 10.1523/JNEUROSCI.1771-05.2005; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tong C, 2003, J NEUROPHYSIOL, V90, P578, DOI 10.1152/jn.01087.2002; Trainin E, 2007, J NEUROPHYSIOL, V97, P3736, DOI 10.1152/jn.01064.2006; Wagner MJ, 2008, J NEUROSCI, V28, P10663, DOI 10.1523/JNEUROSCI.5479-07.2008; WON J, 1995, EXP BRAIN RES, V107, P125; Yang CG, 2011, IEEE T ROBOT, V27, P918, DOI 10.1109/TRO.2011.2158251; [No title captured]; [No title captured]	70	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45075	10.1371/journal.pone.0045075	http://dx.doi.org/10.1371/journal.pone.0045075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056191	Green Published, gold			2022-12-27	WOS:000309831500013
J	Kim, TH; Kim, JS; Kim, ZH; Huang, RB; Wang, RS				Kim, Tae Hwan; Kim, Ju Sung; Kim, Zoo Haye; Huang, Ren Bin; Wang, Ren Sheng			Khz (Fusion of Ganoderma lucidum and Polyporus umbellatus Mycelia) Induces Apoptosis by Increasing Intracellular Calcium Levels and Activating JNK and NADPH Oxidase-Dependent Generation of Reactive Oxygen Species	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; HUMAN LEUKEMIA-CELLS; N-TERMINAL KINASE; OXIDATIVE STRESS; CANCER CELLS; ANGIOTENSIN-II; MAP KINASE; IN-VITRO; MECHANISMS; ANTITUMOR	Khz is a compound derived from the fusion of Ganoderma lucidum and Polyporus umbellatus mycelia that inhibits the growth of cancer cells. The results of the present study show that Khz induced apoptosis preferentially in transformed cells and had only minimal effects on non-transformed cells. Furthermore, Khz induced apoptosis by increasing the intracellular Ca2+ concentration ([Ca2+](i)) and activating JNK to generate reactive oxygen species (ROS) via NADPH oxidase and the mitochondria. Khz-induced apoptosis was caspase-dependent and occurred via a mitochondrial pathway. ROS generation by NADPH oxidase was critical for Khz-induced apoptosis, and although mitochondrial ROS production was also required, it appeared to occur secondary to ROS generation by NADPH oxidase. Activation of NADPH oxidase was demonstrated by the translocation of regulatory subunits p47(phox) and p67(phox) to the cell membrane and was necessary for ROS generation by Khz. Khz triggered a rapid and sustained increase in [Ca2+](i), which activated JNK. JNK plays a key role in the activation of NADPH oxidase because inhibition of its expression or activity abrogated membrane translocation of the p47(phox) and p67(phox) subunits and ROS generation. In summary, these data indicate that Khz preferentially induces apoptosis in cancer cells, and the signaling mechanisms involve an increase in [Ca2+](i), JNK activation, and ROS generation via NADPH oxidase and mitochondria.	[Kim, Tae Hwan; Wang, Ren Sheng] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning, Peoples R China; [Kim, Ju Sung] Harbin Med Univ, Harbin, Peoples R China; [Kim, Zoo Haye] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Huang, Ren Bin] Guangxi Med Univ, Grad Sch Pharmacol, Nanning, Peoples R China	Guangxi Medical University; Harbin Medical University; Nagoya University; Guangxi Medical University	Wang, RS (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning, Peoples R China.	wrsgx@yahoo.com.cn						ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gao YH, 2005, IMMUNOL INVEST, V34, P171, DOI 10.1081/IMM-200055813; Granfeldt D, 2002, J LEUKOCYTE BIOL, V71, P611; Hiraoka W, 1998, J CLIN INVEST, V102, P1961, DOI 10.1172/JCI3437; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Jiang JH, 2010, INT J ONCOL, V37, P1529, DOI 10.3892/ijo_00000806; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim JE, 2008, EXP MOL MED, V40, P709, DOI 10.3858/emm.2008.40.6.709; KLEINSZANTO AJP, 1992, P NATL ACAD SCI USA, V89, P6693, DOI 10.1073/pnas.89.15.6693; Kuppusamy P, 2002, CANCER RES, V62, P307; Lin ZB, 2004, ACTA PHARMACOL SIN, V25, P1387; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Mesner P W Jr, 1997, Adv Pharmacol, V41, P461, DOI 10.1016/S1054-3589(08)61069-8; Miyajima A, 1997, BRIT J CANCER, V76, P206, DOI 10.1038/bjc.1997.363; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Palombo JD, 2002, CANCER LETT, V177, P163, DOI 10.1016/S0304-3835(01)00796-0; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Qin FZ, 2006, FREE RADICAL BIO MED, V40, P236, DOI 10.1016/j.freeradbiomed.2005.08.010; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Saeki K, 2002, BIOCHEM J, V368, P705, DOI 10.1042/BJ20020101; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Wang G, 2006, HYPERTENSION, V48, P482, DOI 10.1161/01.HYP.0000236647.55200.07; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Yu JH, 2005, FREE RADICAL BIO MED, V39, P590, DOI 10.1016/j.freeradbiomed.2005.04.019; Yue GGL, 2006, J ALTERN COMPLEM MED, V12, P777, DOI 10.1089/acm.2006.12.777; Zhao YY, 2010, PLANTA MED, V76, P1755, DOI 10.1055/s-0030-1249926; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512	38	10	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46208	10.1371/journal.pone.0046208	http://dx.doi.org/10.1371/journal.pone.0046208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056263	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500031
J	Deng, SL; Wu, Q; Yu, K; Zhang, YH; Yao, YC; Li, WT; Deng, Z; Liu, GS; Li, W; Lian, ZX				Deng, Shoulong; Wu, Qian; Yu, Kun; Zhang, Yunhai; Yao, Yuchang; Li, Wenting; Deng, Zhuo; Liu, Guoshi; Li, Wu; Lian, Zhengxing			Changes in the Relative Inflammatory Responses in Sheep Cells Overexpressing of Toll-Like Receptor 4 When Stimulated with LPS	PLOS ONE			English	Article							EPITHELIAL-CELLS; ALVEOLAR MACROPHAGES; SIGNALING PATHWAYS; INNATE IMMUNITY; LIPOPOLYSACCHARIDE; EXPRESSION; TLR4; RECOGNITION; ACTIVATION; RESISTANCE	Background: Many groups of Gram-negative bacteria cause diseases harmful to sheep. TLR4 is an important Toll-like receptor (TLR) which responds to common Gram-negative bacterial infections. Activation of TLR4 leads to the induction of inflammatory responses, which is a linkage between the innate and adaptive immune systems. A vector pTLR4-3S was constructed to overexpress TLR4 gene in sheep. In this study, effects of TLR4 overexpression on inflammation response under LPS stimulated were addressed in vivo and in vitro. Methodology/Principal Findings: Sheep fetal fibroblasts were transfected with expression vector pTLR4-3S. Transgenic sheep were produced by microinjection of the constructed plasmids into fertilized eggs. Fetal fibroblasts, monocytemacrophage and fibroblasts isolated from the transgenic sheep were stimulated by LPS. After that immunoactive factors (TNF-alpha, IL-10, IL-6, IL-8, IFN-gamma), nitric oxide, phagocytize ability and adhesion were detected. Furthermore, transgenic sheep were intradermal injected of LPS in ear and observed pathological changes by HE strain. Overexpression of TLR4 gene was observed on transgenic cells and individuals. In vitro, TLR4 overexpression transgenic cells secreted Th1 and Th2 inducing cytokines with a strong LPS mediated inflammation response and promoting the secretion of nitric oxide, and then recovered to initial level. The phagocytosis index of monocyte/macrophage in transgenic sheep was higher than that of non-transgenic sheep (P < 0.05). In vivo, tissue sections showed that transgenic individuals launched inflammation response more quickly. Conclusions/Significance: Overexpression of TLR4 in transgenic sheep enhanced the clearance of invaded microbe through secretion of cytokines, activation of macrophage, oxidation damage and infiltration of neutrophil.	[Deng, Shoulong; Yu, Kun; Li, Wenting; Liu, Guoshi; Lian, Zhengxing] China Agr Univ, Coll Anim Sci & Technol, Lab Anim Genet & Breeding, Beijing 100094, Peoples R China; [Wu, Qian] Beijing Univ Aeronaut & Astronaut, Sch Biol Sci & Med Engn, Beijing 100083, Peoples R China; [Yao, Yuchang; Li, Wu] NE Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China; [Lian, Zhengxing] Natl Key Lab Agrobiotechnol, Beijing, Peoples R China; [Zhang, Yunhai] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Peoples R China; [Deng, Zhuo] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA	China Agricultural University; Beihang University; Northeast Agricultural University - China; Anhui Agricultural University; Oklahoma State University System; Oklahoma State University - Stillwater	Lian, ZX (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Lab Anim Genet & Breeding, Beijing 100094, Peoples R China.	lianzhx@cau.edu.cn	deng, shoulong/GWV-0293-2022; Deng, Shou-Long/GWV-0452-2022; Zhang, Yunhai/O-4453-2014	Zhang, Yunhai/0000-0001-9721-5910; deng, shou-long/0000-0003-1187-3037	National Transgenic Creature Breeding Grand Project [2008ZX08008-005]	National Transgenic Creature Breeding Grand Project	This work was supported by grants from National Transgenic Creature Breeding Grand Project (2008ZX08008-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Choussat R, 2000, AM J CARDIOL, V86, P379, DOI 10.1016/S0002-9149(00)00950-4; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Haraoka M, 1999, J INFECT DIS, V180, P1220, DOI 10.1086/315006; Hart SP, 2008, METHODS, V44, P280, DOI 10.1016/j.ymeth.2007.11.009; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Heo SK, 2008, IMMUNOL LETT, V120, P57, DOI 10.1016/j.imlet.2008.07.002; Hirano S, 1997, IND HEALTH, V35, P353, DOI 10.2486/indhealth.35.353; Hoareau L, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-1; Jaresova I, 2007, MICROBES INFECT, V9, P1359, DOI 10.1016/j.micinf.2007.06.009; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Juarez E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-2; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koedel U, 2007, AM J PATHOL, V171, P200, DOI 10.2353/ajpath.2007.060821; Li HL, 2007, CELL BIOL INT, V31, P831, DOI 10.1016/j.cellbi.2007.01.034; Lillehoj HS, 2004, AVIAN DIS, V48, P244, DOI 10.1637/7054; Ma PL, 2002, CRIT CARE MED, V30, P947, DOI 10.1097/00003246-200204000-00049; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Micera A, 2009, MOL VIS, V15, P2037; Migita K, 2007, J RHEUMATOL, V34, P493; Murphy TJ, 2005, J LEUKOCYTE BIOL, V77, P16, DOI 10.1189/jlb.0704382; Nita IM, 2007, INT J BIOCHEM CELL B, V39, P1165, DOI 10.1016/j.biocel.2007.02.017; Olleros ML, 2008, CYTOKINE, V44, P118, DOI 10.1016/j.cyto.2008.07.001; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi MA, 2003, POULTRY SCI, V82, P691, DOI 10.1093/ps/82.5.691; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Roy MF, 2006, GENES IMMUN, V7, P372, DOI 10.1038/sj.gene.6364309; Schilling JD, 2003, INFECT IMMUN, V71, P1470, DOI 10.1128/IAI.71.3.1470-1480.2003; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Togbe D, 2006, J LEUKOCYTE BIOL, V80, P451, DOI 10.1189/jlb.0206099; Zhande R, 2007, MOL CELL BIOL, V27, P7394, DOI 10.1128/MCB.00600-07; Zhang BL, 2011, ASIAN J ANIM VET ADV, V6, P155, DOI 10.3923/ajava.2011.155.165	38	30	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e47118	10.1371/journal.pone.0047118	http://dx.doi.org/10.1371/journal.pone.0047118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056598	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800073
J	Portalska, KJ; Leferink, A; Groen, N; Fernandes, H; Moroni, L; van Blitterswijk, C; de Boer, J				Portalska, Karolina Janeczek; Leferink, Anne; Groen, Nathalie; Fernandes, Hugo; Moroni, Lorenzo; van Blitterswijk, Clemens; de Boer, Jan			Endothelial Differentiation of Mesenchymal Stromal Cells	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; IN-VITRO; VESSEL DEVELOPMENT; PROGENITOR CELLS; TISSUE; NEOVASCULARIZATION; VIVO; TRANSPLANTATION; ANGIOGENESIS	Human mesenchymal stromal cells (hMSCs) are increasingly used in regenerative medicine for restoring worn-out or damaged tissue. Newly engineered tissues need to be properly vascularized and current candidates for in vitro tissue prevascularization are endothelial cells and endothelial progenitor cells. However, their use in therapy is hampered by their limited expansion capacity and lack of autologous sources. Our approach to engineering large grafts is to use hMSCs both as a source of cells for regeneration of targeted tissue and at the same time as the source of endothelial cells. Here we investigate how different stimuli influence endothelial differentiation of hMSCs. Although growth supplements together with shear force were not sufficient to differentiate hMSCs with respect to expression of endothelial markers such as CD31 and KDR, these conditions did prime the cells to differentiate into cells with an endothelial gene expression profile and morphology when seeded on Matrigel. In addition, we show that endothelial-like hMSCs are able to create a capillary network in 3D culture both in vitro and in vivo conditions. The expansion phase in the presence of growth supplements was crucial for the stability of the capillaries formed in vitro. To conclude, we established a robust protocol for endothelial differentiation of hMSCs, including an immortalized MSC line (iMSCs) which allows for reproducible in vitro analysis in further studies.	[Portalska, Karolina Janeczek; Leferink, Anne; Groen, Nathalie; Fernandes, Hugo; Moroni, Lorenzo; van Blitterswijk, Clemens; de Boer, Jan] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Overijssel, Netherlands	University of Twente	de Boer, J (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Overijssel, Netherlands.	j.deboer@tnw.utwente.nl	Fernandes, Hugo Machado/H-6192-2014; Leferink, Ir. A. M./G-5024-2012; Moroni, Lorenzo/D-2826-2014	Fernandes, Hugo Machado/0000-0002-4574-7648; Leferink, Ir. A. M./0000-0002-3765-8450; Moroni, Lorenzo/0000-0003-1298-6025; van Blitterswijk, Clemens/0000-0003-2371-4615; de Boer, Jan/0000-0001-9188-9324	De Stichting voor de Technische Wetenschappen (STW); Netherlands Institute of Regenerative Medicine	De Stichting voor de Technische Wetenschappen (STW); Netherlands Institute of Regenerative Medicine	This work was sponsored by a research grant from De Stichting voor de Technische Wetenschappen (STW) to JdB. The authors also acknowledge financial support from the Netherlands Institute of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Albersen M, 2011, J SEX MED; Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Aranguren XL, 2009, J MOL MED, V87, P3, DOI 10.1007/s00109-008-0394-3; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bai K, 2010, J BIOMECH, V43, P1176, DOI 10.1016/j.jbiomech.2009.11.030; Bala K, 2011, TISSUE CELL, V43, P216, DOI 10.1016/j.tice.2011.03.004; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; BELLOWS CG, 1989, DEV BIOL, V133, P8, DOI 10.1016/0012-1606(89)90291-1; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Both SK, 2007, TISSUE ENG, V13, P3, DOI 10.1089/ten.2005.0513; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015; Chamberlain MD, 2012, TISSUE ENG PT A, V18, P285, DOI [10.1089/ten.TEA.2011.0393, 10.1089/ten.tea.2011.0393]; Chatterjea A, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/215625; COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Davies PF, 1995, J BIOMECH, V28, P1553, DOI 10.1016/0021-9290(95)00102-6; de la Garza-Rodea AS, 2011, CELL TRANSPLANT; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Doorn J, 2011, TISSUE ENG A; Eichmann A, 2012, CURR OPIN CELL BIOL; Ensley AE, 2011, TISSUE ENG A; Erskine L, 2011, NEURON, V70, P951, DOI 10.1016/j.neuron.2011.02.052; Faroni A, 2011, J NEUROSCI RES, V89, P1351, DOI 10.1002/jnr.22652; Fischer LJ, 2009, J SURG RES, V152, P157, DOI 10.1016/j.jss.2008.06.029; Franz RW, 2009, J VASC SURG, V50, P1378, DOI 10.1016/j.jvs.2009.07.113; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gu A, 2009, EXP CELL RES, V315, P1668, DOI 10.1016/j.yexcr.2009.02.026; Hoganson DM, 2008, PEDIATR RES, V63, P520, DOI 10.1203/01.pdr.0000305879.38476.0c; Hung HS, 2009, CELL TRANSPLANT, V18, P1003, DOI 10.3727/096368909X12483162196683; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Kniazeva E, 2011, TISSUE ENG PT A, V17, P905, DOI [10.1089/ten.tea.2010.0275, 10.1089/ten.TEA.2010.0275]; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Liu JW, 2007, J THROMB HAEMOST, V5, P826, DOI 10.1111/j.1538-7836.2007.02381.x; Lozito TP, 2009, J CELL BIOCHEM, V107, P706, DOI 10.1002/jcb.22166; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; McGuigan AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002258; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Ning HX, 2009, J SEX MED, V6, P967, DOI 10.1111/j.1743-6109.2008.01172.x; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; Oreffo ROC, 1998, SCAND J RHEUMATOL, V27, P415; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Penfornis P, 2011, METHODS MOL BIOL, V698, P11, DOI 10.1007/978-1-60761-999-4_2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poulsom R, 2003, J AM SOC NEPHROL, V14, pS48, DOI 10.1097/01.ASN.0000068162.02174.29; Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rodriguez Luis G., 2004, V294, P23; Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685; Schatteman GC, 2003, ADV EXP MED BIOL, V522, P9; Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006; Siddappa Ramakrishnaiah, 2007, Curr Stem Cell Res Ther, V2, P209, DOI 10.2174/157488807781696267; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Steffenhagen C, 2011, STEM CELLS DEV; Szoke K, 2011, CELL TRANSPLANT; Terramani TT, 2000, IN VITRO CELL DEV-AN, V36, P125; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004; Yang NN, 2011, CYTOTECHNOLOGY, V63, P217, DOI 10.1007/s10616-010-9329-2; Zhang P, 2009, STEM CELLS DEV, V18, P1299, DOI 10.1089/scd.2008.0331; ZUMSTEIN A, 1983, PFLUG ARCH EUR J PHY, V397, P277, DOI 10.1007/BF00580261	75	133	134	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46842	10.1371/journal.pone.0046842	http://dx.doi.org/10.1371/journal.pone.0046842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056481	Green Published, gold			2022-12-27	WOS:000309580800054
J	Kumar, S; ten Siethoff, L; Persson, M; Lard, M; Kronnie, GT; Linke, H; Mansson, A				Kumar, Saroj; ten Siethoff, Lasse; Persson, Malin; Lard, Mercy; Kronnie, Geertruy Te; Linke, Heiner; Mansson, Alf			Antibodies Covalently Immobilized on Actin Filaments for Fast Myosin Driven Analyte Transport	PLOS ONE			English	Article							BIOMOLECULAR MOTOR-DRIVEN; IN-VITRO; F-ACTIN; SLIDING MOVEMENT; STRUCTURAL DYNAMICS; SELECTIVE DETECTION; ACTOMYOSIN FUNCTION; MOLECULAR SHUTTLES; CARGO; PROTEINS	Biosensors would benefit from further miniaturization, increased detection rate and independence from external pumps and other bulky equipment. Whereas transportation systems built around molecular motors and cytoskeletal filaments hold significant promise in the latter regard, recent proof-of-principle devices based on the microtubule-kinesin motor system have not matched the speed of existing methods. An attractive solution to overcome this limitation would be the use of myosin driven propulsion of actin filaments which offers motility one order of magnitude faster than the kinesin-microtubule system. Here, we realized a necessary requirement for the use of the actomyosin system in biosensing devices, namely covalent attachment of antibodies to actin filaments using heterobifunctional cross-linkers. We also demonstrated consistent and rapid myosin II driven transport where velocity and the fraction of motile actin filaments was negligibly affected by the presence of antibody-antigen complexes at rather high density (>20 mu m(-1)). The results, however, also demonstrated that it was challenging to consistently achieve high density of functional antibodies along the actin filament, and optimization of the covalent coupling procedure to increase labeling density should be a major focus for future work. Despite the remaining challenges, the reported advances are important steps towards considerably faster nanoseparation than shown for previous molecular motor based devices, and enhanced miniaturization because of high bending flexibility of actin filaments.	[Kumar, Saroj; ten Siethoff, Lasse; Persson, Malin; Mansson, Alf] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden; [Lard, Mercy; Linke, Heiner] Lund Univ, Nanometer Struct Consortium, Lund, Sweden; [Lard, Mercy; Linke, Heiner] Lund Univ, Div Solid State Phys, Lund, Sweden; [Kronnie, Geertruy Te] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy	Linnaeus University; Lund University; Lund University; University of Padua	Mansson, A (corresponding author), Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden.	alf.mansson@lnu.se	Lard, Mercy/R-2035-2019; Kumar, Saroj/AAV-2592-2021; Persson, Malin/K-6133-2017; Kronnie, Geertruy te/L-1014-2016; Kumar, Saroj/O-6574-2017; Mansson, Alf/ABC-6271-2021; Lard, Mercy/AAV-6577-2021; Linke, Heiner/A-5825-2010; Lard, Mercy/C-4193-2011	Lard, Mercy/0000-0001-9243-4735; Kumar, Saroj/0000-0002-1886-9674; Persson, Malin/0000-0003-2819-3046; Kumar, Saroj/0000-0002-1886-9674; Mansson, Alf/0000-0002-5889-7792; Linke, Heiner/0000-0003-4451-4006; Lard, Mercy/0000-0001-9243-4735; te Kronnie, Geertruy/0000-0001-7143-4795; ten Siethoff, Lasse/0000-0001-6878-3142; /0000-0001-5636-1006	The European commission (FP7) under the contract MONAD [NMP4-SL-2009-228971]; The Carl Trygger Foundation; The Swedish Research Council [621-2007-6137, 621-2010-5146]; Faculty of Natural Sciences and Engineering at Linnaeus University	The European commission (FP7) under the contract MONAD; The Carl Trygger Foundation; The Swedish Research Council(Swedish Research Council); Faculty of Natural Sciences and Engineering at Linnaeus University	This work was funded by The European commission (FP7) under the contract MONAD (NMP4-SL-2009-228971), The Carl Trygger Foundation, The Swedish Research Council (Projects # 621-2007-6137 and 621-2010-5146), nmC@LU, and the Faculty of Natural Sciences and Engineering at Linnaeus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albet-Torres N, 2011, LANGMUIR, V27, P7108, DOI 10.1021/la201081w; Ashikari N, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BL03; Bachand GD, 2006, SMALL, V2, P381, DOI 10.1002/smll.200500262; Balaz M, 2005, ANAL BIOCHEM, V338, P224, DOI 10.1016/j.ab.2004.12.012; Beausang JF, 2008, BIOPHYS J, V95, P5820, DOI 10.1529/biophysj.108.140319; Brunner C, 2007, LAB CHIP, V7, P1263, DOI 10.1039/b707301a; Bunk R, 2005, NANOTECHNOLOGY, V16, P710, DOI 10.1088/0957-4484/16/6/014; Byeon JY, 2010, LANGMUIR, V26, P15430, DOI 10.1021/la1021824; Byun KE, 2007, LANGMUIR, V23, P9535, DOI 10.1021/la7019318; Carroll-Portillo A, 2009, BIOTECHNOL BIOENG, V104, P1182, DOI 10.1002/bit.22501; Carroll-Portillo A, 2009, SMALL, V5, P1835, DOI 10.1002/smll.200900491; DABROWSKA R, 1983, J MUSCLE RES CELL M, V4, P83, DOI 10.1007/BF00711959; Fischer T, 2009, NAT NANOTECHNOL, V4, P162, DOI [10.1038/nnano.2008.393, 10.1038/NNANO.2008.393]; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Grotzky A, 2011, BIOMACROMOLECULES, V12, P134, DOI 10.1021/bm101074s; Grove TJ, 2005, IEEE T ADV PACKAGING, V28, P556, DOI 10.1109/TADVP.2005.858341; HEIDECKER M, 1995, BIOCHEMISTRY-US, V34, P11017, DOI 10.1021/bi00035a007; Hess H, 2001, NANO LETT, V1, P235, DOI 10.1021/nl015521e; Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473; Hiyama S, 2009, NANO LETT, V9, P2407, DOI 10.1021/nl901013k; HUANG ZJ, 1992, ANAL BIOCHEM, V200, P199, DOI 10.1016/0003-2697(92)90299-M; Iyer G, 2011, BIOCONJUGATE CHEM, V22, P1006, DOI 10.1021/bc100593m; Jokerst JV, 2010, ANAL CHEM, V82, P1571, DOI 10.1021/ac901743u; Klinth J, 2003, J MUSCLE RES CELL M, V24, P15, DOI 10.1023/A:1024894130989; Korten T, 2008, LAB CHIP, V8, P1441, DOI 10.1039/b803585g; Korten T, 2010, CURR OPIN BIOTECH, V21, P477, DOI 10.1016/j.copbio.2010.05.001; Kozlov IA, 2004, BIOPOLYMERS, V73, P621, DOI 10.1002/bip.20009; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kron S. J., 1991, METHOD ENZYMOL, P399; Kumar S, 2012, MICR WORKSH MSW 2012; Kumar S, 2011, 2 INT C BIOS TECHN A; Lee KB, 2004, NANO LETT, V4, P1869, DOI 10.1021/nl049002y; Lin CT, 2008, NANO LETT, V8, P1041, DOI 10.1021/nl072742x; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Malcos JL, 2011, APPL MICROBIOL BIOT, V90, P1, DOI 10.1007/s00253-011-3140-7; Mansson A, 2005, IEEE T ADV PACKAGING, V28, P547, DOI 10.1109/TADVP.2005.858309; Mansson A, 2004, BIOCHEM BIOPH RES CO, V314, P529, DOI 10.1016/j.bbrc.2003.12.133; Mansson A, 2003, ANAL BIOCHEM, V314, P281, DOI 10.1016/S0003-2697(02)00610-3; Marston SB, 1996, J MUSCLE RES CELL M, V17, P497, DOI 10.1007/BF00123365; Mulvaney SP, 2009, BIOSENS BIOELECTRON, V24, P1109, DOI 10.1016/j.bios.2008.06.010; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Ng AHC, 2010, ANAL BIOANAL CHEM, V397, P991, DOI 10.1007/s00216-010-3678-8; Nicolau DV, 1999, BIOPHYS J, V77, P1126, DOI 10.1016/S0006-3495(99)76963-8; Nitta T, 2008, NANO LETT, V8, P2305, DOI 10.1021/nl8010885; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Persson M, 2010, LANGMUIR, V26, P9927, DOI 10.1021/la100395a; PROCHNIEWICZ E, 1990, J MOL BIOL, V216, P761, DOI 10.1016/0022-2836(90)90397-5; Raab M, 2008, BIOTECHNOL BIOENG, V99, P764, DOI 10.1002/bit.21645; Ramachandran S, 2006, SMALL, V2, P330, DOI 10.1002/smll.200500265; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; Soto CM, 2008, ANAL CHEM, V80, P5433, DOI 10.1021/ac800541x; Sundberg M, 2003, ANAL BIOCHEM, V323, P127, DOI 10.1016/j.ab.2003.07.022; Sundberg M, 2007, J COLLOID INTERF SCI, V313, P454, DOI 10.1016/j.jcis.2007.04.067; Sundberg M, 2006, LANGMUIR, V22, P7302, DOI 10.1021/la060365i; Sundberg M, 2006, LANGMUIR, V22, P7286, DOI 10.1021/la060854i; Suzuki H, 1997, BIOPHYS J, V72, P1997, DOI 10.1016/S0006-3495(97)78844-1; Taira S, 2006, BIOTECHNOL BIOENG, V95, P533, DOI 10.1002/bit.21055; Takatsuki H, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/24/245101; Takatsuki H, 2010, SMALL, V6, P452, DOI 10.1002/smll.200901369; Turner D, 1996, ANAL BIOCHEM, V242, P20, DOI 10.1006/abio.1996.0422; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Vikhorev PG, 2008, LANGMUIR, V24, P13509, DOI 10.1021/la8016112; Vikhorev PG, 2008, BIOPHYS J, V95, P5809, DOI 10.1529/biophysj.108.140335; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Zhang CY, 2005, NAT MATER, V4, P826, DOI 10.1038/nmat1508; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	70	15	15	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46298	10.1371/journal.pone.0046298	http://dx.doi.org/10.1371/journal.pone.0046298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056279	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000032
J	Pratx, G; Chen, K; Sun, C; Martin, L; Carpenter, CM; Olcott, PD; Xing, L				Pratx, Guillem; Chen, Kai; Sun, Conroy; Martin, Lynn; Carpenter, Colin M.; Olcott, Peter D.; Xing, Lei			Radioluminescence Microscopy: Measuring the Heterogeneous Uptake of Radiotracers in Single Living Cells	PLOS ONE			English	Article							GLUCOSE-UPTAKE ACTIVITY; CANCER; PROBE; PET	Radiotracers play an important role in interrogating molecular processes both in vitro and in vivo. However, current methods are limited to measuring average radiotracer uptake in large cell populations and, as a result, lack the ability to quantify cell-to-cell variations. Here we apply a new technique, termed radioluminescence microscopy, to visualize radiotracer uptake in single living cells, in a standard fluorescence microscopy environment. In this technique, live cells are cultured sparsely on a thin scintillator plate and incubated with a radiotracer. Light produced following beta decay is measured using a highly sensitive microscope. Radioluminescence microscopy revealed strong heterogeneity in the uptake of [F-18]fluorodeoxyglucose (FDG) in single cells, which was found consistent with fluorescence imaging of a glucose analog. We also verified that dynamic uptake of FDG in single cells followed the standard two-tissue compartmental model. Last, we transfected cells with a fusion PET/fluorescence reporter gene and found that uptake of FHBG (a PET radiotracer for transgene expression) coincided with expression of the fluorescent protein. Together, these results indicate that radioluminescence microscopy can visualize radiotracer uptake with single-cell resolution, which may find a use in the precise characterization of radiotracers.	[Pratx, Guillem; Chen, Kai; Sun, Conroy; Martin, Lynn; Carpenter, Colin M.; Xing, Lei] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Olcott, Peter D.] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Pratx, G (corresponding author), Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA.	pratx@stanford.edu	Sun, Conroy/S-3222-2019; Pratx, Guillem/AAK-8006-2020; Sun, Conroy/B-5611-2013	Sun, Conroy/0000-0001-5193-6907; Sun, Conroy/0000-0001-5193-6907; Xing, Lei/0000-0003-2536-5359; Pratx, Guillem/0000-0002-0247-6470	Department of Defense [W81XWH-11-1-0070]; National Institutes of Health, ICMIC [P50CA114747]; NATIONAL CANCER INSTITUTE [P50CA114747] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health, ICMIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided by the Department of Defense under grant W81XWH-11-1-0070 and by the National Institutes of Health, ICMIC P50CA114747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carson RE, 2005, POSITRON EMISSION TO, P127, DOI [10.1007/1-84628-007-9_6, DOI 10.1007/1-84628-007-9_6]; CHARPAK G, 1989, P NATL ACAD SCI USA, V86, P1741, DOI 10.1073/pnas.86.6.1741; Chen LY, 2008, J NUCL MED, V49, P1141, DOI 10.2967/jnumed.107.040568; Dobrucki LW, 2010, NAT REV CARDIOL, V7, P38, DOI 10.1038/nrcardio.2009.201; ENSLEY JF, 1987, CYTOMETRY, V8, P488, DOI 10.1002/cyto.990080509; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; HEIMBERG H, 1993, EMBO J, V12, P2873, DOI 10.1002/j.1460-2075.1993.tb05949.x; Jadvar H, 2009, J NUCL MED, V50, P1820, DOI 10.2967/jnumed.108.054098; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; Kanno S, 2007, J RADIOANAL NUCL CH, V272, P565, DOI 10.1007/s10967-007-0625-z; Leidholdt EM, 2006, ESSENTIAL PHYS MED I; Mettivier G, 2003, PHYS MED BIOL, V48, pN173, DOI 10.1088/0031-9155/48/12/403; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; OBRIEN RT, 1959, NATURE, V183, P1461, DOI 10.1038/1831461a0; Ott R, 2000, PHYS MED BIOL, V45, P2011, DOI 10.1088/0031-9155/45/7/322; PALTSYN AA, 1990, B EXP BIOL MED+, V110, P1731, DOI 10.1007/BF00842611; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Phelps ME, 2000, J NUCL MED, V41, P661; Pugachev A, 2005, INT J RADIAT ONCOL, V62, P545, DOI 10.1016/j.ijrobp.2005.02.009; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; Tseng JC, 2012, MOL IMAGING IN PRESS; Yaghoubi S, 2001, J NUCL MED, V42, P1225; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Yoshioka K, 1996, BIOSCI BIOTECH BIOCH, V60, P1899, DOI 10.1271/bbb.60.1899	28	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46285	10.1371/journal.pone.0046285	http://dx.doi.org/10.1371/journal.pone.0046285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056276	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000029
J	Blees, JS; Bokesch, HR; Rubsamen, D; Schulz, K; Milke, L; Bajer, MM; Gustafson, KR; Henrich, CJ; McMahon, JB; Colburn, NH; Schmid, T; Brune, B				Blees, Johanna S.; Bokesch, Heidi R.; Ruebsamen, Daniela; Schulz, Kathrin; Milke, Larissa; Bajer, Magdalena M.; Gustafson, Kirk R.; Henrich, Curtis J.; McMahon, James B.; Colburn, Nancy H.; Schmid, Tobias; Bruene, Bernhard			Erioflorin Stabilizes the Tumor Suppressor Pdcd4 by Inhibiting Its Interaction with the E3-ligase beta-TrCP1	PLOS ONE			English	Article							NF-KAPPA-B; E3 UBIQUITIN LIGASE; BETA-TRCP; TRANSFORMATION SUPPRESSOR; SESQUITERPENE LACTONES; AP-1 TRANSACTIVATION; COLORECTAL-CANCER; EXPRESSION; PROTEIN; TRANSLATION	Loss of the tumor suppressor Pdcd4 was reported for various tumor entities and proposed as a prognostic marker in tumorigenesis. We previously characterized decreased Pdcd4 protein stability in response to mitogenic stimuli, which resulted from p70(S6K1)-dependent protein phosphorylation, beta-TrCP1-mediated ubiquitination, and proteasomal destruction. Following high-throughput screening of natural product extract libraries using a luciferase-based reporter assay to monitor phosphorylation-dependent proteasomal degradation of the tumor suppressor Pdcd4, we succeeded in showing that a crude extract from Eriophyllum lanatum stabilized Pdcd4 from TPA-induced degradation. Erioflorin was identified as the active component and inhibited not only degradation of the Pdcd4-luciferase-based reporter but also of endogenous Pdcd4 at low micromolar concentrations. Mechanistically, erioflorin interfered with the interaction between the E3-ubiquitin ligase beta-TrCP1 and Pdcd4 in cell culture and in in vitro binding assays, consequently decreasing ubiquitination and degradation of Pdcd4. Interestingly, while erioflorin stabilized additional beta-TrCP-targets (such as I kappa B alpha and beta-catenin), it did not prevent the degradation of targets of other E3-ubiquitin ligases such as p21 (a Skp2-target) and HIF-1 alpha (a pVHL-target), implying selectivity for beta-TrCP. Moreover, erioflorin inhibited the tumor-associated activity of known Pdcd4- and I kappa B alpha-regulated alpha transcription factors, that is, AP-1 and NF-kappa B, altered cell cycle progression and suppressed proliferation of various cancer cell lines. Our studies succeeded in identifying erioflorin as a novel Pdcd4 stabilizer that inhibits the interaction of Pdcd4 with the E3-ubiquitin ligase beta-TrCP1. Inhibition of E3-ligase/target-protein interactions may offer the possibility to target degradation of specific proteins only as compared to general proteasome inhibition.	[Blees, Johanna S.; Ruebsamen, Daniela; Schulz, Kathrin; Milke, Larissa; Bajer, Magdalena M.; Schmid, Tobias; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, Frankfurt, Germany; [Bokesch, Heidi R.; Gustafson, Kirk R.; Henrich, Curtis J.; McMahon, James B.] NCI, Mol Targets Lab, Ctr Canc Res, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Bokesch, Heidi R.; Henrich, Curtis J.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Frederick, MD USA; [Colburn, Nancy H.] NCI, Lab Canc Prevent, Ctr Canc Res, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA	Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schmid, T (corresponding author), Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, Frankfurt, Germany.	T.Schmid@biochem.uni-frankfurt.de		Schmid, Tobias/0000-0002-1952-5259	DFG [BR999, GRK1172]; LOEWE Schwerpunkt OSF [III L 4-518/55.004]; Hessian Ministry of Higher Education, Research and Arts; Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E]; NIH, Frederick National Laboratory for Cancer Research, National Cancer Institute, Center for Cancer Research; U.S. Government; NATIONAL CANCER INSTITUTE [ZICBC010469, ZIABC011467, ZIABC010026] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); LOEWE Schwerpunkt OSF; Hessian Ministry of Higher Education, Research and Arts; Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health (NIH); NIH, Frederick National Laboratory for Cancer Research, National Cancer Institute, Center for Cancer Research; U.S. Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the DFG (BR999 and GRK1172) and the LOEWE Schwerpunkt OSF (III L 4-518/55.004 (2009)) funded by the Hessian Ministry of Higher Education, Research and Arts. This project was funded in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government. This research was also supported in part by the Intramural Research Program of NIH, Frederick National Laboratory for Cancer Research, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Two of the authors (HRB, CJH) are employed by SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, which is a U.S. Government contractor, thus funding comes from the U.S. Government. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Akar U, 2010, MOL CANCER THER, V9, P1180, DOI 10.1158/1535-7163.MCT-09-1025; Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; Blees JS, 2010, J BIOMOL SCREEN, V15, P21, DOI 10.1177/1087057109351028; BOHLMANN F, 1981, PHYTOCHEMISTRY, V20, P1635, DOI 10.1016/S0031-9422(00)98546-7; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Carayol N, 2008, J BIOL CHEM, V283, P8601, DOI 10.1074/jbc.M707934200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Grkovic T, 2011, J NAT PROD, V74, P1015, DOI 10.1021/np100918z; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Jia L, 2011, CURR CANCER DRUG TAR, V11, P347, DOI 10.2174/156800911794519734; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Li JJ, 1997, CANCER RES, V57, P3569; Lindenmeyer MT, 2004, ANAL BIOCHEM, V328, P147, DOI 10.1016/j.ab.2004.01.021; McCloud TG, 2010, MOLECULES, V15, P4526, DOI 10.3390/molecules15074526; Meragelman KM, 2000, J NAT PROD, V63, P427, DOI 10.1021/np990570g; MORIMOTO H, 1981, J NAT PROD, V44, P748, DOI 10.1021/np50018a026; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Patel S, 2008, EXPERT OPIN INV DRUG, V17, P1865, DOI 10.1517/13543780802493366 ; Sambrook J., 2002, MOL CLONING LAB MANU; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Schmid T, 2011, CARCINOGENESIS, V32, P1427, DOI 10.1093/carcin/bgr131; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tang WG, 2005, CANCER RES, V65, P1904, DOI 10.1158/0008-5472.CAN-04-2597; TORRANCE SJ, 1969, PHYTOCHEMISTRY, V8, P2381, DOI 10.1016/S0031-9422(00)88158-3; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; von Knethen A, 1999, J IMMUNOL, V163, P2858; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Zhao LX, 2011, J NAT PROD, V74, P1990, DOI 10.1021/np200603g	50	36	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46567	10.1371/journal.pone.0046567	http://dx.doi.org/10.1371/journal.pone.0046567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056346	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600042
J	Liu, MQ; Bjornlund, L; Ronn, R; Christensen, S; Ekelund, F				Liu, Manqiang; Bjornlund, Lisa; Ronn, Regin; Christensen, Soren; Ekelund, Flemming			Disturbance Promotes Non-Indigenous Bacterial Invasion in Soil Microcosms: Analysis of the Roles of Resource Availability and Community Structure	PLOS ONE			English	Article							TERRESTRIAL ECOSYSTEMS; RELATIVE IMPORTANCE; PROPAGULE PRESSURE; SPECIES-DIVERSITY; PLANT-COMMUNITIES; NAKED AMEBAS; INVASIBILITY; PSEUDOMONAS; BIODIVERSITY; COMPETITION	Background: Invasion-biology is largely based on non-experimental observation of larger organisms. Here, we apply an experimental approach to the subject. By using microbial-based microcosm-experiments, invasion-biology can be placed on firmer experimental, and hence, less anecdotal ground. A better understanding of the mechanisms that govern invasion-success of bacteria in soil communities will provide knowledge on the factors that hinder successful establishment of bacteria artificially inoculated into soil, e. g. for remediation purposes. Further, it will yield valuable information on general principles of invasion biology in other domains of life. Methodology/Principal Findings: Here, we studied invasion and establishment success of GFP-tagged Pseudomonas fluorescens DSM 50090 in laboratory microcosms during a 42-day period. We used soil heating to create a disturbance gradient, and hypothesized that increased disturbance would facilitate invasion; our experiments confirmed this hypothesis. We suggest that the key factors associated with the heating disturbance that explain the enhanced invasion success are increased carbon substrate availability and reduced diversity, and thus, competition-and predation-release. In a second experiment we therefore separated the effects of increased carbon availability and decreased diversity. Here, we demonstrated that the effect of the indigenous soil community on bacterial invasion was stronger than that of resource availability. In particular, introduced bacteria established better in a long term perspective at lower diversity and predation pressure. Conclusion: We propose increased use of microbial systems, for experimental study of invasion scenarios. They offer a simple and cost-efficient way to study and understand biological invasion. Consequently such systems can help us to better predict the mechanisms controlling changes in stability of communities and ecosystems. This is becoming increasingly relevant since anthropogenic disturbance causes increasing global change, which promotes invasion. Moreover, a thorough understanding of factors controlling invasion and establishment of artificially amended microorganisms will mean a major step forward for soil-remediation microbiology.	[Liu, Manqiang; Bjornlund, Lisa; Ronn, Regin; Christensen, Soren; Ekelund, Flemming] Univ Copenhagen, Terr Ecol Sect, Dept Biol, Copenhagen K, Denmark; [Liu, Manqiang] Nanjing Agr Univ, Soil Ecol Lab, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	University of Copenhagen; Nanjing Agricultural University	Ekelund, F (corresponding author), Univ Copenhagen, Terr Ecol Sect, Dept Biol, Copenhagen K, Denmark.	fekelund@bio.ku.dk	Christensen, Soren/J-6246-2014; Rønn, Regin/K-4460-2014; Ekelund, Flemming/M-1731-2014; Liu, Manqiang/G-6566-2012	Christensen, Soren/0000-0002-7067-5586; Rønn, Regin/0000-0002-7486-1191; Ekelund, Flemming/0000-0002-2144-7659; Liu, Manqiang/0000-0001-6654-7795	National Foundation of Sciences in China [30900210]; Chinese-Danish Government Exchange Scholarship; PADA (Priority Academic Program Development of Jiangsu Higher Education Institutions); Danish Strategic Research Council (Det Strategiske Forskningsrad, DSF) [2104-08-0012]; Danish Environmental Agency [MST: 667-00081]	National Foundation of Sciences in China; Chinese-Danish Government Exchange Scholarship; PADA (Priority Academic Program Development of Jiangsu Higher Education Institutions); Danish Strategic Research Council (Det Strategiske Forskningsrad, DSF); Danish Environmental Agency	ML was fully sponsored by the National Foundation of Sciences in China (No. 30900210), the Chinese-Danish Government Exchange Scholarship, and the PADA (Priority Academic Program Development of Jiangsu Higher Education Institutions). FE received funding from The Danish Strategic Research Council (Det Strategiske Forskningsrad, DSF, 2104-08-0012; MIRESOWA). FE and RR received funding from the Danish Environmental Agency (MST: 667-00081, GENEPEASE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2008, PLANT SOIL, V304, P103, DOI 10.1007/s11104-007-9525-9; [Anonymous], 1988, NEW KEY FRESHWATER S; Chantigny MH, 2010, SOIL SCI SOC AM J, V74, P517, DOI 10.2136/sssaj2008.0347; Clark GF, 2009, OIKOS, V118, P1679, DOI 10.1111/j.1600-0706.2009.17564.x; Crawley M. J., 1987, COLONIZATION SUCCESS, V26, P429; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Davis MA, 2001, ECOL LETT, V4, P421, DOI 10.1046/j.1461-0248.2001.00246.x; EKELUND F, 1994, FEMS MICROBIOL REV, V15, P321, DOI 10.1111/j.1574-6976.1994.tb00144.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Eschtruth AK, 2009, ECOL MONOGR, V79, P265, DOI 10.1890/08-0221.1; Fleming GM, 2009, ECOL APPL, V19, P2210, DOI 10.1890/07-1959.1; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Griffiths BS, 2004, MICROB ECOL, V47, P104, DOI 10.1007/s00248-002-2043-7; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hooper DU, 2010, J ECOL, V98, P764, DOI 10.1111/j.1365-2745.2010.01673.x; Kneitel JM, 2006, COMMUNITY ECOL, V7, P245, DOI 10.1556/ComEc.7.2006.2.11; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Litchman E, 2010, ECOL LETT, V13, P1560, DOI 10.1111/j.1461-0248.2010.01544.x; Maron J, 2007, ECOLOGY, V88, P2651, DOI 10.1890/06-1993.1; Matos A, 2005, MICROB ECOL, V49, P257, DOI 10.1007/s00248-004-0179-3; Otfinowski R, 2010, BIOL INVASIONS, V12, P1349, DOI 10.1007/s10530-009-9551-z; Pedersen AL, 2009, MICROB ECOL, V57, P501, DOI 10.1007/s00248-008-9455-y; Romanuk TN, 2005, BIOL INVASIONS, V7, P711, DOI 10.1007/s10530-004-0997-8; RONN R, 1995, PEDOBIOLOGIA, V39, P10; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Schooler SS, 2010, BIOL INVASIONS, V12, P3289, DOI 10.1007/s10530-010-9722-y; Thirup L, 2000, SOIL BIOL BIOCHEM, V32, P1615, DOI 10.1016/S0038-0717(00)00075-4; van Elsas JD, 2007, ISME J, V1, P204, DOI 10.1038/ismej.2007.21; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; WARDLE DA, 1993, OECOLOGIA, V93, P303, DOI 10.1007/BF00317685; Wolters V, 2000, BIOSCIENCE, V50, P1089, DOI 10.1641/0006-3568(2000)050[1089:EOGCOA]2.0.CO;2	31	29	32	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45306	10.1371/journal.pone.0045306	http://dx.doi.org/10.1371/journal.pone.0045306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056198	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600009
J	Busnadiego, I; Maestre, AM; Rodriguez, D; Rodriguez, JF				Busnadiego, Idoia; Maestre, Ana M.; Rodriguez, Dolores; Rodriguez, Jose F.			The Infectious Bursal Disease Virus RNA-Binding VP3 Polypeptide Inhibits PKR-Mediated Apoptosis	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; EUKARYOTIC TRANSLATION INITIATION; NF-KAPPA-B; VACCINIA VIRUS; COMPLEX-FORMATION; MAMMALIAN-CELLS; GENE-EXPRESSION; SUBSTRATE RECOGNITION; TERMINAL DOMAIN	Infectious bursal disease virus (IBDV) is an avian pathogen responsible for an acute immunosuppressive disease that causes major losses to the poultry industry. Despite having a bipartite dsRNA genome, IBDV, as well as other members of the Birnaviridae family, possesses a single capsid layer formed by trimers of the VP2 capsid protein. The capsid encloses a ribonucleoprotein complex formed by the genome associated to the RNA-dependent RNA polymerase and the RNA-binding polypeptide VP3. A previous report evidenced that expression of the mature VP2 IBDV capsid polypeptide triggers a swift programmed cell death response in a wide variety of cell lines. The mechanism(s) underlying this effect remained unknown. Here, we show that VP2 expression in HeLa cells activates the double-stranded RNA (dsRNA)-dependent protein kinase (PKR), which in turn triggers the phosphorylation of the eukaryotic initiation factor 2 alpha (eIF2 alpha). This results in a strong blockade of protein synthesis and the activation of an apoptotic response which is efficiently blocked by coexpression of a dominant negative PKR polypeptide. Our results demonstrate that coexpression of the VP3 polypeptide precludes phosphorylation of both PKR and eIF2 alpha and the onset of programmed cell death induced by VP2 expression. A mutation blocking the capacity of VP3 to bind dsRNA also abolishes its capacity to prevent PKR activation and apoptosis. Further experiments showed that VP3 functionally replaces the host-range vaccinia virus (VACV) E3 protein, thus allowing the E3 deficient VACV deletion mutant WR Delta E3L to grow in non-permissive cell lines. According to results presented here, VP3 can be categorized along with other well characterized proteins such us VACV E3, avian reovirus sigmaA, and influenza virus NS1 as a virus-encoded dsRNA-binding polypeptide with antiapoptotic properties. Our results suggest that VP3 plays a central role in ensuring the viability of the IBDV replication cycle by preventing programmed cell death.	[Busnadiego, Idoia; Maestre, Ana M.; Rodriguez, Dolores; Rodriguez, Jose F.] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rodriguez, JF (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	jfrodrig@cnb.csic.es	Merens, Ana Maestre/I-2445-2019; Rodríguez, José F/T-8500-2017; Busnadiego, Idoia/O-8641-2016; Rodriguez, Dolores/ABF-9855-2020	Merens, Ana Maestre/0000-0002-2494-0879; Rodríguez, José F/0000-0001-7944-5341; Busnadiego, Idoia/0000-0002-8781-9099; Rodriguez, Dolores/0000-0001-6365-4501	Spanish Ministry of Economy and Competitiveness [BIO2006-09407, BIO2009-12443, AGL2011-24758, AGL2010-15495]; FPI fellowship from the Spanish Ministry of Economy and Competitiveness	Spanish Ministry of Economy and Competitiveness(Spanish Government); FPI fellowship from the Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness BIO2006-09407, BIO2009-12443, and AGL2011-24758 to JFR, and AGL2010-15495 to DR. IB was supported by an FPI fellowship from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Aricibasi M, 2010, VET IMMUNOL IMMUNOP, V135, P79, DOI 10.1016/j.vetimm.2009.11.005; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Beattie E, 1996, VIRUS GENES, V12, P89, DOI 10.1007/BF00370005; Bottcher B, 1997, J VIROL, V71, P325; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; CHANG HW, 1995, J VIROL, V69, P6605, DOI 10.1128/JVI.69.10.6605-6608.1995; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chiu CL, 2010, APOPTOSIS, V15, P653, DOI 10.1007/s10495-010-0468-x; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; DELMAS B, 2005, VIRUS TAXONOMY, P561; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Fernandez-Arias A, 1998, J GEN VIROL, V79, P1047, DOI 10.1099/0022-1317-79-5-1047; FernandezArias A, 1997, J VIROL, V71, P8014; Festjens N, 2006, BIOL CHEM, V387, P1005, DOI 10.1515/BC.2006.124; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Gherardi MM, 1999, J IMMUNOL, V162, P6724; Gil J, 1999, MOL CELL BIOL, V19, P4653; Gil J, 2004, J INTERF CYTOK RES, V24, P637, DOI 10.1089/1079990042475706; Gonzalez-Lopez C, 2003, J GEN VIROL, V84, P1629, DOI 10.1099/vir.0.19004-0; Guerra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028677; Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Heljasvaara R, 2001, J VIROL, V75, P5778, DOI 10.1128/JVI.75.13.5778-5795.2001; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Hong JR, 2005, J FISH DIS, V28, P133, DOI 10.1111/j.1365-2761.2004.00604.x; Hong JR, 2002, CELL DEATH DIFFER, V9, P113, DOI 10.1038/sj/cdd/4400933; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; Jungmann A, 2001, J GEN VIROL, V82, P1107, DOI 10.1099/0022-1317-82-5-1107; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; KAPLAN C, 1989, ARCH VIROL, V106, P127, DOI 10.1007/BF01311044; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kepp O, 2009, CELL CYCLE, V8, P860, DOI 10.4161/cc.8.6.7939; Kibenge FSB, 1997, ARCH VIROL, V142, P2401, DOI 10.1007/s007050050251; Kochan G, 2003, ARCH VIROL, V148, P723, DOI 10.1007/s00705-002-0949-5; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LANGLAND JO, 1994, J VIROL, V68, P3821, DOI 10.1128/JVI.68.6.3821-3829.1994; Lawton JA, 2000, ADV VIRUS RES, V55, P185, DOI 10.1016/S0065-3527(00)55004-0; LEE SB, 1993, VIROLOGY, V193, P1037, DOI 10.1006/viro.1993.1223; LEECHEN GJ, 1988, VIROLOGY, V163, P80, DOI 10.1016/0042-6822(88)90235-8; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Liu MH, 2006, J VIROL, V80, P3369, DOI 10.1128/JVI.80.7.3369-3377.2006; Lombardo E, 2000, VIROLOGY, V277, P345, DOI 10.1006/viro.2000.0595; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Majumdar R, 2005, EMBO J, V24, P3737, DOI 10.1038/sj.emboj.7600844; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Maraver A, 2003, J VIROL, V77, P2459, DOI 10.1128/JVI.77.4.2459-2468.2003; MERTENS PPC, 1982, J GEN VIROL, V59, P47, DOI 10.1099/0022-1317-59-1-47; Mundt E, 1997, J VIROL, V71, P5647, DOI 10.1128/JVI.71.7.5647-5651.1997; Nussbaum JM, 2002, NUCLEIC ACIDS RES, V30, P1205, DOI 10.1093/nar/30.5.1205; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Patton JT, 2007, ADV VIRUS RES, V69, P167, DOI 10.1016/S0065-3527(06)69004-0; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Qin LT, 2010, VACCINE, V28, P3735, DOI 10.1016/j.vaccine.2010.02.102; RODENBERG J, 1994, AVIAN DIS, V38, P16, DOI 10.2307/1591831; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; Sharma JM, 2000, DEV COMP IMMUNOL, V24, P223, DOI 10.1016/S0145-305X(99)00074-9; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; Tan SL, 1998, J INTERF CYTOK RES, V18, P757, DOI 10.1089/jir.1998.18.757; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; van den Berg TP, 2000, REV SCI TECH OIE, V19, P527; von Einem UI, 2004, J GEN VIROL, V85, P2221, DOI 10.1099/vir.0.19772-0; WARD GA, 1995, P NATL ACAD SCI USA, V92, P6773, DOI 10.1073/pnas.92.15.6773; Wei L, 2011, VIROLOGY, V417, P211, DOI 10.1016/j.virol.2011.03.003; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wu YP, 2009, ARCH VIROL, V154, P1873, DOI 10.1007/s00705-009-0524-4; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038	76	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46768	10.1371/journal.pone.0046768	http://dx.doi.org/10.1371/journal.pone.0046768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056444	Green Submitted, Green Published, gold			2022-12-27	WOS:000309889400026
J	Jirouskova, M; Zbodakova, O; Gregor, M; Chalupsky, K; Sarnova, L; Hajduch, M; Ehrmann, J; Jirkovska, M; Sedlacek, R				Jirouskova, Marketa; Zbodakova, Olga; Gregor, Martin; Chalupsky, Karel; Sarnova, Lenka; Hajduch, Marian; Ehrmann, Jiri; Jirkovska, Marie; Sedlacek, Radislav			Hepatoprotective Effect of MMP-19 Deficiency in a Mouse Model of Chronic Liver Fibrosis	PLOS ONE			English	Article							HUMAN MATRIX-METALLOPROTEINASE; HEPATIC STELLATE CELLS; DIFFERENTIAL EXPRESSION; RHEUMATOID-ARTHRITIS; TUMOR INVASION; TGF-BETA; RAT; SURFACE; INJURY; PROLIFERATION	Liver fibrosis is characterized by the deposition and increased turnover of extracellular matrix. This process is controlled by matrix metalloproteinases (MMPs), whose expression and activity dynamically change during injury progression. MMP-19, one of the most widely expressed MMPs, is highly expressed in liver; however, its contribution to liver pathology is unknown. The aim of this study was to elucidate the role of MMP-19 during the development and resolution of fibrosis by comparing the response of MMP-19-deficient (MMP19KO) and wild-type mice upon chronic liver CCl4-intoxication. We show that loss of MMP-19 was beneficial during liver injury, as plasma ALT and AST levels, deposition of fibrillar collagen, and phosphorylation of SMAD3, a TGF-beta 1 signaling molecule, were all significantly lower in MMP19KO mice. The ameliorated course of the disease in MMP19KO mice likely results from a slower rate of basement membrane destruction and ECM remodeling as the knockout mice maintained significantly higher levels of type IV collagen and lower expression and activation of MMP-2 after 4 weeks of CCl4-intoxication. Hastened liver regeneration in MMP19KO mice was associated with slightly higher IGF-1 mRNA expression, slightly increased phosphorylation of Akt kinase, decreased TGF-beta 1 mRNA levels and significantly reduced SMAD3 phosphorylation. In addition, primary hepatocytes isolated from MMP19KO mice showed impaired responsiveness towards TGF-beta 1 stimulation, resulting in lower expression of Snail1 and vimentin mRNA. Thus, MMP-19-deficiency improves the development of hepatic fibrosis through the diminished replacement of physiological extracellular matrix with fibrotic deposits in the beginning of the injury, leading to subsequent changes in TGF-beta and IGF-1 signaling pathways.	[Jirouskova, Marketa; Zbodakova, Olga; Gregor, Martin; Chalupsky, Karel; Sarnova, Lenka; Sedlacek, Radislav] ASCR, Inst Mol Genet, Prague, Czech Republic; [Hajduch, Marian; Ehrmann, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic; [Hajduch, Marian; Ehrmann, Jiri] Univ Hosp Olomouc, Olomouc, Czech Republic; [Ehrmann, Jiri] Palacky Univ, Fac Med & Dent, Dept Clin & Mol Pathol, CR-77147 Olomouc, Czech Republic; [Jirkovska, Marie] Charles Univ Prague, Fac Med 1, Inst Histol & Embryol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Palacky University Olomouc; University Hospital Olomouc; Palacky University Olomouc; Charles University Prague	Sedlacek, R (corresponding author), ASCR, Inst Mol Genet, Prague, Czech Republic.	radislav.sedlacek@img.cas.cz	Gregor, Martin/G-4411-2014; Hajduch, Marian/J-4015-2014; Ehrmann, Jiri/C-9074-2009; Jirkovská, Marie/P-2219-2017; Chalupsky, Karel/K-7647-2014; Sedlacek, Radislav/G-4408-2014	Gregor, Martin/0000-0001-6841-9527; Hajduch, Marian/0000-0002-4834-908X; Ehrmann, Jiri/0000-0002-8419-3414; Jirkovská, Marie/0000-0003-3902-4758; 	GAAV (The Grant Agency of the Academy of Sciences of the Czech Republic) [IAA500520812]; GACR (Grantova Agentura Ceske Pepubliky) [P303/10/2044]; Academy of Sciences of the Czech Republic [RVO 68378050]; Ministry of School and Education, Czech Republic [CZ.1.05/1.1.00/02.0109, CZ.1.05/2.1.00/01.0030]	GAAV (The Grant Agency of the Academy of Sciences of the Czech Republic); GACR (Grantova Agentura Ceske Pepubliky); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of School and Education, Czech Republic	Financial support was given to RS by GAAV (The Grant Agency of the Academy of Sciences of the Czech Republic) (IAA500520812; http://www.gaav.cz), GACR (Grantova Agentura Ceske Pepubliky) (P303/10/2044; http://www.gacr.cz/), Academy of Sciences of the Czech Republic (RVO 68378050; http://www.cas.cz/), and by Ministry of School and Education, Czech Republic (Operational Program Research and Development for Innovations) to RS (CZ.1.05/1.1.00/02.0109) and MH (CZ.1.05/2.1.00/01.0030; http://www.msmt.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Beck IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002343; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Chan KC, 2011, INT J CANCER, V129, P1826, DOI 10.1002/ijc.25855; Cossins J, 1996, BIOCHEM BIOPH RES CO, V228, P494, DOI 10.1006/bbrc.1996.1688; Gentilini A, 1998, J CELL PHYSIOL, V174, P240; George J, 1999, P NATL ACAD SCI USA, V96, P12719, DOI 10.1073/pnas.96.22.12719; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880; Gueders MM, 2010, AM J RESP CELL MOL, V43, P286, DOI 10.1165/rcmb.2008-0426OC; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Jelcick AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021858; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kahraman A, 2009, HEPATOL RES, V39, P805, DOI 10.1111/j.1872-034X.2009.00541.x; Kakinuma M, 2005, J CHROMATOGR B, V824, P161, DOI 10.1016/j.jchromb.2005.07.019; Knittel T, 2000, HISTOCHEM CELL BIOL, V113, P443; Kolb C, 1997, IMMUNOL LETT, V57, P83, DOI 10.1016/S0165-2478(97)00057-6; Mauch S, 2002, J IMMUNOL, V168, P1244, DOI 10.4049/jimmunol.168.3.1244; MILANI S, 1994, AM J PATHOL, V144, P528; Moldeus P, 1978, Methods Enzymol, V52, P60; Mueller MS, 2000, GENE, V256, P101, DOI 10.1016/S0378-1119(00)00369-3; Onozuka I, 2011, BIOCHEM BIOPH RES CO, V406, P134, DOI 10.1016/j.bbrc.2011.02.012; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Pendas AM, 1997, J BIOL CHEM, V272, P4281, DOI 10.1074/jbc.272.7.4281; Radbill BD, 2002, DIGEST DIS SCI, V56, P406; Radbill BD, 2011, DIGEST DIS SCI, V56, P406, DOI 10.1007/s10620-010-1296-0; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; Sadowski T, 2005, CELL MOL LIFE SCI, V62, P870, DOI 10.1007/s00018-005-4478-8; Sadowski T, 2003, MOL BIOL CELL, V14, P4569, DOI 10.1091/mbc.E03-01-0009; Sadowski T, 2003, J INVEST DERMATOL, V121, P989, DOI 10.1046/j.1523-1747.2003.12526.x; Sanz S, 2005, GUT, V54, P134, DOI 10.1136/gut.2003.024505; Sedlacek R, 1998, IMMUNOBIOLOGY, V198, P408, DOI 10.1016/S0171-2985(98)80049-1; Stracke JO, 2000, J BIOL CHEM, V275, P14809, DOI 10.1074/jbc.275.20.14809; Stracke JO, 2000, FEBS LETT, V478, P52, DOI 10.1016/S0014-5793(00)01819-6; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; TAKAHARA T, 1995, HEPATOLOGY, V21, P787; Theret N, 1998, AM J PATHOL, V153, P945, DOI 10.1016/S0002-9440(10)65636-2; Titz B, 2004, CELL MOL LIFE SCI, V61, P1826, DOI 10.1007/s00018-004-4105-0; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Ueno H, 2000, HUM GENE THER, V11, P33, DOI 10.1089/10430340050016139; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yu G, 2012, AM J RESP CRIT CARE; Yu Q, 2000, GENE DEV, V14, P163; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197; Zhang M, 2009, OSTEOARTHR CARTILAGE, V17, P100, DOI 10.1016/j.joca.2008.05.007; Zimmermann EM, 2000, AM J PHYSIOL-GASTR L, V278, pG447, DOI 10.1152/ajpgi.2000.278.3.G447	52	24	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46271	10.1371/journal.pone.0046271	http://dx.doi.org/10.1371/journal.pone.0046271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056273	gold, Green Submitted, Green Published			2022-12-27	WOS:000309889400011
J	Belda-Palazon, B; Ruiz, L; Marti, E; Tarraga, S; Tiburcio, AF; Culianez, F; Farras, R; Carrasco, P; Ferrando, A				Belda-Palazon, Borja; Ruiz, Leticia; Marti, Esmeralda; Tarraga, Susana; Tiburcio, Antonio F.; Culianez, Francisco; Farras, Rosa; Carrasco, Pedro; Ferrando, Alejandro			Aminopropyltransferases Involved in Polyamine Biosynthesis Localize Preferentially in the Nucleus of Plant Cells	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; SPERMIDINE SYNTHASE; ARABIDOPSIS-THALIANA; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; S-ADENOSYLMETHIONINE; EXPRESSION; MECHANISM; ACYLTRANSFERASE; DECARBOXYLASE	Plant aminopropyltransferases consist of a group of enzymes that transfer aminopropyl groups derived from decarboxylated S-adenosyl-methionine (dcAdoMet or dcSAM) to propylamine acceptors to produce polyamines, ubiquitous metabolites with positive charge at physiological pH. Spermidine synthase (SPDS) uses putrescine as amino acceptor to form spermidine, whereas spermine synthase (SPMS) and thermospermine synthase (TSPMS) use spermidine as acceptor to synthesize the isomers spermine and thermospermine respectively. In previous work it was shown that both SPDS1 and SPDS2 can physically interact with SPMS although no data concerning the subcellular localization was reported. Here we study the subcellular localization of these enzymes and their protein dimer complexes with gateway-based Bimolecular Fluorescence Complementation (BiFC) binary vectors. In addition, we have characterized the molecular weight of the enzyme complexes by gel filtration chromatography with in vitro assembled recombinant enzymes and with endogenous plant protein extracts. Our data suggest that aminopropyltransferases display a dual subcellular localization both in the cytosol and nuclear enriched fractions, and they assemble preferably as dimers. The BiFC transient expression data suggest that aminopropyltransferase heterodimer complexes take place preferentially inside the nucleus.	[Belda-Palazon, Borja; Marti, Esmeralda; Tarraga, Susana; Culianez, Francisco; Ferrando, Alejandro] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Ruiz, Leticia] Ctr Mojonera, Inst Andaluz Invest & Formac Agr, Almeria, Spain; [Tiburcio, Antonio F.] Univ Barcelona, Unidad Fisiol Vegetal, Barcelona, Spain; [Farras, Rosa] Ctr Invest Principe Felipe, Valencia, Spain; [Carrasco, Pedro] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Barcelona; Prince Felipe Research Center; University of Valencia	Ferrando, A (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	aferrando@ibmcp.upv.es	Carrasco, Pedro/P-3333-2014; Belda-Palazon, Borja/AAH-9916-2020; Farràs, Rosa/B-5180-2014; Garcia, Leticia Ruiz/AAE-4291-2021; Ferrando, Alejandro/F-2346-2014	Carrasco, Pedro/0000-0001-7900-6146; Belda-Palazon, Borja/0000-0003-4926-1917; Farràs, Rosa/0000-0003-4931-1494; Garcia, Leticia Ruiz/0000-0002-8612-966X; Ferrando, Alejandro/0000-0002-1903-9111	Spanish Ministerio de Ciencia e Innovacion [BIO2008-05493-C02-02, BIO2009-11818]; VALi+d predoctoral contract of Generalitat Valenciana [ACIF2010/085]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); VALi+d predoctoral contract of Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	This work was supported by grants BIO2008-05493-C02-02 and BIO2009-11818 from Spanish Ministerio de Ciencia e Innovacion to A. Ferrando. B. Belda-Palazon is a recipient of a VALi+d predoctoral contract of Generalitat Valenciana ACIF2010/085. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Antoni R, 2012, PLANT PHYSIOL, V158, P970, DOI 10.1104/pp.111.188623; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Dufe VT, 2007, J MOL BIOL, V373, P167, DOI 10.1016/j.jmb.2007.07.053; Dufe VT, 2005, FEBS LETT, V579, P6037, DOI 10.1016/j.febslet.2005.09.050; Fellenberg C, 2009, PHYTOCHEMISTRY, V70, P1392, DOI 10.1016/j.phytochem.2009.08.010; Ferrando A, 2001, NUCLEIC ACIDS RES, V29, P3685, DOI 10.1093/nar/29.17.3685; Fuell C, 2010, PLANT PHYSIOL BIOCH, V48, P513, DOI 10.1016/j.plaphy.2010.02.008; Ge CM, 2006, CELL RES, V16, P446, DOI 10.1038/sj.cr.7310056; Genoves A, 2009, VIROLOGY, V395, P133, DOI 10.1016/j.virol.2009.08.042; Grienenberger E, 2009, PLANT J, V58, P246, DOI 10.1111/j.1365-313X.2008.03773.x; Hanfrey C, 2001, PLANT J, V27, P551, DOI 10.1046/j.1365-313X.2001.01100.x; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Johnson DA, 2004, CELL MOTIL CYTOSKEL, V58, P269, DOI 10.1002/cm.20014; Knott JM, 2007, FEBS LETT, V581, P3081, DOI 10.1016/j.febslet.2007.05.074; Korolev S, 2002, NAT STRUCT BIOL, V9, P27, DOI 10.1038/nsb737; LILLIE SH, 1987, YEAST, V3, P63, DOI 10.1002/yea.320030202; Lu PK, 2004, ACTA CRYSTALLOGR D, V60, P2067, DOI 10.1107/S0907444904021985; Luo J, 2009, PLANT CELL, V21, P318, DOI 10.1105/tpc.108.063511; Minguet EG, 2008, MOL BIOL EVOL, V25, P2119, DOI 10.1093/molbev/msn161; Moschou PN, 2008, PLANT SIGNAL BEHAV, V3, P1061, DOI 10.4161/psb.3.12.7172; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Niogret MF, 1996, PLANT J, V9, P549, DOI 10.1046/j.1365-313X.1996.09040549.x; Panicot M, 2002, PLANT CELL, V14, P2539, DOI 10.1105/tpc.004077; Shao L, 2012, AMINO ACIDS, V42, P813, DOI 10.1007/s00726-011-0998-8; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Takahashi T, 2010, ANN BOT-LONDON, V105, P1, DOI 10.1093/aob/mcp259; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Wu H, 2007, BIOCHEMISTRY-US, V46, P8331, DOI 10.1021/bi602498k	34	77	79	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46907	10.1371/journal.pone.0046907	http://dx.doi.org/10.1371/journal.pone.0046907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056524	Green Published, gold			2022-12-27	WOS:000309831500107
J	Kala, S; Moshiri, H; Mehta, V; Yip, CW; Salavati, R				Kala, Smriti; Moshiri, Houtan; Mehta, Vaibhav; Yip, Chun Wai; Salavati, Reza			The Oligonucleotide Binding (OB)-Fold Domain of KREPA4 Is Essential for Stable Incorporation into Editosomes	PLOS ONE			English	Article							RNA EDITING COMPLEX; OB-FOLD DOMAIN; TRYPANOSOMA-BRUCEI; GUIDE-RNA; MESSENGER-RNA; EXORIBONUCLEASE ACTIVITY; DISTINCT EDITOSOMES; MRB1 COMPLEX; PROTEIN; MECHANISM	Most mitochondrial mRNAs in trypanosomatid parasites require uridine insertion/deletion RNA editing, a process mediated by guide RNA (gRNA) and catalyzed by multi-protein complexes called editosomes. The six oligonucleotide/oligosaccharide binding (OB)-fold proteins (KREPA1-A6), are a part of the common core of editosomes. They form a network of interactions among themselves as well as with the insertion and deletion sub-complexes and are essential for the stability of the editosomes. KREPA4 and KREPA6 proteins bind gRNA in vitro and are known to interact directly in yeast two-hybrid analysis. In this study, using several approaches we show a minimal interaction surface of the KREPA4 protein that is required for this interaction. By screening a series of N- and C-terminally truncated KREPA4 fragments, we show that a predicted alpha-helix of KREPA4 OB-fold is required for its interaction with KREPA6. An antibody against the KREPA4 alpha-helix or mutations of this region can eliminate association with KREPA6; while a peptide fragment corresponding to the alpha-helix can independently interact with KREPA6, thereby supporting the identification of KREPA4-KREPA6 interface. We also show that the predicted OB-fold of KREPA4; independent of its interaction with gRNA, is responsible for the stable integration of KREPA4 in the editosomes, and editing complexes co-purified with the tagged OB-fold can catalyze RNA editing. Therefore, we conclude that while KREPA4 interacts with KREPA6 through the alpha-helix region of its OB-fold, the entire OB-fold is required for its integration in the functional editosome, through additional protein-protein interactions.	[Moshiri, Houtan; Salavati, Reza] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Salavati, Reza] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Kala, Smriti; Moshiri, Houtan; Mehta, Vaibhav; Yip, Chun Wai; Salavati, Reza] McGill Univ, Inst Parasitol, Quebec City, PQ, Canada	McGill University; McGill University; McGill University	Salavati, R (corresponding author), McGill Univ, Inst Parasitol, Quebec City, PQ, Canada.	reza.salavati@mcgill.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) grant [210363]; Fonds de recherche du Quebec - Nature et technologies (FQRNT) [134790]; Centre for Host- Parasite Interactions (CHPI)	Natural Sciences and Engineering Research Council of Canada (NSERC) grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Nature et technologies (FQRNT); Centre for Host- Parasite Interactions (CHPI)	This study was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) grant # 210363 to R.S. (http://www.nserc-crsng.gc.ca/index_eng.asp). S.K. was supported by fellowship # 134790 from Fonds de recherche du Quebec - Nature et technologies (FQRNT) (http://www.fqrnt.gouv.qc.ca/en/index.htm) and bridge fund from the Centre for Host- Parasite Interactions (CHPI) (http://www.mcgill.ca/chpi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Ammerman ML, 2012, NUCLEIC ACIDS RES, V40, P5637, DOI 10.1093/nar/gks211; Ammerman ML, 2011, RNA, V17, P865, DOI 10.1261/rna.2446311; Ammerman ML, 2010, RNA, V16, P2239, DOI 10.1261/rna.2285510; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105; BEHRENS SE, 1993, P NATL ACAD SCI USA, V90, P8229, DOI 10.1073/pnas.90.17.8229; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; BROWN JD, 1992, EMBO J, V11, P3721, DOI 10.1002/j.1460-2075.1992.tb05457.x; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Carnes J, 2011, J BIOL CHEM, V286, P19320, DOI 10.1074/jbc.M111.228965; Drozdz M, 2002, EMBO J, V21, P1791, DOI 10.1093/emboj/21.7.1791; Fisk JC, 2009, MOL CELL BIOL, V29, P5214, DOI 10.1128/MCB.00520-09; Guo XM, 2008, MOL CELL BIOL, V28, P6939, DOI 10.1128/MCB.01115-08; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Hermann T, 1997, NUCLEIC ACIDS RES, V25, P2311, DOI 10.1093/nar/25.12.2311; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; Huang CE, 2002, MOL CELL BIOL, V22, P3194, DOI 10.1128/MCB.22.9.3194-3203.2002; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Kala S, 2010, RNA, V16, P1951, DOI 10.1261/rna.2124610; Leung SS, 1999, NUCLEIC ACIDS RES, V27, P778, DOI 10.1093/nar/27.3.778; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Madison-Antenucci S, 2002, CELL, V108, P435, DOI 10.1016/S0092-8674(02)00653-0; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Muller UF, 2002, NUCLEIC ACIDS RES, V30, P447, DOI 10.1093/nar/30.2.447; O'Hearn SF, 2003, MOL CELL BIOL, V23, P7909, DOI 10.1128/MCB.23.21.7909-7919.2003; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Park YJ, 2012, NUCLEIC ACIDS RES, V40, P1828, DOI 10.1093/nar/gkr867; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salavati R, 2006, RNA, V12, P819, DOI 10.1261/rna.2244106; SCHMID B, 1995, NUCLEIC ACIDS RES, V23, P3093, DOI 10.1093/nar/23.16.3093; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Seiwert SD, 1996, CELL, V84, P831, DOI 10.1016/S0092-8674(00)81062-4; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Simpson L, 2010, PROTIST, V161, P2, DOI 10.1016/j.protis.2009.10.001; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Sun J, 2011, CELL RES, V21, P258, DOI 10.1038/cr.2010.138; Tarun SZ, 2008, RNA, V14, P347, DOI 10.1261/rna.763308; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P6392, DOI 10.1093/nar/gkg870; Wu MT, 2011, J STRUCT BIOL, V174, P124, DOI 10.1016/j.jsb.2010.10.007; Zikova A, 2008, INT J PARASITOL, V38, P901, DOI 10.1016/j.ijpara.2007.12.009	57	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46864	10.1371/journal.pone.0046864	http://dx.doi.org/10.1371/journal.pone.0046864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056494	Green Published, Green Submitted, gold			2022-12-27	WOS:000309580800057
J	Kyei, NNA; Campbell, OMR; Gabrysch, S				Kyei, Nicholas N. A.; Campbell, Oona M. R.; Gabrysch, Sabine			The Influence of Distance and Level of Service Provision on Antenatal Care Use in Rural Zambia	PLOS ONE			English	Article							QUALITY-OF-CARE; HEALTH; DELIVERY; MODEL	Background: Antenatal care (ANC) presents important opportunities to reach women with crucial interventions. Studies on determinants of ANC use often focus on household and individual factors; few investigate the role of health service factors, partly due to lack of appropriate data. We assessed how distance to facilities and level of service provision at ANC facilities in Zambia influenced the number and timing of ANC visits and the quality of care received. Methods and Findings: Using the 2005 Zambian national Health Facility Census, we classified ANC facilities according to the level of service provision. In a geographic information system, we linked the facility information to household data from the 2007 DHS to calculate straight-line distances. We performed multivariable multilevel logistic regression on 2405 rural births to investigate the influence of distance to care and of level of provision on three aspects of ANC use: attendance of at least four visits, visit in first trimester and receipt of quality ANC (4+ visits with skilled health worker and 8+ interventions). We found no effect of distance on timing of ANC or number of visits, and better level of provision at the closest facility was not associated with either earlier ANC attendance or higher number of visits. However, there was a strong influence of both distance to a facility, and level of provision at the closest ANC facility on the quality of ANC received; for each 10 km increase in distance, the odds of women receiving good quality ANC decreased by a quarter, while each increase in the level of provision category of the closest facility was associated with a 54% increase in the odds of receiving good quality ANC. Conclusions: To improve ANC quality received by mothers, efforts should focus on improving the level of services provided at ANC facilities and their accessibility.	[Kyei, Nicholas N. A.] 37 Mil Hosp, Publ Hlth Div, Accra, Ghana; [Campbell, Oona M. R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Gabrysch, Sabine] Heidelberg Univ, Inst Publ Hlth, Epidemiol & Biostat Unit, Heidelberg, Germany	University of London; London School of Hygiene & Tropical Medicine; Ruprecht Karls University Heidelberg	Kyei, NNA (corresponding author), 37 Mil Hosp, Publ Hlth Div, Accra, Ghana.	ninaky05@googlemail.com	Gabrysch, Sabine/A-3503-2013	Gabrysch, Sabine/0000-0002-7081-0506; Kyei, Nicholas Nana Adjei/0000-0002-3811-9950; Campbell, Oona/0000-0002-9311-0115	Medical Faculty's Rahel Goitein-Straus Programme; German Academic Exchange Service (DAAD); London School of Hygiene and Tropical Medicine	Medical Faculty's Rahel Goitein-Straus Programme; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); London School of Hygiene and Tropical Medicine	SG is paid through the University of Heidelberg and received salary support from the Medical Faculty's Rahel Goitein-Straus Programme. NK did this work as part of his MSc thesis with a schorlarship support from the German Academic Exchange Service (DAAD). OC is supported by the London School of Hygiene and Tropical Medicine. No funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WORLD HLTH STAT 2010; [Anonymous], WHAT WE DO COLL GEOG; Beeckman K, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-213; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; DONABEDIAN A, 1978, SCIENCE, V200, P856, DOI 10.1126/science.417400; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gage AL, 2006, POP STUD-J DEMOG, V60, P271, DOI 10.1080/00324720600895934; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; Graham WJ, 2011, LANCET; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Ibnouf AH, 2007, SAUDI MED J, V28, P737; Kabakian-Khasholian T, 2000, SOC SCI MED, V51, P103, DOI 10.1016/S0277-9536(99)00443-8; Kinney MV, 2010, PLOS MED, V7, P21; Magadi M, 2000, SOC BIOL, V47, P164; Mathole T, 2004, MIDWIFERY, V20, P122, DOI 10.1016/j.midw.2003.10.003; MAXWELL RJ, 1984, BRIT MED J, V288, P1470, DOI 10.1136/bmj.288.6428.1470; MEASURE DHS Survey Methodology, SURV INSTR COLL GEOG; *MIN HLTH ZAMB, 2005, NAT HLTH STRAT PLAN; Ministry of Health Zambia, 2008, MIDT REV NAT HLTH ST; Ministry of Health Zambia, 2011, NAT HLTH STRAT PLAN; Phillips KA, 1998, HEALTH SERV RES, V33, P571; Ross JA, 2011, MATERN CHILD HLTH J, V24, P24; Shankar A, 2008, LANCET, V371, P1223, DOI 10.1016/S0140-6736(08)60536-X; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; UNICEF UNFPA World Bank, 2010, PACK INT FAM PLANN S; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; WHO, 2010, FACTS SHEET MAT MORT; WHO UNICEF, 2010, COUNTD 2015 DEC REP; World Health Organization, 2006, QUAL CAR PROC MAK ST; World Health Organization UNICEF, 2003, ANT CAR DEV COUNTR P; Xu K, 2010, 8 WHO; Zambia Ministry of Health IHFAN, 2008, TEMPL HLTH FAC CENS	38	65	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46475	10.1371/journal.pone.0046475	http://dx.doi.org/10.1371/journal.pone.0046475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	017HM	23056319	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000309580800021
J	Robciuc, MR; Skrobuk, P; Anisimov, A; Olkkonen, VM; Alitalo, K; Eckel, RH; Koistinen, HA; Jauhiainen, M; Ehnholm, C				Robciuc, Marius R.; Skrobuk, Paulina; Anisimov, Andrey; Olkkonen, Vesa M.; Alitalo, Kari; Eckel, Robert H.; Koistinen, Heikki A.; Jauhiainen, Matti; Ehnholm, Christian			Angiopoietin-Like 4 Mediates PPAR Delta Effect on Lipoprotein Lipase-Dependent Fatty Acid Uptake but Not on Beta-Oxidation in Myotubes	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-DELTA; TISSUE-SPECIFIC REGULATION; SKELETAL-MUSCLE; INSULIN-RESISTANCE; GLUCOSE; METABOLISM; EXPRESSION; PROTEIN-4; MICE; HYPERLIPIDEMIA	Peroxisome proliferator-activated receptor (PPAR) delta is an important regulator of fatty acid (FA) metabolism. Angiopoietin-like 4 (Angptl4), a multifunctional protein, is one of the major targets of PPAR delta in skeletal muscle cells. Here we investigated the regulation of Angptl4 and its role in mediating PPAR delta functions using human, rat and mouse myotubes. Expression of Angptl4 was upregulated during myotubes differentiation and by oleic acid, insulin and PPAR delta agonist GW501516. Treatment with GW501516 or Angptl4 overexpression inhibited both lipoprotein lipase (LPL) activity and LPL-dependent uptake of FAs whereas uptake of BSA-bound FAs was not affected by either treatment. Activation of retinoic X receptor (RXR), PPAR delta functional partner, using bexarotene upregulated Angptl4 expression and inhibited LPL activity in a PPAR delta dependent fashion. Silencing of Angptl4 blocked the effect of GW501516 and bexarotene on LPL activity. Treatment with GW501516 but not Angptl4 overexpression significantly increased palmitate oxidation. Furthermore, Angptl4 overexpression did not affect the capacity of GW501516 to increase palmitate oxidation. Basal and insulin stimulated glucose uptake, glycogen synthesis and glucose oxidation were not significantly modulated by Angptl4 overexpression. Our findings suggest that FAs-PPARdelta/RXR-Angptl4 axis controls the LPL-dependent uptake of FAs in myotubes, whereas the effect of PPAR delta activation on beta-oxidation is independent of Angptl4.	[Robciuc, Marius R.; Jauhiainen, Matti; Ehnholm, Christian] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Skrobuk, Paulina; Olkkonen, Vesa M.; Koistinen, Heikki A.] Minerva Fdn, Unit Metab, Helsinki, Finland; [Skrobuk, Paulina; Koistinen, Heikki A.] Univ Helsinki, Cent Hosp, Div Cardiol, Dept Med, Helsinki, Finland; [Skrobuk, Paulina; Koistinen, Heikki A.] Univ Helsinki, Fac Med, Inst Clin Med, Helsinki, Finland; [Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Mol Canc Biol Lab, Inst Mol Med Finland, Res Programs Unit, Helsinki, Finland; [Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Olkkonen, Vesa M.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Eckel, Robert H.] Univ Colorado, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO USA	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Colorado System; University of Colorado Anschutz Medical Campus	Robciuc, MR (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	marius.robciuc@helsinki.fi	Alitalo, Kari K/J-5013-2014; Koistinen, Heikki/J-7313-2016	Alitalo, Kari K/0000-0002-7331-0902; Koistinen, Heikki/0000-0001-7870-070X; Olkkonen, Vesa/0000-0001-5553-7997	National Institute for Health and Welfare; Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Sigrid Juselius Foundation; Novo Nordisk Fonden; Finnish Academy of Science [127093]; Finska Lakaresallskapet; Paulo Foundation; Oskar Oflunds Stiftelse; United States National Institutes of Health [DK26356]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026356] Funding Source: NIH RePORTER	National Institute for Health and Welfare; Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); Finnish Academy of Science(Academy of Finland); Finska Lakaresallskapet; Paulo Foundation; Oskar Oflunds Stiftelse; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute for Health and Welfare (M.J.), Finnish Foundation for Cardiovascular Research and Magnus Ehrnrooth Foundation (M. R. R., M.J., C. E.), Sigrid Juselius Foundation, Novo Nordisk Fonden and Finnish Academy of Science grant no 127093 (H. A. K), Finska Lakaresallskapet (C. E., M. R. R., P. S.), Paulo Foundation, Oskar Oflunds Stiftelse (M. R. R.) and United States National Institutes of Health Grant DK26356 (RHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; Anisimov A, 2009, CIRC RES, V104, P1302, DOI 10.1161/CIRCRESAHA.109.197830; Assaf C, 2006, BRIT J DERMATOL, V155, P261, DOI 10.1111/j.1365-2133.2006.07329.x; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Davies PJA, 2001, MOL PHARMACOL, V59, P170, DOI 10.1124/mol.59.2.170; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; FARESE RV, 1991, METABOLISM, V40, P214, DOI 10.1016/0026-0495(91)90178-Y; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Gray NE, 2012, J BIOL CHEM; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; Herschey MDVE, 2010, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2010.92, DOI 10.1038/NPROT.2010.92]; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; HUTTUNEN JK, 1975, CLIN CHIM ACTA, V63, P335, DOI 10.1016/0009-8981(75)90055-8; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Klopper JP, 2008, CLIN CANCER RES, V14, P589, DOI 10.1158/1078-0432.CCR-07-0269; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Lichtenstein L, 2010, BBA-MOL CELL BIOL L, V1801, P415, DOI 10.1016/j.bbalip.2009.12.015; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Poirier P, 2000, BIOCHEM BIOPH RES CO, V270, P997, DOI 10.1006/bbrc.2000.2528; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Rune A, 2009, ACTA PHYSIOL, V197, P207, DOI 10.1111/j.1748-1716.2009.02010.x; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Smart-Halajko MC, 2010, ARTERIOSCL THROM VAS, V30, P2277, DOI 10.1161/ATVBAHA.110.212209; Somwar R, 1998, CLIN THER, V20, P125, DOI 10.1016/S0149-2918(98)80040-4; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yamada T, 2006, BIOCHEM BIOPH RES CO, V347, P1138, DOI 10.1016/j.bbrc.2006.07.032; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Young SG, 2011, J LIPID RES	42	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46212	10.1371/journal.pone.0046212	http://dx.doi.org/10.1371/journal.pone.0046212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056264	Green Published, gold, Green Submitted			2022-12-27	WOS:000309580800015
J	Donaghy, L; Kraffe, E; Le Goic, N; Lambert, C; Volety, AK; Soudant, P				Donaghy, Ludovic; Kraffe, Edouard; Le Goic, Nelly; Lambert, Christophe; Volety, Aswani K.; Soudant, Philippe			Reactive Oxygen Species in Unstimulated Hemocytes of the Pacific Oyster Crassostrea gigas: A Mitochondrial Involvement	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; ELECTRON-TRANSPORT; NITRIC-OXIDE; SUPEROXIDE-PRODUCTION; ALTERNATIVE OXIDASE; DEFENSE-MECHANISMS; HUMAN NEUTROPHILS; CHLAMYS-FARRERI; CYTOCHROME-C; AIR EXPOSURE	The Pacific oyster Crassostrea gigas is a sessile bivalve mollusc whose homeostasis relies, at least partially, upon cells circulating in hemolymph and referred to as hemocytes. Oyster's hemocytes have been reported to produce reactive oxygen species (ROS), even in absence of stimulation. Although ROS production in bivalve molluscs is mostly studied for its defence involvement, ROS may also be involved in cellular and tissue homeostasis. ROS sources have not yet been described in oyster hemocytes. The objective of the present work was to characterize the ROS sources in unstimulated hemocytes. We studied the effects of chemical inhibitors on the ROS production and the mitochondrial membrane potential (Delta psi(m)) of hemocytes. First, this work confirmed the specificity of JC-10 probe to measure Delta psi(m) in oyster hemocytes, without being affected by Delta pH, as reported in mammalian cells. Second, results show that ROS production in unstimulated hemocytes does not originate from cytoplasmic NADPH-oxidase, nitric oxide synthase or myeloperoxidase, but from mitochondria. In contrast to mammalian cells, incubation of hemocytes with rotenone (complex I inhibitor) had no effect on ROS production. Incubation with antimycin A (complex III inhibitor) resulted in a dose-dependent ROS production decrease while an over-production is usually reported in vertebrates. In hemocytes of C. gigas, the production of ROS seems similarly dependent on both Delta psi(m) and Delta pH. These findings point out differences between mammalian models and bivalve cells, which warrant further investigation about the fine characterization of the electron transfer chain and the respective involvement of mitochondrial complexes in ROS production in hemocytes of bivalve molluscs.	[Donaghy, Ludovic; Kraffe, Edouard; Le Goic, Nelly; Lambert, Christophe; Soudant, Philippe] Univ Bretagne Occidentale, Inst Univ Europe Mer, UMR 6539, Lab Sci Environnement Marin, Plouzane, France; [Donaghy, Ludovic; Volety, Aswani K.] Florida Gulf Coast Univ, Coll Arts & Sci, Dept Marine & Ecol Sci, Ft Myers, FL USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); State University System of Florida; Florida Gulf Coast University	Soudant, P (corresponding author), Univ Bretagne Occidentale, Inst Univ Europe Mer, UMR 6539, Lab Sci Environnement Marin, Plouzane, France.	philippe.soudant@univ-brest.fr	Donaghy, Ludovic/F-1720-2016	Donaghy, Ludovic/0000-0002-6840-2204; Lambert, Christophe/0000-0002-5885-467X; Soudant, Philippe/0000-0003-3090-5612	CNRS INEE	CNRS INEE	The present work has been supported by a post-doctoral grant from CNRS INEE to L. Donaghy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldieri E, 2008, CURR DRUG METAB, V9, P686, DOI 10.2174/138920008786049285; ALEXANDRE A, 1984, BIOCHIM BIOPHYS ACTA, V767, P120, DOI 10.1016/0005-2728(84)90086-0; Allen SM, 2008, J EXP MAR BIOL ECOL, V357, P165, DOI 10.1016/j.jembe.2008.01.013; Auffret M., 1988, American Fisheries Society Special Publication, P169; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bartosz G, 2009, BIOCHEM PHARMACOL, V77, P1303, DOI 10.1016/j.bcp.2008.11.009; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beninger PG, 2003, BIOL BULL-US, V205, P83, DOI 10.2307/1543448; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Buchner T, 2001, COMP BIOCHEM PHYS B, V129, P109, DOI 10.1016/S1096-4959(01)00311-6; Bugge DA, 2007, FISH SHELLFISH IMMUN, V23, P188, DOI 10.1016/j.fsi.2006.10.006; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Burnett LE, 2001, COAST EST S, V58, P101; CAMPO ML, 1992, J BIOL CHEM, V267, P8123; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; CHAGOT D, 1987, AQUACULTURE, V67, P260, DOI 10.1016/0044-8486(87)90050-0; Chen MY, 2007, J EXP MAR BIOL ECOL, V345, P52, DOI 10.1016/j.jembe.2007.01.007; Chen MY, 2007, AQUACULTURE, V271, P479, DOI 10.1016/j.aquaculture.2007.04.051; Cheng TC, 2000, RE ADV MAR BIOTECHNO, V5, P43; Cheng Thomas C., 1996, P299; Chu FLE, 2000, RE ADV MAR BIOTECHNO, V5, P1; Cima F, 2000, FISH SHELLFISH IMMUN, V10, P677, DOI 10.1006/fsim.2000.0282; Cossarizza A, 1996, EXP CELL RES, V222, P84, DOI 10.1006/excr.1996.0011; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; Delaporte M, 2003, J EXP BIOL, V206, P3053, DOI 10.1242/jeb.00518; Donaghy L, 2009, AQUACULTURE, V297, P10, DOI 10.1016/j.aquaculture.2009.09.003; Donaghy L, 2009, FISH SHELLFISH IMMUN, V27, P296, DOI 10.1016/j.fsi.2009.05.010; Fisher WS, 2004, J SHELLFISH RES, V23, P321; Fisher WS, 2004, J SHELLFISH RES, V23, P353; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Goedken M, 2004, FISH SHELLFISH IMMUN, V16, P539, DOI 10.1016/j.fsi.2003.09.009; Han YH, 2010, MOL CELL BIOCHEM, V333, P211, DOI 10.1007/s11010-009-0222-2; Hegaret H, 2003, J EXP MAR BIOL ECOL, V293, P249, DOI 10.1016/S0022-0981(03)00235-1; Hine PM, 1999, FISH SHELLFISH IMMUN, V9, P367, DOI 10.1006/fsim.1998.0205; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Kalbacova M, 2003, CYTOM PART A, V52A, P110, DOI 10.1002/cyto.a.10031; Karawajew L, 2005, BLOOD, V105, P4767, DOI 10.1182/blood-2004-09-3428; Keller M, 2004, J EXP BIOL, V207, P2529, DOI 10.1242/jeb.01050; Kurochkin IO, 2009, AM J PHYSIOL-REG I, V297, pR1262, DOI 10.1152/ajpregu.00324.2009; Labreuche Y, 2006, MICROBES INFECT, V8, P2715, DOI 10.1016/j.micinf.2006.07.020; Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lambert C, 2003, FISH SHELLFISH IMMUN, V15, P225, DOI 10.1016/S1050-4648(02)00160-2; Lambert C, 2007, AQUACULTURE, V270, P413, DOI 10.1016/j.aquaculture.2007.04.074; LARSON KG, 1989, DIS AQUAT ORGAN, V6, P131, DOI 10.3354/dao006131; Le Grand F, 2011, COMP BIOCHEM PHYS A, V159, P383, DOI 10.1016/j.cbpa.2011.04.006; Li NY, 2003, FREE RADICAL BIO MED, V34, P465, DOI 10.1016/S0891-5849(02)01325-4; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Luetjens CM, 2000, J NEUROSCI, V20, P5715; MAGUIRE JJ, 1992, BIOCHEM BIOPH RES CO, V188, P190, DOI 10.1016/0006-291X(92)92368-8; Manduzio H., 2005, ISJ, V2, P91; Matozzo V, 2001, ARCH ENVIRON CON TOX, V41, P163; McDonald AE, 2004, IUBMB LIFE, V56, P333, DOI 10.1080/1521-6540400000876; McDonald AE, 2009, PHYSIOL PLANTARUM, V137, P328, DOI 10.1111/j.1399-3054.2009.01242.x; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nahrevanian H, 2009, BRAZ J INFECT DIS, V13, P440, DOI 10.1590/S1413-86702009000600010; Ordas MC, 2000, FISH SHELLFISH IMMUN, V10, P611, DOI 10.1006/fsim.2000.0276; OTERO MJ, 1984, MOL CELL BIOCHEM, V61, P183; PIPE RK, 1992, DEV COMP IMMUNOL, V16, P111, DOI 10.1016/0145-305X(92)90012-2; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; RAO KMK, 1992, J LEUKOCYTE BIOL, V51, P496; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Solaini G, 2007, BIOSCIENCE REP, V27, P11, DOI 10.1007/s10540-007-9033-4; Sparks A.K., 1988, American Fisheries Society Special Publication, P139; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; Takahashi Keisuke G., 2000, Tohoku Journal of Agricultural Research, V51, P15; Tschischka K, 2000, J EXP BIOL, V203, P3355; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Zmijewski JW, 2009, AM J PHYSIOL-LUNG C, V296, pL624, DOI DOI 10.1152/ajplung.90522.2008	76	69	72	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46594	10.1371/journal.pone.0046594	http://dx.doi.org/10.1371/journal.pone.0046594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056359	gold, Green Published, Green Submitted			2022-12-27	WOS:000309454000059
J	Miranda, E; Pineda, HM; Oberg, D; Cherubini, G; Garate, Z; Lemoine, NR; Hallden, G				Miranda, Enrique; Pineda, Hector Maya; Oeberg, Daniel; Cherubini, Gioia; Garate, Zita; Lemoine, Nick R.; Hallden, Gunnel			Adenovirus-Mediated Sensitization to the Cytotoxic Drugs Docetaxel and Mitoxantrone Is Dependent on Regulatory Domains in the E1ACR1 Gene-Region	PLOS ONE			English	Article							ONCOGENE-INDUCED SENSITIZATION; PHASE-I TRIAL; PROSTATE-CANCER; ONCOLYTIC ADENOVIRUS; INDUCED APOPTOSIS; INDUCE APOPTOSIS; CELL-CYCLE; P53; MUTANTS; PROTEIN	Oncolytic adenoviruses have shown promising efficacy in clinical trials targeting prostate cancers that frequently develop resistance to all current therapies. The replication-selective mutants Ad Delta Delta and dl922-947, defective in pRb-binding, have been demonstrated to synergise with the current standard of care, mitoxantrone and docetaxel, in prostate cancer models. While expression of the early viral E1A gene is essential for the enhanced cell killing, the specific E1A-regions required for the effects are unknown. Here, we demonstrate that replicating mutants deleted in small E1A-domains, binding pRb (dl1108), p300/CBP (dl1104) and p400/TRRAP or p21 (dl1102) sensitize human prostate cancer cells (PC-3, DU145, 22Rv1) to mitoxantrone and docetaxel. Through generation of non-replicating mutants, we demonstrate that the small E1A12S protein is sufficient to potently sensitize all prostate cancer cells to the drugs even in the absence of viral replication and the E1A transactivating domain, conserved region (CR) 3. Furthermore, the p300/CBP-binding domain in E1ACR1 is essential for drug-sensitisation in the absence (AdE1A1104) but not in the presence of the E1ACR3 (dl1104) domain. AdE1A1104 also failed to increase apoptosis and accumulation of cells in G2/M. All E1ADCR2 mutants (AdE1A1108, dl922-947) and AdE1A1102 or dl1102 enhance cell killing to the same degree as wild type virus. In PC-3 xenografts in vivo the dl1102 mutant significantly prolongs time to tumor progression that is further enhanced in combination with docetaxel. Neither dl1102 nor dl1104 replicates in normal human epithelial cells (NHBE). These findings suggest that additional E1A-deletions might be included when developing more potent replication-selective oncolytic viruses, such as the Ad Delta CR2-mutants, to further enhance potency through synergistic cell killing in combination with current chemotherapeutics.	[Miranda, Enrique; Pineda, Hector Maya; Oeberg, Daniel; Cherubini, Gioia; Garate, Zita; Lemoine, Nick R.; Hallden, Gunnel] Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, London, England	University of London; Queen Mary University London	Hallden, G (corresponding author), Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, London, England.	g.hallden@qmul.ac.uk	Miranda, Enrique/AAD-4621-2020	Miranda, Enrique/0000-0003-3361-3957; Lemoine, Nick/0000-0001-8675-058X	Barts & The London Charity, Cancer Research UK [C633-A6253/A6251]; Prostate Action; Cancer Research UK [12008] Funding Source: researchfish	Barts & The London Charity, Cancer Research UK; Prostate Action; Cancer Research UK(Cancer Research UK)	This project was supported by grants from Barts & The London Charity, Cancer Research UK (C633-A6253/A6251 programme grant) and the Prostate Cancer Research Foundation (currently Prostate Action). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; BALEY PA, 1995, J STEROID BIOCHEM, V52, P403, DOI 10.1016/0960-0760(95)00001-G; Barton KN, 2006, MOL THER, V13, P347, DOI 10.1016/j.ymthe.2005.10.005; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Chang CY, 2006, ONCOGENE, V25, P2656, DOI 10.1038/sj.onc.1209294; Chattopadhyay D, 2001, J VIROL, V75, P9844, DOI 10.1128/JVI.75.20.9844-9856.2001; Cheong SC, 2008, CANCER GENE THER, V15, P40, DOI 10.1038/sj.cgt.7701099; Cherubini G, 2011, GENE THER, V18, P1157, DOI 10.1038/gt.2011.141; Chiou SK, 1997, J VIROL, V71, P3515, DOI 10.1128/JVI.71.5.3515-3525.1997; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Conrad C, 2005, CANCER GENE THER, V12, P284, DOI 10.1038/sj.cgt.7700750; Cook JL, 2003, CANCER RES, V63, P3435; de Vrij J, 2010, HUM GENE THER, V21, P795, DOI 10.1089/hum.2009.203; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI 10.2217/FON.09.117; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; Ekblad M, 2010, CURR OPIN MOL THER, V12, P421; Fabbri F, 2008, J CELL PHYSIOL, V217, P494, DOI 10.1002/jcp.21522; Fox EJ, 2004, NEUROLOGY, V63, pS15, DOI 10.1212/WNL.63.12_suppl_6.S15; Freytag SO, 2007, MOL THER, V15, P1042, DOI 10.1038/sj.mt.6300162; Freytag SO, 2007, MOL THER, V15, P1016, DOI 10.1038/mt.sj.6300120; Freytag SO, 2007, MOL THER, V15, P636, DOI 10.1038/sj.mt.6300068; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Gallimore PH, 2001, ONCOGENE, V20, P7824, DOI 10.1038/sj.onc.1204913; Hakkarainen T, 2009, CLIN CANCER RES, V15, P5396, DOI 10.1158/1078-0432.CCR-08-2571; Helgason GV, 2010, CANCER RES, V70, P4074, DOI 10.1158/0008-5472.CAN-09-2876; HOWE JA, 1990, P NATL ACAD SCI USA, V87, P5883, DOI 10.1073/pnas.87.15.5883; JELSMA TN, 1988, VIROLOGY, V163, P494, DOI 10.1016/0042-6822(88)90290-5; JELSMA TN, 1989, VIROLOGY, V171, P120, DOI 10.1016/0042-6822(89)90518-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang H, 2005, NEOPLASIA, V7, P723, DOI 10.1593/neo.04793; Kharaziha P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.1; Lavery DN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/862125; Leitner S, 2009, CLIN CANCER RES, V15, P1730, DOI 10.1158/1078-0432.CCR-08-2008; Liao Y, 2007, ADV EXP MED BIOL, V608, P144; Loewenstein PM, 2006, VIROLOGY, V351, P312, DOI 10.1016/j.virol.2006.03.041; Loewenstein PM, 2012, VIROLOGY, V428, P70, DOI 10.1016/j.virol.2012.03.021; MYMRYK JS, 1994, ONCOGENE, V9, P1187; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; Oberg D, 2010, CLIN CANCER RES, V16, P541, DOI 10.1158/1078-0432.CCR-09-1960; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Pelka P, 2009, NUCLEIC ACIDS RES, V37, P1095, DOI 10.1093/nar/gkn1057; Putzer BM, 2000, CELL DEATH DIFFER, V7, P177, DOI 10.1038/sj.cdd.4400618; Radhakrishnan S, 2010, HUM GENE THER, V21, P1311, DOI 10.1089/hum.2010.019; Raki M, 2005, GENE THER, V12, P1198, DOI 10.1038/sj.gt.3302517; RAO L, 1992, P NATL ACAD SCI USA, V89, P7742, DOI 10.1073/pnas.89.16.7742; Rasti M, 2005, J VIROL, V79, P5594, DOI 10.1128/JVI.79.9.5594-5605.2005; Samuelson AV, 2005, J BIOL CHEM, V280, P21915, DOI 10.1074/jbc.M414564200; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; Savelyeva I, 2011, ONCOGENE, V30, P865, DOI 10.1038/onc.2010.461; Skjoth IHE, 2006, INT J ONCOL, V28, P217; Small EJ, 2006, MOL THER, V14, P107, DOI 10.1016/j.ymthe.2006.02.011; Wang YH, 2003, NAT BIOTECHNOL, V21, P1328, DOI 10.1038/nbt887; White E, 2001, ONCOGENE, V20, P7836, DOI 10.1038/sj.onc.1204861; WHITE E, 1991, J VIROL, V65, P2968, DOI 10.1128/JVI.65.6.2968-2978.1991	56	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46617	10.1371/journal.pone.0046617	http://dx.doi.org/10.1371/journal.pone.0046617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056370	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000062
J	Ruiz, M; Courilleau, D; Jullian, JC; Fortin, D; Ventura-Clapier, R; Blondeau, JP; Garnier, A				Ruiz, Matthieu; Courilleau, Delphine; Jullian, Jean-Christophe; Fortin, Dominique; Ventura-Clapier, Renee; Blondeau, Jean-Paul; Garnier, Anne			A Cardiac-Specific Robotized Cellular Assay Identified Families of Human Ligands as Inducers of PGC-1 alpha Expression and Mitochondrial Biogenesis	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; HEART-FAILURE; ENDOTHELIAL DYSFUNCTION; FATTY-ACIDS; B VITAMINS; METABOLISM; INHIBITION; RECEPTORS; MECHANISM; DISEASE	Background: Mitochondrial function is dramatically altered in heart failure (HF). This is associated with a decrease in the expression of the transcriptional coactivator PGC-1 alpha, which plays a key role in the coordination of energy metabolism. Identification of compounds able to activate PGC-1 alpha transcription could be of future therapeutic significance. Methodology/Principal Findings: We thus developed a robotized cellular assay to screen molecules in order to identify new activators of PGC-1 alpha in a cardiac-like cell line. This screening assay was based on both the assessment of activity and gene expression of a secreted luciferase under the control of the human PGC-1 alpha promoter, stably expressed in H9c2 cells. We screened part of a library of human endogenous ligands and steroid hormones, B vitamins and fatty acids were identified as activators of PGC-1 alpha expression. The most responsive compounds of these families were then tested for PGC1-alpha gene expression in adult rat cardiomyocytes. These data highly confirmed the primary screening, and the increase in PGC-1 alpha mRNA correlated with an increase in several downstream markers of mitochondrial biogenesis. Moreover, respiration rates of H9c2 cells treated with these compounds were increased evidencing their effectiveness on mitochondrial biogenesis. Conclusions/Significance: Using our cellular reporter assay we could identify three original families, able to activate mitochondrial biogenesis both in cell line and adult cardiomyocytes. This first screening can be extended to chemical libraries in order to increase our knowledge on PGC-1 alpha regulation in the heart and to identify potential therapeutic compounds able to improve mitochondrial function in HF.	[Ruiz, Matthieu; Fortin, Dominique; Ventura-Clapier, Renee; Garnier, Anne] Univ Paris 11, INSERM, U769, Chatenay Malabry, France; [Courilleau, Delphine; Jullian, Jean-Christophe; Blondeau, Jean-Paul] Univ Paris 11, IFR141, CIBLOT Platform, Chatenay Malabry, France; [Jullian, Jean-Christophe] Univ Paris 11, BIOCIS, UMR 8076, Chatenay Malabry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Garnier, A (corresponding author), Univ Paris 11, INSERM, U769, Chatenay Malabry, France.	anne.garnier@u-psud.fr	Blondeau, Jean-Paul/AAH-6395-2019	Garnier, Anne/0000-0002-6241-4554; Blondeau, Jean-Paul/0000-0003-4520-6822; Ventura-Clapier, Renee/0000-0002-7488-4123	Fondation de France [FDF_R08111LL]; Universite Paris-Sud [IFR 141]; LabEx LERMIT	Fondation de France(Fondation de France); Universite Paris-Sud; LabEx LERMIT	This work was supported by grants from "Fondation de France" (FDF_R08111LL), IFR 141 of Universite Paris-Sud and LabEx LERMIT. Renee Ventura-Clapier is senior scientist at Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Austin RC, 2004, CELL DEATH DIFFER, V11, pS56, DOI 10.1038/sj.cdd.4401451; Bionaz M, 2012, BRIT J NUTR, V107, P179, DOI 10.1017/S0007114511002777; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Civitarese AE, 2007, CURR OPIN CLIN NUTR, V10, P679, DOI 10.1097/MCO.0b013e3282f0ecd2; Depeint F, 2006, CHEM-BIOL INTERACT, V163, P113, DOI 10.1016/j.cbi.2006.05.010; Duda MK, 2007, CARDIOVASC RES, V76, P303, DOI 10.1016/j.cardiores.2007.07.002; Faerber G, 2011, J THORAC CARDIOV SUR, V141, P492, DOI 10.1016/j.jtcvs.2010.03.029; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Forges T, 2007, HUM REPROD UPDATE, V13, P225, DOI 10.1093/humupd/dml063; Galvao TF, 2012, CARDIOVASC RES, V93, P24, DOI 10.1093/cvr/cvr258; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Hsieh YC, 2006, FASEB J, V20, P1109, DOI 10.1096/fj.05-5549com; Hsieh YC, 2005, AM J PHYSIOL-HEART C, V289, pH2665, DOI 10.1152/ajpheart.00682.2005; Hu XL, 2011, HYPERTENSION, V58, P696, DOI 10.1161/HYPERTENSIONAHA.111.174128; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Jia HQ, 2010, NEUROBIOL AGING, V31, P636, DOI 10.1016/j.neurobiolaging.2008.05.031; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lau SLY, 2012, J CELL BIOCHEM, V113, P841, DOI 10.1002/jcb.23412; LEEDS FS, 1994, J BIOL CHEM, V269, P3947; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Maurer M, 2010, INT J CARDIOL, V141, P32, DOI 10.1016/j.ijcard.2008.11.131; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Miche E, 2006, CLIN RES CARDIOL, V95, P117, DOI 10.1007/s00392-006-1106-z; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Patten IS, 2012, TRENDS ENDOCRIN MET, V23, P90, DOI 10.1016/j.tem.2011.09.007; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Rimbaud S, 2009, J MOL CELL CARDIOL, V46, P952, DOI 10.1016/j.yjmcc.2009.01.013; Rimbaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026391; Rodriguez-Cuenca S, 2007, AM J PHYSIOL-ENDOC M, V292, pE340, DOI 10.1152/ajpendo.00175.2006; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035; Stanley WC, 2012, CIRC RES, V110, P764, DOI [10.1161/CIRCRESAHA.111.253104, 10.1161/circresaha.111.253104]; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; Wu ZD, 2007, EXPERT OPIN THER TAR, V11, P1329, DOI 10.1517/14728222.11.10.1329; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Zoll J, 2006, J APPL PHYSIOL, V101, P385, DOI 10.1152/japplphysiol.01486.2005	54	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46753	10.1371/journal.pone.0046753	http://dx.doi.org/10.1371/journal.pone.0046753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056435	Green Published, gold			2022-12-27	WOS:000309454000081
J	Weber, E; Guth, C; Weiss, IM				Weber, Eva; Guth, Christina; Weiss, Ingrid M.			GFP Facilitates Native Purification of Recombinant Perlucin Derivatives and Delays the Precipitation of Calcium Carbonate	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GROWTH; EXPRESSION; NACRE; BINDING; CRYSTALLIZATION; NUCLEATION; DYNAMICS	Insolubility is one of the possible functions of proteins involved in biomineralization, which often limits their native purification. This becomes a major problem especially when recombinant expression systems are required to obtain larger amounts. For example, the mollusc shell provides a rich source of unconventional proteins, which can interfere in manifold ways with different mineral phases and interfaces. Therefore, the relevance of such proteins for biotechnological processes is still in its infancy. Here we report a simple and reproducible purification procedure for a GFP-tagged lectin involved in biomineralization, originally isolated from mother-of-pearl in abalone shells. An optimization of E. coli host cell culture conditions was the key to obtain reasonable yields and high degrees of purity by using simple one-step affinity chromatography. We identified a dual functional role for the GFP domain when it became part of a mineralizing system in vitro. First, the GFP domain improved the solubility of an otherwise insoluble protein, in this case recombinant perlucin derivatives. Second, GFP inhibited calcium carbonate precipitation in a concentration dependent manner. This was demonstrated here using a simple bulk assay over a time period of 400 seconds. At concentrations of 2 mu g/ml and higher, the inhibitory effect was observed predominantly for HCO3- as the first ionic interaction partner, but not necessarily for Ca2+. The interference of GFP-tagged perlucin derivatives with the precipitation of calcium carbonate generated different types of GFP-fluorescent composite calcite crystals. GFP-tagging offers therefore a genetically tunable tool to gently modify mechanical and optical properties of synthetic biocomposite minerals.	[Weber, Eva; Guth, Christina; Weiss, Ingrid M.] INM Leibniz Inst New Mat gGmbH, Saarbrucken, Germany	Leibniz Institut fur Neue Materialien (INM)	Weiss, IM (corresponding author), INM Leibniz Inst New Mat gGmbH, Saarbrucken, Germany.	ingrid.weiss@inm-gmbh.de		Weiss, Ingrid/0000-0002-7345-341X	INM - Leibniz Institute for New Materials	INM - Leibniz Institute for New Materials	This study received funding from the INM - Leibniz Institute for New Materials. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Alfasi S, 2011, J BIOTECHNOL, V156, P11, DOI 10.1016/j.jbiotec.2011.08.016; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; Blohm D, 2007, WO, Patent No. [2007EP54252 20070502, 200754252]; Blohm D., 2007, [No title captured], Patent No. [2007125127 (A2), 2007125127, WO 2007125127 (A2)]; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Borukhin S, 2012, ADV FUNCT MATER, V22, P4216, DOI 10.1002/adfm.201201079; Cabantous S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002387; Denis-Quanquin S, 2007, J BIOTECHNOL, V131, P223, DOI 10.1016/j.jbiotec.2007.07.725; Derewenda ZS, 2010, ACTA CRYSTALLOGR D, V66, P604, DOI 10.1107/S090744491000644X; Deutzmann Rainer, 2004, Methods Mol Med, V94, P269; Dodenhof T, 2010, CLONING EXPRESSION S; Gehrke N, 2005, CHEM MATER, V17, P6514, DOI 10.1021/cm052150k; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Harding JH, 2008, CHEM REV, V108, P4823, DOI 10.1021/cr078278y; Heinemann F, 2011, MAT SCI ENG C-MATER, V31, P99, DOI 10.1016/j.msec.2010.08.005; Hofmann A, 2002, ACTA CRYSTALLOGR D, V58, P1400, DOI 10.1107/S0907444902010454; Holder AN, 2009, ARCH BIOCHEM BIOPHYS, V486, P27, DOI 10.1016/j.abb.2009.03.016; Hu NJ, 2008, J BIOL CHEM, V283, P18314, DOI 10.1074/jbc.M801051200; INOUYE S, 1994, FEBS LETT, V341, P277, DOI 10.1016/0014-5793(94)80472-9; Ji BZ, 2010, INTEGR BIOL-UK, V2, P528, DOI 10.1039/c0ib00007h; Kahr B, 2001, CHEM REV, V101, P893, DOI 10.1021/cr980088n; Kahr B, 2010, ACCOUNTS CHEM RES, V43, P684, DOI 10.1021/ar900288m; Keene EC, 2010, CRYST GROWTH DES, V10, P1383, DOI 10.1021/cg901389v; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Kurimoto M, 1999, J AM CHEM SOC, V121, P6952, DOI 10.1021/ja991069d; Levi Y, 1998, CHEM-EUR J, V4, P389, DOI 10.1002/(SICI)1521-3765(19980310)4:3<389::AID-CHEM389>3.0.CO;2-X; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Lowenstam HA, 1989, BIOMINERALIZATION; Ma Y, 2007, ADV FUNCT MATER, V17, P2693, DOI 10.1002/adfm.200700234; Mann K, 2000, EUR J BIOCHEM, V267, P5257, DOI 10.1046/j.1432-1327.2000.01602.x; Mann S., 2001, BIOMINERALIZATION PR; Marin-Garcia L, 2008, CRYST GROWTH DES, V8, P1340, DOI 10.1021/cg701156r; McPherson A., 1999, CRYSTALLIZATION BIOL; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pedelacq JD, 2002, NAT BIOTECHNOL, V20, P927, DOI 10.1038/nbt732; Phillips GN, 1997, CURR OPIN STRUC BIOL, V7, P821, DOI 10.1016/S0959-440X(97)80153-4; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Qiagen,, 2003, QIAEXPRESSIONIST HDB; Reiber A, 2005, THESIS JOHANNES GUTE; Schmidt W.J., 1924, BAUSTEINE TIERKORPER; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Sorensen HP, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-1; Suzuki N, 2010, ACTA CRYSTALLOGR D, V66, P1059, DOI 10.1107/S0907444910032944; Touryan LA, 2001, J CRYST GROWTH, V233, P380, DOI 10.1016/S0022-0248(01)01441-5; Touryan LA, 2009, COLLOID SURFACE B, V74, P401, DOI 10.1016/j.colsurfb.2009.07.004; Vincentelli R, 2011, METHODS, V55, P65, DOI 10.1016/j.ymeth.2011.08.010; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang N, 2008, COMP BIOCHEM PHYS B, V149, P354, DOI 10.1016/j.cbpb.2007.10.007; Wang X, 2010, PROTEIN SCI, V19, P1180, DOI 10.1002/pro.394; Weaver ML, 2010, CRYST GROWTH DES, V10, P2954, DOI 10.1021/cg901626a; Weber E, 2012, MRS ONLINE P LIB, V1465, DOI [1410.1557/opl.2012.1046, DOI 10.1557/OPL.2012.1046]; Weiner S, 2005, SCIENCE, V309, P1027, DOI 10.1126/science.1114920; Weiner Steve, 2009, Frontiers of Materials Science in China, V3, P104, DOI 10.1007/s11706-009-0036-x; Weiss I. M., 2008, MET IONS LIFE SCI BI, P71; Weiss IM, 2006, J STRUCT BIOL, V153, P264, DOI 10.1016/j.jsb.2005.11.006; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; Wu CK, 1997, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P399; Zou J, 2007, BIOCHEMISTRY-US, V46, P12275, DOI 10.1021/bi7007307	62	13	15	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46653	10.1371/journal.pone.0046653	http://dx.doi.org/10.1371/journal.pone.0046653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056388	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000070
J	Muga, R; Sanvisens, A; Fuster, D; Tor, J; Martinez, E; Perez-Hoyos, S; Munoz, A				Muga, Roberto; Sanvisens, Arantza; Fuster, Daniel; Tor, Jordi; Martinez, Elisenda; Perez-Hoyos, Santiago; Munoz, Alvaro			Unhealthy Alcohol Use, HIV Infection and Risk of Liver Fibrosis in Drug Users with Hepatitis C	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; NONINVASIVE MARKERS; COINFECTED PATIENTS; HYALURONIC-ACID; INDIVIDUALS; PROGRESSION; MORTALITY; COHORT	Aim: To analyze alcohol use, clinical data and laboratory parameters that may affect FIB-4, an index for measuring liver fibrosis, in HCV-monoinfected and HCV/HIV-coinfected drug users. Patients and Methods: Patients admitted for substance abuse treatment between 1994 and 2006 were studied. Socio-demographic data, alcohol and drug use characteristics and clinical variables were obtained through hospital records. Blood samples for biochemistry, liver function tests, CD4 cell count, and serology of HIV and HCV infection were collected at admission. Multivariate linear regression was used to analyze the predictors of FIB-4 increase. Results: A total of 472 (83% M, 17% F) patients were eligible. The median age at admission was 31 years (Interquartile range (IQR) 27-35 years), and the median duration of drug use was 10 years (IQR 5.5-15 years). Unhealthy drinking (>50 grams/day) was reported in 32% of the patients. The FIB-4 scores were significantly greater in the HCV/HIV-coinfected patients (1.14, IQR 0.76-1.87) than in the HCV-monoinfected patients (0.75, IQR 0.56-1.11) (p<0.001). In the multivariate analysis, unhealthy drinking (p = 0.034), lower total cholesterol (p = 0.042), serum albumin (p<0.001), higher GGT (p<0.001) and a longer duration of addiction (p = 0.005) were independently associated with higher FIB-4 scores in the HCV-monoinfected drug users. The effect of unhealthy drinking on FIB-4 scores disappeared in the HCV/HIV-coinfected patients, whereas lower serum albumin (p<0.001), a lower CD4 cell count (p = 0.006), higher total bilirubin (p<0.001) and a longer drug addiction duration (p<0.001) were significantly associated with higher FIB-4 values. Conclusions: Unhealthy alcohol use in the HCV-monoinfected patients and HIV-related immunodeficiency in the HCV/HIV-coinfected patients are important risk factors associated with liver fibrosis in the respective populations	[Muga, Roberto; Sanvisens, Arantza; Fuster, Daniel; Tor, Jordi; Martinez, Elisenda] Univ Autonoma Barcelona, Dept Internal Med, Hosp Univ Germans Trias & Pujol, E-08193 Barcelona, Spain; [Fuster, Daniel] Boston Univ, Sch Med, Gen Internal Med Sect, Boston Med Ctr, Boston, MA 02118 USA; [Perez-Hoyos, Santiago] Univ Autonoma Barcelona, Dept Publ Hlth, Inst Recerca Hosp Vall dHebron, E-08193 Barcelona, Spain; [Munoz, Alvaro] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Boston Medical Center; Boston University; Autonomous University of Barcelona; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Muga, R (corresponding author), Univ Autonoma Barcelona, Dept Internal Med, Hosp Univ Germans Trias & Pujol, E-08193 Barcelona, Spain.	rmuga.germanstrias@gencat.cat	Muga, Roberto/AAY-8655-2021; Fuster, Daniel/C-6659-2019; Fuster, Daniel/N-9955-2019; Perez-Hoyos, Santiago/E-2370-2012; Perez Hoyos, Santiago/O-1075-2019	Muga, Roberto/0000-0001-6301-431X; Fuster, Daniel/0000-0003-1262-5860; Fuster, Daniel/0000-0003-1262-5860; Perez-Hoyos, Santiago/0000-0001-9797-4917; Perez Hoyos, Santiago/0000-0001-9797-4917; Sanvisens, Arantza/0000-0001-6269-5491; Martinez-Carbonell, Elisenda/0000-0003-1078-3830	Ministry of Science and Innovation, Spain [RD06/001, RD06/006, PI05/1550]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2008 BE-2 00269]; Ministry of Health [EC11- 042]; Ministry of Education [2010-0945]	Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministry of Health; Ministry of Education	This work was funded by grants from Ministry of Science and Innovation, Spain (grants RD06/001, RD06/006 and PI05/1550), the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) (grant 2008 BE-2 00269), Ministry of Health (grant EC11- 042) and Ministry of Education (grant 2010-0945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhamou Y, 2001, HEPATOLOGY, V34, P283, DOI 10.1053/jhep.2001.26517; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Blackard JT, 2011, CLIN INFECT DIS, V52, P674, DOI 10.1093/cid/ciq199; Chaudhry AA, 2009, HIV MED, V10, P133, DOI 10.1111/j.1468-1293.2008.00662.x; Corey KE, 2009, HEPATOLOGY, V50, P1030, DOI 10.1002/hep.23219; Davis GL, 1997, HEPATOLOGY, V26, pS122, DOI 10.1002/hep.510260721; Fleming CA, 2003, CLIN INFECT DIS, V36, P97, DOI 10.1086/344907; Gebo KA, 2002, HEPATOLOGY, V36, pS161, DOI 10.1053/jhep.2002.36989; Hutchinson SJ, 2005, CLIN GASTROENTEROL H, V3, P1150, DOI 10.1016/S1542-3565(05)00407-6; Inglesby TV, 1999, HEPATOLOGY, V29, P590, DOI 10.1002/hep.510290219; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Massard J, 2006, J HEPATOL, V44, pS19, DOI 10.1016/j.jhep.2005.11.009; Merchante N, 2006, AIDS, V20, P49, DOI 10.1097/01.aids.0000198087.47454.e1; Muga R, 2000, J ACQ IMMUN DEF SYND, V23, P332; National Institute in Alcohol Abuse and Alcoholism, 1995, USDHHS NIH PUBL, P95; Nunes D, 2010, AM J GASTROENTEROL, V105, P1346, DOI 10.1038/ajg.2009.746; Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Sanvisens A, 2011, CURR HIV RES, V9, P256, DOI 10.2174/157016211796320298; Sanvisens A, 2009, J VIRAL HEPATITIS, V16, P513, DOI 10.1111/j.1365-2893.2009.01103.x; Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x; Siu L, 2009, SEMIN LIVER DIS, V29, P188, DOI 10.1055/s-0029-1214374; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sulkowski MS, 2005, CLIN INFECT DIS, V40, pS263, DOI 10.1086/427440; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Tural C, 2003, J VIRAL HEPATITIS, V10, P118, DOI 10.1046/j.1365-2893.2003.00413.x; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Vallet-Pichard A, 2008, HEPATOLOGY, V47, P763, DOI 10.1002/hep.22113; Zinkernagel AS, 2006, ANTIVIR THER, V11, P131	34	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46810	10.1371/journal.pone.0046810	http://dx.doi.org/10.1371/journal.pone.0046810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056462	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400029
J	Woodcock, DW; Rogan, JS; Blanchard, SD				Woodcock, Deborah W.; Rogan, John S.; Blanchard, Samuel D.			Accelerating Anthropogenic Land Surface Change and the Status of Pleistocene Drumlins in New England	PLOS ONE			English	Article							CENTRAL MASSACHUSETTS; SEDIMENTATION	Drumlins are glacially derived landforms that are prominent in the landscape over much of southern New England. We carried out a comprehensive ground-based survey in a three-town study area in eastern Massachusetts with the goals of establishing the extent to drumlins have been altered and assessing the associated environmental consequences and probable driving factors. Results show that many drumlins have been significantly altered through levelling and truncation (creation of steep cut and fill slopes), with projects involving movement of 1-1.5x10(6) m(3) of earth materials not now uncommon. Stormwater and wetlands infractions were documented at all the larger excavation sites and resulted in enforcement actions and fines in many cases; the broader environmental consequences of the loss/alteration of these forested uplands are harder to establish. The excavations are significant in terms of materials cycling: the movement of earth materials, when considered regionally, greatly exceeds natural denudation processes and is also greater than during other periods of high anthropogenic denudation. Our findings suggest that the region's glacial landscapes are at risk given current development patterns. The accelerating rate of land-surface change is undoubtedly also generalizable to other fast-developing regions of the United States. The landform alterations documented are part of a changing pattern of land use and vegetation cover since the Colonial era and are linked to shortages of land for development, current development and building practices, and lack of explicit rationales for preservation of the region's geoheritage.	[Woodcock, Deborah W.] Clark Univ, Marsh Inst, Worcester, MA 01610 USA; [Rogan, John S.; Blanchard, Samuel D.] Clark Univ, Clark Sch Geog, Worcester, MA 01610 USA	Clark University; Clark University	Woodcock, DW (corresponding author), Clark Univ, Marsh Inst, Worcester, MA 01610 USA.	dwoodcock@clarku.edu			Clark University	Clark University	Support through the HERO project at Clark University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBERS RKR, 2008, NE GEOL ENVIRON SCI, V30, P49; Blanchard SD, 2010, GISCI REMOTE SENS, V47, P1, DOI 10.2747/1548-1603.47.1.1; Brown H., 1956, MANS ROLE CHANGING F, P1023; Colgan P.M, 2003, GLACIAL LANDSYSTEMS, P111; Cooley D. R., 2009, Biorational tree-fruit pest management, P145, DOI 10.1079/9781845934842.0145; DeNormandie J., 2009, LOSING GROUND FOOTPR; Evans-Daly L, 1997, IMAGES AM FRAMINGHAM; Foster DR, 2004, FORESTS TIME ECOSYST; Hart JK, 1997, QUATERNARY SCI REV, V16, P93, DOI 10.1016/S0277-3791(96)00023-6; Irland L, 2011, LANDSCAPE HIST NEW E; Jennings KL, 2003, GEOL SOC AM BULL, V115, P182, DOI 10.1130/0016-7606(2003)115<0182:TASODO>2.0.CO;2; Kittredge DB, 2003, FOREST ECOL MANAG, V180, P425, DOI 10.1016/S0378-1127(02)00561-3; Meyer William B, 2009, REMAKING BOSTON ENV, P127; Millington BR, 1930, ECON GEOGR, V6, P408, DOI 10.2307/140533; NEWMAN WA, 1994, SEDIMENT GEOL, V91, P333, DOI 10.1016/0037-0738(94)90138-4; Newman William A., 2006, BOSTONS BACK BAY STO; Seasholes NS., 2003, GAINING GROUND HIST; Shelburne WM, 2001, THESIS U MASSACHUSET; Skehan JW, 2001, ROADSIDE GEOLOGY MAS; Spillane M, 2006, BOSTON GLOBE; Wilkinson BH, 2007, GEOL SOC AM BULL, V119, P140, DOI 10.1130/B25899.1	21	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46702	10.1371/journal.pone.0046702	http://dx.doi.org/10.1371/journal.pone.0046702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056410	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400025
J	Xu, DY; Xu, H; Ren, Y; Liu, CG; Wang, XM; Zhang, H; Lu, P				Xu, Dongyang; Xu, Hong; Ren, Ying; Liu, Caigang; Wang, Xuemei; Zhang, Hao; Lu, Ping			Cancer Stem Cell-Related Gene Periostin: A Novel Prognostic Marker for Breast Cancer	PLOS ONE			English	Article							EXPRESSION; RESISTANCE; NICHE	We investigated the expression status of periostin in breast cancer stem cells and its clinical implications in order to lay a foundation for managing breast cancer. CD44+/CD242/line-tumor cells (CSC) from clinical specimens were sorted using flow cytometry. Periostin expression status was detected in CSC cells and 1,086 breast cancer specimens by Western blot and immunohistochemistry staining, with the CSC ratio determined by immunofluorescence double staining. The relationship between the periostin protein and clinico-pathological parameters and prognosis was subsequently determined. As a result, CSC cells are more likely to generate new tumors in mice and cell microspheres that are deficient in NOD/SCID compared to the control group. Periostin protein was expressed higher in CSC cells compared to the control cells and was found to be related to CSC chemotherapy resistance. Moreover, periostin expression was found to be related to the CSC ratio in 1,086 breast cancer specimens (P = 0.001). In total, 334 (30.76%) of the 1,086 breast cases showed high periostin expression. After universal and Spearman regression correlation analysis, periostin was observed to be related to histological grade, CSC ratio, lymph node metastasis, tumor size, and triple-negative breast cancer (all P<0.05). Furthermore, periostin was shown to attain a significantly more distant bone metastasis and worse disease-specific survival than those with none or low-expressed periostin protein (P = 0.001). In the Cox regression test, periostin protein was detected as an independent prognostic factor (P = 0.001). In conclusion, periostin was found to be related to the CSC and an independent prognostic factor for breast cancer. It is also perhaps a potential target to breast cancer.	[Liu, Caigang] China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Liaoning Provin, Peoples R China; [Xu, Dongyang; Wang, Xuemei; Zhang, Hao; Lu, Ping] China Med Univ, Hosp 1, Dept Ultrasound, Shenyang, Liaoning Provin, Peoples R China; [Xu, Hong] Tumor Hosp Liaoning Prov, Dept Breast Surg, Shenyang, Liaoning Provin, Peoples R China; [Ren, Ying] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University	Liu, CG (corresponding author), China Med Univ, Hosp 1, Dept Breast Surg, Shenyang, Liaoning Provin, Peoples R China.	angel-s205@163.com; xuemeiwangcmu@163.com	Wang, Xuemei/GXF-3702-2022; Liu, Caigang/C-7179-2018	Liu, Caigang/0000-0003-2083-235X; Zhang, Hao/0000-0002-0049-1220	China National Natural Science Foundation [81102029, 81172047]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was funded by the China National Natural Science Foundation (No. 81102029 and 81172047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Contie S, 2011, INT J CANCER, V128, P352, DOI 10.1002/ijc.25591; Dilaveri CA, 2012, INT J WOMENS HEALTH, V4, P35, DOI 10.2147/IJWH.S27624; Dowling EC, 2010, J MED SCREEN, V17, P139, DOI 10.1258/jms.2010.010033; Forsti A, 2007, BREAST CANCER RES TR, V101, P83, DOI 10.1007/s10549-006-9265-1; Gaffan J, 2006, J CLIN ONCOL, V24, P1932, DOI 10.1200/JCO.2005.02.6617; Kyutoku M, 2011, INT J MOL MED, V28, P181, DOI 10.3892/ijmm.2011.712; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Pohjolainen V, 2012, NEPHROL DIAL TRANSPL, V27, P115, DOI 10.1093/ndt/gfr279; Sen K, 2011, AM J PATHOL, V179, P1756, DOI 10.1016/j.ajpath.2011.06.002; Wang J, 2012, CELL MOL BIOL NOISY, V58; Wang W, 2011, CELL BIOL INT, V35, P1085, DOI 10.1042/CBI20110171; Wang Z, 2012, CELL STEM CELL, V10, P111, DOI 10.1016/j.stem.2012.01.002	17	47	52	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46670	10.1371/journal.pone.0046670	http://dx.doi.org/10.1371/journal.pone.0046670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056395	Green Published, gold, Green Submitted			2022-12-27	WOS:000309889400022
J	Dineen, RA; Bradshaw, CM; Constantinescu, CS; Auer, DP				Dineen, Robert A.; Bradshaw, Christopher M.; Constantinescu, Cris S.; Auer, Dorothee P.			Extra-Hippocampal Subcortical Limbic Involvement Predicts Episodic Recall Performance in Multiple Sclerosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE DYSFUNCTION; ALZHEIMERS-DISEASE; NEUROPSYCHOLOGICAL IMPAIRMENT; FORNIX TRANSECTION; DIFFUSION MRI; MEMORY; ATROPHY; INTACT; RECOLLECTION	Background: Episodic memory impairment is a common but poorly-understood phenomenon in multiple sclerosis (MS). We aim to establish the relative contributions of reduced integrity of components of the extended hippocampal-diencephalic system to memory performance in MS patients using quantitative neuroimaging. Methodology/Principal Findings: 34 patients with relapsing-remitting MS and 24 healthy age-matched controls underwent 3 T MRI including diffusion tensor imaging and 3-D T1-weighted volume acquisition. Manual fornix regions-of-interest were used to derive fornix fractional anisotropy (FA). Normalized hippocampal, mammillary body and thalamic volumes were derived by manual segmentation. MS subjects underwent visual recall, verbal recall, verbal recognition and verbal fluency assessment. Significant differences between MS patients and controls were found for fornix FA (0.38 vs. 0.46, means adjusted for age and fornix volume, P<.0005) and mammillary body volumes (age-adjusted means 0.114 ml vs. 0.126 ml, P<.023). Multivariate regression analysis identified fornix FA and mammillary bodies as predictor of visual recall (R-2=.31, P=.003, P=.006), and thalamic volume as predictive of verbal recall (R-2=.37, P<.0005). No limbic measures predicted verbal recognition or verbal fluency. Conclusions/Significance: These findings indicate that structural and ultrastructural alterations in subcortical limbic components beyond the hippocampus predict performance of episodic recall in MS patients with mild memory dysfunction.	[Dineen, Robert A.; Auer, Dorothee P.] Univ Nottingham, Div Radiol & Imaging Sci, Nottingham NG7 2RD, England; [Bradshaw, Christopher M.] Univ Nottingham, Dept Psychopharmacol, Nottingham NG7 2RD, England; [Constantinescu, Cris S.] Univ Nottingham, Div Clin Neurol, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham; University of Nottingham	Dineen, RA (corresponding author), Univ Nottingham, Div Radiol & Imaging Sci, Nottingham NG7 2RD, England.	rob.dineen@nottingham.ac.uk	Sanders, Kate L/D-1507-2019; Milton, David A/A-9794-2011; Dineen, Robert/S-7192-2019	Sanders, Kate L/0000-0002-9581-268X; Auer, Dorothee P./0000-0002-4745-3635; Constantinescu, Cris/0000-0003-2066-7585; Dineen, Robert/0000-0002-9523-2546	Nottingham University Hospitals Charity	Nottingham University Hospitals Charity	The study was part funded by Nottingham University Hospitals Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Aggleton JP, 2001, PHILOS T R SOC B, V356, P1467, DOI 10.1098/rstb.2001.0946; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2004, ARCH NEUROL-CHICAGO, V61, P226, DOI 10.1001/archneur.61.2.226; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Benton A.L., 1974, REVISED VISUAL RETEN; Benton AL, 1983, MULTILINGUAL APHASIA; Bozoki AC, 2011, HUMAN BRAIN MAPPING; Buckley MJ, 2008, BEHAV NEUROSCI, V122, P44, DOI 10.1037/0735-7044.122.1.44; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Charles DP, 2004, J NEUROSCI, V24, P2037, DOI 10.1523/JNEUROSCI.3796-03.2004; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; CRAWFORD JR, 1992, BRIT J CLIN PSYCHOL, V31, P327, DOI 10.1111/j.2044-8260.1992.tb00999.x; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Easton A, 2009, HIPPOCAMPUS, V19, P837, DOI 10.1002/hipo.20567; Goncalves CV, 2009, SAO PAULO MED J, V127, P359, DOI 10.1590/S1516-31802009000600008; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Kern KC, 2012, NEUROIMAGE, V59, P2932, DOI 10.1016/j.neuroimage.2011.09.071; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Mitchell AJ, 2005, LANCET NEUROL, V4, P556, DOI 10.1016/S1474-4422(05)70166-6; Nelson HE, 1991, NATL ADULT READING 2; Pagani E, 2005, AM J NEURORADIOL, V26, P341; Pantel J, 2000, HIPPOCAMPUS, V10, P752, DOI 10.1002/1098-1063(2000)10:6<752::AID-HIPO1012>3.0.CO;2-Y; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; RAO SM, 1985, ARCH NEUROL-CHICAGO, V42, P678, DOI 10.1001/archneur.1985.04060070068018; Rashid W, 2004, MULT SCLER J, V10, P9, DOI 10.1191/1352458504ms985oa; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Roosendaal SD, 2010, RADIOLOGY, V255, P595, DOI 10.1148/radiol.10091433; Rudebeck SR, 2009, J NEUROSCI, V29, P14987, DOI 10.1523/JNEUROSCI.4707-09.2009; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sicotte NL, 2008, BRAIN, V131, P1134, DOI 10.1093/brain/awn030; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tsivilis D, 2008, NAT NEUROSCI, V11, P834, DOI 10.1038/nn.2149; TSOLAKI M, 1994, DEMENTIA, V5, P48, DOI 10.1159/000106694; Turner B, 2001, NEURORADIOLOGY, V43, P608, DOI 10.1007/s002340000457; Vann SD, 2008, NEUROPSYCHOLOGY, V22, P658, DOI 10.1037/a0012542; YOUNGJOHN JR, 1993, CLIN NEUROPSYCHOL, V7, P155, DOI 10.1080/13854049308401517; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053	51	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e44942	10.1371/journal.pone.0044942	http://dx.doi.org/10.1371/journal.pone.0044942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056187	gold, Green Submitted, Green Published			2022-12-27	WOS:000309831500008
J	Mooney, C; Haslam, NJ; Pollastri, G; Shields, DC				Mooney, Catherine; Haslam, Niall J.; Pollastri, Gianluca; Shields, Denis C.			Towards the Improved Discovery and Design of Functional Peptides: Common Features of Diverse Classes Permit Generalized Prediction of Bioactivity	PLOS ONE			English	Article							DATABASE	The conventional wisdom is that certain classes of bioactive peptides have specific structural features that endow their particular functions. Accordingly, predictions of bioactivity have focused on particular subgroups, such as antimicrobial peptides. We hypothesized that bioactive peptides may share more general features, and assessed this by contrasting the predictive power of existing antimicrobial predictors as well as a novel general predictor, PeptideRanker, across different classes of peptides. We observed that existing antimicrobial predictors had reasonable predictive power to identify peptides of certain other classes i.e. toxin and venom peptides. We trained two general predictors of peptide bioactivity, one focused on short peptides (4-20 amino acids) and one focused on long peptides (>20 amino acids). These general predictors had performance that was typically as good as, or better than, that of specific predictors. We noted some striking differences in the features of short peptide and long peptide predictions, in particular, high scoring short peptides favour phenylalanine. This is consistent with the hypothesis that short and long peptides have different functional constraints, perhaps reflecting the difficulty for typical short peptides in supporting independent tertiary structure. We conclude that there are general shared features of bioactive peptides across different functional classes, indicating that computational prediction may accelerate the discovery of novel bioactive peptides and aid in the improved design of existing peptides, across many functional classes. An implementation of the predictive method, PeptideRanker, may be used to identify among a set of peptides those that may be more likely to be bioactive.	[Mooney, Catherine; Haslam, Niall J.; Pollastri, Gianluca; Shields, Denis C.] Natl Univ Ireland Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 4, Ireland; [Mooney, Catherine; Haslam, Niall J.; Shields, Denis C.] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Sci, Dublin 4, Ireland; [Mooney, Catherine; Haslam, Niall J.; Shields, Denis C.] Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Pollastri, Gianluca] Natl Univ Ireland Univ Coll Dublin, Sch Comp Sci & Informat, Dublin 4, Ireland	University College Dublin; University College Dublin; University College Dublin; University College Dublin	Shields, DC (corresponding author), Natl Univ Ireland Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 4, Ireland.	denis.shields@ucd.ie		Pollastri, Gianluca/0000-0002-5825-4949; Mooney, Catherine/0000-0002-7696-1364; Haslam, Niall/0000-0001-7007-5137; Shields, Denis/0000-0003-4015-2474	Science Foundation Ireland [08/IN.1/B1864, 10/RFP/GEN2749]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The work was funded through a Science Foundation Ireland principal investigator grant (grant 08/IN.1/B1864) to DCS and a Science Foundation Ireland research frontiers grant (grant 10/RFP/GEN2749) to GP. (http://www.sfi.ie/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Demidova-Rice TN, 2011, WOUND REPAIR REGEN, V19, P59, DOI 10.1111/j.1524-475X.2010.00642.x; Dziuba J, 1999, NAHRUNG, V43, P190, DOI [10.1002/(SICI)1521-3803(19990601)43:3&lt;190::AID-FOOD190&gt;3.0.CO;2-A, 10.1002/(SICI)1521-3803(19990601)43:3<190::AID-FOOD190>3.3.CO;2-1]; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; FitzGerald RJ, 2000, BRIT J NUTR, V84, pS33; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hruby VJ, 2002, NAT REV DRUG DISCOV, V1, P847, DOI 10.1038/nrd939; Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4; Kaminski S, 2007, J APPL GENET, V48, P189, DOI 10.1007/BF03195213; Lata S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-263; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Liu F, 2008, J PROTEOME RES, V7, P4119, DOI 10.1021/pr800037n; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Mooney C, 2011, BIOINFORMATICS, V27, P2812, DOI 10.1093/bioinformatics/btr494; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Parthasarathi L, 2008, J CHEM INF MODEL, V48, P1943, DOI 10.1021/ci800174c; R Core Team, 2018, R LANG ENV STAT COMP; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025	29	223	231	7	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45012	10.1371/journal.pone.0045012	http://dx.doi.org/10.1371/journal.pone.0045012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056189	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500010
J	Nitzschner, M; Melis, AP; Kaminski, J; Tomasello, M				Nitzschner, Marie; Melis, Alicia P.; Kaminski, Juliane; Tomasello, Michael			Dogs (Canis familiaris) Evaluate Humans on the Basis of Direct Experiences Only	PLOS ONE			English	Article							HUMAN POINTING GESTURES; SOCIAL COGNITION; BEHAVIOR; WOLVES; COOPERATION; RESPOND; FISH; FOOD	Reputation formation is a key component in the social interactions of many animal species. An evaluation of reputation is drawn from two principal sources: direct experience of an individual and indirect experience from observing that individual interacting with a third party. In the current study we investigated whether dogs use direct and/or indirect experience to choose between two human interactants. In the first experiment, subjects had direct interaction either with a "nice" human (who played with, talked to and stroked the dog) or with an "ignoring" experimenter who ignored the dog completely. Results showed that the dogs stayed longer close to the "nice" human. In a second experiment the dogs observed a "nice" or "ignoring" human interacting with another dog. This indirect experience, however, did not lead to a preference between the two humans. These results suggest that the dogs in our study evaluated humans solely on the basis of direct experience.	[Nitzschner, Marie; Melis, Alicia P.; Kaminski, Juliane; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany	Max Planck Society	Nitzschner, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	marie_nitzschner@eva.mpg.de		Kaminski, Juliane/0000-0002-3437-3484	Volkswagenstiftung	Volkswagenstiftung(Volkswagen)	Juliane Kaminski was funded by a grant from the Volkswagenstiftung (http://www.volkswagen-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amy M, 2007, ANIM BEHAV, V74, P57, DOI 10.1016/j.anbehav.2006.07.019; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Brosnan SF, 2009, INT J PRIMATOL, V30, P663, DOI 10.1007/s10764-009-9366-x; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Coppinger R., 2001, DOGS STARTLING NEW U; FRANK H, 1980, Z TIERPSYCHOL, V53, P389; Gacsi M, 2005, DEV PSYCHOBIOL, V47, P111, DOI 10.1002/dev.20082; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Gacsi M, 2001, J COMP PSYCHOL, V115, P423, DOI 10.1037/0735-7036.115.4.423; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2009.06.031; Kundey SMA, 2011, ANIM COGN, V14, P291, DOI 10.1007/s10071-010-0362-5; Marshall-Pescini S, 2011, ANIM BEHAV, V81, P1177, DOI 10.1016/j.anbehav.2011.02.029; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; Petter M, 2009, BEHAV PROCESS, V82, P109, DOI 10.1016/j.beproc.2009.07.002; Pongracz P, 2004, J COMP PSYCHOL, V118, P375, DOI 10.1037/0735-7036.118.4.375; Racca A, 2010, ANIM COGN, V13, P525, DOI 10.1007/s10071-009-0303-3; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Rooney NJ, 2006, ANIM BEHAV, V72, P343, DOI 10.1016/j.anbehav.2005.10.014; Rooney NJ, 2001, ANIM BEHAV, V61, P715, DOI 10.1006/anbe.2000.1661; Russell YI, 2008, BEHAV PROCESS, V78, P108, DOI 10.1016/j.beproc.2007.10.009; Schoon A, 1997, PERFORMANCE DOGS IDE; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Subiaul F, 2008, ANIM COGN, V11, P611, DOI 10.1007/s10071-008-0151-6; Tuber DS, 1996, J COMP PSYCHOL, V110, P103, DOI 10.1037/0735-7036.110.1.103; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; Ward C, 2009, ANIM BEHAV, V78, P1153, DOI 10.1016/j.anbehav.2009.07.033; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wobber V, 2011, DOGS BIOL BEHAV HLTH, P93	39	28	29	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46880	10.1371/journal.pone.0046880	http://dx.doi.org/10.1371/journal.pone.0046880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056507	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500098
J	Byron, SA; Min, E; Thal, TS; Hostetter, G; Watanabe, AT; Azorsa, DO; Little, TH; Tapia, C; Kim, S				Byron, Sara A.; Min, Elizabeth; Thal, Tanya S.; Hostetter, Galen; Watanabe, Aprill T.; Azorsa, David O.; Little, Tanya H.; Tapia, Coya; Kim, Suwon			Negative Regulation of NF-kappa B by the ING4 Tumor Suppressor in Breast Cancer	PLOS ONE			English	Article							MAMMARY TUMORIGENESIS; DOWN-REGULATION; NECROSIS-FACTOR; CELL-MIGRATION; PHD FINGER; GENE; EXPRESSION; INHIBITOR; GROWTH; ACTIVATION	Nuclear Factor kappa B (NF-kappa B) is a key mediator of normal immune response but contributes to aggressive cancer cell phenotypes when aberrantly activated. Here we present evidence that the Inhibitor of Growth 4 (ING4) tumor suppressor negatively regulates NF-kB in breast cancer. We surveyed primary breast tumor samples for ING4 protein expression using tissue microarrays and a newly generated antibody. We found that 34% of tumors expressed undetectable to low levels of the ING4 protein (n = 227). Tumors with low ING4 expression were frequently large in size, high grade, and lymph node positive, suggesting that down-regulation of ING4 may contribute to breast cancer progression. In the same tumor set, we found that low ING4 expression correlated with high levels of nuclear phosphorylated p65/RelA (p-p65), an activated form of NF-kappa B (p = 0.018). Fifty seven percent of ING4-low/p-p65-high tumors were lymph node-positive, indicating a high metastatic tendency of these tumors. Conversely, ectopic expression of ING4 inhibited p65/RelA phosphorylation in T47D and MCF7 breast cancer cells. In addition, ING4 suppressed PMA-induced cell invasion and NF-kappa B-target gene expression in T47D cells, indicating that ING4 inhibited NF-kappa B activity in breast cancer cells. Supportive of the ING4 function in the regulation of NF-kappa B-target gene expression, we found that ING4 expression levels inversely correlated with the expression of NF-kappa B-target genes in primary breast tumors by analyzing public gene expression datasets. Moreover, low ING4 expression or high expression of the gene signature composed of a subset of ING4-repressed NF-kappa B-target genes was associated with reduced disease-free survival in breast cancer patients. Taken together, we conclude that ING4 negatively regulates NF-kappa B in breast cancer. Consequently, down-regulation of ING4 leads to activation of NF-kappa B, contributing to tumor progression and reduced disease-free patient survival in breast cancer.	[Byron, Sara A.; Min, Elizabeth; Thal, Tanya S.; Tapia, Coya; Kim, Suwon] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Watanabe, Aprill T.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA; [Hostetter, Galen; Azorsa, David O.; Little, Tanya H.] Translat Genom Res Inst, Clin Translat Res Div, Phoenix, AZ USA; [Thal, Tanya S.; Tapia, Coya] Univ Arizona, Coll Med, Phoenix, AZ USA	Translational Genomics Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; University of Arizona	Kim, S (corresponding author), Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA.	Suwon@email.arizona.edu		Byron, Sara/0000-0003-0093-0374	National Institute of Health NCI [5K01CA115681]; TGen-VARI Integration Grant; Howard Hughes Medical Institute through the Undergraduate Science Education Program; Helios Education Foundation; Cancer League of Basel Fellowship Grant; Basic Medical Sciences department; Dean's Office at the University of Arizona College of Medicine-Phoenix; NATIONAL CANCER INSTITUTE [K01CA115681] Funding Source: NIH RePORTER	National Institute of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); TGen-VARI Integration Grant; Howard Hughes Medical Institute through the Undergraduate Science Education Program(Howard Hughes Medical Institute); Helios Education Foundation; Cancer League of Basel Fellowship Grant; Basic Medical Sciences department; Dean's Office at the University of Arizona College of Medicine-Phoenix; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health NCI 5K01CA115681 Howard Temin Award (to SK) and TGen-VARI Integration Grant (to SK). EM was supported in part by the Howard Hughes Medical Institute through the Undergraduate Science Education Program (to the Arizona State University School of Life Sciences) and by the Helios Education Foundation (to TGen). CT is a recipient of the Cancer League of Basel Fellowship Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Kim lab and the Cancer and Cell Biology Division at the Translational Genomics Research Institute (TGen) for helpful discussions on the manuscript. We also thank Irma Gonzales and the staff at the TGen Drug Development for their technical assistance with mice. We are also grateful to the Basic Medical Sciences department and the Dean's Office at the University of Arizona College of Medicine-Phoenix for their support that enabled the completion of the study.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Al-Kuraya K, 2007, J CLIN PATHOL, V60, P768, DOI 10.1136/jcp.2006.038281; Azorsa DO, 1999, HYBRIDOMA, V18, P281, DOI 10.1089/027245799315943; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Biswas DK, 2006, J CELL PHYSIOL, V209, P645, DOI 10.1002/jcp.20785; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Coles AH, 2010, P NATL ACAD SCI USA, V107, P11423, DOI 10.1073/pnas.0912116107; Colla S, 2007, BLOOD, V110, P4464, DOI 10.1182/blood-2007-02-074617; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Fang F, 2009, CANCER EPIDEM BIOMAR, V18, P409, DOI 10.1158/1055-9965.EPI-08-0575; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gunduz M, 2005, GENE, V356, P109, DOI 10.1016/j.gene.2005.02.014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Kim S, 2004, P NATL ACAD SCI USA, V101, P16251, DOI 10.1073/pnas.0407158101; Kim S, 2010, CANCER RES, V70, P5155, DOI 10.1158/0008-5472.CAN-10-0425; Li J, 2008, CARCINOGENESIS, V29, P1373, DOI 10.1093/carcin/bgn086; Li J, 2010, CANCER RES, V70, P10445, DOI 10.1158/0008-5472.CAN-10-3040; Li M, 2009, J PATHOL, V219, P87, DOI 10.1002/path.2571; Li XM, 2009, J CANCER RES CLIN, V135, P829, DOI 10.1007/s00432-008-0519-7; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Liu MR, 2009, AM J PATHOL, V174, P1910, DOI 10.2353/ajpath.2009.080706; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Makino K, 2004, ONCOGENE, V23, P3883, DOI 10.1038/sj.onc.1207485; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Nihira K, 2010, CELL DEATH DIFFER, V17, P689, DOI 10.1038/cdd.2009.174; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Palacios A, 2008, J BIOL CHEM, V283, P15956, DOI 10.1074/jbc.M710020200; Pradhan M, 2010, J BIOL CHEM, V285, P31100, DOI 10.1074/jbc.M110.155309; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; Shiseki M, 2003, CANCER RES, V63, P2373; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Tapia C, 2004, INT J ONCOL, V25, P1551; Tapia C, 2011, HUM PATHOL, V42, P983, DOI 10.1016/j.humpath.2010.10.012; Teo HL, 2010, NAT CELL BIOL, V12, P758, DOI 10.1038/ncb2080; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Wang QS, 2010, HISTOPATHOLOGY, V57, P271, DOI 10.1111/j.1365-2559.2010.03623.x; You Q, 2011, PATHOL ONCOL RES, V17, P473, DOI 10.1007/s12253-010-9301-7; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977; Zhou Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-89	56	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46823	10.1371/journal.pone.0046823	http://dx.doi.org/10.1371/journal.pone.0046823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056468	gold, Green Published			2022-12-27	WOS:000309580800051
J	Sunyer, R; Jin, AJ; Nossal, R; Sackett, DL				Sunyer, Raimon; Jin, Albert J.; Nossal, Ralph; Sackett, Dan L.			Fabrication of Hydrogels with Steep Stiffness Gradients for Studying Cell Mechanical Response	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; SUBSTRATE STIFFNESS; RIGIDITY; MOVEMENT; TIPS	Many fundamental cell processes, such as angiogenesis, neurogenesis and cancer metastasis, are thought to be modulated by extracellular matrix stiffness. Thus, the availability of matrix substrates having well-defined stiffness profiles can be of great importance in biophysical studies of cell-substrate interaction. Here, we present a method to fabricate biocompatible hydrogels with a well defined and linear stiffness gradient. This method, involving the photopolymerization of films by progressively uncovering an acrylamide/bis-acrylamide solution initially covered with an opaque mask, can be easily implemented with common lab equipment. It produces linear stiffness gradients of at least 115 kPa/mm, extending from similar to 1 kPa to 240 kPa (in units of Young's modulus). Hydrogels with less steep gradients and narrower stiffness ranges can easily be produced. The hydrogels can be covalently functionalized with uniform coatings of proteins that promote cell adhesion. Cell spreading on these hydrogels linearly correlates with hydrogel stiffness, indicating that this technique effectively modifies the mechanical environment of living cells. This technique provides a simple approach that produces steeper gradients, wider rigidity ranges, and more accurate profiles than current methods.	[Sunyer, Raimon; Nossal, Ralph; Sackett, Dan L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Jin, Albert J.] Natl Inst Biomed Imaging & Bioengn, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Sunyer, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA.	raimon.sunyer@nih.gov	Sunyer, Raimon/G-8605-2013	Sunyer, Raimon/0000-0003-0777-3973; Jin, Albert/0000-0003-3826-1081	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health; Agency of Research and Universities (Ministry of Economy and Knowledge, Catalan Government); Cofund program (Marie Curie Actions, Seventh Framework Programme of the European Union); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000015] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Agency of Research and Universities (Ministry of Economy and Knowledge, Catalan Government); Cofund program (Marie Curie Actions, Seventh Framework Programme of the European Union); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by funds from the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health. R Sunyer was supported by a postdoctoral fellowship from the Agency of Research and Universities (Ministry of Economy and Knowledge, Catalan Government) and the Cofund program (Marie Curie Actions, Seventh Framework Programme of the European Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Aratyn-Schaus Yvonne, 2010, J Vis Exp, DOI 10.3791/2173; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Johnson PM, 2005, POLYMER, V46, P3300, DOI 10.1016/j.polymer.2005.02.085; Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0; Kawano T, 2011, BIOMATERIALS, V32, P2725, DOI 10.1016/j.biomaterials.2011.01.009; Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Ramachandra M, 1996, MOL BIOL CELL, V7, P1485, DOI 10.1091/mbc.7.10.1485; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; ROSS RA, 1983, J NATL CANCER I, V71, P741; Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011; Tse J. R., 2009, CURR PROT CELL BIO; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883	30	146	147	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46107	10.1371/journal.pone.0046107	http://dx.doi.org/10.1371/journal.pone.0046107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056241	Green Submitted, Green Published, gold			2022-12-27	WOS:000309580800010
J	Kosidou, K; Hellner-Gumpert, C; Fredlund, P; Dalman, C; Hallqvist, J; Isacsson, G; Magnusson, C				Kosidou, Kyriaki; Hellner-Gumpert, Clara; Fredlund, Peeter; Dalman, Christina; Hallqvist, Johan; Isacsson, Goran; Magnusson, Cecilia			Immigration, Transition into Adult Life and Social Adversity in Relation to Psychological Distress and Suicide Attempts among Young Adults	PLOS ONE			English	Article							MENTAL-HEALTH; RISK-FACTORS; GENERAL-POPULATION; ETHNIC-GROUPS; PREVALENCE; TRENDS; DISORDERS; BEHAVIOR; ANXIETY; DEPRESSION	Background: The increasing incidence of mental health problems among young people is a major concern in many Western countries. The causal mechanisms underlying these trends are not well established, but factors influenced by current societal changes ought to be implicated. Such factors include immigration and social adversity as well as the timing of taking on adult social roles (e.g. gainful employment, parenthood and own housing tenure). We therefore examined relationships between these factors and the risks of psychological distress as well as suicide attempts in young adults, with a focus on gender differences. Methods: We conducted a population-based study including 10,081 individuals aged 18-29, recruited in 2002 and 2006 in Stockholm, Sweden. Data were collected by record linkage and questionnaires. Results: Non-European immigrants had an increased risk of distress, and female non-European immigrants had a markedly higher risk of suicide attempts. Both early parenthood (<= 24 years) and not being a parent, being a student and the lack of own housing tenure were associated with distress, but only in women. In both sexes, financial strain was associated with the increased risk of distress and suicide attempts, while unemployment was only associated with distress. Conclusions: Immigration from outside Europe and social adversity are associated with mental health problems in young adults, especially females. Postponed transition into adulthood is associated with poor mental health in young women. These factors are influenced by current societal changes, and may have contributed to the increasing incidence of mental health problems among young people in Western countries.	[Kosidou, Kyriaki; Fredlund, Peeter; Dalman, Christina; Magnusson, Cecilia] Karolinska Inst, Div Publ Hlth Epidemiol, Dept Publ Hlth Sci, Stockholm, Sweden; [Hellner-Gumpert, Clara; Isacsson, Goran] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden; [Hallqvist, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci, BMC, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Kosidou, K (corresponding author), Karolinska Inst, Div Publ Hlth Epidemiol, Dept Publ Hlth Sci, Stockholm, Sweden.	kyriaki.kosidou@ki.se		Dalman, Christina/0000-0002-3579-2357; Magnusson, Cecilia/0000-0002-8567-6725	Stockholm County Council, Swedish Council for Working Life and Social Research [DNR2007-2064]	Stockholm County Council, Swedish Council for Working Life and Social Research	This study was supported by a grant by the Stockholm County Council, Swedish Council for Working Life and Social Research (DNR2007-2064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbo E, 2002, BMJ-BRIT MED J, V325, P74, DOI 10.1136/bmj.325.7355.74; Alonso J, 2007, J CLIN PSYCHIAT, V68, P3; Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; Bhugra D, 2005, ACTA PSYCHIAT SCAND, V111, P84, DOI 10.1111/j.1600-0447.2004.00454.x; Boden JM, 2008, J CHILD PSYCHOL PSYC, V49, P151, DOI 10.1111/j.1469-7610.2007.01830.x; Bogdanovica I, 2011, SOC PSYCH PSYCH EPID, V46, P1103, DOI 10.1007/s00127-010-0282-3; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Bremberg S., 2006, UNGDOMAR STRESS PSYK; Burger I, 2009, CRISIS, V30, P63, DOI 10.1027/0227-5910.30.2.63; Carlson DL, 2011, SOC SCI MED, V72, P494, DOI 10.1016/j.socscimed.2010.12.001; Christoffersen MN, 2003, ACTA PSYCHIAT SCAND, V108, P350, DOI 10.1034/j.1600-0447.2003.00165.x; Clarke DE, 2008, PSYCHOL MED, V38, P419, DOI 10.1017/S0033291707002103; de Graaf R, 2000, AM J EPIDEMIOL, V152, P1039, DOI 10.1093/aje/152.11.1039; Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0_10; Eurostat, 2010, POP SOC COND; Fergusson DM, 2007, CRISIS, V28, P95, DOI 10.1027/0227-5910.28.2.95; Fussell E., 2005, FRONTIER ADULTHOOD T, P29, DOI [10. 7208/chicago/9780226748924. 003. 0002, DOI 10.7208/CHICAGO/9780226748924.003.0002]; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Jablonska B, 2009, PSYCHOL MED, V39, P87, DOI 10.1017/S0033291708003176; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; Jorgensen L, 2010, ACTA PSYCHIAT SCAND, V121, P389, DOI 10.1111/j.1600-0447.2009.01500.x; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Kokkevi A, 2011, SOC PSYCH PSYCH EPID, V46, P231, DOI 10.1007/s00127-010-0185-3; Kosidou K, 2010, ACTA PSYCHIAT SCAND, V122, P47, DOI 10.1111/j.1600-0447.2009.01487.x; Lager ACJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-325; Lee C, 2007, DEV PSYCHOL, V43, P877, DOI 10.1037/0012-1649.43.4.877; Legleye S, 2010, J AFFECT DISORDERS, V123, P108, DOI 10.1016/j.jad.2009.10.016; Levecque K, 2007, J AFFECT DISORDERS, V97, P229, DOI 10.1016/j.jad.2006.06.022; Lindstrom M, 2004, SOC SCI MED, V59, P595, DOI 10.1016/j.socscimed.2003.11.006; Lipsicas CB, 2010, CAN J PSYCHIAT, V55, P274, DOI 10.1177/070674371005500502; Lundberg M, 1996, EPIDEMIOLOGY, V7, P655; Lundstrom Sixten., 1999, J OFF STAT, V15, P305, DOI DOI 10.1002/SIM.1903.; MEEHAN PJ, 1992, AM J PSYCHIAT, V149, P41; Mirowsky J, 2002, SOC SCI MED, V54, P1281, DOI 10.1016/S0277-9536(01)00096-X; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; OECD, 2012, FAM DAT; OECD, 2008, PROF IMM POP 21 CENT; Rai D, 2012, J EPIDEMIOL COMMUN H, V66, P586, DOI 10.1136/jech.2010.119644; Ryan P, 2001, J ECON LIT, V39, P34, DOI 10.1257/jel.39.1.34; Schepman K, 2011, SOC SCI MED, V73, P293, DOI 10.1016/j.socscimed.2011.05.015; Schmidtke A, 2004, SUICIDAL BEHAV EUROP; Sconfienza C, 1998, ARBETE HALSA, V33, P22; Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x; Sigfusdottir ID, 2008, SCAND J PUBLIC HEALT, V36, P361, DOI 10.1177/1403494807088457; Statens Offentliga Utredningar (SOU), 2007, 200714 SOU FRITZ, P14; Statistics Sweden, 2007, DEM REP, P4; Statistics Sweden, 1982, SOC IND SEI SWED SOC; Stockholms lans landsting (Stockholm County Council), 2007, STOCKH; Suvisaari J, 2009, PSYCHOL MED, V39, P287, DOI 10.1017/S0033291708003632; Svensson A, 2012, INT J EPIDE IN PRESS; Tick NT, 2007, ACTA PSYCHIAT SCAND, V116, P473, DOI 10.1111/j.1600-0447.2007.01068.x; Wadman C., 2008, HLTH EQUAL TERMS RES; Webb RT, 2011, PSYCHOL MED, V41, P1867, DOI 10.1017/S0033291711000055; West P, 2003, J CHILD PSYCHOL PSYC, V44, P399, DOI 10.1111/1469-7610.00130	54	30	30	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46284	10.1371/journal.pone.0046284	http://dx.doi.org/10.1371/journal.pone.0046284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056275	Green Published, gold			2022-12-27	WOS:000309454000028
J	Larsen, RJ; Knapp, MC; Genoways, HH; Khan, FAA; Larsen, PA; Wilson, DE; Baker, RJ				Larsen, Roxanne J.; Knapp, Michelle C.; Genoways, Hugh H.; Khan, Faisal Ali Anwarali; Larsen, Peter A.; Wilson, Don E.; Baker, Robert J.			Genetic Diversity of Neotropical Myotis (Chiroptera: Vespertilionidae) with an Emphasis on South American Species	PLOS ONE			English	Article							MOLECULAR SYSTEMATICS; NIGRICANS SCHINZ; GENUS MYOTIS; BATS; DNA; MITOCHONDRIAL; IDENTIFICATION; POPULATIONS; PHYLOGENY; SOFTWARE	Background: Cryptic morphological variation in the Chiropteran genus Myotis limits the understanding of species boundaries and species richness within the genus. Several authors have suggested that it is likely there are unrecognized species-level lineages of Myotis in the Neotropics. This study provides an assessment of the diversity in New World Myotis by analyzing cytochrome-b gene variation from an expansive sample ranging throughout North, Central, and South America. We provide baseline genetic data for researchers investigating phylogeographic and phylogenetic patterns of Myotis in these regions, with an emphasis on South America. Methodology and Principal Findings: Cytochrome-b sequences were generated and phylogenetically analyzed from 215 specimens, providing DNA sequence data for the most species of New World Myotis to date. Based on genetic data in our sample, and on comparisons with available DNA sequence data from GenBank, we estimate the number of species-level genetic lineages in South America alone to be at least 18, rather than the 15 species currently recognized. Conclusions: Our findings provide evidence that the perception of lower species richness in South American Myotis is largely due to a combination of cryptic morphological variation and insufficient sampling coverage in genetic- based systematic studies. A more accurate assessment of the level of diversity and species richness in New World Myotis is not only helpful for delimiting species boundaries, but also for understanding evolutionary processes within this globally distributed bat genus.	[Larsen, Roxanne J.; Knapp, Michelle C.; Khan, Faisal Ali Anwarali; Larsen, Peter A.; Baker, Robert J.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Genoways, Hugh H.] Univ Nebraska, State Museum, Lincoln, NE 68588 USA; [Wilson, Don E.] Smithsonian Inst, Natl Museum Amer Hist, Washington, DC 20560 USA	Texas Tech University System; Texas Tech University; University of Nebraska System; University of Nebraska Lincoln; Smithsonian Institution; Smithsonian National Museum of Natural History	Larsen, RJ (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27706 USA.	roxy.larsen@duke.edu	Khan, Faisal Ali Anwarali/J-7670-2012; Larsen, Roxanne/R-3896-2019; Khan, Faisal Ali Anwarali/AAE-9664-2019; Larsen, Roxanne/I-4425-2016	Khan, Faisal Ali Anwarali/0000-0001-7585-4885; Larsen, Roxanne/0000-0001-8139-3261; Khan, Faisal Ali Anwarali/0000-0001-7585-4885; Larsen, Roxanne/0000-0001-8139-3261	Department of Biological Sciences at Texas Tech University; Biological Database; James Sowell	Department of Biological Sciences at Texas Tech University; Biological Database; James Sowell	This research was supported by the Department of Biological Sciences at Texas Tech University, the Biological Database, and James Sowell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRES C.C, 2008, THESIS U SAO PAULO S; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Barquez Ruben M., 1999, Texas Tech University Museum Special Publications, V42, P1; BAUD FJ, 1993, REV SUISSE ZOOL, V100, P595, DOI 10.5962/bhl.part.79874; BOGAN MA, 1978, J MAMMAL, V59, P519, DOI 10.2307/1380228; Bornholdt R, 2008, BRAZ J BIOL, V68, P623, DOI 10.1590/S1519-69842008000300021; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021460; DEWEY TA, 2006, THESIS U MICHIGAN AN; Ditchfield AD, 2000, MOL ECOL, V9, P1307, DOI 10.1046/j.1365-294x.2000.01013.x; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lack JB, 2010, J MAMMAL, V91, P1435, DOI 10.1644/09-MAMM-A-354.1; Larsen RJ, 2012, MAMM BIOL, V77, P124, DOI 10.1016/j.mambio.2011.11.003; LaVal R.K., 1973, Science Bull nat Hist Mus Los Ang Cty, V15, P1; Lim Burton K., 2009, Chiroptera Neotropical, V15, P391; Longmire Jonathan L., 1997, Occasional Papers the Museum Texas Tech University, V163, P1; Lopez-Gonzalez C, 2001, J MAMMAL, V82, P138, DOI 10.1644/1545-1542(2001)082<0138:TSOMCV>2.0.CO;2; MADDISON D, 2005, MACCLADE 4 08; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; Miller Jr GS, 1928, B US NAT MUS, V144, P1; Moratelli R, 2011, ZOOLOGIA-CURITIBA, V28, P789, DOI 10.1590/S1984-46702011000600013; Moratelli R, 2011, MAMM BIOL, V76, P592, DOI 10.1016/j.mambio.2011.01.003; Moratelli Ricardo, 2011, Zootaxa, V2985, P41; Moratelli R, 2011, MAMM BIOL, V76, P608, DOI 10.1016/j.mambio.2010.10.003; Ray DA, 2008, GENOME RES, V18, P717, DOI 10.1101/gr.071886.107; Rodriguez RM, 2004, J MAMMAL, V85, P842, DOI 10.1644/1545-1542(2004)085<0842:MDDDNR>2.0.CO;2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stadelmann B, 2004, ACTA CHIROPTEROL, V6, P177, DOI 10.3161/001.006.0201; Stadelmann B, 2004, J MAMMAL, V85, P133, DOI 10.1644/1545-1542(2004)085<0133:MSOTFB>2.0.CO;2; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas J, 2011, GENE, V474, P52, DOI 10.1016/j.gene.2010.12.007; Weller TJ, 2007, ACTA CHIROPTEROL, V9, P133, DOI 10.3161/1733-5329(2007)9[133:FIOTCV]2.0.CO;2; Wilson DE, 2008, MAMMALS S AM, V1, P468; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615	45	42	48	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46578	10.1371/journal.pone.0046578	http://dx.doi.org/10.1371/journal.pone.0046578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056352	Green Published, gold			2022-12-27	WOS:000309454000058
J	Meszaros, B; Dosztanyi, Z; Simon, I				Meszaros, Balint; Dosztanyi, Zsuzsanna; Simon, Istvan			Disordered Binding Regions and Linear Motifs-Bridging the Gap between Two Models of Molecular Recognition	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; WEB SERVER; PREDICTION; IDENTIFICATION; PRINCIPLES; FEATURES; REVEALS; CONTEXT; DOMAIN	Intrinsically disordered proteins (IDPs) exist without the presence of a stable tertiary structure in isolation. These proteins are often involved in molecular recognition processes via their disordered binding regions that can recognize partner molecules by undergoing a coupled folding and binding process. The specific properties of disordered binding regions give way to specific, yet transient interactions that enable IDPs to play central roles in signaling pathways and act as hubs of protein interaction networks. An alternative model of protein-protein interactions with largely overlapping functional properties is offered by the concept of linear interaction motifs. This approach focuses on distilling a short consensus sequence pattern from proteins with a common interaction partner. These motifs often reside in disordered regions and are considered to mediate the interaction roughly independent from the rest of the protein. Although a connection between linear motifs and disordered binding regions has been established through common examples, the complementary nature of the two concepts has yet to be fully explored. In many cases the sequence based definition of linear motifs and the structural context based definition of disordered binding regions describe two aspects of the same phenomenon. To gain insight into the connection between the two models, prediction methods were utilized. We combined the regular expression based prediction of linear motifs with the disordered binding region prediction method ANCHOR, each specialized for either model to get the best of both worlds. The thorough analysis of the overlap of the two methods offers a bioinformatics tool for more efficient binding site prediction that can serve a wide range of practical implications. At the same time it can also shed light on the theoretical connection between the two co-existing interaction models.	[Meszaros, Balint; Dosztanyi, Zsuzsanna; Simon, Istvan] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Dosztanyi, Z (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.	zsuzsa@enzim.hu; simon.istvan@ttk.mta.hu	Dosztanyi, Zsuzsanna/G-6422-2010; Simon, Istvan/A-2868-2008; Dosztanyi, Zsuzsanna/M-9943-2019; Mészáros, Bálint/C-9481-2012	Dosztanyi, Zsuzsanna/0000-0002-3624-5937; Mészáros, Bálint/0000-0003-0919-4449; Simon, Istvan/0000-0003-1207-4018	Hungarian Science Research Fund (OTKA) [NK 100482]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	Hungarian Science Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by grants Hungarian Science Research Fund (OTKA) NK 100482. The Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences for Z.D. is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002341; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Blow N, 2009, NATURE, V460, P415, DOI 10.1038/460415a; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Chica C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006052; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Davey NE, 2011, NUCLEIC ACIDS RES, V39, pW56, DOI 10.1093/nar/gkr402; Davey NE, 2010, FRONT BIOSCI-LANDMRK, V15, P801, DOI 10.2741/3647; Davey NE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-14; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Edwards RJ, 2012, MOL BIOSYST, V8, P282, DOI 10.1039/c1mb05212h; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Gibson TJ, 2009, TRENDS BIOCHEM SCI, V34, P471, DOI 10.1016/j.tibs.2009.06.007; Gunasekaran K, 2004, J MOL BIOL, V341, P1327, DOI 10.1016/j.jmb.2004.07.002; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Luck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025376; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Mosca R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014969; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Pancsa R, 2012, IUBMB LIFE, V64, P513, DOI 10.1002/iub.1034; Reid JE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr574; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Stein A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000789; Stein A, 2009, FEBS J, V276, P5390, DOI 10.1111/j.1742-4658.2009.07251.x; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Van Roey K., 2012, CURR OPIN STRUCT BIO, DOI 10.10161j.sbi.2012.03.004; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weatheritt RJ, 2012, BIOINFORMATICS, V28, P976, DOI 10.1093/bioinformatics/bts072; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u	52	50	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46829	10.1371/journal.pone.0046829	http://dx.doi.org/10.1371/journal.pone.0046829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056474	gold, Green Submitted, Green Published			2022-12-27	WOS:000309454000091
J	Poletta, FA; Camelo, JSL; Gili, JA; Leoncini, E; Castilla, EE; Mastroiacovo, P				Poletta, Fernando A.; Lopez Camelo, Jorge S.; Gili, Juan A.; Leoncini, Emmanuele; Castilla, Eduardo E.; Mastroiacovo, Pierpaolo			Methodological Approaches to Evaluate Teratogenic Risk Using Birth Defect Registries: Advantages and Disadvantages	PLOS ONE			English	Article							MALFORMED INFANTS; RECALL BIAS; REPORTING BIAS; SELECTION BIAS; PREGNANCY; MALFORMATIONS; DRUGS; ACETAMINOPHEN; ANOMALIES	Background: Different approaches have been used in case-control studies to estimate maternal exposure to medications and the risk of birth defects. However, the performance of these approaches and how they affect the odds ratio (OR) estimates have not been evaluated using birth-defect surveillance programmes. The aim of this study was to evaluate the scope and limitations of three case-control approaches to assess the teratogenic risk of birth defects in mothers exposed to antiepileptic medications, insulin, or acetaminophen. Methodology/Principal Findings: We studied 110,814 non-malformed newborns and 58,514 live newborns with birth defects registered by the Latin American Collaborative Study of Congenital Anomalies (ECLAMC) between 1967 and 2008. Four controls were randomly selected for each case in the same hospital and period, and three different control groups were used: non-malformed newborns (HEALTHY), malformed newborns (SICK), and a subgroup of SICK, only-exposed cases (OECA). Associations were evaluated using OR and Pearson's chi-square (P<0.01). There were no concordance correlations between the HEALTHY and OECA designs, and the average OR differences ranged from 3.0 to 11.5 for the three evaluated medicines. The overestimations observed for HEALTHY design were increased as higher OR values were given, with a high and statistically significant correlation between the difference and the mean. On the contrary, the concordance correlations obtained between the SICK and OECA designs were quite good, with no significant differences in the average risks. Conclusions: The HEALTHY design estimates the true population OR, but shows a high rate of false-positive results presumably caused by differential misclassification bias. This bias decreases with the increase of the proportion of exposed controls. SICK and OECA odds ratios cannot be considered a direct estimate of the true population OR except under certain conditions. However, the SICK and OECA designs could provide practical information to generate hypotheses about potential teratogens.	[Poletta, Fernando A.; Lopez Camelo, Jorge S.; Gili, Juan A.; Castilla, Eduardo E.] Consejo Nacl Invest Cient & Tecn, ECLAMC Estudio Colaborativo Latinoamer Malformac, CEMIC, RA-1033 Buenos Aires, DF, Argentina; [Lopez Camelo, Jorge S.] CIC CONICET, ECLAMC, Inst Multidisciplinario Biol Celular IMBICE, La Plata, Argentina; [Mastroiacovo, Pierpaolo] Headquarters Int Clearinghouse Birth Defects Surv, Rome, Italy; [Castilla, Eduardo E.] Inst Oswaldo Cruz, ECLAMC, BR-20001 Rio De Janeiro, Brazil; [Poletta, Fernando A.; Lopez Camelo, Jorge S.; Gili, Juan A.; Castilla, Eduardo E.] INAGEMP Inst Nacl Genet Med Populac, Rio De Janeiro, Brazil	Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Fundacao Oswaldo Cruz	Camelo, JSL (corresponding author), Consejo Nacl Invest Cient & Tecn, ECLAMC Estudio Colaborativo Latinoamer Malformac, CEMIC, RA-1033 Buenos Aires, DF, Argentina.	jslc@eclamc.org	; , emanuele/A-5466-2010	Lopez-Camelo, Jorge S./0000-0002-3146-5447; , emanuele/0000-0002-7669-8535; Poletta, Fernando/0000-0002-6102-8416	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina [PICT 2008 0429]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), grant number PICT 2008 0429, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpino C, 2000, EPILEPSIA, V41, P1436, DOI 10.1111/j.1528-1157.2000.tb00119.x; Artama M, 2006, INT J EPIDEMIOL, V35, P280, DOI 10.1093/ije/dyi234; Bar-Oz B, 1999, LANCET, V354, P1700, DOI 10.1016/S0140-6736(99)04411-6; BECERRA JE, 1990, PEDIATRICS, V85, P1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CASTILLA EE, 1985, AM J MED GENET, V22, P717, DOI 10.1002/ajmg.1320220408; Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Elwood J. M., 1992, EPIDEMIOLOGY CONTROL; Elwood JM., 1992, CAUSAL RELATIONSHIPS; Feldkamp ML, 2010, OBSTET GYNECOL, V115, P109, DOI 10.1097/AOG.0b013e3181c52616; HOOK EB, 1993, EPIDEMIOLOGY, V4, P182, DOI 10.1097/00001648-199303000-00017; Hook EB, 2000, TERATOLOGY, V61, P325, DOI 10.1002/(SICI)1096-9926(200005)61:5<325::AID-TERA1>3.0.CO;2-M; Infante-Rivard C, 2000, AM J EPIDEMIOL, V152, P480, DOI 10.1093/aje/152.5.480; Jentink J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6581; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; KALLEN B, 1992, EUR J EPIDEMIOL, V8, P256; KALLEN B, 1989, EUR J EPIDEMIOL, V5, P31, DOI 10.1007/BF00145041; KLEINBAUM DG, 1981, AM J EPIDEMIOL, V113, P452, DOI 10.1093/oxfordjournals.aje.a113113; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lisi A, 2010, REPROD TOXICOL, V29, P433, DOI 10.1016/j.reprotox.2010.03.005; MACKENZIE SG, 1989, AM J EPIDEMIOL, V129, P65, DOI 10.1093/oxfordjournals.aje.a115125; Prieto L, 2000, TERATOLOGY, V62, P372, DOI 10.1002/1096-9926(200012)62:6<372::AID-TERA2>3.0.CO;2-D; Prieto L, 2000, TERATOLOGY, V62, P5, DOI 10.1002/1096-9926(200007)62:1<5::AID-TERA3>3.0.CO;2-M; Prieto L, 1999, TERATOLOGY, V60, P1, DOI 10.1002/(SICI)1096-9926(199907)60:1<1::AID-TERA1>3.0.CO;2-9; Scialli AR, 2010, REPROD TOXICOL, V30, P495, DOI 10.1016/j.reprotox.2010.07.007; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; SWAN SH, 1992, EPIDEMIOLOGY, V3, P356, DOI 10.1097/00001648-199207000-00011; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn	32	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46626	10.1371/journal.pone.0046626	http://dx.doi.org/10.1371/journal.pone.0046626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056376	gold, Green Submitted, Green Published			2022-12-27	WOS:000309454000066
J	Skwarczynski, M; Dougall, AM; Khoshnejad, M; Chandrudu, S; Pearson, MS; Loukas, A; Toth, I				Skwarczynski, Mariusz; Dougall, Annette M.; Khoshnejad, Makan; Chandrudu, Saranya; Pearson, Mark S.; Loukas, Alex; Toth, Istvan			Peptide-Based Subunit Vaccine against Hookworm Infection	PLOS ONE			English	Article							A STREPTOCOCCAL VACCINE; MULTIVALENT VACCINE; NEUTRALIZING ANTIBODIES; IN-VITRO; CANDIDATES; NANOPARTICLES; HEMOGLOBINASE; DELIVERY; PROTEIN; DESIGN	Hookworms infect more people than HIV and malaria combined, predominantly in third world countries. Treatment of infection with chemotherapy can have limited efficacy and re-infections after treatment are common. Heavy infection often leads to debilitating diseases. All these factors suggest an urgent need for development of vaccine. In an attempt to develop a vaccine targeting the major human hookworm, Necator americanus, a B-cell peptide epitope was chosen from the apical enzyme in the hemoglobin digestion cascade, the aspartic protease Na-APR-1. The Y-A291 alpha helical epitope is known to induce neutralizing antibodies that inhibit the enzymatic activity of Na-APR-1, thus reducing the capacity for hookworms to digest hemoglobin and obtain nutrients. A(291)Y was engineered such that it was flanked on both termini by a coil-promoting sequence to maintain native conformation, and subsequently incorporated into a Lipid Core Peptide (LCP) self-adjuvanting system. While A(291)Y alone or the chimeric epitope with or without Freund's adjuvants induced negligible IgG responses, the LCP construct incorporating the chimeric peptide induced a strong IgG response in mice. Antibodies produced were able to bind to and completely inhibit the enzymatic activity of Na-APR-1. The results presented show that the new chimeric LCP construct can induce effective enzyme-neutralising antibodies in mice, without the help of any additional toxic adjuvants. This approach offers promise for the development of vaccines against helminth parasites of humans and their livestock and companion animals.	[Dougall, Annette M.; Pearson, Mark S.; Loukas, Alex] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Queensland Trop Hlth Alliance, Cairns, Qld, Australia; [Skwarczynski, Mariusz; Khoshnejad, Makan; Chandrudu, Saranya; Toth, Istvan] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Toth, Istvan] Univ Queensland, Sch Pharm, Woolloongabba, Qld, Australia	James Cook University; University of Queensland; University of Queensland	Loukas, A (corresponding author), James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Queensland Trop Hlth Alliance, Cairns, Qld, Australia.	alex.loukas@jcu.edu.au; i.toth@uq.edu.au	Toth, Istvan/C-1965-2013; Loukas, Alex/B-7355-2014; Dougall, Annette/G-9383-2011; Skwarczynski, Mariusz/A-6707-2009; Pearson, Mark S/O-5636-2014	Toth, Istvan/0000-0002-4572-397X; Loukas, Alex/0000-0002-0896-8441; Skwarczynski, Mariusz/0000-0001-7257-807X; Pearson, Mark/0000-0002-0002-1544	National Health and Medical Research Council of Australia (NHMRC Programme) [496600]	National Health and Medical Research Council of Australia (NHMRC Programme)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC Programme Grant 496600), http://www.nhmrc.gov.au/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors also thank Thalia Guerin for her correction of this manuscript.	Abdel-Aal ABM, 2008, J MED CHEM, V51, P167, DOI 10.1021/jm701091d; Abdel-Aal ABM, 2010, J MED CHEM, V53, P8041, DOI 10.1021/jm1007787; Abid-Essefi S, 2009, J BIOCHEM MOL TOXIC, V23, P233, DOI 10.1002/jbt.20284; ALBONICO M, 1995, T ROY SOC TROP MED H, V89, P538, DOI 10.1016/0035-9203(95)90101-9; Bauer MJ, 2012, VACCINE, V30, P2197, DOI 10.1016/j.vaccine.2011.12.115; Bergeon JA, 2010, J PHARM SCI-US, V99, P2333, DOI 10.1002/jps.21999; Bethony J, 2005, FASEB J, V19, P1743, DOI 10.1096/fj.05-3936fje; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Diemert DJ, 2012, J ALLERGY C IN PRESS; Georgousakis MM, 2009, VACCINE, V27, P6799, DOI 10.1016/j.vaccine.2009.08.049; GIBBONS WA, 1990, LIEBIGS ANN CHEM, P1175; Hayman WA, 1997, INT IMMUNOL, V9, P1723, DOI 10.1093/intimm/9.11.1723; Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Jones B.F., 2004, DRUG DISCOV TODAY, V1, P217; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Koeneman BA, 2009, TOXICOL IN VITRO, V23, P955, DOI 10.1016/j.tiv.2009.05.007; Lin IC, 2011, BIOMACROMOLECULES, V12, P1339, DOI 10.1021/bm200116z; Loukas A, 2005, PLOS MED, V2, P1008, DOI 10.1371/journal.pmed.0020295; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; Mariusz S., 2011, DRUG DELIVERY LETT, V1, P2; Moyle PM, 2008, CURR MED CHEM, V15, P506, DOI 10.2174/092986708783503249; Moyle PM, 2006, J MED CHEM, V49, P6364, DOI 10.1021/jm060475m; Moyle PM, 2006, J ORG CHEM, V71, P6846, DOI 10.1021/jo060960p; Olive C, 2006, J INFECT DIS, V193, P1666, DOI 10.1086/504266; Pearson MS, 2010, J INFECT DIS, V201, P1561, DOI 10.1086/651953; Pearson MS, 2009, FASEB J, V23, P3007, DOI 10.1096/fj.09-131433; Ranjit N, 2009, J INFECT DIS, V199, P904, DOI 10.1086/597048; Skwarczynski M, 2012, AUST J CHEM, V65, P35, DOI 10.1071/CH11292; Skwarczynski M, 2011, METHODS MOL BIOL, V751, P297, DOI 10.1007/978-1-61779-151-2_18; Skwarczynski M, 2011, CURR DRUG DELIV, V8, P282, DOI 10.2174/156720111795256192; Skwarczynski M, 2010, ANGEW CHEM INT EDIT, V49, P5742, DOI 10.1002/anie.201002221; Tolentino K, 2007, AM J TROP MED HYG, V77, P44, DOI 10.4269/ajtmh.2007.77.44; Zaman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030146; Zaman M, 2010, CELL BIO RES PROG, P63; Zaman M, 2010, VACCINE, V28, P2243, DOI 10.1016/j.vaccine.2009.12.046; Zhong Wei, 2009, Current Drug Delivery, V6, P520; Zhong W, 2009, AUST J CHEM, V62, P956, DOI 10.1071/CH09149; Zhong W, 2009, AUST J CHEM, V62, P993, DOI 10.1071/CH09065; Zhong W, 2009, TETRAHEDRON, V65, P3459, DOI 10.1016/j.tet.2009.02.060	40	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46870	10.1371/journal.pone.0046870	http://dx.doi.org/10.1371/journal.pone.0046870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056500	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000309454000096
J	Zhang, B; Zhao, H; Li, T; Gao, X; Gao, Q; Tang, R; Zhang, JT; Chen, ZJ				Zhang, Bo; Zhao, Han; Li, Tao; Gao, Xuan; Gao, Qin; Tang, Rong; Zhang, Jiangtao; Chen, Zi-Jiang			Association Study of Gene LPP in Women with Polycystic Ovary Syndrome	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE 1B; INSULIN-RESISTANCE; PHENOTYPE; PREVALENCE; OBESITY	Background: Previous genome-wide association study (GWAS) of polycystic ovary syndrome (PCOS) in Han Chinese population has found that SNPs in LPP gene were nominally significant in PCOS patients (P around 10E-05). Replication of the GWAS was applied to further confirm the relationship between LPP gene and PCOS. Methods: Three polymorphisms of LPP gene (rs715790, rs4449306, rs6782041) were selected and replicated in additional 1132 PCOS cases and 1142 controls. Genotyping of LPP gene was carried out by Taqman-MGB method. Results: In rs715790, the allele frequency is significantly different between the PCOS group and the control group. Meta-analysis showed that the allele frequencies of the three SNPs rs715790 (P-meta = 1.89E-05, OR = 1.23), rs4449306 (P-meta = 3.0E-04, OR = 1.10), rs6782041 (P-meta = 2.0E-04, OR = 1.09), were significantly different between PCOS cases and controls. Conclusions: Our results suggest that LPP gene might be a novel candidate for PCOS.	[Zhang, Bo; Zhao, Han; Li, Tao; Gao, Xuan; Gao, Qin; Tang, Rong; Zhang, Jiangtao; Chen, Zi-Jiang] Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China; [Zhang, Bo; Zhao, Han; Li, Tao; Gao, Xuan; Gao, Qin; Tang, Rong; Zhang, Jiangtao; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Zhang, Bo; Zhao, Han; Gao, Xuan; Chen, Zi-Jiang] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Zhang, Bo; Zhao, Han; Gao, Xuan; Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China	Shandong University	Chen, ZJ (corresponding author), Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China.	chenzijiang@hotmail.com	Chen, Zi-Jiang/GOE-6119-2022; Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022	Chen, Zi-Jiang/0000-0001-6637-6631	Science research foundation item of no-earnings health vocation [201002013]; National Key Technology Research and Development Program [2011BAI17B00]; National Basic Research Program of China (973 program) [2012CB944700, 2011CB944502]; National Natural Science Foundation of China [30973170, 81000238]	Science research foundation item of no-earnings health vocation; National Key Technology Research and Development Program(National Key Technology R&D Program); National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Science research foundation item of no-earnings health vocation (201002013) and National Key Technology Research and Development Program (2011BAI17B00), National Basic Research Program of China (973 program) (2012CB944700, 2011CB944502), National Natural Science Foundation of China (30973170, 81000238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 1997, J CLIN INVEST, V100, P449, DOI 10.1172/JCI119552; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Carmina E, 2006, FERTIL STERIL, V86, pS7, DOI 10.1016/j.fertnstert.2006.03.012; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Chen Zi-Jiang, 2010, Front Med China, V4, P280, DOI 10.1007/s11684-010-0098-2; Freeman R, 2010, ENDOCR PRACT, V16, P810, DOI 10.4158/EP09330.OR; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Goodarzi MO, 2003, FERTIL STERIL, V80, P255, DOI 10.1016/S0015-0282(03)00734-9; Li T, 2012, J MED GENET, V49, P254, DOI 10.1136/jmedgenet-2011-100727; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Svendsen PF, 2010, FERTIL STERIL, V94, P1052, DOI 10.1016/j.fertnstert.2009.04.008; Traub ML, 2011, WORLD J DIABETES, V2, P33, DOI 10.4239/wjd.v2.i3.33; Wang ET, 2011, OBSTET GYNECOL, V117, P6, DOI 10.1097/AOG.0b013e31820209bb; WHITE MF, 1994, J BIOL CHEM, V269, P1; Wijeyaratne CN, 2011, HUM REPROD, V26, P202, DOI 10.1093/humrep/deq310	15	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46370	10.1371/journal.pone.0046370	http://dx.doi.org/10.1371/journal.pone.0046370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056290	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000033
J	Aeffner, F; Davis, IC				Aeffner, Famke; Davis, Ian C.			Respiratory Syncytial Virus Reverses Airway Hyperresponsiveness to Methacholine in Ovalbumin-Sensitized Mice	PLOS ONE			English	Article							ALVEOLAR FLUID CLEARANCE; ASTHMA EXACERBATIONS; BALB/C MICE; INFLAMMATORY RESPONSES; ANIMAL-MODELS; MOUSE MODEL; IN-VIVO; INFECTION; INTERLEUKIN-8; RSV	Each year, approximately 20% of asthmatics in the United States experience acute symptom exacerbations, which commonly result from pulmonary viral infections. The majority of asthma exacerbations in very young children follow infection with respiratory syncytial virus (RSV). However, pathogenic mechanisms underlying induction of asthma exacerbations by RSV are not well understood. We therefore investigated the effect of post-sensitization RSV infection on lung function in ovalbumin (OVA)-sensitized BALB/c mice as a model of RSV asthma exacerbations. OVA sensitization of uninfected female BALB/c mice increased bronchoalveolar lavage fluid (BALF) eosinophil levels and induced airway hyperresponsiveness to the muscarinic agonist methacholine, as measured by the forced-oscillation technique. In contrast, intranasal infection with replication-competent RSV strain A2 for 2-8 days reduced BALF eosinophil counts and reversed airway hyperresponsiveness in a pertussis toxin-sensitive manner. BALF levels of the chemokine keratinocyte cytokine (KC; a murine homolog of interleukin-8) were elevated in OVA-sensitized, RSV-infected mice and reversal of methacholine hyperresponsiveness in these animals was rapidly inhibited by KC neutralization. Hyporesponsiveness could be induced in OVA-sensitized, uninfected mice by recombinant KC or the G alpha i agonist melittin. These data suggest that respiratory syncytial virus induces KC-mediated activation of G alpha i, resulting in cross-inhibition of Gaq-mediated M3-muscarinic receptor signaling and reversal of airway hyperresponsiveness. As in unsensitized mice, KC therefore appears to play a significant role in induction of airway dysfunction by respiratory syncytial virus. Hence, interleukin-8 may be a promising therapeutic target to normalize lung function in both asthmatics and non-asthmatics with bronchiolitis. However, the OVA-sensitized, RSV-infected mouse may not be an appropriate model for investigating the pathogenesis of viral asthma exacerbations.	[Aeffner, Famke; Davis, Ian C.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	Ohio State University	Davis, IC (corresponding author), Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.	Ian.Davis@cvm.osu.edu		Aeffner, Famke/0000-0002-1405-9228	American Heart Association [0765209B]; Eli Lilly Co. Foundation	American Heart Association(American Heart Association); Eli Lilly Co. Foundation(Eli Lilly)	Funding came from the American Heart Association Beginning Grant-in-Aid 0765209B to I. C. D.; Non-conditional Eli Lilly & Co. Foundation Scholarship to F. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeffner F, 2011, AM J PHYSIOL-LUNG C, V301, pL99, DOI 10.1152/ajplung.00398.2010; Barends M, 2004, J INFECT DIS, V189, P1866, DOI 10.1086/386341; Barends M, 2002, CLIN EXP ALLERGY, V32, P463, DOI 10.1046/j.1365-2222.2002.01317.x; Becnel D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-122; Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Chavez-Bueno S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-46; Cheung DS, 2010, ANN ALLERG ASTHMA IM, V105, P437, DOI 10.1016/j.anai.2010.09.010; Dakhama A, 2005, J IMMUNOL, V175, P1876, DOI 10.4049/jimmunol.175.3.1876; Davis IC, 2007, AM J RESP CELL MOL, V37, P379, DOI 10.1165/rcmb.2007-0142OC; Davis IC, 2007, AM J PHYSIOL-LUNG C, V293, pL281, DOI 10.1152/ajplung.00458.2006; Davis IC, 2006, AM J RESP CRIT CARE, V173, P673, DOI 10.1164/rccm.200508-1200OC; Davis IC, 2004, AM J PHYSIOL-LUNG C, V286, pL112, DOI 10.1152/ajplung.00218.2003; Fujimura M, 1999, ALLERGY, V54, P386, DOI 10.1034/j.1398-9995.1999.00891.x; Govindaraju V, 2006, AM J PHYSIOL-CELL PH, V291, pC957, DOI 10.1152/ajpcell.00451.2005; Hashimoto K, 2002, THORAX, V57, P524, DOI 10.1136/thorax.57.6.524; Hewitt M, 2009, AM J RESP CELL MOL, V40, P83, DOI 10.1165/rcmb.2008-0172OC; Irvin CG, 2003, RESPIR RES, V4, DOI 10.1186/rr199; Jafri HS, 2004, J INFECT DIS, V189, P1856, DOI 10.1086/386372; Jaovisidha P, 1999, J IMMUNOL, V163, P2816; Krishnan V, 2006, AM J RESP CRIT CARE, V174, P633, DOI 10.1164/rccm.200601-007OC; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Lukacs NW, 2006, AM J PATHOL, V169, P977, DOI 10.2353/ajpath.2006.051055; Makela MJ, 2002, AM J RESP CRIT CARE, V165, P824, DOI 10.1164/rccm.2105062; MBIGUINO A, 1991, J VIROL METHODS, V31, P161, DOI 10.1016/0166-0934(91)90154-R; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; Miller AL, 2004, J INFECT DIS, V189, P1419, DOI 10.1086/382958; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Murray Clare S, 2004, Proc Am Thorac Soc, V1, P99, DOI 10.1513/pats.2306027; O'Connor RD, 2010, J ASTHMA, V47, P422, DOI 10.3109/02770901003605332; Pastva A, 2004, J IMMUNOL, V172, P4520, DOI 10.4049/jimmunol.172.7.4520; Peebles RS, 1999, J MED VIROL, V57, P186, DOI 10.1002/(SICI)1096-9071(199902)57:2<186::AID-JMV17>3.0.CO;2-Q; Peebles RS, 2001, J INFECT DIS, V184, P1374; Reddel H, 1999, LANCET, V353, P364, DOI 10.1016/S0140-6736(98)06128-5; Siegle JS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-14; SIGURS N, 1995, PEDIATRICS, V95, P500; SULLENDER WM, 1990, VIROLOGY, V178, P195, DOI 10.1016/0042-6822(90)90394-7; Traylor ZP, 2010, AM J PHYSIOL-LUNG C, V298, pL437, DOI 10.1152/ajplung.00363.2009; Weinberger M, 2004, DRUG DISCOV TODAY, V9, P831, DOI 10.1016/S1359-6446(04)03239-8; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; You DH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-107; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	43	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46660	10.1371/journal.pone.0046660	http://dx.doi.org/10.1371/journal.pone.0046660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056391	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600050
J	Banai, K; Lavner, Y				Banai, Karen; Lavner, Yizhar			Perceptual Learning of Time-Compressed Speech: More than Rapid Adaptation	PLOS ONE			English	Article							TRAINING JAPANESE LISTENERS; STIMULUS UNCERTAINTY; REVERSE HIERARCHIES; OLDER-ADULTS; ENGLISH; NOISE; DISCRIMINATION; TALKER; COMPREHENSION; RECOGNITION	Background: Time-compressed speech, a form of rapidly presented speech, is harder to comprehend than natural speech, especially for non-native speakers. Although it is possible to adapt to time-compressed speech after a brief exposure, it is not known whether additional perceptual learning occurs with further practice. Here, we ask whether multiday training on time-compressed speech yields more learning than that observed during the initial adaptation phase and whether the pattern of generalization following successful learning is different than that observed with initial adaptation only. Methodology/Principal Findings: Two groups of non-native Hebrew speakers were tested on five different conditions of time-compressed speech identification in two assessments conducted 10-14 days apart. Between those assessments, one group of listeners received five practice sessions on one of the time-compressed conditions. Between the two assessments, trained listeners improved significantly more than untrained listeners on the trained condition. Furthermore, the trained group generalized its learning to two untrained conditions in which different talkers presented the trained speech materials. In addition, when the performance of the non-native speakers was compared to that of a group of naive native Hebrew speakers, performance of the trained group was equivalent to that of the native speakers on all conditions on which learning occurred, whereas performance of the untrained non-native listeners was substantially poorer. Conclusions/Significance: Multiday training on time-compressed speech results in significantly more perceptual learning than brief adaptation. Compared to previous studies of adaptation, the training induced learning is more stimulus specific. Taken together, the perceptual learning of time-compressed speech appears to progress from an initial, rapid adaptation phase to a subsequent prolonged and more stimulus specific phase. These findings are consistent with the predictions of the Reverse Hierarchy Theory of perceptual learning and suggest constraints on the use of perceptual-learning regimens during second language acquisition.	[Banai, Karen] Univ Haifa, Dept Commun Sci & Disorders, IL-31999 Haifa, Israel; [Lavner, Yizhar] Tel Hai Coll, Dept Comp Sci, Tel Hai, Israel	University of Haifa; Tel Hai Academy College	Banai, K (corresponding author), Univ Haifa, Dept Commun Sci & Disorders, IL-31999 Haifa, Israel.	kbanai@research.haifa.ac.il	Banai, Karen/J-1448-2019; Lavner, Yizhar/AAA-2458-2019	Banai, Karen/0000-0002-2990-0470; Lavner, Yizhar/0000-0002-2865-0465	Marie-Curie International Reintegration grant [224763]	Marie-Curie International Reintegration grant(European Commission)	This study was supported by Marie-Curie International Reintegration grant 224763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adank P, 2010, NEUROIMAGE, V49, P1124, DOI 10.1016/j.neuroimage.2009.07.032; Adank P, 2009, J ACOUST SOC AM, V126, P2649, DOI 10.1121/1.3216914; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Altmann TM, 1993, EUROSPEECH 93 BERL, V93, P333; Banai K, 2012, VISION RES, V61, P83, DOI 10.1016/j.visres.2012.01.009; Bent T, 2011, J EXP PSYCHOL HUMAN, V37, P1607, DOI 10.1037/a0024281; Bradlow AR, 2008, COGNITION, V106, P707, DOI 10.1016/j.cognition.2007.04.005; Burk MH, 2008, J SPEECH LANG HEAR R, V51, P759, DOI 10.1044/1092-4388(2008/054); Clopper CG, 2004, J PHONETICS, V32, P111, DOI 10.1016/S0095-4470(03)00009-3; Conrad L., 1989, STUDIES 2 LANGUAGE A, V11, P1, DOI DOI 10.1017/S0272263100007804; Davis MH, 2005, J EXP PSYCHOL GEN, V134, P222, DOI 10.1037/0096-3445.134.2.222; Demany L, 2002, J ACOUST SOC AM, V111, P1377, DOI 10.1121/1.1445791; Dupoux E, 1997, J EXP PSYCHOL HUMAN, V23, P914, DOI 10.1037/0096-1523.23.3.914; Golomb JD, 2007, J ACOUST SOC AM, V121, P1701, DOI 10.1121/1.2436635; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Humes LE, 2009, EAR HEARING, V30, P613, DOI 10.1097/AUD.0b013e3181b00d90; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LIVELY SE, 1993, J ACOUST SOC AM, V94, P1242, DOI 10.1121/1.408177; Loebach JL, 2008, J ACOUST SOC AM, V124, P552, DOI 10.1121/1.2931948; LOGAN JS, 1991, J ACOUST SOC AM, V89, P874, DOI 10.1121/1.1894649; Mayo LH, 1997, J SPEECH LANG HEAR R, V40, P686, DOI 10.1044/jslhr.4003.686; Moore DR, 2005, BRAIN LANG, V94, P72, DOI 10.1016/j.bandl.2004.11.009; MOULINES E, 1990, SPEECH COMMUN, V9, P453, DOI 10.1016/0167-6393(90)90021-Z; Nahum M, 2010, VISION RES, V50, P391, DOI 10.1016/j.visres.2009.09.004; Nahum M, 2008, PLOS BIOL, V6, P978, DOI 10.1371/journal.pbio.0060126; Nygaard LC, 1998, PERCEPT PSYCHOPHYS, V60, P355, DOI 10.3758/BF03206860; Ortiz JA, 2010, EXP BRAIN RES, V201, P441, DOI 10.1007/s00221-009-2053-5; Ortiz JA, 2009, J EXP PSYCHOL HUMAN, V35, P188, DOI 10.1037/a0013161; Pallier C, 1998, MEM COGNITION, V26, P844, DOI 10.3758/BF03211403; Peelle JE, 2005, J EXP PSYCHOL HUMAN, V31, P1315, DOI 10.1037/0096-1523.31.6.1315; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Prior A, 2006, PSYCHOPHYSIOLOGY, V43, P440, DOI 10.1111/j.1469-8986.2006.00426.x; Rogers CL, 2006, APPL PSYCHOLINGUIST, V27, P465, DOI 10.1017/S014271640606036X; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Schneider Bruce A., 2001, Seminars in Hearing, V22, P227, DOI 10.1055/s-2001-15628; Sebastian-Galles N, 2000, PERCEPT PSYCHOPHYS, V62, P834, DOI 10.3758/BF03206926; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Song JH, 2012, CEREB CORTEX, V22, P1180, DOI 10.1093/cercor/bhr196; STRANGE W, 1984, PERCEPT PSYCHOPHYS, V36, P131, DOI 10.3758/BF03202673; Tremblay K, 1997, J ACOUST SOC AM, V102, P3762, DOI 10.1121/1.420139; Verhelst W, 2000, SPEECH COMMUN, V30, P207, DOI 10.1016/S0167-6393(99)00051-5; Verhelst W., 1993, ICASSP-93. 1993 IEEE International Conference on Acoustics, Speech, and Signal Processing (Cat. No.92CH3252-4), P554, DOI 10.1109/ICASSP.1993.319366; WINGFIELD A, 1975, J SPEECH HEAR RES, V18, P96, DOI 10.1044/jshr.1801.96; Wright BA, 1997, J NEUROSCI, V17, P3956; Zhao Y, 1997, APPL LINGUIST, V18, P49, DOI 10.1093/applin/18.1.49	48	24	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47099	10.1371/journal.pone.0047099	http://dx.doi.org/10.1371/journal.pone.0047099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	021MR	23056592	Green Submitted, Green Published, gold			2022-12-27	WOS:000309889400056
J	Drastichova, Z; Skrabalova, J; Jedelsky, P; Neckar, J; Kolar, F; Novotny, J				Drastichova, Zdenka; Skrabalova, Jitka; Jedelsky, Petr; Neckar, Jan; Kolar, Frantisek; Novotny, Jiri			Global Changes in the Rat Heart Proteome Induced by Prolonged Morphine Treatment and Withdrawal	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; MESSENGER-RNA EXPRESSION; PHOSPHOLIPASE-C-DELTA; SHOCK-PROTEIN; ADMINISTRATION ALTERS; MEMBRANE-PROTEINS; NUCLEUS-ACCUMBENS; OPIOID RECEPTORS; GENE-EXPRESSION; STRESS-PROTEINS	Morphine belongs among the most commonly used opioids in medical practice due to its strong analgesic effects. However, sustained administration of morphine leads to the development of tolerance and dependence and may cause long-lasting alterations in nervous tissue. Although proteomic approaches enabled to reveal changes in multiple gene expression in the brain as a consequence of morphine treatment, there is lack of information about the effect of this drug on heart tissue. Here we studied the effect of 10-day morphine exposure and subsequent drug withdrawal (3 or 6 days) on the rat heart proteome. Using the iTRAQ technique, we identified 541 proteins in the cytosol, 595 proteins in the plasma membrane-enriched fraction and 538 proteins in the mitochondria-enriched fraction derived from the left ventricles. Altogether, the expression levels of 237 proteins were altered by morphine treatment or withdrawal. The majority of changes (58 proteins) occurred in the cytosol after a 3-day abstinence period. Significant alterations were found in the expression of heat shock proteins (HSP27, alpha-B crystallin, HSP70, HSP10 and HSP60), whose levels were markedly up-regulated after morphine treatment or withdrawal. Besides that morphine exposure up-regulated MAPK p38 (isoform CRA_b) which is a well-known up-stream mediator of phosphorylation and activation of HSP27 and alpha-B crystallin. Whereas there were no alterations in the levels of proteins involved in oxidative stress, several changes were determined in the levels of pro-and anti-apoptotic proteins. These data provide a complex view on quantitative changes in the cardiac proteome induced by morphine treatment or withdrawal and demonstrate great sensitivity of this organ to morphine.	[Drastichova, Zdenka; Skrabalova, Jitka; Novotny, Jiri] Charles Univ Prague, Dept Physiol, Fac Sci, Prague, Czech Republic; [Jedelsky, Petr] Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic; [Neckar, Jan; Kolar, Frantisek] Acad Sci Czech Republ, Inst Physiol, Dept Dev Cardiol, Prague, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Novotny, J (corresponding author), Charles Univ Prague, Dept Physiol, Fac Sci, Prague, Czech Republic.	novotnj99@natur.cuni.cz	Jedelsky, Petr/C-5879-2009; Skrabalova, Jitka/N-5886-2017; Novotny, Jiri/B-2163-2012; Neckar, Jan/C-6645-2012; Kolar, Frantisek/A-7852-2012	Jedelsky, Petr/0000-0003-3813-2343; Skrabalova, Jitka/0000-0002-1953-7911; Novotny, Jiri/0000-0002-6372-0131; Neckar, Jan/0000-0002-1187-9992; Kolar, Frantisek/0000-0002-8723-1826	Grant Agency of the Academy of Sciences of the Czech Republic [IAA501110901]; Charles University Grant Agency [429511]; Czech Ministry of Education, Youth and Sport [MSM0021620858];  [SVV-2012-265206]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Charles University Grant Agency; Czech Ministry of Education, Youth and Sport(Ministry of Education, Youth & Sports - Czech Republic); 	This work was supported by the Grant Agency of the Academy of Sciences of the Czech Republic (IAA501110901), the Charles University Grant Agency (429511), the Czech Ministry of Education, Youth and Sport (MSM0021620858) and by the grant SVV-2012-265206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Husn NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025535; Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; Almela P, 2011, J MOL CELL CARDIOL, V51, P129, DOI 10.1016/j.yjmcc.2011.04.002; Ammon-Treiber S, 2005, ADDICT BIOL, V10, P81, DOI 10.1080/13556210412331308994; Baek KJ, 2001, J BIOL CHEM, V276, P5591, DOI 10.1074/jbc.M008252200; Barrere-Lemaire S, 2005, AM J PHYSIOL-HEART C, V288, pH83, DOI 10.1152/ajpheart.00881.2003; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bhat RS, 2004, J LEUKOCYTE BIOL, V75, P1131, DOI 10.1189/jlb.1203639; Bierczynska-Krzysik A, 2006, INT J MOL MED, V18, P775; Bierczynska-Krzysik A, 2006, NEUROCHEM INT, V49, P401, DOI 10.1016/j.neuint.2006.01.024; Bitar KN, 2002, AM J PHYSIOL-GASTR L, V282, pG894, DOI 10.1152/ajpgi.00141.2001; Bjorkdahl C, 2008, J NEUROSCI RES, V86, P1343, DOI 10.1002/jnr.21589; Bodzon-Kulakowska A, 2009, J SEP SCI, V32, P1200, DOI 10.1002/jssc.200800464; Boronat MA, 2001, BRIT J PHARMACOL, V134, P1263, DOI 10.1038/sj.bjp.0704364; Bu Q, 2012, J PROTEOMICS, V75, P1330, DOI 10.1016/j.jprot.2011.11.008; Chakrabarti S, 2003, P NATL ACAD SCI USA, V100, P13686, DOI 10.1073/pnas.2335885100; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Chen YJ, 2008, NEUROCHEM RES, V33, P2092, DOI 10.1007/s11064-008-9690-0; Chen YY, 2001, FEBS LETT, V509, P191, DOI 10.1016/S0014-5793(01)03062-9; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Chung JH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-520; De Gregori S, 2012, METAB BRAIN DIS, V27, P1, DOI 10.1007/s11011-011-9274-6; Dokas LA, 2011, NEUROPHARMACOLOGY, V61, P12, DOI 10.1016/j.neuropharm.2011.02.010; Drastichova Z, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-89; Ernoult E, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-27; Fan LW, 2003, NEUROSCIENCE, V121, P1063, DOI 10.1016/S0306-4522(03)00299-9; Flemming K, 2010, J PAIN SYMPTOM MANAG, V39, P139, DOI 10.1016/j.jpainsymman.2009.05.014; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gill C, 2002, FASEB J, V16, P135, DOI 10.1096/fj.01-0629com; Gintzler AR, 2006, LIFE SCI, V79, P717, DOI 10.1016/j.lfs.2006.02.016; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gray CC, 1999, INT J BIOCHEM CELL B, V31, P559, DOI 10.1016/S1357-2725(99)00004-7; Hamlin AS, 2007, NEUROPHARMACOLOGY, V53, P330, DOI 10.1016/j.neuropharm.2007.05.017; Hodson EAM, 1998, BBA-MOL CELL RES, V1403, P97, DOI 10.1016/S0167-4889(98)00028-7; Hoover HE, 2000, J BIOL CHEM, V275, P23825, DOI 10.1074/jbc.M003864200; Hu SX, 2002, NEUROPHARMACOLOGY, V42, P829, DOI 10.1016/S0028-3908(02)00030-8; Huang QY, 2011, ARCH ENVIRON CON TOX, V60, P90, DOI 10.1007/s00244-010-9533-2; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kaplan GB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023574; Kieffer BL, 2009, NEUROPHARMACOLOGY, V56, P205, DOI 10.1016/j.neuropharm.2008.07.033; Kim MS, 2001, BIOCHEM PHARMACOL, V61, P779, DOI 10.1016/S0006-2952(01)00541-X; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Lau S, 1997, CIRCULATION, V96, P2287; Li KW, 2006, PROTEOMICS, V6, P2003, DOI 10.1002/pmic.200500045; Li R, 2009, ANESTH ANALG, V108, P23, DOI 10.1213/ane.0b013e3181884ba6; Lien YC, 2006, CANCER RES, V66, P4329, DOI 10.1158/0008-5472.CAN-05-3424; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Lin X, 2009, FEBS J, V276, P2022, DOI 10.1111/j.1742-4658.2009.06938.x; Manchikanti L, 2008, PAIN PHYSICIAN, V11, pS155; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; MANSOUR A, 1994, J COMP NEUROL, V350, P412, DOI 10.1002/cne.903500307; Mao JR, 2002, J NEUROSCI, V22, P7650; Marie-Claire C, 2004, NEUROPSYCHOPHARMACOL, V29, P2208, DOI 10.1038/sj.npp.1300513; Martin JL, 1997, CIRCULATION, V96, P4343; Martinez-Laorden E, 2012, J PHARM EXP THER; Mickiewicz AL, 2011, EUR J NEUROSCI, V33, P259, DOI 10.1111/j.1460-9568.2010.07502.x; Molloy MP, 2000, ANAL BIOCHEM, V280, P1, DOI 10.1006/abio.2000.4514; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Murphy GS, 2006, J CARDIOTHOR VASC AN, V20, P493, DOI 10.1053/j.jvca.2005.07.036; Murray F, 2007, EUR J PHARMACOL, V562, P191, DOI 10.1016/j.ejphar.2007.01.027; Narita M, 2001, PHARMACOL THERAPEUT, V89, P1, DOI 10.1016/S0163-7258(00)00099-1; Neasta J, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-23; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Ohara T, 2005, ANESTH ANALG, V101, P1117, DOI 10.1213/01.ane.0000167772.16584.0f; Pang PS, 2010, EUR HEART J, V31, P784, DOI 10.1093/eurheartj/ehq040; Peart JN, 2011, J PHARMACOL EXP THER, V336, P274, DOI 10.1124/jpet.110.172593; Emeterio EPS, 2006, J NEUROSCI RES, V83, P1352, DOI 10.1002/jnr.20812; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Prokai L, 2005, J MASS SPECTROM, V40, P169, DOI 10.1002/jms.736; Quest AFG, 2004, BIOCHEM CELL BIOL, V82, P129, DOI 10.1139/o03-071; Quillan JM, 2002, J PHARMACOL EXP THER, V302, P1002, DOI 10.1124/jpet.302.3.1002; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Ray PS, 2001, FASEB J, V15, P393, DOI 10.1096/fj.00-0199com; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Robinson AA, 2010, J MOL CELL CARDIOL, V49, P370, DOI 10.1016/j.yjmcc.2010.06.004; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sahara N, 2007, J NEUROSCI RES, V85, P3098, DOI 10.1002/jnr.21417; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Shadforth IP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-145; Shanazari AAP, 2011, ARYA ATHEROSCLER, V7, P111; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Shisheva A, 1999, BIOCHEMISTRY-US, V38, P11711, DOI 10.1021/bi990200r; Sidhu RS, 2005, J BIOL CHEM, V280, P21933, DOI 10.1074/jbc.M412966200; Singhal PC, 2002, J IMMUNOL, V168, P4025, DOI 10.4049/jimmunol.168.8.4025; Skrabalova J, 2012, PHARMACOL REP, V64, P351, DOI 10.1016/S1734-1140(12)70775-2; Suder P, 2009, J PROTEOME RES, V8, P4633, DOI 10.1021/pr900443r; Vallejo R, 2011, PAIN PHYSICIAN, V14, pE343; Wang J, 2011, MOL NEUROBIOL, V44, P269, DOI 10.1007/s12035-011-8202-4; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Xu H, 2005, J PHARMACOL EXP THER, V315, P248, DOI 10.1124/jpet.105.089367; Yagisawa H, 2006, J CELL BIOCHEM, V97, P233, DOI 10.1002/jcb.20677; Yan Wei, 2005, Briefings in Functional Genomics & Proteomics, V4, P27, DOI 10.1093/bfgp/4.1.27; Yang L, 2007, J PROTEOME RES, V6, P2239, DOI 10.1021/pr060649o	96	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47167	10.1371/journal.pone.0047167	http://dx.doi.org/10.1371/journal.pone.0047167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056601	Green Submitted, Green Published, gold			2022-12-27	WOS:000309889400059
J	Nifoussi, SK; Vrana, JA; Domina, AM; De Biasio, A; Gui, J; Gregory, MA; Hann, SR; Craig, RW				Nifoussi, Shanna K.; Vrana, Julie A.; Domina, Aaron M.; De Biasio, Alfredo; Gui, Jingang; Gregory, Mark A.; Hann, Stephen R.; Craig, Ruth W.			Thr 163 Phosphorylation Causes Mcl-1 Stabilization when Degradation Is Independent of the Adjacent GSK3-Targeted Phosphodegron, Promoting Drug Resistance in Cancer	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MULTIPLE-MYELOMA CELLS; BH3 MIMETIC ABT-737; ANTIAPOPTOTIC MCL1; BCL-2 FAMILY; B-CELLS; SIGNALING PATHWAY; DOWN-REGULATION; BREAST-CANCER; C-MYC	The antiapoptotic Bcl-2 family member Mcl-1 is a PEST protein (containing sequences enriched in proline, glutamic acid, serine, and threonine) and is subject to rapid degradation via multiple pathways. Impaired degradation leading to the maintenance of Mcl-1 expression is an important determinant of drug resistance in cancer. Phosphorylation at Thr 163 in the PEST region, stimulated by 12-O-tetradecanoylphorbol acetic acid (TPA)-induced activation of extracellular signal-regulated kinase (ERK), is associated with Mcl-1 stabilization in BL41-3 Burkitt lymphoma cells. This contrasts with the observation that Thr 163 phosphorylation in normal fibroblasts primes glycogen synthase kinase (GSK3)-induced phosphorylation at Ser 159, producing a phosphodegron that targets Mcl-1 for degradation. In the present follow-up studies in BL41-3 cells, Mcl-1 degradation was found to be independent of the GSK3-mediated pathway, providing a parallel to emerging findings showing that Mcl-1 degradation through this pathway is lost in many different types of cancer. Findings in Mcl-1-transfected CHO cells corroborated those in BL41-3 cells in that the GSK3-targeted phosphodegron did not play a major role in Mcl-1 degradation, and a phosphomimetic T163E mutation resulted in marked Mcl-1 stabilization. TPA-treated BL41-3 cells, in addition to exhibiting Thr 163 phosphorylation and Mcl-1 stabilization, exhibited an similar to 10-fold increase in resistance to multiple chemotherapeutic agents, including Ara-C, etoposide, vinblastine, or cisplatin. In these cancer cells in which Mcl-1 degradation is not dependent on the GSK3/phosphodegron-targeted pathway, ERK activation and Thr 163 phosphorylation are associated with pronounced Mcl-1 stabilization and drug resistance - effects that can be suppressed by inhibition of ERK activation.	[Nifoussi, Shanna K.; Craig, Ruth W.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA; [Nifoussi, Shanna K.; Craig, Ruth W.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA; [Hann, Stephen R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Vanderbilt University	Craig, RW (corresponding author), Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA.	W.Craig@Dartmouth.edu		De Biasio, Alfredo/0000-0003-2139-2958	National Institutes of Health [R01 CA 057359]; NATIONAL CANCER INSTITUTE [R01CA057359, P30CA023108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Institutes of Health (R01 CA 057359 to R. W. C.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Awan FT, 2009, BLOOD, V113, P535, DOI 10.1182/blood-2008-08-173450; Baudot AD, 2009, ONCOGENE, V28, P3261, DOI 10.1038/onc.2009.179; Becker NA, 2000, J BIOL CHEM, V275, P15384, DOI 10.1074/jbc.M909687199; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; Chao JR, 1998, MOL CELL BIOL, V18, P4883, DOI 10.1128/MCB.18.8.4883; CRAIG RW, 1984, CANCER RES, V44, P2421; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Domina AM, 2000, J BIOL CHEM, V275, P21688, DOI 10.1074/jbc.M000915200; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Gobessi S, 2009, LEUKEMIA, V23, P686, DOI 10.1038/leu.2008.346; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Huang HM, 2000, BLOOD, V96, P1764, DOI 10.1182/blood.V96.5.1764.h8001764_1764_1771; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jamil S, 2005, BIOCHEM J, V387, P659, DOI 10.1042/BJ20041596; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Liao MM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-44; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Maeta Yoshihiko, 2004, Gastric Cancer, V7, P78; Marriott HM, 2005, J CLIN INVEST, V115, P359, DOI 10.1172/JCI200521766; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mazumder S, 2012, CANCER RES, V72, P3069, DOI 10.1158/0008-5472.CAN-11-4106; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Pepper C, 2008, BLOOD, V112, P3807, DOI 10.1182/blood-2008-05-157131; REYNOLDS JE, 1994, CANCER RES, V54, P6348; Salerni BL, 2010, MOL CANCER THER, V9, P791, DOI 10.1158/1535-7163.MCT-10-0028; Sano M, 2005, HISTOPATHOLOGY, V46, P532, DOI 10.1111/j.1365-2559.2005.02118.x; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Townsend KJ, 1998, ONCOGENE, V17, P1223, DOI 10.1038/sj.onc.1202035; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vilimek D, 2006, BIOCHEM CELL BIOL, V84, P20, DOI 10.1139/O05-154; Vrana JA, 2002, CANCER RES, V62, P892; Vrana JA, 2006, APOPTOSIS, V11, P1275, DOI 10.1007/s10495-006-7787-y; Warr MR, 2011, J BIOL CHEM, V286, P25098, DOI 10.1074/jbc.M111.218321; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Yang T, 1996, J CELL PHYSL, V166; Yewdell JW, 2011, CELL BIOL INT, V35, P457, DOI 10.1042/CBI20110055; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630; Zhou Pengbo, 2004, Methods Mol Biol, V284, P67	58	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e47060	10.1371/journal.pone.0047060	http://dx.doi.org/10.1371/journal.pone.0047060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056582	Green Published, gold			2022-12-27	WOS:000309889400051
J	Wenners, AS; Mehta, K; Loibl, S; Park, H; Mueller, B; Arnold, N; Hamann, S; Weimer, J; Ataseven, B; Darb-Esfahani, S; Schem, C; Mundhenke, C; Khandan, F; Thomssen, C; Jonat, W; Holzhausen, HJ; von Minckwitz, G; Denkert, C; Bauer, M				Wenners, Antonia Sophie; Mehta, Keyur; Loibl, Sibylle; Park, Hyerim; Mueller, Berit; Arnold, Norbert; Hamann, Sigrid; Weimer, Joerg; Ataseven, Beyhan; Darb-Esfahani, Silvia; Schem, Christian; Mundhenke, Christoph; Khandan, Fariba; Thomssen, Christoph; Jonat, Walter; Holzhausen, Hans-Juergen; von Minckwitz, Gunther; Denkert, Carsten; Bauer, Maret			Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; III RANDOMIZED GEPARTRIO; PREOPERATIVE CHEMOTHERAPY; SYSTEMIC THERAPY; GASTRIC-CANCER; DOCETAXEL; CYCLOPHOSPHAMIDE; DOXORUBICIN; CARCINOMA; PROGNOSIS	In our previous work we showed that NGAL, a protein involved in the regulation of proliferation and differentiation, is overexpressed in human breast cancer (BC) and predicts poor prognosis. In neoadjuvant chemotherapy (NACT) pathological complete response (pCR) is a predictor for outcome. The aim of this study was to evaluate NGAL as a predictor of response to NACT and to validate NGAL as a prognostic factor for clinical outcome in patients with primary BC. Immunohistochemistry was performed on tissue microarrays from 652 core biopsies from BC patients, who underwent NACT in the GeparTrio trial. NGAL expression and intensity was evaluated separately. NGAL was detected in 42.2% of the breast carcinomas in the cytoplasm. NGAL expression correlated with negative hormone receptor (HR) status, but not with other baseline parameters. NGAL expression did not correlate with pCR in the full population, however, NGAL expression and staining intensity were significantly associated with higher pCR rates in patients with positive HR status. In addition, strong NGAL expression correlated with higher pCR rates in node negative patients, patients with histological grade 1 or 2 tumors and a tumor size,40 mm. In univariate survival analysis, positive NGAL expression and strong staining intensity correlated with decreased disease-free survival (DFS) in the entire cohort and different subgroups, including HR positive patients. Similar correlations were found for intense staining and decreased overall survival (OS). In multivariate analysis, NGAL expression remained an independent prognostic factor for DFS. The results show that in low-risk subgroups, NGAL was found to be a predictive marker for pCR after NACT. Furthermore, NGAL could be validated as an independent prognostic factor for decreased DFS in primary human BC.	[Wenners, Antonia Sophie; Park, Hyerim; Arnold, Norbert; Hamann, Sigrid; Weimer, Joerg; Schem, Christian; Mundhenke, Christoph; Jonat, Walter; Bauer, Maret] Univ Med Ctr Schleswig Holstein, Dept Gynecol & Obstet, Kiel, Germany; [Mehta, Keyur; Loibl, Sibylle; von Minckwitz, Gunther] GBG Forsch GmbH, German Breast Grp, Neu Isenburg, Germany; [Ataseven, Beyhan] Rot Kreuz Klinikum Muenchen, Dept Obstet & Gynaecol, Munich, Germany; [Khandan, Fariba] St Markus Hosp, Frankfurt, Germany; [Mueller, Berit; Darb-Esfahani, Silvia; Denkert, Carsten] Charite, Inst Pathol, Translat Tumorpathol Unit, Berlin, Germany; [Thomssen, Christoph] Univ Halle Wittenberg, Dept Gynecol, Halle, Germany; [Holzhausen, Hans-Juergen] Univ Halle Wittenberg, Dept Pathol, Halle, Germany	University of Kiel; Schleswig Holstein University Hospital; German Breast Group; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Wenners, AS (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Gynecol & Obstet, Kiel, Germany.	antonia.wenners@uk-sh.de	Thomssen, Christoph/ABC-3102-2021; Weimer, Jörg Paul/E-3472-2010; Denkert, Carsten/AHE-2675-2022; Arnold, Norbert/E-3012-2010; Mundhenke, Christoph/D-2593-2010	Weimer, Jörg Paul/0000-0002-4528-8509; Arnold, Norbert/0000-0003-4523-8808; Mundhenke, Christoph/0000-0002-6989-6250; Denkert, Carsten/0000-0002-2249-0982	Werner and Klara Kreitz Stiftung; Sanofi-Aventis; Roche; Novartis	Werner and Klara Kreitz Stiftung; Sanofi-Aventis(Sanofi-Aventis); Roche(Roche Holding); Novartis(Novartis)	MB and JW were funded by the Werner and Klara Kreitz Stiftung. CT was funded by Sanofi-Aventis and Roche. WJ was funded by Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barresi V, 2011, HUM PATHOL, V42, P1720, DOI 10.1016/j.humpath.2010.05.031; Barresi V, 2010, ONCOL REP, V24, P305, DOI 10.3892/or_00000860; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Bolignano D, 2010, CANCER LETT, V288, P10, DOI 10.1016/j.canlet.2009.05.027; Bonadonna G, 2005, BRIT MED J, V330, P217, DOI 10.1136/bmj.38314.622095.8F; Bratt T, 2000, BBA-PROTEIN STRUCT M, V1482, P318, DOI 10.1016/S0167-4838(00)00154-0; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Fernandez-Sanchez M, 2006, MED ONCOL, V23, P171, DOI 10.1385/MO:23:2:171; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Flower DR, 1996, BIOCHEM J, V318, P1; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Gwira JA, 2005, J BIOL CHEM, V280, P7875, DOI 10.1074/jbc.M413192200; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Huober J, 2010, BREAST CANCER RES TR, V124, P133, DOI 10.1007/s10549-010-1103-9; Jones RL, 2006, LANCET ONCOL, V7, P869, DOI 10.1016/S1470-2045(06)70906-8; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kubben FJGM, 2007, EUR J CANCER, V43, P1869, DOI 10.1016/j.ejca.2007.05.013; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Lee HJ, 2006, INT J CANCER, V118, P2490, DOI 10.1002/ijc.21657; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Mathieu MC, 2004, EUR J CANCER, V40, P342, DOI 10.1016/j.ejca.2003.08.015; Maur M, 2006, ANN ONCOL, V17, pV158, DOI 10.1093/annonc/mdj973; Oakman C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2238; Portera CCSS, 2007, NEOADJUVANT CHEMOTHE; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Stoesz SP, 1995, ONCOGENE, V11, P2233; Sun Y, 2011, CLIN CANCER RES, V17, P4331, DOI 10.1158/1078-0432.CCR-11-0226; Tewari M, 2008, SURG ONCOL, V17, P301, DOI 10.1016/j.suronc.2008.03.003; Thuerigen O, 2006, J CLIN ONCOL, V24, P1839, DOI 10.1200/JCO.2005.04.7019; Tiezzi DG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-36; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; von Minckwitz G, 2008, JNCI-J NATL CANCER I, V100, P552, DOI 10.1093/jnci/djn089; von Minckwitz G, 2008, JNCI-J NATL CANCER I, V100, P542, DOI 10.1093/jnci/djn085; von Minckwitz G, 2011, J CLIN ONCOL, V29, P2150, DOI 10.1200/JCO.2010.31.9079; Wang HJ, 2010, ANAT REC, V293, P1855, DOI 10.1002/ar.21230; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Zhang HH, 2007, J CLIN PATHOL, V60, P555, DOI 10.1136/jcp.2006.039297	43	42	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e45826	10.1371/journal.pone.0045826	http://dx.doi.org/10.1371/journal.pone.0045826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056218	gold, Green Published, Green Submitted			2022-12-27	WOS:000309889400008
J	Ando, K; Obayashi, S; Nagai, Y; Oh-Nishi, A; Minamimoto, T; Higuchi, M; Inoue, T; Itoh, T; Suhara, T				Ando, Kiyoshi; Obayashi, Shigeru; Nagai, Yuji; Oh-Nishi, Arata; Minamimoto, Takafumi; Higuchi, Makoto; Inoue, Takashi; Itoh, Toshio; Suhara, Tetsuya			PET Analysis of Dopaminergic Neurodegeneration in Relation to Immobility in the MPTP-Treated Common Marmoset, a Model for Parkinson's Disease	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PRIMATE MODEL; ALPHA-SYNUCLEIN; TRANSPORTER LIGAND; CALLITHRIX-JACCHUS; NONHUMAN-PRIMATES; CELL-DEATH; MONKEYS; PATHOPHYSIOLOGY; RECEPTOR	Background: Positron Emission Tomography (PET) measurement was applied to the brain of the common marmoset, a small primate species, treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The marmoset shows prominent Parkinson's disease (PD) signs due to dopaminergic neural degeneration. Recently, the transgenic marmoset (TG) carrying human PD genes is developing. For phenotypic evaluations of TG, non-invasive PET measurement is considered to be substantially significant. As a reference control for TG, the brain of the MPTP-marmoset as an established and valid model was scanned by PET. Behavioral analysis was also performed by recording locomotion of the MPTP-marmoset, as an objective measure of PD signs. Methodology/Principal Findings: Marmosets received several MPTP regimens (single MPTP regimen: 2 mg/kg, s.c., per day for 3 consecutive days) were used for PET measurement and behavioral observation. To measure immobility as a central PD sign, locomotion of marmosets in their individual living cages were recorded daily by infrared sensors. Daily locomotion counts decreased drastically after MPTP regimens and remained diminished for several months or more. PET scan of the brain, using [C-11] PE2I as a ligand of the dopamine (DA) transporter, was performed once several months after the last MPTP regimen. The mean binding potential (BPND) in the striatum (putamen and caudate) of the MPTP-marmoset group was significantly lower than that of the MPTP-free control group (n = 5 for each group). In the MPTP-marmosets, the decrease of BPND in the striatum closely correlated with the decrease in locomotion counts (r = 0.98 in putamen and 0.91 in caudate). Conclusion/Significance: The present characterization of neural degeneration using non-invasive PET imaging and of behavioral manifestation in the MPTP marmoset mimics typical PD characteristics and can be useful in evaluating the phenotype of TG marmosets being developed.	[Ando, Kiyoshi; Inoue, Takashi; Itoh, Toshio] Cent Inst Expt Anim, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Obayashi, Shigeru] Chiba Hokusoh Hosp, Nippon Med Sch, Rehabil Ctr, Chiba, Japan; [Nagai, Yuji; Oh-Nishi, Arata; Minamimoto, Takafumi; Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 260, Japan	Nippon Medical School; National Institutes for Quantum Science & Technology	Ando, K (corresponding author), Cent Inst Expt Anim, Kawasaki Ku, Kawasaki, Kanagawa, Japan.	ando@ciea.or.jp	Minamimoto, Takafumi/AAD-8726-2020; Minamimoto, Takafumi/D-6610-2012	Minamimoto, Takafumi/0000-0003-4305-0174; Minamimoto, Takafumi/0000-0003-4305-0174; Inoue, Takashi/0000-0003-4691-7255; Oh-Nishi, Arata/0000-0001-5427-4400; Nagai, Yuji/0000-0001-7005-0749	Neuropsychiatric Disease Project of the Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology, Japan	Neuropsychiatric Disease Project of the Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by a grant to Central Institute for Experimental Animals (CIEA) from the Neuropsychiatric Disease Project of the Ministry of Health, Labor and Welfare and a Grant to The National Institute of Radiological Sciences (NIRS) for the Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2008, PSYCHOPHARMACOLOGY, V195, P509, DOI 10.1007/s00213-007-0929-2; Bergman H, 1998, MOVEMENT DISORD, V13, P29; Bjugstad KB, 2008, EXP NEUROL, V211, P362, DOI 10.1016/j.expneurol.2008.01.025; Blesa J, 2010, NEUROBIOL DIS, V38, P456, DOI 10.1016/j.nbd.2010.03.006; Bonnet AM, 1999, BIOMED PHARMACOTHER, V53, P117, DOI 10.1016/S0753-3322(99)80076-6; Brownell AL, 2003, NEUROIMAGE, V20, P1064, DOI 10.1016/S1053-8119(03)00348-3; BURNS RS, 1984, CAN J NEUROL SCI, V11, P166; Chen MK, 2008, J NEUROCHEM, V105, P78, DOI 10.1111/j.1471-4159.2007.05108.x; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Eslamboli A, 2003, EXP NEUROL, V184, P536, DOI 10.1016/j.expneurol.2003.08.007; Eslamboli A, 2005, BRAIN RES BULL, V68, P140, DOI 10.1016/j.brainresbull.2005.08.005; FINE A, 1988, PROG BRAIN RES, V78, P479; Forno Lysia S., 1993, V60, P600; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Halliday G, 2009, MOVEMENT DISORD, V24, P1519, DOI 10.1002/mds.22481; HANTRAYE P, 1986, LIFE SCI, V39, P1375, DOI 10.1016/0024-3205(86)90336-X; HILDICKSMITH M, 1982, CURR MED RES OPIN, V7, P14; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; JENNER P, 1984, NEUROSCI LETT, V50, P85, DOI 10.1016/0304-3940(84)90467-1; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Knuesel I, 2009, NEUROBIOL AGING, V30, P697, DOI 10.1016/j.neurobiolaging.2007.08.011; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; LANGSTON JW, 1984, ACTA NEUROL SCAND, V70, P49; Luquin MR, 2011, BRAIN RES, V1375, P120, DOI 10.1016/j.brainres.2010.12.033; Masilamoni G, 2010, EXP NEUROL, V226, P265, DOI 10.1016/j.expneurol.2010.08.024; Masilamoni GJ, 2011, BRAIN, V134, P2057, DOI 10.1093/brain/awr137; Mounayar S, 2007, BRAIN, V130, P2898, DOI 10.1093/brain/awm208; Nagai Y, 2012, NEUROSCIENCE RES; Nagai Y, 2007, SYNAPSE, V61, P809, DOI 10.1002/syn.20431; NARABAYASHI H, 1987, EUR NEUROL, V26, P24, DOI 10.1159/000116352; Nomoto M, 1999, Adv Neurol, V80, P125; NOMOTO M, 1985, NEUROSCI LETT, V57, P37, DOI 10.1016/0304-3940(85)90037-0; Olanow CW, 2007, MOVEMENT DISORD, V22, pS335, DOI 10.1002/mds.21675; Piccinin G L, 1989, Riv Neurol, V59, P103; Poyot T, 2001, J CEREBR BLOOD F MET, V21, P782, DOI 10.1097/00004647-200107000-00003; Saiki H, 2010, J NEUROSCI METH, V190, P198, DOI 10.1016/j.jneumeth.2010.05.009; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Schwarz J, 2010, NERVENARZT, V81, P1160, DOI 10.1007/s00115-010-3026-4; SNYDER SH, 1986, NEUROLOGY, V36, P250, DOI 10.1212/WNL.36.2.250; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STEVENS SS, 1958, J EXP PSYCHOL, V56, P328, DOI 10.1037/h0040896; Tai YC, 2005, J NUCL MED, V46, P455; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; TETRUD JW, 1989, ACTA NEUROL SCAND, V80, P35, DOI 10.1111/j.1600-0404.1989.tb01780.x; Tokuno H, 2009, NEUROSCI RES, V64, P128, DOI 10.1016/j.neures.2009.02.003; van Vlieta SAM, 2008, BRAIN RES, V1189, P219, DOI 10.1016/j.brainres.2007.10.059; Verhave PS, 2009, BEHAV BRAIN RES, V200, P214, DOI 10.1016/j.bbr.2009.01.022; Wichmann T, 2003, ANN NY ACAD SCI, V991, P199, DOI 10.1111/j.1749-6632.2003.tb07477.x; WULLNER U, 1994, EXP NEUROL, V126, P305, DOI 10.1006/exnr.1994.1069	50	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46371	10.1371/journal.pone.0046371	http://dx.doi.org/10.1371/journal.pone.0046371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056291	gold, Green Published, Green Submitted			2022-12-27	WOS:000309831500038
J	Horsman, SR; Moore, RA; Lewenza, S				Horsman, Shawn R.; Moore, Richard A.; Lewenza, Shawn			Calcium Chelation by Alginate Activates the Type III Secretion System in Mucoid Pseudomonas aeruginosa Biofilms	PLOS ONE			English	Article							GENE-EXPRESSION; EXOENZYME S; PROTEINS; POLYSACCHARIDES; TRANSCRIPTION; INTEGRATION; EFFECTORS; BACTERIA; REGULON; CELLS	The extracellular biofilm matrix includes primarily DNA and exopolysaccharides (EPS), which function to maintain aggregate structures and to protect biofilms from antibiotics and the immune response. Both polymers are anionic and have cation binding activity, however the impact of this activity on biofilms is not fully understood. Host cell contact is considered the primary signal for activation of most type III secretion systems (T3SS), although calcium limitation is frequently used as a trigger of contact-independent T3SS expression. We hypothesized that alginate, which is a known calcium binding exopolysaccharide produced in mucoid Pseudomonas aeruginosa isolates, can activate the T3SS in biofilms. The addition of exogenous purified alginate to planktonic, non-mucoid PAO1 cultures induced expression of exoS, exoT and exoY-lux reporters of the T3SS in a concentration-dependent manner. Induction by alginate was comparable to induction by the calcium chelator NTA. We extended our analysis of the T3SS in flow chamber-cultivated biofilms, and showed that hyperproduction of alginate in mucA22 mucoid isolates resulted in induction of the exoS-gfp transcriptional reporter compared to non-mucoid paired isolates. We confirmed the transcriptional effects of alginate on the T3SS expression using a FlAsH fluorescence method and showed high levels of the ExoT-Cys(4) protein in mucoid biofilms. Induction of the T3SS could be prevented in planktonic cultures and mucoid biofilms treated with excess calcium, indicating that Ca2+ chelation by the EPS matrix caused contact-independent induction. However, mucoid isolates generally had reduced exoS-lux expression in comparison to paired, non-mucoid isolates when grown as planktonic cultures and agar colonies. In summary, we have shown a mucoid biofilm-specific induction of the type III secretion system and highlight a difference between planktonic and biofilm cultures in the production of virulence factors.	[Horsman, Shawn R.; Moore, Richard A.; Lewenza, Shawn] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	University of Calgary	Lewenza, S (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada.	slewenza@ucalgary.ca			Westaim Corporation; Alberta Science and Research 378 Authority (ASRA); Cystic Fibrosis Canada; NSERC 379 Studentship	Westaim Corporation; Alberta Science and Research 378 Authority (ASRA); Cystic Fibrosis Canada; NSERC 379 Studentship	This research was supported by the Westaim Corporation and the Alberta Science and Research 378 Authority (ASRA) and a grant by Cystic Fibrosis Canada. SH is the recipient of an NSERC 379 Studentship. SL holds the Westaim-ASRA Chair in Biofilm Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2002, FORBES, V169, P124; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; Bruno TF, 2000, J LEUKOCYTE BIOL, V67, P808, DOI 10.1002/jlb.67.6.808; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Cisz M, 2008, J BACTERIOL, V190, P2726, DOI 10.1128/JB.01553-07; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dacheux D, 1999, INFECT IMMUN, V67, P6164, DOI 10.1128/IAI.67.11.6164-6167.1999; DEVRIES CA, 1994, J BACTERIOL, V176, P6677, DOI 10.1128/JB.176.21.6677-6687.1994; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Epelman S, 2002, J LEUKOCYTE BIOL, V71, P458; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Jamison WP, 2008, MICROB PATHOGENESIS, V45, P435, DOI 10.1016/j.micpath.2008.10.002; Jones AK, 2010, J BACTERIOL, V192, P5709, DOI 10.1128/JB.00526-10; KHARAZMI A, 1991, IMMUNOL LETT, V30, P201, DOI 10.1016/0165-2478(91)90026-7; Kim CC, 2004, J BACTERIOL, V186, P4694, DOI 10.1128/JB.186.14.4694-4704.2004; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Lattner D, 2003, INT J BIOL MACROMOL, V33, P81, DOI 10.1016/S0141-8130(03)00070-9; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; Mikkelsen H, 2009, MICROBIOL-SGM, V155, P687, DOI 10.1099/mic.0.025551-0; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Rietsch A, 2004, INFECT IMMUN, V72, P1383, DOI 10.1128/IAI.72.3.1383-1390.2004; Ruter C, 2010, J CELL SCI, V123, P2190, DOI 10.1242/jcs.063016; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Simpson N, 2010, METHODS MOL BIOL, V619, P241, DOI 10.1007/978-1-60327-412-8_14; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smolke CD, 2000, APPL ENVIRON MICROB, V66, P5399, DOI 10.1128/AEM.66.12.5399-5405.2000; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wu WH, 2004, J BACTERIOL, V186, P7575, DOI 10.1128/JB.186.22.7575-7585.2004; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Yang L, 2009, MOL MICROBIOL, V74, P1380, DOI 10.1111/j.1365-2958.2009.06934.x	45	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46826	10.1371/journal.pone.0046826	http://dx.doi.org/10.1371/journal.pone.0046826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056471	Green Submitted, gold, Green Published			2022-12-27	WOS:000309831500087
J	Wang, BY; Wang, H; Yang, ZA				Wang, Biyun; Wang, Hong; Yang, Ziang			MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; IN-VIVO; MICRORNAS; EXPRESSION; BIOGENESIS; GROWTH	miRNAs are emerging as critical regulators in carcinogenesis and tumor progression. Recently, microRNA-122 (miR-122) has been proved to play an important role in hepatocellular carcinoma, but its functions in the context of breast cancer (BC) remain unknown. In this study, we report that miR-122 is commonly downregulated in BC specimens and BC cell lines with important functional consequences. Overexpression of miR-122 not only dramatically suppressed cell proliferation, colony formation by inducing G1-phase cell-cycle arrest in vitro, but also reduced tumorigenicity in vivo. We then screened and identified a novel miR-122 target, insulin-like growth factor 1 receptor (IGF1R), and it was further confirmed by luciferase assay. Overexpression of miR-122 would specifically and markedly reduce its expression. Similar to the restoring miR-122 expression, IGF1R downregulation suppressed cell growth and cell-cycle progression, whereas IGF1R overexpression rescued the suppressive effect of miR-122. To identify the mechanisms, we investigated the Akt/mTOR/p70S6K pathway and found that the expression of Akt, mTOR and p70S6K were suppressed, whereas re-expression of IGF1R which did not contain the 3'UTR totally reversed the inhibition of Akt/mTOR/p70S6K signal pathway profile. We also identified a novel, putative miR-122 target gene, PI3CG, a member of PI3K family, which further suggests miR-122 may be a key regulator of the PI3K/Akt pathway. In clinical specimens, IGF1R was widely overexpressed and its mRNA levels were inversely correlated with miR-122 expression. Taken together, our results demonstrate that miR-122 functions as a tumor suppressor and plays an important role in inhibiting the tumorigenesis through targeting IGF1R and regulating PI3K/Akt/mTOR/p70S6K pathway. Given these, miR-122 may serve as a novel therapeutic or diagnostic/prognostic-target for treating BC.	[Wang, Hong; Yang, Ziang] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China; [Wang, Biyun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Dept Med Oncol,Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yang, ZA (corresponding author), Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China.	coaxin@gmail.com						Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-111; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Guarneri V, 2009, ONCOLOGIST, V14, P645, DOI 10.1634/theoncologist.2009-0078; Heron-Milhavet L, 2002, J BIOL CHEM, V277, P15600, DOI 10.1074/jbc.M111142200; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Ma LN, 2010, CANCER BIOL THER, V9, P554, DOI 10.4161/cbt.9.7.11267; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Mutallip M, 2011, INT J MOL MED, V27, P345, DOI 10.3892/ijmm.2010.589; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Shibuya H, 2010, ONCOLOGY-BASEL, V79, P313, DOI 10.1159/000323283; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu XZ, 2006, CELL BIOL INT, V30, P672, DOI 10.1016/j.cellbi.2006.04.009; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039011, 10.1371/journal.pone.0043230]	30	99	102	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e47053	10.1371/journal.pone.0047053	http://dx.doi.org/10.1371/journal.pone.0047053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056576	Green Published, Green Submitted, gold			2022-12-27	WOS:000309831500129
J	Zhuo, WL; Zhang, L; Zhu, B; Qiu, ZQ; Chen, ZT				Zhuo, Wenlei; Zhang, Liang; Zhu, Bo; Qiu, Zhiqun; Chen, Zhengtang			Association between CYP1A1 Ile462Val Variation and Acute Leukemia Risk: Meta-Analyses Including 2164 Cases and 4160 Controls	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; GLUTATHIONE-S-TRANSFERASE; HUMAN CYTOCHROME-P450 ENZYMES; GENETIC POLYMORPHISMS; CHILDHOOD LEUKEMIA; CANCER-RISK; PARENTAL EXPOSURE; SUSCEPTIBILITY; CHILDREN	Background: Previously, CYP1A1 Ile462Val polymorphism has been indicated to be a risk factor for several malignancies. Increasing reports have focused on the association of CYP1A1 Ile462Val polymorphisms with susceptibility to acute leukemia and have generated controversial results. The goal of the present study was to derive a more precise estimation of the relationship. Methods: Relevant literature has been rigorously searched and screened. Eligible studies were identified for the period up to Apr 2012. Meta-analyses evaluating the association of CYP1A1 Ile462Val variation with acute leukemia were carried out. Subgroup analyses on ethnicity, clinical types and source of controls were further performed. Results: A total of thirteen publications including fourteen case-control studies with 2164 cases and 4160 controls were selected for analysis. The overall data indicated a significant association of CYP1A1 Ile462Val polymorphism with acute leukemia risk (Val/Val vs Ile/Ile OR = 1.49; 95% CI = 1.11-1.98; dominant model: OR = 1.26; 95% CI = 1.05-1.51; recessive model: OR = 1.38; 95% CI = 1.04-1.83). In subgroup analysis on ethnicity, increased risk was shown among mixed ethnicities (Val/Val vs Ile/Ile: OR = 2.36; 95% CI = 1.46-3.82; dominant model: OR = 1.37; 95% CI = 1.01-1.86; recessive model: OR = 2.20; 95% CI = 1.37-3.53) but not Asians or Caucasians. In subgroup analysis on clinical types, increased risk was observed in the acute lymphocytic leukemia (ALL) subgroup (Val/Val vs Ile/Ile: OR = 2.06; 95% CI = 1.42-3.01; recessive model: OR = 1.91; 95% CI = 1.32-2.76) but not in the acute myeloid leukemia (AML) subgroup. Conclusion: The results of the present study suggest that CYP1A1 Ile462Val polymorphism might be a low-penetrant risk factor for acute leukemia. Subgroup analyses suggest that homozygous Val/Val alleles might modify the susceptibility to ALL.	[Zhuo, Wenlei; Zhu, Bo; Chen, Zhengtang] Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing, Peoples R China; [Zhang, Liang; Qiu, Zhiqun] Third Mil Med Univ, Coll Prevent Med, Dept Environm Hyg, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zhuo, WL (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing, Peoples R China.	zhuowenlei@yahoo.com.cn						Advani AS, 2009, SEMIN ONCOL, V36, P213, DOI 10.1053/j.seminoncol.2009.03.007; Castro-Jimenez MA, 2011, PREV CHRONIC DIS, V8; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Boffetta P, 2010, CARCINOGENESIS, V31, P121, DOI 10.1093/carcin/bgp269; D'Alo F, 2004, HAEMATOLOGICA, V89, P664; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flores Pelloso LA, 2007, LEUKEMIA LYMPHOMA, V48, P1211, DOI 10.1080/10428190701332431; Gallegos-Arreola MP, 2004, BLOOD CELL MOL DIS, V33, P326, DOI 10.1016/j.bcmd.2004.07.002; Gao J, 2003, CHIN J BIRTH HLTH HE, V11, P21; Guengerich FP, 1998, MUTAT RES-FUND MOL M, V400, P201; Guo R, 2012, TUMOUR BIOL; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hunger SP, 2011, PEDIATR BLOOD CANCER, V56, P984, DOI 10.1002/pbc.22996; Ilhan Gul, 2006, Asian Pac J Cancer Prev, V7, P515; Infante-Rivard C, 2000, CANCER CAUSE CONTROL, V11, P547, DOI 10.1023/A:1008976116512; Joseph T, 2004, PEDIATR BLOOD CANCER, V43, P560, DOI 10.1002/pbc.20074; Kim HN, 2012, LEUKEMIA LYMPHOMA, V53, P681, DOI 10.3109/10428194.2011.625576; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Krajinovic M, 2002, CLIN CANCER RES, V8, P802; Krajinovic M, 2000, CANCER EPIDEM BIOMAR, V9, P557; Krajinovic M, 1999, BLOOD, V93, P1496, DOI 10.1182/blood.V93.5.1496.405a36_1496_1501; Lee KM, 2009, LEUKEMIA RES, V33, P250, DOI 10.1016/j.leukres.2008.06.031; MacArthur AC, 2008, CANCER CAUSE CONTROL, V19, P283, DOI 10.1007/s10552-007-9091-8; Majumdar S, 2008, EUR J CANCER PREV, V17, P125, DOI 10.1097/CEJ.0b013e3282b6fd68; Manuguerra M, 2007, CARCINOGENESIS, V28, P414, DOI 10.1093/carcin/bgl159; Mathonnet G, 2003, BRIT J HAEMATOL, V123, P45, DOI 10.1046/j.1365-2141.2003.04551.x; MEENAGHAN T, 2012, BRITISH JOURNAL OF N, V21; Meenaghan Teresa, 2012, Br J Nurs, V21, P78; Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011; Razmkhah F, 2011, LABMEDICINE, V42, P220, DOI 10.1309/LM337JWOSVNEHPUI; Selvin S, 2004, CANCER EPIDEM BIOMAR, V13, P1371; Sergentanis TN, 2010, BREAST CANCER RES TR, V122, P459, DOI 10.1007/s10549-009-0694-5; Sergentanis TN, 2012, MOL BIOL REP; Shaik AP, 2009, UROL J, V6, P78; Shu XO, 2004, CANCER EPIDEM BIOMAR, V13, P1230; Sinnett D, 2000, LEUKEMIA LYMPHOMA, V38, P447, DOI 10.3109/10428190009059264; Swinney RM, 2011, CANCER EPIDEM BIOMAR, V20, P1537, DOI 10.1158/1055-9965.EPI-10-1265; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Wang LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034897; Yamaguti GG, 2010, ACTA HAEMATOL-BASEL, V124, P182, DOI 10.1159/000320275; Yamaguti GG, 2009, EUR J HAEMATOL, V83, P270, DOI 10.1111/j.1600-0609.2009.01272.x; Yan JR, 2012, PEDIATR BLOOD CANCER, V58, P513, DOI 10.1002/pbc.23137; Yang Y, 2009, ENVIRON TOXICOL PHAR, V28, P161, DOI 10.1016/j.etap.2009.03.004; Ye Z, 2005, EUR J CANCER, V41, P980, DOI 10.1016/j.ejca.2005.01.014; Yu K, 2010, EUR J HUM GENET, V18, P370, DOI 10.1038/ejhg.2009.131; Zhan P, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-99; Zhang YD, 2011, BIOMED ENVIRON SCI, V24, P683, DOI 10.3967/0895-3988.2011.06.014; Zheng Y, 2012, MOL BIOL REP, V39, P3533, DOI 10.1007/s11033-011-1126-2; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483; Zhuo WL, 2009, ARCH MED RES, V40, P169, DOI 10.1016/j.arcmed.2009.01.003; Zhuo WL, 2009, J CANCER RES CLIN, V135, P1081, DOI 10.1007/s00432-009-0548-x	53	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46974	10.1371/journal.pone.0046974	http://dx.doi.org/10.1371/journal.pone.0046974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056546	gold, Green Published, Green Submitted			2022-12-27	WOS:000309580800065
J	Arhzaouy, K; Strucksberg, KH; Tung, SM; Tangavelou, K; Stumpf, M; Faix, J; Schroder, R; Clemen, CS; Eichinger, L				Arhzaouy, Khalid; Strucksberg, Karl-Heinz; Tung, Sze Man; Tangavelou, Karthikeyan; Stumpf, Maria; Faix, Jan; Schroeder, Rolf; Clemen, Christoph S.; Eichinger, Ludwig			Heteromeric p97/p97(R155C) Complexes Induce Dominant Negative Changes in Wild- Type and Autophagy 9-Deficient Dictyostelium strains	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; INCLUSION-BODY MYOPATHY; PAGET-DISEASE; AAA-ATPASE; VCP; P97; DISCOIDEUM; CLEARANCE; MUTATIONS; BONE	Heterozygous mutations in the human VCP (p97) gene cause autosomal-dominant IBMPFD (inclusion body myopathy with early onset Paget's disease of bone and frontotemporal dementia), ALS14 (amyotrophic lateral sclerosis with or without frontotemporal dementia) and HSP (hereditary spastic paraplegia). Most prevalent is the R155C point mutation. We studied the function of p97 in the social amoeba Dictyostelium discoideum and have generated strains that ectopically express wildtype (p97) or mutant p97 (p97(R155C)) fused to RFP in AX2 wild-type and autophagy 9 knock-out (ATG9(KO)) cells. Native gel electrophoresis showed that both p97 and p97(R155C) assemble into hexamers. Co-immunoprecipitation studies revealed that endogenous p97 and p97(R155C)-RFP form heteromers. The mutant strains displayed changes in cell growth, phototaxis, development, proteasomal activity, ubiquitinylated proteins, and ATG8(LC3) indicating mis-regulation of multiple essential cellular processes. Additionally, immunofluorescence analysis revealed an increase of protein aggregates in ATG9(KO)/p97(R155C)-RFP and ATG9(KO) cells. They were positive for ubiquitin in both strains, however, solely immunoreactive for p97 in the ATG9(KO) mutant. A major finding is that the expression of p97(R155C)-RFP in the ATG9(KO) strain partially or fully rescued the pleiotropic phenotype. We also observed dose-dependent effects of p97 on several cellular processes. Based on findings in the single versus the double mutants we propose a novel mode of p97 interaction with the core autophagy protein ATG9 which is based on mutual inhibition.	[Arhzaouy, Khalid; Strucksberg, Karl-Heinz; Tung, Sze Man; Tangavelou, Karthikeyan; Stumpf, Maria; Clemen, Christoph S.; Eichinger, Ludwig] Univ Cologne, Intitute Biochem 1, Fac Med, D-50931 Cologne, Germany; [Strucksberg, Karl-Heinz; Schroeder, Rolf] Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany; [Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-3000 Hannover, Germany	University of Cologne; University of Erlangen Nuremberg; Hannover Medical School	Eichinger, L (corresponding author), Univ Cologne, Intitute Biochem 1, Fac Med, D-50931 Cologne, Germany.	ludwig.eichinger@uni-koeln.de	Eichinger, Ludwig/AAJ-8895-2021; Clemen, Christoph/B-2761-2011; Schröder, Rolf/B-2774-2011	Eichinger, Ludwig/0000-0003-1594-6117; Clemen, Christoph/0000-0002-1291-4219; Schroder, Rolf/0000-0002-2772-2615	German Research Foundation [DFG-FOR1228: SCHR 562/9-1, CL 381/3-1, EI 399/5-1]; Koln Fortune	German Research Foundation(German Research Foundation (DFG)); Koln Fortune	The work was supported by grants from the German Research Foundation(DFG-FOR1228: SCHR 562/9-1, CL 381/3-1, EI 399/5-1) awarded to RS, CC and LE as well as from Koln Fortune awarded to CC and LE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Annette Muller-Taubenberger (ABI Cell Biology, LMU Munich) for the mRFPmars vector, Dr. Paul Fisher for his thoughts on the phototaxis result, and Jan Matthias for the ATG8 antibody. The work was supported by grants from the German Research Foundation (DFG-FOR1228: SCHR 562/9-1, CL 381/3-1, EI 399/5-1) awarded to RS, CC and LE as well as from Koln Fortune awarded to CC and LE.	Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183; Bonini NM, 2011, J MOL NEUROSCI, V45, P676, DOI 10.1007/s12031-011-9548-9; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; BRINK M, 1990, J CELL BIOL, V111, P1477, DOI 10.1083/jcb.111.4.1477; Calvo-Garrido J, 2010, AUTOPHAGY, V6, P686, DOI 10.4161/auto.6.6.12513; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Clemen CS, 2010, BRAIN, V133, P2920, DOI 10.1093/brain/awq222; Clemen CS, BRAIN IN PRESS; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; Eichinger L, 2003, CURR GENET, V44, P59, DOI 10.1007/s00294-003-0416-1; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; McGurk L, 2011, SCIENCE, V334, P1212, DOI 10.1126/science.1216073; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; Otto GP, 2004, J BIOL CHEM, V279, P15621, DOI 10.1074/jbc.M311139200; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; SCHAUER TM, 1993, J STRUCT BIOL, V111, P135, DOI 10.1006/jsbi.1993.1044; Schelhaas HJ, BRAIN IN PRESS; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; SIMPSON PA, 1984, J CELL BIOL, V99, P287, DOI 10.1083/jcb.99.1.287; Stojkovic T, 2009, NEUROMUSCULAR DISORD, V19, P316, DOI 10.1016/j.nmd.2009.02.012; Strucksberg KH, 2010, ANAL BIOCHEM, V399, P225, DOI 10.1016/j.ab.2009.12.026; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Tung SM, 2010, CELL MICROBIOL, V12, P765, DOI 10.1111/j.1462-5822.2010.01432.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; WILLIAMS KL, 1976, GENETICS, V82, P287; Williams RSB, 2006, TRENDS MOL MED, V12, P415, DOI 10.1016/j.molmed.2006.07.003; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	48	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46879	10.1371/journal.pone.0046879	http://dx.doi.org/10.1371/journal.pone.0046879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056506	Green Published, gold			2022-12-27	WOS:000309454000098
J	Yang, L; Qiu, FM; Lu, XX; Huang, DS; Ma, GP; Guo, Y; Hu, M; Zhou, YM; Pan, MG; Tan, YG; Zhong, HB; Ji, WD; Wei, QY; Ran, PX; Zhong, NS; Zhou, YF; Lu, JC				Yang, Lei; Qiu, Fuman; Lu, Xiaoxiao; Huang, Dongsheng; Ma, Guanpei; Guo, Yuan; Hu, Min; Zhou, Yumin; Pan, Mingan; Tan, Yigang; Zhong, Haibo; Ji, Weidong; Wei, Qingyi; Ran, Pixin; Zhong, Nanshan; Zhou, Yifeng; Lu, Jiachun			Functional Polymorphisms of CHRNA3 Predict Risks of Chronic Obstructive Pulmonary Disease and Lung Cancer in Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR SUBUNIT GENES; SUSCEPTIBILITY LOCUS; FUNCTION DECLINE; EPITHELIAL-CELL; TOBACCO; NICOTINE; VARIANTS; PROLIFERATION; PREVALENCE	Recently, several genome-wide association studies (GWAS) have identified many susceptible single nucleotide polymorphisms (SNPs) for chronic obstructive pulmonary disease (COPD) and lung cancer which are two closely related diseases. Among those SNPs, some of them are shared by both the diseases, reflecting there is possible genetic similarity between the diseases. Here we tested the hypothesis that whether those shared SNPs are common predictor for risks or prognosis of COPD and lung cancer. Two SNPs (rs6495309 and rs1051730) located in nicotinic acetylcholine receptor alpha 3 (CHRNA3) gene were genotyped in 1511 patients with COPD, 1559 lung cancer cases and 1677 controls in southern and eastern Chinese populations. We found that the rs6495309CC and rs6495309CT/CC variant genotypes were associated with increased risks of COPD (OR = 1.32, 95% C. I. = 1.14-1.54) and lung cancer (OR = 1.57; 95% CI = 1.31-1.87), respectively. The rs6495309CC genotype contributed to more rapid decline of annual Forced expiratory volume in one second (FEV1) in both COPD cases and controls (P<0.05), and it was associated with advanced stages of COPD (P = 0.033); the rs6495309CT/CC genotypes conferred a poor survival for lung cancer (HR = 1.41, 95% CI = 1.13-1.75). The luciferase assays further showed that nicotine and other tobacco chemicals had diverse effects on the luciferase activity of the rs6495309C or T alleles. However, none of these effects were found for another SNP, rs1051730G>A. The data show a statistical association and suggest biological plausibility that the rs6495309T>C polymorphism contributed to increased risks and poor prognosis of both COPD and lung cancer.	[Yang, Lei; Qiu, Fuman; Lu, Xiaoxiao; Huang, Dongsheng; Ma, Guanpei; Ji, Weidong; Lu, Jiachun] Guangzhou Med Univ, Sch Publ Hlth, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zhou, Yumin; Ran, Pixin; Zhong, Nanshan] Guangzhou Med Univ, Guangzhou Inst Resp Dis, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Huang, Dongsheng; Tan, Yigang] Guangzhou Chest Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Guo, Yuan] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Pan, Mingan] Sun Yat Sen Univ, Dept Resp Med, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Zhong, Haibo] Guangzhou Red Cross Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Hu, Min; Zhou, Yifeng] Soochow Univ, Lab Canc Mol Genet, Coll Med, Suzhou, Peoples R China; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Sun Yat Sen University; Soochow University - China; University of Texas System; UTMD Anderson Cancer Center	Lu, JC (corresponding author), Guangzhou Med Univ, Sch Publ Hlth, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	jcLu@gzhmc.edu.cn			National Natural Scientific Foundation of China [30671813, 30872178, 81072366]; Guangdong Provincial High Level Experts Grants [2010-79]; Changjiang Scholars and Innovative Research Team in University grant [IRT0961]; Guangdong natural science foundation team [10351012003000000];  [81170043];  [81001278];  [30872142]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial High Level Experts Grants; Changjiang Scholars and Innovative Research Team in University grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong natural science foundation team; ; ; 	This study was supported by the National Natural Scientific Foundation of China grants 30671813, 30872178, 81072366 (JCL), and partly by 81170043 (PXR), 81001278 (Y. Zhou), 30872142 (WDJ); Guangdong Provincial High Level Experts Grants 2010-79 (JCL); Changjiang Scholars and Innovative Research Team in University grant IRT0961 and Guangdong natural science foundation team grant 10351012003000000 (NSZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyan G, 2006, INT J ONCOL, V29, P745; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Caramori G, 2011, THORAX, V66, P521, DOI 10.1136/thx.2010.156448; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Dasari V, 2006, AM J RESP CELL MOL, V35, P3, DOI 10.1165/rcmb.2006-0051SF; Ding D, 2010, ADDICT BEHAV, V35, P989, DOI 10.1016/j.addbeh.2010.06.016; Ferrer M, 1997, ANN INTERN MED, V127, P1072, DOI 10.7326/0003-4819-127-12-199712150-00003; Hansel NN, 2009, EUR RESPIR J, V34, P103, DOI 10.1183/09031936.00120408; He JQ, 2009, THORAX, V64, P698, DOI 10.1136/thx.2008.111278; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Koshiol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007380; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu B, 2012, AM J HUM GENET, V91, P384, DOI 10.1016/j.ajhg.2012.07.003; Liu B, 2010, CARCINOGENESIS, V31, P1405, DOI 10.1093/carcin/bgq126; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; MATTSON ME, 1987, AM J PUBLIC HEALTH, V77, P425, DOI 10.2105/AJPH.77.4.425; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; NAKAMURA Y, 1995, AM J RESP CRIT CARE, V151, P1497, DOI 10.1164/ajrccm.151.5.7735606; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; REDLINE S, 1989, AM J EPIDEMIOL, V129, P827, DOI 10.1093/oxfordjournals.aje.a115197; Rooney C, 2011, RESPIRATION, V81, P89, DOI 10.1159/000323946; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Shiraishi K, 2009, CARCINOGENESIS, V30, P65, DOI 10.1093/carcin/bgn257; Siedlinski M, 2011, THORAX, V66, P894, DOI 10.1136/thoraxjnl-2011-200154; Tanaka S, 2011, INT J CLIN ONCOL; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Uh Hae-Won, 2007, BMC Proc, V1 Suppl 1, pS114; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Yang L, 2011, CARCINOGENESIS; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335; Zheng HC, 2011, J ONCOL, V2011, DOI 10.1155/2011/635379; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou YM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6387	45	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46071	10.1371/journal.pone.0046071	http://dx.doi.org/10.1371/journal.pone.0046071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056235	Green Published, gold, Green Submitted			2022-12-27	WOS:000309454000015
J	Badri, DV; De-la-Pena, C; Lei, ZT; Manter, DK; Chaparro, JM; Guimaraes, RL; Sumner, LW; Vivanco, JM				Badri, Dayakar V.; De-la-Pena, Clelia; Lei, Zhentian; Manter, Daniel K.; Chaparro, Jacqueline M.; Guimaraes, Rejane L.; Sumner, Lloyd W.; Vivanco, Jorge M.			Root Secreted Metabolites and Proteins Are Involved in the Early Events of Plant-Plant Recognition Prior to Competition	PLOS ONE			English	Article							MYROSINASE-BINDING PROTEINS; ARABIDOPSIS; COMMUNICATION; COOPERATION; INDUCTION; DIVERSITY; IDENTITY; GENOTYPE; LECTINS; ORIGIN	The mechanism whereby organisms interact and differentiate between others has been at the forefront of scientific inquiry, particularly in humans and certain animals. It is widely accepted that plants also interact, but the degree of this interaction has been constricted to competition for space, nutrients, water and light. Here, we analyzed the root secreted metabolites and proteins involved in early plant neighbor recognition by using Arabidopsis thaliana Col-0 ecotype (Col) as our focal plant co-cultured in vitro with different neighbors [A. thaliana Ler ecotype (Ler) or Capsella rubella (Cap)]. Principal component and cluster analyses revealed that both root secreted secondary metabolites and proteins clustered separately between the plants grown individually (Col-0, Ler and Cap grown alone) and the plants co-cultured with two homozygous individuals (Col-Col, Ler-Ler and Cap-Cap) or with different individuals (Col-Ler and Col-Cap). In particularly, we observed that a greater number of defense- and stress-related proteins were secreted when our control plant, Col, was grown alone as compared to when it was co-cultured with another homozygous individual (Col-Col) or with a different individual (Col-Ler and Col-Cap). However, the total amount of defense proteins in the exudates of the co-cultures was higher than in the plant alone. The opposite pattern of expression was identified for stress-related proteins. These data suggest that plants can sense and respond to the presence of different plant neighbors and that the level of relatedness is perceived upon initial interaction. Furthermore, the role of secondary metabolites and defense- and stress-related proteins widely involved in plant-microbe associations and abiotic responses warrants reassessment for plant-plant interactions.	[Badri, Dayakar V.; De-la-Pena, Clelia; Chaparro, Jacqueline M.; Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Badri, Dayakar V.; De-la-Pena, Clelia; Chaparro, Jacqueline M.; Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA; [Manter, Daniel K.] ARS, USDA, Soil Plant Nutrient Res Unit, Ft Collins, CO USA; [Guimaraes, Rejane L.] Biorad Labs, Hercules, CA USA	Colorado State University; Colorado State University; United States Department of Agriculture (USDA)	Vivanco, JM (corresponding author), Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA.	j.vivanco@colostate.edu	Sumner, Lloyd W/A-3270-2013	Sumner, Lloyd W/0000-0002-4086-663X; De-la-Pena, Clelia/0000-0002-9093-9489; Manter, Daniel/0000-0001-7729-7197	National Science Foundation [MCB-0950857]; Samuel Roberts Noble Foundation; NSF [DBI-0109732]; Direct For Biological Sciences [0950857] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Samuel Roberts Noble Foundation; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant received from the National Science Foundation (MCB-0950857 to JMV.) ZL and LWS were supported by The Samuel Roberts Noble Foundation. Funds for the nano LC-QTOF/MS/MS instrumentation were provided in part by the NSF Plant Genome Research Program (DBI-0109732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, COMMUN INTEGR BIOL, DOI DOI 10.4161/CIB.3.1.10118; Arimura G, 2001, BIOCHEM SYST ECOL, V29, P1049, DOI 10.1016/S0305-1978(01)00049-7; Badri DV, 2009, CURR OPIN BIOTECH, V20, P642, DOI 10.1016/j.copbio.2009.09.014; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Biedrzycki ML, 2011, PLANT SIGNAL BEHAV, V6, P1515, DOI 10.4161/psb.6.10.16525; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boyd S. A., 1990, Soil biochemistry. Volume 6., P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broz AK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-115; Callaway RM, 2002, TRENDS ECOL EVOL, V17, P104, DOI 10.1016/S0169-5347(01)02438-7; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; de Kroon H, 2007, SCIENCE, V318, P1562, DOI 10.1126/science.1150726; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Duroux L, 2003, J MOL EVOL, V57, P397, DOI 10.1007/s00239-003-2489-3; Erschadi S, 2000, THEOR APPL GENET, V100, P633, DOI 10.1007/s001229900099; Falik O, 2005, PLANT CELL ENVIRON, V28, P562, DOI 10.1111/j.1365-3040.2005.01304.x; Gagliano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037382; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; Geshi N, 1998, PLANTA, V204, P295, DOI 10.1007/s004250050259; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Holzapfel C, 2003, OECOLOGIA, V134, P72, DOI 10.1007/s00442-002-1062-x; Jung YC, 2005, PLANT CELL REP, V24, P366, DOI 10.1007/s00299-005-0944-x; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; Kenton P, 2000, MOL PLANT PATHOL, V1, P367, DOI 10.1046/j.1364-3703.2000.00040.x; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; Mahall BE, 1996, AM J BOT, V83, P93, DOI 10.2307/2445959; Masclaux F, 2010, NEW PHYTOL, V185, P322, DOI 10.1111/j.1469-8137.2009.03057.x; Murase A, 2003, SOIL BIOL BIOCHEM, V35, P733, DOI 10.1016/S0038-0717(03)00087-7; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nowack MK, 2010, BIOCHEM SOC T, V38, P604, DOI 10.1042/BST0380604; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Onishi M, 2006, PLANT PHYSIOL BIOCH, V44, P574, DOI 10.1016/j.plaphy.2006.09.009; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PEUMANS WJ, 1995, HISTOCHEM J, V27, P253, DOI 10.1007/BF00398968; READER RJ, 1994, ECOLOGY, V75, P1753, DOI 10.2307/1939634; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Schenk HJ, 1999, ADV ECOL RES, V28, P145, DOI 10.1016/S0065-2504(08)60032-X; Sumner LW, 2002, RAPID COMMUN MASS SP, V16, P160, DOI 10.1002/rcm.555; Taipalensuu J, 1997, EUR J BIOCHEM, V243, P605, DOI 10.1111/j.1432-1033.1997.t01-1-00605.x; Tautenhahn R, 2012, ANAL CHEM; Velazhahan R, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P107; Wang J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000127; Warwick SI, 1997, CAN J BOT, V75, P960, DOI 10.1139/b97-107; Welinder KG, 2002, EUR J BIOCHEM, V269, P6063, DOI 10.1046/j.1432-1033.2002.03311.x; Wenke K, 2010, PLANTA, V231, P499, DOI 10.1007/s00425-009-1076-2; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; WOLPERT JS, 1976, BIOCHEM BIOPH RES CO, V70, P729, DOI 10.1016/0006-291X(76)90653-7; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yi HS, 2009, PLANT PHYSIOL, V151, P2152, DOI 10.1104/pp.109.144782; ZANTUA MI, 1977, SOIL BIOL BIOCHEM, V9, P135, DOI 10.1016/0038-0717(77)90050-5; Zhang J, 2009, PLANT J, V57, P171, DOI 10.1111/j.1365-313X.2008.03676.x; Ziolkowski PA, 2009, NUCLEIC ACIDS RES, V37, P3189, DOI 10.1093/nar/gkp183	62	40	46	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46640	10.1371/journal.pone.0046640	http://dx.doi.org/10.1371/journal.pone.0046640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056382	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600049
J	Goswami, ND; Hecker, EJ; Vickery, C; Ahearn, MA; Cox, GM; Holland, DP; Naggie, S; Piedrahita, C; Mosher, A; Torres, Y; Norton, BL; Suchindran, S; Park, PH; Turner, D; Stout, JE				Goswami, Neela D.; Hecker, Emily J.; Vickery, Carter; Ahearn, Marshall A.; Cox, Gary M.; Holland, David P.; Naggie, Susanna; Piedrahita, Carla; Mosher, Ann; Torres, Yvonne; Norton, Brianna L.; Suchindran, Sujit; Park, Paul H.; Turner, Debbie; Stout, Jason E.			Geographic Information System-based Screening for TB, HIV, and Syphilis (GIS-THIS): A Cross-Sectional Study	PLOS ONE			English	Article							TUBERCULOSIS TRANSMISSION; SPATIAL-DISTRIBUTION; RISK-FACTORS; CARE; PATTERNS; COSTS; RECOMMENDATIONS; INFECTION; THERAPY; ADULTS	Objective: To determine the feasibility and case detection rate of a geographic information systems (GIS)-based integrated community screening strategy for tuberculosis, syphilis, and human immunodeficiency virus (HIV). Design: Prospective cross-sectional study of all participants presenting to geographic hot spot screenings in Wake County, North Carolina. Methods: The residences of tuberculosis, HIV, and syphilis cases incident between 1/1/05-12/31/07 were mapped. Areas with high densities of all 3 diseases were designated "hot spots." Combined screening for tuberculosis, HIV, and syphilis were conducted at the hot spots; participants with positive tests were referred to the health department. Results and Conclusions: Participants (N = 247) reported high-risk characteristics: 67% previously incarcerated, 40% had lived in a homeless shelter, and 29% had a history of crack cocaine use. However, 34% reported never having been tested for HIV, and 41% did not recall prior tuberculin skin testing. Screening identified 3% (8/240) of participants with HIV infection, 1% (3/239) with untreated syphilis, and 15% (36/234) with latent tuberculosis infection. Of the eight persons with HIV, one was newly diagnosed and co-infected with latent tuberculosis; he was treated for latent TB and linked to an HIV provider. Two other HIV-positive persons had fallen out of care, and as a result of the study were linked back into HIV clinics. Of 27 persons with latent tuberculosis offered therapy, nine initiated and three completed treatment. GIS-based screening can effectively penetrate populations with high disease burden and poor healthcare access. Linkage to care remains challenging and will require creative interventions to impact morbidity.	[Goswami, Neela D.; Hecker, Emily J.; Ahearn, Marshall A.; Cox, Gary M.; Holland, David P.; Naggie, Susanna; Mosher, Ann; Norton, Brianna L.; Suchindran, Sujit; Park, Paul H.; Stout, Jason E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Piedrahita, Carla; Torres, Yvonne; Turner, Debbie] Wake Cty Human Serv, Raleigh, NC USA; [Vickery, Carter] Wake Cty Community Serv, Raleigh, NC USA	Duke University	Goswami, ND (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	neela.goswami@duke.edu; jason.stout@duke.edu		Stout, Jason/0000-0002-6698-8176; Park, Paul/0000-0001-7332-8320	National Institutes of Health T32 AIDS Training Grant [5T32-AI007392-22]; Duke Center for AIDS Research (CFAR), an National Institutes of Health [P30A164518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, T32AI007392] Funding Source: NIH RePORTER	National Institutes of Health T32 AIDS Training Grant; Duke Center for AIDS Research (CFAR), an National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health T32 AIDS Training Grant to N.D.G. (5T32-AI007392-22) and a developmental grant to J.E.S. from the Duke Center for AIDS Research (CFAR), an National Institutes of Health funded program (P30A164518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2010, REP TUB US 2009; Centers for Disease Control and Prevention, 2009, PROGR COLL SERV INT; Centers for Disease Control and Prevention (CDCP), 2010, SEX TRANSM DIS SURV; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Gallagher TC, 1997, MED CARE, V35, P814, DOI 10.1097/00005650-199708000-00007; Geanuracos CG, 2007, AM J PUBLIC HEALTH, V97, P1974, DOI 10.2105/AJPH.2005.076851; Gesink DC, 2011, AM J EPIDEMIOL, V174, P81, DOI 10.1093/aje/kwr035; Goswami ND, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-305; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Heimer R, 2008, AIDS, V22, P123, DOI 10.1097/QAD.0b013e3282f244ef; Hixson BA, 2011, J URBAN HEALTH, V88, P129, DOI 10.1007/s11524-010-9510-0; Holtgrave DR, 2007, PLOS MED, V4, P1011, DOI 10.1371/journal.pmed.0040194; Kistemann T, 2002, SOC SCI MED, V55, P7, DOI 10.1016/S0277-9536(01)00216-7; Kleinschmidt I, 2007, AM J TROP MED HYG, V77, P1163, DOI 10.4269/ajtmh.2007.77.1163; Law DCG, 2004, SEX TRANSM INFECT, V80, P294, DOI 10.1136/sti.2003.006700; Law DCG, 2006, ANN EPIDEMIOL, V16, P797, DOI 10.1016/j.annepidem.2006.05.003; Magnus M, 2009, AIDS, V23, P1277, DOI 10.1097/QAD.0b013e32832b51da; Mehta SD, 2008, PUBLIC HEALTH REP, V123, P608, DOI 10.1177/003335490812300511; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Moonan PK, 2006, AM J RESP CRIT CARE, V174, P599, DOI 10.1164/rccm.200512-1977OC; Mugavero MJ, 2007, CLIN INFECT DIS, V45, P127, DOI 10.1086/518587; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Randremanana RV, 2009, TROP MED INT HEALTH, V14, P429, DOI 10.1111/j.1365-3156.2009.02239.x; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schleihauf E, 2009, SEX TRANSM INFECT, V85, P45, DOI 10.1136/sti.2008.030197; Shi LY, 2005, J GEN INTERN MED, V20, P148, DOI 10.1111/j.1525-1497.2005.40136.x; Sullivan AB, 2011, ANN EPIDEMIOL, V21, P245, DOI 10.1016/j.annepidem.2010.11.015; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Uphold CR, 2005, AIDS PATIENT CARE ST, V19, P473, DOI 10.1089/apc.2005.19.473; Walensky RP, 2005, MED DECIS MAKING, V25, P321, DOI 10.1177/0272989X05276955	36	36	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46029	10.1371/journal.pone.0046029	http://dx.doi.org/10.1371/journal.pone.0046029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NG	23056227	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600020
J	Pignatelli, J; Jones, MC; LaLonde, DP; Turner, CE				Pignatelli, Jeanine; Jones, Matthew C.; LaLonde, David P.; Turner, Christopher E.			Beta2-Adaptin Binds Actopaxin and Regulates Cell Spreading, Migration and Matrix Degradation	PLOS ONE			English	Article							CLATHRIN-DEPENDENT ENDOCYTOSIS; FOCAL ADHESION PROTEIN; METALLOPROTEINASE MT1-MMP; MEDIATED ENDOCYTOSIS; ACTIN POLYMERIZATION; RECYCLING PATHWAYS; MEMBRANE; SRC; INVASION; INVADOPODIA	Cell adhesion to the extracellular matrix is a key event in cell migration and invasion and endocytic trafficking of adhesion receptors and signaling proteins plays a major role in regulating these processes. Beta2-adaptin is a subunit of the AP-2 complex and is involved in clathrin-mediated endocytosis. Herein, beta 2-adaptin is shown to bind to the focal adhesion protein actopaxin and localize to focal adhesions during cells spreading in an actopaxin dependent manner. Furthermore, beta 2-adaptin is enriched in adhesions at the leading edge of migrating cells and depletion of beta 2-adaptin by RNAi increases cell spreading and inhibits directional cell migration via a loss of cellular polarity. Knockdown of beta 2-adaptin in both U2OS osteosarcoma cells and MCF10A normal breast epithelial cells promotes the formation of matrix degrading invadopodia, adhesion structures linked to invasive migration in cancer cells. These data therefore suggest that actopaxin-dependent recruitment of the AP-2 complex, via an interaction with beta 2-adaptin, to focal adhesions mediates cell polarity and migration and that beta 2-adaptin may control the balance between the formation of normal cell adhesions and invasive adhesion structures.	[Pignatelli, Jeanine; Jones, Matthew C.; Turner, Christopher E.] SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA; [LaLonde, David P.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University	Turner, CE (corresponding author), SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA.	turnerce@upstate.edu		Jones, Matthew/0000-0003-4723-3277	National Institutes of Health [RO1HL070244]; National Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health RO1HL070244 to C. E. Turner and a National Cancer Center predoctoral fellowship to J. Pignatelli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTANKOV G, 1993, J CELL BIOL, V120, P1449, DOI 10.1083/jcb.120.6.1449; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Batchelder EM, 2010, MOL BIOL CELL, V21, P3070, DOI 10.1091/mbc.E09-12-1044; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Boyd ND, 2002, BIOCHEMISTRY-US, V41, P7232, DOI 10.1021/bi011501f; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Chao WT, 2010, MOL CELL BIOL, V30, P4463, DOI 10.1128/MCB.01207-09; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Clark ES, 2009, ONCOGENE, V28, P431, DOI 10.1038/onc.2008.389; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; De Deyne PG, 1998, J CELL SCI, V111, P2729; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Huttenlocher A, 2001, CSH PERSPECT BIOL, V3; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Olski TM, 2001, J CELL SCI, V114, P525; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2005, J CELL SCI, V118, P4975, DOI 10.1242/jcs.02610; Ren G, 2009, J BIOL CHEM, V284, P18913, DOI 10.1074/jbc.M109.000307; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Sharma A, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-50; Smythe E, 2006, J CELL SCI, V119, P4589, DOI 10.1242/jcs.03247; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang Y, 2011, MOL BIOL CELL, V22, P1529, DOI 10.1091/mbc.E10-09-0785; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006	63	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46228	10.1371/journal.pone.0046228	http://dx.doi.org/10.1371/journal.pone.0046228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056266	Green Submitted, Green Published, gold			2022-12-27	WOS:000309452600027
J	Gonzalez-Reiche, AS; Morales-Betoulle, ME; Alvarez, D; Betoulle, JL; Muller, ML; Sosa, SM; Perez, DR				Gonzalez-Reiche, Ana S.; Morales-Betoulle, Maria E.; Alvarez, Danilo; Betoulle, Jean-Luc; Mueller, Maria L.; Sosa, Silvia M.; Perez, Daniel R.			Influenza A Viruses from Wild Birds in Guatemala Belong to the North American Lineage	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; SOUTH-AMERICA; PASSERINE BIRDS; MIGRATORY WATERFOWL; RESIDENT DUCKS; CONTAINS GENES; H5N1; HEMAGGLUTININ; TRANSMISSION; OUTBREAK	The role wild bird species play in the transmission and ecology of avian influenza virus (AIV) is well established; however, there are significant gaps in our understanding of the worldwide distribution of these viruses, specifically about the prevalence and/or significance of AIV in Central and South America. As part of an assessment of the ecology of AIV in Guatemala, we conducted active surveillance in wild birds on the Pacific and Atlantic coasts. Cloacal and tracheal swab samples taken from resident and migratory wild birds were collected from February 2007 to January 2010.1913 samples were collected and virus was detected by real time RT-PCR (rRT-PCR) in 28 swab samples from ducks (Anas discors). Virus isolation was attempted for these positive samples, and 15 isolates were obtained from the migratory duck species Blue-winged teal. The subtypes identified included H7N9, H11N2, H3N8, H5N3, H8N4, and H5N4. Phylogenetic analysis of the viral sequences revealed that AIV isolates are highly similar to viruses from the North American lineage suggesting that bird migration dictates the ecology of these viruses in the Guatemalan bird population.	[Gonzalez-Reiche, Ana S.; Perez, Daniel R.] Univ Maryland Coll Pk, Dept Vet Med, College Pk, MD 20742 USA; [Gonzalez-Reiche, Ana S.; Perez, Daniel R.] Virginia Maryland Reg Coll Vet Med, College Pk, MD USA; [Gonzalez-Reiche, Ana S.; Morales-Betoulle, Maria E.; Alvarez, Danilo; Betoulle, Jean-Luc; Mueller, Maria L.; Sosa, Silvia M.] CES UVG, Lab Ecol Arbovirus & Virus Zoonoticos, Guatemala City, Guatemala; [Betoulle, Jean-Luc] Fdn Para Ecodesarrollo & Conservacion FUNDAECO, Guatemala City, Guatemala	University System of Maryland; University of Maryland College Park	Gonzalez-Reiche, AS (corresponding author), Univ Maryland Coll Pk, Dept Vet Med, College Pk, MD 20742 USA.	agonzalez@ces.uvg.edu.gt; dperez1@umd.edu	Perez, Daniel R./D-5044-2016; Gonzalez-Reiche, Ana/ABH-2585-2020	Perez, Daniel R./0000-0002-6569-5689; Gonzalez-Reiche, Ana/0000-0003-3583-4497; Arroyo-Rodriguez, Victor/0000-0002-0858-0324; Chapman, Colin/0000-0002-8827-8140	National Institute of Allergy and Infectious Diseases (NIAID) Center for Research on Influenza Pathogenesis (CRIP) through University of Maryland College Park [HHSN266200700010C]; Guatemala's National Council of Science and Technology (CONCYT) [97-2006]; Centers for Disease Control [U50/CCU021236-01]; Universidad del Valle de Guatemala [U50/CCU021236-01, Z507225]; University of Maryland [Z507225]	National Institute of Allergy and Infectious Diseases (NIAID) Center for Research on Influenza Pathogenesis (CRIP) through University of Maryland College Park; Guatemala's National Council of Science and Technology (CONCYT); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Universidad del Valle de Guatemala; University of Maryland	This work was mainly supported by the National Institute of Allergy and Infectious Diseases (NIAID) Center for Research on Influenza Pathogenesis (CRIP) through University of Maryland College Park contract No. HHSN266200700010C, with partial funding from the Avian Influenza Coordinated Agricultural Project (AICAP) Subaward Z507225 between the University of Maryland and Universidad del Valle de Guatemala, Guatemala's National Council of Science and Technology (CONCYT) through the project FODECYT 97-2006, and the Cooperative Agreement between the Centers for Disease Control and Universidad del Valle de Guatemala No. #U50/CCU021236-01 for collection of terrestrial bird samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Alvarez P, 2010, VIROLOGY, V396, P76, DOI 10.1016/j.virol.2009.10.009; Artois M, 2009, REV SCI TECH OIE, V28, P69, DOI 10.20506/rst.28.1.1854; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Boyce WM, 2009, COMP IMMUNOL MICROB, V32, P275, DOI 10.1016/j.cimid.2008.01.002; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Carbonell M., 2002, KNOW YOUR DUCKS WATE; Cerezo A, 2009, REV BIOL TROP, V57, P401; Cerezo AM, 2001, DETERMINACION COMP E; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Cuevas-Dominguez EA, 2009, REDVET REV ELECT VET, V10; de Andrade CR, 2009, J BRAS PNEUMOL, V35, P470, DOI 10.1590/S1806-37132009000500014; de Jong MCM, 2009, REV SCI TECH OIE, V28, P333; Dierauf LA, 2006, JAVMA-J AM VET MED A, V228, P1877, DOI 10.2460/javma.228.12.1877; Dugan VG, 2011, VIROLOGY, V417, P98, DOI 10.1016/j.virol.2011.05.004; Eagles D, 2009, REV SCI TECH OIE, V28, P341, DOI 10.20506/rst.28.1.1864; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; Feare CJ, 2010, AVIAN DIS, V54, P201, DOI 10.1637/8766-033109-ResNote.1; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Ferro PJ, 2010, AVIAN DIS, V54, P655, DOI 10.1637/8810-040109-ResNote.1; Fouchier RAM, 2009, REV SCI TECH OIE, V28, P49, DOI 10.20506/rst.28.1.1863; Fuller TL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-187; Gammonley JH, 1995, LIFE HIST MANAGEMENT; Ghersi BM, 2009, EMERG INFECT DIS, V15, P935, DOI 10.3201/eid1506.080981; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Greenberg R, 1993, BRIDGING AM MIGRATOR; Gronesova P, 2008, SCAND J INFECT DIS, V40, P954, DOI 10.1080/00365540802400576; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Hanson BA, 2005, J WILDLIFE DIS, V41, P624, DOI 10.7589/0090-3558-41.3.624; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Howell S. N. G., 1995, GUIDE BIRDS MEXICO N; IBRAHIM HM, 1990, VET REC, V127, P528; Kaleta EF, 2004, DEUT TIERARZTL WOCH, V111, P467; Kelly TR, 2008, J AVIAN MED SURG, V22, P1, DOI 10.1647/2006-036R.1; Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lee CW, 2004, AVIAN PATHOL, V33, P288, DOI 10.1080/0307945042000203407; Lupiani B, 2009, COMP IMMUNOL MICROB, V32, P311, DOI 10.1016/j.cimid.2008.01.004; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Melville DS, 2006, LETT APPL MICROBIOL, V42, P435, DOI 10.1111/j.1472-765X.2006.01892.x; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; NESTOROWICZ A, 1987, VIROLOGY, V160, P411, DOI 10.1016/0042-6822(87)90012-2; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; OIE, 2011, UPD HYGHL PATH AV IN; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Pedersen K, 2010, AVIAN DIS, V54, P405, DOI 10.1637/8693-031309-Reg.1; Perdue ML, 2000, VET MICROBIOL, V74, P77, DOI 10.1016/S0378-1135(00)00168-1; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Peterson AT, 2008, EMERG INFECT DIS, V14, P1644, DOI 10.3201/eid1410.080169; Rappole J. H., 1995, NEARCTIC AVIAN MIGRA; ROY G, 1983, REV CAN BIOL EXPTL, V42, P73; Senne DA, 2003, AVIAN DIS, V47, P798, DOI 10.1637/0005-2086-47.s3.798; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; Senne DA, 2010, AVIAN DIS, V54, P179, DOI 10.1637/8921-050809-Review.1; Siguenza de Micheo R, 2007, INFORM CONTEOS ANATI; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2007, AVIAN DIS, V51, P273, DOI 10.1637/7529-032106R.1; Spackman E, 2006, J VIROL, V80, P7760, DOI 10.1128/JVI.00445-06; Spackman Erica, 2008, V436, P13, DOI 10.1007/978-1-59745-279-3_3; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Villarreal C, 2009, REV SCI TECH OIE, V28, P261, DOI 10.20506/rst.28.1.1877; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Webster R, 2002, WHO MANUAL ANIMAL IN; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010	72	52	54	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32873	10.1371/journal.pone.0032873	http://dx.doi.org/10.1371/journal.pone.0032873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427902	Green Published, Green Submitted, gold			2022-12-27	WOS:000303129700018
J	Xiao, D; Bommareddy, A; Kim, SH; Sehrawat, A; Hahm, ER; Singh, SV				Xiao, Dong; Bommareddy, Ajay; Kim, Su-Hyeong; Sehrawat, Anuradha; Hahm, Eun-Ryeong; Singh, Shivendra V.			Benzyl Isothiocyanate Causes FoxO1-Mediated Autophagic Death in Human Breast Cancer Cells	PLOS ONE			English	Article							PROSTATE-CANCER; INDUCED APOPTOSIS; INHIBITION; CONSTITUENT; MTOR; PREVENTION; INDUCTION; TARGET; GROWTH; CHAIN	Benzyl isothiocyanate (BITC), a constituent of edible cruciferous vegetables, inhibits growth of breast cancer cells but the mechanisms underlying growth inhibitory effect of BITC are not fully understood. Here, we demonstrate that BITC treatment causes FoxO1-mediated autophagic death in cultured human breast cancer cells. The BITC-treated breast cancer cells (MDA-MB-231, MCF-7, MDA-MB-468, BT-474, and BRI-JM04) and MDA-MB-231 xenografts from BITC-treated mice exhibited several features characteristic of autophagy, including appearance of double-membrane vacuoles (transmission electron microscopy) and acidic vesicular organelles (acridine orange staining), cleavage of microtubule-associated protein 1 light chain 3 (LC3), and/or suppression of p62 (p62/SQSTM1 or sequestosome 1) expression. On the other hand, a normal human mammary epithelial cell line (MCF-10A) was resistant to BITC-induced autophagy. BITC-mediated inhibition of MDA-MB-231 and MCF-7 cell viability was partially but statistically significantly attenuated in the presence of autophagy inhibitors 3-methyl adenine and bafilomycin A1. Stable overexpression of Mn-superoxide dismutase, which was fully protective against apoptosis, conferred only partial protection against BITC-induced autophagy. BITC treatment decreased phosphorylation of mTOR and its downstream targets (P70s6k and 4E-BP1) in cultured MDA-MB-231 and MCF-7 cells and MDA-MB-231 xenografts, but activation of mTOR by transient overexpression of its positive regulator Rheb failed to confer protection against BITC-induced autophagy. Autophagy induction by BITC was associated with increased expression and acetylation of FoxO1. Furthermore, autophagy induction and cell growth inhibition resulting from BITC exposure were significantly attenuated by small interfering RNA knockdown of FoxO1. In conclusion, the present study provides novel insights into the molecular circuitry of BITC-induced cell death involving FoxO1-mediated autophagy.	[Xiao, Dong; Kim, Su-Hyeong; Sehrawat, Anuradha; Hahm, Eun-Ryeong; Singh, Shivendra V.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15260 USA; [Bommareddy, Ajay] Wilkes Univ, Sch Pharm, Dept Pharmaceut Sci, Wilkes Barre, PA USA; [Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wilkes University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, SV (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15260 USA.	singhs@upmc.edu			National Cancer Institute at the National Institutes of Health [RO1 CA129347-05, P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA129347] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by a grant from the National Cancer Institute at the National Institutes of Health (RO1 CA129347-05). This research project used the Cell and Tissue Imaging Facility, and Tissue and Research Pathology Facility supported by a grant from the National Cancer Institute at the National Institutes of Health (P30CA047904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; DeMasters G, 2006, MOL CANCER THER, V5, P2786, DOI 10.1158/1535-7163.MCT-06-0316; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fowke JH, 2003, CANCER RES, V63, P3980; Gibson SB, 2010, AUTOPHAGY, V6, P835, DOI 10.4161/auto.6.7.13335; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; HULKA BS, 1995, LANCET, V346, P883, DOI 10.1016/S0140-6736(95)92713-1; Iwamaru A, 2007, ONCOGENE, V26, P1840, DOI 10.1038/sj.onc.1209992; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2003, CANCER RES, V63, P2103; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Kim SH, 2011, CARCINOGENESIS, V32, P359, DOI 10.1093/carcin/bgq267; Kim SH, 2010, CANCER PREV RES, V3, P718, DOI 10.1158/1940-6207.CAPR-10-0048; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Obiorah I, 2011, MATURITAS, V70, P315, DOI 10.1016/j.maturitas.2011.09.006; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scherz-Shouval R, 2007, AUTOPHAGY, V3, P371, DOI 10.4161/auto.4214; Singh SV, 2008, CANCER RES, V68, P9503, DOI 10.1158/0008-5472.CAN-08-1677; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tseng E, 2004, EXP BIOL MED, V229, P835, DOI 10.1177/153537020422900817; Warin R, 2010, MOL CARCINOGEN, V49, P500, DOI 10.1002/mc.20600; Warin R, 2009, CANCER RES, V69, P9473, DOI 10.1158/0008-5472.CAN-09-2960; WATTENBERG LW, 1977, J NATL CANCER I, V58, P395, DOI 10.1093/jnci/58.2.395; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Xiao D, 2008, J BIOL CHEM, V283, P30151, DOI 10.1074/jbc.M802529200; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Zhang YS, 2003, MOL CANCER THER, V2, P1045; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	39	56	62	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2012	7	3							e32597	10.1371/journal.pone.0032597	http://dx.doi.org/10.1371/journal.pone.0032597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940QX	22457718	gold, Green Submitted, Green Published			2022-12-27	WOS:000303909200005
J	Jiang, JJ; Huang, LZ; Yu, WZ; Wu, X; Zhou, P; Li, XX				Jiang, Jingjing; Huang, Lvzhen; Yu, Wenzhen; Wu, Xi; Zhou, Peng; Li, Xiaoxin			Overexpression of HTRA1 Leads to Down-Regulation of Fibronectin and Functional Changes in RF/6A Cells and HUVECs	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; SERINE-PROTEASE HTRA1; RETINAL-PIGMENT EPITHELIUM; ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; GENE POLYMORPHISMS; JAPANESE PATIENTS; CHINESE PATIENTS; A1 HTRA1; EXPRESSION	Multiple genetic studies have suggested that high-temperature requirement serine protease (HTRA1) is associated with polypoidal choroidal vasculopathy (PCV). To date, no functional studies have investigated the biological effect of HTRA1 on vascular endothelial cells, essential vascular components involved in polypoidal vascular abnormalities and arteriosclerosis-like changes. In vitro studies were performed to investigate the effect of HTRA1 on the regulation of fibronectin, laminin, vascular endothelial growth factor (VEGF), platelet derived growth factor receptor (PDGFR) and matrix metalloparoteinases 2 (MMP-2) and the role of HTRA1 in choroid-retina endothelial (RF/6A) and human umbilical vein endothelial (HUVEC) cells. Lentivirus-mediated overexpression of HTRA1 was used to explore effects of the protease on RF/6A and HUVEC cells in vitro. HTRA1 overexpression inhibited the proliferation, cell cycle, migration and tube formation of RF/6A and HUVEC cells, effects that might contribute to the early stage of PCV pathological lesions. Fibronectin mRNA and protein levels were significantly down-regulated following the upregulation of HTRA1, whereas the expressions of laminin, VEGF and MMP-2 were unaffected by alterations in HTRA1 expression. The decreased biological function of vascular endothelial cells and the degradation of extracellular matrix proteins, such as fibronectin, may be involved in a contributory role for HTRA1 in PCV pathogenesis.	[Jiang, Jingjing; Huang, Lvzhen; Yu, Wenzhen; Wu, Xi; Zhou, Peng; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Jiang, Jingjing; Huang, Lvzhen; Yu, Wenzhen; Wu, Xi; Zhou, Peng; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Jiang, Jingjing] China Japan Friendship Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Zhou, Peng] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China	Peking University; China-Japan Friendship Hospital; Fudan University	Li, XX (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drlixiaoxin@163.com	jiang, jun/GWC-9329-2022	Jiang, Jingjing/0000-0002-5077-1204; xu, wanghong/0000-0003-2045-2218; zhang, zhijie/0000-0002-1276-787X; Jiang, Qingwu/0000-0001-8921-3317	National Basic Research Program of China (973 Program) [2011CB510200]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Basic Research Program of China (973 Program (2011CB510200)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; An E, 2010, INVEST OPHTH VIS SCI, V51, P3379, DOI 10.1167/iovs.09-4853; Austin BA, 2009, INVEST OPHTH VIS SCI, V50, P2896, DOI 10.1167/iovs.08-2495; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Canfield AE, 2007, BIOCHEM SOC T, V35, P669, DOI 10.1042/BST0350669; Chan CC, 2007, T AM OPHTHAL SOC, V105, P97; Chan Chi-Chao, 2007, Trans Am Ophthalmol Soc, V105, P92; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Darribere T, 2000, MECH DEVELOP, V92, P239, DOI 10.1016/S0925-4773(00)00245-8; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; DeAngelis MM, 2008, OPHTHALMOLOGY, V115, P1209, DOI 10.1016/j.ophtha.2007.10.032; Gotoh N, 2010, JPN J OPHTHALMOL, V54, P609, DOI 10.1007/s10384-010-0865-2; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; HARKER LA, 1976, J CLIN INVEST, V58, P731, DOI 10.1172/JCI108520; Huang LZ, 2010, INVEST OPHTH VIS SCI, V51, P3193, DOI 10.1167/iovs.09-3779; Huang LZ, 2009, MOL VIS, V15, P1057; Jo N, 2006, AM J PATHOL, V168, P2036, DOI 10.2353/ajpath.2006.050588; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Lafaut BA, 2000, GRAEF ARCH CLIN EXP, V238, P752, DOI 10.1007/s004170000180; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lee KY, 2008, INVEST OPHTH VIS SCI, V49, P2613, DOI 10.1167/iovs.07-0860; Libby P, 2006, Handb Exp Pharmacol, P285; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Matsuoka M, 2004, BRIT J OPHTHALMOL, V88, P809, DOI 10.1136/bjo.2003.032466; Nakahara T, 2006, CANCER RES, V66, P1434, DOI 10.1158/0008-5472.CAN-05-0923; Nakashizuka H, 2008, INVEST OPHTH VIS SCI, V49, P4729, DOI 10.1167/iovs.08-2134; Ng TK, 2011, INVEST OPHTH VIS SCI, V52, P3706, DOI 10.1167/iovs.10-6773; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Park DH, 2012, JPN J OPHTHALMOL, V56, P60, DOI 10.1007/s10384-011-0089-0; Patel N, 2003, J PHARMACOL EXP THER, V306, P838, DOI 10.1124/jpet.103.052167; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tiaden AN, 2012, J BIOL CHEM, V287, P21335, DOI 10.1074/jbc.M112.341032; Tong Y, 2010, MOL VIS, V16, P1958; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; VLODAVSKY I, 1981, NATURE, V289, P304, DOI 10.1038/289304a0; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478, DOI 10.1001/archopht.1997.01100150480005; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258	48	13	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46115	10.1371/journal.pone.0046115	http://dx.doi.org/10.1371/journal.pone.0046115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056244	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500028
J	Jiang, JY; Qiu, H; Zhao, GM; Zhou, Y; Zhang, ZJ; Zhang, H; Jiang, QW; Sun, Q; Wu, HY; Yang, LM; Ruan, XN; Xu, WH				Jiang, Junyi; Qiu, Hua; Zhao, Genming; Zhou, Yi; Zhang, Zhijie; Zhang, Hong; Jiang, Qingwu; Sun, Qiao; Wu, Hongyan; Yang, Liming; Ruan, Xiaonan; Xu, Wang-Hong			Dietary Fiber Intake Is Associated with HbA1c Level among Prevalent Patients with Type 2 Diabetes in Pudong New Area of Shanghai, China	PLOS ONE			English	Article							LOW-GLYCEMIC-INDEX; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; WOMENS HEALTH; CEREAL FIBER; MELLITUS; OUTPATIENTS; LOAD; CARBOHYDRATE; HEMOGLOBIN	Background: Dietary factors play an important role in glycemic control in diabetic patients. However, little is known about their effects among Chinese diabetic patients, whose diets are typically abundant in fiber and high in glycemic index (GI) values. Methodology/Principal Findings: 934 patients with type 2 diabetes and 918 healthy volunteers from Pudong New Area, Shanghai, China, were interviewed during the period of Oct-Dec, 2006 to elicit demographic characteristics and lifestyle factors. Dietary habits were assessed using a validated food frequency questionnaire. Anthropometric measurements, biospecimen collection and biochemical assays were conducted at the interview according to a standard protocol. In this population, diabetic patients consumed lower levels of energy and macronutrients but had higher levels of fasting plasma glucose (FPG), glycolated hemoglobin A1c (HbA1c), triglyceride and body mass index than healthy adults. While the average consumption levels of the nutrients among diabetic patients did not vary along duration of the disease, the average levels of FPG and HbA1c increased with increasing duration. Regardless of diabetes duration, HbA1c level was observed lower in patients having a higher fiber or lower GI intake. Compared with those with the lowest tertile intake of fiber, the adjusted odds ratios (ORs) for poor glycemic control reduced from 0.75 (95% CI: 0.54-1.06) to 0.51 (95% CI: 0.34-0.75) with increasing tertile intake (P for trend,0.001). Conclusions: Dietary fiber may play an important role in reducing HbA1c level. Increasing fiber intake may be an effective approach to improve glycemic control among Chinese diabetic patients.	[Qiu, Hua; Zhou, Yi; Zhang, Hong; Sun, Qiao; Wu, Hongyan; Yang, Liming; Ruan, Xiaonan] Pudong New Area Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Jiang, Junyi; Zhao, Genming; Zhang, Zhijie; Jiang, Qingwu; Xu, Wang-Hong] Fudan Univ, Minist Educ, Sch Publ Hlth, Dept Epidemiol,Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China	Shanghai Center for Disease Control & Prevention; Fudan University	Ruan, XN (corresponding author), Pudong New Area Ctr Dis Control & Prevent, Shanghai, Peoples R China.	ruan_118@hotmail.com; wanghong.xu@fudan.edu.cn	jiang, jun/GWC-9329-2022	Jiang, Jingjing/0000-0002-5077-1204; xu, wanghong/0000-0003-2045-2218; zhang, zhijie/0000-0002-1276-787X; Jiang, Qingwu/0000-0001-8921-3317	Shanghai Municipal Health Bureau [08GWZX0201]; Pudong Health Bureau of Shanghai [PWRd2010-03]	Shanghai Municipal Health Bureau; Pudong Health Bureau of Shanghai	This research was funded by Shanghai Municipal Health Bureau (08GWZX0201) and Academic Leaders Training Program of Pudong Health Bureau of Shanghai (Grant No. PWRd2010-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard ND, 2006, DIABETES CARE, V29, P1777, DOI 10.2337/dc06-0606; Brand-Miller J, 2003, DIABETES CARE, V26, P2261, DOI 10.2337/diacare.26.8.2261; Chandalia M, 2000, NEW ENGL J MED, V342, P1392, DOI 10.1056/NEJM200005113421903; Esposito K, 2010, METAB SYNDR RELAT D, V8, P255, DOI 10.1089/met.2009.0096; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Franz MJ, 2003, DIABETES CARE, V26, P2466, DOI 10.2337/diacare.26.8.2466; Haimoto H, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-21; He MA, 2010, CIRCULATION, V121, P2162, DOI 10.1161/CIRCULATIONAHA.109.907360; Hessler DM, 2010, PATIENT ED COUNS; Hinata M, 2007, DIABETES RES CLIN PR, V77, P327, DOI 10.1016/j.diabres.2006.10.008; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jenkins DJA, 2008, JAMA-J AM MED ASSOC, V300, P2742, DOI 10.1001/jama.2008.808; Jenkins DJA, 2002, AM J CLIN NUTR, V76, p266S, DOI 10.1093/ajcn/76.1.266S; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; Kim MS, 2008, NUTR RES PRACT, V2, P62; Larsen RN, 2011, DIABETOLOGIA, V54, P731, DOI 10.1007/s00125-010-2027-y; Lau C, 2005, DIABETES CARE, V28, P1397, DOI 10.2337/diacare.28.6.1397; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Pearce KL, 2011, BRIT J NUTR, V105, P584, DOI 10.1017/S0007114510003983; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Roush George, 2011, Conn Med, V75, P325; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Thomas DE, 2010, BRIT J NUTR, V104, P797, DOI 10.1017/S0007114510001534; Villegas R, 2010, INT J EPIDEMIOL, V39, P889, DOI 10.1093/ije/dyq008; Wolever TMS, 2008, AM J CLIN NUTR, V87, P114, DOI 10.1093/ajcn/87.1.114; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yin Wen-ya, 2005, Zhonghua Yufang Yixue Zazhi, V39, P342; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605; Ziai SA, 2005, J ETHNOPHARMACOL, V102, P202, DOI 10.1016/j.jep.2005.06.042	30	13	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46552	10.1371/journal.pone.0046552	http://dx.doi.org/10.1371/journal.pone.0046552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23056244	Green Submitted, gold, Green Published			2022-12-27	WOS:000310135800008
J	Jones, DT; Vemuri, P; Murphy, MC; Gunter, JL; Senjem, ML; Machulda, MM; Przybelski, SA; Gregg, BE; Kantarci, K; Knopman, DS; Boeve, BF; Petersen, RC; Jack, CR				Jones, David T.; Vemuri, Prashanthi; Murphy, Matthew C.; Gunter, Jeffrey L.; Senjem, Matthew L.; Machulda, Mary M.; Przybelski, Scott A.; Gregg, Brian E.; Kantarci, Kejal; Knopman, David S.; Boeve, Bradley F.; Petersen, Ronald C.; Jack, Clifford R., Jr.			Non-Stationarity in the "Resting Brain's" Modular Architecture	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE NETWORK; AGE-RELATED-CHANGES; SMALL-WORLD; MRI; ORGANIZATION; FMRI; RECONFIGURATION; DYNAMICS; ADULTS	Task-free functional magnetic resonance imaging (TF-fMRI) has great potential for advancing the understanding and treatment of neurologic illness. However, as with all measures of neural activity, variability is a hallmark of intrinsic connectivity networks (ICNs) identified by TF-fMRI. This variability has hampered efforts to define a robust metric of connectivity suitable as a biomarker for neurologic illness. We hypothesized that some of this variability rather than representing noise in the measurement process, is related to a fundamental feature of connectivity within ICNs, which is their non-stationary nature. To test this hypothesis, we used a large (n = 892) population-based sample of older subjects to construct a well characterized atlas of 68 functional regions, which were categorized based on independent component analysis network of origin, anatomical locations, and a functional meta-analysis. These regions were then used to construct dynamic graphical representations of brain connectivity within a sliding time window for each subject. This allowed us to demonstrate the non-stationary nature of the brain's modular organization and assign each region to a "meta-modular" group. Using this grouping, we then compared dwell time in strong sub-network configurations of the default mode network (DMN) between 28 subjects with Alzheimer's dementia and 56 cognitively normal elderly subjects matched 1: 2 on age, gender, and education. We found that differences in connectivity we and others have previously observed in Alzheimer's disease can be explained by differences in dwell time in DMN sub-network configurations, rather than steady state connectivity magnitude. DMN dwell time in specific modular configurations may also underlie the TF-fMRI findings that have been described in mild cognitive impairment and cognitively normal subjects who are at risk for Alzheimer's dementia.	[Jones, David T.; Knopman, David S.; Boeve, Bradley F.; Petersen, Ronald C.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Vemuri, Prashanthi; Murphy, Matthew C.; Gunter, Jeffrey L.; Senjem, Matthew L.; Gregg, Brian E.; Kantarci, Kejal; Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Machulda, Mary M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Przybelski, Scott A.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Jones, DT (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	jack.clifford@mayo.edu	Senjem, Matthew L/GRF-6799-2022; Jack, Clifford R/F-2508-2010; Vemuri, Prashanthi/K-7030-2012; Harris, Adrian/ABA-3343-2020; Buffa, Francesca M./D-2574-2013	Senjem, Matthew L/0000-0001-9308-9275; Jack, Clifford R/0000-0001-7916-622X; Lechertier, Tanguy/0000-0002-0202-8424; Kantarci, Kejal/0000-0002-8001-2081; Bicknell, Roy/0000-0002-0941-8919; Harris, Adrian/0000-0003-1376-8409; Jones, J Louise/0000-0003-3880-3274; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Buffa, Francesca M./0000-0003-0409-406X; Mitter, Richard/0000-0002-1279-3760; Jones, David/0000-0002-4807-9833	National Institute on Aging [R01AG11378, P50 AG16574, U01 AG06786, K99AG37573]; Mayo Foundation; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [U01AG006786, P50AG016574, K99AG037573, R01AG011378, R01AG041851] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mayo Foundation; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The National Institute on Aging (R01AG11378, P50 AG16574, U01 AG06786, K99AG37573), the Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation, and Alzheimer's Association New Investigator grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cate AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004645; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; GLOOR P, 1994, ELECTROEN CLIN NEURO, V90, P253, DOI 10.1016/0013-4694(94)90143-0; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Roberts RO, 2008, NEUROEPIDEMIOLOGY, V30, P58, DOI 10.1159/000115751; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2011, ARCH NEUROL-CHICAGO, V68, P1107, DOI 10.1001/archneurol.2011.202; Seibert TM, 2012, NEUROIMAGE, V59, P2452, DOI 10.1016/j.neuroimage.2011.08.105; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	47	280	286	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39731	10.1371/journal.pone.0039731	http://dx.doi.org/10.1371/journal.pone.0039731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761880	gold, Green Submitted, Green Published			2022-12-27	WOS:000305826400031
J	Choi, YH; Jit, M; Flasche, S; Gay, N; Miller, E				Choi, Yoon Hong; Jit, Mark; Flasche, Stefan; Gay, Nigel; Miller, Elizabeth			Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales	PLOS ONE			English	Article							CONJUGATE VACCINE; SEROTYPE REPLACEMENT; CARRIAGE; IMPACT	Introduction: England and Wales recently replaced the 7-valent pneumococcal conjugate vaccine (PCV7) with its 13-valent equivalent (PCV13), partly based on projections from mathematical models of the long-term impact of such a switch compared to ceasing pneumococcal conjugate vaccination altogether. Methods: A compartmental deterministic model was used to estimate parameters governing transmission of infection and competition between different groups of pneumococcal serotypes prior to the introduction of PCV13. The best-fitting parameters were used in an individual based model to describe pneumococcal transmission dynamics and effects of various options for the vaccination programme change in England and Wales. A number of scenarios were conducted using (i) different assumptions about the number of invasive pneumococcal disease cases adjusted for the increasing trend in disease incidence prior to PCV7 introduction in England and Wales, and (ii) a range of values representing serotype replacement induced by vaccination of the additional six serotypes in PCV13. Results: Most of the scenarios considered suggest that ceasing pneumococcal conjugate vaccine use would cause an increase in invasive pneumococcal disease incidence, while replacing PCV7 with PCV13 would cause an overall decrease. However, the size of this reduction largely depends on the level of competition induced by the additional serotypes in PCV13. The model estimates that over 20 years of PCV13 vaccination, around 5000-62000 IPD cases could be prevented compared to stopping pneumococcal conjugate vaccination altogether. Conclusion: Despite inevitable uncertainty around serotype replacement effects following introduction of PCV13, the model suggests a reduction in overall invasive pneumococcal disease incidence in all cases. Our results provide useful evidence on the benefits of PCV13 to countries replacing or considering replacing PCV7 with PCV13, as well as data that can be used to evaluate the cost-effectiveness of such a switch.	[Choi, Yoon Hong; Jit, Mark; Flasche, Stefan; Miller, Elizabeth] Hlth Protect Agcy, Hlth Protect Serv Colindale, London, England; [Jit, Mark] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England; [Flasche, Stefan] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Gay, Nigel] Fu Consulting, Hungerford, Berks, England	Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine; University of Strathclyde	Choi, YH (corresponding author), Hlth Protect Agcy, Hlth Protect Serv Colindale, London, England.	yoon.choi@hpa.org.uk	Jit, Mark/HDM-7797-2022; Choi, Yoon Hong/AAY-1740-2020	Choi, Yoon Hong/0000-0001-5561-4366; Miller, Jason/0000-0002-6912-2925; Jit, Mark/0000-0001-6658-8255; Flasche, Stefan/0000-0002-5808-2606; Choi, Yongwook/0000-0003-4017-9669; Chan, Agnes/0000-0003-2373-9580	NHGRI NIH HHS [5R01HG004701-03, R01 HG004701] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Auranen K, 2010, AM J EPIDEMIOL, V171, P169, DOI 10.1093/aje/kwp351; Boccalini S, 2011, VACCINE, V29, P9521, DOI 10.1016/j.vaccine.2011.10.013; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; De Wals P, 2009, CLIN THER, V31, P2152, DOI 10.1016/j.clinthera.2009.10.014; Flasche S, 2011, EUROSURVEILLANCE, V16, P13; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Robberstad B, 2011, VACCINE, V29, P8564, DOI 10.1016/j.vaccine.2011.09.025; Strutton DR, 2012, J INFECTION, V64, P54, DOI 10.1016/j.jinf.2011.10.015; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	16	749	773	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39927	10.1371/journal.pone.0039927	http://dx.doi.org/10.1371/journal.pone.0039927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974CF	23056405	Green Published, gold, Green Accepted			2022-12-27	WOS:000306406700015
J	Zhang, SP; Chen, LG; Cui, B; Chuang, HY; Yu, JQ; Wang-Rodriguez, J; Tang, L; Chen, G; Basak, GW; Kipps, TJ				Zhang, Suping; Chen, Liguang; Cui, Bing; Chuang, Han-Yu; Yu, Jianqiang; Wang-Rodriguez, Jessica; Tang, Li; Chen, George; Basak, Grzegorz W.; Kipps, Thomas J.			ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; ELEMENT-BINDING PROTEIN; BRACHYDACTYLY TYPE-B; RNAI SCREEN; I-EPSILON; CREB; THERAPY; TARGET; GENE	Receptor-tyrosine-kinase-like orphan receptor 1 (ROR1) is expressed during embryogenesis and by certain leukemias, but not by normal adult tissues. Here we show that the neoplastic cells of many human breast cancers express the ROR1 protein and high-level expression of ROR1 in breast adenocarcinoma was associated with aggressive disease. Silencing expression of ROR1 in human breast cancer cell lines found to express this protein impaired their growth in vitro and also in immune-deficient mice. We found that ROR1 could interact with casein kinase 1 epsilon (CK1 epsilon) to activate phosphoinositide 3-kinase-mediated AKT phosphorylation and cAMP-response-element-binding protein (CREB), which was associated with enhanced tumor-cell growth. Wnt5a, a ligand of ROR1, could induce ROR1-dependent signaling and enhance cell growth. This study demonstrates that ROR1 is expressed in human breast cancers and has biological and clinical significance, indicating that it may be a potential target for breast cancer therapy.	[Zhang, Suping; Chen, Liguang; Cui, Bing; Chuang, Han-Yu; Yu, Jianqiang; Wang-Rodriguez, Jessica; Tang, Li; Chen, George; Basak, Grzegorz W.; Kipps, Thomas J.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Zhang, SP (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	tkipps@ucsd.edu	Cui, Bing/F-3599-2018	Cui, Bing/0000-0001-8374-7801; zhang, Si/0000-0002-5682-4995; Chen, George/0000-0002-1342-0835	National Institutes of Health [PO1-CA081534]; Leukemia and Lymphoma Society of America; NATIONAL CANCER INSTITUTE [P01CA081534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant PO1-CA081534 (to TJK) and a Specialized Centers of Research grant (to TJK) from the Leukemia and Lymphoma Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Chhabra A, 2007, ONCOL REP, V18, P953; Chicha L, 2005, ANN NY ACAD SCI, V1044, P236, DOI 10.1196/annals.1349.029; Choudhury A, 2010, BR J HAEMATOL; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; IOZZO RV, 1995, CANCER RES, V55, P3495; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Katoh M, 2005, INT J MOL MED, V15, P533; LEJEUNE S, 1995, CLIN CANCER RES, V1, P215; Linnerth NM, 2008, INT J GYNECOL CANCER, V18, P1248, DOI 10.1111/j.1525-1438.2007.01177.x; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MCGUIRE WL, 1975, CANCER, V36, P638; Modak C, 2008, BIOCHEM BIOPH RES CO, V368, P801, DOI 10.1016/j.bbrc.2008.02.001; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Shabani M, 2007, TUMOR BIOL, V28, P318, DOI 10.1159/000121405; STOLL BA, 1979, PRACTITIONER, V222, P211; Sun CX, 2005, J CLIN INVEST, V115, P35, DOI 10.1172/JCI200522656; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WILSON C, 1993, P NATL ACAD SCI USA, V90, P7109, DOI 10.1073/pnas.90.15.7109; Xiao X, 2010, CURR CANCER DRUG TAR, V10, P384, DOI 10.2174/156800910791208535; Yang WS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r92; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	45	173	194	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e31127	10.1371/journal.pone.0031127	http://dx.doi.org/10.1371/journal.pone.0031127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403610	Green Submitted, gold, Green Published			2022-12-27	WOS:000303017700007
J	Chen, YX; Zheng, SP; Qi, D; Zheng, SJ; Guo, JL; Zhang, SL; Weng, ZH				Chen, Yixiong; Zheng, Shaoping; Qi, Dan; Zheng, Shaojiang; Guo, Junli; Zhang, Shuling; Weng, Zhihong			Inhibition of Notch Signaling by a gamma-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; STELLATE CELLS; MAMMALIAN NOTCH; LIVER FIBROSIS; MYOFIBROBLAST DIFFERENTIATION; PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; DEFICIENT MICE; PATHWAY	Notch signaling is essential to the regulation of cell differentiation, and aberrant activation of this pathway is implicated in human fibrotic diseases, such as pulmonary, renal, and peritoneal fibrosis. However, the role of Notch signaling in hepatic fibrosis has not been fully investigated. In the present study, we show Notch signaling to be highly activated in a rat model of liver fibrosis induced by carbon tetrachloride (CCl4), as indicated by increased expression of Jagged1, Notch3, and Hes1. Blocking Notch signaling activation by a gamma-secretase inhibitor, DAPT, significantly attenuated liver fibrosis and decreased the expression of snail, vimentin, and TGF-beta 1 in association with the enhanced expression of E-cadherin. The study in vitro revealed that DAPT treatment could suppress the EMT process of rat hepatic stellate cell line (HSC-T6). Interestingly, DAPT treatment was found not to affect hepatocyte proliferation in vivo. In contrast, DAPT can inhibit hepatocyte apoptosis to some degree. Our study provides the first evidence that Notch signaling is implicated in hepatic fibrogenesis and DAPT treatment has a protective effect on hepatocytes and ameliorates liver fibrosis. These findings suggest that the inhibition of Notch signaling might present a novel therapeutic approach for hepatic fibrosis.	[Chen, Yixiong; Qi, Dan; Zhang, Shuling; Weng, Zhihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Zheng, Shaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ultrasonog, Wuhan 430074, Peoples R China; [Zheng, Shaojiang; Guo, Junli] Hainan Med Coll, Dept Pathol, Haikou, Peoples R China; [Zheng, Shaojiang; Guo, Junli] Hainan Med Coll, Hainan Prov Key Lab Trop Med, Haikou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hainan Medical University; Hainan Medical University	Weng, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China.	wzh941@126.com	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Kassis, Judith/0000-0001-9268-3213	National Natural Science Foundation of China [30900663]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Natural Science Foundation of China (30900663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi-Ikeda K, 2011, AM J RESP CELL MOL, V45, P136, DOI 10.1165/rcmb.2010-0140OC; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; BETTENHAUSEN B, 1995, GENOMICS, V28, P436, DOI 10.1006/geno.1995.1172; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Chen SW, 2008, GENE THER, V15, P1424, DOI 10.1038/gt.2008.93; Chen YX, 2012, WORLD J GASTROENTERO, V18, P1397, DOI 10.3748/wjg.v18.i12.1397; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kinoshita K, 2007, GUT, V56, P396, DOI 10.1136/gut.2005.085704; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lin Y, 2005, LIVER INT, V25, P796, DOI 10.1111/j.1478-3231.2005.01098.x; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nijjar SS, 2002, AM J PATHOL, V160, P1695, DOI 10.1016/S0002-9440(10)61116-9; Nijjar SS, 2001, HEPATOLOGY, V34, P1184, DOI 10.1053/jhep.2001.29399; Pan Q, 2007, DIGEST DIS SCI, V52, P2591, DOI 10.1007/s10620-006-9676-1; Rao PK, 2000, EXP CELL RES, V260, P379, DOI 10.1006/excr.2000.5034; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184; Shawber C, 1996, DEVELOPMENT, V122, P3765; Sheahan S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-191; Shimizu M, 2001, HEPATOLOGY, V33, P569, DOI 10.1053/jhep.2001.22650; Teng YQ, 2007, J CLIN INVEST, V117, P304, DOI 10.1172/JCI31200; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Wei P, 2010, MOL CANCER THER, V9, P1618, DOI 10.1158/1535-7163.MCT-10-0034; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu FX, 2010, AM J PATHOL, V176, P650, DOI 10.2353/ajpath.2010.090447	50	180	195	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46512	10.1371/journal.pone.0046512	http://dx.doi.org/10.1371/journal.pone.0046512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	22276200	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000052
J	Zhang, ZJ; Ng, R; Man, SC; Li, TYJ; Wong, W; Tan, QR; Wong, HK; Chung, KF; Wong, MT; Tsang, WKA; Yip, KC; Ziea, E; Wong, VT				Zhang, Zhang-Jin; Ng, Roger; Man, Sui Cheung; Li, Tsui Yin Jade; Wong, Wendy; Tan, Qing-Rong; Wong, Hei Kiu; Chung, Ka-Fai; Wong, Man-Tak; Tsang, Wai-Kiu Alfert; Yip, Ka-chee; Ziea, Eric; Wong, Vivian Taam			Dense Cranial Electroacupuncture Stimulation for Major Depressive Disorder-A Single-Blind, Randomized, Controlled Study	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; PLACEBO NEEDLE; ACUPUNCTURE; FLUOXETINE; MECHANISMS; BRAIN; TOLERABILITY; EXPRESSION; PROJECTION; EFFICACY	Background: Previous studies suggest that electroacupuncture possesses therapeutic benefits for depressive disorders. The purpose of this study was to determine whether dense cranial electroacupuncture stimulation (DCEAS) could enhance the antidepressant efficacy in the early phase of selective serotonin reuptake inhibitor (SSRI) treatment of major depressive disorder (MDD). Methods: In this single-blind, randomized, controlled study, patients with MDD were randomly assigned to 9-session DCEAS or noninvasive electroacupuncture (n-EA) control procedure in combination with fluoxetine (FLX) for 3 weeks. Clinical outcomes were measured using the 17-item Hamilton Depression Rating Scale (HAMD-17), Clinical Global Impression-severity (CGI-S), and Self-rating Depression Scale (SDS) as well as the response and remission rates. Results: Seventy-three patients were randomly assigned to n-EA (n = 35) and DCEAS (n = 38), of whom 34 in n-EA and 36 in DCEAS group were analyzed. DCEAS-treated patients displayed a significantly greater reduction from baseline in HAMD-17 scores at Day 3 through Day 21 and in SDS scores at Day 3 and Day 21 compared to patients receiving n-EA. DCEAS intervention also produced a higher rate of clinically significant response compared to n-EA procedure (19.4% (7/36) vs. 8.8% (3/34)). The incidence of adverse events was similar in the two groups. Conclusions: DCEAS is a safe and effective intervention that augments the antidepressant efficacy. It can be considered as an additional therapy in the early phase of SSRI treatment of depressed patients. Trail Registration:Controlled-Trials.com ISRCTN88008690	[Zhang, Zhang-Jin; Ng, Roger; Man, Sui Cheung; Li, Tsui Yin Jade; Wong, Wendy; Wong, Hei Kiu] Univ Hong Kong, LKS Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Man-Tak; Tsang, Wai-Kiu Alfert; Yip, Ka-chee] Kowloon Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Tan, Qing-Rong] Fourth Mil Med Univ, Dept Psychiat, Xian 710032, Shaanxi, Peoples R China; [Chung, Ka-Fai] Univ Hong Kong, LKS Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ziea, Eric; Wong, Vivian Taam] Hosp Author, Chinese Med Sect, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Air Force Military Medical University; University of Hong Kong	Zhang, ZJ (corresponding author), Univ Hong Kong, LKS Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	zhangzj@hku.hk	Wong, Wendy/H-3939-2016; zhang, zheng/HCH-9684-2022; zhang, zhang/GQZ-6804-2022	Wong, Wendy/0000-0001-8731-0498; wang, li/0000-0002-1459-3412	Food and Health Bureau of Hong Kong [06070831]	Food and Health Bureau of Hong Kong	This study was supported by Health and Health Services Research Fund (HHSRF) from Food and Health Bureau of Hong Kong (ref.No.: 06070831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2005, DRUG DISCOV TODAY, V10, P578, DOI 10.1016/S1359-6446(05)03398-2; Allen JJB, 2006, J CLIN PSYCHIAT, V67, P1665, DOI 10.4088/JCP.v67n1101; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreescu C, 2011, J CLIN PSYCHIAT, V72, P1129, DOI 10.4088/JCP.10m06105; ARBAB MAR, 1988, J CEREBR BLOOD F MET, V8, P54, DOI 10.1038/jcbfm.1988.8; Arroll B, 2005, ANN FAM MED, V3, P449, DOI 10.1370/afm.349; Barnes Patricia M, 2004, Adv Data, P1; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Benham A, 2009, ACUPUNCT MED, V27, P65, DOI 10.1136/aim.2008.000174; Blier P, 2003, EUR NEUROPSYCHOPHARM, V13, P57, DOI 10.1016/S0924-977X(02)00173-6; BLIER P, 1994, TRENDS PHARMACOL SCI, V15, P220, DOI 10.1016/0165-6147(94)90315-8; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; Dhond RP, 2007, J ALTERN COMPLEM MED, V13, P603, DOI 10.1089/acm.2007.7040; Enck P, 2010, AUTON NEUROSCI-BASIC, V157, P68, DOI 10.1016/j.autneu.2010.03.005; Fink M, 2001, FORSCH KOMP KLAS NAT, V8, P368, DOI 10.1159/000057254; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Hong CJ, 2003, J CLIN PSYCHIAT, V64, P921, DOI 10.4088/JCP.v64n0810; Huang Y, 2004, SHANGHAI ZHEN JIU ZA, V23, P5; Keller Martin B, 2002, Psychopharmacol Bull, V36 Suppl 2, P133; Kirkcaldie M, 1997, CONVULSIVE THER, V13, P83; KUBOTA K, 1988, ANAT ANZEIGER, V165, P229; Kwon YB, 2000, AM J CHINESE MED, V28, P435, DOI 10.1142/S0192415X00000519; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; LEE HC, 1994, J GERIATR PSYCH NEUR, V7, P216, DOI 10.1177/089198879400700404; Lee HJ, 2004, AM J CHINESE MED, V32, P795, DOI 10.1142/S0192415X04002405; Li A, 2007, BRAIN RES, V1186, P171, DOI 10.1016/j.brainres.2007.10.022; Li Hong-Jie, 2011, Zhongguo Zhen Jiu, V31, P3; Simpson KL, 1997, J COMP NEUROL, V385, P135; Simpson KL, 1999, J COMP NEUROL, V411, P524, DOI 10.1002/(SICI)1096-9861(19990830)411:3<524::AID-CNE13>3.0.CO;2-X; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3; STARK P, 1985, J CLIN PSYCHIAT, V46, P53; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Takahashi T, 2010, NEUROSCI RES, V68, P103, DOI 10.1016/j.neures.2010.06.012; Takahashi T, 2006, J GASTROENTEROL, V41, P408, DOI 10.1007/s00535-006-1773-6; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; van Dijk KRA, 2002, REV NEUROSCIENCE, V13, P257; Wang H, 2008, J AFFECT DISORDERS, V111, P125, DOI 10.1016/j.jad.2008.04.020; Yeung WF, 2011, SLEEP, V34, P807, DOI 10.5665/SLEEP.1056; Yu YWY, 2006, EUR NEUROPSYCHOPHARM, V16, P498, DOI 10.1016/j.euroneuro.2005.12.004; Zhang WJ, 2009, J ALTERN COMPLEM MED, V15, P837, DOI 10.1089/acm.2008.0607; Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005; Zhang ZJ, 2009, J NERV MENT DIS, V197, P619, DOI 10.1097/NMD.0b013e3181b05fd1; Zhang ZJ, 2011, ECAM IN PRESS; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zhou F, 2010, ACUPUNCTURE THERAPY FOR NEUROLOGICAL DISEASES: A NEUROBIOLOGICAL VIEW, P32, DOI 10.1007/978-3-642-10857-0_2	48	102	105	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2012	7	1							e29651	10.1371/journal.pone.0029651	http://dx.doi.org/10.1371/journal.pone.0029651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904IR	22238631	gold, Green Submitted, Green Published			2022-12-27	WOS:000301188800023
J	Yang, WH; He, KL; Zhang, J; Guo, SY				Yang, Wenhui; He, Kanglai; Zhang, Jie; Guo, Shuyuan			pH-Controlled Bacillus thuringiensis Cry1Ac Protoxin Loading and Release from Polyelectrolyte Microcapsules	PLOS ONE			English	Article							CALCIUM-CARBONATE PARTICLES; LOW-MOLECULAR-WEIGHT; DELTA-ENDOTOXIN; SPODOPTERA-EXIGUA; INSECTICIDAL ACTIVITY; MULTILAYER FILMS; DOMAIN III; TOXICITY; ENCAPSULATION; FORMULATIONS	Crystal proteins synthesized by Bacillus thuringiensis (Bt) have been used as biopesticides because of their toxicity to the insect larval hosts. To protect the proteins from environmental stress to extend their activity, we have developed a new microcapsule formulation. Poly (acrylic acid) (PAH) and poly (styrene sulfonate) (PSS) were fabricated through layer-by-layer self-assembly based on a CaCO3 core. Cry1Ac protoxins were loaded into microcapsules through layer-by-layer self-assembly at low pH, and the encapsulated product was stored in water at 4 degrees C. Scanning electron microscopy (SEM) was used to observe the morphology of the capsules. To confirm the successful encapsulation, the loading results were observed with a confocal laser scattering microscope (CLSM), using fluorescein-labeled Cry1Ac protoxin (FITC-Cry1Ac). The protoxins were released from the capsule under the alkaline condition corresponding to the midgut of certain insects, a condition which seldom exists elsewhere in the environment. The following bioassay experiment demonstrated that the microcapsules with Cry1Ac protoxins displayed approximately equivalent insecticidal activity to the Asian corn borer compared with free Cry1Ac protoxins, and empty capsules proved to have no effect on insects. Further result also indicated that the formulation could keep stable under the condition of heat and desiccation. These results suggest that this formulation provides a promising methodology that protects protoxins from the environment and releases them specifically in the target insects' midgut, which has shown potential as biopesticide in the field.	[Yang, Wenhui; Guo, Shuyuan] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [He, Kanglai; Zhang, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Beijing Institute of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, WH (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	guosy@bit.edu.cn	Yang, Wan/K-7592-2013	Yang, Wan/0000-0002-7555-9728	Major State Basic Research Development Program of China (973 Program) [2009CB118902]; Natural Science Foundation of China [31171911]; National High Technology Research and Development Program of China (863 Program) [2011AA10A203]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the grants from the Major State Basic Research Development Program of China (973 Program; No. 2009CB118902), the Natural Science Foundation of China (No. 31171911), and the National High Technology Research and Development Program of China (863 Program; No. 2011AA10A203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipov A, 2003, MACROMOL RAPID COMM, V24, P274, DOI 10.1002/marc.200390041; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Chung AJ, 2002, LANGMUIR, V18, P1176, DOI 10.1021/la010873m; Colfen H, 2003, CURR OPIN COLLOID IN, V8, P23, DOI 10.1016/S1359-0294(03)00012-8; Cote JC, 2001, PHYTOPROTECTION, V82, P73, DOI 10.7202/706218ar; de Maagd RA, 2000, APPL ENVIRON MICROB, V66, P1559, DOI 10.1128/AEM.66.4.1559-1563.2000; DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; DIDYMUS JM, 1993, J CHEM SOC FARADAY T, V89, P2891, DOI 10.1039/ft9938902891; Donath E, 2002, CHEM-EUR J, V8, P5481, DOI 10.1002/1521-3765(20021202)8:23<5481::AID-CHEM5481>3.0.CO;2-8; Gao CY, 2002, ANGEW CHEM INT EDIT, V41, P3789, DOI 10.1002/1521-3773(20021018)41:20<3789::AID-ANIE3789>3.0.CO;2-D; Garcia-Gutierrez K, 2011, BIOPROC BIOSYST ENG, V34, P701, DOI 10.1007/s00449-011-0519-x; Huang DF, 2007, J INVERTEBR PATHOL, V95, P175, DOI 10.1016/j.jip.2007.02.016; IGNOFFO CM, 1971, J ECON ENTOMOL, V64, P850, DOI 10.1093/jee/64.4.850; IGNOFFO CM, 1992, FLA ENTOMOL, V75, P516, DOI 10.2307/3496133; Jada A, 2003, COLLOID SURFACE A, V219, P7, DOI 10.1016/S0927-7757(03)00010-4; Jada A, 2000, J MATER SCI LETT, V19, P2077, DOI 10.1023/A:1026737701570; Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8; Lamprecht A, 2000, EUR J PHARM BIOPHARM, V49, P1, DOI 10.1016/S0939-6411(99)00063-6; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; MACINTOSH SC, 1990, J AGR FOOD CHEM, V38, P1145, DOI 10.1021/jf00094a051; Myasnik M, 2001, CURR MICROBIOL, V43, P140, DOI 10.1007/s002840010276; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Rajamohan F, 1996, P NATL ACAD SCI USA, V93, P14338, DOI 10.1073/pnas.93.25.14338; Regev A, 1996, APPL ENVIRON MICROB, V62, P3581, DOI 10.1128/AEM.62.10.3581-3586.1996; Sopena F, 2009, CIENC INVESTIG AGRAR, V36, P27; Sukhorukov GB, 2001, MACROMOL RAPID COMM, V22, P44, DOI 10.1002/1521-3927(20010101)22:1<44::AID-MARC44>3.0.CO;2-U; Tamez-Guerra P, 2000, J ECON ENTOMOL, V93, P219, DOI 10.1603/0022-0493-93.2.219; Tiourina OP, 2001, MACROMOL BIOSCI, V1, P209, DOI 10.1002/1616-5195(20010701)1:5<209::AID-MABI209>3.3.CO;2-P; Tong WJ, 2006, J PHYS CHEM B, V110, P12905, DOI 10.1021/jp055258w; Tong WJ, 2005, J PHYS CHEM B, V109, P13159, DOI 10.1021/jp0511092; Wei W, 2008, ADV MATER, V20, P2292, DOI 10.1002/adma.200702663; Xue J, 2008, FEMS MICROBIOL LETT, V280, P95, DOI 10.1111/j.1574-6968.2007.01053.x; Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596; Zhao QH, 2008, NANOMED-NANOTECHNOL, V4, P302, DOI 10.1016/j.nano.2008.06.004	35	152	155	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45233	10.1371/journal.pone.0045233	http://dx.doi.org/10.1371/journal.pone.0045233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024810	Green Published, Green Submitted, gold			2022-12-27	WOS:000308860100068
J	Wang, YS; Chou, WW; Chen, KC; Cheng, HY; Lin, RT; Juo, SHH				Wang, Yung-Song; Chou, Wen-Wen; Chen, Ku-Chung; Cheng, Hsin-Yun; Lin, Ruey-Tay; Juo, Suh-Hang Hank			microRNA-152 Mediates DNMT1-Regulated DNA Methylation in the Estrogen Receptor alpha Gene	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; ATHEROSCLEROSIS; EXPRESSION; HYPOMETHYLATION; INHIBITION; DISEASE; INFLAMMATION; MECHANISMS; MIGRATION; DNMT3B	Background: Estrogen receptor alpha (ER alpha) has been shown to protect against atherosclerosis. Methylation of the ER alpha gene can reduce ER alpha expression leading to a higher risk for cardiovascular disease. Recently, microRNAs have been found to regulate DNA methyltransferases (DNMTs) and thus control methylation status in several genes. We first searched for microRNAs involved in DNMT-associated DNA methylation in the ER alpha gene. We also tested whether statin and a traditional Chinese medicine (San-Huang-Xie-Xin-Tang, SHXXT) could exert a therapeutic effect on microRNA, DNMT and ER alpha methylation. Methodology/Principal Findings: The ER alpha expression was decreased and ER alpha methylation was increased in LPS-treated human aortic smooth muscle cells (HASMCs) and the aorta from rats under a high-fat diet. microRNA-152 was found to be down regulated in the LPS-treated HASMCs. We validated that microRNA-152 can knock down DNMT1 in HASMCs leading to hypermethylation of the ER alpha gene. Statin had no effect on microRNA-152, DNMT1 or ER alpha expression. On the contrary, SHXXT could restore microRNA-152, decrease DNMT1 and increase ER alpha expression in both cellular and animal studies. Conclusions/Significance: The present study showed that microRNA-152 decreases under the pro-atherosclerotic conditions. The reduced microRNA-152 can lose an inhibitory effect on DNA methyltransferase, which leads to hypermethylation of the ER alpha gene and a decrease of ER alpha level. Although statin can not reverse these cascade proatherosclerotic changes, the SHXXT shows a promising effect to inhibit this unwanted signaling pathway.	[Wang, Yung-Song; Chou, Wen-Wen; Chen, Ku-Chung; Cheng, Hsin-Yun; Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan; [Lin, Ruey-Tay] Kaohsiung Med Univ, Dept Neurol, Kaohsiung, Taiwan; [Lin, Ruey-Tay] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Wang, YS (corresponding author), Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan.	tay@kmu.edu.tw; hjuo@kmu.edu.tw	Juo, Suh-Hang/C-9545-2009; Liu, Xingyue/A-3019-2013	Liu, Xingyue/0000-0002-9168-0659; Gao, Yanzheng/0000-0002-3814-3555	Ministry of Economic Affairs (Taiwan, R.O.C.) [98-EC-17-A-20-S1-134]; National Science Council (Taiwan, R.O.C.) [NSC 99-2628-B-037-037-MY3]; National Health Research Institutes (Taiwan, R.O.C.) [NHRI-Ex96-9607PI]; Department of Health, Executive Yuan (Taiwan, R.O.C.) [DOH99-TD-C-111-002]; Kaohsiung Medical University Hospital [KMUH98-8I11, KMUH99-9M19]	Ministry of Economic Affairs (Taiwan, R.O.C.)(Ministry of Economic Affairs, Taiwan); National Science Council (Taiwan, R.O.C.)(Ministry of Science and Technology, Taiwan); National Health Research Institutes (Taiwan, R.O.C.)(National Health Research Institutes - Taiwan); Department of Health, Executive Yuan (Taiwan, R.O.C.); Kaohsiung Medical University Hospital	This work was supported by the following grants: No. 98-EC-17-A-20-S1-134 from the Ministry of Economic Affairs (Taiwan, R.O.C., Website: www.moea.gov.tw), NSC 99-2628-B-037-037-MY3 from the National Science Council (Taiwan, R.O.C., Website: web1.nsc.gov.tw), NHRI-Ex96-9607PI from the National Health Research Institutes (Taiwan, R.O.C., Website: www.nhri.org.tw), Excellence for Cancer Research Center Grant (DOH99-TD-C-111-002) from the Department of Health, Executive Yuan (Taiwan, R.O.C., Website: www.doh.gov.tw), and Kaohsiung Medical University Hospital intramural grants (KMUH98-8I11 and KMUH99-9M19; Website: www.kmuh.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Chen KC, 2011, FASEB J; Christian RC, 2006, J CLIN ENDOCR METAB, V91, P2713, DOI 10.1210/jc.2005-2672; Diomede L, 2001, ARTERIOSCL THROM VAS, V21, P1327, DOI 10.1161/hq0801.094222; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Farmer J A, 2000, Curr Atheroscler Rep, V2, P208, DOI 10.1007/s11883-000-0022-3; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Hiltunen M, 2002, VASC MED, V7, P5, DOI 10.1191/1358863x02vm418oa; Hiltunen MO, 2003, ARTERIOSCL THROM VAS, V23, P1750, DOI 10.1161/01.ATV.0000092871.30563.41; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Jiang YD, 2007, DNA CELL BIOL, V26, P603, DOI 10.1089/dna.2007.0584; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Laukkanen MO, 1999, ARTERIOSCL THROM VAS, V19, P2171, DOI 10.1161/01.ATV.19.9.2171; Lee ME, 1999, TRENDS CARDIOVAS MED, V9, P49, DOI 10.1016/S1050-1738(99)00002-X; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Matouk CC, 2008, CIRC RES, V102, P873, DOI 10.1161/CIRCRESAHA.107.171025; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; Nakamura Y, 2004, MOL CELL ENDOCRINOL, V219, P17, DOI 10.1016/j.mce.2004.02.013; Newman PE, 1999, MED HYPOTHESES, V53, P421, DOI 10.1054/mehy.1998.0794; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okubo T, 2000, ENDOCR J, V47, P205, DOI 10.1507/endocrj.47.205; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubanyi GM, 2002, VASC PHARMACOL, V38, P81, DOI 10.1016/S0306-3623(02)00130-1; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Seeger H, 2001, MENOPAUSE, V8, P5, DOI 10.1097/00042192-200101000-00003; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Wang YS, 2011, J ETHNOPHARMACOL, V133, P442, DOI 10.1016/j.jep.2010.10.018; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Ying AK, 2000, CARDIOVASC RES, V46, P172, DOI 10.1016/S0008-6363(00)00004-3	42	140	155	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30635	10.1371/journal.pone.0030635	http://dx.doi.org/10.1371/journal.pone.0030635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	23056623	Green Published, gold, Green Submitted			2022-12-27	WOS:000301640600043
J	Chen, YP; Xiao, XM; Li, J; Reichetzeder, C; Wang, ZN; Hocher, B				Chen, You-Peng; Xiao, Xiao-Min; Li, Jian; Reichetzeder, Christoph; Wang, Zi-Neng; Hocher, Berthold			Paternal Body Mass Index (BMI) Is Associated with Offspring Intrauterine Growth in a Gender Dependent Manner	PLOS ONE			English	Article							HIGH-FAT DIET; IMPAIRED GLUCOSE-TOLERANCE; BIRTH-WEIGHT; FOOD-INTAKE; METABOLIC SYNDROME; SEX-DIFFERENCES; DEVELOPMENTAL ORIGINS; BLOOD-PRESSURE; PROTEIN-DIET; PREGNANCY	Background: Environmental alternations leading to fetal programming of cardiovascular diseases in later life have been attributed to maternal factors. However, animal studies showed that paternal obesity may program cardio-metabolic diseases in the offspring. In the current study we tested the hypothesis that paternal BMI may be associated with fetal growth. Methods and Results: We analyzed the relationship between paternal body mass index (BMI) and birth weight, ultrasound parameters describing the newborn's body shape as well as parameters describing the newborns endocrine system such as cortisol, aldosterone, renin activity and fetal glycated serum protein in a birth cohort of 899 father/mother/child triplets. Since fetal programming is an offspring sex specific process, male and female offspring were analyzed separately. Multivariable regression analyses considering maternal BMI, paternal and maternal age, hypertension during pregnancy, maternal total glycated serum protein, parity and either gestational age (for birth weight) or time of ultrasound investigation (for ultrasound parameters) as confounding showed that paternal BMI is associated with growth of the male but not female offspring. Paternal BMI correlated with birth parameters of male offspring only: birth weight; biparietal diameter, head circumference; abdominal diameter, abdominal circumference; and pectoral diameter. Cortisol was likewise significantly correlated with paternal BMI in male newborns only. Conclusions: Paternal BMI affects growth of the male but not female offspring. Paternal BMI may thus represent a risk factor for cardiovascular diseases of male offspring in later life. It remains to be demonstrated whether this is linked to an offspring sex specific paternal programming of cortisol secretion.	[Chen, You-Peng; Hocher, Berthold] Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Xiao, Xiao-Min; Li, Jian; Wang, Zi-Neng] Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Reichetzeder, Christoph; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Nuthetal Potsdam, Germany; [Reichetzeder, Christoph; Hocher, Berthold] Inst Pharmacol, Cardiovasc Res Ctr, Berlin, Germany	Jinan University; Jinan University; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chen, YP (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China.	hocher@uni-potsdam.de	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Kassis, Judith/0000-0001-9268-3213	Hoffmann La Roche Ltd, Basel, Switzerland	Hoffmann La Roche Ltd, Basel, Switzerland(Hoffmann-La Roche)	This study was supported by a grant from Hoffmann La Roche Ltd, Basel, Switzerland to Dr. B. Hocher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Aufdenblatten M, 2009, PEDIATR RES, V65, P198, DOI 10.1203/PDR.0b013e31818d6c24; Augustyniak RA, 2010, AM J PHYSIOL-REG I, V298, pR1375, DOI 10.1152/ajpregu.00848.2009; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P1198, DOI 10.1111/j.1365-2826.2010.02067.x; Clausen JO, 1997, AM J EPIDEMIOL, V146, P23, DOI 10.1093/oxfordjournals.aje.a009188; Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hocher B, 2000, LANCET, V355, P1241, DOI 10.1016/S0140-6736(00)02094-8; Hocher B, 2007, J PHYSIOL-LONDON, V579, P287, DOI 10.1113/jphysiol.2007.127738; Hogberg U, 2000, GYNECOL OBSTET INVES, V49, P160, DOI 10.1159/000010239; Jahan-Mihan A, 2011, NUTR RES, V31, P644, DOI 10.1016/j.nutres.2011.08.003; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Leon DA, 2005, CIRCULATION, V112, P3478, DOI 10.1161/CIRCULATIONAHA.104.497610; Li J, 2012, NEUROSCI BIOBEHAV R, V36, P1085, DOI 10.1016/j.neubiorev.2011.12.006; Li J, 2011, J HYPERTENS, V29, P1712, DOI 10.1097/HJH.0b013e328349a2e6; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288; Manabe M, 2005, PEDIATR INT, V47, P60, DOI 10.1111/j.1442-200x.2004.02002.x; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Szeto IMY, 2008, AM J PHYSIOL-REG I, V295, pR575, DOI 10.1152/ajpregu.90354.2008; Tang C, 2010, CHIN J BIRTH HLTH HE, P4; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Thone-Reineke C, 2006, AM J PHYSIOL-REG I, V291, pR1025, DOI 10.1152/ajpregu.00898.2005; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; WIDDOWSON EM, 1975, PEDIATR RES, V9, P154, DOI 10.1203/00006450-197503000-00010; Xie Y, 2007, PROG OBSTET GYNECOL, V16, P440; Yazbek SN, 2010, HUM MOL GENET, V19, P4134, DOI 10.1093/hmg/ddq332; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462	45	180	195	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36329	10.1371/journal.pone.0036329	http://dx.doi.org/10.1371/journal.pone.0036329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22276200	Green Published, gold			2022-12-27	WOS:000305343400019
J	Zhang, Z; Wang, WZ; Shi, ZB; Wang, L; Zhang, JX				Zhang, Zhen; Wang, Wenzhong; Shi, Zhanbiao; Wang, Li; Zhang, Jianxin			Mental Health Problems among the Survivors in the Hard-Hit Areas of the Yushu Earthquake	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HOPKINS SYMPTOM CHECKLIST-25; TRAUMATIC STRESS; ADULT SURVIVORS; PTSD CHECKLIST; GENDER; INSTRUMENTS; PREVALENCE; EXPOSURE; VICTIMS	Background: On April 14, 2010, an earthquake registering 7.1 on the Richter scale shook Qinghai Province in southwest China. The earthquake caused numerous casualties and much damage. The epicenter, Yushu County, suffered the most severe damage. As a part of the psychological relief work, the present study evaluated the mental health statuses of the people affected and identified the mental disorder risk factors related to earthquakes. Methods: Five hundred and five earthquake survivors living in Yushu County were investigated 3-4 months after the earthquake. Participant demographic data including gender, age, marital status, ethnicity, educational level, and religious beliefs were collected. The Earthquake-Specific Trauma Exposure Indicators assessed the intensity of exposure to trauma during the earthquake. The PTSD Checklist-Civilian version (PCL-C) and the Hopkins Symptoms Checklist-25 (HSCL-25) assessed the symptoms and prevalence rates of probable Posttraumatic Stress Disorder (PTSD) as well as anxiety and depression, respectively. The Perceived Social Support Scale (PSSS) evaluated subjective social support. Results: The prevalence rates of probable PTSD, anxiety, and depression were 33.7%, 43.8% and 38.6%, respectively. Approximately one fifth of participants suffered from all three conditions. Individuals who were female, felt initial fear during the earthquake, and had less social support were the most likely to have poor mental health. Conclusions: The present study revealed that there are serious mental problems among the hard-hit survivors of the Yushu earthquake. Survivors at high risk for mental disorders should be specifically considered. The present study provides useful information for rebuilding and relief work.	[Zhang, Zhen; Wang, Wenzhong; Shi, Zhanbiao; Wang, Li; Zhang, Jianxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Zhang, JX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	zhangjx@psych.an.cn	Wong, Wendy/H-3939-2016; zhang, zheng/HCH-9684-2022; zhang, zhang/GQZ-6804-2022	Wong, Wendy/0000-0001-8731-0498; wang, li/0000-0002-1459-3412	Youth Foundation of the Institute of Psychology, CAS [Y0CX441S01]; Development Foundation of the Institute of Psychology, CAS [O9CX143014]	Youth Foundation of the Institute of Psychology, CAS; Development Foundation of the Institute of Psychology, CAS	The Youth Foundation of the Institute of Psychology, CAS (No. Y0CX441S01) and the Development Foundation of the Institute of Psychology, CAS (No. O9CX143014) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno Ron, 2007, Am J Public Health, V97 Suppl 1, pS103, DOI 10.2105/AJPH.2006.087007; Altindag A, 2005, COMPR PSYCHIAT, V46, P328, DOI 10.1016/j.comppsych.2005.01.005; Armenian HK, 2000, ACTA PSYCHIAT SCAND, V102, P58, DOI 10.1034/j.1600-0447.2000.102001058.x; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; Bland SH, 1997, J NERV MENT DIS, V185, P188, DOI 10.1097/00005053-199703000-00008; BLUMENTHAL JA, 1987, PSYCHOSOM MED, V49, P331, DOI 10.1097/00006842-198707000-00002; Bramsen I, 2000, AM J PSYCHIAT, V157, P1115, DOI 10.1176/appi.ajp.157.7.1115; BROMET E, 1995, EPIDEMIOL REV, V17, P113, DOI 10.1093/oxfordjournals.epirev.a036166; Chen CH, 2007, COMPR PSYCHIAT, V48, P269, DOI 10.1016/j.comppsych.2006.12.003; Chen YY, 2006, J RELIG HEALTH, V45, P371, DOI 10.1007/s10943-006-9040-y; Cook J.D., 1990, J TRAUMA STRESS, V3, P541, DOI [10.1002/jts.2490030406, DOI 10.1002/JTS.2490030406, 10.1007/BF02039587]; Cox BJ, 2004, BEHAV RES THER, V42, P105, DOI 10.1016/S0005-7967(03)00105-0; David D, 1996, J TRAUMA STRESS, V9, P607, DOI 10.1002/jts.2490090316; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Falsetti SA, 2003, J TRAUMA STRESS, V16, P391, DOI 10.1023/A:1024422220163; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Gavranidou M, 2003, DEPRESS ANXIETY, V17, P130, DOI 10.1002/da.10103; Grant DM, 2008, J ABNORM PSYCHOL, V117, P662, DOI 10.1037/a0012591; GREEN BL, 1992, J NERV MENT DIS, V180, P760, DOI 10.1097/00005053-199212000-00004; Huang L., 1996, CHIN MENT HLTH J, V10, P160; Kumar MS, 2007, AM J PUBLIC HEALTH, V97, P99, DOI 10.2105/AJPH.2005.071167; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Li HH, 2010, PSYCHOL REP, V107, P733, DOI 10.2466/03.15.20.PR0.107.6.733-739; Lilly MM, 2009, J ANXIETY DISORD, V23, P767, DOI 10.1016/j.janxdis.2009.02.015; Liu AZ, 2006, CAN J PSYCHIAT, V51, P350, DOI 10.1177/070674370605100603; Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sharan P, 1996, AM J PSYCHIAT, V153, P556; Shi Qi-chang, 2005, Zhonghua Yufang Yixue Zazhi, V39, P229; Solomon Z, 2005, SOC PSYCH PSYCH EPID, V40, P947, DOI 10.1007/s00127-005-0973-3; Stratta P, 2012, J RELIG HLT IN PRESS; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Ventevogel P, 2007, SOC PSYCH PSYCH EPID, V42, P328, DOI 10.1007/s00127-007-0161-8; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; [王婷 WANG Ting], 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P1272; Wang XD, 2000, AM J PSYCHIAT, V157, P1260, DOI 10.1176/appi.ajp.157.8.1260; [王相兰 WANG Xianglan], 2008, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V29, P367; Weathers F., 1993, P ANN C INT SOC TRAU; Wu KK., 2008, HONG KONG J PSYCHIAT, V18, P144; Xu JJ, 2011, INT J PSYCHIAT MED, V42, P167, DOI 10.2190/PM.42.2.e; Yu S., 2011, J SICHUAN NORMAL U S, V38, P45; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022371; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; Zhangs W., 1998, CHINESE J PSYCHIAT, V31, P69	50	102	105	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46449	10.1371/journal.pone.0046449	http://dx.doi.org/10.1371/journal.pone.0046449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020RP	22238631	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500041
